PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jenkins, AC; Dodell-Feder, D; Saxe, R; Knobe, J				Jenkins, Adrianna C.; Dodell-Feder, David; Saxe, Rebecca; Knobe, Joshua			The Neural Bases of Directed and Spontaneous Mental State Attributions to Group Agents	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; SOCIAL COGNITION; UNIVERSAL DIMENSIONS; DECISION-MAKING; MIND; BRAIN; SELF; PSYCHOLOGY; CORTEX; FMRI	In daily life, perceivers often need to predict and interpret the behavior of group agents, such as corporations and governments. Although research has investigated how perceivers reason about individual members of particular groups, less is known about how perceivers reason about group agents themselves. The present studies investigate how perceivers understand group agents by investigating the extent to which understanding the 'mind' of the group as a whole shares important properties and processes with understanding the minds of individuals. Experiment 1 demonstrates that perceivers are sometimes willing to attribute a mental state to a group as a whole even when they are not willing to attribute that mental state to any of the individual members of the group, suggesting that perceivers can reason about the beliefs and desires of group agents over and above those of their individual members. Experiment 2 demonstrates that the degree of activation in brain regions associated with attributing mental states to individuals-i.e., brain regions associated with mentalizing or theory-of-mind, including the medial prefrontal cortex (MPFC), temporo-parietal junction (TPJ), and precuneus-does not distinguish individual from group targets, either when reading statements about those targets' mental states (directed) or when attributing mental states implicitly in order to predict their behavior (spontaneous). Together, these results help to illuminate the processes that support understanding group agents themselves.	[Jenkins, Adrianna C.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jenkins, Adrianna C.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Dodell-Feder, David] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Saxe, Rebecca] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Knobe, Joshua] Yale Univ, Program Cognit Sci, New Haven, CT USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Yale University	Jenkins, AC (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	adrianna.jenkins@berkeley.edu		Jenkins, Adrianna/0000-0002-4731-2103	John Merck Scholars Program award	John Merck Scholars Program award	This work was supported by a John Merck Scholars Program award to RS (http://www.jmfund.org/jm_scholars_program.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R P, 1998, Pers Soc Psychol Rev, V2, P243, DOI 10.1207/s15327957pspr0204_2; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Allport G., 1979, NATURE PREJUDICE, V25th; Ames DL, 2008, PSYCHOL SCI, V19, P642, DOI 10.1111/j.1467-9280.2008.02135.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2004, FRONTAL TEMPOROPARIE; Arico A, 2010, REV PHILOS PSYCHOL, V1, P371, DOI 10.1007/s13164-010-0029-9; Arico A, 2011, MIND LANG, V26, P327, DOI 10.1111/j.1468-0017.2011.01420.x; BARON J, 1993, J RISK UNCERTAINTY, V7, P17, DOI 10.1007/BF01065312; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bloom P, 1999, COGNITION, V71, pB1, DOI 10.1016/S0010-0277(99)00014-1; Bloom PB, 1995, CONTEMPORARY INTERNATIONAL HYPNOSIS, P1, DOI 10.1016/0010-0277(94)00648-5; Blum Lawrence., 2004, PHILOS PAP, V33, P251, DOI [DOI 10.1080/05568640409485143, 10.1080/05568640409485143]; Bonnington C., 2013, WIRED; Branaccio D, 2013, MARKETPLACE; Bruneau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063085; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Castelli F, 2000, MOVEMENT MIND FUNCTI; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Contreras JM, 2013, J COGNITIVE NEUROSCI, V25, P1406, DOI 10.1162/jocn_a_00403; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Martino B, 2013, NEURON, V79, P1222, DOI 10.1016/j.neuron.2013.07.003; Dennett D, 1987, TRUE BELIEVERS INTEN, P13; Diallo A, 2013, FORBES; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Goel V, 1995, MODELING OTHER MINDS; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Huebner B, 2010, REV PHILOS PSYCHOL, V1, P225, DOI 10.1007/s13164-009-0009-0; Jenkins A., 2011, SOCIAL NEUROSCIENCE; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Jenkins AC, 2011, SOC NEUROSCI-UK, V6, P211, DOI 10.1080/17470919.2010.507948; Jenkins AC, 2010, CEREB CORTEX, V20, P404, DOI 10.1093/cercor/bhp109; Kashima Y, 2005, EUR J SOC PSYCHOL, V35, P147, DOI 10.1002/ejsp.237; Knobe J, 2008, PHENOMENOL COGN SCI, V7, P67, DOI 10.1007/s11097-007-9066-y; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Krienen FM, 2010, J NEUROSCI, V30, P13906, DOI 10.1523/JNEUROSCI.2180-10.2010; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mitchell JP, 2002, DISTINCT NEURAL SYST, P99; Morewedge CK, 2013, CONSCIOUS COGN, V22, P1195, DOI 10.1016/j.concog.2013.08.002; Perner J, 2006, SOC NEUROSCI-UK, V1, P245, DOI 10.1080/17470910600989896; Phelan M, 2013, PHENOMENOL COGN SCI, V12, P703, DOI 10.1007/s11097-012-9278-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R., 2010, HDB THEORY MIND, P1, DOI DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Scholz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004869; Solan L, 2005, GEORGETOWN LAW J, V93; Spears R., 1997, SOCIAL PSYCHOL STERE, P171; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Stuss DT, 2001, FRONTAL LOBES ARE NE; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; Tollefsen D., 2002, J SOC PHILOS, V33, P395, DOI DOI 10.1111/0047-2786.00149; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Waytz A, 2012, PSYCHOL SCI, V23, P77, DOI 10.1177/0956797611423546; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Young L, 2010, NEUROPSYCHOLOGIA, V48, P2658, DOI 10.1016/j.neuropsychologia.2010.05.012; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	81	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105341	10.1371/journal.pone.0105341	http://dx.doi.org/10.1371/journal.pone.0105341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140705	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200073
J	Le Manach, Y; Kahn, D; Bachelot-Loza, C; Le Sache, F; Smadja, DM; Remones, V; Loriot, MA; Coriat, P; Gaussem, P				Le Manach, Yannick; Kahn, David; Bachelot-Loza, Christilla; Le Sache, Frederic; Smadja, David M.; Remones, Veronique; Loriot, Marie-Anne; Coriat, Pierre; Gaussem, Pascale			Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; NONCARDIAC SURGERY; RESPONSIVENESS; RESISTANCE; PHOSPHORYLATION; DISCONTINUATION; TRANSFUSION; VARIABILITY	Aims: To investigate functional platelet recovery after preoperative withdrawal of aspirin and clopidogrel and platelet function 5 days after treatment resumption. Methods/Results: We conducted an observational study, which prospectively included consecutive patients taking aspirin, taking clopidogrel, and untreated controls (15 patients in each group). The antiplatelet drugs were withdrawn five days before surgery (baseline) and were reintroduced two days after surgery. Platelet function was evaluated by optical aggregation in the presence of collagen, arachidonic acid (aspirin) and ADP (clopidogrel) and by VASP assay (clopidogrel). Platelet-leukocyte complex (PLC) level was quantified at each time-point. At baseline, platelet function was efficiently inhibited by aspirin and had recovered fully in most patients 5 days after drug withdrawal. PLC levels five days after aspirin reintroduction were similar to baseline (+4 +/- 10%; p = 0.16), in line with an effective platelet inhibition. Chronic clopidogrel treatment was associated with variable platelet inhibition and its withdrawal led to variable functional recovery. PLC levels were significantly increased five days after clopidogrel reintroduction (+10 +/- 15%; p = 0.02), compared to baseline. Conclusions: Aspirin withdrawal 5 days before high-bleeding-risk procedures was associated with functional platelet recovery, and its reintroduction two days after surgery restored antiplaletet efficacy five days later. This was not the case of clopidogrel, and further work is therefore needed to define its optimal perioperative management.	[Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia, Hamilton, ON, Canada; [Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Le Manach, Yannick] David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Perioperat Med & Surg Res Unit, Hamilton, ON, Canada; [Le Manach, Yannick; Kahn, David; Le Sache, Frederic; Coriat, Pierre] Hop La Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Bachelot-Loza, Christilla; Smadja, David M.; Gaussem, Pascale] Fac Pharm, INSERM, UMR S1140, Paris, France; [Bachelot-Loza, Christilla; Smadja, David M.; Loriot, Marie-Anne; Gaussem, Pascale] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Smadja, David M.; Remones, Veronique; Gaussem, Pascale] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France; [Loriot, Marie-Anne] INSERM, UMR S1147, Paris, France; [Loriot, Marie-Anne] Hop Europeen Georges Pompidou, AP HP, Paris, France	McMaster University; McMaster University; Population Health Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaussem, P (corresponding author), Fac Pharm, INSERM, UMR S1140, Paris, France.	pascale.gaussem@egp.aphp.fr	Gaussem, Pascale/AGY-9723-2022; Gaussem, Pascale/ABA-2228-2020; Gaussem, P./ABA-1222-2020; Le Manach, Yannick/AAE-5700-2019; Smadja, David/M-3872-2017	Gaussem, P./0000-0002-9139-2147; Le Manach, Yannick/0000-0003-0474-8545; Bachelot-Loza, Christilla/0000-0002-6264-902X; Loriot, Marie-Anne/0000-0001-9102-2667; Smadja, David/0000-0001-7731-9202	Inserm; Leducq TransAtlantic Network of Excellence on Atherothrombosis Research [04CVD01]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Leducq TransAtlantic Network of Excellence on Atherothrombosis Research	The work conducted at Inserm U1140 (formerly U765) was supported by research grants from Inserm and from the Leducq TransAtlantic Network of Excellence on Atherothrombosis Research (Grant 04CVD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo P, 2006, BRIT J ANAESTH, V97, P580, DOI 10.1093/bja/ael228; Aleil B, 2005, J THROMB HAEMOST, V3, P85, DOI 10.1111/j.1538-7836.2004.01063.x; Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Blindt R, 2007, THROMB HAEMOSTASIS, V98, P1329, DOI 10.1160/TH07-05-0324; Bonello L, 2007, J THROMB HAEMOST, V5, P1630, DOI 10.1111/j.1538-7836.2007.02609.x; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Fellahi JL, 2011, ANESTHESIOLOGY, V114, P330, DOI 10.1097/ALN.0b013e318201662f; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Godet G, 2005, ANESTHESIOLOGY, V102, P739, DOI 10.1097/00000542-200504000-00008; Gulbins H, 2009, THORAC CARDIOV SURG, V57, P18, DOI 10.1055/s-2008-1038791; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hosokawa K, THROMB HAEMOST, V109, P102; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Le Manach Y, 2005, ANESTHESIOLOGY, V102, P885, DOI 10.1097/00000542-200505000-00004; Le Manach Y, 2007, ANESTH ANALG, V104, P1326, DOI 10.1213/01.ane.0000263029.72643.10; Le Manach Y, 2012, ANESTHESIOLOGY, V117, P1203, DOI 10.1097/ALN.0b013e31825adaea; Lordkipanidze M, 2009, PHARMACOL THERAPEUT, V123, P178, DOI 10.1016/j.pharmthera.2009.03.019; Maltais S, 2008, EUR J CARDIO-THORAC, V34, P127, DOI 10.1016/j.ejcts.2008.03.052; Mantz J, 2011, BRIT J ANAESTH, V107, P899, DOI 10.1093/bja/aer274; Maugeri N, 2000, AM J HEMATOL, V65, P93, DOI 10.1002/1096-8652(200010)65:2<93::AID-AJH1>3.0.CO;2-4; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239; Ouattara A, 2007, EUR HEART J, V28, P1025, DOI 10.1093/eurheartj/ehm049; Price MJ, 2008, AM J CARDIOL, V102, P790, DOI 10.1016/j.amjcard.2008.02.109; Samama CM, 2001, ANESTHESIOLOGY, V94, P74; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Zisman E, 2010, EUR J ANAESTH, V27, P617, DOI 10.1097/EJA.0b013e328335b354	37	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104491	10.1371/journal.pone.0104491	http://dx.doi.org/10.1371/journal.pone.0104491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141121	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200023
J	McIntyre, KM; Setzkorn, C; Hepworth, PJ; Morand, S; Morse, AP; Baylis, M				McIntyre, K. Marie; Setzkorn, Christian; Hepworth, Philip J.; Morand, Serge; Morse, Andrew P.; Baylis, Matthew			A Quantitative Prioritisation of Human and Domestic Animal Pathogens in Europe	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; RISK; ZOONOSES; INJURIES; HEALTH	Disease or pathogen risk prioritisations aid understanding of infectious agent impact within surveillance or mitigation and biosecurity work, but take significant development. Previous work has shown the H-(Hirsch-) index as an alternative proxy. We present a weighted risk analysis describing infectious pathogen impact for human health (human pathogens) and wellbeing (domestic animal pathogens) using an objective, evidence-based, repeatable approach; the H-index. This study established the highest H-index European pathogens. Commonalities amongst pathogens not included in previous surveillance or risk analyses were examined. Differences between host types (humans/animals/zoonotic) in pathogen H-indices were explored as a One Health impact indicator. Finally, the acceptability of the H-index proxy for animal pathogen impact was examined by comparison with other measures. 57 pathogens appeared solely in the top 100 highest H-indices (1) human or (2) animal pathogens list, and 43 occurred in both. Of human pathogens, 66 were zoonotic and 67 were emerging, compared to 67 and 57 for animals. There were statistically significant differences between H-indices for host types (humans, animal, zoonotic), and there was limited evidence that H-indices are a reasonable proxy for animal pathogen impact. This work addresses measures outlined by the European Commission to strengthen climate change resilience and biosecurity for infectious diseases. The results include a quantitative evaluation of infectious pathogen impact, and suggest greater impacts of human-only compared to zoonotic pathogens or scientific under-representation of zoonoses. The outputs separate high and low impact pathogens, and should be combined with other risk assessment methods relying on expert opinion or qualitative data for priority setting, or could be used to prioritise diseases for which formal risk assessments are not possible because of data gaps.	[McIntyre, K. Marie; Setzkorn, Christian; Hepworth, Philip J.; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Neston, Cheshire, England; [McIntyre, K. Marie; Setzkorn, Christian] Natl Consortium Zoonosis Res, Neston, Cheshire, England; [Morand, Serge] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Morand, Serge] Rech Agron Dev Agr Res Dev CIRAD, Unite Rech, Anim & Gest Integree Risques AGIRs, Montpellier, France; [Morse, Andrew P.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Baylis, Matthew] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging Infect Includ, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; University of Liverpool; University of Liverpool	McIntyre, KM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst Campus, Neston, Cheshire, England.	k.m.mcintyre@liv.ac.uk	Morand, Serge/M-5433-2018; Baylis, Matthew/S-7694-2019	Morand, Serge/0000-0003-3986-7659; Baylis, Matthew/0000-0003-0335-187X; Morse, Andrew/0000-0002-0413-2065; McIntyre, Kirsty Marie/0000-0003-1360-122X	NERC through the ERA-ENVHEALTH network [NE/G002827/1]; Leverhulme Trust Research Leadership Award [F/0025/AC]; Biotechnology and Biological Sciences Research Council [BB/K003798/1] Funding Source: researchfish; Natural Environment Research Council [NE/G002827/1] Funding Source: researchfish; BBSRC [BB/K003798/1] Funding Source: UKRI; NERC [NE/G002827/1] Funding Source: UKRI	NERC through the ERA-ENVHEALTH network; Leverhulme Trust Research Leadership Award(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC [NE/G002827/1] through the ERA-ENVHEALTH network, awarded to MB, and a Leverhulme Trust Research Leadership Award [F/0025/AC], awarded to MB. The funders had no role in the writing of the manuscript or decision to submit.	Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Commission of the European Communities, 2009, CISC VIS NETW IND GL; De Mendiburu F, 2009, AGRICOLAE PACKAGE CR; Doherty J A, 2000, Can J Infect Dis, V11, P21; Dufour B, 2008, REV SCI TECH OIE, V27, P541; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lashley Felissa R, 2004, Expert Rev Anti Infect Ther, V2, P299, DOI 10.1586/14787210.2.2.299; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; McIntyre KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019558; McIntyre KM, PREV VET MED; Murphy FA, 2008, PREV VET MED, V86, P216, DOI 10.1016/j.prevetmed.2008.02.009; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI MED SUBJ HEAD M; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI NUCL DAT HOM; National Center for Biotechnology Information U.S. National Library of Medicine Bethesda Maryland US, NCBI TAX DAT HOM; OIE, 2013, TROP SPP INF; R Core Team, 2021, R LANGUAGE ENV STAT; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weinberg J, 1999, EUR J PUBLIC HEALTH, V9, P236, DOI 10.1093/eurpub/9.3.236; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	25	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103529	10.1371/journal.pone.0103529	http://dx.doi.org/10.1371/journal.pone.0103529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136810	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100009
J	Schoonmaker, AL; Lieffers, VJ; Landhausser, SM				Schoonmaker, Amanda L.; Lieffers, Victor J.; Landhaeusser, Simon M.			Uniform versus Asymmetric Shading Mediates Crown Recession in Conifers	PLOS ONE			English	Article							SCOTS PINE; PHOTOSYNTHETIC CAPACITY; XYLEM VULNERABILITY; CARBON ALLOCATION; SEASONAL-CHANGES; GAS-EXCHANGE; BRANCHES; GROWTH; TREES; TRANSLOCATION	In this study we explore the impact of asymmetrical vs. uniform crown shading on the mortality and growth of upper and lower branches within tree crowns, for two conifer species: shade intolerant lodgepole pine (Pinus contorta) and shade tolerant white spruce (Picea glauca). We also explore xylem hydraulics, foliar nutrition, and carbohydrate status as drivers for growth and expansion of the lower and upper branches in various types of shading. This study was conducted over a two-year period across 10 regenerating forest sites dominated by lodgepole pine and white spruce, in the lower foothills of Alberta, Canada. Trees were assigned to one of four shading treatments: (1), complete uniform shading of the entire tree, (2) light asymmetric shading where the lower 1/4-1/3 of the tree crown was shaded, (3) heavy asymmetric shading as in (2) except with greater light reduction and (4) control in which no artificial shading occurred and most of the entire crown was exposed to full light. Asymmetrical shading of only the lower crown had a larger negative impact on the bud expansion and growth than did uniform shading, and the effect was stronger in pine relative to spruce. In addition, lower branches in pine also had lower carbon reserves, and reduced xylem-area specific conductivity compared to spruce. For both species, but particularly the pine, the needles of lower branches tended to store less C than upper branches in the asymmetric shade, which could suggest a movement of reserves away from the lower branches. The implications of these findings correspond with the inherent shade tolerance and self-pruning behavior of these conifers and supports a carbon based mechanism for branch mortality - mediated by an asymmetry in light exposure of the crown.	[Schoonmaker, Amanda L.] Northern Alberta Inst Technol, Boreal Res Inst, Peace River, AB, Canada; [Lieffers, Victor J.; Landhaeusser, Simon M.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Schoonmaker, AL (corresponding author), Northern Alberta Inst Technol, Boreal Res Inst, Peace River, AB, Canada.	aschoonmaker@nait.ca	Landhäusser, Simon M/F-9910-2016	Landhäusser, Simon M/0000-0002-4466-1607; Lieffers, Victor/0000-0001-6939-4093	Weyerhaueser; NSERC (National Science and Engineering Research Council); West Fraser Timber	Weyerhaueser; NSERC (National Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); West Fraser Timber	This study was supported by Weyerhaueser and West Fraser Timber. NSERC (National Science and Engineering Research Council) also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah IG, 2004, TREE PHYSIOL, V24, P1099, DOI 10.1093/treephys/24.10.1099; Beckingham JD, 1996, FIELD GUIDE ECOSITES, V5; Brockley RP, 1996, 266 FRDA MIN OFR CAN; Burgess SSO, 2006, PLANT CELL ENVIRON, V29, P229, DOI 10.1111/j.1365-3040.2005.01415.x; Chow PS, 2004, TREE PHYSIOL, V24, P1129, DOI 10.1093/treephys/24.10.1129; Cochard H, 1999, PLANT CELL ENVIRON, V22, P101, DOI 10.1046/j.1365-3040.1999.00367.x; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Crawley M.J., 2007, R BOOK; CREGG BM, 1993, TREES-STRUCT FUNCT, V7, P208, DOI 10.1007/BF00202075; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Di Stefano J, 2004, FOREST ECOL MANAG, V187, P173, DOI 10.1016/S0378-1127(03)00331-1; Environment Canada, 2011, NAT CLIM DAT INF ARC; ERICSSON A, 1978, PHYSIOL PLANTARUM, V43, P351, DOI 10.1111/j.1399-3054.1978.tb01593.x; Fraser EC, 2006, TREE PHYSIOL, V26, P1019, DOI 10.1093/treephys/26.8.1019; HANSEN J, 1994, TREES-STRUCT FUNCT, V8, P172, DOI 10.1007/BF00196844; Henriksson J, 2001, OECOLOGIA, V126, P482, DOI 10.1007/s004420000547; Kagawa A, 2006, NEW PHYTOL, V171, P793, DOI 10.1111/j.1469-8137.2006.01780.x; Kellow JT, 1998, AM J EVAL, V19, P123, DOI 10.1016/S1098-2140(99)80186-6; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOZLOWSKI TT, 1964, AM J BOT, V51, P522, DOI 10.2307/2440281; Kupper P, 2006, TREES-STRUCT FUNCT, V20, P265, DOI 10.1007/s00468-005-0033-3; Lacointe A, 2004, PLANT CELL ENVIRON, V27, P1159, DOI 10.1111/j.1365-3040.2004.01221.x; Landhausser SM, 2012, TREES-STRUCT FUNCT, V26, P653, DOI 10.1007/s00468-011-0633-z; Landhausser SM, 2001, TREE PHYSIOL, V21, P243, DOI 10.1093/treephys/21.4.243; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Lippu Jukka, 1998, Silva Fennica, V32, P3; Livingston NJ, 1998, PLANT CELL ENVIRON, V21, P795, DOI 10.1046/j.1365-3040.1998.00314.x; Makela A, 1997, FOREST SCI, V43, P7; Meng SX, 2006, J ECOL, V94, P681, DOI 10.1111/j.1365-2745.2006.01121.x; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Naidu SL, 1998, CAN J FOREST RES, V28, P1116, DOI 10.1139/cjfr-28-8-1116; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Pate JS, 2000, AUST J PLANT PHYSIOL, V27, P869, DOI 10.1071/PP99149; PATRICK JW, 1993, PLANT CELL ENVIRON, V16, P1019, DOI 10.1111/j.1365-3040.1996.tb02049.x; Pearcy RW, 2007, FUNCTIONAL PLANT ECO; Plavcova L, 2011, PLANT CELL ENVIRON, V34, P501, DOI 10.1111/j.1365-3040.2010.02258.x; Protz CG, 2000, CAN J FOREST RES, V30, P1088, DOI 10.1139/cjfr-30-7-1088; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renninger HJ, 2007, TREE PHYSIOL, V27, P33, DOI 10.1093/treephys/27.1.33; SCHIER GA, 1970, FOREST SCI, V16, P1; Schneider A, 1989, TREES-STRUCT FUNCT, V3, P185, DOI 10.1007/BF00225352; SCHOETTLE AW, 1991, TREE PHYSIOL, V9, P245, DOI 10.1093/treephys/9.1-2.245; Schoonmaker AL, 2010, PLANT CELL ENVIRON, V33, P382, DOI 10.1111/j.1365-3040.2009.02088.x; Souza RP, 1999, BIOL PLANTARUM, V42, P631, DOI 10.1023/A:1002656207366; Sprugel DG, 2002, TREE PHYSIOL, V22, P1119, DOI 10.1093/treephys/22.15-16.1119; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Takenaka A, 2000, TREE PHYSIOL, V20, P987; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Valladares F., 2007, FUNCTIONAL PLANT ECO; von Felten S, 2007, TREES-STRUCT FUNCT, V21, P283, DOI 10.1007/s00468-006-0118-7; Witowski J, 1997, TREE PHYSIOL, V17, P757; Yoshimura K, 2010, PLANT CELL ENVIRON, V33, P750, DOI 10.1111/j.1365-3040.2009.02100.x	53	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104187	10.1371/journal.pone.0104187	http://dx.doi.org/10.1371/journal.pone.0104187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136823	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100019
J	Zhang, XY; Li, J				Zhang, Xue-yan; Li, Jun			Susceptibility-Weighted Imaging in Heat Stroke	PLOS ONE			English	Article								Objective: To assess the role of susceptibility-weighted imaging in the detection of intracranial hemorrhage after heat stroke and in the prognosis. Materials and Methods: The study group consisted of eight patients after heat stroke, with a score of 3 to 9 in Glasgow Coma Scale. The MR studies were performed with a 1.5 T scanner. Susceptibility-weighted imaging data were collected within 2-5 days after heat stroke. The study was approved by ethics committee, and written informed consents were obtained from family members of the patients. Results: Punctate hemorrhages were detected in brain stem, corona radiata and frontal lobe by susceptibility-weighted imaging for three patients. Among the three cases, two patients came to death in the 5th day and the 25th day after heat stroke respectively. Another patient became a persistent vegetative state and died about 3 months later. Five patients with no hemorrhage detected gradually recovered and cerebellar dysfunction remained to various degrees. Conclusions: Heat stroke is a life-threatening condition characterized by hyperthermia and accompanied by various complications such as disseminated intravascular coagulation. Susceptibility-weighted imaging is a very useful tool for detection of intracranial hemorrhage and may probably evaluate the prognosis after heat stroke.	[Zhang, Xue-yan] Binzhou Med Univ, Coll Nursing, Yantai, Shandong, Peoples R China; [Li, Jun] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Li, J (corresponding author), Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Shandong, Peoples R China.	bzmceducn@sina.com						Albukrek D, 1997, NEURORADIOLOGY, V39, P195, DOI 10.1007/s002340050392; Bazille C, 2005, J NEUROPATH EXP NEUR, V64, P970, DOI 10.1097/01.jnen.0000186924.88333.0d; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Haacke EM, 2006, Z MED PHYS, V16, P237, DOI 10.1078/0939-3889-00321; Lee IS, 2009, AM J NEURORADIOL, V30, P142, DOI [10.3174/ajnr.A1273, 10.3174/ajnr.A1432]; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Mahajan Sajan, 2008, Proc (Bayl Univ Med Cent), V21, P433; Muccio CF, 2013, CLIN NEUROL NEUROSUR, V115, P1558, DOI 10.1016/j.clineuro.2013.01.005; Murcia-Gubianas C, 2012, MED INTENSIVA, V36, P526, DOI 10.1016/j.medin.2011.05.003; Ookura R, 2009, INTERNAL MED, V48, P1105, DOI 10.2169/internalmedicine.48.2030; Prasun P, 2012, CLIN DYSMORPHOL, V21, P24, DOI 10.1097/MCD.0b013e32834cef61; Sonkar SK, 2012, BMJ CASE REP, V19, P2012; Sudhakar PJ, 2007, PEDIATR RADIOL, V37, P1289, DOI 10.1007/s00247-007-0612-0; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013	14	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105247	10.1371/journal.pone.0105247	http://dx.doi.org/10.1371/journal.pone.0105247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137376	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100080
J	Bussiere, C; Sicsic, J; Pelletier-Fleury, N				Bussiere, Clemence; Sicsic, Jonathan; Pelletier-Fleury, Nathalie			The Effects of Obesity and Mobility Disability in Access to Breast and Cervical Cancer Screening in France: Results from the National Health and Disability Survey	PLOS ONE			English	Article							UNITED-STATES; SELF-REPORT; INTERVIEW SURVEY; BODY-WEIGHT; WOMEN; MAMMOGRAPHY; OVERWEIGHT; ADULTS; DISPARITIES; SERVICES	Objectives: We aimed to disentangle the effects of obesity and mobility limitation on cervical and breast cancer screening among community dwelling women. Methods: The data source was the French national Health and Disability Survey - Household Section, 2008. The Body Mass Index (BMI) was used to categorize obesity status. We constructed a continuous score of mobility limitations to assess the severity of disability (Cronbach's alpha = 0.84). Logistic regressions were performed to examine the association between obesity, mobility limitations and the use of Pap test (n = 8 133) and the use of mammography (n = 7 561). Adjusted odds ratios were calculated (AOR). Interaction terms between obesity and the disability score were included in models testing for effect modifications. Results: Compared with non-obese women, the odds of having a Pap test in the past 3 years was 24% lower in obese women (AOR = 0.76; 95% CI: 0.65 to 0.89), the odds of having a mammogram in the past 2 years was 23% lower (AOR = 0.77; 95% CI: 0.66 to 0.91). Each time the disability score was 5 points higher, the odds of having a Pap test decreases by 20% (AOR = 0.96; 95% CI: 0.94 to 0.98), the odds of having a mammogram decreases by 25% (AOR = 0.95; 95% CI: 0.94 to 0.97). There was no significant interaction between obesity and disability score. Conclusion: Obesity and mobility limitation are independently associated with a lower likelihood of cervical and breast cancer screening. Protective outreach and follow-up are necessary to reduce inequalities and thus to reduce health disparities in these vulnerable and high-risk populations of obese women with disabilities.	[Bussiere, Clemence; Sicsic, Jonathan; Pelletier-Fleury, Nathalie] INSERM, Cermes3, U988, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bussiere, C (corresponding author), INSERM, Cermes3, U988, Villejuif, France.	clemence.bussiere@u-psud.fr	SICSIC, Jonathan/M-1549-2018; Pelletier-Fleury, Nathalie/R-4220-2018	SICSIC, Jonathan/0000-0002-5509-4791; Pelletier-Fleury, Nathalie/0000-0002-4821-4863				Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Angus J, 2012, J CANCER EDUC, V27, P75, DOI 10.1007/s13187-011-0273-4; [Anonymous], CURRENT POPULATION R; Armour BS, 2013, OBESITY, V21, P852, DOI 10.1002/oby.20312; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barr JK, 2008, AM J HEALTH PROMOT, V22, P381, DOI 10.4278/ajhp.22.6.381; Bigby JA, 2005, CANCER CAUSE CONTROL, V16, P35, DOI 10.1007/s10552-004-1263-1; Blackwell DL, 2008, WOMEN HEALTH ISS, V18, P85, DOI 10.1016/j.whi.2007.10.006; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Carney CP, 2006, J GEN INTERN MED, V21, P1097, DOI 10.1111/j.1525-1497.2006.00565.x; Cohen SS, 2008, CANCER-AM CANCER SOC, V112, P1892, DOI 10.1002/cncr.23408; Cronin KA, 2009, CANCER EPIDEM BIOMAR, V18, P1699, DOI 10.1158/1055-9965.EPI-09-0020; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Duport N, 2007, DEPISTAGE ORG CANC C; Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423, DOI 10.1007/BF03405254; Ells LJ, 2006, OBES REV, V7, P341, DOI 10.1111/j.1467-789X.2006.00233.x; European Commission, 2009, ENS ACC NOND PEOPL D; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Froehlich-Grobe K, 2013, AM J PREV MED, V45, P83, DOI 10.1016/j.amepre.2013.02.021; Froehlich-Grobe K, 2011, AM J PREV MED, V41, P541, DOI 10.1016/j.amepre.2011.07.015; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hewitt M, 2004, PREV MED, V39, P270, DOI 10.1016/j.ypmed.2004.03.035; Hsia J, 2000, PREV MED, V31, P261, DOI 10.1006/pmed.2000.0697; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Lagu T, 2013, ANN INTERN MED, V158, P441, DOI 10.7326/0003-4819-158-6-201303190-00003; Lin SJ, 2008, J R SOC PROMO HEALTH, V128, P327, DOI 10.1177/1466424007092802; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Newmann SJ, 2005, CANCER CAUSE CONTROL, V16, P63, DOI 10.1007/s10552-004-1290-y; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Park JK, 2012, ASIAN PAC J CANCER P, V13, P3271, DOI 10.7314/APJCP.2012.13.7.3271; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rasch EK, 2008, ARCH PHYS MED REHAB, V89, P210, DOI 10.1016/j.apmr.2007.08.146; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Schootman M, 2003, CANCER CAUSE CONTROL, V14, P97, DOI 10.1023/A:1023091308625; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Tukker A, 2009, PUBLIC HEALTH NUTR, V12, P359, DOI 10.1017/S1368980008002103; U. S Preventive Services Task Force, 2013, REC AD USPSTF CERV C; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; WHO, 2007, EARL DET CANC; WHO, 2007, BREAST CANC PREV CON; WHO ICF, 2018, DEFINITION; Wisdom JP, 2010, SOC WORK PUBLIC HLTH, V25, P368, DOI 10.1080/19371910903240969	49	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104901	10.1371/journal.pone.0104901	http://dx.doi.org/10.1371/journal.pone.0104901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133662	gold, Green Published			2022-12-27	WOS:000341302700050
J	Palmer, NA; Saathoff, AJ; Tobias, CM; Twigg, P; Xia, YN; Vogel, KP; Madhavan, S; Sattler, SE; Sarath, G				Palmer, Nathan A.; Saathoff, Aaron J.; Tobias, Christian M.; Twigg, Paul; Xia, Yuannan; Vogel, Kenneth P.; Madhavan, Soundararajan; Sattler, Scott E.; Sarath, Gautam			Contrasting Metabolism in Perenniating Structures of Upland and Lowland Switchgrass Plants Late in the Growing Season	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS; SENESCENCE; PROTEINS; DORMANCY; ANTIOXIDANT; PEROXIDASES; REGULATORS; TOLERANCE; DISCOVERY	Background: Switchgrass (Panicum virgatum L.) is being developed as a bioenergy crop for many temperate regions of the world. One way to increase biomass yields is to move southern adapted lowland cultivars to more northern latitudes. However, many southerly adapted switchgrass germplasm can suffer significant winter kill in northerly climes. Materials and Methods: Here, we have applied next-generation sequencing in combination with biochemical analyses to query the metabolism of crowns and rhizomes obtained from two contrasting switchgrass cultivars. Crowns and rhizomes from field-grown lowland (cv Kanlow) and upland (cv Summer) switchgrass cultivars were collected from three randomly selected post-flowering plants. Summer plants were senescing, whereas Kanlow plants were not at this harvest date. Results: Principal component analysis (PCA) differentiated between both the Summer and Kanlow transcriptomes and metabolomes. Significant differences in transcript abundances were detected for 8,050 genes, including transcription factors such as WRKYs and those associated with phenylpropanoid biosynthesis. Gene-set enrichment analyses showed that a number of pathways were differentially up-regulated in the two populations. For both populations, protein levels and enzyme activities agreed well with transcript abundances for genes involved in the phenylpropanoid pathway that were up-regulated in Kanlow crowns and rhizomes. The combination of these datasets suggests that dormancy-related mechanisms had been triggered in the crowns and rhizomes of the Summer plants, whereas the crowns and rhizomes of Kanlow plants had yet to enter dormancy. Conclusions: Delayed establishment of dormancy at more northerly latitudes could be one factor that reduces winter-survival in the high-yielding Kanlow plants. Understanding the cellular signatures that accompany the transition to dormancy can be used in the future to select plants with improved winter hardiness.	[Palmer, Nathan A.; Saathoff, Aaron J.; Sattler, Scott E.; Sarath, Gautam] Univ Nebraska, USDA ARS, Forage & Bioenergy Res Unit, Lincoln, NE 68588 USA; [Palmer, Nathan A.; Saathoff, Aaron J.; Sattler, Scott E.; Sarath, Gautam] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Tobias, Christian M.] USDA ARS, Western Reg Res Ctr, Genom & Gene Discovery Res Unit, Albany, CA 94710 USA; [Twigg, Paul] Univ Nebraska, Dept Biol, Kearney, NE USA; [Xia, Yuannan] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Vogel, Kenneth P.] USDA ARS, Lincoln, NE 68583 USA; [Madhavan, Soundararajan] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Sarath, G (corresponding author), Univ Nebraska, USDA ARS, Forage & Bioenergy Res Unit, Lincoln, NE 68588 USA.	Gautam.Sarath@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Sattler, Scott/0000-0002-6814-4073	Office of Science (BER), U. S. Department of Energy [DE-AI02-09ER64829]; USDA-ARS CRIS [5440-21000-030-00D]	Office of Science (BER), U. S. Department of Energy(United States Department of Energy (DOE)); USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Office of Science (BER), U. S. Department of Energy Grant Number DE-AI02-09ER64829, and by the USDA-ARS CRIS project 5440-21000-030-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Alderson J, 1995, USDA SCS, V170; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anderson JV, 2010, TOP CURR GENET, V21, P69, DOI 10.1007/978-3-642-12422-8_5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berr A, 2011, BBA-GENE REGUL MECH, V1809, P567, DOI 10.1016/j.bbagrm.2011.07.001; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Casler M, 2012, HDB BIOENERGY CROP P, P563, DOI DOI 10.1201/B11711-25; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Childs KL, PLANT GENOM IN PRESS; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dogramaci M, 2011, FUNCT INTEGR GENOMIC, V11, P611, DOI 10.1007/s10142-011-0239-y; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Ersoz ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044112; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Gomez-Vasquez R, 2004, ANN BOT-LONDON, V94, P87, DOI 10.1093/aob/mch107; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hemming MN, 2011, PLANT SCI, V180, P447, DOI 10.1016/j.plantsci.2010.12.001; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Palmer NA, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00549; Palmer NA, 2010, J AGR FOOD CHEM, V58, P5220, DOI 10.1021/jf904445q; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Saathoff AJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00202; Saathoff AJ, 2010, BIOENERG RES, V4, P1; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Sarath G, 2014, PLANT SCI, V217, P140, DOI 10.1016/j.plantsci.2013.12.012; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RC, 2011, R LANG ENV STAT COMP; Tripathi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-270; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Vogel KP, 2014, J PLANT REGIST, V8, P242, DOI 10.3198/jpr2013.12.0076crc; Vogel K.P., 2004, WARM SEASON C4 GRASS, P561, DOI DOI 10.2134/AGRONMONOGR45.C16; Vogel KP, 2011, RSC ENERGY ENVIRON S, P341; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xing SF, 2012, TRENDS PLANT SCI, V17, P423, DOI 10.1016/j.tplants.2012.03.008; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104; Zhao CS, 2008, PLANT J, V53, P425, DOI 10.1111/j.1365-313X.2007.03350.x; Zhao KM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-135; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	65	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105138	10.1371/journal.pone.0105138	http://dx.doi.org/10.1371/journal.pone.0105138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133804	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700076
J	Rahman, KM; Corcoran, DB; Bui, TTT; Jackson, PJM; Thurston, DE				Rahman, Khondaker M.; Corcoran, David B.; Bui, Tam T. T.; Jackson, Paul J. M.; Thurston, David E.			Pyrrolobenzodiazepines (PBDs) Do Not Bind to DNA G-Quadruplexes	PLOS ONE			English	Article							PYRROLO<1,4>BENZODIAZEPINE ANTITUMOR ANTIBIOTICS; CROSS-LINKING ABILITY; BIOLOGICAL EVALUATION; TRANSCRIPTION FACTOR; POLYAMIDE CONJUGATE; STRUCTURAL BASIS; DUPLEX DNA; PHASE-I; SEQUENCE; ANTHRAMYCIN	The pyrrolo[2,1-c][1,4] benzodiazepines (PBDs) are a family of sequence-selective, minor-groove binding DNA-interactive agents that covalently attach to guanine residues. A recent publication in this journal (Raju et al, PloS One, 2012, 7, 4, e35920) reported that two PBD molecules were observed to bind with high affinity to the telomeric quadruplex of Tetrahymena glaucoma based on Electrospray Ionisation Mass Spectrometry (ESI-MS), Circular Dichroism, UV-Visible and Fluorescence spectroscopy data. This was a surprising result given the close 3-dimensional shape match between the structure of all PBD molecules and the minor groove of duplex DNA, and the completely different 3-dimensional structure of quadruplex DNA. Therefore, we evaluated the interaction of eight PBD molecules of diverse structure with a range of parallel, antiparallel and mixed DNA quadruplexes using DNA Thermal Denaturation, Circular Dichroism and Molecular Dynamics Simulations. Those PBD molecules without large C8-substitutents had an insignificant affinity for the eight quadruplex types, although those with large pi-system-containing C8-substituents (as with the compounds evaluated by Raju and co-workers) were found to interact to some extent. Our molecular dynamics simulations support the likelihood that molecules of this type, including those examined by Raju and co-workers, interact with quadruplex DNA through their C8-substituents rather than the PBD moiety itself. It is important for the literature to be clear on this matter, as the mechanism of action of these agents will be under close scrutiny in the near future due to the growing number of PBD-based agents entering the clinic as both single-agents and as components of antibody-drug conjugates (ADCs).	[Rahman, Khondaker M.; Corcoran, David B.; Bui, Tam T. T.; Jackson, Paul J. M.; Thurston, David E.] Kings Coll London, Inst Pharmaceut Sci, Dept Pharm, London, England	University of London; King's College London	Rahman, KM (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Dept Pharm, London, England.	k.miraz.rahman@kcl.ac.uk; david.thurston@kcl.ac.uk	Rahman, Miraz/M-2749-2017	Rahman, Miraz/0000-0001-8566-8648; Bui, Tam Thu Thi/0000-0002-8074-4928; Corcoran, David/0000-0001-6959-8707	King's College London	King's College London	This research was supported by internal funding available within King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Antonow D, 2011, CHEM REV, V111, P2815, DOI 10.1021/cr100120f; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Baraldi PG, 1999, J MED CHEM, V42, P5131, DOI 10.1021/jm991033w; BARKLEY MD, 1986, BIOCHEMISTRY-US, V25, P3021, DOI 10.1021/bi00358a043; Bates P, 2007, EMBO REP, V8, P1003, DOI 10.1038/sj.embor.7401073; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brucoli F, 2013, J MED CHEM, V56, P6339, DOI 10.1021/jm4001852; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973; Case D.A., AMBER 11; Case D.A., 2022, AMBER 2020; Cipolla L, 2009, ANTI-CANCER AGENT ME, V9, P1, DOI 10.2174/187152009787047743; Clingen PH, 2005, NUCLEIC ACIDS RES, V33, P3283, DOI 10.1093/nar/gki639; Darby RAJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e39; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; FARMER JD, 1988, TETRAHEDRON LETT, V29, P5105, DOI 10.1016/S0040-4039(00)80691-7; Fogolari F, 1999, BIOPHYS J, V76, P1, DOI 10.1016/S0006-3495(99)77173-0; Fotso S, 2010, MINI-REV ORG CHEM, V7, P68; Fotso S, 2009, J NAT PROD, V72, P690, DOI 10.1021/np800827w; Gabelica V, 2007, J AM CHEM SOC, V129, P895, DOI 10.1021/ja065989p; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gregson SJ, 2001, J MED CHEM, V44, P737, DOI 10.1021/jm001064n; Hadjivassileva T, 2005, J ANTIMICROB CHEMOTH, V56, P513, DOI 10.1093/jac/dki256; Haider S, 2010, METHODS MOL BIOL, V608, P17, DOI 10.1007/978-1-59745-363-9_2; Hartley JA, 2011, EXPERT OPIN INV DRUG, V20, P733, DOI 10.1517/13543784.2011.573477; Hochhauser D, 2009, CLIN CANCER RES, V15, P2140, DOI 10.1158/1078-0432.CCR-08-1315; Hopton SR, 2011, BIOCHEMISTRY-US, V50, P4720, DOI 10.1021/bi102017e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HURLEY LH, 1988, CHEM RES TOXICOL, V1, P258, DOI 10.1021/tx00005a002; Janjigian YY, 2010, CANCER CHEMOTH PHARM, V65, P833, DOI 10.1007/s00280-009-1088-4; Kamal A, 2006, MINI-REV MED CHEM, V6, P53, DOI 10.2174/138955706775197875; Kamal A, 2005, BIOORGAN MED CHEM, V13, P2021, DOI 10.1016/j.bmc.2005.01.010; Kamal A, 2008, BIOORGAN MED CHEM, V16, P7804, DOI 10.1016/j.bmc.2008.06.056; Kamal A, 2010, EUR J MED CHEM, V45, P3870, DOI 10.1016/j.ejmech.2010.05.041; Kamal A, 2009, BIOORGAN MED CHEM, V17, P1557, DOI 10.1016/j.bmc.2008.12.068; KOHN KW, 1970, J MOL BIOL, V51, P551, DOI 10.1016/0022-2836(70)90008-2; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Kraus GA, 1999, TETRAHEDRON LETT, V40, P2039, DOI 10.1016/S0040-4039(99)00087-8; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LEIMGRUBER W, 1965, J AM CHEM SOC, V87, P5791, DOI 10.1021/ja00952a050; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; OSADA H, 1990, AGR BIOL CHEM TOKYO, V54, P2883, DOI 10.1080/00021369.1990.10870397; Parkinson GN, 2008, J MOL BIOL, V381, P1145, DOI 10.1016/j.jmb.2008.06.022; Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PUVVADA MS, 1993, NUCLEIC ACIDS RES, V21, P3671, DOI 10.1093/nar/21.16.3671; Puvvada MS, 1997, BIOCHEMISTRY-US, V36, P2478, DOI 10.1021/bi952490r; Puzanov I, 2011, CLIN CANCER RES, V17, P3794, DOI 10.1158/1078-0432.CCR-10-2056; Rahman KM, 2013, J MED CHEM, V56, P2911, DOI 10.1021/jm301882a; Rahman KM, 2012, CHEM COMMUN, V48, P8760, DOI 10.1039/c2cc31277h; Rahman KM, 2012, J ANTIMICROB CHEMOTH, V67, P1683, DOI 10.1093/jac/dks127; Rahman KM, 2011, ORG BIOMOL CHEM, V9, P1632, DOI 10.1039/c0ob00762e; Rahman KM, 2010, ACS MED CHEM LETT, V1, P427, DOI 10.1021/ml100131b; Rahman KM, 2009, J AM CHEM SOC, V131, P13756, DOI 10.1021/ja902986x; Rahman KM, 2009, CHEM COMMUN, P4097, DOI 10.1039/b902359c; Rahman KM, 2009, CHEM COMMUN, P227, DOI 10.1039/b816163a; Rahman KM, 2011, NUCL ACIDS RES; Raju G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035920; Rosado H, 2011, J ANTIMICROB CHEMOTH, V66, P985, DOI 10.1093/jac/dkr044; Seifert J, 2012, ORG BIOMOL CHEM, V10, P6850, DOI 10.1039/c2ob25654a; Smellie M, 2003, BIOCHEMISTRY-US, V42, P8232, DOI 10.1021/bi034313t; Thurston D. E., 1993, MOL ASPECTS ANTICANC, P54; Thurston DE, 2006, CHEM PHARM ANTICANCE, V1, P281; Wells G, 2005, CLIN CANCER RES, V11, p9015S; Wells G, 2006, J MED CHEM, V49, P5442, DOI 10.1021/jm051199z; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172	71	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105021	10.1371/journal.pone.0105021	http://dx.doi.org/10.1371/journal.pone.0105021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133504	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700062
J	Seitz, AE; Younes, N; Steiner, CA; Prevots, DR				Seitz, Amy E.; Younes, Naji; Steiner, Claudia A.; Prevots, D. Rebecca			Incidence and Trends of Blastomycosis-Associated Hospitalizations in the United States	PLOS ONE			English	Article							ENDEMIC FUNGAL-INFECTIONS; PULMONARY BLASTOMYCOSIS; GEOGRAPHIC-DISTRIBUTION; PRACTICE GUIDELINES; OLDER PERSONS; WISCONSIN; OUTBREAK; DERMATITIDIS; MANAGEMENT; TENNESSEE	We used the State Inpatient Databases from the United States Agency for Healthcare Research and Quality to provide state-specific age-adjusted blastomycosis-associated hospitalization incidence throughout the entire United States. Among the 46 states studied, states within the Mississippi and Ohio River valleys had the highest age-adjusted hospitalization incidence. Specifically, Wisconsin had the highest age-adjusted hospitalization incidence (2.9 hospitalizations per 100,000 person-years). Trends were studied in the five highest hospitalization incidence states. From 2000 to 2011, blastomycosis-associated hospitalizations increased significantly in Illinois and Kentucky with an average annual increase of 4.4% and 8.4%, respectively. Trends varied significantly by state. Overall, 64% of blastomycosis-associated hospitalizations were among men and the median age at hospitalization was 53 years. This analysis provides a complete epidemiologic description of blastomycosis-associated hospitalizations throughout the endemic area in the United States.	[Seitz, Amy E.; Prevots, D. Rebecca] NIAID, Epidemiol Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Seitz, Amy E.; Younes, Naji] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Epidemiol & Biostat, Washington, DC USA; [Steiner, Claudia A.] US Agcy Healthcare Res & Qual, Healthcare Cost Utilizat Project, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Seitz, AE (corresponding author), NIAID, Epidemiol Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	seitza@niaid.nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2014, HCUP SID DAT DOC HEA; American Hospital Association Resource Center, 2012, FAST FACTS US HOSP; Baddley JW, 2012, EMERG INFECT DIS, V18, P361, DOI 10.3201/eid1802.111617; Baddley JW, 2011, EMERG INFECT DIS, V17, P1664, DOI 10.3201/eid1709.101987; Baumgardner Dennis J, 2011, WMJ, V110, P68; Baumgardner DJ, 2011, MED MYCOL, V49, P49, DOI 10.3109/13693786.2010.488658; Bradsher R W, 1997, Semin Respir Infect, V12, P229; Bradsher RW, 2003, INFECT DIS CLIN N AM, V17, P21, DOI 10.1016/S0891-5520(02)00038-7; Brown EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059237; Cano MV, 2003, EPIDEMIOL INFECT, V131, P907, DOI 10.1017/S0950268803008987; Carlos WG, 2010, CHEST, V138, P1377, DOI 10.1378/chest.10-0627; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P601; Chapman S W, 1997, Semin Respir Infect, V12, P219; Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300; Chapman SW, 2000, CLIN INFECT DIS, V30, P679, DOI 10.1086/313750; Chu JH, 2006, CLIN INFECT DIS, V42, P822, DOI 10.1086/500405; COCKERILL FR, 1984, CHEST, V86, P688, DOI 10.1378/chest.86.5.688; FRYE MD, 1991, MYCOPATHOLOGIA, V116, P15, DOI 10.1007/BF00436085; FURCOLOW ML, 1970, AM J EPIDEMIOL, V92, P121, DOI 10.1093/oxfordjournals.aje.a121184; Goldenberg S, 2008, MEDICINE, V36, P295; Goldman M, 1999, CLIN CHEST MED, V20, P507, DOI 10.1016/S0272-5231(05)70232-X; HAMMERMAN KJ, 1974, SABOURAUDIA, V12, P33; Haselow D, 2012, EMERG INFECT DIS, V18, P360, DOI 10.3201/eid1802.111537; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; Herrmann JA, 2011, JAVMA-J AM VET MED A, V239, P335, DOI 10.2460/javma.239.3.335; Illinois Department of Public Health, 2009, REP COMM DIS CAS 200; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1987, J INFECT DIS, V155, P262, DOI 10.1093/infdis/155.2.262; Kralt D, 2009, MYCOPATHOLOGIA, V167, P115, DOI 10.1007/s11046-008-9163-7; Light RB, 2008, MED MYCOL, V46, P835, DOI 10.1080/13693780802132763; MacDonald PDM, 2006, EMERG INFECT DIS, V12, P1242, DOI 10.3201/eid1708.050781; Monaco WE, 2013, DIAGN MICR INFEC DIS, V75, P423, DOI 10.1016/j.diagmicrobio.2013.01.010; Nage CA, 2012, RESP MED, V106, P769, DOI 10.1016/j.rmed.2012.02.004; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; PAPPAS PG, 1993, MEDICINE, V72, P311, DOI 10.1097/00005792-199309000-00003; Pfister JR, 2011, CLIN MED RES, V9, P57, DOI 10.3121/cmr.2010.958; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Roy M, 2013, CLIN INFECT DIS, V57, P655, DOI 10.1093/cid/cit366; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; SAROSI GA, 1979, AM REV RESPIR DIS, V120, P911; Vasquez JE, 1998, CHEST, V114, P436, DOI 10.1378/chest.114.2.436; Watts B, 2007, NEW ENGL J MED, V356, P1456, DOI 10.1056/NEJMcps055322; Woodward M., 2013, EPIDEMIOLOGY STUDY D	43	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105466	10.1371/journal.pone.0105466	http://dx.doi.org/10.1371/journal.pone.0105466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126839	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300112
J	Vasko, MR; Malty, RH; Guo, CL; Duarte, DB; Zhang, YH; Nicol, GD				Vasko, Michael R.; Malty, Ramy Habashy; Guo, Chunlu; Duarte, Djane B.; Zhang, Yihong; Nicol, Grant D.			Nerve Growth Factor Mediates a Switch in Intracellular Signaling for PGE(2)-Induced Sensitization of Sensory Neurons from Protein Kinase A to Epac	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROSTAGLANDIN E-2; CYCLIC-AMP; C-EPSILON; PKC-EPSILON; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; INFLAMMATORY PAIN; EXCHANGE PROTEIN; PHOSPHOLIPASE-C	We examined whether nerve growth factor (NGF), an inflammatory mediator that contributes to chronic hypersensitivity, alters the intracellular signaling that mediates the sensitizing actions of PGE(2) from activation of protein kinase A (PKA) to exchange proteins directly activated by cAMP (Epacs). When isolated sensory neurons are grown in the absence of added NGF, but not in cultures grown with 30 ng/ml NGF, inhibiting protein kinase A (PKA) activity blocks the ability of PGE(2) to augment capsaicin-evoked release of the neuropeptide CGRP and to increase the number of action potentials (APs) evoked by a ramp of current. Growing sensory neurons in culture in the presence of increasing concentrations of NGF increases the expression of Epac2, but not Epac1. An intradermal injection of complete Freund's adjuvant into the rat hindpaw also increases the expression of Epac2, but not Epac1 in the dorsal root ganglia and spinal cord: an effect blocked by intraplantar administration of NGF antibodies. Treating cultures grown in the presence of 30 ng/ml NGF with Epac1siRNA significantly reduced the expression of Epac1, but not Epac2, and did not block the ability of PGE(2) to augment capsaicin-evoked release of CGRP from sensory neurons. Exposing neuronal cultures grown in NGF to Epac2siRNAreduced the expression of Epac2, but not Epac1 and prevented the PGE(2)-induced augmentation of capsaicin and potassium-evoked CGRP release in sensory neurons and the PGE(2)-induced increase in the number of APs generated by a ramp of current. In neurons grown with no added NGF, Epac siRNAs did not attenuate PGE(2)-induced sensitization. These results demonstrate that NGF, through increasing Epac2 expression, alters the signaling cascade that mediates PGE(2)-induced sensitization of sensory neurons, thus providing a novel mechanism for maintaining PGE(2)-induced hypersensitivity during inflammation.	[Vasko, Michael R.; Malty, Ramy Habashy; Guo, Chunlu; Zhang, Yihong; Nicol, Grant D.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Vasko, Michael R.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Malty, Ramy Habashy] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Duarte, Djane B.] Univ Brasilia, Fac Ciencias Saude FS, Ribeiro Asa Norte, Brazil	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidade de Brasilia	Vasko, MR (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.	vaskom@iupui.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of Health [RO1069915]; Egyptian Government Missions Program; National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Egyptian Government Missions Program; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this publication was supported by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award RO1069915 M. R. V., and a fellowship grant to RRMH from the Egyptian Government Missions Program. These studies were conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, J PHYSIOL-LONDON, V545, P441, DOI 10.1113/jphysiol.2002.029561; Aley KO, 1999, J NEUROSCI, V19, P2181; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Amann R, 1996, PAIN, V64, P323, DOI 10.1016/0304-3959(95)00120-4; Banik RK, 2005, PAIN, V117, P68, DOI 10.1016/j.pain.2005.05.017; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bolyard LA, 2000, PAIN, V88, P277, DOI 10.1016/S0304-3959(00)00341-9; BOMBARDIERI S, 1981, BRIT J PHARMACOL, V73, P893, DOI 10.1111/j.1476-5381.1981.tb08743.x; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Burkey TH, 2004, METH MOLEC MED, P189; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; CUI M, 1995, NEUROSCIENCE, V66, P459, DOI 10.1016/0306-4522(94)00567-O; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dmitrieva N, 1996, PAIN, V66, P87, DOI 10.1016/0304-3959(96)02993-4; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; DONNERER J, 1992, NEUROSCIENCE, V49, P693, DOI 10.1016/0306-4522(92)90237-V; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Eijkelkamp N, 2010, J NEUROSCI, V30, P12806, DOI 10.1523/JNEUROSCI.3142-10.2010; Evellin S, 2002, J BIOL CHEM, V277, P16805, DOI 10.1074/jbc.M112024200; Fehrenbacher JC, 2005, PAIN, V113, P113, DOI 10.1016/j.pain.2004.09.031; Fehrenbacher JC, 2005, CONTRIBUTION INFLAMM; FERREIRA SH, 1979, PROSTAGLANDINS, V18, P179, DOI 10.1016/0090-6980(79)90103-5; FERREIRA SH, 1973, BRIT J PHARMACOL, V49, P86, DOI 10.1111/j.1476-5381.1973.tb08270.x; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; GREAVES MW, 1971, BMJ-BRIT MED J, V2, P258, DOI 10.1136/bmj.2.5756.258; Guo C, 2007, VIEW IT PLANN; Habashy RR, 2010, LONG TERM EXPOSURE N; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kavelaars A, 2011, BRAIN BEHAV IMMUN, V25, P1055, DOI 10.1016/j.bbi.2011.03.019; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malty RRH, 2012, MECH DOWNREGULATIONS; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Parada CA, 2005, PAIN, V113, P185, DOI 10.1016/j.pain.2004.10.021; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rueff A, 1996, J NEUROPHYSIOL, V76, P3593, DOI 10.1152/jn.1996.76.5.3593; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Sachs D, 2009, BRIT J PHARMACOL, V156, P826, DOI 10.1111/j.1476-5381.2008.00093.x; SCHMID A, 1995, EUR J BIOCHEM, V228, P23, DOI 10.1111/j.1432-1033.1995.tb20223.x; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Southall MD, 2000, NEUROSCI LETT, V287, P33, DOI 10.1016/S0304-3940(00)01158-7; Southall MD, 2002, PAIN, V96, P285, DOI 10.1016/S0304-3959(01)00458-4; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; TRANG LE, 1977, SCAND J RHEUMATOL, V6, P151, DOI 10.3109/03009747709095440; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; VASKO MR, 1994, J NEUROSCI, V14, P4987; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Villarreal CF, 2009, BIOCHEM PHARMACOL, V77, P867, DOI 10.1016/j.bcp.2008.11.015; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	91	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104529	10.1371/journal.pone.0104529	http://dx.doi.org/10.1371/journal.pone.0104529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126967	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300033
J	Hirsch, O; Kluckner, VJ; Brandt, S; Moss, A; Weck, M; Florath, I; Wabitsch, M; Hebebrand, J; Schimmelmann, BG; Christiansen, H				Hirsch, Oliver; Kluckner, Viktoria J.; Brandt, Stephanie; Moss, Anja; Weck, Melanie; Florath, Ines; Wabitsch, Martin; Hebebrand, Johannes; Schimmelmann, Benno G.; Christiansen, Hanna			Restrained and External-Emotional Eating Patterns in Young Overweight Children-Results of the Ulm Birth Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; RISK-FACTORS; WEIGHT; BEHAVIORS; PSYCHOPATHOLOGY; QUESTIONNAIRE; ASSOCIATION; PREVALENCE; ADULTHOOD	Childhood obesity is one of the greatest public health challenges in Western countries. Abnormal eating behavior is thought to be a developmental trajectory to obesity. The Eating Pattern Inventory for Children (EPI-C) has not been used for children as young as eight years, and possible associations with body weight have not yet been established. Five hundred and twenty-one children of the Ulm Birth Cohort Study (UBCS; age eight) filled out the EPI-C and BMI was assessed. Adequacy of the scales was tested with confirmatory factor analysis and a MANOVA and cluster analysis established associations between eating patterns and BMI. The factor structure of the EPI-C was confirmed (GFI =.968) and abnormal eating behavior was associated with overweight (chi(2) (8) = 79.29, p<.001). The EPI-C is a valid assessment tool in this young age group. Overweight children consciously restrain their eating.	[Hirsch, Oliver; Christiansen, Hanna] Univ Marburg, Dept Child & Adolescent Psychol, Marburg, Germany; [Kluckner, Viktoria J.; Schimmelmann, Benno G.] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Brandt, Stephanie; Moss, Anja; Wabitsch, Martin] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Weck, Melanie; Florath, Ines] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat & Psychotherapy, Essen, Germany	Philipps University Marburg; University of Bern; University Hospital of Bern; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Hirsch, O (corresponding author), Univ Marburg, Dept Child & Adolescent Psychol, Marburg, Germany.	oliver.hirsch@staff.uni-marburg.de	Hirsch, Oliver/H-2876-2019		"Kompetenznetz Adipositas" (Competence Network for Adipositas) - Federals Ministry of Education and Research [FKZ 01GI0840]	"Kompetenznetz Adipositas" (Competence Network for Adipositas) - Federals Ministry of Education and Research	This work was supported by the "Kompetenznetz Adipositas" (Competence Network for Adipositas) funded by the Federals Ministry of Education and Research (FKZ 01GI0840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0043503; Anschutz DJ, 2009, AM J CLIN NUTR, V89, P1328, DOI 10.3945/ajcn.2008.27075; Arbuckle J., 2008, AMOS 17 0 USERS GUID; Blunch N. J., 2008, INTRO STRUCTURAL EQU; Braet C, 1997, BEHAV RES THER, V35, P863, DOI 10.1016/S0005-7967(97)00045-4; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Butryn ML, 2005, INT J EAT DISORDER, V37, P285, DOI 10.1002/eat.20098; Campbell KJ, 2006, INT J OBESITY, V30, P1272, DOI 10.1038/sj.ijo.0803266; Carnell S, 2013, PHYSL BEHAV; Casey PH, 2012, J PERINATOL, V32, P91, DOI 10.1038/jp.2011.75; Christiansen H, 2013, WENN KINDER JUGENDLI, P135; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Field AE, 2003, PEDIATRICS, V112, P900, DOI 10.1542/peds.112.4.900; Florath I, 2014, PEDIATR OBES, V9, P121, DOI 10.1111/j.2047-6310.2012.00146.x; Flores G, 2013, INT J OBESITY, V37, P31, DOI 10.1038/ijo.2012.168; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grissom R.J., 2012, EFFECT SIZES RES; Halvarsson K, 1998, EUR EAT DISORD REV, V6, P115, DOI 10.1002/(SICI)1099-0968(199806)6:2<115::AID-ERV222>3.3.CO;2-D; Huber PJ, 2009, WILEY SERIES PROBABI; Jennings A, 2012, OBESITY, V20, P1462, DOI 10.1038/oby.2012.72; Knussmann R., 1996, VERGLEICHENDE BIOL M; LANDMAN GB, 1989, PEDIATR ANN, V18, P373, DOI 10.3928/0090-4481-19890601-08; LATHROP RG, 1990, EDUC PSYCHOL MEAS, V50, P325, DOI 10.1177/0013164490502010; Lee Sarah M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Long JM, 2012, J SPEC PEDIATR NURS, V17, P41, DOI 10.1111/j.1744-6155.2011.00309.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Martin R., 1957, LEHRBUCH ANTHR, V3rd; McVey G, 2004, CAN MED ASSOC J, V170, P1559, DOI 10.1503/cmaj.1031247; Micali N, 2011, J DEV BEHAV PEDIATR, V32, P572, DOI 10.1097/DBP.0b013e31822bc7b7; Moreno G, 2013, J SCHOOL HEALTH, V83, P157, DOI 10.1111/josh.12011; Olstad DL, 2009, APPL PHYSIOL NUTR ME, V34, P551, DOI 10.1139/H09-016; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Raykov T., 2006, 1 COURSE STRUCTURAL, V2nd; Rifas-Shiman SL, 2012, OBESITY, V20, P1261, DOI 10.1038/oby.2011.350; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Schacht M, 2006, J CLIN PSYCHOL, V62, P1259, DOI 10.1002/jclp.20300; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Sinha A, 2009, OBES SURG, V19, P113, DOI 10.1007/s11695-008-9650-4; Snoek HM, 2013, APPETITE, V67, P81, DOI 10.1016/j.appet.2013.03.014; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Tanofsky-Kraff M, 2005, INT J EAT DISORDER, V38, P112, DOI 10.1002/eat.20158; Tanofsky-Kraff M, 2004, J CONSULT CLIN PSYCH, V72, P53, DOI 10.1037/0022-006X.72.1.53; Truby H, 2002, BRIT J CLIN PSYCHOL, V41, P185, DOI 10.1348/014466502163967; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Volker MA, 2006, PSYCHOL SCHOOLS, V43, P653, DOI 10.1002/pits.20176; Weiber R., 2010, STRUCTURAL EQUATION; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wijnhoven TMA, 2013, PEDIATR OBES, V8, P79, DOI 10.1111/j.2047-6310.2012.00090.x	51	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105303	10.1371/journal.pone.0105303	http://dx.doi.org/10.1371/journal.pone.0105303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141134	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200069
J	Maslunka, C; Gifford, B; Tucci, J; Gurtler, V; Seviour, RJ				Maslunka, Christopher; Gifford, Bianca; Tucci, Joseph; Guertler, Volker; Seviour, Robert J.			Insertions or Deletions (Indels) in the rrn 16S-23S rRNA Gene Internal Transcribed Spacer Region (ITS) Compromise the Typing and Identification of Strains within the Acinetobacter calcoaceticus-baumannii (Acb) Complex and Closely Related Members	PLOS ONE			English	Article							GENOMIC SPECIES 13TU; INTERGENIC SPACER; SEQUENCE-ANALYSIS; RAPID IDENTIFICATION; BACTERIA; OPERON; PATHOGENESIS; PROBES; ARRAY; SPP.	To determine whether ITS sequences in the rrn operon are suitable for identifying individual Acinetobacter Acb complex members, we analysed length and sequence differences between multiple ITS copies within the genomes of individual strains. Length differences in ITS reported previously between A. nosocomialis BCRC15417(T) (615 bp) and other strains (607 bp) can be explained by presence of an insertion (indel 13i/1) in the longer ITS variant. The same Indel 13i/1 was also found in ITS sequences of ten strains of A. calcoaceticus, all 639 bp long, and the 628 bp ITS of Acinetobacter strain BENAB127. Four additional indels (13i/2-13i/5) were detected in Acinetobacter strain c/t13TU 10090 ITS length variants (608, 609, 620, 621 and 630 bp). These ITS variants appear to have resulted from horizontal gene transfer involving other Acinetobacter species or in some cases unrelated bacteria. Although some ITS copies in strain c/t13TU 10090 are of the same length (620 bp) as those in Acinetobacter strains b/n1&3, A. pittii (10 strains), A. calcoaceticus and A. oleivorans (not currently acknowledged as an Acb member), their individual ITS sequences differ. Thus ITS length by itself can not by itself be used to identify Acb complex strains. A shared indel in ITS copies in two separate Acinetobacter species compromises the specificity of ITS targeted probes, as shown with the Aun-3 probe designed to target the ITS in A. pitti. The presence of indel 13i/5 in the ITS of Acinetobacter strain c/t13TU means it too responded positively to this probe. Thus, neither ITS sequencing nor the currently available ITS targeted probes can distinguish reliably between Acb member species.	[Maslunka, Christopher; Gifford, Bianca; Tucci, Joseph; Seviour, Robert J.] La Trobe Univ, Biotechnol Res Ctr, Bendigo, Vic, Australia; [Guertler, Volker] Bundoora Campus RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia	La Trobe University; Royal Melbourne Institute of Technology (RMIT)	Seviour, RJ (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	r.seviour@latrobe.edu.au		seviour, robert/0000-0002-1366-0484	La Trobe University Postgraduate Scholarship; Australian Research Council	La Trobe University Postgraduate Scholarship; Australian Research Council(Australian Research Council)	CM was supported by a La Trobe University Postgraduate Scholarship. BG was supported by an Australian Post Graduate Award from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Barry T, 1991, PCR Methods Appl, V1, P51; BEACHAM AM, 1990, WATER RES, V24, P23, DOI 10.1016/0043-1354(90)90060-J; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Carr EL, 2004, SYST APPL MICROBIOL, V27, P478, DOI 10.1078/0723202041438491; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dijkshoorn Lenie, 2008, P1; GERISCHER U., 2008, ACINETOBACTER MOL BI; GERNERSMIDT P, 1993, APMIS, V101, P826, DOI 10.1111/j.1699-0463.1993.tb00187.x; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Golanbar GD, 2011, J CLIN MICROBIOL, V49, P2121, DOI 10.1128/JCM.02373-10; Goncalves ER, 2002, INT J SYST EVOL MICR, V52, P355, DOI 10.1099/00207713-52-2-355; Gurtler V, 2013, J MICROBIOL METH, V93, P257, DOI 10.1016/j.mimet.2013.02.013; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Gurtler V, 2014, METHODS MIC IN PRESS, V41; Gurtler V, 2012, J MICROBIOL METH, V90, P167, DOI 10.1016/j.mimet.2012.05.002; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Ko WC, 2008, J CLIN MICROBIOL, V46, P2052, DOI 10.1128/JCM.00014-08; Lagatolla C, 1998, RES MICROBIOL, V149, P557, DOI 10.1016/S0923-2508(99)80003-5; Lai CC, 2012, J CLIN MICROBIOL, V50, P2982, DOI 10.1128/JCM.01194-12; Lebuhn M, 2006, SYST APPL MICROBIOL, V29, P265, DOI 10.1016/j.syapm.2005.11.003; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Luz SP, 1998, J BACTERIOL, V180, P2144, DOI 10.1128/JB.180.8.2144-2151.1998; Maslunka C, 2006, SYST APPL MICROBIOL, V29, P216, DOI 10.1016/j.syapm.2005.07.015; Maslunka C, 2008, J MICROBIOL METH, V73, P227, DOI 10.1016/j.mimet.2008.03.003; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peix A, 2009, SYST APPL MICROBIOL, V32, P334, DOI 10.1016/j.syapm.2009.03.004; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Su SC, 2009, J MED MICROBIOL, V58, P596, DOI 10.1099/jmm.0.004606-0; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vaneechoutte M, 2009, J CLIN MICROBIOL, V47, P1281; Zarrilli R, 2009, J CLIN MICROBIOL, V47, P1281, DOI 10.1128/JCM.02022-08; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11	50	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105390	10.1371/journal.pone.0105390	http://dx.doi.org/10.1371/journal.pone.0105390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141005	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200085
J	Yahi, N; Fantini, J				Yahi, Nouara; Fantini, Jacques			Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide	PLOS ONE			English	Article							BETA-PROTEIN; MEMBRANE MICRODOMAINS; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN; CHOLESTEROL; DISEASE; DOMAIN; HIV-1; GM1; RAFTS	A broad range of microbial and amyloid proteins interact with cell surface glycolipids which behave as infectivity and/or toxicity cofactors in human pathologies. Here we have deciphered the biochemical code that determines the glycolipid-binding specificity of two major amyloid proteins, Alzheimer's beta-amyloid peptide (Ab) and Parkinson's disease associated protein alpha-synuclein. We showed that both proteins interact with selected glycolipids through a common loop-shaped motif exhibiting little sequence homology. This 12-residue domain corresponded to fragments 34-45 of alpha-synuclein and 5-16 of Ab. By modulating the amino acid sequence of alpha-synuclein at only two positions in which we introduced a pair of histidine residues found in Ab, we created a chimeric alpha-synuclein/A beta peptide with extended ganglioside-binding properties. This chimeric peptide retained the property of alpha-synuclein to recognize GM3, and acquired the capacity to recognize GM1 (an Ab-inherited characteristic). Free histidine (but not tryptophan or asparagine) and Zn2+ (but not Na+) prevented this interaction, confirming the key role of His-13 and His-14 in ganglioside binding. Molecular dynamics studies suggested that the chimeric peptide recognized cholesterol-constrained conformers of GM1, including typical chalice-shaped dimers, that are representative of the condensed cholesterol-ganglioside complexes found in lipid raft domains of the plasma membrane of neural cells. Correspondingly, the peptide had a particular affinity for raft-like membranes containing both GM1 and cholesterol. The chimeric peptide also interacted with several other gangliosides, including major brain gangliosides (GM4, GD1a, GD1b, and GT1b) but not with neutral glycolipids such as GlcCer, LacCer or asialo-GM1. It could inhibit the binding of A beta 1-42 onto neural SH-SY5Y cells and did not induce toxicity in these cells. In conclusion, deciphering the glycolipid code of amyloid proteins allowed us to create a universal ganglioside-binding peptide of only 12-residues with potential therapeutic applications in infectious and neurodegenerative diseases that involve cell surface gangliosides as receptors.	[Yahi, Nouara; Fantini, Jacques] Aix Marseille Univ, Fac Sci, PPSN EA4674, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Fantini, J (corresponding author), Aix Marseille Univ, Fac Sci, PPSN EA4674, Marseille, France.	jacques.fantini@univ-amu.fr		Fantini, Jacques/0000-0001-8653-5521				Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; ASOU H, 1989, CELL STRUCT FUNCT, V14, P561, DOI 10.1247/csf.14.561; Aubert-Jousset E, 2004, STRUCTURE, V12, P1437, DOI 10.1016/j.str.2004.05.016; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; Di Scala C, 2014, BIOCHEMISTRY-US, V53, P4489, DOI 10.1021/bi500373k; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 2007, CURR MED CHEM, V14, P2911, DOI 10.2174/092986707782360033; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fantini J, 2013, ADV EXP MED BIOL, V991, P15, DOI 10.1007/978-94-007-6331-9_2; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00120; Fantini J, 2011, BBA-BIOMEMBRANES, V1808, P2343, DOI 10.1016/j.bbamem.2011.06.017; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamel S, 2010, J CELL BIOL, V188, P581, DOI 10.1083/jcb.200907116; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; Hammache D, 2000, METHOD ENZYMOL, V312, P495; Hannson HA, 1977, P NATL ACAD SCI USA, V74, P3782; Heuss SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074392; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Jang H, 2013, PHYS CHEM CHEM PHYS, V15, P8868, DOI 10.1039/c3cp00017f; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Matsubara T, 1999, FEBS LETT, V456, P253, DOI 10.1016/S0014-5793(99)00962-X; Matsubara T, 2008, BIOCHEMISTRY-US, V47, P6745, DOI 10.1021/bi8000837; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; Oikawa N, 2009, NEUROREPORT, V20, P1043, DOI 10.1097/WNR.0b013e32832e4b9d; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Rasool S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-37; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Taieb N, 2004, ADV DRUG DELIVER REV, V56, P779, DOI 10.1016/j.addr.2003.09.007; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062	50	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104751	10.1371/journal.pone.0104751	http://dx.doi.org/10.1371/journal.pone.0104751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140899	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200031
J	Adhikari, K; Hartemink, AE; Minasny, B; Kheir, RB; Greve, MB; Greve, MH				Adhikari, Kabindra; Hartemink, Alfred E.; Minasny, Budiman; Kheir, Rania Bou; Greve, Mette B.; Greve, Mogens H.			Digital Mapping of Soil Organic Carbon Contents and Stocks in Denmark	PLOS ONE			English	Article							TERRAIN ATTRIBUTES; DEPTH FUNCTIONS; PREDICTION; GRASSLANDS; TOPSOIL; MAPS; ECOSYSTEMS; CROPLANDS; PROFILE; STORAGE	Estimation of carbon contents and stocks are important for carbon sequestration, greenhouse gas emissions and national carbon balance inventories. For Denmark, we modeled the vertical distribution of soil organic carbon (SOC) and bulk density, and mapped its spatial distribution at five standard soil depth intervals (0-5, 5-15, 15-30, 30-60 and 60-100 cm) using 18 environmental variables as predictors. SOC distribution was influenced by precipitation, land use, soil type, wetland, elevation, wetness index, and multi-resolution index of valley bottom flatness. The highest average SOC content of 20 g kg(-1) was reported for 0-5 cm soil, whereas there was on average 2.2 g SOC kg(-1) at 60-100 cm depth. For SOC and bulk density prediction precision decreased with soil depth, and a standard error of 2.8 g kg(-1) was found at 60-100 cm soil depth. Average SOC stock for 0-30 cm was 72 t ha(-1) and in the top 1 m there was 120 t SOC ha(-1). In total, the soils stored approximately 570 Tg C within the top 1 m. The soils under agriculture had the highest amount of carbon (444 Tg) followed by forest and semi-natural vegetation that contributed 11% of the total SOC stock. More than 60% of the total SOC stock was present in Podzols and Luvisols. Compared to previous estimates, our approach is more reliable as we adopted a robust quantification technique and mapped the spatial distribution of SOC stock and prediction uncertainty. The estimation was validated using common statistical indices and the data and high-resolution maps could be used for future soil carbon assessment and inventories.	[Adhikari, Kabindra; Hartemink, Alfred E.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Minasny, Budiman] Univ Sydney, Dept Environm Sci, Sydney, NSW 2006, Australia; [Kheir, Rania Bou; Greve, Mette B.; Greve, Mogens H.] Aarhus Univ, Dept Agroecol, Tjele, Denmark	University of Wisconsin System; University of Wisconsin Madison; University of Sydney; Aarhus University	Adhikari, K (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	kadhikari@wisc.edu	Hartemink, Alfred/G-1149-2011; Greve, Mette/AAF-5998-2020; Minasny, Budiman/B-4744-2011; Adhikari, Kabindra/H-3273-2019	Hartemink, Alfred/0000-0002-5797-6798; Minasny, Budiman/0000-0002-1182-2371; Adhikari, Kabindra/0000-0002-1365-7015; Greve, Mette Balslev/0000-0002-9079-6131	Danish Ministry of Climate and Energy through SINKS Project	Danish Ministry of Climate and Energy through SINKS Project	The study was funded by the Danish Ministry of Climate and Energy through SINKS Project (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Adhikari K, 2013, SOIL SCI SOC AM J, V77, P860, DOI 10.2136/sssaj2012.0275; [Anonymous], 1985, DAN J GEOGR, DOI DOI 10.1080/; Arrouays D, 2001, SOIL USE MANAGE, V17, P7, DOI 10.1111/j.1475-2743.2001.tb00002.x; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Beckett PHT, 1971, SOILS FERTILIZERS, V34, P1; Bendix J., 2004, GELANDEKLIMATOLOGIE; Bishop TFA, 1999, GEODERMA, V91, P27, DOI 10.1016/S0016-7061(99)00003-8; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bui E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003506; Bui EN, 2006, ECOL MODEL, V191, P431, DOI 10.1016/j.ecolmodel.2005.05.021; Chaplot V, 2010, GLOBAL CHANGE BIOL, V16, P1380, DOI 10.1111/j.1365-2486.2009.02013.x; Chapman SJ, 2013, EUR J SOIL SCI, V64, P455, DOI 10.1111/ejss.12041; Danmarks Meteorologiske Institut, 1998, DANM KLIM 1997; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Doblas-Miranda E, 2013, BIOGEOSCIENCES, V10, P8353, DOI 10.5194/bg-10-8353-2013; Dorji T, 2014, FOREST ECOL MANAG, V318, P91, DOI 10.1016/j.foreco.2014.01.003; ESRI, 2012, ARCGIS REL 10 1; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Greve MH, 2014, SOIL SCI IN PRESS; Greve MH, 2007, GEOGR TIDSSKR-DEN, V107, P1; Hartemink A E, 2014, SOIL CARBON; Hartemink A. E., 2014, PEERJ PREPRINTS, V2; Hartemink AE, 2014, GEODERMA, V230, P305, DOI 10.1016/j.geoderma.2014.03.008; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; JENNY H, 1968, Prib. Sist. Avtom., V32, P5; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kempen B, 2011, GEODERMA, V162, P107, DOI 10.1016/j.geoderma.2011.01.010; Kheir RB, 2010, J ENVIRON MANAGE, V91, P1150, DOI 10.1016/j.jenvman.2010.01.001; Krogh L, 2003, AGR ECOSYST ENVIRON, V96, P19, DOI 10.1016/S0167-8809(03)00016-1; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lacoste M, 2011, GEOMORPHOLOGY, V133, P90, DOI 10.1016/j.geomorph.2011.06.026; Madsen H.B., 1992, DANISH SOIL CLASSIFI; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; Martin MP, 2011, BIOGEOSCIENCES, V8, P1053, DOI 10.5194/bg-8-1053-2011; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Meersmans J, 2011, GLOBAL CHANGE BIOL, V17, P466, DOI 10.1111/j.1365-2486.2010.02183.x; Mendonca-Santos ML, 2010, PROGR SOIL SCI, V2, P255, DOI 10.1007/978-90-481-8863-5_21; Minasny B, 2006, AUST J SOIL RES, V44, P233, DOI 10.1071/SR05136; Minasny B., 2005, VESPER VERSION 1 62; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; Mishra U, 2010, SOIL SCI SOC AM J, V74, P906, DOI 10.2136/sssaj2009.0158; Mishra U, 2009, SOIL SCI SOC AM J, V73, P614, DOI 10.2136/sssaj2007.0410; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Mueller TG, 2003, SOIL SCI SOC AM J, V67, P258, DOI 10.2136/sssaj2003.0258; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Odgers NP, 2012, GEODERMA, V189, P153, DOI 10.1016/j.geoderma.2012.05.026; Olesen JE, 1991, AJMET NOTAT NO 24 AF; OSTERGAARD HS, 1990, KVADRATNETTET NITRAT; PONCEHERNANDEZ R, 1986, J SOIL SCI, V37, P455, DOI 10.1111/j.1365-2389.1986.tb00377.x; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2018, R LANG ENV STAT COMP; Razakamanarivo RH, 2011, GEODERMA, V162, P335, DOI 10.1016/j.geoderma.2011.03.006; Ross CW, 2013, SCI TOTAL ENVIRON, V461, P149, DOI 10.1016/j.scitotenv.2013.04.070; Smith J, 2005, GLOBAL CHANGE BIOL, V11, P2141, DOI 10.1111/j.1365-2486.2005.001075.x; Stjernholm M, 2004, CORINE LANDCOVER UPD; Taghizadeh-Toosi A, 2014, EUR J SOIL SCI, V65, P730, DOI 10.1111/ejss.12169; Vasenev VI, 2014, GEODERMA, V226, P103, DOI 10.1016/j.geoderma.2014.03.007; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zhao YC, 2010, PROGR SOIL SCI, V2, P227, DOI 10.1007/978-90-481-8863-5_19	65	182	187	10	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105519	10.1371/journal.pone.0105519	http://dx.doi.org/10.1371/journal.pone.0105519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137066	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100104
J	Rauen, J; Kreer, C; Paillard, A; van Duikeren, S; Benckhuijsen, WE; Camps, MG; Valentijn, ARPM; Ossendorp, F; Drijfhout, JW; Arens, R; Burgdorf, S				Rauen, Judith; Kreer, Christoph; Paillard, Arlette; van Duikeren, Suzanne; Benckhuijsen, Willemien E.; Camps, Marcel G.; Valentijn, A. Rob P. M.; Ossendorp, Ferry; Drijfhout, Jan W.; Arens, Ramon; Burgdorf, Sven			Enhanced Cross-Presentation and Improved CD8(+) T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN DENDRITIC CELLS; MANNOSE RECEPTOR; ANTIGEN-PRESENTATION; CARBOHYDRATE-RECOGNITION; DC-SIGN; VACCINES; VACCINATION; MECHANISMS; TOLERANCE	The use of synthetic long peptides (SLP) has been proven to be a promising approach to induce adaptive immune responses in vaccination strategies. Here, we analyzed whether the efficiency to activate cytotoxic T cells by SLP-based vaccinations can be increased by conjugating SLPs to mannose residues. We could demonstrate that mannosylation of SLPs results in increased internalization by the mannose receptor (MR) on murine antigen-presenting cells. MR-mediated internalization targeted the mannosylated SLPs into early endosomes, from where they were cross-presented very efficiently compared to non-mannosylated SLPs. The influence of SLP mannosylation was specific for cross-presentation, as no influence on MHC II-restricted presentation was observed. Additionally, we showed that vaccination of mice with mannosylated SLPs containing epitopes from either ovalbumin or HPV E7 resulted in enhanced proliferation and activation of antigen-specific CD8(+) T cells. These findings demonstrate that mannosylation of SLPs augments the induction of a cytotoxic T cell response in vitro and in vivo and might be a promising approach to induce cytotoxic T cell responses in e. g. cancer therapy and anti-viral immunity.	[Rauen, Judith; Kreer, Christoph; Paillard, Arlette; Burgdorf, Sven] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [van Duikeren, Suzanne; Benckhuijsen, Willemien E.; Camps, Marcel G.; Ossendorp, Ferry; Drijfhout, Jan W.; Arens, Ramon; Burgdorf, Sven] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Valentijn, A. Rob P. M.] Leiden Univ, Med Ctr, Dept Bioorgan Synth, Leiden, Netherlands	University of Bonn; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Burgdorf, S (corresponding author), Univ Bonn, Life & Med Sci Inst, Bonn, Germany.	burgdorf@uni-bonn.de	Benckhuijsen, Willemina/Y-2490-2018; Arens, Ramon/V-4010-2018; Kreer, Christoph/ABG-7275-2021; Drijfhout, Jan Wouter/ABA-6318-2021	Benckhuijsen, Willemina/0000-0002-8898-5195; Arens, Ramon/0000-0001-5058-4110; Kreer, Christoph/0000-0002-9140-9850; Drijfhout, Jan Wouter/0000-0003-4808-5296	grant C1 of the collaborative research center 645 of the German research Foundation (DFG); LUMC	grant C1 of the collaborative research center 645 of the German research Foundation (DFG); LUMC	This work was supported by grant C1 of the collaborative research center 645 of the German research Foundation (DFG) to SB and by a Gisela Thier grant from LUMC to RA. SB is a member of the DFG Excellence cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos V, 1996, VACCINE, V14, P930, DOI 10.1016/0264-410X(95)00258-3; Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1714, DOI 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C; Arens R, 2013, SEMIN IMMUNOL, V25, P182, DOI 10.1016/j.smim.2013.04.008; Arens R, 2012, ADV IMMUNOL, V114, P217, DOI 10.1016/B978-0-12-396548-6.00009-3; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; De Gregorio E, 2012, MICROB BIOTECHNOL, V5, P149, DOI 10.1111/j.1751-7915.2011.00276.x; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Faure F, 2009, EUR J IMMUNOL, V39, P380, DOI 10.1002/eji.200838669; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kel J, 2007, AM J PATHOL, V170, P272, DOI 10.2353/ajpath.2007.060335; Kel JM, 2008, INT IMMUNOL, V20, P117, DOI 10.1093/intimm/dxm123; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Luca ME, 2005, J NEUROIMMUNOL, V160, P178, DOI 10.1016/j.jneuroim.2004.11.014; McKenzie EJ, 2007, J IMMUNOL, V178, P4975, DOI 10.4049/jimmunol.178.8.4975; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mommaas AM, 1999, EUR J IMMUNOL, V29, P571, DOI 10.1002/(SICI)1521-4141(199902)29:02<571::AID-IMMU571>3.0.CO;2-E; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Smith CM, 2011, J IMMUNOL, V187, P1201, DOI 10.4049/jimmunol.1002152; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; van Duikeren S, 2012, J IMMUNOL, V189, P3397, DOI 10.4049/jimmunol.1201540; van Hall T, 2012, ADV IMMUNOL, V114, P51, DOI 10.1016/B978-0-12-396548-6.00003-2; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Zehner M, 2011, P NATL ACAD SCI USA, V108, P9933, DOI 10.1073/pnas.1102397108; Zom GGP, 2012, ADV IMMUNOL, V114, P177, DOI 10.1016/B978-0-12-396548-6.00007-X; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	41	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103755	10.1371/journal.pone.0103755	http://dx.doi.org/10.1371/journal.pone.0103755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137039	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100013
J	Reich, O; Rosemann, T; Rapold, R; Blozik, E; Senn, O				Reich, Oliver; Rosemann, Thomas; Rapold, Roland; Blozik, Eva; Senn, Oliver			Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization	PLOS ONE			English	Article							BEERS CRITERIA; DRUG-USE; ELDERLY OUTPATIENTS; PHARMACY DATA; OUTCOMES; POPULATION; RISK; PRESCRIPTIONS; EXPENDITURES; POLYPHARMACY	Objectives: To describe the prevalence and determinants of potentially inappropriate medication (PIM) use and association with hospitalizations in an elderly managed care population in Switzerland. Methods: Using health care claims data of four health insurers for a sample of managed care patients 65 years of age and older to compare persons on PIM with persons not on PIM. Beers' 2012 and PRISCUS criteria were used to determine the potential inappropriateness of prescribed medications. The sample included 16'490 elderly patients on PIM and 33'178 patients not on PIM in the time period of January 1, 2008 through December 31, 2012. Prevalence estimates are standardized to the population of Switzerland. Associations between PIM and hospitalizations were examined by multivariate Cox regression analyses controlling for possible confounding variables. Results: The estimated prevalence of PIM use in our managed care sample was 22.5%. Logistic regression analysis showed that number of different medications used in the previous year, total costs in the previous year and hospitalization in the previous year all significantly increased the likelihood of receiving PIM. Multiple Cox regression analysis revealed that those on cumulative levels of PIM use acted significantly as a factor related to greater hospitalization rates: the adjusted HR was 1.13 (95% CI 1.07-1.19) for 1 PIM, 1.27 (95% CI 1.19-1.35) for 2 PIM, 1.35 (95% CI 1.22-1.50) for 3 PIM, and 1.63 (95% CI 1.40-1.90) for more than 3 PIM compared to no PIM use. Conclusions: The prevalence of PIM in managed care health plans are widely found but seem to be much lower than rates of non-managed care plans. Furthermore, our study revealed a significant association with adverse outcomes in terms of hospitalizations. These findings stress the need for further development of interventions to decrease drug-related problems and manage patients with multiple chronic conditions.	[Reich, Oliver; Rapold, Roland] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland; [Rosemann, Thomas; Senn, Oliver] Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, CH-8091 Zurich, Switzerland; [Blozik, Eva] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany	University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Reich, O (corresponding author), Helsana Grp, Dept Hlth Sci, Zurich, Switzerland.	oliver.reich@helsana.ch		Senn, Oliver/0000-0003-4422-7250; Rapold, Roland/0000-0001-8287-290X	Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland	Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland	This work was supported by an unconditional grant from the Swiss Academy of Medical Sciences (SAMS), Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert SM, 2010, DRUG AGING, V27, P407, DOI 10.2165/11315990-000000000-00000; Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Barnett MJ, 2006, J MANAGE CARE PHARM, V12, P362, DOI 10.18553/jmcp.2006.12.5.362; Barry Patrick J, 2008, Curr Psychiatry Rep, V10, P37, DOI 10.1007/s11920-008-0008-3; Blozik E, 2013, DRUG AGING, V30, P561, DOI 10.1007/s40266-013-0073-0; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Cannon Katrina T, 2006, Am J Geriatr Pharmacother, V4, P134, DOI 10.1016/j.amjopharm.2006.06.010; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Cossman RE, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-25; Dedhiya SD, 2010, AM J GERIATR PHARMAC, V8, P562, DOI 10.1016/S1543-5946(10)80005-4; Federal Office of Public Health FOPH, 2013, STAT ONL KRANK 2012; Federal Statistical Office, 2010, SZEN BEV SCHW 2010 2; Fick D, 2001, J MANAGE CARE PHARM, V7, P407, DOI [10.18553/jmcp.2001.7.5.407, DOI 10.18553/JMCP.2001.7.5.407]; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fick DM, 2008, RES NURS HEALTH, V31, P42, DOI 10.1002/nur.20232; Fu AZ, 2007, MED CARE, V45, P472, DOI 10.1097/01.mlr.0000254571.05722.34; Galvin R, 2014, EUR J CLIN PHARMACOL, V70, P599, DOI 10.1007/s00228-014-1651-8; Giron MST, 2001, J AM GERIATR SOC, V49, P277, DOI 10.1046/j.1532-5415.2001.4930277.x; Goltz L, 2012, INT J CLIN PHARM TH, V50, P185, DOI 10.5414/CP201441; Hanlon JT, 2002, J AM GERIATR SOC, V50, P26, DOI 10.1046/j.1532-5415.2002.50004.x; Harugeri A, 2010, J POSTGRAD MED, V56, P186, DOI 10.4103/0022-3859.68642; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Huber CA, 2013, J CLIN EPIDEMIOL, V66, P1118, DOI 10.1016/j.jclinepi.2013.04.011; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Klarin I, 2005, DRUG AGING, V22, P69, DOI 10.2165/00002512-200522010-00005; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Lin HY, 2008, DRUG AGING, V25, P49, DOI 10.2165/00002512-200825010-00006; Liu Gordon G, 2002, J Am Pharm Assoc (Wash), V42, P847; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; O'Shea M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-23; Oliveira MG, 2012, INT J CLIN PHARM-NET, V34, P626, DOI 10.1007/s11096-012-9656-9; Opondo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043617; Price SD, 2014, ANN PHARMACOTHER, V48, P6, DOI 10.1177/1060028013504904; Reich O, 2012, INT J INTEGR CARE, V12; Rothberg MB, 2008, J HOSP MED, V3, P91, DOI 10.1002/jhm.290; Ruggiero C, 2010, DRUG AGING, V27, P747, DOI 10.2165/11538240-000000000-00000; Schubert I, 2013, PHARMACOEPIDEM DR S, V22, P719, DOI 10.1002/pds.3429; Sichieri K, 2013, ADV PHARMACOL PHARM, V1, P74, DOI 10.13189/app.2013.010205; Siebert S, 2013, Z GERONTOL GERIATR, V46, P35, DOI 10.1007/s00391-012-0324-4; Simon SR, 2005, J AM GERIATR SOC, V53, P227, DOI 10.1111/j.1532-5415.2005.53107.x; Stockl KM, 2010, AM J MANAG CARE, V16, pE1; Swiss Federal Office of Statistics SFOS, 2013, STAND WOHNB NACH GES; Tamura BK, 2012, CLIN GERIATR MED, V28, P217, DOI 10.1016/j.cger.2012.01.005; Tragni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078827; de Lima TJV, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-52; Zuckerman IH, 2006, MED CARE, V44, P722, DOI 10.1097/01.mlr.0000215849.15769.be	52	84	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105425	10.1371/journal.pone.0105425	http://dx.doi.org/10.1371/journal.pone.0105425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136981	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100093
J	Geng, YK; Pang, BS; Hao, CY; Tang, SJ; Zhang, XY; Li, T				Geng, Yuke; Pang, Binshuang; Hao, Chenyang; Tang, Saijun; Zhang, Xueyong; Li, Tian			Expression of Wheat High Molecular Weight Glutenin Subunit 1Bx Is Affected by Large Insertions and Deletions Located in the Upstream Flanking Sequences	PLOS ONE			English	Article							ENDOSPERM-SPECIFIC EXPRESSION; TRITICUM-AESTIVUM L; TRANSGENIC RICE; GLUTELIN GENE; ACTIVATES TRANSCRIPTION; QUALITY TRAITS; PROTEIN GENES; BREAD WHEAT; GCN4 MOTIF; IDENTIFICATION	To better understand the transcriptional regulation of high molecular weight glutenin subunit (HMW-GS) expression, we isolated four Glu-1Bx promoters from six wheat cultivars exhibiting diverse protein expression levels. The activities of the diverse Glu-1Bx promoters were tested and compared with beta-glucuronidase (GUS) reporter fusions. Although all the full-length Glu-1Bx promoters showed endosperm-specific activities, the strongest GUS activity was observed with the 1Bx7(OE) promoter in both transient expression assays and stable transgenic rice lines. A 43 bp insertion in the 1Bx7(OE) promoter, which is absent in the 1Bx7 promoter, led to enhanced expression. Analysis of promoter deletion constructs confirmed that a 185 bp MITE (miniature inverted-repeat transposable element) in the 1Bx14 promoter had a weak positive effect on Glu-1Bx expression, and a 54 bp deletion in the 1Bx13 promoter reduced endosperm-specific activity. To investigate the effect of the 43 bp insertion in the 1Bx7(OE) promoter, a functional marker was developed to screen 505 Chinese varieties and 160 European varieties, and only 1Bx7-type varieties harboring the 43 bp insertion in their promoters showed similar overexpression patterns. Hence, the 1Bx7(OE) promoter should be important tool in crop genetic engineering as well as in molecular assisted breeding.	[Geng, Yuke; Hao, Chenyang; Zhang, Xueyong; Li, Tian] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Beijing 100193, Peoples R China; [Geng, Yuke; Tang, Saijun] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Pang, Binshuang] Beijing Acad Agr & Forestry Sci, Beijing Engn & Tech Res Ctr Hybrid Wheat, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Beijing Academy of Agriculture & Forestry	Zhang, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Beijing 100193, Peoples R China.	zhangxueyong@caas.cn; litian@caas.cn			National Transgenic Research Project [ZX08002-004]; National Natural Science Foundation of China [30671293]	National Transgenic Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Transgenic Research Project (ZX08002-004) and National Natural Science Foundation of China (30671293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON OD, 1989, THEOR APPL GENET, V77, P689, DOI 10.1007/BF00261246; Anderson OD, 2002, GENOME, V45, P367, DOI 10.1139/G01-137; Anderson OD, 1997, P INT WHEAT QUAL C, P205; Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Butaye KMJ, 2005, MOL BREEDING, V16, P79, DOI 10.1007/s11032-005-4929-9; Butow BJ, 2004, THEOR APPL GENET, V109, P1525, DOI 10.1007/s00122-004-1776-8; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; Cho HJ, 2004, PLANT CELL REP, V23, P104, DOI 10.1007/s00299-004-0789-8; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; CLOUTIER S, 2005, P INT C PLANT GEN BI, P40; Cornish GB, 2001, AUST J AGR RES, V52, P1339, DOI 10.1071/AR01060; Dong GQ, 2007, PLANT MOL BIOL, V63, P73, DOI 10.1007/s11103-006-9073-3; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Furtado A, 2008, PLANT BIOTECHNOL J, V6, P679, DOI 10.1111/j.1467-7652.2008.00352.x; GALILI G, 1983, THEOR APPL GENET, V66, P77, DOI 10.1007/BF00281853; GUPTA RB, 1994, J CEREAL SCI, V19, P9, DOI 10.1006/jcrs.1994.1003; HALFORD NG, 1989, PLANT SCI, V62, P207, DOI 10.1016/0168-9452(89)90083-6; HALFORD NG, 1987, THEOR APPL GENET, V75, P117, DOI 10.1007/BF00249151; HARBERD NP, 1987, MOL GEN GENET, V209, P326, DOI 10.1007/BF00329661; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jiang QT, 2012, GENETICA, V140, P325, DOI 10.1007/s10709-012-9683-4; Juhasz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029501; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Li W, 2004, THEOR APPL GENET, V109, P1093, DOI 10.1007/s00122-004-1726-5; Liu JJ, 2003, EUPHYTICA, V131, P147, DOI 10.1023/A:1023972032592; MARCHYLO BA, 1992, J CEREAL SCI, V15, P29, DOI 10.1016/S0733-5210(09)80054-4; MARKS MD, 1985, J BIOL CHEM, V260, P6445; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Onate L, 1999, J BIOL CHEM, V274, P9175, DOI 10.1074/jbc.274.14.9175; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; Ortiz Juan Pablo A., 1997, Journal of Applied Genetics, V38, P123; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qu LQ, 2008, J EXP BOT, V59, P2417, DOI 10.1093/jxb/ern110; Radovanovic N, 2003, MOL BREEDING, V12, P51, DOI 10.1023/A:1025484523771; Ragupathy R, 2008, THEOR APPL GENET, V116, P283, DOI 10.1007/s00122-007-0666-2; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; REDDY P, 1993, THEOR APPL GENET, V85, P616, DOI 10.1007/BF00220921; Sambrook J., 2002, MOL CLONING LAB MANU; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sha S, 1996, BIOSCI BIOTECH BIOCH, V60, P335, DOI 10.1271/bbb.60.335; Shaw LM, 2009, FUNCT INTEGR GENOMIC, V9, P485, DOI 10.1007/s10142-009-0130-2; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Takaiwa F, 1996, PLANT MOL BIOL, V30, P1207, DOI 10.1007/BF00019553; THOMAS MS, 1990, PLANT CELL, V2, P1171, DOI 10.1105/tpc.2.12.1171; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wessler S R, 1998, Symp Soc Exp Biol, V51, P115; Wieser H, 2000, EUR FOOD RES TECHNOL, V211, P262, DOI 10.1007/s002170000165; Wu CY, 1998, PLANT J, V14, P673, DOI 10.1046/j.1365-313x.1998.00167.x; Yan Y, 2004, THEOR APPL GENET, V108, P1349, DOI 10.1007/s00122-003-1547-y; Yang Zu-Jun, 2006, Acta Genetica Sinica, V33, P929, DOI 10.1016/S0379-4172(06)60127-3; Zhang XB, 2002, J GEN VIROL, V83, P1069, DOI 10.1099/0022-1317-83-5-1069; ZHENG ZW, 1993, PLANT J, V4, P357, DOI 10.1046/j.1365-313X.1993.04020357.x	55	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105363	10.1371/journal.pone.0105363	http://dx.doi.org/10.1371/journal.pone.0105363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133580	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700104
J	Leggatt, RA; Hollo, T; Vandersteen, WE; McFarlane, K; Goh, B; Prevost, J; Devlin, RH				Leggatt, Rosalind A.; Hollo, Tanya; Vandersteen, Wendy E.; McFarlane, Kassandra; Goh, Benjamin; Prevost, Joelle; Devlin, Robert H.			Rearing in Seawater Mesocosms Improves the Spawning Performance of Growth Hormone Transgenic and Wild-Type Coho Salmon	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; POLYMORPHIC MICROSATELLITE MARKERS; TILAPIA OREOCHROMIS-NILOTICUS; REPEAT-ENRICHED LIBRARIES; EXPRESSED SEQUENCE TAGS; RAINBOW-TROUT; ATLANTIC SALMON; REPRODUCTIVE-PERFORMANCE; BREEDING SUCCESS; CHINOOK SALMON	Growth hormone (GH) transgenes can significantly accelerate growth rates in fish and cause associated alterations to their physiology and behaviour. Concern exists regarding potential environmental risks of GH transgenic fish, should they enter natural ecosystems. In particular, whether they can reproduce and generate viable offspring under natural conditions is poorly understood. In previous studies, GH transgenic salmon grown under contained culture conditions had lower spawning behaviour and reproductive success relative to wild-type fish reared in nature. However, wild-type salmon cultured in equal conditions also had limited reproductive success. As such, whether decreased reproductive success of GH transgenic salmon is due to the action of the transgene or to secondary effects of culture (or a combination) has not been fully ascertained. Hence, salmon were reared in large (350,000 L), semi-natural, seawater tanks (termed mesocosms) designed to minimize effects of standard laboratory culture conditions, and the reproductive success of wild-type and GH transgenic coho salmon from mesocosms were compared with that of wild-type fish from nature. Mesocosm rearing partially restored spawning behaviour and success of wild-type fish relative to culture rearing, but remained lower overall than those reared in nature. GH transgenic salmon reared in the mesocosm had similar spawning behaviour and success as wild-type fish reared in the mesocosm when in full competition and without competition, but had lower success in male-only competition experiments. There was evidence of genotype x environmental interactions on spawning success, so that spawning success of transgenic fish, should they escape to natural systems in early life, cannot be predicted with low uncertainty. Under the present conditions, we found no evidence to support enhanced mating capabilities of GH transgenic coho salmon compared to wild-type salmon. However, it is clear that GH transgenic salmon are capable of successful spawning, and can reproduce with wild-type fish from natural systems.	[Leggatt, Rosalind A.; Hollo, Tanya; Vandersteen, Wendy E.; McFarlane, Kassandra; Goh, Benjamin; Prevost, Joelle; Devlin, Robert H.] Fisheries & Oceans Canada, West Vancouver Labs, W Vancouver, BC, Canada	Fisheries & Oceans Canada	Devlin, RH (corresponding author), Fisheries & Oceans Canada, West Vancouver Labs, W Vancouver, BC, Canada.	Robert.devlin@dfo-mpo.gc.ca			Canadian Regulatory System for Biotechnology grant	Canadian Regulatory System for Biotechnology grant	Funding for this project was through a Canadian Regulatory System for Biotechnology grant to RHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2011, TRANSGENIC RES, V20, P583, DOI 10.1007/s11248-010-9443-0; Aikio S, 2008, OIKOS, V117, P406, DOI 10.1111/j.2007.0030-1299.16061.x; Anderson JH, 2013, EVOL APPL, V6, P165, DOI 10.1111/j.1752-4571.2012.00271.x; [Anonymous], ENV RISK ASSESSMENT; Berejikian BA, 2000, J FISH BIOL, V57, P647, DOI 10.1111/j.1095-8649.2000.tb00266.x; Berejikian BA, 1997, ICES J MAR SCI, V54, P1040, DOI 10.1016/S1054-3139(97)80008-2; Berejikian BA, 2001, N AM J FISH MANAGE, V21, P255, DOI 10.1577/1548-8675(2001)021<0255:RBABSO>2.0.CO;2; Berejikian BA, 2001, CAN J FISH AQUAT SCI, V58, P804, DOI 10.1139/cjfas-58-4-804; Berejikian BA, 2009, CAN J FISH AQUAT SCI, V66, P781, DOI 10.1139/F09-041; Bessey C, 2004, T AM FISH SOC, V133, P1205, DOI 10.1577/T04-010.1; Burner C.J., 1951, FISH B, V52, P95; Cairney M, 2000, MOL ECOL, V9, P2175, DOI 10.1046/j.1365-294X.2000.105312.x; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Devlin RH, 1995, AQUACULTURE, V137, P161, DOI 10.1016/0044-8486(95)01090-4; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1995, CAN J FISH AQUAT SCI, V52, P1376, DOI 10.1139/f95-133; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; DFO, 2013, 2013023 DFO; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; DUNHAM RA, 1995, BIOTECHNOLOGY RISK A, P127; Figueiredo MA, 2013, ANIM REPROD SCI, V139, P162, DOI 10.1016/j.anireprosci.2013.03.012; Fitzpatrick JL, 2011, AQUACULTURE, V312, P185, DOI 10.1016/j.aquaculture.2010.11.044; FLEMING IA, 1993, ECOL APPL, V3, P230, DOI 10.2307/1941826; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; FLEMING IA, 1989, EVOLUTION, V43, P141, DOI 10.1111/j.1558-5646.1989.tb04213.x; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fleming Ian A., 2001, Nordic Journal of Freshwater Research, V75, P71; Hedrick PW, 2001, CAN J FISH AQUAT SCI, V58, P841, DOI 10.1139/cjfas-58-5-841; Howard RD, 2004, P NATL ACAD SCI USA, V101, P2934, DOI 10.1073/pnas.0306285101; Jhingan E, 2003, J FISH BIOL, V63, P806, DOI 10.1046/j.1095-8649.2003.00194.x; Kim JH, 2013, FISH SHELLFISH IMMUN, V34, P1553, DOI 10.1016/j.fsi.2013.03.365; Kobayashi SI, 2007, AQUACULTURE, V270, P427, DOI 10.1016/j.aquaculture.2007.05.016; Leggatt RA, 2012, AQUACULTURE, V356, P193, DOI 10.1016/j.aquaculture.2012.05.016; Lian H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065506; Maclean N, 2000, FISH FISH, V1, P146, DOI 10.1046/j.1467-2979.2000.00014.x; Moreau DTR, 2011, EVOL APPL, V4, P736, DOI 10.1111/j.1752-4571.2011.00196.x; Muir WM, 2001, AM NAT, V158, P1, DOI 10.1086/320860; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Olsen JB, 2000, MOL ECOL, V9, P2185, DOI 10.1046/j.1365-294X.2000.105317.x; Ostenfeld TH, 1998, J FISH BIOL, V52, P850, DOI 10.1111/j.1095-8649.1998.tb00825.x; Palti Y, 2002, MOL ECOL NOTES, V2, P449, DOI 10.1046/j.1471-8286.2002.00274.x; Pennington KM, 2011, T AM FISH SOC, V140, P221, DOI 10.1080/00028487.2011.545012; Pennington Kelly M., 2010, Environmental Biosafety Research, V9, DOI 10.1051/ebr/2010005; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Rexroad CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-54; Rexroad CE, 2002, MAR BIOTECHNOL, V4, P12, DOI 10.1007/s10126-001-0058-6; Rexroad CE, 2003, T AM FISH SOC, V132, P1214, DOI 10.1577/T02-086; Rexroad CE, 2001, ANIM GENET, V32, P317, DOI 10.1046/j.1365-2052.2001.0730b.x; Rodriguez F, 2003, MOL ECOL NOTES, V3, P619, DOI 10.1046/j.1471-8286.2003.00531.x; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Valosaari KR, 2008, EVOL APPL, V1, P608, DOI 10.1111/j.1752-4571.2008.00046.x; Zhu Z, 1985, J APPL ICHTHYOL, V1, P31, DOI DOI 10.1111/J.1439-0426.1985.TB00408.X	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105377	10.1371/journal.pone.0105377	http://dx.doi.org/10.1371/journal.pone.0105377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133780	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700108
J	Mwebaze, RM; Kibirige, D				Mwebaze, Raymond Mbayo; Kibirige, Davis			Peripheral Arterial Disease among Adult Diabetic Patients Attending a Large Outpatient Diabetic Clinic at a National Referral Hospital in Uganda: A Descriptive Cross Sectional Study	PLOS ONE			English	Article							INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; MICROALBUMINURIA; COMPLICATIONS; PREVALENCE; MORTALITY; MELLITUS; AFRICA; RISK	Background: Peripheral arterial disease (PAD) is one of the recognised diabetic macro vascular complications. It is a marker of generalised systemic atherosclerosis and is closely associated with symptomatic coronary and cerebrovascular disease, hence significant morbidity and mortality. Among African adult diabetic populations, screening and diagnosis of PAD is frequently suboptimal. The aim of this study was to determine the prevalence and associated clinical factors of PAD in adult ambulatory diabetic patients attending the outpatient diabetic clinic of Mulago national referral and teaching hospital, Kampala Uganda. Methods: In this descriptive cross sectional study, 146 ambulatory adult diabetic patients were studied. Information about their socio-demographic and clinical characteristics, fasting lipid profile status, blood pressure, glycated haemoglobin (HbA1c) levels and presence of albuminuria was collected using a pre tested questionnaire. Measurement of ankle brachial index (ABI) to assess for PAD, defined as a ratio less than 0.9 was performed using a portable 5-10 MHz Doppler device. Clinical factors associated with PAD were determined by comparing specific selected characteristics in patients with PAD and those without. Results: The mean age/standard deviation of the study participants was 53.9/12.4 years with a male predominance (75, 51.4%). PAD was prevalent in 57 (39%) study participants. Of these, 34 (59.6%) had symptomatic PAD. The noted clinical factors associated with PAD in this study population were presence of symptoms of intermittent claudication and microalbuminuria. Conclusions: This study documents a high prevalence of PAD among adult ambulatory Ugandan diabetic patients. Aggressive screening for PAD using ABI measurement in adult diabetic patients should be emphasised in Uganda especially in the presence of symptoms of intermittent claudication and microalbuminuria.	[Mwebaze, Raymond Mbayo] St Raphael St Francis Hosp Nsambya, Dept Med & Diabet, Endocrine Clin, Kampala, Uganda; [Mwebaze, Raymond Mbayo] Uganda Martyrs Univ, Mother Kevin Postgrad Med Sch, Nkozi, Uganda; [Kibirige, Davis] Uganda Martyrs Hosp Lubaga, Dept Med, Kampala, Uganda	Uganda Martyrs University	Kibirige, D (corresponding author), Uganda Martyrs Hosp Lubaga, Dept Med, Kampala, Uganda.	kibirigedavis@gmail.com		kibirige, Davis/0000-0001-5127-3031				Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; American Diabetes Association Diabetes, 2014, DIABETES CARE, V37, pS14; Criqui MH, 2001, VASC MED, V6, P3, DOI 10.1177/1358836X0100600i102; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DECKERT T, 1992, DIABETES CARE, V15, P1181, DOI 10.2337/diacare.15.9.1181; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Gulam-Abbas Z, 2002, DIABETIC MED, V19, P575, DOI 10.1046/j.1464-5491.2002.00740.x; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Kibirige D, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-40; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Murabito JM, 1997, CIRCULATION, V96, P44; Natha B, 2014, SAMJ S AFR MED J, V104, P148, DOI 10.7196/samj.7919; Oyelade B, 2012, AFR J PRIM HEALTH CA, V4, P354; Paul AK, 2007, SAMJ S AFR MED J, V97, P285; Rabia K, 2007, Med J Malaysia, V62, P130; Rheeder P, 2004, SAMJ S AFR MED J, V94, P379; Singh PP, 2011, DIABETES CARE, V34, P464, DOI 10.2337/dc10-1734; Sobngwi E, 2012, DIABETES RES CLIN PR, V95, P30, DOI 10.1016/j.diabres.2011.10.018; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Uloko Andrew E, 2012, Indian J Endocrinol Metab, V16, P558, DOI 10.4103/2230-8210.98011; White C, 2007, NEW ENGL J MED, V356, P1241, DOI 10.1056/NEJMcp064483	22	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105211	10.1371/journal.pone.0105211	http://dx.doi.org/10.1371/journal.pone.0105211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133533	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700087
J	Nunoura, T; Takaki, Y; Kazama, H; Kakuta, J; Shimamura, S; Makita, H; Hirai, M; Miyazaki, M; Takai, K				Nunoura, Takuro; Takaki, Yoshihiro; Kazama, Hiromi; Kakuta, Jungo; Shimamura, Shigeru; Makita, Hiroko; Hirai, Miho; Miyazaki, Masayuki; Takai, Ken			Physiological and Genomic Features of a Novel Sulfur-Oxidizing Gammaproteobacterium Belonging to a Previously Uncultivated Symbiotic Lineage Isolated from a Hydrothermal Vent	PLOS ONE			English	Article							OKINAWENSIS SP NOV.; GEN. NOV.; PHYLOGENETIC DIVERSITY; EPSILON-PROTEOBACTERIA; MICROBIAL COMMUNITIES; MOLECULAR ANALYSIS; RIFTIA-PACHYPTILA; SULFATE-REDUCTION; ESCHERICHIA-COLI; BACTERIUM	Strain Hiromi 1, a sulfur-oxidizing gammaproteobacterium was isolated from a hydrothermal vent chimney in the Okinawa Trough and represents a novel genus that may include a phylogenetic group found as endosymbionts of deep-sea gastropods. The SSU rRNA gene sequence similarity between strain Hiromi 1 and the gastropod endosymbionts was approximately 97%. The strain was shown to grow both chemolithoautotrophically and chemolithoheterotrophically with an energy metabolism of sulfur oxidation and O-2 or nitrate reduction. Under chemolithoheterotrophic growth conditions, the strain utilized organic acids and proteinaceous compounds as the carbon and/or nitrogen sources but not the energy source. Various sugars did not support growth as a sole carbon source. The observation of chemolithoheterotrophy in this strain is in line with metagenomic analyses of endosymbionts suggesting the occurrence of chemolithoheterotrophy in gammaproteobacterial symbionts. Chemolithoheterotrophy and the presence of homologous genes for virulence- and quorum sensing-related functions suggest that the sulfur-oxidizing chomolithotrophic microbes seek animal bodies and microbial biofilm formation to obtain supplemental organic carbons in hydrothermal ecosystems.	[Nunoura, Takuro; Takaki, Yoshihiro; Kazama, Hiromi; Kakuta, Jungo; Shimamura, Shigeru; Makita, Hiroko; Hirai, Miho; Miyazaki, Masayuki; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Extremobiosphere Res Program, Subsurface Geobiol & Adv Res SUGAR Project, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Nunoura, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Extremobiosphere Res Program, Subsurface Geobiol & Adv Res SUGAR Project, Yokosuka, Kanagawa, Japan.	takuron@jamstec.go.jp	Makita, Hiroko/U-8718-2017; Nunoura, Takuro/AAL-6266-2020	Makita, Hiroko/0000-0002-9547-8351; Nunoura, Takuro/0000-0003-2323-0880	JAMSTEC;  [18658135]	JAMSTEC; 	The study was partially supported by a Grant-in-Aid for Exploratory Research (no. 18658135 to TN), and was supported mostly by operating expenses of the authors' institute JAMSTEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Christie W. W., 1997, ADV LIPID METHODOLOG, V4, P119; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Dahl Christiane, 2008, V27, P289; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedrich CG, 2008, MICROBIAL SULFUR METABOLISM, P139, DOI 10.1007/978-3-540-72682-1_12; Frigaard Niels-Ulrik, 2008, V27, P337; Frigaard NU, 2008, MICROBIAL SULFUR METABOLISM, P60, DOI 10.1007/978-3-540-72682-1_6; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fujiwara Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011808; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; GILLIS M, 2001, BERGEYS MANUAL SYSTE, V1, P43, DOI DOI 10.1007/978-0-387-21609-6_7; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Grimm F, 2008, MICROBIAL SULFUR METABOLISM, P101, DOI 10.1007/978-3-540-72682-1_9; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Harmer TL, 2008, APPL ENVIRON MICROB, V74, P3895, DOI 10.1128/AEM.02470-07; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; HUBER H, 1989, ARCH MICROBIOL, V151, P479, DOI 10.1007/BF00454862; Imhoff JF, 2005, BERGEYS MANUAL SYSTE, V2, P28; Imhoff JF., 2005, BERGEYS MANUAL SYSTE, V2, P12; Imhoff JF, 2005, BERGEYS MANUAL SYSTE, V2, P20; Imhoff JF., 2005, BERGEYS MANUAL SYS B, V2, P3; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; KAMPF C, 1980, ARCH MICROBIOL, V127, P125, DOI 10.1007/BF00428016; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kawagucci S, 2013, CHEM GEOL, V339, P213, DOI 10.1016/j.chemgeo.2012.05.003; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Kleiner M, 2012, P NATL ACAD SCI USA, V109, pE1173, DOI 10.1073/pnas.1121198109; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marshall KT, 2013, ISME J, V7, P452, DOI 10.1038/ismej.2012.78; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; MIDI, 1999, SHERL MICR ID SYST O; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Mori K, 2011, INT J SYST EVOL MICR, V61, P2412, DOI 10.1099/ijs.0.026963-0; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nakagawa S, 2014, ISME J, V8, P40, DOI 10.1038/ismej.2013.131; Newton ILG, 2007, SCIENCE, V315, P998, DOI 10.1126/science.1138438; Nunoura T, 2008, INT J SYST EVOL MICR, V58, P676, DOI 10.1099/ijs.0.64615-0; Nunoura T, 2009, FEMS MICROBIOL ECOL, V67, P351, DOI 10.1111/j.1574-6941.2008.00636.x; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Ramos AR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00137; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Sorokin DY, 2007, ARCH MICROBIOL, V187, P441, DOI 10.1007/s00203-006-0208-3; Sorokin DY, 2010, INT J SYST EVOL MICR, V60, P444, DOI 10.1099/ijs.0.012880-0; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Sucharita K, 2010, INT J SYST EVOL MICR, V60, P1103, DOI 10.1099/ijs.0.013284-0; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Suzuki Y, 2006, MAR ECOL PROG SER, V315, P167, DOI 10.3354/meps315167; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takai K, 2000, INT J SYST EVOL MICR, V50, P489, DOI 10.1099/00207713-50-2-489; Takai K, 2005, INT J SYST EVOL MICR, V55, P183, DOI 10.1099/ijs.0.63330-0; Takai K, 2004, INT J SYST EVOL MICR, V54, P2325, DOI 10.1099/ijs.0.63284-0; Takai K, 2003, FEMS MICROBIOL LETT, V218, P167, DOI 10.1111/j.1574-6968.2003.tb11514.x; Takai K, 2002, INT J SYST EVOL MICR, V52, P1089, DOI 10.1099/00207713-52-4-1089; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; TAKAKUWA S, 1977, J GEN APPL MICROBIOL, V23, P163, DOI 10.2323/jgam.23.163; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Welte C, 2009, FEBS LETT, V583, P1281, DOI 10.1016/j.febslet.2009.03.020; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11; Zaar A, 2003, ARCH MICROBIOL, V179, P174, DOI 10.1007/s00203-002-0514-3; Zane GM, 2010, APPL ENVIRON MICROB, V76, P5500, DOI 10.1128/AEM.00691-10; ZILLIG W, 1990, J BACTERIOL, V172, P3959, DOI 10.1128/jb.172.7.3959-3965.1990	98	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104959	10.1371/journal.pone.0104959	http://dx.doi.org/10.1371/journal.pone.0104959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133584	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700056
J	Watson, CM; El-Asrag, M; Parry, DA; Morgan, JE; Logan, CV; Carr, IM; Sheridan, E; Charlton, R; Johnson, CA; Taylor, G; Toomes, C; McKibbin, M; Inglehearn, CF; Ali, M				Watson, Christopher M.; El-Asrag, Mohammed; Parry, David A.; Morgan, Joanne E.; Logan, Clare V.; Carr, Ian M.; Sheridan, Eamonn; Charlton, Ruth; Johnson, Colin A.; Taylor, Graham; Toomes, Carmel; McKibbin, Martin; Inglehearn, Chris F.; Ali, Manir			Mutation Screening of Retinal Dystrophy Patients by Targeted Capture from Tagged Pooled DNAs and Next Generation Sequencing	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; MISSENSE MUTATIONS; VISUAL FUNCTION; GENE-THERAPY; ABCA4 GENE; DISEASE; MICE; FREQUENCY	Purpose: Retinal dystrophies are genetically heterogeneous, resulting from mutations in over 200 genes. Prior to the development of massively parallel sequencing, comprehensive genetic screening was unobtainable for most patients. Identifying the causative genetic mutation facilitates genetic counselling, carrier testing and prenatal/pre-implantation diagnosis, and often leads to a clearer prognosis. In addition, in a proportion of cases, when the mutation is known treatment can be optimised and patients are eligible for enrolment into clinical trials for gene-specific therapies. Methods: Patient genomic DNA was sheared, tagged and pooled in batches of four samples, prior to targeted capture and next generation sequencing. The enrichment reagent was designed against genes listed on the RetNet database (July 2010). Sequence data were aligned to the human genome and variants were filtered to identify potential pathogenic mutations. These were confirmed by Sanger sequencing. Results: Molecular analysis of 20 DNAs from retinal dystrophy patients identified likely pathogenic mutations in 12 cases, many of them known and/or confirmed by segregation. These included previously described mutations in ABCA4 (c.6088C> T,p.R2030*; c.5882G>A,p.G1961E), BBS2 (c.1895G>C,p.R632P), GUCY2D (c.2512C>T, p.R838C), PROM1 (c.1117C> T,p.R373C), RDH12 (c.601T. C, p.C201R; c.506G>A, p.R169Q), RPGRIP1 (c.3565C>T, p.R1189*) and SPATA7 (c.253C>T, p.R85*) and new mutations in ABCA4 (c.3328+ 1G>C), CRB1 (c.2832_2842+23del), RP2 (c.884-1G>T) and USH2A (c.12874A. G,p.N4292D). Conclusions: Tagging and pooling DNA prior to targeted capture of known retinal dystrophy genes identified mutations in 60% of cases. This relatively high success rate may reflect enrichment for consanguineous cases in the local Yorkshire population, and the use of multiplex families. Nevertheless this is a promising high throughput approach to retinal dystrophy diagnostics.	[Watson, Christopher M.; Charlton, Ruth; Taylor, Graham] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [El-Asrag, Mohammed; Logan, Clare V.; Johnson, Colin A.; Toomes, Carmel; McKibbin, Martin; Inglehearn, Chris F.; Ali, Manir] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Parry, David A.; Morgan, Joanne E.; Carr, Ian M.; Sheridan, Eamonn] Univ Leeds, Leeds Inst Biomed & Clin Sci, Genet Sect, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Leeds; Saint James's University Hospital	Ali, M (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England.	medma@leeds.ac.uk	Ali, Manir/ABE-5251-2020; Elasrag, Mohammed/ABF-5702-2020; Inglehearn, Chris/GYD-9783-2022	Ali, Manir/0000-0003-3204-3788; Elasrag, Mohammed/0000-0003-3750-7414; Johnson, Colin/0000-0002-2979-8234; Toomes, Carmel/0000-0001-8373-9545; Watson, Christopher Mark/0000-0003-2371-1844; Logan, Clare/0000-0003-4323-1602; Parry, David/0000-0003-0376-7736	Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research [022]; Sir Jules Thorn Charitable Trust; Egyptian Government; Medical Research Council [MR/K011154/1, MR/L01629X/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [MR/L01629X/1, MR/K011154/1] Funding Source: UKRI	Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research; Sir Jules Thorn Charitable Trust; Egyptian Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Leeds Teaching Hospitals NHS Trust Challenge Fund, Yorkshire Eye Research (grant number 022) and the Sir Jules Thorn Charitable Trust. ME-A is funded by a Scholarship from the Egyptian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Burke TR, 2012, INVEST OPHTH VIS SCI, V53, P4458, DOI 10.1167/iovs.11-9166; Cella W, 2009, EXP EYE RES, V89, P16, DOI 10.1016/j.exer.2009.02.001; Coppieters F, 2012, GENET MED, V14, P576, DOI 10.1038/gim.2011.51; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fedick A, 2014, CLIN GENET, V85, P578, DOI 10.1111/cge.12231; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Khan MI, 2010, MOL VIS, V16, P2753; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Mackay DS, 2011, MOL VIS, V17, P2706; Mackay DS, 2011, INVEST OPHTH VIS SCI, V52, P3032, DOI 10.1167/iovs.10-7025; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Michaelides M, 2010, INVEST OPHTH VIS SCI, V51, P4771, DOI 10.1167/iovs.09-4561; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Singh HP, 2006, AM J OPHTHALMOL, V141, P906, DOI 10.1016/j.ajo.2005.12.009; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Van Ghelue  M, 2000, Ophthalmic Genet, V21, P197, DOI 10.1076/1381-6810(200012)21:4;1-H;FT197; Wilkie SE, 2000, HUM MOL GENET, V9, P3065, DOI 10.1093/hmg/9.20.3065; Willis TA, 2013, BRIT J OPHTHALMOL, V97, P1148, DOI 10.1136/bjophthalmol-2013-303434; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104281	10.1371/journal.pone.0104281	http://dx.doi.org/10.1371/journal.pone.0104281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133751	Green Published, gold			2022-12-27	WOS:000341302700027
J	Weaver, MR; Burnett, SM; Crozier, I; Kinoti, SN; Kirunda, I; Mbonye, MK; Naikoba, S; Ronald, A; Rubashembusya, T; Zawedde, S; Willis, KS				Weaver, Marcia R.; Burnett, Sarah M.; Crozier, Ian; Kinoti, Stephen N.; Kirunda, Ibrahim; Mbonye, Martin K.; Naikoba, Sarah; Ronald, Allan; Rubashembusya, Timothy; Zawedde, Stella; Willis, Kelly S.			Improving Facility Performance in Infectious Disease Care in Uganda: A Mixed Design Study with Pre/Post and Cluster Randomized Trial Components	PLOS ONE			English	Article							CHILDHOOD ILLNESS STRATEGY; INTEGRATED MANAGEMENT; ANTIRETROVIRAL TREATMENT; QUALITY IMPROVEMENT; MORTALITY; NURSES; IMPACT	Background: The effects of two interventions, Integrated Management of Infectious Disease (IMID) training program and On-Site Support (OSS), were tested on 23 facility performance indicators for emergency triage assessment and treatment (ETAT), malaria, pneumonia, tuberculosis, and HIV. Methods: The trial was implemented in 36 primary care facilities in Uganda. From April 2010, two mid-level practitioners per facility participated in IMID training. Eighteen of 36 facilities were randomly assigned to Arm A, and received OSS in 2010 (nine monthly two-day sessions); 18 facilities assigned to Arm B did not receive OSS in 2010. Data were collected from Nov 2009 to Dec 2010 using a revised Ministry of Health outpatient medical form and nine registers. We analyzed the effect of IMID training alone by measuring changes before and during IMID training in Arm B, the combined effect of IMID training and OSS by measuring changes in Arm A, and the incremental effect of OSS by comparing changes across Arms A and B. Results: IMID training was associated with statistically significant improvement in three indicators: outpatients triaged (adjusted relative risks (aRR) = 1.29, 99% CI = 1.01,1.64), emergency and priority patients admitted, detained, or referred (aRR = 1.59, 99% CI = 1.04,2.44), and pneumonia suspects assessed (aRR = 2.31, 99% CI = 1.50,3.55). IMID training and OSS combined was associated with improvements in six indicators: three ETAT indicators (outpatients triaged (aRR = 2.03, 99% CI = 1.13,3.64), emergency and priority patients admitted, detained or referred (aRR = 3.03, 99% CI = 1.40,6.56), and emergency patients receiving at least one appropriate treatment (aRR = 1.77, 99% CI = 1.10,2.84)); two malaria indicators (malaria cases receiving appropriate antimalarial (aRR = 1.50, 99% CI = 1.04,2.17), and patients with negative malaria test results prescribed antimalarial (aRR = 0.67, 99% CI = 0.46,0.97)); and enrollment in HIV care (aRR = 1.58, 99% CI = 1.32,1.89). OSS was associated with incremental improvement in emergency patients receiving at least one appropriate treatment (adjusted ratio of RR = 1.84,99% CI = 1.09,3.12). Conclusion: The trial showed that the OSS intervention significantly improved performance in one of 23 facility indicators.	[Weaver, Marcia R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Weaver, Marcia R.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Burnett, Sarah M.; Crozier, Ian; Willis, Kelly S.] Accordia Global Hlth Fdn, Washington, DC USA; [Burnett, Sarah M.; Mbonye, Martin K.; Naikoba, Sarah] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Kinoti, Stephen N.] Univ Res Co LLC, Ctr Human Serv, Bethesda, MD USA; [Kinoti, Stephen N.] Fio Corp, Toronto, ON, Canada; [Kirunda, Ibrahim] Elizabeth Glaser Pediat AIDS Fdn, Mbarara, Uganda; [Mbonye, Martin K.; Naikoba, Sarah; Rubashembusya, Timothy; Zawedde, Stella] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Rubashembusya, Timothy] Univ Manchester, Inst Dev Policy & Management, Manchester, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Antwerp; Makerere University; University of Manitoba; University of Manchester	Weaver, MR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	mweaver@uw.edu		Ronald, Allan/0000-0002-5746-3490; Zawedde-Muyanja, Stella/0000-0002-8823-7082	Bill & Melinda Gates Foundation [94298]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation. http://www.gatesfoundation.org/Pages/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions contained within the manuscript are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d; Boonyasai RT, 2007, JAMA-J AM MED ASSOC, V298, P1023, DOI 10.1001/jama.298.9.1023; Breslow NE, 2003, BIOMETRICS, V59, P1, DOI 10.1111/1541-0420.00001; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Government of Uganda Ministry of Health, 2004, HLTH SECT STRAT PLAN; Huicho L, 2005, HEALTH POLICY PLANN, V20, pI32, DOI 10.1093/heapol/czi052; Institute for Healthcare Improvement, 2003, BREAKTHR SER IHIS CO; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Lindegren ML, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010119; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Naikoba S, 2012, INT J CARE PATHWAYS, V16, P152, DOI DOI 10.1177/2040402613479342; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Republic of Uganda Ministry of Health, 2009, INT CAS FIND FORM; Republic of Uganda Ministry of Health. Quality Assurance Program, 2007, IND MON COMPR HIV AI; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Stop TB Department and Department of HIV/AIDS World Health Organization United States President's Emergency Plan for Aids Relief The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, GUID MON EV COLL TB; *UN GEN ASS SPEC S, 2007, MON DECL COMM HIV AI; UNAIDS, 2011, COUNTD ZER GLOB PLAN; United States Government, 2011, GLOB HLTH IN STRAT D; Weaver MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051319; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization Joint United Nations Program on HIV/AIDS (UNAIDS), 2011, TREATM 2 0 FRAM ACT	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103017	10.1371/journal.pone.0103017	http://dx.doi.org/10.1371/journal.pone.0103017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133799	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700004
J	Abbondanzo, SJ; Chang, SL				Abbondanzo, Susan J.; Chang, Sulie L.			HIV-1 Transgenic Rats Display Alterations in Immunophenotype and Cellular Responses Associated with Aging	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AGE-RELATED DISEASES; MOLECULAR-MECHANISMS; MONOCYTE SUBSETS; HEPATITIS-C; T-CELLS; EXPRESSION; INFECTION; ACTIVATION; RISK	Advances in anti-retroviral therapy over the last two decades have allowed life expectancy in patients infected with the human immunodeficiency virus to approach that of the general population. The process of aging in mammalian species, including rats, results in immune response changes, alterations in immunological phenotypes, and ultimately increased susceptibility to many infectious diseases. In order to investigate the immunological pathologies associated with chronic HIV-1 disease, particularly in aging individuals, the HIV-1 transgenic (HIV-1Tg) rat model was utilized. HIV-1Tg rats were challenged with lipopolysaccharide (LPS) to determine immunological alterations during the aging process. LPS is known to cause an imbalance in cytokine and chemokine release, and provides a method to identify changes in immune responses to bacterial infection in an HIV animal model. An immune profile and accompanying cellular consequences as well as changes in inflammatory cytokine and chemokine release related to age and genotype were assessed in HIV-1Tg rats. The percentage of T cells decreased with age, particularly T cytotoxic cells, whereas T helper cells increased with age. Neutrophils and monocytes increased in HIV-1Tg rats during maturation compared to age-matched F344 control rats. Aging HIV-1Tg rats displayed a significant increase in the pro-inflammatory cytokines, IL-6 and TNF-alpha, along with an increase in the chemokine, KC/GRO, in comparison to age-matched controls. Our data indicate that immunophenotype and immune responses can change during aging in HIV-positive individuals. This information could be important in determining the most beneficial age-dependent therapeutic treatment for HIV patients.	[Chang, Sulie L.] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA; Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA	Seton Hall University; Seton Hall University	Chang, SL (corresponding author), Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA.	sulie.chang@shu.edu			United States National Institutes of Health [AA-019415, DA07058, DA-016149, DA-026356, DA-036175]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007058, K02DA016149, R01DA026356, R21DA036175] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported, in part, by United States National Institutes of Health grants AA-019415, DA07058, DA-016149, DA-026356, and DA-036175 to SLC. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2011, TOP ANTIVIR MED, V20, P101; [Anonymous], 2012, HIV UK 2012 REP; [Anonymous], 2012, J AM GERIATR SOC, V60, P974; Barrett L, 2012, AIDS REV, V14, P159; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Chang SL, 2007, J VIROL, V81, P8406, DOI 10.1128/JVI.00155-07; Chang SL, 2012, J NEUROIMMUNE PHARM, V7, P332, DOI 10.1007/s11481-011-9324-1; Chen R, 2005, J NEUROIMMUNOL, V163, P53, DOI 10.1016/j.jneuroim.2005.02.012; Dawson HD, 1999, J NUTR, V129, P1782, DOI 10.1093/jn/129.10.1782; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; Grau V, 2000, IMMUNOBIOLOGY, V202, P94, DOI 10.1016/S0171-2985(00)80056-X; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Homji NF, 2012, INT J CLIN EXP MED, V5, P105; Homji NF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-3; Joshi PC, 2008, AM J RESP CELL MOL, V39, P218, DOI 10.1165/rcmb.2007-0344OC; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad; Manfredi R, 2004, Infez Med, V12, P152; Manfredi Roberto, 2004, Expert Rev Anti Infect Ther, V2, P821, DOI 10.1586/14789072.2.6.821; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; Nath A, 2012, J NEUROVIROL, V18, P245, DOI 10.1007/s13365-012-0111-4; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Pahlavani MA, 2001, FEBS LETT, V491, P114, DOI 10.1016/S0014-5793(01)02184-6; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Reid W, 2004, VIROLOGY, V321, P111, DOI 10.1016/j.virol.2003.12.010; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Ropolo A, 2001, EXP GERONTOL, V36, P519, DOI 10.1016/S0531-5565(00)00222-9; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schmucker DL, 2002, EXP GERONTOL, V37, P1089, DOI 10.1016/S0531-5565(02)00065-7; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Smith RL, 2013, FRONT GENET, V3, P328; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; van Maanen M, 2003, CURR HIV RES, V1, P121; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wolf J, 2012, EXP GERONTOL, V47, P749, DOI 10.1016/j.exger.2012.07.001; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yadav A, 2006, VIROLOGY, V353, P357, DOI 10.1016/j.virol.2006.05.026; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074390	53	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105256	10.1371/journal.pone.0105256	http://dx.doi.org/10.1371/journal.pone.0105256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127062	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300098
J	Alba, C; Bowers, MD; Blumenthal, D; Hufbauer, RA				Alba, Christina; Bowers, M. Deane; Blumenthal, Dana; Hufbauer, Ruth A.			Chemical and Mechanical Defenses Vary among Maternal Lines and Leaf Ages in Verbascum thapsus L. (Scrophulariaceae) and Reduce Palatability to a Generalist Insect	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; IRIDOID GLYCOSIDES; NATURAL ENEMIES; COMMON MULLEIN; HERBIVORY; SPECIALIST; PERFORMANCE; RESISTANCE; EVOLUTION; TRICHOMES	Intra-specific variation in host-plant quality affects herbivore foraging decisions and, in turn, herbivore foraging decisions mediate plant fitness. In particular, variation in defenses against herbivores, both among and within plants, shapes herbivore behavior. If variation in defenses is genetically based, it can respond to natural selection by herbivores. We quantified intra-specific variation in iridoid glycosides, trichome length, and leaf strength in common mullein (Verbascum thapsus L, Scrophulariaceae) among maternal lines within a population and among leaves within plants, and related this variation to feeding preferences of a generalist herbivore, Trichopulsia ni Hubner. We found significant variation in all three defenses among maternal lines, with T. ni preferring plants with lower investment in chemical, but not mechanical, defense. Within plants, old leaves had lower levels of all defenses than young leaves, and were strongly preferred by T. ni. Caterpillars also preferred leaves with trichomes removed to leaves with trichomes intact. Differences among maternal lines indicate that phenotypic variation in defenses likely has a genetic basis. Furthermore, these results reveal that the feeding behaviors of T. ni map onto variation in plant defense in a predictable way. This work highlights the importance of variation in host-plant quality in driving interactions between plants and their herbivores.	[Alba, Christina; Hufbauer, Ruth A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Alba, Christina; Hufbauer, Ruth A.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Bowers, M. Deane] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Blumenthal, Dana] USDA ARS, Ft Collins, CO 80522 USA	Colorado State University; Colorado State University; University of Colorado System; University of Colorado Boulder; United States Department of Agriculture (USDA)	Alba, C (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	christina.alba@ibot.cas.cz	Hufbauer, Ruth/ABA-3984-2020; Alba, Christina/H-1579-2014	Hufbauer, Ruth/0000-0002-8270-0638; Alba, Christina/0000-0001-7040-8480; BOWERS, M/0000-0002-5697-888X	United States Department of Agriculture, Colorado Agricultural Experiment Station [COL00680, COL00222A]; Harold David Harrington Graduate Fellowship; Colorado State University; Academy of Sciences of the Czech Republic [RVO 67985939]	United States Department of Agriculture, Colorado Agricultural Experiment Station; Harold David Harrington Graduate Fellowship; Colorado State University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	RH was supported by the United States Department of Agriculture, Colorado Agricultural Experiment Station (grant numbers COL00680 and COL00222A; URL aes.agsci.colostate.edu). CA received support from the Harold David Harrington Graduate Fellowship administered through the Biology Department at Colorado State University. Funding for page charges was provided by the Colorado State University Libraries Open Access Research and Scholarship Fund. CA was funded by long-term research development project no. RVO 67985939 from the Academy of Sciences of the Czech Republic URL http://cas.cz) during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the of the manuscript.	ADLER LS, 1995, OECOLOGIA, V101, P75, DOI 10.1007/BF00328903; Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; AGREN J, 1994, AM NAT, V143, P1, DOI 10.1086/285593; AIDE TM, 1989, OIKOS, V55, P66, DOI 10.2307/3565873; Alba C, 2013, CHEMOECOLOGY, V23, P83, DOI 10.1007/s00049-012-0121-y; Alba C, 2012, BIOL INVASIONS, V14, P2505, DOI 10.1007/s10530-012-0247-4; Alba C, 2011, BIOL INVASIONS, V13, P2379, DOI 10.1007/s10530-011-0050-7; Aranwela N, 1999, NEW PHYTOL, V144, P369, DOI 10.1046/j.1469-8137.1999.00506.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Bottrell DG, 1998, ANNU REV ENTOMOL, V43, P347, DOI 10.1146/annurev.ento.43.1.347; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1984, J CHEM ECOL, V10, P1567, DOI 10.1007/BF00988425; Bowers MD, 1991, HERBIVORES THEIR INT; Choong MF, 1996, FUNCT ECOL, V10, P668, DOI 10.2307/2390178; Chu CC, 2001, ANN ENTOMOL SOC AM, V94, P743, DOI 10.1603/0013-8746(2001)094[0743:SOUCCT]2.0.CO;2; Clapham A. R., 1952, FLORA BRIT ISLES; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; DAMTOFT S, 1994, PHYTOCHEMISTRY, V35, P1187, DOI 10.1016/S0031-9422(00)94819-2; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Elle E, 1999, EVOLUTION, V53, P22, DOI 10.1111/j.1558-5646.1999.tb05330.x; Facknath S, 2005, ENTOMOL EXP APPL, V115, P79, DOI 10.1111/j.1570-7458.2005.00286.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; GROSS KL, 1978, CAN J PLANT SCI, V58, P401, DOI 10.4141/cjps78-062; Handley R, 2005, ECOL ENTOMOL, V30, P284, DOI 10.1111/j.0307-6946.2005.00699.x; Hanley ME, 2002, FUNCT ECOL, V16, P216, DOI 10.1046/j.1365-2435.2002.00612.x; Hanson FE, 1983, HERBIVOROUS INSECTS; Hare JD, 1992, PLANT RESISTNAC HERB; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HERMS DA, 1992, Q REV BIOL, V67, P478; Jamieson MA, 2010, J CHEM ECOL, V36, P70, DOI 10.1007/s10886-009-9728-z; Kessler A, 2004, SCIENCE, V306, P2042; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Koricheva J, 2002, OIKOS, V98, P537, DOI 10.1034/j.1600-0706.2002.980319.x; LARSSON S, 1988, ECOL ENTOMOL, V13, P19, DOI 10.1111/j.1365-2311.1988.tb00329.x; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LOWMAN MD, 1983, AUST J ECOL, V8, P17, DOI 10.1111/j.1442-9993.1983.tb01515.x; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Menken SBJ, 1996, ENTOMOL EXP APPL, V80, P297, DOI 10.1007/BF00194779; MITICH LW, 1989, WEED TECHNOL, V3, P704; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; NICHOLSORIANS CM, 1989, BIOTROPICA, V21, P80, DOI 10.2307/2388446; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; PUTTICK GM, 1988, J CHEM ECOL, V14, P335, DOI 10.1007/BF01022550; Rasmann S, 2012, PLANT SIGNAL BEHAV, V7, P447, DOI 10.4161/psb.19525; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; Robinson G.S., 2010, HOSTS A DATABASE WOR; Salisbury E. J ., 1942, REPROD CAPACITY PLAN; Sanson G, 2001, AUSTRAL ECOL, V26, P535, DOI 10.1046/j.1442-9993.2001.01154.x; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Valkama E, 2004, ANN BOT-LONDON, V94, P233, DOI 10.1093/aob/mch131; Valverde PL, 2001, J EVOLUTION BIOL, V14, P424, DOI 10.1046/j.1420-9101.2001.00295.x; van Dam NM, 1999, J HERED, V90, P220, DOI 10.1093/jhered/90.1.220; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Wheeler GS, 1996, BIOL CONTROL, V7, P1, DOI 10.1006/bcon.1996.0056; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wilbur H. D., 2013, NeoBiota, P21; WOODMAN RL, 1991, OIKOS, V60, P11, DOI 10.2307/3544986; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868	71	11	11	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104889	10.1371/journal.pone.0104889	http://dx.doi.org/10.1371/journal.pone.0104889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127229	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300060
J	Kobashigawa, LC; Xu, YC; Padbury, JF; Tseng, YT; Yano, N				Kobashigawa, Laura C.; Xu, Yan Chun; Padbury, James F.; Tseng, Yi-Tang; Yano, Naohiro			Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study	PLOS ONE			English	Article							FERRITIN HEAVY-CHAIN; INDUCED CARDIOTOXICITY; INDUCED APOPTOSIS; TYROSINE KINASE; HEART-FAILURE; CELL-DEATH; MECHANISM; GLUCOSE; SYSTEM; TRANSCRIPTION	Doxorubicin (Dox) is one of the most widely used antitumor drugs, but its cumulative cardiotoxicity have been major concerns in cancer therapeutic practice for decades. Recent studies established that metformin (Met), an oral anti-diabetic drug, provides protective effects in Dox-induced cardiotoxicity. Met has been shown to increase fatty acid oxidation, an effect mediated by AMP activated protein kinase (AMPK). Here we delineate the intracellular signaling factors involved in Met mediated protection against Dox-induced cardiotoxicity in the H9c2 cardiomyoblast cell line. Treatment with low dose Met (0.1 mM) increased cell viabilities and Ki-67 expressions while decreasing LDH leakages, ROS generations and [Ca2+](i). The protective effect was reversed by a co-treatment with compound-C, an AMPK specific inhibitor, or by an over expression of a dominant-negative AMPK alpha cDNA. Inhibition of PKA with H89 or a suppression of Src kinase by a small hairpin siRNA also abrogated the protective effect of the low dose Met. Whereas, with a higher dose of Met (1.0 mM), the protective effects were abolished regardless of the enhanced AMPK, PKA/CREB1 and Src kinase activity. In high dose Met treated cells, expression of platelet-derived growth factor receptor (PDGFR) was significantly suppressed. Furthermore, the protective effect of low dose Met was totally reversed by co-treatment with AG1296, a PDGFR specific antagonist. These data provide in vitro evidence supporting a signaling cascade by which low dose Met exerts protective effects against Dox via sequential involvement of AMPK, PKA/CREB1, Src and PDGFR. Whereas high dose Met reverses the effect by suppressing PDGFR expression.	[Kobashigawa, Laura C.; Xu, Yan Chun; Padbury, James F.; Tseng, Yi-Tang; Yano, Naohiro] Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA	Brown University; Women & Infants Hospital Rhode Island	Tseng, YT (corresponding author), Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA.	ytseng@wihri.org; nyano@wihri.org			National Center for Research Resources [SP20RR018728-10]; National Institute of General Medical Science from the National Institute of Health [8 P20 GM103537-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103537] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Science from the National Institute of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Center for Research Resources (SP20RR018728-10) and the National Institute of General Medical Science (8 P20 GM103537-10) from the National Institute of Health (to Y-TT and JFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, DIABETOLOGIA, V49, P2174, DOI 10.1007/s00125-006-0338-9; Asensio-Lopez MC, 2014, FREE RADICAL BIO MED, V67, P19, DOI 10.1016/j.freeradbiomed.2013.11.003; Asensio-Lopez MC, 2013, FREE RADICAL BIO MED, V57, P188, DOI 10.1016/j.freeradbiomed.2012.09.009; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Faure P, 1999, DIABETES, V48, P353, DOI 10.2337/diabetes.48.2.353; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOTTLIEB JA, 1973, CANCER RES, V33, P3024; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Iarussi D, 2001, CURR MED CHEM, V8, P1649, DOI 10.2174/0929867013371888; Kalivendi SV, 2001, J BIOL CHEM, V276, P47266, DOI 10.1074/jbc.M106829200; Kalka D, 1998, ARCH GERONTOL GERIAT, V27, P251, DOI 10.1016/S0167-4943(98)00122-8; Kanigur-Sultuybek G, 1995, J Basic Clin Physiol Pharmacol, V6, P271; Kewalramani G, 2009, CARDIOVASC RES, V84, P42, DOI 10.1093/cvr/cvp166; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mahrouf M, 2006, BIOCHEM PHARMACOL, V72, P176, DOI 10.1016/j.bcp.2006.04.027; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Pan QR, 2009, HORM METAB RES, V41, P799, DOI 10.1055/s-0029-1234043; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; WANG JJ, 1971, CANCER, V28, P837, DOI 10.1002/1097-0142(1971)28:4<837::AID-CNCR2820280406>3.0.CO;2-4; WONG K, 1994, J BIOL CHEM, V269, P28878; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Yuan HD, 2011, BIOSCI BIOTECH BIOCH, V75, P1079, DOI 10.1271/bbb.100881; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	42	71	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104888	10.1371/journal.pone.0104888	http://dx.doi.org/10.1371/journal.pone.0104888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127116	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300059
J	Lopez-Sanchez, A; Schroeder, J; Roig, S; Sobral, M; Dirzo, R				Lopez-Sanchez, Aida; Schroeder, John; Roig, Sonia; Sobral, Mar; Dirzo, Rodolfo			Effects of Cattle Management on Oak Regeneration in Northern Californian Mediterranean Oak Woodlands	PLOS ONE			English	Article							QUERCUS-DOUGLASII; RECRUITMENT; CONSERVATION; PATTERNS; SYSTEMS; LOBATA; ILEX; BIODIVERSITY; POPULATIONS; ENVIRONMENT	Oak woodlands of Mediterranean ecosystems, a major component of biodiversity hotspots in Europe and North America, have undergone significant land-use change in recent centuries, including an increase in grazing intensity due to the widespread presence of cattle. Simultaneously, a decrease in oak regeneration has been observed, suggesting a link between cattle grazing intensity and limited oak regeneration. In this study we examined the effect of cattle grazing on coast live oak (Quercus agrifolia Nee) regeneration in San Francisco Bay Area, California. We studied seedling, sapling and adult density of coast live oak as well as vertebrate herbivory at 8 independent sites under two grazing conditions: with cattle and wildlife presence (n = 4) and only with wildlife (n = 4). The specific questions we addressed are: i) to what extent cattle management practices affect oak density, and ii) what is the effect of rangeland management on herbivory and size of young oak plants. In areas with cattle present, we found a 50% reduction in young oak density, and plant size was smaller, suggesting that survival and growth young plants in those areas are significantly limited. In addition, the presence of cattle raised the probability and intensity of herbivory (a 1.5 and 1.8-fold difference, respectively). These results strongly suggest that the presence of cattle significantly reduced the success of young Q. agrifolia through elevated herbivory. Given the potential impact of reduced recruitment on adult populations, modifying rangeland management practices to reduce cattle grazing pressure seems to be an important intervention to maintain Mediterranean oak woodlands.	[Lopez-Sanchez, Aida; Roig, Sonia] Univ Politecn Madrid, Dept Silvopascicultura, Madrid, Spain; [Lopez-Sanchez, Aida; Roig, Sonia] Univ Politecn Madrid, Ecol & Gest Forestal Sostenible Res Grp, Madrid, Spain; [Schroeder, John; Sobral, Mar; Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Stanford University	Lopez-Sanchez, A (corresponding author), Univ Politecn Madrid, Dept Silvopascicultura, Madrid, Spain.	aida.lopez.sanchez@gmail.com	López-Sánchez, Aida/AAA-9038-2019; Sobral, Mar/Q-9812-2017; Roig, Sonia/F-8302-2010	López-Sánchez, Aida/0000-0003-3857-2816; Sobral, Mar/0000-0001-6995-0491; Roig, Sonia/0000-0002-2057-3020	(Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport	(Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport	This study has been developed thanks to a study abroad fellowship (Formacion del Profesorado Universitario) of Spain Ministry of Education, Culture and Sport to ALS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez JA, 2008, FOREST ECOL MANAG, V255, P1976, DOI 10.1016/j.foreco.2007.12.019; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen-Diaz B. H., 1992, Madrono, V39, P47; Allen-Diaz B, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P313; Bartolome J.W., 1987, P S MULT US MAN CAL, P26; Bates D, 2012, LME4 LINEAR MIXED EF; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bolsinger C. L., 1988, RESOURCE B USDA; Brown RW, 1991, THESIS U CALIFORNIA; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Callaway R. M., 1991, Madrono, V38, P158; CALLAWAY RM, 1992, ECOLOGY, V73, P2118, DOI 10.2307/1941460; Callaway RM, 1998, J VEG SCI, V9, P647, DOI 10.2307/3237283; Carmona CP, 2013, BIOL CONSERV, V159, P240, DOI 10.1016/j.biocon.2012.11.015; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Dahlgren RA, 1997, BIOGEOCHEMISTRY, V39, P45, DOI 10.1023/A:1005812621312; Danielsen K, 1990, THESIS U CALIFORNIA; DAVIS FW, 1991, US FOR SERV T R PSW, V126, P81; Dufour-Dror JM, 2007, ACTA OECOL, V31, P223, DOI 10.1016/j.actao.2006.11.003; Eichhorn MP, 2006, AGROFOREST SYST, V67, P29, DOI 10.1007/s10457-005-1111-7; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fox J., 2018, R COMPANION APPL REG, VThird; Garzon-Heydt J, 2004, IALE PUBLICATION SER, P259; Gea-Izquierdo G, 2008, CAN J FOREST RES, V38, P101, DOI 10.1139/X07-142; GORDON DR, 1989, OECOLOGIA, V79, P533, DOI 10.1007/BF00378672; Greenwood G.B., 1993, EXTENT OWNERSHIP CAL; GRIFFIN JR, 1971, ECOLOGY, V52, P862, DOI 10.2307/1936034; GRIFFIN JR, 1976, AM MIDL NAT, V95, P422, DOI 10.2307/2424405; Huntsinger L, 1991, PSW126 USDA FOR SERV; Johnson S, 1985, PAC DISCOV, V38, P4; Mahall BE, 2009, AM J BOT, V96, P751, DOI 10.3732/ajb.0800247; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Maranon T., 2009, WEB ECOLOGY, V9, P30, DOI [10.5194/we-9-30-2009, DOI 10.5194/WE-9-30-2009]; Matzner SL, 2003, TREE PHYSIOL, V23, P777, DOI 10.1093/treephys/23.11.777; McClaran M. P., 1989, Madrono, V36, P141; McClaran M. P, 1987, P S MULT US MAN CAL; McCreary DD, 2004, US FOR SERV RMRS-P, V35, P109; Muick P.C., 1987, ASSESSMENT NATURAL R; MUICK PC, 1991, US FOR SERV T R PSW, V126, P21; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Noble IR, 1997, SCIENCE, V277, P522, DOI 10.1126/science.277.5325.522; Papachristou TG, 2005, SMALL RUMINANT RES, V59, P141, DOI 10.1016/j.smallrumres.2005.05.003; Plieninger T, 2004, J ARID ENVIRON, V57, P345, DOI 10.1016/S0140-1963(03)00103-4; Plieninger T, 2010, ECOSYSTEMS, V13, P644, DOI 10.1007/s10021-010-9345-2; PLUMB TR, 1991, US FOR SERV T R PSW, V126, P74; Roche LM, 2012, BIODIVERS CONSERV, V21, P2555, DOI 10.1007/s10531-012-0317-z; Serrada Hierro R., 2004, Investigacion Agraria, Sistemas y Recursos Forestales, P127; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Standiford R, 2003, P 12 WORLD FOR C QUE, P111; Standiford Richard, 1997, Madrono, V44, P170; Stromberg MR, 1996, ECOL APPL, V6, P1189, DOI 10.2307/2269601; Swiecki TJ, 1997, PROCEEDINGS OF A SYMPOSIUM ON OAK WOODLANDS: ECOLOGY, MANAGEMENT, AND URBAN INTERFACE ISSUES, P147; Swiecki TJ, 1998, FREMONTIA, V26, P19; TRIMBLE SW, 1995, GEOMORPHOLOGY, V13, P233, DOI 10.1016/0169-555X(95)00028-4; Tyler CM, 2008, FOREST ECOL MANAG, V255, P3063, DOI 10.1016/j.foreco.2008.01.073; Tyler CM, 2006, Q REV BIOL, V81, P127, DOI 10.1086/506025; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Welker JM, 1987, P INT C MEAS SOIL PL, P229; WHITE KL, 1966, ECOLOGY, V47, P229, DOI 10.2307/1933769; Zamora R, 2001, FOREST ECOL MANAG, V144, P33, DOI 10.1016/S0378-1127(00)00362-5; Zavaleta ES, 2007, DIVERS DISTRIB, V13, P735, DOI 10.1111/j.1472-4642.2007.00384.x; Zuur Alain F., 2009, P1; [No title captured]	66	26	26	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105472	10.1371/journal.pone.0105472	http://dx.doi.org/10.1371/journal.pone.0105472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126939	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300113
J	Weil, MM; Ray, FA; Genik, PC; Yu, YJ; McCarthy, M; Fallgren, CM; Ullrich, RL				Weil, Michael M.; Ray, F. Andrew; Genik, Paula C.; Yu, Yongjia; McCarthy, Maureen; Fallgren, Christina M.; Ullrich, Robert L.			Effects of Si-28 Ions, Fe-56 Ions, and Protons on the Induction of Murine Acute Myeloid Leukemia and Hepatocellular Carcinoma	PLOS ONE			English	Article							MICE; CARCINOGENESIS; INFLAMMATION; NEUTRON; CANCER; RAYS	Estimates of cancer risks posed to space-flight crews by exposure to high atomic number, high-energy (HZE) ions are subject to considerable uncertainty because epidemiological data do not exist for human populations exposed to similar radiation qualities. We assessed the carcinogenic effects of 300 MeV/n Si-28 or 600 MeV/n Fe-56 ions in a mouse model for radiation-induced acute myeloid leukemia and hepatocellular carcinoma. C3H/HeNCrl mice were irradiated with 0.1, 0.2, 0.4, or 1 Gy of 300 MeV/n Si-28 ions, 600 MeV/n Fe-56 ions or 1 or 2 Gy of protons simulating the 1972 solar particle event (1972SPE) at the NASA Space Radiation Laboratory. Additional mice were irradiated with Cs-137 gamma rays at doses of 1, 2, or 3 Gy. All groups were followed until they were moribund or reached 800 days of age. We found that Si-28 or Fe-56 ions do not appear to be substantially more effective than gamma rays for the induction of acute myeloid leukemia. However, Si-28 or Fe-56 ion irradiated mice had a much higher incidence of hepatocellular carcinoma than gamma ray irradiated or proton irradiated mice. These data demonstrate a clear difference in the effects of these HZE ions on the induction of leukemia compared to solid tumors, suggesting potentially different mechanisms of tumorigenesis. Also seen in this study was an increase in metastatic hepatocellular carcinoma in the Si-28 and Fe-56 ion irradiated mice compared with those exposed to gamma rays or 1972SPE protons, a finding with important implications for setting radiation exposure limits for space-flight crew members.	[Weil, Michael M.; Ray, F. Andrew; Genik, Paula C.; Fallgren, Christina M.] Colorado State Univ, Ft Collins, CO 80523 USA; [Yu, Yongjia; McCarthy, Maureen; Ullrich, Robert L.] Univ Texas Med Branch, Galveston, TX 77555 USA	Colorado State University; University of Texas System; University of Texas Medical Branch Galveston	Weil, MM (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.	michael.weil@colostate.edu		Genik, Paula C/0000-0003-2149-599X	National Aeronautics and Space Administration [NNX09AM08G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by grant NNX09AM08G from the National Aeronautics and Space Administration (www.nasa.gov/exploration/humanresearch/) to RLU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPEN EL, 1994, ADV SPACE RES, V14, P573, DOI 10.1016/0273-1177(94)90512-6; ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; Alzahrani B, 2014, CANCER LETT, V345, P223, DOI 10.1016/j.canlet.2013.08.036; Bielefeldt-Ohmann H, 2012, HEALTH PHYS, V103, P568, DOI 10.1097/HP.0b013e318265a257; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; CLAPP NK, 1974, RADIAT RES, V57, P158, DOI 10.2307/3573764; Cucinotta FA, 2011, NASATP2011216155; Cucinotta FA., 2009, HUMAN HLTH PERFORMAN, P119; Cucinotta FA., 2013, TP2013217375 NASA; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Darakhshan F, 2006, CARCINOGENESIS, V27, P311, DOI 10.1093/carcin/bgi207; Datta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059295; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Finney DJ, 1947, PROBIT ANAL STAT TRE; Foumier C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00643; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; ICRP, 2013, ICPR PUBL, V123; Miller RC, 1999, P NATL ACAD SCI USA, V96, P19, DOI 10.1073/pnas.96.1.19; MOLE RH, 1983, BRIT J CANCER, V47, P285, DOI 10.1038/bjc.1983.37; NCRP, 2006, 153 NCRP; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Shuryak I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028559; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; THESEUS, 2012, CLUSTER 3 SPACE RAD; Turusov VS, 1994, PATHOLOGY TUMOURS LA; ULLRICH RL, 1977, RADIAT RES, V72, P487, DOI 10.2307/3574612; ULLRICH RL, 1983, RADIAT RES, V93, P506, DOI 10.2307/3576029; ULLRICH RL, 1987, RADIAT RES, V109, P165, DOI 10.2307/3576877; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1	34	62	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104819	10.1371/journal.pone.0104819	http://dx.doi.org/10.1371/journal.pone.0104819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126721	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300055
J	Carvalho, N; Noiret, N; Vandel, P; Monnin, J; Chopard, G; Laurent, E				Carvalho, Nicolas; Noiret, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles; Laurent, Eric			Saccadic Eye Movements in Depressed Elderly Patients	PLOS ONE			English	Article							COGNITIVE INHIBITION; NEUROPSYCHOLOGICAL DEFICITS; EXECUTIVE FUNCTION; AFFECTIVE-DISORDER; PREFRONTAL CORTEX; MAJOR DEPRESSION; TASK-PERFORMANCE; ANTISACCADE TASK; CORTICAL CONTROL; WORKING-MEMORY	The primary aim of this study was to characterize oculomotor performances in elderly depressed patients. The second aim was to investigate whether cognitive inhibition measured by the antisaccade task was associated with a psychomotor retardation or rather with a more specific cognitive-motor inhibition deficit. Twenty patients with a major depressive disorder and forty-seven healthy subjects performed two eye movement tasks. Saccadic reaction time and error rates were analyzed in the prosaccade task to obtain basic parameters of eye movements. Saccade latency, error rates and correction rates were evaluated in the antisaccade task to investigate inhibition capacities. Performances were impaired in patients, who exhibited a higher reaction time and error rates compared to controls. The higher time cost of inhibition suggested that the reaction time was not related to global psychomotor retardation alone. The higher time cost of inhibition could be explained by a specific alteration of inhibition processes evaluated by the antisaccade task. These changes were associated with the severity of depression. These findings provide a new perspective on cognitive inhibition in elderly depressed patients and could have important clinical implications for our understanding of critical behaviors involving deficits in inhibitory processes in the elderly.	[Carvalho, Nicolas; Noiret, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles] Univ Hosp, Dept Clin Psychiat, Besancon, France; [Carvalho, Nicolas; Vandel, Pierre; Monnin, Julie; Chopard, Gilles] Univ Franche Comte, Neurosci Lab, EA 481, F-25030 Besancon, France; [Vandel, Pierre; Monnin, Julie] Besancon Univ Hosp, CIC IT Inserm 808, Besancon, France; [Noiret, Nicolas; Laurent, Eric] Univ Franche Comte, Psychol Lab, EA 3188, F-25030 Besancon, France; [Laurent, Eric] CNRS, UMSR FED MSHE Ledoux 3124 4209, F-25030 Besancon, France; [Laurent, Eric] Univ Franche Comte, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Franche-Comte	Carvalho, N (corresponding author), Univ Hosp, Dept Clin Psychiat, Besancon, France.	nic.carvalh@gmail.com; eric.laurent@univ-fcomte.fr	carvalho, Nicolas/M-9650-2019; Laurent, Eric/AAM-1161-2020; LAURENT, Éric/AAW-4345-2020	LAURENT, Éric/0000-0002-7112-6765; Vandel, Pierre/0000-0002-0189-8364; CHOPARD, Gilles/0000-0003-2380-1057	French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC) [2009-A00942-55]	French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC)	This study was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique: PHRC no2009-A00942-55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alexopoulos GS, 2003, J CLIN PSYCHIAT, V64, P18; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; AUSTIN MP, 1992, J AFFECT DISORDERS, V25, P21, DOI 10.1016/0165-0327(92)90089-O; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BALL DM, 1991, PSYCHOPHARMACOLOGY, V105, P361, DOI 10.1007/BF02244431; Basso MR, 1999, NEUROPSYCHOLOGY, V13, P69, DOI 10.1037/0894-4105.13.1.69; Baudic S, 2004, J GERIATR PSYCH NEUR, V17, P195, DOI 10.1177/0891988704269823; Baudic S, 2007, PSYCHOL NEUROPSYCHIA, V5, P65, DOI 10.1684/pnv.2007.0036; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Bonin-Guillaume S, 2008, PSYCHOL NEUROPSYCHIA, V6, P137, DOI 10.1684/pnv.2008.0121; BOONE KB, 1995, NEUROPSYCHOLOGY, V9, P390, DOI 10.1037/0894-4105.9.3.390; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Crevits L, 2005, PSYCHIAT RES, V135, P113, DOI 10.1016/j.psychres.2003.10.008; Currie J, 1991, ARCH NEUROL-CHICAGO, V48, P949, DOI DOI 10.1001/ARCHNEUR.1991.00530180102024; De Lissnyder E, 2011, COGNITION EMOTION, V25, P886, DOI 10.1080/02699931.2010.514711; Dombrovski AY, 2008, AM J GERIAT PSYCHIAT, V16, P109, DOI 10.1097/JGP.0b013e3180f6338d; Eenshuistra RM, 2004, BRAIN COGNITION, V56, P177, DOI 10.1016/j.bandc.2004.02.077; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; FAFROWICZ M, 1995, NEUROPSYCHOBIOLOGY, V32, P156, DOI 10.1159/000119316; Ferreira S, 2010, REV NEUROL-FRANCE, V166, P606, DOI 10.1016/j.neurol.2009.12.005; FISCHER B, 1992, EXP BRAIN RES, V89, P415; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Flechtner KM, 2002, EUR ARCH PSY CLIN N, V252, P49, DOI 10.1007/s004060200011; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster SM, 2013, PSYCHOL AGING, V28, P179, DOI 10.1037/a0030928; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gallagher D, 2012, J AFFECTIVE DISORDER; Gallo JJ, 2000, JAMA-J AM MED ASSOC, V284, P1570, DOI 10.1001/jama.284.12.1570; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Godijn R, 2007, PERCEPT PSYCHOPHYS, V69, P802, DOI 10.3758/BF03193780; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Goldman WP, 1999, NEUROLOGY, V53, P956, DOI 10.1212/WNL.53.5.956; Gooding DC, 2004, PSYCHOL MED, V34, P921, DOI 10.1017/S003329170300165X; Green JF, 1998, BIOL PSYCHIAT, V44, P709, DOI 10.1016/S0006-3223(97)00452-6; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; HARNISHFEGER KK, 1994, LEARN INDIVID DIFFER, V6, P331, DOI 10.1016/1041-6080(94)90021-3; Houghton George, 1994, P53; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Joormann J, 2007, APPL PREV PSYCHOL, V12, P128, DOI 10.1016/j.appsy.2007.09.002; Katsanis J, 1997, J ABNORM PSYCHOL, V106, P468, DOI 10.1037/0021-843X.106.3.468; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lockwood KA, 2000, AM J GERIAT PSYCHIAT, V8, P201, DOI 10.1176/appi.ajgp.8.3.201; Mahlberg R, 2001, EUR ARCH PSY CLIN N, V251, P205, DOI 10.1007/s004060170028; Malsert J, 2012, PSYCHIAT RES, V200, P1051, DOI 10.1016/j.psychres.2012.05.007; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Mecocci P, 2004, AGING CLIN EXP RES, V16, P176, DOI 10.1007/BF03327382; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nijboer T, 2010, NEUROREPORT, V21, P386, DOI 10.1097/WNR.0b013e328337f95f; Palmer BW, 1996, J AFFECT DISORDERS, V41, P17, DOI 10.1016/0165-0327(96)00059-6; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; Rafal Robert, 1994, P1; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Richard-Devantoy S, 2012, J AFFECT DISORDERS, V140, P193, DOI 10.1016/j.jad.2012.03.006; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Shafiq-Antonacci R, 2003, ARCH NEUROL-CHICAGO, V60, P1272, DOI 10.1001/archneur.60.9.1272; Signoret J. L., 1989, EVALUATION TROUBLES; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sweeney JA, 1998, BIOL PSYCHIAT, V43, P584, DOI 10.1016/S0006-3223(97)00485-X; Thorpe L, 2001, CAN J NEUROL SCI, V28, pS83, DOI 10.1017/S0317167100001256; Townsend JD, 2013, BIOL PSYCHIAT, V73, P127, DOI 10.1016/j.biopsych.2012.06.030; Unsworth N, 2011, ACTA PSYCHOL, V137, P90, DOI 10.1016/j.actpsy.2011.03.004; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Winograd-Gurvich C, 2006, J AFFECT DISORDERS, V93, P193, DOI 10.1016/j.jad.2006.03.018	79	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105355	10.1371/journal.pone.0105355	http://dx.doi.org/10.1371/journal.pone.0105355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25122508	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000119
J	Jahn, K; Hille, C				Jahn, Karolina; Hille, Carsten			Asante Calcium Green and Asante Calcium Red-Novel Calcium Indicators for Two-Photon Fluorescence Lifetime Imaging	PLOS ONE			English	Article							INTRACELLULAR CA2+; SALIVARY-GLANDS; DUCT CELLS; COCKROACH; EXCITATION; MICROSCOPY; DYNAMICS; BINDING; NA+; PH	For a comprehensive understanding of cellular processes and potential dysfunctions therein, an analysis of the ubiquitous intracellular second messenger calcium is of particular interest. This study examined the suitability of the novel Ca2+-sensitive fluorescent dyes Asante Calcium Red (ACR) and Asante Calcium Green (ACG) for two-photon (2P)-excited time-resolved fluorescence measurements. Both dyes displayed sufficient 2P fluorescence excitation in a range of 720-900 nm. In vitro, ACR and ACG exhibited a biexponential fluorescence decay behavior and the two decay time components in the ns-range could be attributed to the Ca2+-free and Ca2+-bound dye species. The amplitude-weighted average fluorescence decay time changed in a Ca2+-dependent way, unraveling in vitro dissociation constants K-D of 114 nM and 15 nM for ACR and ACG, respectively. In the presence of bovine serum albumin, the absorption and steady-state fluorescence behavior of ACR was altered and its biexponential fluorescence decay showed about 5-times longer decay time components indicating dye-protein interactions. Since no ester derivative of ACG was commercially available, only ACR was evaluated for 2P-excited fluorescence lifetime imaging microscopy (2P-FLIM) in living cells of American cockroach salivary glands. In living cells, ACR also exhibited a biexponential fluorescence decay with clearly resolvable short (0.56 ns) and long (2.44 ns) decay time components attributable to the Ca2+-free and Ca2+-bound ACR species. From the amplitude-weighted average fluorescence decay times, an in situ K-D of 180 nM was determined. Thus, quantitative [Ca2+](i) recordings were realized, unraveling a reversible dopamine-induced [Ca2+](i) elevation from 21 nM to 590 nM in salivary duct cells. It was concluded that ACR is a promising new Ca2+ indicator dye for 2P-FLIM recordings applicable in diverse biological systems.	[Jahn, Karolina; Hille, Carsten] Univ Potsdam, Dept Phys Chem ALS ComBi, Potsdam, Germany	University of Potsdam	Hille, C (corresponding author), Univ Potsdam, Dept Phys Chem ALS ComBi, Potsdam, Germany.	hille@uni-potsdam.de		Hille, Carsten/0000-0003-3454-8077	German Research Foundation [1850/30001355]; Federal Ministry of Education and Research [03IPT517Y]; University of Potsdam	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Potsdam	This work was funded by the German Research Foundation (1850/30001355, www.dfg.de), the Federal Ministry of Education and Research (03IPT517Y, www.bmbf.de), and the University of Potsdam (to KJ, www.uni-potsdam.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, TEFL FLUOR ION IND H; BANCEL F, 1992, ANAL BIOCHEM, V204, P231, DOI 10.1016/0003-2697(92)90232-V; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borst JW, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/10/102002; Chen F, 2003, INT J PHOTOENERGY, V5, P209, DOI 10.1155/S1110662X03000345; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diaspro A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-36; Dietrich S, 2010, PROC SPIE, V7569, DOI 10.1117/12.849742; Escamilla P. R., 2012, patent, Patent No. [WO 2012040204 A2, 2012040204]; Fery-Forgues S, 1999, J CHEM EDUC, V76, P1260, DOI 10.1021/ed076p1260; Gersbach M, 2009, OPT LETT, V34, P362, DOI 10.1364/OL.34.000362; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRISON SM, 1989, AM J PHYSIOL, V256, pC1250, DOI 10.1152/ajpcell.1989.256.6.C1250; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Hille C, 2006, CELL CALCIUM, V39, P305, DOI 10.1016/j.ceca.2005.11.006; Hille C, 2008, PHOTOCHEM PHOTOBIOL, V8, P319; Hille C, 2008, J EXP BIOL, V211, P568, DOI 10.1242/jeb.010207; Hirshfield KM, 1996, BIOPHYS CHEM, V62, P25, DOI 10.1016/S0301-4622(96)00027-0; HOVEMADSEN L, 1992, BIOPHYS J, V63, P89, DOI 10.1016/S0006-3495(92)81597-7; Hyrc KL, 2013, CELL CALCIUM, V54, P320, DOI 10.1016/j.ceca.2013.08.001; JUST F, 1994, J MORPHOL, V220, P35, DOI 10.1002/jmor.1052200105; Lahn M, 2011, AM J PHYSIOL-CELL PH, V300, pC1323, DOI 10.1152/ajpcell.00320.2010; Lakowicz J R, 1992, J Fluoresc, V2, P47, DOI 10.1007/BF00866388; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; LAKOWICZ JR, 1992, CELL CALCIUM, V13, P131, DOI 10.1016/0143-4160(92)90041-P; LAKOWICZ JR, 1994, CELL CALCIUM, V15, P7, DOI 10.1016/0143-4160(94)90100-7; Lang I, 1999, J EXP BIOL, V202, P729; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Makarov NS, 2008, OPT EXPRESS, V16, P4029, DOI 10.1364/OE.16.004029; Makarov NS, 2010, THESIS MONTANA STATE; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Sagolla K, 2013, ANAL BIOANAL CHEM, V405, P8525, DOI 10.1007/s00216-013-7290-6; SNARE MJ, 1982, J PHOTOCHEM, V18, P335, DOI 10.1016/0047-2670(82)87023-8; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; SZMACINSKI H, 1994, TOPICS FLUORESCENCE, V4, P295; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsien RY, 1999, CALCIUM AS A CELLULAR REGULATOR, P28; Walz B, 2006, ARCH INSECT BIOCHEM, V62, P141, DOI 10.1002/arch.20128; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wilms CD, 2007, J MICROSC-OXFORD, V225, P209, DOI 10.1111/j.1365-2818.2007.01746.x; Wurth C, 2011, ANAL CHEM, V83, P3431, DOI 10.1021/ac2000303; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu T, 2004, J BIOCHEM BIOPH METH, V58, P219, DOI 10.1016/j.jbbm.2003.11.001; Yoshiki K, 2005, OPT REV, V12, P415, DOI 10.1007/s10043-005-0415-1	48	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105334	10.1371/journal.pone.0105334	http://dx.doi.org/10.1371/journal.pone.0105334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140519	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200072
J	Lowe, EC; Wilder, SM; Hochuli, DF				Lowe, Elizabeth C.; Wilder, Shawn M.; Hochuli, Dieter F.			Urbanisation at Multiple Scales Is Associated with Larger Size and Higher Fecundity of an Orb-Weaving Spider	PLOS ONE			English	Article							NEPHILA-PLUMIPES ARANEAE; CARABID BEETLE ASSEMBLAGES; HABITAT FRAGMENTATION; GLOBAL CHANGE; WEB SPIDERS; LAND-USE; URBAN; DIVERSITY; ECOLOGY; BIRD	Urbanisation modifies landscapes at multiple scales, impacting the local climate and changing the extent and quality of natural habitats. These habitat modifications significantly alter species distributions and can result in increased abundance of select species which are able to exploit novel ecosystems. We examined the effect of urbanisation at local and landscape scales on the body size, lipid reserves and ovary weight of Nephila plumipes, an orb weaving spider commonly found in both urban and natural landscapes. Habitat variables at landscape, local and microhabitat scales were integrated to create a series of indexes that quantified the degree of urbanisation at each site. Spider size was negatively associated with vegetation cover at a landscape scale, and positively associated with hard surfaces and anthropogenic disturbance on a local and microhabitat scale. Ovary weight increased in higher socioeconomic areas and was positively associated with hard surfaces and leaf litter at a local scale. The larger size and increased reproductive capacity of N. plumipes in urban areas show that some species benefit from the habitat changes associated with urbanisation. Our results also highlight the importance of incorporating environmental variables from multiple scales when quantifying species responses to landscape modification.	[Lowe, Elizabeth C.; Wilder, Shawn M.; Hochuli, Dieter F.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Lowe, EC (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	Elizabeth.lowe@sydney.edu.au	Hochuli, Dieter/E-5023-2010	Hochuli, Dieter/0000-0002-6673-4475; Lowe, Elizabeth/0000-0003-3792-3178; Wilder, Shawn/0000-0003-0359-7220				ABS (Australian Bureal Statistics), 2011, CENS COMM PROF; Agnarsson I, 2011, NATURWISSENSCHAFTEN, V98, P163, DOI 10.1007/s00114-010-0750-3; Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Antonov A, 2003, ORNIS FENNICA, V80, P21; Barbaro L, 2005, ECOSCIENCE, V12, P110, DOI 10.2980/i1195-6860-12-1-110.1; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bolger DT, 2008, DIVERS DISTRIB, V14, P655, DOI 10.1111/j.1472-4642.2008.00470.x; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Christie Fiona J., 2010, Urban Ecosystems, V13, P169, DOI 10.1007/s11252-009-0115-x; Churchill TB, 1999, J INSECT CONSERV, V3, P287, DOI 10.1023/A:1009638706789; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dominoni DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0593; Dousset B, 2003, ISPRS J PHOTOGRAMM, V58, P43, DOI 10.1016/S0924-2716(03)00016-9; Dugdale JS, 1996, J ROY SOC NEW ZEAL, V26, P251, DOI 10.1080/03014223.1996.9517513; Eisenbeis G, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P243, DOI 10.1017/CBO9780511609763.016; Emery Timothy J., 2004, P124; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gering JC, 1999, ECOGRAPHY, V22, P532, DOI 10.1111/j.1600-0587.1999.tb00542.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Griffiths BV, 2003, AUST J ZOOL, V51, P119, DOI 10.1071/ZO02048; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grostal P, 1997, OECOLOGIA, V111, P570, DOI 10.1007/s004420050273; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Heiling AM, 1999, BEHAV ECOL SOCIOBIOL, V46, P43, DOI 10.1007/s002650050590; HERBERSTEIN ME, 1994, AUST J ECOL, V19, P451, DOI 10.1111/j.1442-9993.1994.tb00511.x; Higgins L, 2011, J ARACHNOL, V39, P399, DOI 10.1636/B11-18.1; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Johnson JC, 2012, AM MIDL NAT, V168, P333, DOI 10.1674/0003-0031-168.2.333; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kasumovic MM, 2009, ECOLOGY, V90, P2287, DOI 10.1890/08-1540.1; Kinzig AP, 2005, ECOL SOC, V10; Koivula M, 1999, ECOGRAPHY, V22, P424, DOI 10.1111/j.1600-0587.1999.tb00579.x; Lassau SA, 2005, DIVERS DISTRIB, V11, P73, DOI 10.1111/j.1366-9516.2005.00124.x; Li DQ, 1996, J THERM BIOL, V21, P245, DOI 10.1016/0306-4565(96)00009-5; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Lo CP, 1997, INT J REMOTE SENS, V18, P287, DOI 10.1080/014311697219079; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Meineke EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059687; Miyashita T, 1998, BIOL CONSERV, V86, P357, DOI 10.1016/S0006-3207(98)00025-1; MIYASHITA T, 1992, RES POPUL ECOL, V34, P143, DOI 10.1007/BF02513527; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Partecke J, 2004, P ROY SOC B-BIOL SCI, V271, P1995, DOI 10.1098/rspb.2004.2821; Puzin C, 2011, ANIM BIOL, V61, P127, DOI 10.1163/157075511X566461; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schneider JM, 2002, J EVOLUTION BIOL, V15, P84, DOI 10.1046/j.1420-9101.2002.00363.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Trubl P, 2012, URBAN ECOSYST, V15, P599, DOI 10.1007/s11252-011-0223-2; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; UETZ GW, 1979, OECOLOGIA, V40, P29, DOI 10.1007/BF00388808; Wilder SM, 2010, OECOLOGIA, V162, P617, DOI 10.1007/s00442-009-1518-3; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	64	43	48	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105480	10.1371/journal.pone.0105480	http://dx.doi.org/10.1371/journal.pone.0105480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140809	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200092
J	Lechner, M; Hernandez-Rosales, M; Doerr, D; Wieseke, N; Thevenin, A; Stoye, J; Hartmann, RK; Prohaska, SJ; Stadler, PF				Lechner, Marcus; Hernandez-Rosales, Maribel; Doerr, Daniel; Wieseke, Nicolas; Thevenin, Annelyse; Stoye, Jens; Hartmann, Roland K.; Prohaska, Sonja J.; Stadler, Peter F.			Orthology Detection Combining Clustering and Synteny for Very Large Datasets	PLOS ONE			English	Article							GENE ORDER; HOMOLOGY; DUPLICATIONS; PREDICTION; ORTHOMCL; DISTANCE; DATABASE; BROWSER; SEARCH; FATE	The elucidation of orthology relationships is an important step both in gene function prediction as well as towards understanding patterns of sequence evolution. Orthology assignments are usually derived directly from sequence similarities for large data because more exact approaches exhibit too high computational costs. Here we present PoFF, an extension for the standalone tool Proteinortho, which enhances orthology detection by combining clustering, sequence similarity, and synteny. In the course of this work, FFAdj-MCS, a heuristic that assesses pairwise gene order using adjacencies (a similarity measure related to the breakpoint distance) was adapted to support multiple linear chromosomes and extended to detect duplicated regions. PoFF largely reduces the number of false positives and enables more fine-grained predictions than purely similarity-based approaches. The extension maintains the low memory requirements and the efficient concurrency options of its basis Proteinortho, making the software applicable to very large datasets.	[Lechner, Marcus; Hartmann, Roland K.] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Hernandez-Rosales, Maribel; Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany; [Hernandez-Rosales, Maribel] Univ Brasilia, Inst Ciencias Exatas, Dept Ciencia Comp, Brasilia, DF, Brazil; [Doerr, Daniel; Thevenin, Annelyse; Stoye, Jens] Univ Bielefeld, Fac Technol, Genome Informat, D-33615 Bielefeld, Germany; [Doerr, Daniel; Thevenin, Annelyse; Stoye, Jens] Univ Bielefeld, Inst Bioinformat, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Wieseke, Nicolas] Univ Leipzig, Fac Math & Comp Sci, D-04109 Leipzig, Germany; [Prohaska, Sonja J.] Univ Leipzig, Dept Comp Sci, Computat EvoDevo Grp, D-04109 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, RNom Grp, Leipzig, Germany	Philipps University Marburg; Leipzig University; Leipzig University; Max Planck Society; Universidade de Brasilia; University of Bielefeld; University of Bielefeld; Leipzig University; Leipzig University; University of Vienna; University of Copenhagen; The Santa Fe Institute; Fraunhofer Gesellschaft	Lechner, M (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	lechner@staff.uni-marburg.de	Stadler, Peter F. F/L-7857-2015	Stadler, Peter F. F/0000-0002-5016-5191	German Research Foundation; Open Access Publication Fund of Bielefeld University Library; Deutsche Forschungsgemeinschaft [GRK-1384, MA5082/1-1, MI439/14-1]; CLIB Graduate Cluster Industrial Biotechnology	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University Library; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CLIB Graduate Cluster Industrial Biotechnology	We acknowledge support for the Article Processing Charge by the German Research Foundation and the Open Access Publication Fund of Bielefeld University Library. This work was supported in part by the Deutsche Forschungsgemeinschaft grants no. GRK-1384, MA5082/1-1, MI439/14-1. DD receives a scholarship from the CLIB Graduate Cluster Industrial Biotechnology. AT is a research fellow of the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Bergeron A, 2002, LECT NOTES COMPUT SC, V2452, P464; Bergeron A, 2006, J COMPUT BIOL, V13, P1340, DOI 10.1089/cmb.2006.13.1340; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Braga MDV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S8; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Creevey CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002269; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; Dewey CN, 2011, BRIEF BIOINFORM, V12, P401, DOI 10.1093/bib/bbr040; Doerr D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S3; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Franzen O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003000; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hellmuth M, 2013, J MATH BIOL, V66, P399, DOI 10.1007/s00285-012-0525-x; Hernandez-Rosales M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S3-A8; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Keller-Schmidt S, 2010, 10123298V1 ARXIV; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lehmann J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-351; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liben-Nowell D, 2002, J ALGORITHMS, V43, P264, DOI 10.1016/S0196-6774(02)00006-8; Liu HL, 2013, PLANT CELL REP, V32, P379, DOI 10.1007/s00299-012-1371-4; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mahmood K, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1261; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shi Guanqun, 2011, PLoS One, V6, pe20892, DOI 10.1371/journal.pone.0020892; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Strope CL, 2009, MOL BIOL EVOL, V26, P2581, DOI 10.1093/molbev/msp174; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ting C, 2006, J COMB OPTIM, V12, P419, DOI 10.1007/s10878-006-9008-6; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WATTERSON GA, 1982, J THEOR BIOL, V99, P1, DOI 10.1016/0022-5193(82)90384-8; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xu W, 2007, J COMPUT BIOL, V14, P423, DOI 10.1089/cmb.2007.A004	60	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105015	10.1371/journal.pone.0105015	http://dx.doi.org/10.1371/journal.pone.0105015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137074	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100060
J	Ma, ZR; Zhang, HJ; Shang, WJ; Zhu, FL; Han, WQ; Zhao, XE; Han, DL; Wang, PG; Chen, M				Ma, Zhongrui; Zhang, Huajie; Shang, Wenjing; Zhu, Faliang; Han, Weiqing; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min			Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; POLYSACCHARIDE; TOXIN; LIPOPOLYSACCHARIDE; GLYCOSYLATION; COLONIZATION; IMMUNIZATION; INFECTION; FUSION; FAILS	Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about their cellular responses. In this study, we exploited a novel approach based on bacterial protein N-linked glycosylation system to produce glycoconjugate containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein and examined its humoral and cellular responses in BALB/c mice. The transfer of E. coli O157:H7 O-antigen to MBP was confirmed by western blot and MALDI-TOF MS. Mice injected with glycoconjugate O-Ag-MBP elicited serum bactericidal antibodies including anti-E. coli O157:H7 O-antigen IgG and IgM. Interestingly, O-Ag-MBP also stimulated the secretion of anti-E. coli O157:H7 O-antigen IgA in intestine. In addition, O-Ag-MBP stimulated cellular responses by recruiting Th1-biased CD4(+) T cells, CD8(+) T cells. Meanwhile, O-Ag-MBP induced the upregulation of Th1-related IFN-gamma and downregulation of Th2-related IL-4, and the upregulation of IFN-gamma was stimulated by MBP in a dose-dependent manner. MBP showed TLR4 agonist-like properties to activate Th1 cells as carrier protein of O-Ag-MBP. Thus, glycoconjugate vaccine E. coli O157:H7-specific O-Ag-MBP produced by bacterial protein N-linked glycosylation system was able to elicit both humoral and Th1-biased cellular responses.	[Ma, Zhongrui; Zhang, Huajie; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min] Shandong Univ, Natl Glycoengn Res Ctr, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Ma, Zhongrui; Zhang, Huajie; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min] Shandong Univ, Natl Glycoengn Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Shang, Wenjing] Binzhou Med Univ, Dept Biochem & Mol Biol, YanTai, Shandong, Peoples R China; [Zhu, Faliang] Shandong Univ, Dept Immunol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Han, Weiqing] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Han, Weiqing] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Shandong University; Shandong University; Binzhou Medical University; Shandong University; Nankai University; Nankai University	Chen, M (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	chenmin@sdu.edu.cn	WANG, Peng/GSN-5263-2022		Significant New Drugs Development [2012ZX09502001-005]; 973 Program [2012CB822102]; National Natural Science Foundation [31070824, 31270983]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Significant New Drugs Development; 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by Significant New Drugs Development (2012ZX09502001-005 http://www.most.gov.cn), 973 Program (No. 2012CB822102, http://www.most.gov.cn/), National Natural Science Foundation (No. 31070824, 31270983, http://www.nsfc.gov.cn), The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (http://www.moe.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conlan JW, 2000, CAN J MICROBIOL, V46, P283; Conlan JW, 1999, CAN J MICROBIOL, V45, P279, DOI 10.1139/cjm-45-4-279; Cuccui J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130002; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fernandez S, 2007, INFECT IMMUN, V75, P1359, DOI 10.1128/IAI.00486-06; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Goldwater PN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-12; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Knuf M, 2011, VACCINE, V29, P4881, DOI 10.1016/j.vaccine.2011.04.053; Konadu E, 1999, INFECT IMMUN, V67, P6191, DOI 10.1128/IAI.67.11.6191-6193.1999; Konadu EY, 1998, J INFECT DIS, V177, P383, DOI 10.1086/514203; Lockhart Stephen, 2003, Expert Rev Vaccines, V2, P633, DOI 10.1586/14760584.2.5.633; MEHL M, 1988, J BASIC MICROB, V28, P437, DOI 10.1002/jobm.3620280704; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; RAGHUPATHY P, 1978, BMJ-BRIT MED J, V1, P1518, DOI 10.1136/bmj.1.6126.1518; Riggs P, 2000, MOL BIOTECHNOL, V15, P51, DOI 10.1385/MB:15:1:51; Rossi GR, 2005, CANCER RES, V65, P10555, DOI 10.1158/0008-5472.CAN-05-0627; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; [台桂香 Tai Guixiang], 2003, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V10, P202; UNDERDOWN BJ, 1986, ANNU REV IMMUNOL, V4, P389, DOI 10.1146/annurev.iy.04.040186.002133; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Wetter M, 2013, GLYCOCONJUGATE J, V30, P511, DOI 10.1007/s10719-012-9451-9; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	31	15	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105215	10.1371/journal.pone.0105215	http://dx.doi.org/10.1371/journal.pone.0105215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137044	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100076
J	Tang, L; Liu, WQ; Fang, X; Sun, Q; Zhu, SL; Wang, CX; Wang, XY; Li, YG; Zhu, DL; Sanderson, KE; Johnston, RN; Liu, GR; Liu, SL				Tang, Le; Liu, Wei-Qiao; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Li, Yong-Guo; Zhu, Da-Ling; Sanderson, Kenneth E.; Johnston, Randal N.; Liu, Gui-Rong; Liu, Shu-Lin			CTAG-Containing Cleavage Site Profiling to Delineate Salmonella into Natural Clusters	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; RIBOSOMAL-RNA; BACTERIAL; PARATYPHI; MAP; EVOLUTIONARY; ADAPTATION; BOUNDARIES; DYNAMICS	Background: The bacterial genus Salmonella contains thousands of serotypes that infect humans or other hosts, causing mild gastroenteritis to potentially fatal systemic infections in humans. Pathogenically distinct Salmonella serotypes have been classified as individual species or as serological variants of merely one or two species, causing considerable confusion in both research and clinical settings. This situation reflects a long unanswered question regarding whether the Salmonella serotypes exist as discrete genetic clusters (natural species) of organisms or as phenotypic (e. g. pathogenic) variants of a single (or two) natural species with a continuous spectrum of genetic divergence among them. Our recent work, based on genomic sequence divergence analysis, has demonstrated that genetic boundaries exist among Salmonella serotypes, circumscribing them into clear-cut genetic clusters of bacteria. Methodologies/Principal Findings: To further test the genetic boundary concept for delineating Salmonella into clearly defined natural lineages (e. g., species), we sampled a small subset of conserved genomic DNA sequences, i.e., the endonuclease cleavage sites that contain the highly conserved CTAG sequence such as TCTAGA for XbaI. We found that the CTAG-containing cleavage sequence profiles could be used to resolve the genetic boundaries as reliably and efficiently as whole genome sequence comparisons but with enormously reduced requirements for time and resources. Conclusions: Profiling of CTAG sequence subsets reflects genetic boundaries among Salmonella lineages and can delineate these bacteria into discrete natural clusters.	[Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China; [Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Zhu, Da-Ling; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Dept Biopharmaceut Sci, Harbin, Peoples R China; [Tang, Le; Fang, Xin; Sun, Qiang; Zhu, Song-Ling; Wang, Chun-Xiao; Wang, Xiao-Yu; Li, Yong-Guo; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, HMU UCFM Ctr Infect & Genom, Harbin, Peoples R China; [Liu, Wei-Qiao; Sanderson, Kenneth E.; Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Li, Yong-Guo; Liu, Shu-Lin] Harbin Med Univ, Affiliated Hosp 1, Dept Infect Dis, Harbin, Peoples R China; [Zhu, Da-Ling] Harbin Med Univ, Coll Pharm, Daqing, Peoples R China; [Johnston, Randal N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary; Harbin Medical University; Harbin Medical University; University of Calgary	Liu, GR (corresponding author), Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China.	slliu@ucalgary.ca	Johnston, Randal/B-9247-2009	Sun, Qiang/0000-0002-6703-1587	Heilongjiang Innovation Endowment Award [YJSCX2012-197HLJ]; National Natural Science Foundation of China [NSFC30970078, NSFC30970119, 81030029, 81271786, NSFC-NIH 81161120416]; Natural Science Foundation of Heilongjiang Province of China; Canadian Institutes of Health Research	Heilongjiang Innovation Endowment Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Heilongjiang Innovation Endowment Award for graduate studies (YJSCX2012-197HLJ) to LT; a National Natural Science Foundation of China (NSFC30970078) and a grant of Natural Science Foundation of Heilongjiang Province of China to GRL; a grant of Canadian Institutes of Health Research to RNJ; and grants of the National Natural Science Foundation of China (NSFC30970119, 81030029, 81271786, NSFC-NIH 81161120416) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; BHAGWAT AS, 1992, NUCLEIC ACIDS RES, V20, P1663, DOI 10.1093/nar/20.7.1663; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Covert AW, 2013, P NATL ACAD SCI USA, V110, pE3171, DOI 10.1073/pnas.1313424110; CROSA JH, 1973, J BACTERIOL, V115, P307, DOI 10.1128/JB.115.1.307-315.1973; EDWARDS PR, 1952, AM J CLIN PATHOL, V22, P692, DOI 10.1093/ajcp/22.7_ts.692; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Koeppel AF, 2013, ISME J, V7, P1080, DOI 10.1038/ismej.2013.3; LEMINOR L, 1987, INT J SYST BACTERIOL, V37, P465, DOI 10.1099/00207713-37-4-465; LEMINOR L, 1984, BERGEYS MANUAL SYSTE, V1, P427; Liu Shu-Lin, 2007, V394, P39, DOI 10.1007/978-1-59745-512-1_3; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; LIU SL, 1995, J BACTERIOL, V177, P3355, DOI 10.1128/jb.177.11.3355-3357.1995; Liu SL, 1999, J BACTERIOL, V181, P6747, DOI 10.1128/JB.181.21.6747-6755.1999; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; MARSHALL P, 1991, GENE, V104, P241, DOI 10.1016/0378-1119(91)90256-B; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Popoff MY, 2005, BERGEYS MANUAL SYSTE, V2, P764; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang L, 2013, GENOMICS, V102, P331, DOI 10.1016/j.ygeno.2013.07.014; Tang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-489; Tang L, 2012, ANTON LEEUW INT J G, V101, P67, DOI 10.1007/s10482-011-9680-0; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103388	10.1371/journal.pone.0103388	http://dx.doi.org/10.1371/journal.pone.0103388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137186	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100007
J	Barnes, VM; Kennedy, AD; Panagakos, F; Devizio, W; Trivedi, HM; Jonsson, T; Guo, LN; Cervi, S; Scannapieco, FA				Barnes, Virginia M.; Kennedy, Adam D.; Panagakos, Fotinos; Devizio, William; Trivedi, Harsh M.; Joensson, Thomas; Guo, Lining; Cervi, Shannon; Scannapieco, Frank A.			Global Metabolomic Analysis of Human Saliva and Plasma from Healthy and Diabetic Subjects, with and without Periodontal Disease	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; 2-HYDROXYBUTYRIC ACID; MITOCHONDRIAL GLUTATHIONE; ALPHA-KETOBUTYRATE; OXIDATIVE STRESS; AMYLASE-BINDING; BIOMARKERS; MELLITUS; CERAMIDE; SERUM	Recent studies suggest that periodontal disease and type 2 diabetes mellitus are bi-directionally associated. Identification of a molecular signature for periodontitis using unbiased metabolic profiling could allow identification of biomarkers to assist in the diagnosis and monitoring of both diabetes and periodontal disease. This cross-sectional study identified plasma and salivary metabolic products associated with periodontitis and/or diabetes in order to discover biomarkers that may differentiate or demonstrate an interaction of these diseases. Saliva and plasma samples were analyzed from 161 diabetic and non-diabetic human subjects with a healthy periodontium, gingivitis and periodontitis. Metabolite profiling was performed using Metabolon's platform technology. A total of 772 metabolites were found in plasma and 475 in saliva. Diabetics had significantly higher levels of glucose and alpha-hydroxybutyrate, the established markers of diabetes, for all periodontal groups of subjects. Comparison of healthy, gingivitis and periodontitis saliva samples within the non-diabetic group confirmed findings from previous studies that included increased levels of markers of cellular energetic stress, increased purine degradation and glutathione metabolism through increased levels of oxidized glutathione and cysteine-glutathione disulfide, markers of oxidative stress, including increased purine degradation metabolites (e.g. guanosine and inosine), increased amino acid levels suggesting protein degradation, and increased omega-3 (docosapentaenoate) and omega-6 fatty acid (linoleate and arachidonate) signatures. Differences in saliva between diabetic and non-diabetic cohorts showed altered signatures of carbohydrate, lipid and oxidative stress exist in the diabetic samples. Global untargeted metabolic profiling of human saliva in diabetics replicated the metabolite signature of periodontal disease progression in non-diabetic patients and revealed unique metabolic signatures associated with periodontal disease in diabetics. The metabolites identified in this study that discriminated the periodontal groups may be useful for developing diagnostics and therapeutics tailored to the diabetic population.	[Barnes, Virginia M.; Panagakos, Fotinos; Devizio, William; Trivedi, Harsh M.] Colgate Palmol Technol Ctr, Piscataway, NJ USA; [Cervi, Shannon; Scannapieco, Frank A.] Metabolon, Durham, NC 27713 USA; [Kennedy, Adam D.; Joensson, Thomas; Guo, Lining] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA	Metabolon; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Scannapieco, FA (corresponding author), Metabolon, Durham, NC 27713 USA.	fas1@buffalo.edu	Scannapieco, Frank A./AAE-1584-2020	Scannapieco, Frank A./0000-0002-8804-6593	Colgate Palmolive Co.	Colgate Palmolive Co.	This study was funded by a grant from Colgate Palmolive Co. The funder and Metabolon provided support in the form of salaries for authors VMB, FP, WD, HMT, and TJ, LG, ADK respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Acker-Hewitt TL, 2012, APPL PHYSIOL NUTR ME, V37, P276, DOI [10.1139/h11-160, 10.1139/H11-160]; Akalin FA, 2008, ARCH ORAL BIOL, V53, P44, DOI 10.1016/j.archoralbio.2007.07.009; Akalin FA, 2007, J CLIN PERIODONTOL, V34, P558, DOI 10.1111/j.1600-051X.2007.01091.x; Al-Tarawneh SK, 2011, OMICS, V15, P353, DOI 10.1089/omi.2010.0134; Alpagot T, 2001, J CLIN PERIODONTOL, V28, P353, DOI 10.1034/j.1600-051x.2001.028004353.x; Alpagot T, 2001, J PERIODONTAL RES, V36, P169, DOI 10.1034/j.1600-0765.2001.360305.x; Barnes VM, 2011, J DENT RES, V90, P1293, DOI 10.1177/0022034511416240; Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Barnes VM, 2010, J PERIODONTOL, V81, P1273, DOI 10.1902/jop.2010.100070; Barnes Virginia Monsul, 2011, J Clin Dent, V22, P200; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Bessonneau V, 2013, BIOANALYSIS, V5, P783, DOI [10.4155/BIO.13.35, 10.4155/bio.13.35]; Bieberich E, 2011, J LIPIDS IN PRESS; BRASS EP, 1986, BIOCHIM BIOPHYS ACTA, V888, P18, DOI 10.1016/0167-4889(86)90065-0; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Christodoulides N, 2007, ANN NY ACAD SCI, V1098, P411, DOI 10.1196/annals.1384.035; Cobb Jeff, 2013, J Diabetes Sci Technol, V7, P100; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Dunn W, 2013, NEUROLOGY, V80, pS41, DOI 10.1212/WNL.0b013e3182872c54; Embery G, 1994, Adv Dent Res, V8, P329; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; Fredericks M A, 1971, J Dent Educ, V35, P232; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Garcia-German D, 2012, Rev Esp Cir Ortop Traumatol, V56, P422, DOI 10.1016/j.recot.2012.05.002; Garcia- German D, 2012, REV ESP CIR ORTOP TR, V56, P422; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; GARCIARUIZ C, 1995, HEPATOLOGY, V21, P207, DOI 10.1016/0270-9139(95)90430-1; Genco RJ, 2014, J AM DENT ASSOC, V145, P57, DOI 10.14219/jada.2013.7; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Hansen SH, 2013, ADV EXP MED BIOL, V776, P3, DOI 10.1007/978-1-4614-6093-0_1; Hargreaves CE, 2013, J IMMUNOL, V190, P5373, DOI 10.4049/jimmunol.1203412; Judice PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068936; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Keles GC, 2010, INFLAMM RES, V59, P543, DOI 10.1007/s00011-010-0158-8; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; LANDAAS S, 1975, CLIN CHIM ACTA, V58, P23, DOI 10.1016/0009-8981(75)90481-7; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Leyden JJ, 2004, CUTIS, V73, P11; LOBENE R R, 1986, Clinical Preventive Dentistry, V8, P3; Lobene R R, 1979, Pharmacol Ther Dent, V4, P33; MANDEL ID, 1989, J AM DENT ASSOC, V119, P298, DOI 10.14219/jada.archive.1989.0211; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Nerby CL, 2009, CLIN BIOCHEM, V42, P158, DOI 10.1016/j.clinbiochem.2008.08.086; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nieman DC, 2013, J PROTEOME RES, V12, P4577, DOI 10.1021/pr400717j; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peralta ER, 2009, AUTOPHAGY, V5, P407, DOI 10.4161/auto.5.3.7809; PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7; Pradeep AR, 2007, J PERIODONTOL, V78, P2325, DOI 10.1902/jop.2007.070135; Pradeep AR, 2007, J PERIODONTOL, V78, P1962, DOI 10.1902/jop.2007.070096; Pussinen PJ, 2007, CURR MED CHEM, V14, P2402, DOI 10.2174/092986707781745604; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Quick KL, 2000, J NEUROSCI METH, V97, P139, DOI 10.1016/S0165-0270(00)00179-5; Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Salvi GE, 2010, J CLIN PERIODONTOL, V37, P9, DOI 10.1111/j.1600-051X.2009.01500.x; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; SCANNAPIECO FA, 1994, J DENT RES, V73, P1627, DOI 10.1177/00220345940730100701; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Silva AR, 2001, BRAZ J MED BIOL RES, V34, P627, DOI 10.1590/S0100-879X2001000500010; Sima C, 2010, J PERIODONTAL RES, V45, P748, DOI 10.1111/j.1600-0765.2010.01295.x; STUCHELL RN, 1984, OTOLARYNG CLIN N AM, V17, P697; TABAK LA, 1982, J ORAL PATHOL MED, V11, P1, DOI 10.1111/j.1600-0714.1982.tb00138.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Toth BI, 2009, J INVEST DERMATOL, V129, P329, DOI 10.1038/jid.2008.258; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; WADDINGTON RJ, 1994, ARCH ORAL BIOL, V39, P361, DOI 10.1016/0003-9969(94)90165-1; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiang X, 2013, J PERIODONTOL; YANG W, 1985, CLIN CHIM ACTA, V145, P173, DOI 10.1016/0009-8981(85)90284-0; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5	80	81	83	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105181	10.1371/journal.pone.0105181	http://dx.doi.org/10.1371/journal.pone.0105181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133529	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700079
J	Choudhary, S; Kishore, N				Choudhary, Sinjan; Kishore, Nand			Addressing Mechanism of Fibrillization/Aggregation and Its Prevention in Presence of Osmolytes: Spectroscopic and Calorimetric Approach	PLOS ONE			English	Article							THIOFLAVIN T-BINDING; PROTEIN AGGREGATION; AMYLOID FIBRILS; IN-VITRO; ALPHA-SYNUCLEIN; PRION PROTEIN; LYSOZYME; FIBRILLATION; INHIBITION; STABILITY	Understanding the mechanism of protein fibrillization/aggregation and its prevention is the basis of development of therapeutic strategies for amyloidosis. An attempt has been made to understand the nature of interactions of osmolytes L-proline, 4-hydroxy-L-proline, sarcosine and trimethylamine N-oxide with the different stages of fibrillization of hen egg-white lysozyme by using a combination of isothermal titration calorimetry, differential scanning calorimetry, fluorescence spectroscopy, and transmission electron microscopy. Based on thioflavin T fluorescence emission intensities and microscopic images, the nucleation, elongation, and saturation phases of fibrillization have been identified. Isothermal titration calorimetry and differential scanning calorimetry have enabled a quantitative analysis of the nature of interactions of these osmolytes with various conformational states of lysozyme at different stages of fibrillization/aggregation. It is concluded that interaction of the osmolytes with lysozyme fibrils at both the nucleation and elongation stages are important steps in the prevention of fibrillization/aggregation. Identification of the nature of interactions is a key step towards the discovery and synthesis of target oriented potential inhibitors of these associations. This study is a first report in which calorimetry has been used to address interaction of potential inihibitiors with the protein at different stages of fibrillization.	[Choudhary, Sinjan] Univ Mumbai, Bombay, Maharashtra, India; [Choudhary, Sinjan] Ctr Excellence Basic Sci, Dept Atom Energy, Mumbai, Maharashtra, India; [Kishore, Nand] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India	University of Mumbai; UM-DAE Centre for Excellence in Basic Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Choudhary, S (corresponding author), Univ Mumbai, Bombay, Maharashtra, India.	sinjan.choudhary@cbs.ac.in; nandk@chem.iitb.ac.in			Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi	The authors are grateful to the Department of Science and Technology and Council of Scientific and Industrial Research, New Delhi for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FB, 1999, BIOPOLYMERS, V50, P401, DOI 10.1002/(SICI)1097-0282(19991005)50:4&lt;401::AID-BIP6&gt;3.0.CO;2-V; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; BOYER PM, 1992, CHEM ENG SCI, V47, P241, DOI 10.1016/0009-2509(92)80218-2; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Dong XY, 2004, J BIOTECHNOL, V114, P135, DOI 10.1016/j.jbiotec.2004.06.012; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; HOBBS JR, 1963, J PATHOL BACTERIOL, V86, P437, DOI 10.1002/path.1700860218; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; KELENYL G, 1967, J HISTOCHEM CYTOCHEM, V15, P172; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumar TKS, 1998, BIOCHEM MOL BIOL INT, V46, P509; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Mishra R, 2005, J BIOL CHEM, V280, P15553, DOI 10.1074/jbc.M410947200; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Muzaffar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027906; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Qi W, 2009, BIOCHEMISTRY-US, V48, P8908, DOI 10.1021/bi9006397; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Tanaka M, 2005, J MOL MED, V83, P343, DOI 10.1007/s00109-004-0632-2; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2001, FEBS LETT, V509, P31, DOI 10.1016/S0014-5793(01)03121-0; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wall J, 1999, METHOD ENZYMOL, V309, P204; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yoshimoto N, 2003, BIOMACROMOLECULES, V4, P1530, DOI 10.1021/bm015662a	41	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104600	10.1371/journal.pone.0104600	http://dx.doi.org/10.1371/journal.pone.0104600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133607	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700033
J	Conde, L; Riby, J; Zhang, JQ; Bracci, PM; Skibola, CF				Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Bracci, Paige M.; Skibola, Christine F.			Copy Number Variation Analysis on a Non-Hodgkin Lymphoma Case-Control Study Identifies an 11q25 Duplication Associated with Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; FOLLICULAR LYMPHOMA; NONCODING RNAS; SUSCEPTIBILITY; SURVIVAL; REVEALS; LOCUS; GENE	Recent GWAS have identified several susceptibility loci for NHL. Despite these successes, much of the heritable variation in NHL risk remains to be explained. Common copy-number variants are important genomic sources of variability, and hence a potential source to explain part of this missing heritability. In this study, we carried out a CNV analysis using GWAS data from 681 NHL cases and 749 controls to explore the relationship between common structural variation and lymphoma susceptibility. Here we found a novel association with diffuse large B-cell lymphoma (DLBCL) risk involving a partial duplication of the C-terminus region of the LOC283177 long non-coding RNA that was further confirmed by quantitative PCR. For chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), known somatic deletions were identified on chromosomes 13q14, 11q22-23, 14q32 and 22q11.22. Our study shows that GWAS data can be used to identify germline CNVs associated with disease risk for DLBCL and somatic CNVs for CLL/SLL.	[Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Skibola, Christine F.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Conde, Lucia; Riby, Jacques; Zhang, Jianqing; Skibola, Christine F.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco	Conde, L (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	lconde@uab.edu; cskibola@uab.edu	Zhang, Jianqing/Q-3161-2019; Conde, Lucia/D-9295-2011	Zhang, Jianqing/0000-0001-5246-3371; Conde, Lucia/0000-0001-5180-543X	National Institutes of Health [CA122663, CA154643-01A1, CA104682, CA087014]; NATIONAL CANCER INSTITUTE [R01CA154643, R01CA104682, R01CA087014, R01CA122663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA122663, CA154643-01A1 and CA104682 (C.F.S.) and CA087014 (P.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Edsgard Daniel, 2013, Front Endocrinol (Lausanne), V4, P2, DOI 10.3389/fendo.2013.00002; Fernandez-Rozadilla C, 2014, HUM GENET, V133, P525, DOI 10.1007/s00439-013-1390-4; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Kuusisto KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071802; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Mraz M, 2013, LEUKEMIA RES, V37, P802, DOI 10.1016/j.leukres.2013.03.018; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Speedy HE, 2014, NAT GENET, V46, P56, DOI 10.1038/ng.2843; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017	21	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105382	10.1371/journal.pone.0105382	http://dx.doi.org/10.1371/journal.pone.0105382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133503	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700110
J	Torres, MJ; Dorigny, B; Kuhn, M; Berr, C; Barberger-Gateau, P; Letenneur, L				Torres, Marion J.; Dorigny, Beatrice; Kuhn, Mirjam; Berr, Claudine; Barberger-Gateau, Pascale; Letenneur, Luc			Nutritional Status in Community-Dwelling Elderly in France in Urban and Rural Areas	PLOS ONE			English	Article							COMPREHENSIVE ASSESSMENT; INTERRATER RELIABILITY; MALNUTRITION; RISK; PREVALENCE; HEALTHY; PEOPLE	Malnutrition is a frequent condition in elderly people, especially in nursing homes and geriatric wards. Its frequency is less well known among elderly living at home. The objective of this study was to describe the nutritional status evaluated by the Mini Nutritional Assessment (MNA) of elderly community-dwellers living in rural and urban areas in France and to investigate its associated factors. Methods: Subjects aged 65 years and over from the Approche Multidisciplinaire Integree (AMI) cohort (692 subjects living in a rural area) and the Three-City (3C) cohort (8,691 subjects living in three large urban zones) were included. A proxy version of the MNA was reconstructed using available data from the AMI cohort. Sensitivity and specificity were used to evaluate the agreement between the proxy version and the standard version in AMI. The proxy MNA was computed in both cohorts to evaluate the frequency of poor nutritional status. Factors associated with this state were investigated in each cohort separately. Results: In the rural sample, 38.0% were females and the mean age was 75.5 years. In the urban sample, 60.3% were females and the mean age was 74.1 years. Among subjects in living in the rural sample, 7.4% were in poor nutritional status while the proportion was 18.5% in the urban sample. Female gender, older age, being widowed, a low educational level, low income, low body mass index, being demented, having a depressive symptomatology, a loss of autonomy and an intake of more than 3 drugs appeared to be independently associated with poor nutritional status. Conclusion: Poor nutritional status was commonly observed among elderly people living at home in both rural and urban areas. The associated factors should be further considered for targeting particularly vulnerable individuals.	[Torres, Marion J.; Barberger-Gateau, Pascale; Letenneur, Luc] Univ Bordeaux, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France; [Torres, Marion J.; Barberger-Gateau, Pascale; Letenneur, Luc] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France; [Torres, Marion J.; Dorigny, Beatrice] Danone Res, Nutricia Adv Med Nutr, Saint Ouen, France; [Kuhn, Mirjam] Nutricia Res, Adv Med Nutr, Utrecht, Netherlands; [Berr, Claudine] Univ Montpellier I, Hop La Colombiere, INSERM, U1061, F-34093 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Danone Nutricia; Danone Nutricia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Torres, MJ (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM, Epidemiol Biostat U897, F-33000 Bordeaux, France.	Marion.Torres@isped.u-bordeaux2.fr	berr, Claudine/D-5238-2014; LETENNEUR, Luc/T-4424-2019	berr, Claudine/0000-0001-5254-7655; LETENNEUR, Luc/0000-0002-3274-937X; Torres, Marion J/0000-0002-7609-5531	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Conseils Regionaux of Aquitaine; Languedoc-Roussillon and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques'; Mutuelle Generale de l'Education Nationale; Institut de la longevite; Conseil General de la Cote d'or; AGRICA (CAMARCA); la Mutualite Sociale Agricole (MSA) de Gironde; la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE)	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Conseils Regionaux of Aquitaine(Region Nouvelle-Aquitaine); Languedoc-Roussillon and Bourgogne(Region Bourgogne-Franche-ComteRegion Occitanie); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques'; Mutuelle Generale de l'Education Nationale; Institut de la longevite; Conseil General de la Cote d'or(Region Bourgogne-Franche-Comte); AGRICA (CAMARCA); la Mutualite Sociale Agricole (MSA) de Gironde; la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA); AGRICA (CRCCA); AGRICA (CCPMA PREVOYANCE); AGRICA (CPCEA); AGRICA (AGRI PREVOYANCE)	The 3C Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen - Bordeaux II University and the Sanofi-Synthelabo Company. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Conseils Regionaux of Aquitaine, Languedoc-Roussillon and Bourgogne, Fondation de France, Ministry of Research-INSERM Programme 'Cohortes et collections de donnees biologiques', Mutuelle Generale de l'Education Nationale, Institut de la longevite, Conseil General de la Cote d'or. The authors thank the Genopole of Lille, the Laboratory of Biochemistry of the University Hospital of Dijon (Prof. Gambert) and Montpellier (Prof. Descomps), the Neuroradiology Departments of the University Hospitals of Bordeaux (Prof. Caille), Dijon (Prof. Krause) and Montpellier (Prof. Bonafe), the University Hospital Gui de Chauliac in Montpellier, the Council of Dijon and the Conseil General of Cote d'Or. The 3C Study supports are listed on the Study website (www.three-city-study.com). The AMI project was funded by AGRICA (CAMARCA, CRCCA, CCPMA PREVOYANCE, CPCEA, AGRI PREVOYANCE), la Mutualite Sociale Agricole (MSA) de Gironde, la Caisse Centrale de la Mutualite Sociale Agricole (CCMSA). The authors declare that the funders of the cohorts and the commercial company that finance some authors of this paper had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi M, 2008, ASIA PAC J CLIN NUTR, V17, P285; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Brownie Sonya, 2006, Int J Nurs Pract, V12, P110, DOI 10.1111/j.1440-172X.2006.00557.x; Chen CCH, 2001, J ADV NURS, V36, P131, DOI 10.1046/j.1365-2648.2001.01950.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cuervo M, 2009, PUBLIC HEALTH NUTR, V12, P82, DOI 10.1017/S136898000800195X; Ferdous T, 2009, PUBLIC HEALTH NUTR, V12, P2270, DOI 10.1017/S1368980009005096; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Guigoz Y, 1996, NUTR REV, V54, pS59; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hickson M, 2006, POSTGRAD MED J, V82, P2, DOI 10.1136/pgmj.2005.037564; Iizaka S, 2008, GERIATR GERONTOL INT, V8, P24, DOI 10.1111/j.1447-0594.2008.00443.x; Johansson L, 2009, J NUTR HEALTH AGING, V13, P855, DOI 10.1007/s12603-009-0242-3; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Larrieu S, 2004, J Nutr Health Aging, V8, P497; Locher JL, 2005, J GERONTOL A-BIOL, V60, P1475, DOI 10.1093/gerona/60.11.1475; Loser C, 2010, DTSCH ARZTEBL INT, V107, P911, DOI 10.3238/arztebl.2010.0911; Morillas J, 2006, NUTR HOSP, V21, P650; *NAT CTR HLTH STAT, 2001, HLTH US 2001 URB RUR; Nykanen I, 2013, EUR J PUBLIC HEALTH, V23, P405, DOI 10.1093/eurpub/cks026; Payette H, 2005, CAN J PUBLIC HEALTH, V96, pS27, DOI 10.1007/BF03405198; Peres K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-558; Pickering G, 2004, ARCH GERONTOL GERIAT, V38, P174, DOI 10.1016/j.archger.2003.09.004; Raynaud-Simon A, 2011, CLIN NUTR, V30, P312, DOI 10.1016/j.clnu.2010.12.003; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Salminen H, 2006, EUR J CLIN NUTR, V60, P486, DOI 10.1038/sj.ejcn.1602341; Soini H, 2005, J NUTR HEALTH AGING, V9, P249; Timpini A, 2011, J NUTR HEALTH AGING, V15, P233, DOI 10.1007/s12603-010-0286-4; Ulger Z, 2010, CLIN NUTR, V29, P507, DOI 10.1016/j.clnu.2010.01.006; United Nations, 2017, WORLD POP AG; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61	37	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105137	10.1371/journal.pone.0105137	http://dx.doi.org/10.1371/journal.pone.0105137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133755	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700075
J	White, D; Kemp, RI; Jenkins, R; Matheson, M; Burton, AM				White, David; Kemp, Richard I.; Jenkins, Rob; Matheson, Michael; Burton, A. Mike			Passport Officers' Errors in Face Matching	PLOS ONE			English	Article							RECOGNITION ABILITY; UNFAMILIAR FACES; IMAGES; VIDEO; PHOTOGRAPHS; PEOPLE	Photo-ID is widely used in security settings, despite research showing that viewers find it very difficult to match unfamiliar faces. Here we test participants with specialist experience and training in the task: passport-issuing officers. First, we ask officers to compare photos to live ID-card bearers, and observe high error rates, including 14% false acceptance of 'fraudulent' photos. Second, we compare passport officers with a set of student participants, and find equally poor levels of accuracy in both groups. Finally, we observe that passport officers show no performance advantage over the general population on a standardised face-matching task. Across all tasks, we observe very large individual differences: while average performance of passport staff was poor, some officers performed very accurately - though this was not related to length of experience or training. We propose that improvements in security could be made by emphasising personnel selection.	[White, David; Kemp, Richard I.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Jenkins, Rob] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Matheson, Michael] Australian Passport Off, Dept Foreign Affairs & Trade, Barton, Australia; [Burton, A. Mike] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	University of New South Wales Sydney; University of York - UK; University of Aberdeen	White, D (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	david.white@unsw.edu.au	Jenkins, Rob/C-5289-2008; White, David/AAS-9824-2021; Burton, Mike/A-9491-2008; White, David/B-5883-2008	Burton, Mike/0000-0002-2035-2084; White, David/0000-0002-6366-2699; Kemp, Richard/0000-0003-2819-265X	Australian Research Council [LP110100448]; Economic and Social Research Council, UK [RES-000-22-2519]; ESRC; European Research Council [ES/J022950/1, ERC-ADG 323262];  [ARC: LX0083067]; Economic and Social Research Council [ES/F026153/1, ES/J022950/1] Funding Source: researchfish; ESRC [ES/J022950/1, ES/F026153/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); ; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an Australian Research Council grant to RK (LP110100448) (http://www.arc.gov.au/); a bilaterally funded grant to RK (ARC: LX0083067), AMB and RJ (Economic and Social Research Council, UK: RES-000-22-2519) (http://www.esrc.ac.uk/); and awards from ESRC and European Research Council to AMB (ES/J022950/1; ERC-ADG 323262) (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Jenkins R, 2011, PHILOS T R SOC B, V366, P1671, DOI 10.1098/rstb.2010.0379; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Megreya AM, 2007, PERCEPT PSYCHOPHYS, V69, P1175, DOI 10.3758/BF03193954; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Susilo T, 2013, CURR OPIN NEUROBIOL, V23, P423, DOI 10.1016/j.conb.2012.12.011; Towler A, 2014, PERCEPTION, V43, P214, DOI 10.1068/p7676; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; WOODHEAD MM, 1979, ERGONOMICS, V22, P333, DOI 10.1080/00140137908924617	17	190	191	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103510	10.1371/journal.pone.0103510	http://dx.doi.org/10.1371/journal.pone.0103510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133682	Green Published, Green Accepted, gold			2022-12-27	WOS:000341302700010
J	Chaturvedi, S; Sidana, S; Elson, P; Khorana, AA; McCrae, KR				Chaturvedi, Shruti; Sidana, Surbhi; Elson, Paul; Khorana, Alok A.; McCrae, Keith R.			Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer	PLOS ONE			English	Article							UNSUSPECTED PULMONARY EMBOLI; TISSUE FACTOR EXPRESSION; DEEP-VEIN THROMBOSIS; ANGIOGENESIS; RISK; CARCINOMA; PREVENTION; MANAGEMENT; SYSTEM; IMPACT	Introduction: The association between malignancy and venous thromboembolic disease (VTE) is well established. The independent impact of VTE, both symptomatic and incidental, on survival in patients with prostate cancer is not known. We conducted a retrospective cohort study to evaluate the effect of VTE of survival in prostate cancer. Methods: Data regarding clinical characteristics, treatment and outcomes of 453 consecutive prostate cancer patients were collected. Fisher exact (categorical variables) and t-test (continuous variables) were utilized to test associations with VTE and mortality. Survival was estimated using the Kaplan Meier method. A Cox regression model was used to model the mortality hazard ratio (HR). Results: At diagnosis, 358 (83%) patients had early stage disease, 43 (10%) had locally advanced disease and 32 (7%) had metastatic disease. During the follow up period, 122 (27%) patients died and 41 (9%) developed VTE (33 deep vein thrombosis, 5 pulmonary embolism, and 3 patients with both DVT and PE). Twenty-five VTE events were symptomatic and 16 were incidentally diagnosed on CT scans obtained for other reasons. VTE was associated with increased mortality [HR 6.89 (4.29-11.08), p < 0.001] in a multivariable analysis adjusted for cancer stage, performance status, treatments and co-morbidities. There was no difference in survival between patients who had symptomatic and incidental VTE. Conclusion: Venous thromboembolic disease, both symptomatic and incidental, is a predictor of poor survival in patients with prostate cancer, especially those with advanced disease. Further studies are needed to evaluate the benefit of prophylactic and therapeutic anticoagulation in this population.	[Chaturvedi, Shruti; Sidana, Surbhi] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Khorana, Alok A.; McCrae, Keith R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	McCrae, KR (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	mccraek@ccf.org		Khorana, Alok/0000-0002-9509-0998; Sidana, Surbhi/0000-0003-3288-7614; Chaturvedi, Shruti/0000-0001-6832-2389	National Institutes of Health [U01HL072033, R01HL089796]; Sondra and Stephen Hardis Chair in Oncology Research; Scott Hamilton CARES initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072033, R01HL089796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sondra and Stephen Hardis Chair in Oncology Research; Scott Hamilton CARES initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants U01HL072033 and R01HL089796 to K. R. McCrae. A. A. Khorana acknowledges the Sondra and Stephen Hardis Chair in Oncology Research and the Scott Hamilton CARES initiative for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Abe K, 1999, P NATL ACAD SCI USA, V96, P8663, DOI 10.1073/pnas.96.15.8663; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Browne AM, 2010, J THORAC ONCOL, V5, P798, DOI 10.1097/JTO.0b013e3181d6153a; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Deitcher SR, 2003, SEMIN THROMB HEMOST, V29, P247; den Exter PL, 2011, J CLIN ONCOL, V29, P2405, DOI 10.1200/JCO.2010.34.0984; Desai SR, 2007, THORAX, V62, P470, DOI 10.1136/thx.2006.067884; Franchini M, 2012, SEMIN THROMB HEMOST, V38, P95, DOI 10.1055/s-0031-1300955; Gross CP, 2007, J GEN INTERN MED, V22, P321, DOI 10.1007/s11606-006-0019-x; Gussoni G, 2013, THROMB RES, V131, P24, DOI 10.1016/j.thromres.2012.10.007; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hall IE, 2009, J CANCER EPIDEMIOL, V2009, DOI 10.1155/2009/182521; Han LY, 2006, J CLIN ONCOL, V24, P755, DOI 10.1200/JCO.2005.02.9181; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Kaushal V, 2008, APPL IMMUNOHISTO M M, V16, P1; Khorana AA, 2003, J THROMB HAEMOST, V1, P2463, DOI 10.1111/j.1538-7836.2003.00501.x; Libertiny G, 1999, BRIT J SURG, V86, P907, DOI 10.1046/j.1365-2168.1999.01129.x; Lindholm PF, 2010, PROSTATE, V70, P1672, DOI 10.1002/pros.21202; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Nakagawa K, 1998, SEMIN THROMB HEMOST, V24, P207, DOI 10.1055/s-2007-995843; Nitori N, 2005, CLIN CANCER RES, V11, P2531, DOI 10.1158/1078-0432.CCR-04-0866; O'Connell C, 2011, J THROMB HAEMOST, V9, P305, DOI 10.1111/j.1538-7836.2010.04114.x; Ohta S, 2002, ANTICANCER RES, V22, P2991; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Prestidge T, 2012, INTERN MED J, V42, P71, DOI 10.1111/j.1445-5994.2010.02401.x; RICKLES FR, 1983, BLOOD, V62, P14; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Vrana JA, 1996, CANCER RES, V56, P5063; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	34	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e94048	10.1371/journal.pone.0094048	http://dx.doi.org/10.1371/journal.pone.0094048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126949	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300001
J	Jablonsky, J; Schwarz, D; Hagemann, M				Jablonsky, Jiri; Schwarz, Doreen; Hagemann, Martin			Multi-Level Kinetic Model Explaining Diverse Roles of Isozymes in Prokaryotes	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; SYNECHOCYSTIS SP PCC-6803; LOW CO2; CYANOBACTERIA; METABOLISM; GENE; INACTIVATION; TRANSPORT; BIOLOGY	Current standard methods for kinetic and genomic modeling cannot provide deep insight into metabolic regulation. Here, we developed and evaluated a multi-scale kinetic modeling approach applicable to any prokaryote. Specifically, we highlight the primary metabolism of the cyanobacterium Synechococcus elongatus PCC 7942. The model bridges metabolic data sets from cells grown at different CO2 conditions by integrating transcriptomic data and isozymes. Identification of the regulatory roles of isozymes allowed the calculation and explanation of the absolute metabolic concentration of 3-phosphoglycerate. To demonstrate that this method can characterize any isozyme, we determined the function of two glycolytic glyceraldehyde-3-phosphate dehydrogenases: one co-regulates high concentrations of the 3-phosphoglycerate, the other shifts the bifurcation point in hexose regulation, and both improve biomass production. Moreover, the regulatory roles of multiple phosphoglycolate phosphatases were defined for varying (non-steady) CO2 conditions, suggesting their protective role against toxic photorespiratory intermediates.	[Jablonsky, Jiri] Univ South Bohemia, FFPW, Lab Expt Complex Syst, Ceske Budejovice, Czech Republic; [Schwarz, Doreen; Hagemann, Martin] Univ Rostock, Dept Plant Physiol, D-18055 Rostock, Germany	University of South Bohemia Ceske Budejovice; University of Rostock	Jablonsky, J (corresponding author), Univ South Bohemia, FFPW, Lab Expt Complex Syst, Ceske Budejovice, Czech Republic.	jiri.jablonsky@gmail.com	Jablonsky, Jiri/F-7958-2015	Schwarz, Doreen/0000-0002-1071-5865	Postdok JU [CZ.1.07/2.3.00/30.0006]; CENAKVA [CZ.1.05/2.1.00/01.0024]; German Research Foundation (DFG) as part of the German photorespiration research group PROMICS [FOR 1186]; MEYS under the NPU I program [LO1205]	Postdok JU; CENAKVA; German Research Foundation (DFG) as part of the German photorespiration research group PROMICS(German Research Foundation (DFG)); MEYS under the NPU I program	This work was financially supported by Postdok JU CZ.1.07/2.3.00/30.0006, CENAKVA CZ.1.05/2.1.00/01.0024, and the German Research Foundation (DFG) as part of the German photorespiration research group PROMICS (FOR 1186). The results of the project LO1205 were obtained with a financial support from the MEYS under the NPU I program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; ANDERSON LE, 1971, BIOCHIM BIOPHYS ACTA, V235, P237, DOI 10.1016/0005-2744(71)90051-9; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; COLMAN B, 1989, AQUAT BOT, V34, P211, DOI 10.1016/0304-3770(89)90057-0; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Ducat DC, 2011, P NATL ACAD SCI USA, V108, P3941, DOI 10.1073/pnas.1016026108; Edwards G., 1983, C3 C4 MECH CELLULAR; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Huege J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016278; Jablonsky J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058281; Jablonsky J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-185; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Koksharova O, 1998, PLANT MOL BIOL, V36, P183, DOI 10.1023/A:1005925732743; Koksharova OA, 2004, MICROBIOLOGY+, V73, P330, DOI 10.1023/B:MICI.0000032245.17669.72; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Nakashima N, 2014, APPL ENVIRON MICROB, V80, P564, DOI 10.1128/AEM.02376-13; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; OGAWA T, 1991, PLANT PHYSIOL, V96, P280, DOI 10.1104/pp.96.1.280; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Steuer R, 2012, J EXP BOT, V63, P2259, DOI 10.1093/jxb/ers018; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004	29	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105292	10.1371/journal.pone.0105292	http://dx.doi.org/10.1371/journal.pone.0105292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127487	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300102
J	Lu, X; Zhang, ZD; Guo, XM; Choy, JS; Yang, JR; Svendsen, M; Kassab, G				Lu, Xiao; Zhang, Zhen-Du; Guo, Xiaomei; Choy, Jenny Susana; Yang, Junrong; Svendsen, Mark; Kassab, Ghassan			Response of Various Conduit Arteries in Tachycardia- and Volume Overload-Induced Heart Failure	PLOS ONE			English	Article							NADPH OXIDASE; ENDOTHELIAL-CELLS; ANIMAL-MODELS; HEMODYNAMICS; GENERATION; STRESS	Although hemodynamics changes occur in heart failure (HF) and generally influence vascular function, it is not clear whether various HF models will affect the conduit vessels differentially or whether local hemodynamic forces or systemic factors are more important determinants of vascular response in HF. Here, we studied the hemodynamic changes in tachycardia or volume-overload HF swine model (created by either high rate pacing or distal abdominal aortic-vena cava fistula, respectively) on carotid, femoral, and renal arteries function and molecular expression. The ejection fraction was reduced by 50% or 30% in tachycardia or volume-overload model in four weeks, respectively. The LV end diastolic volume was increased from 65 +/- 22 to 115 +/- 78 ml in tachycardia and 67 +/- 19 to 148 +/- 68 ml in volume-overload model. Flow reversal was observed in diastolic phase in carotid artery of both models and femoral artery in volume-overload model. The endothelial function was also significantly impaired in carotid and renal arteries of tachycardia and volume-overload animals. The endothelial dysfunction was observed in femoral artery of volume-overload animals but not tachycardia animals. The adrenergic receptor-dependent contractility decreased in carotid and femoral arteries of tachycardia animals. The protein expressions of NADPH oxidase subunits increased in the three arteries and both animal models while expression of MnSOD decreased in carotid artery of tachycardia and volume-overload model. In conclusion, different HF models lead to variable arterial hemodynamic changes but similar vascular and molecular expression changes that reflect the role of both local hemodynamics as well as systemic changes in HF.	[Lu, Xiao; Zhang, Zhen-Du; Guo, Xiaomei; Choy, Jenny Susana; Yang, Junrong; Svendsen, Mark; Kassab, Ghassan] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, G (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu			National Institute of Health-National Heart, Lung, and Blood Institute Grant [R01 HL084529-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084529] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grant R01 HL084529-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHOW E, 1990, AM J PHYSIOL, V258, pH1603, DOI 10.1152/ajpheart.1990.258.5.H1603; Elkayam U, 1996, J AM COLL CARDIOL, V28, P176, DOI 10.1016/0735-1097(96)00092-7; Godbole AS, 2009, AM J PHYSIOL-HEART C, V296, pH152, DOI 10.1152/ajpheart.01251.2007; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; HENRION D, 1992, EUR J PHARMACOL, V224, P13, DOI 10.1016/0014-2999(92)94812-A; Kawai H, 2000, AM J PHYSIOL-HEART C, V278, pH1708, DOI 10.1152/ajpheart.2000.278.5.H1708; Kostelec M, 2006, J THORAC CARDIOV SUR, V132, P875, DOI 10.1016/j.jtcvs.2006.03.067; Lu X, 2007, ANN BIOMED ENG, V35, P356, DOI 10.1007/s10439-006-9243-0; Paslawska U, 2010, INT J CARDIOL; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Power JM, 1999, AUST NZ J MED, V29, P395, DOI 10.1111/j.1445-5994.1999.tb00734.x; REMME WJ, 1994, EUR HEART J, V15, P129, DOI 10.1093/eurheartj/15.suppl_D.129; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; TAYLOR RR, 1968, J CLIN INVEST, V47, P1333, DOI 10.1172/JCI105825; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; WILSON JR, 1987, CIRCULATION, V75, P857, DOI 10.1161/01.CIR.75.4.857; ZEIGLER DW, 1986, AM J PHYSIOL, V251, pH196, DOI 10.1152/ajpheart.1986.251.1.H196; Zhang H, 1999, CARDIOVASC RES, V44, P215, DOI 10.1016/S0008-6363(99)00183-2; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zheng H, 2010, J APPL PHYSIOL, V109, P1619, DOI 10.1152/japplphysiol.01356.2009; ZUCKER IH, 1995, PROG CARDIOVASC DIS, V37, P397, DOI 10.1016/S0033-0620(05)80020-9	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e101645	10.1371/journal.pone.0101645	http://dx.doi.org/10.1371/journal.pone.0101645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127035	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300002
J	Perez-Carbonell, L; Balaguer, F; Toiyama, Y; Egoavil, C; Rojas, E; Guarinos, C; Andreu, M; Llor, X; Castells, A; Jover, R; Boland, CR; Goel, A				Perez-Carbonell, Lucia; Balaguer, Francesc; Toiyama, Yuji; Egoavil, Cecilia; Rojas, Estefania; Guarinos, Carla; Andreu, Montserrat; Llor, Xavier; Castells, Antoni; Jover, Rodrigo; Boland, C. Richard; Goel, Ajay			IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; CELL LUNG-CANCER; TUMOR MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; COLON-CANCER; PROMOTER METHYLATION; PHENOTYPE; DNA; EXPRESSION; PROGNOSIS	Background and Aim: Aberrant hypermethylation of cancer-related genes has emerged as a promising strategy for the development of diagnostic, prognostic and predictive biomarkers in human cancer, including colorectal cancer (CRC). The aim of this study was to perform a systematic and comprehensive analysis of a panel of CRC-specific genes as potential diagnostic, prognostic and predictive biomarkers in a large, population-based CRC cohort. Patients and Methods: Methylation status of the SEPT9, TWIST1, IGFBP3, GAS7, ALX4 and miR137 genes was studied by quantitative bisulfite pyrosequencing in a population-based cohort of 425 CRC patients. Results: Methylation levels of all genes analyzed were significantly higher in tumor tissues compared to normal mucosa (p < 0.0001); however, cancer-associated hypermethylation was most frequently observed for miR137 (86.7%) and IGFBP3 (83%) in CRC patients. Methylation analysis using the combination of these two genes demonstrated greatest accuracy for the identification of colonic tumors (sensitivity 95.5%; specificity 90.5%). Low levels of IGFBP3 promoter methylation emerged as an independent risk factor for predicting poor disease free survival in stage II and III CRC patients (HR = 0.49, 95% CI: 0.28-0.85, p = 0.01). Our results also suggest that stage II & III CRC patients with high levels of IGFBP3 methylation do not benefit from adjuvant 5FU-based chemotherapy. Conclusion: By analyzing a large, population-based CRC cohort, we demonstrate the potential clinical significance of miR137 and IGFBP3 hypermethylation as promising diagnostic biomarkers in CRC. Our data also revealed that IGFBP3 hypermethylation may serve as an independent prognostic and predictive biomarker in stage II and III CRC patients.	[Perez-Carbonell, Lucia; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Charles Sammons Canc Ctr, Dallas, TX 75207 USA; [Perez-Carbonell, Lucia; Toiyama, Yuji; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Balaguer, Francesc; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Hosp Clin, CIBERehd,IDIBAPS, Barcelona, Spain; [Egoavil, Cecilia; Rojas, Estefania] Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; [Guarinos, Carla] Hosp Gen Univ Alicante, Res Unit, Alicante, Spain; [Andreu, Montserrat] Hosp Mar, Dept Gastroenterol, Barcelona, Spain; [Llor, Xavier] Univ Illinois, Dept Med, Chicago, IL USA; [Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Jover, Rodrigo] Hosp Gen Univ Alicante, Unidad Gastroenterol, Alicante, Spain	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General University Hospital of Alicante; General University Hospital of Alicante; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; General University Hospital of Alicante	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Charles Sammons Canc Ctr, Dallas, TX 75207 USA.	rickbo@baylorhealth.edu; ajay.goel@baylorhealth.edu	Castells, Antoni/ABC-1002-2021; Jover, Rodrigo/ABC-3258-2021; BALAGUER, FRANCESC/G-2389-2016; Egoavil, Cecilia/X-5134-2018; Egoavil, Cecilia/ABG-8531-2020; Balaguer, Francesc/GPX-7801-2022	Castells, Antoni/0000-0001-8431-2033; Jover, Rodrigo/0000-0003-3742-3413; Egoavil, Cecilia/0000-0003-0166-4901; Egoavil, Cecilia/0000-0003-0166-4901; Goel, Ajay/0000-0003-1396-6341; Balaguer, Francesc/0000-0002-0206-0539; Rojas Calvente, Estefania/0000-0001-6004-525X	National Cancer Institute, National Institutes of Health [R01 CA72851, CA181572]; Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III [PI10/00384]; Generalitat Valenciana [ValI+D Acif/2010/018]; NATIONAL CANCER INSTITUTE [R01CA181572, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grant R01 CA72851 and CA181572 from the National Cancer Institute, National Institutes of Health and funds from the Baylor Research Institute. Lucia Perez-Carbonell is a recipient of a 2012 post-doctoral grant from Fundacion Alfonso Martin Escudero. Francesc Balaguer is a recipient of a grant from the Instituto de Salud Carlos III (PI10/00384). CIBEREHD is funded by the Instituto de Salud Carlos III. Carla Guarinos is a recipient of a grant from the Generalitat Valenciana (ValI+D Acif/2010/018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Borinstein SC, 2010, MOL CARCINOGEN, V49, P94, DOI 10.1002/mc.20581; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Cortes-Sempere M, 2013, ONCOGENE, V32, P1274, DOI 10.1038/onc.2012.146; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Kawasaki T, 2007, NEOPLASIA, V9, P1091, DOI 10.1593/neo.07760; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Min BH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-344; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Petko Z, 2005, CLIN CANCER RES, V11, P1203; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pinol V, 2004, EUR J GASTROEN HEPAT, V16, P39, DOI 10.1097/00042737-200401000-00007; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Regueiro CR, 2005, GASTROENTEROLOGY, V129, P1083, DOI 10.1053/j.gastro.2005.06.012; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wright CM, 2000, BRIT J SURG, V87, P1197, DOI 10.1046/j.1365-2168.2000.01508.x; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	44	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104285	10.1371/journal.pone.0104285	http://dx.doi.org/10.1371/journal.pone.0104285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127039	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300018
J	Shi, YZ; Forneris, N; Rajora, OP				Shi, Yong-Zhong; Forneris, Natascha; Rajora, Om P.			Highly Informative Single-Copy Nuclear Microsatellite DNA Markers Developed Using an AFLP-SSR Approach in Black Spruce (Picea mariana) and Red Spruce (P. rubens)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; TRANSMISSION RATIO DISTORTION; GENETIC-LINKAGE MAP; PERSICA L. BATSCH; WHITE SPRUCE; POPULATION-STRUCTURE; CONIFER GENOME; DIVERSITY ASSESSMENT; ARACHIS-HYPOGAEA; SEGREGATION	Background: Microsatellites or simple sequence repeats (SSRs) are highly informative molecular markers for various biological studies in plants. In spruce (Picea) and other conifers, the development of single-copy polymorphic genomic microsatellite markers is quite difficult, owing primarily to the large genome size and predominance of repetitive DNA sequences throughout the genome. We have developed highly informative single-locus genomic microsatellite markers in black spruce (Picea mariana) and red spruce (Picea rubens) using a simple but efficient method based on a combination of AFLP and microsatellite technologies. Principal Findings: A microsatellite-enriched library was constructed from genomic AFLP DNA fragments of black spruce. Sequencing of the 108 putative SSR-containing clones provided 94 unique sequences with microsatellites. Twenty-two of the designed 34 primer pairs yielded scorable amplicons, with single-locus patterns. Fourteen of these microsatellite markers were characterized in 30 black spruce and 30 red spruce individuals drawn from many populations. The number of alleles at a polymorphic locus ranged from 2 to 18, with a mean of 9.3 in black spruce, and from 3 to 15, with a mean of 6.2 alleles in red spruce. The polymorphic information content or expected heterozygosity ranged from 0.340 to 0.909 (mean = 0.67) in black spruce and from 0.161 to 0.851 (mean = 0.62) in red spruce. Ten SSR markers showing inter-parental polymorphism inherited in a single-locus Mendelian mode, with two cases of distorted segregation. Primer pairs for almost all polymorphic SSR loci resolved microsatellites of comparable size in Picea glauca, P. engelmannii, P. sitchensis, and P. abies. Significance: The AFLP-based microsatellite-enriched library appears to be a rapid, cost-effective approach for isolating and developing single-locus informative genomic microsatellite markers in black spruce. The markers developed should be useful in black spruce, red spruce and other Picea species for various genetics, genomics, breeding, forensics, conservation studies and applications.	[Shi, Yong-Zhong; Forneris, Natascha; Rajora, Om P.] Dalhousie Univ, Dept Biol, Forest Genet & Biotechnol Grp, Halifax, NS, Canada; [Rajora, Om P.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada	Dalhousie University; University of New Brunswick	Rajora, OP (corresponding author), Dalhousie Univ, Dept Biol, Forest Genet & Biotechnol Grp, Halifax, NS, Canada.	Om.Rajora@unb.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [STPGP 234783 - 00]; Genome Canada; Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds; Canada Research Chair Program [CRC950-201869]; NSERC [STPGP 234783 - 00]; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds; Canada Research Chair Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Project grant (STPGP 234783 - 00), http://www.nserc-crsng.gc.ca/index_eng.asp, Genome Canada Large-scale project funds, http://www.genomecanada.ca/, Stora Enso Port Hawkesbury Ltd (closed) Research Chairs funds, and Canada Research Chair Program (CRC950-201869) funds, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx, to Om P. Rajora. Yongzhong Shi was financially supported by NSERC Strategic Grants funds (STPGP 234783 - 00) to Om P. Rajora and Natascha Forneris was financially supported by Genome Canada funding to Om P. Rajora. Om P. Rajora held the Stora Enso Senior Chair in Forest Genetics and Biotechnology at Dalhousie University, which was supported by Stora Enso Port Hawkesbury Ltd., and the Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB, which was supported by the Canada Research Chair Program (CRC950-201869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stora Enso Port Hawkesbury Ltd. (closed) has/had no competing interest and no restrictions on sharing of data and/or materials. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Areshchenkova T, 2002, THEOR APPL GENET, V104, P229, DOI 10.1007/s00122-001-0775-2; Bashalkhanov S, 2013, MOL ECOL, V22, P5877, DOI 10.1111/mec.12546; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; BOBOLA MS, 1992, CAN J FOREST RES, V22, P255, DOI 10.1139/x92-033; Bobola MS, 1996, CAN J FOREST RES, V26, P433, DOI 10.1139/x26-049; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P551, DOI 10.1007/BF00222447; CHEN H, 1995, GENOMICS, V25, P1, DOI 10.1016/0888-7543(95)80103-S; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dobrzeniecka S, 2009, SILVAE GENET, V58, P168, DOI 10.1515/sg-2009-0022; Donini P, 1998, GENET RESOUR CROP EV, V45, P415, DOI 10.1023/A:1008612917967; Elsik CG, 2001, THEOR APPL GENET, V103, P1189, DOI 10.1007/s001220100725; Fageria MS, 2013, EVOL APPL, V6, P778, DOI 10.1111/eva.12064; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Fishman L, 2008, EVOLUTION, V62, P2958, DOI 10.1111/j.1558-5646.2008.00475.x; Georgi LL, 2002, THEOR APPL GENET, V105, P1151, DOI 10.1007/s00122-002-0967-4; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HAWLEY GJ, 1994, CAN J BOT, V72, P1778, DOI 10.1139/b94-219; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Hodgetts RB, 2001, THEOR APPL GENET, V102, P1252, DOI 10.1007/s00122-001-0546-0; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Kang BY, 2011, GENOME, V54, P128, DOI 10.1139/G10-099; Kang BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-515; Kinlaw CS, 1997, TRENDS PLANT SCI, V2, P356, DOI 10.1016/S1360-1385(97)84624-9; Li Y, 2010, AM J BOT, V97, pE39, DOI 10.3732/ajb.1000098; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Miao YC, 2012, INT J MOL SCI, V13, P11165, DOI 10.3390/ijms130911165; MORGENSTERN EK, 1972, CAN J GENET CYTOL, V14, P443, DOI 10.1139/g72-055; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Perron M, 2000, P NATL ACAD SCI USA, V97, P11331, DOI 10.1073/pnas.200417097; PERRON M, 1995, THEOR APPL GENET, V91, P142, DOI 10.1007/BF00220871; Pfeiffer A, 1997, GENOME, V40, P411, DOI 10.1139/g97-055; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rahman MH, 2002, GENOME, V45, P1083, DOI [10.1139/g02-077, 10.1139/G02-077]; Rahman MH, 2001, PLANT CELL REP, V20, P531, DOI 10.1007/s002990100365; Rajora OP, 2000, CAN J BOT, V78, P941, DOI 10.1139/cjb-78-7-941; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 2003, THEOR APPL GENET, V106, P1203, DOI 10.1007/s00122-002-1169-9; Rajora OP, 2003, THEOR APPL GENET, V106, P470, DOI 10.1007/s00122-002-1082-2; Rajora OP, 2001, MOL GEN GENET, V264, P871, DOI 10.1007/s004380000377; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; Reece KS, 2004, J HERED, V95, P346, DOI 10.1093/jhered/esh058; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Scotti I, 2002, THEOR APPL GENET, V106, P40, DOI 10.1007/s00122-002-0986-1; Scotti I, 2002, THEOR APPL GENET, V104, P1035, DOI 10.1007/s00122-001-0843-7; Scotti I, 2000, GENOME, V43, P41, DOI 10.1139/gen-43-1-41; Sokal RR, 1995, BIOMETRY; Tang SX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-48; Taramino G, 1997, THEOR APPL GENET, V95, P66, DOI 10.1007/s001220050533; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Yamamoto T, 2002, MOL ECOL NOTES, V2, P14, DOI 10.1046/j.1471-8286.2002.00128.x; Yamamoto T, 2002, MOL ECOL NOTES, V2, P298, DOI 10.1046/j.1471-8286.2002.00242.x; Yang JB, 2009, HORTSCIENCE, V44, P2043, DOI 10.21273/HORTSCI.44.7.2043; Yazdani R, 2003, HEREDITAS, V138, P219, DOI 10.1034/j.1601-5223.2003.01524.x; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhou Y, 2002, GENOME, V45, P91, DOI 10.1139/g01-119; [No title captured]	61	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103789	10.1371/journal.pone.0103789	http://dx.doi.org/10.1371/journal.pone.0103789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126846	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300008
J	Jackson, JW; Schneeweiss, S; VanderWeele, TJ; Blacker, D				Jackson, John W.; Schneeweiss, Sebastian; VanderWeele, Tyler J.; Blacker, Deborah			Quantifying the Role of Adverse Events in the Mortality Difference between First and Second-Generation Antipsychotics in Older Adults: Systematic Review and Meta-Synthesis	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; TORSADE-DE-POINTES; VENOUS THROMBOEMBOLISM; CEREBROVASCULAR EVENTS; NONDIFFERENTIAL MISCLASSIFICATION; ATYPICAL ANTIPSYCHOTICS; ELDERLY-PATIENTS; ISCHEMIC-STROKE; RISK; DEATH	Background: Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous thromboembolism, myocardial infarction, pneumonia, and hip fracture. Objectives: 1) Review robust epidemiologic evidence comparing mortality and medical event risk between FGAs and SGAs in older adults; 2) Quantify how much these medical events explain the observed mortality difference between FGAs and SGAs. Data sources: Pubmed and Science Citation Index. Study eligibility criteria, participants, and interventions: Studies of antipsychotic users that: 1) evaluated mortality or medical events specified above; 2) restricted to populations with a mean age of 65 years or older 3) compared FGAs to SGAs, or both to a non-user group; (4) employed a "new user" design; (5) adjusted for confounders assessed prior to antipsychotic initiation; (6) and did not require survival after antipsychotic initiation. A separate search was performed for mortality estimates associated with the specified medical events. Study appraisal and synthesis methods: For each medical event, we used a non-parametric model to estimate lower and upper bounds for the proportion of the mortality difference-comparing FGAs to SGAs-mediated by their difference in risk for the medical event. Results: We provide a brief, updated summary of the included studies and the biological plausibility of these mechanisms. Of the 1122 unique citations retrieved, we reviewed 20 observational cohort studies that reported 28 associations. We identified hip fracture, stroke, myocardial infarction, and ventricular arrhythmias as potential intermediaries on the causal pathway from antipsychotic type to death. However, these events did not appear to explain the entire mortality difference. Conclusions: The current literature suggests that hip fracture, stroke, myocardial infarction, and ventricular arrhythmias partially explain the mortality difference between SGAs and FGAs.	[Jackson, John W.; Schneeweiss, Sebastian] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Jackson, John W.; Schneeweiss, Sebastian; Blacker, Deborah] Harvard Univ, Sch Med, Boston, MA USA; [Jackson, John W.; Schneeweiss, Sebastian; VanderWeele, Tyler J.; Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [VanderWeele, Tyler J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Blacker, Deborah] Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Jackson, JW (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	john.jackson@mail.harvard.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	NIMH Training Grant in Training in Psychiatric Genetics and Translational Research [T32 MH017119]; Horace W. Goldsmith Fellowship at Harvard University; NIA [P50 AG005134]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	NIMH Training Grant in Training in Psychiatric Genetics and Translational Research; Horace W. Goldsmith Fellowship at Harvard University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	John W. Jackson was supported by NIMH Training Grant in Training in Psychiatric Genetics and Translational Research (T32 MH017119) and the Horace W. Goldsmith Fellowship at Harvard University. Sebastian Schneeweiss had no relevant funding. Tyler J. VanderWeele: NIH R01 ES 0178876. Deborah Blacker was supported by NIA P50 AG005134. The funders had no role in the motivation for the study or the study design, data collection and analysis, interpretation of results, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; APA Work Group on Alzheimer's Disease and other Dementias, 2007, Am J Psychiatry, V164, P5; Aparasu RR, 2012, MED CARE, V50, P961, DOI 10.1097/MLR.0b013e31826ec185; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Brauer R, 2011, BRIT J CLIN PHARMACO, V72, P871, DOI 10.1111/j.1365-2125.2011.04043.x; Chan MC, 2010, INT J GERIATR PSYCH, V25, P362, DOI 10.1002/gps.2347; Collins TC, 2003, J CLIN EPIDEMIOL, V56, P81, DOI 10.1016/S0895-4356(02)00570-X; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Drzyzga L, 2006, BRAIN BEHAV IMMUN, V20, P532, DOI 10.1016/j.bbi.2006.02.002; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Engdahl J, 2002, RESUSCITATION, V52, P235, DOI 10.1016/S0300-9572(01)00464-6; Finkel S, 2005, INT PSYCHOGERIATR, V17, P617, DOI 10.1017/S1041610205002280; Gareri P, 2014, J CLIN PSYCHOPHARM, V34, P109, DOI 10.1097/JCP.0b013e3182a6096e; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Gruneir A, 2011, PHARMACOEPIDEM DR S, V20, P221, DOI 10.1002/pds.2058; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; Hagg S, 2002, CNS DRUGS, V16, P765; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Huybrechts KF, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e977; Huybrechts KF, 2012, J AM GERIATR SOC, V60, P420, DOI 10.1111/j.1532-5415.2011.03853.x; Huybrechts KF, 2012, J CLIN PSYCHOPHARM, V32, P11, DOI 10.1097/JCP.0b013e31823f6f46; Huybrechts KF, 2011, AM J EPIDEMIOL, V174, P1089, DOI 10.1093/aje/kwr213; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Jonsson AK, 2012, CNS DRUGS, V26, P649, DOI 10.2165/11633920-000000000-00000; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Kaplan V, 2003, CRIT CARE CLIN, V19, P729, DOI 10.1016/S0749-0704(03)00057-5; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kikawada M, 2005, DRUG AGING, V22, P115, DOI 10.2165/00002512-200522020-00003; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Liperoti R, 2005, ARCH INTERN MED, V165, P2677, DOI 10.1001/archinte.165.22.2677; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Lopez OL, 2013, AM J PSYCHIAT, V170, P1051, DOI 10.1176/appi.ajp.2013.12081046; Maglione M, 2011, OFF LABEL USE ATYPTI; Maglione M., 2011, OFF LABEL USE ATYPIC; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Oderda LH, 2012, ANN PHARMACOTHER, V46, P917, DOI 10.1345/aph.1Q589; Ogburn EL, 2012, AM J EPIDEMIOL, V176, P555, DOI 10.1093/aje/kws131; Ogburn EL, 2012, EPIDEMIOLOGY, V23, P433, DOI 10.1097/EDE.0b013e31824d1f63; Pearl J, 2012, PREV SCI, V13, P426, DOI 10.1007/s11121-011-0270-1; Pierre JM, 2005, DRUG SAFETY, V28, P191, DOI 10.2165/00002018-200528030-00002; Pratt N, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-72; Pratt N, 2010, PHARMACOEPIDEM DR S, V19, P699, DOI 10.1002/pds.1942; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Rossom RC, 2010, J AM GERIATR SOC, V58, P1027, DOI 10.1111/j.1532-5415.2010.02873.x; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Sacchetti E, 2008, J PSYCHOPHARMACOL, V22, P39, DOI 10.1177/0269881107080792; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Salzman C, 2005, CLIN GERIATRIC PSYCH; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schneeweiss S, 2009, CNS DRUGS, V23, P171, DOI 10.2165/00023210-200923020-00006; Schneider LS, 2003, SCHIZOPHRENIA BULL, V29, P57, DOI 10.1093/oxfordjournals.schbul.a006991; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Sesso HD, 2006, CONTEMP CLIN TRIALS, V27, P333, DOI 10.1016/j.cct.2005.11.007; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Soros P, 2012, LANCET NEUROL, V11, P179, DOI 10.1016/S1474-4422(11)70291-5; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Swan JT, 2012, CRIT CARE, V16, DOI 10.1186/cc11342; Trifiro Gianluca, 2011, Curr Infect Dis Rep, V13, P262, DOI 10.1007/s11908-011-0175-y; Trifiro G, 2009, PHARMACOL RES, V59, P1, DOI 10.1016/j.phrs.2008.09.017; Wang PS, 2007, J CLIN PSYCHOPHARM, V27, P707, DOI 10.1097/JCP.0b013e31815a882b; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wang S, 2012, STROKE, V43, P28, DOI 10.1161/STROKEAHA.111.617191; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zhang R, 2011, PHARMACOPSYCHIATRY, V44, P183, DOI 10.1055/s-0031-1280814	75	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105376	10.1371/journal.pone.0105376	http://dx.doi.org/10.1371/journal.pone.0105376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140533	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200081
J	Lee, CY; Liu, YL; Lin, CL; Liu, GY; Hung, HC				Lee, Chien-Yun; Liu, Yi-Liang; Lin, Chih-Li; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Roles of the Dimer-Interface Residues in Human Ornithine Decarboxylase	PLOS ONE			English	Article							METHOTREXATE-INDUCED APOPTOSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; ANTIZYME INHIBITOR; ACTIVE-SITE; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; SUBSTRATE-BINDING; PROTEIN; DEGRADATION	Ornithine decarboxylase (ODC) catalyzes the decarboxylation of ornithine to putrescine and is the rate-limiting enzyme in the polyamine biosynthesis pathway. ODC is a dimeric enzyme, and the active sites of this enzyme reside at the dimer interface. Once the enzyme dissociates, the enzyme activity is lost. In this paper, we investigated the roles of amino acid residues at the dimer interface regarding the dimerization, protein stability and/or enzyme activity of ODC. A multiple sequence alignment of ODC and its homologous protein antizyme inhibitor revealed that 5 of 9 residues (residues 165, 277, 331, 332 and 389) are divergent, whereas 4 (134, 169, 294 and 322) are conserved. Analytical ultracentrifugation analysis suggested that some dimer-interface amino acid residues contribute to formation of the dimer of ODC and that this dimerization results from the cooperativity of these interface residues. The quaternary structure of the sextuple mutant Y331S/Y389D/R277S/D332E/V322D/D134A was changed to a monomer rather than a dimer, and the K-d value of the mutant was 52.8 mu M, which is over 500-fold greater than that of the wild-type ODC (ODC_WT). In addition, most interface mutants showed low but detectable or negligible enzyme activity. Therefore, the protein stability of these interface mutants was measured by differential scanning calorimetry. These results indicate that these dimer-interface residues are important for dimer formation and, as a consequence, are critical for enzyme catalysis.	[Lee, Chien-Yun; Liu, Yi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lee, Chien-Yun] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lee, Chien-Yun] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 115, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Chih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] NCHU, ABC, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ & Hosp, Inst Microbiol & Immunol, Taichung, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Lin, Chih-Li/H-9515-2019; Lin, Chih-Li/GQZ-6480-2022; Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Lin, Chih-Li/0000-0003-4553-3727; Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	Ministry of Science and Technology, ROC [NSC 102-2321-B-005-008]; Ministry of Education, Taiwan, R.O.C. under the ATU plan	Ministry of Science and Technology, ROC; Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology (http://web1.most.gov.tw/), ROC (NSC 102-2321-B-005-008 to HCH) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1984, ADV ENZYME REGUL, V23, P311, DOI 10.1016/0065-2571(85)90054-8; Hsieh JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024366; Hsu HC, 1999, AUTOIMMUNITY, V29, P299, DOI 10.3109/08916939908994750; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026835; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019253; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OBrien TG, 1997, CANCER RES, V57, P2630; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park JK, 2002, MOL PHARMACOL, V62, P1400, DOI 10.1124/mol.62.6.1400; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seiler N, 1998, INT J ONCOL, V13, P993; Smith MK, 1997, CANCER RES, V57, P2104; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	56	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104865	10.1371/journal.pone.0104865	http://dx.doi.org/10.1371/journal.pone.0104865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140796	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200038
J	Loffing, F; Solter, F; Hagemann, N				Loffing, Florian; Soelter, Florian; Hagemann, Norbert			Left Preference for Sport Tasks Does Not Necessarily Indicate Left-Handedness: Sport-Specific Lateral Preferences, Relationship with Handedness and Implications for Laterality Research in Behavioural Sciences	PLOS ONE			English	Article							HAND PREFERENCE; FIGHTING HYPOTHESIS; TAKEOFF LEG; FREQUENCY; ADVANTAGE; INVENTORY; DOMINANCE; EXPLAIN; WORLD; AGE	In the elite domain of interactive sports, athletes who demonstrate a left preference (e.g., holding a weapon with the left hand in fencing or boxing in a 'southpaw' stance) seem overrepresented. Such excess indicates a performance advantage and was also interpreted as evidence in favour of frequency-dependent selection mechanisms to explain the maintenance of left-handedness in humans. To test for an overrepresentation, the incidence of athletes' lateral preferences is typically compared with an expected ratio of left- to right-handedness in the normal population. However, the normal population reference values did not always relate to the sport-specific tasks of interest, which may limit the validity of reports of an excess of 'left-oriented' athletes. Here we sought to determine lateral preferences for various sport-specific tasks (e.g., baseball batting, boxing) in the normal population and to examine the relationship between these preferences and handedness. To this end, we asked 903 participants to indicate their lateral preferences for sport-specific and common tasks using a paper-based questionnaire. Lateral preferences varied considerably across the different sport tasks and we found high variation in the relationship between those preferences and handedness. In contrast to unimanual tasks (e.g., fencing or throwing), for bimanually controlled actions such as baseball batting, shooting in ice hockey or boxing the incidence of left preferences was considerably higher than expected from the proportion of left-handedness in the normal population and the relationship with handedness was relatively low. We conclude that (i) task-specific reference values are mandatory for reliably testing for an excess of athletes with a left preference, (ii) the term 'handedness' should be more cautiously used within the context of sport-related laterality research and (iii) observation of lateral preferences in sports may be of limited suitability for the verification of evolutionary theories of handedness.	[Loffing, Florian; Soelter, Florian; Hagemann, Norbert] Univ Kassel, Inst Sports & Sports Sci, D-34125 Kassel, Germany; [Soelter, Florian] Univ Munster, Inst Sport & Exercise Sci, D-48149 Munster, Germany	Universitat Kassel; University of Munster	Loffing, F (corresponding author), Univ Kassel, Inst Sports & Sports Sci, D-34125 Kassel, Germany.	f.loffing@uni-kassel.de	Loffing, Florian/I-3582-2015; Loffing, Florian/AGJ-4713-2022	Loffing, Florian/0000-0002-5496-9146; Loffing, Florian/0000-0002-5496-9146; Hagemann, Norbert/0000-0002-7721-7916	German Research Foundation (DFG) [HA 4361/5-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) [HA 4361/5-2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2012, J R SOC INTERFACE, V9, P2718, DOI 10.1098/rsif.2012.0211; AGGLETON JP, 1990, INT J SPORT PSYCHOL, V21, P46; Baker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079793; Brooks R, 2004, P ROY SOC B-BIOL SCI, V271, pS64, DOI 10.1098/rsbl.2003.0100; Brown S, 2006, MAMM GENOME, V17, P1, DOI 10.1007/s00335-005-0900-7; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Cohen J.E., 1988, STAT POWER ANAL BEHA; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; Dane S, 2005, PERCEPT MOTOR SKILL, V100, P743, DOI 10.2466/PMS.100.3.743-746; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Faurie C, 2004, P ROY SOC B-BIOL SCI, V271, pS43, DOI 10.1098/rsbl.2003.0092; Faurie C, 2013, ANN NY ACAD SCI, V1288, P110, DOI 10.1111/nyas.12159; Fazio R, 2012, LATERALITY, V17, P70, DOI 10.1080/1357650X.2010.532801; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; FRIBERG O, 1988, INT J SPORTS MED, V9, P349, DOI 10.1055/s-2007-1025039; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Gorney C, 2009, NY TIMES; Gorynia I, 2000, CORTEX, V36, P1, DOI 10.1016/S0010-9452(08)70832-3; Groothuis TGG, 2013, ANN NY ACAD SCI, V1288, P100, DOI 10.1111/nyas.12164; Grouios G, 2004, PERCEPT MOTOR SKILL, V98, P53; Gursoy R, 2009, BRIT J SPORT MED, V43, P142, DOI 10.1136/bjsm.2007.043547; Hagemann N, 2009, ATTEN PERCEPT PSYCHO, V71, P1641, DOI 10.3758/APP.71.7.1641; Holtzen DW, 2000, INT J NEUROSCI, V105, P101, DOI 10.3109/00207450009003270; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; Loffing F., 2012, BIAS HUMAN BEHAV, P163; Loffing F, 2014, Z SPORTPSYCHOL, V21, P63, DOI 10.1026/1612-5010/a000117; Loffing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049325; Loffing F, 2012, ATTEN PERCEPT PSYCHO, V74, P446, DOI 10.3758/s13414-011-0252-1; Loffing F, 2010, HIGH ABIL STUD, V21, P19, DOI 10.1080/13598139.2010.488084; Loffing F, 2010, J SPORT SCI, V28, P435, DOI 10.1080/02640410903536459; MCLEAN JM, 1982, NEW ENGL J MED, V307, P1278; McManus I.C., 2002, RIGHT HAND LEFT HAND; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Miyaguchi K, 2010, J STRENGTH COND RES, V24, P2516, DOI 10.1519/JSC.0b013e3181e380b5; Oberbeck H, 1989, SEITIGKEITSPHANOMENE; Oberbeck H, 1992, LEISTUNGSSPORT, V22, P35; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERS M, 1992, NEUROPSYCHOLOGIA, V30, P373, DOI 10.1016/0028-3932(92)90110-8; Peters M, 2006, BRAIN COGNITION, V62, P177, DOI 10.1016/j.bandc.2006.04.005; Pollet TV, 2013, ANIM BEHAV, V86, P839, DOI 10.1016/j.anbehav.2013.07.026; Puterman J, 2010, J SPORT SCI, V28, P1581, DOI 10.1080/02640414.2010.514281; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Schachter SC, 2000, SIDE BIAS: A NEUROPSYCHOLOGICAL PERSPECTIVE, P155; Schorer J, 2012, J SPORT SCI, V30, P507, DOI 10.1080/02640414.2012.654811; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; WOOD CJ, 1989, BRIT J PSYCHOL, V80, P227, DOI 10.1111/j.2044-8295.1989.tb02316.x; Ziyagil MA, 2010, PERCEPT MOTOR SKILL, V111, P65, DOI 10.2466/04.05.19.25.PMS.111.4.65-70	49	41	41	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105800	10.1371/journal.pone.0105800	http://dx.doi.org/10.1371/journal.pone.0105800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141020	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200122
J	Margeridon-Thermet, S; Le Pogam, S; Li, L; Liu, TF; Shulman, N; Shafer, RW; Najera, I				Margeridon-Thermet, Severine; Le Pogam, Sophie; Li, Lewyn; Liu, Tommy F.; Shulman, Nancy; Shafer, Robert W.; Najera, Isabel			Similar Prevalence of Low-Abundance Drug-Resistant Variants in Treatment-Naive Patients with Genotype 1a and 1b Hepatitis C Virus Infections as Determined by Ultradeep Pyrosequencing	PLOS ONE			English	Article							PLUS PEGINTERFERON ALPHA-2A; DIRECT-ACTING ANTIVIRALS; IN-VITRO RESISTANCE; INHIBITOR; POLYMERASE; NS5B; RIBAVIRIN; NONNUCLEOSIDE; COMBINATION; THERAPY	Background and Objectives: Hepatitis C virus (HCV) variants that confer resistance to direct-acting-antiviral agents (DAA) have been detected by standard sequencing technology in genotype (G) 1 viruses from DAA-naive patients. It has recently been shown that virological response rates are higher and breakthrough rates are lower in G1b infected patients than in G1a infected patients treated with certain classes of HCV DAAs. It is not known whether this corresponds to a difference in the composition of G1a and G1b HCV quasispecies in regards to the proportion of naturally occurring DAA-resistant variants before treatment. Methods: We used ultradeep pyrosequencing to determine the prevalence of low-abundance (<25% of the sequence reads) DAA-resistant variants in 191 NS3 and 116 NS5B isolates from 208 DAA-naive G1-infected patients. Results: A total of 3.5 million high-quality reads of >= 200 nucleotides were generated. The median coverage depth was 4150x and 4470x per NS3 and NS5B amplicon, respectively. Both G1a and G1b populations showed Shannon entropy distributions, with no difference between G1a and G1b in NS3 or NS5B region at the nucleotide level. A higher number of substitutions that confer resistance to protease inhibitors were observed in G1a isolates (mainly at amino acid 80 of the NS3 region). The prevalence of amino acid substitutions that confer resistance to NS5B non-nucleoside inhibitors was similar in G1a and G1b isolates. The NS5B S282T variant, which confers resistance to the polymerase inhibitors mericitabine and sofosbuvir, was not detected in any sample. Conclusion: The quasispecies genetic diversity and prevalence of DAA-resistant variants was similar in G1a and G1b isolates and in both NS3 and NS5B regions, suggesting that this is not a determinant for the higher level of DAA resistance observed across G1a HCV infected patients upon treatment.	[Margeridon-Thermet, Severine; Liu, Tommy F.; Shafer, Robert W.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Le Pogam, Sophie; Li, Lewyn; Najera, Isabel] Roche, Infect Dis Discovery, Pharma Res Early Dev, Nutley, NJ 07110 USA; [Le Pogam, Sophie; Shulman, Nancy] Genentech Inc, Pharma Dev, San Francisco, CA 94080 USA; [Najera, Isabel] Roche, Pharma Res Early Dev, Infect Dis Discovery, Shanghai, Peoples R China	Stanford University; Roche Holding; Roche Holding; Genentech	Najera, I (corresponding author), Roche, Infect Dis Discovery, Pharma Res Early Dev, Nutley, NJ 07110 USA.	isabel.najera@roche.com			F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was supported by F. Hoffmann-La Roche Ltd. The funder provided support in the form of salaries for authors SLP, LL, NS & IN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Gane EJ, 2014, ANTIMICROB AGENTS CH, V58, P1136, DOI 10.1128/AAC.01515-13; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; INA Y, 1994, J MOL EVOL, V38, P50; Jacobson I, 2013, J HEPATOL, V58, pS574, DOI 10.1016/S0168-8278(13)61424-5; Jensen DM, 2014, HEPATOL INT, V8, pS201; Jesudian AB, 2013, CLIN GASTROENTEROL H, V11, P612, DOI 10.1016/j.cgh.2013.04.003; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; Lagace L, 2010, HEPATOLOGY, V52, p1205A; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lam AM, 2011, J VIROL, V85, P12334, DOI 10.1128/JVI.05639-11; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009; Le Pogam S, 2012, ANTIMICROB AGENTS CH, V56, P5494, DOI 10.1128/AAC.01035-12; Le Pogam S, 2008, J ANTIMICROB CHEMOTH, V61, P1205, DOI 10.1093/jac/dkn085; Le Pogam S, 2012, HEPATOLOGY, V56, p571A; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; Lenz O, 2012, GASTROENTEROLOGY, V143, P1176, DOI 10.1053/j.gastro.2012.07.117; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Marcellin P, 2013, GASTROENTEROLOGY, V145, P790, DOI 10.1053/j.gastro.2013.06.051; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Moreau I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-78; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6; Ogert RA, 2013, ANTIVIR THER, V18, P387, DOI 10.3851/IMP2549; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Pelosi LA, 2012, ANTIMICROB AGENTS CH, V56, P5230, DOI 10.1128/AAC.01209-12; Pockros PJ, 2008, HEPATOLOGY, V48, P385, DOI 10.1002/hep.22357; Pockros PJ, 2013, HEPATOLOGY, V58, P514, DOI 10.1002/hep.26275; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Randolph JT, 2009, J MED CHEM, V52, P3174, DOI 10.1021/jm801485z; Seiwert SD, 2007, J HEPATOL, V46, pS244, DOI 10.1016/S0168-8278(07)62245-4; Shih IH, 2011, ANTIMICROB AGENTS CH, V55, P4196, DOI 10.1128/AAC.00307-11; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Svarovskaia E, 2013, J HEPATOL, V58, pS496, DOI 10.1016/S0168-8278(13)61222-2; Thomas XV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041191; Thompson PA, 2008, HEPATOLOGY, V48, p1164A; Tong X, 2014, ANTIMICROB AGENTS CH; Tong X, 2013, J INFECT DIS; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Trimoulet P, 2013, ANTIVIR THER, V18, P723, DOI 10.3851/IMP2632; Troke PJF, 2012, ANTIMICROB AGENTS CH, V56, P1331, DOI 10.1128/AAC.05611-11; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zheng XF, 2011, BIOORG MED CHEM LETT, V21, P2925, DOI 10.1016/j.bmcl.2011.03.067	55	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105569	10.1371/journal.pone.0105569	http://dx.doi.org/10.1371/journal.pone.0105569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140696	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200100
J	Pandey, MK; Upadhyaya, HD; Rathore, A; Vadez, V; Sheshshayee, MS; Sriswathi, M; Govil, M; Kumar, A; Gowda, MVC; Sharma, S; Hamidou, F; Kumar, VA; Khera, P; Bhat, RS; Khan, AW; Singh, S; Li, HJ; Monyo, E; Nadaf, HL; Mukri, G; Jackson, SA; Guo, BZ; Liang, XQ; Varshney, RK				Pandey, Manish K.; Upadhyaya, Hari D.; Rathore, Abhishek; Vadez, Vincent; Sheshshayee, M. S.; Sriswathi, Manda; Govil, Mansee; Kumar, Ashish; Gowda, M. V. C.; Sharma, Shivali; Hamidou, Falalou; Kumar, V. Anil; Khera, Pawan; Bhat, Ramesh S.; Khan, Aamir W.; Singh, Sube; Li, Hongjie; Monyo, Emmanuel; Nadaf, H. L.; Mukri, Ganapati; Jackson, Scott A.; Guo, Baozhu; Liang, Xuanqiang; Varshney, Rajeev K.			Genomewide Association Studies for 50 Agronomic Traits in Peanut Using the 'Reference Set' Comprising 300 Genotypes from 48 Countries of the Semi-Arid Tropics of the World	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; ARACHIS-HYPOGAEA L.; MINI CORE COLLECTION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; RUST RESISTANCE; MARKERS; IDENTIFICATION; DIVERSITY; GENOMICS	Peanut is an important and nutritious agricultural commodity and a livelihood of many small-holder farmers in the semi-arid tropics (SAT) of world which are facing serious production threats. Integration of genomics tools with on-going genetic improvement approaches is expected to facilitate accelerated development of improved cultivars. Therefore, high-resolution genotyping and multiple season phenotyping data for 50 important agronomic, disease and quality traits were generated on the 'reference set' of peanut. This study reports comprehensive analyses of allelic diversity, population structure, linkage disequilibrium (LD) decay and marker-trait association (MTA) in peanut. Distinctness of all the genotypes can be established by using either an unique allele detected by a single SSR or a combination of unique alleles by two or more than two SSR markers. As expected, DArT features (2.0 alleles/locus, 0.125 PIC) showed lower allele frequency and polymorphic information content (PIC) than SSRs (22.21 alleles /locus, 0.715 PIC). Both marker types clearly differentiated the genotypes of diploids from tetraploids. Multi-allelic SSRs identified three sub-groups (K = 3) while the LD simulation trend line based on squared-allele frequency correlations (r(2)) predicted LD decay of 15-20 cM in peanut genome. Detailed analysis identified a total of 524 highly significant MTAs (pvalue.2.1610-6) with wide phenotypic variance (PV) range (5.81-90.09%) for 36 traits. These MTAs after validation may be deployed in improving biotic resistance, oil/seed/nutritional quality, drought tolerance related traits, and yield/yield components.	[Pandey, Manish K.; Upadhyaya, Hari D.; Rathore, Abhishek; Vadez, Vincent; Sriswathi, Manda; Govil, Mansee; Kumar, Ashish; Sharma, Shivali; Kumar, V. Anil; Khera, Pawan; Khan, Aamir W.; Singh, Sube; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India; [Sheshshayee, M. S.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Kumar, Ashish] Jawahar Lal Nehru Krishi Vishwa Vidyalaya JNKVV, Plant Pathol, Jabalpur, Madhya Pradesh, India; [Gowda, M. V. C.; Nadaf, H. L.; Mukri, Ganapati] Univ Agr Sci, Dept Genet & Plant Breeding, Dharwad, Karnataka, India; [Hamidou, Falalou] Int Crops Res Inst Semi Arid Trop, Sahelian Ctr, Niamey, Niger; [Bhat, Ramesh S.] Univ Agr Sci, Dept Biotechnol, Dharwad, Karnataka, India; [Li, Hongjie] ShanDong Shofine Seed Technol Co Ltd, Jining, Shandong, Peoples R China; [Monyo, Emmanuel] Int Crops Res Inst Semi Arid Trop, Nairobi, Kenya; [Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Liang, Xuanqiang] GAAS, Crop Res Inst, Guangzhou, Guangdong, Peoples R China	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Agricultural Sciences Bangalore; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Guangdong Academy of Agricultural Sciences	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	r.k.varshney@cgiar.org	Vadez, Vincent/C-5310-2014; Sreeman, Sheshshayee/ABI-2719-2020; Khan, Mohammad Aamir Waseem/AAP-1262-2021; Vadez, Vincent/GLU-8981-2022; Bhat, Ramesh S/C-8080-2014; Updhayaya, Hari/C-4858-2014; Varshney, Rajeev K/C-5295-2014	Khan, Mohammad Aamir Waseem/0000-0001-9734-8123; Updhayaya, Hari/0000-0002-5166-6844; Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530; jackson, scott/0000-0002-3172-1607; Sreeman, Sheshshayee/0000-0002-2634-8596	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme; Peanut Foundation, USA; ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China; ARS [ARS-0425281] Funding Source: Federal RePORTER	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme; Peanut Foundation, USA; ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was undertaken as a part of Tropical Legumes I (TLI-Objective 1: Groundnut) funded by Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme (http://www.generationcp.org/) and The Peanut Foundation, USA (http://www.peanutfoundation.org/). This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China provided support in the form of a salary for author HL who participated in data analysis using analytical tools, but did not have any additional role in the study design and data collection, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hamidou F, 2012, FIELD CROP RES, V126, P189, DOI 10.1016/j.fcr.2011.10.009; Heckenberger M, 2004, MOL BREEDING, V10, P181; Herselman L, 2004, THEOR APPL GENET, V109, P1426, DOI 10.1007/s00122-004-1756-z; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kilian A., 2008, P 3 INT C AR GEN BIO; Kulwal P, 2012, THEOR APPL GENET, V125, P793, DOI 10.1007/s00122-012-1872-0; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Nandakumar N, 2004, EUPHYTICA, V136, P257, DOI 10.1023/B:EUPH.0000032706.92360.c6; Nigam SN, 2005, ANN APPL BIOL, V146, P433, DOI 10.1111/j.1744-7348.2005.040076.x; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Selvaraj MG, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-13; Sharma S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00309; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Song QJ, 1999, PLANT VAR SEEDS, V12, P207; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Tommasini L, 2003, THEOR APPL GENET, V106, P1091, DOI 10.1007/s00122-002-1125-8; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; Upadhyaya HD, 2012, CROP SCI, V52, P2628, DOI 10.2135/cropsci2012.05.0306; Upadhyaya HD, 2011, EUPHYTICA, V182, P103, DOI 10.1007/s10681-011-0518-7; Upadhyaya HD, 2005, CROP SCI, V45, P1432, DOI 10.2135/cropsci2004.0389; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P139, DOI 10.1023/A:1022945715628; Upadhyaya HD, 2002, CROP SCI, V42, P2150, DOI 10.2135/cropsci2002.2150; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Varshney R.K., 2007, GENOMICS ASSISTED CR, P1; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P1172, DOI 10.1038/nbt.2440; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Weir BS, 1996, METHODS DISCRETE POP, VII; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003	48	61	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105228	10.1371/journal.pone.0105228	http://dx.doi.org/10.1371/journal.pone.0105228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140620	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000342687200064
J	Arnott, ER; Early, JB; Wade, CM; McGreevy, PD				Arnott, Elizabeth R.; Early, Jonathan B.; Wade, Claire M.; McGreevy, Paul D.			Environmental Factors Associated with Success Rates of Australian Stock Herding Dogs	PLOS ONE			English	Article							TRAINING METHODS; HOUSING CONDITIONS; CANINE WELFARE; WORKING DOG; BEHAVIOR; PERSONALITY; ABILITY; GUIDE; ENRICHMENT; CORTISOL	This study investigated the current management practices associated with stock herding dogs on Australian farms. A parallel goal was to determine whether these practices and the characteristics of the dog handlers were associated with success rates. Success rate refers to the proportion of dogs acquired by the farmer that were retained as working dogs. Data on a total of 4,027 dogs were obtained through The Farm Dog Survey which gathered information from 812 herding dog owners around Australia. Using logistic regression, significant associations were identified between success rate and seven variables: dog breed, housing method, trial participation, age of the dog at acquisition, electric collar use, hypothetical maximum treatment expenditure and the conscientiousness score of the owner's personality. These findings serve as a guide to direct further research into ways of optimising herding dog performance and welfare. They emphasise the importance of not only examining the genetic predispositions of the working dog but also the impact the handler can have on a dog's success in the workplace.	[Arnott, Elizabeth R.; Early, Jonathan B.; Wade, Claire M.; McGreevy, Paul D.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Arnott, ER (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	Elizabeth.arnott@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378; Wade, Claire/0000-0003-3413-4771	Rural Industries Research and Development Corporation [PRJ 007 806]; Meat and Livestock Australia	Rural Industries Research and Development Corporation; Meat and Livestock Australia(Meat and Livestock Australia)	This study was supported by Rural Industries Research and Development Corporation, PRJ 007 806 (http://www.rirdc.gov.au/), to CMW PDM, and by Meat and Livestock Australia, (http://www.mla.com.au/) to CMW PDM. The funders assisted with data collection by promoting the survey to their contacts or on the websites. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	ABS, 2012, AUSTR SOC TRENDS; Allan MF, 2008, MEAT SCI, V80, P79, DOI 10.1016/j.meatsci.2008.05.023; [Anonymous], 2008, WITHDR GUID DOGS; Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; Arnott ER, 2014, ANIM WELFARE, V23, P189, DOI 10.7120/09627286.23.2.189; Arnott ER, 2014, ANIMAL WELF IN PRESS; Arvelius P, 2013, J ANIM BREED GENET, V130, P142, DOI 10.1111/jbg.12026; Arvelius P, 2012, J VET BEHAV CLIN APP; Bakker DM, 2005, AUST J SOIL RES, V43, P575, DOI 10.1071/SR03118; Barnett JL, 1997, AUST J AGR RES, V48, P385, DOI 10.1071/A96102; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Batt LS, 2008, J VET BEHAV, V3, P143, DOI 10.1016/j.jveb.2008.04.003; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Ben Alexander M, 2011, APPL ANIM BEHAV SCI, V132, P152, DOI 10.1016/j.applanim.2011.04.008; Blackwell EJ, 2012, BMC VET RES, P8; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Branson N., 2009, AUSTR WORKING DOG SU; Broderick S, 2011, BRIT FOOD J, V113, P1217, DOI 10.1108/00070701111177656; COSTA PT, 1992, J PERS DISORD, V6, P343, DOI 10.1521/pedi.1992.6.4.343; Courreau JF, 2005, APPL ANIM BEHAV SCI, V91, P233, DOI 10.1016/j.applanim.2004.09.003; Evans RI, 2007, JAVMA-J AM VET MED A, V231, P1215, DOI 10.2460/javma.231.8.1215; FAO, 2021, 4081 FAO, P67; FOX MW, 1965, LAB ANIM CARE, V15, P363; Gaines SA, 2008, J FORENSIC SCI, V53, P1400, DOI 10.1111/j.1556-4029.2008.00879.x; Gedye J., 2000, TRAINING NOTES FARME; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; Hampson B. A., 2007, Equine and Comparative Exercise Physiology, V4, P37, DOI 10.1017/S1478061507772006; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; HETTS S, 1992, APPL ANIM BEHAV SCI, V34, P137, DOI 10.1016/S0168-1591(05)80063-2; Hiby EF, 2004, ANIM WELFARE, V13, P63; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Keating BA, 2010, CROP PASTURE SCI, V61, P269, DOI 10.1071/CP09282; Kis A, 2012, INTERACT STUD, V13, P373, DOI 10.1075/is.13.3.03kis; Lefebvre D, 2007, APPL ANIM BEHAV SCI, V104, P49, DOI 10.1016/j.applanim.2006.05.004; Lefebvre D, 2009, J ETHOL, V27, P255, DOI 10.1007/s10164-008-0114-z; Love SB, 2010, COMP EXERC PHYSIOL, V7, P109, DOI 10.1017/S1755254010000310; Maejima M, 2007, APPL ANIM BEHAV SCI, V107, P287, DOI 10.1016/j.applanim.2006.10.005; McGreevy P, 2005, CARROTS STICKS PRINC; McGreevy P.D., 2009, MODERN DOGS LIFE; McNair Ingenuity Research Pty Ltd, 2012, QUANT AGR READ SURV; Morales LE, 2013, MEAT SCI, V94, P239, DOI 10.1016/j.meatsci.2013.02.005; Overall KL, 2012, WHAT DO WE REALLY KN; Parsons AD., 2010, KELPIE; Paulhus DL, 2002, ROLE OF CONSTRUCTS IN PYSCHOLOGICAL AND EDUCATIONAL MEASUREMENT, P49; Phillips CJC, 2005, AUST VET J, V83, P558, DOI 10.1111/j.1751-0813.2005.tb13336.x; Polkinghorne RJ, 2010, MEAT SCI, V86, P227, DOI 10.1016/j.meatsci.2010.05.010; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rooney N, 2009, J VET BEHAV, V4, P127, DOI 10.1016/j.jveb.2008.10.037; Rooney NJ, 2007, APPL ANIM BEHAV SCI, V103, P90, DOI 10.1016/j.applanim.2006.03.016; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Salgirli Y, 2012, REV MED VET-TOULOUSE, V163, P530; Sanders CR, 2006, J CONTEMP ETHNOGR, V35, P148, DOI 10.1177/0891241605283456; Saucier G, 1999, J PERS SOC PSYCHOL, V76, P613, DOI 10.1037/0022-3514.76.4.613; Schmutz SM, 1998, J HERED, V89, P233, DOI 10.1093/jhered/89.3.233; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Stafford K, 2012, VET J, V192, P257, DOI 10.1016/j.tvjl.2012.02.007; Taylor KD, 2007, ANIM WELFARE, V16, P435; [Victorian Government Department of Environment and Primary Industries Industries DoEaP], 2013, COD PRACT OP BREED R; Vincent IC, 1997, VET J, V153, P179, DOI 10.1016/S1090-0233(97)80038-X; Wells AED, 2011, J AGR ENVIRON ETHIC, V24, P645, DOI 10.1007/s10806-010-9284-0; Wilkie R, 2005, J RURAL STUD, V21, P213, DOI 10.1016/j.jrurstud.2004.10.002; Yeon S. C., 2001, Journal of Applied Animal Welfare Science, V4, P257, DOI 10.1207/S15327604JAWS0404_03	65	21	21	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104457	10.1371/journal.pone.0104457	http://dx.doi.org/10.1371/journal.pone.0104457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136828	Green Published, gold			2022-12-27	WOS:000340742100037
J	Fellet, MR; Lorenzo, MG; Elliot, SL; Carrasco, D; Guarneri, AA				Fellet, Maria Raquel; Lorenzo, Marcelo Gustavo; Elliot, Simon Luke; Carrasco, David; Guarneri, Alessandra Aparecida			Effects of Infection by Trypanosoma cruzi and Trypanosoma rangeli on the Reproductive Performance of the Vector Rhodnius prolixus	PLOS ONE			English	Article							TRIATOMA-INFESTANS; FEEDING-BEHAVIOR; BLOOD MEAL; LIPOPHORIN; PARASITE; TRANSMISSION; BRASILIENSIS; HEMIPTERA; PATTERNS; MANIPULATION	The insect Rhodnius prolixus is responsible for the transmission of Trypanosoma cruzi, which is the etiological agent of Chagas disease in areas of Central and South America. Besides this, it can be infected by other trypanosomes such as Trypanosoma rangeli. The effects of these parasites on vectors are poorly understood and are often controversial so here we focussed on possible negative effects of these parasites on the reproductive performance of R. prolixus, specifically comparing infected and uninfected couples. While T. cruzi infection did not delay pre-oviposition time of infected couples at either temperature tested (25 and 30 degrees C) it did, at 25 degrees C, increase the e-value in the second reproductive cycle, as well as hatching rates. Meanwhile, at 30 degrees C, T. cruzi infection decreased the e-value of insects during the first cycle and also the fertility of older insects. When couples were instead infected with T. rangeli, pre-oviposition time was delayed, while reductions in the e-value and hatching rate were observed in the second and third cycles. We conclude that both T. cruzi and T. rangeli can impair reproductive performance of R. prolixus, although for T. cruzi, this is dependent on rearing temperature and insect age. We discuss these reproductive costs in terms of potential consequences on triatomine behavior and survival.	[Fellet, Maria Raquel; Lorenzo, Marcelo Gustavo; Guarneri, Alessandra Aparecida] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil; [Elliot, Simon Luke] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Carrasco, David] Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, Alnarp, Sweden	Fundacao Oswaldo Cruz; Universidade Federal de Vicosa; Swedish University of Agricultural Sciences	Guarneri, AA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil.	guarneri@cpqrr.fiocruz.br	Elliot, Simon Luke/A-5557-2013; Lorenzo, Marcelo Gustavo/V-3951-2019; Carrasco, David/G-1883-2017; guarneri, Alessandra A/I-4124-2012; Carvalho, Claudine/J-6347-2014; Lorenzo, Marcelo Gustavo/R-1301-2018	Elliot, Simon Luke/0000-0002-7469-2949; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Carrasco, David/0000-0003-1375-2562; Lorenzo, Marcelo Gustavo/0000-0002-4000-5514; Guarneri, Alessandra Aparecida/0000-0002-9162-2731	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular; Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou; Programa Estrategico de Apoio a Pesquisa em Saude	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular; Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou; Programa Estrategico de Apoio a Pesquisa em Saude	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (AAG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (AAG and MGL), Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (AAG and MGL), Fundacao Oswaldo Cruz/Centro de Pesquisas Rene Rachou (MRF, AAG and MGL) and Programa Estrategico de Apoio a Pesquisa em Saude (AAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFCHAIN D, 1979, J PARASITOL, V65, P507, DOI 10.2307/3280312; ANEZ N, 1984, ACTA TROP, V41, P93; ANEZ N, 1984, Memorias do Instituto Oswaldo Cruz, V79, P249, DOI 10.1590/S0074-02761984000200012; Araujo RV, 2011, J INSECT PHYSIOL, V57, P265, DOI 10.1016/j.jinsphys.2010.11.016; ASIN S, 1992, MEM I OSWALDO CRUZ, V87, P369, DOI 10.1590/S0074-02761992000300006; Atella GC, 2005, AN ACAD BRAS CIENC, V77, P405, DOI 10.1590/S0001-37652005000300005; Botto-Mahan C, 2008, PHYSIOL ENTOMOL, V33, P25, DOI 10.1111/j.1365-3032.2007.00596.x; Brecher G., 1944, PARASITOLOGY, V35, P220, DOI 10.1017/S0031182000021648; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200; COPPENS I, 1995, J BIOL CHEM, V270, P5736, DOI 10.1074/jbc.270.11.5736; COPPENS I, 1995, MOL BIOCHEM PARASIT, V73, P179, DOI 10.1016/0166-6851(95)00114-G; d'Alessandro A., 1976, P327; Daflon-Teixeira NF, 2009, MEM I OSWALDO CRUZ, V104, P1031, DOI 10.1590/S0074-02762009000700016; DAVEY K G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P103, DOI 10.1590/S0074-02761987000700020; de Moraes MH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-20; De Rosario-Martinez H, 2013, PHIA POSTHOC INTERAC; Dettloff M, 2001, CELL TISSUE RES, V306, P449, DOI 10.1007/s00441-001-0468-9; Eichler S, 1998, J INSECT PHYSIOL, V44, P131, DOI 10.1016/S0022-1910(97)00095-4; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; Elliot SL, 2003, ECOLOGY, V84, P2568, DOI 10.1890/02-8013; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; Folly E, 2003, BIOCHEM BIOPH RES CO, V310, P555, DOI 10.1016/j.bbrc.2003.09.038; Garcia ES, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-105; GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2; GREWAL MANOHAR SINGH, 1957, EXPTL PARASITOL, V6, P123, DOI 10.1016/0014-4894(57)90010-3; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Guarneri AA, 2000, J MED ENTOMOL, V37, P373, DOI 10.1603/0022-2585(2000)037[0373:IOTBMS]2.0.CO;2; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Hurd H., 1990, Advances in Parasitology, V29, P271, DOI 10.1016/S0065-308X(08)60108-6; Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4; Kollien AH, 1998, ACTA TROP, V70, P127, DOI 10.1016/S0001-706X(97)00117-4; Kollien AH, 1998, J EUKARYOT MICROBIOL, V45, P59, DOI 10.1111/j.1550-7408.1998.tb05070.x; LAKE P, 1967, P ENTOMOL SOC ONT, V98, P53; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; LENT H, 1979, B AM MUS NAT HIST, V163, P127; LIMA MM, 1992, ANN ENTOMOL SOC AM, V85, P458, DOI 10.1093/aesa/85.4.458; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Machado EA, 1996, ARCH INSECT BIOCHEM, V31, P185, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;185::AID-ARCH6&gt;3.0.CO;2-Z; NEVES D P, 1975, Revista Brasileira de Biologia, V35, P317; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; ODALY JA, 1994, ACTA TROP, V56, P265, DOI 10.1016/0001-706X(94)90099-X; Oliveira TG, 2010, MEM I OSWALDO CRUZ, V105, P1057, DOI 10.1590/S0074-02762010000800018; Paul KS, 2003, TRENDS PARASITOL, V8, P381; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; SCHAUB GA, 1986, ACTA TROP, V43, P349; SCHAUB GA, 1988, T ROY SOC TROP MED H, V82, P94, DOI 10.1016/0035-9203(88)90273-8; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schilman PE, 2004, ACTA TROP, V90, P115, DOI 10.1016/j.actatropica.2003.11.006; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Schofield CJ, 1994, TRIATOMINAEBIOLOGY C; SCHOTTELIUS J, 1987, TROP MED PARASITOL, V38, P323; Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933; TOBIE EJ, 1965, J PARASITOL, V51, P837, DOI 10.2307/3276172; TOBIE EJ, 1970, J INVERTEBR PATHOL, V15, P118, DOI 10.1016/0022-2011(70)90106-0; Valle D, 1995, MEM I O CRUZ, V88, P1; VALLEJO GA, 1986, REV BIOL TROP, V34, P75; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; WATKINS R, 1971, J INVERTEBR PATHOL, V17, P59, DOI [10.1016/0022-2011(71)90126-1, 10.1016/0022-2011(71)90127-3]; ZELEDON R, 1970, J MED ENTOMOL, V7, P462, DOI 10.1093/jmedent/7.4.462; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	67	47	48	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105255	10.1371/journal.pone.0105255	http://dx.doi.org/10.1371/journal.pone.0105255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136800	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100081
J	Harasti, D; Martin-Smith, K; Gladstone, W				Harasti, David; Martin-Smith, Keith; Gladstone, William			Does a No-Take Marine Protected Area Benefit Seahorses?	PLOS ONE			English	Article							LIFE-HISTORY; FISH ASSEMBLAGES; HIPPOCAMPUS-COMES; ARTISANAL FISHERY; REEF FISH; RESERVES; CONSERVATION; MANAGEMENT; ABUNDANCE; BEHAVIOR	Seahorses are iconic charismatic species that are often used to 'champion' marine conservation causes around the world. As they are threatened in many countries by over-exploitation and habitat loss, marine protected areas (MPAs) could help with their protection and recovery. MPAs may conserve seahorses through protecting essential habitats and removing fishing pressures. Populations of White's seahorse, Hippocampus whitei, a species endemic to New South Wales, Australia, were monitored monthly from 2006 to 2009 using diver surveys at two sites within a no-take marine protected areas established in 1983, and at two control sites outside the no-take MPA sites. Predators of H. whitei were also identified and monitored. Hippocampus whitei were more abundant at the control sites. Seahorse predators (3 species of fish and 2 species of octopus) were more abundant within the no-take MPA sites. Seahorse and predator abundances were negatively correlated. Substantial variability in the seahorse population at one of the control sites reinforced the importance of long-term monitoring and use of multiple control sites to assess the outcomes of MPAs for seahorses. MPAs should be used cautiously to conserve seahorse populations as there is the risk of a negative impact through increased predator abundance.	[Harasti, David] NSW Dept Primary Ind, Nelson Bay, NSW, Australia; [Martin-Smith, Keith] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Gladstone, William] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	NSW Department of Primary Industries; University of Tasmania; University of Technology Sydney	Harasti, D (corresponding author), NSW Dept Primary Ind, Nelson Bay, NSW, Australia.	david.harasti@dpi.nsw.gov.au	Harasti, David/I-1266-2019	Harasti, David/0000-0002-2851-9838; Gladstone, William/0000-0003-4517-4605				Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, 2013 IUCN RED LIST T; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bassett DK, 2008, MAR FRESHWATER RES, V59, P1079, DOI 10.1071/MF08036; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caldwell IR, 2012, AQUAT CONSERV, V22, P427, DOI 10.1002/aqc.2238; Currie JC, 2012, AFR J MAR SCI, V34, P269, DOI 10.2989/1814232X.2012.709963; Curtis JMR, 2007, AQUAT CONSERV, V17, P468, DOI 10.1002/aqc.798; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; DPI N, 2013, SPEC COMM RECR SALTW; DPI N, 2005, SEACH THEOR REL; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Foster SJ, 2005, CONSERV BIOL, V19, P1044, DOI 10.1111/j.1523-1739.2005.00192.x; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Gotz A, 2009, AFR J MAR SCI, V31, P241, DOI 10.2989/AJMS.2009.31.2.12.884; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Harasti D, 2014, J FISH BIOL, V85, P1413, DOI 10.1111/jfb.12492; Harasti D, 2013, J FISH BIOL, V83, P1344, DOI 10.1111/jfb.12237; Harasti D, 2012, J FISH BIOL, V81, P1297, DOI 10.1111/j.1095-8649.2012.03406.x; Harasti D, 2010, AQUAT CONSERV, V20, P159, DOI 10.1002/aqc.1066; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; Kingsford M., 1998, STUDYING TEMPERATE M; Kleiber D, 2011, REV FISH BIOL FISHER, V21, P205, DOI 10.1007/s11160-010-9167-5; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Marcus JE, 2007, MAR POLLUT BULL, V54, P1483, DOI 10.1016/j.marpolbul.2007.04.011; Martin-Smith KM, 2005, BIOL CONSERV, V123, P533, DOI 10.1016/j.biocon.2005.01.003; Martin-Smith KM, 2004, OCEAN COAST MANAGE, V47, P165, DOI 10.1016/j.ocecoaman.2004.02.002; McClenachan L, 2010, CONSERV LETT, V5, P73; Mislan KAS, 2008, MAR FRESHWATER RES, V59, P246, DOI 10.1071/MF07116; Morgan SK, 2007, J FISH BIOL, V71, P701, DOI 10.1111/j.1095-8649.2007.01535.x; Morgan SK, 2013, MAR FRESHWATER RES, V64, P185, DOI 10.1071/MF12171; Perante NC, 2002, J FISH BIOL, V60, P821, DOI 10.1006/jfbi.2002.1878; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Scales H, 2009, POSEIDONS STEED STOR; Schmid MS, 2002, VIE MILIEU, V52, P201; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shokri MR, 2009, AQUAT CONSERV, V19, P588, DOI 10.1002/aqc.1009; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; Vincent ACJ, 2005, ENVIRON BIOL FISH, V72, P1, DOI 10.1007/s10641-004-4192-7; Vincent ACJ, 2007, FISH RES, V86, P207, DOI 10.1016/j.fishres.2007.06.006; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Yasue M, 2012, ENVIRON CONSERV, V39, P183, DOI 10.1017/S0376892911000622	55	31	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105462	10.1371/journal.pone.0105462	http://dx.doi.org/10.1371/journal.pone.0105462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137253	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100097
J	Kocsi, S; Demeter, G; Erces, D; Kaszaki, J; Molnar, Z				Kocsi, Szilvia; Demeter, Gabor; Erces, Daniel; Kaszaki, Jozsef; Molnar, Zsolt			Central Venous-To-Arterial CO2-Gap May Increase in Severe Isovolemic Anemia	PLOS ONE			English	Article							OXYGEN-SATURATION; PCO2 DIFFERENCE; TRANSFUSION; LACTATE; INJURY; SHOCK; CO2	Despite blood transfusions are administered to restore adequate tissue oxygenation, transfusion guidelines consider only hemoglobin as trigger value, which gives little information about the balance between oxygen delivery and consumption. Central venous oxygen saturation is an alternative, however its changes reflect systemic metabolism and fail to detect regional hypoxia. A complementary parameter to ScvO(2) may be central venous-to-arterial carbon dioxide difference (CO2-gap). Our aim was to investigate the change of alternative transfusion trigger values in experimental isovolemic anemia. After splenectomy, anesthetized Vietnamese mini pigs (n = 13, weight range: 18-30 kg) underwent controlled bleeding in five stages (T-1-T-5). During each stage approximately 10% of the estimated starting total blood volume was removed and immediately replaced with an equal volume of colloid. Hemodynamic measurements and blood gas analysis were then performed. Each stage of bleeding resulted in a significant fall in hemoglobin, the O-2-extraction increased significantly from T-3 and ScvO(2) showed a similar pattern and dropped below the physiological threshold of 70% at T-4. By T4 CO2-gap increased significantly and well correlated with VO2/DO2 and ScvO(2). To our knowledge, this is the first study to show that anemia caused altered oxygen extraction may have an effect on CO2-gap.	[Kocsi, Szilvia; Demeter, Gabor; Molnar, Zsolt] Univ Szeged, Dept Anaesthesiol & Intens Therapy, Szeged, Hungary; [Kocsi, Szilvia] Hungarian Def Forces Mil Hosp, Dept Anaesthesiol & Intens Therapy, Budapest, Hungary; [Erces, Daniel; Kaszaki, Jozsef] Univ Szeged, Inst Surg Res, Szeged, Hungary	Szeged University; Szeged University	Kocsi, S (corresponding author), Univ Szeged, Dept Anaesthesiol & Intens Therapy, Szeged, Hungary.	kocsi.szilvia@gmail.com						Adamczyk S, 2009, ANN FR ANESTH, V28, P522, DOI 10.1016/j.annfar.2009.03.013; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Galvin I, 2011, ANN UPD INTENS CARE, P117; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Guyton AC, 2006, TXB MED PHYSL, P502; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Kocsi S, 2012, ACTA ANAESTH SCAND, V56, P291, DOI 10.1111/j.1399-6576.2011.02622.x; Lamia B, 2006, MINERVA ANESTESIOL, V72, P597; Maddirala S, 2010, CRIT CARE CLIN, V26, P323, DOI 10.1016/j.ccc.2009.12.006; Marino PL, 2014, ICU BOOK, P171; Mekontso-Dessap A, 2002, INTENS CARE MED, V28, P272, DOI 10.1007/s00134-002-1215-8; Meletti José Fernando Amaral, 2003, Rev. Bras. Anestesiol., V53, P623, DOI 10.1590/S0034-70942003000500009; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; SCHLICHTIG R, 1994, J APPL PHYSIOL, V76, P2443, DOI 10.1152/jappl.1994.76.6.2443; Vallee F, 2008, INTENS CARE MED, V34, P2218, DOI 10.1007/s00134-008-1199-0; Vallet B, 2000, J APPL PHYSIOL, V89, P1317, DOI 10.1152/jappl.2000.89.4.1317; Vallet B, 2010, CRIT CARE, V14, DOI 10.1186/cc8854; Vincent JL, 2006, CRIT CARE MED, V34, pS96, DOI 10.1097/01.CCM.0000214314.57109.CD; West JB, 1990, RESP PHYSL ESSENTIAL, P69; Westbrook A, 2010, INTENS CARE MED, V36, P1138, DOI 10.1007/s00134-010-1867-8	22	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105148	10.1371/journal.pone.0105148	http://dx.doi.org/10.1371/journal.pone.0105148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137377	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100071
J	Lindquist, E; Alezzawi, M; Aronsson, H				Lindquist, Emelie; Alezzawi, Mohamed; Aronsson, Henrik			Bioinformatic Indications That COPI- and Clathrin-Based Transport Systems Are Not Present in Chloroplasts: An Arabidopsis Model	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; PEROXIDASE GENE FAMILY; ACETYL-COA CARBOXYLASE; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; REPEAT PROTEINS; MEMBRANE-TRAFFICKING; ENVELOPE MEMBRANE; VESICLE TRANSPORT; SIGNAL PEPTIDES	Coated vesicle transport occurs in the cytosol of yeast, mammals and plants. It consists of three different transport systems, the COPI, COPII and clathrin coated vesicles (CCV), all of which participate in the transfer of proteins and lipids between different cytosolic compartments. There are also indications that chloroplasts have a vesicle transport system. Several putative chloroplast-localized proteins, including CPSAR1 and CPRabA5e with similarities to cytosolic COPII transport-related proteins, were detected in previous experimental and bioinformatics studies. These indications raised the hypothesis that a COPI- and/or CCV-related system may be present in chloroplasts, in addition to a COPII-related system. To test this hypothesis we bioinformatically searched for chloroplast proteins that may have similar functions to known cytosolic COPI and CCV components in the model plants Arabidopsis thaliana and Oryza sativa (subsp. japonica) (rice). We found 29 such proteins, based on domain similarity, in Arabidopsis, and 14 in rice. However, many components could not be identified and among the identified most have assigned roles that are not related to either COPI or CCV transport. We conclude that COPII is probably the only active vesicle system in chloroplasts, at least in the model plants. The evolutionary implications of the findings are discussed.	[Lindquist, Emelie; Alezzawi, Mohamed; Aronsson, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Aronsson, H (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	henrik.aronsson@bioenv.gu.se			Olle Engkvist Byggmastare Foundation; Libyan Higher Education	Olle Engkvist Byggmastare Foundation; Libyan Higher Education	This work was supported by Olle Engkvist Byggmastare Foundation (to H.A.), and a PhD student fellowship from the Libyan Higher Education (to M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Andersson MX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-40; Andersson MX, 2001, PLANT PHYSIOL, V127, P184, DOI 10.1104/pp.127.1.184; Aronsson H, 2008, PLANT CELL MONOGRAPH; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bassham DC, 2008, ARABIDOPSIS BOOK, V6, pe0116; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Cevher-Keskin B, 2013, INT J MOL SCI, V14, P18181, DOI 10.3390/ijms140918181; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Fulop K, 2005, CELL CYCLE, V4, P1084; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Garcia C, 2010, PLANT J, V63, P73, DOI 10.1111/j.1365-313X.2010.04225.x; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Gutierrez C, 2009, ARABIDOPSIS BOOK, V7; Han XX, 2012, J INTEGR PLANT BIOL, V54, P486, DOI 10.1111/j.1744-7909.2012.01132.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Ito E, 2012, PLANT J, V69, P204, DOI 10.1111/j.1365-313X.2011.04782.x; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Karim S, 2014, PLANT MOL BIOL, V84, P675, DOI 10.1007/s11103-013-0161-x; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; Khan NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059898; Kim SY, 2010, PLANT SIGNAL BEHAV, V5, P458, DOI 10.4161/psb.5.4.11342; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larson-Rabin Z, 2009, PLANT PHYSIOL, V149, P874, DOI 10.1104/pp.108.132449; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Maurino VG, 2010, CURR OPIN PLANT BIOL, V13, P249, DOI 10.1016/j.pbi.2010.01.006; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Monaghan J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000526; Moore I, 1997, P NATL ACAD SCI USA, V94, P762, DOI 10.1073/pnas.94.2.762; MORRE DJ, 1991, PLANT PHYSIOL, V97, P1558, DOI 10.1104/pp.97.4.1558; Movafeghi A, 1999, PLANT PHYSIOL, V119, P1437, DOI 10.1104/pp.119.4.1437; Nickel W, 2002, J CELL SCI, V115, P3235; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Niihama M, 2009, PLANT CELL PHYSIOL, V50, P2057, DOI 10.1093/pcp/pcp137; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Ortiz-Zapater E, 2006, PLANT J, V48, P757, DOI 10.1111/j.1365-313X.2006.02909.x; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Park CJ, 2013, PLANT SCI, V210, P53, DOI 10.1016/j.plantsci.2013.05.003; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Rantfors M, 2000, PHYSIOL PLANTARUM, V110, P262, DOI 10.1034/j.1399-3054.2000.110217.x; Robinson C, 2001, TRAFFIC, V2, P245, DOI 10.1034/j.1600-0854.2001.1r010.x; Robinson DG, 2007, CRIT REV PLANT SCI, V26, P199, DOI 10.1080/07352680701495820; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Schwacke R, 2007, MOL GENET GENOMICS, V277, P631, DOI 10.1007/s00438-007-0214-4; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Solymosi K., 2013, PLASTID DEV LEAVES G, V36, P39, DOI DOI 10.1007/978-94-007-5724-0_3; Spetea C, 2012, CURRENT CHEM BIOL, V6, P230, DOI DOI 10.2174/2212796811206030006; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Teixeira FK, 2004, J MOL EVOL, V59, P761, DOI 10.1007/s00239-004-2666-z; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Wei Z, 2009, PROTEOMICS, V9, P2798, DOI 10.1002/pmic.200800840; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Westphal S, 2003, PLANT CELL PHYSIOL, V44, P217, DOI 10.1093/pcp/pcg023; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Wienkoop S, 2004, PHYTOCHEMISTRY, V65, P1641, DOI 10.1016/j.phytochem.2004.03.026; Wilbur JD, 2005, TRAFFIC, V6, P346, DOI 10.1111/j.1600-0854.2005.00277.x; YANAI Y, 1995, PLANT CELL PHYSIOL, V36, P779, DOI 10.1093/oxfordjournals.pcp.a078822; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	131	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104423	10.1371/journal.pone.0104423	http://dx.doi.org/10.1371/journal.pone.0104423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137124	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100033
J	Luo, BB; Li, B; Wang, WK; Liu, XJ; Xia, YF; Zhang, C; Zhang, MX; Zhang, Y; An, FS				Luo, Beibei; Li, Bo; Wang, Wenke; Liu, Xiangjuan; Xia, Yanfei; Zhang, Cheng; Zhang, Mingxiang; Zhang, Yun; An, Fengshuang			NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model	PLOS ONE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; NF-KAPPA-B; INFLAMMASOME ACTIVATION; CELL-DEATH; OXIDATIVE STRESS; HIGH GLUCOSE; PYROPTOSIS; HEART; METALLOTHIONEIN; PATHOGENESIS	Background: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is associated with metabolic disorder and cell death, which are important triggers in diabetic cardiomyopathy (DCM). We aimed to explore whether NLRP3 inflammasome activation contributes to DCM and the mechanism involved. Methods: Type 2 diabetic rat model was induced by high fat diet and low dose streptozotocin. The characteristics of type 2 DCM were evaluated by metabolic tests, echocardiography and histopathology. Gene silencing therapy was used to investigate the role of NLRP3 in the pathogenesis of DCM. High glucose treated H9c2 cardiomyocytes were used to determine the mechanism by which NLRP3 modulated the DCM. The cell death in vitro was detected by TUNEL and EthD-III staining. TXNIP-siRNA and pharmacological inhibitors of ROS and NF-B were used to explore the mechanism of NLRP3 inflammasome activation. Results: Diabetic rats showed severe metabolic disorder, cardiac inflammation, cell death, disorganized ultrastructure, fibrosis and excessive activation of NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), pro-caspase-1, activated caspase-1 and mature interleukin-1b (IL-1b). Evidence for pyroptosis was found in vivo, and the caspase-1 dependent pyroptosis was found in vitro. Silencing of NLRP3 in vivo did not attenuate systemic metabolic disturbances. However, NLRP3 gene silencing therapy ameliorated cardiac inflammation, pyroptosis, fibrosis and cardiac function. Silencing of NLRP3 in H9c2 cardiomyocytes suppressed pyroptosis under high glucose. ROS inhibition markedly decreased nuclear factor-kB (NF-kB) phosphorylation, thioredoxin interacting/inhibiting protein (TXNIP), NLRP3 inflammasome, and mature IL-1b in high glucose treated H9c2 cells. Inhibition of NF-kB reduced the activation of NLRP3 inflammasome. TXNIP-siRNA decreased the activation of caspase-1 and IL-1b. Conclusion: NLRP3 inflammasome contributed to the development of DCM. NF-kB and TXNIP mediated the ROS-induced caspase-1 and IL-1b activation, which are the effectors of NLRP3 inflammasome. NLRP3 gene silencing may exert a protective effect on DCM.	[An, Fengshuang] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	An, FS (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	anfengshuang@aliyun.com			National Natural Science Foundation of China [81370325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81370325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bell David S H, 2008, Endocr Pract, V14, P924; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cai L, 2006, FREE RADICAL BIO MED, V41, P851, DOI 10.1016/j.freeradbiomed.2006.06.007; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Corsini E, 2013, FOOD CHEM TOXICOL, V61, P74, DOI 10.1016/j.fct.2013.02.038; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Devi TS, 2012, EXP DIABETES RES, DOI 10.1155/2012/438238; Dong Z, 2011, J CELL BIOCHEM, V112, P2097, DOI 10.1002/jcb.23128; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Lacombe VA, 2007, AM J PHYSIOL-REG I, V293, pR1787, DOI 10.1152/ajpregu.00059.2007; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lian LH, 2012, J INVEST DERMATOL, V132, P1346, DOI 10.1038/jid.2011.482; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062148; Liu L, 2013, INT J BIOCHEM CELL B, V45, P2027, DOI 10.1016/j.biocel.2013.06.018; Liu XM, 2012, CARDIOVASC DRUG THER, V26, P121, DOI 10.1007/s10557-012-6372-6; Luo BB, 2013, CLIN CHEM LAB MED, V51, P1521, DOI 10.1515/cclm-2012-0600; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; McCoy AJ, 2010, J IMMUNOL, V185, P7077, DOI 10.4049/jimmunol.1002165; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Ti Y, 2011, DIABETES, V60, P2963, DOI 10.2337/db11-0549; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wree A, 2013, HEPATOLOGY; Yang JR, 2013, AM J PHYSL RENAL PHY; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	49	186	210	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104771	10.1371/journal.pone.0104771	http://dx.doi.org/10.1371/journal.pone.0104771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136835	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100046
J	Pares-Badell, O; Barbaglia, G; Jerinic, P; Gustavsson, A; Salvador-Carulla, L; Alonso, J				Pares-Badell, Oleguer; Barbaglia, Gabriela; Jerinic, Petra; Gustavsson, Anders; Salvador-Carulla, Luis; Alonso, Jordi			Cost of Disorders of the Brain in Spain	PLOS ONE			English	Article							SOCIAL-ECONOMIC COSTS; ADJUSTED LIFE YEARS; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; HEALTH-CARE; MULTIPLE-SCLEROSIS; MENTAL-DISORDERS; SOCIETAL COSTS; INFORMAL CARE; FOLLOW-UP	Background: Brain disorders represent a high burden in Europe and worldwide. The objective of this study was to provide specific estimates of the economic costs of brain disorders in Spain, based on published epidemiological and economic evidence. Methods: A cost-of-illness study with a societal perspective of 19 brain disorders was carried out. Cost data published between 2004 and 2012 was obtained from a systematic literature review. Direct healthcare, direct non-medical and indirect costs were considered, prioritizing bottom-up information. All costs were converted to Euro and to year 2010. The missing values were imputed with European estimates. Sensitivity analyses based on qualitative assessment of the literature and on a Monte Carlo simulation were performed. Results: The review identified 33 articles with information on costs for 11 disorders (8 neurological, 3 mental). The average per-patient cost ranged from 36,946 (sic) for multiple sclerosis to 402 (sic) for headache. The societal cost of the 19 brain disorders in Spain in 2010 was estimated in 84 (sic) billion. Societal costs ranged from 15 (sic) billion for dementia to 65 (sic) million for eating disorders. Mental disorders societal cost were 46 (sic)billions (55% of the total), while neurological disorder added up to 38 (sic) billion. Healthcare costs represented 37% of the societal costs of brain disorders, whereas direct non-medical constituted 29% and indirect costs 33%. Conclusion: Brain disorders have a substantial economic impact in Spain (equivalent to almost 8% of the country's GDP). Economic data on several important brain disorders, specially mental disorders, is still sparse.	[Pares-Badell, Oleguer; Barbaglia, Gabriela; Jerinic, Petra; Alonso, Jordi] Inst Hosp Mar Invest Med, IMIM, Hlth Serv Res Grp, Barcelona, Spain; [Barbaglia, Gabriela; Alonso, Jordi] CIBERESP, Barcelona, Spain; [Barbaglia, Gabriela; Alonso, Jordi] Pompeu Fabra Univ, Barcelona, Spain; [Gustavsson, Anders] Quantify Res, Stockholm, Sweden; [Gustavsson, Anders] Karolinska Inst, Alzheimers Dis Res Ctr, Stockholm, Sweden; [Salvador-Carulla, Luis] Univ Sydney, Fac Hlth Sci, Ctr Disabil Res & Policy, Sydney, NSW 2006, Australia	Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Karolinska Institutet; University of Sydney	Alonso, J (corresponding author), Inst Hosp Mar Invest Med, IMIM, Hlth Serv Res Grp, Barcelona, Spain.	jalonso@imim.es	Salvador-Carulla, Luis/K-6512-2013; Barbaglia, María Gabriela/B-1036-2015; PRISMA, Grupo/AAI-6753-2021; Alonso, Jordi/A-5514-2010; Pares-Badell, Oleguer/I-4755-2015	Salvador-Carulla, Luis/0000-0002-5742-9866; Barbaglia, María Gabriela/0000-0002-6501-7079; Alonso, Jordi/0000-0001-8627-9636; Pares-Badell, Oleguer/0000-0003-2568-7550	Quantify Research, Stockholm	Quantify Research, Stockholm	The author(s) received no specific funding for this work. Co-author Anders Gustavsson is employed by Quantify Research, Stockholm. Quantify Research, Stockholm provided support in the form of salary for author AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Antonanzas F, 2013, EXPERT REV PHARM OUT, V13, P433, DOI 10.1586/14737167.2013.815418; Arroyo R, 2011, EXPERT REV PHARM OUT, V11, P205, DOI [10.1586/ERP.11.6, 10.1586/erp.11.6]; Badia X, 2004, PHARMACOECONOMICS, V22, P591, DOI 10.2165/00019053-200422090-00004; Beguiristain JM, 2005, REV NEUROLOGIA, V40, P406, DOI 10.33588/rn.4007.2004436; Bloudek LM, 2012, J HEADACHE PAIN, V13, P361, DOI 10.1007/s10194-012-0460-7; Casado V, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-143; Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI [10.1590/S1135-57272009000100011, 10.1590/s1135-57272009000100011]; Catala-Lopez F, 2011, REV NEUROLOGIA, V52, P65, DOI 10.33588/rn.5202.2010611; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Cubo E, 2009, NEUROLOGIA, V24, P15; Departament de Salut Generalitat de Catalunya, 2013, EST COST CARR DRPER; Fineberg NA, 2013, J PSYCHOPHARMACOL, V27, P761, DOI 10.1177/0269881113495118; Fishman G., 1996, MONTE CARLO CONCEPTS; Rada AG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3196; Genova-Maleras R, 2012, PUBLIC HEALTH, V126, P1024, DOI 10.1016/j.puhe.2012.08.012; Gonzalez-Pinto AM, 2010, J AFFECT DISORDERS, V121, P152, DOI 10.1016/j.jad.2009.05.010; Grupo de trabajo sobre GPC, 2009, EL GUIAS PRACT CLIN; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Hervas A, 2007, GAC SANIT, V21, P444, DOI 10.1157/13112236; Hervas-Angulo A, 2006, REV NEUROLOGIA, V43, P518, DOI 10.33588/rn.4309.2005830; Jimenez-Martin S, 2012, EUR J HEALTH ECON, V13, P461, DOI 10.1007/s10198-011-0317-z; Karampampa K, 2012, MULT SCLER J, V18, P35, DOI 10.1177/1352458512441566d; Kobelt G, 2006, EUR J HEALTH ECON, V7, P65; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Lopez-Bastida J, 2006, NEUROLOGY, V67, P2186, DOI 10.1212/01.wnl.0000249311.80411.93; Lopez-Bastida J, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-17; Lopez-Bastida J, 2009, AMYOTROPH LATERAL SC, V10, P237, DOI 10.1080/17482960802430781; Lopez-Pousa S, 2004, MED CLIN-BARCELONA, V122, P767, DOI 10.1157/13062665; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maercker A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13751; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navarrete-Navarro P, 2007, EUR J NEUROL, V14, P556, DOI 10.1111/j.1468-1331.2007.01756.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Oliva-Moreno J, 2009, EUR J HEALTH ECON, V10, P361, DOI 10.1007/s10198-008-0135-0; Olivares JM, 2008, APPL HEALTH ECON HEA, V6, P41, DOI 10.2165/00148365-200806010-00004; Olivia J, 2007, PHARMACOECON SPANISH, V4, P83; Rice D P, 2000, Inj Prev, V6, P177, DOI 10.1136/ip.6.3.177; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Rovira J, 2012, COMMUNITY MENT HLT J, V48, P372, DOI 10.1007/s10597-012-9503-4; Salvador-Carulla L, 2007, GAC SANIT, V21, P314, DOI 10.1157/13108504; Salvador-Carulla L, 2011, J AFFECT DISORDERS, V132, P130, DOI 10.1016/j.jad.2011.02.019; Salvador-Carulla L, 2010, J MENT HEALTH POLICY, V13, P73; Sancho J, 2008, EPILEPSY RES, V81, P176, DOI 10.1016/j.eplepsyres.2008.05.008; Serna-Arnaiz MC, 2007, REV ESP EC SALUD, V6, P395; Sicras A, 2005, DEMENT GERIATR COGN, V19, P305, DOI 10.1159/000084556; Sicras Mainar A, 2008, Farm Hosp, V32, P309; Sicras-Mainar A, 2012, ATEN PRIM, V44, P667, DOI 10.1016/j.aprim.2012.04.007; Sicras-Mainar A, 2010, GAC SANIT, V24, P13, DOI 10.1016/j.gaceta.2009.05.012; Stovner LJ, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2010.01367.x; Turro-Garriga O, 2010, REV NEUROLOGIA, V51, P201, DOI 10.33588/rn.5104.2010117; Valderas JM, 2009, GAC SANIT, V23, P82, DOI 10.1016/j.gaceta.2008.07.006; Vazquez-Polo FJ, 2005, J MENT HEALTH POLICY, V8, P153; Villanueva V, 2014, NEUROLOGIA IN PRESS; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	61	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105471	10.1371/journal.pone.0105471	http://dx.doi.org/10.1371/journal.pone.0105471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133395	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700117
J	Dai, L; Deng, CF; Li, YH; Zhu, J; Mu, Y; Deng, Y; Mao, M; Wang, YP; Li, Q; Ma, SG; Ma, XM; Zhang, YW				Dai, Li; Deng, Changfei; Li, Yanhua; Zhu, Jun; Mu, Yi; Deng, Ying; Mao, Meng; Wang, Yanping; Li, Qi; Ma, Shuangge; Ma, Xiaomei; Zhang, Yawei			Birth Weight Reference Percentiles for Chinese	PLOS ONE			English	Article							GESTATIONAL-AGE PATTERNS; FETAL-GROWTH; UNITED-STATES; INTRAUTERINE GROWTH; DIABETES-MELLITUS; RACE; POPULATION; STANDARDS; HYPERTENSION; RETARDATION	Objective: To develop a reference of population-based gestational age-specific birth weight percentiles for contemporary Chinese. Methods: Birth weight data was collected by the China National Population-based Birth Defects Surveillance System. A total of 1,105,214 live singleton births aged >= 28 weeks of gestation without birth defects during 2006-2010 were included. The lambda-mu-sigma method was utilized to generate percentiles and curves. Results: Gestational age-specific birth weight percentiles for male and female infants were constructed separately. Significant differences were observed between the current reference and other references developed for Chinese or non-Chinese infants. Conclusion: There have been moderate increases in birth weight percentiles for Chinese infants of both sexes and most gestational ages since 1980s, suggesting the importance of utilizing an updated national reference for both clinical and research purposes.	[Dai, Li; Deng, Changfei; Zhu, Jun; Mu, Yi; Deng, Ying; Wang, Yanping; Li, Qi] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Peoples R China; [Dai, Li; Zhu, Jun; Deng, Ying; Mao, Meng] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu 610064, Peoples R China; [Li, Yanhua] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Ma, Shuangge; Ma, Xiaomei; Zhang, Yawei] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Sichuan University; Sichuan University; Sichuan University; Yale University	Dai, L (corresponding author), Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu 610064, Peoples R China.	daili@scu.edu.cn; yawei.zhang@yale.edu			National Natural Science Foundation of China [81072375]; U.S. National Institutes of Health [K02HD070324]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K02HD070324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Grant 81072375 from the National Natural Science Foundation of China to LD and Grant K02HD070324 from the U.S. National Institutes of Health to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Alshimmiri M. M., 2004, Archives of Gynecology and Obstetrics, V269, P111, DOI 10.1007/s00404-002-0434-0; Bakketeig LS, 1998, EUR J CLIN NUTR, V52, pS1; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, 2007, Zhonghua Er Ke Za Zhi, V45, P609; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; da Veiga PV, 2008, MATERN CHILD HLTH J, V12, P194, DOI 10.1007/s10995-007-0238-8; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Hutcheon JA, 2008, BJOG-INT J OBSTET GY, V115, P1397, DOI 10.1111/j.1471-0528.2008.01870.x; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; Janssen Patricia A, 2007, Open Med, V1, pe74; Kierans William J, 2008, BMC Pregnancy Childbirth, V8, P1, DOI 10.1186/1471-2393-8-1; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Larkin JC, 2012, OBSTET GYNECOL, V119, P21, DOI 10.1097/AOG.0b013e31823dc56e; Madan Ashima, 2002, J Perinatol, V22, P230, DOI 10.1038/sj.jp.7210703; McCarton CM, 1996, PEDIATRICS, V98, P1167; Ogunyemi D, 2007, SOUTH MED J, V100, P615, DOI 10.1097/SMJ.0b013e318048798c; Pearl M, 2001, AM J PUBLIC HEALTH, V91, P1808, DOI 10.2105/AJPH.91.11.1808; Pedreira CE, 2011, AN ACAD BRAS CIENC, V83, P619, DOI 10.1590/S0001-37652011005000008; Resnik R, 2007, AM J OBSTET GYNECOL, V197, P221, DOI 10.1016/j.ajog.2007.07.019; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Swamy GK, 2012, J EPIDEMIOL COMMUN H, V66, P136, DOI 10.1136/jech.2009.088567; Teramoto S, 2006, PEDIATR INT, V48, P274, DOI 10.1111/j.1442-200X.2006.02203.x; Thomas P, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e21; Wang Juan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P15; WANG XB, 1994, INT J EPIDEMIOL, V23, P119, DOI 10.1093/ije/23.1.119; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Yee TW, 2008, R NEWS, V8, P28; YIP R, 1991, PEDIATRICS, V87, P688; Zhang B., 1992, CHIN J PRACT PEDIAT, V7, P306; Zhang BL, 1997, CHINESE MED J-PEKING, V110, P148; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; Zheng XY, 2013, EUR J OBSTET GYN R B, V166, P70, DOI 10.1016/j.ejogrb.2012.09.016	40	144	160	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104779	10.1371/journal.pone.0104779	http://dx.doi.org/10.1371/journal.pone.0104779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127131	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300051
J	Root, JJ; Bentler, KT; Shriner, SA; Mooers, NL; VanDalen, KK; Sullivan, HJ; Franklin, AB				Root, J. Jeffrey; Bentler, Kevin T.; Shriner, Susan A.; Mooers, Nicole L.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.			Ecological Routes of Avian Influenza Virus Transmission to a Common Mesopredator: An Experimental Evaluation of Alternatives	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; A VIRUSES; PATHOGENICITY; ANTIBODIES; INFECTION; POPULATIONS; PERSISTENCE; SUBTYPES; WATER; H7N1	Background: Wild raccoons have been shown to be naturally exposed to avian influenza viruses (AIV). However, the mechanisms associated with these natural exposures are not well-understood. Methodology/Principal Findings: We experimentally tested three alternative routes (water, eggs, and scavenged waterfowl carcasses) of AIV transmission that may explain how raccoons in the wild are exposed to AIV. Raccoons were exposed to 1) water and 2) eggs spiked with an AIV (H4N6), as well as 3) mallard carcasses experimentally inoculated with the same virus. Three of four raccoons exposed to the high dose water treatment yielded apparent nasal shedding of >10(2.0) PCR EID50 equivalent/mL. Little to no shedding was observed from the fecal route. The only animals yielding evidence of serologic activity during the study period were three animals associated with the high dose water treatment. Conclusions/Significance: Overall, our results indicate that virus-laden water could provide a natural exposure route of AIV for raccoons and possibly other mammals associated with aquatic environments. However, this association appears to be related to AIV concentration in the water, which would constitute an infective dose. In addition, strong evidence of infection was only detected in three of four animals exposed to a high dose (e.g., 10(5.0) EID50/mL) of AIV in water. As such, water-borne transmission to raccoons may require repeated exposures to water with high concentrations of virus.	[Root, J. Jeffrey; Bentler, Kevin T.; Shriner, Susan A.; Mooers, Nicole L.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA)	Root, JJ (corresponding author), USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80526 USA.	Jeff.root@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Bentler KT, 2012, WILDLIFE SOC B, V36, P807, DOI 10.1002/wsb.193; Bertran K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-24; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Goldman E. A., 1950, N AM FAUNA, V60, P1, DOI [10.3996/nafa.60.0001, DOI 10.3996/NAFA.60.0001]; GREENWOOD RJ, 1979, AM MIDL NAT, V102, P191, DOI 10.2307/2425085; Hall JS, 2008, J WILDLIFE DIS, V44, P362, DOI 10.7589/0090-3558-44.2.362; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Horimoto T, 2011, EMERG INFECT DIS, V17, P714, DOI 10.3201/eid1704.101604; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Lyall-Watson M, 1962, P ZOOL SOC LOND, V141, P371; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; Pedersen J, 2008, 151004 USDA AVPRO; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Pillai SPS, 2010, AVIAN DIS, V54, P830, DOI 10.1637/9102-101209-Reg.1; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Root JJ, 2014, PLOS ONE; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Szretter K. J., 2006, CURRENT PROTOCOLS MI, V15G; TEVIS L, 1947, J MAMMAL, V28, P323, DOI 10.2307/1375355; URBAN D, 1970, J WILDLIFE MANAGE, V34, P372, DOI 10.2307/3799024; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851	34	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102964	10.1371/journal.pone.0102964	http://dx.doi.org/10.1371/journal.pone.0102964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127468	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300006
J	Rousseau, C; Beauregard, C; Daignault, K; Petrakos, H; Thombs, BD; Steele, R; Vasiliadis, HM; Hechtman, L				Rousseau, Cecile; Beauregard, Caroline; Daignault, Katherine; Petrakos, Harriet; Thombs, Brett D.; Steele, Russell; Vasiliadis, Helen-Maria; Hechtman, Lily			A Cluster Randomized-Controlled Trial of a Classroom-Based Drama Workshop Program to Improve Mental Health Outcomes among Immigrant and Refugee Youth in Special Classes	PLOS ONE			English	Article							SELF-CONTAINED CLASSROOMS; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; ACADEMIC ENGAGEMENT; CHILDREN; INTERVENTION; STRENGTHS; STUDENTS; SCHOOLS; ADOLESCENTS	Objectives: The aim of this cluster randomized trial was to evaluate the effectiveness of a school-based theatre intervention program for immigrant and refugee youth in special classes for improving mental health and academic outcomes. The primary hypothesis was that students in the theatre intervention group would report a greater reduction in impairment from symptoms compared to students in the control and tutoring groups. Methods: Special classrooms in five multiethnic high schools were randomly assigned to theater intervention (n = 10), tutoring (n = 10) or control status (n = 9), for a total of 477 participants. Students and teachers were non-blinded to group assignment. The primary outcome was impairment from emotional and behavioural symptoms assessed by the Impact Supplement of the Strengths and Difficulties Questionnaire (SDQ) completed by the adolescents. The secondary outcomes were the SDQ global scores (teacher and youth reports), impairment assessed by teachers and school performance. The effect of the interventions was assessed through linear mixed effect models which incorporate the correlation between students in the same class, due to the nature of the randomization of the interventions by classroom. Results: The theatre intervention was not associated with a greater reduction in self-reported impairment and symptoms in youth placed in special class because of learning, emotional and behavioural difficulties than a tutoring intervention or a non-active control group. The estimates of the different models show a non-significant decrease in both self-reported and impairment scores in the theatre intervention group for the overall group, but the impairment score decreased significantly for first generation adolescents while it increased for second generation adolescents. Conclusion: The difference between the population of immigrant and refugee youth newcomers studied previously and the sample of this trial may explain some of the differences in the observed impact of the theatre intervention.	[Rousseau, Cecile] McGill Univ, Div Social & Cultural Psychiat, Montreal, PQ, Canada; [Beauregard, Caroline] Univ Montreal, Dept Educ Psychol & Adult Educ, Montreal, PQ, Canada; [Daignault, Katherine; Steele, Russell] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Petrakos, Harriet] Concordia Univ, Dept Educ, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Vasiliadis, Helen-Maria] Univ Sherbrooke, Dept Community Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Hechtman, Lily] McGill Univ, Div Child Psychiat, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University; Concordia University - Canada; Lady Davis Institute; McGill University; University of Sherbrooke; McGill University	Rousseau, C (corresponding author), McGill Univ, Div Social & Cultural Psychiat, Montreal, PQ, Canada.	cecile.rousseau@mcgill.ca	Steele, Russell J/G-6926-2017		Canadian Institute for Health Research [IRSC-229984]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by a grant from the Canadian Institute for Health Research, No. IRSC-229984. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhundov N, 1999, FORCED MIGRATION DEC, V1999, P20; Anderson JA, 2001, J EMOT BEHAV DISORD, V9, P106, DOI 10.1177/106342660100900205; Bibeau G, 1992, SANTE MENTALE VISAGE; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Danev M., 1998, ART THERAPISTS REFUG; Everitt B. S., 2008, CLIN TRIALS PSYCHIAT; Glick JE, 2003, DEMOGRAPHY, V40, P759, DOI 10.2307/1515207; Goodman A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-258; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hodes M., 2000, CHILD PSYCHOL PSYCHI, V5, P57, DOI [DOI 10.1017/S136064170000215X, 10.1017/S136064170000215X]; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Kanoute F., 2002, REV SCI LEDUCATION, V28, P171; Lane KL, 2005, BEHAV DISORDERS, V30, P363; Lane KL, 2005, BEHAV DISORDERS, V30, P349; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; Lopez A, 1992, NUESTRO ORIGEN NUEST; Manassis K, 2010, DEPRESSION ANXIETY; MILLER KE, 1994, AM J ORTHOPSYCHIAT, V64, P346, DOI 10.1037/h0079548; Moneta I, 2008, ART PSYCHOTHER, V35, P329, DOI 10.1016/j.aip.2008.07.001; National Collaborating Centre for Mental Health, 2005, POSTTRAUMATIC STRESS; Nylund B. V., 1999, FORCED MIGRATION REV, V6, P16; Rasco LM, 2004, MENTAL HEALTH OF REFUGEES, P375; Reddy LA, 2009, J SCHOOL PSYCHOL, V47, P77, DOI 10.1016/j.jsp.2008.11.001; Rousseau C, 2005, J CHILD PSYCHOL PSYC, V46, P180, DOI 10.1111/j.1469-7610.2004.00344.x; Rousseau C, 1996, AM J ORTHOPSYCHIAT, V66, P239, DOI 10.1037/h0080175; Rousseau C, 2008, CHILD ADOL PSYCH CL, V17, P533, DOI 10.1016/j.chc.2008.02.002; Rousseau Cecile, 2007, Clin Child Psychol Psychiatry, V12, P451; Rousseau C, 2012, CHILD ADOL MENT H-UK, V17, P187, DOI 10.1111/j.1475-3588.2011.00629.x; Rumbaut Ruben, 2001, ETHNICITIES CHILDREN; Stein BD, 2003, JAMA-J AM MED ASSOC, V290, P603, DOI 10.1001/jama.290.5.603; Suarez-Orozco C, 2009, TEACH COLL REC, V111, P712; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2012, WORLD PSYCHIATRY, V11, P114, DOI 10.1016/j.wpsyc.2012.05.008; Tucker CM, 2002, PSYCHOL SCHOOLS, V39, P477, DOI 10.1002/pits.10038; Van Hook J, 2002, DEMOGRAPHY, V39, P639, DOI 10.1353/dem.2002.0042; Wilson SJ, 2007, AM J PREV MED, V33, pS130, DOI 10.1016/j.amepre.2007.04.011	38	17	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104704	10.1371/journal.pone.0104704	http://dx.doi.org/10.1371/journal.pone.0104704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25127251	Green Published, gold			2022-12-27	WOS:000340879300044
J	Stempler, S; Yizhak, K; Ruppin, E				Stempler, Shiri; Yizhak, Keren; Ruppin, Eytan			Integrating Transcriptomics with Metabolic Modeling Predicts Biomarkers and Drug Targets for Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HUMAN BRAIN; AMINO-ACID; EXPRESSION; GENE; PLASMA	Accumulating evidence links numerous abnormalities in cerebral metabolism with the progression of Alzheimer's disease (AD), beginning in its early stages. Here, we integrate transcriptomic data from AD patients with a genome-scale computational human metabolic model to characterize the altered metabolism in AD, and employ state-of-the-art metabolic modelling methods to predict metabolic biomarkers and drug targets in AD. The metabolic descriptions derived are first tested and validated on a large scale versus existing AD proteomics and metabolomics data. Our analysis shows a significant decrease in the activity of several key metabolic pathways, including the carnitine shuttle, folate metabolism and mitochondrial transport. We predict several metabolic biomarkers of AD progression in the blood and the CSF, including succinate and prostaglandin D2. Vitamin D and steroid metabolism pathways are enriched with predicted drug targets that could mitigate the metabolic alterations observed. Taken together, this study provides the first network wide view of the metabolic alterations associated with AD progression. Most importantly, it offers a cohort of new metabolic leads for the diagnosis of AD and its treatment.	[Stempler, Shiri; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Stempler, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	shirist2@post.tau.ac.il; ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Israeli Science Foundation (ISF); Israeli Cancer Research Fund (ICRF); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; Joseph Sagol Fellowship for brain research at Tel Aviv University; Edmond J. Safra Bioinformatics center at Tel-Aviv University; Azrieli Foundation	Israeli Science Foundation (ISF)(Israel Science Foundation); Israeli Cancer Research Fund (ICRF); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Joseph Sagol Fellowship for brain research at Tel Aviv University; Edmond J. Safra Bioinformatics center at Tel-Aviv University; Azrieli Foundation	E.R.'s research is supported by a grant from the Israeli Science Foundation (ISF) and Israeli Cancer Research Fund (ICRF) to E. R. and by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant No 41/11). S. S. gratefully acknowledges the support of the Joseph Sagol Fellowship for brain research at Tel Aviv University. K.Y. is partially supported by a fellowship from the Edmond J. Safra Bioinformatics center at Tel-Aviv University and is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev VP, 2012, J PROTEOME RES; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; BASUN H, 1990, J NEURAL TRANSM-PARK, V2, P295, DOI 10.1007/BF02252924; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bjorkhem I, 2006, ACTA NEUROL SCAND, V114, P43, DOI 10.1111/j.1600-0404.2006.00684.x; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Faux NG, 2011, J ALZHEIMERS DIS, V27, P909, DOI 10.3233/JAD-2011-110752; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164; Henriksen K, 2013, ALZHEIMERS DEMENT; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; KALARIA RN, 1992, ANN NEUROL, V32, P583, DOI 10.1002/ana.410320417; Kim TY, 2011, CURR OPIN BIOTECHNOL; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Lehmann DJ, 2011, NEUROSCI LETT, V504, P79, DOI 10.1016/j.neulet.2011.08.057; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; MASTROGIACOMO F, 1993, J NEUROCHEM, V61, P2007, DOI 10.1111/j.1471-4159.1993.tb07436.x; Matsuzaki T, 2011, NEUROLOGY, V77, P1068, DOI 10.1212/WNL.0b013e31822e145d; Mohler EG, 2011, J NEUROSCI, V31, P5406, DOI 10.1523/JNEUROSCI.4046-10.2011; Molina JA, 2002, J NEURAL TRANSM, V109, P1035, DOI 10.1007/s007020200087; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7; Redjems-Bennani N, 1998, GERONTOLOGY, V44, P300, DOI 10.1159/000022031; Riverol Mario, 2011, Front Neurol, V2, P46, DOI 10.3389/fneur.2011.00046; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; Serot JM, 2001, J NEURAL TRANSM, V108, P93, DOI 10.1007/s007020170100; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Stempler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045879; Stempler S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.003; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Wang L, 2012, NEUROBIOL AGING, V33; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yizhak K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3632	50	38	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105383	10.1371/journal.pone.0105383	http://dx.doi.org/10.1371/journal.pone.0105383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127241	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300108
J	Xiao, X; Lucas, HD; Paller, KA; Ding, JH; Guo, CY				Xiao, Xin; Lucas, Heather D.; Paller, Ken A.; Ding, Jin-hong; Guo, Chun-yan			Retrieval Intention Modulates the Effects of Directed Forgetting Instructions on Recollection	PLOS ONE			English	Article							IMPLICIT MEMORY; EXPLICIT; ERP	The neurocognitive basis of memory retrieval is often examined by investigating brain potential old/new effects, which are differences in brain activity between successfully remembered repeated stimuli and correctly rejected new stimuli in a recognition test. In this study, we combined analyses of old/new effects for words with an item-method directed-forgetting manipulation in order to isolate differences between the retrieval processes elicited by words that participants were initially instructed to commit to memory and those that participants were initially instructed to forget. We compared old/new effects elicited by to-be-forgotten (TBF) words with those elicited by to-be-remembered (TBR) words in both an explicit-memory test (a recognition test) and an implicit-memory test (a lexical-decision test). Behavioral results showed clear directed forgetting effects in the recognition test, but not in the lexical decision test. Mirroring the behavioral findings, analyses of brain potentials showed evidence of directed forgetting only in the recognition test. In this test, potentials from 450-650 ms (P600 old/new effects) were more positive for TBR relative to TBF words. By contrast, P600 effects evident during the lexical-decision test did not differ in magnitude between TBR and TBF items. When taken in the context of prior studies that have linked similar parietal old/new effects to the recollection of episodic information, these data suggest that directed-forgetting effects manifest primarily in greater episodic retrieval by TBR than TBF items, and that retrieval intention may be important for these directed-forgetting effects to occur.	[Xiao, Xin; Ding, Jin-hong; Guo, Chun-yan] Capital Normal Univ, Beijing Key Lab Learning & Cognit, Dept Psychol, Beijing, Peoples R China; [Lucas, Heather D.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL USA	Capital Normal University; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Guo, CY (corresponding author), Capital Normal Univ, Beijing Key Lab Learning & Cognit, Dept Psychol, Beijing, Peoples R China.	guocy@hotmail.com	Paller, Ken/M-2676-2019; Lucas, Heather D/H-2736-2019	Paller, Ken/0000-0003-4415-4143	National Natural Science Foundation of China [31271078]; Beijing Municipal Commission of Education Key program of science and technology [KZ201410028034]; Scientific Research Base Development Program of the Beijing Municipal Commission of Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Key program of science and technology; Scientific Research Base Development Program of the Beijing Municipal Commission of Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present study was supported by the National Natural Science Foundation of China (31271078), the Beijing Municipal Commission of Education Key program of science and technology (KZ201410028034), and Scientific Research Base Development Program of the Beijing Municipal Commission of Education. The funders of this project had no role in the study design, data collection and analysis, or preparation of the manuscript.	AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Brinegar KA, 2013, PSYCHON B REV, V20, P528, DOI 10.3758/s13423-013-0383-6; Cheng SK, 2012, BIOL PSYCHOL, V89, P283, DOI 10.1016/j.biopsycho.2011.10.019; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; Curran T., 2006, BINDING HUMAN MEMORY, P467, DOI DOI 10.1093/ACPROF:OSO/9780198529675.003.0018; Dew ITZ, 2011, ANN NY ACAD SCI, V1224, P174, DOI 10.1111/j.1749-6632.2010.05946.x; Falsetti S.A., 2002, J COGN PSYCHOTHER, V16, P127, DOI DOI 10.1891/JCOP.16.2.127.63993; Fleck DE, 2001, PSYCHOL REC, V51, P207, DOI 10.1007/BF03395395; GRAF P, 1982, SCIENCE, V218, P1243, DOI 10.1126/science.7146909; Hsieh LT, 2009, BRAIN RES, V1250, P190, DOI 10.1016/j.brainres.2008.11.016; Jacoby L.L., 1984, NEUROPSYCHOLOGY MEMO, P145; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lehman M, 2009, J EXP PSYCHOL LEARN, V35, P970, DOI 10.1037/a0015728; Lucas HD, 2012, NEUROPSYCHOLOGIA, V50, P3041, DOI 10.1016/j.neuropsychologia.2012.07.036; Mace J.H., 2010, ACT REMEMBERING UNDE, P71, DOI DOI 10.1002/9781444328202.CH5; MacKenzie G, 2009, NEUROPSYCHOLOGIA, V47, P2756, DOI 10.1016/j.neuropsychologia.2009.05.025; MACLEOD CM, 1989, J EXP PSYCHOL LEARN, V15, P13, DOI 10.1037/0278-7393.15.1.13; Malmberg KJ, 2005, J EXP PSYCHOL LEARN, V31, P322, DOI 10.1037/0278-7393.31.2.322; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; Paller KA, 1999, COGNITIVE BRAIN RES, V7, P519, DOI 10.1016/S0926-6410(98)00050-0; Paller KA, 2000, BEHAV NEUROL, V12, P127, DOI 10.1155/2000/865250; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paz-Caballero MD, 1999, EUR J COGN PSYCHOL, V11, P239, DOI 10.1080/713752308; Reynolds M, 1999, BEHAV RES THER, V37, P201, DOI 10.1016/S0005-7967(98)00132-6; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; Sahakyan L, 2005, J EXP PSYCHOL LEARN, V31, P789, DOI 10.1037/0278-7393.31.4.789; Sahakyan L, 2009, J MEM LANG, V61, P134, DOI 10.1016/j.jml.2009.02.006; Schooler LJ, 2001, PSYCHOL REV, V108, P257, DOI 10.1037/0033-295X.108.1.257; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; SMITH ME, 1990, J EXP PSYCHOL LEARN, V16, P1033, DOI 10.1037/0278-7393.16.6.1033; SMITH SM, 1984, MEM COGNITION, V12, P477, DOI 10.3758/BF03198309; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Ullsperger M, 2000, J COGNITIVE NEUROSCI, V12, P924, DOI 10.1162/08989290051137477; Van Hooff JC, 2009, BRAIN COGNITION, V71, P153, DOI 10.1016/j.bandc.2009.05.001; Vonk J, 2006, MEM COGNITION, V34, P505, DOI 10.3758/BF03193574; Voss JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00227; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	45	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104701	10.1371/journal.pone.0104701	http://dx.doi.org/10.1371/journal.pone.0104701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140658	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200028
J	Shen, JJ; Niu, WN; Zhou, M; Zhang, HB; Ma, J; Wang, L; Zhang, HY				Shen, Jianjun; Niu, Weina; Zhou, Ming; Zhang, Hongbo; Ma, Jun; Wang, Ling; Zhang, Hongyan			RETRACTED: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							EXPRESSION; P53	Gastric cancer is one of the most frequent malignancies in tumors in the East Asian countries. Identifying precise prognostic markers and effective therapeutic targets is important in the treatment of gastric cancer. microRNAs (miRNAs) play important roles in tumorigenesis. However, the mechanisms by which miRNAs regulate gastric cancer metastasis remain poorly understood. In this study, we found that the levels of miR-410 in gastric cancer and cell lines were much lower than that in the normal control, respectively, and the lower level of miR-410 was significantly associated with lymph-node metastasis. Transfection of miR-410 mimics could significantly inhibit the cell proliferation, migration and invasion in the HGC-27 gastric cancer cell lines. In contrast, knockdown of miR-410 had the opposite effect on the cell proliferation, migration and invasion. Moreover, we also found that MDM2 was negatively regulated by miR-410 at the post-transcriptional level, via a specific target site with the 3'UTR by luciferase reporter assay. The expression of MDM2 was inversely correlated with miR-410 expression in gastric cancer tissues, and overexpression of MDM2 in miR-410-transfected gastric cancer cells effectively rescued the inhibition of cell proliferation and invasion caused by miR-410. Thus, our findings suggested that miR-410 acted as a new tumor suppressor by targeting the MDM2 gene and inhibiting gastric cancer cells proliferation, migration and invasion. The findings of this study contributed to the current understanding of these functions of miR-410 in gastric cancer.	[Shen, Jianjun; Zhou, Ming; Zhang, Hongbo; Ma, Jun; Wang, Ling; Zhang, Hongyan] Anhui Prov Hosp, Dept Radiat Oncol, Hefei, Peoples R China; [Niu, Weina] Anhui Canc Hosp, Dept Oncol, Hefei, Peoples R China		Zhang, HY (corresponding author), Anhui Prov Hosp, Dept Radiat Oncol, Hefei, Peoples R China.	zhanghongyan3334@163.com			Anhui Provincial Natural Science Foundation [1208085QH169]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	Anhui Provincial Natural Science Foundation (NO. 1208085QH169) http://220.178.98.52/zrkxjj/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Chien WW, 2011, ONCOGENE, V30, P1880, DOI 10.1038/onc.2010.570; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Craig VJ, 2011, CANCER RES, V71, P3616, DOI 10.1158/0008-5472.CAN-10-3907; Dong Z, 2014, CANCER LETT, V343, P249, DOI 10.1016/j.canlet.2013.09.034; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gattolliat CH, 2011, BRIT J CANCER, V105, P1352, DOI 10.1038/bjc.2011.388; Gunther T, 2000, MODERN PATHOL, V13, P621, DOI 10.1038/modpathol.3880107; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kim J, 2011, PATHOL INT, V61, P67, DOI 10.1111/j.1440-1827.2010.02615.x; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Kunte DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045591; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Li Z., 2014, GASTRIC CANC; Nag S, 2014, CURR MED CHEM, V21, P553, DOI 10.2174/09298673113206660325; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Park HS, 2013, INT J CLIN ONCOL; Peng QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082773; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Truini A, 2014, CELL MOL LIFE SCI; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang H.J., 2010, EUR J CANC; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Ye Y, 2013, CANCER SCI, V104, P590, DOI 10.1111/cas.12111; Yongchun Z, 2014, CANC LETT; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao YH, 2014, ACTA BIOCH BIOPH SIN, V46, P180, DOI 10.1093/abbs/gmt147	35	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104510	10.1371/journal.pone.0104510	http://dx.doi.org/10.1371/journal.pone.0104510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136862	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100038
J	Ali, MB; Ben Ali, Y; Aissa, I; Gargouri, Y				Ali, Madiha Bou; Ben Ali, Yassine; Aissa, Imen; Gargouri, Youssef			Eukaryotic Expression System Pichia pastoris Affects the Lipase Catalytic Properties: A Monolayer Study	PLOS ONE			English	Article							TURKEY PANCREATIC LIPASE; AFFINITY-CHROMATOGRAPHY; PROTEINS; PURIFICATION; CLONING; BINDING	Recombinant DNA methods are being widely used to express proteins in both prokaryotic and eukaryotic cells for both fundamental and applied research purposes. Expressed protein must be well characterized to be sure that it retains the same properties as the native one, especially when expressed protein will be used in the pharmaceutical field. In this aim, interfacial and kinetic properties of native, untagged recombinant and tagged recombinant forms of a pancreatic lipase were compared using the monomolecular film technique. Turkey pancreatic lipase (TPL) was chosen as model. A kinetic study on the dependence of the stereoselectivity of these three forms on the surface pressure was performed using three dicaprin isomers spread in the form of monomolecular films at the air-water interface. The heterologous expression and the N-His-tag extension were found to modify the pressure preference and decrease the catalytic hydrolysis rate of three dicaprin isomers. Besides, the heterologous expression was found to change the TPL regioselectivity without affecting its stereospecificity contrary to the N-tag extension which retained that regioselectivity and changed the stereospecificity at high surface pressures. The study of parameters, termed Recombinant expression Effects on Catalysis (REC), N-Tag Effects on Catalysis (TEC), and N-Tag and Recombinant expression Effects on Catalysis (TREC) showed that the heterologous expression effects on the catalytic properties of the TPL were more deleterious than the presence of an N-terminal tag extension.	[Ali, Madiha Bou; Ben Ali, Yassine; Aissa, Imen; Gargouri, Youssef] Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia	Universite de Sfax; Ecole Nationale dIngenieurs de Sfax (ENIS)	Gargouri, Y (corresponding author), Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia.	ytgargouri@yahoo.fr						Ali MB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-24; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY JL, 1995, J IMMUNOL METHODS, V179, P105, DOI 10.1016/0022-1759(94)00278-5; Chaga G, 1999, J CHROMATOGR A, V864, P247; Fendri A, 2006, BIOCHIMIE, V88, P1401, DOI 10.1016/j.biochi.2006.05.022; Gaberc-Porekar V, 1999, J CHROMATOGR A, V852, P117, DOI 10.1016/S0021-9673(99)00374-X; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hang Q, 1999, J BIOL CHEM, V274, P15305, DOI 10.1074/jbc.274.22.15305; Horchani H, 2010, J COLLOID INTERF SCI, V350, P586, DOI 10.1016/j.jcis.2010.07.021; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Passafiume M, 1998, FEBS LETT, V441, P407, DOI 10.1016/S0014-5793(98)01581-6; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; ROGALSKA E, 1993, CHIRALITY, V5, P24, DOI 10.1002/chir.530050106; Rogalska E, 1995, CHIRALITY IN PRESS; SASSENFELD HM, 1990, TRENDS BIOTECHNOL, V8, P88, DOI 10.1016/0167-7799(90)90145-N; Sayari A, 2000, BIOCHIMIE, V82, P153, DOI 10.1016/S0300-9084(00)00379-5; SHARMA SK, 1991, BIOTECHNOL APPL BIOC, V14, P69; VERGER R, 1973, CHEM PHYS LIPIDS, V10, P127, DOI 10.1016/0009-3084(73)90009-1	22	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104221	10.1371/journal.pone.0104221	http://dx.doi.org/10.1371/journal.pone.0104221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133585	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700024
J	Amjad, MW; Amin, MCIM; Mahali, SM; Katas, H; Ismail, I; ul Hassan, MN; Chuang, VTG				Amjad, M. Wahab; Amin, Mohd Cairul I. Mohd; Mahali, Shalela M.; Katas, Haliza; Ismail, Ismanizan; ul Hassan, M. Naeem; Chuang, Victor T. Giam			Nanoscale Diblock Copolymer Micelles: Characterizations and Estimation of the Effective Diffusion Coefficients of Biomolecules Release through Cylindrical Diffusion Model	PLOS ONE			English	Article							CONTROLLED DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; CHITOSAN NANOPARTICLES; BIODEGRADABLE POLYMERS; TARGETED DELIVERY; TAT PEPTIDE; BSA; THERAPEUTICS; STABILITY; BIOLOGY	Biomolecules have been widely investigated as potential therapeutics for various diseases. However their use is limited due to rapid degradation and poor cellular uptake in vitro and in vivo. To address this issue, we synthesized a new nano-carrier system comprising of cholic acid-polyethylenimine (CA-PEI) copolymer micelles, via carbodiimide-mediated coupling for the efficient delivery of small interfering ribonucleic acid (siRNA) and bovine serum albumin (BSA) as model protein. The mean particle size of siRNA- or BSA-loaded CA-PEI micelles ranged from 100-150 nm, with zeta potentials of +3-+11 mV, respectively. Atomic force, transmission electron and field emission scanning electron microscopy demonstrated that the micelles exhibited excellent spherical morphology. No significant morphology or size changes were observed in the CA-PEI micelles after siRNA and BSA loading. CA-PEI micelles exhibited sustained release profile, the effective diffusion coefficients were successfully estimated using a mathematically-derived cylindrical diffusion model and the release data of siRNA and BSA closely fitted into this model. High siRNA and BSA binding and loading efficiencies (95% and 70%, respectively) were observed for CA-PEI micelles. Stability studies demonstrated that siRNA and BSA integrity was maintained after loading and release. The CA-PEI micelles were non cytotoxic to V79 and DLD-1 cells, as shown by alamarBlue and LIVE/DEAD cell viability assays. RT-PCR study revealed that siRNA-loaded CA-PEI micelles suppressed the mRNA for ABCB1 gene. These results revealed the promising potential of CA-PEI micelles as a stable, safe, and versatile nano-carrier for siRNA and the model protein delivery.	[Amjad, M. Wahab; Amin, Mohd Cairul I. Mohd; Katas, Haliza] Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Fed Territory, Malaysia; [Mahali, Shalela M.] Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Terengganu, Terengganu, Malaysia; [Ismail, Ismanizan; ul Hassan, M. Naeem] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia; [Chuang, Victor T. Giam] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia	Universiti Kebangsaan Malaysia; Universiti Malaysia Terengganu; Universiti Kebangsaan Malaysia; Curtin University	Mahali, SM (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Ctr Drug Delivery Res, Kuala Lumpur, Fed Territory, Malaysia.	mciamin@pharmacy.ukm.my	Naeem-ul-Hassan, Muhammad/K-8886-2019; Mohd Mahali, Shalela Mohd/AAX-7558-2021; Chuang, Victor/A-3644-2011; KATAS, HALIZA/I-6417-2016; Amjad, Muhammad Wahab/AHA-5553-2022	Naeem-ul-Hassan, Muhammad/0000-0003-3709-6248; Chuang, Victor/0000-0002-2141-630X; KATAS, HALIZA/0000-0001-7249-1628; MAHALI, SHALELA/0000-0003-3458-991X; Amjad, Muhammad Wahab/0000-0002-5832-8602	Universiti Kebangsaan Malaysia (UKM) [UKM-GUP-SK-07-23-045]; Ministry of Science, Technology and Innovation, Malaysia [02-01-02-SF0738]	Universiti Kebangsaan Malaysia (UKM); Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project was funded by a Research University Grant (UKM-GUP-SK-07-23-045) from Universiti Kebangsaan Malaysia (UKM) and Science Fund (02-01-02-SF0738) from the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Boucetta H, 2008, CHEM COMMUN, P459, DOI 10.1039/b712350g; Amjad MW, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-687; Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117; Butt AM, 2012, J NANOMATER, V2012, DOI 10.1155/2012/916573; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chaudhuri P, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025102; Check E, 2005, NAT MED, V11, P243, DOI 10.1038/nm0305-243; Dash S, 2010, ACTA POL PHARM, V67, P217; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Devalapally H, 2007, J PHARM SCI-US, V96, P2547, DOI 10.1002/jps.20875; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Han XL, 2012, J PHOTOCH PHOTOBIO B, V109, P1, DOI 10.1016/j.jphotobiol.2011.12.010; Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021; Kirchhoff F, 2008, CELL, V134, P566, DOI 10.1016/j.cell.2008.08.004; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Larsericsdotter H, 2005, J COLLOID INTERF SCI, V289, P26, DOI 10.1016/j.jcis.2005.03.064; Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c; Liu HA, 2011, INVEST OPHTH VIS SCI, V52, P4789, DOI 10.1167/iovs.10-5891; Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025; Luckachan GE, 2011, J POLYM ENVIRON, V19, P637, DOI 10.1007/s10924-011-0317-1; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Manosroi J, 2013, DRUG DEV IND PHARM, V39, P520, DOI 10.3109/03639045.2012.684388; Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018; Narla SN, 2014, BIOCHEM BIOPH RES CO, V443, P562, DOI 10.1016/j.bbrc.2013.12.006; Sakai-Kato K, 2003, J PHARMACEUT BIOMED, V31, P299, DOI 10.1016/S0731-7085(02)00638-6; Torchilin VP, 2008, ADV DRUG DELIVER REV, V60, P548, DOI 10.1016/j.addr.2007.10.008; Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259; Wang S, 2009, J IND MANAG OPTIM, V5, P127, DOI 10.3934/jimo.2009.5.127	30	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105234	10.1371/journal.pone.0105234	http://dx.doi.org/10.1371/journal.pone.0105234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133390	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700093
J	Davanco, MG; Aguiar, ACC; dos Santos, LA; Padilha, EC; Campos, ML; de Andrade, CR; da Fonseca, LM; dos Santos, JL; Chin, CM; Krettli, AU; Peccinini, RG				Davanco, Marcelo Gomes; Campos Aguiar, Anna Caroline; dos Santos, Leandro Alves; Padilha, Elias Carvalho; Campos, Michel Leandro; de Andrade, Cleverton Roberto; da Fonseca, Luiz Marcos; dos Santos, Jean Leandro; Chin, Chung Man; Krettli, Antoniana Ursine; Peccinini, Rosangela Goncalves			Evaluation of Antimalarial Activity and Toxicity of a New Primaquine Prodrug	PLOS ONE			English	Article							PLASMODIUM-GALLINACEUM; DIPEPTIDE DERIVATIVES; IN-VITRO; DRUGS; ERYTHROCYTES; DISCOVERY; MEMBRANE; SCREEN; RAT	Plasmodium vivax is the most prevalent of the five species causing malaria in humans. The current available treatment for P. vivax malaria is limited and unsatisfactory due to at least two drawbacks: the undesirable side effects of primaquine (PQ) and drug resistance to chloroquine. Phenylalanine-alanine-PQ (Phe-Ala-PQ) is a PQ prodrug with a more favorable pharmacokinetic profile compared to PQ. The toxicity of this prodrug was evaluated in in vitro assays using a human hepatoma cell line (HepG2), a monkey kidney cell line (BGM), and human red blood cells deficient in the enzyme glucose-6-phosphate-dehydrogenase (G6PD). In addition, in vivo toxicity assays were performed with rats that received multiple doses of Phe-Ala-PQ to evaluate biochemical, hematological, and histopathological parameters. The activity was assessed by the inhibition of the sporogonic cycle using a chicken malaria parasite. Phe-Ala-PQ blocked malaria transmission in Aedes mosquitoes. When compared with PQ, it was less cytotoxic to BGM and HepG2 cells and caused less hemolysis of G6PD-deficient red blood cells at similar concentrations. The prodrug caused less alteration in the biochemical parameters than did PQ. Histopathological analysis of the liver and kidney did show differences between the control and Phe-Ala-PQ-treated groups, but they were not statistically significant. Taken together, the results highlight the prodrug as a novel lead compound candidate for the treatment of P. vivax malaria and as a blocker of malaria transmission.	[Davanco, Marcelo Gomes; Padilha, Elias Carvalho; Campos, Michel Leandro; Peccinini, Rosangela Goncalves] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Principios Ativos Nat & Toxicol, Sao Paulo, Brazil; [Campos Aguiar, Anna Caroline; Krettli, Antoniana Ursine] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [dos Santos, Leandro Alves; de Andrade, Cleverton Roberto] Univ Estadual Paulista UNESP, Fac Odontol Araraquara, Dept Fisiol & Patol, Sao Paulo, Brazil; [da Fonseca, Luiz Marcos] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Anal Clin, Sao Paulo, Brazil; [dos Santos, Jean Leandro; Chin, Chung Man] Univ Estadual Paulista UNESP, Fac Ciencias Farm, Lab Pesquisa & Desenvolvimento Farmacos Lapdesf, Sao Paulo, Brazil	Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Peccinini, RG (corresponding author), Univ Estadual Paulista UNESP, Fac Ciencias Farm, Dept Principios Ativos Nat & Toxicol, Sao Paulo, Brazil.	peccinin@fcfar.unesp.br	Dos Santos, Jean Leandro/O-9111-2019; Chin, Chung Man/W-2762-2019; Davanço, Marcelo Gomes/A-7196-2015; de Campos, Michel Leandro/G-2855-2014; Santos, Jean Leandro dos/E-8753-2016; de+Andrade, Cleverton Roberto/AAA-6683-2019; de Andrade, Cleverton Roberto Roberto/D-9138-2012; Padilha, Elias Carvalho/J-5671-2015; Chung/AAP-8459-2021; Peccinini, Rosangela/G-6068-2015; Aguiar, Anna Caroline/J-6970-2015; Man Chin, Chung/C-2259-2013	de Campos, Michel Leandro/0000-0002-7147-7637; Santos, Jean Leandro dos/0000-0002-2460-2829; de+Andrade, Cleverton Roberto/0000-0001-7015-7175; de Andrade, Cleverton Roberto Roberto/0000-0001-7015-7175; Padilha, Elias Carvalho/0000-0002-3794-9389; Peccinini, Rosangela/0000-0002-2692-8101; Aguiar, Anna Caroline/0000-0003-0139-8279; Man Chin, Chung/0000-0003-4141-0455; Alves dos Santos, Leandro/0000-0001-8088-5790	Sao Paulo Research Foundation - FAPESP [09/51075-5, 11/11239-9]; National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES; National Council for Scientific and Technological Development - CNPq (Neglected Diseases); Minas Gerais State Research Foundation - FAPEMIG	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development - CNPq (Neglected Diseases)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Foundation - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Sao Paulo Research Foundation - FAPESP (process 09/51075-5 and process 11/11239-9, http://www.bv.fapesp.br/5394 and http://www.bv.fapesp.br/5395); National Institute of Science and Technology - Pharmaceutical Innovation (INCT-if); Coordination for the Improvement of Higher Education Personnel - CAPES; National Council for Scientific and Technological Development - CNPq (Neglected Diseases, Project 2012-14); and Minas Gerais State Research Foundation - FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALVING A S, 1960, Bull World Health Organ, V22, P621; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; CARVALHO LH, 1992, BRAZ J MED BIOL RES, V25, P247; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Chung MC, 1997, J PHARM SCI, V86, P1127, DOI 10.1021/js970006v; Cushion MT, 2009, CURR MED CHEM, V16, P2514, DOI 10.2174/092986709788682038; Davanco MG, 2012, BIOPHARM DRUG DISPOS, V33, P437, DOI 10.1002/bdd.1807; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Deye GA, 2012, AM J TROP MED HYG, V86, P931, DOI 10.4269/ajtmh.2012.11-0552; FERRANTE A, 1984, PARASITE IMMUNOL, V6, P571, DOI 10.1111/j.1365-3024.1984.tb00826.x; FRASER IM, 1968, ANN NY ACAD SCI, V151, P777, DOI 10.1111/j.1749-6632.1968.tb48261.x; GINSBURG H, 1988, BIOCHEM PHARMACOL, V37, P2013, DOI 10.1016/0006-2952(88)90549-7; GWADZ RW, 1983, EXP PARASITOL, V55, P188, DOI 10.1016/0014-4894(83)90013-9; Heurtault B, 2001, ANN TROP MED PARASIT, V95, P529, DOI 10.1080/00034980120067226; Katsuragawa Tony H., 2004, Rev. Bras. Hematol. Hemoter., V26, P268, DOI 10.1590/S1516-84842004000400007; Kaur K, 2011, BIOORGAN MED CHEM, V19, P197, DOI 10.1016/j.bmc.2010.11.036; Kim T, 2009, J INFECT CHEMOTHER, V15, P343, DOI 10.1007/s10156-009-0710-z; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; Mata G, 2012, BIOORGAN MED CHEM, V20, P886, DOI 10.1016/j.bmc.2011.11.059; MIHALY GW, 1984, BRIT J CLIN PHARMACO, V17, P441, DOI 10.1111/j.1365-2125.1984.tb02369.x; Na-Bangchang K, 2009, FUND CLIN PHARMACOL, V23, P387, DOI 10.1111/j.1472-8206.2009.00709.x; Naoum Paulo Cesar, 2004, Rev. Bras. Hematol. Hemoter., V26, P19, DOI 10.1590/S1516-84842004000100004; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; PHILIP A, 1988, J MED CHEM, V31, P870, DOI 10.1021/jm00399a032; Portela MJ, 1999, PHARM RES-DORDR, V16, P949, DOI 10.1023/A:1018922425551; Schiff U, 1866, CLIN TESTS HISTOPATH, P100; SCHLESINGER PH, 1988, ANTIMICROB AGENTS CH, V32, P793, DOI 10.1128/AAC.32.6.793; SCHMIDT LH, 1986, AM J TROP MED HYG, V35, P1077, DOI 10.4269/ajtmh.1986.35.1077; Sticova E, 2013, WORLD J GASTROENTERO, V19, P6398, DOI 10.3748/wjg.v19.i38.6398; Tekwani BL, 2006, CURR OPIN INFECT DIS, V19, P623, DOI 10.1097/QCO.0b013e328010b848; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; TROUET A, 1981, B WORLD HEALTH ORGAN, V59, P449; Vale N, 2009, J MED CHEM, V52, P7800, DOI 10.1021/jm900738c; Vale N, 2009, EUR J MED CHEM, V44, P2506, DOI 10.1016/j.ejmech.2009.01.018; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Vale-Costa S, 2012, ANTIMICROB AGENTS CH, V56, P5774, DOI 10.1128/AAC.00873-12; Walsh JJ, 2009, CURR PHARM DESIGN, V15, P2970, DOI 10.2174/138161209789058183; Wang C, 2010, BIOCHEM BIOPH RES CO, V402, P773, DOI 10.1016/j.bbrc.2010.10.108; Weerasinghe K. L., 2002, Ceylon Medical Journal, V47, P83; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams HD, 2013, PHARMACOL REV, V65, P315, DOI 10.1124/pr.112.005660; Yardley V, 2010, ANTIMICROB AGENTS CH, V54, P5356, DOI 10.1128/AAC.00985-10; Zeeman AM, 2014, ANTIMICROB AGENTS CH, V58, P1586, DOI 10.1128/AAC.01927-13	48	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105217	10.1371/journal.pone.0105217	http://dx.doi.org/10.1371/journal.pone.0105217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133630	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700089
J	Emukule, GO; Khagayi, S; McMorrow, ML; Ochola, R; Otieno, N; Widdowson, MA; Ochieng, M; Feikin, DR; Katz, MA; Mott, JA				Emukule, Gideon O.; Khagayi, Sammy; McMorrow, Meredith L.; Ochola, Rachel; Otieno, Nancy; Widdowson, Marc-Alain; Ochieng, Melvin; Feikin, Daniel R.; Katz, Mark A.; Mott, Joshua A.			The Burden of Influenza and RSV among Inpatients and Outpatients in Rural Western Kenya, 2009-2012	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; YOUNG-CHILDREN; MORTALITY; ILLNESS; INFECTIONS; HOSPITALIZATION; IMMUNIZATION; METAANALYSIS; SEASONALITY	Background: In Kenya, detailed data on the age-specific burden of influenza and RSV are essential to inform use of limited vaccination and treatment resources. Methods: We analyzed surveillance data from August 2009 to July 2012 for hospitalized severe acute respiratory illness (SARI) and outpatient influenza-like illness (ILI) at two health facilities in western Kenya to estimate the burden of influenza and respiratory syncytial virus (RSV). Incidence rates were estimated by dividing the number of cases with laboratory-confirmed virus infections by the mid-year population. Rates were adjusted for healthcare-seeking behavior, and to account for patients who met the SARI/ILI case definitions but were not tested. Results: The average annual incidence of influenza-associated SARI hospitalization per 1,000 persons was 2.7 (95% CI 1.8-3.9) among children <5 years and 0.3 (95% CI 0.2-0.4) among persons >= 5 years; for RSV-associated SARI hospitalization, it was 5.2 (95% CI 4.0-6.8) among children <5 years and 0.1 (95% CI 0.0-0.2) among persons >= 5 years. The incidence of influenza-associated medically-attended ILI per 1,000 was 24.0 (95% CI 16.6-34.7) among children <5 years and 3.8 (95% CI 2.6-5.7) among persons >= 5 years. The incidence of RSV-associated medically-attended ILI was 24.6 (95% CI 17.0-35.4) among children <5 years and 0.8 (95% CI 0.3-1.9) among persons >= 5 years. Conclusions: Influenza and RSV both exact an important burden in children. This highlights the possible value of influenza vaccines, and future RSV vaccines, for Kenyan children.	[Emukule, Gideon O.; Katz, Mark A.; Mott, Joshua A.] Kenya Country Off, Ctr Dis Control & Prevent CDC, Nairobi, Kenya; [Khagayi, Sammy; Ochola, Rachel; Otieno, Nancy; Ochieng, Melvin] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Khagayi, Sammy; Ochola, Rachel; Otieno, Nancy; Ochieng, Melvin] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [McMorrow, Meredith L.; Widdowson, Marc-Alain; Mott, Joshua A.] US Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA; [Katz, Mark A.] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [McMorrow, Meredith L.; Mott, Joshua A.] US PHS, Rockville, MD USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Public Health Service	Emukule, GO (corresponding author), Kenya Country Off, Ctr Dis Control & Prevent CDC, Nairobi, Kenya.	uyr9@cdc.gov	McMorrow, Meredith/M-1274-2019	McMorrow, Meredith/0000-0001-6363-4033; Otieno, Nancy Awuor/0000-0002-7083-4735	Global Disease Detection Division of CDC	Global Disease Detection Division of CDC	The funding for this project is from Core Funding of the Global Disease Detection Division of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Dalal W, 2012, J ACQUIR IMMUNE DEFI; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Feikin DR, 2013, PEDIAT INFECT DIS J, V32; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Keitel W, 2013, MMWR-MORBID MORTAL W, V62, P356; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nascimento-Carvalho C M, 2001, Braz J Infect Dis, V5, P87; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Okiro EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052520; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; Schickli JH, 2012, VIRUS RES, V169, P38, DOI 10.1016/j.virusres.2012.06.027; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Simoes EAF, 2001, LANCET, V358, P1382, DOI 10.1016/S0140-6736(01)06488-1; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; WHO, 2013, GLOB EP SURV STAND I; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2011, 2 M SAG WORK GROUP I; World Health Organization, 2012, BACKGR PAP INFL VACC; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	37	60	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105543	10.1371/journal.pone.0105543	http://dx.doi.org/10.1371/journal.pone.0105543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133576	Green Published, gold			2022-12-27	WOS:000341302700120
J	Jin, L; Bhuiya, MW; Li, MM; Liu, XQ; Han, JX; Deng, WW; Wang, M; Yu, O; Zhang, ZZ				Jin, Lu; Bhuiya, Mohammad Wadud; Li, Mengmeng; Liu, XiangQi; Han, Jixiang; Deng, WeiWei; Wang, Min; Yu, Oliver; Zhang, Zhengzhu			Metabolic Engineering of Saccharomyces cerevisiae for Caffeine and Theobromine Production	PLOS ONE			English	Article							PURINE ALKALOIDS; N-METHYLTRANSFERASES; SYNTHASE GENE; BIOSYNTHESIS; CAMELLIA; PURIFICATION; LEAVES; PLANTS; 7-METHYLXANTHINE; XANTHOSINE	Caffeine (1, 3, 7-trimethylxanthine) and theobromine (3, 7-dimethylxanthine) are the major purine alkaloids in plants, e. g. tea (Camellia sinensis) and coffee (Coffea arabica). Caffeine is a major component of coffee and is used widely in food and beverage industries. Most of the enzymes involved in the caffeine biosynthetic pathway have been reported previously. Here, we demonstrated the biosynthesis of caffeine (0.38 mg/L) by co-expression of Coffea arabica xanthosine methyltransferase (CaXMT) and Camellia sinensis caffeine synthase (TCS) in Saccharomyces cerevisiae. Furthermore, we endeavored to develop this production platform for making other purine-based alkaloids. To increase the catalytic activity of TCS in an effort to increase theobromine production, we identified four amino acid residues based on structural analyses of 3D-model of TCS. Two TCS1 mutants (Val317Met and Phe217Trp) slightly increased in theobromine accumulation and simultaneously decreased in caffeine production. The application and further optimization of this biosynthetic platform are discussed.	[Jin, Lu; Li, Mengmeng; Liu, XiangQi; Deng, WeiWei; Wang, Min; Zhang, Zhengzhu] Anhui Agr Univ, Key Lab Tea Biochem & Biotechnol, Minist Educ, Hefei, Peoples R China; [Bhuiya, Mohammad Wadud; Han, Jixiang] Conagen Inc, St Louis, MO USA; [Yu, Oliver] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Anhui Agricultural University; Donald Danforth Plant Science Center	Zhang, ZZ (corresponding author), Anhui Agr Univ, Key Lab Tea Biochem & Biotechnol, Minist Educ, Hefei, Peoples R China.	zzz@ahau.edu.cn		Zhang, Zhengzhu/0000-0003-1564-1428; Deng, Wei-Wei/0000-0003-0732-7076	Natural Science Foundation of China (NSFC) [31170649]; Program for Changjiang Scholars, and the Innovative Research Team in University [IRT1101]; US National Science Foundation (NSF) [MCB-0923779]; US Department of Energy (DOE) [DE-SC0001295]; NSF-MRI [DBI-0521250]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars, and the Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants from the Natural Science Foundation of China (NSFC No. 31170649), the Program for Changjiang Scholars, and the Innovative Research Team in University (No. IRT1101). This work was also supported in part by grants from US National Science Foundation (NSF) (MCB-0923779) and US Department of Energy (DOE) (DE-SC0001295) to O. Yu. Funding for the 4000QTRAP mass spectrometer was provided through an NSF-MRI grant (DBI-0521250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashihara H, 1996, PLANT PHYSIOL, V111, P747, DOI 10.1104/pp.111.3.747; Ashihara H, 1997, PLANT CELL PHYSIOL, V38, P413, DOI 10.1093/oxfordjournals.pcp.a029184; Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Cornell KA, 2009, J ANTIMICROB CHEMOTH, V63, P1163, DOI 10.1093/jac/dkp129; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Haferkamp I, 2013, J BACTERIOL, V195, P3183, DOI 10.1128/JB.00195-13; Hansen MR, 2005, BBA-GEN SUBJECTS, V1723, P55, DOI 10.1016/j.bbagen.2005.01.012; Hughes EH, 2002, METAB ENG, V4, P41, DOI 10.1006/mben.2001.0205; Ito E, 1999, J PLANT PHYSIOL, V154, P145, DOI 10.1016/S0176-1617(99)80202-8; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Kato M, 1996, PHYSIOL PLANTARUM, V98, P629, DOI [10.1111/j.1399-3054.1996.tb05720.x, 10.1034/j.1399-3054.1996.980325.x]; Kato M, 1999, PLANT PHYSIOL, V120, P579, DOI 10.1104/pp.120.2.579; Kim HS, 2006, MICROBIOL-SGM, V152, P1169, DOI 10.1099/mic.0.28703-0; Koshiishi C, 2001, FEBS LETT, V499, P50, DOI 10.1016/S0014-5793(01)02512-1; Kutchan TM, 2008, ADV PL BIOCH MOL BIO, V1, P283, DOI 10.1016/S1755-0408(07)01010-7; Lee JH, 2010, P NATL ACAD SCI USA, V107, P17557, DOI 10.1073/pnas.1006848107; MAGNI G, 1982, ARCH BIOCHEM BIOPHYS, V213, P426, DOI 10.1016/0003-9861(82)90568-9; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Mizuno K, 2003, FEBS LETT, V534, P75, DOI 10.1016/S0014-5793(02)03781-X; Ogawa M, 2001, J BIOL CHEM, V276, P8213, DOI 10.1074/jbc.M009480200; Osamu N, 1988, AGR BIOL CHEM TOKYO, V52, P169; Pasquali G, 2006, J BIOSCI BIOENG, V101, P287, DOI 10.1263/jbb.101.287; Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; SUZUKI T, 1992, PHYTOCHEMISTRY, V31, P2575, DOI 10.1016/0031-9422(92)83590-U; Uefuji H, 2003, PLANT PHYSIOL, V132, P372, DOI 10.1104/pp.102.019679; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Verpoorte R., 1998, ALKALOIDS, V50, P453; Wang YC, 2011, METAB ENG, V13, P455, DOI 10.1016/j.ymben.2011.04.005; Yoneyama N, 2006, MOL GENET GENOMICS, V275, P125, DOI 10.1007/s00438-005-0070-z; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	33	14	16	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105368	10.1371/journal.pone.0105368	http://dx.doi.org/10.1371/journal.pone.0105368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133732	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700107
J	Shiba, D; Hatou, S; Ono, T; Hosoda, S; Tanabe, S; Ozeki, N; Yuki, K; Shimoyama, M; Fukagawa, K; Shimmura, S; Tsubota, K				Shiba, Daisuke; Hatou, Shin; Ono, Takeshi; Hosoda, Shingo; Tanabe, Sachiko; Ozeki, Naoki; Yuki, Kenya; Shimoyama, Masaru; Fukagawa, Kazumi; Shimmura, Shigeto; Tsubota, Kazuo			Multivariable Logistic Regression Model: A Novel Mathematical Model that Predicts Visual Field Sensitivity from Macular Ganglion Cell Complex Thickness in Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL NERVE-FIBER; LAYER THICKNESS; LINEAR-MODEL; DOMAIN OCT; PERIMETRY; DAMAGE; EYES	Purpose: To design a mathematical model that can predict the relationship between the ganglion cell complex (GCC) thickness and visual field sensitivity (VFS) in glaucoma patients. Design: Retrospective cross-sectional case series. Method: Within 3 months from VFS measurements by the Humphrey field analyzer 10-2 program, 83 eyes underwent macular GCC thickness measurements by spectral-domain optical coherence tomography (SD-OCT). Data were used to construct a multiple logistic model that depicted the relationship between the explanatory variables (GCC thickness, age, sex, and spherical equivalent of refractive errors) determined by a regression analysis and the mean VFS corresponding to the SD-OCT scanned area. Analyses were performed in half or 8 segmented local areas as well as in whole scanned areas. A simple logistic model that included GCC thickness as the single explanatory variable was also constructed. The ability of the logistic models to depict the real GCC thickness/VFS in SAP distribution was analyzed by the chi(2) test of goodness-of-fit. The significance of the model effect was analyzed by analysis of variance (ANOVA). Results: Scatter plots between the GCC thickness and the mean VFS showed sigmoid curves. The chi(2) test of goodness-of-fit revealed that the multiple logistic models showed a good fit for the real GCC thickness/VFS distribution in all areas except the nasal-inferior-outer area. ANOVA revealed that all of the multiple logistic models significantly predicted the VFS based on the explanatory variables. Although simple logistic models also exhibited significant VFS predictability based on the GCC thickness, the model effect was less than that observed for the multiple logistic models. Conclusions: The currently proposed logistic models are useful methods for depicting relationships between the explanatory variables, including the GCC thickness, and the mean VFS in glaucoma patients.	[Shiba, Daisuke; Hatou, Shin; Ono, Takeshi; Hosoda, Shingo; Tanabe, Sachiko; Ozeki, Naoki; Yuki, Kenya; Shimoyama, Masaru; Fukagawa, Kazumi; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Shiba, Daisuke; Ozeki, Naoki; Yuki, Kenya; Fukagawa, Kazumi] Keisho Kai Iidabashi Eye Clin, Tokyo, Japan; [Tanabe, Sachiko] Tanabe Eye Clin, Kai, Yamanashi, Japan; [Shimoyama, Masaru] Shimoyama Eye Clin, Shizuoka, Japan	Keio University	Shiba, D (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shiba@personal.email.ne.jp		Hatou, Shin/0000-0001-9273-5909				Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Glantz S, 2001, REGRESSION QUALITATI, P607; Harwerth RS, 2007, INVEST OPHTH VIS SCI, V48, P763, DOI 10.1167/iovs.06-0688; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P4254, DOI 10.1167/iovs.08-2697; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kanamori A, 2013, ACTA OPHTHALMOL, V91, pE196, DOI 10.1111/aos.12028; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Nilforushan N, 2012, INVEST OPHTH VIS SCI, V53, P2740, DOI 10.1167/iovs.11-8320; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Sato S, 2013, INVEST OPHTH VIS SCI, V54, P3046, DOI 10.1167/iovs.12-11173; Shin HY, 2013, INVEST OPHTHALMOL VI; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Zeimer R, 1998, OPHTHALMOLOGY, V105, P224, DOI 10.1016/S0161-6420(98)92743-9	20	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104126	10.1371/journal.pone.0104126	http://dx.doi.org/10.1371/journal.pone.0104126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133512	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700022
J	Sui, SC; Zhao, J; Wang, JW; Zhang, R; Guo, CD; Yu, T; Li, N				Sui, Shunchao; Zhao, Jie; Wang, Jianwu; Zhang, Ran; Guo, Chengdong; Yu, Tian; Li, Ning			Comparative Proteomics of Milk Fat Globule Membrane Proteins from Transgenic Cloned Cattle	PLOS ONE			English	Article							RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; MAMMARY EPITHELIAL-CELLS; ALPHA-LACTALBUMIN; SAMPLE PREPARATION; STATISTICAL-MODEL; DAIRY-PRODUCTS; LIPID GLOBULES; BOVINE; EXPRESSION; GLAND	The use of transgenic livestock is providing new methods for obtaining pharmaceutically useful proteins. However, the protein expression profiles of the transgenic animals, including expression of milk fat globule membrane (MFGM) proteins, have not been well characterized. In this study, we compared the MFGM protein expression profile of the colostrum and mature milk from three lines of transgenic cloned (TC) cattle, i.e., expressing recombinant human alpha-lactalbumin (TC-LA), lactoferrin (TC-LF) or lysozyme (TC-LZ) in the mammary gland, with those from cloned non-transgenic (C) and conventionally bred normal animals (N). We identified 1, 225 proteins in milk MFGM, 166 of which were specifically expressed only in the TC-LA group, 265 only in the TC-LF group, and 184 only in the TC-LZ group. There were 43 proteins expressed only in the transgenic cloned animals, but the concentrations of these proteins were below the detection limit of silver staining. Functional analysis also showed that the 43 proteins had no obvious influence on the bovine mammary gland. Quantitative comparison revealed that MFGM proteins were up-or down-regulated more than twofold in the TC and C groups compared to N group: 126 in colostrum and 77 in mature milk of the TC-LA group; 157 in colostrum and 222 in mature milk of the TC-LF group; 49 in colostrum and 98 in mature milk of the TC-LZ group; 98 in colostrum and 132 in mature milk in the C group. These up-and down-regulated proteins in the transgenic animals were not associated with a particular biological function or pathway, which appears that expression of certain exogenous proteins has no general deleterious effects on the cattle mammary gland.	[Sui, Shunchao; Zhao, Jie; Zhang, Ran; Guo, Chengdong; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wang, Jianwu] Beijing GenProtein Biotech Co Ltd, Beijing, Peoples R China; [Wang, Jianwu; Yu, Tian] Wuxi Kingenew Biotechnol Co Ltd, Wuxi, Jiangsu, Peoples R China	China Agricultural University	Li, N (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglicaulab@gmail.com			"863'' High-Tech Research Development Project [2010AA10A105, 2011AA100601]	"863'' High-Tech Research Development Project	This project was supported by the "863'' High-Tech Research Development Project (project grant numbers 2010AA10A105 and 2011AA100601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2011, INFECT IMMUN, V79, P3833, DOI 10.1128/IAI.00040-11; Affolter M, 2010, J PROTEOMICS, V73, P1079, DOI 10.1016/j.jprot.2009.11.008; Auty MAE, 2001, J DAIRY RES, V68, P417, DOI 10.1017/S0022029901004873; Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021; Baldassarre H, 2009, TRANSGENIC RES, V18, P621, DOI 10.1007/s11248-009-9254-3; Baldassarre H, 2008, TRANSGENIC RES, V17, P863, DOI 10.1007/s11248-008-9184-5; Bianchi L, 2009, J PROTEOMICS, V72, P853, DOI 10.1016/j.jprot.2008.11.020; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; D'Amato A, 2009, J PROTEOME RES, V8, P3925, DOI 10.1021/pr900221x; Gordon K, 1992, Biotechnology, V24, P425; Guri A, 2012, J DAIRY SCI, V95, P6937, DOI 10.3168/jds.2012-5734; Heid HW, 2005, EUR J CELL BIOL, V84, P245, DOI 10.1016/j.ejcb.2004.12.002; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inagaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P1386, DOI 10.1271/bbb.100060; Keenan TW, 2001, ADV EXP MED BIOL, V501, P125; Keenan TW, 2001, J MAMMARY GLAND BIOL, V6, P365, DOI 10.1023/A:1011383826719; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Laible G, 2007, THERIOGENOLOGY, V67, P166, DOI 10.1016/j.theriogenology.2006.09.028; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Liao YL, 2011, J PROTEOME RES, V10, P3530, DOI 10.1021/pr200149t; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Moore JB, 2011, ADV NUTR, V2, P355, DOI 10.3945/an.111.000554; Mowbray AL, 2008, J BIOL CHEM, V283, P1622, DOI 10.1074/jbc.M707985200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Parker P, 2010, GLYCOCONJUGATE J, V27, P89, DOI 10.1007/s10719-009-9269-2; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Picariello G, 2012, J CHROMATOGR A, V1227, P219, DOI 10.1016/j.chroma.2012.01.014; Quaranta S, 2001, ELECTROPHORESIS, V22, P1810, DOI 10.1002/1522-2683(200105)22:9&lt;1810::AID-ELPS1810&gt;3.0.CO;2-M; Rudolph NS, 1999, TRENDS BIOTECHNOL, V17, P367, DOI 10.1016/S0167-7799(99)01341-4; Sharp JA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-48; SIMONS JP, 1987, NATURE, V328, P530, DOI 10.1038/328530a0; Spertino S, 2012, MOL BIOSYST, V8, P967, DOI 10.1039/c2mb05400k; SPITSBERG VL, 1995, EUR J BIOCHEM, V230, P872, DOI 10.1111/j.1432-1033.1995.tb20630.x; Takahashi Y, 2003, COMP BIOCHEM PHYS B, V136, P905, DOI 10.1016/j.cbpc.2003.09.004; Viturro E, 2006, J DAIRY SCI, V89, P553, DOI 10.3168/jds.S0022-0302(06)72118-X; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Wheeler MB, 2003, ANIM REPROD SCI, V79, P265, DOI 10.1016/S0378-4320(03)00168-4; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yonezawa T, 2009, BIOCHEM BIOPH RES CO, V384, P535, DOI 10.1016/j.bbrc.2009.05.012; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697	46	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105378	10.1371/journal.pone.0105378	http://dx.doi.org/10.1371/journal.pone.0105378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133402	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700109
J	Bluteau, G; Zhuang, L; Amann, R; Trueb, B				Bluteau, Gilles; Zhuang, Lei; Amann, Ruth; Trueb, Beat			Targeted Disruption of the Intracellular Domain of Receptor FgfrL1 in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FIBROBLAST; CARTILAGE; PROTEINS; SIGNALS	FgfrL1 is the fifth member of the fibroblast growth factor receptor (Fgfr) family. Studies with FgfrL1 deficient mice have demonstrated that the gene plays an important role during embryonic development. FgfrL1 knock-out mice die at birth as they have a malformed diaphragm and lack metanephric kidneys. Similar to the classical Fgfrs, the FgfrL1 protein contains an extracellular part composed of three Ig-like domains that interact with Fgf ligands and heparin. However, the intracellular part of FgfrL1 is not related to the classical receptors and does not possess any tyrosine kinase activity. Curiously enough, the amino acid sequence of this domain is barely conserved among different species, with the exception of three motifs, namely a dileucine peptide, a tandem tyrosine-based motif YXX Phi and a histidine-rich sequence. To investigate the function of the intracellular domain of FgfrL1, we have prepared genetically modified mice that lack the three conserved sequence motifs, but instead contain a GFP cassette (FgfrL1 Delta C-GFP). To our surprise, homozygous FgfrL1 Delta C-GFP knock-in mice are viable, fertile and phenotypically normal. They do not exhibit any alterations in the diaphragm or the kidney, except for a slight reduction in the number of glomeruli that does not appear to affect life expectancy. In addition, the pancreas of both FgfrL1 Delta C-GFP knock-in and FgfrL1 knock-out mice do not show any disturbances in the production of insulin, in contrast to what has been suggested by recent studies. Thus, the conserved motifs of the intracellular FgfrL1 domain are dispensable for organogenesis and normal life. We conclude that the extracellular domain of the protein must conduct the vital functions of FgfrL1.	[Bluteau, Gilles; Zhuang, Lei; Amann, Ruth; Trueb, Beat] Univ Bern, Dept Clin Res, Bern, Switzerland; [Trueb, Beat] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Trueb, B (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	beat.trueb@dkf.unibe.ch	Trueb, Beat/AAL-9621-2020	Trueb, Beat/0000-0001-8684-6856	Swiss National Science Foundation [31003A-143350]; Helmut Horten Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	This work was supported by grants from the Swiss National Science Foundation (grant 31003A-143350) and the Helmut Horten Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2013, INT J MOL MED, V32, P983, DOI 10.3892/ijmm.2013.1484; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baertschi S, 2007, FEBS J, V274, P6241, DOI 10.1111/j.1742-4658.2007.06143.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; di Martino E, 2013, GENE CHROMOSOME CANC, V52, P860, DOI 10.1002/gcc.22082; Dingemann J, 2011, EUR J PEDIATR SURG, V21, P46, DOI 10.1055/s-0030-1262853; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gerber SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033457; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Silva PN, 2013, J BIOL CHEM, V2013, P2; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Steinberg F, 2010, J BIOL CHEM, V285, P37704, DOI 10.1074/jbc.M110.140517; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Trueb B, 2013, CELL MOL LIFE SCI, V70, P2505, DOI 10.1007/s00018-012-1189-9; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Wiedemann M, 2001, BBA-GENE STRUCT EXPR, V1520, P247, DOI 10.1016/S0167-4781(01)00267-6; Zhuang L, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-33	27	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105210	10.1371/journal.pone.0105210	http://dx.doi.org/10.1371/journal.pone.0105210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126760	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300095
J	Chen, YW; Huang, HS; Shieh, YS; Ma, KH; Huang, SH; Hueng, DY; Sytwu, HK; Lin, GJ				Chen, Yuan-Wu; Huang, Hsu-Shan; Shieh, Yi-Shing; Ma, Kuo-Hsing; Huang, Shing-Hwa; Hueng, Dueng-Yuan; Sytwu, Huey-Kang; Lin, Gu-Jiun			A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells In Vitro and In Vivo	PLOS ONE			English	Article							ANTHRACYCLINE ANTIBIOTICS; APOPTOSIS; ADRIAMYCIN; CARCINOMA; DAMAGE; IAP; MECHANISMS; EXPRESSION; INHIBITOR; P53	Objective: Oral squamous cell carcinoma (OSCC) is a prevalent cancer, especially in developing countries. Anthracyclines and their anthraquinone derivatives, such as doxorubicin, exhibit a cell growth inhibitory effect and have been used as anticancer drugs for many years. However, the cardiotoxicity of anthracycline antibiotics is a major concern in their clinical application. NSC745885 is a novel compound synthesized from 1,2-diaminoanthraquinone, which subsequently reacts with thionyl chloride and triethylamine. The present study aimed to investigate the anti-oral cancer potential and the safety of NSC745885. Methods: We investigated the anti-cancer potential of NSC745885 in oral squamous carcinoma cell lines and in an in vivo oral cancer xenograft mouse model. The expression of apoptotic related genes were evaluated by real-time RT-PCR and western bloting, and the in vivo assessment of apoptotic marker were measured by immunohistochemical staining. The anti-tumor efficiency and safety between doxorubicin and NSC745885 were also compared. Results: Our results demonstrated that NSC745885 exhibits anti-oral cancer activity through the induction of apoptosis in cancer cells and in tumor-bearing mice, and this treatment did not induce marked toxicity in experimental mice. This compound also exhibits a comparable anti-tumor efficiency and a higher safety in experimental mice when compared to doxorubicin. Conclusions: The data of this study provide evidence for NSC745885 as a potential novel therapeutic drug for the treatment of human OSCC.	[Chen, Yuan-Wu; Shieh, Yi-Shing] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Chen, Yuan-Wu] Triserv Gen Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Huang, Hsu-Shan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Ma, Kuo-Hsing; Huang, Shing-Hwa; Lin, Gu-Jiun] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Shing-Hwa] Triserv Gen Hosp, Dept Gen Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Sytwu, Huey-Kang] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Lin, GJ (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	lingujiun@mail.ndmctsgh.edu.tw	Hueng, Dueng-Yuan/AAM-7807-2021	Hueng, Dueng-Yuan/0000-0001-7868-3161; Huang, Hsu-Shan/0000-0001-8162-5608; Lin, Gu-Jiun/0000-0003-4302-8196	National Science Council, Taiwan, R.O.C. [NSC101-2320-B-016-016, NSC102-2314-B-016-018-MY3]; Tri-Service General Hospital, Republic of China [TSGH-C102-019, TSGH-C100-034, TSGH-C101-009-S06]; C.Y. Foundation for Advancement of Education, Science and Medicine	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Republic of China; C.Y. Foundation for Advancement of Education, Science and Medicine	This study was supported by research grants from the National Science Council, Taiwan, R.O.C. (NSC101-2320-B-016-016 to G.-J. Lin and NSC102-2314-B-016-018-MY3 to Y.-W. Chen), Tri-Service General Hospital, Republic of China (Grant No. TSGH-C102-019, TSGH-C100-034 and TSGH-C101-009-S06) and in part by the C.Y. Foundation for Advancement of Education, Science and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1997, CANCER LETT, V118, P101, DOI 10.1016/S0304-3835(97)00234-6; Bugger H, 2011, CANCER CHEMOTH PHARM, V67, P1381, DOI 10.1007/s00280-010-1441-7; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Daley Tom, 2003, J Can Dent Assoc, V69, P577; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee YT, 2005, CANCER LETT, V223, P19, DOI 10.1016/j.canlet.2004.09.048; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LING YH, 1993, CANCER RES, V53, P1845; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martschick A, 2009, ANTICANCER RES, V29, P2307; Meissner K, 2002, J HISTOCHEM CYTOCHEM, V50, P1351, DOI 10.1177/002215540205001008; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; SKLADANOWSKI A, 1993, BIOCHEM PHARMACOL, V46, P375, DOI 10.1016/0006-2952(93)90512-U; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; van Almen GC, 2011, J MOL CELL CARDIOL, V51, P318, DOI 10.1016/j.yjmcc.2011.05.010; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028335; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yoon KA, 2003, INT J MOL MED, V11, P343; Zucchi Riccardo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P151, DOI 10.2174/1568011033353434	32	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104703	10.1371/journal.pone.0104703	http://dx.doi.org/10.1371/journal.pone.0104703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127132	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300043
J	Pritchard, RE; Prassinos, AJ; Osborne, JD; Raviv, Z; Balish, MF				Pritchard, Rachel E.; Prassinos, Alexandre J.; Osborne, John D.; Raviv, Ziv; Balish, Mitchell F.			Reduction of Hydrogen Peroxide Accumulation and Toxicity by a Catalase from Mycoplasma iowae	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; VIRULENCE DETERMINANT; AVIAN MYCOPLASMA; MYCOIDES SC; PNEUMONIAE; GLYCEROL; METABOLISM; GALLISEPTICUM; CYTOTOXICITY; INFECTION	Mycoplasma iowae is a well-established avian pathogen that can infect and damage many sites throughout the body. One potential mediator of cellular damage by mycoplasmas is the production of H2O2 via a glycerol catabolic pathway whose genes are widespread amongst many mycoplasma species. Previous sequencing of M. iowae serovar I strain 695 revealed the presence of not only genes for H2O2 production through glycerol catabolism but also the first documented mycoplasma gene for catalase, which degrades H2O2. To test the activity of M. iowae catalase in degrading H2O2, we studied catalase activity and H2O2 accumulation by both M. iowae serovar K strain DK-CPA, whose genome we sequenced, and strains of the H2O2-producing species Mycoplasma gallisepticum engineered to produce M. iowae catalase by transformation with the M. iowae putative catalase gene, katE. H2O2-mediated virulence by M. iowae serovar K and catalase-producing M. gallisepticum transformants were also analyzed using a Caenorhabditis elegans toxicity assay, which has never previously been used in conjunction with mycoplasmas. We found that M. iowae katE encodes an active catalase that, when expressed in M. gallisepticum, reduces both the amount of H2O2 produced and the amount of damage to C. elegans in the presence of glycerol. Therefore, the correlation between the presence of glycerol catabolism genes and the use of H2O2 as a virulence factor by mycoplasmas might not be absolute.	[Pritchard, Rachel E.; Prassinos, Alexandre J.; Balish, Mitchell F.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Osborne, John D.] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Raviv, Ziv] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA	Miami University; University of Alabama System; University of Alabama Birmingham; Ohio State University	Balish, MF (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	balishmf@miamioh.edu	Osborne, John/F-3445-2016	Osborne, John/0000-0002-0851-1150	National Institutes of Health Public Service Grant [R15 AI073994]; Hybrid Turkeys, Kitchener, Ontario, Canada; Miami University Doctoral-Undergraduate Opportunities in Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI073994] Funding Source: NIH RePORTER	National Institutes of Health Public Service Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hybrid Turkeys, Kitchener, Ontario, Canada; Miami University Doctoral-Undergraduate Opportunities in Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (www.nih.gov) Public Service Grant R15 AI073994 to MFB, by funding from Hybrid Turkeys (www.hybridturkeys.com), Kitchener, Ontario, Canada to ZR, and by the Miami University Doctoral-Undergraduate Opportunities in Scholarship Program (miamioh.edu) to REP and AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo EM, 1998, VET MICROBIOL, V59, P109, DOI 10.1016/S0378-1135(97)00184-3; AlAnkari ARS, 1996, AVIAN PATHOL, V25, P205, DOI 10.1080/03079459608419137; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BANAI M, 1978, INFECT IMMUN, V21, P365, DOI 10.1128/IAI.21.2.365-372.1978; BARBER TL, 1971, APPL MICROBIOL, V21, P594, DOI 10.1128/AEM.21.4.594-599.1971; Berent LM, 2003, INFECT IMMUN, V71, P3657, DOI 10.1128/IAI.71.6.3657-3662.2003; BRADBURY JM, 1988, AVIAN PATHOL, V17, P149, DOI 10.1080/03079458808436435; BRADBURY JM, 1983, YALE J BIOL MED, V56, P912; BRENNAN PC, 1969, J BACTERIOL, V98, P1036, DOI 10.1128/JB.98.3.1036-1040.1969; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; do Nascimento NC, 2012, J BACTERIOL, V194, P1605, DOI 10.1128/JB.06781-11; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; GEOURJON C, 1995, COMPUT APPL BIOSCI, V13, P209; Grosshennig S, 2013, INFECT IMMUN, V81, P896, DOI [10.1128/IAI.01212, 10.1128/IAI.01212-12]; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; HEDREYDA CT, 1993, PLASMID, V30, P170, DOI 10.1006/plas.1993.1047; Hong Y, 2005, J CLIN MICROBIOL, V43, P909, DOI 10.1128/JCM.43.2.909-912.2005; Houshaymi BM, 1997, VET REC, V140, P182, DOI 10.1136/vr.140.7.182; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Johansson K.E., 2002, MOL BIOL PATHOGENICI; Jurkovic DA, 2012, J BACTERIOL, V194, P2877, DOI 10.1128/JB.00060-12; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Ley DH, 2010, AVIAN PATHOL, V39, P87, DOI 10.1080/03079451003599276; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martinez MA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-44; MIRSALIMI SM, 1989, AVIAN DIS, V33, P310, DOI 10.2307/1590849; Moy TI, 2004, INFECT IMMUN, V72, P4512, DOI 10.1128/IAI.72.8.4512-4520.2004; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Schmidl SR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002263; SHAHMAJID M, 1987, AVIAN DIS, V31, P365, DOI 10.2307/1590887; Shima S, 2001, APPL ENVIRON MICROB, V67, P3041, DOI 10.1128/AEM.67.7.3041-3045.2001; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Taylor RR, 1996, VET MICROBIOL, V51, P291, DOI 10.1016/0378-1135(96)00039-9; TRAMPEL DW, 1994, AVIAN DIS, V38, P905, DOI 10.2307/1592133; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Wei S, 2012, J BACTERIOL, V194, P547, DOI 10.1128/JB.06297-11; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zhang WB, 2014, J BACTERIOL, V196, P1012, DOI 10.1128/JB.00954-13	48	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105188	10.1371/journal.pone.0105188	http://dx.doi.org/10.1371/journal.pone.0105188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127127	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300091
J	Franceschi, V; Jacca, S; Sassu, EL; Stellari, FF; van Santen, VL; Donofrio, G				Franceschi, Valentina; Jacca, Sarah; Sassu, Elena L.; Stellari, Fabio F.; van Santen, Vicky L.; Donofrio, Gaetano			Generation and Characterization of the First Immortalized Alpaca Cell Line Suitable for Diagnostic and Immunization Studies	PLOS ONE			English	Article							HERPESVIRUS-4 BASED VECTOR; LLAMA LAMA-GLAMA; BOVINE HERPESVIRUS-4; VICUGNA-PACOS; NEOSPORA-CANINUM; AOTUS TYPE-2; IN-VITRO; INFECTION; VIRUS; TUBERCULOSIS	Raising of alpacas as exotic livestock for wool and meat production and as companion animals is growing in importance in the United States, Europe and Australia. Furthermore the alpaca, as well as the rest of the camelids, possesses the peculiarity of producing single-chain antibodies from which nanobodies can be generated. Nanobodies, due to their structural simplicity and reduced size, are very versatile in terms of manipulation and bio-therapeutic exploitation. In fact the biotech companies involved in nanobody production and application continue to grow in number and size. Hence, the development of reagents and tools to assist in the further growth of this new scientific and entrepreneurial reality is becoming a necessity. These are needed mainly to address alpaca disease diagnosis and prophylaxis, and to develop alpaca immunization strategies for nanobody generation. For instance an immortalized alpaca cell line would be extremely valuable. In the present work the first stabilized alpaca cell line from alpaca skin stromal cells (ASSCs) was generated and characterized. This cell line was shown to be suitable for replication of viruses bovine herpesvirus-1, bovine viral diarrhea virus and caprine herpesvirus-1 and the endocellular parasite Neospora caninum. Moreover ASSCs were easy to transfect and transduce by several methods. These two latter characteristics are extremely useful when recombinant antigens need to be produced in a host homologous system. This work could be considered as a starting point for the expansion of the biotechnologies linked to alpaca farming and industry.	[Franceschi, Valentina; Jacca, Sarah; Sassu, Elena L.; Stellari, Fabio F.; Donofrio, Gaetano] Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy; [van Santen, Vicky L.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	University of Parma; Auburn University System; Auburn University	Donofrio, G (corresponding author), Univ Parma, Dept Med Vet Sci, I-43100 Parma, Italy.	gaetano.donofrio@unipr.it	van Santen, Vicky/A-7098-2018; franceschi, valentina/AAR-5566-2020	van Santen, Vicky/0000-0002-0029-0517; franceschi, valentina/0000-0003-3945-2285; Donofrio, Gaetano/0000-0002-8984-0377	Italian Minister of the Education, University and Research [PRIN 2010LLXR94_004]	Italian Minister of the Education, University and Research	The authors would like to thank the Italian Minister of the Education, University and Research for the financial support (PRIN 2010LLXR94_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre IM, 2014, VET MICROBIOL, V168, P324, DOI 10.1016/j.vetmic.2013.11.034; AlKurashi M, 2011, VET PARASITOL, V177, P267, DOI 10.1016/j.vetpar.2010.11.053; BARAHONA HH, 1973, J INFECT DIS, V127, P171, DOI 10.1093/infdis/127.2.171; Bedenice D, 2011, J VET INTERN MED, V25, P605, DOI 10.1111/j.1939-1676.2011.0719.x; BUBLOT M, 1991, J GEN VIROL, V72, P715, DOI 10.1099/0022-1317-72-3-715; Chavez-Velasquez A, 2004, J PARASITOL, V90, P864, DOI 10.1645/GE-260R; Donofrio G, 2008, VACCINE, V26, P6031, DOI 10.1016/j.vaccine.2008.09.023; Donofrio G, 2004, J NEUROVIROL, V10, P123, DOI 10.1080/13550280490279780; Donofrio G, 2002, J VIROL METHODS, V101, P49, DOI 10.1016/S0166-0934(01)00419-0; Donofrio G, 2008, J VIROL METHODS, V148, P303, DOI 10.1016/j.jviromet.2007.12.006; Donofrio G, 2006, J VIROL METHODS, V136, P126, DOI 10.1016/j.jviromet.2006.04.008; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Donofrio G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052758; Donofrio G, 2011, VACCINE, V29, P867, DOI 10.1016/j.vaccine.2010.11.048; Donofrio G, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-73; Donofrio G, 2009, CLIN VACCINE IMMUNOL, V16, P1675, DOI 10.1128/CVI.00224-09; Donofrio G, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-68; Egyed L, 1997, VET MICROBIOL, V57, P283, DOI 10.1016/S0378-1135(97)00105-3; Elsheikha HM, 2006, VET PARASITOL, V135, P223, DOI 10.1016/j.vetpar.2005.09.014; Gidlewski T, 2000, VET PATHOL, V37, P77, DOI 10.1354/vp.37-1-77; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kadwell M, 2001, P ROY SOC B-BIOL SCI, V268, P2575, DOI 10.1098/rspb.2001.1774; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Martignani E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013372; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; MORENOLOPEZ J, 1989, J VET MED B, V36, P481, DOI 10.1111/j.1439-0450.1989.tb00633.x; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; POVLSEN CO, 1973, INT J CANCER, V11, P30, DOI 10.1002/ijc.2910110105; Rhodes S, 2012, CLIN VACCINE IMMUNOL, V19, P1677, DOI 10.1128/CVI.00405-12; Rogers AD, 2006, J ANIM SCI, V84, P2566, DOI 10.2527/jas.2006-106; Ryan EG, 2008, IRISH VET J, V61, P527, DOI 10.1186/2046-0481-61-8-527; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Sensebe L, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/678063; Serrano-Martinez E, 2007, VET PARASITOL, V150, P39, DOI 10.1016/j.vetpar.2007.08.048; Serrano-Martinez E, 2004, VET REC, V155, P748; Starnes A, 2007, VET REC, V160, P416, DOI 10.1136/vr.160.12.416; Stellari FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039716; Thys B, 2010, ANTIVIR RES, V87, P257, DOI 10.1016/j.antiviral.2010.05.012; Tibary A, 2006, THERIOGENOLOGY, V66, P633, DOI 10.1016/j.theriogenology.2006.04.008; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Wommack K. Eric, 2009, V501, P3, DOI 10.1007/978-1-60327-164-6_1; Zimmermann W, 2001, J VIROL, V75, P1186, DOI 10.1128/JVI.75.3.1186-1194.2001	46	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105643	10.1371/journal.pone.0105643	http://dx.doi.org/10.1371/journal.pone.0105643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140515	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200117
J	Schweigmann, U; Biliczki, P; Ramirez, RJ; Marschall, C; Takac, I; Brandes, RP; Kotzot, D; Girmatsion, Z; Hohnloser, SH; Ehrlich, JR				Schweigmann, Ulrich; Biliczki, Peter; Ramirez, Rafael J.; Marschall, Christoph; Takac, Ina; Brandes, Ralf P.; Kotzot, Dieter; Girmatsion, Zenawit; Hohnloser, Stefan H.; Ehrlich, Joachim R.			Elevated Heart Rate Triggers Action Potential Alternans and Sudden Death. Translational Study of a Homozygous KCNH2 Mutation	PLOS ONE			English	Article							LONG-QT-SYNDROME; HUMAN VENTRICULAR TISSUE; POTASSIUM CHANNEL; TRANSMURAL DISPERSION; HERG; REPOLARIZATION; ARRHYTHMIAS; DEFECTS; MODEL	Background: Long QT syndrome (LQTS) leads to arrhythmic events and increased risk for sudden cardiac death (SCD). Homozygous KCNH2 mutations underlying LQTS-2 have previously been termed "human HERG knockout'' and typically express severe phenotypes. We studied genotype-phenotype correlations of an LQTS type 2 mutation identified in the homozygous index patient from a consanguineous Turkish family after his brother died suddenly during febrile illness. Methods and Results: Clinical work-up, DNA sequencing, mutagenesis, cell culture, patch-clamp, in silico mathematical modelling, protein biochemistry, confocal microscopy were performed. Genetic analysis revealed a homozygous C-terminal KCNH2 mutation (p.R835Q) in the index patient (QTc similar to 506 ms with notched T waves). Parents were I-D cousins - both heterozygous for the mutation and clinically unremarkable (QTc similar to 447 ms, father and similar to 396 ms, mother). Heterologous expression of KCNH2-R835Q showed mildly reduced current amplitudes. Biophysical properties of ionic currents were also only nominally changed with slight acceleration of deactivation and more negative V-50 in R835Q-currents. Protein biochemistry and confocal microscopy revealed similar expression patterns and trafficking of WT and R835Q, even at elevated temperature. In silico analysis demonstrated mildly prolonged ventricular action potential duration (APD) compared to WT at a cycle length of 1000 ms. At a cycle length of 350 ms M-cell APD remained stable in WT, but displayed APD alternans in R835Q. Conclusion: Kv11.1 channels affected by the C-terminal R835Q mutation display mildly modified biophysical properties, but leads to M-cell APD alternans with elevated heart rate and could precipitate SCD under specific clinical circumstances associated with high heart rates.	[Schweigmann, Ulrich] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Biliczki, Peter; Girmatsion, Zenawit; Hohnloser, Stefan H.; Ehrlich, Joachim R.] Goethe Univ Frankfurt, Div Clin Electrophysiol, D-60054 Frankfurt, Germany; [Ramirez, Rafael J.] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Marschall, Christoph] Lab Human Genet, Martinsried, Germany; [Takac, Ina; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Kotzot, Dieter] Med Univ Innsbruck, Sect Human Genet, A-6020 Innsbruck, Austria; [Biliczki, Peter; Ehrlich, Joachim R.] Deutsch Klin Diagnost, Div Cardiol, Wiesbaden, Germany	Medical University of Innsbruck; Goethe University Frankfurt; University of Michigan System; University of Michigan; Goethe University Frankfurt; Medical University of Innsbruck	Ehrlich, JR (corresponding author), Goethe Univ Frankfurt, Div Clin Electrophysiol, D-60054 Frankfurt, Germany.	joachimehrlich@t-online.de	Brandes, Ralf P/L-3058-2017; Ramirez, Rafael J./AAI-7712-2020	Brandes, Ralf P/0000-0002-8035-0048; 	Else Kroner-Fresenius-Stiftung; Deutsche Stiftung fur Herzforschung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081080] Funding Source: NIH RePORTER	Else Kroner-Fresenius-Stiftung; Deutsche Stiftung fur Herzforschung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Joachim R. Ehrlich received funding from Else Kroner-Fresenius-Stiftung and Deutsche Stiftung fur Herzforschung. Administrative help from Gesellschaft zur Forderung der Forschung an der DKD is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2008, J CLIN INVEST, V118, P2552, DOI 10.1172/JCI35337; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x; Biliczki P, 2008, HEART RHYTHM, V5, P1159, DOI 10.1016/j.hrthm.2008.04.016; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Burashnikov A, 2008, CIRC-ARRHYTHMIA ELEC, V1, P202, DOI 10.1161/CIRCEP.107.691931; Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071; Crotti L, 2009, CIRCULATION, V120, P1657, DOI 10.1161/CIRCULATIONAHA.109.879643; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Hayashi K, 2010, HEART RHYTHM, V7, P973, DOI 10.1016/j.hrthm.2010.03.038; Hoorntje T, 1999, CIRCULATION, V100, P1264, DOI 10.1161/01.CIR.100.12.1264; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Johnson WH, 2003, PEDIATR RES, V53, P744, DOI 10.1203/01.PDR.0000059750.17002.B6; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Piippo K, 2000, J AM COLL CARDIOL, V35, P1919, DOI 10.1016/S0735-1097(00)00636-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Teng GQ, 2008, CIRC RES, V103, P1483, DOI 10.1161/CIRCRESAHA.108.177055; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; ZAREBA W, 1994, J AM COLL CARDIOL, V23, P1541, DOI 10.1016/0735-1097(94)90653-X; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103150	10.1371/journal.pone.0103150	http://dx.doi.org/10.1371/journal.pone.0103150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140878	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200004
J	Brown, RM; Weghorst, JA; Olson, KV; Duya, MRM; Barley, AJ; Duya, MV; Shekelle, M; Neri-Arboleda, I; Esselstyn, JA; Dominy, NJ; Ong, PS; Moritz, GL; Luczon, A; Diesmos, MLL; Diesmos, AC; Siler, CD				Brown, Rafe M.; Weghorst, Jennifer A.; Olson, Karen V.; Duya, Mariano R. M.; Barley, Anthony J.; Duya, Melizar V.; Shekelle, Myron; Neri-Arboleda, Irene; Esselstyn, Jacob A.; Dominy, Nathaniel J.; Ong, Perry S.; Moritz, Gillian L.; Luczon, Adrian; Diesmos, Mae Lowe L.; Diesmos, Arvin C.; Siler, Cameron D.			Conservation Genetics of the Philippine Tarsier: Cryptic Genetic Variation Restructures Conservation Priorities for an Island Archipelago Primate	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; SPECIES DELIMITATION; INFERENCE; MODEL; BIODIVERSITY; MARKERS; DIVERSIFICATION; INDIVIDUALS; SYSTEMATICS	Establishment of conservation priorities for primates is a particular concern in the island archipelagos of Southeast Asia, where rates of habitat destruction are among the highest in the world. Conservation programs require knowledge of taxonomic diversity to ensure success. The Philippine tarsier is a flagship species that promotes environmental awareness and a thriving ecotourism economy in the Philippines. However, assessment of its conservation status has been impeded by taxonomic uncertainty, a paucity of field studies, and a lack of vouchered specimens and genetic samples available for study in biodiversity repositories. Consequently, conservation priorities are unclear. In this study we use mitochondrial and nuclear DNA to empirically infer geographic partitioning of genetic variation and to identify evolutionarily distinct lineages for conservation action. The distribution of Philippine tarsier genetic diversity is neither congruent with expectations based on biogeographical patterns documented in other Philippine vertebrates, nor does it agree with the most recent Philippine tarsier taxonomic arrangement. We identify three principal evolutionary lineages that do not correspond to the currently recognized subspecies, highlight the discovery of a novel cryptic and range-restricted subcenter of genetic variation in an unanticipated part of the archipelago, and identify additional geographically structured genetic variation that should be the focus of future studies and conservation action. Conservation of this flagship species necessitates establishment of protected areas and targeted conservation programs within the range of each genetically distinct variant of the Philippine tarsier.	[Brown, Rafe M.; Weghorst, Jennifer A.; Olson, Karen V.; Barley, Anthony J.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Brown, Rafe M.; Olson, Karen V.; Barley, Anthony J.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Duya, Mariano R. M.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Duya, Melizar V.] Univ Philippines Diliman, Diliman Sci Res Fdn Inc, Quezon City, Philippines; [Shekelle, Myron] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Neri-Arboleda, Irene] Thomas Glen Erin Anim Hosp, Mississauga, ON, Canada; [Esselstyn, Jacob A.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Esselstyn, Jacob A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Ong, Perry S.; Luczon, Adrian] Univ Philippines, Inst Biol, Quezon City 1101, Philippines; [Moritz, Gillian L.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Diesmos, Mae Lowe L.] Univ Santo Tomas, Manila, Philippines; [Diesmos, Arvin C.] Philippine Natl Museum, Div Zool, Herpetol Sect, Manila, Philippines; [Siler, Cameron D.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Siler, Cameron D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Kansas; University of Kansas; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman; Ewha Womans University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Dartmouth College; University of the Philippines System; University of the Philippines Diliman; Dartmouth College; University of Santo Tomas; National Museum of the Philippines; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Brown, RM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	rafe@ku.edu	Diesmos, Mae Lowe/AGG-8517-2022; Dominy, Nathaniel Jay/A-6151-2013; Diesmos, Arvin C./AGG-8542-2022; Duya, Mariano Roy/AFK-6305-2022	Dominy, Nathaniel Jay/0000-0001-5916-418X; Duya, Mariano Roy/0000-0002-7643-293X; Esselstyn, Jacob/0000-0002-1823-4062; Ong, Perry/0000-0002-1597-1921	University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology; National Geographic Society [NGS 8446-08]; Primate Action Fund; Ewha Womans University; David and Lucile Packard Foundation [2007-31754]; U.S. National Science Foundation [DEB 0743491]; Division Of Environmental Biology [0743491] Funding Source: National Science Foundation	University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology; National Geographic Society(National Geographic Society); Primate Action Fund; Ewha Womans University; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for fieldwork was provided by the University of Kansas Biodiversity Institute and Department of Ecology and Evolutionary Biology (to RMB, CDS, and JAE), the National Geographic Society (NGS 8446-08 to RMB, JAW, MS and INA), funds from the Primate Action Fund (to MS), Ewha Womans University (Ewha Global Top5 Grant 2013 to MS), the David and Lucile Packard Foundation (Fellowship in Science and Engineering no. 2007-31754, to NJD), and U.S. National Science Foundation (DEB 0743491 to RMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Bearder SK, 1999, PRIMATES, V40, P267, DOI 10.1007/BF02557715; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Brook BW, 2002, CONSERV ECOL, V6; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; BROWN RM, 2009, ENCY ISLANDS, P723; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Dagosto M, 2003, RUT HUM EVO, P237; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esselstyn JA, 2008, J MAMMAL, V89, P815, DOI 10.1644/07-MAMM-A-285.1; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2003, EVOLUTION, V57, P1436; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Groves C, 1998, PRIMATES, V39, P13, DOI 10.1007/BF02557740; Groves C.P., 2001, PRIMATE TAXONOMY; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HILL WCO, 1955, PRIMATES COMP ANATOM, V2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; MADDISON D, 2005, MACCLADE ANAL PHYLOG; Melnick DJ, 1999, NATURE HUMAN SOC QUE, P264; Merker S, 2007, MOL ECOL NOTES, V7, P1216, DOI 10.1111/j.1471-8286.2007.01836.x; Merker S, 2008, CONSERV GENET, V9, P1349, DOI 10.1007/s10592-007-9487-8; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Niemitz C., 1984, P1; Posa MRC, 2008, BIOSCIENCE, V58, P231, DOI 10.1641/B580309; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER V 1 4; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shekelle M, 2008, IUCN 2014 IUCN RED L; Shekelle M, 2013, HDB MAMMALS WORLD, V3, P63; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Spinks PQ, 2010, CONSERV GENET RESOUR, V2, P127, DOI 10.1007/s12686-010-9184-7; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324	53	23	24	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104340	10.1371/journal.pone.0104340	http://dx.doi.org/10.1371/journal.pone.0104340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136854	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100029
J	de Souza, FM; do Prado, TN; Pinheiro, JD; Peres, RL; Lacerda, TC; Loureiro, RB; Carvalho, JA; Fregona, G; Dias, ES; Cosme, LB; Rodrigues, RR; Riley, LW; Maciel, ELN				de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Pinheiro, Jair dos Santos; Peres, Renata Lyrio; Lacerda, Thamy Carvalho; Loureiro, Rafaela Borge; Carvalho, Jose Americo; Fregona, Geisa; Dias, Elias Santos; Cosme, Lorrayne Beliqui; Rodrigues, Rodrigo Ribeiro; Riley, Lee Wood; Noia Maciel, Ethel Leonor			Comparison of Interferon-gamma Release Assay to Two Cut-Off Points of Tuberculin Skin Test to Detect Latent Mycobacterium tuberculosis Infection in Primary Health Care Workers	PLOS ONE			English	Article							QUANTIFERON-TB-GOLD; HOUSEHOLD CONTACTS; TEST POSITIVITY; TUBE ASSAY; RISK; DIAGNOSIS; CONVERSIONS; DISCORDANCE; PREDICTORS; DISEASE	Background: An interferon-gamma release assay, QuantiFERON-TB (QFT) test, has been introduced an alternative test for the diagnosis of latent Mycobacterium tuberculosis infection LTBI). Here, we compared the performance of QFT with tuberculin skin test (TST) measured at two different cut-off points among primary health care work (HCW) in Brazil. Methods: A cross-sectional study was carried out among HCWs in four Brazilian cities with a known history of high incidence of TB. Results of the QFT were compared to TST results based on both >= 5 mm and >= 10 mm as cut-off points. Results: We enrolled 632 HCWs. When the cut-off value of >= 10 mm was used, agreement between QFT and TST was 69% (k = 0.31), and when the cut-off of >= 5 mm was chosen, the agreement was 57% (k = 0.22). We investigated possible factors of discordance of TST vs QFT. Compared to the TST2/QFT2 group, risk factors for discordance in the TST+/QFT2 group with TST cut-off of $ 5 mm included age between 41-45 years [OR = 2.70; CI 95%: 1.32-5.51] and 46-64 years [OR = 2.04; CI 95%: 1.05-3.93], BCG scar [OR = 2.72; CI 95%: 1.40-5.25], and having worked only in primary health care [OR = 2.30; CI 95%: 1.09-4.86]. On the other hand, for the cut-off of $ 10 mm, BCG scar [OR = 2.26; CI 95%: 1.03-4.91], being a household contact of a TB patient [OR = 1.72; CI 95%: 1.01-2.92] and having had a previous TST [OR = 1.66; CI 95%: 1.05-2.62], were significantly associated with the TST+/QFT2 group. No statistically significant associations were found among the TST2/QFT+ discordant group with either TST cut-off value. Conclusions: Although we identified BCG vaccination to contribute to the discordance at both TST cut-off measures, the current Brazilian recommendation for the initiation of LTBI treatment, based on information gathered from medical history, TST, chest radiograph and physical examination, should not be changed.	[de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Peres, Renata Lyrio; Lacerda, Thamy Carvalho; Loureiro, Rafaela Borge; Fregona, Geisa; Dias, Elias Santos; Cosme, Lorrayne Beliqui; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil; [de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Peres, Renata Lyrio; Rodrigues, Rodrigo Ribeiro] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil; [Lacerda, Thamy Carvalho; Fregona, Geisa; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil; [Carvalho, Jose Americo; Fregona, Geisa] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Programa Controle TB, Vitoria, ES, Brazil; [Riley, Lee Wood] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Pinheiro, Jair dos Santos] Secretaria Municipal Saude, Nucleo Controle TB, Manaus, Amazonas, Brazil; [Loureiro, Rafaela Borge] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, BR-20550011 Rio De Janeiro, Brazil; [Dias, Elias Santos; Cosme, Lorrayne Beliqui] Univ Fed Espirito Santo, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; University of California System; University of California Berkeley; Universidade do Estado do Rio de Janeiro; Universidade Federal do Espirito Santo	Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.	ethel.maciel@gmail.com	Pinheiro, Jair/AAE-5785-2019; Ribeiro-Rodrigues, Rodrigo/AAY-7820-2020; Maciel, Ethel Leonor LN/G-1027-2012	Ribeiro-Rodrigues, Rodrigo/0000-0002-0675-110X; Maciel, Ethel Leonor LN/0000-0003-4826-3355; Nascimento do Prado, Thiago/0000-0001-8132-6288	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) MCT/CNPq - Universal [14/2009]; FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo) [012/11]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) MCT/CNPq - Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)	This study was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) MCT/CNPq No. 14/2009 - Universal and the FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo) according to the Universal 012/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], ARQ CIENC SAUDE; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Brasil, SECR VIG SAD MIN SAD, P2022; Canada, 2010, RECOMMENDATIONS INTE; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Cook S, 2003, INFECT CONT HOSP EP, V24, P807, DOI 10.1086/502141; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010; Florence CS, 2006, HEALTH SERV RES, V41, P1741, DOI 10.1111/j.1475-6773.2006.00580.x; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI 10.1590/S0034-89102010000200014; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; Reichman LB, 2008, GUIDELINES DIAGNOSIS; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335; Saleiro Sandra, 2007, Rev Port Pneumol, V13, P789; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010; Sociedade Brasileira de Pneumologia e Tisiologia, 2004, J BRAS PNEUMOL, V30, P86; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; Tuuminen T, 2013, CLIN VACCINE IMMUNOL, V20, P1778, DOI 10.1128/CVI.00476-13; United States of America, 2010, UPD GUID US INT GAMM; Wang L, 2003, THORAX, V58, P188; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhao XR, 2009, AM J CLIN PATHOL, V132, P678, DOI 10.1309/AJCPUHC34NBDGKKL; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	45	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102773	10.1371/journal.pone.0102773	http://dx.doi.org/10.1371/journal.pone.0102773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137040	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100004
J	Tang, T; Li, X; Yang, X; Yu, X; Wang, JH; Liu, FS; Huang, DW				Tang, Ting; Li, Xiang; Yang, Xue; Yu, Xue; Wang, Jianhui; Liu, Fengsong; Huang, Dawei			Transcriptional Response of Musca domestica Larvae to Bacterial Infection	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; INNATE IMMUNE-SYSTEM; MOLECULAR-CLONING; GENE-EXPRESSION; RECOGNITION PROTEINS; SCAVENGER RECEPTORS; BINDING-PROTEIN; RNA-SEQ; DROSOPHILA; LYSOZYME	The house fly Musca domestica, a cosmopolitan dipteran insect, is a significant vector for human and animal bacterial pathogens, but little is known about its immune response to these pathogens. To address this issue, we inoculated the larvae with a mixture of Escherichia coli and Staphylococcus aureus and profiled the transcriptome 6, 24, and 48 h thereafter. Many genes known to controlling innate immunity in insects were induced following infection, including genes encoding pattern recognition proteins (PGRPs), various components of the Toll and IMD signaling pathways and of the proPO-activating and redox systems, and multiple antimicrobial peptides. Interestingly, we also uncovered a large set of novel immune response genes including two broad-spectrum antimicrobial peptides (muscin and domesticin), which might have evolved to adapt to house-fly's unique ecological environments. Finally, genes mediating oxidative phosphorylation were repressed at 48 h post-infection, suggesting disruption of energy homeostasis and mitochondrial function at the late stages of infection. Collectively, our data reveal dynamic changes in gene expression following bacterial infection in the house fly, paving the way for future in-depth analysis of M. domestica's immune system.	[Tang, Ting; Li, Xiang; Yang, Xue; Yu, Xue; Liu, Fengsong; Huang, Dawei] Hebei Univ, Coll Life Sci, Baoding, Peoples R China; [Wang, Jianhui] Yale Univ, Dept Pathol, New Haven, CT USA; [Huang, Dawei] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Hebei University; Yale University; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, FS (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Peoples R China.	liufengsong@hbu.edu.cn; huangdw@ioz.ac.cn		wang, jianhui/0000-0002-6261-4863	Natural Science Foundation of China [31101669, 31301925]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20101301120005]; Natural Science Foundation of Hebei Province [C2011201027]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was financially supported by Natural Science Foundation of China (31101669, 31301925), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20101301120005), and Natural Science Foundation of Hebei Province (No. C2011201027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Beresford PJ, 1997, DEV COMP IMMUNOL, V21, P253, DOI 10.1016/S0145-305X(97)00011-6; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; BULET P, 1993, J BIOL CHEM, V268, P14893; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gao Y, 2000, INSECT MOL BIOL, V9, P553, DOI 10.1046/j.1365-2583.2000.00216.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; ITO Y, 1995, J BIOCHEM-TOKYO, V118, P546, DOI 10.1093/oxfordjournals.jbchem.a124943; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael J Morgan, 2011, Cell Research, V21, P103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nayduch D, 2013, J MED ENTOMOL, V50, P847, DOI 10.1603/ME12167; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Sackton TB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000797; Scott JG, 2009, J MED ENTOMOL, V46, P175, DOI 10.1603/033.046.0202; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang T, 2012, GENE, V505, P211, DOI 10.1016/j.gene.2012.06.025; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	57	25	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104867	10.1371/journal.pone.0104867	http://dx.doi.org/10.1371/journal.pone.0104867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137050	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100049
J	Hu, SX; Rotschafer, JH; Lokensgard, JR; Cheeran, MCJ				Hu, Shuxian; Rotschafer, Jessica H.; Lokensgard, James R.; Cheeran, Maxim C-J.			Activated CD8(+) T Lymphocytes Inhibit Neural Stem/Progenitor Cell Proliferation: Role of Interferon-Gamma	PLOS ONE			English	Article							EXPERIMENTAL HERPES-ENCEPHALITIS; STEM-CELLS; ADULT BRAIN; IMMUNE CELLS; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; NEUROGENESIS; INJURY; EXPRESSION; STROKE	The ability of neural stem/progenitor cells (NSCs) to self-renew, migrate to damaged sites, and differentiate into neurons has renewed interest in using them in therapies for neurodegenerative disorders. Neurological diseases, including viral infections of the brain, are often accompanied by chronic inflammation, whose impact on NSC function remains unexplored. We have previously shown that chronic neuroinflammation, a hallmark of experimental herpes simplex encephalitis (HSE) in mice, is dominated by brain-infiltrating activated CD8 T-cells. In the present study, activated CD8 lymphocytes were found to suppress NSC proliferation profoundly. Luciferase positive (luc(+)) NSCs co-cultured with activated, MHC-matched, CD8(+) lymphocytes (luc(-)) showed two-to five-fold lower luminescence than co-cultures with unstimulated lymphocytes. On the other hand, similarly activated CD4(+) lymphocytes did not suppress NSC growth. This differential lymphocyte effect on proliferation was confirmed by decreased BrdU uptake by NSC cultured with activated CD8 T-cells. Interestingly, neutralizing antibodies to interferon-gamma (IFN-gamma) reversed the impact of CD8 lymphocytes on NSCs. Antibodies specific to the IFN-gamma receptor-1 subunit complex abrogated the inhibitory effects of both CD8 lymphocytes and IFN-gamma, indicating that the inhibitory effect of these cells was mediated by IFN-gamma in a receptor-specific manner. In addition, activated CD8 lymphocytes decreased levels of nestin and Sox2 expression in NSCs while increasing GFAP expression, suggesting possible induction of an altered differentiation state. Furthermore, NSCs obtained from IFN-gamma receptor-1 knock-out embryos were refractory to the inhibitory effects of activated CD8(+) T lymphocytes on cell proliferation and Sox2 expression. Taken together, the studies presented here demonstrate a role for activated CD8 T-cells in regulating NSC function mediated through the production of IFN-gamma. This cytokine may influence neuro-restorative processes and ultimately contribute to the long-term sequelae commonly seen following herpes encephalitis.	[Hu, Shuxian; Lokensgard, James R.; Cheeran, Maxim C-J.] Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Rotschafer, Jessica H.; Cheeran, Maxim C-J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cheeran, MCJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA.	cheeran@umn.edu	Cheeran, Maxim C-J/C-2135-2009	Cheeran, Maxim C-J/0000-0002-5331-4746	National Institutes of Health (NIH) [RO1 NS065817, RO1 MH066703, RO1 NS038836, T32 DA007097]; AHC Faculty Development Grant, University of Minnesota; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836, R01NS065817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007097] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHC Faculty Development Grant, University of Minnesota; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded in part by National Institutes of Health (NIH) grants RO1 NS065817, RO1 MH066703, RO1 NS038836, and T32 DA007097, and the AHC Faculty Development Grant, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Armien AG, 2010, BRAIN PATHOL, V20, P738, DOI 10.1111/j.1750-3639.2009.00354.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Chaitanya GV, 2010, NEUROSCIENCE, V165, P1203, DOI 10.1016/j.neuroscience.2009.10.067; Cheeran MCJ, 2008, J NEUROVIROL, V14, P437, DOI 10.1080/13550280802356845; Cheeran MCJ, 2005, J NEUROSCI RES, V82, P839, DOI 10.1002/jnr.20682; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez-Perez O, 2012, NEUROSCIENCE, V226, P270, DOI 10.1016/j.neuroscience.2012.08.053; Gonzalez-Perez Oscar, 2010, J Stem Cells, V5, P23, DOI jsc.2010.5.1.23; Gonzalez-Perez Oscar, 2010, Current Immunology Reviews, V6, P167; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G., 2011, ADULT NEUROGENESIS, V2nd ed.; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Li L, 2010, J NEUROSCI, V30, P9038, DOI 10.1523/JNEUROSCI.5691-09.2010; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Ling CY, 2003, J NEUROIMMUNOL, V141, P90, DOI 10.1016/S0165-5728(03)00249-2; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Lynch MA, 2012, BRAIN BEHAV IMMUN, V26, P1, DOI 10.1016/j.bbi.2011.05.013; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; McGowan PO, 2011, BRAIN RES, V1383, P187, DOI 10.1016/j.brainres.2011.02.054; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mutnal MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033143; Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; Rotschafer JH, 2013, NEUROBIOL DIS, V58, P144, DOI 10.1016/j.nbd.2013.05.018; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Sekeljic V, 2012, BRAIN STRUCT FUNCT, V217, P411, DOI 10.1007/s00429-011-0336-7; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Thiel Gerald, 2013, Biochem J, V450, pe1, DOI 10.1042/BJ20130176; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Walter J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00052; Walter J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-18; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	60	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105219	10.1371/journal.pone.0105219	http://dx.doi.org/10.1371/journal.pone.0105219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133679	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700090
J	Mineshita, M; Kida, H; Nishine, H; Handa, H; Inoue, T; Miyazawa, T				Mineshita, Masamichi; Kida, Hirotaka; Nishine, Hiroki; Handa, Hiroshi; Inoue, Takeo; Miyazawa, Teruomi			Left and Right Lung Asynchrony as a Physiological Indicator for Unilateral Bronchial Obstruction in Interventional Bronchoscopy	PLOS ONE			English	Article							CENTRAL AIRWAY-OBSTRUCTION; PULMONARY-DISEASE; TRACHEOBRONCHIAL STENOSIS; REGIONAL VENTILATION; BREATH SOUNDS; STENTS; DIAGNOSIS; CT	Background: In patients with bronchial obstruction, pulmonary function tests may not change significantly after intervention. The airflow asynchrony in both lungs due to unilateral bronchial obstruction may be applicable as a physiological indicator. The airflow asynchrony is reflected by the difference in the left and right lung sound development at tidal breathing. Objectives: To investigate the usefulness of left and right lung asynchrony due to unilateral bronchial obstruction as a physiological indicator for interventional bronchoscopy. Methods: Fifty cases with central airway obstruction were classified into three groups: tracheal, bronchial and extensive obstruction. The gap index was defined as the absolute value of the average of gaps between the left and right lung sound intensity peaks for a 12-second duration. Results: Before interventional bronchoscopy, the gap index was significantly higher in the bronchial (p < 0.05) and extensive obstruction groups (p < 0.05) than in the tracheal group. The gap index in cases with unilateral bronchial obstruction of at least 80% (0.18=0.04 seconds) was significantly higher than in cases with less than 80% obstruction (0.02=0.01 seconds, p < 0.05). After intervention for bronchial obstruction, the dyspnea scale (p < 0.001) and gap index significantly improved (p < 0.05), although no significant improvements were found in spirometric assessments. The responder rates for dyspnea were 79.3% for gap indexes over 0.06 seconds and 55.6% for gap indexes of 0.06 seconds or under. Conclusions: Assessment of left and right lung asynchrony in central airway obstruction with bronchial involvement may provide useful physiological information for interventional bronchoscopy.	[Mineshita, Masamichi; Kida, Hirotaka; Nishine, Hiroki; Handa, Hiroshi; Inoue, Takeo; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan	Saint Marianna University	Mineshita, M (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan.	m-mine@marianna-u.ac.jp			Japan Society for the Promotion of Science [24591143]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) Grant number (24591143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker HD, 2009, RESPIRATION, V77, P179, DOI 10.1159/000182972; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dellinger RP, 2007, CRIT CARE, V11, DOI 10.1186/cc5706; Doi M, 1999, J BRONCHOL, V6, P155; DUMON JF, 1990, CHEST, V97, P328, DOI 10.1378/chest.97.2.328; Ernst A, 2004, AM J RESP CRIT CARE, V169, P1278, DOI 10.1164/rccm.200210-1181SO; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Handa H, 2014, RESP CARE, V59, P231, DOI 10.4187/respcare.02094; Handa H, 2012, RESP CARE, V57, P634, DOI 10.4187/respcare.01363; Herth F, 2001, CHEST, V119, P1910, DOI 10.1378/chest.119.6.1910; Maher TM, 2008, THORAX, V63, P542, DOI 10.1136/thx.2007.086405; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Mineshita M, 2014, RESPIR INVESTIG, V52, P28, DOI 10.1016/j.resinv.2013.05.008; Mineshita M, 2014, RESPIRATION, V87, P45, DOI 10.1159/000350228; Miyazawa T, 1998, Respirology, V3, P229, DOI 10.1111/j.1440-1843.1998.tb00127.x; Miyazawa T, 2000, CHEST, V118, P959, DOI 10.1378/chest.118.4.959; Miyazawa T, 2004, AM J RESP CRIT CARE, V169, P1096, DOI 10.1164/rccm.200311-1784OC; Miyazu Y, 2003, CHEST, V124, P2393, DOI 10.1378/chest.124.6.2393; Nishine H, 2012, AM J RESP CRIT CARE, V185, P24, DOI 10.1164/rccm.201104-0701OC; Oki M, 2012, EUR RESPIR J, V40, P1483, DOI 10.1183/09031936.00015012; Park EA, 2010, RADIOLOGY, V256, P985, DOI 10.1148/radiol.10091502; PLOYSONGSANG Y, 1978, AM REV RESPIR DIS, V117, P657; PLOYSONGSANG Y, 1977, AM REV RESPIR DIS, V116, P187; Ryu YJ, 2006, EUR RESPIR J, V28, P1029, DOI 10.1183/09031936.00020906; Saad CP, 2003, CHEST, V124, P1993, DOI 10.1378/chest.124.5.1993; Seijo LM, 2001, NEW ENGL J MED, V344, P740, DOI 10.1056/NEJM200103083441007; Shi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086638; Wang Z, 2008, J ASTHMA, V45, P575, DOI 10.1080/02770900802017744; Wang Z, 2009, RESPIRATION, V77, P134, DOI 10.1159/000178023; Yigla M, 2008, AM J ROENTGENOL, V191, P845, DOI 10.2214/AJR.07.3151	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105327	10.1371/journal.pone.0105327	http://dx.doi.org/10.1371/journal.pone.0105327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133760	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700100
J	Gharib, SA; Pippin, JW; Ohse, T; Pickering, SG; Krofft, RD; Shankland, SJ				Gharib, Sina A.; Pippin, Jeffrey W.; Ohse, Takamoto; Pickering, Scott G.; Krofft, Ronald D.; Shankland, Stuart J.			Transcriptional Landscape of Glomerular Parietal Epithelial Cells	PLOS ONE			English	Article							DE-NOVO EXPRESSION; PODOCYTE PROTEINS; RETINOIC ACID; IN-VITRO; KIDNEY; REGENERATION; PAX8; DIFFERENTIATION; NEPHROPATHY; MICROARRAY	Very little is known about the function of glomerular parietal epithelial cells (PECs). In this study, we performed genome-wide expression analysis on PEC-enriched capsulated vs. PEC-deprived decapsulated rat glomeruli to determine the transcriptional state of PECs under normal conditions. We identified hundreds of differentially expressed genes that mapped to distinct biologic modules including development, tight junction, ion transport, and metabolic processes. Since developmental programs were highly enriched in PECs, we characterized several of their candidate members at the protein level. Collectively, our findings confirm that PECs are multifaceted cells and help define their diverse functional repertoire.	[Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Computat Med Core, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Pippin, Jeffrey W.; Pickering, Scott G.; Krofft, Ronald D.; Shankland, Stuart J.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Ohse, Takamoto] Univ Tokyo, Div Nephrol, Tokyo, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo	Gharib, SA (corresponding author), Univ Washington, Ctr Lung Biol, Computat Med Core, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	sagharib@u.washington.edu		GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) [DK056799, DK083391]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056799, R01DK083391] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) grants DK056799, DK083391, and the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Arakawa M, 1977, Contrib Nephrol, V6, P73; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Chen P, 2013, AM J PATHOL, V183, P1405, DOI 10.1016/j.ajpath.2013.07.007; GAUTHIER VJ, 1988, KIDNEY INT, V33, P897, DOI 10.1038/ki.1988.82; Gharib SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037669; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Guhr SSO, 2013, KIDNEY INT, V84, P532, DOI 10.1038/ki.2013.115; Hauser PV, 2009, NEPHRON EXP NEPHROL, V112, pE43, DOI 10.1159/000213505; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kabgani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034907; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Marlier A, 2004, GENE EXPR PATTERNS, V5, P179, DOI 10.1016/j.modgep.2004.08.005; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Ohse T, 2010, AM J PHYSIOL-RENAL, V298, pF702, DOI 10.1152/ajprenal.00428.2009; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Ohse T, 2009, KIDNEY INT, V76, P1225, DOI 10.1038/ki.2009.386; Paul R, 1997, CANCER RES, V57, P2741; Peired A, 2013, J AM SOC NEPHROL, V24, P1756, DOI 10.1681/ASN.2012090950; Petermann AT, 2002, KIDNEY INT, V61, P40, DOI 10.1046/j.1523-1755.2002.00102.x; Pitera JE, 2008, HUM MOL GENET, V17, P3953, DOI 10.1093/hmg/ddn297; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2013, CURR OPIN NEPHROL HY; Smeets B, 2009, J AM SOC NEPHROL, V20, P2593, DOI 10.1681/ASN.2009020132; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tong GX, 2009, MODERN PATHOL, V22, P1218, DOI 10.1038/modpathol.2009.88; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; XIANG YY, 1994, CANCER RES, V54, P3034; Zhang J, 2012, AM J PHYSIOL-RENAL, V302, pF571, DOI 10.1152/ajprenal.00516.2011	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105289	10.1371/journal.pone.0105289	http://dx.doi.org/10.1371/journal.pone.0105289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127402	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300101
J	Nayak, MK; Dash, A; Singh, N; Dash, D				Nayak, Manasa K.; Dash, Ayusman; Singh, Nitesh; Dash, Debabrata			Aspirin Delimits Platelet Life Span by Proteasomal Inhibition	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRIMARY PREVENTION; CELL-CYCLE; SUBUNIT INTERACTIONS; INDUCED APOPTOSIS; INDUCE APOPTOSIS; CYTOCHROME-C; CANCER CELLS; ACTIVATION; RISK	Aspirin is widely used in clinical settings as an anti-inflammatory and anti-platelet drug due its inhibitory effect on cyclooxygenase activity. Although the drug has long been considered to be an effective and safe therapeutic regime against inflammatory and cardiovascular disorders, consequences of its cyclooxygenase-independent attributes on platelets, the key players in thrombogenesis, beg serious investigation. In this report we explored the effect of aspirin on platelet lifespan in murine model and its possible cytotoxicity against human platelets in vitro. Aspirin administration in mice led to significant reduction in half-life of circulating platelets, indicative of enhanced rate of platelet clearance. Aspirin-treated human platelets were found to be phagocytosed more efficiently by macrophages, associated with attenuation in platelet proteasomal activity and upregulation of conformationally active Bax, which were consistent with enhanced platelet apoptosis. Although the dosage of aspirin administered in mice was higher than the therapeutic regimen against cardiovascular events, it is comparable with the recommended anti-inflammatory prescription. Thus, above observations provide cautionary framework to critically re-evaluate prophylactic and therapeutic dosage regime of aspirin in systemic inflammatory as well as cardiovascular ailments.	[Nayak, Manasa K.; Singh, Nitesh; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India; [Dash, Ayusman] Indian Inst Sci Educ & Res, Kolkata, India	Banaras Hindu University (BHU); Indian Institute of Science Education & Research (IISER) - Kolkata	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddash.biochem@gmail.com	DASH, DEBABRATA/AAF-1837-2020; Dash, Ayusman/GLV-4745-2022; Nayak, Manasa/AAZ-9439-2021; SINGH, NITESH/GRS-3129-2022	Dash, Ayusman/0000-0003-1394-3174; SINGH, NITESH/0000-0002-1345-1148; Nayak, Manasa/0000-0001-6461-0543	Department of Biotechnology (DBT); Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); DBT	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This research was supported by grants received by D. Dash from the Department of Biotechnology (DBT)(http://dbtindia.nic.in/index.asp) and the Department of Science and Technology (DST)(http://www.dst.gov.in), Government of India, the Council of Scientific and Industrial Research (CSIR)(http://www.csir.res.in/), and the Indian Council of Medical Research (ICMR)(http://www.icmr.nic.in). D. Dash thankfully acknowledges Tata Innovation Fellowship grant received from DBT for carrying out this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2005, J BIOL CHEM, V280, P39716, DOI 10.1074/jbc.M507762200; Algra A, 2009, LANCET, V373, P1821, DOI 10.1016/S0140-6736(09)61003-5; [Anonymous], 1988, BRIT MED J, V296, P316; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Dreser M. H., 1970, PFLUGERS ARCH, V76, P306, DOI [10.1007/bf01662127, DOI 10.1007/BF01662127]; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Glickman MH, 2000, SEMIN CELL DEV BIOL, V11, P149, DOI 10.1006/scdb.2000.0161; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Gupta RA, 1998, GASTROENTEROLOGY, V114, P1095, DOI 10.1016/S0016-5085(98)70330-0; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Ho CC, 2003, EUR J CLIN INVEST, V33, P875, DOI 10.1046/j.1365-2362.2003.01240.x; Hu YZ, 2013, INT J CLIN PHARM TH, V51, P228, DOI 10.5414/CP201808; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; Kuku I, 2012, J HEMATOL, V1, P44, DOI 10.4021/jh28w; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Lopez JJ, 2007, J THROMB HAEMOST, V5, P1283, DOI 10.1111/j.1538-7836.2007.02505.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Medicines and Healthcare Products Regulatory Agency Commission on Human Medicines, 2009, DRUG SAFETY UPDATE, V3, P3; Nayak MK, 2013, J BIOL CHEM, V288, P6826, DOI 10.1074/jbc.M112.403154; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Nayak MK, 2011, CELL CALCIUM, V49, P226, DOI 10.1016/j.ceca.2011.02.005; NORRVING B, 1991, LANCET, V338, P1345; Park K, 2013, CLEV CLIN J MED, V80, P318, DOI 10.3949/ccjm.80a.12146; Pereira J, 1999, THROMB HAEMOSTASIS, V82, P1318; Piazza GA, 1997, CANCER RES, V57, P2452; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; ROTH S, 1989, ARCH INTERN MED, V149, P775, DOI 10.1001/archinte.149.4.775; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Shiff SJ, 1996, EXP CELL RES, V222, P179, DOI 10.1006/excr.1996.0023; SHIFF SJ, 1995, J CLIN INVEST, V96, P491, DOI 10.1172/JCI118060; The Swedish Cooperative Study Group, 1986, STROKE, V18, P325; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WEISS HJ, 1967, LANCET, V2, P495; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhao LL, 2013, PLATELETS, V24, P637, DOI 10.3109/09537104.2012.754417; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	58	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105049	10.1371/journal.pone.0105049	http://dx.doi.org/10.1371/journal.pone.0105049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126950	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300073
J	Prusty, RK; Kumar, A				Prusty, Ranjan Kumar; Kumar, Abhishek			Socioeconomic Dynamics of Gender Disparity in Childhood Immunization in India, 1992-2006	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SEX DIFFERENTIALS; SON PREFERENCE; HEALTH-CARE; RURAL INDIA; CHILDREN; FERTILITY; MORTALITY; WEALTH; DISCRIMINATION	Background: Recent evidence indicated that gender disparity in child health is minimal and narrowed over time in India. However, considering the geographical and socio-cultural diversity in India, the gender gap may persist across disaggregated socioeconomic context which may be masked by average level. This study examines the dynamics of gender disparity in childhood immunization across regions, residence, wealth, caste and religion in India during 1992-2006. Method: We used multi-waves of the cross-sectional data of National Family Health Survey conducted in India between 1992-93 and 2005-06. Gender disparity ratio was used to measure the gender gap in childhood immunization across the selected socioeconomic characteristics. Multinomial regression analysis was used to examine the gender gap after accounting for other covariates. Result: Results indicate that, at aggregate level, gender disparity in full immunization is minimal and has stagnated during the study period. However, gender disparity - disfavouring female children - becomes apparent across the regions, poor households, and religion - particularly among Muslims. Adjusted gender disparity ratio indicates that, full immunization is lower among female than male children of the western region, poor household and among Muslims. Between 1992-93 and 2005-06, the disparity in full immunization had narrowed in the northern region whereas it had, astonishingly, increased in some of the western and southern states of the country. Conclusion: Our findings emphasize the need to integrate gender issues in the ongoing immunization programme in India, with particular attention to urban areas, developed states, and to the Muslim community.	[Prusty, Ranjan Kumar; Kumar, Abhishek] Int Inst Populat Sci, Bombay, Maharashtra, India	International Institute for Population Sciences	Prusty, RK (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	prustyranjan2006@gmail.com	Prusty, Ranjan Kumar/M-9013-2019	Prusty, Ranjan Kumar/0000-0001-7972-6725				Agarwal S, 2005, INDIAN PEDIATR, V42, P653; Anonymous, 2012, Morbidity and Mortality Weekly Report, V61, P883; [Anonymous], INDIAN PEDIAT; Antai D, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.238; Antai D, 2012, INT J INFECT DIS, V16, pE136, DOI 10.1016/j.ijid.2011.11.004; Arnold F, 1998, POP STUD-J DEMOG, V52, P301, DOI 10.1080/0032472031000150486; Arnold F, 2002, POPUL DEV REV, V28, P739; Arokiasamy P, 2011, HEALTH POLICY PLANN, V26, P429, DOI 10.1093/heapol/czq075; BASU AM, 1989, POP STUD-J DEMOG, V43, P193, DOI 10.1080/0032472031000144086; Bhagat RB, 2005, SINGAPORE J TROP GEO, V26, P61, DOI 10.1111/j.0129-7619.2005.00204.x; Bhagyalaxmi A, 2007, Indian J Public Health, V51, P52; Bhat, 2002, ECON POLIT WEEKLY, V37, P5105; Bhat PNM, 2003, DEMOGRAPHY, V40, P637, DOI 10.2307/1515201; BHAT PNM, 2002, ECON POLIT WEEKLY, V37, P5244; Boerma J, 1994, DHS METHODOLOGICAL R; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Corsi D., 2009, BMC INT HLTH HUMA S1, V9, P1, DOI DOI 10.1186/1472-698X-9-S1-S3; Dalal A, 2005, INDIAN PEDIATR, V42, P401; Das Gupta M, 1999, DEV CHANGE, V30, P619, DOI 10.1111/1467-7660.00131; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0; Elliott C, 2006, CHILD CARE HLTH DEV, V32, P415, DOI 10.1111/j.1365-2214.2006.00623.x; FIKREE FF, 2004, BMJ-BRIT MED J, V328, P823, DOI DOI 10.1136/BMJ.328.7443.823; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 1998, 1867 POL RES; Gaudin S, 2006, SOC SCI MED, V62, P694, DOI 10.1016/j.socscimed.2005.06.042; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) & Macro International, 2000, NAT FAM HLTH SURV NF, VI; International Institute for Population Sciences (IIPS) & Macro International, 2007, NAT FAM HLTH SURF NF, VI; International Institute for Population Sciences (IIPS) & Macro International, 1995, NAT FAM HLTH SURV N, VI; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Jones N, 2008, GENDER IMMUNIZATIO A; KISHOR S, 1993, AM SOCIOL REV, V58, P247, DOI 10.2307/2095969; Kumar A, 2011, J POPUL RES, V28, P301, DOI 10.1007/s12546-011-9069-y; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; Lauridsen J, 2011, HLTH EC REV, V1, P2; Liddle J, 1986, DAUGHTERS INDEPENEDE; Madaan N, 2013, TIMES INDIA; MAKINSON C, 1994, INT J GYNECOL OBSTET, V46, P119, DOI 10.1016/0020-7292(94)90226-7; Malhotra A., 2005, MEASURING EMPOWERMEN, DOI DOI 10.1596/0-8213-6057-4; Mandelbaum DG, 1988, WOMEN SECLUSION MENS, Vxvi; Mathew JL, 2012, INDIAN PEDIATR, V49, P203, DOI 10.1007/s13312-012-0063-z; Miller B. D., 1981, The endangered sex: neglect of female children in rural North India.; Ministry of Health and Family Welfare (MOHFW), 2005, NATL RUR HLTH MISS 2; Ministry of Health and Family Welfare (MOHFW), 2003, ANN REP 2002 03; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; MORGAN SP, 1995, POPUL DEV REV, V21, P541, DOI 10.2307/2137749; Moulton LH, 2005, TROP MED INT HEALTH, V10, P947, DOI 10.1111/j.1365-3156.2005.01434.x; Murphy R, 2003, POPUL DEV REV, V29, P595, DOI 10.1111/j.1728-4457.2003.00595.x; Nasir R., 2006, ANTHROPOLOGIST, V8, P275; Oomman N, 2002, REPROD HEALTH MATTER, V10, P184, DOI 10.1016/S0968-8080(02)00029-0; Pande RP, 2007, POPUL RES POLICY REV, V26, P1, DOI 10.1007/s11113-006-9017-2; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Parpiev Z, 2009, 0910E EC ED RES CONS; Phukan RK, 2009, J TROP PEDIATRICS, V55, P249, DOI 10.1093/tropej/fmn025; Rahman L, 2004, POPUL DEV REV, V30, P239, DOI 10.1111/j.1728-4457.2004.012_1.x; Ram F., 2004, POPULATION HLTH DEV, P40; Registrar General of India, 2000, SURV CAUS DEATH RUR; Rutstein S.O., 2004, DHS COMP REPORTS; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035045; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Singh P, 2000, Indian Pediatr, V37, P1194; Srinivas MN, 1976, REMEMEBERED VILLAGE; UNICEF, 2009, COV EV SURV; VLASSOFF C, 1990, POP STUD-J DEMOG, V44, P5, DOI 10.1080/0032472031000144356; WHO, 2008, IMM SURV ASS MON; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	73	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104598	10.1371/journal.pone.0104598	http://dx.doi.org/10.1371/journal.pone.0104598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25127396	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300037
J	Silva-Flores, R; Perez-Verdin, G; Wehenkel, C				Silva-Flores, Ramon; Perez-Verdin, Gustavo; Wehenkel, Christian			Patterns of Tree Species Diversity in Relation to Climatic Factors on the Sierra Madre Occidental, Mexico	PLOS ONE			English	Article							RICHNESS; SCALE; BIODIVERSITY; ENERGY; WATER; TEMPERATURE; REGRESSION; VEGETATION; GRADIENTS; FORESTS	Biological diversity can be defined as variability among living organisms from all sources, including terrestrial organisms, marine and other aquatic ecosystems, and the ecological complexes which they are part of. This includes diversity within species, between species, and of ecosystems. Numerous diversity indices combine richness and evenness in a single expression, and several climate-based explanations have been proposed to explain broad-scale diversity patterns. However, climate-based water-energy dynamics appears to be an essential factor that determines patterns of diversity. The Mexican Sierra Madre Occidental occupies an area of about 29 million hectares and is located between the Neotropical and Holarctic ecozones. It shelters a high diversity of flora, including 24 different species of Pinus (ca. 22% on the whole), 54 species of Quercus (ca. 9-14%), 7 species of Arbutus (ca. 50%) and many other trees species. The objectives of this study were to model how tree species diversity is related to climatic and geographic factors and stand density and to test the Metabolic Theory, Productivity-Diversity Hypothesis, Physiological Tolerance Hypothesis, Mid-Domain Effect, and the Water-Energy Dynamic Theory on the Sierra Madre Occidental, Durango. The results supported the Productivity-Diversity Hypothesis, Physiological Tolerance Hypothesis and Water-Energy Dynamic Theory, but not the Mid-Domain Effect or Metabolic Theory. The annual aridity index was the variable most closely related to the diversity indices analyzed. Contemporary climate was found to have moderate to strong effects on the minimum, median and maximum tree species diversity. Because water-energy dynamics provided a satisfactory explanation for the patterns of minimum, median and maximum diversity, an understanding of this factor is critical to future biodiversity research. Quantile regression of the data showed that the three diversity parameters of tree species are generally higher in cold, humid temperate climates than in dry, hot climates.	[Silva-Flores, Ramon] Univ Juarez Estado Durango, Durango, Mexico; [Perez-Verdin, Gustavo] Inst Politecn Nacl, CIIDIR, Durango, Mexico; [Wehenkel, Christian] Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Durango, Mexico	Universidad Juarez del Estado de Durango; Instituto Politecnico Nacional - Mexico; Universidad Juarez del Estado de Durango	Wehenkel, C (corresponding author), Univ Juarez Estado Durango, Inst Silvicultura & Ind Madera, Ciudad Univ, Durango, Mexico.	wehenkel@ujed.mx	PEREZ-VERDIN, GUSTAVO/A-4248-2011	PEREZ-VERDIN, GUSTAVO/0000-0001-6788-2763	Consejo Nacional de Ciencia y Tecnologia (CONACYT)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We are grateful to the Comision Nacional Forestal (CONAFOR) for sharing the National Forest and Soil Inventory data and to the Consejo Nacional de Ciencia y Tecnologia (CONACYT) for the support awarded for a doctoral research project. We also thank Maria del Socorro Gonzalez-Elizondo and Daniel Moya-Navarro, for their helpful suggestions in an early manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alkemade R, 2011, REG ENVIRON CHANGE, V11, pS143, DOI 10.1007/s10113-010-0161-1; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; ARROYO MTK, 1988, ANN MO BOT GARD, V75, P55, DOI 10.2307/2399466; Badii MH, 2008, DAENA INT J GOOD CON, V3, P632; Begon M., 1996, ECOLOGY; Bharali S, 2011, NATURE SCI, V9, P125; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CBD (Convention on Biological Diversity), 2011, HDB CONV BIOL DIV; Chen XW, 2003, CHEMOSPHERE, V51, P215, DOI 10.1016/S0045-6535(02)00809-3; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; CONAFOR (Comision Nacional Forestal), 2004, INV NACL FOR SUEL; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Eiserhardt WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027027; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gregorius HR, 2008, ECOL MODEL, V211, P90, DOI 10.1016/j.ecolmodel.2007.08.026; Gregorius Hans-Rolf, 2010, Diversity, V2, P370; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hebda RJ, 1994, BIODIVERSITY BRIT CO, P343; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Hutchinson MF, 1991, DATA ASSIMILATION SY, P104; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2011, QUANTILE REGRESSION; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; McNeely J. A., 1988, EC BIOL DIVERSITY DE; Norse EA, 1988, CONSERVING BIOSCIENC; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; Rehfeldt GE, 2006, RMRSGTR165; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; Rzedowski J., 1978, VEGETACION MEXICO; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sang Weiguo, 2009, Ecological Research, V24, P303, DOI 10.1007/s11284-008-0507-z; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharma CM, 2009, J AM SCI, V5, P119, DOI DOI 10.7537/MARSJAS050509.15; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Gonzalez-Elizondo MS, 2012, ACTA BOT MEX, V100, P351, DOI 10.21829/abm100.2012.40; SRNyMA (Secretaria de Recursos Naturales y Medio Ambiente), 2006, PROGR ESTR FOR 2030; Statistical Analysis System SAS Institute Inc, 2004, SAS ETS 9 1 US GUID; Tabachnick B. G., 2001, USING MULTIVARIATE S; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wehenkel C, 2014, FOREST ECOL MANAG, V316, P117, DOI 10.1016/j.foreco.2013.05.056; Wehenkel C, 2012, TREE GENET GENOMES, V8, P1085, DOI 10.1007/s11295-012-0488-5; Wehenkel C, 2011, ANN FOREST SCI, V68, P385, DOI 10.1007/s13595-011-0027-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wolfgang KH, 2012, APPL MULTIVARIATE ST; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wright David H., 1993, P66; ZEIDE B, 1991, FOREST SCI, V37, P517; Zyczkowski K, 2003, OPEN SYST INF DYN, V10, P297, DOI 10.1023/A:1025128024427	65	38	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105034	10.1371/journal.pone.0105034	http://dx.doi.org/10.1371/journal.pone.0105034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127455	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300070
J	Wang, HQ; Yang, J; Yang, JY; Jiang, L; Wen, TF; Wang, WT; Xu, MQ; Li, B; Yan, LN				Wang, Haiqing; Yang, Jian; Yang, Jiayin; Jiang, Li; Wen, Tianfu; Wang, Wentao; Xu, Mingqing; Li, Bo; Yan, Lunan			Development and Validation of a Prediction Score for Complications after Hepatectomy in Hepatitis B-Related Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							LIVER RESECTION; SURGICAL COMPLICATIONS; PORTAL-HYPERTENSION; RISK-FACTORS; MORTALITY; MANAGEMENT; CLASSIFICATION; MORBIDITY; DIAGNOSIS; CIRRHOSIS	Objective and Background: The aim of the present study was to develop and validate a prediction score for postoperative complications by severity and guide perioperative management and patient selection in hepatitis B-related hepatocellular carcinoma patients undergoing liver resection. Methods: A total of 1543 consecutive liver resections cases were included in the study. Randomly selected sample set of 70% of the study cohort was used to develop a score to predict complications III-V and the remaining 30% was used to validate the score. Based on the preoperative and predictable intraoperative parameters, logistic regression analysis was used to identify risk factors and create an integer score for the predicting of complication. Results: American Society of Anesthesiologists category, portal hypertension, major liver resection (more than 3 segments) and extrahepatic procedures were identified as independent predictors for complications III-V by logistic regression analysis. A score system integrating these 4 factors was stratified into three groups and significantly predicted the risk of complications III-V, with a rate of 1.6%, 11.9% and 65.6% for low, moderate and high risk, respectively. Using the score, the complications risk could be predicted accurately in the validation set, without significant differences between predicted (10.4%) and observed (8.4%) risks for complications III-V (P = 0.466). Conclusions: Based on four preoperative risk factors, we have developed and validated an integer-based risk score to predict postoperative severe complications after liver resection for hepatitis B-related hepatocellular carcinoma patients in high-volume surgical center. This score may contribute to preoperative risk stratification and clinical decision-making.	[Wang, Haiqing; Yang, Jian; Yang, Jiayin; Jiang, Li; Wen, Tianfu; Wang, Wentao; Xu, Mingqing; Li, Bo; Yan, Lunan] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Yan, LN (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	yanlunan_68@163.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	National Sciences and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Sciences and Technology Major Project of China	This study is supported by a grant from the National Sciences and Technology Major Project of China (2012ZX10002-016) and (2012ZX10002-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres A, 2011, ARCH SURG-CHICAGO, V146, P1246, DOI 10.1001/archsurg.2011.175; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Breitenstein S, 2010, ANN SURG, V252, P726, DOI 10.1097/SLA.0b013e3181fb8c1a; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; de Franchis R, 2008, DIGEST LIVER DIS, V40, P312, DOI 10.1016/j.dld.2007.12.007; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Johnson NA, 2008, HEPATOLOGY, V47, P1513, DOI 10.1002/hep.22220; Kusano T, 2009, EJSO-EUR J SURG ONC, V35, P1179, DOI 10.1016/j.ejso.2009.04.008; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LN WY Yan, 1994, ASIAN J SURG, V17, P365; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Nanashima A, 2010, J HEPATO-BIL-PAN SCI, V17, P871, DOI 10.1007/s00534-010-0281-5; Oussoultzoglou E, 2010, ARCH SURG-CHICAGO, V145, P1075, DOI 10.1001/archsurg.2010.225; Peng CJ, 2009, TRANSPL P, V41, P3556, DOI 10.1016/j.transproceed.2009.06.235; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Rahbari NN, 2011, ANN SURG ONCOL, V18, P3640, DOI 10.1245/s10434-011-1829-6; Ramacciato G, 2012, AM SURGEON, V78, P456; Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sadamori H, 2010, J HEPATO-BIL-PAN SCI, V17, P709, DOI 10.1007/s00534-010-0275-3; Santambrogio R, 2013, HPB, V15, P78, DOI 10.1111/j.1477-2574.2012.00594.x; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043087; Shouval D, 2013, J HEPATOL, V58, P1063, DOI 10.1016/j.jhep.2013.03.002; Simons JP, 2009, ANN SURG, V250, P929, DOI 10.1097/SLA.0b013e3181bc9c2f; Simons JP, 2009, J SURG RES, V156, P21, DOI 10.1016/j.jss.2009.03.073; Slankamenac K, 2009, ANN SURG, V250, P720, DOI 10.1097/SLA.0b013e3181bdd840; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Wen TF, 2007, HEPATOL RES, V37, P346, DOI 10.1111/j.1872-034X.2007.00061.x; Yan L N, 1994, Zhonghua Wai Ke Za Zhi, V32, P35	38	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105114	10.1371/journal.pone.0105114	http://dx.doi.org/10.1371/journal.pone.0105114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126946	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300081
J	Ye, ZP; He, HY; Wang, H; Li, WS; Luo, L; Huang, ZC; Guo, Y				Ye, Zhuo-peng; He, Hai-yong; Wang, Hui; Li, Wen-sheng; Luo, Lun; Huang, Zhen-chao; Guo, Ying			RETRACTED: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8(+) T Cells (Retracted article. See vol. 16, 2021)	PLOS ONE			English	Article; Retracted Publication							TGF-BETA; DISINTEGRIN; GENERATION; ACTIVATION; INDUCTION	CD8(+) T cells play an important role in the anti-tumor activities of the body. The dysfunction of CD8(+) T cells in glioma is unclear. This study aims to elucidate the glioma cell-derived ADAM10 (A Disintegrin and metalloproteinase domain-containing protein 10) in the suppression of CD8(+) effector T cells by the induction of regulatory B cells. In this study, glioma cells were isolated from surgically removed glioma tissue and stimulated by Phorbol myristate acetage (PMA) in the culture. The levels of ADAM10 in the culture were determined by enzyme-linked immunosorbent assay. Immune cells were assessed by flow cytometry. The results showed that the isolated glioma cells express ADAM10, which was markedly up regulated after stimulated with PMA. The glioma-derived ADAM10 induced activated B cells to differentiate into regulatory B cells, the later suppressed CD8(+) T cell proliferation as well as the induced regulatory T cells, which also showed the immune suppressor effect on CD8(+) effector T cell proliferation. In conclusion, glioma cells produce ADAM10 to induce Bregs; the latter suppresses CD8(+) T cells and induces Tregs.	[Ye, Zhuo-peng; He, Hai-yong; Wang, Hui; Li, Wen-sheng; Luo, Lun; Huang, Zhen-chao; Guo, Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurosurg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Guo, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurosurg, Guangzhou 510275, Guangdong, Peoples R China.	yingrguoe@163.com						Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Devaud C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25961; Hofmann S, 2012, J THROMB HAEMOST, V10, P2581, DOI 10.1111/jth.12013; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Liu T, 2009, J CELL MOL MED, V13, P1765, DOI 10.1111/j.1582-4934.2008.00583.x; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Saito T, 2014, INT J ORAL MAX SURG, V43, P373, DOI 10.1016/j.ijom.2013.06.016; Selvaraj RK, 2013, DEV COMP IMMUNOL, V41, P397, DOI 10.1016/j.dci.2013.04.018; Sommer A, 2012, J BIOL CHEM, V287, P23678, DOI 10.1074/jbc.M112.362756; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wolpert F, 2014, NEURO-ONCOLOGY, V16, P382, DOI 10.1093/neuonc/not232	15	11	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105350	10.1371/journal.pone.0105350	http://dx.doi.org/10.1371/journal.pone.0105350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127032	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300106
J	Osadchii, OE				Osadchii, Oleg E.			Impact of Hypokalemia on Electromechanical Window, Excitation Wavelength and Repolarization Gradients in Guinea-Pig and Rabbit Hearts	PLOS ONE			English	Article							TORSADES-DE-POINTES; POTASSIUM-DEPLETED SOLUTIONS; DELAYED RECTIFIER; PREDICTIVE-VALUE; SERUM POTASSIUM; K+ CURRENT; QT QS2; DRUG; RISK; PROLONGATION	Normal hearts exhibit a positive time difference between the end of ventricular contraction and the end of QT interval, which is referred to as the electromechanical (EM) window. Drug-induced prolongation of repolarization may lead to the negative EM window, which was proposed to be a novel proarrhythmic marker. This study examined whether abnormal changes in the EM window may account for arrhythmogenic effects produced by hypokalemia. Left ventricular pressure, electrocardiogram, and epicardial monophasic action potentials were recorded in perfused hearts from guinea-pig and rabbit. Hypokalemia (2.5 mM K+) was found to prolong repolarization, reduce the EM window, and promote tachyarrhythmia. Nevertheless, during both regular pacing and extrasystolic excitation, the increased QT interval invariably remained shorter than the duration of mechanical systole, thus yielding positive EM window values. Hypokalemia-induced arrhythmogenicity was associated with slowed ventricular conduction, and shortened effective refractory periods, which translated to a reduced excitation wavelength index. Hypokalemia also evoked non-uniform prolongation of action potential duration in distinct epicardial regions, which resulted in increased spatial variability in the repolarization time. These findings suggest that arrhythmogenic effects of hypokalemia are not accounted for by the negative EM window, and are rather attributed to abnormal changes in ventricular conduction times, refractoriness, excitation wavelength, and spatial repolarization gradients.	[Osadchii, Oleg E.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Osadchii, Oleg E.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Aalborg University	Osadchii, OE (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	osadchiy@hst.aau.dk	Osadchii, Oleg/P-3786-2017	Osadchii, Oleg/0000-0003-0222-3227	Novo Nordisk Foundation; Obel Family Foundation; Novo Nordisk Fonden [NNF12OC0000968] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Obel Family Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Novo Nordisk Foundation and the Obel Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akylbekova EL, 2014, AM HEART J, V167, P116, DOI 10.1016/j.ahj.2013.10.009; Alderman MH, 2012, HYPERTENSION, V59, P926, DOI 10.1161/HYPERTENSIONAHA.111.180554; Belardinelli L, 2005, HEART RHYTHM, V2, pS16, DOI 10.1016/j.hrthm.2004.10.032; BOUDOULAS H, 1981, CIRCULATION, V64, P28, DOI 10.1161/01.CIR.64.1.28; BOUDOULAS H, 1982, AM J CARDIOL, V50, P1229, DOI 10.1016/0002-9149(82)90454-4; BOUDOULAS H, 1981, CHEST, V80, P613, DOI 10.1378/chest.80.5.613; Bowling CB, 2010, CIRC-HEART FAIL, V3, P253, DOI 10.1161/CIRCHEARTFAILURE.109.899526; Brahmajothi MV, 1997, CIRC RES, V81, P128, DOI 10.1161/01.RES.81.1.128; CHAMBERS JB, 1987, AM HEART J, V114, P355, DOI 10.1016/0002-8703(87)90503-5; Cheng JH, 1999, CARDIOVASC RES, V43, P135, DOI 10.1016/S0008-6363(99)00061-9; DECAPRIO L, 1984, AM J CARDIOL, V53, P818, DOI 10.1016/0002-9149(84)90411-9; EISNER DA, 1979, J PHYSIOL-LONDON, V294, P279, DOI 10.1113/jphysiol.1979.sp012930; EISNER DA, 1979, J PHYSIOL-LONDON, V294, P255, DOI 10.1113/jphysiol.1979.sp012929; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; Guns PJ, 2012, J PHARMACOL TOX MET, V66, P125, DOI 10.1016/j.vascn.2012.03.007; Guns PJ, 2012, BRIT J PHARMACOL, V166, P689, DOI 10.1111/j.1476-5381.2011.01795.x; Killeen MJ, 2007, ACTA PHYSIOL, V189, P33, DOI 10.1111/j.1748-1716.2006.01643.x; Kirchhof PF, 1998, CIRCULATION, V97, P2567, DOI 10.1161/01.CIR.97.25.2567; KISHIDA H, 1979, CIRC RES, V44, P800, DOI 10.1161/01.RES.44.6.800; Laursen M, 2011, J PHARMACOL TOX MET, V64, P134, DOI 10.1016/j.vascn.2011.05.001; LI C, 1992, METHOD FIND EXP CLIN, V14, P107; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; Minami T, 2004, PACE, V27, P212, DOI 10.1111/j.1540-8159.2004.00412.x; Osadchii OE, 2009, ACTA PHYSIOL, V197, P273, DOI 10.1111/j.1748-1716.2009.02028.x; Osadchii OE, 2006, PFLUG ARCH EUR J PHY, V452, P155, DOI 10.1007/s00424-005-0025-6; Osadchii OE, 2011, AM J PHYSIOL-HEART C, V300, pH989, DOI 10.1152/ajpheart.00816.2010; Osadchii OE, 2010, AM J PHYSIOL-HEART C, V298, pH210, DOI 10.1152/ajpheart.00695.2009; Osadchii OE, 2009, EXP PHYSIOL, V94, P434, DOI 10.1113/expphysiol.2008.045567; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SANGUINETTI MC, 1992, PFLUG ARCH EUR J PHY, V420, P180, DOI 10.1007/BF00374988; SMEETS JLRM, 1986, CIRC RES, V58, P96, DOI 10.1161/01.RES.58.1.96; Su JL, 2012, AM J EMERG MED, V30, P1089, DOI 10.1016/j.ajem.2011.07.009; ter Bekke RMA, 2012, PROG BIOPHYS MOL BIO, V110, P347, DOI 10.1016/j.pbiomolbio.2012.07.007; Thomsen MB, 2006, PHARMACOL THERAPEUT, V112, P150, DOI 10.1016/j.pharmthera.2005.04.009; van der Linde HJ, 2010, BRIT J PHARMACOL, V161, P1444, DOI 10.1111/j.1476-5381.2010.00934.x; Vargas HM, 2010, BRIT J PHARMACOL, V161, P1441, DOI 10.1111/j.1476-5381.2010.00980.x; Veerman CC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1002, DOI 10.1161/CIRCEP.113.000239; VINCENT GM, 1991, AM J CARDIOL, V68, P498, DOI 10.1016/0002-9149(91)90785-J; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Yang T, 2014, CIRCULATION, V130, P224, DOI 10.1161/CIRCULATIONAHA.113.007765	40	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105599	10.1371/journal.pone.0105599	http://dx.doi.org/10.1371/journal.pone.0105599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141124	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200113
J	Paillon, C; Wantiez, L; Kulbicki, M; Labonne, M; Vigliola, L				Paillon, Christelle; Wantiez, Laurent; Kulbicki, Michel; Labonne, Maylis; Vigliola, Laurent			Extent of Mangrove Nursery Habitats Determines the Geographic Distribution of a Coral Reef Fish in a South-Pacific Archipelago	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; ELEMENTAL CHEMISTRY; SPATIAL VARIATION; AGE VALIDATION; TURNEFFE ATOLL; MARINE FAUNA; RANGE SIZE; OTOLITHS; CONNECTIVITY; PATTERNS	Understanding the drivers of species' geographic distribution has fundamental implications for the management of biodiversity. For coral reef fishes, mangroves have long been recognized as important nursery habitats sustaining biodiversity in the Western Atlantic but there is still debate about their role in the Indo-Pacific. Here, we combined LA-ICP-MS otolith microchemistry, underwater visual censuses (UVC) and mangrove cartography to estimate the importance of mangroves for the Indo-Pacific coral reef fish Lutjanus fulviflamma in the archipelago of New Caledonia. Otolith elemental compositions allowed high discrimination of mangroves and reefs with 83.8% and 98.7% correct classification, respectively. Reefs were characterized by higher concentrations of Rb and Sr and mangroves by higher concentrations of Ba, Cr, Mn and Sn. All adult L. fulviflamma collected on reefs presented a mangrove signature during their juvenile stage with 85% inhabiting mangrove for their entire juvenile life (about 1 year). The analysis of 2942 UVC revealed that the species was absent from isolated islands of the New Caledonian archipelago where mangroves were absent. Furthermore, strong positive correlations existed between the abundance of L. fulviflamma and the area of mangrove (r = 0.84 for occurrence, 0.93 for density and 0.89 for biomass). These results indicate that mangrove forest is an obligatory juvenile habitat for L. fulviflamma in New Caledonia and emphasize the potential importance of mangroves for Indo-Pacific coral reef fishes.	[Paillon, Christelle; Vigliola, Laurent] IRD, Lab Excellence LABEX Corail, CoReUs UR227, Noumea, New Caledonia; [Paillon, Christelle; Wantiez, Laurent] UNC, LIVE EA4243, Noumea, New Caledonia; [Kulbicki, Michel] IRD, Lab Excellence LABEX Corail, CoReUs UR227, Lab Arago, Banyuls Sur Mer, France; [Labonne, Maylis] Inst Univ Europe Mer, IRD, LEMAR UMR 6539, Plouzane, France	Institut de Recherche pour le Developpement (IRD); Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Paillon, C (corresponding author), IRD, Lab Excellence LABEX Corail, CoReUs UR227, Noumea, New Caledonia.	christelle.paillon@gmail.com	Wantiez, Laurent/L-3343-2013; Vigliola, Laurent/J-7107-2016; Paillon, Christelle/HGB-2144-2022	Wantiez, Laurent/0000-0001-5024-2057; Vigliola, Laurent/0000-0003-4715-7470; Kulbicki, Michel/0000-0003-1258-5061	Developing Agency of New Caledonia (ADECAL); Economic Zone of New Caledonia program (ZONECO); South Province of New Caledonia; Total Foundation; Pristine Seas project by the National Geographic Society; UNESCO World heritage survey by the Governement of New Caledonia; Southern Province; Northern Province; Research Institute for Development (IRD); University of New Caledonia (UNC)	Developing Agency of New Caledonia (ADECAL); Economic Zone of New Caledonia program (ZONECO); South Province of New Caledonia; Total Foundation(Total SA); Pristine Seas project by the National Geographic Society(National Geographic Society); UNESCO World heritage survey by the Governement of New Caledonia; Southern Province; Northern Province; Research Institute for Development (IRD); University of New Caledonia (UNC)	This study was funded by the Developing Agency of New Caledonia (ADECAL), the Economic Zone of New Caledonia program (ZONECO) and the South Province of New Caledonia. Dive data from the remote reefs of New Caledonia were collected as part of the Pristine Reef project funded by the Total Foundation, the Pristine Seas project funded by the National Geographic Society, and the UNESCO World heritage survey funded by the Governement of New Caledonia. The rest of the UVC data was collected by various projects funded by the Southern Province and the Northern Province, and by the Research Institute for Development (IRD) and the University of New Caledonia (UNC) core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JA, 2006, MAR ECOL PROG SER, V306, P269, DOI 10.3354/meps306269; Bruland KW, 2003, TREATISE GEOCHEMISTR, P23, DOI DOI 10.1016/B0-08-043751-6/06105-3; Burke LM, 2011, REEFS AT RISK REVISI; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Carpenter K.E., 2001, LIVING MARINE RESO 3, V5; Chittaro PM, 2006, ESTUAR COAST SHELF S, V67, P673, DOI 10.1016/j.ecss.2005.12.014; Chittaro PM, 2013, CORAL REEFS, V32, P341, DOI 10.1007/s00338-012-0990-0; Chittaro PM, 2009, OECOLOGIA, V160, P49, DOI 10.1007/s00442-009-1282-4; Chittaro PM, 2005, ESTUARIES, V28, P373, DOI 10.1007/BF02693920; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; D'Agata S, CURRENT BIOLOGY IN P; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dove SG, 1998, MAR BIOL, V130, P377, DOI 10.1007/s002270050258; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2003, ESTUAR COAST SHELF S, V57, P1049, DOI 10.1016/S0272-7714(03)00009-X; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gillanders BM, 2000, MAR ECOL PROG SER, V201, P273, DOI 10.3354/meps201273; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Igulu MM, 2011, J EXP MAR BIOL ECOL, V401, P118, DOI 10.1016/j.jembe.2011.01.022; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Kulbicki M, 2005, CYBIUM, V29, P235; Labrosse P., 2002, UNDERWATER VISUAL FI; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Lea E., 1910, PUBLICATIONS CIRCONS, V53, P7; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Loubens G., 1980, Cahiers de l'Indo-Pacifique, V2, P41; Lugendo BR, 2007, B MAR SCI, V80, P497; Lugendo BR, 2005, AQUAT LIVING RESOUR, V18, P149, DOI 10.1051/alr:2005016; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Mateo I, 2010, MAR ECOL PROG SER, V402, P197, DOI 10.3354/meps08445; McMahon KW, 2012, P NATL ACAD SCI USA, V109, P15372, DOI 10.1073/pnas.1206378109; Mellin C, 2007, ESTUAR COAST SHELF S, V75, P481, DOI 10.1016/j.ecss.2007.05.026; Mercier L, 2012, MAR ECOL PROG SER, V444, P175, DOI 10.3354/meps09444; Mercier L, 2011, ECOL APPL, V21, P1352, DOI 10.1890/09-1887.1; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Newman SJ, 1996, MAR FRESHWATER RES, V47, P575, DOI 10.1071/MF9960575; Newman SJ, 2002, ESTUAR COAST SHELF S, V55, P67, DOI 10.1006/ecss.2001.0887; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paris JP, 1981, GEOLOGIE DE LA NOUVE; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; Pelletier B, 2012, ATLAS DE LA NOUVELLE, P33; Sale PF, 1991, THE ECOLOGY OF FISHE; Sale PF, 2010, PRESERVING REEF CONN; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; Thollot Pierre, 1992, Cybium, V16, P331; THRESHER RE, 1989, MAR ECOL PROG SER, V57, P187, DOI 10.3354/meps057187; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Tukey JW, 1977, EXPLORATORY DATA ANA; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; Virly S, 2007, TYPOLOGIES ET BIODIV; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Warner RR, 2005, LIMNOL OCEANOGR, V50, P1529, DOI 10.4319/lo.2005.50.5.1529	70	15	15	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105158	10.1371/journal.pone.0105158	http://dx.doi.org/10.1371/journal.pone.0105158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140697	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200055
J	Righi, G; Tierney, AL; Tager-Flusberg, H; Nelson, CA				Righi, Giulia; Tierney, Adrienne L.; Tager-Flusberg, Helen; Nelson, Charles A.			Functional Connectivity in the First Year of Life in Infants at Risk for Autism Spectrum Disorder: An EEG Study	PLOS ONE			English	Article							LANGUAGE; ACTIVATION; CHILDREN; SPEECH; REPRESENTATIONS; SYNCHRONIZATION; COHERENCE; TODDLERS; TASK	In the field of autism research, recent work has been devoted to studying both behavioral and neural markers that may aide in early identification of autism spectrum disorder (ASD). These studies have often tested infants who have a significant family history of autism spectrum disorder, given the increased prevalence observed among such infants. In the present study we tested infants at high-and low-risk for ASD (based on having an older sibling diagnosed with the disorder or not) at 6-and 12-months-of-age. We computed intrahemispheric linear coherence between anterior and posterior sites as a measure of neural functional connectivity derived from electroencephalography while the infants were listening to speech sounds. We found that by 12-months-of-age infants at risk for ASD showed reduced functional connectivity compared to low risk infants. Moreover, by 12-months-of-age infants later diagnosed with ASD showed reduced functional connectivity, compared to both infants at low risk for the disorder and infants at high risk who were not later diagnosed with ASD. Significant differences in functional connectivity were also found between low-risk infants and high-risk infants who did not go onto develop ASD. These results demonstrate that reduced functional connectivity appears to be related to genetic vulnerability for ASD. Moreover, they provide further evidence that ASD is broadly characterized by differences in neural integration that emerge during the first year of life.	[Righi, Giulia] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Tierney, Adrienne L.] Harvard Univ, Harvard Coll Writing Program, Cambridge, MA 02138 USA; [Tager-Flusberg, Helen] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Nelson, Charles A.] Boston Childrens Hosp, Div Dev Med, Boston, MA 02115 USA; [Nelson, Charles A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Nelson, Charles A.] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Nelson, CA (corresponding author), Boston Childrens Hosp, Div Dev Med, Boston, MA 02115 USA.	charles_nelson@harvard.edu		Tager-Flusberg, Helen/0000-0002-8768-5414	National Institute on Deafness and Other Communication Disorders (NIDCD) [R21 DC 08637]; Autism Speaks; NIDCD [RO1 DC 10290]; Simon's Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008637, R01DC010290] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Autism Speaks; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Simon's Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by grant from National Institute on Deafness and Other Communication Disorders (NIDCD) R21 DC 08637 and Autism Speaks to HTF. Funding was provided by grant NIDCD RO1 DC 10290 and the Simon's Foundation to CAN and HTF. The agencies/funders had NO role in design data analysis or publication.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barnea-Goraly N, 2010, ARCH GEN PSYCHIAT, V67, P1052, DOI 10.1001/archgenpsychiatry.2010.123; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Brock J, 2002, DEV PSYCHOPATHOL, V14, P209, DOI 10.1017/S0954579402002018; Catarino A, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-1; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Gabard-Durnam L, 2013, J AUTISM DEV DISORD, P1; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Hoehl S, 2012, DEV NEUROPSYCHOL, V37, P187, DOI 10.1080/87565641.2011.627958; Jones EJH, 2014, NEUROSCI BIOBEHAV R, V39, P1, DOI 10.1016/j.neubiorev.2013.12.001; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kawahara H, 1999, SPEECH COMMUN, V27, P187, DOI 10.1016/S0167-6393(98)00085-5; Knaus TA, 2008, J INT NEUROPSYCH SOC, V14, P967, DOI 10.1017/S1355617708081216; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Lindgren KA, 2009, AUTISM RES, V2, P22, DOI 10.1002/aur.63; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Mullen E. M, 1995, MULLEN SCALES EARLY; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Rivera-Gaxiola M, 2005, DEVELOPMENTAL SCI, V8, P162, DOI 10.1111/j.1467-7687.2005.00403.x; Rogers SJ, 2009, AUTISM RES, V2, P125, DOI 10.1002/aur.81; Rutter M., 2003, SOCIAL COMMUNICATION; Seery AM, 2013, DEV COGN NEUROS-NETH, V5, P10, DOI 10.1016/j.dcn.2012.11.007; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Tager-Flusberg H, 2010, NEURAL NETWORKS, V23, P1072, DOI 10.1016/j.neunet.2010.07.008; Tierney AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039127; Toth K, 2007, J AUTISM DEV DISORD, V37, P145, DOI 10.1007/s10803-006-0336-2; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Viding E, 2007, BEHAV GENET, V37, P51, DOI 10.1007/s10519-006-9105-4; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zwaigenbaum L, 2007, J AUTISM DEV DISORD, V37, P466, DOI 10.1007/s10803-006-0179-x; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	47	67	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105176	10.1371/journal.pone.0105176	http://dx.doi.org/10.1371/journal.pone.0105176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140874	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200057
J	Schniepp, R; Wuehr, M; Huth, S; Pradhan, C; Schlick, C; Brandt, T; Jahn, K				Schniepp, Roman; Wuehr, Max; Huth, Sabrina; Pradhan, Cauchy; Schlick, Cornelia; Brandt, Thomas; Jahn, Klaus			The Gait Disorder in Downbeat Nystagmus Syndrome	PLOS ONE			English	Article							OLDER-ADULTS; CEREBELLAR; LOCOMOTION; VARIABILITY; GRAVITY; VISION	Background: Downbeat nystagmus (DBN) is a common form of acquired fixation nystagmus with key symptoms of oscillopsia and gait disturbance. Gait disturbance could be a result of impaired visual feedback due to the involuntary ocular oscillations. Alternatively, a malfunction of cerebellar locomotor control might be involved, since DBN is considered a vestibulocerebellar disorder. Methods: Investigation of walking in 50 DBN patients (age 72 +/- 11 years, 23 females) and 50 healthy controls (HS) (age 70 +/- 11 years, 23 females) using a pressure sensitive carpet (GAITRite). The patient cohort comprised subjects with only ocular motor signs (DBN) and subjects with an additional limb ataxia (DBNCA). Gait investigation comprised different walking speeds and walking with eyes closed. Results: In DBN, gait velocity was reduced (p<0.001) with a reduced stride length (p<0.001), increased base of support (p<0.050), and increased double support (p<0.001). Walking with eyes closed led to significant gait changes in both HS and DBN. These changes were more pronounced in DBN patients (p<0.001). Speed-dependency of gait variability revealed significant differences between the subgroups of DBN and DBNCA (p<0.050). Conclusions: (I) Impaired visual control caused by involuntary ocular oscillations cannot sufficiently explain the gait disorder. (II) The gait of patients with DBN is impaired in a speed dependent manner. (III) Analysis of gait variability allows distinguishing DBN from DBNCA: Patients with pure DBN show a speed dependency of gait variability similar to that of patients with afferent vestibular deficits. In DBNCA, gait variability resembles the pattern found in cerebellar ataxia.	[Schniepp, Roman; Huth, Sabrina; Jahn, Klaus] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Schniepp, Roman; Wuehr, Max; Huth, Sabrina; Pradhan, Cauchy; Schlick, Cornelia; Brandt, Thomas; Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders DSGZ, Munich, Germany; [Brandt, Thomas] Univ Munich, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; University of Munich	Schniepp, R (corresponding author), Univ Munich, Dept Neurol, D-80539 Munich, Germany.	roman.schniepp@med.uni-muenchen.de	Jahn, Klaus/F-9902-2010; Jahn, Klaus/AAC-4969-2021	Jahn, Klaus/0000-0002-1669-3652; Wuhr, Max/0000-0001-5115-3777	German research foundation (Deutsche Forschungsgemeinschaft) [DFG JA 1087/1-1]; German Hertie Foundation; Federal Ministry for Education and Science (BMBF) of Germany [80121000-49]	German research foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Hertie Foundation; Federal Ministry for Education and Science (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	The work was supported by the German research foundation (Deutsche Forschungsgemeinschaft, DFG JA 1087/1-1), the German Hertie Foundation and the Federal Ministry for Education and Science (BMBF, Nr. 80121000-49) of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Buchele W, 1983, Adv Otorhinolaryngol, V30, P291; Cromwell RL, 2002, J GERONTOL A-BIOL, V57, pM442, DOI 10.1093/gerona/57.7.M442; Crowdy KA, 2000, EXP BRAIN RES, V135, P437, DOI 10.1007/s002210000539; Gagey P M, 1999, POSTUROLOGIE REGULAT, P45; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Hallemans A, 2010, GAIT POSTURE, V32, P547, DOI 10.1016/j.gaitpost.2010.07.018; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hufner K, 2007, NEUROLOGY, V69, P1128, DOI 10.1212/01.wnl.0000276953.00969.48; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2010, RESTOR NEUROL NEUROS, V28, P105, DOI 10.3233/RNN-2010-0506; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Leigh RJ, 2006, CONT NEUROLOGY SERIE, V70; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Marti S, 2002, ANN NEUROL, V52, P712, DOI 10.1002/ana.10370; Marti S, 2008, EXP BRAIN RES, V188, P613, DOI 10.1007/s00221-008-1396-7; Miles FA, 1999, ANN NY ACAD SCI, V871, P260, DOI 10.1111/j.1749-6632.1999.tb09190.x; Mori S, 1998, ANN NY ACAD SCI, V860, P94, DOI 10.1111/j.1749-6632.1998.tb09041.x; Mori S, 2001, ADV NEUROL, V87, P25; NELSON AJ, 1974, PHYS THER, V54, P1059, DOI 10.1093/ptj/54.10.1059; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pierrot-Deseilligny C, 2009, ANN NY ACAD SCI, V1164, P155, DOI 10.1111/j.1749-6632.2009.03864.x; Pradhan C, 2013, J NEUROSCIENCE NEURO, V2, P542; Schniepp R, 2014, J NEUROL, V261, P213, DOI 10.1007/s00415-013-7189-3; Schniepp R, 2012, MOVEMENT DISORD, V27, P125, DOI 10.1002/mds.23978; Spiegel R, 2010, NEUROLOGY, V75, P1928, DOI 10.1212/WNL.0b013e3181feb22f; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; WAESPE W, 1989, PROG BRAIN RES, V80, P225; Wagner JN, 2008, J NEUROL NEUROSUR PS, V79, P672, DOI 10.1136/jnnp.2007.126284; Wuehr M, 2013, GAIT POSTURE, V37, P214, DOI 10.1016/j.gaitpost.2012.07.003; Wuehr M, 2013, EXP BRAIN RES, V224, P287, DOI 10.1007/s00221-012-3310-6	34	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105463	10.1371/journal.pone.0105463	http://dx.doi.org/10.1371/journal.pone.0105463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140517	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200090
J	Schurch, AC; Schipper, D; Bijl, MA; Dau, J; Beckmen, KB; Schapendonk, CME; Raj, VS; Osterhaus, ADME; Haagmans, BL; Tryland, M; Smits, SL				Schurch, Anita C.; Schipper, Debby; Bijl, Maarten A.; Dau, Jim; Beckmen, Kimberlee B.; Schapendonk, Claudia M. E.; Raj, V. Stalin; Osterhaus, Albert D. M. E.; Haagmans, Bart L.; Tryland, Morten; Smits, Saskia L.			Metagenomic Survey for Viruses in Western Arctic Caribou, Alaska, through Iterative Assembly of Taxonomic Units	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SEQUENCE; PAPILLOMAVIRUSES	Pathogen surveillance in animals does not provide a sufficient level of vigilance because it is generally confined to surveillance of pathogens with known economic impact in domestic animals and practically nonexistent in wildlife species. As most (re-) emerging viral infections originate from animal sources, it is important to obtain insight into viral pathogens present in the wildlife reservoir from a public health perspective. When monitoring living, free-ranging wildlife for viruses, sample collection can be challenging and availability of nucleic acids isolated from samples is often limited. The development of viral metagenomics platforms allows a more comprehensive inventory of viruses present in wildlife. We report a metagenomic viral survey of the Western Arctic herd of barren ground caribou (Rangifer tarandus granti) in Alaska, USA. The presence of mammalian viruses in eye and nose swabs of 39 free-ranging caribou was investigated by random amplification combined with a metagenomic analysis approach that applied exhaustive iterative assembly of sequencing results to define taxonomic units of each metagenome. Through homology search methods we identified the presence of several mammalian viruses, including different papillomaviruses, a novel parvovirus, polyomavirus, and a virus that potentially represents a member of a novel genus in the family Coronaviridae.	[Schurch, Anita C.; Schipper, Debby; Bijl, Maarten A.; Schapendonk, Claudia M. E.; Raj, V. Stalin; Osterhaus, Albert D. M. E.; Haagmans, Bart L.; Smits, Saskia L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Smits, Saskia L.] Viroclin Biosci, Rotterdam, Netherlands; [Dau, Jim] Alaska Dept Fish & Game, Kotzebue, AK USA; [Beckmen, Kimberlee B.] Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA; [Tryland, Morten] UiT, Dept Arctic & Marine Biol, Res Grp Arctic Infect Biol, Tromso, Norway; [Tryland, Morten] Genok Ctr Biosafety, Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; Alaska Department of Fish & Game; Alaska Department of Fish & Game; UiT The Arctic University of Tromso	Smits, SL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	s.smits@erasmusmc.nl	Haagmans, Bart/E-9791-2015; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Schurch, Anita/0000-0003-1894-7545; Beckmen, Kimberlee/0000-0003-0747-7883; Tryland, Morten/0000-0001-5394-5196; Raj, Victor Stalin/0000-0003-2250-8481	European Community under European Commission [223498]; Virgo Consortium; Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]	European Community under European Commission; Virgo Consortium; Dutch government; Netherlands Genomics Initiative (NGI)	This work was partially funded by the European Community's Seventh Framework Program (FP7/2007-2013) under the project "European Management Platform for Emerging and Reemerging Infectious disease Entities" European Commission agreement no. 223498 and the Virgo Consortium, funded by the Dutch government project number FES0908, and by the Netherlands Genomics Initiative (NGI) project number 050-060-452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Burns K, 2007, FIELDS VIROLOGY, P2437; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Cotmore SF, 2013, ARCH VIROL, P1; das Neves CG, 2009, VIRUS RES, V145, P321, DOI 10.1016/j.virusres.2009.08.002; Dau J.R., 2007, CARIBOU MANAGEMENT R, P174; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Delbue S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/542092; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; ERIKSSON A, 1994, J VIROL, V68, P8365, DOI 10.1128/JVI.68.12.8365-8373.1994; Evans AL, 2008, J WILDLIFE DIS, V44, P1051, DOI 10.7589/0090-3558-44.4.1051; Evans AL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-5; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS146, DOI 10.1089/bsp.2012.0077; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Loon SC, 2004, BRIT J OPHTHALMOL, V88, P861, DOI 10.1136/bjo.2003.035931; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Renshaw RW, 2012, J VIROL, V86, P8903, DOI 10.1128/JVI.01261-12; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; ROBBINS SG, 1990, LAB INVEST, V62, P417; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069711; Stiles J, 2011, VET OPHTHALMOL, V14, P9, DOI 10.1111/j.1463-5224.2011.00901.x; Terai M, 2002, J VIROL, V76, P10020, DOI 10.1128/JVI.76.19.10020-10023.2002; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wendl MC, 2012, J MATH BIOL, P1	45	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105227	10.1371/journal.pone.0105227	http://dx.doi.org/10.1371/journal.pone.0105227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140520	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200063
J	Skewes-Cox, P; Sharpton, TJ; Pollard, KS; DeRisi, JL				Skewes-Cox, Peter; Sharpton, Thomas J.; Pollard, Katherine S.; DeRisi, Joseph L.			Profile Hidden Markov Models for the Detection of Viruses within Metagenomic Sequence Data	PLOS ONE			English	Article							PROTEIN FAMILIES DATABASE; HOMOLOGY DETECTION; IDENTIFICATION; ALIGNMENT; VIROLOGY; ILLNESS; TRENDS; GENE; RNA	Rapid, sensitive, and specific virus detection is an important component of clinical diagnostics. Massively parallel sequencing enables new diagnostic opportunities that complement traditional serological and PCR based techniques. While massively parallel sequencing promises the benefits of being more comprehensive and less biased than traditional approaches, it presents new analytical challenges, especially with respect to detection of pathogen sequences in metagenomic contexts. To a first approximation, the initial detection of viruses can be achieved simply through alignment of sequence reads or assembled contigs to a reference database of pathogen genomes with tools such as BLAST. However, recognition of highly divergent viral sequences is problematic, and may be further complicated by the inherently high mutation rates of some viral types, especially RNA viruses. In these cases, increased sensitivity may be achieved by leveraging position-specific information during the alignment process. Here, we constructed HMMER3-compatible profile hidden Markov models (profile HMMs) from all the virally annotated proteins in RefSeq in an automated fashion using a custom-built bioinformatic pipeline. We then tested the ability of these viral profile HMMs ("vFams'') to accurately classify sequences as viral or non-viral. Cross-validation experiments with full-length gene sequences showed that the vFams were able to recall 91% of left-out viral test sequences without erroneously classifying any non-viral sequences into viral protein clusters. Thorough reanalysis of previously published metagenomic datasets with a set of the best-performing vFams showed that they were more sensitive than BLAST for detecting sequences originating from more distant relatives of known viruses. To facilitate the use of the vFams for rapid detection of remote viral homologs in metagenomic data, we provide two sets of vFams, comprising more than 4,000 vFams each, in the HMMER3 format. We also provide the software necessary to build custom profile HMMs or update the vFams as more viruses are discovered (http://derisilab.ucsf.edu/software/vFam).	[Skewes-Cox, Peter] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Med Biochem & Biophys, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Sharpton, Thomas J.; Pollard, Katherine S.] Univ Calif San Francisco, J David Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Med Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Skewes-Cox, Peter/0000-0003-1633-5190; Sharpton, Thomas/0000-0002-5996-7764	Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [1660, 3300]; National Science Foundation [DMS-1069303]; Gladstone Institutes; Scleroderma Research Foundation; PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); Gladstone Institutes(University of California System); Scleroderma Research Foundation; PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (JLD), the Gordon and Betty Moore Foundation (Grants #1660 and #3300), the National Science Foundation (Grant #DMS-1069303), and Gladstone Institutes (KSP, TJS), the Scleroderma Research Foundation and the PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program (PS-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BACCHETTI S, 1986, J VIROL, V57, P1177, DOI 10.1128/JVI.57.3.1177-1181.1986; Bexfield N, 2010, VET J; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dong J, 2008, J MOL DIAGN, V10, P185, DOI 10.2353/jmoldx.2008.070063; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Iwamoto T, 2001, J GEN VIROL, V82, P2653, DOI 10.1099/0022-1317-82-11-2653; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kellam P, 1998, TRENDS MICROBIOL, V6, P160, DOI 10.1016/S0966-842X(98)01239-6; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Krishnamurthy N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Ruby JG, 2013, PRICE SOFTWARE TARGE; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Woolhouse MEJ, 2008, P ROY SOC B-BIOL SCI, V275, P2111, DOI 10.1098/rspb.2008.0294; Yamashita T, 1998, J VIROL, V72, P8408, DOI 10.1128/JVI.72.10.8408-8412.1998; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	45	97	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105067	10.1371/journal.pone.0105067	http://dx.doi.org/10.1371/journal.pone.0105067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140992	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200049
J	Chiarovano, E; Darlington, C; Vidal, PP; Lamas, G; de Waele, C				Chiarovano, Elodie; Darlington, Cynthia; Vidal, Pierre-Paul; Lamas, Georges; de Waele, Catherine			The Role of Cervical and Ocular Vestibular Evoked Myogenic Potentials in the Assessment of Patients with Vestibular Schwannomas	PLOS ONE			English	Article							BONE-CONDUCTED VIBRATION; CLINICAL-APPLICATIONS; UTRICULAR FUNCTION; SOUND; FOREHEAD; OVEMP; NERVE	Objectives: To investigate the clinical utility of VEMPs in patients suffering from unilateral vestibular schwannoma (VS) and to determine the optimal stimulation parameter (air conducted sound, bone conducted vibration) for evaluating the function of the vestibular nerve. Methods: Data were obtained in 63 patients with non-operated VS, and 20 patients operated on VS. Vestibular function was assessed by caloric, cervical and ocular VEMP testing. 37/63 patients with conclusive ACS ocular VEMPs responses were studied separately. Results: In the 63 non-operated VS patients, cVEMPs were abnormal in 65.1% of patients in response to AC STB and in 49.2% of patients to AC clicks. In the 37/63 patients with positive responses from the unaffected side, oVEMPs were abnormal in 75.7% of patients with ACS, in 67.6% with AFz and in 56.8% with mastoid BCV stimulation. In 16% of the patients, VEMPs were the only abnormal test (normal caloric and normal hearing). Among the 26 patients who did not show oVEMP responses on either side with ACS, oVEMPs responses could be obtained with AFz (50%) and with mastoid stimulation (89%). Conclusions: The VEMP test demonstrated significant clinical value as it yielded the only abnormal test results in some patients suffering from a unilateral vestibular schwannoma. For oVEMPs, we suggest that ACS stimulation should be the initial test. In patients who responded to ACS and who had normal responses, BCV was not required. In patients with abnormal responses on the affected side using ACS, BCV at AFz should be used to confirm abnormal function of the superior vestibular nerve. In patients who exhibited no responses on either side to ACS, BCV was the only approach allowing assessment of the function of the superior vestibular nerve. We favor using AFz stimulation first because it is easier to perform in clinical practice than mastoid stimulation.	[Chiarovano, Elodie; Vidal, Pierre-Paul; de Waele, Catherine] Univ Paris 05, Ctr Univ St Peres, CESEM, CNRS UMR 8194, Paris, France; [Darlington, Cynthia] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Lamas, Georges] Salpetriere Hosp, ENT Dept, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	de Waele, C (corresponding author), Univ Paris 05, Ctr Univ St Peres, CESEM, CNRS UMR 8194, Paris, France.	catherine.de-waele@parisdescartes.fr		Chiarovano, Elodie/0000-0002-3738-0700				Chiarovano E, 2011, CLIN NEUROPHYSIOL, V122, P1650, DOI 10.1016/j.clinph.2011.01.006; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; Curthoys IS, 2009, ACTA OTORHINOLARYNGO, V29, P179; Curthoys IS, 2011, CLIN NEUROPHYSIOL, V122, P611, DOI 10.1016/j.clinph.2010.07.018; De Waele C, 1999, ANN NY ACAD SCI, V871, P392; Iwasaki S, 2005, OTOL NEUROTOL, V26, P1196, DOI 10.1097/01.mao.0000194890.44023.e6; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Janky KL, 2013, OTOL NEUROTOL, V34, P127, DOI 10.1097/MAO.0b013e318271c32a; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Kantner C, 2012, HEARING RES, V294, P55, DOI 10.1016/j.heares.2012.10.008; Kinoshita M, 2013, OTOL NEUROTOL, V34, P1342, DOI 10.1097/MAO.0b013e31828d6539; Lin MC, 2013, IEEE T VIS COMPUT GR, V19, P177, DOI 10.1109/TVCG.2013.6; Manzari L, 2010, ACTA OTORHINOLARYNGO, V30, P175; Murofushi T, 1998, ARCH OTOLARYNGOL, V124, P509, DOI 10.1001/archotol.124.5.509; Murofushi T, 1999, ARCH OTOLARYNGOL, V125, P660, DOI 10.1001/archotol.125.6.660; Murofushi T, 2011, ACTA OTO-LARYNGOL, V131, P945, DOI 10.3109/00016489.2011.580003; Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e; OKADA Y, 1991, ACTA OTO-LARYNGOL, P150; Patko T, 2003, CLIN NEUROPHYSIOL, V114, P1344, DOI 10.1016/S1388-2457(03)00119-6; Piras G, 2013, EUR ARCH OTO-RHINO-L, V270, P497, DOI 10.1007/s00405-012-2018-3; Rosengren SM, 2010, CLIN NEUROPHYSIOL, V121, P636, DOI 10.1016/j.clinph.2009.10.016; Rosengren SM, 2011, CLIN NEUROPHYSIOL, V122, P2282, DOI 10.1016/j.clinph.2011.04.001; Rosengren SM, 2009, J VESTIBUL RES-EQUIL, V19, P33, DOI 10.3233/VES-2009-0345; Tseng CC, 2012, OTOLARYNG HEAD NECK, V146, P289, DOI 10.1177/0194599811425884; Ushio M, 2009, CLIN NEUROPHYSIOL, V120, P1149, DOI 10.1016/j.clinph.2009.01.017; Viciana D, 2012, EUR ARCH OTO-RHINO-L, V269, P1857, DOI 10.1007/s00405-011-1912-4; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA; Welgampola MS, 2001, CLIN NEUROPHYSIOL, V112, P1971, DOI 10.1016/S1388-2457(01)00645-9	31	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105026	10.1371/journal.pone.0105026	http://dx.doi.org/10.1371/journal.pone.0105026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137289	Green Submitted, gold, Green Published			2022-12-27	WOS:000340742100062
J	Howes, PD; Wongsriruksa, S; Laughlin, Z; Witchel, HJ; Miodownik, M				Howes, Philip D.; Wongsriruksa, Supinya; Laughlin, Zoe; Witchel, Harry J.; Miodownik, Mark			The Perception of Materials through Oral Sensation	PLOS ONE			English	Article							HAPTIC PERCEPTION; TACTILE PERCEPTION; TOUCH PERCEPTION; FINGER FRICTION; TASTE; ROUGHNESS; TEXTURE; DISCRIMINATION; DIMENSIONS; PREDICT	This paper presents the results of a multimodal study of oral perception conducted with a set of material samples made from metals, polymers and woods, in which both the somatosensory and taste factors were examined. A multidimensional scaling analysis coupled with subjective attribute ratings was performed to assess these factors both qualitatively and quantitatively. The perceptual somatosensory factors of warmth, hardness and roughness dominated over the basic taste factors, and roughness was observed to be a less significant sensation compared to touch-only experiments. The perceptual somatosensory ratings were compared directly with physical property data in order to assess the correlation between the perceived properties and measured physical properties. In each case, a strong correlation was observed, suggesting that physical properties may be useful in industrial design for predicting oral perception.	[Howes, Philip D.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Wongsriruksa, Supinya] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Laughlin, Zoe; Miodownik, Mark] UCL, Inst Making, London, England; [Witchel, Harry J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England	Imperial College London; University of London; King's College London; University of London; University College London; University of Brighton; University of Sussex	Miodownik, M (corresponding author), UCL, Inst Making, London, England.	m.miodownik@ucl.ac.uk	Howes, Philip D./U-8901-2017	Howes, Philip D./0000-0002-1862-8395	Leverhulme Trust [f/07 040/AF]; EPSRC [EP/I00159X/2, EP/I00159X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I00159X/2, EP/I00159X/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the Leverhulme Trust, grant number: f/07 040/AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DT, 1997, J NEUROSCI, V17, P7480; Boliek CA, 2007, J ORAL REHABIL, V34, P433, DOI 10.1111/j.1365-2842.2007.01735.x; Chen XJ, 2009, INT J DES, V3, P67; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Engelen L, 2008, J TEXTURE STUD, V39, P83, DOI 10.1111/j.1745-4603.2007.00132.x; Epke EM, 2007, PHYSIOL BEHAV, V92, P487, DOI 10.1016/j.physbeh.2007.04.022; Erickson RP, 2008, BEHAV BRAIN SCI, V31, P59, DOI 10.1017/S0140525X08003348; Green BG, 2003, FOOD QUAL PREFER, V14, P99, DOI 10.1016/S0950-3293(02)00071-X; Ho HN, 2006, PERCEPT PSYCHOPHYS, V68, P118, DOI 10.3758/BF03193662; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; HOLLINS M, 1993, PERCEPT PSYCHOPHYS, V54, P697, DOI 10.3758/BF03211795; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; Hollins M, 2010, ANNU REV PSYCHOL, V61, P243, DOI 10.1146/annurev.psych.093008.100419; Jacobs R, 1998, Clin Oral Investig, V2, P3, DOI 10.1007/s007840050035; Kawagishi S, 2009, J ORAL REHABIL, V36, P872, DOI 10.1111/j.1365-2842.2009.02005.x; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Laughlin Z, 2011, FOOD QUAL PREFER, V22, P628, DOI 10.1016/j.foodqual.2011.03.012; Lawless HT, 2005, CHEM SENSES, V30, P185, DOI 10.1093/chemse/bji014; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Miodownik MA, 2007, PURE APPL CHEM, V79, P1635, DOI 10.1351/pac200779101635; Picard D, 2003, ACTA PSYCHOL, V114, P165, DOI 10.1016/j.actpsy.2003.08.001; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V24, P24, DOI 10.1016/j.foodqual.2011.08.005; Rolls ET, 2011, J TEXTURE STUD, V42, P137, DOI 10.1111/j.1745-4603.2011.00296.x; Schiffman SS, 2009, ANN NY ACAD SCI, V1170, P725, DOI 10.1111/j.1749-6632.2009.03924.x; Skedung L, 2011, TRIBOL INT, V44, P505, DOI 10.1016/j.triboint.2010.04.010; Skedung L, 2010, TRIBOL LETT, V37, P389, DOI 10.1007/s11249-009-9538-z; Spence C, 2011, PSYCHOL MARKET, V28, P267, DOI 10.1002/mar.20392; Stevens DA, 2006, PHYSIOL BEHAV, V87, P272, DOI 10.1016/j.physbeh.2005.10.013; Stevens DA, 2008, CHEM SENSES, V33, P405, DOI 10.1093/chemse/bjn002; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Tiest WMB, 2010, VISION RES, V50, P2775, DOI 10.1016/j.visres.2010.10.005; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; Tiest WMB, 2009, ATTEN PERCEPT PSYCHO, V71, P481, DOI 10.3758/APP.71.3.481; Wongsriruksa S, 2012, MATER DESIGN, V42, P238, DOI 10.1016/j.matdes.2012.05.054	37	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105035	10.1371/journal.pone.0105035	http://dx.doi.org/10.1371/journal.pone.0105035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136793	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000340742100063
J	Li, Q; Liu, M; Ma, F; Luo, Y; Cai, RG; Wang, LM; Xu, NZ; Xu, BH				Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe			Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; IDENTIFICATION; RESISTANCE; CELLS; GENE; TRASTUZUMAB; PATHWAY; MARKERS	Background: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associated with chemosensitivity. Methods: Sixty-eight breast cancer patients received neoadjuvant chemotherapy with epirubicin plus paclitaxel. The serum of the patients was collected before chemotherapy and stored at -80 degrees C. The samples were classified into two groups in term of the chemosensitivity. We identified the differential expression patterns of miRNAs between the chemotherapy sensitive and resistant groups using microRNA profiling. Four miRNAs that were differentially expressed between the two groups were further validated in another 56 samples. We created a model fitting formula and a receiver operating characteristics (ROC) curve using logistic regression analysis to evaluate the prediction potency. Results: We identified 8 miRNAs differentially expressed between the two groups: 6 miRNAs were up-regulated, and 2 miRNAs were down-regulated in the resistant group compared with the sensitive group. The expression of miR-19a and miR-205 were determined to have significant differences between the two groups (P<0.05). A predictive model of these two miRNAs was created by the logistic regression analysis. The probability of this model was 89.71%. Based on the ROC curve, the specificity was 75.00%, and the sensitivity was 81.25%. Conclusions: The combination of miR-19a and miR-205 in the serum may predict the chemosensitivity of luminal A subtype of breast cancer to epirubicin plus paclitaxel neoadjuvant chemotherapy.	[Li, Qian; Ma, Fei; Luo, Yang; Cai, Ruigang; Xu, Binghe] Chinese Acad Med Sci, Inst Canc, Dept Med Oncol, Beijing 100021, Peoples R China; [Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Li, Qian; Liu, Mei; Ma, Fei; Luo, Yang; Cai, Ruigang; Wang, Liming; Xu, Ningzhi; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Mei; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100021, Peoples R China; [Liu, Mei; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Wang, Liming] Chinese Acad Med Sci, Inst Canc, Dept Abdominal Surg, Beijing 100021, Peoples R China; [Li, Qian] Peking Univ, Hosp 3, Dept Tumor Chemotherapy & Radiat Sickness, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University	Xu, BH (corresponding author), Chinese Acad Med Sci, Inst Canc, Dept Med Oncol, Beijing 100021, Peoples R China.	bhxu@hotmail.com	Wang, Liming/AAD-7697-2020; Cai, Rui/GRO-1869-2022	Ma, Fei/0000-0001-9432-1902; li, qian/0000-0002-7204-0429	National Natural Science Foundation [81372830]; Beijing Hope Run Special Fund [LC2013L09]; Capital Clinical Feature Applied Research Fund [Z141107002514010]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Hope Run Special Fund; Capital Clinical Feature Applied Research Fund	This work was supported by National Natural Science Foundation grant (81372830), Beijing Hope Run Special Fund (LC2013L09) and Capital Clinical Feature Applied Research Fund (Z141107002514010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava R, 2010, CANCER-AM CANCER SOC, V116, P1431, DOI 10.1002/cncr.24876; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Coates AS, 2012, J CLIN ONCOL, V30, P1260, DOI 10.1200/JCO.2011.37.7879; Farazi TA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r9; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Hayes DF, 2012, J CLIN ONCOL, V30, P1264, DOI 10.1200/JCO.2011.38.4529; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Hu XW, 2013, MOL CANCER RES, V11, P240, DOI 10.1158/1541-7786.MCR-12-0432; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612; Liang ZX, 2011, PHARM RES-DORDR, V28, P3091, DOI 10.1007/s11095-011-0570-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Mo WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054775; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Sochor M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-448; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; von Minckwitz G, 2013, CURR OPIN OBSTET GYN, V25, P66, DOI 10.1097/GCO.0b013e32835c0889; von Minckwitz G, 2011, BREAST, V20, pS142, DOI 10.1016/S0960-9776(11)70312-5; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034210; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yao YS, 2014, ONCOL LETT, V7, P541, DOI 10.3892/ol.2013.1697; Ye XM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-134	32	50	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104870	10.1371/journal.pone.0104870	http://dx.doi.org/10.1371/journal.pone.0104870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137071	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100050
J	Viluksela, M; Heikkinen, P; van der Ven, LTM; Rendel, F; Roos, R; Esteban, J; Korkalainen, M; Lensu, S; Miettinen, HM; Savolainen, K; Sankari, S; Lilienthal, H; Adamsson, A; Toppari, J; Herlin, M; Finnila, M; Tuukkanen, J; Leslie, HA; Hamers, T; Hamscher, G; Al-Anati, L; Stenius, U; Dervola, KS; Bogen, IL; Fonnum, F; Andersson, PL; Schrenk, D; Halldin, K; Hakansson, H				Viluksela, Matti; Heikkinen, Paivi; van der Ven, Leo T. M.; Rendel, Filip; Roos, Robert; Esteban, Javier; Korkalainen, Merja; Lensu, Sanna; Miettinen, Hanna M.; Savolainen, Kari; Sankari, Satu; Lilienthal, Hellmuth; Adamsson, Annika; Toppari, Jorma; Herlin, Maria; Finnila, Mikko; Tuukkanen, Juha; Leslie, Heather A.; Hamers, Timo; Hamscher, Gerd; Al-Anati, Lauy; Stenius, Ulla; Dervola, Kine-Susann; Bogen, Inger-Lise; Fonnum, Frode; Andersson, Patrik L.; Schrenk, Dieter; Halldin, Krister; Hakansson, Helen			Toxicological Profile of Ultrapure 2,2 ',3,4,4 ',5,5 '-Heptachlorbiphenyl (PCB 180) in Adult Rats	PLOS ONE			English	Article							DIOXIN-LIKE-PCBS; ARYL-HYDROCARBON RECEPTOR; DIBENZO-P-DIOXINS; POLYCHLORINATED-BIPHENYLS PCBS; THYROID-HORMONE; POSTNATAL EXPOSURE; IN-VITRO; DEVELOPMENTAL EXPOSURE; SUBCHRONIC TOXICITY; RETINOIC ACID	PCB 180 is a persistent non-dioxin-like polychlorinated biphenyl (NDL-PCB) abundantly present in food and the environment. Risk characterization of NDL-PCBs is confounded by the presence of highly potent dioxin-like impurities. We used ultrapure PCB 180 to characterize its toxicity profile in a 28-day repeat dose toxicity study in young adult rats extended to cover endocrine and behavioral effects. Using a loading dose/maintenance dose regimen, groups of 5 males and 5 females were given total doses of 0, 3, 10, 30, 100, 300, 1000 or 1700 mg PCB 180/kg body weight by gavage. Dose-responses were analyzed using benchmark dose modeling based on dose and adipose tissue PCB concentrations. Body weight gain was retarded at 1700 mg/kg during loading dosing, but recovered thereafter. The most sensitive endpoint of toxicity that was used for risk characterization was altered open field behavior in females; i.e. increased activity and distance moved in the inner zone of an open field suggesting altered emotional responses to unfamiliar environment and impaired behavioral inhibition. Other dose-dependent changes included decreased serum thyroid hormones with associated histopathological changes, altered tissue retinoid levels, decreased hematocrit and hemoglobin, decreased follicle stimulating hormone and luteinizing hormone levels in males and increased expression of DNA damage markers in liver of females. Dose-dependent hypertrophy of zona fasciculata cells was observed in adrenals suggesting activation of cortex. There were gender differences in sensitivity and toxicity profiles were partly different in males and females. PCB 180 adipose tissue concentrations were clearly above the general human population levels, but close to the levels in highly exposed populations. The results demonstrate a distinct toxicological profile of PCB 180 with lack of dioxin-like properties required for assignment of WHO toxic equivalency factor. However, PCB 180 shares several toxicological targets with dioxin-like compounds emphasizing the potential for interactions.	[Viluksela, Matti; Heikkinen, Paivi; Korkalainen, Merja; Lensu, Sanna; Miettinen, Hanna M.] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland; [Viluksela, Matti] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [van der Ven, Leo T. M.] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Rendel, Filip; Roos, Robert; Esteban, Javier; Herlin, Maria; Al-Anati, Lauy; Stenius, Ulla; Halldin, Krister; Hakansson, Helen] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Esteban, Javier] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Alicante, Spain; [Lensu, Sanna] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Savolainen, Kari] ISLAB Lab Ctr, Kuopio, Finland; [Sankari, Satu] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Lilienthal, Hellmuth] Ruhr Univ Bochum, German Social Accid Insurance, IPA Inst Prevent & Occupat Med, Ctr Toxicol, Bochum, Germany; [Adamsson, Annika; Toppari, Jorma] Univ Turku, Dept Physiol, Turku, Finland; [Toppari, Jorma] Univ Turku, Dept Paediat, Turku, Finland; [Finnila, Mikko; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Leslie, Heather A.; Hamers, Timo] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Hamscher, Gerd] Univ Giessen, Inst Food Chem & Food Biotechnol, D-35390 Giessen, Germany; [Dervola, Kine-Susann; Bogen, Inger-Lise; Fonnum, Frode] Univ Oslo, Inst Basic Med Sci, Dept Biochem, Oslo, Norway; [Andersson, Patrik L.] Umea Univ, Dept Chem, Umea, Sweden; [Schrenk, Dieter] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany	Finland National Institute for Health & Welfare; University of Eastern Finland; Netherlands National Institute for Public Health & the Environment; Karolinska Institutet; Universidad Miguel Hernandez de Elche; University of Jyvaskyla; University of Helsinki; Ruhr University Bochum; University of Turku; University of Turku; University of Oulu; Vrije Universiteit Amsterdam; Justus Liebig University Giessen; University of Oslo; Umea University; University of Kaiserslautern	Viluksela, M (corresponding author), Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland.	matti.viluksela@thl.fi	Esteban, Javier/A-5640-2019; Fonnum, Frode/S-4387-2019; Finnila, Mikko/X-6492-2019; Hamscher, Gerd/B-2100-2012; Hamers, Timo HM/L-2999-2013; Tuukkanen, Juha/R-3728-2018	Esteban, Javier/0000-0003-3760-8223; Hamers, Timo HM/0000-0002-5733-3290; Tuukkanen, Juha/0000-0002-1723-6461; Hakansson, Helen/0000-0002-7524-8209; Halldin, Krister/0000-0002-9838-4983; Finnila, Mikko/0000-0002-3348-5759; Noren Dervola, Kine Susann/0000-0002-0941-6948; Bogen, Inger Lise/0000-0003-2877-0624	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food) [FOOD-CT-2005-022923]; National Fund Research, Luxembourg (FNR); Marie Curie Actions of the European Commission; Academy of Finland; Sigrid Juselius Foundation; Formas [2007-1524]	European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food); National Fund Research, Luxembourg (FNR)(Luxembourg National Research Fund); Marie Curie Actions of the European Commission(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Formas(Swedish Research Council Formas)	This study was funded by the European Commission (ATHON (Assessing the toxicity and hazards of NDL-PCBs present in food), FOOD-CT-2005-022923). The authors are solely responsible for the contents of this paper, which does not necessarily represent the opinion of the European Community. RR was also supported by the National Fund Research, Luxembourg (FNR) and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), J. Toppari by the Academy of Finland and the Sigrid Juselius Foundation and KH by Formas (2007-1524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anati L, 2009, CHEM-BIOL INTERACT, V182, P191, DOI 10.1016/j.cbi.2009.09.004; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Andreola F, 1997, CANCER RES, V57, P2835; BAUER PJ, 1981, ANAL BIOCHEM, V110, P61, DOI 10.1016/0003-2697(81)90112-3; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1794; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloom MS, 2009, INT J HYG ENVIR HEAL, V212, P599, DOI 10.1016/j.ijheh.2009.04.005; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59, DOI 10.1177/074823379801400107; Brtko J, 2011, CURR DRUG METAB, V12, P71, DOI 10.2174/138920011795016881; Carreira SC, 2011, PLACENTA, V32, P283, DOI 10.1016/j.placenta.2010.12.024; Chauhan KR, 2000, TOXICOL APPL PHARM, V162, P10, DOI 10.1006/taap.1999.8826; CHU I, 1995, FUND APPL TOXICOL, V26, P282, DOI 10.1006/faat.1995.1099; Chu I, 1998, J APPL TOXICOL, V18, P285; Chu I, 1996, J APPL TOXICOL, V16, P121, DOI 10.1002/(SICI)1099-1263(199603)16:2<121::AID-JAT320>3.0.CO;2-G; Chu I, 1996, J TOXICOL ENV HEALTH, V49, P301, DOI 10.1080/009841096160844; CHU I, 1994, FUND APPL TOXICOL, V22, P457, DOI 10.1006/faat.1994.1051; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Crofton KM, 2005, ENVIRON HEALTH PERSP, V113, P1549, DOI 10.1289/ehp.8195; Danielsson C., 2008, ORGANOHALOGEN COMP, V70, P1201; EFSA, 2005, EFSA J, V263, P1, DOI DOI 10.2903/J.EFSA.2005.284; Esteban J, 2014, TOXICOL LETT, V229, P41, DOI 10.1016/j.toxlet.2014.04.021; FABINY DL, 1971, CLIN CHEM, V17, P696; FELASA, 1996, Lab Anim. (NY)., V30, P193; Fernandez MF, 2008, CHEMOSPHERE, V71, P1196, DOI 10.1016/j.chemosphere.2007.09.064; Fletcher N, 2005, TOXICOL SCI, V86, P264, DOI 10.1093/toxsci/kfi183; Gahrs M, 2013, TOXICOL APPL PHARM, V272, P77, DOI 10.1016/j.taap.2013.05.034; Gibaldi M, 1975, PHARMACOKINETICS; Gutleb AC, 2010, TOXICOL LETT, V192, P126, DOI 10.1016/j.toxlet.2009.10.008; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hallgren S, 2001, ARCH TOXICOL, V75, P200, DOI 10.1007/s002040000208; Hamers T, 2011, TOXICOL SCI, V121, P88, DOI 10.1093/toxsci/kfr043; Hany J, 1999, NEUROTOXICOL TERATOL, V21, P147, DOI 10.1016/S0892-0362(98)00038-5; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Herlin M, 2010, TOXICOLOGY, V273, P1, DOI 10.1016/j.tox.2010.04.006; IPCS, 1994, ASS HUM HLTH RISKS C, P170; Jamsa T, 2001, J BONE MINER RES, V16, P1812, DOI 10.1359/jbmr.2001.16.10.1812; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Johannessen CU, 2001, EPILEPSY RES, V47, P247, DOI 10.1016/S0920-1211(01)00308-4; Johansen EB, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-18; Kiviranta H, 2002, ENVIRON HEALTH PERSP, V110, P355, DOI 10.1289/ehp.02110355; Kiviranta H, 2005, CHEMOSPHERE, V60, P854, DOI 10.1016/j.chemosphere.2005.01.064; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; KONTUR PJ, 1994, J NEUROCHEM, V62, P282; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; Lecavalier P, 1997, J TOXICOL ENV HEALTH, V51, P265, DOI 10.1080/00984109708984026; Lee DW, 2012, TOXICOL SCI, V125, P496, DOI 10.1093/toxsci/kfr313; Lilienthal H, 2013, TOXICOLOGY, V311, P52, DOI 10.1016/j.tox.2013.01.025; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Lundberg R, 2006, TOXICOLOGY, V228, P33, DOI 10.1016/j.tox.2006.08.016; Mariussen E, 2002, TOXICOL APPL PHARM, V179, P137, DOI 10.1006/taap.2002.9353; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Minzenberg MJ, 2012, NEUROTHERAPEUTICS, V9, P610, DOI 10.1007/s13311-012-0128-7; MORSE DC, 1995, CHEM-BIOL INTERACT, V95, P41, DOI 10.1016/0009-2797(94)03347-1; Morse DC, 1996, TOXICOL APPL PHARM, V136, P269, DOI 10.1006/taap.1996.0034; Nishimura N, 2005, ARCH TOXICOL, V79, P260, DOI 10.1007/s00204-004-0626-4; Novak J, 2008, ENVIRON INT, V34, P898, DOI 10.1016/j.envint.2007.12.024; NTP (National Toxicology Programe), 2006, NIH PUBL; Oberg M, 2002, TOXICOL SCI, V70, P171, DOI 10.1093/toxsci/70.2.171; OECD, 2006, OECD SER TEST ASS, V57; Park HY, 2009, ENVIRON HEALTH PERSP, V117, P1600, DOI 10.1289/ehp.0900611; Rice DC, 1998, NEUROTOXICOL TERATOL, V20, P391, DOI 10.1016/S0892-0362(97)00134-7; Rice DC, 2005, EFSA J, V284, P1; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Roegge CS, 2006, NEUROTOXICOL TERATOL, V28, P260, DOI 10.1016/j.ntt.2005.12.009; Roos R, 2011, TOXICOLOGY, V284, P42, DOI 10.1016/j.tox.2011.03.013; Sable HJK, 2009, NEUROTOXICOL TERATOL, V31, P149, DOI 10.1016/j.ntt.2008.12.006; Sagiv SK, 2012, ENVIRON HEALTH PERSP, V120, P904, DOI 10.1289/ehp.1104372; Sagiv SK, 2010, AM J EPIDEMIOL, V171, P593, DOI 10.1093/aje/kwp427; Schmidt CK, 2003, ARCH TOXICOL, V77, P371, DOI 10.1007/s00204-003-0457-8; Schuchardt JP, 2009, FEBS J, V276, P3043, DOI 10.1111/j.1742-4658.2009.07023.x; Simon E, 2013, ENVIRON SCI TECHNOL, V47, P8902, DOI 10.1021/es401696u; Simon E, 2011, ENVIRON SCI TECHNOL, V45, P7936, DOI 10.1021/es2016389; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenberg M, 2008, CHEMOSPHERE, V71, P1909, DOI 10.1016/j.chemosphere.2008.01.007; Stenberg M, 2011, CHEMOSPHERE, V85, P1423, DOI 10.1016/j.chemosphere.2011.08.019; Stewart P, 2003, ENVIRON HEALTH PERSP, V111, P1670, DOI 10.1289/ehp.6173; Tanabe S, 2002, MAR POLLUT BULL, V45, P69, DOI 10.1016/S0025-326X(02)00175-3; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tian YH, 2011, SYNAPSE, V65, P1032, DOI 10.1002/syn.20934; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; Tripp G, 2012, NEUROTHERAPEUTICS, V9, P622, DOI 10.1007/s13311-012-0132-y; US EPA, 2012, EPA600R10038F, V1; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; VANLEEUWEN FXR, 2002, ORGANOHALOGEN COMPD, V56, P311; Viluksela M, 1997, TOXICOL APPL PHARM, V146, P207, DOI 10.1006/taap.1997.8239; Viluksela M, 1998, TOXICOL APPL PHARM, V151, P57, DOI 10.1006/taap.1998.8384; Virtanen HE, 2012, INT J ANDROL, V35, P283, DOI 10.1111/j.1365-2605.2011.01233.x; VONEULER G, 1991, BRAIN RES, V561, P93, DOI 10.1016/0006-8993(91)90753-I; Wahlefeld A.W., 1974, DETERMINATION SERUM, P1831; Wimmerova S, 2011, CHEMOSPHERE, V82, P687, DOI 10.1016/j.chemosphere.2010.10.099; Yoshinari K, 2001, MOL PHARMACOL, V59, P278, DOI 10.1124/mol.59.2.278	96	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104639	10.1371/journal.pone.0104639	http://dx.doi.org/10.1371/journal.pone.0104639			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137063	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100041
J	Watson, M; Hawkes, E; Meyer, P				Watson, Michael; Hawkes, Emily; Meyer, Peter			Transmission of Epi-Alleles with MET1-Dependent Dense Methylation in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC VARIATION; CPG METHYLATION; INHERITANCE; STABILITY; PATTERNS; MUTATION; METHYLTRANSFERASES; IMMOBILIZATION; EPIGENOME	DNA methylation in plants targets cytosines in three sequence contexts, CG, CHG and CHH (H representing A, C or T). Each of these patterns has traditionally been associated with distinct DNA methylation pathways with CHH methylation being controlled by the RNA dependent DNA methylation (RdDM) pathway employing small RNAs as a guide for the de novo DOMAINS REARRANGED METHYLTRANSFERASE (DRM2), and maintenance DNA METHYLTRANSFERASE1 (MET1) being responsible for faithful propagation of CG methylation. Here we report an unusual 'dense methylation' pattern under the control of MET1, with methylation in all three sequence contexts. We identified epi-alleles of dense methylation at a non coding RNA locus (At4g15242) in Arabidopsis ecotypes, with distinct dense methylation and expression characteristics, which are stably maintained and transmitted in genetic crosses and which can be heritably altered by depletion of MET1. This suggests that, in addition to its classical CG maintenance function, at certain loci MET1 plays a role in creating transcriptional diversity based on the generation of independent epi-alleles. Database inspection identified several other loci with MET1-dependent dense methylation patterns. Arabidopsis ecotypes contain distinct epi-alleles of these loci with expression patterns that inversely correlate with methylation density, predominantly within the transcribed region. In Arabidopsis, dense methylation appears to be an exception as it is only found at a small number of loci. Its presence does, however, highlight the potential for MET1 as a contributor to epigenetic diversity, and it will be interesting to investigate the representation of dense methylation in other plant species.	[Watson, Michael; Hawkes, Emily; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Meyer, P (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk			BBSRC Case studentship	BBSRC Case studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MW was supported by a BBSRC Case studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DAS OP, 1994, GENETICS, V136, P1121; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Greaves IK, 2014, P NATL ACAD SCI USA, V111, P2017, DOI 10.1073/pnas.1323656111; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Kakutani T, 1999, GENETICS, V151, P831; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; O'Malley R C, 2012, Cold Spring Harb Symp Quant Biol, V77, P135, DOI 10.1101/sqb.2012.77.014571; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Silveira AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003437; Stam M, 2000, PLANT J, V21, P27, DOI 10.1046/j.1365-313x.2000.00650.x; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vejlupkova Z., 2003, Maize Genetics Cooperation Newsletter, P24; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; You WH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-51; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	43	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105338	10.1371/journal.pone.0105338	http://dx.doi.org/10.1371/journal.pone.0105338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137154	Green Published, gold			2022-12-27	WOS:000340742100087
J	Zhang, J; Carnduff, L; Norman, G; Josey, T; Wang, YS; Sawyer, TW; Martyniuk, CJ; Langlois, VS				Zhang, Jing; Carnduff, Lisa; Norman, Grant; Josey, Tyson; Wang, Yushan; Sawyer, Thomas W.; Martyniuk, Christopher J.; Langlois, Valerie S.			Transcriptional Profiling in Rat Hair Follicles following Simulated Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; INFLAMMATORY RESPONSE; CEREBROSPINAL-FLUID; ENRICHMENT ANALYSIS; CEREBRAL-ISCHEMIA; GENOMIC PROFILE; HEAD-INJURY; APOPTOSIS; CALCIUM	With wide adoption of explosive-dependent weaponry during military activities, Blast-induced neurotrauma (BINT)-induced traumatic brain injury (TBI) has become a significant medical issue. Therefore, a robust and accessible biomarker system is in demand for effective and efficient TBI diagnosis. Such systems will also be beneficial to studies of TBI pathology. Here we propose the mammalian hair follicles as a potential candidate. An Advanced Blast Simulator (ABS) was developed to generate shock waves simulating traumatic conditions on brains of rat model. Microarray analysis was performed in hair follicles to identify the gene expression profiles that are associated with shock waves. Gene set enrichment analysis (GSEA) and sub-network enrichment analysis (SNEA) were used to identify cell processes and molecular signaling cascades affected by simulated bomb blasts. Enrichment analyses indicated that genes with altered expression levels were involved in central nervous system (CNS)/peripheral nervous system (PNS) responses as well as signal transduction including Ca2+, K+-transportation-dependent signaling, Toll-Like Receptor (TLR) signaling and Mitogen Activated Protein Kinase (MAPK) signaling cascades. Many of the pathways identified as affected by shock waves in the hair follicles have been previously reported to be TBI responsive in other organs such as brain and blood. The results suggest that the hair follicle has some common TBI responsive molecular signatures to other tissues. Moreover, various TBI-associated diseases were identified as preferentially affected using a gene network approach, indicating that the hair follicle may be capable of reflecting comprehensive responses to TBI conditions. Accordingly, the present study demonstrates that the hair follicle is a potentially viable system for rapid and non-invasive TBI diagnosis.	[Zhang, Jing; Carnduff, Lisa; Norman, Grant; Langlois, Valerie S.] Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada; [Josey, Tyson; Wang, Yushan; Sawyer, Thomas W.] Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada; [Martyniuk, Christopher J.] Univ New Brunswick, Fredericton, NB, Canada; [Martyniuk, Christopher J.] Canadian River Inst, Fredericton, NB, Canada	Royal Military College - Canada; University of New Brunswick	Langlois, VS (corresponding author), Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada.	valerie.langlois@rmc.ca	Zhang, Jing/F-4468-2017	Zhang, Jing/0000-0002-6076-7321; Langlois, Valerie S./0000-0003-4031-6838; Martyniuk, Christopher J./0000-0003-0921-4796	Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF)	Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF)	This research was supported by the Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF), http://www.drdc-rddc.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054657; Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; [Anonymous], 2004, SCI STKE; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergad PL, 2000, AM J PHYSIOL-CELL PH, V279, pC1906, DOI 10.1152/ajpcell.2000.279.6.C1906; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chishti YZ, 2013, GEN COMP ENDOCR, V192, P115, DOI 10.1016/j.ygcen.2013.04.033; Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI; Defense Manpower Data Center (DMDC), 2008, GLOB WAR TERR CAUS R; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; DRAGUNOW M, 1995, BRAIN RES REV, V21, P1, DOI 10.1016/0165-0173(95)00003-L; Elsayed NM, 1996, EXP LUNG RES, V22, P179, DOI 10.3109/01902149609050846; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Garrett MR, 2003, MAMM GENOME, V14, P268, DOI 10.1007/s00335-002-2245-9; Gilibert S, 2009, J HYPERTENS, V27, P1186, DOI 10.1097/HJH.0b013e328329e4c0; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; He M, 2013, CHIN J TRAUMATOL, V16, P136, DOI 10.3760/cma.j.issn.1008-1275.2013.03.002; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hnasko TS, 2012, ANNU REV PHYSIOL, V74, P225, DOI 10.1146/annurev-physiol-020911-153315; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Langlois VS, 2013, MECH DEVELOP, V130, P304, DOI 10.1016/j.mod.2012.12.002; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Maejima D, 2011, MICROCIRCULATION, V18, P474, DOI 10.1111/j.1549-8719.2011.00108.x; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Moreno C, 2011, AM J PHYSIOL-HEART C, V300, pH1530, DOI 10.1152/ajpheart.01026.2010; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mott FW, 1916, LANCET, V1, P331; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Olson N Eric, 2006, NeuroRx, V3, P373; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritzel D, 2011, MIL VET HLTH RES FOR; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; STENN KS, 1994, J INVEST DERMATOL, V103, P107, DOI 10.1111/1523-1747.ep12391844; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang SJ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat046; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yamada T, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.029; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	83	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104518	10.1371/journal.pone.0104518	http://dx.doi.org/10.1371/journal.pone.0104518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136963	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100039
J	Chen, QR; Hu, Y; Yan, CH; Buetow, K; Meerzaman, D				Chen, Qing-Rong; Hu, Ying; Yan, Chunhua; Buetow, Kenneth; Meerzaman, Daoud			Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; SUSCEPTIBILITY; POLYMORPHISMS; GLIOMA; CELLS; RISK	Prior expression quantitative trait locus (eQTL) studies have demonstrated heritable variation determining differences in gene expression. The majority of eQTL studies were based on cell lines and normal tissues. We performed cis-eQTL analysis using glioblastoma multiforme (GBM) data sets obtained from The Cancer Genome Atlas (TCGA) to systematically investigate germline variation's contribution to tumor gene expression levels. We identified 985 significant cis-eQTL associations (FDR<0.05) mapped to 978 SNP loci and 159 unique genes. Approximately 57% of these eQTLs have been previously linked to the gene expression in cell lines and normal tissues; 43% of these share cis associations known to be associated with functional annotations. About 25% of these cis-eQTL associations are also common to those identified in Breast Cancer from a recent study. Further investigation of the relationship between gene expression and patient clinical information identified 13 eQTL genes whose expression level significantly correlates with GBM patient survival (p<0.05). Most of these genes are also differentially expressed in tumor samples and organ-specific controls (p<0.05). Our results demonstrated a significant relationship of germline variation with gene expression levels in GBM. The identification of eQTLs-based expression associated survival might be important to the understanding of genetic contribution to GBM cancer prognosis.	[Chen, Qing-Rong; Hu, Ying; Yan, Chunhua; Buetow, Kenneth; Meerzaman, Daoud] NIH, Natl Canc Inst, Ctr Biomed Informat & Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, QR (corresponding author), NIH, Natl Canc Inst, Ctr Biomed Informat & Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	chenqi@mail.nih.gov						Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Boyle LH, 2013, P NATL ACAD SCI USA, V110, P3465, DOI 10.1073/pnas.1222342110; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coutinho P, 2010, GENET MOL RES, V9, P539, DOI 10.4238/vol9-1gmr753; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; ELEXPURUCAMIRUAGA J, 1995, CANCER RES, V55, P4237; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Kappei D, 2013, EMBO J, V32, P1681, DOI 10.1038/emboj.2013.105; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Lai R, 2005, CANCER EPIDEM BIOMAR, V14, P1784, DOI 10.1158/1055-9965.EPI-05-0105; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Rousalova I, 2010, INT J ONCOL, V36, P275, DOI 10.3892/ijo_00000498; Saraiva N, 2013, J CELL BIOL, V202, P699, DOI 10.1083/jcb.201301016; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shpak M, 2014, GENOMICS, V103, P252, DOI 10.1016/j.ygeno.2014.02.005; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wuchty S, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-11; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	34	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105393	10.1371/journal.pone.0105393	http://dx.doi.org/10.1371/journal.pone.0105393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133526	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700111
J	Durand, MT; Becari, C; de Oliveira, M; do Carmo, JM; Silva, CAA; Prado, CM; Fazan, R; Salgado, HC				Durand, Marina T.; Becari, Christiane; de Oliveira, Mauro; do Carmo, Jussara M.; Aguiar Silva, Carlos Alberto; Prado, Cibele M.; Fazan, Rubens, Jr.; Salgado, Helio C.			Pyridostigmine Restores Cardiac Autonomic Balance after Small Myocardial Infarction in Mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CHOLINERGIC STIMULATION; VENTRICULAR-FUNCTION; ACETYLCHOLINESTERASE INHIBITION; PARASYMPATHETIC CONTROL; VAGAL-STIMULATION; MAXIMAL EXERCISE; FAILURE; IMPROVES; MODULATION	The effect of pyridostigmine (PYR) - an acetylcholinesterase inhibitor - on hemodynamics and cardiac autonomic control, was never studied in conscious myocardial infarcted mice. Telemetry transmitters were implanted into the carotid artery under isoflurane anesthesia. Seven to ten days after recovery from the surgery, basal arterial pressure and heart rate were recorded, while parasympathetic and sympathetic tone (Delta HR) was evaluated by means of methyl atropine and propranolol. After the basal hemodynamic recording the mice were subjected to left coronary artery ligation for producing myocardial infarction (MI), or sham operation, and implantation of minipumps filled with PYR or saline. Separate groups of anesthetized (isoflurane) mice previously (4 weeks) subjected to MI, or sham coronary artery ligation, were submitted to cardiac function examination. The mice exhibited an infarct length of approximately 12%, no change in arterial pressure and increased heart rate only in the 1st week after MI. Vagal tone decreased in the 1 st week, while the sympathetic tone was increased in the 1 st and 4 th week after MI. PYR prevented the increase in heart rate but did not affect the arterial pressure. Moreover, PYR prevented the increase in sympathetic tone throughout the 4 weeks. Concerning the parasympathetic tone, PYR not only impaired its attenuation in the 1 st week, but enhanced it in the 4 th week. MI decreased ejection fraction and increased diastolic and systolic volume. Therefore, the pharmacological increase of peripheral acetylcholine availability by means of PYR prevented tachycardia, increased parasympathetic and decreased sympathetic tone after MI in mice.	[Durand, Marina T.; Becari, Christiane; de Oliveira, Mauro; Aguiar Silva, Carlos Alberto; Fazan, Rubens, Jr.; Salgado, Helio C.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Prado, Cibele M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil; [do Carmo, Jussara M.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Mississippi; University of Mississippi Medical Center	Salgado, HC (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil.	hcsalgado@fmrp.usp.br	Becari, Christiane/ABE-7066-2021; Junior, Rubens Fazan/V-3114-2019; Durand, Marina/AAH-2846-2020; Becari, Christiane/J-6895-2015; Prado, Cibele M/P-5773-2016	Becari, Christiane/0000-0001-8548-9674; Junior, Rubens Fazan/0000-0002-6200-6008; Durand, Marina/0000-0002-5625-4662; Prado, Cibele M/0000-0003-4321-0879	Fapesp [2012/03349-1]; NAP-NIC-USP [12.1.24345.01.0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-NIC-USP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from Fapesp (2012/03349-1), NAP-NIC-USP (12.1.24345.01.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Androne AS, 2003, HEART, V89, P854, DOI 10.1136/heart.89.8.854; Arenja N, 2013, AM J MED, V126, P515, DOI 10.1016/j.amjmed.2012.11.028; Azevedo ER, 1999, CIRCULATION, V100, P274, DOI 10.1161/01.CIR.100.3.274; Behling A, 2003, AM HEART J, V146, P494, DOI 10.1016/S0002-8703(03)00319-3; Bernatova I, 2003, PHARMACOL BIOCHEM BE, V74, P901, DOI 10.1016/S0091-3057(03)00012-1; Bibevski S, 2011, HEART FAIL REV, V16, P129, DOI 10.1007/s10741-010-9190-6; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Bridgman P, 2005, AM J PHYSIOL-HEART C, V289, pH586, DOI 10.1152/ajpheart.00474.2004; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1; Castro RRT, 2006, INT J CARDIOL, V107, P138, DOI 10.1016/j.ijcard.2005.01.035; Castro RRT, 2004, HEART, V90, P1119, DOI 10.1136/hrt.2003.028167; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; de La Fuente RN, 2013, CLIN EXP PHARMACOL P, V40, P610, DOI 10.1111/1440-1681.12121; Desai MY, 2011, HEART FAIL REV, V16, P179, DOI 10.1007/s10741-010-9195-1; Dewland TA, 2007, AM J PHYSIOL-HEART C, V293, pH86, DOI 10.1152/ajpheart.01339.2006; Dunlap ME, 2003, AM J PHYSIOL-HEART C, V285, pH1632, DOI 10.1152/ajpheart.01051.2002; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Higuchi MD, 1999, J CARDIAC SURG, V14, P401; Infanger DW, 2010, CIRC RES, V106, P1763, DOI 10.1161/CIRCRESAHA.109.213025; Ishise H, 1998, J APPL PHYSIOL, V84, P1234, DOI 10.1152/jappl.1998.84.4.1234; Katare RG, 2010, J MOL CELL CARDIOL, V49, P234, DOI 10.1016/j.yjmcc.2010.03.007; Kumashiro H, 1999, BASIC RES CARDIOL, V94, P78, DOI 10.1007/s003950050129; LaCroix C, 2008, AM J PHYSIOL-HEART C, V294, pH810, DOI 10.1152/ajpheart.00724.2007; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; LEVY MN, 1969, J APPL PHYSIOL, V27, P465, DOI 10.1152/jappl.1969.27.4.465; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; MANABE N, 1991, J AUTONOM NERV SYST, V32, P233, DOI 10.1016/0165-1838(91)90117-L; MUSCHOLL E, 1980, AM J PHYSIOL, V239, pH713, DOI 10.1152/ajpheart.1980.239.6.H713; Nobrega ACL, 2001, CLIN AUTON RES, V11, P11, DOI 10.1007/BF02317797; Nobrega ACL, 2008, INT J CARDIOL, V125, P418, DOI 10.1016/j.ijcard.2007.01.043; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Sabino JPJ, 2013, AUTON NEUROSCI-BASIC, V173, P58, DOI 10.1016/j.autneu.2012.11.007; Salto-Tellez M, 2004, CARDIOVASC PATHOL, V13, P91, DOI 10.1016/s1054-8807(03)00129-7; Sam F, 2000, AM J PHYSIOL-HEART C, V279, pH422, DOI 10.1152/ajpheart.2000.279.1.H422; Schwartz PJ, 2013, NETH HEART J, V21, P82, DOI 10.1007/s12471-012-0368-5; Schwartz PJ, 2011, HEART FAIL REV, V16, P101, DOI 10.1007/s10741-010-9179-1; Serra SM, 2009, J CARD FAIL, V15, P124, DOI 10.1016/j.cardfail.2008.10.018; Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; VANHOUTTE PM, 1980, AM J PHYSIOL, V238, pH275, DOI 10.1152/ajpheart.1980.238.3.H275; WATANABE AM, 1984, FED PROC, V43, P2618; Yutzey KE, 2007, CIRCULATION, V115, P792, DOI 10.1161/CIRCULATIONAHA.106.682534; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zheng C, 2005, P ANN INT IEEE EMBS, P7072; Zimerman LI, 2010, BRAZ J MED BIOL RES, V43, P211, DOI 10.1590/S0100-879X2010005000001	55	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104476	10.1371/journal.pone.0104476	http://dx.doi.org/10.1371/journal.pone.0104476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133392	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700029
J	Kiss, T; Kovacs, K; Komocsi, A; Tornyos, A; Zalan, P; Sumegi, B; Gallyas, F; Kovacs, K				Kiss, Tamas; Kovacs, Krisztina; Komocsi, Andras; Tornyos, Adrienn; Zalan, Petra; Sumegi, Balazs; Gallyas, Ferenc, Jr.; Kovacs, Krisztina			Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ARTERIAL-HYPERTENSION; SIGNALING PATHWAYS; RODENT MODEL; TNF-ALPHA; INFLAMMATION; INHIBITION; EXPRESSION; SORAFENIB	Pulmonary arterial hypertension (PH) is associated with high mortality due to right ventricular failure and hypoxia, therefore to understand the mechanism by which pulmonary vascular remodeling initiates these processes is very important. We used a well-characterized monocrotaline (MCT)-induced rat PH model, and analyzed lung morphology, expression of cytokines, mitogen-activated protein kinase (MAPK) phosphorylation, and phosphatidylinositol 3-kinase-Akt (PI-3k-Akt) pathway and nuclear factor (NF)-kappa B activation in order to elucidate the mechanisms by which sildenafil's protective effect in PH is exerted. Besides its protective effect on lung morphology, sildenafil suppressed multiple cytokines involved in neutrophil and mononuclear cells recruitment including cytokine-induced neutrophil chemoattractant (CINC)-1, CINC-2 alpha/beta, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-1 alpha, lipopolysaccharide induced CXC chemokine (LIX), monokine induced by gamma interferon (MIG), macrophage inflammatory protein (MIP)-1 alpha, and MIP-3 alpha. NF-kappa B activation and phosphorylation were also attenuated by sildenafil. Furthermore, sildenafil reduced extracellular signal-regulated kinase (ERK) 1/ 2 and p38 MAPK activation while enhanced activation of the cytoprotective Akt pathway in PH. These data suggest a beneficial effect of sildenafil on inflammatory and kinase signaling mechanisms that substantially contribute to its protective effects, and may have potential implications in designing future therapeutic strategies in the treatment of pulmonary hypertension.	[Kiss, Tamas] Univ Pecs, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Kovacs, Krisztina] Univ Pecs, Dept Pathol, Pecs, Hungary; [Komocsi, Andras; Tornyos, Adrienn] Univ Pecs, Inst Heart, Pecs, Hungary; [Zalan, Petra; Sumegi, Balazs; Gallyas, Ferenc, Jr.; Kovacs, Krisztina] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs] MTA PTE, Nucl Mitochondrial Res Grp, Pecs, Hungary; [Sumegi, Balazs] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Kovacs, K (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary.	krisztina.kovacs@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Kovacs, Krisztina/E-9712-2010; Gallyas, Ferenc/C-2272-2012	Gallyas, Ferenc/0000-0002-1906-4333	"National Excellence Program - Elaborating and operating an inland student and researcher personal support system" [TAMOP 4.2.4. A/2-11-1-2012-0001]; European Union; European Social Fund; Bolyai Scholarship [PTE-AOK-KA-2013/3]; OTKA [NN109841]	"National Excellence Program - Elaborating and operating an inland student and researcher personal support system"; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Bolyai Scholarship(Hungarian Academy of Sciences); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was realized in the frames of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system." The project was subsidized by the European Union and co-financed by the European Social Fund. This work was also supported by Bolyai Scholarship, PTE-AOK-KA-2013/3 and OTKA NN109841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousawi AM, 2010, SHOCK, V34, P261, DOI 10.1097/SHK.0b013e3181d8e2a6; Alexandru B, 2001, Pneumologia, V50, P85; Badesch DB, 2007, J RHEUMATOL, V34, P2417; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Clayton RA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-4; de Visser YP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-30; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Dumitrascu Rio, 2008, BMC Pulm Med, V8, P25, DOI 10.1186/1471-2466-8-25; Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC; Fan ZY, 2014, DNA CELL BIOL, V33, P12, DOI 10.1089/dna.2013.2022; Fartoukh M, 1988, CHEST S, V114, p50S; Firth AL, 2010, DIS MODEL MECH, V3, P268, DOI 10.1242/dmm.003616; Fukudome EY, 2012, SURGERY, V152, P254, DOI 10.1016/j.surg.2012.03.013; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Guo YL, 2013, J HUAZHONG U SCI-MED, V33, P470, DOI 10.1007/s11596-013-1144-5; Hosokawa S, 2013, CARDIOVASC RES, V99, P35, DOI 10.1093/cvr/cvt105; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176; Kim TJ, 2007, VASC PHARMACOL, V46, P43, DOI 10.1016/j.vph.2006.06.007; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Lagente V, 2004, J PHARMACOL EXP THER, V310, P367, DOI 10.1124/jpet.103.061739; LALICH JJ, 1977, ARCH PATHOL LAB MED, V101, P69; Lepetit H, 2005, EUR RESPIR J, V25, P834, DOI 10.1183/09031936.05.00072504; Li B, 2007, ANESTH ANALG, V105, P1034, DOI 10.1213/01.ane.0000278736.81133.26; Liu JW, 2009, SHOCK, V32, P317, DOI 10.1097/SHK.0b013e31819c374c; Lu J, 2004, J THORAC CARDIOV SUR, V128, P850, DOI 10.1016/j.jtcvs.2004.03.003; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Moreno-Vinasco L, 2008, PHYSIOL GENOMICS, V33, P278, DOI 10.1152/physiolgenomics.00169.2007; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Nedvig K, 2012, J MOL NEUROSCI, V48, P788, DOI 10.1007/s12031-012-9870-x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Ross DJ, 2012, J HEART LUNG TRANSPL, V31, P865, DOI 10.1016/j.healun.2012.04.008; Rossi F, 2006, REGUL PEPTIDES, V133, P155, DOI 10.1016/j.regpep.2005.09.029; Rubin LJ, 2011, CHEST, V140, P1274, DOI 10.1378/chest.10-0969; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Suwara MI, 2013, MUCOSAL IMMUNOL; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wang T, 2009, EUR RESPIR J, V33, P1122, DOI 10.1183/09031936.00055908; WILSON DW, 1989, MICROVASC RES, V38, P57; Yanagisawa R, 2012, CIRC J, V76, P1245, DOI 10.1253/circj.CJ-11-1192; Zeng Z, 2010, CARDIOVASC THER, V28, P23, DOI 10.1111/j.1755-5922.2009.00115.x	55	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104890	10.1371/journal.pone.0104890	http://dx.doi.org/10.1371/journal.pone.0104890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133539	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000341302700047
J	Nenseth, HZ; Dezitter, X; Tesikova, M; Mueller, F; Klokk, TI; Hager, GL; Saatcioglu, F				Nenseth, Hatice Z.; Dezitter, Xavier; Tesikova, Martina; Mueller, Florian; Klokk, Tove I.; Hager, Gordon L.; Saatcioglu, Fahri			Distinctly Different Dynamics and Kinetics of Two Steroid Receptors at the Same Response Elements in Living Cells	PLOS ONE			English	Article							LIGAND-SPECIFIC DYNAMICS; LONG TERMINAL REPEAT; ANDROGEN-RECEPTOR; GLUCOCORTICOID-RECEPTOR; DNA-BINDING; ACTINOMYCIN-D; TRANSCRIPTIONAL ELONGATION; IN-VITRO; P-TEFB; PROMOTER	Closely related transcription factors (TFs) can bind to the same response elements (REs) with similar affinities and activate transcription. However, it is unknown whether transcription is similarly orchestrated by different TFs bound at the same RE. Here we have compared the recovery half time (t(1/2)), binding site occupancy and the resulting temporal changes in transcription upon binding of two closely related steroid receptors, the androgen and glucocorticoid receptors (AR and GR), to their common hormone REs (HREs). We show that there are significant differences at all of these levels between AR and GR at the MMTV HRE when activated by their ligands. These data show that two TFs bound at the same RE can have significantly different modes of action that can affect their responses to environmental cues.	[Nenseth, Hatice Z.; Dezitter, Xavier; Tesikova, Martina; Klokk, Tove I.; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, Oslo, Norway; [Mueller, Florian] Inst Pasteur, Computat Imaging & Modeling Unit, Paris, France; [Hager, Gordon L.] Natl Inst Hlth, Natl Canc Inst, Lab Receptor Biol & Gene Express, Bethesda, MD USA; [Saatcioglu, Fahri] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway	University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	fahris@ibv.uio.no	Dezitter, Xavier/H-6923-2018; Mueller, Florian/C-9075-2012	Dezitter, Xavier/0000-0001-6932-6947; Mueller, Florian/0000-0002-9622-4396; Nenseth, Hatice Zeynep/0000-0002-8385-3476	Norwegian Research Council; Norwegian Cancer Society; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); University of Oslo	This work was supported by funds from the Norwegian Research Council (www.forskningsradet.no), Norwegian Cancer Society (www.kreftforeningen.no), and University of Oslo (www.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; CATO ACB, 1987, EMBO J, V6, P363, DOI 10.1002/j.1460-2075.1987.tb04763.x; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; Czyz M, 1998, ACTA BIOCHIM POL, V45, P67, DOI 10.18388/abp.1998_4319; Dezitter X, 2011, J STEROID BIOCHEM, V126, P104, DOI 10.1016/j.jsbmb.2011.04.008; ELBI C, 2004, SCI STKE, pPL10; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; FUNDER JW, 1993, SCIENCE, V259, P1132, DOI 10.1126/science.8382375; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Haelens A, 2001, BIOCHEM J, V353, P611, DOI 10.1042/0264-6021:3530611; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Lee YF, 1999, P NATL ACAD SCI USA, V96, P14724, DOI 10.1073/pnas.96.26.14724; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSCHKE KB, 1995, ENDOCRINE, V3, P819, DOI 10.1007/BF02935687; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; PUVIONDUTILLEUL F, 1992, EUR J CELL BIOL, V58, P149; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RUNDLETT SE, 1995, MOL CELL ENDOCRINOL, V109, P1, DOI 10.1016/0303-7207(95)03477-O; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Whitacre DC, 2001, ENDOCRINE, V15, P111, DOI 10.1385/ENDO:15:1:111; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105204	10.1371/journal.pone.0105204	http://dx.doi.org/10.1371/journal.pone.0105204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133404	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700085
J	Ponsuwanna, P; Kumpornsin, K; Chookajorn, T				Ponsuwanna, Patrath; Kuempornsin, Krittikorn; Chookajorn, Thanat			Genome-Wide Prediction of the Polymorphic Ser Gene Family in Tetrahymena thermophila Based on Motif Analysis	PLOS ONE			English	Article							IMMOBILIZATION ANTIGEN LOCUS; MOLECULAR CHARACTERIZATION; SURFACE PROTEIN; EXPRESSION; SEQUENCE; MALARIA; CELL; STABILITY; SELECTION; BIOLOGY	Even though antigenic variation is employed among parasitic protozoa for host immune evasion, Tetrahymena thermophila, a free-living ciliate, can also change its surface protein antigens. These cysteine-rich glycosylphosphatidylinositol (GPI)-linked surface proteins are encoded by a family of polymorphic Ser genes. Despite the availability of T. thermophila genome, a comprehensive analysis of the Ser family is limited by its high degree of polymorphism. In order to overcome this problem, a new approach was adopted by searching for Ser candidates with common motif sequences, namely length-specific repetitive cysteine pattern and GPI anchor site. The candidate genes were phylogenetically compared with the previously identified Ser genes and classified into subtypes. Ser candidates were often found to be located as tandem arrays of the same subtypes on several chromosomal scaffolds. Certain Ser candidates located in the same chromosomal arrays were transcriptionally expressed at specific T. thermophila developmental stages. These Ser candidates selected by the motif analysis approach can form the foundation for a systematic identification of the entire Ser gene family, which will contribute to the understanding of their function and the basis of T. thermophila antigenic variation.	[Ponsuwanna, Patrath; Kuempornsin, Krittikorn] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10700, Thailand; [Chookajorn, Thanat] Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria, Bangkok 10700, Thailand	Mahidol University; Mahidol University	Chookajorn, T (corresponding author), Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria, Bangkok 10700, Thailand.	thanat.cho@mahidol.edu			Commission of Higher Education-Thailand Research Fund-Mahidol University [RMU5380054]; CPMO-National Science and Technology Development Agency; Thailand Research Fund through the Royal Golden Jubilee PhD Program [PHD/0044/2554]	Commission of Higher Education-Thailand Research Fund-Mahidol University; CPMO-National Science and Technology Development Agency; Thailand Research Fund through the Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This work was supported by the Commission of Higher Education-Thailand Research Fund-Mahidol University (RMU5380054) and the CPMO-National Science and Technology Development Agency. KK was supported by The Thailand Research Fund through the Royal Golden Jubilee PhD Program (PHD/0044/2554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Chang JY, 2011, BIOCHEMISTRY-US, V50, P3414, DOI 10.1021/bi200131j; Chookajorn T, 2004, P NATL ACAD SCI USA, V101, P911, DOI 10.1073/pnas.2637116100; Chookajorn T, 2008, TRENDS PARASITOL, V24, P455, DOI 10.1016/j.pt.2008.07.005; Chookajorn T, 2007, TRENDS PARASITOL, V23, P563, DOI 10.1016/j.pt.2007.08.022; Collins K, 2005, CURR BIOL, V15, pR317, DOI 10.1016/j.cub.2005.04.039; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; DEAK JC, 1995, GENE, V164, P163, DOI 10.1016/0378-1119(95)00446-D; DOERDER FP, 1985, GENETICS, V111, P273; Doerder FP, 2000, BIOCHEM BIOPH RES CO, V278, P621, DOI 10.1006/bbrc.2000.3857; Doerder FP, 2000, GENE, V257, P319, DOI 10.1016/S0378-1119(00)00380-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; ELLIOTT AM, 1959, ANNU REV MICROBIOL, V13, P79, DOI 10.1146/annurev.mi.13.100159.000455; Gerber CA, 2002, GENETICS, V160, P1469; HALLBERG RL, 1984, MOL CELL BIOL, V4, P2170, DOI 10.1128/MCB.4.10.2170; HARRISON GS, 1985, NUCLEIC ACIDS RES, V13, P73, DOI 10.1093/nar/13.1.73; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; KO YG, 1992, J PROTOZOOL, V39, P719, DOI 10.1111/j.1550-7408.1992.tb04454.x; Kusch J, 2001, J MEMBRANE BIOL, V180, P101, DOI 10.1007/s002320010062; LOVE HD, 1988, MOL CELL BIOL, V8, P427, DOI 10.1128/MCB.8.1.427; Lujan HD, 2011, ESSAYS BIOCHEM, V51, P177, DOI [10.1042/BSE0510177, 10.1042/bse0510177]; MARGOLIN P, 1959, J PROTOZOOL, V6, P207, DOI 10.1111/j.1550-7408.1959.tb04359.x; MCMILLAN PJ, 1995, NUCLEIC ACIDS RES, V23, P942, DOI 10.1093/nar/23.6.942; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Miller M.A., 2010, P GAT COMP ENV WORKS; PHILLIPS RB, 1967, GENETICS, V56, P667; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141; RON A, 1992, J PROTOZOOL, V39, P508, DOI 10.1111/j.1550-7408.1992.tb04840.x; Simon EM, 2008, BIODIVERS CONSERV, V17, P365, DOI 10.1007/s10531-007-9255-6; Simon MC, 2007, J EUKARYOT MICROBIOL, V54, P1, DOI 10.1111/j.1550-7408.2006.00226.x; SMITH DL, 1992, J PROTOZOOL, V39, P420, DOI 10.1111/j.1550-7408.1992.tb01475.x; SMITH DL, 1992, J PROTOZOOL, V39, P628, DOI 10.1111/j.1550-7408.1992.tb04862.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARGELL LA, 1990, NUCLEIC ACIDS RES, V18, P6637, DOI 10.1093/nar/18.22.6637; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Templeton TJ, 2007, TRENDS PARASITOL, V23, P205, DOI 10.1016/j.pt.2007.03.001; TONDRAVI MM, 1990, MOL CELL BIOL, V10, P6091, DOI 10.1128/MCB.10.11.6091; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; WILLIAMS NE, 1985, MOL CELL BIOL, V5, P1925, DOI 10.1128/MCB.5.8.1925	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105201	10.1371/journal.pone.0105201	http://dx.doi.org/10.1371/journal.pone.0105201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133747	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700083
J	Xiao, XY; Ou, B; Yang, HY; Wu, H; Luo, BM				Xiao, Xiaoyun; Ou, Bing; Yang, Haiyun; Wu, Huan; Luo, Baoming			Breast Contrast-Enhanced Ultrasound: Is a Scoring System Feasible? -A Preliminary Study in China	PLOS ONE			English	Article							POWER DOPPLER US; CANCER TUMOR SIZE; PREOPERATIVE ASSESSMENT; BI-RADS; LESIONS; ELASTOGRAPHY; MICROBUBBLE; AGENT; MAMMOGRAPHY; SONOGRAPHY	Objectives: Although many studies about breast contrast-enhanced ultrasound had been conducted, clear diagnostic criteria for evaluating enhancement patterns are still lacking. This study aims to identify significant indicators for breast contrast-enhanced ultrasound and to establish an initial scoring system. Materials and Methods: Totally 839 patients were included in the study. This study was divided into two parts. 364 patients were included in part 1 while 475 in part 2. Conventional ultrasound and contrast-enhanced ultrasound were used to examine each lesion. Only the cases in part 2 were also examined by elastography. In part 1, Logistic regression analysis was performed to predict significant variables. A 5-point scoring system was developed based on the results. In part 2, the scoring system was used to evaluate all the breast lesions. To evaluate the diagnostic efficacy of the new scoring system, it was compared with the system established for elastography and conventional ultrasound (BI-RADS). Results: Three independent variables, namely, lesion scope, margin, and shape were selected in the final step of the logistic regression analysis in part 1. In part 2, the area under the ROC (receiver operating characteristic) curve for the contrast-enhanced scoring system was 0.912. The difference in the diagnostic capabilities of the contrast-enhanced scoring system and elastography was not statistically significant (P = 0.17). The difference in the diagnostic capabilities of the contrast-enhanced scoring system and BI-RADS was statistically significant (P<0.001). Conclusions: The contrast-enhanced patterns of benign and malignant breast tumors are different. The application of a 5-point scoring system for contrast-enhanced ultrasound is clinically promising.	[Xiao, Xiaoyun; Ou, Bing; Yang, Haiyun; Wu, Huan; Luo, Baoming] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xiao, XY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	papayaxxy@163.com						Algul Ali, 2003, Tani Girisim Radyol, V9, P199; American College of Radiology, 2003, BREAST IM REP DAT SY; Are C, 2013, J SURG ONCOL, V107, P221, DOI 10.1002/jso.23248; Balleyguier C, 2009, EUR J RADIOL, V69, P14, DOI 10.1016/j.ejrad.2008.07.037; Berg WA, 2000, RADIOLOGY, V214, P59, DOI 10.1148/radiology.214.1.r00ja2559; Berg WA, 2005, AM J ROENTGENOL, V185, P952, DOI 10.2214/AJR.04.0929; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; Caproni N, 2010, EUR RADIOL, V20, P1384, DOI 10.1007/s00330-009-1690-1; Cho N, 2008, KOREAN J RADIOL, V9, P111, DOI 10.3348/kjr.2008.9.2.111; del Carmen MG, 2003, CANCER-AM CANCER SOC, V98, P590, DOI 10.1002/cncr.11517; Du J, 2008, J ULTRAS MED, V27, P844; Du J, 2008, J ULTRAS MED, V27, P833, DOI 10.7863/jum.2008.27.6.833; Golshan M, 2004, BREAST, V13, P265, DOI 10.1016/j.breast.2004.05.005; Heusinger K, 2005, BREAST CANCER RES TR, V94, P17, DOI 10.1007/s10549-005-6653-x; Hlawatsch A, 2002, AM J ROENTGENOL, V179, P1493, DOI 10.2214/ajr.179.6.1791493; Huber S, 2001, ULTRASOUND MED BIOL, V27, P3, DOI 10.1016/S0301-5629(00)00282-9; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Jiang YX, 2007, ULTRASOUND MED BIOL, V33, P1873, DOI 10.1016/j.ultrasmedbio.2007.06.002; Kedar RP, 1996, RADIOLOGY, V198, P679, DOI 10.1148/radiology.198.3.8628854; Kettenbach J, 2005, EUR J RADIOL, V53, P238, DOI 10.1016/j.ejrad.2004.04.017; Kook SH, 2003, J CLIN ULTRASOUND, V31, P227, DOI 10.1002/jcu.10172; Liberman L, 2003, AM J ROENTGENOL, V181, P519, DOI 10.2214/ajr.181.2.1810519; Lichtenbeld HC, 1998, INT J CANCER, V77, P455, DOI 10.1002/(SICI)1097-0215(19980729)77:3<455::AID-IJC23>3.3.CO;2-C; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Metz S, 2003, ACAD RADIOL, V10, P484, DOI 10.1016/S1076-6332(03)80056-9; Moon WK, 2000, RADIOLOGY, V217, P240, DOI 10.1148/radiology.217.1.r00oc03240; Ozdemir A, 2004, J ULTRAS MED, V23, P183; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Reinikainen H, 2001, ACTA RADIOL, V42, P106, DOI 10.1080/028418501127346341; Ricci P, 2007, ULTRASCHALL MED, V28, P57, DOI 10.1055/s-2006-927226; Saracco A, 2009, ACTA RADIOL, V50, P854, DOI 10.1080/02841850903085576; Satake H, 2000, EUR RADIOL, V10, P1726, DOI 10.1007/s003300000465; Schroder RJ, 2002, ROFO-FORTSCHR RONTG, V174, P1132, DOI 10.1055/s-2002-33940; Sedgwick E, 2011, SEMIN ROENTGENOL, V46, P245, DOI 10.1053/j.ro.2011.04.001; Shoma A, 2006, BREAST J, V12, P252, DOI 10.1111/j.1075-122X.2006.00249.x; Suzuki Tomoyoshi, 2006, Int J Clin Oncol, V11, P108, DOI 10.1007/s10147-006-0564-7; Svensson W.E, 1997, EUR J ULTRASOUND, V6, P77; Szabo BK, 2003, ACTA RADIOL, V44, P379, DOI 10.1034/j.1600-0455.2003.00084.x; Tan SM, 2008, BREAST, V17, P252, DOI 10.1016/j.breast.2007.10.015; Taskin F, 2012, J CLIN ULTRASOUND, V40, P261, DOI 10.1002/jcu.21923; Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823; van Esser S, 2007, Cancer Imaging, V7, P63, DOI 10.1102/1470-7330.2007.0012; Wan CF, 2012, RADIOLOGY, V262, P450, DOI 10.1148/radiol.11110789; Xu HX, 2009, WORLD J RADIOL, V1, P15, DOI 10.4329/wjr.v1.i1.15; Yang WT, 2001, RADIOLOGY, V220, P795, DOI 10.1148/radiol.2203001545; Yang WT, 1997, J ULTRAS MED, V16, P791; Zeggelink WFAK, 2003, MED PHYS, V30, P2919, DOI 10.1118/1.1621136; Zhao HJ, 2010, EUR J RADIOL, V73, P288, DOI 10.1016/j.ejrad.2009.05.043; Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807; Zhu QL, 2008, ULTRASOUND MED BIOL, V34, P1232, DOI 10.1016/j.ultrasmedbio.2008.01.004	51	36	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105517	10.1371/journal.pone.0105517	http://dx.doi.org/10.1371/journal.pone.0105517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133534	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700119
J	Castanho, CD; Prado, PI				Castanho, Camila de Toledo; Prado, Paulo Inacio			Benefit of Shading by Nurse Plant Does Not Change along a Stress Gradient in a Coastal Dune	PLOS ONE			English	Article							POSITIVE INTERACTIONS; ENVIRONMENTAL GRADIENTS; PRIMARY SUCCESSION; SEEDLING ESTABLISHMENT; FACILITATION; SHRUB; RESTORATION; VEGETATION; COMPETITION; HYPOTHESIS	The proximity of adult neighbors often increases the performance of woody seedlings under harsh environmental conditions but this nurse plant effect becomes less intense when abiotic stress is alleviated, as predicted by the stress gradient hypothesis (SGH). Although some studies have tested how the net nurse effect is changed by stress, few studies have tested how the mechanism that drives the facilitative effect of nurse responds to changes in stress. We conducted field experiments in a subtropical coastal dune to test if shading drives the known nurse effect of adults of the tree Guapira opposita on seedling performance of another tree species, Ternstroemia brasiliensis. We transplanted T. brasiliensis seedlings to three neighbor environments: under a G. opposita crown, under artificial shade and without neighbor as a control. Furthermore, assuming that proximity to the seashore correlates with stress intensity, we tested if the potential shade-driven facilitation became less intense as stress decreased. Regardless of the proximity to the seashore, after a year, the survival of T. brasiliensis seedlings was twice as high when the seedlings were under G. opposita or under artificial shade compared to the control, indicating that the nurse effect is driven by shade and that this facilitation mechanism is constant along the stress gradient. However, G. opposita and artificial shade had a negative effect on seedlings growth. Overall, our results showed that the facilitation mechanism behind the nurse effect did not wane as the stress was reduced. Furthermore, in spite of the potential costs in terms of biomass production, our study highlights the potential of nurse plants and artificial shade as techniques to improve the survival of transplanted seedlings used in the restoration of degraded shrubland coastal dunes.	[Castanho, Camila de Toledo; Prado, Paulo Inacio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo	Castanho, CD (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, Brazil.	ctcastanho@gmail.com	Prado, Paulo I/G-3353-2012; Prado, Paulo Inácio/AAN-6512-2021; Castanho, Camila T/D-4583-2012	Prado, Paulo Inácio/0000-0002-7174-5005; Castanho, Camila T/0000-0002-0198-3200	CAPES - Improvement of Higher Education Personnel; FAPESP - Sao Paulo Research Foundation [2012/09794-7]; CNPq - Brazilian National Council for Scientific and Technological Development	CAPES - Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP - Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by CAPES - Improvement of Higher Education Personnel - http://www.capes.gov.br - that provided a PhD scholarship for CTC; FAPESP - Sao Paulo Research Foundation (project No 2012/09794-7) - http://www.fapesp.br - with a posdoctoral fellowship for CTC; CNPq - Brazilian National Council for Scientific and Technological Development - http://www.cnpq.br - with a grant for PIP; and Petrobras - http://www.petrobras.com.br - that provided support for field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BOT SISTEMATICA GUIA; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; Armas C, 2009, J VEG SCI, V20, P535, DOI 10.1111/j.1654-1103.2009.01055.x; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bonanomi G, 2011, PLANT ECOL, V212, P1777, DOI 10.1007/s11258-011-9948-5; Correia Cristiane Maria Brandão, 2010, Braz. J. Bot., V33, P607, DOI 10.1590/S0100-84042010000400009; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butterfield BJ, 2013, FUNCT ECOL, V27, P907, DOI 10.1111/1365-2435.12019; Callaway RM, 1998, OIKOS, V82, P202, DOI 10.2307/3546931; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CALLAWAY RM, 1992, ECOLOGY, V73, P2118, DOI 10.2307/1941460; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Castanho CT, 2012, J VEG SCI, V23, P952, DOI 10.1111/j.1654-1103.2012.01414.x; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Cushman JH, 2010, J VEG SCI, V21, P821, DOI 10.1111/j.1654-1103.2010.01196.x; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; Franks SJ, 2003, PLANT ECOL, V168, P1, DOI 10.1023/A:1024426608966; Gomez-Aparicio L, 2005, J VEG SCI, V16, P191, DOI 10.1111/j.1654-1103.2005.tb02355.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Hastwell GT, 2003, J ECOL, V91, P941, DOI 10.1046/j.1365-2745.2003.00832.x; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Joy DA, 2002, PLANT ECOL, V160, P125, DOI 10.1023/A:1015812923216; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; KELLMAN M, 1992, J VEG SCI, V3, P679, DOI 10.2307/3235836; Kennedy PG, 2006, OECOLOGIA, V148, P464, DOI 10.1007/s00442-006-0382-7; King EG, 2008, RESTOR ECOL, V16, P464, DOI 10.1111/j.1526-100X.2007.00310.x; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Kunstler G, 2006, J VEG SCI, V17, P379, DOI 10.1111/j.1654-1103.2006.tb02458.x; Lacerda L.D., 1993, DRY COASTAL ECOSYSTE, P477; Lane C, 2008, J COASTAL RES, V24, P213, DOI 10.2112/07-0853.1; Larcher W, 1995, PHYSL PLANT ECOLOGY, P213; Lichter J, 2000, J ECOL, V88, P825, DOI 10.1046/j.1365-2745.2000.00503.x; Lubke RA, 2004, ECOL STU AN, V171, P67; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Martinez ML, 2003, PLANT ECOL, V168, P333, DOI 10.1023/A:1024406707115; MAUN MA, 1994, VEGETATIO, V111, P59; Maun MA, 1999, ECOL LETT, V2, P14, DOI 10.1046/j.1461-0248.1999.21048.x; Ogura A, 2008, ECOL RES, V23, P107, DOI 10.1007/s11284-007-0347-2; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Pakeman RJ, 2009, BIOL LETTERS, V5, P577, DOI 10.1098/rsbl.2009.0384; Sa CFC (n.d.), NYCT LIST ESP FLOR B; Scarano FR, 2002, ANN BOT-LONDON, V90, P517, DOI 10.1093/aob/mcf189; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; Smit C, 2006, J APPL ECOL, V43, P305, DOI 10.1111/j.1365-2664.2006.01147.x; Smit C, 2006, FOREST ECOL MANAG, V237, P471, DOI 10.1016/j.foreco.2006.09.069; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Taiz L., 2002, PLANT PHYSIOL, V9, P172; van Zonneveld MJ, 2012, J VEG SCI, V23, P541, DOI 10.1111/j.1654-1103.2011.01379.x; Wilson JB, 2001, ECOL LETT, V2, P233; Yang L, 2010, J VEG SCI, V21, P262, DOI 10.1111/j.1654-1103.2009.01140.x; YARRANTON GA, 1974, J ECOL, V62, P417, DOI 10.2307/2258988; Zuur Alain F., 2009, P1	58	10	10	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105082	10.1371/journal.pone.0105082	http://dx.doi.org/10.1371/journal.pone.0105082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127399	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300077
J	Li, XL; Rendon, JL; Choudhry, MA				Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.			T Cell IFN-gamma Suppression Following Alcohol and Burn Injury Is Independent of miRNA155	PLOS ONE			English	Article							NF-KAPPA-B; BACTERIAL TRANSLOCATION; DOWN-REGULATION; THERMAL-INJURY; RODENT MODEL; INTOXICATION; MICRORNA-155; ACTIVATION; MECHANISMS; DAMAGE	miRNA155 has been implicated in normal T cell function and their differentiations into the Th1 subtype. We have shown that acute alcohol (ethanol) intoxication combined with burn injury suppresses T cell IFN-gamma release. Herein, we examined whether the decrease in IFN-gamma is resulted from altered expression of miRNA155 and transcription factors -NFAT, Tbx21, Jun and Fos - in T cells following ethanol and burn injury. Mice received ethanol (similar to 3 g/Kg) 4 hours prior to similar to 12.5% total body surface area sham or burn injury and were sacrificed one day after injury. Splenic T cells were harvested and cultured with anti-CD3 (2 mu g/ml) in the presence or absence of rIL-12 (10 ng/ml) or PMA (10 ng/ml) plus ionomycin (50 ng/ml) for 48 hours. We observed a significant decrease in miRNA155, NFAT, Tbx21, Jun and Fos expression as well as IFN-gamma release in T cells cultured with anti-CD3 following ethanol and burn injury compared with shams. The co-treatment of T cells with rIL-12 prevented the decrease in IFN-gamma and NFAT, Tbx21, Jun and Fos, but not miRNA155. In contrast, the co-treatment with PMA plus ionomycin normalized the expression of NFAT. It did not prevent the decrease in IFN-gamma, Tbx21, Jun, Fos and miRNA155. Finally, results obtained in miRNA155(-/-) mice did not show any change in T cell release of IFN-gamma or expression of nuclear factors compared to wildtype mice. Together, these findings suggest that while ethanol and burn injury decreases the expression of miRNA155, it may not be involved in decreased IFN-gamma under those conditions.	[Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Alcohol Res Program, Maywood, IL 60153 USA; [Li, Xiaoling; Rendon, Juan L.; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Li, Xiaoling; Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Dept Surg, Maywood, IL 60153 USA; [Choudhry, Mashkoor A.] Loyola Univ, Chicago Hlth Sci Div, Dept Microbiol & Immunol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Choudhry, MA (corresponding author), Loyola Univ, Chicago Hlth Sci Div, Alcohol Res Program, Maywood, IL 60153 USA.	mchoudhry@luc.edu			National Institutes of Health [R01AA015731, F30AA020167]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA020167, R01AA015731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by the National Institutes of Health - R01AA015731 (MAC) and F30AA020167 (JLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CHATILA T, 1989, J IMMUNOL, V143, P1283; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; Choudhry MA, 2001, SHOCK, V16, P183, DOI 10.1097/00024382-200116030-00003; Choudhry MA, 1998, J IMMUNOL, V160, P929; Choudhry MA, 2002, AM J PHYSIOL-GASTR L, V282, pG937, DOI 10.1152/ajpgi.00235.2001; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fazal N, 2005, BBA-MOL BASIS DIS, V1741, P113, DOI 10.1016/j.bbadis.2004.10.006; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Grobmyer S. R., 1996, Journal of Burn Care and Rehabilitation, V17, P532, DOI 10.1097/00004630-199611000-00010; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Humar M, 2004, J PHARMACOL EXP THER, V311, P1232, DOI 10.1124/jpet.104.071332; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Kelly JL, 1999, SHOCK, V12, P39, DOI 10.1097/00024382-199907000-00006; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; Li XL, 2008, SHOCK, V29, P377, DOI 10.1097/shk.0b013e31815abe80; Li XL, 2012, MOL MED, V18, P982, DOI 10.2119/molmed.2011.00513; Li XL, 2011, J BURN CARE RES, V32, P489, DOI 10.1097/BCR.0b013e3182223c9e; Li XL, 2009, J IMMUNOL, V183, P3955, DOI 10.4049/jimmunol.0804103; Li XL, 2006, J LEUKOCYTE BIOL, V79, P453, DOI 10.1189/jlb.0705369; Li XL, 2005, AM J PHYSIOL-REG I, V289, pR37, DOI 10.1152/ajpregu.00782.2004; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MCGILL V, 1995, J TRAUMA, V38, P931, DOI 10.1097/00005373-199506000-00019; Messingham KAN, 2002, ALCOHOL, V28, P137, DOI 10.1016/S0741-8329(02)00278-1; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Suilleabhain CB, 2001, SHOCK, V15, P432, DOI 10.1097/00024382-200115060-00004; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rendon JL, 2014, ANN SURG, V259, P582, DOI 10.1097/SLA.0b013e3182a626f2; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Russ Brendan E., 2013, Frontiers in Genetics, V4, P218, DOI 10.3389/fgene.2013.00218; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwacha MG, 2002, INT J MOL MED, V10, P239; Silver GM, 2008, J BURN CARE RES, V29, P784, DOI 10.1097/BCR.0b013e31818481bc; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105314	10.1371/journal.pone.0105314	http://dx.doi.org/10.1371/journal.pone.0105314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126745	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300103
J	Bansode, SB; Jana, AK; Batkulwar, KB; Warkad, SD; Joshi, RS; Sengupta, N; Kulkarni, MJ				Bansode, Sneha B.; Jana, Asis K.; Batkulwar, Kedar B.; Warkad, Shrikant D.; Joshi, Rakesh S.; Sengupta, Neelanjana; Kulkarni, Mahesh J.			Molecular Investigations of Protriptyline as a Multi-Target Directed Ligand in Alzheimer's Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; AMYLOID-BETA-PROTEIN; DYNAMICS SIMULATIONS; CHOLINERGIC HYPOTHESIS; INHIBITORS; AGGREGATION; DOCKING; MECHANISMS; PROGRESS; ACCURACY	Alzheimer's disease (AD) is a complex neurodegenerative disorder involving multiple cellular and molecular processes. The discovery of drug molecules capable of targeting multiple factors involved in AD pathogenesis would greatly facilitate in improving therapeutic strategies. The repositioning of existing non-toxic drugs could dramatically reduce the time and costs involved in developmental and clinical trial stages. In this study, preliminary screening of 140 FDA approved nervous system drugs by docking suggested the viability of the tricyclic group of antidepressants against three major AD targets, viz. Acetylcholinesterase (AChE), beta-secretase (BACE-1), and amyloid beta (A beta) aggregation, with one member, protriptyline, showing highest inhibitory activity. Detailed biophysical assays, together with isothermal calorimetry, fluorescence quenching experiments, kinetic studies and atomic force microscopy established the strong inhibitory activity of protriptyline against all three major targets. The molecular basis of inhibition was supported with comprehensive molecular dynamics simulations. Further, the drug inhibited glycation induced amyloid aggregation, another important causal factor in AD progression. This study has led to the discovery of protriptyline as a potent multi target directed ligand and established its viability as a promising candidate for AD treatment.	[Bansode, Sneha B.; Batkulwar, Kedar B.; Warkad, Shrikant D.; Joshi, Rakesh S.; Kulkarni, Mahesh J.] CSIR Natl Chem Lab, Div Biochem Sci, Prote Facil, Pune, Maharashtra, India; [Jana, Asis K.; Sengupta, Neelanjana] CSIR Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sengupta, N (corresponding author), CSIR Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India.	n.sengupta@ncl.res.in; mj.kulkarni@ncl.res.in	Bansode, Sneha/AGJ-7133-2022; Kulkarni, Mahesh J/G-1473-2010	Warkad, Shrikant/0000-0002-9683-6018; Batkulwar, Kedar/0000-0002-4115-7958; Joshi, Rakesh S./0000-0001-8016-1178	CSIR Network project [BSC0115]	CSIR Network project(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR Network project, BSC0115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhatwa M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-10; Alzheimer's Association, FDA APPR TREATM ALZH; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Cappelli A, 2005, J MED CHEM, V48, P3564, DOI 10.1021/jm0493461; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; Gulyaeva N, 2003, EUR J MED CHEM, V38, P391, DOI 10.1016/S0223-5234(03)00044-8; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hill EH, 2012, LANGMUIR, V28, P14849, DOI 10.1021/la303158c; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Hussain I, 2004, IDRUGS, V7, P653; Jana AK, 2012, BIOPHYS J, V102, P1889, DOI 10.1016/j.bpj.2012.03.036; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; Lee S, 2014, J AM CHEM SOC, V136, P299, DOI 10.1021/ja409801p; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Mabanglo MF, 2012, BIOCHEMISTRY-US, V51, P917, DOI 10.1021/bi201662k; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santini S, 2004, STRUCTURE, V12, P1245, DOI 10.1016/j.str.2004.04.018; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Small David H, 2005, Expert Opin Emerg Drugs, V10, P817, DOI 10.1517/14728214.10.4.817; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tai K, 2002, J AM CHEM SOC, V124, P6153, DOI 10.1021/ja017310h; Tamhane VA, 2005, BBA-GEN SUBJECTS, V1722, P156, DOI 10.1016/j.bbagen.2004.12.017; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Zhang C, 2012, DISCOV MED, V14, P189; Zhang HY, 2005, FEBS LETT, V579, P5260, DOI 10.1016/j.febslet.2005.09.006; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	56	27	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105196	10.1371/journal.pone.0105196	http://dx.doi.org/10.1371/journal.pone.0105196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141174	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200060
J	Emslie, MJ; Cheal, AJ; Johns, KA				Emslie, Michael J.; Cheal, Alistair J.; Johns, Kerryn A.			Retention of Habitat Complexity Minimizes Disassembly of Reef Fish Communities following Disturbance: A Large-Scale Natural Experiment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHASE-SHIFTS; STRUCTURAL COMPLEXITY; HERBIVOROUS FISHES; SPECIES RICHNESS; IRIOMOTE ISLAND; LIVE CORAL; RESILIENCE; BIODIVERSITY	High biodiversity ecosystems are commonly associated with complex habitats. Coral reefs are highly diverse ecosystems, but are under increasing pressure from numerous stressors, many of which reduce live coral cover and habitat complexity with concomitant effects on other organisms such as reef fishes. While previous studies have highlighted the importance of habitat complexity in structuring reef fish communities, they employed gradient or meta-analyses which lacked a controlled experimental design over broad spatial scales to explicitly separate the influence of live coral cover from overall habitat complexity. Here a natural experiment using a long term (20 year), spatially extensive (similar to 115,000 kms(2)) dataset from the Great Barrier Reef revealed the fundamental importance of overall habitat complexity for reef fishes. Reductions of both live coral cover and habitat complexity had substantial impacts on fish communities compared to relatively minor impacts after major reductions in coral cover but not habitat complexity. Where habitat complexity was substantially reduced, species abundances broadly declined and a far greater number of fish species were locally extirpated, including economically important fishes. This resulted in decreased species richness and a loss of diversity within functional groups. Our results suggest that the retention of habitat complexity following disturbances can ameliorate the impacts of coral declines on reef fishes, so preserving their capacity to perform important functional roles essential to reef resilience. These results add to a growing body of evidence about the importance of habitat complexity for reef fishes, and represent the first large-scale examination of this question on the Great Barrier Reef.	[Emslie, Michael J.; Cheal, Alistair J.; Johns, Kerryn A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Emslie, MJ (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.emslie@aims.gov.au			Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility; Australian Government's National Environment Research Program (Tropical Ecosystems Hub)	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility(Australian Government); Australian Government's National Environment Research Program (Tropical Ecosystems Hub)(Australian Government)	The study was supported by Australian Institute of Marine Science and the Australian Government's Marine and Tropical Sciences Research Facility and National Environment Research Program (Tropical Ecosystems Hub). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEVIZON WS, 1989, B MAR SCI, V44, P646; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Burt JA, 2013, MAR POLLUT BULL, V72, P342, DOI 10.1016/j.marpolbul.2012.10.019; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Cole AJ, 2012, FUNCT ECOL, V26, P307, DOI 10.1111/j.1365-2435.2011.01935.x; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gelman A., 2007, DATA ANAL USING REGR; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jonker M, 2013, SURVEYS BENTHIC REEF; Lewis AR, 1997, MAR ECOL PROG SER, V161, P37, DOI 10.3354/meps161037; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Noonan SHC, 2012, MAR ECOL PROG SER, V456, P127, DOI 10.3354/meps09687; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Core Team, 2021, R LANGUAGE ENV STAT; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; RUSSELL BC, 1977, NEW ZEAL J MAR FRESH, V11, P23, DOI 10.1080/00288330.1977.9515659; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; Sano M, 2004, FISHERIES SCI, V70, P41, DOI 10.1111/j.1444-2906.2003.00768.x; Spies TA, 1998, NORTHWEST SCI, V72, P34; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Zuur A.F, 2012, ZERO INFLATED MODELS	66	53	53	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105384	10.1371/journal.pone.0105384	http://dx.doi.org/10.1371/journal.pone.0105384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140801	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200083
J	Lenormand, M; Tugores, A; Colet, P; Ramasco, JJ				Lenormand, Maxime; Tugores, Antonia; Colet, Pere; Ramasco, Jose J.			Tweets on the Road	PLOS ONE			English	Article								The pervasiveness of mobile devices, which is increasing daily, is generating a vast amount of geo-located data allowing us to gain further insights into human behaviors. In particular, this new technology enables users to communicate through mobile social media applications, such as Twitter, anytime and anywhere. Thus, geo-located tweets offer the possibility to carry out in-depth studies on human mobility. In this paper, we study the use of Twitter in transportation by identifying tweets posted from roads and rails in Europe between September 2012 and November 2013. We compute the percentage of highway and railway segments covered by tweets in 39 countries. The coverages are very different from country to country and their variability can be partially explained by differences in Twitter penetration rates. Still, some of these differences might be related to cultural factors regarding mobility habits and interacting socially online. Analyzing particular road sectors, our results show a positive correlation between the number of tweets on the road and the Average Annual Daily Traffic on highways in France and in the UK. Transport modality can be studied with these data as well, for which we discover very heterogeneous usage patterns across the continent.	[Lenormand, Maxime; Tugores, Antonia; Colet, Pere; Ramasco, Jose J.] Inst Fis Interdisciplinar & Sistemas Complejos IF, Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Lenormand, M (corresponding author), Inst Fis Interdisciplinar & Sistemas Complejos IF, Palma De Mallorca, Spain.	maxime@ifisc.uib-csic.es	Ramasco, Jose Javier/F-2860-2010; Colet, Pere/A-2472-2011	Ramasco, Jose Javier/0000-0003-2499-6095; Colet, Pere/0000-0002-5992-6292	Spanish Ministry of Economy (MINECO); FEDER (EU) [FIS2011-24785, FIS2012-30634]; EU Commission; Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands; Ramon y Cajal program of MINECO	Spanish Ministry of Economy (MINECO)(Spanish Government); FEDER (EU)(European Commission); EU Commission(European CommissionEuropean Commission Joint Research Centre); Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands; Ramon y Cajal program of MINECO(Spanish Government)	Partial financial support has been received from the Spanish Ministry of Economy (MINECO) and FEDER (EU) under projects MODASS (FIS2011-24785) and INTENSE@COSYP (FIS2012-30634), and from the EU Commission through projects EUNOIA, LASAGNE and INSIGHT. ML acknowledges funding from the Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands and JJR from the Ramon y Cajal program of MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ferrara E., 2013, P 1 ACM C ONL SOC NE, P213, DOI DOI 10.1145/2512938.2512956; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Furletti B, 2013, P 2 ACM SIGKDD INT W, P5; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hasan S, 2012, J STAT PHYS, V151, P1; Hawelka B, 2013, ARXIV13110680; Isaacman S., 2012, ACM, P239, DOI DOI 10.1145/2307636.2307659; Lenormand M, 2014, ARXIV14040333; Louail T, 2014, ARXIV1404540; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pei T., 2013, ARXIV13106129; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Reades J, 2007, IEEE PERVAS COMPUT, V6, P30, DOI 10.1109/MPRV.2007.53; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Soto Victor, 2011, P 3 ACM WORKSHOP HOT, P17, DOI [10.1145/2000172.2000179, DOI 10.1145/2000172.2000179]; Toole J, 2014, P ACM SIGKDD INT WOR, P1; Varol O., 2014, P 2014 ACM C WEB SCI, P81, DOI DOI 10.1145/2615569; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579	27	23	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105407	10.1371/journal.pone.0105407	http://dx.doi.org/10.1371/journal.pone.0105407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141161	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200087
J	Morimoto, K; Ozawa, T; Awazu, K; Ito, N; Honda, N; Matsumoto, S; Tsuruta, D				Morimoto, Kuniyuki; Ozawa, Toshiyuki; Awazu, Kunio; Ito, Nobuhisa; Honda, Norihiro; Matsumoto, Sohkichi; Tsuruta, Daisuke			Photodynamic Therapy Using Systemic Administration of 5-Aminolevulinic Acid and a 410-nm Wavelength Light-Emitting Diode for Methicillin-Resistant Staphylococcus aureus-Infected Ulcers in Mice	PLOS ONE			English	Article							ENDOGENOUS PROTOPORPHYRIN; MURINE MODEL; PHOTOSENSITIZER; INACTIVATION; EXPRESSION; EFFICACY	Bacterial resistance to antibiotics has become a worldwide problem. One potential alternative for bacterial control is photodynamic therapy. 5-aminolevulinic acid is a natural precursor of the photosensitizer protoporphyrin IX. Relatively little is known about the antibacterial efficacy of photodynamic therapy using the systemic administration of 5-aminolevulinic acid; a few reports have shown that 5-aminolevulinic acid exerts photodynamic effects on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. In this study, we evaluated the effectiveness of photodynamic therapy using 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode in vitro and in vivo for the treatment of MRSA. We found that 5-aminolevulinic acid photodynamic therapy with the light-emitting diode had an in-vitro bactericidal effect on MRSA. In vivo, protoporphyrin IX successfully accumulated in MRSA on ulcer surfaces after intraperitoneal administration of 5-aminolevulinic acid to mice. Furthermore, 5-aminolevulinic acid photodynamic therapy accelerated wound healing and decreased bacterial counts on ulcer surfaces; in contrast, vancomycin treatment did not accelerate wound healing. Our findings indicate that 5-aminolevulinic acid photodynamic therapy may be a new treatment option for MRSA-infected wounds.	[Morimoto, Kuniyuki; Ozawa, Toshiyuki; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Awazu, Kunio; Ito, Nobuhisa; Honda, Norihiro] Osaka Univ, Grad Sch Engn, Med Beam Phys Lab, Osaka, Japan; [Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan	Osaka Metropolitan University; Osaka University; Osaka Metropolitan University	Ozawa, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan.	ozawa@med.osaka-cu.ac.jp		Matsumoto, Sohkichi/0000-0002-6106-7538	MEXT KAKENHI [25861726]; Grants-in-Aid for Scientific Research [25861726] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grant Number 25861726 (http://www.jsps.go.jp/index1.html). KM received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN NI, 1956, BIOCHEM J, V64, P80, DOI 10.1042/bj0640080; Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44; CAIRNDUFF F, 1994, BRIT J CANCER, V69, P605, DOI 10.1038/bjc.1994.112; Dai TH, 2013, PHOTOMED LASER SURG, V31, P531, DOI 10.1089/pho.2012.3365; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Enwemeka CS, 2008, LASER SURG MED, V40, P734, DOI 10.1002/lsm.20724; Fotinos N, 2008, ANTIMICROB AGENTS CH, V52, P1366, DOI 10.1128/AAC.01372-07; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gollnick SO, 1997, CANCER RES, V57, P3904; GRANT WE, 1993, LANCET, V342, P147, DOI 10.1016/0140-6736(93)91347-O; Griffiths MA, 1997, J ANTIMICROB CHEMOTH, V40, P873, DOI 10.1093/jac/40.6.873; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Harris F, 2012, MED RES REV, V32, P1292, DOI 10.1002/med.20251; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hongcharu W, 2000, J INVEST DERMATOL, V115, P183, DOI 10.1046/j.1523-1747.2000.00046.x; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7; KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9; Kohl E, 2010, J EUR ACAD DERMATOL, V24, P1261, DOI 10.1111/j.1468-3083.2010.03625.x; Maclean M, 2008, J PHOTOCH PHOTOBIO B, V92, P180, DOI 10.1016/j.jphotobiol.2008.06.006; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2007, LASER MED SCI, V22, P83, DOI 10.1007/s10103-006-0409-7; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; MANYAK MJ, 1988, J CLIN ONCOL, V6, P380, DOI 10.1200/JCO.1988.6.2.380; Morton CA, 2000, BRIT J DERMATOL, V143, P767, DOI 10.1046/j.1365-2133.2000.03773.x; Morton CA, 1998, ARCH DERMATOL, V134, P248, DOI 10.1001/archderm.134.2.248; Morton CA, 1996, BRIT J DERMATOL, V135, P766, DOI 10.1111/j.1365-2133.1996.tb03887.x; Ochsner M, 1997, J PHOTOCH PHOTOBIO B, V39, P1, DOI 10.1016/S1011-1344(96)07428-3; Ormrod D, 2000, Am J Clin Dermatol, V1, P133, DOI 10.2165/00128071-200001020-00009; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Perichon B, 2004, ANTIMICROB AGENTS CH, V48, P4281, DOI 10.1128/AAC.48.11.4281-4285.2004; Pollock B, 2004, BRIT J DERMATOL, V151, P616, DOI 10.1111/j.1365-2133.2004.06110.x; POTTIER RH, 1986, PHOTOCHEM PHOTOBIOL, V44, P679, DOI 10.1111/j.1751-1097.1986.tb04726.x; Reyes N, 2005, ANTIMICROB AGENTS CH, V49, P4344, DOI 10.1128/AAC.49.10.4344-4346.2005; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Tanaka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039823; Tanaka M, 2011, LASER SURG MED, V43, P221, DOI 10.1002/lsm.21037; Tanaka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P403, DOI 10.1111/j.1751-1097.2009.00658.x; Tang Hi M., 2007, Journal of Infection and Chemotherapy, V13, P87, DOI 10.1007/s10156-006-0501-8; Taub Amy Forman, 2004, J Drugs Dermatol, V3, pS10; Tubby S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-211; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; WILSON M, 1995, J MED MICROBIOL, V42, P62, DOI 10.1099/00222615-42-1-62; Yow CMN, 2012, PHOTOCHEM PHOTOBIOL, V88, P626, DOI 10.1111/j.1751-1097.2012.01085.x	47	48	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105173	10.1371/journal.pone.0105173	http://dx.doi.org/10.1371/journal.pone.0105173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140800	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200056
J	Bumke-Vogt, C; Osterhoff, MA; Borchert, A; Guzman-Perez, V; Sarem, Z; Birkenfeld, AL; Bahr, V; Pfeiffer, AFH				Bumke-Vogt, Christiane; Osterhoff, Martin A.; Borchert, Andrea; Guzman-Perez, Valentina; Sarem, Zeinab; Birkenfeld, Andreas L.; Baehr, Volker; Pfeiffer, Andreas F. H.			The Flavones Apigenin and Luteolin Induce FOXO1 Translocation but Inhibit Gluconeogenic and Lipogenic Gene Expression in Human Cells	PLOS ONE			English	Article							RESVERATROL SUPPLEMENTATION; INSULIN SENSITIVITY; TRANSCRIPTION; PREVENTION; PHOSPHORYLATION; METABOLISM; PROTEINS; DIETS	The flavones apigenin (4',5,7,-trihydroxyflavone) and luteolin (3',4',5,7,-tetrahydroxyflavone) are plant secondary metabolites with antioxidant, antiinflammatory, and anticancer activities. We evaluated their impact on cell signaling pathways related to insulin-resistance and type 2 diabetes. Apigenin and luteolin were identified in our U-2 OS (human osteosarcoma) cell screening assay for micronutrients triggering rapid intracellular translocation of the forkhead box transcription factor O1 (FOXO1), an important mediator of insulin signal transduction. Insulin reversed the translocation of FOXO1 as shown by live cell imaging. The impact on the expression of target genes was evaluated in HepG2 (human hepatoma) cells. The mRNA-expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pc), the lipogenic enzymes fatty-acid synthase (FASN) and acetyl-CoA-carboxylase (ACC) were down-regulated by both flavones with smaller effective dosages of apigenin than for luteolin. PKB/AKT-, PRAS40-, p70S6K-, and S6-phosphorylation was reduced by apigenin and luteolin but not that of the insulin-like growth factor receptor IGF-1R by apigenin indicating a direct inhibition of the PKB/AKT-signaling pathway distal to the IGF-1 receptor. N-acetyl-L-cysteine did not prevent FOXO1 nuclear translocation induced by apigenin and luteolin, suggesting that these flavones do not act via oxidative stress. The roles of FOXO1, FOXO3a, AKT, sirtuin1 (SIRT1), and nuclear factor (erythroid-derived2)-like2 (NRF2), investigated by siRNA knockdown, showed differential patterns of signal pathways involved and a role of NRF2 in the inhibition of gluconeogenic enzyme expression. We conclude that these flavones show an antidiabetic potential due to reduction of gluconeogenic and lipogenic capacity despite inhibition of the PKB/AKT pathway which justifies detailed investigation in vivo.	[Bumke-Vogt, Christiane; Osterhoff, Martin A.; Borchert, Andrea; Guzman-Perez, Valentina; Sarem, Zeinab; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany; [Bumke-Vogt, Christiane; Osterhoff, Martin A.; Birkenfeld, Andreas L.; Baehr, Volker; Pfeiffer, Andreas F. H.] Charite, Dept Endocrinol Diabetol & Nutr, D-13353 Berlin, Germany; [Guzman-Perez, Valentina] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pontificia Universidad Javeriana	Osterhoff, MA (corresponding author), German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany.	martino@dife.de	Pfeiffer, Andreas F.H./AAJ-2311-2020; Guzmán-Pérez, Valentina/AAB-5471-2020; Birkenfeld, Andreas L./U-3954-2019	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Birkenfeld, Andreas L./0000-0003-1407-9023; Guzman-Perez, Valentina/0000-0002-6668-3161	"Investitionsbank Berlin" (IBB) [10140311]; "German Academic Exchange Service" (DAAD) [A/09/72490]	"Investitionsbank Berlin" (IBB); "German Academic Exchange Service" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	MAO was in part funded by "Investitionsbank Berlin" (IBB): http://www.ibb.de/Foerderangebote.aspx. Project Title: "Entwicklung einer biotechnologischen Methode zur Identifikation gesundheitlich vorteilhafter Pflanzeninhaltsstoffe zur Pravention von Diabetes Typ 2" (Ref-No: 10140311). VG was funded by the "German Academic Exchange Service" (DAAD): https://www.daad.de/de/index.html. (Ref-No: A/09/72490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat AM, 2009, J CLIN ENDOCR METAB, V94, P5093, DOI 10.1210/jc.2009-0875; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Besse-Patin Aurele, 2014, Int J Cell Biol, V2014, P519153, DOI 10.1155/2014/519153; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Crandall JP, 2008, NAT CLIN PRACT ENDOC, V4, P382, DOI 10.1038/ncpendmet0843; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Lien EJ, 1999, FREE RADICAL BIO MED, V26, P285, DOI 10.1016/S0891-5849(98)00190-7; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Park JM, 2010, BIOCHEM BIOPH RES CO, V403, P329, DOI 10.1016/j.bbrc.2010.11.028; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Weickert MO, 2011, AM J CLIN NUTR, V94, P459, DOI 10.3945/ajcn.110.004374; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	30	46	51	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104321	10.1371/journal.pone.0104321	http://dx.doi.org/10.1371/journal.pone.0104321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136826	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100028
J	Falcao, ASC; Kataoka, MSD; Ribeiro, NAB; Diniz, JAP; Alves, SM; Ribeiro, ALR; de Siqueira, AS; da Silva, AL; Ramos, RTJ; Freitas, VM; Jaeger, RG; Pinheiro, JJV				Carreira Falcao, Aline Semblano; da Silva Kataoka, Maria Sueli; Bailao Ribeiro, Nelson Antonio; Picanco Diniz, Jose Antonio, Jr.; Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.; de Siqueira, Adriane Sousa; da Silva, Artur Luiz; Juca Ramos, Rommel Thiago; Freitas, Vanessa M.; Jaeger, Ruy G.; Pinheiro, Joao J. V.			A Novel Cell Line Derived from Pleomorphic Adenoma Expresses MMP2, MMP9, TIMP1, TIMP2, and Shows Numeric Chromosomal Anomalies	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; SALIVARY-GLAND; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; BASEMENT-MEMBRANE; READ ALIGNMENT; CANCER; GENE; AMELOBLASTOMA; MICROSCOPY	Pleomorphic adenoma is the most common salivary gland neoplasm, and it can be locally invasive, despite its slow growth. This study aimed to establish a novel cell line (AP-1) derived from a human pleomorphic adenoma sample to better understand local invasiveness of this tumor. AP-1 cell line was characterized by cell growth analysis, expression of epithelial and myoepithelial markers by immunofluorescence, electron microscopy, 3D cell culture assays, cytogenetic features and transcriptomic study. Expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs)was also analyzed by immunofluorescence and zymography. Furthermore, epithelial and myoepithelial markers, MMPs and TIMPs were studied in the tumor that originated the cell line. AP-1 cells showed neoplastic epithelial and myoepithelial markers, such as cytokeratins, vimentin, S100 protein and smooth-muscle actin. These molecules were also found in vivo, in the tumor that originated the cell line. MMPs and TIMPs were observed in vivo and in AP-1 cells. Growth curve showed that AP-1 exhibited a doubling time of 3.342 days. AP-1 cells grown inside Matrigel recapitulated tumor architecture. Different numerical and structural chromosomal anomalies were visualized in cytogenetic analysis. Transcriptomic analysis addressed expression of 7 target genes (VIM, TIMP2, MMP2, MMP9, TIMP1, ACTA2 e PLAG1). Results were compared to transcriptomic profile of nonneoplastic salivary gland cells (HSG). Only MMP9 was not expressed in both libraries, and VIM was expressed solely in AP-1 library. The major difference regarding gene expression level between AP-1 and HSG samples occurred for MMP2. This gene was 184 times more expressed in AP-1 cells. Our findings suggest that AP-1 cell line could be a useful model for further studies on pleomorphic adenoma biology.	[Carreira Falcao, Aline Semblano; da Silva Kataoka, Maria Sueli; Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.; Pinheiro, Joao J. V.] Fed Univ Para UFPA, Sch Dent, Dept Oral & Maxillofacial Pathol, Belem, Para, Brazil; [Bailao Ribeiro, Nelson Antonio] Evandro Chagas Inst, Mol Biol Lab, Belem, Para, Brazil; [Picanco Diniz, Jose Antonio, Jr.] Evandro Chagas Inst, Electron Microscopy Lab, Belem, Para, Brazil; [Alves, Sergio Melo, Jr.; Ribeiro Ribeiro, Andre L.] Univ Ctr Para CESUPA, Sch Dent, Dept Oral & Maxillofacial Surg, Belem, Para, Brazil; [de Siqueira, Adriane Sousa; Freitas, Vanessa M.; Jaeger, Ruy G.; Pinheiro, Joao J. V.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [da Silva, Artur Luiz; Juca Ramos, Rommel Thiago] Univ Fed Para UFPA, Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Instituto Evandro Chagas; Centro Universitario do Estado do Para (CESUPA); Universidade de Sao Paulo; Universidade Federal do Para	Pinheiro, JJV (corresponding author), Fed Univ Para UFPA, Sch Dent, Dept Oral & Maxillofacial Pathol, Belem, Para, Brazil.	joaopinheiro@ufpa.br	Pinheiro, João/AAR-1577-2020; Ramos, Rommel Thiago Juca/L-9329-2013; Freitas, Vanessa M/D-7897-2012; Ribeiro, Andre Luis/K-2558-2013; Luiz Silva, Artur da Costa da/AAI-3516-2021; Ribeiro, Andre/C-9338-2019; Jaeger, Ruy G/G-8230-2011; Alves, Sergio/AAE-9583-2019; Siqueira, Adriane S/D-8352-2013; da Silva Kataoka, Maria Sueli/GON-5256-2022; Pinheiro, João JV/H-2653-2012	Pinheiro, João/0000-0002-6914-6441; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Freitas, Vanessa M/0000-0001-9613-8626; Ribeiro, Andre Luis/0000-0001-8124-2156; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Ribeiro, Andre/0000-0001-8124-2156; Jaeger, Ruy G/0000-0002-1564-0356; Alves, Sergio/0000-0003-0272-9279; Pinheiro, João JV/0000-0002-6914-6441	Para State Research Foundation (FAPESPA) [060/2007]; Rede Paraense de Genomica e Protemica; Brazilian National Council for Scientific and Technological Development (CNPq) [480752/2010-9]; State of Sao Paulo Research Foundation (FAPESP) [2009/17336-6]; CNPq [504667/2008-4]	Para State Research Foundation (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Rede Paraense de Genomica e Protemica; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by Para State Research Foundation (FAPESPA, grant 060/2007), Rede Paraense de Genomica e Proteomica, and Brazilian National Council for Scientific and Technological Development (CNPq, grant 480752/2010-9). Adriane S. Siqueira is recipient of Graduate fellowship from the State of Sao Paulo Research Foundation (FAPESP, grant 2009/17336-6). Joao J. V. Pinheiro is recipient of a Post Doctoral fellowship from CNPq (504667/2008-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony J, 2012, HEAD NECK PATHOL, V6, P1, DOI 10.1007/s12105-011-0281-z; Bahrami A, 2012, HEAD NECK PATHOL, V6, P377, DOI 10.1007/s12105-012-0330-2; Bahrami A, 2012, HEAD NECK PATHOL, V6, P328, DOI 10.1007/s12105-012-0353-8; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BULLERDIEK J, 1993, CYTOGENETIC SUBTYPIN; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DeRoche TC, 2008, ARCH PATHOL LAB MED, V132, P1907, DOI 10.1043/1543-2165-132.12.1907; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Ellis GL, 1996, TUMORS SALIVARY GLAN; Freitas VM, 2004, ORAL ONCOL, V40, P483, DOI 10.1016/j.oraloncology.2003.10.002; Friedrich RE, 2005, ANTICANCER RES, V25, P1703; HURET JL, 2010, ATLAS GENETICS CYTOG; Ito FA, 2009, MED ORAL PATOL ORAL, V14, pE57; Jaeger MMM, 1997, VIRCHOWS ARCH, V430, P467, DOI 10.1007/s004280050057; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kas K, 1997, GENOMICS, V43, P349, DOI 10.1006/geno.1997.4819; Kitagawa M, 2007, INT J ONCOL, V31, P339; KLIGERMAN AD, 1977, J FISH RES BOARD CAN, V34, P266, DOI 10.1139/f77-039; KONDO T, 1971, CANCER-AM CANCER SOC, V27, P403, DOI 10.1002/1097-0142(197102)27:2<403::AID-CNCR2820270225>3.0.CO;2-B; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maruyama S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-247; Mendenhall WM, 2008, AM J CLIN ONCOL-CANC, V31, P95, DOI 10.1097/COC.0b013e3181595ae0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pereira Antonio L.A., 2005, Rev. Bras. Otorrinolaringol., V71, P81, DOI 10.1590/S0034-72992005000100014; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riad MA, 2011, LARYNGOSCOPE, V121, P1467, DOI 10.1002/lary.21830; Rosa LEB, 1997, ORAL ONCOL, V33, P209, DOI 10.1016/S0964-1955(96)00070-X; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SEABRIGH.M, 1971, LANCET, V2, P971; Siqueira AS, 2010, HISTOPATHOLOGY, V57, P128, DOI 10.1111/j.1365-2559.2010.03596.x; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Thomas GT, 1999, ORAL ONCOL, V35, P227, DOI 10.1016/S1368-8375(99)00004-4; Thompson MW, 1991, THOMPSON THOMPSON GE; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zhang XJ, 2009, HISTOPATHOLOGY, V55, P250, DOI 10.1111/j.1365-2559.2009.03355.x	43	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105231	10.1371/journal.pone.0105231	http://dx.doi.org/10.1371/journal.pone.0105231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137137	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100078
J	Fournier, P; Dumont, A; Tourigny, C; Philibert, A; Coulibaly, A; Traore, M				Fournier, Pierre; Dumont, Alexandre; Tourigny, Caroline; Philibert, Aline; Coulibaly, Aliou; Traore, Mamadou			The Free Caesareans Policy in Low-Income Settings: An Interrupted Time Series Analysis in Mali (2003-2012)	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; CESAREAN DELIVERY; MATERNAL MORTALITY; HEALTH; OUTCOMES; QUALITY; ACCESS; TRENDS; BIRTH; RATES	Introduction: Several countries have instituted fee exemptions for caesareans to reduce maternal and newborn mortality. Objectives: To evaluate the effect of fee exemptions for caesareans on population caesarean rates taking into account different levels of accessibility. Methods: The observation period was from January 2003 to May 2012 in one Region and covered 11.7 million person-years. Exemption fees for caesareans were adopted on June 26, 2005. Data were obtained from a registration system implemented in 2003 that tracks all obstetrical emergencies and interventions including caesareans. The pre-intervention period was 30 months and the post-intervention period was 83 months. We used an interrupted time series to evaluate the trend before and after the policy adoption and the overall tendency. Findings: During the study period, the caesarean rate increased from 0.25 to 1.5% for the entire population. For women living in cities with district hospitals that provided caesareans, the rate increased from 1.7% before the policy was enforced to 5.7% 83 months later. No significant change in trends was observed among women living in villages with a healthcare centre or those in villages with no healthcare facility. For the latter, the caesarean rate increased from 0.4 to 1%. Conclusions: After nine years of implementation policy in Mali, the caesarean rate achieved in cities with a district hospital reached the full beneficial effect of this measure, whereas for women living elsewhere this policy did not increase the caesarean rate to a level that could contribute effectively to reduce their risk of maternal death. Only universal access to this essential intervention could reduce the inequities and increase the effectiveness of this policy.	[Fournier, Pierre; Tourigny, Caroline; Philibert, Aline; Coulibaly, Aliou] Res Ctr Univ Montreal Hosp CR CHUM, Montreal, PQ, Canada; [Fournier, Pierre] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Dumont, Alexandre] Univ Paris 05, Sorbonne Paris Cite, UMR 216, Inst Dev Res, Paris, France; [Traore, Mamadou] Referral Hlth Ctr Commune V, Unite Rech & Format Sante Mere & Enfant URFOSAME, Bamako, Mali	Universite de Montreal; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Fournier, P (corresponding author), Res Ctr Univ Montreal Hosp CR CHUM, Montreal, PQ, Canada.	pierre.fournier@umontreal.ca	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193	Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada); Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada)	Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada); Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada)	This research was supported by the Governance, Equity and Health Initiative of the International Development Research Centre (IDRC) in Ottawa (Canada) and by the Teasdale-Corti Global Health Research Partnership Program of the Global Health Research Initiative (Canadian Institutes of Health Research, Canadian International Development Agency, Health Canada, IDRC and Public Health Agency of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; El-Khoury M, 2011, AMELIORER ACCES SERI; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; Fournier P, 2012, APPROACHES PRATIQUES, P325; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gibbons L, 2010, 30 WHO; Group CEPaOoC, 1998, INCL INT TIM SER ITS; Gustafsson NKJ, 2011, INT J EPIDEMIOL, V40, P432, DOI 10.1093/ije/dyq153; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Holtz SA, 2007, STUD FAMILY PLANN, V38, P47, DOI 10.1111/j.1728-4465.2007.00115.x; MAIGA Z, 1999, STUDIES HLTH SERVICE; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Ministere de l'E conomie et des Finances Institut National de la Statistique Bureau central de recensement, 2011, RES DEF, V1; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; Pirkle CM, 2011, MATERN CHILD HLTH J, V15, P1081, DOI 10.1007/s10995-010-0655-y; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Richard F, 2008, INT J GYNECOL OBSTET, V103, P283, DOI 10.1016/j.ijgo.2008.08.008; Richard F, 2010, AM J PUBLIC HEALTH, V100, P1845, DOI 10.2105/AJPH.2009.179689; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; StataCorp, 2021, STATA STAT SOFTWARE; UNDP, 2013, HUMAN DEV REPORT; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Witter S, 2010, HEALTH POLICY PLANN, V25, P384, DOI 10.1093/heapol/czq013; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007; [No title captured]	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105130	10.1371/journal.pone.0105130	http://dx.doi.org/10.1371/journal.pone.0105130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25137072	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100068
J	Guo, P; Xu, XJ; Huang, BL; Sun, D; Zhang, J; Chen, XJ; Zhang, Q; Huo, X; Hao, YT				Guo, Pi; Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Zhang, Qin; Huo, Xia; Hao, Yuantao			Blood Lead Levels and Associated Factors among Children in Guiyu of China: A Population-Based Study	PLOS ONE			English	Article							WASTE RECYCLING TOWN; PORT-PIRIE COHORT; ELECTRONIC WASTE; INTELLECTUAL IMPAIRMENT; EXPOSURE; CHILDHOOD; REGRESSION; SELECTION; HEALTH; LASSO	Objectives: Children's health problems caused by the electronic waste (e-waste) lead exposure in China remains. To assess children's blood lead levels (BLLs) in Guiyu of China and investigate risk factors of children's elevated BLLs in Guiyu. Material and Methods: 842 children under 11 years of age from Guiyu and Haojiang were enrolled in this population-based study during 2011-2013. Participants completed a lifestyle and residential environment questionnaire and their physical growth indices were measured, and blood samples taken. Blood samples were tested to assess BLLs. Children's BLLs between the two groups were compared and factors associated with elevated BLLs among Guiyu children were analyzed by group Lasso logistic regression model. Results: Children living in Guiyu had significant higher BLLs (7.06 mu g/dL) than the quantity (5.89 mu g/dL) of Haojiang children (P<0.05). Subgroup analyses of BLLs exceeding 10 mu g/dL showed the proportion (24.80%) of high-level BLLs for Guiyu children was greater than that (12.84%) in Haojiang (P<0.05). Boys had greater BLLs than girls, irrespectively of areas (P<0.05). The number of e-waste piles or recycling workshops around the house (odds ratio, 2.28; 95% confidence interval [CI], 1.37 to 3.87) significantly contributed to the elevated BLLs of children in Guiyu, and girls had less risk (odds ratio, 0.51; 95% CI, 0.31 to 0.83) of e-waste lead exposure than boys. Conclusions: This analysis reinforces the importance of shifting e-waste recycling piles or workshops to non-populated areas as part of a comprehensive response to e-waste lead exposure control in Guiyu. To correct the problem of lead poisoning in children in Guiyu should be a long-term mission.	[Guo, Pi; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Huo, Xia] Shantou Univ, Coll Med, Lab Environm Med & Dev Toxicol, Shantou, Peoples R China; [Xu, Xijin; Huang, Binliang; Sun, Di; Zhang, Jian; Chen, Xiaojuan; Huo, Xia] Shantou Univ, Coll Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Peoples R China; [Zhang, Qin] Shantou Univ, Good Clin Practice Off, Canc Hosp, Coll Med, Shantou, Peoples R China	Sun Yat Sen University; Shantou University; Shantou University; Shantou University	Huo, X (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	xhuo@stu.edu.cn; haoyt@mail.sysu.edu.cn		Huo, Xia/0000-0002-2102-4840	Natural Science Foundation of China, NSFC [21177080, 21377077]; Natural Science Foundation of Guangdong province [S2011020002399]	Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Natural Science Foundation of China, NSFC (21177080, 21377077) and Natural Science Foundation of Guangdong province (S2011020002399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Binns HJ, 2007, PEDIATRICS, V120, pE1285, DOI 10.1542/peds.2005-1770; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Duarte M. F., 2011, TR201010 DUK U DEP C; Gavaghan H, 2002, B WORLD HEALTH ORGAN, V80, P82; Grigg J, 2004, ARCH DIS CHILD, V89, P244, DOI 10.1136/adc.2002.022202; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Huo X, 2007, ENVIRON HEALTH PERSP, V115, P1113, DOI 10.1289/ehp.9697; Jain NB, 2006, ENVIRON HEALTH PERSP, V114, P466, DOI 10.1289/ehp.8399; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Li Y, 2008, J ENVIRON MONITOR, V10, P1233, DOI 10.1039/b804959a; Li Y, 2013, J APPL STAT, V40, P699, DOI 10.1080/02664763.2012.724660; Liu JX, 2011, NEUROTOXICOLOGY, V32, P458, DOI 10.1016/j.neuro.2011.03.012; Lundgren K., 2012, GLOBAL IMPACT E WAST; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Noel-Brune M, 2013, LANCET GLOB HEALTH, V1, pE70, DOI 10.1016/S2214-109X(13)70020-2; Peng ML, 2011, ZHONG GUO ER TONG BA, V19, P740; Qi Qiping, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P162; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; Team RDC, 2005, R LANG ENV STAT COMP; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tong S, 1998, JAMA-J AM MED ASSOC, V280, P1915, DOI 10.1001/jama.280.22.1915; UE P, 2007, E WAST; Wong CSC, 2007, ENVIRON POLLUT, V145, P434, DOI 10.1016/j.envpol.2006.05.017; Woolston A, 2010, J EPIDEMIOL COMMUN H, V64, pA59, DOI 10.1136/jech.2010.120477.65; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018; Xu XJ, 2014, ENVIRON SCI POLLUT R, V21, P3540, DOI 10.1007/s11356-013-2289-2; Xu XJ, 2012, REPROD TOXICOL, V33, P94, DOI 10.1016/j.reprotox.2011.12.006; Yan CH, 2013, ENVIRON HEALTH PERSP, V121, pA294, DOI 10.1289/ehp.1307558; Yang H, 2013, ENVIRON SCI POLLUT R, V20, P4441, DOI 10.1007/s11356-012-1366-2; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zhang Shuai-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P651; Zheng GN, 2013, J EXPO SCI ENV EPID, V23, P67, DOI 10.1038/jes.2012.84; Zheng LK, 2008, ENVIRON RES, V108, P15, DOI 10.1016/j.envres.2008.04.002; Zhou H, 2011, BIOCOMPUT-PAC SYM, P106	39	30	32	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105470	10.1371/journal.pone.0105470	http://dx.doi.org/10.1371/journal.pone.0105470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136795	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100099
J	He, DY; Li, R; Huang, Q; Lei, P				He, Dayi; Li, Ran; Huang, Qi; Lei, Ping			Transportation Optimization with Fuzzy Trapezoidal Numbers Based on Possibility Theory	PLOS ONE			English	Article								In this paper, a parametric method is introduced to solve fuzzy transportation problem. Considering that parameters of transportation problem have uncertainties, this paper develops a generalized fuzzy transportation problem with fuzzy supply, demand and cost. For simplicity, these parameters are assumed to be fuzzy trapezoidal numbers. Based on possibility theory and consistent with decision-makers' subjectiveness and practical requirements, the fuzzy transportation problem is transformed to a crisp linear transportation problem by defuzzifying fuzzy constraints and objectives with application of fractile and modality approach. Finally, a numerical example is provided to exemplify the application of fuzzy transportation programming and to verify the validity of the proposed methods.	[He, Dayi; Li, Ran; Huang, Qi; Lei, Ping] China Univ Geosci, Lab Resources & Environm Management, Sch Humanities & Econ Management, Beijing, Peoples R China	China University of Geosciences	Lei, P (corresponding author), China Univ Geosci, Lab Resources & Environm Management, Sch Humanities & Econ Management, Beijing, Peoples R China.	leipingleiping@hotmail.com	He, Dayi/GRS-0898-2022	He, Dayi/0000-0002-8890-7998	Fundamental Research Funds for the Central Universities [2-9-2012-86]; Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR [CCA2012.05]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR	This research is supported by the Fundamental Research Funds for the Central Universities (2-9-2012-86) and supported by Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR (CCA2012.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basirzadeh H., 2011, APPL MATH SCI, V5, P1549; CHANAS S, 1984, FUZZY SET SYST, V13, P211, DOI 10.1016/0165-0114(84)90057-5; Chanas S, 1996, FUZZY SET SYST, V82, P299, DOI 10.1016/0165-0114(95)00278-2; Chanas S., 1993, TRANSPORT PLAN TECHN, V17, P203, DOI [https://doi.org/10.1080/03081069308717511, DOI 10.1080/03081069308717511]; Chaudhuri A., 2013, ARXIV13071893; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; DUBOIS D, 1987, FUZZY SET SYST, V24, P279, DOI 10.1016/0165-0114(87)90028-5; Dubois D, 2000, HDB FUZZ SET SER, V7, P343; DUBOIS D, 1988, ARTIF INTELL, V35, P243, DOI 10.1016/0004-3702(88)90014-8; Gaines BR, 1975, POSSIBLE AUTOMATA; Geoffrion A.M., 1967, MANAGE SCI, V13, P672, DOI [DOI 10.1287/MNSC.13.9.672, 10.1287/mnsc.13.9.672]; Kataoka S, 1963, ECONOMETRICA     FEB, P181; Liu ST, 2004, EUR J OPER RES, V153, P661, DOI 10.1016/S0377-2217(02)00731-2; Nagoorgani A., 2006, J PHYS SCI, V10, P63; Narayanamoorthy S, 2013, INT J INTELLIGENT SY, P5; Negoita C., 1978, FUZZY SETS SYST, V1, P3, DOI DOI 10.1016/S0165-0114(99)80004-9; Pandian P., 2010, APPL MATH SCI, V4, P79; Stancu-Minasian I, 1990, STOCHASTIC VERSUS FU, P71	18	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105142	10.1371/journal.pone.0105142	http://dx.doi.org/10.1371/journal.pone.0105142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137239	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100070
J	Koivisto, E; Acosta, AJ; Moilanen, AM; Tokola, H; Aro, J; Pennanen, H; Sakkinen, H; Kaikkonen, L; Ruskoaho, H; Rysa, J				Koivisto, Elina; Acosta, Alicia Jurado; Moilanen, Anne-Mari; Tokola, Heikki; Aro, Jani; Pennanen, Harri; Sakkinen, Hanna; Kaikkonen, Leena; Ruskoaho, Heikki; Rysa, Jaana			Characterization of the Regulatory Mechanisms of Activating Transcription Factor 3 by Hypertrophic Stimuli in Rat Cardiomyocytes	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; ATF3 GENE-EXPRESSION; PROTEIN-KINASE; HEART-FAILURE; GATA-4; PATHWAYS; DISEASE; ALPHA; ENDOTHELIN-1; APOPTOSIS	Aims: Activating transcription factor 3 (ATF3) is a stress-activated immediate early gene suggested to have both detrimental and cardioprotective role in the heart. Here we studied the mechanisms of ATF3 activation by hypertrophic stimuli and ATF3 downstream targets in rat cardiomyocytes. Methods and Results: When neonatal rat cardiomyocytes were exposed to endothelin-1 (ET-1, 100 nM) and mechanical stretching in vitro, maximal increase in ATF3 expression occurred at 1 hour. Inhibition of extracellular signal-regulated kinase (ERK) by PD98059 decreased ET-1- and stretch-induced increase of ATF3 protein but not ATF3 mRNA levels, whereas protein kinase A (PKA) inhibitor H89 attenuated both ATF3 mRNA transcription and protein expression in response to ET-1 and stretch. To characterize further the regulatory mechanisms upstream of ATF3, p38 mitogen-activated protein kinase (MAPK) signaling was investigated using a gain-of-function approach. Adenoviral overexpression of p38 alpha, but not p38 beta, increased ATF3 mRNA and protein levels as well as DNA binding activity. To investigate the role of ATF3 in hypertrophic process, we overexpressed ATF3 by adenovirus-mediated gene transfer. In vitro, ATF3 gene delivery attenuated the mRNA transcription of interleukin-6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1), and enhanced nuclear factor-kappa B (NF-kappa B) and Nkx-2.5 DNA binding activities. Reduced PAI-1 expression was also detected in vivo in adult rat heart by direct intramyocardial adenovirus-mediated ATF3 gene delivery. Conclusions: These data demonstrate that ATF3 activation by ET-1 and mechanical stretch is partly mediated through ERK and cAMP-PKA pathways, whereas p38 MAPK pathway is involved in ATF3 activation exclusively through p38 alpha isoform. ATF3 activation caused induction of modulators of the inflammatory response NF-kappa B and Nkx-2.5, as well as attenuation of pro-fibrotic and pro-inflammatory proteins IL-6 and PAI-1, suggesting cardioprotective role for ATF3 in the heart.	[Koivisto, Elina; Acosta, Alicia Jurado; Moilanen, Anne-Mari; Tokola, Heikki; Aro, Jani; Pennanen, Harri; Sakkinen, Hanna; Kaikkonen, Leena; Ruskoaho, Heikki; Rysa, Jaana] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Moilanen, Anne-Mari; Tokola, Heikki] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Fac Pharm, Helsinki, Finland; [Rysa, Jaana] Univ Eastern Finland, Sch Pharm, Kuopio, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Eastern Finland	Ruskoaho, H (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@helsinki.fi		Rysa, Jaana/0000-0003-2205-6323	Academy of Finland - Center of Excellence; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; Finnish Cultural Foundation	Academy of Finland - Center of Excellence(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Emil Aaltonen Foundation; Ida Montin Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by grants from the Academy of Finland - Center of Excellence (HR), Sigrid Juselius Foundation (HR), Finnish Foundation for Cardiovascular Research (EK, AJA, A-MM, HT, HP, HS, LK, HR, JR), Emil Aaltonen Foundation (EK), Ida Montin Foundation(EK) and Finnish Cultural Foundation (EK, JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bottone FG, 2005, J PHARMACOL EXP THER, V315, P668, DOI 10.1124/jpet.105.089607; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chakraborti S, 2007, MOL CELL BIOCHEM, V298, P1, DOI 10.1007/s11010-006-9355-8; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chu WF, 2012, CARDIOVASC RES, V96, P90, DOI 10.1093/cvr/cvs230; Clerk A, 2007, PHYSIOL GENOMICS, V29, P118, DOI 10.1152/physiolgenomics.00168.2006; Clerk A, 2009, ADV ENZYME REGUL, V49, P30, DOI 10.1016/j.advenzreg.2008.12.007; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Giraldo A, 2012, BIOCHEM J, V444, P343, DOI 10.1042/BJ20120125; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Keesler GA, 1998, PROTEIN EXPRES PURIF, V14, P221, DOI 10.1006/prep.1998.0947; Kehat I, 2006, CARDIOVASC RES, V70, P543, DOI 10.1016/j.cardiores.2006.02.018; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Koren L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068396; Kuhn M, 2004, BASIC RES CARDIOL, V99, P76, DOI 10.1007/s00395-004-0460-0; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Luosujarvi H, 2010, BLOOD PRESSURE, V19, P54, DOI 10.3109/08037050903464519; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Pohjolainen V, 2008, HUM PATHOL, V39, P1695, DOI 10.1016/j.humpath.2008.04.015; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruskoaho H, 2003, ENDOCR REV, V24, P341, DOI 10.1210/er.2003-0006; Rysa J, 2006, BLOOD PRESSURE, V15, P375, DOI 10.1080/08037050601037851; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; Yang CJ, 2013, CARDIOVASC RES, V97, P33, DOI 10.1093/cvr/cvs287; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	55	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105168	10.1371/journal.pone.0105168	http://dx.doi.org/10.1371/journal.pone.0105168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136830	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100073
J	Pastuszak-Lewandoska, D; Domanska, D; Czarnecka, KH; Kordiak, J; Migdalska-Sek, M; Nawrot, E; Kiszalkiewicz, J; Antczak, A; Gorski, P; Brzezianska, E				Pastuszak-Lewandoska, Dorota; Domanska, Daria; Czarnecka, Karolina H.; Kordiak, Jacek; Migdalska-Sek, Monika; Nawrot, Ewa; Kiszalkiewicz, Justyna; Antczak, Adam; Gorski, Pawel; Brzezianska, Ewa			Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN PROSTATE-CANCER; HUMAN BREAST-CANCER; SIGNAL TRANSDUCER; TRANSCRIPTION FACTORS; CYCLOOXYGENASE-2 EXPRESSION; PROTEIN INHIBITOR; ACTIVATED STAT3; POOR-PROGNOSIS; IN-VIVO	Signal transducers and activators of transcription (STATs), their inhibitors and cyclooxygenase-2 (COX-2) participate in transformations of many various types of cancers. The aim of the present study was to evaluate the relationship between STAT5A/B, COX-2, and PIAS3 mRNA expression and tumor staging, metastasis status, and histopathological subtype in 71 patients with confirmed non-small cell lung cancer (NSCLC) diagnosis. Total RNA was isolated from NSCLC tissue samples and the expression of the studied genes was assessed using TaqMan probes in real-time PCR assay. The expression levels of STAT5A, STAT5B, and COX-2 genes were increased in 69%, 79%, and 71% NSCLC samples respectively, while PIAS3 expression was decreased in the majority (69%) of the studied tissues. Statistically significant differences were observed between STAT5 isoforms (P = 0.0008), with higher expression of STAT5B. We found statistically significant positive correlation between STAT5B and COX-2 (rho = 0.045), and significant negative correlation between STAT5B and PIAS3 (rho = -0.049). The negative correlation between STAT5B and PIAS3 (rho = -0.43) was also observed in T2a+T2b tumor group. Additionally, STAT5B and COX-2 expression levels were significantly different between T1a+T1b and T2a+T2b tumors (P = 0.002 and P = 0.041, respectively), with higher expression of both genes in T2 tumor stage. PIAS3 expression was significantly lower in NSCC subtype as compared with SCC subtype (P = 0.017). Also, STAT5A and STAT5B immunoexpression was assessed, and the results indicated significantly higher protein levels in NSCLC patients as compared with controls (P = 0.048 and P = 0.034, respectively). High STAT5B immunoexpression was positively correlated with STAT5B gene expression in tumors (rho = 0.755). STAT5B protein level was also significantly higher in T2a+T2b tumors, reflecting high STAT5B gene expression in this group. There was no statistically significant association between mRNA and protein expression levels of the studied genes and patients' characteristics: age, gender, smoking. The obtained results highlight the importance of the genes STAT5B and COX-2 in lung cancer progression.	[Pastuszak-Lewandoska, Dorota; Domanska, Daria; Czarnecka, Karolina H.; Migdalska-Sek, Monika; Nawrot, Ewa; Kiszalkiewicz, Justyna; Brzezianska, Ewa] Med Univ Lodz, Dept Mol Bases Med, Lodz, Poland; [Kordiak, Jacek] Med Univ Lodz, Dept Chest Surg Gen & Oncol Surg, Univ Hosp 2, Lodz, Poland; [Antczak, Adam] Med Univ Lodz, Dept Gen & Oncol Pulmonol, Lodz, Poland; [Gorski, Pawel] Med Univ Lodz, Dept Pneumol & Allergol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz	Brzezianska, E (corresponding author), Med Univ Lodz, Dept Mol Bases Med, Lodz, Poland.	ewa.brzezianska@umed.lodz.pl	Pastuszak-Lewandoska, Dorota/S-9465-2016; Czarnecka, Karolina H./C-8609-2011	Pastuszak-Lewandoska, Dorota/0000-0001-7602-9203; Czarnecka, Karolina H./0000-0003-4013-513X; Kordiak, Jacek/0000-0002-9991-9070	Medical University of Lodz, Poland [502/03-1-151/04/502-14-069]	Medical University of Lodz, Poland	The study was supported by the Medical University of Lodz, Poland (grant no 502/03-1-151/04/502-14-069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash I, 2012, CARCINOGENESIS, V33, P2320, DOI 10.1093/carcin/bgs362; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brantley EC, 2008, CLIN CANCER RES, V14, P4694, DOI 10.1158/1078-0432.CCR-08-0618; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cao SQ, 2011, INT J ONCOL, V39, P383, DOI 10.3892/ijo.2011.1053; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Dabir S, 2011, CANCER BIOL THER, V12, P139, DOI 10.4161/cbt.12.2.15732; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Du W, 2012, J CELL PHYSIOL, V227, P2421, DOI 10.1002/jcp.22977; Furth PA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2921; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Groen HJM, 2011, J CLIN ONCOL, V29, P4320, DOI 10.1200/JCO.2011.35.5214; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hida T, 1998, CANCER RES, V58, P3761; Hosomi Y, 2000, LUNG CANCER, V30, P73, DOI 10.1016/S0169-5002(00)00132-X; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang H, 2013, CLIN CHIM ACTA, V419, P26, DOI 10.1016/j.cca.2013.01.012; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kluge A, 2011, MOL ONCOL, V5, P256, DOI 10.1016/j.molonc.2011.03.004; Leahy KM, 2000, CURR MED CHEM, V7, P1163, DOI 10.2174/0929867003374336; Li F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-27; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu Jun-Ru, 2007, Ai Zheng, V26, P458; Mascaux C, 2006, BRIT J CANCER, V95, P139, DOI 10.1038/sj.bjc.6603226; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Ogata Y, 2006, NEOPLASIA, V8, P817, DOI 10.1593/neo.06409; Pold M, 2004, CANCER RES, V64, P1853, DOI 10.1158/0008-5472.CAN-03-3262; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Sung YH, 2005, MECH AGEING DEV, V126, P732, DOI 10.1016/j.mad.2005.01.007; Tan SH, 2008, ENDOCR-RELAT CANCER, V15, P367, DOI 10.1677/ERC-08-0013; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Xi SC, 2003, CANCER RES, V63, P6763; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104265	10.1371/journal.pone.0104265	http://dx.doi.org/10.1371/journal.pone.0104265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137041	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100022
J	Guzzo, CM; Ringel, A; Cox, E; Uzoma, I; Zhu, H; Blackshaw, S; Wolberger, C; Matunis, MJ				Guzzo, Catherine M.; Ringel, Alison; Cox, Eric; Uzoma, Ijeoma; Zhu, Heng; Blackshaw, Seth; Wolberger, Cynthia; Matunis, Michael J.			Characterization of the SUMO-Binding Activity of the Myeloproliferative and Mental Retardation (MYM)-Type Zinc Fingers in ZNF261 and ZNF198	PLOS ONE			English	Article							PROTEIN MODIFICATION; NUCLEAR-BODIES; UBIQUITIN; MOTIF; GENE; PML; RECOGNITION; SUMOYLATION; CLONING; DISEASE	SUMO-binding proteins interact with SUMO modified proteins to mediate a wide range of functional consequences. Here, we report the identification of a new SUMO-binding protein, ZNF261. Four human proteins including ZNF261, ZNF198, ZNF262, and ZNF258 contain a stretch of tandem zinc fingers called myeloproliferative and mental retardation (MYM)-type zinc fingers. We demonstrated that MYM-type zinc fingers from ZNF261 and ZNF198 are necessary and sufficient for SUMO-binding and that individual MYM-type zinc fingers function as SUMO-interacting motifs (SIMs). Our binding studies revealed that the MYM-type zinc fingers from ZNF261 and ZNF198 interact with the same surface on SUMO-2 recognized by the archetypal consensus SIM. We also present evidence that MYM-type zinc fingers in ZNF261 contain zinc, but that zinc is not required for SUMO-binding. Immunofluorescence microscopy studies using truncated fragments of ZNF198 revealed that MYM-type zinc fingers of ZNF198 are necessary for localization to PML-nuclear bodies (PML-NBs). In summary, our studies have identified and characterized the SUMO-binding activity of the MYM-type zinc fingers in ZNF261 and ZNF198.	[Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Ringel, Alison; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Cox, Eric; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Uzoma, Ijeoma; Zhu, Heng] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Matunis, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	mmatuni1@jhu.edu		Wolberger, Cynthia/0000-0001-8578-2969; Ringel, Alison/0000-0002-6451-9376; Cox, Eric/0000-0001-7691-4835; Matunis, Michael/0000-0002-9350-6611	AACR [08-40-02-GUZZ]; National Institutes of Health (NIH) [GMO60980, U54RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980, T32GM007445] Funding Source: NIH RePORTER	AACR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by AACR postdoctoral fellowship 08-40-02-GUZZ to CMG and National Institutes of Health (NIH) grants GMO60980 and U54RR020839 to MJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Keusekotten K, 2014, BIOCHEM J, V457, P207, DOI 10.1042/BJ20130753; Kunapuli P, 2003, ONCOGENE, V22, P3417, DOI 10.1038/sj.onc.1206408; Kunapuli P, 2006, EXP CELL RES, V312, P3739, DOI 10.1016/j.yexcr.2006.06.037; Kung CC, 2014, BIOCH J; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Lu CY, 2010, NUCLEIC ACIDS RES, V38, P488, DOI 10.1093/nar/gkp1008; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; QIU HW, 1994, J BIOL CHEM, V269, P2773; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smedley D, 1998, HUM MOL GENET, V7, P637, DOI 10.1093/hmg/7.4.637; Sohal J, 2000, CYTOGENET CELL GENET, V89, P24, DOI 10.1159/000015584; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Sung KS, 2011, EXP CELL RES, V317, P1060, DOI 10.1016/j.yexcr.2010.12.016; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vogt B, 2012, METHODS MOL BIOL, V832, P249, DOI 10.1007/978-1-61779-474-2_18; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	49	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105271	10.1371/journal.pone.0105271	http://dx.doi.org/10.1371/journal.pone.0105271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133527	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700095
J	Ramanarayanan, V; Lammert, A; Goldstein, L; Narayanan, S				Ramanarayanan, Vikram; Lammert, Adam; Goldstein, Louis; Narayanan, Shrikanth			Are Articulatory Settings Mechanically Advantageous for Speech Motor Control?	PLOS ONE			English	Article								We address the hypothesis that postures adopted during grammatical pauses in speech production are more "mechanically advantageous'' than absolute rest positions for facilitating efficient postural motor control of vocal tract articulators. We quantify vocal tract posture corresponding to inter-speech pauses, absolute rest intervals as well as vowel and consonant intervals using automated analysis of video captured with real-time magnetic resonance imaging during production of read and spontaneous speech by 5 healthy speakers of American English. We then use locally-weighted linear regression to estimate the articulatory forward map from low-level articulator variables to high-level task/goal variables for these postures. We quantify the overall magnitude of the first derivative of the forward map as a measure of mechanical advantage. We find that postures assumed during grammatical pauses in speech as well as speech-ready postures are significantly more mechanically advantageous than postures assumed during absolute rest. Further, these postures represent empirical extremes of mechanical advantage, between which lie the postures assumed during various vowels and consonants. Relative mechanical advantage of different postures might be an important physical constraint influencing planning and control of speech production.	[Ramanarayanan, Vikram; Lammert, Adam; Narayanan, Shrikanth] Univ So Calif, Viterbi Sch Engn, Signal Anal & Interpretat Lab, Los Angeles, CA 90089 USA; [Goldstein, Louis; Narayanan, Shrikanth] Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Ramanarayanan, V (corresponding author), Univ So Calif, Viterbi Sch Engn, Signal Anal & Interpretat Lab, Los Angeles, CA 90089 USA.	vikram.ramanarayanan@gmail.com	Narayanan, Shrikanth S/D-5676-2012		NIH [DC007124, 5T32DC009975]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003172, T32DC009975, R01DC007124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH Grant DC007124 and a graduate traineeship NIH 5T32DC009975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson E.K., 2005, FORMAL ENG DESIGN SY; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; Browman C., 1995, MIND MOTION EXPLORAT, P175; Chung W., 2008, SPRINGER HDB ROBOTIC; ESLING JH, 1983, TESOL QUART, V17, P89, DOI 10.2307/3586426; Fujimura O, 1979, FRONTIERS SPEECH COM, P17; Gick B, 2004, PHONETICA, V61, P220, DOI 10.1159/000084159; Honikman Beatrice, 1964, HONOUR D JONES, P73; Joos MA., 1948, LANGUAGE, V24, P5, DOI [10.2307/522229, DOI 10.2307/522229]; Lammert A, 2014, J SPEECH CO IN PRESS; Laver J, 1978, HISTORIOGRAPHIA LING, V5, P1; Laver J., 1980, PHONETIC DESCRIPTION; Mennen I, 2010, SECOND LANG RES, V26, P13, DOI 10.1177/0267658309337617; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Ohman S, 1967, PERIPHERAL MOTOR COM, P30; PELLOM B, 2001, TRCSLR200101 U COL; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Ramanarayanan V, 2009, J ACOUST SOC AM, V126, pEL160, DOI 10.1121/1.3213452; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Sweet H, 1890, PRIMER PHONETICS; Wilson I, 2006, J ACOUST SOC AM, V120, P3295; Wrench A., 2000, WORKSH PHON PHON ASR	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104168	10.1371/journal.pone.0104168	http://dx.doi.org/10.1371/journal.pone.0104168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133544	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700023
J	Alaimo, JT; Hahn, NH; Mullegama, SV; Elsea, SH				Alaimo, Joseph T.; Hahn, Natalie H.; Mullegama, Sureni V.; Elsea, Sarah H.			Dietary Regimens Modify Early Onset of Obesity in Mice Haploinsufficient for Rai1	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; MOUSE MODELS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; FAT DISTRIBUTION; ADIPOSE-TISSUE; METHYLATION; OVEREXPRESSION; PHENOTYPES; GENOTYPE	Smith-Magenis syndrome is a complex genomic disorder in which a majority of individuals are obese by adolescence. While an interstitial deletion of chromosome 17p11.2 is the leading cause, mutation or deletion of the RAI1 gene alone results in most features of the disorder. Previous studies have shown that heterozygous knockout of Rai1 results in an obese phenotype in mice and that Smith-Magenis syndrome mouse models have a significantly reduced fecundity and an altered transmission pattern of the mutant Rai1 allele, complicating large, extended studies in these models. In this study, we show that breeding C57Bl/6J Rai1(+/-) mice with FVB/NJ to create F1 Rai1(+/-) offspring in a mixed genetic background ameliorates both fecundity and Rai1 allele transmission phenotypes. These findings suggest that the mixed background provides a more robust platform for breeding and larger phenotypic studies. We also characterized the effect of dietary intake on Rai1(+/-) mouse growth during adolescent and early adulthood developmental stages. Animals fed a high carbohydrate or a high fat diet gained weight at a significantly faster rate than their wild type littermates. Both high fat and high carbohydrate fed Rai1(+/-) mice also had an increase in body fat and altered fat distribution patterns. Interestingly, Rai1(+/-) mice fed different diets did not display altered fasting blood glucose levels. These results suggest that dietary regimens are extremely important for individuals with Smith-Magenis syndrome and that food high in fat and carbohydrates may exacerbate obesity outcomes.	[Alaimo, Joseph T.; Mullegama, Sureni V.; Elsea, Sarah H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hahn, Natalie H.; Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Baylor College of Medicine; Virginia Commonwealth University	Elsea, SH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	elsea@bcm.edu	Alaimo, Joseph/AHC-1981-2022	Elsea, Sarah/0000-0002-1400-8519	Smith-Magenis Syndrome Research Foundation	Smith-Magenis Syndrome Research Foundation	This work was supported by Smith-Magenis Syndrome Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Darvekar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078907; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2009, EUR J MED GENET, V52, P224, DOI 10.1016/j.ejmg.2008.12.002; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Herrera BM, 2011, MATURITAS, V69, P41, DOI 10.1016/j.maturitas.2011.02.018; Kim DH, 2013, INT J OBESITY, V37, P853, DOI 10.1038/ijo.2012.141; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Smith ACM, 2002, GENET MED, V4, P118, DOI 10.1097/00125817-200205000-00004; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Tanabe LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032245; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Williams SR, 2012, AM J HUM GENET, V90, P941, DOI 10.1016/j.ajhg.2012.04.013; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Yan J, 2007, AM J HUM GENET, V80, P518, DOI 10.1086/512043	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105077	10.1371/journal.pone.0105077	http://dx.doi.org/10.1371/journal.pone.0105077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127133	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300075
J	Cao, MH; You, H; Hermonat, PL				Cao, Maohua; You, Hong; Hermonat, Paul L.			The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication	PLOS ONE			English	Article							ADENO-ASSOCIATED VIRUS; HUMAN-PAPILLOMAVIRUS; INFECTION; TYPE-2; CELLS; MUTANTS	Adeno-associated virus (AAV) (type 2) is a popular human gene therapy vector with a long active transgene expression period and no reported vector-induced adverse reactions. Yet the basic molecular biology of this virus has not been fully addressed. One potential gene at the far 3' end of the AAV2 genome, previously referred to as X (nt 3929 to 4393), overlapping the 3' end of the cap gene, has never been characterized, although we did previously identify a promoter just up-stream (p81). Computer analysis suggested that X was involved in replication and transcription. The X protein was identified during active AAV2 replication using a polyclonal antibody against a peptide starting at amino acid 98. Reagents for the study of X included an AAV2 deletion mutant (dl78-91), a triple nucleotide substitution mutant that destroys all three 5' AUG-initiation products of X, with no effect on the cap coding sequence, and X-positive-293 cell lines. Here, we found that X up-regulated AAV2 DNA replication in differentiating keratinocytes (without helper virus, autonomous replication) and in various forms of 293 cell-based assays with help from wild type adenovirus type 5 (wt Ad5) or Ad5 helper plasmid (pHelper). The strongest contribution by X was seen in increasing wt AAV2 DNA replication in keratinocytes and dl78-91 in Ad5-infected X-positive-293 cell lines (both having multi-fold effects). Mutating the X gene in pAAV-RC (pAAV-RC-3Xneg) yielded approximately a similar to 33% reduction in recombinant AAV vector DNA replication and virion production, but a larger effect was seen when using this same X-knockout AAV helper plasmid in X-positive-293 cell lines versus normal 293 cells (again, multi-fold). Taken together these data strongly suggest that AAV2 X encodes a protein involved in the AAV life cycle, particularly in increasing AAV2 DNA replication, and suggests that further studies are warranted.	[Cao, Maohua; Hermonat, Paul L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [You, Hong; Hermonat, Paul L.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Hermonat, PL (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.	Paul.Hermonat@va.gov	You, Hong/G-6686-2011		VA Merit Review; NIH [R56 AI093695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093695] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by VA Merit Review and NIH R56 AI093695 grants to PLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKLOW NR, 1971, AM J EPIDEMIOL, V94, P359, DOI 10.1093/oxfordjournals.aje.a121331; BLACKLOW NR, 1968, J NATL CANCER I, V40, P319; Buchlis G, 2012, BLOOD, V119, P3038, DOI 10.1182/blood-2011-09-382317; BULLER RML, 1978, J VIROL, V25, P331, DOI 10.1128/JVI.25.1.331-338.1978; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Hemonat PL, 1999, J HUMAN VIROL, V2, P359; Hermonat P.L., 1984, THESIS U FL; HERMONAT PL, 1984, P NATL ACAD SCI-BIOL, V81, P6466, DOI 10.1073/pnas.81.20.6466; HERMONAT PL, 1984, J VIROL, V51, P329, DOI 10.1128/JVI.51.2.329-339.1984; Hermonat PL, 2014, HUMAN GENE IN PRESS; Kang BY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-79; Meyers C, 2001, VIROLOGY, V287, P30, DOI 10.1006/viro.2001.0968; Meyers C, 2000, VIROLOGY, V272, P338, DOI 10.1006/viro.2000.0385; Nagy V, 2006, NATURE METHODS, V3; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; TRATSCHIN JD, 1984, J VIROL, V51, P611, DOI 10.1128/JVI.51.3.611-619.1984; You CX, 2012, ONCOIMMUNOLOGY, V1, P847, DOI 10.4161/onci.20504; You H, 2006, VIROLOGY, V344, P532, DOI 10.1016/j.virol.2005.08.039; Zhu H, 2013, J GENET SYNDR GENE T, V4, P135	20	25	32	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104596	10.1371/journal.pone.0104596	http://dx.doi.org/10.1371/journal.pone.0104596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127256	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300036
J	Eto, K; Nishimura, W; Oishi, H; Udagawa, H; Kawaguchi, M; Hiramoto, M; Fujiwara, T; Takahashi, S; Yasuda, K				Eto, Koki; Nishimura, Wataru; Oishi, Hisashi; Udagawa, Haruhide; Kawaguchi, Miho; Hiramoto, Masaki; Fujiwara, Toshiyoshi; Takahashi, Satoru; Yasuda, Kazuki			MafA Is Required for Postnatal Proliferation of Pancreatic beta-Cells	PLOS ONE			English	Article							GROWTH-HORMONE; PLACENTAL-LACTOGEN; INSULIN-SECRETION; SIGNAL TRANSDUCER; TRANSCRIPTION FACTOR; GLUCOSE-HOMEOSTASIS; PROLACTIN RECEPTOR; CYCLIN D2; EXPRESSION; ISLETS	The postnatal proliferation and maturation of insulin-secreting pancreatic beta-cells are critical for glucose metabolism and disease development in adults. Elucidation of the molecular mechanisms underlying these events will be beneficial to direct the differentiation of stem cells into functional beta-cells. Maturation of beta-cells is accompanied by increased expression of MafA, an insulin gene transcription factor. Transcriptome analysis of MafA knockout islets revealed MafA is required for the expression of several molecules critical for beta-cell function, including Glut2, ZnT8, Granuphilin, Vdr, Pcsk1 and Urocortin 3, as well as Prolactin receptor (Prlr) and its downstream target Cyclin D2 (Ccnd2). Inhibition of MafA expression in mouse islets or beta-cell lines resulted in reduced expression of Prlr and Ccnd2, and MafA transactivated the Prlr promoter. Stimulation of beta-cells by prolactin resulted in the phosphorylation and translocation of Stat5B and an increased nuclear pool of Ccnd2 via Prlr and Jak2. Consistent with these results, the loss of MafA resulted in impaired proliferation of beta-cells at 4 weeks of age. These results suggest that MafA regulates the postnatal proliferation of beta-cells via prolactin signaling.	[Eto, Koki; Nishimura, Wataru; Udagawa, Haruhide; Kawaguchi, Miho; Hiramoto, Masaki; Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Dept Metab Disorders, Diabet Res Ctr, Tokyo, Japan; [Eto, Koki; Fujiwara, Toshiyoshi] Okayama Univ, Dept Surg Gastroenterol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	National Center for Global Health & Medicine - Japan; Okayama University; University of Tsukuba	Nishimura, W (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Metab Disorders, Diabet Res Ctr, Tokyo, Japan.	wnishimura@ri.ncgm.go.jp; kyasuda@ri.ncgm.go.jp	Nishimura, Wataru/R-9215-2019	Nishimura, Wataru/0000-0002-8068-1277	JSPS KAKENHI [22591022, 21390283]; National Center for Global Health and Medicine [22-103, 25-102]; Takeda Science Foundation; Japan Diabetes Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Diabetes Foundation	This study was supported by JSPS KAKENHI (22591022), a grant from the National Center for Global Health and Medicine (22-103), the Takeda Science Foundation, and the Japan Diabetes Foundation to WN, JSPS KAKENHI (21390283) and a grant from the National Center for Global Health and Medicine (25-102) to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Arumugam R, 2011, ENDOCRINOLOGY, V152, P856, DOI 10.1210/en.2010-1258; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Fleenor D, 2000, PEDIATR RES, V47, P136, DOI 10.1203/00006450-200001000-00023; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Friedrichsen BN, 2001, MOL ENDOCRINOL, V15, P136, DOI 10.1210/me.15.1.136; Friedrichsen BN, 2003, MOL ENDOCRINOL, V17, P945, DOI 10.1210/me.2002-0356; Georgia S, 2010, DIABETES, V59, P987, DOI 10.2337/db09-0838; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; HOSOKAWA Y, 1994, GENE, V147, P249, DOI 10.1016/0378-1119(94)90075-2; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes E, 2011, ENDOCRINOLOGY, V152, P847, DOI 10.1210/en.2010-1250; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; JOHNSTON DG, 1980, CLIN ENDOCRINOL, V13, P361, DOI 10.1111/j.1365-2265.1980.tb03397.x; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Maccario M, 1996, EUR J ENDOCRINOL, V135, P205, DOI 10.1530/eje.0.1350205; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MOLDRUP A, 1993, ENDOCRINOLOGY, V133, P1165, DOI 10.1210/en.133.3.1165; NIELSEN JH, 1982, ENDOCRINOLOGY, V110, P600, DOI 10.1210/endo-110-2-600; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Nishimura W, 2013, ENDOCRINOLOGY, V154, P4388, DOI 10.1210/en.2012-2248; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Picard F, 2002, P NATL ACAD SCI USA, V99, P15644, DOI 10.1073/pnas.202612199; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; SORENSON RL, 1993, ENDOCRINOLOGY, V133, P2227, DOI 10.1210/en.133.5.2227; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Weinhaus AJ, 2007, J ENDOCRINOL, V193, P367, DOI 10.1677/JOE-07-0043; Yokouchi H, 2013, ACTA OPHTHALMOL, V91, pE289, DOI 10.1111/aos.12097; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	46	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104184	10.1371/journal.pone.0104184	http://dx.doi.org/10.1371/journal.pone.0104184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126749	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300015
J	Felix-Silva, J; Souza, T; Menezes, YAS; Cabral, B; Camara, RBG; Silva, AA; Rocha, HAO; Rebecchi, IMM; Zucolotto, SM; Fernandes-Pedrosa, MF				Felix-Silva, Juliana; Souza, Thiago; Menezes, Yamara A. S.; Cabral, Barbara; Camara, Rafael B. G.; Silva-Junior, Arnobio A.; Rocha, Hugo A. O.; Rebecchi, Ivanise M. M.; Zucolotto, Silvana M.; Fernandes-Pedrosa, Matheus F.			Aqueous Leaf Extract of Jatropha gossypiifolia L. (Euphorbiaceae) Inhibits Enzymatic and Biological Actions of Bothrops jararaca Snake Venom	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; PHOSPHOLIPASE A(2); ETHANOLIC EXTRACT; GOSSYPIFOLIA L.; PAW EDEMA; METALLOPROTEINASES; CONSTITUENTS; LEAVES; ANTICOAGULANT; QUANTITATION	Snakebites are a serious public health problem due their high morbi-mortality. The main available specific treatment is the antivenom serum therapy, which has some disadvantages, such as poor neutralization of local effects, risk of immunological reactions, high cost and difficult access in some regions. In this context, the search for alternative therapies is relevant. Therefore, the aim of this study was to evaluate the antiophidic properties of Jatropha gossypiifolia, a medicinal plant used in folk medicine to treat snakebites. The aqueous leaf extract of the plant was prepared by decoction and phytochemical analysis revealed the presence of sugars, alkaloids, flavonoids, tannins, terpenes and/or steroids and proteins. The extract was able to inhibit enzymatic and biologic activities induced by Bothrops jararaca snake venom in vitro and in vivo. The blood incoagulability was efficiently inhibited by the extract by oral route. The hemorrhagic and edematogenic local effects were also inhibited, the former by up to 56% and the latter by 100%, in animals treated with extract by oral and intraperitoneal routes, respectively. The inhibition of myotoxic action of B. jararaca reached almost 100%. According to enzymatic tests performed, it is possible to suggest that the antiophidic activity may be due an inhibitory action upon snake venom metalloproteinases (SVMPs) and/or serine proteinases (SVSPs), including fibrinogenolytic enzymes, clotting factors activators and thrombin like enzymes (SVTLEs), as well upon catalytically inactive phospholipases A(2) (Lys49 PLA(2)). Anti-inflammatory activity, at least partially, could also be related to the inhibition of local effects. Additionally, protein precipitating and antioxidant activities may also be important features contributing to the activity presented. In conclusion, the results demonstrate the potential antiophidic activity of J. gossypiifolia extract, including its significant action upon local effects, suggesting that it may be used as a new source of bioactive molecules against bothropic venom.	[Felix-Silva, Juliana; Souza, Thiago; Menezes, Yamara A. S.; Silva-Junior, Arnobio A.; Fernandes-Pedrosa, Matheus F.] Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut TecBioFar, Programa Posgrad Ciencias Farmaceut PPgCF, BR-59072970 Natal, RN, Brazil; [Cabral, Barbara; Zucolotto, Silvana M.] Univ Fed Rio Grande do Norte, Dept Farm, Lab Farmacognosia, BR-59072970 Natal, RN, Brazil; [Camara, Rafael B. G.; Rocha, Hugo A. O.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Lab Biotecnol Polimeros Nat BIOPOL, BR-59072970 Natal, RN, Brazil; [Rebecchi, Ivanise M. M.] Univ Fed Rio Grande do Norte, Dept Anal Clin & Toxicol, Lab Hematol Clin, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Fernandes-Pedrosa, MF (corresponding author), Univ Fed Rio Grande do Norte, Lab Tecnol & Biotecnol Farmaceut TecBioFar, Programa Posgrad Ciencias Farmaceut PPgCF, BR-59072970 Natal, RN, Brazil.	mpedrosa@ufrnet.br	Félix-Silva, Juliana/K-7066-2012; Menezes, Yamara/K-1783-2016; Zucolotto, Silvana Maria/A-8557-2014; Câmara, Rafael Barros Gomes da/X-7416-2019; Rocha, Hugo Alexandre Oliveira/X-6411-2019; da Silva, Arnobio A/L-4252-2013; Félix-Silva, Juliana/AAA-1737-2019; Fernandes-Pedrosa, Matheus/C-6398-2014; Silva, André/HHN-2071-2022; de Oliveira Rocha, Hugo Alexandre/I-5130-2019; Rocha, Hugo Alexandre Oliveira/X-6410-2019	Félix-Silva, Juliana/0000-0003-3131-9025; Menezes, Yamara/0000-0002-3532-5273; Zucolotto, Silvana Maria/0000-0002-2768-0793; da Silva, Arnobio A/0000-0002-7516-1787; Félix-Silva, Juliana/0000-0003-3131-9025; Fernandes-Pedrosa, Matheus/0000-0003-4221-9580; Rocha, Hugo Alexandre Oliveira/0000-0003-2252-1221	CAPES [23038000814/2011-83]; CNPq [483842/2010-9]; BNB [ETENE/2010]; FAPERN [PRONEM/2011]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BNB; FAPERN(Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN))	This research was supported by grants from CAPES (23038000814/2011-83), CNPq (483842/2010-9), BNB (ETENE/2010) and FAPERN (PRONEM/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambikabothy J, 2011, J ETHNOPHARMACOL, V137, P257, DOI 10.1016/j.jep.2011.05.013; Pereanez JA, 2013, TOXICON, V71, P41, DOI 10.1016/j.toxicon.2013.05.013; [Anonymous], 2014, INT J PHARM PHARM SC; Araujo SD, 2007, INFLAMM RES, V56, P409, DOI 10.1007/s00011-007-7054-x; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bhagat R, 2011, J SCI IND RES INDIA, V70, P289; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brasil, 2011, REN REL NCAL PLANT M; CURY Y, 1994, TOXICON, V32, P1425, DOI 10.1016/0041-0101(94)90414-6; Dantas Jose Oliveira, 2006, Biologia Geral e Experimental, V6, P32; de Albuquerque UP, 2007, J ETHNOPHARMACOL, V110, P76, DOI 10.1016/j.jep.2006.09.010; De PRC, 2010, J VENOM ANIM TOXINS, V16, P311, DOI 10.1590/S1678-91992010000200012; de Paula RC, 2009, PROTEIN PEPTIDE LETT, V16, P899, DOI 10.2174/092986609788923365; de Roodt AR, 2000, TOXICON, V38, P865, DOI 10.1016/S0041-0101(99)00205-6; Devappa RK, 2010, J TOXICOL ENV HEAL B, V13, P476, DOI 10.1080/10937404.2010.499736; Dey A, 2012, INT J PHARMACOL, V8, P62, DOI 10.3923/ijp.2012.62.79; Di Stasi L.C., 2002, PLANTAS MED AMAZONIA; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4; Felix-Silva J, 2014, EVID-BASED COMPL ALT, V2014, P1; Franke K, 2004, BIOCHEM SYST ECOL, V32, P219, DOI 10.1016/S0305-1978(03)00140-6; Fuly, 2011, BIOMED PREV NUTR, V1, P61, DOI [10.1016/j.bionut.2010.09.003, DOI 10.1016/J.BIONUT.2010.09.003]; Gomes A, 2010, INDIAN J EXP BIOL, V48, P865; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; HABERMANN E, 1972, ANAL BIOCHEM, V50, P163, DOI 10.1016/0003-2697(72)90495-2; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; KORNALIK F, 1985, PHARMACOL THERAPEUT, V29, P353, DOI 10.1016/0163-7258(85)90008-7; KUPPUSAMY UR, 1993, PHARMACOL TOXICOL, V72, P290, DOI 10.1111/j.1600-0773.1993.tb01652.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maiorano VA, 2005, J ETHNOPHARMACOL, V102, P364, DOI 10.1016/j.jep.2005.06.039; Mao WJ, 2009, INT J BIOL MACROMOL, V44, P70, DOI 10.1016/j.ijbiomac.2008.10.003; Gutierrez JM, 2011, BIOLOGICALS, V39, P129, DOI 10.1016/j.biologicals.2011.02.005; Mariz SR, 2012, REV BRAS FARMACOGN, V22, P663, DOI 10.1590/S0102-695X2012005000024; MEBS D, 1983, TOXICON, V21, P393, DOI 10.1016/0041-0101(83)90096-X; Melo-Silveira RF, 2012, INT J MOL SCI, V13, P409, DOI 10.3390/ijms13010409; Ministerio da Saude, 2009, CADERNO 14; Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagaharika Y, 2013, J ACUTE DIS, V2, P156, DOI 10.1016/S2221-6189(13)60118-3; Nunez V, 2004, BRAZ J MED BIOL RES, V37, P969, DOI 10.1590/S0100-879X2004000700005; Ode O.J., 2010, INT J APPL BIOL PHAR, V1, P1330; Panda BB, 2009, GLOBAL J PHARM, V3, P1; Pilon AC, 2013, PHYTOCHEM ANALYSIS, V24, P401, DOI 10.1002/pca.2423; Ramos OHP, 2006, COMP BIOCHEM PHYS C, V142, P328, DOI 10.1016/j.cbpc.2005.11.005; Robert S, 2010, J ETHNOPHARMACOL, V128, P641, DOI 10.1016/j.jep.2010.02.007; Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958; Sabandar CW, 2013, PHYTOCHEMISTRY, V85, P7, DOI 10.1016/j.phytochem.2012.10.009; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Santhosh MS, 2013, MINI-REV MED CHEM, V13, P106; Shenoy PA, 2013, J ETHNOPHARMACOL, V147, P373, DOI 10.1016/j.jep.2013.03.022; STOCKER K, 1982, TOXICON, V20, P265, DOI 10.1016/0041-0101(82)90225-2; SUBRAMAN.SS, 1971, PHYTOCHEMISTRY, V10, P1690, DOI 10.1016/0031-9422(71)85055-0; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006; Melo KRT, 2013, MOLECULES, V18, P14543, DOI 10.3390/molecules181214543; THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949; TREBIEN HA, 1989, AGENTS ACTIONS, V26, P292, DOI 10.1007/BF01967293; Wagner H., 2001, PLANT DRUGS ANAL THI; Zhang XP, 2009, CHEM BIODIVERS, V6, P2166, DOI 10.1002/cbdv.200700461	67	33	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104952	10.1371/journal.pone.0104952	http://dx.doi.org/10.1371/journal.pone.0104952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126759	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300063
J	Kang, MJ; Hansen, TJ; Mickiewicz, M; Kaczynski, TJ; Fye, S; Gunawardena, S				Kang, Min Jung; Hansen, Timothy J.; Mickiewicz, Monique; Kaczynski, Tadeusz J.; Fye, Samantha; Gunawardena, Shermali			Disruption of Axonal Transport Perturbs Bone Morphogenetic Protein (BMP) - Signaling and Contributes to Synaptic Abnormalities in Two Neurodegenerative Diseases	PLOS ONE			English	Article							PRESYNAPTIC ACTIVE ZONES; MOUSE MODEL; KINESIN MUTATIONS; II RECEPTOR; DROSOPHILA; GROWTH; MOTOR; SYNAPTOTAGMIN; EXPRESSION; PLASTICITY	Formation of new synapses or maintenance of existing synapses requires the delivery of synaptic components from the soma to the nerve termini via axonal transport. One pathway that is important in synapse formation, maintenance and function of the Drosophila neuromuscular junction (NMJ) is the bone morphogenetic protein (BMP)-signaling pathway. Here we show that perturbations in axonal transport directly disrupt BMP signaling, as measured by its downstream signal, phospho Mad (p-Mad). We found that components of the BMP pathway genetically interact with both kinesin-1 and dynein motor proteins. Thick vein (TKV) vesicle motility was also perturbed by reductions in kinesin-1 or dynein motors. Interestingly, dynein mutations severely disrupted p-Mad signaling while kinesin-1 mutants showed a mild reduction in p-Mad signal intensity. Similar to mutants in components of the BMP pathway, both kinesin-1 and dynein motor protein mutants also showed synaptic morphological defects. Strikingly TKV motility and p-Mad signaling were disrupted in larvae expressing two human disease proteins; expansions of glutamine repeats (polyQ77) and human amyloid precursor protein (APP) with a familial Alzheimer's disease (AD) mutation (APPswe). Consistent with axonal transport defects, larvae expressing these disease proteins showed accumulations of synaptic proteins along axons and synaptic abnormalities. Taken together our results suggest that similar to the NGF-TrkA signaling endosome, a BMP signaling endosome that directly interacts with molecular motors likely exist. Thus problems in axonal transport occurs early, perturbs BMP signaling, and likely contributes to the synaptic abnormalities observed in these two diseases.	[Kang, Min Jung; Hansen, Timothy J.; Mickiewicz, Monique; Kaczynski, Tadeusz J.; Fye, Samantha; Gunawardena, Shermali] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gunawardena, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sg99@buffalo.edu		gunawardena, shermali/0000-0001-8776-9397	John R. Oishei Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R03-NS084386-01]; University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA); Honors College Research and Creative Activities Fund; Department of Biological Sciences McCroskey Endowment Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS084386] Funding Source: NIH RePORTER	John R. Oishei Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA); Honors College Research and Creative Activities Fund; Department of Biological Sciences McCroskey Endowment Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the John R. Oishei Foundation and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) (R03-NS084386-01) to SG. TJH was supported by fellowships from the University at Buffalo (UB) Center for Undergraduate Research and Creative Activities (CURCA), the Honors College Research and Creative Activities Fund, and the Department of Biological Sciences McCroskey Endowment Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Bowman AB, 1999, J CELL BIOL, V146, P165; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cai Q, 2009, NEUROSCIENTIST, V15, P78, DOI 10.1177/1073858408329511; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chia PH, 2013, J CELL BIOL, V203, P11, DOI 10.1083/jcb.201307020; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cummings DM, 2006, HUM MOL GENET, V15, P2856, DOI 10.1093/hmg/ddl224; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dolma K, 2014, HUM MOL GENET, V23, P1121, DOI 10.1093/hmg/ddt505; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fiorillo C, 2014, HUM MUTAT, V35, P298, DOI 10.1002/humu.22491; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Fuentes-Medel Y, 2010, NEURON, V66, P473, DOI 10.1016/j.neuron.2010.05.016; Fye Samantha, 2010, J Vis Exp, DOI 10.3791/2128; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Gunawardena S, 2013, PHARM RES-DORDR, V30, P2459, DOI 10.1007/s11095-013-1037-0; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Holbert S, 2003, P NATL ACAD SCI USA, V100, P2712, DOI 10.1073/pnas.0437967100; Hurd DD, 1996, GENETICS, V144, P1075; Kaczynski TJ, 2010, JOVE-J VIS EXP, V46, P2150; Keshishian H, 2002, NEURON, V33, P491, DOI 10.1016/S0896-6273(02)00597-4; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Kuznicki Michelle L, 2010, J Vis Exp, DOI 10.3791/2151; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LAMPERT PW, 1971, ACTA NEUROPATHOL B S, V5, P49; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Lione LA, 1999, J NEUROSCI, V19, P10428; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morel M, 2012, ACTA NEUROPATHOL, V123, P71, DOI 10.1007/s00401-011-0901-4; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Orth M, 2010, J NEUROL NEUROSUR PS, V81, P267, DOI 10.1136/jnnp.2009.171926; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; PERIN MS, 1991, J BIOL CHEM, V266, P615; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Schippling S, 2009, BIOL PSYCHIAT, V65, P959, DOI 10.1016/j.biopsych.2008.12.026; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Torroja L, 1999, J NEUROSCI, V19, P7793; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vanlandingham PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065997; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Ye X, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.004; Zhao JL, 2013, MOL CELL NEUROSCI, V52, P87, DOI 10.1016/j.mcn.2012.10.005; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	94	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104617	10.1371/journal.pone.0104617	http://dx.doi.org/10.1371/journal.pone.0104617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127478	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300038
J	Nehls, J; Koppensteiner, H; Brack-Werner, R; Floss, T; Schindler, M				Nehls, Julia; Koppensteiner, Herwig; Brack-Werner, Ruth; Floss, Thomas; Schindler, Michael			HIV-1 Replication in Human Immune Cells Is Independent of TAR DNA Binding Protein 43 (TDP-43) Expression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; RESTRICTION FACTORS; NUCLEAR FACTOR; NEF; RELEASE; RNA; VPU; TRANSCRIPTION; MACROPHAGES	The TAR DNA binding protein (TDP-43) was originally identified as a host cell factor binding to the HIV-1 LTR and thereby suppressing HIV-1 transcription and gene expression (Ou et al., J. Virol. 1995, 69(6): 3584). TDP-43 is a global regulator of transcription, can influence RNA metabolism in many different ways and is ubiquitously expressed. Thus, TDP-43 could be a major factor restricting HIV-1 replication at the level of LTR transcription and gene expression. These facts prompted us to revisit the role of TDP-43 for HIV-1 replication. We utilized established HIV-1 cell culture systems as well as primary cell models and performed a comprehensive analysis of TDP-43 function and investigated its putative impact on HIV-1 gene expression. In HIV-1 infected cells TDP-43 was neither degraded nor sequestered from the nucleus. Furthermore, TDP-43 overexpression as well as siRNA mediated knockdown did not affect HIV-1 gene expression and virus production in T cells and macrophages. In summary, our experiments argue against a restricting role of TDP-43 during HIV-1 replication in immune cells.	[Nehls, Julia; Koppensteiner, Herwig; Brack-Werner, Ruth; Schindler, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Virol, Neuherberg, Germany; [Floss, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Dev Genet, Neuherberg, Germany; [Schindler, Michael] Univ Clin Tubingen, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schindler, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Virol, Neuherberg, Germany.	michael.schindler@helmholtz-muenchen.de	Schindler, Michael/C-1647-2015; Brack-Werner, Ruth/M-4615-2014	Schindler, Michael/0000-0001-8989-5813; Brack-Werner, Ruth/0000-0002-8651-9318	Helmholtz Zentrum Munchen; German Research Foundation [DFG SCHI1073/4-1]; Else Kroner-Fresenius Stiftung; KNDD2 [FKZ 01 GI 1005D]	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung; KNDD2	Financial support for this study was provided by intramural funding of the Helmholtz Zentrum Munchen. JN and MS received funding from the German Research Foundation (DFG SCHI1073/4-1) and the Else Kroner-Fresenius Stiftung. TF was supported by the KNDD2 grants FKZ 01 GI 1005D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Budini M, 2011, J MOL NEUROSCI, V45, P473, DOI 10.1007/s12031-011-9573-8; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Koppensteiner H, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-1; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Meggendorfer M, 2010, CHROMOSOME RES, V18, P401, DOI 10.1007/s10577-010-9133-z; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105478	10.1371/journal.pone.0105478	http://dx.doi.org/10.1371/journal.pone.0105478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127017	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300114
J	von Drygalski, A; Bhat, V; Gale, AJ; Burnier, L; Cramer, TJ; Griffin, JH; Mosnier, LO				von Drygalski, Annette; Bhat, Vikas; Gale, Andrew J.; Burnier, Laurent; Cramer, Thomas J.; Griffin, John H.; Mosnier, Laurent O.			An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C	PLOS ONE			English	Article							ACUTE TRAUMATIC COAGULOPATHY; IN-VIVO; SEVERE SEPSIS; INACTIVATION; SAFETY; MUTANT; HEMOSTASIS; HEMORRHAGE; THROMBIN; MICE	Objective: An increased risk of bleeding is observed in patients receiving activated protein C (APC), which may be a limiting factor for the application of novel APC therapies. Since APC's therapeutic effects often require its cytoprotective activities on cells but not APC's anticoagulant activities, an agent that specifically antagonizes APC's anticoagulant effects but not its cytoprotective effects could provide an effective means to control concerns for risk of bleeding. We hypothesized that (super)FVa, an engineered activated FVa-variant that restores hemostasis in hemophilia could reduce APC-induced bleeding. Approach and Results: (Super)FVa was engineered with mutations of the APC cleavage sites (Arg506/306/679Gln) and a disulfide bond (Cys609-Cys1691) between the A2 and A3 domains, which augment its biological activity and cause high resistance to APC. (Super)FVa normalized APC-prolonged clotting times and restored APC-suppressed thrombin generation in human and murine plasma at concentrations where wild-type (wt) FVa did not show effects. Following intravenous injection of APC into BALB/c mice, addition to whole blood ex vivo of (super)FVa but not wt-FVa significantly normalized whole blood clotting. Blood loss following tail clip or liver laceration was significantly reduced when (super)FVa was administered intravenously to BALB/c mice prior to intravenous APC-treatment. Furthermore, (super)FVa abolished mortality (similar to 50%) associated with excessive bleeding following liver laceration in mice treated with APC. Conclusions: Our results provide proof of concept that (super)FVa is effective in preventing APC-induced bleeding and may provide therapeutic benefits as a prohemostatic agent in various situations where bleeding is a serious risk.	[von Drygalski, Annette; Bhat, Vikas; Gale, Andrew J.; Burnier, Laurent; Griffin, John H.; Mosnier, Laurent O.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [von Drygalski, Annette; Bhat, Vikas; Cramer, Thomas J.; Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA	Scripps Research Institute; University of California System; University of California San Diego	von Drygalski, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	avondrygalski@ucsd.edu	Burnier, Laurent P/E-5807-2011	Burnier, Laurent P/0000-0001-7767-0334; Griffin, John/0000-0002-4302-2547	American Society of Hematology; Bayer Early Career Investigator Award; Swiss National Science Foundation; Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB); Novartis [PBGEP3-134242, PASMP3_140065]; National Institutes of Health [R01HL021544, PO1HL031950, R01HL052246, R01HL104165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104165, R01HL021544, P01HL031950, R01HL052246] Funding Source: NIH RePORTER	American Society of Hematology; Bayer Early Career Investigator Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB); Novartis(Novartis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by a Research Training Award for Fellows from the American Society of Hematology (A. v. D.), a Bayer Early Career Investigator Award (A. v. D.), postdoctoral fellowships from the Swiss National Science Foundation, the Fondation Suisse pour les Bourses en Medecine et Biologie (FSBMB) and Novartis PBGEP3-134242 and PASMP3_140065 (L. B.), and National Institutes of Health grants R01HL021544, PO1HL031950, and R01HL052246 (J. H. G.) and R01HL104165 (L. O. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj MS, 2011, J BIOL CHEM, V286, P4329, DOI 10.1074/jbc.M110.191163; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Burnier L, 2013, BLOOD CELL MOL DIS, V50, P252, DOI 10.1016/j.bcmd.2013.01.002; Charbonneau S, 2012, J TRAUMA ACUTE CARE, V72, P136, DOI 10.1097/TA.0b013e31823183b4; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Christiaans SC, 2014, SHOCK; Cramer TJ, 2009, PATHOPHYSIOL HAEMO T, V37, P17, DOI 10.1159/000315141; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Fernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P1721, DOI 10.3324/haematol.2009.009233; Franchini M, 2010, THROMB RES, V125, P119, DOI 10.1016/j.thromres.2009.11.003; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; HEEB MJ, 1988, THROMB RES, V52, P33, DOI 10.1016/0049-3848(88)90038-2; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Jasuja GK, 2013, THROMB RES, V131, P31, DOI 10.1016/j.thromres.2012.10.010; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Karakaya K, 2009, J INVEST SURG, V22, P201, DOI 10.1080/08941930902866246; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2011, J BIOL CHEM, V286, P502, DOI 10.1074/jbc.M110.147959; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; von Drygalski A, 2014, J THROMB HAEMOST, V12, P363, DOI 10.1111/jth.12489	31	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104304	10.1371/journal.pone.0104304	http://dx.doi.org/10.1371/journal.pone.0104304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127130	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300019
J	Chang, MC; Chang, HH; Wang, TM; Chan, CP; Lin, BR; Yeung, SY; Yeh, CY; Cheng, RH; Jeng, JH				Chang, Mei-Chi; Chang, Hsiao-Hua; Wang, Tong-Mei; Chan, Chiu-Po; Lin, Bor-Ru; Yeung, Sin-Yuet; Yeh, Chien-Yang; Cheng, Ru-Hsiu; Jeng, Jiiang-Huei			Antiplatelet Effect of Catechol Is Related to Inhibition of Cyclooxygenase, Reactive Oxygen Species, ERK/p38 Signaling and Thromboxane A(2) Production	PLOS ONE			English	Article							IN-VITRO; PLATELET-AGGREGATION; ANTIOXIDANT ACTIVITY; HYDROQUINONE; ACTIVATION; CELLS; CYTOTOXICITY; ANTAGONIST; MODULATION; FLAVONOIDS	Catechol (benzenediol) is present in plant-derived products, such as vegetables, fruits, coffee, tea, wine, areca nut and cigarette smoke. Because platelet dysfunction is a risk factor of cardiovascular diseases, including stroke, atherosclerosis and myocardial infarction, the purpose of this study was to evaluate the anti-platelet and anti-inflammatory effect of catechol and its mechanisms. The effects of catechol on cyclooxygenase (COX) activity, arachidonic acid (AA)-induced aggregation, thromboxane B-2 (TXB2) production, lactate dehydrogenase (LDH) release, reactive oxygen species (ROS) production and extracellular signal-regulated kinase (ERK)/p38 phosphorylation were determined in rabbit platelets. In addition, its effect on IL-1b-induced prostaglandin E-2 (PGE(2)) production by fibroblasts was determined. The ex vivo effect of catechol on platelet aggregation was also measured. Catechol (5-25 mu M) suppressed AA-induced platelet aggregation and inhibited TXB2 production at concentrations of 0.5-5 mu M; however, it showed little cytotoxicity and did not alter U46619-induced platelet aggregation. Catechol (10-50 mu M) suppressed COX-1 activity by 29-44% and COX-2 activity by 29-50%. It also inhibited IL-1b- induced PGE2 production, but not COX-2 expression of fibroblasts. Moreover, catechol (1-10 mu M) attenuated AA-induced ROS production in platelets and phorbol myristate acetate (PMA)-induced ROS production in human polymorphonuclear leukocytes. Exposure of platelets to catechol decreased AA-induced ERK and p38 phosphorylation. Finally, intravenous administration of catechol (2.5-5 mu mole/mouse) attenuated ex vivo AA-induced platelet aggregation. These results suggest that catechol exhibited anti-platelet and anti-inflammatory effects, which were mediated by inhibition of COX, ROS and TXA(2) production as well as ERK/p38 phosphorylation. The anti-platelet effect of catechol was confirmed by ex vivo analysis. Exposure to catechol may affect platelet function and thus cardiovascular health.	[Chang, Mei-Chi; Cheng, Ru-Hsiu] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Lab Pharmacol & Toxicol, Taipei, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Chang, Hsiao-Hua; Wang, Tong-Mei; Yeh, Chien-Yang; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Univ, Taipei, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Diagnotherapeut, Taipei, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Jeng, JH (corresponding author), Natl Taiwan Univ Hosp, Grad Inst Clin Dent, Lab Pharmacol & Toxicol, Taipei, Taiwan.	jhjeng@ntu.edu.tw		CHANG, HSIAO-HUA/0000-0002-8417-8847; WANG, TONG-MEI/0000-0002-9885-6899; LIN, BOR-RU/0000-0001-9545-7393; Jeng, Jiiang-Huei/0000-0002-2068-5380	National Science Council [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002]; Chang Gung Memorial Hospital [CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors would like to thank Miss HF Jeng for her technical assistance. This study is supported by grants from National Science Council (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094 and NSC-101-2320-B-255-002) and Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; ALANKO J, 1995, PROSTAG LEUKOTR ESS, V52, P299, DOI 10.1016/0952-3278(95)90030-6; Alexandru N, 2012, THROMB RES, V129, P116, DOI 10.1016/j.thromres.2011.09.026; [Anonymous], 1985, IARC MON EV CARC RIS, V37, P141; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Chang MC, 2007, BRIT J PHARMACOL, V152, P73, DOI 10.1038/sj.bjp.0707367; Chang MC, 2006, INT ENDOD J, V39, P819, DOI 10.1111/j.1365-2591.2006.01156.x; Chang MC, 1998, BLOOD, V91, P1582, DOI 10.1182/blood.V91.5.1582.1582_1582_1589; Chang MC, 2012, TOXICOL APPL PHARM, V263, P287, DOI 10.1016/j.taap.2012.06.021; Chang MC, 2009, J ORAL PATHOL MED, V38, P434, DOI 10.1111/j.1600-0714.2008.00701.x; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; de Oliveira DM, 2010, HUM EXP TOXICOL, V29, P199, DOI 10.1177/0960327109360364; DeCaprio AP, 1999, CRIT REV TOXICOL, V29, P283, DOI 10.1080/10408449991349221; Dileep KV, 2012, CHEM BIOL DRUG DES, V79, P143, DOI 10.1111/j.1747-0285.2011.01258.x; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Hsiao G, 2007, CARDIOVASC RES, V75, P782, DOI 10.1016/j.cardiores.2007.05.005; IULIANO L, 1994, EUR J BIOCHEM, V221, P695, DOI 10.1111/j.1432-1033.1994.tb18782.x; Jeng JH, 2002, FREE RADICAL BIO MED, V32, P860, DOI 10.1016/S0891-5849(02)00749-9; Jung CT, 2003, FOOD CHEM TOXICOL, V41, P885, DOI 10.1016/S0278-6915(03)00040-1; Kim SD, 2008, EUR J PHARMACOL, V584, P361, DOI 10.1016/j.ejphar.2008.02.008; KITAGAWA S, 1991, CHEM PHARM BULL, V39, P1062; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; Lee Shern-Fwu, 1994, Journal of Biomedical Science, V1, P125, DOI 10.1007/BF02257986; Lee YM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-45; Lopez-Farre A, 2001, NEPHROL DIAL TRANSPL, V16, P45, DOI 10.1093/ndt/16.suppl_1.45; Mansoor S, 2010, TOXICOLOGY, V271, P107, DOI 10.1016/j.tox.2010.03.013; Martinho FC, 2012, J ENDODONT, V38, P740, DOI 10.1016/j.joen.2012.02.021; McGregor D, 2007, CRIT REV TOXICOL, V37, P887, DOI 10.1080/10408440701638970; McNicol A, 2003, BIOCHEM PHARMACOL, V65, P1243, DOI 10.1016/S0006-2952(03)00069-8; Myburg RB, 2002, ENVIRON HEALTH PERSP, V110, P813, DOI 10.1289/ehp.02110813; Ostertag LM, 2011, MOL NUTR FOOD RES, V55, P1624, DOI 10.1002/mnfr.201100135; Ribeiro D, 2013, EUR J MED CHEM, V67, P280, DOI 10.1016/j.ejmech.2013.06.019; SCHAEFER D, 1995, INT J CANCER, V60, P520, DOI 10.1002/ijc.2910600416; SUBRAHMANYAM VV, 1991, ARCH BIOCHEM BIOPHYS, V286, P76, DOI 10.1016/0003-9861(91)90010-G; Sun L, 2004, ANN BIOMED ENG, V32, P1193, DOI 10.1114/B:ABME.0000039353.97347.28; TENG CM, 1988, THROMB HAEMOSTASIS, V59, P304; Thavasi V, 2009, J PHYS CHEM A, V113, P3068, DOI 10.1021/jp806679v; Tsoumani ME, 2012, CURR VASC PHARMACOL, V10, P539; Wang M, 2008, J INTERN MED, V263, P500, DOI 10.1111/j.1365-2796.2008.01938.x; Willoughby Scott, 2002, Eur J Cardiovasc Nurs, V1, P273; Wright B, 2013, J FOOD SCI, V78, pN1921, DOI 10.1111/1750-3841.12293; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yamada K, 1999, IN VITRO CELL DEV-AN, V35, P169; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	47	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104310	10.1371/journal.pone.0104310	http://dx.doi.org/10.1371/journal.pone.0104310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122505	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000035
J	Sanchez, MV; Ebensen, T; Schulze, K; Cargnelutti, D; Blazejewska, P; Scodeller, EA; Guzman, CA				Sanchez, Maria Victoria; Ebensen, Thomas; Schulze, Kai; Cargnelutti, Diego; Blazejewska, Paulina; Scodeller, Eduardo A.; Guzman, Carlos A.			Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge	PLOS ONE			English	Article							CD4(+) T-CELLS; A VIRUS; INTRACELLULAR NEUTRALIZATION; MUCOSAL IMMUNITY; MAJOR TARGET; VACCINE; NUCLEOPROTEIN; ANTIGEN; MEMORY; IMMUNOGENICITY	There is a critical need for new influenza vaccines able to protect against constantly emerging divergent virus strains. This will be sustained by the induction of vigorous cellular responses and humoral immunity capable of acting at the portal of entry of this pathogen. In this study we evaluate the protective efficacy of intranasal vaccination with recombinant influenza nucleoprotein (rNP) co-administrated with bis-(3',5')-cyclic dimeric adenosine monophosphate (c-di-AMP) as adjuvant. Immunization of BALB/c mice with two doses of the formulation stimulates high titers of NP-specific IgG in serum and secretory IgA at mucosal sites. This formulation also promotes a strong Th1 response characterized by high secretion of INF-gamma and IL-2. The immune response elicited promotes efficient protection against virus challenge. These results suggest that c-di-AMP is a potent mucosal adjuvant which may significantly contribute towards the development of innovative mucosal vaccines against influenza.	[Sanchez, Maria Victoria; Cargnelutti, Diego; Scodeller, Eduardo A.] Consejo Nacl Invest Cient & Tecn, Inst Expt Med & Biol Cuyo IMBECU CCT, Virol Lab, Mendoza, Argentina; [Sanchez, Maria Victoria; Ebensen, Thomas; Schulze, Kai; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Blazejewska, Paulina] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Helmholtz Association; Helmholtz-Center for Infection Research; Boehringer Ingelheim	Ebensen, T (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	Thomas.Ebensen@helmholtz-hzi.de		Cargnelutti, Diego Esteban/0000-0002-1246-7551; Sanchez, Maria/0000-0003-2252-959X	EU (PANFLUVAC); EU (TRANSVAC); BMBF; German Academic Exchange Service (DAAD); CONICET	EU (PANFLUVAC); EU (TRANSVAC); BMBF(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work at the HZI was supported in part by grants from the EU (PANFLUVAC, TRANSVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield), EuroNanoMed (HCVAX) and ERANetRUS (HCRUS). Maria Victoria Sanchez had a fellowship from CONICET and was in part supported by a fellowship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyegbo MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061101; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Boonnak K, 2012, J CLIN INVEST, V122, P2768, DOI 10.1172/JCI65208; Boyce TG, 2000, VACCINE, V19, P217, DOI 10.1016/S0264-410X(00)00171-7; Brokstad KA, 2002, J INFECT DIS, V185, P878, DOI 10.1086/339710; Cargnelutti DE, 2012, J MICROBIOL BIOTECHN, V22, P416, DOI 10.4014/jmb.1106.06021; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Ebensen T, 2007, CLIN VACCINE IMMUNOL, V14, P952, DOI 10.1128/CVI.00119-07; Ebensen T, 2007, VACCINE, V25, P1464, DOI 10.1016/j.vaccine.2006.10.033; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Ebensen T, 2009, ADV EXP MED BIOL, V655, P171, DOI 10.1007/978-1-4419-1132-2_13; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Ennis FA, 1999, VIROLOGY, V259, P256, DOI 10.1006/viro.1999.9765; Falkeborn T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070527; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gopal R, 2014, AM J PATHOL, V184, P55, DOI 10.1016/j.ajpath.2013.09.012; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huang BY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-322; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069649; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; MacLeod MKL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061775; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; McKinstry KK, 2013, ARCH IMMUNOL THER EX, V61, P341, DOI 10.1007/s00005-013-0236-z; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Patterson DP, 2013, ACS NANO, V7, P3036, DOI 10.1021/nn4006544; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Rimmelzwaan GF, 2000, VACCINE, V19, P1180, DOI 10.1016/S0264-410X(00)00310-8; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Schotsaert M, 2012, EXPERT REV VACCINES, V11, P949, DOI [10.1586/erv.12.71, 10.1586/ERV.12.71]; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; Svindland SC, 2013, INFLUENZA OTHER RESP, V7, P1181, DOI 10.1111/irv.12056; Tamura S, 1996, J IMMUNOL, V156, P3892; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; Vitelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055435; Wang W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044883, 10.1371/journal.pone.0052488]; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zhong WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010583; Zhou DH, 2011, J VIROL, V85, P11090, DOI 10.1128/JVI.00768-11	68	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104824	10.1371/journal.pone.0104824	http://dx.doi.org/10.1371/journal.pone.0104824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140692	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200037
J	Chen, ZX; Wang, YN; Liu, W; Zhao, GN; Lee, S; Balogh, A; Zou, YN; Guo, YQ; Zhang, Z; Gu, WW; Li, CY; Tigyi, G; Yue, JM				Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Lee, Suechin; Balogh, Andrea; Zou, Yanan; Guo, Yuqi; Zhang, Zhan; Gu, Weiwang; Li, Chengyao; Tigyi, Gabor; Yue, Junming			Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; STEM-CELLS; KLF4; GROWTH; CARCINOMA; GENE; EMT; METASTASIS; INVASION	Ovarian cancer presents therapeutic challenges due to its typically late detection, aggressive metastasis, and therapeutic resistance. The transcription factor Kruppel-like factor 4 (KLF4) has been implicated in human cancers as a tumor suppressor or oncogene, although its role depends greatly on the cellular context. The role of KLF4 in ovarian cancer has not been elucidated in mechanistic detail. In this study, we investigated the role of KLF4 in ovarian cancer cells by transducing the ovarian cancer cell lines SKOV3 and OVCAR3 with a doxycycline-inducible KLF4 lentiviral vector. Overexpression of KLF4 reduced cell proliferation, migration, and invasion. The epithelial cell marker gene E-cadherin was significantly upregulated, whereas the mesenchymal cell marker genes vimentin, twist1 and snail2 (slug) were downregulated in both KLF4-expressing SKOV3 and OVCAR3 cells. KLF4 inhibited the transforming growth factor beta (TGF beta)-induced epithelial to mesenchymal transition (EMT) in ovarian cancer cells. Taken together, our data demonstrate that KLF4 functions as a tumor suppressor gene in ovarian cancer cells by inhibiting TGF beta-induced EMT.	[Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Yue, Junming] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Chen, Zixuan; Wang, Yinan; Liu, Wen; Zhao, Guannan; Yue, Junming] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN USA; [Wang, Yinan; Liu, Wen; Lee, Suechin; Balogh, Andrea; Gu, Weiwang; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Chen, Zixuan; Li, Chengyao] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Zhao, Guannan; Guo, Yuqi; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou 450052, Peoples R China; [Zou, Yanan] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Southern Medical University - China; Zhengzhou University; Harbin Medical University	Li, CY (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com; jyue@uthsc.edu		Zhao, Guannan/0000-0003-3155-8528	National Institute of Health [HL095957, HD061420, CA092160]; UTHSC; Western clinic Cancer Center; Chinese Government [2010CB530204, 112102310110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSC; Western clinic Cancer Center; Chinese Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was partially supported by National Institute of Health (HL095957, HD061420 to J.Y., and CA092160 to G.T.) and UTHSC startup funding, Western clinic Cancer Center (J.Y.) and Chinese Government (2010CB530204 to C.L., 112102310110 to Y.G., 2011DFA33290 to W.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Brosh R, 2013, CELL DEATH DIFFER, V20, P312, DOI 10.1038/cdd.2012.125; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042436; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Deng YF, 2012, STEM CELLS DEV, V21, P2485, DOI 10.1089/scd.2012.0018; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Guo Y, 2013, PHARM RES; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Le Magnen C, 2013, EUR J CANCER, V49, P955, DOI 10.1016/j.ejca.2012.09.023; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2013, CURR CANC DRUG TARGE; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; LIU Z, 2013, HISTOPATHOLOGY; Lowe KA, 2013, GYNECOL ONCOL, V130, P107, DOI 10.1016/j.ygyno.2013.03.026; Miyamoto S, 2013, CARCINOGENESIS; Mohan N, 2013, MOL ONCOL, V7, P464, DOI 10.1016/j.molonc.2012.12.002; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Radisky DC, 2007, NAT CELL BIOL, V9, P361, DOI 10.1038/ncb0407-361; Reichl P, 2012, CURR PHARM DESIGN, V18, P4135, DOI 10.2174/138161212802430477; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Su ZL, 2013, CLIN CHIM ACTA, V415, P341, DOI 10.1016/j.cca.2012.10.058; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yoon O, 2012, ONCOL LETT, V4, P1033, DOI 10.3892/ol.2012.834; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu F, 2013, INT J CANC; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	37	29	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105331	10.1371/journal.pone.0105331	http://dx.doi.org/10.1371/journal.pone.0105331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137052	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100085
J	de Bourcy, CFA; De Vlaminck, I; Kanbar, JN; Wang, JB; Gawad, C; Quake, SR				de Bourcy, Charles F. A.; De Vlaminck, Iwijn; Kanbar, Jad N.; Wang, Jianbin; Gawad, Charles; Quake, Stephen R.			A Quantitative Comparison of Single-Cell Whole Genome Amplification Methods	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; EVOLUTION; ALIGNMENT; CLONING; RARE	Single-cell sequencing is emerging as an important tool for studies of genomic heterogeneity. Whole genome amplification (WGA) is a key step in single-cell sequencing workflows and a multitude of methods have been introduced. Here, we compare three state-of-the-art methods on both bulk and single-cell samples of E. coli DNA: Multiple Displacement Amplification (MDA), Multiple Annealing and Looping Based Amplification Cycles (MALBAC), and the PicoPLEX single-cell WGA kit (NEB-WGA). We considered the effects of reaction gain on coverage uniformity, error rates and the level of background contamination. We compared the suitability of the different WGA methods for the detection of copy-number variations, for the detection of single-nucleotide polymorphisms and for de-novo genome assembly. No single method performed best across all criteria and significant differences in characteristics were observed; the choice of which amplifier to use will depend strongly on the details of the type of question being asked in any given experiment.	[de Bourcy, Charles F. A.; De Vlaminck, Iwijn; Gawad, Charles; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Kanbar, Jad N.; Wang, Jianbin; Gawad, Charles; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gawad, Charles] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol Stem Cell Transplantat & Canc B, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Kanbar, Jad N.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	quake@stanford.edu	Gawad, Charles/AAP-5448-2021; Wang, Jianbin/G-7533-2015; Gawad, Charles/N-8073-2018; t, lf/AAJ-4924-2020; De Vlaminck, Iwijn/P-6479-2015	Wang, Jianbin/0000-0001-6725-7925; Gawad, Charles/0000-0002-4728-8203; De Vlaminck, Iwijn/0000-0001-6085-7311	United States Department of Energy Joint Genome Institute Emerging Technologies Opportunity Program; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Science Foundation Partnerships for International Research and Education (PIRE) [0968421]; International Fulbright Science and Technology Award; Bureau of Educational and Cultural Affairs of the United States Department of State; Melvin and Joan Lane Stanford Graduate Fellowship; Leukemia and Lymphoma Society; American Society of Hematology; Child Health Research Institute at Stanford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER; Office Of The Director [0968421] Funding Source: National Science Foundation	United States Department of Energy Joint Genome Institute Emerging Technologies Opportunity Program; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation Partnerships for International Research and Education (PIRE)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); International Fulbright Science and Technology Award; Bureau of Educational and Cultural Affairs of the United States Department of State; Melvin and Joan Lane Stanford Graduate Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; Child Health Research Institute at Stanford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by the United States Department of Energy Joint Genome Institute (jgi.doe.gov) Emerging Technologies Opportunity Program [supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231], and by the National Science Foundation (www.nsf.gov) Partnerships for International Research and Education (PIRE) award number 0968421. CFdB is supported by an International Fulbright Science and Technology Award (scienceandtech.fulbrightonline.org) [sponsored by the Bureau of Educational and Cultural Affairs of the United States Department of State] and a Melvin and Joan Lane Stanford Graduate Fellowship (sgf.stanford.edu); CG is supported by the Leukemia and Lymphoma Society (www.lls.org), the American Society of Hematology (www.hematology.org), and the Child Health Research Institute at Stanford (chri.stanford.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blainey PC, 2014, NAT METHODS, V11, P19, DOI 10.1038/nmeth.2783; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hongoh Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8_2; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Koboldt DC, 2002, CURRENT PROTOCOLS BI; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larson D, 2009, BAM READCOUNT; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martin M, 2011, CUTADAPT REMOVES ADA; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	35	198	206	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105585	10.1371/journal.pone.0105585	http://dx.doi.org/10.1371/journal.pone.0105585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136831	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100109
J	Hang, HL; Yu, YB; Wu, N; Huang, QF; Xia, Q; Bian, JM				Hang, Hualian; Yu, Yabin; Wu, Ning; Huang, Qingfeng; Xia, Qiang; Bian, Jianmin			Induction of Highly Functional Hepatocytes from Human Umbilical Cord Mesenchymal Stem Cells by HNF4 alpha Transduction	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HNF-4; OF-THE-ART; HEPATIC DIFFERENTIATION; GENE-EXPRESSION; BONE-MARROW; LIVER DEVELOPMENT; IN-VITRO; TRANSPLANTATION; SPECIFICATION; ENDODERM	Aim: To investigate the differentiation potential of human umbilical mesenchymal stem cells (HuMSCs) and the key factors that facilitate hepatic differentiation. Methods: HuMSCs were induced to become hepatocyte-like cells according to a previously published protocol. The differentiation status of the hepatocyte-like cells was examined by observing the morphological changes under an inverted microscope and by immunofluorescence analysis. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) overexpression was achieved by plasmid transfection of the hepatocyte-like cells. The expression of proteins and genes of interest was then examined by Western blotting and reverse transcription-polymerase chain reaction (RT-PCR) or real-time RT-PCR methods. Results: Our results demonstrated that HuMSCs can easily be induced into hepatocyte-like cells using a published differentiation protocol. The overexpression of HNF4 alpha in the induced HuMSCs significantly enhanced the expression levels of hepatic-specific proteins and genes. HNF4 alpha overexpression may be associated with liver-enriched transcription factor networks and the Wnt/beta-Catenin pathway. Conclusion: The overexpression of HNF4 alpha improves the hepatic differentiation of HuMSCs and is a simple way to improve cellular sources for clinical applications.	[Hang, Hualian; Xia, Qiang] Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, Shanghai 200030, Peoples R China; [Hang, Hualian; Yu, Yabin; Wu, Ning; Huang, Qingfeng; Bian, Jianmin] NanJing Med Univ, Dept Gen Surg, Nanjing Hosp, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Xia, Q (corresponding author), Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg, Shanghai 200030, Peoples R China.	xiaqiang@shsmu.edu.cn; jianminbian@163.com			National Natural Science Foundation of China [81100306]; Science and Technology Commission Medical Foundation of Shanghai [134119a9501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Medical Foundation of Shanghai	Project supported by the National Natural Science Foundation of China (No 81100306) and the Science and Technology Commission Medical Foundation of Shanghai (No. 134119a9501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Ek M, 2007, BIOCHEM PHARMACOL, V74, P496, DOI 10.1016/j.bcp.2007.05.009; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ke ZF, 2008, BIOCHEM BIOPH RES CO, V367, P342, DOI 10.1016/j.bbrc.2007.12.134; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Medicetty S, 2004, EXP NEUROL, V190, P32, DOI 10.1016/j.expneurol.2004.06.023; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Terry C, 2006, CRYOBIOLOGY, V53, P149, DOI 10.1016/j.cryobiol.2006.05.004; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang HS, 2011, CELL TRANSPLANT, V20, P455, DOI 10.3727/096368910X522270; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Yoshida Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1089, DOI 10.1152/ajpgi.00187.2007	28	23	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104133	10.1371/journal.pone.0104133	http://dx.doi.org/10.1371/journal.pone.0104133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137413	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100017
J	Hopfenmuller, S; Steffan-Dewenter, I; Holzschuh, A				Hopfenmueller, Sebastian; Steffan-Dewenter, Ingolf; Holzschuh, Andrea			Trait-Specific Responses of Wild Bee Communities to Landscape Composition, Configuration and Local Factors	PLOS ONE			English	Article							HABITAT AREA; AGRICULTURAL LANDSCAPES; CLIMATE-CHANGE; FRUIT-SET; CONNECTIVITY; DIVERSITY; CONSERVATION; POLLINATORS; RESOURCES; RICHNESS	Land-use intensification and loss of semi-natural habitats have induced a severe decline of bee diversity in agricultural landscapes. Semi-natural habitats like calcareous grasslands are among the most important bee habitats in central Europe, but they are threatened by decreasing habitat area and quality, and by homogenization of the surrounding landscape affecting both landscape composition and configuration. In this study we tested the importance of habitat area, quality and connectivity as well as landscape composition and configuration on wild bees in calcareous grasslands. We made detailed trait-specific analyses as bees with different traits might differ in their response to the tested factors. Species richness and abundance of wild bees were surveyed on 23 calcareous grassland patches in Southern Germany with independent gradients in local and landscape factors. Total wild bee richness was positively affected by complex landscape configuration, large habitat area and high habitat quality (i.e. steep slopes). Cuckoo bee richness was positively affected by complex landscape configuration and large habitat area whereas habitat specialists were only affected by the local factors habitat area and habitat quality. Small social generalists were positively influenced by habitat area whereas large social generalists (bumblebees) were positively affected by landscape composition (high percentage of semi-natural habitats). Our results emphasize a strong dependence of habitat specialists on local habitat characteristics, whereas cuckoo bees and bumblebees are more likely affected by the surrounding landscape. We conclude that a combination of large high-quality patches and heterogeneous landscapes maintains high bee species richness and communities with diverse trait composition. Such diverse communities might stabilize pollination services provided to crops and wild plants on local and landscape scales.	[Hopfenmueller, Sebastian; Steffan-Dewenter, Ingolf; Holzschuh, Andrea] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Hopfenmuller, S (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany.	sebastian.hopfenmueller@uni-wuerzburg.de	Holzschuh, Andrea/X-8989-2018	Holzschuh, Andrea/0000-0002-5235-4746	European Community's Seventh Framework Programme [244090]; German Research Foundation (DFG); University of Wuerzburg	European Community's Seventh Framework Programme(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This research received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 244090, STEP Project (Status and Trends of European Pollinators: www.step-project.net). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BayLfU, 2003, ROT LIST GEF TIER BA; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Bruckmann SV, 2010, J APPL ECOL, V47, P799, DOI 10.1111/j.1365-2664.2010.01828.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Dias ATC, 2013, J ECOL, V101, P29, DOI 10.1111/1365-2745.12024; Diekotter T, 2006, BIODIVERS CONSERV, V15, P57, DOI 10.1007/s10531-004-2932-9; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; Ekroos J, 2013, LANDSCAPE ECOL, V28, P1283, DOI 10.1007/s10980-013-9864-2; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Flick T, 2012, AGR ECOSYST ENVIRON, V156, P123, DOI 10.1016/j.agee.2012.05.006; Franzen M, 2010, P ROY SOC B-BIOL SCI, V277, P79, DOI 10.1098/rspb.2009.1584; Franzen M, 2009, J INSECT CONSERV, V13, P89, DOI 10.1007/s10841-007-9123-4; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Holzschuh A, 2009, ECOL APPL, V19, P123, DOI 10.1890/08-0384.1; Holzschuh A, 2012, BIOL CONSERV, V153, P101, DOI 10.1016/j.biocon.2012.04.032; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; Jauker B, 2013, LANDSCAPE ECOL, V28, P107, DOI 10.1007/s10980-012-9820-6; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Krewenka KM, 2011, BIOL CONSERV, V144, P1816, DOI 10.1016/j.biocon.2011.03.014; Le Feon V, 2010, AGR ECOSYST ENVIRON, V137, P143, DOI 10.1016/j.agee.2010.01.015; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; MAC ARTHUR ROBERT H., 1967; Mandery K, 2001, BIENEN WESPEN FRANKE; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Calvillo LM, 2010, J INSECT CONSERV, V14, P323, DOI 10.1007/s10841-010-9262-x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 1997, ECOL ENTOMOL, V22, P319, DOI 10.1046/j.1365-2311.1997.00071.x; Raatikainen KM, 2009, BIODIVERS CONSERV, V18, P1067, DOI 10.1007/s10531-008-9462-9; Rands SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025971; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sardinas HS, 2014, BASIC APPL ECOL, V15, P161, DOI 10.1016/j.baae.2014.02.004; Sokal RR, 2003, BIOMETRY; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Steffan-Dewenter I, 2000, ECOL LETT, V3, P449, DOI 10.1046/j.1461-0248.2000.00175.x; Thomas JA, 2011, J INSECT CONSERV, V15, P241, DOI 10.1007/s10841-010-9341-z; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P., 1990, WILDBIENEN BADEN WUR; Westrich P., 1996, CONSERVATION BEES; Williams NM, 2012, ECOLOGY, V93, P1049, DOI 10.1890/11-1006.1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	73	73	74	3	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104439	10.1371/journal.pone.0104439	http://dx.doi.org/10.1371/journal.pone.0104439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137311	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100035
J	Kloke, V; Schreiber, RS; Bodden, C; Mollers, J; Ruhmann, H; Kaiser, S; Lesch, KP; Sachser, N; Lewejohann, L				Kloke, Vanessa; Schreiber, Rebecca S.; Bodden, Carina; Moellers, Julian; Ruhmann, Hanna; Kaiser, Sylvia; Lesch, Klaus-Peter; Sachser, Norbert; Lewejohann, Lars			Hope for the Best or Prepare for the Worst? Towards a Spatial Cognitive Bias Test for Mice	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; EMOTIONAL INFORMATION; LABORATORY ENVIRONMENT; ATTENTIONAL BIAS; PROMOTER REGION; ANIMAL BEHAVIOR; AFFECTIVE STATE; DEFICIENT MICE; JUDGMENT BIAS; KNOCKOUT MICE	Cognitive bias, the altered information processing resulting from the background emotional state of an individual, has been suggested as a promising new indicator of animal emotion. Comparable to anxious or depressed humans, animals in a putatively negative emotional state are more likely to judge an ambiguous stimulus as if it predicts a negative event, than those in positive states. The present study aimed to establish a cognitive bias test for mice based on a spatial judgment task and to apply it in a pilot study to serotonin transporter (5-HTT) knockout mice, a well-established mouse model for the study of anxiety- and depression-related behavior. In a first step, we validated that our setup can assess different expectations about the outcome of an ambiguous stimulus: mice having learned to expect something positive within a maze differed significantly in their behavior towards an unfamiliar location than animals having learned to expect something negative. In a second step, the use of spatial location as a discriminatory stimulus was confirmed by showing that mice interpret an ambiguous stimulus depending on its spatial location, with a position exactly midway between a positive and a negative reference point provoking the highest level of ambiguity. Finally, the anxiety- and depression-like phenotype of the 5-HTT knockout mouse model manifested - comparable to human conditions - in a trend for a negatively distorted interpretation of ambiguous information, albeit this effect was not statistically significant. The results suggest that the present cognitive bias test provides a useful basis to study the emotional state in mice, which may not only increase the translational value of animal models in the study of human affective disorders, but which is also a central objective of animal welfare research.	[Kloke, Vanessa; Schreiber, Rebecca S.; Bodden, Carina; Moellers, Julian; Ruhmann, Hanna; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Kloke, Vanessa; Schreiber, Rebecca S.; Kaiser, Sylvia; Sachser, Norbert; Lewejohann, Lars] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany; [Lesch, Klaus-Peter] Univ Wurzburg, Div Mol Psychiat, Lab Translat Neurosci, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Lewejohann, Lars] Univ Osnabruck, Osnabruck, Germany	University of Munster; University of Munster; University of Wurzburg; University Osnabruck	Kloke, V (corresponding author), Univ Munster, Dept Behav Biol, D-48149 Munster, Germany.	vanessa.kloke@uni-muenster.de	Lesch, Klaus-Peter/J-4906-2013; Lewejohann, Lars/H-3717-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Lewejohann, Lars/0000-0002-0202-4351; Kaiser, Sylvia/0000-0003-2770-7367; Bodden, Carina/0000-0002-8749-8846	German Science Foundation (DFG) [SFB/TRR58]; DFG; Open Access Publication Fund of University of Munster	German Science Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Open Access Publication Fund of University of Munster	This study was supplied by a grant from the German Science Foundation (DFG,http://www.dfg.de) to N. S. and K. P. L. (SFB/TRR58, Project A1). The authors acknowledge support of financing open access publishing by the DFG and the Open Access Publication Fund of University of Munster (http://www.unimuenster.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MH, 2013, PSYCHOPHARMACOLOGY, V226, P601, DOI 10.1007/s00213-012-2932-5; Araragi N, 2013, CURR DRUG TARGETS, V14, P549, DOI 10.2174/1389450111314050005; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bethell EJ, 2012, ANIM WELFARE, V21, P185, DOI 10.7120/09627286.21.2.185; Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039; BRADLEY BP, 1995, BEHAV RES THER, V33, P755, DOI 10.1016/0005-7967(95)00029-W; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Browning M, 2012, BIOL PSYCHIAT, V72, P572, DOI 10.1016/j.biopsych.2012.04.014; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; CASTO R, 1989, AM J PHYSIOL, V256, pR1121, DOI 10.1152/ajpregu.1989.256.5.R1121; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Engelmann M, 1996, PSYCHONEUROENDOCRINO, V21, P391, DOI 10.1016/0306-4530(96)00006-6; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; Eysenck M.W., 2005, COGNITIVE PSYCHOL ST; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Guillot PV, 1996, BEHAV BRAIN RES, V77, P211, DOI 10.1016/0166-4328(95)00163-8; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Knapp DJ, 1995, J NEUROSCI METH, V62, P1, DOI 10.1016/0165-0270(95)00044-5; Koizumi A, 2010, NEUROREPORT, V21, P422, DOI 10.1097/WNR.0b013e32833833f0; Lang TJ, 2012, EUR J PERSONALITY, V26, P145, DOI 10.1002/per.855; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; MACKINTOSH JH, 1973, ANIM BEHAV, V21, P464, DOI 10.1016/S0003-3472(73)80006-5; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MacLeod AK, 1997, COGNITION EMOTION, V11, P467, DOI 10.1080/026999397379881; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; Mendl M, 2011, CURR BIOL, V21, pR463, DOI 10.1016/j.cub.2011.05.028; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miranda R, 2007, COGNITIVE THER RES, V31, P71, DOI 10.1007/s10608-006-9063-4; Moriarty O, 2012, J NEUROSCI METH, V204, P1, DOI 10.1016/j.jneumeth.2011.10.024; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; ROBERTS WA, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P7; Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837; Stober J, 2000, COGNITION EMOTION, V14, P725, DOI 10.1080/02699930050117693; Stollstorff M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00327; Van den Hove D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022715; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	76	36	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105431	10.1371/journal.pone.0105431	http://dx.doi.org/10.1371/journal.pone.0105431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137069	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100095
J	Oliveira, MT; Matzek, V; Medeiros, CD; Rivas, R; Falcao, HM; Santos, MG				Oliveira, Marciel Teixeira; Matzek, Virginia; Medeiros, Camila Dias; Rivas, Rebeca; Falcao, Hiram Marinho; Santos, Mauro Guida			Stress Tolerance and Ecophysiological Ability of an Invader and a Native Species in a Seasonally Dry Tropical Forest	PLOS ONE			English	Article							LIPID-PEROXIDATION; CATALASE; CAATINGA; PLANTS; NORTHEASTERN; CONSERVATION; ATTRIBUTES; PROLINE; TRAITS; GROWTH	Ecophysiological traits of Prosopis juliflora (Sw.) DC. and a phylogenetically and ecologically similar native species, Anadenanthera colubrina (Vell.) Brenan, were studied to understand the invasive species' success in caatinga, a seasonally dry tropical forest ecosystem of the Brazilian Northeast. To determine if the invader exhibited a superior resource-capture or a resource-conservative strategy, we measured biophysical and biochemical parameters in both species during dry and wet months over the course of two years. The results show that P. juliflora benefits from a flexible strategy in which it frequently outperforms the native species in resource capture traits under favorable conditions (e.g., photosynthesis), while also showing better stress tolerance (e.g., antioxidant activity) and water-use efficiency in unfavorable conditions. In addition, across both seasons the invasive has the advantage over the native with higher chlorophyll/carotenoids and chlorophyll a/b ratios, percent N, and leaf protein. We conclude that Prosopis juliflora utilizes light, water and nutrients more efficiently than Anadenanthera colubrina, and suffers lower intensity oxidative stress in environments with reduced water availability and high light radiation.	[Oliveira, Marciel Teixeira; Medeiros, Camila Dias; Rivas, Rebeca; Falcao, Hiram Marinho; Santos, Mauro Guida] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Matzek, Virginia] Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA	Universidade Federal de Pernambuco; Santa Clara University	Santos, MG (corresponding author), Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil.	mauro.gsantos@ufpe.br	OLIVEIRA, MARCIEL/A-9995-2015; Falcão, Hiram/AAO-1891-2020; Santos, Mauro/D-7026-2012; Medeiros, Camila/S-3957-2018	OLIVEIRA, MARCIEL/0000-0001-9706-5625; Falcão, Hiram/0000-0003-3198-1801; Santos, Mauro/0000-0001-5146-4591; Medeiros, Camila/0000-0002-5822-5603	Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE) [PBPG-0525-2.05/09]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [9906/11-8]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MTO was funded by the Brazilian Fundacao de Amparo a Pesquisa e Tecnologia de Pernambuco (FACEPE), scholarship #PBPG-0525-2.05/09, and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, scholarship #9906/11-8. MGS was supported by a fellowship from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Altschul S.V.R., 1964, CONTRIB GRAY HERB HA, V193, P3; Andrade L.A., 2008, NAT CONSERVACAO, V6, P61; Andrade LA, 2010, ACTA SCI-BIOL SCI, V32, P249, DOI DOI 10.4025/ACTASCIBIOLSCI.V32I3.4535; Barker DH, 2006, NEW PHYTOL, V169, P799, DOI 10.1111/j.1469-8137.2006.01628.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P219; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Chen LS, 2003, J EXP BOT, V54, P2165, DOI 10.1093/jxb/erg220; da Costa RC, 2007, J ARID ENVIRON, V68, P237, DOI 10.1016/j.jaridenv.2006.06.003; Dabrowska G, 2007, ACTA BIOL CRACOV BOT, V49, P7; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; De Gara Laura, 2004, Phytochemistry Reviews, V3, P195, DOI 10.1023/B:PHYT.0000047795.82713.99; Dolatabadian A, 2008, J AGRON CROP SCI, V194, P206, DOI 10.1111/j.1439-037X.2008.00301.x; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dudley BD, 2014, ECOLOGICAL IN PRESS; Feng YL, 2008, PHYSIOL PLANTARUM, V132, P350, DOI 10.1111/j.1399-3054.2007.01019.x; Freitas ADS, 2008, FERTILIDADE SOLO PRO, P27; Frosi G, 2013, ACTA PHYSIOL PLANT, V35, P335, DOI 10.1007/s11738-012-1076-x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Funk JL, 2013, PHYSIOLOGY, V1; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; James JJ, 2005, OECOLOGIA, V145, P113, DOI 10.1007/s00442-005-0109-1; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; KLOEPPEL BD, 1995, TREE PHYSIOL, V15, P739, DOI 10.1093/treephys/15.11.739; Leal IR, 2005, CONSERV BIOL, V19, P701, DOI 10.1111/j.1523-1739.2005.00703.x; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Lima GPP, 2002, REV BRASILEIRA AGROC, V8, P107; Lima Michele Soares de, 2010, Braz. J. Bot., V33, P437, DOI 10.1590/S0100-84042010000300007; Matzek V, 2011, BIOL INVASIONS, V13, P3005, DOI 10.1007/s10530-011-9985-y; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagel JM, 2004, BIOL INVASIONS, V6, P101, DOI 10.1023/B:BINV.0000010125.93370.32; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pegado Cláudia Maria Alves, 2006, Acta Bot. Bras., V20, P887, DOI 10.1590/S0102-33062006000400013; Pinheiro EAR, 2013, J ARID ENVIRON, V89, P1, DOI 10.1016/j.jaridenv.2012.10.003; Piza I. M. T., 2003, Revista Brasileira de Agrociencia, V9, P361; Pysek Petr, 2007, V193, P97; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rivas R, 2013, PLANT PHYSIOL BIOCH, V63, P200, DOI 10.1016/j.plaphy.2012.11.026; Santos MG, 2014, THEOR EXP PLANT PHYS, V26, P83, DOI 10.1007/s40626-014-0008-0; Schulten JR, 2014, PAC SCI, V68, P267, DOI 10.2984/68.2.7; THOMAS RL, 1967, AGRON J, V59, P240, DOI 10.2134/agronj1967.00021962005900030010x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x	56	19	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105514	10.1371/journal.pone.0105514	http://dx.doi.org/10.1371/journal.pone.0105514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137048	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100103
J	Pena-Gomez, FT; Guerrero, PC; Bizama, G; Duarte, M; Bustamante, RO				Pena-Gomez, Francisco T.; Guerrero, Pablo C.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.			Climatic Niche Conservatism and Biogeographical Non-Equilibrium in Eschscholzia californica (Papaveraceae), an Invasive Plant in the Chilean Mediterranean Region	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RANGE MARGINS; EVOLUTION; SHIFTS; POPULATIONS; ADAPTATION; COMMUNITIES; DIVERSITY; INSIGHTS; ECOLOGY	Species climate requirements are useful for predicting their geographic distribution. It is often assumed that the niche requirements for invasive plants are conserved during invasion, especially when the invaded regions share similar climate conditions. California and central Chile have a remarkable degree of convergence in their vegetation structure, and a similar Mediterranean climate. Such similarities make these geographic areas an interesting natural experiment for testing climatic niche dynamics and the equilibrium of invasive species in a new environment. We tested to see if the climatic niche of Eschscholzia californica is conserved in the invaded range (central Chile), and we assessed whether the invasion process has reached a biogeographical equilibrium, i.e., occupy all the suitable geographic locations that have suitable conditions under native niche requirements. We compared the climatic niche in the native and invaded ranges as well as the projected potential geographic distribution in the invaded range. In order to compare climatic niches, we conducted a Principal Component Analysis (PCA) and Species Distribution Models (SDMs), to estimate E. californica's potential geographic distribution. We also used SDMs to predict altitudinal distribution limits in central Chile. Our results indicated that the climatic niche occupied by E. californica in the invaded range is firmly conserved, occupying a subset of the native climatic niche but leaving a substantial fraction of it unfilled. Comparisons of projected SDMs for central Chile indicate a similarity, yet the projection from native range predicted a larger geographic distribution in central Chile compared to the prediction of the model constructed for central Chile. The projected niche occupancy profile from California predicted a higher mean elevation than that projected from central Chile. We concluded that the invasion process of E. californica in central Chile is consistent with climatic niche conservatism but there is potential for further expansion in Chile.	[Pena-Gomez, Francisco T.; Guerrero, Pablo C.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Pena-Gomez, Francisco T.; Bizama, Gustavo; Duarte, Milen; Bustamante, Ramiro O.] Univ Chile, Fac Ciencias, Dept Cs Ecol, Santiago, Chile; [Guerrero, Pablo C.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Bot, Concepcion, Chile	Universidad de Chile; Universidad de Chile; Universidad de Concepcion	Bustamante, RO (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	rbustama@uchile.cl	Peña-Gomez, Francisco Tomas/H-1404-2019; BUSTAMANTE, RAMIRO/I-7353-2019; Guerrero, Pablo/J-4296-2012	Guerrero, Pablo/0000-0003-1034-1899; Duarte, Milen/0000-0003-4784-9880	Fondecyt [1100072, 3130456]; Instituto de Ecologia y Biodiversidad (IEB) [ICM-02-005, PBF-23]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Instituto de Ecologia y Biodiversidad (IEB)	This study was financed by Fondecyt 1100072 to Ramiro O. Bustamante (URL: http://www.conicyt.cl/fondecyt/). The authors acknowledge partial support from projects ICM-02-005 and PBF-23 of Instituto de Ecologia y Biodiversidad (IEB) (URL: http://www.ieb-chile.cl/). Pablo. C. Guerrero is funded by the Fondecyt 3130456 (URL: http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Alexander JM, 2009, ECOGRAPHY, V32, P334, DOI 10.1111/j.1600-0587.2008.05605.x; Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Arroyo Mary T. Kalin, 2000, P385; Arroyo MTK, 1995, ECOL STU AN, P43, DOI DOI 10.1007/978-1-4612-2490-7_; Barbosa FG, 2012, AUSTRAL ECOL, V10, P1442; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Becker T, 2005, PERSPECT PLANT ECOL, V7, P173, DOI 10.1016/j.ppees.2005.09.006; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; California Climate and Agricultural Network, 2021, INV CAL AGR CLIM SOL; CLARK C, 1978, SYST BOT, V3, P374, DOI 10.2307/2418748; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; COWLING RM, 1980, VEGETATIO, V43, P191, DOI 10.1007/BF00158749; Development Core Team, 2006, R LANG ENV STAT COMP; di Castri F., 1973, MEDITERRANEAN TYPE E, P21; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 9 3; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; FRIASL D, 1975, PLANT SYST EVOL, V123, P185, DOI 10.1007/BF00989403; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Geber MA, 2005, EVOLUTION, V59, P521; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jimenez A, 2008, J BIOGEOGR, V35, P614, DOI 10.1111/j.1365-2699.2007.01799.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Le Maitre DC, 2008, GLOBAL ECOL BIOGEOGR, V17, P569, DOI 10.1111/j.1466-8238.2008.00407.x; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; Leger EA, 2005, DIVERS DISTRIB, V11, P311, DOI 10.1111/j.1366-9516.2005.00165.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; MOONEY H A, 1970, Flora (Jena), V159, P480; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pena-Gomez FT, 2012, GAYANA BOT, V69, P113, DOI 10.4067/S0717-66432012000100011; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; RUNDEL PW, 1982, OECOLOGIA, V55, P409, DOI 10.1007/BF00376930; Sax DF, 2002, DIVERS DISTRIB, V8, P193, DOI 10.1046/j.1472-4642.2002.00147.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webber BL, 2012, SCIENCE, V338, DOI 10.1126/science.1225980; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x	59	18	19	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105025	10.1371/journal.pone.0105025	http://dx.doi.org/10.1371/journal.pone.0105025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137175	Green Submitted, gold, Green Published			2022-12-27	WOS:000340742100061
J	Chen, X; Sheng, XI; Liu, XX; Li, HP; Liu, Y; Rong, WN; Ha, SP; Liu, WZ; Kang, XL; Zhao, KX; Zhao, C				Chen, Xue; Sheng, Xuniun; Liu, Xiaoxing; Li, Huiping; Liu, Yani; Rong, Weining; Ha, Shaoping; Liu, Wenzhou; Kang, Xiaoli; Zhao, Kanxing; Zhao, Chen			Targeted Next-Generation Sequencing Reveals Novel USH2A Mutations Associated with Diverse Disease Phenotypes: Implications for Clinical and Molecular Diagnosis	PLOS ONE			English	Article							USHER-SYNDROME GENES; PRE-MESSENGER-RNA; RETINITIS-PIGMENTOSA; JAPANESE PATIENTS; CHINESE FAMILIES; LONG ISOFORM; IDENTIFICATION; PROTEIN; EXPRESSION; PREDICTION	USH2A mutations have been implicated in the disease etiology of several inherited diseases, including Usher syndrome type 2 (USH2), nonsyndromic retinitis pigmentosa (RP), and nonsyndromic deafness. The complex genetic and phenotypic spectrums relevant to USH2A defects make it difficult to manage patients with such mutations. In the present study, we aim to determine the genetic etiology and to characterize the correlated clinical phenotypes for three Chinese pedigrees with nonsyndromic RP, one with RP sine pigmento (RPSP), and one with USH2. Family histories and clinical details for all included patients were reviewed. Ophthalmic examinations included best corrected visual acuities, visual field measurements, funduscopy, and electroretinography. Targeted next-generation sequencing (NGS) was applied using two sequence capture arrays to reveal the disease causative mutations for each family. Genotype-phenotype correlations were also annotated. Seven USH2A mutations, including four missense substitutions (p.P2762A, p.G3320C, p.R3719H, and p.G4763R), two splice site variants (c.8223+1G>A and c.8559-2T>C), and a nonsense mutation (p.Y3745*), were identified as disease causative in the five investigated families, of which three reported to have consanguineous marriage. Among all seven mutations, six were novel, and one was recurrent. Two homozygous missense mutations (p.P2762A and p.G3320C) were found in one individual family suggesting a potential double hit effect. Significant phenotypic divergences were revealed among the five families. Three families of the five families were affected with early, moderated, or late onset RP, one with RPSP, and the other one with USH2. Our study expands the genotypic and phenotypic variability relevant to USH2A mutations, which would help with a clear insight into the complex genetic and phenotypic spectrums relevant to USH2A defects, and is complementary for a better management of patients with such mutations. We have also demonstrated that a targeted NGS approach is a valuable tool for the genetic diagnosis of USH2 and RP.	[Chen, Xue; Liu, Xiaoxing; Zhao, Chen] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Sheng, Xuniun; Li, Huiping; Liu, Yani; Rong, Weining; Ha, Shaoping; Liu, Wenzhou] Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China; [Kang, Xiaoli] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhao, Kanxing] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Zhao, Chen] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Tianjin Medical University; Sun Yat Sen University	Zhao, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dr.zhaochen@gmail.com			National Key Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81222009, 81170856, 81160124, 81260154, 81170867]; Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program [BK2012046]; Jiangsu Province's Key Provincial Talents Program [RC201149]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates [CXZZ13_0590]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province's Key Provincial Talents Program; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Key Basic Research Program of China (973 Program, 2013CB967500); National Natural Science Foundation of China (81222009, 81170856, 81160124, 81260154, and 81170867); Thousand Youth Talents Program of China (to C. Z.); Jiangsu Outstanding Young Investigator Program (BK2012046); Jiangsu Province's Key Provincial Talents Program (RC201149); the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (to C. Z.); Jiangsu Province's Scientific Research Innovation Program for Postgraduates (CXZZ13_0590 to X. C.); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bernal S, 2003, J Med Genet, V40, pe8, DOI 10.1136/jmg.40.1.e8; Bhattacharya G, 2002, HEARING RES, V163, P1, DOI 10.1016/S0378-5955(01)00344-6; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Chen X, 2014, HUM MOL GENET, V23, P2926, DOI 10.1093/hmg/ddu005; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Dai HJ, 2008, MOL VIS, V14, P2067; Davies WIL, 2014, PERS MED, V11, P99, DOI [10.2217/PME.13.95, 10.2217/pme.13.95]; Davies WIL, 2012, GENET MED, V14, P891, DOI 10.1038/gim.2012.73; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kaiserman N, 2007, ARCH OPHTHALMOL-CHIC, V125, P219, DOI 10.1001/archopht.125.2.219; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; McGee TL, 2010, J MED GENET, V47, P499, DOI 10.1136/jmg.2009.075143; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Nakanishi H, 2009, CLIN GENET, V76, P383, DOI 10.1111/j.1399-0004.2009.01257.x; Nakanishi H, 2011, J HUM GENET, V56, P484, DOI 10.1038/jhg.2011.45; Nakanishi H, 2010, J HUM GENET, V55, P701, DOI 10.1038/jhg.2010.83; Pan XY, 2014, MOL VIS, V20, P770; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; Rong WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097808; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105439	10.1371/journal.pone.0105439	http://dx.doi.org/10.1371/journal.pone.0105439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133613	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700113
J	Kim, KH; Kang, YM; Im, CH; Ali, A; Kim, SY; Je, HJ; Kim, MK; Rho, HS; Lee, HS; Kong, WS; Ryu, JS				Kim, Kyung-Hee; Kang, Young Min; Im, Chak Han; Ali, Asjad; Kim, Sun Young; Je, Hee-Jeong; Kim, Min-Keun; Rho, Hyun Su; Lee, Hyun Sook; Kong, Won-Sik; Ryu, Jae-San			Identification and Functional Analysis of Pheromone and Receptor Genes in the B3 Mating Locus of Pleurotus eryngii	PLOS ONE			English	Article							SCHIZOPHYLLUM-COMMUNE; MUSHROOM; COPRINUS; SPECIFICITIES; GROWTH; TRANSFORMATION; TRICHOGYNES; RECOGNITION; FERTILITY; EVOLUTION	Pleurotus eryngii has recently become a major cultivated mushroom; it uses tetrapolar heterothallism as a part of its reproductive process. Sexual development progresses only when the A and B mating types are compatible. Such mating incompatibility occasionally limits the efficiency of breeding programs in which crossing within loci-shared strains or backcrossing strategies are employed. Therefore, understanding the mating system in edible mushroom fungi will help provide a short cut in the development of new strains. We isolated and identified pheromone and receptor genes in the B3 locus of P. eryngii and performed a functional analysis of the genes in the mating process by transformation. A genomic DNA library was constructed to map the entire mating-type locus. The B3 locus was found to contain four pheromone precursor genes and four receptor genes. Remarkably, receptor PESTE3.3.1 has just 34 amino acid residues in its C-terminal cytoplasmic region; therefore, it seems likely to be a receptor-like gene. Real-time quantitative RT-PCR (real-time qRT-PCR) revealed that most pheromone and receptor genes showed significantly higher expression in monokaryotic cells than dikaryotic cells. The pheromone genes PEphb3.1 and PEphb3.3 and the receptor gene PESTE3.3.1 were transformed into P5 (A3B4). The transformants were mated with a tester strain (A4B4), and the progeny showed clamp connections and a normal fruiting body, which indicates the proposed role of these genes in mating and fruiting processes. This result also confirms that PESTE3.3.1 is a receptor gene. In this study, we identified pheromone and receptor genes in the B3 locus of P. eryngii and found that some of those genes appear to play a role in the mating and fruiting processes. These results might help elucidate the mechanism of fruiting differentiation and improve breeding efficiency.	[Kim, Kyung-Hee; Kang, Young Min; Im, Chak Han; Ali, Asjad; Kim, Sun Young; Je, Hee-Jeong; Kim, Min-Keun; Ryu, Jae-San] Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea; [Kang, Young Min] KIOM, Herbal Med Res Div, Taejon, South Korea; [Rho, Hyun Su; Lee, Hyun Sook] Gyeongsang Natl Univ, Dept Microbiol, Jinju, South Korea; [Kong, Won-Sik] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Mushroom Res Div, Eumsung, South Korea	Korea Institute of Oriental Medicine (KIOM); Gyeongsang National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Ryu, JS (corresponding author), Gyeongsangnam Do Agr Res & Extens Serv, Environm Friendly Res Div, Jinju, South Korea.	coolmush88@gmail.com		Ali, Asjad/0000-0002-0415-4598; Kong, Won-Sik/0000-0001-6800-2545; Ryu, Jae-San/0000-0002-8541-3079	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00821602014]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ00821602014), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was designed and started by the corresponding author who is an employee of the GNARES. GNARES is a non-profit organization by the Gyeongnam government.	CALDWELL GA, 1995, MICROBIOL REV, V59, P406, DOI 10.1128/MMBR.59.3.406-422.1995; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Erdmann S, 2012, EUKARYOT CELL, V11, P571, DOI 10.1128/EC.05214-11; Fowler TJ, 2001, GENETICS, V158, P1491; GIASSON L, 1989, MOL GEN GENET, V218, P72, DOI 10.1007/BF00330567; Gola S, 2000, FUNGAL GENET BIOL, V30, P191, DOI 10.1006/fgbi.2000.1222; Gola S, 2003, CURR GENET, V42, P276, DOI 10.1007/s00294-002-0353-4; Halsall JR, 2000, GENETICS, V154, P1115; Hegner J, 1999, FUNGAL GENET BIOL, V26, P190, DOI 10.1006/fgbi.1999.1119; Im CH, 2014, P 2014 C MICR BIOT T, P33; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; James TY, 2004, FUNGAL GENET BIOL, V41, P813, DOI 10.1016/j.fgb.2004.04.005; Kim H, 2006, EUKARYOT CELL, V5, P544, DOI 10.1128/EC.5.3.544-554.2006; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; KOLTIN Y, 1967, P NATL ACAD SCI USA, V57, P55, DOI 10.1073/pnas.57.1.55; KURJAN J, 1993, ANNU REV GENET, V27, P147; Larraya LM, 2001, APPL ENVIRON MICROB, V67, P3385, DOI 10.1128/AEM.67.8.3385-3390.2001; Niculita-Hirzel H, 2008, NEW PHYTOL, V180, P329, DOI 10.1111/j.1469-8137.2008.02525.x; Nieuwenhuis BP, 2013, HEREDITY, P1; O'Shea SF, 1998, GENETICS, V148, P1081; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Olesnicky NS, 2000, GENETICS, V156, P1025; 박순영, 2010, [The Korean Journal of Mycology, 한국균학회지], V38, P48; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; RICHARDSON WVJ, 1993, MOL GEN GENET, V238, P304, DOI 10.1007/BF00279559; Riquelme M, 2005, GENETICS, V170, P1105, DOI 10.1534/genetics.105.040774; Ryu JS, 2012, J MICROBIOL BIOTECHN, V22, P1177, DOI 10.4014/jmb.1108.08085; Shi L, 2014, MICROBIOL RES, V51, P303; SPECHT CA, 1995, CURR GENET, V28, P374, DOI 10.1007/BF00326436; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; WENDLAND J, 1995, EMBO J, V14, P5271, DOI 10.1002/j.1460-2075.1995.tb00211.x; YEADON PJ, 1995, CURR GENET, V28, P155, DOI 10.1007/BF00315782; Zadrazil F., 2004, SCI CULTIVATION EDIB; Zervakis GI, 2001, MICROBIOL-SGM, V147, P3183, DOI 10.1099/00221287-147-11-3183	35	18	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104693	10.1371/journal.pone.0104693	http://dx.doi.org/10.1371/journal.pone.0104693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133513	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700038
J	Masia, M; Robledano, C; de la Tabla, VO; Antequera, P; Lumbreras, B; Hernandez, I; Gutierrez, F				Masia, Mar; Robledano, Catalina; de la Tabla, Victoria Ortiz; Antequera, Pedro; Lumbreras, Blanca; Hernandez, Ildefonso; Gutierrez, Felix			Coinfection with Human Herpesvirus 8 Is Associated with Persistent Inflammation and Immune Activation in Virologically Suppressed HIV-Infected Patients	PLOS ONE			English	Article							MULTICENTRIC CASTLEMAN DISEASE; INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; T-CELL-ACTIVATION; NON-AIDS EVENTS; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; KAPOSIS-SARCOMA; RISK-FACTORS; MARKERS	Objectives: Infection with co-pathogens is one of the postulated factors contributing to persistent inflammation and non-AIDS events in virologically-suppressed HIV-infected patients. We aimed to investigate the relationship of human herpesvirus-8 (HHV-8), a vasculotropic virus implicated in the pathogenesis of Kaposi's sarcoma, with inflammation and subclinical atherosclerosis in HIV-infected patients. Methods: Prospective study including virologically suppressed HIV-infected patients. Several blood biomarkers (highly-sensitive C-reactive protein [hsCRP], tumour necrosis factor-alpha, interleukin-6, monocyte chemoattractant protein-1, vascular cell adhesion molecule-1, intercellular cell adhesion molecule-1, malondialdehyde, plasminogen activator inhibitor [PAI-1], D-dimer, sCD14, sCD163, CD4/CD38/HLA-DR, and CD8/CD38/HLA-DR), serological tests for HHV-8 and the majority of herpesviruses, carotid intima-media thickness, and endothelial function through flow-mediated dilatation of the brachial artery were measured. Results: A total of 136 patients were included, 34.6% of them infected with HHV-8. HHV-8-infected patients were more frequently co-infected with herpes simplex virus type 2 (HSV-2) (P<0.001), and less frequently with hepatitis C virus (HCV) (P = 0.045), and tended to be older (P = 0.086). HHV-8-infected patients had higher levels of hsCRP (median [interquartile range], 3.63 [1.32-7.54] vs 2.08 [0.89-4.11] mg/L, P = 0.009), CD4/CD38/HLA-DR (7.67% [4.10-11.86]% vs 3.86% [2.51-7.42]%, P = 0.035) and CD8/CD38/HLA-DR (8.02% [4.98-14.09]% vs 5.02% [3.66-6.96]%, P = 0.018). After adjustment for the traditional cardiovascular risk factors, HCV and HSV-2 infection, the associations remained significant: adjusted difference between HHV-8 positive and negative patients (95% confidence interval) for hsCRP, 74.19% (16.65-160.13)%; for CD4/CD38/HLA-DR, 89.65% (14.34-214.87)%; and for CD8/CD38/HLA-DR, 58.41% (12.30-123.22)%. Flow-mediated dilatation and total carotid intima-media thickness were not different according to HHV-8 serostatus. Conclusion: In virologically suppressed HIV-infected patients, coinfection with HHV-8 is associated with increased inflammation and immune activation. This might contribute to increase the risk of non-AIDS events, including accelerated atherosclerotic disease.	[Masia, Mar; Robledano, Catalina; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain; [de la Tabla, Victoria Ortiz; Antequera, Pedro] Hosp Univ San Juan, Microbiol Serv, Alicante, Spain; [Lumbreras, Blanca; Hernandez, Ildefonso] Univ Miguel Hernandez, Dept Publ Hlth, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Masia, M (corresponding author), Univ Miguel Hernandez, Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain.	marmasiac@gmail.com	Hernández-Aguado, Ildefonso/I-2634-2015; Masiá, Mar/U-7510-2017; Rodero, Félix Gutiérrez/Q-7880-2018	Hernández-Aguado, Ildefonso/0000-0003-1911-5759; Masiá, Mar/0000-0001-9878-2458; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Lumbreras, Blanca/0000-0003-1665-0860	Plan Nacional R+D+I [RD12/0017/0023]; ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [FIBELX10/11, FIBELX10/12]; Instituto de Salud Carlos III-FIS [PI081893, PI13/002256]	Plan Nacional R+D+I; ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work has been partially funded by the RD12/0017/0023 project as part of the Plan Nacional R+D+I, and co-financed by ISCIII- Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIBELX10/11, FIBELX10/12, and Instituto de Salud Carlos III-FIS [PI081893, PI13/002256]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; Aldaz P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-300; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; Crabtree KL, 2014, CANCER EPIDEM BIOMAR, V23, P300, DOI 10.1158/1055-9965.EPI-13-0730; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Giuliani M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-143; Grahame-Clarke C, 2001, AIDS, V15, P1902, DOI 10.1097/00002030-200109280-00029; Gutierrez F, 2006, J CLIN VIROL, V37, P79, DOI 10.1016/j.jcv.2006.05.011; Gutierrez F, 2008, AIDS, V22, P1369, DOI 10.1097/QAD.0b013e3282f7cb88; Hannachi N, 2012, PATHOL BIOL, V60, P282, DOI 10.1016/j.patbio.2011.10.008; Hechter RC, 2012, ATHEROSCLEROSIS, V223, P433, DOI 10.1016/j.atherosclerosis.2012.03.002; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Macy EM, 1997, CLIN CHEM, V43, P52; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; Masia M, 2010, ANTIVIR THER, V15, P101, DOI 10.3851/IMP1491; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798	28	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105442	10.1371/journal.pone.0105442	http://dx.doi.org/10.1371/journal.pone.0105442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133669	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700114
J	Bisanz, JE; Seney, S; McMillan, A; Vongsa, R; Koenig, D; Wong, L; Dvoracek, B; Gloor, GB; Sumarah, M; Ford, B; Herman, D; Burton, JP; Reid, G				Bisanz, Jordan E.; Seney, Shannon; McMillan, Amy; Vongsa, Rebecca; Koenig, David; Wong, LungFai; Dvoracek, Barbara; Gloor, Gregory B.; Sumarah, Mark; Ford, Brenda; Herman, Dorli; Burton, Jeremy P.; Reid, Gregor			A Systems Biology Approach Investigating the Effect of Probiotics on the Vaginal Microbiome and Host Responses in a Double Blind, Placebo-Controlled Clinical Trial of Post-Menopausal Women	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GR-1; BACTERIAL VAGINOSIS; REUTERI RC-14; RECEPTOR; FLORA; HIV; INTERLEUKIN-18; IDENTIFICATION; AUGMENTATION; PREVALENCE	A lactobacilli dominated microbiota in most pre and post-menopausal women is an indicator of vaginal health. The objective of this double blinded, placebo-controlled crossover study was to evaluate in 14 post-menopausal women with an intermediate Nugent score, the effect of 3 days of vaginal administration of probiotic L. rhamnosus GR-1 and L. reuteri RC-14 (2.5610(9) CFU each) on the microbiota and host response. The probiotic treatment did not result in an improved Nugent score when compared to when placebo. Analysis using 16S rRNA sequencing and metabolomics profiling revealed that the relative abundance of Lactobacillus was increased following probiotic administration as compared to placebo, which was weakly associated with an increase in lactate levels. A decrease in Atopobium was also observed. Analysis of host responses by microarray showed the probiotics had an immune-modulatory response including effects on pattern recognition receptors such as TLR2 while also affecting epithelial barrier function. This is the first study to use an interactomic approach for the study of vaginal probiotic administration in post-menopausal women. It shows that in some cases multifaceted approaches are required to detect the subtle molecular changes induced by the host to instillation of probiotic strains.	[Bisanz, Jordan E.; Seney, Shannon; McMillan, Amy; Gloor, Gregory B.; Burton, Jeremy P.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Ctr Human Microbiome & Probiot Res, London, ON, Canada; [Bisanz, Jordan E.; McMillan, Amy; Gloor, Gregory B.; Burton, Jeremy P.; Reid, Gregor] Univ Western Ontario, London, ON, Canada; [Vongsa, Rebecca; Koenig, David; Wong, LungFai; Dvoracek, Barbara] Kimberly Clark Inc, Corp Res & Engn Microbial Control, Neenah, WI USA; [Sumarah, Mark] Agr & Agri Food Canada, London, ON, Canada; [Ford, Brenda; Herman, Dorli] Springbank Med Clin, London, ON, Canada; [Burton, Jeremy P.] Univ Western Ontario, Div Urol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Kimberly-Clark; Agriculture & Agri Food Canada; Western University (University of Western Ontario)	Reid, G (corresponding author), Lawson Hlth Res Inst, Canadian Ctr Human Microbiome & Probiot Res, London, ON, Canada.	gregor@uwo.ca	Reid, Gregor/ABE-8327-2020; Gloor, Greg B/D-1671-2013; Burton, Jeremy/AAR-8902-2020	Reid, Gregor/0000-0001-9658-5696; Burton, Jeremy/0000-0002-3591-6436; Sumarah, Mark/0000-0003-0977-1656; Gloor, Gregory/0000-0001-5803-3380; Bisanz, Jordan/0000-0002-8649-1706	Kimberly Clark Corperation; Kimberly Clark	Kimberly Clark Corperation; Kimberly Clark	This project was funded by Kimberly Clark Corperation who were involved in the study design, analysis and preparation of the manuscript. This work was funded by Kimberly Clark and RV, DK, LW and BD are employees of Kimberly Clark. In order to avoid conflict of interest, all authors, including employees of Kimberly Clark, were blinded to which treatment was received by which subject, until all the sample analysis had been completed.	AITCHISON J, 1981, J INT ASS MATH GEOL, V13, P175, DOI 10.1007/BF01031393; Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; Anukam K, 2006, MICROBES INFECT, V8, P1450, DOI 10.1016/j.micinf.2006.01.003; Biet F, 2002, J MOL MED-JMM, V80, P147, DOI 10.1007/s00109-001-0307-1; Bisanz JE, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003291; Bolton M, 2008, SEX TRANSM DIS, V35, P214, DOI 10.1097/OLQ.0b013e31815b017a; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Burton JP, 2002, J INFECT DIS, V186, P1770, DOI 10.1086/345761; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Harandi AM, 2001, J VIROL, V75, P6705, DOI 10.1128/JVI.75.14.6705-6709.2001; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, INT J GYNECOL OBSTET, V111, P245, DOI 10.1016/j.ijgo.2010.07.008; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jacobsson B, 2003, BJOG-INT J OBSTET GY, V110, P598, DOI 10.1046/j.1471-0528.2003.02445.x; Kaya D, 2012, J CYTOL, V29, P226, DOI 10.4103/0970-9371.103939; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Martinez RCR, 2009, CAN J MICROBIOL, V55, P133, DOI [10.1139/w08-102, 10.1139/W08-102]; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Nappi RE, 2009, MATURITAS, V63, P138, DOI 10.1016/j.maturitas.2009.03.021; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0; Reid G, 2010, GUT MICROBES, V1, P200, DOI 10.4161/gmic.1.3.12013; Rizzo A, 2013, INT IMMUNOPHARMACOL, V17, P453, DOI 10.1016/j.intimp.2013.07.005; Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sultan R, 2013, APPL ENVIRON MICROB, V79, P4887, DOI 10.1128/AEM.00982-13; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Vasquez A, 2005, SYST APPL MICROBIOL, V28, P430, DOI 10.1016/j.syapm.2005.02.011; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	41	39	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104511	10.1371/journal.pone.0104511	http://dx.doi.org/10.1371/journal.pone.0104511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127240	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300028
J	Kamiya, K; Kobashi, H; Shimizu, K; Igarashi, A				Kamiya, Kazutaka; Kobashi, Hidenaga; Shimizu, Kimiya; Igarashi, Akihito			Clinical Outcomes of Penetrating Keratoplasty Performed with the VisuMax Femtosecond Laser System and Comparison with Conventional Penetrating Keratoplasty	PLOS ONE			English	Article								Purpose: To assess the clinical outcomes of femtosecond laser-assisted keratoplasty (FLAK) using the VisuMax femtosecond laser system, and to compare them with those of conventional penetrating keratoplasty (PK). Methods: We retrospectively examined 20 eyes of 20 consecutive patients undergoing FLAK and 20 eyes of 20 age-and diagnosis-matched patients undergoing conventional PK. We quantitatively assessed corneal astigmatism, refractive astigmatism, and corrected visual acuity, 1, 3, and 6 months postoperatively, and endothelial cell density 6 months postoperatively. Results: Corneal and refractive astigmatism after FLAK were significantly lower after FLAK than that after conventional PK at 3 and 6 months postoperatively (p = 0.04 and p = 0.03, respectively, Mann-Whitney U test). FLAK provided significantly faster visual recovery than conventional PK at 1 month postoperatively (p = 0.02), but not at 3 and 6 months postoperatively (p = 0.52 and p = 0.80, respectively). We found no significant differences in the change in endothelial cell density between the two groups (p = 0.30). Conclusions: FLAK using the VisuMax femtosecond laser system induces significantly less corneal and refractive astigmatism than conventional PK, and provides significantly faster visual recovery in the early postoperative period, possibly because the geometry of the donor-recipient matching is more physiological and requires less tight sutures. It is suggested that FLAK has advantages over conventional PK, in terms of astigmatism and fast visual recovery.	[Kamiya, Kazutaka; Kobashi, Hidenaga; Shimizu, Kimiya; Igarashi, Akihito] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Bahar I, 2009, BRIT J OPHTHALMOL, V93, P73, DOI 10.1136/bjo.2008.148346; Bahar I, 2008, CORNEA, V27, P209, DOI 10.1097/ICO.0b013e31815b7d50; Birnbaum F, 2013, GRAEF ARCH CLIN EXP, V251, P95, DOI 10.1007/s00417-012-2054-0; Buratto L, 2007, AM J OPHTHALMOL, V143, P737, DOI 10.1016/j.ajo.2007.01.056; Chamberlain WD, 2011, OPHTHALMOLOGY, V118, P486, DOI 10.1016/j.ophtha.2010.08.002; Cheng YYY, 2008, CORNEA, V27, P679, DOI 10.1097/QAI.0b013e31815bad0c; Farid M, 2007, OPHTHALMOLOGY, V114, P2208, DOI 10.1016/j.ophtha.2007.08.048; Farid M, 2009, OPHTHALMOLOGY, V116, P1638, DOI 10.1016/j.ophtha.2009.05.003; Gaster RN, 2012, BRIT J OPHTHALMOL, V96, P1195, DOI 10.1136/bjophthalmol-2012-301662; Hoffart L, 2008, AM J OPHTHALMOL, V146, P50, DOI 10.1016/j.ajo.2008.02.025; Holzer MP, 2007, AM J OPHTHALMOL, V143, P524, DOI 10.1016/j.ajo.2006.08.029; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P353, DOI 10.1111/j.1755-3768.2008.01493.x; Lee J, 2009, BRIT J OPHTHALMOL, V93, P861, DOI 10.1136/bjo.2008.149690; Meltendorf C, 2006, CORNEA, V25, P1090, DOI 10.1097/01.ico.0000228784.46463.e9; Por YM, 2008, AM J OPHTHALMOL, V145, P772, DOI 10.1016/j.ajo.2008.01.003; Price FW, 2008, AM J OPHTHALMOL, V145, P210, DOI 10.1016/j.ajo.2007.09.026; Seitz B, 2005, AM J OPHTHALMOL, V139, P941, DOI 10.1016/j.ajo.2004.11.028; Steinert RF, 2007, AM J OPHTHALMOL, V143, P689, DOI 10.1016/j.ajo.2006.11.043	18	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105464	10.1371/journal.pone.0105464	http://dx.doi.org/10.1371/journal.pone.0105464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126741	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300111
J	Mafficini, A; Amato, E; Fassan, M; Simbolo, M; Antonello, D; Vicentini, C; Scardoni, M; Bersani, S; Gottardi, M; Rusev, B; Malpeli, G; Corbo, V; Barbi, S; Sikora, KO; Lawlor, RT; Tortora, G; Scarpa, A				Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Tortora, Giampaolo; Scarpa, Aldo			Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis	PLOS ONE			English	Article							SEQUENCING PLATFORMS; SOMATIC MUTATIONS; CANCER; ADENOCARCINOMA; LANDSCAPE; EVOLUTION; CARCINOMA; TISSUES; GENOME; GENES	Background: Detection of molecular tumor heterogeneity has become of paramount importance with the advent of targeted therapies. Analysis for detection should be comprehensive, timely and based on routinely available tumor samples. Aim: To evaluate the diagnostic potential of targeted multigene next-generation sequencing (TM-NGS) in characterizing gastrointestinal cancer molecular heterogeneity. Methods: 35 gastrointestinal tract tumors, five of each intestinal type gastric carcinomas, pancreatic ductal adenocarcinomas, pancreatic intraductal papillary mucinous neoplasms, ampulla of Vater carcinomas, hepatocellular carcinomas, cholangiocarcinomas, pancreatic solid pseudopapillary tumors were assessed for mutations in 46 cancer-associated genes, using Ion Torrent semiconductor-based TM-NGS. One ampulla of Vater carcinoma cell line and one hepatic carcinosarcoma served to assess assay sensitivity. TP53, PIK3CA, KRAS, and BRAF mutations were validated by conventional Sanger sequencing. Results: TM-NGS yielded overlapping results on matched fresh-frozen and formalin-fixed paraffin-embedded (FFPE) tissues, with a mutation detection limit of 1% for fresh-frozen high molecular weight DNA and 2% for FFPE partially degraded DNA. At least one somatic mutation was observed in all tumors tested; multiple alterations were detected in 20/35 (57%) tumors. Seven cancers displayed significant differences in allelic frequencies for distinct mutations, indicating the presence of intratumor molecular heterogeneity; this was confirmed on selected samples by immunohistochemistry of p53 and Smad4, showing concordance with mutational analysis. Conclusions: TM-NGS is able to detect and quantitate multiple gene alterations from limited amounts of DNA, moving one step closer to a next-generation histopathologic diagnosis that integrates morphologic, immunophenotypic, and multigene mutational analysis on routinely processed tissues, essential for personalized cancer therapy.	[Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Scarpa, Aldo] Univ & Hosp Trust Verona, Appl Res Canc Network ARC NET, Verona, Italy; [Mafficini, Andrea; Amato, Eliana; Fassan, Matteo; Simbolo, Michele; Antonello, Davide; Vicentini, Caterina; Scardoni, Maria; Bersani, Samantha; Gottardi, Marisa; Rusev, Borislav; Malpeli, Giorgio; Corbo, Vincenzo; Barbi, Stefano; Sikora, Katarzyna O.; Lawlor, Rita T.; Scarpa, Aldo] Univ & Hosp Trust Verona, Dept Pathol & Diagnost, Verona, Italy; [Antonello, Davide; Malpeli, Giorgio] Univ & Hosp Trust Verona, Dept Surg, Verona, Italy; [Tortora, Giampaolo] Univ & Hosp Trust Verona, Oncol Unit, Dept Med, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Scarpa, A (corresponding author), Univ & Hosp Trust Verona, Appl Res Canc Network ARC NET, Verona, Italy.	aldo.scarpa@univr.it	scarpa, aldo/K-6832-2016; Tortora, Giampaolo/HGB-6261-2022; Corbo, Vincenzo/J-7754-2016; Tortora, Giampaolo/AAA-1252-2019; Mafficini, Andrea/AAK-8158-2020; Simbolo, Michele/AAB-1851-2019; Fassan, Matteo/F-5152-2012	scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Mafficini, Andrea/0000-0002-7471-3121; Simbolo, Michele/0000-0002-0866-4499; Malpeli, Giorgio/0000-0002-2996-2903; Fassan, Matteo/0000-0001-6515-5482; Tortora, Giampaolo/0000-0002-1378-4962; lawlor, Rita/0000-0003-3160-0634	AIRC [12182, 6421]; Italian Cancer Genome Project grant from the Italian Ministry of Research [FIRB - RBAP10AHJB]; Ministry of Health [CUP_J33G13000210001]; FP7 European Community CAM-PAC [602783]	AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Cancer Genome Project grant from the Italian Ministry of Research; Ministry of Health; FP7 European Community CAM-PAC	This work has been supported by AIRC grant n. 12182 and n. 6421; Italian Cancer Genome Project grant from the Italian Ministry of Research (FIRB - RBAP10AHJB) and Ministry of Health (CUP_J33G13000210001), FP7 European Community CAM-PAC (Grant no: 602783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amato E, 2014, J PATHOL; Balschun K, 2011, J MOL DIAGN, V13, P436, DOI 10.1016/j.jmoldx.2011.03.002; Barbi S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-32; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Ellison DW, 2011, J CLIN ONCOL, V29, P1400, DOI 10.1200/JCO.2010.30.2810; Fassan M, 2013, GASTRIC CANC; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jorgensen JT, 2013, EXPERT REV MOL DIAGN, V13, P667, DOI 10.1586/14737159.2013.834799; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luchini C, 2014, J CLIN ONCOL; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ow TJ, 2013, CANCER; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scarpa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080478; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Sorio C, 2004, VIRCHOWS ARCH, V444, P269, DOI 10.1007/s00428-003-0936-6; Ulivi P, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-87; Voss JS, 2013, HUM PATHOL IN PRESS; Wang P, 2012, ONCOGENE; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zamo A, 2012, J MOL DIAGN, V14, P30, DOI 10.1016/j.jmoldx.2011.07.007; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	37	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104979	10.1371/journal.pone.0104979	http://dx.doi.org/10.1371/journal.pone.0104979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127237	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300068
J	Majtan, T; Pey, AL; Fernandez, R; Fernandez, JA; Martinez-Cruz, LA; Kraus, JP				Majtan, Tomas; Pey, Angel L.; Fernandez, Roberto; Fernandez, Jose A.; Martinez-Cruz, Luis A.; Kraus, Jan P.			Domain Organization, Catalysis and Regulation of Eukaryotic Cystathionine Beta-Synthases	PLOS ONE			English	Article							CYSTEINE BIOSYNTHESIS; HYDROGEN-SULFIDE; SACCHAROMYCES-CEREVISIAE; TRANS-SULFURATION; REDOX REGULATION; STRUCTURAL BASIS; WILD-TYPE; HEME; TRANSSULFURATION; ADENOSYLMETHIONINE	Cystathionine beta-synthase (CBS) is a key regulator of sulfur amino acid metabolism diverting homocysteine, a toxic intermediate of the methionine cycle, via the transsulfuration pathway to the biosynthesis of cysteine. Although the pathway itself is well conserved among eukaryotes, properties of eukaryotic CBS enzymes vary greatly. Here we present a side-by-side biochemical and biophysical comparison of human (hCBS), fruit fly (dCBS) and yeast (yCBS) enzymes. Preparation and characterization of the full-length and truncated enzymes, lacking the regulatory domains, suggested that eukaryotic CBS exists in one of at least two significantly different conformations impacting the enzyme's catalytic activity, oligomeric status and regulation. Truncation of hCBS and yCBS, but not dCBS, resulted in enzyme activation and formation of dimers compared to native tetramers. The dCBS and yCBS are not regulated by the allosteric activator of hCBS, S-adenosylmethionine (AdoMet); however, they have significantly higher specific activities in the canonical as well as alternative reactions compared to hCBS. Unlike yCBS, the heme-containing dCBS and hCBS showed increased thermal stability and retention of the enzyme's catalytic activity. The mass-spectrometry analysis and isothermal titration calorimetry showed clear presence and binding of AdoMet to yCBS and hCBS, but not dCBS. However, the role of AdoMet binding to yCBS remains unclear, unlike its role in hCBS. This study provides valuable information for understanding the complexity of the domain organization, catalytic specificity and regulation among eukaryotic CBS enzymes.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Granada, Spain; [Fernandez, Roberto; Fernandez, Jose A.] Univ,Basque Country UPV EHU, Fac Sci & Technol, Dept Phys Chem, Leioa, Spain; [Martinez-Cruz, Luis A.] CIC bioGUNE, Struct Biol Unit, Derio, Bizkaia, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Granada; University of Basque Country; CIC bioGUNE	Kraus, JP (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Fernandez, Jose Andres/E-8565-2011; Majtan, Tomas/AAE-8426-2021; Martinez-Cruz, Luis Alfonso/G-2285-2011	Fernandez, Jose Andres/0000-0002-7315-2326; Majtan, Tomas/0000-0002-2751-2124; Fernandez, Roberto Antonio/0000-0002-3424-9758; Martinez-Cruz, Luis Alfonso/0000-0002-5856-9377; Pey, Angel Luis/0000-0001-7706-3243	American Heart Association [0920079G, 09GRNT2110159]; National Institutes of Health [HL065217]; Jerome Lejeune Foundation;  [RYC2009-04147];  [P11-CTS-07187];  [CSD2009-00088];  [BIO2012-34937]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune Foundation; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Postdoctoral Fellowship 0920079G from the American Heart Association (to TM), by National Institutes of Health Grant HL065217, by American Heart Association Grant In-Aid 09GRNT2110159, by a grant from the Jerome Lejeune Foundation (all to JPK) and by a research contract RYC2009-04147 (to ALP). In addition, grant support (P11-CTS-07187, CSD2009-00088 and BIO2012-34937) to Dr. Jose M. Sanchez-Ruiz (University of Granada) and SGIker technical and human support (UPV/EHU, MICINN, GV/EJ, ESF) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; CHEREST H, 1993, J BACTERIOL, V175, P5366, DOI 10.1128/JB.175.17.5366-5374.1993; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; COOPER AJL, 1983, ANNU REV BIOCHEM, V52, P187, DOI 10.1146/annurev.bi.52.070183.001155; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Frank N, 2008, ARCH BIOCHEM BIOPHYS, V470, P64, DOI 10.1016/j.abb.2007.11.006; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Hebert A, 2011, FEMS YEAST RES, V11, P366, DOI 10.1111/j.1567-1364.2011.00725.x; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; KAYASTHA AM, 1991, ANAL BIOCHEM, V193, P200, DOI 10.1016/0003-2697(91)90009-I; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KERY V, 1994, J BIOL CHEM, V269, P25283; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lloyd D, 2006, TRENDS MICROBIOL, V14, P456, DOI 10.1016/j.tim.2006.08.003; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Majtan T, 2012, PROTEIN EXPRES PURIF, V82, P317, DOI 10.1016/j.pep.2012.01.019; Majtan T, 2010, J BIOL CHEM, V285, P15866, DOI 10.1074/jbc.M110.107722; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Marciano D, 2012, MOL BIOCHEM PARASIT, V185, P114, DOI [10.10, 10.1016/j.molbiopara.2012.07.009]; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P3338, DOI 10.1021/bi00409a033; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Su Y, 2013, BIOCHEMISTRY-US, V52, P741, DOI 10.1021/bi300615c; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 1999, BIOCHEMISTRY-US, V38, P7406, DOI 10.1021/bi995077i; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, J BIOL CHEM, V10, P10; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vozdek R, 2012, BIOCHEM J, V443, P535, DOI 10.1042/BJ20111478; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	50	36	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105290	10.1371/journal.pone.0105290	http://dx.doi.org/10.1371/journal.pone.0105290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122507	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000112
J	Lange, D; Del-Claro, K				Lange, Denise; Del-Claro, Kleber			Ant-Plant Interaction in a Tropical Savanna: May the Network Structure Vary over Time and Influence on the Outcomes of Associations?	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; EXTRAFLORAL NECTARIES; ECOLOGICAL NETWORKS; CERRADO VEGETATION; SEED DISPERSAL; FOOD RESOURCES; FRUIT-SET; SPECIALIZATION; HERBIVORE; ARCHITECTURE	Plant-animal interactions occur in a community context of dynamic and complex ecological interactive networks. The understanding of who interacts with whom is a basic information, but the outcomes of interactions among associates are fundamental to draw valid conclusions about the functional structure of the network. Ecological networks studies in general gave little importance to know the true outcomes of interactions and how they may change over time. We evaluate the dynamic of an interaction network between ants and plants with extrafloral nectaries, by verifying the temporal variation in structure and outcomes of mutualism for the plant community (leaf herbivory). To reach this goal, we used two tools: bipartite network analysis and experimental manipulation. The networks exhibited the same general pattern as other mutualistic networks: nestedness, asymmetry and low specialization and this pattern was maintained over time, but with internal changes (species degree, connectance and ant abundance). These changes influenced the protection effectiveness of plants by ants, which varied over time. Our study shows that interaction networks between ants and plants are dynamic over time, and that these alterations affect the outcomes of mutualisms. In addition, our study proposes that the set of single systems that shape ecological networks can be manipulated for a greater understanding of the entire system.	[Lange, Denise; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	kdelclaro@gmail.com	Del-Claro, Kleber/N-3700-2019; Del-Claro, K/C-5570-2013	Del-Claro, K/0000-0001-8886-9568	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301605/2013-0, 473055/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors had financial support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - for K Del Claro 301605/2013-0; 473055/2012-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - dor D. Lange PNPD). The authors ensure that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2010, 2010 GLOBECOM; Appolinario V., 2002, Boletim do Herbario Ezechias Paulo Heringer, V10, P57; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Benadi G, 2013, ECOL MODEL, V258, P65, DOI 10.1016/j.ecolmodel.2013.03.002; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Chamberlain SA, 2010, OECOLOGIA, V164, P741, DOI 10.1007/s00442-010-1673-6; Dattilo W, 2014, PLOS ONE IN PRESS; Dattilo W, 2014, J TROP ECOL, V30, P165, DOI 10.1017/S0266467413000813; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dattilo W, 2013, ECOL ENTOMOL, V38, P374, DOI 10.1111/een.12029; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Del-Claro K, 2000, OECOLOGIA, V124, P156, DOI 10.1007/s004420050002; Del-Claro K, 2013, BIOSCI J, V29, P439; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dirzo Rodolfo, 1995, P304, DOI 10.1017/CBO9780511753398.012; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dunne JA, 2006, ECOLOGICAL NETWORKS, P325; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Gibb H, 2009, INSECT SOC, V56, P405, DOI 10.1007/s00040-009-0038-9; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holland JN, 2011, OIKOS, V120, P381, DOI 10.1111/j.1600-0706.2010.18958.x; Holldobler B., 1990, pi; HORVITZ CC, 1984, ECOLOGY, V65, P1369, DOI 10.2307/1939117; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Lach L, 2009, POPUL ECOL, V51, P237, DOI 10.1007/s10144-008-0132-2; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Machado SR, 2008, PLANT BIOLOGY, V10, P660, DOI 10.1111/j.1438-8677.2008.00068.x; Mello MAR, 2011, ACTA OECOL, V37, P37, DOI 10.1016/j.actao.2010.11.004; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; OLIVEIRA PS, 1987, BIOTROPICA, V19, P140, DOI 10.2307/2388736; OLIVEIRA PS, 1987, OECOLOGIA, V74, P228, DOI 10.1007/BF00379363; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Rico-Gray V, 1998, AM MIDL NAT, V140, P21, DOI 10.1674/0003-0031(1998)140[0021:RASVOA]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; SCHEMSKE DW, 1982, ECOLOGY, V63, P932, DOI 10.2307/1937233; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; Stanton ML, 2011, ECOLOGY, V92, P1073, DOI 10.1890/i0012-9658-92-5-1073; Suzuki N, 2004, ECOL RES, V19, P275, DOI 10.1111/j.1440-1703.2004.00636.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057	73	55	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105574	10.1371/journal.pone.0105574	http://dx.doi.org/10.1371/journal.pone.0105574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141007	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200103
J	Lermen, D; Schmitt, D; Bartel-Steinbach, M; Schroter-Kermani, C; Kolossa-Gehring, M; von Briesen, H; Zimmermann, H				Lermen, Dominik; Schmitt, Daniel; Bartel-Steinbach, Martina; Schroeter-Kermani, Christa; Kolossa-Gehring, Marike; von Briesen, Hagen; Zimmermann, Heiko			A New Approach to Standardize Multicenter Studies: Mobile Lab Technology for the German Environmental Specimen Bank	PLOS ONE			English	Article							PLASMA SAMPLES; ERRORS; SYSTEM; POPULATIONS; EXPOSURE; STATE; AREA; UNIT; VAN	Technical progress has simplified tasks in lab diagnosis and improved quality of test results. Errors occurring during the pre-analytical phase have more negative impact on the quality of test results than errors encountered during the total analytical process. Different infrastructures of sampling sites can highly influence the quality of samples and therewith of analytical results. Annually the German Environmental Specimen Bank (ESB) collects, characterizes, and stores blood, plasma, and urine samples of 120-150 volunteers each on four different sampling sites in Germany. Overarching goal is to investigate the exposure to environmental pollutants of non-occupational exposed young adults combining human biomonitoring with questionnaire data. We investigated the requirements of the study and the possibility to realize a highly standardized sampling procedure on a mobile platform in order to increase the required quality of the pre-analytical phase. The results lead to the development of a mobile epidemiologic laboratory (epiLab) in the project "Labor der Zukunft" (future's lab technology). This laboratory includes a 14.7 m(2) reception area to record medical history and exposure-relevant behavior, a 21.1 m(2) examination room to record dental fillings and for blood withdrawal, a 15.5 m(2) biological safety level 2 laboratory to process and analyze samples on site including a 2.8 m(2) personnel lock and a 3.6 m(2) cryofacility to immediately freeze samples. Frozen samples can be transferred to their final destination within the vehicle without breaking the cold chain. To our knowledge, we herewith describe for the first time the implementation of a biological safety laboratory (BSL) 2 lab and an epidemiologic unit on a single mobile platform. Since 2013 we have been collecting up to 15.000 individual human samples annually under highly standardized conditions using the mobile laboratory. Characterized and free of alterations they are kept ready for retrospective analyses in their final archive, the German ESB.	[Lermen, Dominik; Bartel-Steinbach, Martina; von Briesen, Hagen; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Saarland, Germany; [Schmitt, Daniel; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn, Dept Lab & Informat Technol, St Ingbert, Saarland, Germany; [Schroeter-Kermani, Christa; Kolossa-Gehring, Marike] Fed Environm Agcy UBA, Berlin, Germany; [Zimmermann, Heiko] Univ Saarland, Saarbrucken, Saarland, Germany	Fraunhofer Gesellschaft; Fraunhofer Gesellschaft; Saarland University	Zimmermann, H (corresponding author), Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Saarland, Germany.	heiko.zimmermann@ibmt.fraunhofer.de		Kolossa-Gehring, Marike/0000-0001-8644-7564; Zimmermann, Heiko/0000-0001-8595-1304; Bartel-Steinbach, Martina/0000-0002-7451-005X	Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety [301 02 048]; government and the State Chancellery of the federal state Saarland (Germany) [C/1-LdZ-2011]	Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; government and the State Chancellery of the federal state Saarland (Germany)	DL and HvB received funding for the sampling from the Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety. Grant Number: 301 02 048 http://www.bmub.bund.de/en/. DS and HZ received funding from the government and the State Chancellery of the federal state Saarland (Germany). Grant Number: C/1-LdZ-2011 http://www.saarland.de/staatskanzlei.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVELA H, 1990, RADIAT PROT DOSIM, V32, P177, DOI 10.1093/oxfordjournals.rpd.a080734; Ausschuss fur Biologische Arbeitsstoffe, 2013, ARBEITSSTOFFEN LAB G, V51, P1010; Becker K, 2013, INT J HYG ENVIR HEAL, V216, P250, DOI 10.1016/j.ijheh.2013.01.002; Bonini P, 2002, CLIN CHEM, V48, P691; Carraro P, 2012, CLIN CHEM, V58, P638, DOI 10.1373/clinchem.2011.175711; Chong B, 2007, APPL BIOSAFETY, V12, P238; Emons H, 1997, CHEMOSPHERE, V34, P1875, DOI 10.1016/S0045-6535(97)00050-7; Favaloro EJ, 2012, LABMEDICINE, V43, P54, DOI 10.1309/LM749BQETKYPYPVM; Germann A, 2009, PROCEDIA VACCINOL, V1, P49, DOI 10.1016/j.provac.2009.07.010; Hammerling JA, 2012, LABMEDICINE, V43, P41, DOI 10.1309/LM6ER9WJR1IHQAUY; Honsa JD, 2003, J AOAC INT, V86, P1038; Hooijberg E, 2012, J VET DIAGN INVEST, V24, P458, DOI 10.1177/1040638712441782; Joas R, 2012, INT J HYG ENVIR HEAL, V215, P172, DOI 10.1016/j.ijheh.2011.08.010; King B, 2005, J NATL MED ASSOC, V97, P648; Koch HM, 2012, J EXPO SCI ENV EPID, V22, P610, DOI 10.1038/jes.2012.39; Kohl H, 1998, ACCREDIT QUAL ASSUR, V3, P422; Kolb CE, 2004, ENVIRON SCI TECHNOL, V38, P5694, DOI 10.1021/es030718p; Kolossa-Gehring M, 2012, INT J HYG ENVIR HEAL, V215, P120, DOI 10.1016/j.ijheh.2011.10.013; Krol DM, 2007, J HEALTH CARE POOR U, V18, P331, DOI 10.1353/hpu.2007.0038; Lazzari MA, 2012, LAB MED, V43, P9; Lima-Oliveira G, 2013, INT J LAB HEMATOL, V36, P37; Lippi G, 2013, CLIN CHEM LAB MED, V51, P229, DOI 10.1515/cclm-2012-0597; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Njanpop-Lafourcade BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068401; Ozarda Y, 2013, CLIN CHEM LAB MED, V51, P1027, DOI 10.1515/cclm-2013-0249; Plebani M, 2010, ANN CLIN BIOCHEM, V47, P101, DOI 10.1258/acb.2009.009222; Prohl A, 1997, ENVIRON HEALTH PERSP, V105, P844, DOI 10.2307/3433702; Romero A, 2012, CLIN CHIM ACTA, V413, P166, DOI 10.1016/j.cca.2011.09.017; Schroter-Kermani C, 2013, INT J HYG ENVIR HEAL, V216, P633, DOI 10.1016/j.ijheh.2012.08.004; Schutze A, 2014, INT J HYG ENVIR HEAL, V217, P421, DOI 10.1016/j.ijheh.2013.08.004; Schulz C, 2012, INT J HYG ENVIR HEAL, V215, P435, DOI 10.1016/j.ijheh.2012.02.002; Shapiro A, 2006, PEDIATRICS, V117, pS412, DOI 10.1542/peds.2006-0099N; Simundic AM, 2013, CLIN CHEM LAB MED, V51, P1585, DOI 10.1515/cclm-2013-0283; Takizawa M, 2001, IEEE T INF TECHNOL B, V5, P2, DOI 10.1109/4233.908348; WAHNER HW, 1994, J BONE MINER RES, V9, P951; WALSH MJ, 1972, BRIT HEART J, V34, P701; Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1; Walter S, 2011, ANN NEUROL, V69, P581, DOI 10.1002/ana.22355; Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009; Weibring P, 2003, APPL OPTICS, V42, P3583, DOI 10.1364/AO.42.003583; WENNERBLOM B, 1982, EUR HEART J, V3, P504, DOI 10.1093/oxfordjournals.eurheartj.a061345; Wiesmuller GA, 2007, INT J HYG ENVIR HEAL, V210, P299, DOI 10.1016/j.ijheh.2007.01.036; Wiesmuller GA, 2011, ENCY ENV HLTH, P507, DOI DOI 10.1016/B978-0-444-52272-6.00450-5; Wilhelm M, 2009, INT J HYG ENVIR HEAL, V212, P142, DOI 10.1016/j.ijheh.2008.04.008; Zavala M, 2006, ATMOS CHEM PHYS, V6, P5129, DOI 10.5194/acp-6-5129-2006	45	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105401	10.1371/journal.pone.0105401	http://dx.doi.org/10.1371/journal.pone.0105401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141120	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200086
J	Tang, CH; Fang, LS; Fan, TY; Wang, LH; Lin, CY; Lee, SH; Wang, WH				Tang, Chuan-Ho; Fang, Lee-Shing; Fan, Tung-Yung; Wang, Li-Hsueh; Lin, Ching-Yu; Lee, Shu-Hui; Wang, Wei-Hsien			Cellular Membrane Accommodation to Thermal Oscillations in the Coral Seriatopora caliendrum	PLOS ONE			English	Article							2-PHOTON FLUORESCENCE MICROSCOPY; SUBCLASS-SPECIFIC ALTERATIONS; LIPID-COMPOSITION; CLIMATE-CHANGE; LONG-TERM; BILAYERS; VESICLES; CELLS; PHOSPHOLIPIDS; PERMEABILITY	In the present study, the membrane lipid composition of corals from a region with tidally induced upwelling was investigated. The coral community is subject to strong temperature oscillations yet flourishes as a result of adaptation. Glycerophosphocholine profiling of the dominant pocilloporid coral, Seriatopora caliendrum, was performed using a validated method. The coral inhabiting the upwelling region shows a definite shift in the ratio of lipid molecular species, covering several subclasses. Mainly, the coral possesses a higher percentage of saturated, monounsaturated and polyunsaturated plasmanylcholines and a lower percentage of polyunsaturated phosphatidylcholines. Higher levels of lyso-plasmanylcholines containing saturated or monounsaturated fatty acid chains were also revealed in coral tissue at the distal portion of the branch. Based on the physicochemical properties of these lipids, we proposed mechanisms for handling cellular membrane perturbations, such as tension, induced by thermal oscillation to determine how coral cells are able to spontaneously maintain their physiological functions, in both molecular and physical terms. Interestingly, the biochemical and biophysical properties of these lipids also have beneficial effects on the resistance, maintenance, and growth of the corals. The results of this study suggest that lipid metabolic adjustment is a major factor in the adaption of S. caliendrum in upwelling regions.	[Tang, Chuan-Ho; Fan, Tung-Yung; Wang, Wei-Hsien] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tang, Chuan-Ho; Fan, Tung-Yung; Wang, Li-Hsueh] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Pingtung, Taiwan; [Fang, Lee-Shing] Cheng Shiu Univ, Dept Sport Hlth & Leisure, Kaohsiung, Taiwan; [Wang, Li-Hsueh] Natl Dong Hwa Univ, Inst Marine Biotechnol, Pingtung, Taiwan; [Lin, Ching-Yu] Natl Taiwan Univ, Inst Environm Hlth, Taipei 10764, Taiwan; [Lee, Shu-Hui] Natl Kaohsiung Marine Univ, Kaohsiung, Taiwan; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Cheng Shiu University; National Dong Hwa University; National Taiwan University; National Kaohsiung University of Science & Technology; National Sun Yat Sen University; National Sun Yat Sen University	Tang, CH (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.	chtang@nmmba.gov.tw; whw@nmmba.gov.tw		LIN, CHING-YU/0000-0002-7144-0383	National Science Council in Taiwan [NSC101-2313-B-291-003]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by National Science Council (NSC101-2313-B-291-003) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DH, 1977, LIPIDS, V12, P188, DOI 10.1007/BF02533292; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; CHABOT MC, 1990, CANCER RES, V50, P7174; Chen C.T.A., 2004, J MAR SCI TECHNOL, V12, P442; Chen CS, 2012, SCI CHINA LIFE SCI, V55, P599, DOI 10.1007/s11427-012-4345-4; CHEN X, 1994, BIOCHEMISTRY-US, V33, P13769, DOI 10.1021/bi00250a030; Clode PL, 2002, J EXP BIOL, V205, P3543; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Frolov VA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004747; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; Grosman N, 2001, INT IMMUNOPHARMACOL, V1, P1321, DOI 10.1016/S1567-5769(01)00064-9; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kraichely RE, 2009, AM J PHYSIOL-GASTR L, V296, pG833, DOI 10.1152/ajpgi.90610.2008; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; KWOK R, 1981, BIOPHYS J, V35, P637, DOI 10.1016/S0006-3495(81)84817-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee HJ, 1999, ESTUAR COAST SHELF S, V49, P775, DOI 10.1006/ecss.1999.0524; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Matsuki H, 2007, BBA-BIOMEMBRANES, V1768, P479, DOI 10.1016/j.bbamem.2006.10.005; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pandey PR, 2011, J PHYS CHEM B, V115, P3155, DOI 10.1021/jp1090203; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Saltveit ME, 2000, DISCOVERIES PLANT BI, P423; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Soong K, 2003, CORAL REEFS, V22, P224, DOI 10.1007/s00338-003-0311-8; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tang CH, 2012, ANAL BIOANAL CHEM, V404, P2949, DOI 10.1007/s00216-012-6414-8; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1; Zeng YC, 1998, BIOCHEMISTRY-US, V37, P2346, DOI 10.1021/bi9725172	49	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105345	10.1371/journal.pone.0105345	http://dx.doi.org/10.1371/journal.pone.0105345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140803	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200074
J	Coelho, DS; Gaspar, CJ; Domingos, PM				Coelho, Dina S.; Gaspar, Catarina J.; Domingos, Pedro M.			Ire1 Mediated mRNA Splicing in a C-Terminus Deletion Mutant of Drosophila Xbp1	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; RETINAL DEGENERATION; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; MECHANISM; NUCLEUS; PATHWAY; KINASE	The Unfolded Protein Response is a homeostatic mechanism that permits eukaryotic cells to cope with Endoplasmic Reticulum (ER) stress caused by excessive accumulation of misfolded proteins in the ER lumen. The more conserved branch of the UPR relies on an ER transmembrane enzyme, Ire1, which, upon ER stress, promotes the unconventional splicing of a small intron from the mRNA encoding the transcription factor Xbp1. In mammals, two specific regions (the hydrophobic region 2 - HR2 - and the C-terminal translational pausing site) present in the Xbp1(unspliced) protein mediate the recruitment of the Xbp1 mRNA-ribosome-nascent chain complex to the ER membrane, so that Xbp1 mRNA can be spliced by Ire1. Here, we generated a Drosophila Xbp1 deletion mutant (Excision101) lacking both HR2 and C-terminal region, but not the Ire1 splicing site. We show that Ire1-dependent splicing of Xbp1 mRNA is reduced, but not abolished in Excision101. Our results suggest the existence of additional mechanisms for ER membrane targeting of Xbp1 mRNA that are independent of the C-terminal domain of Drosophila Xbp1(unspliced).	[Coelho, Dina S.; Gaspar, Catarina J.; Domingos, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade Nova de Lisboa	Domingos, PM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	domingp@itqb.unl.pt	Domingos, Pedro/F-5557-2011	Domingos, Pedro/0000-0003-4523-5631; Gaspar, Catarina/0000-0002-5295-6165; Coelho, Dina/0000-0002-4929-8990	Fundacao para a Ciencia e a Tecnologia, Portugal [PEst-OE/EQB/LA0004/2011, PTDC/BIA-BCM/105217/2008, PTDC/SAU-OBD/104399/2008, FCT-ANR/NEU-NMC/0006/2013]; Marie Curie International Reintegration [PIRG03-GA-2008-230935]; Gulbenkian Foundation	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Marie Curie International Reintegration(European Commission); Gulbenkian Foundation	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal, through grants PEst-OE/EQB/LA0004/2011, PTDC/BIA-BCM/105217/2008, PTDC/SAU-OBD/104399/2008 and FCT-ANR/NEU-NMC/0006/2013, by a Marie Curie International Reintegration grant (PIRG03-GA-2008-230935). D. S. C. was supported by a doctoral fellowship from the Gulbenkian Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; BRAND AH, 1993, DEVELOPMENT, V118, P401; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Coelho DS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00076; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Gaddam D, 2013, MOL BIOL CELL, V24, P14, DOI 10.1091/mbc.E12-06-0491; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Moore KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075723; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105588	10.1371/journal.pone.0105588	http://dx.doi.org/10.1371/journal.pone.0105588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136861	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100110
J	Du, XY; Li, BZ; Liu, H; Yang, D; Yu, W; Liao, JK; Huang, ZC; Xia, KC				Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao			The Response of Human Thermal Sensation and Its Prediction to Temperature Step-Change (Cool-Neutral-Cool)	PLOS ONE			English	Article							COMFORT; PERCEPTION; ENVIRONMENTS	This paper reports on studies of the effect of temperature step-change (between a cool and a neutral environment) on human thermal sensation and skin temperature. Experiments with three temperature conditions were carried out in a climate chamber during the period in winter. Twelve subjects participated in the experiments simulating moving inside and outside of rooms or cabins with air conditioning. Skin temperatures and thermal sensation were recorded. Results showed overshoot and asymmetry of TSV due to the step-change. Skin temperature changed immediately when subjects entered a new environment. When moving into a neutral environment from cool, dynamic thermal sensation was in the thermal comfort zone and overshoot was not obvious. Air-conditioning in a transitional area should be considered to limit temperature difference to not more than 5 degrees C to decrease the unacceptability of temperature step-change. The linear relationship between thermal sensation and skin temperature or gradient of skin temperature does not apply in a step-change environment. There is a significant linear correlation between TSV and Q(loss) in the transient environment. Heat loss from the human skin surface can be used to predict dynamic thermal sensation instead of the heat transfer of the whole human body.	[Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao] Chongqing Univ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Minist Educ, Chongqing 630044, Peoples R China; [Du, Xiuyuan; Li, Baizhan; Liu, Hong; Yang, Dong; Yu, Wei; Liao, Jianke; Huang, Zhichao; Xia, Kechao] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldg, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Li, BZ (corresponding author), Chongqing Univ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Minist Educ, Chongqing 630044, Peoples R China.	baizhanli@163.com	li, bz/GVR-7133-2022; li, bing/GWQ-9617-2022	Li, Baizhan/0000-0001-7526-1748	National Key Basic Research Program of China (The 973 Program) [2012CB720100]; National Key Technology R&D Program of China [2012BAJ02B00]; 111 Project [B13041]	National Key Basic Research Program of China (The 973 Program); National Key Technology R&D Program of China(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project)	This research is supported by the National Key Basic Research Program of China (The 973 Program) (Grant No. 2012CB720100), the National Key Technology R&D Program of China (Grant No. 2012BAJ02B00) and the 111 Project (Grant No. B13041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WINDS P C AD CHANG N; [Anonymous], 2012, GBT507852012; [Anonymous], 2011, 552010 ASHRAE VENT A; Arens E, 2006, J THERM BIOL, V31, P60, DOI 10.1016/j.jtherbio.2005.11.027; BELL CR, 1971, BRIT J IND MED, V28, P259; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Chen CP, 2011, BUILD ENVIRON, V46, P2387, DOI 10.1016/j.buildenv.2011.05.021; Choi J, 2010, BUILD ENVIRON, V45, P1529, DOI 10.1016/j.buildenv.2010.01.004; Chun C, 2005, BUILD ENVIRON, V40, P633, DOI 10.1016/j.buildenv.2004.08.001; Chun C, 2004, BUILD ENVIRON, V39, P1187, DOI 10.1016/j.buildenv.2004.02.003; Chun C, 2008, BUILD ENVIRON, V43, P877, DOI 10.1016/j.buildenv.2007.01.031; Chun CY, 1998, BUILD ENVIRON, V33, P151, DOI 10.1016/S0360-1323(97)00047-4; de Dear RJ, 2013, INDOOR AIR, V23, P442, DOI 10.1111/ina.12046; de Dear R.J., 1993, INDOOR AIR, V3, P181, DOI [10.1111/j.1600-0668.1993.t01-1-00004.x, DOI 10.1111/J.1600-0668.1993.T01-1-00004.X]; de Dear R, 2011, BUILD RES INF, V39, P108, DOI 10.1080/09613218.2011.552269; De dear RJ., 1994, ASHRAE T, V100, P457; Dedear R.J., 1985, ASHRAE T, V91, P452; Fanger PO., 1970, THERMAL COMFORT; Fiala D., 2003, ASHRAE T, P179, DOI 10.1590/S1517-838220080002000021; Gagge A.P., 2011, HEAT EXCHANGE HUMAN, P69, DOI [DOI 10.1002/CPHY.CP090105, 10.1002/cphy.cp090105]; GAGGE AP, 1967, ENVIRON RES, V1, P1, DOI 10.1016/0013-9351(67)90002-3; Hashiguchi N, 2010, EUR J APPL PHYSIOL, V109, P41, DOI 10.1007/s00421-009-1158-7; Humphreys MA, 2002, ENERG BUILDINGS, V34, P667, DOI 10.1016/S0378-7788(02)00018-X; IBM, 2012, IBMSPSS STAT 20 REL; Indraganti M, 2010, ENERG BUILDINGS, V42, P273, DOI 10.1016/j.enbuild.2009.09.003; ISO, 2005, 7730 ISO; Jin Q, 2011, BUILD ENVIRON, V51, P330; Jing SL, 2013, INDOOR BUILT ENVIRON, V22, P598, DOI 10.1177/1420326X12447614; Kaynakli O, 2003, INT COMMUN HEAT MASS, V30, P1179, DOI 10.1016/S0735-1933(03)00183-0; Kim J, 2013, BUILD ENVIRON, V70, P245, DOI 10.1016/j.buildenv.2013.08.022; Liu H, 2007, J CENT SOUTH UNIV T, V14, P43, DOI 10.1007/s11771-007-0362-z; Liu H, 2014, BUILD ENVIRON, V73, P232, DOI 10.1016/j.buildenv.2013.12.007; Ma XL, 2011, THESIS CHONGQING U; MOHURD, 2012, GB507362012 MOHURD; Nagano K, 2005, INT J BIOMETEOROL, V50, P33, DOI 10.1007/s00484-005-0265-3; Nakano J, 2006, WINDS P COMPF EN US; Nevins R.G., 1966, ASHRAE T, V72, P283; Ring J.W., 1991, INDOOR AIR, V1, P448, DOI [10.1111/j.1600-0668.1991.00009.x, DOI 10.1111/J.1600-0668.1991.00009.X, DOI 10.1111/INA.1991.1.ISSUE-4]; Schiller G.E., 1988, ASHRAE T, V94, P280; Zhang H, 2004, EUR J APPL PHYSIOL, V92, P728, DOI 10.1007/s00421-004-1137-y; Zhang H., 2003, THESIS U CALIFORNIA; Zhang H, 2013, THERMAL COMFORT STUD; Zhang YF, 2010, HEATING VENTILATING, V40, P26; Zhao RY, 2007, BUILD ENVIRON, V42, P3926, DOI 10.1016/j.buildenv.2006.06.030; Zhu Y.X., 2005, BUILT ENV	45	44	44	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104320	10.1371/journal.pone.0104320	http://dx.doi.org/10.1371/journal.pone.0104320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136808	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100027
J	Kanan, Y; Siefert, JC; Kinter, M; Al-Ubaidi, MR				Kanan, Yogita; Siefert, Joseph C.; Kinter, Michael; Al-Ubaidi, Muayyad R.			Complement Factor H, Vitronectin, and Opticin Are Tyrosine-Sulfated Proteins of the Retinal Pigment Epithelium	PLOS ONE			English	Article							MACULAR DEGENERATION; O-SULFATION; TYROSYLPROTEIN SULFOTRANSFERASE-2; P-SELECTIN; S-PROTEIN; BINDING; GENE; IDENTIFICATION; CELLS; SITE	Lack of tyrosine sulfation of ocular proteins results in disorganized photoreceptor structure and drastically reduced visual function, demonstrating the importance of this post-translational modification to vision. To understand the role that tyrosine sulfation plays in the function of ocular proteins, we identified some tyrosine-sulfated proteins in the retinal pigment epithelium using two independent methods, immuno-affinity column purification with an anti-sulfotyrosine specific antibody and computer-based sequence analysis of retinal pigment epithelium secretome by means of the prediction program Sulfinator. Radioactive labeling followed by thin layer electrophoresis revealed that three proteins, vitronectin, opticin, and complement factor H (CFH), were post-translationally modified by tyrosine sulfation. The identification of vitronectin and CFH as tyrosine-sulfated proteins is significant, since both are deposited in drusen in the eyes of patients with age-related macular degeneration (AMD). Furthermore, mutations in CFH have been determined to be a major risk factor in the development of AMD. Future studies that seek to understand the role of CFH in the development of AMD should take into account the role that tyrosine sulfation plays in the interaction of this protein with its partners, and examine whether modulating sulfation provides a potential therapeutic target.	[Kanan, Yogita; Siefert, Joseph C.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Kinter, Michael] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Kanan, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	ykanan@ouhsc.edu; muayyad-al-ubaidi@ouhsc.edu		Siefert, Joseph/0000-0001-5584-8672; Kinter, Michael/0000-0001-7409-8918	National Eye Institute; Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Foundation Fighting Blindness(European Commission)	This study was supported by the National Eye Institute to MRA, Oklahoma Center for the Advancement of Science and Technology to YK, and Foundation Fighting Blindness to MRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or any of its institutes.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; BAEUERLE PA, 1988, J BIOL CHEM, V263, P14925; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; BUDARF ML, 1982, J BIOL CHEM, V257, P128; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Choi Y, 2010, PROTEOMICS, V10, P72, DOI 10.1002/pmic.200900146; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HINTNER H, 1991, J INVEST DERMATOL, V96, P747, DOI 10.1111/1523-1747.ep12470980; HIROSE S, 1988, J BIOL CHEM, V263, P7426; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; HORTIN G, 1986, J BIOL CHEM, V261, P1786; HORTIN G, 1986, J BIOL CHEM, V261, P5827; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; JENNE D, 1989, EUR J BIOCHEM, V185, P391, DOI 10.1111/j.1432-1033.1989.tb15127.x; Kanan Y., 2014, J BIOL CHEM IN PRESS; Kanan Y, 2012, ADV EXP MED BIOL, V723, P835, DOI 10.1007/978-1-4614-0631-0_107; Kanan Y, 2010, J NEUROCHEM, V113, P477, DOI 10.1111/j.1471-4159.2010.06609.x; Kanan Y, 2009, EXP EYE RES, V89, P559, DOI 10.1016/j.exer.2009.05.010; Karagianni N, 2010, ADV EXP MED BIOL, V703, P1, DOI 10.1007/978-1-4419-5635-4_1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KRAJEWSKI T, 1968, ACTA CHEM SCAND, V22, P1339, DOI 10.3891/acta.chem.scand.22-1339; Le Goff MM, 2012, J BIOL CHEM, V287, P28027, DOI 10.1074/jbc.M111.331157; Le Goff MM, 2012, INVEST OPHTH VIS SCI, V53, P228, DOI 10.1167/iovs.11-8514; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; Liu ZJ, 2011, ACTA PHARMACOL SIN, V32, P1038, DOI 10.1038/aps.2011.53; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Ma J, 2012, CYTOKINE, V59, P100, DOI 10.1016/j.cyto.2012.03.025; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; Morse E E, 1971, Ann Clin Lab Sci, V1, P155; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Nicholas HB, 1999, ENDOCRINE, V11, P285, DOI 10.1385/ENDO:11:3:285; Nishimura Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001174; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; Pauleikhoff D, 1992, Ophthalmologe, V89, P39; Pechtl IC, 2011, J BIOL CHEM, V286, P11082, DOI 10.1074/jbc.M110.211839; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; Perkins SJ, 2010, BIOCHEM SOC T, V38, P894, DOI 10.1042/BST0380894; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; POHL WR, 1991, AM REV RESPIR DIS, V143, P1369, DOI 10.1164/ajrccm/143.6.1369; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Rodgers SD, 2001, BIOPHYS J, V81, P2001, DOI 10.1016/S0006-3495(01)75850-X; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanders EJ, 2003, INVEST OPHTH VIS SCI, V44, P5404, DOI 10.1167/iovs.03-0500; Schmidt C, 2008, REV ECON POLIT, V118, P3; SCHWAEBLE W, 1987, EUR J IMMUNOL, V17, P1485, DOI 10.1002/eji.1830171015; Seger D, 2000, FEBS LETT, V480, P169, DOI 10.1016/S0014-5793(00)01917-7; Sherry DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039702; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Sparrow JR, 2012, MOL ASPECTS MED, V33, P436, DOI 10.1016/j.mam.2012.03.007; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; Wasmuth S, 2009, INVEST OPHTH VIS SCI, V50, P5304, DOI 10.1167/iovs.08-3326; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Wyatt MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068088; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	82	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105409	10.1371/journal.pone.0105409	http://dx.doi.org/10.1371/journal.pone.0105409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136834	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100091
J	Monk, A; Charlton-Robb, K; Buddhadasa, S; Thompson, RM				Monk, Alissa; Charlton-Robb, Kate; Buddhadasa, Saman; Thompson, Ross M.			Comparison of Mercury Contamination in Live and Dead Dolphins from a Newly Described Species, Tursiops australis	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MARINE MAMMALS; HEAVY-METALS; STRIPED DOLPHINS; SMALL CETACEANS; COAST; ORGANOCHLORINES; BIOMAGNIFICATION; METHYLMERCURY; SEALS	Globally it is estimated that up to 37% of all marine mammals are at a risk of extinction, due in particular to human impacts, including coastal pollution. Dolphins are known to be at risk from anthropogenic contaminants due to their longevity and high trophic position. While it is known that beach-cast animals are often high in contaminants, it has not been possible to determine whether levels may also be high in live animals from the same populations. In this paper we quantitatively assess mercury contamination in the two main populations of a newly described dolphin species from south eastern Australia, Tursiops australis. This species appear to be limited to coastal waters in close proximity to a major urban centre, and as such is likely to be vulnerable to anthropogenic pollution. For the first time, we were able to compare blubber mercury concentrations from biopsy samples of live individuals and necropsies of beach-cast animals and show that beach-cast animals were highly contaminated with mercury, at almost three times the levels found in live animals. Levels in live animals were also high, and are attributable to chronic low dose exposure to mercury from the dolphin's diet. Measurable levels of mercury were found in a number of important prey fish species. This illustrates the potential for low dose toxins in the environment to pass through marine food webs and potentially contribute to marine mammal deaths. This study demonstrates the potential use of blubber from biopsy samples to make inferences about the health of dolphins exposed to mercury.	[Monk, Alissa; Thompson, Ross M.] Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia; [Monk, Alissa; Charlton-Robb, Kate; Thompson, Ross M.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Monk, Alissa] Dolphin Res Inst, Hastings, Vic, Australia; [Charlton-Robb, Kate] Australian Marine Mammal Conservat Fdn, Hampton East, VA, Australia; [Buddhadasa, Saman] Commonwealth Govt, Natl Measurement Inst, Port Melbourne, Vic, Australia	University of Canberra; Monash University; National Measurement Institute Australia - NMI	Monk, A (corresponding author), Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia.	alissa.monk@canberra.edu.au	Thompson, Ross/D-7996-2013	Thompson, Ross/0000-0002-5287-2455; Robb, Kate/0000-0002-7038-3612	West Gippsland Catchment Management Authority; Gippsland Lakes Task Force and Coast Action/Coastcare; ARC Future Fellowship [FT110100957]	West Gippsland Catchment Management Authority; Gippsland Lakes Task Force and Coast Action/Coastcare; ARC Future Fellowship(Australian Research Council)	Funded by contributions from the West Gippsland Catchment Management Authority (http://www.wgcma.vic.gov.au/), Gippsland Lakes Task Force and Coast Action/Coastcare (http://www.coastcare.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ross Thompson was funded in part by an ARC Future Fellowship (FT110100957).	Atwell L, 1998, CAN J FISH AQUAT SCI, V55, P1114, DOI 10.1139/cjfas-55-5-1114; Augier H, 1993, MARINE POLLUTION B, V26, P598; Basu N, 2006, J TOXICOL ENV HEAL A, V69, P1133, DOI 10.1080/15287390500362394; Basu N, 2009, ENVIRON TOXICOL CHEM, V28, P133, DOI 10.1897/08-251.1; Beck KM, 1997, MAR POLLUT BULL, V34, P734, DOI 10.1016/S0025-326X(97)00071-4; Becker P.R., 2000, MAR FISH REV, V62, P81; Bennett PM, 2001, ENVIRON POLLUT, V112, P33, DOI 10.1016/S0269-7491(00)00105-6; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Burke L., 2001, PILOT ANAL GLOBAL EC; Cardellicchio N, 2000, MAR ENVIRON RES, V49, P55, DOI 10.1016/S0141-1136(99)00048-3; Charlton Kate, 2006, Journal of Cetacean Research and Management, V8, P173; Charlton-Robb K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024047; Chen M-H, 2002, MARINE POLLUTION B, V45, P1; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; Das K, 2003, N P TOX ENV, P135; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Fabris G, 1999, MAR POLLUT BULL, V38, P970, DOI 10.1016/S0025-326X(99)00112-5; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; IUCN, 2013, IUCN RED LIST THREAT; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Lavery TJ, 2008, SCI TOTAL ENVIRON, V390, P77, DOI 10.1016/j.scitotenv.2007.09.016; Law RJ, 2003, MAR POLLUT BULL, V46, P1206, DOI 10.1016/S0025-326X(03)00220-0; Moeller LM, 2008, MOL PHYLOGENET EVOL, V49, P674, DOI 10.1016/j.ympev.2008.08.011; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; MUIR DCG, 1988, ARCH ENVIRON CON TOX, V17, P613, DOI 10.1007/BF01055830; OLSSON M, 1994, SCI TOTAL ENVIRON, V154, P217, DOI 10.1016/0048-9697(94)90089-2; Owen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016457; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Piotrowski JK, 1980, 20 U COLL LOND MON A; Pulster EL, 2005, ENVIRON TOXICOL CHEM, V24, P3128, DOI 10.1897/05-156R.1; Roditi-Elasar M, 2003, MAR POLLUT BULL, V46, P503, DOI 10.1016/S0025-326X(03)00003-1; RONALD K, 1977, Science of the Total Environment, V8, P1, DOI 10.1016/0048-9697(77)90057-2; Ruelas JR, 2000, MAR POLLUT BULL, V40, P1063, DOI 10.1016/S0025-326X(00)00162-4; Stavros HCW, 2011, CHEMOSPHERE, V82, P1649, DOI 10.1016/j.chemosphere.2010.11.019; Stockin KA, 2007, SCI TOTAL ENVIRON, V387, P333, DOI 10.1016/j.scitotenv.2007.05.016; Wagemann R, 1998, SCI TOTAL ENVIRON, V218, P19, DOI 10.1016/S0048-9697(98)00192-2; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	37	11	11	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104887	10.1371/journal.pone.0104887	http://dx.doi.org/10.1371/journal.pone.0104887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137255	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100052
J	Rifat, M; Milton, AH; Hall, J; Oldmeadow, C; Islam, MA; Husain, A; Akhanda, MW; Siddiquea, BN				Rifat, Mahfuza; Milton, Abul Hasnat; Hall, John; Oldmeadow, Christopher; Islam, Md. Akramul; Husain, Ashaque; Akhanda, Md. Wahiduzzaman; Siddiquea, Bodrun Naher			Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors	PLOS ONE			English	Article							DRUG-RESISTANCE; PREVALENCE; PAKISTAN	Objective: To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh. Methods: This case-control study was set in central, district and sub-district level hospitals of rural and urban Bangladesh. Included were 250 multidrug resistant tuberculosis (MDR-TB) patients as cases and 750 drug susceptible tuberculosis patients as controls. We recruited cases from all three government hospitals treating MDR-TB in Bangladesh during the study period. Controls were selected randomly from those local treatment units that had referred the cases. Information was collected through face-to-face interviews and record reviews. Unadjusted and multivariable logistic regression were used to analyse the data. Results: Previous treatment history was shown to be the major contributing factor to MDR-TB in univariate analysis. After adjusting for other factors in multivariable analysis, age group "18-25'' (OR 1.77, CI 1.07-2.93) and "26-45'' (OR 1.72, CI 1.12-2.66), some level of education (OR 1.94, CI 1.32-2.85), service and business as occupation (OR 2.88, CI 1.29-6.44; OR 3.71, CI 1.59-8.66, respectively), smoking history (OR 1.58, CI 0.99-2.5), and type 2 diabetes (OR 2.56 CI 1.51-4.34) were associated with MDR-TB. Previous treatment was not included in the multivariable analysis as it was correlated with multiple predictors. Conclusion: Previous tuberculosis treatment was found to be the major risk factor for MDR-TB. This study also identified age 18 to 45 years, some education up to secondary level, service and business as occupation, past smoking status, and type 2 diabetes as comorbid illness as risk factors. National Tuberculosis programme should address these risk factors in MDR-TB control strategy. The integration of MDR-TB control activities with diabetes and tobacco control programmes is needed in Bangladesh.	[Rifat, Mahfuza; Milton, Abul Hasnat; Hall, John; Oldmeadow, Christopher] Univ Newcastle, Newcastle, NSW 2300, Australia; [Rifat, Mahfuza; Islam, Md. Akramul; Siddiquea, Bodrun Naher] BRAC, Dhaka, Bangladesh; [Husain, Ashaque] Directorate Gen Hlth Serv, Natl TB Control Programme, Dhaka, Bangladesh; [Akhanda, Md. Wahiduzzaman] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh	University of Newcastle; Bangladesh Rural Advancement Committee BRAC	Rifat, M (corresponding author), Univ Newcastle, Newcastle, NSW 2300, Australia.	mahfuza.rifat@uon.edu.au		Hall, John/0000-0001-9839-5626; Oldmeadow, Christopher/0000-0001-6104-1322; Atun, Rifat/0000-0002-1531-5983	Australian Respiratory Council; University of Newcastle, Australia; BRAC Bangladesh	Australian Respiratory Council; University of Newcastle, Australia; BRAC Bangladesh	This research was supported by the Australian Respiratory Council, the University of Newcastle, Australia, and BRAC Bangladesh. The funders had no role in study design, data collection and analysis or decision to publish or preparation of manuscript.	Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2008, 4 WHO; [Anonymous], 2012, ANN REPORT; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Brewer TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025861; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Diande S, 2009, MICROB DRUG RESIST, V15, P217, DOI 10.1089/mdr.2009.0906; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Farmer P, 2001, INT J TUBERC LUNG D, V5, P885; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Flora M S, 2013, Bangladesh Med Res Counc Bull, V39, P34; Government of India, 2018, GUIDELINES CLIN OPER; Kim HR, 2011, J HOSP INFECT, V77, P134, DOI 10.1016/j.jhin.2010.07.004; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Magee MJ, 2013, INT J INFECT DIS, V17, pE404, DOI 10.1016/j.ijid.2012.12.029; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2012, BANGL DEM HLTH SURV; National TB Control Programme DGoHS Bangladesh, 2012, OP MAN MAN MULT TB M; National TB Control Programme DGoHS Bangladesh, 2013, 1 BANGL NAT TUB DRUG; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Siddiquea BN, 2013, PUBLIC HEALTH ACTION, V3, P243, DOI 10.5588/pha.13.0051; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2007, WHO UN MON TB TOB CO; World Health Organization, 2011, GLOB PLAN STOP TB TR; World Health Organization, 2011, WHO PROGRESS REPORT; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Zaman K, 2005, SCAND J INFECT DIS, V37, P21, DOI 10.1080/00365540410026095	36	41	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105214	10.1371/journal.pone.0105214	http://dx.doi.org/10.1371/journal.pone.0105214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136966	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100075
J	Sharma, M; Wilton, J; Senn, H; Fowler, S; Tan, DHS				Sharma, Malika; Wilton, James; Senn, Heather; Fowler, Shawn; Tan, Darrell H. S.			Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; COST-EFFECTIVENESS; LIMITED KNOWLEDGE; PREVENTION; INFECTION; MEN; PROVIDERS; ATTITUDES; SEX; WILLINGNESS	Recent evidence has demonstrated the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention, but concerns persist around its use. Little is known about Canadian physicians' knowledge of and willingness to prescribe PrEP. We disseminated an online survey to Canadian family, infectious disease, internal medicine, and public health physicians between September 2012-June 2013 to determine willingness to prescribe PrEP. Criteria for analysis were met by 86 surveys. 45.9% of participants felt "very familiar" with PrEP, 49.4% felt that PrEP should be approved by Health Canada, and 45.4% of respondents were willing to prescribe PrEP. Self-identifying as an HIV expert (odds ratio, OR=4.1, 95% confidence interval, CI=1.6-10.2), familiarity with PrEP (OR=5.0, 95%CI=1.3-19.0) and having been asked by patients about PrEP (OR=4.0, 95%CI=1.5-10.5) were positively associated with willingness to prescribe PrEP on univariable analysis. The latter two were the strongest predictors on multivariate analysis. Participants cited cost and efficacy as major concerns. 75.3% did not feel that information had been adequately disseminated among physicians. In summary, Canadian physicians demonstrate varying levels of support for PrEP and express concerns about its implementation. Further research on real-world effectiveness, continuing medical education, and clinical support is needed to prepare physicians for this prevention strategy.	[Sharma, Malika; Tan, Darrell H. S.] Univ Toronto, Div Infect Dis, Toronto, ON, Canada; [Wilton, James] Canadian AIDS Treatment Informat Exchange, Toronto, ON, Canada; [Senn, Heather; Tan, Darrell H. S.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Fowler, Shawn; Tan, Darrell H. S.] Hassle Free Clin, Toronto, ON, Canada; [Tan, Darrell H. S.] St Michaels Hosp, Div Infect Dis, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Tan, DHS (corresponding author), Univ Toronto, Div Infect Dis, 100 Coll St, Toronto, ON, Canada.	darrell.tan@gmail.com		Wilton, James/0000-0002-2295-7511; Sharma, Malika/0000-0002-3729-4554	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DHST is supported by a Randomized Controlled Trials Mentoring Grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2013, AV INT PROPH PREEXP; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen SE, 2014, TOP ANTIVIR MED, V22, P500; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Feinberg J, 2012, ANN INTERN MED, V157, P521, DOI 10.7326/0003-4819-157-7-201210020-00513; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Krakower D, 2012, ANN INTERN MED, V157, P490, DOI 10.7326/0003-4819-157-7-201210020-00510; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu A, 2013, 8 INT C HIV TREATM P; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mayer KH, 2014, TOP ANTIVIR MED, V22, P499; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Nair G, 2013, 20 C RETR OPP INF; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Senn H, 2013, AIDS RES HUM RETROV, V29, P1183, DOI [10.1089/aid.2013.0090, 10.1089/AID.2013.0090]; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Wood LV, 2012, ANN INTERN MED, V157, P519, DOI 10.7326/0003-4819-157-7-201210020-00511; Yoong DM, 2013, PREPARING PREP ASSES	38	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105283	10.1371/journal.pone.0105283	http://dx.doi.org/10.1371/journal.pone.0105283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133648	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700098
J	Chung, CJ; Chang, CH; Liu, CS; Huang, CP; Chang, YH; Chien, SN; Tsai, PH; Hsieh, HA				Chung, Chi-Jung; Chang, Chao-Hsiang; Liu, Chiu-Shong; Huang, Chi-Ping; Chang, Yi-Huei; Chien, Ssu-Ning; Tsai, Ping-Huan; Hsieh, Hui-An			Association of DNA Methyltransferases 3A and 3B Polymorphisms, and Plasma Folate Levels with the Risk of Urothelial Carcinoma	PLOS ONE			English	Article							DNMT3B PROMOTER POLYMORPHISMS; CANCER RISK; COLORECTAL-CANCER; BLADDER-CANCER; GASTRIC-CANCER; BREAST-CANCER; SERUM FOLATE; COLON-CANCER; POPULATION; METHYLATION	Background: Interindividual genetic variations of human DNA methyltransferases (DNMTs), which involve the methyl donor from the folate-related one-carbon metabolism pathway, are hypothesized as a risk factor for urothelial carcinoma (UC). Therefore, we evaluated the role of gene-environment interaction in UC carcinogenesis. Methods: A hospital-based case-control study was conducted by recruiting 192 patients with UC and 381 controls. Their plasma folate levels were measured using a competitive immunoassay kit. In addition, DNMT3A -448A>G and DNMT3B - -579G>T genotyping was evaluated using a polymerase chain reaction-restriction fragment length polymorphism technique. Multivariate logistic regression and 95% confidence intervals (CIs) were applied to estimate the UC risk. Results: We observed that patients with UC exhibited a higher prevalence rate of folate insufficiency (folate levels <= 6 ng/mL) compared with the controls (35.94% and 18.37%, respectively). Furthermore, folate levels were higher in the prevalent UC patients than in the incident UC patients. However, folate insufficiency was similarly associated with a nearly two-fold increase in the risk of UC regardless of the UC patient group. In addition, the frequencies of the variant alleles for DNMT3A and DNMT3B were 0.80 and 0.92, respectively, and no association was observed with UC risk. However, participants with a variant homozygous genotype of DNMT3B -579G>T and folate insufficiency or with high cumulative cigarette smoking exhibited an increased risk of UC. Conclusion: Overall, environmental factors may contribute more significantly to UC carcinogenesis compared with genetic susceptibility. Future studies should investigate other polymorphisms of DNMT3A and DNMT3B to determine genetic susceptibility.	[Chung, Chi-Jung; Chien, Ssu-Ning; Tsai, Ping-Huan; Hsieh, Hui-An] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chang, Chao-Hsiang; Huang, Chi-Ping; Chang, Yi-Huei] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan; [Chang, Chao-Hsiang; Liu, Chiu-Shong] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Liu, Chiu-Shong] China Med Univ, Dept Family Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chung, CJ (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan.	cjchung@mail.cmu.edu.tw	Chung, Chi-Jung/G-4755-2013		National Science Council of the ROC [NSC 100-2314-B-039-035, NSC 101-2314-B-039-025-MY3]; China Medical University Hospital [DMR-CS-001-100, DMR-100-163]; China Medical University [CMU101-N1-02]	National Science Council of the ROC(Ministry of Science and Technology, Taiwan); China Medical University Hospital; China Medical University(China Medical University)	This study was supported by grants from the National Science Council of the ROC (NSC 100-2314-B-039-035 and NSC 101-2314-B-039-025-MY3), the China Medical University Hospital (DMR-CS-001-100 and DMR-100-163), and China Medical University (CMU101-N1-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XY, 2013, ASIAN PAC J CANCER P, V14, P5713, DOI 10.7314/APJCP.2013.14.10.5713; Chang KP, 2008, ONCOL REP, V19, P217; Chen KJ, 2011, ASIA PAC J CLIN NUTR, V20, P275; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P1638, DOI 10.1016/j.scitotenv.2011.01.046; Chung CJ, 2010, CANCER CAUSE CONTROL, V21, P1605, DOI 10.1007/s10552-010-9589-3; Coppede F, 2013, HUM REPROD, V28, P545, DOI 10.1093/humrep/des376; Coppede F, 2012, CURR ALZHEIMER RES, V9, P550, DOI 10.2174/156720512800618062; Daraei A, 2011, J RES MED SCI, V16, P807; de Vogel S, 2013, INT J EPIDEMIOL, V42, P201, DOI 10.1093/ije/dys199; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Duncan TM, 2013, NUTRIENTS, V5, P2457, DOI 10.3390/nu5072457; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GORROD JW, 1974, JNCI-J NATL CANCER I, V52, P1421, DOI 10.1093/jnci/52.5.1421; He H, 2013, INT J FOOD SCI NUTR; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Khorshied MM, 2012, GENE, V511, P34, DOI 10.1016/j.gene.2012.09.024; Kile ML, 2008, NUTR REV, V66, P349, DOI 10.1111/j.1753-4887.2008.00043.x; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P1409, DOI 10.1158/1055-9965.EPI-05-0830; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Mostowska A, 2013, MOL BIOL REP, V40, P4893, DOI 10.1007/s11033-013-2589-0; Nazki FH, 2014, GENE, V533, P11, DOI 10.1016/j.gene.2013.09.063; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Ohnishi S, 2002, JPN J CANCER RES, V93, P736, DOI 10.1111/j.1349-7006.2002.tb01314.x; Pufulete M, 2005, BRIT J CANCER, V92, P838, DOI 10.1038/sj.bjc.6602439; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Saad AA, 2006, CANCER EPIDEM BIOMAR, V15, P740, DOI 10.1158/1055-9965.EPI-05-0813; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Strope SA, 2008, J UROLOGY, V180, P31, DOI 10.1016/j.juro.2008.03.045; Sun MY, 2012, GENET MOL RES, V11, P4330, DOI 10.4238/2012.September.26.1; Szczepanska M, 2013, EUR J OBSTET GYN R B, V166, P81, DOI 10.1016/j.ejogrb.2012.09.003; Tan W, 2005, CARCINOGENESIS, V26, P1430, DOI 10.1093/carcin/bgi090; Xu F, 2010, CURR MED CHEM, V17, P4052, DOI 10.2174/092986710793205372; Yang XX, 2012, INT J MOL SCI, V13, P8364, DOI 10.3390/ijms13078364; Zhang SL, 2009, J HUAZHONG U SCI-MED, V29, P215, DOI 10.1007/s11596-009-0216-z; Zheng Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074626	42	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104968	10.1371/journal.pone.0104968	http://dx.doi.org/10.1371/journal.pone.0104968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126948	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300065
J	Diaz, A; Zarouri, B; Fergany, M; Eduardo, I; Alvarez, JM; Pico, B; Monforte, AJ				Diaz, Aurora; Zarouri, Belkacem; Fergany, Mohamed; Eduardo, Iban; Alvarez, Jose M.; Pico, Belen; Monforte, Antonio J.			Mapping and Introgression of QTL Involved in Fruit Shape Transgressive Segregation into 'Piel de Sapo' Melon (Cucucumis melo L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CUCUMIS-SATIVUS L.; RECOMBINANT INBRED LINES; TOMATO SUGAR CONTENT; NEAR-ISOGENIC LINES; FLOWERING-TIME; PHOTOPERIOD SENSITIVITY; ETHYLENE BIOSYNTHESIS; GENOMIC LIBRARY; GENETIC-CONTROL	A mapping F-2 population from the cross 'Piel de Sapo' x PI124112 was selectively genotyped to study the genetic control of morphological fruit traits by QTL (Quantitative Trait Loci) analysis. Ten QTL were identified, five for FL (Fruit Length), two for FD (Fruit Diameter) and three for FS (Fruit Shape). At least one robust QTL per character was found, flqs8.1 (LOD = 16.85, R-2 = 34%), fdqs12.1 (LOD = 3.47, R-2 = 11%) and fsqs8.1 (LOD = 14.85, R-2 = 41%). flqs2.1 and fsqs2.1 cosegregate with gene a (andromonoecious), responsible for flower sex determination and with pleiotropic effects on FS. They display a positive additive effect (a) value, so the PI124112 allele causes an increase in FL and FS, producing more elongated fruits. Conversely, the negative a value for flqs8.1 and fsqs8.1 indicates a decrease in FL and FS, what results in rounder fruits, even if PI124112 produces very elongated melons. This is explained by a significant epistatic interaction between fsqs2.1 and fsqs8.1, where the effects of the alleles at locus a are attenuated by the additive PI124112 allele at fsqs8.1. Roundest fruits are produced by homozygous for PI124112 at fsqs8.1 that do not carry any dominant A allele at locus a (PiPiaa). A significant interaction between fsqs8.1 and fsqs12.1 was also detected, with the alleles at fsqs12.1 producing more elongated fruits. fsqs8.1 seems to be allelic to QTL discovered in other populations where the exotic alleles produce elongated fruits. This model has been validated in assays with backcross lines along 3 years and ultimately obtaining a fsqs8.1-NIL (Near Isogenic Line) in 'Piel de Sapo' background which yields round melons.	[Diaz, Aurora; Monforte, Antonio J.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46071 Valencia, Spain; [Zarouri, Belkacem] Inst Madrileno Invest & Desarrollo Rural Agr & Al, Dept Invest Agroalimentaria, Mol Biol Lab, Madrid, Spain; [Fergany, Mohamed; Eduardo, Iban] IRTA CSIC UAB, Ctr Recerca Agrigenom CRAG, Barcelona, Spain; [Alvarez, Jose M.] Ctr Invest & Tecnol Agroalimentaria Aragon CITA, Zaragoza, Spain; [Pico, Belen] Univ Politecn Valencia, Inst Conservat & Breeding Agr Biodivers, COMAV UPV, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Universitat Politecnica de Valencia	Diaz, A (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46071 Valencia, Spain.	audiaber@ibmcp.upv.es; amonforte@ibmcp.upv.es	Bermúdez, Aurora Díaz/AFB-9080-2022; MONFORTE, Antonio José/B-4784-2009; Eduardo, Iban/J-9383-2015; PICO, BELEN/K-6517-2014; Díaz, Aurora/AGY-7093-2022	MONFORTE, Antonio José/0000-0003-3461-3094; Eduardo, Iban/0000-0002-9963-2934; PICO, BELEN/0000-0001-7761-990X; Díaz, Aurora/0000-0001-7297-1699; Zarouri, Belkacem/0000-0002-4816-2266	Spanish Ministry of Economy and Competitiveness [AGL2009-12698-C02-02, AGL2012-40130-C02-02]; CSIC; GRAG; Spanish Ministry of Education; Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); CSIC; GRAG; Spanish Ministry of Education(Spanish Government); Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain	This work was supported by grants AGL2009-12698-C02-02 and AGL2012-40130-C02-02 from the Spanish Ministry of Economy and Competitiveness to AJM. AD was supported by a JAE-Doc contract from CSIC, MF by a Postdoctoral contract from GRAG, IE by a fellowship from the former Spanish Ministry of Education and BZ by a fellowship from Instituto Agronomico Mediterraneo de Zaragoza (IAMZ), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chen KY, 2004, GENETICS, V168, P1563, DOI 10.1534/genetics.103.022558; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Dhillon N. P. S., 2012, Plant Breeding Reviews, V35, P85; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eduardo I, 2005, THEOR APPL GENET, V112, P139, DOI 10.1007/s00122-005-0116-y; Eduardo I, 2007, J AM SOC HORTIC SCI, V132, P80, DOI 10.21273/JASHS.132.1.80; Essafi A, 2009, THEOR APPL GENET, V118, P275, DOI 10.1007/s00122-008-0897-x; Esteras C, 2013, THEOR APPL GENET, V126, P1285, DOI 10.1007/s00122-013-2053-5; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Ferguson AR, 1999, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.1999.498.4; Fernandez-Silva I, 2009, J HERED, V100, P229, DOI 10.1093/jhered/esn075; Fernandez-Silva I, 2010, THEOR APPL GENET, V121, P931, DOI 10.1007/s00122-010-1361-2; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; KENIGSBUCH D, 1990, GENOME, V33, P317, DOI 10.1139/g90-049; Khavkin E, 1997, THEOR APPL GENET, V95, P343, DOI 10.1007/s001220050569; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li DW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-396; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Monforte AJ, 2005, EUPHYTICA, V144, P31, DOI 10.1007/s10681-005-0201-y; Monforte AJ, 2004, THEOR APPL GENET, V108, P750, DOI 10.1007/s00122-003-1483-x; Monforte AJ, 2014, J EXP BOT; Noguera FJ, 2005, THEOR APPL GENET, V110, P714, DOI 10.1007/s00122-004-1897-0; Paris MK, 2008, MOL BREEDING, V22, P405, DOI 10.1007/s11032-008-9185-3; Perin C, 2002, MOL GENET GENOMICS, V266, P933, DOI 10.1007/s00438-001-0612-y; Pitrat Michel, 2008, V1, P283; Roy A, 2012, GENET RESOUR CROP EV, V59, P755, DOI 10.1007/s10722-011-9716-3; SALVI S, 2007, GENOMICS ASSISTED CR, V1, P207; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Stepansky A, 1999, PLANT SYST EVOL, V217, P313, DOI 10.1007/BF00984373; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tomason Y, 2013, MOL BREEDING, V31, P829, DOI 10.1007/s11032-013-9837-9; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; van der Knaap E, 2002, THEOR APPL GENET, V104, P241, DOI 10.1007/s00122-001-0776-1; Vegas J, 2013, THEOR APPL GENET, V126, P1531, DOI 10.1007/s00122-013-2071-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yuan XJ, 2008, EUPHYTICA, V164, P473, DOI 10.1007/s10681-008-9722-5; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	63	34	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104188	10.1371/journal.pone.0104188	http://dx.doi.org/10.1371/journal.pone.0104188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126852	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000340879300016
J	Huang, Y; Mao, Y; Buczek-Thomas, JA; Nugent, MA; Zaia, J				Huang, Yu; Mao, Yang; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Zaia, Joseph			Oligosaccharide Substrate Preferences of Human Extracellular Sulfatase Sulf2 Using Liquid Chromatography-Mass Spectrometry Based Glycomics Approaches	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; UP-REGULATES GLYPICAN-3; HEPARAN-SULFATE; CELL-SURFACE; 6-O-ENDOSULFATASES SULF1; SIGNALING PATHWAYS; DECREASES SURVIVAL; PROTEOGLYCANS; BINDING; ENDOSULFATASE	Sulfs are extracellular endosulfatases that selectively remove the 6-O-sulfate groups from cell surface heparan sulfate (HS) chain. By altering the sulfation at these particular sites, Sulfs function to remodel HS chains. As a result of the remodeling activity, HSulf2 regulates a multitude of cell-signaling events that depend on interactions between proteins and HS. Previous efforts to characterize the substrate specificity of human Sulfs (HSulfs) focused on the analysis of HS disaccharides and synthetic repeating units. In this study, we characterized the substrate preferences of human HSulf2 using HS oligosaccharides with various lengths and sulfation degrees from several naturally occurring HS sources by applying liquid chromatography mass spectrometry based glycomics methods. The results showed that HSulf2 preferentially digests highly sulfated HS oligosaccharides with zero acetyl groups and this preference is length dependent. In terms of length of oligosaccharides, HSulf2 digestion induced more sulfation decrease on DP6 (DP: degree of polymerization) compared to DP2, DP4 and DP8. In addition, the HSulf2 preferentially digests the oligosaccharide domain located at the non-reducing end (NRE) of the HS and heparin chain. In addition, the HSulf2 digestion products were altered only for specific isomers. HSulf2 treated NRE oligosaccharides also showed greater decrease in cell proliferation than those from internal domains of the HS chain. After further chromatographic separation, we identified the three most preferred unsaturated hexasaccharide for HSulf2.	[Huang, Yu; Mao, Yang; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Mao, Yang/0000-0002-9674-1158	NIH [P41GN104603, R01HL098950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL131554, R01HL098950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grants P41GN104603 and R01HL098950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Alaoui HL, 2009, J THORAC ONCOL, V4, pS557; Alhasan SF, 2012, GUT, V61, pA111, DOI 10.1136/gutjnl-2012-302514b.94; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buresh-Stiemke RA, 2012, DEV DYNAM, V241, P2005, DOI 10.1002/dvdy.23886; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Fujita K, 2010, MECH DEVELOP, V127, P235, DOI 10.1016/j.mod.2009.12.001; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gill RBS, 2011, BIOCHEM BIOPH RES CO, V414, P468, DOI 10.1016/j.bbrc.2011.09.088; Guiral EC, 2010, DEV BIOL, V341, P375, DOI 10.1016/j.ydbio.2010.02.034; Hayano S, 2012, J BIOL CHEM, V287, P12217, DOI 10.1074/jbc.M111.332924; Higginson JR, 2012, J NEUROSCI, V32, P15902, DOI 10.1523/JNEUROSCI.6340-11.2012; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Huang Y, 2011, ANAL CHEM, V83, P8222, DOI 10.1021/ac201964n; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; KRAEMER PM, 1970, J CELL BIOL, V47, pA110; Lai JP, 2008, GASTROENTEROLOGY, V134, pA762; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; LINDAHL U, 1977, UPSALA J MED SCI, V82, P78, DOI 10.3109/03009737709179069; Nagamine S, 2012, J BIOL CHEM, V287, P9579, DOI 10.1074/jbc.M111.290262; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Naimy H, 2010, GLYCOBIOLOGY, V20, P1472; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107; Pempe EH, 2012, GLYCOBIOLOGY, V22, P1353, DOI 10.1093/glycob/cws092; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Staples GO, 2010, ANAL CHEM, V82, P516, DOI 10.1021/ac901706f; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wittstock U, 2000, IUBMB LIFE, V49, P71, DOI 10.1080/152165400306395; Yang JD, 2011, GENE CHROMOSOME CANC, V50, P122, DOI 10.1002/gcc.20838; Zhao W, 2007, FEBS LETT, V581, P4960, DOI 10.1016/j.febslet.2007.09.033	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105143	10.1371/journal.pone.0105143	http://dx.doi.org/10.1371/journal.pone.0105143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127119	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300083
J	Reale, M; Kamal, MA; Patruno, A; Costantini, E; D'Angelo, C; Pesce, M; Greig, NH				Reale, Marcella; Kamal, Mohammad A.; Patruno, Antonia; Costantini, Erica; D'Angelo, Chiara; Pesce, Miko; Greig, Nigel H.			Neuronal Cellular Responses to Extremely Low Frequency Electromagnetic Field Exposure: Implications Regarding Oxidative Stress and Neurodegeneration	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AMYOTROPHIC-LATERAL-SCLEROSIS; REMITTING MULTIPLE-SCLEROSIS; PRO-INFLAMMATORY CYTOKINES; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; NEUROBLASTOMA-CELLS; PARKINSONS-DISEASE; LEARN MODEL; NEUROGENESIS	Neurodegenerative diseases comprise both hereditary and sporadic conditions characterized by an identifying progressive nervous system dysfunction and distinctive neuopathophysiology. The majority are of non-familial etiology and hence environmental factors and lifestyle play key roles in their pathogenesis. The extensive use of and ever increasing worldwide demand for electricity has stimulated societal and scientific interest on the environmental exposure to low frequency electromagnetic fields (EMFs) on human health. Epidemiological studies suggest a positive association between 50/60-Hz power transmission fields and leukemia or lymphoma development. Consequent to the association between EMFs and induction of oxidative stress, concerns relating to development of neurodegenerative diseases, such as Alzheimer disease (AD), have been voiced as the brain consumes the greatest fraction of oxygen and is particularly vulnerable to oxidative stress. Exposure to extremely low frequency (ELF)-EMFs are reported to alter animal behavior and modulate biological variables, including gene expression, regulation of cell survival, promotion of cellular differentiation, and changes in cerebral blood flow in aged AD transgenic mice. Alterations in inflammatory responses have also been reported, but how these actions impact human health remains unknown. We hence evaluated the effects of an electromagnetic wave (magnetic field intensity 1mT; frequency, 50-Hz) on a well-characterized immortalized neuronal cell model, human SH-SY5Y cells. ELF-EMF exposure elevated the expession of NOS and O-2(-), which were countered by compensatory changes in antioxidant catylase (CAT) activity and enzymatic kinetic parameters related to CYP-450 and CAT activity. Actions of ELF-EMFs on cytokine gene expression were additionally evaluated and found rapidly modified. Confronted with co-exposure to H2O2-induced oxidative stress, ELF-EMF proved not as well counteracted and resulted in a decline in CAT activity and a rise in O-2(-) levels. Together these studies support the further evaluation of ELF-EMF exposure in cellular and in vivo preclinical models to define mechanisms potentially impacted in humans.	[Reale, Marcella; Costantini, Erica; D'Angelo, Chiara] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Kamal, Mohammad A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Patruno, Antonia; Pesce, Miko] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA	G d'Annunzio University of Chieti-Pescara; King Abdulaziz University; G d'Annunzio University of Chieti-Pescara; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Reale, M (corresponding author), Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy.	mreale@unich.it; greign@grc.nia.nih.gov	Costantini, erica/AAD-9167-2020; Kamal, Mohammad Amjad/J-2918-2014; D'Angelo, Chiara/AAH-5200-2019; Reale, Marcella/G-4299-2013; Patruno, Alessandro/T-6621-2019	Costantini, erica/0000-0003-2175-4226; Kamal, Mohammad Amjad/0000-0003-0088-0565; D'Angelo, Chiara/0000-0002-1477-0706; Reale, Marcella/0000-0002-4164-8781; Pesce, Mirko/0000-0001-8836-2564; Patruno, Alessandro/0000-0002-6459-0674	Italian MIUR; King Fahd Medical Research Center, King Abdulaziz University; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Italian MIUR(Ministry of Education, Universities and Research (MIUR)); King Fahd Medical Research Center, King Abdulaziz University; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Italian MIUR to M. R. and A. P., the King Fahd Medical Research Center, King Abdulaziz University for M. A. K., and the Intramural Research Program, National Institute on Aging, National Institutes of Health for N. H. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHOD ENZYMAT AN, P673; Antonini RA, 2006, TOXICOL LETT, V164, P268, DOI 10.1016/j.toxlet.2006.01.006; Arendash GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035751; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Azizi G, 2014, AM J ALZHEIMERS DIS; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Becker RE, 2014, NAT REV DRUG DISCOV, V13, P157, DOI 10.1038/nrd3842-c2; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Bonda DJ, 2011, CURR ALZHEIMER RES, V8, P639; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Bossu P, 2010, CURR PHARM DESIGN, V16, P4213, DOI 10.2174/138161210794519147; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Consales C., 2012, INT J CELL BIOL, V2012; Del Vecchio G, 2009, BIOELECTROMAGNETICS, V30, P564, DOI 10.1002/bem.20507; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Eleuteri AM, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/834239; Falone S, 2007, INT J BIOCHEM CELL B, V39, P2093, DOI 10.1016/j.biocel.2007.06.001; Feychting M, 2005, ANNU REV PUBL HEALTH, V26, P165, DOI 10.1146/annurev.publhealth.26.021304.144445; Ortiz GG, 2009, DIS MARKERS, V26, P35, DOI [10.1155/2009/325847, 10.3233/DMA-2009-0602]; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; International Programme On Chemical Safety, 1984, ENV HLTH CRI; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2007, CURR ALZHEIMER RES, V4, P219, DOI 10.2174/156720507780362164; Lisi A, 2006, BIOELECTROMAGNETICS, V27, P641, DOI 10.1002/bem.20255; Luukkonen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018021; Martinez-Samano J, 2012, ARCH MED RES, V43, P183, DOI 10.1016/j.arcmed.2012.04.003; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Moreno-Gonzalez I, 2012, CURR PHARM DESIGN, V18, P1148, DOI 10.2174/138161212799315768; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P657, DOI 10.1038/nrd3842; Patruno A, 2011, CNS NEUROL DISORD-DR, V10, P936, DOI 10.2174/187152711799219325; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Reale M, 2012, CURR ALZHEIMER RES, V9, P447, DOI 10.2174/156720512800492549; Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Reale M, 2006, NITRIC OXIDE-BIOL CH, V15, P50, DOI 10.1016/j.niox.2005.11.010; Reale M, 2012, INT J MOL SCI, V13, P12656, DOI 10.3390/ijms131012656; Ren RF, 1997, MOL BRAIN RES, V48, P315, DOI 10.1016/S0169-328X(97)00108-3; Saracchi E, 2014, AGING DIS, V5, P27, DOI 10.14366/AD.2014.050027; Simko M, 2004, J CELL BIOCHEM, V93, P83, DOI 10.1002/jcb.20198; Sonnier H, 2003, NEUROSCI LETT, V337, P163, DOI 10.1016/S0304-3940(02)01329-0; Stefani IC, 2012, CURR ALZHEIMER RES, V9, P373; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Sunkari VG, 2011, ELECTROMAGN BIOL MED, V30, P80, DOI 10.3109/15368378.2011.566774; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Taskiran D, 2000, INT J NEUROSCI, V101, P65, DOI 10.3109/00207450008986493; Tasset I, 2012, NEUROSCIENCE, V209, P54, DOI 10.1016/j.neuroscience.2012.02.034; Tasset I, 2013, BRAIN STIMUL, V6, P84, DOI 10.1016/j.brs.2012.03.015; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tunez I, 2006, J NEUROCHEM, V97, P619, DOI 10.1111/j.1471-4159.2006.03724.x; Tunez I, 2009, REV NEUROLOGIA, V48, P430, DOI 10.33588/rn.4808.2008678; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Vaz AR, 2011, EXP NEUROL, V229, P381, DOI 10.1016/j.expneurol.2011.03.004; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; WHO, 2007, EX LOW FREQU FIELD, V35	69	53	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104973	10.1371/journal.pone.0104973	http://dx.doi.org/10.1371/journal.pone.0104973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127118	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300067
J	Tiano, L; Garcia-Robledo, E; Revsbech, NP				Tiano, Laura; Garcia-Robledo, Emilio; Revsbech, Niels Peter			A New Highly Sensitive Method to Assess Respiration Rates and Kinetics of Natural Planktonic Communities by Use of the Switchable Trace Oxygen Sensor and Reduced Oxygen Concentrations	PLOS ONE			English	Article							ELECTRON-TRANSPORT ACTIVITY; ATTACHED BACTERIA; MINIMUM ZONES; FECAL PELLETS; SOUTH-PACIFIC; WATER-COLUMN; CARBON-CYCLE; MARINE SNOW; LOW O-2; OCEAN	Oxygen respiration rates in pelagic environments are often difficult to quantify as the resolutions of our methods for O-2 concentration determination are marginal for observing significant decreases during bottle incubations of less than 24 hours. Here we present the assessment of a new highly sensitive method, that combine Switchable Trace Oxygen (STOX) sensors and all-glass bottle incubations, where the O-2 concentration was artificially lowered. The detection limit of respiration rate by this method is inversely proportional to the O-2 concentration, down to <2 nmol L-1 h(-1) for water with an initial O-2 concentration of 500 nmol L-1. The method was tested in Danish coastal waters and in oceanic hypoxic waters. It proved to give precise measurements also with low oxygen consumption rates (similar to 7 nmol L-1 h(-1)), and to significantly decrease the time required for incubations (<= 14 hours) compared to traditional methods. This method provides continuous real time measurements, allowing for a number of diverse possibilities, such as modeling the rate of oxygen decrease to obtain kinetic parameters. Our data revealed apparent half-saturation concentrations (K-m values) one order of magnitude lower than previously reported for marine bacteria, varying between 66 and 234 nmol L-1 O-2. Km values vary between different microbial planktonic communities, but our data show that it is possible to measure reliable respiration rates at concentrations similar to 0.5-1 mu mol L-1 O-2 that are comparable to the ones measured at full air saturation.	[Tiano, Laura; Garcia-Robledo, Emilio; Revsbech, Niels Peter] Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark	Aarhus University	Tiano, L (corresponding author), Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark.	tiano.laura@gmail.com	Revsbech, Niels P/I-8040-2013; Garcia-Robledo, Emilio/B-3781-2017	Garcia-Robledo, Emilio/0000-0002-4337-6433; Revsbech, Niels Peter/0000-0002-2193-262X	Danish Natural Science Research Council [10-083140]; European Research Council [267233]; Ramon Areces Foundation (Spain)	Danish Natural Science Research Council(Danish Natural Science Research Council); European Research Council(European Research Council (ERC)European Commission); Ramon Areces Foundation (Spain)	Financial support was given by the Danish Natural Science Research Council, grant no. 10-083140, and European Research Council, grant no. 267233. E. Garcia-Robledo was funded by Ramon Areces Foundation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Andersson JH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018756; Aristegui J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016227; ARISTEGUI J, 1995, J PLANKTON RES, V17, P1563, DOI 10.1093/plankt/17.7.1563; Aristegui Javier, 2005, P181; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Dalsgaard T, 2013, GEOCHIM COSMOCHIM AC, V106, P247, DOI 10.1016/j.gca.2012.12.038; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Nguyen D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007343; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; DEVOL AH, 1978, DEEP-SEA RES, V25, P137, DOI 10.1016/0146-6291(78)90001-2; DOWD JE, 1965, J BIOL CHEM, V240, P863; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Gattuso JP, 2002, J PLANKTON RES, V24, P1197, DOI 10.1093/plankt/24.11.1197; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; HARREMOES P, 1977, Vatten, V33, P122; HARRISON WG, 1986, POLAR BIOL, V6, P145, DOI 10.1007/BF00274877; Holtappels M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089369; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; JOHNSON MJ, 1967, J BACTERIOL, V94, P101, DOI 10.1128/JB.94.1.101-108.1967; Jorgensen B.B., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kirchman DL, 1997, NATURE, V385, P121, DOI 10.1038/385121a0; KOCH AL, 1990, ADV MICROB ECOL, V11, P37; KUZMA MM, 1993, PLANT PHYSIOL, V101, P161, DOI 10.1104/pp.101.1.161; Labasque T, 2004, MAR CHEM, V88, P53, DOI 10.1016/j.marchem.2004.03.004; Longmuir IS, 1949, OPTICAL CONFIGURATIO, V57, P81; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Maldonado F, 2012, J EXP MAR BIOL ECOL, V434, P110, DOI 10.1016/j.jembe.2012.08.010; Martinez-Garcia S, 2009, LIMNOL OCEANOGR-METH, V7, P459, DOI 10.4319/lom.2009.7.459; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Nielsen K, 2003, AMBIO, V32, P287, DOI 10.1639/0044-7447(2003)032[0287:ARCATT]2.0.CO;2; PACKARD TT, 1971, J MAR RES, V29, P235; Ploug H, 2001, LIMNOL OCEANOGR, V46, P1624, DOI 10.4319/lo.2001.46.7.1624; Ploug H, 2008, LIMNOL OCEANOGR, V53, P1878, DOI 10.4319/lo.2008.53.5.1878; POMEROY LR, 1994, APPL ENVIRON MICROB, V60, P328, DOI 10.1128/AEM.60.1.328-332.1994; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rice CW, 1978, CULTURE, V134, P115; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; Robinson C., 2008, MICROB ECOL OCEAN, p299, DOI DOI 10.1002/9780470281840.CH9; Sherr EB, 1999, AQUAT MICROB ECOL, V20, P213, DOI 10.3354/ame020213; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; Tarpgaard IH, 2011, GEOCHIM COSMOCHIM AC, V75, P2997, DOI 10.1016/j.gca.2011.03.028; Taylor GT, 1996, CAN J MICROBIOL, V42, P911, DOI 10.1139/m96-117; Tiano L, 2013, MICROBIAL RESP GENE, P200; Ulloa O, 2012, P NATL ACAD SCI; Williams P.J. le B., 1984, NATO Conference Series IV Marine Sciences, V15, P357; WILLIAMS PJ, 1973, LIMNOL OCEANOGR, V18, P159, DOI 10.4319/lo.1973.18.1.0159; Williams PJL, 1998, NATURE, V394, P55; WILLIAMS PJL, 1981, OCEANOL ACTA, V4, P359	63	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105399	10.1371/journal.pone.0105399	http://dx.doi.org/10.1371/journal.pone.0105399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127458	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300110
J	Capraro, V; Smyth, C; Mylona, K; Niblo, GA				Capraro, Valerio; Smyth, Conor; Mylona, Kalliopi; Niblo, Graham A.			Benevolent Characteristics Promote Cooperative Behaviour among Humans	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; DICTATOR GAMES; INDIRECT RECIPROCITY; PRISONERS-DILEMMA; SOCIAL DILEMMAS; ULTIMATUM GAMES; EVOLUTION; ALTRUISM; PUNISHMENT; PREFERENCES	Cooperation is fundamental to the evolution of human society. We regularly observe cooperative behaviour in everyday life and in controlled experiments with anonymous people, even though standard economic models predict that they should deviate from the collective interest and act so as to maximise their own individual payoff. However, there is typically heterogeneity across subjects: some may cooperate, while others may not. Since individual factors promoting cooperation could be used by institutions to indirectly prime cooperation, this heterogeneity raises the important question of who these cooperators are. We have conducted a series of experiments to study whether benevolence, defined as a unilateral act of paying a cost to increase the welfare of someone else beyond one's own, is related to cooperation in a subsequent one-shot anonymous Prisoner's dilemma. Contrary to the predictions of the widely used inequity aversion models, we find that benevolence does exist and a large majority of people behave this way. We also find benevolence to be correlated with cooperative behaviour. Finally, we show a causal link between benevolence and cooperation: priming people to think positively about benevolent behaviour makes them significantly more cooperative than priming them to think malevolently. Thus benevolent people exist and cooperate more.	[Capraro, Valerio; Smyth, Conor; Mylona, Kalliopi; Niblo, Graham A.] Univ Southampton, Dept Math Sci, Southampton, Hants, England	University of Southampton	Capraro, V (corresponding author), Univ Southampton, Dept Math Sci, Southampton, Hants, England.	V.Capraro@soton.ac.uk		MYLONA, KALLIOPI/0000-0002-1460-0715; Niblo, Graham/0000-0003-0648-7027	EPSRC (Engineering and Physical Sciences Research Council) [EP/I016945/1]; EPSRC [EP/I016945/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I016945/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The author CS has been supported by the EPSRC (Engineering and Physical Sciences Research Council), grant reference EP/I016945/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1989, J POLIT ECON, V97, P1447, DOI 10.1086/261662; Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barcelo H, 2014, GROUP SIZE EFFECT CO; Blanco M, 2011, GAME ECON BEHAV, V72, P321, DOI 10.1016/j.geb.2010.09.008; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Branas-Garza P, 2006, J ECON BEHAV ORGAN, V60, P306, DOI 10.1016/j.jebo.2004.10.005; Capraro V, 2014, DO GOOD ACTIONS INSP; Capraro V, 2014, COOPERATION INCREASE; Capraro V, 2013, LECT NOTES COMPUT SC, V8146, P146, DOI 10.1007/978-3-642-41392-6_13; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Crockett MJ, 2009, ANN NY ACAD SCI, V1167, P76, DOI 10.1111/j.1749-6632.2009.04506.x; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dreber A, 2014, J ECON BEHAV ORGAN, V98, P41, DOI 10.1016/j.jebo.2013.12.007; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Franzen A, 2013, EXP ECON, V16, P155, DOI 10.1007/s10683-012-9337-5; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miyaji K, 2013, CHAOS SOLITON FRACT, V56, P13, DOI 10.1016/j.chaos.2013.05.007; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Peysakhovich A., 2013, HABITS VIRTUE CREATI; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Rand DG, 2013, REFLECTION DOES NOT; Rand DG, NATURE COMM IN PRESS, V5, P3677; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Thaler S, 2012, IEEE INTERNET COMPUT, V16, P52, DOI 10.1109/MIC.2012.67; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764; Zelmer J., 2003, Experimental Economics, V6, P299, DOI 10.1023/A:1026277420119	58	39	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e102881	10.1371/journal.pone.0102881	http://dx.doi.org/10.1371/journal.pone.0102881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140707	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000342687200002
J	Gong, YH; Yu, XR; Shang, QL; Shi, XY; Gao, XW				Gong, You-Hui; Yu, Xin-Rui; Shang, Qing-Li; Shi, Xue-yan; Gao, Xi-Wu			Oral Delivery Mediated RNA Interference of a Carboxylesterase Gene Results in Reduced Resistance to Organophosphorus Insecticides in the Cotton Aphid, Aphis gossypii Glover	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MALATHION RESISTANCE; MOLECULAR-BASIS; ESTERASE GENES; PEA APHID; HOMOPTERA; AMPLIFICATION; EXPRESSION; STRAINS; DSRNA	Background: RNA interference (RNAi) is an effective tool to examine the function of individual genes. Carboxylesterases (CarE, EC 3.1.1.1) are known to play significant roles in the metabolism of xenobiotic compounds in many insect species. Previous studies in our laboratory found that CarE expression was up-regulated in Aphis gossypii (Glover) (Hemiptera: Aphididae) adults of both omethoate and malathion resistant strains, indicating the potential involvement of CarE in organophosphorus (OP) insecticide resistance. Functional analysis (RNAi) is therefore warranted to investigate the role of CarE in A. gossypii to OPs resistance. Result: CarE expression in omethoate resistant individuals of Aphis gossypii was dramatically suppressed following ingestion of dsRNA-CarE. The highest knockdown efficiency (33%) was observed at 72 h after feeding when dsRNA-CarE concentration was 100 ng/mL. The CarE activities from the CarE knockdown aphids were consistent with the correspondingly significant reduction in CarE expression. The CarE activity in the individuals of control aphids was concentrated in the range of 650-900 mOD/per/min, while in the individuals of dsRNA-CarE-fed aphids, the CarE activity was concentrated in the range of 500-800 mOD/per/min. In vitro inhibition experiments also demonstrated that total CarE activity in the CarE knockdown aphids decreased significantly as compared to control aphids. Bioassay results of aphids fed dsRNA-CarE indicated that suppression of CarE expression increased susceptibility to omethoate in individuals of the resistant aphid strains. Conclusion: The results of this study not only suggest that ingestion of dsRNA through artificial diet could be exploited for functional genomic studies in cotton aphids, but also indicate that CarE can be considered as a major target of organophosphorus insecticide (OPs) resistance in A. gossypii. Further, our results suggest that the CarE would be a propitious target for OPs resistant aphid control, and insect-resistant transgenic plants may be obtained through plant RNAi-mediated silencing of insect CarE expression.	[Gong, You-Hui; Yu, Xin-Rui; Shi, Xue-yan; Gao, Xi-Wu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Shang, Qing-Li] Jilin Univ, Coll Plant Sci & Technol, Changchun 130023, Peoples R China	China Agricultural University; Jilin University	Shi, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	shixueyan@cau.edu.cn; gaoxiwu@263.net.cn			National Basic Research and Development Program of China [2012CB114103]; National Natural Science Foundation of China [31330064, 30871661]	National Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research and Development Program of China (Contract No. 2012CB114103) (http://program.most.gov.cn/) and the National Natural Science Foundation of China (31330064 and 30871661) (http://isisn.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; de Carvalho RA, 2006, VET PARASITOL, V140, P344, DOI 10.1016/j.vetpar.2006.04.010; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bizzaro D, 2005, PESTIC BIOCHEM PHYS, V81, P51, DOI 10.1016/j.pestbp.2004.09.005; BLACKMAN R.L., 1984, ORIENT INSECTS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao CW, 2008, INSECT SCI, V15, P209, DOI 10.1111/j.1744-7917.2008.00202.x; Cao CW, 2008, PESTIC BIOCHEM PHYS, V90, P175, DOI 10.1016/j.pestbp.2007.11.004; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Cui F, 2007, FASEB J, V21, P3584, DOI 10.1096/fj.07-8237com; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; DEVONSHIRE AL, 1991, ANNU REV ENTOMOL, V36, P1, DOI 10.1146/annurev.en.36.010191.000245; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heidari R, 2004, INSECT BIOCHEM MOLEC, V34, P353, DOI 10.1016/j.ibmb.2004.01.001; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karunaratne SHPP, 1995, J BIOL CHEM, V270, P31124, DOI 10.1074/jbc.270.52.31124; Karunaratne SHPP, 1994, THESIS U LONDON; Liu YY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-236; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; OBRIEN PJ, 1992, J ECON ENTOMOL, V85, P651, DOI 10.1093/jee/85.3.651; Owusu EO, 1996, J ECON ENTOMOL, V89, P302, DOI 10.1093/jee/89.2.302; Pan YO, 2009, COMP BIOCHEM PHYS B, V152, P266, DOI 10.1016/j.cbpb.2008.12.002; Paton MG, 2000, BIOCHEM J, V346, P17, DOI 10.1042/0264-6021:3460017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; SAITO T, 1993, APPL ENTOMOL ZOOL, V28, P263, DOI 10.1303/aez.28.263; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; Sun LJ, 2005, J ECON ENTOMOL, V98, P1325, DOI 10.1603/0022-0493-98.4.1325; SUN YQ, 1987, ACTA ENTOMOL SINICA, V30, P13; Suzuki K, 1998, APPL ENTOMOL ZOOL, V33, P11, DOI 10.1303/aez.33.11; SUZUKI K, 1993, APPL ENTOMOL ZOOL, V28, P439, DOI 10.1303/aez.28.439; TAKADA H, 1988, ENTOMOL EXP APPL, V48, P37, DOI 10.1007/BF00343382; Taskin V, 2004, RUSS J GENET+, V40, P1215, DOI 10.1023/B:RUGE.0000048663.17417.97; Taskin V, 2004, RUSS J GENET+, V40, P377, DOI 10.1023/B:RUGE.0000024974.58424.f9; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas JG, 2000, INSECT MOL BIOL, V9, P655, DOI 10.1046/j.1365-2583.2000.00228.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Young SJ, 2005, PEST MANAG SCI, V61, P397, DOI 10.1002/ps.996; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang JZ, 2011, PEST MANAG SCI, V67, P183, DOI 10.1002/ps.2049	64	80	86	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e102823	10.1371/journal.pone.0102823	http://dx.doi.org/10.1371/journal.pone.0102823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140535	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200001
J	Novotna, A; Dvorak, Z				Novotna, Aneta; Dvorak, Zdenek			Omeprazole and Lansoprazole Enantiomers Induce CYP3A4 in Human Hepatocytes and Cell Lines via Glucocorticoid Receptor and Pregnane X Receptor Axis	PLOS ONE			English	Article							PROTON PUMP INHIBITOR; EXPRESSION; PHARMACOKINETICS; ESOMEPRAZOLE; ARTICLE; ENZYMES; ISOMER	Benzimidazole drugs lansoprazole and omeprazole are used for treatment of various gastrointestinal pathologies. Both compounds cause drug-drug interactions because they activate aryl hydrocarbon receptor and induce CYP1A genes. In the current paper, we examined the effects of lansoprazole and omeprazole enantiomers on the expression of key drug-metabolizing enzyme CYP3A4 in human hepatocytes and human cancer cell lines. Lansoprazole enantiomers, but not omeprazole, were equipotent inducers of CYP3A4 mRNA in HepG2 cells. All forms (S-, R-, rac-) of lansoprazole and omeprazole induced CYP3A4 mRNA and protein in human hepatocytes. The quantitative profiles of CYP3A4 induction by individual forms of lansoprazole and omeprazole exerted enantiospecific patterns. Lansoprazole dose-dependently activated pregnane X receptor PXR in gene reporter assays, and slightly modulated rifampicin-inducible PXR activity, with similar potency for each enantiomer. Omeprazole dose-dependently activated PXR and inhibited rifampicin-inducible PXR activity. The effects of S- omeprazole were much stronger as compared to those of R- omeprazole. All forms of lansoprazole, but not omeprazole, slightly activated glucocorticoid receptor and augmented dexamethasone-induced GR transcriptional activity. Omeprazole and lansoprazole influenced basal and ligand inducible expression of tyrosine aminotransferase, a GR-target gene, in HepG2 cells and human hepatocytes. Overall, we demonstrate here that omeprazole and lansoprazole enantiomers induce CYP3A4 in HepG2 cells and human hepatocytes. The induction comprises differential interactions of omeprazole and lansoprazole with transcriptional regulators PXR and GR, and some of the effects were enantiospecific. The data presented here might be of toxicological and clinical importance, since the effects occurred in therapeutically relevant concentrations.	[Novotna, Aneta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2001, ALIMENT PHARM THERAP, V15, P1563, DOI 10.1046/j.1365-2036.2001.01087.x; Andersson T, 2008, CLIN DRUG INVEST, V28, P263, DOI 10.2165/00044011-200828050-00001; Dvorak Z, 2010, DRUG METAB REV, V42, P621, DOI 10.3109/03602532.2010.484462; Fery Y, 2010, TOXICOLOGY, V277, P11, DOI 10.1016/j.tox.2010.08.008; Gerbal-Chaloin S, 2006, CELL SIGNAL, V18, P740, DOI 10.1016/j.cellsig.2005.07.007; Katsuki H, 1996, PHARMACEUT RES, V13, P611, DOI 10.1023/A:1016062508580; Kendall MJ, 2003, ALIMENT PHARM THERAP, V17, P1, DOI 10.1046/j.1365-2036.17.s1.1.x; Metz DC, 2009, ALIMENT PHARM THER, V29, P928, DOI 10.1111/j.1365-2036.2009.03984.x; Niioka T, 2008, EUR J CLIN PHARMACOL, V64, P503, DOI 10.1007/s00228-007-0455-5; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653; Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Yoshinari K, 2008, BIOCHEM PHARMACOL, V76, P139, DOI 10.1016/j.bcp.2008.04.005	17	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105580	10.1371/journal.pone.0105580	http://dx.doi.org/10.1371/journal.pone.0105580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141173	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200105
J	Zhu, YJ; Hanafy, MA; Killingsworth, CR; Walcott, GP; Young, ME; Pogwizd, SM				Zhu, Yujie; Hanafy, Mohamed A.; Killingsworth, Cheryl R.; Walcott, Gregory P.; Young, Martin E.; Pogwizd, Steven M.			Morning Surge of Ventricular Arrhythmias in a New Arrhythmogenic Canine Model of Chronic Heart Failure Is Associated with Attenuation of Time-Of-Day Dependence of Heart Rate and Autonomic Adaptation, and Reduced Cardiac Chaos	PLOS ONE			English	Article							FREQUENCY-DOMAIN MEASURES; RATE-VARIABILITY ANALYSIS; R INTERVAL DYNAMICS; CIRCADIAN VARIATION; SPONTANEOUS ONSET; NERVE ACTIVITY; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; CORRELATION DIMENSION; STELLATE GANGLION	Patients with chronic heart failure (CHF) exhibit a morning surge in ventricular arrhythmias, but the underlying cause remains unknown. The aim of this study was to determine if heart rate dynamics, autonomic input (assessed by heart rate variability (HRV)) and nonlinear dynamics as well as their abnormal time-of-day-dependent oscillations in a newly developed arrhythmogenic canine heart failure model are associated with a morning surge in ventricular arrhythmias. CHF was induced in dogs by aortic insufficiency & aortic constriction, and assessed by echocardiography. Holter monitoring was performed to study time-of-day-dependent variation in ventricular arrhythmias (PVCs, VT), traditional HRV measures, and nonlinear dynamics (including detrended fluctuations analysis alpha 1 and alpha 2 (DFA alpha 1 & DFA alpha 2), correlation dimension (CD), and Shannon entropy (SE)) at baseline, as well as 240 days (240d) and 720 days (720d) following CHF induction. LV fractional shortening was decreased at both 240d and 720d. Both PVCs and VT increased with CHF duration and showed a morning rise (2.5-fold & 1.8-fold increase at 6 AM-noon vs midnight-6 AM) during CHF. The morning rise in HR at baseline was significantly attenuated by 52% with development of CHF (at both 240d & 720d). Morning rise in the ratio of low frequency to high frequency (LF/HF) HRV at baseline was markedly attenuated with CHF. DFA alpha 1, DFA alpha 2, CD and SE all decreased with CHF by 31, 17, 34 and 7%, respectively. Time-of-day-dependent variations in LF/HF, CD, DFA alpha 1 and SE, observed at baseline, were lost during CHF. Thus in this new arrhythmogenic canine CHF model, attenuated morning HR rise, blunted autonomic oscillation, decreased cardiac chaos and complexity of heart rate, as well as aberrant time-of-day-dependent variations in many of these parameters were associated with a morning surge of ventricular arrhythmias.	[Zhu, Yujie; Hanafy, Mohamed A.; Killingsworth, Cheryl R.; Walcott, Gregory P.; Young, Martin E.; Pogwizd, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Pogwizd, SM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	spogwizd@uab.edu			National Heart, Lung, and Blood Institute [HL-097268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097268] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grant HL-097268, SMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Almoznino-Sarafian D, 2009, EUR J INTERN MED, V20, P779, DOI 10.1016/j.ejim.2009.08.006; ARNTZ HR, 1993, CIRCULATION, V88, P2284, DOI 10.1161/01.CIR.88.5.2284; Arzeno NM, 2007, P ANN INT IEEE EMBS, P5051, DOI 10.1109/IEMBS.2007.4353475; Baumert M, 2004, METHOD INFORM MED, V43, P202, DOI 10.1055/s-0038-1633859; Beckers F, 2006, BIOMED TECH, V51, P194, DOI 10.1515/BMT.2006.035; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Boudreau P, 2011, IEEE ENG MED BIO, P681, DOI 10.1109/IEMBS.2011.6090153; Ceyhan M, 2003, CHRONOBIOL INT, V20, P337, DOI 10.1081/CBI-120019342; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Englund A, 1999, J AM COLL CARDIOL, V34, P1560, DOI 10.1016/S0735-1097(99)00369-1; Frenneaux MP, 2004, HEART, V90, P1248, DOI 10.1136/hrt.2003.026146; Fries Roland, 2002, Med Sci Monit, V8, pCR751; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Garber JC, 2011, GUIDE FOR THE CARE A; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GOLDBERGER AL, 1990, ANN NY ACAD SCI, V591, P402; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; GUEVARA MR, 1995, CHAOS, V5, P174, DOI 10.1063/1.166065; Guzzetti S, 2005, EUR HEART J, V26, P357, DOI 10.1093/eurheartj/ehi067; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; Liu C, 2012, HEART RHYTHM, V9, pS407; Makikallio TH, 1997, AM J CARDIOL, V80, P779; Makikallio TH, 2001, AM J CARDIOL, V87, P178, DOI 10.1016/S0002-9149(00)01312-6; Makikallio TH, 1999, AM J CARDIOL, V83, P880, DOI 10.1016/S0002-9149(98)01068-6; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; Manolis AG, 1997, PACE, V20, P203, DOI 10.1111/j.1540-8159.1997.tb04843.x; Matveev M, 2006, NORMAL AND ABNORMAL; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Moe GW, 1999, CARDIOVASC RES, V42, P591, DOI 10.1016/S0008-6363(99)00032-2; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Muller JE, 1999, AM HEART J, V137, pS1, DOI 10.1016/S0002-8703(99)70390-X; Notarius CF, 1999, CLIN SCI, V96, P557, DOI 10.1042/CS19980347; Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045; Opthof T, 2000, CIRCULATION, V101, P2975, DOI 10.1161/01.CIR.101.25.2975; PACKER M, 1985, CIRCULATION, V72, P681, DOI 10.1161/01.CIR.72.4.681; PANINA G, 1995, AM HEART J, V129, P748, DOI 10.1016/0002-8703(95)90325-9; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Piccirillo G, 2009, HEART RHYTHM, V6, P546, DOI 10.1016/j.hrthm.2009.01.006; Platisa MM, 2008, EUR BIOPHYS J BIOPHY, V37, P1247, DOI 10.1007/s00249-007-0254-z; POGWIZD SM, 1995, CIRCULATION, V92, P1034, DOI 10.1161/01.CIR.92.4.1034; Ponard JGC, 2007, BIOPHYS J, V92, P3734, DOI 10.1529/biophysj.106.091892; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; QUYYUMI AA, 1992, CIRCULATION, V86, P22, DOI 10.1161/01.CIR.86.1.22; RAEDER EA, 1988, J AM COLL CARDIOL, V12, P656, DOI 10.1016/S0735-1097(88)80052-4; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; Segerson NM, 2008, J CARDIOVASC ELECTR, V19, P1031, DOI 10.1111/j.1540-8167.2008.01174.x; SIEGEL D, 1992, AM J CARDIOL, V69, P344, DOI 10.1016/0002-9149(92)90231-M; Singh RB, 2003, INT J CARDIOL, V87, P9, DOI 10.1016/S0167-5273(02)00308-X; SKINNER JE, 1991, CIRC RES, V68, P966, DOI 10.1161/01.RES.68.4.966; SKINNER JE, 1993, AM HEART J, V125, P731, DOI 10.1016/0002-8703(93)90165-6; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; TWIDALE N, 1989, AM J CARDIOL, V64, P1204, DOI 10.1016/0002-9149(89)90881-3; vandeBorne P, 1997, CIRCULATION, V95, P1449; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Vybiral T, 1993, J AM COLL CARDIOL, V22, P557, DOI 10.1016/0735-1097(93)90064-8; Wagner CD, 1998, CARDIOVASC RES, V40, P257, DOI 10.1016/S0008-6363(98)00251-X; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Wessel N, 2000, PHYS REV E, V61, P733, DOI 10.1103/PhysRevE.61.733; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Yan J, 2013, HEART RHYTHM, V10, pS416; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007	78	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105379	10.1371/journal.pone.0105379	http://dx.doi.org/10.1371/journal.pone.0105379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140699	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200082
J	Koshiar, RL; Somajo, S; Norstrom, E; Dahlback, B				Koshiar, Ruzica Livaja; Somajo, Sofia; Norstrom, Eva; Dahlback, Bjorn			Erythrocyte-Derived Microparticles Supporting Activated Protein C-Mediated Regulation of Blood Coagulation	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY; SICKLE-CELL-DISEASE; FACTOR VA; THROMBIN GENERATION; VITAMIN-K; FLOW-CYTOMETRY; TFPI-ALPHA; FACTOR-IXA; FACTOR XA	Elevated levels of erythrocyte-derived microparticles are present in the circulation in medical conditions affecting the red blood cells. Erythrocyte-derived microparticles expose phosphatidylserine thus providing a suitable surface for procoagulant reactions leading to thrombin formation via the tenase and prothrombinase complexes. Patients with elevated levels of circulating erythrocyte-derived microparticles have increased thrombin generation in vivo. The aim of the present study was to investigate whether erythrocyte-derived microparticles are able to support the anticoagulant reactions of the protein C system. Erythrocyte-derived microparticles were isolated using ultracentrifugation after incubation of freshly prepared erythrocytes with the ionophore A23187 or from outdated erythrocyte concentrates, the different microparticles preparations yielding similar results. According to flow cytometry analysis, the microparticles exposed phoshatidylserine and bound lactadherin, annexin V, and protein S, which is a cofactor to activated protein C. The microparticles were able to assemble the tenase and prothrombinase complexes and to stimulate the formation of thrombin in plasma-based thrombin generation assay both in presence and absence of added tissue factor. The addition of activated protein C in the thrombin generation assay inhibited thrombin generation in a dose-dependent fashion. The anticoagulant effect of activated protein C in the thrombin generation assay was inhibited by a monoclonal antibody that prevents binding of protein S to microparticles and also attenuated by anti-TFPI antibodies. In the presence of erythrocyte-derived microparticles, activated protein C inhibited tenase and prothrombinase by degrading the cofactors FVIIIa and FVa, respectively. Protein S stimulated the Arg306-cleavage in FVa, whereas efficient inhibition of FVIIIa depended on the synergistic cofactor activity of protein S and FV. In summary, the erythrocyte-derived microparticle surface is suitable for the anticoagulant reactions of the protein C system, which may be important to balance the initiation and propagation of coagulation in vivo.	[Koshiar, Ruzica Livaja; Somajo, Sofia; Norstrom, Eva; Dahlback, Bjorn] Lund Univ, Dept Lab Med, Div Clin Chem, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem, Skane Univ Hosp, Malmo, Sweden.	Bjorn.Dahlback@med.lu.se	Somajo, Sofia/ABB-8170-2021	Somajo, Sofia/0000-0003-0433-8079; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Heart and Lung Foundation [20110251]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by Swedish Research Council #71430 (http://www.vr.se), and Heart and Lung Foundation #20110251 (http://www.hjartlungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SS, 2003, J THROMB HAEMOST, V1, P2348, DOI 10.1046/j.1538-7836.2003.00428.x; Ahnstrom J, 2012, BLOOD, V120, P5059, DOI 10.1182/blood-2012-05-432005; Ahnstrom J, 2011, BLOOD, V117, P6685, DOI 10.1182/blood-2010-11-317099; ALLAN D, 1980, BIOCHEM J, V188, P881, DOI 10.1042/bj1880881; Ataga KI, 2003, AM J MED, V115, P721, DOI 10.1016/j.amjmed.2003.07.011; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bezeaud A, 2002, BRIT J HAEMATOL, V117, P409, DOI 10.1046/j.1365-2141.2002.03445.x; Burnier L, 2009, THROMB HAEMOSTASIS, V101, P439, DOI 10.1160/TH08-08-0521; Canellini G, 2012, BLOOD TRANSFUS-ITALY, V10, pS39, DOI 10.2450/2012.007S; Castoldi E, 2010, J THROMB HAEMOST, V8, P294, DOI 10.1111/j.1538-7836.2009.03712.x; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; Gerotziafas GT, 2012, THROMB HAEMOSTASIS, V107, P1044, DOI 10.1160/TH11-10-0689; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HOFFMAN M, 1992, THROMB HAEMOSTASIS, V68, P74; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Hou J, 2011, VOX SANG, V100, P187, DOI 10.1111/j.1423-0410.2010.01375.x; Hugel B, 1999, BLOOD, V93, P3451, DOI 10.1182/blood.V93.10.3451.410k27_3451_3456; Inal JM, 2012, ARCH IMMUNOL THER EX, V60, P107, DOI 10.1007/s00005-012-0165-2; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Koch CG, 2013, ANN THORAC SURG, V96, P1894, DOI 10.1016/j.athoracsur.2013.05.116; LANE PA, 1994, AM J HEMATOL, V47, P295, DOI 10.1002/ajh.2830470409; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; MALM J, 1990, EUR J BIOCHEM, V187, P737, DOI 10.1111/j.1432-1033.1990.tb15361.x; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NELSESTUEN GL, 1973, P NATL ACAD SCI USA, V70, P3366, DOI 10.1073/pnas.70.12.3366; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; NOVOTNY WF, 1988, BLOOD, V72, P2020; Pattanapanyasat K, 2004, CYTOM PART B-CLIN CY, V57B, P23, DOI 10.1002/cyto.b.10064; Piccin A, 2012, ANN HEMATOL, V91, P1669, DOI 10.1007/s00277-012-1447-9; Rubin O, 2008, VOX SANG, V95, P288, DOI 10.1111/j.1423-0410.2008.01101.x; Rubin O, 2013, TRANSFUSION, V53, P1744, DOI 10.1111/trf.12008; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Shen L, 1997, BIOCHEMISTRY-US, V36, P16025, DOI 10.1021/bi971730v; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Somajo S, 2014, THROMBOSIS RES; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; TANS G, 1991, BLOOD, V77, P2641; TRACY PB, 1982, BLOOD, V60, P59; van Beers EJ, 2009, HAEMATOL-HEMATOL J, V94, P1513, DOI 10.3324/haematol.2009.008938; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Wood JP, 2014, ARTERIOSCL THROM VAS, V34, P169, DOI 10.1161/ATVBAHA.113.302655	54	58	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104200	10.1371/journal.pone.0104200	http://dx.doi.org/10.1371/journal.pone.0104200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136857	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100020
J	Zander, MA; Cancino, GI; Gridley, T; Kaplan, DR; Miller, FD				Zander, Mark A.; Cancino, Gonzalo I.; Gridley, Thomas; Kaplan, David R.; Miller, Freda D.			The Snail Transcription Factor Regulates the Numbers of Neural Precursor Cells and Newborn Neurons throughout Mammalian Life	PLOS ONE			English	Article							SELF-RENEWAL; STEM; PROTEIN; EXPRESSION; SURVIVAL; FAMILY; MOUSE; GENE; P53; DIFFERENTIATION	The Snail transcription factor regulates diverse aspects of stem cell biology in organisms ranging from Drosophila to mammals. Here we have asked whether it regulates the biology of neural precursor cells (NPCs) in the forebrain of postnatal and adult mice, taking advantage of a mouse containing a floxed Snail allele (Snail(fl/fl) mice). We show that when Snail is inducibly ablated in the embryonic cortex, this has long-term consequences for cortical organization. In particular, when Snail(fl/fl) mice are crossed to Nestin-cre mice that express Cre recombinase in embryonic neural precursors, this causes inducible ablation of Snail expression throughout the postnatal cortex. This loss of Snail causes a decrease in proliferation of neonatal cortical neural precursors and mislocalization and misspecification of cortical neurons. Moreover, these precursor phenotypes persist into adulthood. Adult neural precursor cell proliferation is decreased in the forebrain subventricular zone and in the hippocampal dentate gyrus, and this is coincident with a decrease in the number of adult-born olfactory and hippocampal neurons. Thus, Snail is a key regulator of the numbers of neural precursors and newborn neurons throughout life.	[Zander, Mark A.; Cancino, Gonzalo I.; Kaplan, David R.; Miller, Freda D.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Zander, Mark A.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Gridley, Thomas] Univ Maine, Maine Med Ctr, Res Inst, Scarborough, ME USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Maine Medical Center; University of Maine System; University of Maine Orono	Miller, FD (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Cancino, Gonzalo/ABF-6049-2021	Cancino, Gonzalo/0000-0001-8697-7282	Canadian Institute of Health Research [MOP-38021, MOP-13958]; Howard Hughes Medical Institute Senior International Research Scholar; Heart and Stroke Foundation of Canada; Becas Chile postdoctoral fellowship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute Senior International Research Scholar; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Becas Chile postdoctoral fellowship	This work was funded by Canadian Institute of Health Research grants MOP-38021 and MOP-13958 to FDM and DRK (http://www.cihr-irsc.gc.ca/). FDM is a Howard Hughes Medical Institute Senior International Research Scholar, and FDM and DRK hold Canada Research Chairs. GIC was funded by a Heart and Stroke Foundation of Canada (www.heartandstroke.com) and Becas Chile postdoctoral fellowship (www.becaschile.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ashraf SI, 2001, DEVELOPMENT, V128, P4757; BARBE MF, 1991, J NEUROSCI, V11, P519; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Cancino GI, 2013, J NEUROSCI, V33, P12569, DOI 10.1523/JNEUROSCI.1251-13.2013; Dugani CB, 2009, J NEUROSCI, V29, P6710, DOI 10.1523/JNEUROSCI.5878-08.2009; Fatt MP, 2014, CELL DEATH DIFFER, V21, P1546, DOI 10.1038/cdd.2014.61; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kusek G, 2012, CELL STEM CELL, V11, P505, DOI 10.1016/j.stem.2012.06.006; Lai SL, 2012, DEV CELL, V23, P849, DOI 10.1016/j.devcel.2012.09.007; Liang HX, 2012, BIOL OPEN, V1, P1200, DOI 10.1242/bio.20122287; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Murray SA, 2006, GENESIS, V44, P7, DOI 10.1002/gene.20178; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; OLEARY DDM, 1992, EXP NEUROL, V115, P121, DOI 10.1016/0014-4886(92)90234-H; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rembold M, 2014, GENE DEV, V28, P167, DOI 10.1101/gad.230953.113; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsui D, 2014, DEV BIOL, V385, P230, DOI 10.1016/j.ydbio.2013.11.005; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zander MA, 2014, J NEUROSCI, V34, P5164, DOI 10.1523/JNEUROSCI.0370-14.2014	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104767	10.1371/journal.pone.0104767	http://dx.doi.org/10.1371/journal.pone.0104767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136812	Green Submitted, gold, Green Published			2022-12-27	WOS:000340742100045
J	Kansiime, C; Rutebemberwa, E; Mugisha, A; Mugisha, S; Asiimwe, BB; Rwego, IB; Kiwanuka, SN				Kansiime, Catherine; Rutebemberwa, Elizeus; Mugisha, Anthony; Mugisha, Samuel; Asiimwe, Benon B.; Rwego, Innocent B.; Kiwanuka, Suzanne N.			Determinants of Patients' Choice of Provider in Accessing Brucellosis Care among Pastoral Communities Adjacent to Lake Mburo National Park in Kiruhura District, Uganda	PLOS ONE			English	Article							HEALTH-SEEKING BEHAVIOR; SUB-SAHARAN AFRICA; SERVICES; POOR; CHILDREN; EQUITY	Background: Brucellosis is the commonest zoonotic infection worldwide with symptoms similar to other febrile syndromes such as malaria and typhoid fever. It is often easily misdiagnosed, resulting in underreporting and misdirected treatments. Understanding of the factors that influence brucellosis care seeking is essential in enhancing its effective management. Our study sought to determine the factors associated with choice of provider in accessing care for brucellosis among pastoral communities in Uganda. Methods: This was a cross-sectional survey involving 245 randomly selected respondents previously diagnosed and treated for brucellosis, two months before the study. They were enrolled from three sub-counties neighboring Lake Mburo National Park between December 2012 to April 2013. Data on socio-demographics, availability, accessibility, affordability and acceptability of health services were collected. A multivariable logistic regression model was fitted to determine association between independent and outcome variables using odds ratios and 95% confidence intervals with p-value <= 0.05 considered statistically significant. Results: Of the 245 respondents, 127(51.8%) sought health care at government facilities and the rest at private. Respondents who were less likely to choose a government facility were either single (OR: 0.50, CI: 0.26-0.97), had general weakness (OR: 0.09, CI: 0.01-0.72) or whom family took a decision (OR: 0.52, CI: 0.28-0.97). At multivariable analysis, choice of government facility was influenced by primary education (aOR: 0.46, CI: 0.22-0.97), having six to ten household members (aOR: 3.71, CI: 1.84-7.49), family advice (aOR: 0.64, CI: 0.23-0.91), distance >= 10 kms (aOR: 0.44, CI: 0.21-0.92), high costs at private clinics (aOR: 0.01, CI: 0.02-0.15) and no diagnosis at government facility (aOR: 0.11, CI: 0.01-0.97). Females were more likely to seek health care at government facilities, while those with tertiary education were less likely, after the first provider. Conclusions: Females and households with six to ten members were more likely to choose government facilities. Government facilities need to be equipped to attract more patients.	[Kansiime, Catherine; Rutebemberwa, Elizeus; Kiwanuka, Suzanne N.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Mugisha, Anthony] Makerere Univ, Sch Vet Med & Anim Resources, Kampala, Uganda; [Mugisha, Samuel; Rwego, Innocent B.] Makerere Univ, Coll Nat Sci, Dept Biol Sci, Kampala, Uganda; [Asiimwe, Benon B.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Rwego, Innocent B.] Univ Minnesota, Coll Vet Med, Ecosyst Hlth Initiat, St Paul, MN 55108 USA	Makerere University; Makerere University; Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Kansiime, C (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.	cathie.kansiime@gmail.com	; Rwego, Innocent Bidason/I-5049-2013	Rutebemberwa, Elizeus/0000-0001-8363-7928; Rwego, Innocent Bidason/0000-0003-1274-7788	International Development Research Council (IDRC), Canada	International Development Research Council (IDRC), Canada	CK, SM, BBA, IBR received funding from the International Development Research Council (IDRC), Canada. http://www.idrc.ca/EN/Page/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amone Joseph, 2005, Int J Equity Health, V4, P6, DOI 10.1186/1475-9276-4-6; [Anonymous], UG MOH ANN HLTH SECT; Aye M, 2002, SOC SCI MED, V55, P1929, DOI 10.1016/S0277-9536(01)00322-7; Bakeera SK, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-25; Bax HI, 2007, NETH J MED, V65, P352; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Government of Uganda, 2005, HLTH SECT PERF REP; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kish L, 1965, SURVEY SAMPLING; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; MCPAKE B, 2002, HLTH EC INT PERSPECT; Merle V, 2009, J HOSP INFECT, V71, P263, DOI 10.1016/j.jhin.2008.11.025; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; Obrist B, 2007, PLOS MED, V4, P1584, DOI 10.1371/journal.pmed.0040308; Odaga J, 2004, HLTH POLICY DEV, V2, P192; Oliver A, 2004, J EPIDEMIOL COMMUN H, V58, P655, DOI 10.1136/jech.2003.017731; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Robertson R, 2011, J HEALTH SERV RES PO, V16, P22, DOI 10.1258/jhsrp.2010.010084; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Smits LH, 2004, AFR J BIOTECHNOL, V3, P631; Tai WTC, 2004, HEALTH SERV RES, V39, P1903, DOI 10.1111/j.1475-6773.2004.00324.x; Thorson A, 2000, LANCET, V356, P1823, DOI 10.1016/S0140-6736(00)03241-4; WHO, 2006, ZOON FOOD SAF; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454	34	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105276	10.1371/journal.pone.0105276	http://dx.doi.org/10.1371/journal.pone.0105276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133548	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700096
J	Raicevich, S; Minute, F; Finoia, MG; Caranfa, F; Di Muro, P; Scapolan, L; Beltramini, M				Raicevich, Sasa; Minute, Fabrizio; Finoia, Maria Grazia; Caranfa, Francesca; Di Muro, Paolo; Scapolan, Lucia; Beltramini, Mariano			Synergistic and Antagonistic Effects of Thermal Shock, Air Exposure, and Fishing Capture on the Physiological Stress of Squilla mantis (Stomatopoda)	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; ACID-BASE-BALANCE; DECAPOD CRUSTACEANS; ION-TRANSPORT; MORTALITY; AMMONIUM; L.; RESPIRATION; TEMPERATURE; EXCRETION	This study is aimed at assessing the effects of multiple stressors (thermal shock, fishing capture, and exposure to air) on the benthic stomatopod Squilla mantis, a burrowing crustacean quite widespread in the Mediterranean Sea. Laboratory analyses were carried out to explore the physiological impairment onset over time, based on emersion and thermal shocks, on farmed individuals. Parallel field-based studies were carried out to also investigate the role of fishing (i.e., otter trawling) in inducing physiological imbalance in different seasonal conditions. The dynamics of physiological recovery from physiological disruption were also studied. Physiological stress was assessed by analysing hemolymph metabolites (L-Lactate, D-glucose, ammonia, and H+), as well as glycogen concentration in muscle tissues. The experiments were carried out according to a factorial scheme considering the three factors (thermal shock, fishing capture, and exposure to air) at two fixed levels in order to explore possible synergistic, additive, or antagonistic effects among factors. Additive effects on physiological parameters were mainly detected when the three factors interacted together while synergistic effects were found as effect of the combination of two factors. This finding highlights that the physiological adaptive and maladaptive processes induced by the stressors result in a dynamic response that may encounter physiological limits when high stress levels are sustained. Thus, a further increase in the physiological parameters due to synergies cannot be reached. Moreover, when critical limits are encountered, mortality occurs and physiological parameters reflect the response of the last survivors. In the light of our mortality studies, thermal shock and exposure to air have the main effect on the survival of S. mantis only on trawled individuals, while lab-farmed individuals did not show any mortality during exposure to air until after 2 hours.	[Raicevich, Sasa] ISPRA, Natl Inst Environm Protect & Res, Chioggia, Italy; [Minute, Fabrizio; Caranfa, Francesca; Di Muro, Paolo; Scapolan, Lucia; Beltramini, Mariano] Univ Padua, Dept Biol, Padua, Italy; [Finoia, Maria Grazia] ISPRA, Natl Inst Environm Protect & Res, Rome, Italy	Italian Institute for Environmental Protection & Research (ISPRA); University of Padua; Italian Institute for Environmental Protection & Research (ISPRA)	Beltramini, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it		Raicevich, Sasa/0000-0002-9323-031X	Regione Veneto "Progetto Clodia", MURST; FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers) [266544]; ISPRA	Regione Veneto "Progetto Clodia", MURST; FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers); ISPRA	This work was financially supported by Regione Veneto "Progetto Clodia", MURST (ex-60%), Co-funded by the FP7 EU project GAP2 (Bridging the gap between science, stakeholders and policy makers), Grant agreement no.: 266544, and ISPRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RJA, 1997, MAR ECOL-P S Z N I, V18, P337, DOI 10.1111/j.1439-0485.1997.tb00446.x; Bergmann M, 2001, J EXP MAR BIOL ECOL, V259, P215, DOI 10.1016/S0022-0981(01)00231-3; Bergmann M, 2001, ICES J MAR SCI, V58, P163, DOI 10.1006/jmsc.2000.0999; Box GE., 1978, STAT EXPT; Bridges CR, 2001, J EXP BIOL, V204, P1021; CARROLL NV, 1956, J BIOL CHEM, V220, P583; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; da Silva-Castiglioni D, 2010, COMP BIOCHEM PHYS A, V156, P436, DOI 10.1016/j.cbpa.2010.03.025; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070662; Durand F, 2000, COMP BIOCHEM PHYS A, V127, P259, DOI 10.1016/S1095-6433(00)00253-1; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Froglia C., 1989, Collana U.Z.I. Selected Symposia and Monographs, P221; Froglia C, 1996, 14MED93016 EU DG; Gamito R, 2003, FISH RES, V63, P423, DOI 10.1016/S0165-7836(03)00108-5; Gehan EA, 1975, SURVIVAL DISTRIBUTIO, P120; Giomi F, 2008, HYDROBIOLOGIA, V606, P195, DOI 10.1007/s10750-008-9336-x; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris RR, 2004, ICES J MAR SCI, V61, P127, DOI 10.1016/j.icesjms.2003.08.002; HENRY RP, 1992, AM ZOOL, V32, P407; IVLEVA IV, 1980, INT REV GES HYDROBIO, V65, P1, DOI 10.1002/iroh.19800650102; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; Lorenzon S, 2004, J EXP ZOOL PART A, V301A, P727, DOI 10.1002/jez.a.59; Lorenzon S, 2013, FISH RES, V137, P9, DOI 10.1016/j.fishres.2012.08.015; MANGUM CP, 1985, J CRUSTACEAN BIOL, V5, P185, DOI 10.2307/1547865; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Maynou F, 2004, CRUSTACEANA, V77, P1081, DOI 10.1163/1568540042900295; McMahon BR, 2001, RESP PHYSIOL, V128, P349, DOI 10.1016/S0034-5687(01)00311-5; Narayanaswamy BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058909; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Pranovi F, 2001, MAR BIOL, V139, P863; PRESSLEY TA, 1981, AM J PHYSIOL, V241, pR370, DOI 10.1152/ajpregu.1981.241.5.R370; Qadri SA, 2007, J EXP BIOL, V210, P1245, DOI 10.1242/jeb.02709; Raicevich S, 2011, HYDROBIOLOGIA, V664, P107, DOI 10.1007/s10750-010-0590-3; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P343, DOI 10.1016/0300-9629(93)90523-7; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Stoner AW, 2012, REV FISH SCI, V20, P111, DOI 10.1080/10641262.2012.689025; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Todgham AE, 2013, INTEGR COMP BIOL, V53, P539, DOI 10.1093/icb/ict086; TOWLE DW, 1987, AM J PHYSIOL, V252, pR479, DOI 10.1152/ajpregu.1987.252.3.R479; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Weihrauch D, 2001, AM ZOOL, V41, P1621; Weihrauch D, 2002, J EXP BIOL, V205, P2765	51	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105060	10.1371/journal.pone.0105060	http://dx.doi.org/10.1371/journal.pone.0105060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133593	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700064
J	Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M				Stotz, Michael; Szkandera, Joanna; Seidel, Julia; Stojakovic, Tatjana; Samonigg, Hellmut; Reitz, Daniel; Gary, Thomas; Kornprat, Peter; Schaberl-Moser, Renate; Hoefler, Gerald; Gerger, Armin; Pichler, Martin			Evaluation of Uric Acid as a Prognostic Blood-Based Marker in a Large Cohort of Pancreatic Cancer Patients	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; NEOADJUVANT FOLFIRINOX; DUCTAL ADENOCARCINOMA; LYMPHOCYTE RATIO; SURVIVAL; PANCREATICODUODENECTOMY; INFLAMMATION; GEMCITABINE; PROGRESSION; NEUTROPHIL	Background: Recently, chemical blood parameters gain more attraction as potential prognostic parameters in pancreatic cancer (PC). In the present study we investigated the prognostic relevance of the uric acid (UA) level in blood plasma at the time of diagnosis for overall survival (OS) in a large cohort of patients with PC. Patients and Methods: Data from 466 consecutive patients with ductal adenocarcinoma of the pancreas were evaluated retrospectively. Overall survival (OS) was analysed using the Kaplan-Meier method. To further evaluate the prognostic significance of the UA level, univariate and multivariate Cox regression models were calculated. Results: None of the clinicopathological parameters (tumour grade, clinical stage, age, CA19-9 level, Karnofski Index (KI) or surgical resection) except gender was associated with UA level. In univariate analysis we observed the elevated UA level (<5.1 versus >= 5.1 mg/dl, p = 0.017) as poor prognostic factor for OS. In the multivariate analysis that included age, gender, tumour grade, tumour stage, surgical resection, CA19-9 level, the KI and UA level we confirmed the UA level as independent prognostic factor for OS (HR = 1.373%; CI = 1.077-1.751; p = 0.011). Conclusion: In conclusion, we identified the UA level at time of diagnosis as an independent prognostic factor in PC patients. Our results indicate that the UA level might represent a novel and useful marker for patient stratification in PC management.	[Stotz, Michael; Szkandera, Joanna; Seidel, Julia; Samonigg, Hellmut; Reitz, Daniel; Schaberl-Moser, Renate; Gerger, Armin; Pichler, Martin] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Inst Clin Med, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Gary, Thomas] Med Univ Graz, Dept Med, Div Angiol, Graz, Austria; [Kornprat, Peter] Med Univ Graz, Dept Surg, Div Gen Surg, Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Stotz, Michael; Szkandera, Joanna; Gerger, Armin] Med Univ Graz, Dept Med, Div Clin Oncol, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria; [Pichler, Martin] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center	Stotz, M (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	michael.stotz@medunigraz.at	, Kornprat/AAH-6353-2019; Hoefler, Gerald/H-1796-2016	Reitz, Daniel/0000-0003-0539-9092; Hoefler, Gerald/0000-0002-9056-3063; Pichler, Martin/0000-0002-8701-9462; Szkandera, Joanna/0000-0002-2217-893X				Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Benckert C, 2012, SURG TODAY, V42, P169, DOI 10.1007/s00595-011-0045-0; Christians KK, 2014, ONCOLOGIST, V19, P266, DOI 10.1634/theoncologist.2013-0273; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dhankhar R, 2011, CLIN LAB, V57, P795; Dziaman T, 2013, INT J CANC; Fabbrini E, 2013, DIABETES; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Fortner JG, 1996, ANN SURG, V223, P147, DOI 10.1097/00000658-199602000-00006; Heinemann V, 2013, ANN ONCOL, V24, P2484, DOI 10.1093/annonc/mdt239; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hochberg J, 2007, HAEMATOLOGICA, V93, P9, DOI 10.3324/haematol.12327; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Lin H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-121; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R; Ozaki H, 1999, SURG TODAY, V29, P16; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stotz M, 2013, J CLIN PATHOL, V66, P753, DOI 10.1136/jclinpath-2012-201394; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225; Szkandera J, 2013, TUMOR BIOL, V34, P2183, DOI 10.1007/s13277-013-0754-7; Tinchon C, 2013, ACTA ONCOL, V52, P1231, DOI 10.3109/0284186X.2013.771821; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-194	37	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104730	10.1371/journal.pone.0104730	http://dx.doi.org/10.1371/journal.pone.0104730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133546	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700039
J	Zhang, Y; Wang, HZ; Yang, ZS; Li, JZ				Zhang, Yan; Wang, Hongzhi; Yang, Zhongsheng; Li, Jianzhong			Relative Accuracy Evaluation	PLOS ONE			English	Article							TRUTH	The quality of data plays an important role in business analysis and decision making, and data accuracy is an important aspect in data quality. Thus one necessary task for data quality management is to evaluate the accuracy of the data. And in order to solve the problem that the accuracy of the whole data set is low while a useful part may be high, it is also necessary to evaluate the accuracy of the query results, called relative accuracy. However, as far as we know, neither measure nor effective methods for the accuracy evaluation methods are proposed. Motivated by this, for relative accuracy evaluation, we propose a systematic method. We design a relative accuracy evaluation framework for relational databases based on a new metric to measure the accuracy using statistics. We apply the methods to evaluate the precision and recall of basic queries, which show the result's relative accuracy. We also propose the method to handle data update and to improve accuracy evaluation using functional dependencies. Extensive experimental results show the effectiveness and efficiency of our proposed framework and algorithms.	[Zhang, Yan; Wang, Hongzhi; Yang, Zhongsheng; Li, Jianzhong] Harbin Inst Technol, Dept Comp Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Wang, HZ (corresponding author), Harbin Inst Technol, Dept Comp Sci & Technol, Harbin 150006, Peoples R China.	wangzh@hit.edu.cn	Wang, Hongzhi/F-2847-2011	Wang, Hongzhi/0000-0002-7521-2871	NGFR [2012CB316200, 2012AA011004]	NGFR	This paper was partially supported by NGFR 973 grant 2012CB316200 and NGFR 863 grant 2012AA011004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P275, DOI 10.1145/304181.304207; Al-ward YF, 2010, J AL NAHRAIN U, V13, P247; Arenas M., 1999, Proceedings of the Eighteenth ACM SIGMOD-SIGACT-SIGART Symposium on Principles of Database Systems, P68, DOI 10.1145/303976.303983; Batini B, 2006, DATA QUALITY CONCEPT; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dong X., 2009, P VLDB ENDOWMENT, V2, P562, DOI DOI 10.14778/1687627.1687691; Dong XL, 2010, PROC VLDB ENDOW, V3, P1617, DOI 10.14778/1920841.1921054; English L, 2000, DM REV MAGAZINE; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Florescu D, 1997, PROCEEDINGS OF THE TWENTY-THIRD INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES, P216; Getoor L, 2012, PROC VLDB ENDOW, V5, P2018, DOI 10.14778/2367502.2367564; Gibbons P. B., 1998, SIGMOD Record, V27, P331, DOI 10.1145/276305.276334; Gotz M, 2009, P 12 INT C DAT THEOR, P149, DOI DOI 10.1145/1514894.1514913; Maykranz D, 2014, J THEOR BIOL, V349, P44, DOI 10.1016/j.jtbi.2014.01.029; Pasternack J., 2011, 22 INT JOINT C ART I, P2324; Pasternack J., 2010, COLING, P877; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Perez Luis L, 2010, P 2010 ACM SIGMOD IN, P687; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Poosala V, 1999, PROC INT CONF DATA, P252, DOI 10.1109/ICDE.1999.754932; Raman A, 2001, CALIF MANAGE REV, V43, P136, DOI 10.2307/41166093; Vilarem C, 2002, THESIS U TORONTO; VRBSKY SV, 1994, J SYST SOFTWARE, V27, P243, DOI 10.1016/0164-1212(94)90046-9; Wang D, 2011, P DMSN, P7; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Yin XX, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1048; Zhang Y, 2014, LECT NOTES COMPUT SC, V8491, P205, DOI 10.1007/978-3-319-07782-6_19; Zhao B, 2012, PROC VLDB ENDOW, V5, P550, DOI 10.14778/2168651.2168656	31	1	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103853	10.1371/journal.pone.0103853	http://dx.doi.org/10.1371/journal.pone.0103853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133752	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700019
J	Zongo, I; Some, FA; Somda, SAM; Parikh, S; Rouamba, N; Rosenthal, PJ; Tarning, J; Lindegardh, N; Nosten, F; Ouedraogo, JB				Zongo, Issaka; Some, Fabrice A.; Somda, Serge A. M.; Parikh, Sunil; Rouamba, Noel; Rosenthal, Philip J.; Tarning, Joel; Lindegardh, Niklas; Nosten, Francois; Ouedraogo, Jean Bosco			Efficacy and Day 7 Plasma Piperaquine Concentrations in African Children Treated for Uncomplicated Malaria with Dihydroartemisinin-Piperaquine	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; IN-VITRO SENSITIVITIES; ARTEMETHER-LUMEFANTRINE; POPULATION PHARMACOKINETICS; ARTESUNATE-MEFLOQUINE; AMODIAQUINE; SAFETY; WOMEN; POLYMORPHISMS	Background: One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-piperaquine (DHA-PQ). However, the pharmacokinetics of piperaquine and the relationship between drug levels and clinical efficacy are incompletely characterized, particularly in children. Methods: We performed a single-arm open-label trial in Bobo-Dioulasso, Burkina Faso. A total of 379 participants aged 6 months or more with uncomplicated falciparum malaria were enrolled. Each participant received daily dose of DHA-PQ for three days and followed for 42 days. Parasitological efficacy was analyzed, considering rates of recrudescence and overall recurrence. PK was an exploratory endpoint and a priori, no sample size had been determined. Day 7 capillary and venous plasma concentrations of piperaquine were measured in children aged 2-10 years. Results: Of the 379 participants, 365 (96.3%) completed 42 days of follow-up. The median daily dose of PQ was 18.5 mg/kg [6.5-24]. Treatment with DHA-PQ was well tolerated with fever and parasitemia resolution within 48 hours in nearly all children. Recurrent malaria within 42 days of follow-up occurred in 31.3% (10/34) of children less than 2 years old, 16.0% (16/106) of those aged 2-5 years, 9.4% (15/160) of those aged 5-10 years, and none (0/68) of those over 10 years old. After genotyping, 3 of 41 recurrent episodes were recrudescence. An exploratory analysis shows that children with successful treatment outcomes had significantly higher median plasma concentrations of PQ compared to those with recurrent malaria within 42 days after therapy, considering either capillary samples (68 ng/ml [50-85] compared to 48 ng/ml [36-55], p < 0.001) or venous samples (42 ng/ml [29-59] compared to 25 ng/ml [19-44], p < 0.001). Conclusion: DHA-PQ was effective for uncomplicated P. falciparum malaria treatment and offers an alternative to other ACTs. Recurrent malaria was mainly due to new infections after treatment and was correlated with low day 7 PQ concentration in the youngest patients.	[Zongo, Issaka; Some, Fabrice A.; Rouamba, Noel; Ouedraogo, Jean Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Somda, Serge A. M.; Ouedraogo, Jean Bosco] Ctr Muraz Bobo Dioulasso, Non Transmissible Dis Dept, Bobo Dioulasso, Burkina Faso; [Parikh, Sunil] Yale Univ, Sch Publ Hlth, Dept Med, New Haven, CT USA; [Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Tarning, Joel; Lindegardh, Niklas; Nosten, Francois] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX1 2JD, England	Centre Muraz; Yale University; University of California System; University of California San Francisco; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Ouedraogo, JB (corresponding author), Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso.	jbouedraogo.irssbobo@fasonet.bf	Nosten, Francois/AAC-5509-2019; SOMDA, Serge M. A./M-2182-2019	Nosten, Francois/0000-0002-7951-0745; SOMDA, Serge M. A./0000-0001-9855-9395; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Tarning, Joel/0000-0003-4566-4030; SOME, Anyirekun Fabrice/0000-0002-1530-1493	Holley Cotec Pharma., Beijing; Fogarty International Center of the National Institutes of Health; Doris Duke Charitable Foundation; Wellcome Trust of Great Britain	Holley Cotec Pharma., Beijing; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Wellcome Trust of Great Britain(Wellcome Trust)	This investigation was supported by Holley Cotec Pharma., Beijing, the Fogarty International Center of the National Institutes of Health and the Doris Duke Charitable Foundation, for which PJR is a Distinguished Clinical Scientist. The Mahidol-Oxford-University-Research Unit and the Shoklo-Malaria-Research Unit are supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Ashley EA, 2006, ANTIMICROB AGENTS CH, V50, P2281, DOI 10.1128/AAC.00040-06; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Creek DJ, 2013, J INFECT DIS, V207, P1646, DOI 10.1093/infdis/jit078; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Gutman J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-58; Hao MM, 2013, ANTIMICROB AGENTS CH, V57, P1723, DOI 10.1128/AAC.02306-12; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Katrak S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-272; Krudsood S, 2010, ANTIMICROB AGENTS CH, V54, P3730, DOI 10.1128/AAC.01187-09; Lim P, 2010, ANTIMICROB AGENTS CH, V54, P2135, DOI 10.1128/AAC.01304-09; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nambozi M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-50; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Omari AAA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005564; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P5500, DOI 10.1128/AAC.05067-11; Salman S, 2011, ANTIMICROB AGENTS CH, V55, P5306, DOI 10.1128/AAC.05136-11; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Tarning J, 2008, ANTIMICROB AGENTS CH, V52, P1052, DOI 10.1128/AAC.00955-07; Tarning J, 2006, J PHARMACEUT BIOMED, V41, P213, DOI 10.1016/j.jpba.2005.10.027; Tarning J, 2005, ANTIMICROB AGENTS CH, V49, P5127, DOI 10.1128/AAC.49.12.5127-5128.2005; Tarning J, 2012, CLIN PHARMACOL THER, V91, P497, DOI 10.1038/clpt.2011.254; Tarning J, 2012, ANTIMICROB AGENTS CH, V56, P5764, DOI 10.1128/AAC.01242-12; Tarning J, 2009, ANTIMICROB AGENTS CH, V53, P3837, DOI 10.1128/AAC.00195-09; WHO, 2003, ASS MON ANT DRUG EFF; WHO, 2010, GUID TREATM MAL, V2nd; Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	36	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103200	10.1371/journal.pone.0103200	http://dx.doi.org/10.1371/journal.pone.0103200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133389	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700005
J	Bachstetter, AD; Webster, SJ; Tu, T; Goulding, DS; Haiech, J; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Webster, Scott J.; Tu, Tao; Goulding, Danielle S.; Haiech, Jacques; Watterson, D. Martin; Van Eldik, Linda J.			Generation and Behavior Characterization of CaMKII beta Knockout Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-CAMKII; MOUSE MODEL; BRAIN; PLASTICITY; SYNAPSES; STAGE	The calcium/calmodulin-dependent protein kinase II (CaMKII) is abundant in the brain, where it makes important contributions to synaptic organization and homeostasis, including playing an essential role in synaptic plasticity and memory. Four genes encode isoforms of CaMKII (alpha, beta, delta, gamma), with CaMKII alpha and CaMKII beta highly expressed in the brain. Decades of molecular and cellular research, as well as the use of a large number of CaMKII alpha mutant mouse lines, have provided insight into the pivotal roles of CaMKII alpha in brain plasticity and cognition. However, less is known about the CaMKII beta isoform. We report the development and extensive behavioral and phenotypic characterization of a CaMKII beta knockout (KO) mouse. The CaMKII beta KO mouse was found to be smaller at weaning, with an altered body mass composition. The CaMKII beta KO mouse showed ataxia, impaired forelimb grip strength, and deficits in the rotorod, balance beam and running wheel tasks. Interestingly, the CaMKII beta KO mouse exhibited reduced anxiety in the elevated plus maze and open field tests. The CaMKII beta KO mouse also showed cognitive impairment in the novel object recognition task. Our results provide a comprehensive behavioral characterization of mice deficient in the beta isoform of CaMKII. The neurologic phenotypes and the construction of the genotype suggest the utility of this KO mouse strain for future studies of CaMKII beta in brain structure, function and development.	[Bachstetter, Adam D.; Webster, Scott J.; Goulding, Danielle S.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Tu, Tao; Watterson, D. Martin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Haiech, Jacques] Univ Strasbourg, Lab Innovat Therapeut, Strasbourg, France	University of Kentucky; University of Kentucky; Northwestern University; Feinberg School of Medicine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	haiech, jacques J/F-2890-2010	Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866; haiech, jacques/0000-0003-2908-8053	National Institute on Aging [F32 AG037280, K99 AG044445]; National Institute of Neurological Disorders and Stroke [F32 NS084605]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS084605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280, K99AG044445] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ADB was supported by National Institute on Aging F32 AG037280 and K99 AG044445. SJW was supported by National Institute of Neurological Disorders and Stroke F32 NS084605. Metabolic measurements were supported by National Institutes of Health P20 RR021954 and P20 GM103527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-146; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; BARNETT SA, 1981, BEHAV NEURAL BIOL, V31, P73, DOI 10.1016/S0163-1047(81)91098-0; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Cervia D, 2011, GEN PHYSIOL BIOPHYS, V30, P251, DOI 10.4149/gpb_2011_03_251; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FOX MW, 1965, ANIM BEHAV, V13, P232, DOI 10.1016/0003-3472(65)90040-0; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Puram SV, 2011, NAT NEUROSCI, V14, P973, DOI 10.1038/nn.2857; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Vallano ML, 2000, GLIA, V30, P154, DOI 10.1002/(SICI)1098-1136(200004)30:2<154::AID-GLIA5>3.0.CO;2-S; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Waggener CT, 2013, J NEUROSCI, V33, P10453, DOI 10.1523/JNEUROSCI.5875-12.2013; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182	28	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105191	10.1371/journal.pone.0105191	http://dx.doi.org/10.1371/journal.pone.0105191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127391	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300093
J	Kang, DH; Lee, JY; Hah, YS; Chung, DY; Lee, DH; Cho, KS				Kang, Dong Hyuk; Lee, Joo Yong; Hah, Yoon Soo; Chung, Doo Yong; Lee, Dae Hun; Cho, Kang Su			Correlation of Prostatic Urethral Angle with the Severity of Urinary Symptom and Peak Flow Rate in Men with Small Prostate Volume	PLOS ONE			English	Article							BLADDER OUTLET OBSTRUCTION; TRANSITION ZONE INDEX; TRACT SYMPTOMS; NATURAL-HISTORY; HYPERPLASIA; SCORE; UROFLOWMETRY; ANGULATION; ETIOLOGY	Purpose: To evaluate the effects of prostatic anatomical factors on male lower urinary tract symptoms (LUTS) and the peak flow rate (Qmax) in patients with small prostate volume (PV). Materials and Methods: Records were obtained from a prospectively maintained database of first-visit men with LUTS. Patients whose total PV (TPV) was greater than 30 mL were excluded; 444 patients were enrolled in the study. The TPV, transitional zone volume (TZV), transitional zone index (TZI), intravesical prostatic protrusion (IPP), and prostatic urethral angle (PUA) were measured by transrectal ultrasonography. LUTS were evaluated using the International Prostate Symptom Score (IPSS) and the Overactive Bladder Symptom Score (OABSS) questionnaires. Uroflowmetric measurements were also made. Results: PUA (r = 0.269, P < 0.001), TZV (r = 0.160, P < 0.001), and TZI (r = 0.109, P = 0.022) significantly correlated with the IPSS. Qmax (r = -0.334, P < 0.001) and OABSS (r = 0.211, P < 0.001) correlated only with PUA. In a multivariate regression analysis, PUA and age were independently associated with IPSS, OABSS, and Qmax. For IPSS of 20 or greater, the area under the ROC curve (AUC) of PUA was 0.667 and the cut-off value was 43.7 degrees. When Qmax was 10 mL/s or less, the AUC of PUA was 0.664 and the cut-off value was 43.5 degrees. Conclusions: PUA has a significant association with symptom severity and Qmax among prostatic anatomical factors analyzed in men with LUTS and small PV. PUA should be considered as an important clinical factor in male LUTS management. Furthermore, the impact of PUA on response to medical treatment and disease progression needs to be investigated.	[Kang, Dong Hyuk] Yangpyeong Hlth Ctr, Dept Urol, Yangpyeong, South Korea; [Lee, Joo Yong; Hah, Yoon Soo; Chung, Doo Yong] Yonsei Univ, Coll Med, Dept Urol, Severance Hosp,Urol Sci Inst, Seoul, South Korea; [Lee, Dae Hun] Yonsei Univ Hlth Syst, Dept Urol, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Dept Urol, Gangnam Severance Hosp,Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, KS (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Gangnam Severance Hosp,Urol Sci Inst, Seoul, South Korea.	kscho99@yuhs.ac	Lee, Joo Yong/C-3851-2013	Lee, Joo Yong/0000-0002-3470-1767; Cho, Kang Su/0000-0002-3500-8833; Hah, Yoon Soo/0000-0001-6424-4619				Bang WJ, 2012, UROLOGY, V80, P1333, DOI 10.1016/j.urology.2012.08.058; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; Chia SJ, 2003, BJU INT, V91, P371, DOI 10.1046/j.1464-410X.2003.04088.x; Cho KS, 2008, UROLOGY, V71, P858, DOI 10.1016/j.urology.2008.01.019; Cho KS, 2008, MED HYPOTHESES, V70, P532, DOI 10.1016/j.mehy.2007.07.012; Choi J, 2002, EUR UROL, V42, P7, DOI 10.1016/S0302-2838(02)00222-1; elDin KE, 1996, UROLOGY, V48, P393; Franciosi M, 2007, INT UROL NEPHROL, V39, P871, DOI 10.1007/s11255-006-9148-8; GIRMAN CJ, 1995, J UROLOGY, V153, P1510, DOI 10.1016/S0022-5347(01)67448-2; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; KAPLAN SA, 1995, J UROLOGY, V154, P1764, DOI 10.1016/S0022-5347(01)66779-X; Ku JH, 2010, UROLOGY, V75, P1467, DOI 10.1016/j.urology.2009.08.049; Kuo HC, 1999, UROLOGY, V54, P90, DOI 10.1016/S0090-4295(99)00092-8; Kurita Y, 1998, UROLOGY, V51, P595, DOI 10.1016/S0090-4295(97)00685-7; Lee HH, 2013, UROLOGY, V81, P915, DOI 10.1016/j.urology.2012.12.020; MCNEAL J, 1990, UROL CLIN N AM, V17, P477; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Park YJ, 2012, KOREAN J UROL, V53, P410, DOI 10.4111/kju.2012.53.6.410; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; Sciarra A, 1998, PROSTATE, V34, P121; Soler R, 2013, EUR UROL, V64, P610, DOI 10.1016/j.eururo.2013.04.042; Zhang KQ, 2007, UROLOGY, V70, P1096, DOI 10.1016/j.urology.2007.08.008	22	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104395	10.1371/journal.pone.0104395	http://dx.doi.org/10.1371/journal.pone.0104395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127394	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300021
J	Rosa, RG; Joazeiro, PP; Bianco, J; Kunz, M; Weber, JF; Waldman, SD				Rosa, Renata G.; Joazeiro, Paulo P.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.			Growth Factor Stimulation Improves the Structure and Properties of Scaffold-Free Engineered Auricular Cartilage Constructs	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTICULAR-CARTILAGE; IN-VITRO; ELASTIC CARTILAGE; GENE-EXPRESSION; TISSUE; CHONDROCYTES; INSULIN; RECONSTRUCTION; CULTURE	The reconstruction of the external ear to correct congenital deformities or repair following trauma remains a significant challenge in reconstructive surgery. Previously, we have developed a novel approach to create scaffold-free, tissue engineering elastic cartilage constructs directly from a small population of donor cells. Although the developed constructs appeared to adopt the structural appearance of native auricular cartilage, the constructs displayed limited expression and poor localization of elastin. In the present study, the effect of growth factor supplementation (insulin, IGF-1, or TGF-beta 1) was investigated to stimulate elastogenesis as well as to improve overall tissue formation. Using rabbit auricular chondrocytes, bioreactor-cultivated constructs supplemented with either insulin or IGF-1 displayed increased deposition of cartilaginous ECM, improved mechanical properties, and thicknesses comparable to native auricular cartilage after 4 weeks of growth. Similarly, growth factor supplementation resulted in increased expression and improved localization of elastin, primarily restricted within the cartilaginous region of the tissue construct. Additional studies were conducted to determine whether scaffold-free engineered auricular cartilage constructs could be developed in the 3D shape of the external ear. Isolated auricular chondrocytes were grown in rapid-prototyped tissue culture molds with additional insulin or IGF-1 supplementation during bioreactor cultivation. Using this approach, the developed tissue constructs were flexible and had a 3D shape in very good agreement to the culture mold (average error <400 mu m). While scaffold-free, engineered auricular cartilage constructs can be created with both the appropriate tissue structure and 3D shape of the external ear, future studies will be aimed assessing potential changes in construct shape and properties after subcutaneous implantation.	[Rosa, Renata G.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada; [Rosa, Renata G.; Bianco, Juares; Kunz, Manuela; Weber, Joanna F.; Waldman, Stephen D.] Queens Univ, Kingston, ON, Canada; [Rosa, Renata G.; Joazeiro, Paulo P.; Bianco, Juares] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil; [Kunz, Manuela] Queens Univ, Sch Comp, Kingston, ON, Canada; [Weber, Joanna F.] Queens Univ, Dept Mech & Mat Engn, Kingston, ON, Canada; [Waldman, Stephen D.] Ryerson Univ, Dept Chem Engn, Toronto, ON, Canada; [Waldman, Stephen D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	Queens University - Canada; Queens University - Canada; Universidade de Sao Paulo; Universidade Estadual de Campinas; Queens University - Canada; Queens University - Canada; Toronto Metropolitan University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Waldman, SD (corresponding author), Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON K7L 2V7, Canada.	swaldman@ryerson.ca	Bianco, Juares/G-7543-2012					Arevalo-Silva CA, 2001, TISSUE ENG, V7, P81, DOI 10.1089/107632700300003314; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bos PK, 2001, OSTEOARTHR CARTILAGE, V9, P382, DOI 10.1053/joca.2000.0399; Brenner JM, 2013, BIOTECHNOL PROGR, V29, P213, DOI 10.1002/btpr.1670; BRENT B, 1977, PLAST RECONSTR SURG, V59, P475, DOI 10.1097/00006534-197759040-00001; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Cigan AD, 2013, TISSUE ENG PT A, V19, P1941, DOI [10.1089/ten.tea.2012.0596, 10.1089/ten.TEA.2012.0596]; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FOSTER J, 1987, COLLAGEN REL RES, V7, P161; Fujisawa T, 2008, OSTEOARTHR CARTILAGE, V16, P787, DOI 10.1016/j.joca.2007.11.001; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; Giardini-Rosa R, 2014, TISSUE ENG PT A, V20, P1012, DOI [10.1089/ten.TEA.2013.0159, 10.1089/ten.tea.2013.0159]; GOLDBERG RL, 1990, CONNECT TISSUE RES, V24, P265, DOI 10.3109/03008209009152154; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Heinegard D, 1998, OSTEOARTHRITIS, P74; Hellingman CA, 2011, CELL TRANSPLANT, V20, P925, DOI 10.3727/096368910X539119; Hinton RJ, 2009, ORTHOD CRANIOFAC RES, V12, P168, DOI 10.1111/j.1601-6343.2009.01450.x; Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772; JURVELIN JS, 1995, J BIOMECH, V28, P231, DOI 10.1016/0021-9290(94)00060-H; Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015; Kelly TAN, 2008, ANN BIOMED ENG, V36, P769, DOI 10.1007/s10439-008-9476-1; Khan AA, 2009, BIOTECHNOL PROGR, V25, P508, DOI 10.1002/btpr.108; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kisiday JD, 2005, TISSUE ENG, V11, P141, DOI 10.1089/ten.2005.11.141; Lammi PE, 2002, BONE, V31, P690, DOI 10.1016/S8756-3282(02)00904-3; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; MADSEN K, 1983, DEV BIOL, V96, P63, DOI 10.1016/0012-1606(83)90311-1; MAOR G, 1993, CALCIFIED TISSUE INT, V52, P291, DOI 10.1007/BF00296654; MISHELL RI, 1980, IMMUNOPHARMACOLOGY, V2, P233, DOI 10.1016/0162-3109(80)90052-1; MOSKALEWSKI S, 1979, AM J ANAT, V155, P339, DOI 10.1002/aja.1001550305; MOSKALEWSKI S, 1977, ACTA ANAT, V97, P231; MOSKALEWSKI S, 1981, CONNECT TISSUE RES, V8, P171, DOI 10.3109/03008208109152369; NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001; Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695; Ng KW, 2011, ANN BIOMED ENG, V39, P2491, DOI 10.1007/s10439-011-0356-8; Nimeskern L, 2014, TISSUE ENG PART B-RE, V20, P17, DOI 10.1089/ten.TEB.2013.0117; Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Shi JY, 2012, AM J PATHOL, V180, P715, DOI 10.1016/j.ajpath.2011.10.022; Shibata S, 2012, EUR J HISTOCHEM, V56, pe23; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; van Osch GJVM, 2000, TISSUE ENG, V6, P321, DOI 10.1089/107632700418047; von Bomhard A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071667; Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yanaga H, 2012, TISSUE ENG PT A, V18, P2020, DOI [10.1089/ten.tea.2011.0370, 10.1089/ten.TEA.2011.0370]; Yanaga H, 2009, AESTHET PLAST SURG, V33, P795, DOI 10.1007/s00266-009-9399-8; Yoon DM, 2006, ADV EXP MED BIOL, V585, P67; Yotsuyanagi T, 1999, PLAST RECONSTR SURG, V103, P1120, DOI 10.1097/00006534-199904040-00002	58	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105170	10.1371/journal.pone.0105170	http://dx.doi.org/10.1371/journal.pone.0105170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126941	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300089
J	Shen, YX; Liu, WL; Li, YH; Guan, HL				Shen, You-xin; Liu, Wei-li; Li, Yu-hui; Guan, Hui-lin			Large Sample Area and Size Are Needed for Forest Soil Seed Bank Studies to Ensure Low Discrepancy with Standing Vegetation	PLOS ONE			English	Article							SPECIES-AREA; RAIN-FORESTS; DENSITY; COMMUNITIES; RICHNESS	A large number of small-sized samples invariably shows that woody species are absent from forest soil seed banks, leading to a large discrepancy with the seedling bank on the forest floor. We ask: 1) Does this conventional sampling strategy limit the detection of seeds of woody species? 2) Are large sample areas and sample sizes needed for higher recovery of seeds of woody species? We collected 100 samples that were 10 cm (length) x10 cm (width) x10 cm (depth), referred to as larger number of small-sized samples (LNSS) in a 1 ha forest plot, and placed them to germinate in a greenhouse, and collected 30 samples that were 1 m x 1 m x10 cm, referred to as small number of large-sized samples (SNLS) and placed them (10 each) in a nearby secondary forest, shrub land and grass land. Only 15.7% of woody plant species of the forest stand were detected by the 100 LNSS, contrasting with 22.9%, 37.3% and 20.5% woody plant species being detected by SNLS in the secondary forest, shrub land and grassland, respectively. The increased number of species vs. sampled areas confirmed power-law relationships for forest stand, the LNSS and SNLS at all three recipient sites. Our results, although based on one forest, indicate that conventional LNSS did not yield a high percentage of detection for woody species, but SNLS strategy yielded a higher percentage of detection for woody species in the seed bank if samples were exposed to a better field germination environment. A 4 m(2) minimum sample area derived from power equations is larger than the sampled area in most studies in the literature. Increased sample size also is needed to obtain an increased sample area if the number of samples is to remain relatively low.	[Shen, You-xin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Shen, You-xin] Chinese Acad Sci, Restorat Ecol Grp, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Liu, Wei-li] Kunming Met Res Inst, Kunming, Peoples R China; [Li, Yu-hui; Guan, Hui-lin] Yunnan Normal Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Normal University	Shen, YX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China.	yxshen@xtbg.ac.cn			"Light in Western China" Program of Chinese Academy of Sciences; National Nature Scientific Foundation of China [41262013, 41371514, 41361075]	"Light in Western China" Program of Chinese Academy of Sciences; National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by grants from the "Light in Western China" Program of Chinese Academy of Sciences and the National Nature Scientific Foundation of China (41262013, 41371514, 41361075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BIGWOOD DW, 1988, ECOLOGY, V69, P497, DOI 10.2307/1940448; Bossuyt B, 2000, FUNCT ECOL, V14, P766, DOI 10.1046/j.1365-2435.2000.00483.x; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Butler BJ, 1998, BIOTROPICA, V30, P214, DOI 10.1111/j.1744-7429.1998.tb00056.x; CAIN STANLEY A., 1938, AMER MIDI NAT, V19, P573, DOI 10.2307/2420468; Cannone N, 2004, ANTARCT SCI, V16, P157, DOI 10.1017/S0954102004001956; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Dainou K, 2011, ECOL ENG, V37, P1499, DOI 10.1016/j.ecoleng.2011.05.004; Darwin C, 1859, ORIGIN SPECIES MEANS; DENSLOW JS, 1995, ECOL APPL, V5, P962, DOI 10.2307/2269347; Du XJ, 2007, FOREST ECOL MANAG, V238, P212, DOI 10.1016/j.foreco.2006.10.018; Dupuy JM, 1998, BIOTROPICA, V30, P223, DOI 10.1111/j.1744-7429.1998.tb00057.x; Esmailzadeh O, 2011, J AGR SCI TECH-IRAN, V13, P411; Ferner M, 2005, ECOLOGY SEEDS; FORCELLA F, 1984, AUST J AGR RES, V35, P645, DOI 10.1071/AR9840645; Forey E, 2012, COMMUNITY ECOL, V13, P194, DOI 10.1556/ComEc.13.2012.2.9; Garcia-Orth X, 2008, RESTOR ECOL, V16, P435, DOI 10.1111/j.1526-100X.2007.00320.x; Garwood N.C., 1989, ECOLOGY SOIL SEED BA, V1, P149, DOI DOI 10.1016/B978-0-12-440405-2.50014-2; GROSS KL, 1990, J ECOL, V78, P1079, DOI 10.2307/2260953; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jin Z., 1998, VEGETATION KUNMING; Pereira-Diniz SG, 2006, PLANT ECOL, V183, P337, DOI 10.1007/s11258-005-9044-9; Plue J, 2012, J VEG SCI, V23, P505, DOI 10.1111/j.1654-1103.2011.01361.x; Plue J, 2010, SEED SCI RES, V20, P13, DOI 10.1017/S0960258509990201; Shen YX, 2007, SEED SCI RES, V17, P99, DOI 10.1017/S0960258507708139; [沈有信 Shen Youxin], 2005, [广西植物, Guihaia], V25, P321; Storch D, 2012, NATURE, V488, P78, DOI 10.1038/nature11226; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Thompson K., 2000, Seeds: the ecology of regeneration in plant communities, P215, DOI 10.1079/9780851994321.0215; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Wu, 1980, VEGETATION CHINA; Zhang F.M., 1997, STUDY LUNAN STONE FO	37	6	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105235	10.1371/journal.pone.0105235	http://dx.doi.org/10.1371/journal.pone.0105235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140738	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200065
J	Choi, YS; Lee, SK; Bae, WJ; Kim, SJ; Cho, HJ; Hong, SH; Lee, JY; Hwang, TK; Kim, SW				Choi, Yong Sun; Lee, Sang Kuon; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Hwang, Tae-Kon; Kim, Sae Woong			Bariatric Surgery Improves the Cavernosal Neuronal, Vasorelaxation, and Contraction Mechanisms for Erectile Dysfunction As Result of Amelioration of Glucose Homeostasis in a Diabetic Rat Model	PLOS ONE			English	Article							CORPUS CAVERNOSUM; PENILE ERECTION; MICE LACKING; WEIGHT-LOSS; BODY-IMAGE; OBESE; PREVALENCE	Background: Bariatric surgery is an effective treatment option for both obesity and obesity-related type 2 diabetes mellitus (T2DM). However, little is known regarding the effects of bariatric surgery on erectile dysfunction among patients with T2DM. Therefore, we investigated whether bariatric surgery would lead to structural and biochemical changes in the corpus cavernosum. Material and Method: Twenty-five male Otsuka Long-Evans Tokushima Fatty rats were assigned to either a control group (sham operation, n = 10) or a bariatric surgery group (gastric bypass surgery, n = 15). Four weeks after the operation, each group of rats was evaluated with an oral glucose tolerance test (OGTT). The penile intracavernous pressure was measured for erectile functional analysis. Histologic evaluation of the tissue was performed with Masson's trichrome staining. Endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), Rho kinase, and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels in the corpus cavernosum were assayed by using western blot and ELISA. Results: The mean body weight of the bariatric surgery group was lower than the control group (p = 0.002). The postoperative OGTT result was lower in the bariatric surgery group than in the control group (p = 0.014), and this was lower than the preoperative value (p = 0.037). The intracavernous pressure/mean arterial pressure ratio was higher in the bariatric surgery group compared to the control group (p = 0.021), and a higher cavernosum smooth muscle/collagen ratio was observed in the bariatric surgery group compared to the control group (p = 0.025). Likewise, the expression of eNOS and nNOS was higher in bariatric surgery group than in the control group (p = 0.027 and p = 0.008, respectively). Decreased expression of Rho kinase and levels of 8-OHdG were observed in the bariatric surgery group (p = 0.032). Conclusion: In this animal model, bariatric surgery appears to ameliorate T2DM-related metabolic dysfunction leading to structural and biochemical changes in the corpus cavernosum, and thus, results in improvement of erectile dysfunction associated with T2DM.	[Choi, Yong Sun; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Hwang, Tae-Kon; Kim, Sae Woong] Catholic Univ Korea, Dept Urol, Coll Med, Seoul, South Korea; [Lee, Sang Kuon] Catholic Univ Korea, Dept Surg, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, SW (corresponding author), Catholic Univ Korea, Dept Urol, Coll Med, Seoul, South Korea.	ksw1227@catholic.ac.kr	Cho, Hyuk Jin/AAU-7753-2020	Cho, Hyuk Jin/0000-0003-2599-2950				Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Burnett AL, 2002, J ANDROL, V23, P92, DOI 10.1002/j.1939-4640.2002.tb02601.x; Burnett AL, 1996, MOL MED, V2, P288, DOI 10.1007/BF03401627; Chitaley K, 2001, INT J IMPOT RES, V13, P67, DOI 10.1038/sj.ijir.3900647; Chitaley K, 2009, J UROLOGY, V182, pS45, DOI 10.1016/j.juro.2009.07.089; Dallal RM, 2008, J AM COLL SURGEONS, V207, P859, DOI 10.1016/j.jamcollsurg.2008.08.006; DETEJADA IS, 1988, AM J PHYSIOL, V254, pH459, DOI 10.1152/ajpheart.1988.254.3.H459; Dixon JB, 2002, OBES SURG, V12, P65, DOI 10.1381/096089202321144612; Hidalgo-Tamola J, 2009, J SEX MED, V6, P916, DOI 10.1111/j.1743-6109.2008.01116.x; Jang H, 2012, REPROD FERT DEVELOP, V24, P649, DOI 10.1071/RD11174; Jesmin S, 2003, J MOL ENDOCRINOL, V31, P401, DOI 10.1677/jme.0.0310401; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kolotkin RL, 2006, OBESITY, V14, P472, DOI 10.1038/oby.2006.62; KREMEN AJ, 1954, ANN SURG, V140, P439, DOI 10.1097/00000658-195409000-00018; Lee YS, 2013, UROLOGY, V81, P873, DOI 10.1016/j.urology.2012.09.064; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Ranasinghe WKB, 2011, BJU INT, V107, P88, DOI 10.1111/j.1464-410X.2010.09509.x; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Takahashi R, 2003, J UROLOGY, V169, P2412, DOI 10.1097/01.ju.0000065808.45445.a1; Varela JE, 2011, CURR OPIN CLIN NUTR, V14, P396, DOI 10.1097/MCO.0b013e3283468e50; Werlinger K, 1997, J SEX MARITAL THER, V23, P74; Wessells H, 2006, BJU INT, V97, P1047, DOI 10.1111/j.1464-410X.2006.06059.X; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	25	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104042	10.1371/journal.pone.0104042	http://dx.doi.org/10.1371/journal.pone.0104042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137300	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100016
J	Kim, JG; Bae, JH; Kim, JA; Heo, K; Yang, K; Yi, JM				Kim, Joong-Gook; Bae, Jin-Han; Kim, Jin-Ah; Heo, Kyu; Yang, Kwangmo; Yi, Joo Mi			Combination Effect of Epigenetic Regulation and Ionizing Radiation in Colorectal Cancer Cells	PLOS ONE			English	Article							DNA METHYLTRANSFERASE; INDUCED APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE; 5-AZA-2'-DEOXYCYTIDINE; RADIOSENSITIVITY; METHYLATION; INHIBITOR; P53; ENHANCEMENT; ACTIVATION	Exposure of cells to ionizing radiation (IR) induces, not only, activation of multiple signaling pathways that play critical roles in cell fate determination, but also alteration of molecular pathways involved in cell death or survival. Recently, DNA methylation has been established as a critical epigenetic process involved in the regulation of gene expression in cancer cells, suggesting that DNA methylation inhibition may be an effective cancer treatment strategy. Because alterations of gene expression by DNA methylation have been considered to influence radioresponsiveness, we investigated the effect of a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5-aza-dC), on radiosensitivity. In addition, we investigated the underlying cellular mechanisms of combination treatments of ionizing irradiation (IR) and 5-aza-dC in human colon cancer cells. Colon cancer cell lines were initially tested for radiation sensitivity by IR in vitro and were treated with two different doses of 5-aza-dC. Survival of these cell lines was measured using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and clonogenic assays. The effects of 5-aza-dC along with irradiation on cell growth, cell cycle distribution, apoptosis, and apoptosis-related gene expression were examined. Combination irradiation treatment with 5-aza-dC significantly decreased growth activity compared with irradiation treatment alone or with 5-aza-dC treatment alone. The percentage of HCT116 cells in the sub-G1 phase and their apoptotic rate was increased when cells were treated with irradiation in combination with 5-aza-dC compared with either treatment alone. These observations were strongly supported by increased caspase activity, increased comet tails using comet assays, and increased protein levels of apoptosis-associated molecules (caspase 3/9, cleaved PARP). Our data demonstrated that 5-aza-dC enhanced radiosensitivity in colon cancer cells, and the combination effects of 5-aza-dC with radiation showed greater cellular effects than that of single treatment, suggesting that the combination of 5-aza-dC and radiation has the potential to become a clinical strategy for the treatment of cancer.	[Kim, Joong-Gook; Bae, Jin-Han; Kim, Jin-Ah; Heo, Kyu; Yang, Kwangmo; Yi, Joo Mi] Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Pusan, South Korea; [Yang, Kwangmo] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Yang, K (corresponding author), Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Pusan, South Korea.	kmyang@dirams.re.kr; jmyi@dirams.re.kr		Heo, Kyu/0000-0001-8833-4731	National R&D Program through the Dongnam Institute of Radiological & Medical Sciences - Korean Ministry of Education, Science, and Technology [50596-2014]; National Research Foundation (NRF); Ministry of Science, ICT and Future Planning (MSIP), Korean government through its National Nuclear Technology Program [2013M2A2A7043665]	National R&D Program through the Dongnam Institute of Radiological & Medical Sciences - Korean Ministry of Education, Science, and Technology; National Research Foundation (NRF); Ministry of Science, ICT and Future Planning (MSIP), Korean government through its National Nuclear Technology Program	This study was supported by a National R&D Program (50596-2014) through the Dongnam Institute of Radiological & Medical Sciences funded by the Korean Ministry of Education, Science, and Technology. This work was also supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning (MSIP), Korean government, through its National Nuclear Technology Program (2013M2A2A7043665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELE R, 1987, EUR J CANCER CLIN ON, V23, P1921, DOI 10.1016/0277-5379(87)90060-5; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; De Schutter H, 2009, INT J RADIAT ONCOL, V73, P904, DOI 10.1016/j.ijrobp.2008.10.032; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hofstetter B, 2010, INT J RADIAT ONCOL, V76, P1512, DOI 10.1016/j.ijrobp.2009.10.037; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Plimack ER, 2007, J CLIN ONCOL, V25, P4519, DOI 10.1200/JCO.2007.12.6029; Pulukuri SMK, 2005, INT J ONCOL, V26, P863; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Wang L, 2013, CANCER BIOTHER RADIO, V28, P34, DOI 10.1089/cbr.2012.1170; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang Y, 2001, J BIOL CHEM, V276, P28842, DOI 10.1074/jbc.M010525200	32	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105405	10.1371/journal.pone.0105405	http://dx.doi.org/10.1371/journal.pone.0105405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136811	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100090
J	Bahaji, A; Baroja-Fernandez, E; Sanchez-Lopez, AM; Munoz, FJ; Li, J; Almagro, G; Montero, M; Pujol, P; Galarza, R; Kaneko, K; Oikawa, K; Wada, K; Mitsui, T; Pozueta-Romero, J				Bahaji, Abdellatif; Baroja-Fernandez, Edurne; Maria Sanchez-Lopez, Angela; Jose Munoz, Francisco; Li, Jun; Almagro, Goizeder; Montero, Manuel; Pujol, Pablo; Galarza, Regina; Kaneko, Kentaro; Oikawa, Kazusato; Wada, Kaede; Mitsui, Toshiaki; Pozueta-Romero, Javier			HPLC-MS/MS Analyses Show That the Near-Starchless aps1 and pgm Leaves Accumulate Wild Type Levels of ADPglucose: Further Evidence for the Occurrence of Important ADPglucose Biosynthetic Pathway(s) Alternative to the pPGI-pPGM-AGP Pathway	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; ADENOSINE-DIPHOSPHATE GLUCOSE; SUCROSE SYNTHASE ACTIVITY; IN-SOURCE LEAVES; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; GLYCOGEN BIOSYNTHESIS; TRANSITORY STARCH; LEAF STARCH; MOLECULAR CHARACTERIZATION	In leaves, it is widely assumed that starch is the end-product of a metabolic pathway exclusively taking place in the chloroplast that (a) involves plastidic phosphoglucomutase (pPGM), ADPglucose (ADPG) pyrophosphorylase (AGP) and starch synthase (SS), and (b) is linked to the Calvin-Benson cycle by means of the plastidic phosphoglucose isomerase (pPGI). This view also implies that AGP is the sole enzyme producing the starch precursor molecule, ADPG. However, mounting evidence has been compiled pointing to the occurrence of important sources, other than the pPGI-pPGM-AGP pathway, of ADPG. To further explore this possibility, in this work two independent laboratories have carried out HPLC-MS/MS analyses of ADPG content in leaves of the near-starchless pgm and aps1 mutants impaired in pPGM and AGP, respectively, and in leaves of double aps1/pgm mutants grown under two different culture conditions. We also measured the ADPG content in wild type (WT) and aps1 leaves expressing in the plastid two different ADPG cleaving enzymes, and in aps1 leaves expressing in the plastid GlgC, a bacterial AGP. Furthermore, we measured the ADPG content in ss3/ss4/aps1 mutants impaired in starch granule initiation and chloroplastic ADPG synthesis. We found that, irrespective of their starch contents, pgm and aps1 leaves, WT and aps1 leaves expressing in the plastid ADPG cleaving enzymes, and aps1 leaves expressing in the plastid GlgC accumulate WT ADPG content. In clear contrast, ss3/ss4/aps1 leaves accumulated ca. 300 fold-more ADPG than WT leaves. The overall data showed that, in Arabidopsis leaves, (a) there are important ADPG biosynthetic pathways, other than the pPGI-pPGM-AGP pathway, (b) pPGM and AGP are not major determinants of intracellular ADPG content, and (c) the contribution of the chloroplastic ADPG pool to the total ADPG pool is low.	[Bahaji, Abdellatif; Baroja-Fernandez, Edurne; Maria Sanchez-Lopez, Angela; Jose Munoz, Francisco; Li, Jun; Almagro, Goizeder; Montero, Manuel; Pozueta-Romero, Javier] Univ Publ Navarra, Inst Agrobiotecnol, CSIC, Nafarroa, Spain; [Pujol, Pablo; Galarza, Regina] Univ Publ Navarra, Serv Apoyo Invest, Nafarroa, Spain; [Kaneko, Kentaro; Oikawa, Kazusato; Wada, Kaede; Mitsui, Toshiaki] Niigata Univ, Dept Appl Biol Chem, Niigata, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Universidad Publica de Navarra; Niigata University	Pozueta-Romero, J (corresponding author), Univ Publ Navarra, Inst Agrobiotecnol, CSIC, Nafarroa, Spain.	javier.pozueta@unavarra.es	Pozueta-Romero, Javier/AAP-9341-2021; Muñoz, Francisco/I-3547-2012; Mitsui, Toshikai/N-9773-2017; Bahaji, Abdellatif/C-4105-2015; Montero, Manuel/K-7166-2013; Pozueta-Romero, Javier/G-3766-2011; Sánchez-López, Ángela María/Y-9884-2019; Almagro, Goizeder/Y-9900-2019; Edurne, Baroja-Fernandez/I-4037-2012	Pozueta-Romero, Javier/0000-0002-0335-9663; Muñoz, Francisco/0000-0002-0426-2118; Mitsui, Toshikai/0000-0002-9165-8830; Bahaji, Abdellatif/0000-0002-5270-497X; Montero, Manuel/0000-0002-8036-8758; Pozueta-Romero, Javier/0000-0002-0335-9663; Sánchez-López, Ángela María/0000-0001-9620-0258; Almagro, Goizeder/0000-0001-7035-9965; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Oikawa, Kazusato/0000-0002-1033-9089	Comision Interministerial de Ciencia y Tecnologia [BIO2010-18239]; Fondo Europeo de Desarrollo Regional (Spain); Government of Navarra [IIM010491.RI1]; Iden Biotechnology; Ministry of Education, Culture, Sports, Science and Technology, Japan [22114507, 22380186]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission); Government of Navarra; Iden Biotechnology; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by the grants [BIO2010-18239] from the Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) and [IIM010491.RI1] from the Government of Navarra, and by Iden Biotechnology. This research was also supported by Scientific Research on Innovative Areas [22114507] and Grants-in-Aid for Scientific Research (B) [22380186] from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Bahaji A, 2014, 12 PLANT MOL BIOL M; Bahaji A, 2013, 13 SPAIN PORT C PLAN; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P1162, DOI 10.1093/pcp/pcr067; Baroja-Fernandez E, 2005, TRENDS PLANT SCI, V10, P156, DOI 10.1016/j.tplants.2005.02.003; Baroja-Fernandez E, 2004, P NATL ACAD SCI USA, V101, P13080, DOI 10.1073/pnas.0402883101; Baroja-Fernandez E, 2003, PLANT CELL PHYSIOL, V44, P500, DOI 10.1093/pcp/pcg062; Baroja-Fernandez E, 2001, PLANT CELL PHYSIOL, V42, P1311, DOI 10.1093/pcp/pce175; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, pE777, DOI 10.1073/pnas.1201538109; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chen MJ, 2011, PLANT CELL, V23, P2991, DOI 10.1105/tpc.111.085829; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Crumpton-Taylor M, 2013, NEW PHYTOL, V200, P1064, DOI 10.1111/nph.12455; DANKERT M, 1964, BIOCHIM BIOPHYS ACTA, V81, P78, DOI 10.1016/0926-6569(64)90337-2; DAVID M, 1990, J CLIN INVEST, V86, P612, DOI 10.1172/JCI114752; DELMER DP, 1972, J BIOL CHEM, V247, P3822; Eydallin G, 2007, FEBS LETT, V581, P4417, DOI 10.1016/j.febslet.2007.08.016; Eydallin G, 2007, FEBS LETT, V581, P2947, DOI 10.1016/j.febslet.2007.05.044; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; FOX TC, 1984, PLANT PHYSIOL, V76, P763, DOI 10.1104/pp.76.3.763; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GAUDET G, 1992, EUR J BIOCHEM, V207, P155, DOI 10.1111/j.1432-1033.1992.tb17032.x; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Giese JO, 2005, FEBS LETT, V579, P827, DOI 10.1016/j.febslet.2004.12.071; Guedon E, 2000, J BACTERIOL, V182, P2010, DOI 10.1128/JB.182.7.2010-2017.2000; Guerra LT, 2013, J BIOTECHNOL, V166, P65, DOI 10.1016/j.jbiotec.2013.04.005; Kaneko K, 2014, PLANT CELL PHYSIOL, V55, P320, DOI 10.1093/pcp/pct139; KIEL JAKW, 1994, MOL MICROBIOL, V11, P203, DOI 10.1111/j.1365-2958.1994.tb00301.x; Kleczkowski LA, 2000, BBA-PROTEIN STRUCT M, V1476, P103, DOI 10.1016/S0167-4838(99)00229-0; Kleczkowski LA, 1999, FEBS LETT, V448, P153, DOI 10.1016/S0014-5793(99)00346-4; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; LEHMANN M, 1976, ARCH MICROBIOL, V111, P93, DOI 10.1007/BF00446554; Lepek VC, 2002, MOL PLANT MICROBE IN, V15, P368, DOI 10.1094/MPMI.2002.15.4.368; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; Lozovaya VV, 1996, PLANT PHYSIOL, V111, P921, DOI 10.1104/pp.111.3.921; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Marroqui S, 2001, J BACTERIOL, V183, P854, DOI 10.1128/JB.183.3.854-864.2001; Martin MC, 1997, J BACTERIOL, V179, P7784, DOI 10.1128/jb.179.24.7784-7789.1997; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; MASSILLON D, 1995, J BIOL CHEM, V270, P19351, DOI 10.1074/jbc.270.33.19351; McCoy JG, 2006, BIOCHEMISTRY-US, V45, P3154, DOI 10.1021/bi052232m; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980; Moran-Zorzano MT, 2007, FEBS LETT, V581, P4423, DOI 10.1016/j.febslet.2007.08.017; Moreno-Bruna B, 2001, P NATL ACAD SCI USA, V98, P8128, DOI 10.1073/pnas.131214098; Munoz FJ, 2005, PLANT CELL PHYSIOL, V46, P1366, DOI 10.1093/pcp/pci148; Munoz FJ, 2006, BIOCATAL BIOTRANSFOR, V24, P63, DOI 10.1080/10242420500518839; MURATA T, 1966, ARCH BIOCHEM BIOPHYS, V113, P34, DOI 10.1016/0003-9861(66)90153-6; MURATA T, 1977, AGR BIOL CHEM TOKYO, V41, P1995, DOI 10.1080/00021369.1977.10862796; NEIJSSEL OM, 1990, BIOCHIM BIOPHYS ACTA, V1018, P252, DOI 10.1016/0005-2728(90)90260-B; Neuhaus HE, 2005, TRENDS PLANT SCI, V10, P154, DOI 10.1016/j.tplants.2005.02.002; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; OKITA TW, 1992, PLANT PHYSIOL, V100, P560, DOI 10.1104/pp.100.2.560; Olsson T, 2003, J BIOL CHEM, V278, P44439, DOI 10.1074/jbc.M306265200; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; POZUETAROMERO J, 1991, PLANT PHYSIOL, V97, P1565, DOI 10.1104/pp.97.4.1565; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; Rao M, 1995, PLANT PHYSIOL, V107, P195; Rodriguez-Lopez M, 2000, P NATL ACAD SCI USA, V97, P8705, DOI 10.1073/pnas.120168097; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; SCOTT P, 1995, PLANT PHYSIOL, V108, P1569, DOI 10.1104/pp.108.4.1569; SILVIUS JE, 1979, PLANT PHYSIOL, V64, P1070, DOI 10.1104/pp.64.6.1070; Smith AM, 2012, P NATL ACAD SCI USA, V109, pE776, DOI 10.1073/pnas.1200878109; Sokolov LN, 1998, BIOCHEM J, V336, P681, DOI 10.1042/bj3360681; STITT M, 1989, PHYSIOL PLANTARUM, V77, P633, DOI 10.1111/j.1399-3054.1989.tb05402.x; STITT M, 1981, BIOCHIM BIOPHYS ACTA, V638, P1, DOI 10.1016/0005-2728(81)90179-1; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TACKE M, 1991, PLANTA, V185, P220, DOI 10.1007/BF00194064; Tanase K, 2000, PLANT CELL PHYSIOL, V41, P408, DOI 10.1093/pcp/41.4.408; Ugalde JE, 1998, J BACTERIOL, V180, P6557, DOI 10.1128/JB.180.24.6557-6564.1998; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Walters RG, 2004, PLANT PHYSIOL, V135, P891, DOI 10.1104/pp.104.040469; Wang AY, 1999, PLANT CELL PHYSIOL, V40, P800, DOI 10.1093/oxfordjournals.pcp.a029608; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yu TS, 2000, PLANT PHYSIOL, V123, P319, DOI 10.1104/pp.123.1.319; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zervosen A, 1998, J MOL CATAL B-ENZYM, V5, P25, DOI 10.1016/S1381-1177(98)00040-X; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	98	17	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104997	10.1371/journal.pone.0104997	http://dx.doi.org/10.1371/journal.pone.0104997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133777	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700060
J	Dahl, M; Maturi, V; Lonn, P; Papoutsoglou, P; Zieba, A; Vanlandewijck, M; van der Heide, LP; Watanabe, Y; Soderberg, O; Hottiger, MO; Heldin, CH; Moustakas, A				Dahl, Markus; Maturi, Varun; Lonn, Peter; Papoutsoglou, Panagiotis; Zieba, Agata; Vanlandewijck, Michael; van der Heide, Lars P.; Watanabe, Yukihide; Soderberg, Ola; Hottiger, Michael O.; Heldin, Carl-Henrik; Moustakas, Aristidis			Fine-Tuning of Smad Protein Function by Poly(ADP-Ribose) Polymerases and Poly(ADP-Ribose) Glycohydrolase during Transforming Growth Factor beta Signaling	PLOS ONE			English	Article							ADP-RIBOSYLATION; PARP-1; TRANSCRIPTION; BINDING; ACETYLATION; EXPRESSION; RECEPTORS; LYSINE-36; PROGRESS; OUTCOMES	Background: Initiation, amplitude, duration and termination of transforming growth factor beta (TGF beta) signaling via Smad proteins is regulated by post-translational modifications, including phosphorylation, ubiquitination and acetylation. We previously reported that ADP-ribosylation of Smads by poly(ADP-ribose) polymerase 1 (PARP-1) negatively influences Smad-mediated transcription. PARP-1 is known to functionally interact with PARP-2 in the nucleus and the enzyme poly(ADP-ribose) glycohydrolase (PARG) can remove poly(ADP-ribose) chains from target proteins. Here we aimed at analyzing possible cooperation between PARP-1, PARP-2 and PARG in regulation of TGF beta signaling. Methods: A robust cell model of TGF beta signaling, i.e. human HaCaT keratinocytes, was used. Endogenous Smad3 ADP-ribosylation and protein complexes between Smads and PARPs were studied using proximity ligation assays and co-immunoprecipitation assays, which were complemented by in vitro ADP-ribosylation assays using recombinant proteins. Real-time RT-PCR analysis of mRNA levels and promoter-reporter assays provided quantitative analysis of gene expression in response to TGF beta stimulation and after genetic perturbations of PARP-1/-2 and PARG based on RNA interference. Results: TGF beta signaling rapidly induces nuclear ADP-ribosylation of Smad3 that coincides with a relative enhancement of nuclear complexes of Smads with PARP-1 and PARP-2. Inversely, PARG interacts with Smads and can de-ADP-ribosylate Smad3 in vitro. PARP-1 and PARP-2 also form complexes with each other, and Smads interact and activate auto-ADP-ribosylation of both PARP-1 and PARP-2. PARP-2, similar to PARP-1, negatively regulates specific TGF beta target genes (fibronectin, Smad7) and Smad transcriptional responses, and PARG positively regulates these genes. Accordingly, inhibition of TGF beta-mediated transcription caused by silencing endogenous PARG expression could be relieved after simultaneous depletion of PARP-1. Conclusion: Nuclear Smad function is negatively regulated by PARP-1 that is assisted by PARP-2 and positively regulated by PARG during the course of TGF beta signaling.	[Dahl, Markus; Maturi, Varun; Lonn, Peter; Papoutsoglou, Panagiotis; Vanlandewijck, Michael; van der Heide, Lars P.; Watanabe, Yukihide; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden; [Zieba, Agata; Soderberg, Ola] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland; [Moustakas, Aristidis] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University; University of Zurich; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden.	aris.moustakas@imbim.uu.se	Söderberg, Ola/O-5130-2017; Hottiger, Michael O./J-7747-2013; Papoutsoglou, Panagiotis/AAF-8898-2019; Maturi, Varun/K-1837-2019	Söderberg, Ola/0000-0003-2883-1925; Hottiger, Michael O./0000-0002-7323-2270; Papoutsoglou, Panagiotis/0000-0003-2115-3500; Maturi, Varun/0000-0003-1177-0839; Vanlandewijck, Michael/0000-0002-0709-7808; van der Heide, Lars P./0000-0003-1779-425X	Ludwig Cancer Research; Swedish Research Council [K2007-66X-14936-04-3, K2010-67X-14936-07-3, K2013-66X-14936-10-5, K2012-77PK-21931-01-2]; Bodossaki Foundation, Greece	Ludwig Cancer Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bodossaki Foundation, Greece	This work was supported by Ludwig Cancer Research grants to A. M. and C.-H. H., the Swedish Research Council grants K2007-66X-14936-04-3, K2010-67X-14936-07-3 and K2013-66X-14936-10-5 to A. M., the Swedish Research Council grant K2012-77PK-21931-01-2 to P. L., and the Bodossaki Foundation, Greece to P. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Haenni SS, 2008, INT J BIOCHEM CELL B, V40, P2274, DOI 10.1016/j.biocel.2008.03.008; Haenni SS, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-39; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hottiger MO, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001645; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yelamos J, 2011, AM J CANCER RES, V1, P328; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250	33	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103651	10.1371/journal.pone.0103651	http://dx.doi.org/10.1371/journal.pone.0103651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133494	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000341302700014
J	Socias, ME; Marshall, BDL; Aristegui, I; Zalazar, V; Romero, M; Sued, O; Kerr, T				Socias, Maria Eugenia; Marshall, Brandon D. L.; Aristegui, Ines; Zalazar, Virginia; Romero, Marcela; Sued, Omar; Kerr, Thomas			Towards Full Citizenship: Correlates of Engagement with the Gender Identity Law among Transwomen in Argentina	PLOS ONE			English	Article							TRANSGENDER WOMEN; RISK BEHAVIORS; UNDOCUMENTED IMMIGRANTS; TRANSMITTED INFECTIONS; HEALTH-CARE; HIV; ACCESS; DISCRIMINATION; INTERVENTIONS; POPULATIONS	Introduction: In May 2012, Argentina passed its "Gender Identity'' Law, which aimed to address the legal invisibility, discrimination and marginalization that transgender individuals have historically faced. The aim of this study was to explore factors associated with engagement with the Gender Identity Law among transwomen living in Argentina. Methods: Data were derived from a 2013 nationwide, cross-sectional study involving transwomen in Argentina. Using multivariate logistic regression, we assessed the prevalence and factors associated with acquiring a gender-congruent identity card within the first 18 months of enactment of the Gender Identity Law. Results: Among 452 transwomen, 260 (57.5%) reported that they had obtained a new gender-congruent identity card. In multivariate analysis, factors positively associated with acquiring a new ID were: previously experiencing discrimination by healthcare workers (adjusted odd ratio [aOR] = 2.01, 95% CI: 1.27-3.20); having engaged in transition procedures (aOR = 3.06, 95% CI: 1.58-5.93); and having a job other than sex work (aOR = 1.81, 95% CI: 1.06-3.10). Foreign born transwomen were less likely to have obtained a new ID (aOR = 0.14, 95% CI: 0.06-0.33). Conclusions: More than half of transwomen in our sample acquired a new gender-congruent ID within the first 18 months of enactment of the Gender Identity Law. However, access to and uptake of this right has been heterogeneous. In particular, our findings suggest that the most empowered transwomen may have been among the first to take advantage of this right. Although educational level, housing conditions, HIV status and sex work were not associated with the outcome, foreign-born status was a strong negative correlate of new ID acquisition. Therefore, additional efforts should be made in order to ensure that benefits of this founding policy reach all transwomen in Argentina.	[Socias, Maria Eugenia; Aristegui, Ines; Zalazar, Virginia; Sued, Omar] Fdn Huesped, Buenos Aires, DF, Argentina; [Marshall, Brandon D. L.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Romero, Marcela] ATTTA, Buenos Aires, DF, Argentina; [Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Kerr, Thomas] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V5Z 1M9, Canada	Brown University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Socias, ME (corresponding author), Fdn Huesped, Buenos Aires, DF, Argentina.	eugenia.socias@huesped.org.ar	Sued, Omar/H-3325-2019	Sued, Omar/0000-0001-5818-770X; Aristegui, Ines/0000-0002-1196-5620	Open Society Foundations [OR2012-01282]	Open Society Foundations	The fieldwork for this study was supported by a grant from the Open Society Foundations (#OR2012-01282). However, no additional funding for publication was granted. http://www.opensocietyfoundations.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ANO LEY IDENTIAD G; Aristegui I, 2012, PERCEPCIONES EXPERIE; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; Berkins L., 2007, CUMBIA COPETEO LAGRI; Bradford J, 2009, AM J PUBLIC HEALTH, V103, P1820; Brennan J, 2012, AM J PUBLIC HEALTH, V102, P1751, DOI 10.2105/AJPH.2011.300433; Campbell RM, 2014, J IMMIGR MINOR HEALT, V16, P165, DOI 10.1007/s10903-012-9740-1; Chavez KR, 2011, J HOMOSEXUAL, V58, P189, DOI 10.1080/00918369.2011.540175; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Cray A, 2012, ID ACCURATELY REFLEC; Cruz TM, 2014, SOC SCI MED, V110, P65, DOI 10.1016/j.socscimed.2014.03.032; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Goldenberg SM, 2012, J IMMIGR MINOR HEALT, V14, P48, DOI 10.1007/s10903-011-9505-2; Gonzales G, 2014, NEW ENGL J MED, V370, P1373, DOI 10.1056/NEJMp1400254; Grant J.M., 2011, INJUSTICE EVERY TURN; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Institute of Medicine (IOM), 2011, HLTH LESB GAY BIS TR; Kenagy GP, 2005, HEALTH SOC WORK, V30, P19, DOI 10.1093/hsw/30.1.19; Kerr T, 2014, J AIDS CLIN RES, V5, pe114; Khan SI, 2009, J HEALTH POPUL NUTR, V27, P441, DOI 10.3329/jhpn.v27i4.3388; Kullgren JT, 2003, AM J PUBLIC HEALTH, V93, P1630, DOI 10.2105/AJPH.93.10.1630; Magalhaes L, 2010, J IMMIGR MINOR HEALT, V12, P132, DOI 10.1007/s10903-009-9280-5; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Manalansan MF, 2006, INT MIGR REV, V40, P224, DOI 10.1111/j.1747-7379.2006.00009.x; Morrow KM, 2007, AIDS BEHAV, V11, P586, DOI 10.1007/s10461-007-9213-z; Nemoto T, 2004, AIDS CARE, V16, P724, DOI 10.1080/09540120413331269567; Nuttbrock L, 2009, JAIDS-J ACQ IMM DEF, V52, P417, DOI 10.1097/QAI.0b013e3181ab6ed8; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Organizacion Panamericana de la Salud, 2013, EL DES AT INT; Sausa LA, 2007, ARCH SEX BEHAV, V36, P768, DOI 10.1007/s10508-007-9210-3; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Sevelius JM, 2009, AIDS EDUC PREV, V21, P113, DOI 10.1521/aeap.2009.21.2.113; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Stroumsa D, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2013.301789; Styperek Andrew, 2013, J Clin Aesthet Dermatol, V6, P22; Wallace PM, 2010, INT J TRANSGENDERISM, V12, P167, DOI 10.1080/15532739.2010.514222; Wight RG, 2013, AM J PUBLIC HEALTH, V103, P339, DOI 10.2105/AJPH.2012.301113	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105402	10.1371/journal.pone.0105402	http://dx.doi.org/10.1371/journal.pone.0105402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133547	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700112
J	Byun, K; Bayarsaikhan, D; Bayarsaikhan, E; Son, M; Oh, S; Lee, J; Son, HI; Won, MH; Kim, SU; Song, BJ; Lee, B				Byun, Kyunghee; Bayarsaikhan, Delger; Bayarsaikhan, Enkhjargal; Son, Myeongjoo; Oh, Seyeon; Lee, Jaesuk; Son, Hye-in; Won, Moo-Ho; Kim, Seung U.; Song, Byoung-Joon; Lee, Bonghee			Microglial AGE-Albumin Is Critical in Promoting Alcohol-Induced Neurodegeneration in Rats and Humans	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BINGE ETHANOL EXPOSURE; INCREASED MCP-1; BRAIN; ACTIVATION; NEUROINFLAMMATION; REGIONS; NEUROGENESIS; EXPRESSION; MECHANISM	Alcohol is a neurotoxic agent, since long-term heavy ingestion of alcohol can cause various neural diseases including fetal alcohol syndrome, cerebellar degeneracy and alcoholic dementia. However, the molecular mechanisms of alcohol-induced neurotoxicity are still poorly understood despite numerous studies. Thus, we hypothesized that activated microglial cells with elevated AGE-albumin levels play an important role in promoting alcohol-induced neurodegeneration. Our results revealed that microglial activation and neuronal damage were found in the hippocampus and entorhinal cortex following alcohol treatment in a rat model. Increased AGE-albumin synthesis and secretion were also observed in activated microglial cells after alcohol exposure. The expressed levels of receptor for AGE (RAGE)-positive neurons and RAGE-dependent neuronal death were markedly elevated by AGE-albumin through the mitogen activated protein kinase pathway. Treatment with soluble RAGE or AGE inhibitors significantly diminished neuronal damage in the animal model. Furthermore, the levels of activated microglial cells, AGE-albumin and neuronal loss were significantly elevated in human brains from alcoholic indivisuals compared to normal controls. Taken together, our data suggest that increased AGE-albumin from activated microglial cells induces neuronal death, and that efficient regulation of its synthesis and secretion is a therapeutic target for preventing alcohol-induced neurodegeneration.	[Byun, Kyunghee; Bayarsaikhan, Delger; Bayarsaikhan, Enkhjargal; Son, Myeongjoo; Oh, Seyeon; Lee, Jaesuk; Lee, Bonghee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Ctr Genom & Prote, Inchon, South Korea; [Byun, Kyunghee; Lee, Bonghee] Gachon Univ, Grad Sch Med, Dept Anat & Cell Biol, Inchon, South Korea; [Son, Hye-in] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA	Gachon University; Gachon University; University of California System; University of California Berkeley; Kangwon National University; Kangwon National University; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Song, BJ (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA.	bj.song@nih.gov; bhlee@gachon.ac.kr	Son, myeongjoo/GWQ-6808-2022		National Research Foundation - Korean government [20120002979]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	National Research Foundation - Korean government(Korean Government); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Research Foundation grant funded by the Korean government (K. B.) (20120002979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P252, DOI 10.1111/j.1530-0277.2012.01889.x; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Byun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037917; Crew FT, 2011, BRAIN BEHAV IMMUN, V25, P4; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hinojosa AE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-77; Jeanblanc J, 2013, EUR J NEUROSCI, V37, P607, DOI 10.1111/ejn.12067; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Matsumoto I, 2009, ALCOHOL ALCOHOLISM, V44, P171, DOI 10.1093/alcalc/agn104; McClain JA, 2011, BRAIN BEHAV IMMUN, V25, pS120, DOI 10.1016/j.bbi.2011.01.006; MONTOLIU C, 1995, J NEUROCHEM, V65, P2561; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nelson S, 2012, NAT REV IMMUNO, V2, P205; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Nowoslawski L, 2005, J NEUROPATH EXP NEUR, V64, P490, DOI 10.1093/jnen/64.6.490; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Sullivan EV, 2008, EXP NEUROL, V213, P10, DOI 10.1016/j.expneurol.2008.05.016; Tateno M, 2008, PSYCHIAT INVEST, V5, P21, DOI 10.4306/pi.2008.5.1.21; Vetreno RP, 2013, NEUROBIOL DIS, V59, P52, DOI 10.1016/j.nbd.2013.07.002; Vilpoux C, 2009, ALCOHOL CLIN EXP RES, V33, P945, DOI 10.1111/j.1530-0277.2009.00916.x; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052	39	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104699	10.1371/journal.pone.0104699	http://dx.doi.org/10.1371/journal.pone.0104699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140518	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200027
J	Cabieses, B; Uphoff, E; Pinart, M; Anto, JM; Wright, J				Cabieses, Baltica; Uphoff, Eleonora; Pinart, Mariona; Maria Anto, Josep; Wright, John			A Systematic Review on the Development of Asthma and Allergic Diseases in Relation to International Immigration: The Leading Role of the Environment Confirmed	PLOS ONE			English	Article							SOCIAL DETERMINANTS; HYGIENE HYPOTHESIS; PREVALENCE; HEALTH; CHILDREN; POPULATION; HETEROGENEITY; SENSITIZATION; ASSOCIATIONS; ADOLESCENTS	Background: The prevalence of asthma and allergic diseases is rising worldwide. Evidence on potential causal pathways of asthma and allergies is growing, but findings have been contradictory, particularly on the interplay between allergic diseases and understudied social determinants of health like migration status. This review aimed at providing evidence for the association between migration status and asthma and allergies, and to explore the mechanisms between migration status and the development of asthma and allergies. Methods and Findings: Systematic review on asthma and allergies and immigration status in accordance with the guidelines set by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The pooled odds ratio (OR) of the prevalence of asthma in immigrants compared to the host population was 0.60 (95% CI 0.45-0.84), and the pooled OR for allergies was 1.01 (95% CI 0.62-1.69). The pooled OR for the prevalence of asthma in first generation versus second generation immigrants was 0.37 (95% CI 0.25-0.58). Comparisons between populations in their countries of origin and those that emigrated vary depending on their level of development; more developed countries show higher rates of asthma and allergies. Conclusions: Our findings suggest a strong influence of the environment on the development of asthma and allergic diseases throughout the life course. The prevalence of asthma is generally higher in second generation than first generation immigrants. With length of residence in the host country the prevalence of asthma and allergic diseases increases steadily. These findings are consistent across study populations, host countries, and children as well as adults. Differences have been found to be significant when tested in a linear model, as well as when comparing between early and later age of migration, and between shorter and longer time of residence.	[Cabieses, Baltica] Univ Desarrollo, Clin Alemana, CAS UDD, Lo Barnechea Santiago, Chile; [Cabieses, Baltica; Uphoff, Eleonora; Wright, John] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Cabieses, Baltica; Uphoff, Eleonora] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Pinart, Mariona; Maria Anto, Josep] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Pinart, Mariona; Maria Anto, Josep] IMIM Hosp del Mar Res Inst, Barcelona, Spain; [Pinart, Mariona; Maria Anto, Josep] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Pinart, Mariona; Maria Anto, Josep] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Clinica Alemana; Universidad del Desarrollo; Bradford Royal Infirmary; University of York - UK; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University	Cabieses, B (corresponding author), Univ Desarrollo, Clin Alemana, CAS UDD, Lo Barnechea Santiago, Chile.	bcabieses@udd.cl	Pinart Gilberga, Mariona/GLS-8842-2022; Pinart, Mariona/L-1931-2015; Cabieses, Baltica/V-5024-2017; Anto, J M/H-2676-2014; Wright, John/H-1624-2012	Pinart Gilberga, Mariona/0000-0002-8223-1325; Pinart, Mariona/0000-0002-8223-1325; Cabieses, Baltica/0000-0003-0756-1954; Anto, J M/0000-0002-4736-8529; Wright, John/0000-0001-9572-7293; Uphoff, Eleonora/0000-0002-9759-2502	MeDALL project; NIHR Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humberside; Health Cooperation Work Programme of the 7th Framework programme [261357]	MeDALL project; NIHR Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humberside; Health Cooperation Work Programme of the 7th Framework programme	This review was funded by the MeDALL project and the NIHR Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humberside. MeDALL is a collaborative project funded by the Health Cooperation Work Programme of the 7th Framework programme (grant agreement No. 261357). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsowaidi S, 2010, INT ARCH ALLERGY IMM, V153, P274, DOI 10.1159/000314368; [Anonymous], 2006, Nat Biotechnol, V24, P368; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-8; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Cabieses B, 2013, REV PANAM SALUD PUBL, V34, P68; Cabieses B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1013; D'Amato G, 2011, WORLD ALLERGY ORGAN, V4, P121, DOI 10.1097/WOX.0b013e3182260a57; Davies A A, 2010, World Hosp Health Serv, V46, P5; Davis KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053723; Ding HL, 2009, J IMMIGR MINOR HEALT, V11, P446, DOI 10.1007/s10903-008-9200-0; Dominguez-Ortega J, 2011, AN SIST SANIT NAVAR, V34, P43; Dumanovsky T, 2007, J ASTHMA, V44, P297, DOI 10.1080/02770900701344140; Eldeirawi K, 2005, J ALLERGY CLIN IMMUN, V116, P42, DOI 10.1016/j.jaci.2005.03.041; Eldeirawi K, 2009, J ASTHMA, V46, P796, DOI 10.3109/02770900903114572; Esteban-Vasallo MD, 2009, GAC SANIT, V23, P548, DOI 10.1016/j.gaceta.2009.05.009; Farfel A, 2007, ISRAEL MED ASSOC J, V9, P149; Fennelly Katherine, 2007, Minn Med, V90, P51; Gagnier JJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-106; Hjern A, 1999, PEDIATR ALLERGY IMMU, V10, P101, DOI 10.1034/j.1399-3038.1999.00023.x; Hoffmann B, 2009, INT J HYG ENVIR HEAL, V212, P146, DOI 10.1016/j.ijheh.2008.04.002; Huh J, 2008, J IMMIGR MINOR HEALT, V10, P103, DOI 10.1007/s10903-007-9065-7; Johnson Mary, 2005, J Immigr Health, V7, P165, DOI 10.1007/s10903-005-3673-x; Jung J, 2013, CLIN EXP ALLERGY, V43, P425, DOI 10.1111/cea.12089; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P686, DOI 10.1007/s00103-007-0230-x; Kaneko Y, 2013, INT J CHRONIC OBSTR, V8, P65, DOI 10.2147/COPD.S39617; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Koinis-Mitchell D, 2011, J PEDIATR PSYCHOL, V36, P1130, DOI 10.1093/jpepsy/jsr041; Lamarche Paul A, 2011, Healthc Policy, V6, P46; Lee T, 2003, PUBLIC HEALTH REP, V118, P215, DOI 10.1093/phr/118.3.215; Marcon A, 2011, RESP MED, V105, P204, DOI 10.1016/j.rmed.2010.09.009; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Nations U, 2003, WORLD MIGR MAN MIGR; Nwaru Bright I, 2013, Clin Transl Allergy, V3, P13, DOI 10.1186/2045-7022-3-13; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Ormerod LP, 1999, RESP MED, V93, P16, DOI 10.1016/S0954-6111(99)90071-9; Palloni A, 2004, DEMOGRAPHY, V41, P385, DOI 10.1353/dem.2004.0024; Pawankar R, 2012, CURR OPIN ALLERGY CL, V12, P39, DOI 10.1097/ACI.0b013e32834ec13b; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Pluye P., 2011, PROPOSAL MIXED METHO; Prady SL, 2014, ACUPUNCT MED, V32, P56, DOI 10.1136/acupmed-2013-010364; Rosenberg R, 1999, Fam Med, V31, P276; Rottem M, 2005, INT ARCH ALLERGY IMM, V136, P198, DOI 10.1159/000083894; Sakai R, 2009, ACTA PAEDIATR, V98, P573, DOI 10.1111/j.1651-2227.2008.01130.x; Schlaud M, 2007, BUNDESGESUNDHEITSBLA, V50, P701, DOI 10.1007/s00103-007-0231-9; Svendsen ER, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-55; Tobias A, 2001, EUR RESPIR J, V18, P459, DOI 10.1183/09031936.01.00026501; van Amsterdam JGC, 2004, INT ARCH ALLERGY IMM, V133, P248, DOI 10.1159/000076831; van Dellen QM, 2007, RESP MED, V101, P779, DOI 10.1016/j.rmed.2006.08.002; Victorino CC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-53; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wang HY, 2008, CAN MED ASSOC J, V179, P1133, DOI 10.1503/cmaj.071797; Williams DR, 2009, PEDIATRICS, V123, pS174, DOI 10.1542/peds.2008-2233H; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561	57	80	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105347	10.1371/journal.pone.0105347	http://dx.doi.org/10.1371/journal.pone.0105347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141011	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200076
J	Kiss, A; Tratsiakovich, Y; Gonon, AT; Fedotovskaya, O; Lanner, JT; Andersson, DC; Yang, JN; Pernow, J				Kiss, Attila; Tratsiakovich, Yahor; Gonon, Adrian T.; Fedotovskaya, Olga; Lanner, Johanna T.; Andersson, Daniel C.; Yang, Jiangning; Pernow, John			The Role of Arginase and Rho Kinase in Cardioprotection from Remote Ischemic Perconditioning in Non-Diabetic and Diabetic Rat In Vivo	PLOS ONE			English	Article							PPAR-ALPHA ACTIVATION; REDUCES INFARCT SIZE; NITRIC-OXIDE; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; UP-REGULATION; INHIBITION; HEART; PEROXYNITRITE; DYSFUNCTION	Background: Pharmacological inhibition of arginase and remote ischemic perconditioning (RIPerc) are known to protect the heart against ischemia/reperfusion (IR) injury. Purpose: The objective of this study was to investigate whether (1) peroxynitrite-mediated RhoA/Rho associated kinase (ROCK) signaling pathway contributes to arginase upregulation following myocardial IR; (2) the inhibition of this pathway is involved as a cardioprotective mechanism of remote ischemic perconditioning and (3) the influence of diabetes on these mechanisms. Methods: Anesthetized rats were subjected to 30 min left coronary artery ligation followed by 2 h reperfusion and included in two protocols. In protocol 1 rats were randomized to 1) control IR, 2) RIPerc induced by bilateral femoral artery occlusion for 15 min during myocardial ischemia, 3) RIPerc and administration of the nitric oxide synthase inhibitor N-G-monomethyl-L-arginine (L-NMMA), 4) administration of the ROCK inhibitor hydroxyfasudil or 5) the peroxynitrite decomposition catalyst FeTPPS. In protocol 2 non-diabetic and type 1 diabetic rats were randomosed to IR or RIPerc as described above. Results: Infarct size was significantly reduced in rats treated with FeTPPS, hydroxyfasudil and RIPerc compared to controls (P<0.001). FeTPPS attenuated both ROCK and arginase activity (P<0.001 vs. control). Similarly, RIPerc reduced arginase and ROCK activity, peroxynitrite formation and enhanced phospho-eNOS expression (P<0.05 vs. control). The cardioprotective effect of RIPerc was abolished by L-NMMA. The protective effect of RIPerc and its associated changes in arginase and ROCK activity were abolished in diabetes. Conclusion: Arginase is activated by peroxynitrite/ROCK signaling cascade in myocardial IR. RIPerc protects against IR injury via a mechanism involving inhibition of this pathway and enhanced eNOS activation. The beneficial effect and associated molecular changes of RIPerc is abolished in type 1 diabetes.	[Kiss, Attila; Tratsiakovich, Yahor; Andersson, Daniel C.; Yang, Jiangning; Pernow, John] Karolinska Inst, Karolinska Univ Hosp, Div Cardiol, Dept Med, Stockholm, Sweden; [Gonon, Adrian T.] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden; [Fedotovskaya, Olga; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Kiss, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Cardiol, Dept Med, Stockholm, Sweden.	attila.kiss@ki.se	Kiss, Attila/ABF-3583-2021; Andersson, Daniel/AAE-9968-2019	Kiss, Attila/0000-0003-4652-1998; Andersson, Daniel/0000-0003-4548-702X; Lanner, Johanna/0000-0002-1222-9473; Pernow, John/0000-0003-4766-0922; GONON, ADRIAN/0000-0002-9337-3679	Swedish Research Council Medicine [10857]; Swedish Heart and Lung Foundation; Stockholm County Council (ALF); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; European Foundation for the Study of Diabetes; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010417] Funding Source: researchfish	Swedish Research Council Medicine(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; European Foundation for the Study of Diabetes; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work supported by the Swedish Research Council Medicine (10857), the Swedish Heart and Lung Foundation, the Stockholm County Council (ALF), Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme, Gustav V and Queen Victoria Foundation, European Foundation for the Study of Diabetes and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Bulhak A, 2006, BASIC RES CARDIOL, V101, P244, DOI 10.1007/s00395-005-0580-1; Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Cicek FA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-51; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Gonon AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042038; Gonon AT, 2000, J CARDIOVASC PHARM, V36, P405, DOI 10.1097/00005344-200009000-00018; Gronros J, 2013, ACTA PHYSIOL, V208, P172, DOI 10.1111/apha.12097; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; LEFER DJ, 1993, CIRCULATION, V88, P2337, DOI 10.1161/01.CIR.88.5.2337; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Maliszewska-Scislo M, 2003, AM J PHYSIOL-HEART C, V284, pH1601, DOI 10.1152/ajpheart.00578.2002; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Tang YH, 2011, CHINESE MED J-PEKING, V124, P1683, DOI 10.3760/cma.j.issn.0366-6999.2011.11.015; Tratsiakovich Y, 2013, EUR J PHARMACOL, V712, P16, DOI 10.1016/j.ejphar.2013.04.044; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Utsunomiya T, 2001, BRIT J PHARMACOL, V134, P1724, DOI 10.1038/sj.bjp.0704410; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Zhao JL, 2009, INT J CARDIOL, V133, P179, DOI 10.1016/j.ijcard.2007.12.024; Zhou H, 2012, CURR PHARM DESIGN, V18, P2964, DOI 10.2174/138161212800672688	34	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104731	10.1371/journal.pone.0104731	http://dx.doi.org/10.1371/journal.pone.0104731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140754	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200029
J	McDougal, SJ; Alexander, J; Dhanireddy, S; Harrington, RD; Stekler, JD				McDougal, Sarah J.; Alexander, Jeremiah; Dhanireddy, Shireesha; Harrington, Robert D.; Stekler, Joanne D.			Non-Occupational Post-Exposure Prophylaxis for HIV: 10-Year Retrospective Analysis in Seattle, Washington	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG EXPOSURE; SEXUAL EXPOSURE; COST-EFFECTIVENESS; ZIDOVUDINE TREATMENT; UNITED-STATES; INFECTION; RISK; MEN; TRANSMISSION	Despite treatment guidelines in place since 2005, non-occupational post-exposure HIV prophylaxis (nPEP) remains an underutilized prevention strategy. We conducted a retrospective chart review of patients presenting to a publicly-funded HIV clinic in Seattle, Washington for nPEP between 2000 and 2010 (N = 360). nPEP prescriptions were provided for 324 (90%) patients; 83% of prescription decisions were appropriate according to Centers for Disease Control and Prevention guidelines, but only 31% (N = 111/360) of patients were considered "high risk.'' In order to use limited resources most efficiently, public health agencies should target messaging for this high-cost intervention to individuals with high-risk HIV exposures.	[McDougal, Sarah J.; Alexander, Jeremiah; Dhanireddy, Shireesha; Harrington, Robert D.; Stekler, Joanne D.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Stekler, Joanne D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Alexander, Jeremiah] Vet Affairs Puget Sound, Gen Med Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	McDougal, SJ (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	sjmcd13@uw.edu						Armishaw J, 2011, INT J STD AIDS, V22, P714, DOI 10.1258/ijsa.2011.011174; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Buskin S, 2008, HIV AIDS EPIDEMIOLOG; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; *CDC, 1995, MMWR-MORBID MORTAL W, V44, P929; (CDC) CfDCaP, 2010, MMWR-MORBID MORTAL W, V24, P1201; Chacko L, 2012, SEX TRANSM INFECT, V88, P335, DOI 10.1136/sextrans-2011-050371; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Correll Patricia, 2000, N S W Public Health Bull, V11, P113, DOI 10.1071/NB00052; de Silva S, 2006, INT J STD AIDS, V17, P629, DOI 10.1258/095646206778113177; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Golden MR, 2012, SEX TRANSM DIS, V39, P659, DOI 10.1097/OLQ.0b013e31825727cb; Grob PM, 1997, NAT MED, V3, P665, DOI 10.1038/nm0697-665; Herida M, 2006, AIDS, V20, P1753, DOI 10.1097/01.aids.0000242822.74624.5f; HIV/AIDS Epidemiology Unit PHSKC Washington State Department of Health, 2010, EPIDEMIOLOGY; HIV/AIDS Epidemiology Unit PHSKCatIDAU Washington State Department of Health, 2012, HIV AIDS EP REP 2 HA, P81; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; Kunches LM, 2001, J ACQ IMMUN DEF SYND, V26, P263, DOI 10.1097/00126334-200103010-00008; Laporte A, 2002, AIDS, V16, P397, DOI 10.1097/00002030-200202150-00011; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lunding S, 2010, SEX TRANSM DIS, V37, P49, DOI 10.1097/OLQ.0b013e3181b6f284; McCarty EJ, 2011, INT J STD AIDS, V22, P407, DOI 10.1258/ijsa.2009.009463; Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284; Miles IJ, 2013, MMWR-MORBID MORTAL W, V62, P183; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Pinkerton SD, 2004, AIDS, V18, P2065, DOI 10.1097/00002030-200410210-00011; Pinkerton SD, 2004, ARCH INTERN MED, V164, P46, DOI 10.1001/archinte.164.1.46; Poynten IM, 2007, HIV MED, V8, P374, DOI 10.1111/j.1468-1293.2007.00483.x; Rey D, 2008, AIDS CARE, V20, P537, DOI 10.1080/09540120701867198; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Sonder GJB, 2007, SEX TRANSM DIS, V34, P288, DOI 10.1097/01.olq.0000237838.43716.ee; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Tissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007	36	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105030	10.1371/journal.pone.0105030	http://dx.doi.org/10.1371/journal.pone.0105030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140868	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200048
J	Sabour, D; Xu, XP; Chung, ACK; Le Menuet, D; Ko, K; Tapia, N; Arauzo-Bravo, MJ; Gentile, L; Greber, B; Hubner, K; Sebastiano, V; Wu, GM; Scholer, HR; Cooney, AJ				Sabour, Davood; Xu, Xueping; Chung, Arthur C. K.; Le Menuet, Damien; Ko, Kinarm; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Gentile, Luca; Greber, Boris; Huebner, Karin; Sebastiano, Vittorio; Wu, Guangming; Schoeler, Hans R.; Cooney, Austin J.			Germ Cell Nuclear Factor Regulates Gametogenesis in Developing Gonads	PLOS ONE			English	Article							MOUSE PROTAMINE GENES; ORPHAN RECEPTOR; RETINOIC ACID; DNA-BINDING; MEIOTIC INITIATION; EXPRESSION; GCNF; PLURIPOTENCY; REPRESSION; CLONING	Expression of germ cell nuclear factor (GCNF; Nr6a1), an orphan member of the nuclear receptor gene family of transcription factors, during gastrulation and neurulation is critical for normal embryogenesis in mice. Gcnf represses the expression of the POU-domain transcription factor Oct4 (Pou5f1) during mouse post-implantation development. Although Gcnf expression is not critical for the embryonic segregation of the germ cell lineage, we found that sexually dimorphic expression of Gcnf in germ cells correlates with the expression of pluripotency-associated genes, such as Oct4, Sox2, and Nanog, as well as the early meiotic marker gene Stra8. To elucidate the role of Gcnf during mouse germ cell differentiation, we generated an ex vivo Gcnf-knockdown model in combination with a regulated CreLox mutation of Gcnf. Lack of Gcnf impairs normal spermatogenesis and oogenesis in vivo, as well as the derivation of germ cells from embryonic stem cells (ESCs) in vitro. Inactivation of the Gcnf gene in vivo leads to loss of repression of Oct4 expression in both male and female gonads.	[Sabour, Davood; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Gentile, Luca; Greber, Boris; Huebner, Karin; Wu, Guangming; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Xu, Xueping; Chung, Arthur C. K.; Le Menuet, Damien; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chung, Arthur C. K.] Univ Hong Kong, Ctr Inflammatory Dis & Mol Therapies, Pokfulam, Hong Kong, Peoples R China; [Le Menuet, Damien] Fac Med Paris Sud, INSERM, U693, Paris, France; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Stem Cell Res, Seoul, South Korea; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Sch Med, Dept Neurosci, Seoul, South Korea; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian, Spain; [Sebastiano, Vittorio] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Baylor College of Medicine; University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Konkuk University; Konkuk University; Konkuk University Medical Center; Instituto de Investigacion Sanitaria Biodonostia; Stanford University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de; acooney@bcm.edu	, HS/AAB-4434-2019; Le Menuet, Damien/B-1489-2019; Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/E-4908-2019; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Le Menuet, Damien/0000-0002-0802-7190; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Gentile, Luca/0000-0002-7393-7502; Wu, Guangming/0000-0003-1923-7609; Greber, Boris/0000-0002-9404-7293; Tapia, Natalia/0000-0003-0226-1952	Max Planck Society; DFG [FOR 1041]; National Institutes of Health grant [NIH P01 GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Max Planck Society and the DFG grant for research unit germ cell potential, FOR 1041 (HSR) and National Institutes of Health grant NIH P01 GM081627 (AJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IY, 1998, FEBS LETT, V424, P73, DOI 10.1016/S0014-5793(98)00142-2; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barreto G, 2003, MECH DEVELOP, V120, P415, DOI 10.1016/S0925-4773(03)00018-2; Braat AK, 1999, MOL REPROD DEV, V53, P369, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;369::AID-MRD1&gt;3.0.CO;2-U; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; Chung ACK, 2006, DEV BIOL, V293, P13, DOI 10.1016/j.ydbio.2005.12.017; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Chung ACK, 2001, INT J BIOCHEM CELL B, V33, P1141, DOI 10.1016/S1357-2725(01)00081-4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; HIROSE T, 1995, GENE, V152, P247, DOI 10.1016/0378-1119(94)00656-D; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hummelke GC, 2004, MOL REPROD DEV, V68, P394, DOI 10.1002/mrd.20092; Hummelke GC, 2001, FRONT BIOSCI, V6, pD1186, DOI 10.2741/Hummelke; Hummelke GC, 1998, MOL REPROD DEV, V50, P396, DOI 10.1002/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joos TO, 1996, MECH DEVELOP, V60, P45, DOI 10.1016/S0925-4773(96)00599-0; Katz D, 1997, ENDOCRINOLOGY, V138, P4364, DOI 10.1210/en.138.10.4364; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lan ZJ, 2003, EMBO J, V22, P4070, DOI 10.1093/emboj/cdg405; Lan ZJ, 2003, BIOL REPROD, V68, P282, DOI 10.1095/biolreprod.102.008151; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Okumura LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066062; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schmitz TP, 1999, BBA-GENE STRUCT EXPR, V1446, P173, DOI 10.1016/S0167-4781(99)00079-2; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Yang GY, 2003, BIOL REPROD, V68, P1620, DOI 10.1095/biolreprod.102.012013; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang YL, 1998, MOL REPROD DEV, V50, P93, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;93::AID-MRD12&gt;3.0.CO;2-Z	50	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103985	10.1371/journal.pone.0103985	http://dx.doi.org/10.1371/journal.pone.0103985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140725	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200010
J	Spencer, AJ; Furze, J; Honeycutt, JD; Calvert, A; Saurya, S; Colloca, S; Wyllie, DH; Gilbert, SC; Bregu, M; Cottingham, MG; Hill, AVS				Spencer, Alexandra J.; Furze, Julie; Honeycutt, Jared D.; Calvert, Alice; Saurya, Saroj; Colloca, Stefano; Wyllie, David H.; Gilbert, Sarah C.; Bregu, Migena; Cottingham, Matthew G.; Hill, Adrian V. S.			4-1BBL Enhances CD8(+) T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; DENDRITIC CELLS; COSTIMULATORY MOLECULES; PROTECTIVE IMMUNITY; ADENOVIRAL VECTOR; MALARIA VACCINES; VIRUS ANKARA; DNA VACCINE; IN-VIVO; EXPRESSION	T cells play a central role in the immune response to many of the world's major infectious diseases. In this study we investigated the tumour necrosis factor receptor superfamily costimulatory molecule, 4-1BBL (CD137L, TNFSF9), for its ability to increase T cell immunogenicity induced by a variety of recombinant vectored vaccines. To efficiently test this hypothesis, we assessed a number of promoters and developed a stable bi-cistronic vector expressing both the antigen and adjuvant. Co-expression of 4-1BBL, together with our model antigen TIP, was shown to increase the frequency of murine antigen-specific IFN-gamma secreting CD8(+) T cells in three vector platforms examined. Enhancement of the response was not limited by co-expression with the antigen, as an increase in CD8(+) immunogenicity was also observed by co-administration of two vectors each expressing only the antigen or adjuvant. However, when this regimen was tested in non-human primates using a clinical malaria vaccine candidate, no adjuvant effect of 4-1BBL was observed limiting its potential use as a single adjuvant for translation into a clinical vaccine.	[Spencer, Alexandra J.; Furze, Julie; Honeycutt, Jared D.; Calvert, Alice; Saurya, Saroj; Wyllie, David H.; Gilbert, Sarah C.; Bregu, Migena; Cottingham, Matthew G.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Colloca, Stefano] Okairos, Rome, Italy	University of Oxford; Jenner Institute	Spencer, AJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	alex.spencer@ndm.ox.ac.uk	Spencer, Alexandra/AAE-6494-2019; Gilbert, Sarah C./H-2857-2019	Spencer, Alexandra/0000-0001-7958-6961; Gilbert, Sarah C./0000-0002-6823-9750; Cottingham, Matthew/0000-0003-0766-6465	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative [HILL05GCGH0]; Wellcome Trust [095540/Z/11/Z]; National Center for Research Resources (NCRR) [P51 RR000167];  [RR15459];  [RR020141]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, P51RR000167, C06RR015459] Funding Source: NIH RePORTER; Wellcome Trust [104750/Z/14/Z] Funding Source: researchfish	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been funded by grants from the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative (HILL05GCGH0) with additional funding from the Wellcome Trust (095540/Z/11/Z). Non-human primate studies were supported by National Center for Research Resources (NCRR) grant number P51 RR000167, and was conducted at a facility constructed with support from grants RR15459 and RR020141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Belousova N, 2006, MOL PHARMACOL, V70, P1488, DOI 10.1124/mol.106.025619; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Bukczynski J, 2005, J IMMUNOL, V175, P6378, DOI 10.4049/jimmunol.175.10.6378; Calarota SA, 2008, VACCINE, V26, P3121, DOI 10.1016/j.vaccine.2008.02.017; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Cottingham MG, 2012, BIOTECHNOL BIOENG, V109, P719, DOI 10.1002/bit.24342; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dawicki W, 2004, EUR J IMMUNOL, V34, P743, DOI 10.1002/eji.200324278; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998; Diehl L, 2002, J IMMUNOL, V168, P3755, DOI 10.4049/jimmunol.168.8.3755; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Forbes EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044943; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Ganguly S, 2010, VACCINE, V28, P1300, DOI 10.1016/j.vaccine.2009.11.020; Harrison JM, 2006, VIRAL IMMUNOL, V19, P593, DOI 10.1089/vim.2006.19.593; Harrison JM, 2006, VACCINE, V24, P6867, DOI 10.1016/j.vaccine.2006.06.007; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hirao LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024250; Hodge JW, 1999, CANCER RES, V59, P5800; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; JEANG KT, 1984, MOL CELL BIOL, V4, P2214, DOI 10.1128/MCB.4.10.2214; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Kanagavelu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090100; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kuang YL, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.054; Kuang YL, 2010, CANCER LETT, V293, P254, DOI 10.1016/j.canlet.2010.01.011; Kudo-Saito C, 2006, VACCINE, V24, P4975, DOI 10.1016/j.vaccine.2006.03.042; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Munks MW, 2004, IMMUNOLOGY, V112, P559, DOI 10.1111/j.1365-2567.2004.01917.x; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; POLLOK KE, 1995, EUR J IMMUNOL, V25, P488, DOI 10.1002/eji.1830250227; POLLOK KE, 1993, J IMMUNOL, V150, P771; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Serghides L, 2005, J IMMUNOL, V175, P6368, DOI 10.4049/jimmunol.175.10.6368; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Sheehy SH, 2011, MOL THERAPY IN PRESS; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wiethe C, 2003, J IMMUNOL, V170, P2912, DOI 10.4049/jimmunol.170.6.2912; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Xiao C, 2007, ANTIVIR RES, V76, P11, DOI 10.1016/j.antiviral.2007.04.002	61	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105520	10.1371/journal.pone.0105520	http://dx.doi.org/10.1371/journal.pone.0105520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140889	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200093
J	Beydoun, MA; Gamaldo, AA; Canas, JA; Beydoun, HA; Shah, MT; McNeely, JM; Zonderman, AB				Beydoun, May A.; Gamaldo, Alyssa A.; Canas, Jose A.; Beydoun, Hind A.; Shah, Mauli T.; McNeely, Jessica M.; Zonderman, Alan B.			Serum Nutritional Biomarkers and Their Associations with Sleep among US Adults in Recent National Surveys	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE LEVELS; RESTLESS LEGS SYNDROME; VITAMIN-D; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; COGNITIVE IMPAIRMENT; ANTIOXIDANT STATUS; METABOLIC SYNDROME; SAMPLE SELECTION; CHRONIC DISEASE	Background: The associations between nutritional biomarkers and measures of sleep quantity and quality remain unclear. Methods: Cross-sectional data from the National Health and Nutrition Examination Surveys (NHANES) 2005-2006 were used. We selected 2,459 adults aged 20-85, with complete data on key variables. Five sleep measures were constructed as primary outcomes: (A) Sleep duration; (B) Sleep disorder; (C) Three factors obtained from factor analysis of 15 items and labeled as "Poor sleep-related daytime dysfunction'' (Factor 1), "Sleepiness'' (Factor 2) and "Sleep disturbance'' (Factor 3). Main exposures were serum concentrations of key nutrients, namely retinol, retinyl esters, carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein+zeaxanthin, lycopene), folate, vitamin B-12, total homocysteine (tHcy), vitamin C, 25-hydroxyvitamin D (25(OH) D) and vitamin E. Main analyses consisted of multiple linear, logistic and multinomial logit models. Results: Among key findings, independent inverse associations were found between serum vitamin B-12 and sleep duration, 25(OH) D and sleepiness (as well as insomnia), and between folate and sleep disturbance. Serum total carotenoids concentration was linked to higher odds of short sleep duration (i.e. 5-6 h per night) compared to normal sleep duration (7-8 h per night). Conclusions: A few of the selected serum nutritional biomarkers were associated with sleep quantity and quality. Longitudinal studies are needed to ascertain temporality and assess putative causal relationships.	[Beydoun, May A.; Gamaldo, Alyssa A.; Shah, Mauli T.; McNeely, Jessica M.; Zonderman, Alan B.] NIA, NIH, IRP, Baltimore, MD 21224 USA; [Canas, Jose A.] Nemours Childrens Clin, Jacksonville, FL USA; [Beydoun, Hind A.] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [Shah, Mauli T.; McNeely, Jessica M.] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Eastern Virginia Medical School; University System of Maryland; University of Maryland Baltimore County	Beydoun, MA (corresponding author), NIA, NIH, IRP, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Zonderman, Alan B/A-5807-2013; Canas, Jose Atilio/Y-8500-2019	Zonderman, Alan B/0000-0003-3530-2319; Canas, Jose Atilio/0000-0003-4788-8820; Zonderman, Alan B/0000-0002-6523-4778	National Institute on Aging; Intramural Research Program (NIA/NIH/IRP); NATIONAL INSTITUTE ON AGING [ZIAAG000199] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program (NIA/NIH/IRP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was entirely supported by the National Institute on Aging, Intramural Research Program (NIA/NIH/IRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock A. C., 2013, DISCOVERING STRUCTUR, DOI DOI 10.1080/10538712.2011.607753; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; [Anonymous], 2002, Mayo Clin Health Lett, V20, P6; [Anonymous], ARS MYPYRAMID EQ DAT; [Anonymous], CFDCAP NAT HLTH NUTR; [Anonymous], 2009, NAT HLTH NUTR EX SUR; [Anonymous], ASS PACK INS IMX AN; Balaban H, 2012, SLEEP MED, V13, P953, DOI 10.1016/j.sleep.2012.04.009; Beydoun MA, 2013, BRIT J NUTR, V109, P1714, DOI 10.1017/S0007114512003467; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Beydoun MA, 2011, J NUTR, V141, P903, DOI 10.3945/jn.110.136580; Beydoun MA, 2010, PSYCHOSOM MED, V72, P862, DOI 10.1097/PSY.0b013e3181f61863; Beydoun MA, 2010, J NUTR, V140, P338, DOI 10.3945/jn.109.113878; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; Bozkurt NC, 2012, ENDOCRINE, V41, P518, DOI 10.1007/s12020-012-9595-1; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; Centers for Disease Control and Prevention. National Center for Health Statistics, 2010, NAT HLTH NUTR EX SUR; Challet E, 2013, NEUROBIOL AGING, V34, P1589, DOI 10.1016/j.neurobiolaging.2012.11.021; Chen MG, 2011, J CLIN NEUROSCI, V18, P1454, DOI 10.1016/j.jocn.2011.01.037; Cheng YJ, 2007, DIABETES CARE, V30, P2264, DOI 10.2337/dc07-0372; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; Day RM, 2009, RESPIROLOGY, V14, P1134, DOI 10.1111/j.1440-1843.2009.01623.x; Dunn JE, 2007, NEUROLOGY, V68, P670, DOI 10.1212/01.wnl.0000255940.13116.86; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Grandner MA, 2013, J SLEEP RES; Grandner MA, 2013, APPETITE, V64, P71, DOI 10.1016/j.appet.2013.01.004; Grandner MA, 2010, SLEEP MED, V11, P180, DOI 10.1016/j.sleep.2009.07.014; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Haghighatdoost F, 2012, NUTRITION, V28, P1146, DOI 10.1016/j.nut.2012.04.015; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hochberg Y, 1987, MULTIPLE COMP PROCED; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Imaki Masahide, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P115, DOI 10.2114/jpa.21.115; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kim S, 2011, PUBLIC HEALTH NUTR, V14, P889, DOI 10.1017/S136898001000296X; Kitaoka K, 2011, BRAIN RES, V1423, P10, DOI 10.1016/j.brainres.2011.09.023; KRINSKY NI, 1993, ANNU REV NUTR, V13, P561, DOI 10.1146/annurev.nutr.13.1.561; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Lavie L, 2001, CHEST, V120, P900, DOI 10.1378/chest.120.3.900; Lee KA, 2001, J WOMEN HEALTH GEN-B, V10, P335, DOI 10.1089/152460901750269652; Lichstein KL, 2007, SLEEP MED, V9, P27, DOI 10.1016/j.sleep.2006.12.009; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lohr S.L., 2010, SAMPLING DESIGN ANAL, Vsecond; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Mayer G, 1996, NEUROPSYCHOPHARMACOL, V15, P456, DOI 10.1016/S0893-133X(96)00055-3; McCarty DE, 2012, J CLIN SLEEP MED, V8, P693, DOI 10.5664/jcsm.2266; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; Mey J, 2004, NEUROSCIENTIST, V10, P409, DOI 10.1177/1073858404263520; Milaneschi Y., 2013, MOL PSYCHIAT; MUSIOL IM, 1992, NEUROSCIENCE, V48, P841, DOI 10.1016/0306-4522(92)90272-4; Ohayon MM, 2005, SLEEP, V28, P981; OHTA T, 1991, SLEEP, V14, P414; Oishi J, 2009, ACTA MED OKAYAMA, V63, P9; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pernet P, 2000, CLIN CHEM, V46, P1440; Peuhkuri K, 2012, NUTR RES, V32, P309, DOI 10.1016/j.nutres.2012.03.009; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Puhani PA, 2000, J ECON SURV, V14, P53, DOI 10.1111/1467-6419.00104; Ravaglia G, 2008, AM J CLIN NUTR, V87, P1306, DOI 10.1093/ajcn/87.5.1306; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Schmidt R, 1998, J AM GERIATR SOC, V46, P1407, DOI 10.1111/j.1532-5415.1998.tb06008.x; Schmutte Timothy, 2007, Behav Sleep Med, V5, P39; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Singh T D, 2009, Indian J Chest Dis Allied Sci, V51, P217; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Soory Mena, 2009, Infectious Disorders - Drug Targets, V9, P400; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; STATA, 2009, STAT DAT AN REL 11 0; Thakre Tushar P, 2012, Sleep Disord, V2012, P634920, DOI 10.1155/2012/634920; USDA, FOOD NUTR DAT DIET S; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Voutilainen S, 2006, AM J CLIN NUTR, V83, P1265; Watanabe M, 2010, SLEEP, V33, P161, DOI 10.1093/sleep/33.2.161; Weaver TE, 1997, SLEEP, V20, P835; Zadeh SS, 2011, NUTR RES PRACT, V5, P230, DOI 10.4162/nrp.2011.5.3.230	89	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103490	10.1371/journal.pone.0103490	http://dx.doi.org/10.1371/journal.pone.0103490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137304	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100008
J	Ambrosio, L; Morriss, S; Riaz, A; Bailey, R; Ding, J; MacIntosh, GC				Ambrosio, Linda; Morriss, Stephanie; Riaz, Ayesha; Bailey, Ryan; Ding, Jian; MacIntosh, Gustavo C.			Phylogenetic Analyses and Characterization of RNase X25 from Drosophila melanogaster Suggest a Conserved Housekeeping Role and Additional Functions for RNase T2 Enzymes in Protostomes	PLOS ONE			English	Article							GENE-EXPRESSION; CYSTIC LEUKOENCEPHALOPATHY; SECRETORY RIBONUCLEASES; OXIDATIVE STRESS; E-RNS; FAMILY; GENOME; STARVATION; AUTOPHAGY; MEMBER	Ribonucleases belonging to the RNase T2 family are enzymes associated with the secretory pathway that are almost absolutely conserved in all eukaryotes. Studies in plants and vertebrates suggest they have an important housekeeping function in rRNA recycling. However, little is known about this family of enzymes in protostomes. We characterized RNase X25, the only RNase T2 enzyme in Drosophila melanogaster. We found that RNase X25 is the major contributor of ribonuclease activity in flies as detected by in gel assays, and has an acidic pH preference. Gene expression analyses showed that the RNase X25 transcript is present in all adult tissues and developmental stages. RNase X25 expression is elevated in response to nutritional stresses; consistent with the hypothesis that this enzyme has a housekeeping role in recycling RNA. A correlation between induction of RNase X25 expression and autophagy was observed. Moreover, induction of gene expression was triggered by oxidative stress suggesting that RNase X25 may have additional roles in stress responses. Phylogenetic analyses of this family in protostomes showed that RNase T2 genes have undergone duplication events followed by divergence in several phyla, including the loss of catalytic residues, and suggest that RNase T2 proteins have acquired novel functions. Among those, it is likely that a role in host immunosuppression evolved independently in several groups, including parasitic Platyhelminthes and parasitoid wasps. The presence of only one RNase T2 gene in the D. melanogaster genome, without any other evident secretory RNase activity detected, makes this organism an ideal system to study the cellular functions of RNase T2 proteins associated with RNA recycling and maintenance of cellular homeostasis. On the other hand, the discovery of gene duplications in several protostome genomes also presents interesting new avenues to study additional biological functions of this ancient family of proteins.	[Ambrosio, Linda; Morriss, Stephanie; Bailey, Ryan; MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Riaz, Ayesha] Iowa State Univ, Interdept Genet Grad Program, Ames, IA USA; [Ding, Jian] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	Iowa State University; Iowa State University; Harvard University; Boston Children's Hospital; Harvard Medical School	Ambrosio, L (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	lima@iastate.edu; gustavo@iastate.edu	Ding, Jian/F-6996-2015	Ding, Jian/0000-0002-5578-5410; MacIntosh, Gustavo/0000-0003-1350-1229; Riaz, Ayesha/0000-0002-4627-4133	Fulbright Fellowship; United States National Science Foundation [MBC-1051818]	Fulbright Fellowship; United States National Science Foundation(National Science Foundation (NSF))	A.R. is the recipient of a Fulbright Fellowship. This work was supported by grant No. MBC-1051818 from the United States National Science Foundation to G.C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquati F, 2005, INT J ONCOL, V26, P1159; Ali MR, 2012, J INVERTEBR PATHOL, V110, P389, DOI 10.1016/j.jip.2012.05.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ashburner M., 2004, DROSOPHILA LAB HDB; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burke Gaelen R., 2012, Insects, V3, P91, DOI 10.3390/insects3010091; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fitzsimmons CM, 2005, MOL BIOCHEM PARASIT, V144, P123, DOI 10.1016/j.molbiopara.2005.08.003; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Henneke M, 2009, NAT GENET, V41, P773, DOI 10.1038/ng.398; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Hillwig MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-170; HIME G, 1995, GENE, V158, P203, DOI 10.1016/0378-1119(94)00896-Z; Hulst MM, 1998, J VIROL, V72, P151, DOI 10.1128/JVI.72.1.151-157.1998; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Irie M, 1999, PHARMACOL THERAPEUT, V81, P77, DOI 10.1016/S0163-7258(98)00035-7; Jimenez-Sanchez M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2212; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x; Li HM, 2009, INSECT MOL BIOL, V18, P21, DOI 10.1111/j.1365-2583.2008.00844.x; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MacIntosh GC, 2011, NUCLEIC ACIDS MOL BI, V26, P89, DOI 10.1007/978-3-642-21078-5_4; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; MacIntosh GC, 2010, MOL GENET GENOMICS, V283, P381, DOI 10.1007/s00438-010-0524-9; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Park B, 2012, INSECT SCI, V19, P47, DOI 10.1111/j.1744-7917.2011.01421.x; Park B, 2010, J INVERTEBR PATHOL, V105, P156, DOI 10.1016/j.jip.2010.06.003; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Python S, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003412, 10.1371/annotation/4290dfee-64fd-4157-89e3-8edbba912420]; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; YEN Y, 1991, PLANT PHYSIOL, V97, P1487, DOI 10.1104/pp.97.4.1487; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	59	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105444	10.1371/journal.pone.0105444	http://dx.doi.org/10.1371/journal.pone.0105444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133712	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700115
J	Andreev-Andrievskiy, A; Popova, A; Boyle, R; Alberts, J; Shenkman, B; Vinogradova, O; Dolgov, O; Anokhin, K; Tsvirkun, D; Soldatov, P; Nemirovskaya, T; Ilyin, E; Sychev, V				Andreev-Andrievskiy, Alexander; Popova, Anfisa; Boyle, Richard; Alberts, Jeffrey; Shenkman, Boris; Vinogradova, Olga; Dolgov, Oleg; Anokhin, Konstantin; Tsvirkun, Darya; Soldatov, Pavel; Nemirovskaya, Tatyana; Ilyin, Eugeniy; Sychev, Vladimir			Mice in Bion-M 1 Space Mission: Training and Selection	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; HEART-RATE; STRESS; MOUSE; SPACEFLIGHT; SUSCEPTIBILITY; RESPONSES; STRENGTH	After a 16-year hiatus, Russia has resumed its program of biomedical research in space, with the successful 30-day flight of the Bion-M 1 biosatellite (April 19-May 19, 2013). The principal species for biomedical research in this project was the mouse. This paper presents an overview of the scientific goals, the experimental design and the mouse training/selection program. The aim of mice experiments in the Bion-M 1 project was to elucidate cellular and molecular mechanisms, underlying the adaptation of key physiological systems to long-term exposure in microgravity. The studies with mice combined in vivo measurements, both in flight and post-flight (including continuous blood pressure measurement), with extensive in vitro studies carried out shortly after return of the mice and in the end of recovery study. Male C57/BL6 mice group housed in space habitats were flown aboard the Bion-M 1 biosatellite, or remained on ground in the control experiment that replicated environmental and housing conditions in the spacecraft. Vivarium control groups were used to account for housing effects and possible seasonal differences. Mice training included the co-adaptation in housing groups and mice adaptation to paste food diet. The measures taken to co-adapt aggressive male mice in housing groups and the peculiarities of "space'' paste food are described. The training program for mice designated for in vivo studies was broader and included behavioral/functional test battery and continuous behavioral measurements in the home-cage. The results of the preliminary tests were used for the selection of homogenous groups. After the flight, mice were in good condition for biomedical studies and displayed signs of pronounced disadaptation to Earth's gravity. The outcomes of the training program for the mice welfare are discussed. We conclude that our training program was effective and that male mice can be successfully employed in space biomedical research.	[Andreev-Andrievskiy, Alexander; Popova, Anfisa; Shenkman, Boris; Vinogradova, Olga; Tsvirkun, Darya; Soldatov, Pavel; Nemirovskaya, Tatyana; Ilyin, Eugeniy; Sychev, Vladimir] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Andreev-Andrievskiy, Alexander; Popova, Anfisa] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Boyle, Richard] NASA, Ames Res Ctr, Biovisualizat Imaging & Simulat Technol Ctr BioVI, Moffett Field, CA 94035 USA; [Alberts, Jeffrey] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Dolgov, Oleg; Anokhin, Konstantin] Russian Acad Med Sci, Anokhin Inst Normal Physiol, Moscow, Russia; [Anokhin, Konstantin] Kurchatov Inst, Kurchatov NBIC Ctr, Natl Res Ctr, Moscow, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Lomonosov Moscow State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Indiana University System; Indiana University Bloomington; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; National Research Centre - Kurchatov Institute	Andreev-Andrievskiy, A (corresponding author), Russian Acad Sci, Inst Biomed Problems, Moscow, Russia.	aandrievsky@gmail.com	Popova, Anfisa/M-8917-2019; Shenkman, Boris/AAB-1536-2020; Vinogradova, Olga/E-6494-2014; Andreev-Andrievskiy, Alexander/B-7336-2013; Tsvirkun, Darya/AAH-7043-2020; Anokhin, Konstantin V./K-7983-2014	Vinogradova, Olga/0000-0002-4622-0522; Andreev-Andrievskiy, Alexander/0000-0002-1173-8153; Tsvirkun, Darya/0000-0002-6599-6844; Anokhin, Konstantin V./0000-0003-4437-6002	Russian Federal Space Agency; Russian Academy of Sciences; Division of Physiology and Fundamental Medicine of Russian Academy of Sciences; RFBR [12-04-01665-a]	Russian Federal Space Agency; Russian Academy of Sciences(Russian Academy of Sciences); Division of Physiology and Fundamental Medicine of Russian Academy of Sciences; RFBR(Russian Foundation for Basic Research (RFBR))	The project was supported by the Russian Federal Space Agency and the Russian Academy of Sciences. These funders took part in study design and data collection, but had no role in data analysis or decision to publish. The study was also supported by the Division of Physiology and Fundamental Medicine of Russian Academy of Sciences ("Integrative physiology" program) and RFBR grant 12-04-01665-a. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev-Andrievskiy AA, 2014, PHYSIOL BEHAV, V132, P1, DOI 10.1016/j.physbeh.2014.03.033; [Anonymous], 1986, EUR CONV PROT VERT A, V18; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Behnke BJ, 2013, FASEB J, V27, P399, DOI 10.1096/fj.12-218503; Bouwknecht JA, 2000, EUR J PHARMACOL, V400, P59, DOI 10.1016/S0014-2999(00)00387-3; Buckey JC, 2003, NEUROLAB SPACELAB MI; Burgess C, 2007, S-P B SPACE EXPLOR, P1; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; FELASA, 2007, EUR ACC CAR AN US EX; Festing M.F.W., 2002, DESIGN ANIMAL EXPT R; Gariepy JL, 2002, PHARMACOL BIOCHEM BE, V73, P7, DOI 10.1016/S0091-3057(02)00789-X; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Grigoriev AI, 2007, VESTN ROS AKAD NAUK, V77, P963; Howard B R, 2002, ILAR J, V43, P194; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Ilyin E A, 2000, J Gravit Physiol, V7, pS1; Kurtz TW, 2005, RECOMMENDATIONS BL 2; Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019; Lujan HL, 2006, AM J PHYSIOL-HEART C, V291, pH2933, DOI 10.1152/ajpheart.00514.2006; Malkki HAI, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00171; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Morgan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090012; National Research Council, 2010, GUIDE CARE USE LAB A, P41; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Van Bogaert MJV, 2006, GENES BRAIN BEHAV, V5, P139, DOI 10.1111/j.1601-183X.2005.00143.x; Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; WARD R, 1990, J ANAT, V173, P87; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923	36	60	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104830	10.1371/journal.pone.0104830	http://dx.doi.org/10.1371/journal.pone.0104830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133741	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700043
J	Cai, J; Wu, GZ; Tan, XR; Han, Y; Chen, CY; Li, CW; Wang, N; Zou, X; Chen, XJ; Zhou, FY; He, DF; Zhou, L; Jose, PA; Zeng, CY				Cai, Jin; Wu, Gengze; Tan, Xiaorong; Han, Yu; Chen, Caiyu; Li, Chuanwei; Wang, Na; Zou, Xue; Chen, Xinjian; Zhou, Faying; He, Duofen; Zhou, Lin; Jose, Pedro A.; Zeng, Chunyu			Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice	PLOS ONE			English	Article							CELLS; COMMUNICATION; EXOSOMES	Our previous study showed that besides mRNAs and microRNAs, there are DNA fragments within extracellular vesicles (EVs). The BCR/ABL hybrid gene, involved in the pathogenesis of chronic myeloid leukemia (CML), could be transferred from K562 EVs to neutrophils and decrease their phagocytic activity in vitro. Our present study provides evidence that BCR/ABL DNAs transferred from EVs have pathophysiological significance in vivo. Two months after injection of K562 EVs into the tail vein of Sprague-Dawley (SD) rats, they showed some characteristics of CML, e.g., feeble, febrile, and thin, with splenomegaly and neutrophilia but with reduced neutrophil phagocytic activity. These findings were also observed in immunodeficient NOD/SCID mice treated with K562 EVs; BCR/ABL mRNA and protein were found in their neutrophils. The administration of actinomycin D, an inhibitor of de novo mRNA synthesis, prevented the abnormalities caused by K562 EVs in NOD/SCID mice related to CML, including neutrophilia and bone marrow hyperplasia. As a specific inhibitor of tyrosine kinases, imatinib blocked the activity of tyrosine kinases and the expression of phospho-Crkl, induced by the de novo BCR/ABL protein caused by K562 EVs bearing BCR/ABL DNA. Our current study shows the pathophysiological significance of transferred tumor gene from EVs in vivo, which may represent an important mechanism for tumorigenesis, tumor progression, and metastasis.	[Cai, Jin; Wu, Gengze; Tan, Xiaorong; Han, Yu; Chen, Caiyu; Li, Chuanwei; Wang, Na; Zou, Xue; Chen, Xinjian; Zhou, Faying; He, Duofen; Zhou, Lin; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Cai, Jin] Air Force Nanjing Area Command, Logist Dept, Clin Hlth Serv, Nanjing, Jiangsu, Peoples R China; [Jose, Pedro A.] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Jose, Pedro A.] Univ Maryland, Sch Med, Dept Physiol, Div Nephrol, Baltimore, MD 21201 USA	Army Medical University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zeng, CY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	chunyuzeng01@163.com			National Natural Science Foundation of China [31130029]; National Basic Research Program of China [2012CB517801]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092196] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by grants from the National Natural Science Foundation of China (31130029), the National Basic Research Program of China (2012CB517801), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cai J, 2011, SENSOR ACTUAT B-CHEM, V155, P500, DOI 10.1016/j.snb.2010.12.053; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Kasimir-Bauer S, 1998, LEUKEMIA RES, V22, P115, DOI 10.1016/S0145-2126(97)00185-9; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pisetsky DS, 2011, IMMUNOL RES, V49, P227, DOI 10.1007/s12026-010-8184-8; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Puissant A, 2012, J MOL CELL BIOL, V4, P207, DOI 10.1093/jmcb/mjs010; RAM Z, 1993, J NEUROSURG, V79, P400, DOI 10.3171/jns.1993.79.3.0400; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Shibata Y, 2010, GENOME MED, V2, DOI 10.1186/gm191; Wang H, 2012, MOL MED, V18, P159, DOI 10.2119/molmed.2011.00295; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	23	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105200	10.1371/journal.pone.0105200	http://dx.doi.org/10.1371/journal.pone.0105200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133686	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700082
J	Perevozchikova, SA; Trikin, RM; Heinze, RJ; Romanova, EA; Oretskaya, TS; Friedhoff, P; Kubareva, EA				Perevozchikova, Svetlana A.; Trikin, Roman M.; Heinze, Roger J.; Romanova, Elena A.; Oretskaya, Tatiana S.; Friedhoff, Peter; Kubareva, Elena A.			Is Thymidine Glycol Containing DNA a Substrate of E. coli DNA Mismatch Repair System?	PLOS ONE			English	Article							UV-LIGHT PHOTOPRODUCTS; ESCHERICHIA-COLI; THYMINE GLYCOL; PROTEIN MUTS; EXCISION-REPAIR; FUNCTIONAL INTERACTIONS; RECOGNITION COMPLEX; MOLECULAR SWITCH; BASE-PAIRS; BINDING	The DNA mismatch repair (MMR) system plays a crucial role in the prevention of replication errors and in the correction of some oxidative damages of DNA bases. In the present work the most abundant oxidized pyrimidine lesion, 5,6-dihydro-5,6-dihydroxythymidine (thymidine glycol, Tg) was tested for being recognized and processed by the E. coli MMR system, namely complex of MutS, MutL and MutH proteins. In a partially reconstituted MMR system with MutS-MutL-MutH proteins, G/Tg and A/Tg containing plasmids failed to provoke the incision of DNA. Tg residue in the 30-mer DNA duplex destabilized double helix due to stacking disruption with neighboring bases. However, such local structural changes are not important for E. coli MMR system to recognize this lesion. A lack of repair of Tg containing DNA could be due to a failure of MutS (a first acting protein of MMR system) to interact with modified DNA in a proper way. It was shown that Tg in DNA does not affect on ATPase activity of MutS. On the other hand, MutS binding affinities to DNA containing Tg in G/Tg and A/Tg pairs are lower than to DNA with a G/T mismatch and similar to canonical DNA. Peculiarities of MutS interaction with DNA was monitored by Forster resonance energy transfer (FRET) and fluorescence anisotropy. Binding of MutS to Tg containing DNAs did not result in the formation of characteristic DNA kink. Nevertheless, MutS homodimer orientation on Tg-DNA is similar to that in the case of G/T-DNA. In contrast to G/T-DNA, neither G/Tg- nor A/Tg-DNA was able to stimulate ADP release from MutS better than canonical DNA. Thus, Tg residue in DNA is unlikely to be recognized or processed by the E. coli MMR system. Probably, the MutS transformation to active "sliding clamp" conformation on Tg-DNA is problematic.	[Perevozchikova, Svetlana A.; Romanova, Elena A.; Oretskaya, Tatiana S.; Kubareva, Elena A.] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Perevozchikova, Svetlana A.; Romanova, Elena A.; Oretskaya, Tatiana S.; Kubareva, Elena A.] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow, Russia; [Trikin, Roman M.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Heinze, Roger J.; Friedhoff, Peter] Univ Giessen, Inst Biochem, D-35390 Giessen, Germany	Lomonosov Moscow State University; Lomonosov Moscow State University; University of Bern; Justus Liebig University Giessen	Kubareva, EA (corresponding author), Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia.	kubareva@belozersky.msu.ru	Romanova, Elena/D-5856-2013; Friedhoff, Peter/G-7905-2012; Kubareva, Elena A/I-3184-2012; Oretskaya, Tatiana S/E-2556-2012	Friedhoff, Peter/0000-0003-1946-1117	European Community [HEALTHF4-2008-223545]; Deutsche Forschungsgemeinschaft [GRK 1384]; Russian Foundation for Basic Research [RFBR-DFG 14-04-91343]; RFBR [13-04-00615]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RFBR(Russian Foundation for Basic Research (RFBR))	This research was supported by the European Community Seventh Framework Program FP7/2007-2013 under Grant HEALTHF4-2008-223545 (to P. F. and R.J.H.), Deutsche Forschungsgemeinschaft Grant GRK 1384 (to P. F. and R.J.H.) and Russian Foundation for Basic Research Grant RFBR-DFG 14-04-91343 (to T.O. and S. P.) and RFBR Grant 13-04-00615 (to E. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Bellon S, 2009, NUCLEIC ACIDS RES, V37, P4430, DOI 10.1093/nar/gkp422; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brown J, 2001, BIOCHEM J, V354, P627, DOI 10.1042/0264-6021:3540627; Brown KL, 2008, J AM CHEM SOC, V130, P11701, DOI 10.1021/ja8016544; Brown KL, 2010, NUCLEIC ACIDS RES, V38, P428, DOI 10.1093/nar/gkp844; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Cristovao M, 2012, NUCLEIC ACIDS RES, V40, P5448, DOI 10.1093/nar/gks138; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Dolinnaya NG, 2013, BIOCHIMIE, V95, P134, DOI 10.1016/j.biochi.2012.09.008; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fedotova E A, 2008, Bioorg Khim, V34, P236; FENG G, 1995, BIOTECHNIQUES, V19, P956; FENG WY, 1991, GENETICS, V129, P1007; Goodrich J., 2007, BINDING KINETICS MOL; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; HARE D, 1986, BIOCHEMISTRY-US, V25, P7445, DOI 10.1021/bi00371a029; Heinze RJ, 2009, NUCLEIC ACIDS RES, V37, P4453, DOI 10.1093/nar/gkp380; Heo SD, 2007, BIOCHEM BIOPH RES CO, V364, P264, DOI 10.1016/j.bbrc.2007.09.130; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Li GM, 1996, J BIOL CHEM, V271, P24084, DOI 10.1074/jbc.271.39.24084; Lieb M, 2001, J BACTERIOL, V183, P6487, DOI 10.1128/JB.183.21.6487-6490.2001; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; McTigue MM, 2004, DNA REPAIR, V3, P313, DOI 10.1016/j.dnarep.2003.11.009; Mello JA, 1996, CHEM BIOL, V3, P579, DOI 10.1016/S1074-5521(96)90149-0; Monti MC, 2011, NUCLEIC ACIDS RES, V39, P8052, DOI 10.1093/nar/gkr498; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Mukherjee S, 2009, BIOPHYS J, V96, P1707, DOI 10.1016/j.bpj.2008.10.071; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Sass LE, 2010, BIOCHEMISTRY-US, V49, P3174, DOI 10.1021/bi901871u; Scatchard G, 1949, SCIENCE, V51, P660; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730; Young LC, 2003, J INVEST DERMATOL, V121, P435, DOI 10.1046/j.1523-1747.2003.12450.x; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	53	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104963	10.1371/journal.pone.0104963	http://dx.doi.org/10.1371/journal.pone.0104963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133614	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700057
J	Brun, P; Pathak, S; Castagliuolo, I; Palu, G; Brun, P; Zuin, M; Cavazzana, R; Martines, E				Brun, Paola; Pathak, Surajit; Castagliuolo, Ignazio; Palu, Giorgio; Brun, Paola; Zuin, Matteo; Cavazzana, Roberto; Martines, Emilio			Helium Generated Cold Plasma Finely Regulates Activation of Human Fibroblast-Like Primary Cells	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; OXIDATIVE STRESS; HACAT-KERATINOCYTES; NONTHERMAL PLASMA; ELECTRIC-FIELDS; RECEPTOR-GAMMA; PPAR-GAMMA; MYOFIBROBLASTS; APOPTOSIS; RESPONSES	Non-thermal atmospheric pressure plasmas are being developed for a wide range of health care applications, including wound healing. However in order to exploit the potential of plasma for clinical applications, the understanding of the mechanisms involved in plasma-induced activation of fibroblasts, the cells active in the healing process, is mandatory. In this study, the role of helium generated plasma in the tissue repairing process was investigated in cultured human fibroblast-like primary cells, and specifically in hepatic stellate cells and intestinal subepithelial myofibroblasts. Five minutes after treatment, plasma induced formation of reactive oxygen species (ROS) in cultured cells, as assessed by flow cytometric analysis of fluorescence-activated 2',7'-dichlorofluorescein diacetate probe. Plasma-induced intracellular ROS were characterized by lower concentrations and shorter half-lives with respect to hydrogen peroxide-induced ROS. Moreover ROS generated by plasma treatment increased the expression of peroxisome proliferator activated receptor (PPAR)-gamma, nuclear receptor that modulates the inflammatory responses. Plasma exposure promoted wound healing in an in vitro model and induced fibroblast migration and proliferation, as demonstrated, respectively, by trans-well assay and partitioning between daughter cells of carboxyfluorescein diacetate succinimidyl ester fluorescent dye. Plasma-induced fibroblast migration and proliferation were found to be ROS-dependent as cellular incubation with antioxidant agents (e.g. N-acetyl L-cysteine) cancelled the biological effects. This study provides evidence that helium generated plasma promotes proliferation and migration in liver and intestinal fibroblast-like primary cells mainly by increasing intracellular ROS levels. Since plasma-evoked ROS are time-restricted and elicit the PPAR-gamma anti-inflammatory molecular pathway, this strategy ensures precise regulation of human fibroblast activation and can be considered a valid therapeutic approach for liver and gut lesions.	[Brun, Paola; Pathak, Surajit; Castagliuolo, Ignazio; Palu, Giorgio] Univ Padua, Microbiol Unit, Dept Mol Med, Padua, Italy; [Pathak, Surajit] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Brun, Paola] Univ Padua, Unit Histol, Dept Mol Med, Padua, Italy; [Zuin, Matteo; Cavazzana, Roberto; Martines, Emilio] Consorzio RFX, Padua, Italy; [Zuin, Matteo; Martines, Emilio] Ist Gas Ionizzati CNR, Padua, Italy	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto Gas Ionizzati (IGI-CNR)	Brun, P (corresponding author), Univ Padua, Microbiol Unit, Dept Mol Med, Padua, Italy.	paola.brun.1@unipd.it	castagliuolo, ignazio/K-9963-2016; zuin, matteo/AAX-8015-2020; ZUIN, Matteo/G-5540-2018; Martines, Emilio/B-1418-2009; Pathak, Surajit/AAH-4022-2020; Brun, Paola/K-5729-2016; Brun, Paola/A-3380-2016	castagliuolo, ignazio/0000-0001-9888-7030; ZUIN, Matteo/0000-0002-0282-2978; Martines, Emilio/0000-0002-4181-2959; Pathak, Surajit/0000-0002-7306-1272; Brun, Paola/0000-0002-3279-9000; Brun, Paola/0000-0002-4204-3549	European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant); Italian Ministry of University and Research [2009HLNNRL_002]	European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID-Research Grant 2011) to PB and from Italian Ministry of University and Research (2009HLNNRL_002) to IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Cataldi A, 2010, CURR PHARM DESIGN, V16, P1387, DOI 10.2174/138161210791033969; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; de Valence S, 2013, EUR J PHARM BIOPHARM, V85, P78, DOI 10.1016/j.ejpb.2013.06.012; Di Mari JF, 2003, GASTROENTEROLOGY, V124, P1855, DOI 10.1016/S0016-5085(03)00399-8; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Giro G, 2013, J BIOMED MATER RES A, V101, P98, DOI 10.1002/jbm.a.34304; Grahn JC, 2003, WOUND REPAIR REGEN, V11, P64, DOI 10.1046/j.1524-475X.2003.11110.x; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Haertel B, 2011, EXP DERMATOL, V20, P282, DOI 10.1111/j.1600-0625.2010.01159.x; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Ikehara Y, 2013, J PHOTOPOLYM SCI TEC, V26, P555; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Nandi D, 2010, IMMUNOBIOLOGY, V215, P443, DOI 10.1016/j.imbio.2009.08.003; Nishimura KY, 1996, J CELL SCI, V109, P199; Novo E, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S4; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511; Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sanz Alberto, 2008, Curr Aging Sci, V1, P10; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; VANZANDWIJK N, 1995, J CELL BIOCHEM, P24; Volotskova O, 2011, PLASMA MED, V1, P85, DOI [DOI 10.1615/PlasmaMed.v1.i1.70, DOI 10.1615/PLASMAMED.V1.I1.70]; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Xu JY, 2003, AM J PHYSIOL-GASTR L, V285, pG20, DOI 10.1152/ajpgi.00474.2002	52	57	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104397	10.1371/journal.pone.0104397	http://dx.doi.org/10.1371/journal.pone.0104397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127477	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300022
J	Figueiredo, LB; Sakamoto, T; Coelho, LFL; Rocha, ESD; Cota, MMG; Ferreira, GP; de Oliveira, JG; Kroon, EG				Figueiredo, Leandra Barcelos; Sakamoto, Tetsu; Leomil Coelho, Luiz Felipe; de Oliveira Rocha, Eliseu Soares; Gomes Cota, Marcela Menezes; Ferreira, Gustavo Portela; de Oliveira, Jaquelline Germano; Kroon, Erna Geessien			Dengue Virus 2 American-Asian Genotype Identified during the 2006/2007 Outbreak in Piaui, Brazil Reveals a Caribbean Route of Introduction and Dissemination of Dengue Virus in Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; CO-CIRCULATION; TYPE-2; EVOLUTION; EMERGENCE; PROTEIN; STATE	Dengue virus (DENV) is the most widespread arthropod-borne virus, and the number and severity of outbreaks has increased worldwide in recent decades. Dengue is caused by DENV-1, DENV-2, DENV-3 and DENV-4 which are genetically distant. The species has been subdivided into genotypes based on phylogenetic studies. DENV-2, which was isolated from dengue fever patients during an outbreak in Piaui, Brazil in 2006/2007 was analyzed by sequencing the envelope (E) gene. The results indicated a high similarity among the isolated viruses, as well as to other DENV-2 from Brazil, Central America and South America. A phylogenetic and phylogeographic analysis based on DENV-2E gene sequences revealed that these viruses are grouped together with viruses of the American-Asian genotype in two distinct lineages. Our results demonstrate the co-circulation of two American-Asian genotype lineages in northeast Brazil. Moreover, we reveal that DENV-2 lineage 2 was detected in Piaui before it disseminated to other Brazilian states and South American countries, indicating the existence of a new dissemination route that has not been previously described.	[Figueiredo, Leandra Barcelos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil; [Sakamoto, Tetsu] Univ Fed Minas Gerais, Lab Biodados, Belo Horizonte, MG, Brazil; [Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Lab Vacinas, Alfenas, MG, Brazil; [de Oliveira Rocha, Eliseu Soares; Gomes Cota, Marcela Menezes] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil; [Ferreira, Gustavo Portela] Univ Fed Piaui, Lab Biotecnol, Parnaiba, Piaui, Brazil; [de Oliveira, Jaquelline Germano] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Alfenas; Universidade Federal de Minas Gerais; Universidade Federal do Piaui; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.	ernagkroon@gmail.cozm	Coelho, Luiz FL/G-5853-2012; Kroon, Erna Geessien/B-3631-2015; Sakamoto, Tetsu/N-7951-2014; Kroon, Erna/V-5444-2019; De Oliveira, Jaquelline/ABE-3725-2021	Kroon, Erna Geessien/0000-0003-2721-3826; Sakamoto, Tetsu/0000-0003-3023-0117; Rocha, Eliseu/0000-0002-2854-0768; Coelho, Luiz Felipe/0000-0003-4289-384X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); INCT; PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); INCT; PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	This study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), INCT and PRONEX-Dengue, Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; de Castro JAF, 2003, MEM I OSWALDO CRUZ, V98, P1021, DOI 10.1590/S0074-02762003000800007; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006; Drummond A., 2002, BEAUTI BAYESIAN EVOL; Drummond A.J., 2002, BEAST BAYESIAN EVOLU; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Gardella-Garcia CE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-117; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Posada D, 2011, JMODELTEST PHYLOGENE; Rambaut A, 2002, TREEANOTATOR V1 6 1; Rambaut A., 2006, TREE FIGURE DRAWING; Rambaut A., 2003, TRACER MCMC TRACE AN; Rambaut A, 2013, PATH O GEN SOFTWARE; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Thiel HJ, 2007, FIELDS VIROLOGY, P810; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0	47	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104516	10.1371/journal.pone.0104516	http://dx.doi.org/10.1371/journal.pone.0104516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127366	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300029
J	Loberto, N; Tebon, M; Lampronti, I; Marchetti, N; Aureli, M; Bassi, R; Giri, MG; Bezzerri, V; Lovato, V; Cantu, C; Munari, S; Cheng, SH; Cavazzini, A; Gambari, R; Sonnino, S; Cabrini, G; Dechecchi, MC				Loberto, Nicoletta; Tebon, Maela; Lampronti, Ilaria; Marchetti, Nicola; Aureli, Massimo; Bassi, Rosaria; Giri, Maria Grazia; Bezzerri, Valentino; Lovato, Valentina; Cantu, Cinzia; Munari, Silvia; Cheng, Seng H.; Cavazzini, Alberto; Gambari, Roberto; Sonnino, Sandro; Cabrini, Giulio; Dechecchi, Maria Cristina			GBA2-Encoded beta-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CERAMIDE; MIGLUSTAT; INFECTION; GBA2; SPHINGOLIPIDS; NASAL; INHIBITION; METABOLISM; DISEASE	Current anti-inflammatory strategies for the treatment of pulmonary disease in cystic fibrosis (CF) are limited; thus, there is continued interest in identifying additional molecular targets for therapeutic intervention. Given the emerging role of sphingolipids (SLs) in various respiratory disorders, including CF, drugs that selectively target the enzymes associated with SL metabolism are under development. Miglustat, a well-characterized iminosugar-based inhibitor of beta-glucosidase 2 (GBA2), has shown promise in CF treatment because it reduces the inflammatory response to infection by P. aeruginosa and restores F508del-CFTR chloride channel activity. This study aimed to probe the molecular basis for the anti-inflammatory activity of miglustat by examining specifically the role of GBA2 following the infection of CF bronchial epithelial cells by P. aeruginosa. We also report the anti-inflammatory activity of another potent inhibitor of GBA2 activity, namely N-(5-adamantane-1-yl-methoxy) pentyl)-deoxynojirimycin (Genz-529648). In CF bronchial cells, inhibition of GBA2 by miglustat or Genz-529648 significantly reduced the induction of IL-8 mRNA levels and protein release following infection by P. aeruginosa. Hence, the present data demonstrate that the anti-inflammatory effects of miglustat and Genz-529648 are likely exerted through inhibition of GBA2.	[Tebon, Maela; Bezzerri, Valentino; Lovato, Valentina; Cantu, Cinzia; Munari, Silvia; Cabrini, Giulio; Dechecchi, Maria Cristina] Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, Verona, Italy; [Loberto, Nicoletta; Aureli, Massimo; Bassi, Rosaria; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Lampronti, Ilaria; Gambari, Roberto] Univ Ferrara, Sect Biochem & Mol Biol, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Marchetti, Nicola; Cavazzini, Alberto] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Giri, Maria Grazia] Univ Hosp Verona, Dept Pathol & Diagnost, Med Phys Unit, Verona, Italy; [Cheng, Seng H.] Genzyme, Framingham, MA USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Milan; University of Ferrara; University of Ferrara; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Sanofi-Aventis; Genzyme Corporation	Dechecchi, MC (corresponding author), Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, Verona, Italy.	cristina.dechecchi@ospedaleuniverona.it	Aureli, Massimo/G-3876-2014; Cavazzini, Alberto/B-7051-2015; Bezzerri, Valentino/AFW-5965-2022; Cheng, Seng H/AAC-6564-2022; Dechecchi, Maria Cristina/K-5139-2016; Cabrini, Giulio/K-4761-2016; Sonnino, Sandro/R-4154-2017; Gambari, Roberto/F-9555-2015; Marchetti, Nicola/G-4933-2010; Bezzerri, Valentino/K-8132-2016; Lampronti, Ilaria/F-5522-2016	Aureli, Massimo/0000-0003-1916-2440; Cavazzini, Alberto/0000-0002-2510-0871; Bezzerri, Valentino/0000-0002-6849-4487; Dechecchi, Maria Cristina/0000-0002-5005-6585; Cabrini, Giulio/0000-0003-2720-0742; Sonnino, Sandro/0000-0001-8180-5908; Gambari, Roberto/0000-0001-9205-6033; Marchetti, Nicola/0000-0001-5595-570X; Bezzerri, Valentino/0000-0002-5937-378X; BASSI, ROSARIA/0000-0001-7409-4730; Lampronti, Ilaria/0000-0002-1972-7766	Italian Cystic Fibrosis Research Foundation (grant FFC) [14/2012]	Italian Cystic Fibrosis Research Foundation (grant FFC)	This research was supported by Italian Cystic Fibrosis Research Foundation (grant FFC # 14/2012) with the contribution of "Picasso. Capolavori dal Museo Nazionale Picasso di Parigi", Festa d'Estate Villa Sigurta Verona, Delegazione FFC Lago di Garda e Arezzo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Akha AAS, 2013, IMMUNOLOGY, V140, P111, DOI 10.1111/imm.12122; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; Aureli M, 2012, NEUROCHEM RES, V37, P1296, DOI 10.1007/s11064-012-0725-1; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Caretti A, 2014, BBA-GEN SUBJECTS, V1840, P586, DOI 10.1016/j.bbagen.2013.10.018; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Dechecchi MC, 2008, J CYST FIBROS, V7, P555, DOI 10.1016/j.jcf.2008.06.002; Dechecchi MC, 2012, CYSTIC FIBROSIS HUMA; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoffman LR, 2013, CHEST, V143, P207, DOI 10.1378/chest.12-1639; Hollak CEM, 2009, PHARMACOEPIDEM DR S, V18, P770, DOI 10.1002/pds.1779; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Leonard A, 2012, J CYST FIBROS, V11, P231, DOI 10.1016/j.jcf.2011.12.004; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Nahrlich L, 2013, CELL PHYSIOL BIOCHEM, V31, P505, DOI 10.1159/000350071; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Weenekes T, 2010, J MED CHEM, V53, P689; WELSH JM, 2001, METABOLIC MOL BASES; Yang Y, 2001, THER ADV RESPIR DIS, V5, P325; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yu H, 2009, AM J RESP CELL MOL, V41, P367, DOI 10.1165/rcmb.2008-0295OC; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	48	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104763	10.1371/journal.pone.0104763	http://dx.doi.org/10.1371/journal.pone.0104763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141135	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200033
J	Wang, N; Liang, HW; Zhou, Y; Wang, C; Zhang, SY; Pan, Y; Wang, YB; Yan, X; Zhang, JF; Zhang, CY; Zen, K; Li, DH; Chen, X				Wang, Nan; Liang, Hongwei; Zhou, Yong; Wang, Chen; Zhang, Suyang; Pan, Yi; Wang, Yanbo; Yan, Xin; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Li, Donghai; Chen, Xi			miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC	PLOS ONE			English	Article							MICRORNA; EXPRESSION; ACTIVATION; KINASES; BIOGENESIS	SRC, also known as proto-oncogene c-Src, is a non-receptor tyrosine kinase that plays an important role in cancer progression by promoting survival, angiogenesis, proliferation, and invasion pathways. In this study, we found that SRC protein levels were consistently upregulated in lung cancer tissues, but that SRC mRNA levels varied randomly, suggesting that a post-transcriptional mechanism was involved in SRC regulation. Because microRNAs (miRNAs) are powerful post-transcriptional regulators of gene expression, we used bioinformatic analyses to search for miRNAs that potentially target SRC. We identified specific targeting sites for miR-203 in the 3'-untranslated region (3'-UTR) of SRC. We then experimentally validated miR-203 as a direct regulator of SRC using cell transfection and luciferase assays and showed that miR-203 inhibited SRC expression and consequently triggered suppression of the SRC/Ras/ERK pathway. Finally, we demonstrated that the repression of SRC by miR-203 suppressed the proliferation and migration and promoted the apoptosis of lung cancer cells. In summary, this study provides the first clues regarding the role of miR-203 as a tumor suppressor in lung cancer cells through the inhibition of SRC translation.	[Wang, Nan; Liang, Hongwei; Wang, Chen; Zhang, Suyang; Pan, Yi; Wang, Yanbo; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Li, Donghai; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr microRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yong] Nanjing Univ, Coll Med, Affiliated Gulou Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Li, DH (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr microRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	donghaili@nju.edu.cn; xichen@nju.edu.cn	Pan, Yi/AAJ-2341-2021; wang, chen/GWM-9481-2022		National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]; Research Special Fund for Public Welfare Industry of Health [201302018]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Research Special Fund for Public Welfare Industry of Health; program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2014CB542300), the National Natural Science Foundation of China (No. 81101330, 31271378, and 81250044), the Natural Science Foundation of Jiangsu Province (No. BK2011013 and BK2012014), and the Research Special Fund for Public Welfare Industry of Health (No. 201302018). This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; HE L, 2004, NAT REV GENET, V5, P522; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson FM, 2007, ANTI-CANCER AGENT ME, V7, P651, DOI 10.2174/187152007784111278; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Masaki T, 2003, EUR J CANCER, V39, P1447, DOI 10.1016/S0959-8049(03)00276-4; MAZURENKO NN, 1992, EUR J CANCER, V28A, P372, DOI 10.1016/S0959-8049(05)80056-5; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	34	70	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105570	10.1371/journal.pone.0105570	http://dx.doi.org/10.1371/journal.pone.0105570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140799	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200101
J	Zhou, MW; Wang, W; Huang, WB; Zhang, XL				Zhou, Minwen; Wang, Wei; Huang, Wenbin; Zhang, Xiulan			Diabetes Mellitus as a Risk Factor for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OPTIC-NERVE HEAD; ANGELES LATINO EYE; INTRAOCULAR-PRESSURE; ELDERLY POPULATION; BARBADOS EYE; NITRIC-OXIDE; BLOOD-FLOW; PREVALENCE; HYPERTENSION; PROGRESSION	Objective: To determine the association between diabetes mellitus (DM) and primary open-angle glaucoma (POAG). Methods: This is a systematic review and meta-analysis of case-control and cohort studies. The literature search included two databases (PubMed and Embase) and the reference lists of the retrieved studies. Separate meta-analyses for case-control studies and cohort studies were conducted using random-effects models, with results reported as adjusted odds ratios (ORs) and relative risks (RRs), respectively. Results: Thirteen studies-seven case-control studies and six population-based cohort studies-were included in this metaanalysis. The pooled RR of the association between DM and POAG based on the risk estimates of the six cohort studies was 1.40 (95% CI, 1.25-1.57). The pooled OR of the association between DM and POAG based on the risk estimates of the seven case-control studies was 1.49 (95% CI, 1.17-1.88). There was considerable heterogeneity among the case-control studies that reported an association between DM mellitus and POAG (P<0.001) and no significant heterogeneity among the cohort studies (P = 0.377). After omitting the case-control study that contributed significantly to the heterogeneity, the pooled OR for the association between DM and POAG was 1.35 (95% CI, 1.06-1.74). Conclusions: Individuals with DM have an increased risk of developing POAG.	[Wang, Wei; Huang, Wenbin; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Minwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhou, Minwen] Shanghai Key Lab Fundus Dis, Shanghai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81170849, 81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81170849, 81371008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Charliat G, 1994, Ophthalmic Epidemiol, V1, P131, DOI 10.3109/09286589409047221; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; Danylkova NO, 2006, BRAIN RES, V1096, P20, DOI 10.1016/j.brainres.2006.04.061; de Voogd S, 2006, OPHTHALMOLOGY, V113, P1827, DOI 10.1016/j.ophtha.2006.03.063; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Jiang XJ, 2012, OPHTHALMOLOGY, V119, P2245, DOI 10.1016/j.ophtha.2012.05.030; Johnson EC, 1996, EXP EYE RES, V62, P663, DOI 10.1006/exer.1996.0077; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KATZ J, 1988, AM J PREV MED, V4, P110, DOI 10.1016/S0749-3797(18)31205-4; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; MAPSTONE R, 1985, BRIT MED J, V291, P93, DOI 10.1136/bmj.291.6488.93; Motsko SP, 2008, OPHTHALMOLOGY, V115, P1581, DOI 10.1016/j.ophtha.2008.01.016; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Peters D, 2013, AM J OPHTHALMOL; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rivera JL, 2008, CURR OPIN OPHTHALMOL, V19, P102, DOI 10.1097/ICU.0b013e3282f493b3; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Sommer A, 1996, ARCH OPHTHALMOL-CHIC, V114, P235, DOI 10.1001/archopht.1996.01100130229029; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; TIELSCH JM, 1995, OPHTHALMOLOGY, V102, P48; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Uhm K B, 1992, Korean J Ophthalmol, V6, P91; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Welinder Lotte G, 2009, Clin Epidemiol, V1, P125; Wells G.A., NEWCASTLE OTTAWA SCA; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; WILSON MR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1066; Wise LA, 2011, ANN EPIDEMIOL, V21, P430, DOI 10.1016/j.annepidem.2011.03.006	45	92	95	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102972	10.1371/journal.pone.0102972	http://dx.doi.org/10.1371/journal.pone.0102972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137059	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100005
J	Ishikawa, M; Ito, H; Kitaori, T; Murata, K; Shibuya, H; Furu, M; Yoshitomi, H; Fujii, T; Yamamoto, K; Matsuda, S				Ishikawa, Masahiro; Ito, Hiromu; Kitaori, Toshiyuki; Murata, Koichi; Shibuya, Hideyuki; Furu, Moritoshi; Yoshitomi, Hiroyuki; Fujii, Takayuki; Yamamoto, Koji; Matsuda, Shuichi			MCP/CCR2 Signaling Is Essential for Recruitment of Mesenchymal Progenitor Cells during the Early Phase of Fracture Healing	PLOS ONE			English	Article							BONE-MARROW-CELLS; STEM-CELLS; REPAIR; GROWTH; MORTALITY; CCR2	Objective: The purpose of this study was to investigate chemokine profiles and their functional roles in the early phase of fracture healing in mouse models. Methods: The expression profiles of chemokines were examined during fracture healing in wild-type (WT) mice using a polymerase chain reaction array and histological staining. The functional effect of monocyte chemotactic protein-1 (MCP-1) on primary mouse bone marrow stromal cells (mBMSCs) was evaluated using an in vitro migration assay. MCP-1(-/-) and C-C chemokine receptor 2 (CCR2)(-/-) mice were fractured and evaluated by histological staining and micro-computed tomography (micro-CT). RS102895, an antagonist of CCR2, was continuously administered in WT mice before or after rib fracture and evaluated by histological staining and micro-CT. Bone graft exchange models were created in WT and MCP-1(-/-) mice and were evaluated by histological staining and micro-CT. Results: MCP-1 and MCP-3 expression in the early phase of fracture healing were up-regulated, and high levels of MCP-1 and MCP-3 protein expression observed in the periosteum and endosteum in the same period. MCP-1, but not MCP-3, increased migration of mBMSCs in a dose-dependent manner. Fracture healing in MCP-1(-/-) and CCR2(-/-) mice was delayed compared with WT mice on day 21. Administration of RS102895 in the early, but not in the late phase, caused delayed fracture healing. Transplantation of WT-derived graft into host MCP-1(-/-) mice significantly increased new bone formation in the bone graft exchange models. Furthermore, marked induction of MCP-1 expression in the periosteum and endosteum was observed around the WT-derived graft in the host MCP-1(-/-) mouse. Conversely, transplantation of MCP-1(-/-) mouse-derived grafts into host WT mice markedly decreased new bone formation. Conclusions: MCP-1/CCR2 signaling in the periosteum and endosteum is essential for the recruitment of mesenchymal progenitor cells in the early phase of fracture healing.	[Ishikawa, Masahiro; Ito, Hiromu; Kitaori, Toshiyuki; Murata, Koichi; Shibuya, Hideyuki; Furu, Moritoshi; Fujii, Takayuki; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Ishikawa, Masahiro; Furu, Moritoshi] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yoshitomi, Hiroyuki] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Yamamoto, Koji] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp		Murata, Koichi/0000-0002-7896-3937; Matsuda, Shuichi/0000-0003-0802-1255; , Hiroyuki/0000-0001-7339-9030	Ministry of Education of Japan [19591756, 21591942]	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids from the Ministry of Education of Japan (No. 19591756, 21591942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2010, EUR CELLS MATER, V20, P121; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Docheva D, 2008, CURR RHEUMATOL REV, V4, P155, DOI 10.2174/157339708785133479; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190; Ito H, 2011, MOD RHEUMATOL, V21, P113, DOI 10.1007/s10165-010-0357-8; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; Murata K, 2014, J BONE MINER RES, V29, P316, DOI 10.1002/jbmr.2040; Murata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037163; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Tsou C, 2007, J CLIN INVEST, V117, P2; Tsuboi M, 2007, J BONE JOINT SURG BR, V89B, P461, DOI [10.1302/0301-620X.89B4.18552, 10.1302/0301-620X.89B4]; Utvag SE, 1996, J ORTHOP TRAUMA, V10, P279, DOI 10.1097/00005131-199605000-00009; Van Linthout S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/757154; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987	40	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104954	10.1371/journal.pone.0104954	http://dx.doi.org/10.1371/journal.pone.0104954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133509	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700054
J	Kim, JW; Seung, H; Kwon, KJ; Ko, MJ; Lee, EJ; Oh, HA; Choi, CS; Kim, KC; Gonzales, EL; You, JS; Choi, DH; Lee, J; Han, SH; Yang, SM; Cheong, JH; Shin, CY; Bahn, GH				Kim, Ji-Woon; Seung, Hana; Kwon, Kyung Ja; Ko, Mee Jung; Lee, Eun Joo; Oh, Hyun Ah; Choi, Chang Soon; Kim, Ki Chan; Gonzales, Edson Luck; You, Jueng Soo; Choi, Dong-Hee; Lee, Jongmin; Han, Seol-Heui; Yang, Sung Min; Cheong, Jae Hoon; Shin, Chan Young; Bahn, Geon Ho			Subchronic Treatment of Donepezil Rescues Impaired Social, Hyperactive, and Stereotypic Behavior in Valproic Acid-Induced Animal Model of Autism	PLOS ONE			English	Article							BTBR-T+TF/J MICE; MOUSE MODEL; SPECTRUM DISORDERS; ALZHEIMERS-DISEASE; NICOTINIC RECEPTORS; TRANSGENIC MICE; RATS; ACETYLCHOLINE; DEFICITS; MEMORY	Autism spectrum disorder (ASD) is a group of pervasive developmental disorders with core symptoms such as sociability deficit, language impairment, and repetitive/restricted behaviors. Although worldwide prevalence of ASD has been increased continuously, therapeutic agents to ameliorate the core symptoms especially social deficits, are very limited. In this study, we investigated therapeutic potential of donepezil for ASD using valproic acid-induced autistic animal model (VPA animal model). We found that prenatal exposure of valproic acid (VPA) induced dysregulation of cholinergic neuronal development, most notably the up-regulation of acetylcholinesterase (AChE) in the prefrontal cortex of affected rat and mouse offspring. Similarly, differentiating cortical neural progenitor cell in culture treated with VPA showed increased expression of AChE in vitro. Chromatin precipitation experiments revealed that acetylation of histone H3 bound to AChE promoter region was increased by VPA. In addition, other histone deacetyalse inhibitors (HDACIs) such as trichostatin A and sodium butyrate also increased the expression of AChE in differentiating neural progenitor cells suggesting the essential role of HDACIs in the regulation of AChE expression. For behavioral analysis, we injected PBS or donepezil (0.3 mg/kg) intraperitoneally to control and VPA mice once daily from postnatal day 14 all throughout the experiment. Subchronic treatment of donepezil improved sociability and prevented repetitive behavior and hyperactivity of VPA-treated mice offspring. Taken together, these results provide evidence that dysregulation of ACh system represented by the up-regulation of AChE may serve as an effective pharmacological therapeutic target against autistic behaviors in VPA animal model of ASD, which should be subjected for further investigation to verify the clinical relevance.	[Kim, Ji-Woon; Seung, Hana; Ko, Mee Jung; Lee, Eun Joo; Oh, Hyun Ah; Choi, Chang Soon; Kim, Ki Chan; Gonzales, Edson Luck; You, Jueng Soo; Choi, Dong-Hee; Lee, Jongmin; Han, Seol-Heui; Yang, Sung Min; Shin, Chan Young] Konkuk Univ, Sch Med, Dept Neurosci, Seoul, South Korea; [Kwon, Kyung Ja] Konkuk Univ, Ctr Res Neurosci, Inst Biomed Sci & Technol, Seoul, South Korea; [Cheong, Jae Hoon] Sahmyook Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Bahn, Geon Ho] Kyung Hee Univ, Sch Med, Dept Neuropsychiat, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Sahmyook University; Kyung Hee University	Shin, CY (corresponding author), Konkuk Univ, Sch Med, Dept Neurosci, Seoul, South Korea.	chanyshin@kku.ac.k; mompeian@khu.ac.kr	Bahn, Geon Ho/Q-4424-2019; bahn, geon ho/AAT-3577-2021; Kim, Ji-Woon/GXV-6752-2022	bahn, geon ho/0000-0002-3550-0422; Lee, Jongmin/0000-0001-8718-0099; Kim, Ki Chan/0000-0002-4899-1929; Kim, Ji-Woon/0000-0003-3890-0592; Ko, Mee Jung/0000-0003-0169-1387	Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea [A120029]	Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of health & welfare, Republic of Korea (No. A120029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Chez MG, 2004, J CHILD NEUROL, V19, P165; Chilian B, 2013, CLIN GENET; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Cohen O, 2002, MOL PSYCHIATR, V7, P874, DOI 10.1038/sj.mp.4001103; Cutuli D, 2009, J ALZHEIMERS DIS, V17, P161, DOI 10.3233/JAD-2009-1040; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Friedman SD, 2006, ARCH GEN PSYCHIAT, V63, P786, DOI 10.1001/archpsyc.63.7.786; Ghosh A, 2013, NAT REV DRUG DISCOV, V12, P777, DOI 10.1038/nrd4102; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hardan AY, 2002, J CHILD ADOL PSYCHOP, V12, P237, DOI 10.1089/104454602760386923; Hertzman M, 2003, INT J PSYCHIAT MED, V33, P395, DOI 10.2190/JE5Q-1NFT-FL40-7PMW; Holmes A, 2002, J MOL NEUROSCI, V18, P151, DOI 10.1385/JMN:18:1-2:151; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Iwasaki E, 2012, DIGEST DIS SCI, V57, P858, DOI 10.1007/s10620-011-1953-y; Karvat G, 2014, NEUROPSYCHOPHARMACOL, V39, P831, DOI 10.1038/npp.2013.274; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; LINDHOUT D, 1992, EPILEPSIA, V33, pS41; LINDHOUT D, 1986, LANCET, V1, P1392; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McTighe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062189; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Moriguchi S, 2005, J PHARMACOL EXP THER, V315, P125, DOI 10.1124/jpet.105.087908; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nicolson R, 2006, J CHILD ADOL PSYCHOP, V16, P621, DOI 10.1089/cap.2006.16.621; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Petersen AK, 2013, EUR J MED GENET, V56, P118, DOI 10.1016/j.ejmg.2012.11.003; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Politte L. C., 2013, PSYCHOPHARMACOLOGY B; Ray MA, 2005, NEUROBIOL DIS, V19, P366, DOI 10.1016/j.nbd.2005.01.017; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sarter M, 2004, NEUROBIOL AGING, V25, P1127, DOI 10.1016/j.neurobiolaging.2003.11.011; Sarter M, 2012, NEUROPHARMACOLOGY, V62, P1544, DOI 10.1016/j.neuropharm.2010.12.001; Sarter M, 2011, BEHAV NEUROSCI, V125, P825, DOI 10.1037/a0026227; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Silverman JL, 2013, DRUG DISCOV TODAY; Sokol DK, 2002, J CHILD NEUROL, V17, P245, DOI 10.1177/088307380201700401; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Won H, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00019; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262	67	67	71	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104927	10.1371/journal.pone.0104927	http://dx.doi.org/10.1371/journal.pone.0104927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133713	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700051
J	Schaefer, ST; Gessner, S; Scherag, A; Rump, K; Frey, UH; Siffert, W; Westendorf, AM; Steinmann, J; Peters, J; Adamzik, M				Schaefer, Simon T.; Gessner, Sophia; Scherag, Andre; Rump, Katharina; Frey, Ulrich H.; Siffert, Winfried; Westendorf, Astrid M.; Steinmann, Joerg; Peters, Juergen; Adamzik, Michael			Hydrocortisone Fails to Abolish NF-kappa B1 Protein Nuclear Translocation in Deletion Allele Carriers of the NFKB1 Promoter Polymorphism (-94ins/delATTG) and Is Associated with Increased 30-Day Mortality in Septic Shock	PLOS ONE			English	Article							NEGATIVE REGULATION; ORGAN FAILURE; SEPSIS; SCORE; GUIDELINES; MONOCYTES; THERAPY	Background: Previous investigations and meta-analyses on the effect of glucocorticoids on mortality in septic shock revealed mixed results. This heterogeneity might be evoked by genetic variations. Such candidate is a promoter polymorphism (-94ins/delATTG) of the gene encoding the ubiquitous transcription-factor nuclear-factor-kappa B (NF-kappa B) which binds to recognition elements in the promoter of several genes encoding for the innate immune-system. In turn, hydrocortisone inhibits NF-kappa B nuclear translocation and thus transcription of key immune-response regulators. Accordingly, we tested the hypotheses that hydrocortisone has a NFKB1 genotype dependent effect on 1) NF-kappa B1 nuclear translocation evoked by lipopolysaccharide (LPS) in monocytes in vitro, and 2) mortality in septic shock. Methods: Monocytes of volunteers with the homozygous insertion (II; n = 5) or deletion (DD; n = 6) NFKB1 genotype were incubated with 10 mu gml(-1) LPS +/- hydrocortisone (10(-5) M), and NF-kappa B1 nuclear translocation was assessed (immunofluorescence). Furthermore, we analyzed 30-day-mortality in 160 patients with septic shock stratified for both genotype and hydrocortisone therapy. Results: Hydrocortisone inhibited LPS induced nuclear translocation of NF-kappa B1 in II (25% +/- 11; p = 0.0001) but not in DD genotypes (51% +/- 15; p = n.s.). Onehundredandfour of 160 patients with septic shock received hydrocortisone, at the discretion of the intensivist. NFKB1 deletion allele carriers (ID/DD) receiving hydrocortisone had a much greater 30-day-mortality (57.6%) than II genotypes (24.4%; HR:3.18, 95%-CI:1.61-6.28; p = 0.001). In contrast, 30-day mortality was 22.2% in ID/DD and 25.0% in II genotypes without hydrocortisone therapy. Results were similar when using propensity score matching to account for possible bias in the intensivists' decision to administer hydrocortisone. Conclusion: Hydrocortisone fails to inhibit LPS induced nuclear NF-kappa B1 translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG). In septic shock, hydrocortisone treatment is associated with markedly increased 30-day-mortality only in such carriers. Accordingly, previous heterogeneous results regarding the benefit of hydrocortisone in septic shock may be reconciled by genetic variation of the NFKB1 promoter polymorphism.	[Schaefer, Simon T.; Gessner, Sophia; Rump, Katharina; Frey, Ulrich H.; Peters, Juergen; Adamzik, Michael] Univ Duisburg Essen, Klin Anasthesiol & Intens Med, Essen, Germany; [Schaefer, Simon T.; Gessner, Sophia; Rump, Katharina; Frey, Ulrich H.; Peters, Juergen; Adamzik, Michael] Univ Klinikum Essen, Essen, Germany; [Scherag, Andre] Univ Klinikum Jena, Klin Epidemiol, Integriertes Forschungs & Behandlungszent IFB, Sepsis & Sepsisfolgen Ctr Sepsis Control & Care C, Jena, Germany; [Rump, Katharina; Adamzik, Michael] Univ Duisburg Essen, Essen, Germany; [Rump, Katharina; Siffert, Winfried; Adamzik, Michael] Univ Klinikum Essen, Essen, Germany; [Rump, Katharina; Adamzik, Michael] Knappschaftskrankenhaus Bochum, Klin Anasthesiol & Intensivmed, Bochum, Germany; [Rump, Katharina; Adamzik, Michael] Ruhr Univ Bochum, Bochum, Germany; [Siffert, Winfried] Univ Duisburg Essen, Inst Pharmakogenet, Essen, Germany; [Westendorf, Astrid M.; Steinmann, Joerg] Inst Med Mikrobiol, Zurich, Switzerland	University of Duisburg Essen; University of Duisburg Essen; Friedrich Schiller University of Jena; University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen	Schaefer, ST (corresponding author), Univ Duisburg Essen, Klin Anasthesiol & Intens Med, Essen, Germany.	simon.schaefer@uk-essen.de	Rump, Katharina/AAJ-9090-2020; Adamzik, Michael/HGE-9286-2022; Schaefer, Simon Thomas/AAA-8869-2021; Westendorf, Astrid M./AAX-1937-2020; Frey, Ulrich H/C-2752-2019	Rump, Katharina/0000-0003-2220-519X; Schaefer, Simon Thomas/0000-0001-7289-6000; Scherag, Andre/0000-0002-9406-4704; Frey, Ulrich/0000-0003-2961-6629	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1002]; IFORES Research Grant of the medical faculty of the University Duisburg-Essen [D/D107-40240]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); IFORES Research Grant of the medical faculty of the University Duisburg-Essen	A. S. was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002. S. S. was supported by an IFORES Research Grant of the medical faculty of the University Duisburg-Essen (No.: D/D107-40240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2008, BASIC RES CARDIOL, V103, P598, DOI 10.1007/s00395-008-0750-z; Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Adamzik M, 2013, ANESTHESIOLOGY, V118, P123, DOI 10.1097/ALN.0b013e318277a652; Aegerter P, 2005, INTENS CARE MED, V31, P416, DOI 10.1007/s00134-005-2557-9; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; [Anonymous], 2010, SER EV SOFA SCOR PRE, P1; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Billing AM, 2011, INNATE IMMUN-LONDON, V17, P302, DOI 10.1177/1753425910369269; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Casserly B, 2012, INTENS CARE MED, V38, P1946, DOI 10.1007/s00134-012-2720-z; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Luca F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061654; Matot I, 2001, INTENS CARE MED, V27, pS3, DOI 10.1007/PL00003795; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; Schafer ST, 2013, ANESTHESIOLOGY, V118, P1426, DOI 10.1097/ALN.0b013e31828baa67; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; UNLAP T, 1995, MOL BRAIN RES, V28, P193, DOI 10.1016/0169-328X(94)00202-P; Wang CS, 2014, ANESTH ANALG, V118, P346, DOI 10.1213/ANE.0000000000000050; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	30	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104953	10.1371/journal.pone.0104953	http://dx.doi.org/10.1371/journal.pone.0104953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133403	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700053
J	Ackaert, C; Kofler, S; Horejs-Hoeck, J; Zulehner, N; Asam, C; von Grafenstein, S; Fuchs, JE; Briza, P; Liedl, KR; Bohle, B; Ferreira, F; Brandstetter, H; Oostingh, GJ; Duschl, A				Ackaert, Chloe; Kofler, Stefan; Horejs-Hoeck, Jutta; Zulehner, Nora; Asam, Claudia; von Grafenstein, Susanne; Fuchs, Julian E.; Briza, Peter; Liedl, Klaus R.; Bohle, Barbara; Ferreira, Fatima; Brandstetter, Hans; Oostingh, Gertie J.; Duschl, Albert			The Impact of Nitration on the Structure and Immunogenicity of the Major Birch Pollen Allergen Bet v 1.0101	PLOS ONE			English	Article							AIR-POLLUTION; PROTEIN STRUCTURES; ASTHMA; IGE; RECOGNITION; REACTIVITY; PARAMETERS; RESPONSES; BET-V-1; ANTIGEN	Allergy prevalence has increased in industrialized countries. One contributing factor could be pollution, which can cause nitration of allergens exogenously (in the air) or endogenously (in inflamed lung tissue). We investigated the impact of nitration on both the structural and immunological behavior of the major birch pollen allergen Bet v 1.0101 to determine whether nitration might be a factor in the increased incidence of allergy. Bet v 1.0101 was nitrated with tetranitromethane. Immune effects were assessed by measuring the proliferation of specific T-cell lines (TCLs) upon stimulation with different concentrations of nitrated and unmodified allergen, and by measurement of cytokine release of monocyte-derived dendritic cells (moDCs) and primary DCs (primDCs) stimulated with nitrated versus unmodified allergen. HPLC-MS, crystallography, gel electrophoresis, amino acid analysis, size exclusion chromatography and molecular dynamics simulation were performed to characterize structural changes after nitration of the allergen. The proliferation of specific TCLs was higher upon stimulation with the nitrated allergen in comparison to the unmodified allergen. An important structural consequence of nitration was oligomerization. Moreover, analysis of the crystal structure of nitrated Bet v 1.0101 showed that amino acid residue Y83, located in the hydrophobic cavity, was nitrated to 100%. Both moDCs and primDCs showed decreased production of T(H)1-priming cytokines, thus favoring a T(H)2 response. These results implicate that nitration of Bet v 1.0101 might be a contributing factor to the observed increase in birch pollen allergy, and emphasize the importance of protein modifications in understanding the molecular basis of allergenicity.	[Ackaert, Chloe; Kofler, Stefan; Horejs-Hoeck, Jutta; Briza, Peter; Brandstetter, Hans; Oostingh, Gertie J.; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Zulehner, Nora; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Zulehner, Nora; Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Asam, Claudia; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [von Grafenstein, Susanne; Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem Theoret Chem, A-6020 Innsbruck, Austria; [von Grafenstein, Susanne; Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria	Salzburg University; Medical University of Vienna; Medical University of Vienna; Salzburg University; University of Innsbruck; University of Innsbruck	Duschl, A (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	albert.duschl@sbg.ac.at	Horejs-Hoeck, Jutta/AAF-1735-2019; Liedl, Klaus/ABB-4725-2021; Brandstetter, Hans/E-6754-2011; Ferreira, Fatima/AAB-4321-2019; Horejs-Hoeck, Jutta/E-5010-2011; Liedl, Klaus R/F-3099-2015; Briza, Peter/D-7309-2012; Oostingh, Gertie Janneke/HHC-1098-2022; Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011	Horejs-Hoeck, Jutta/0000-0002-0984-204X; Liedl, Klaus/0000-0002-0985-2299; Brandstetter, Hans/0000-0002-6089-3045; Ferreira, Fatima/0000-0003-0989-2335; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Liedl, Klaus R/0000-0002-0985-2299; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Bohle, Barbara/0000-0002-5105-7985; Oostingh, Gertie Janneke/0000-0001-5083-217X	Austrian Science Fund; Austrian Academy of Sciences at University of Innsbruck;  [P22236_B13]; Austrian Science Fund (FWF) [P 22236] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences at University of Innsbruck; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund. The grant number is P22236_B13 and the URL is http://www.fwf.ac.at. JEF is a recipient of a DOC fellowship of the Austrian Academy of Sciences at University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Case D., 2010, AMBER11 AMBERTOOLS V; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Franze T, 2003, ANALYST, V128, P824, DOI 10.1039/b303132b; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Ghosh S, 2011, BBA-GEN SUBJECTS, V1810, P1008, DOI 10.1016/j.bbagen.2011.06.009; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ilyinskii PO, 2008, VACCINE, V26, P3223, DOI 10.1016/j.vaccine.2008.03.078; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; Karle AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031483; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Kofler S, 2014, J BIOL CHEM, V289, P540, DOI 10.1074/jbc.M113.518795; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myung Y, 2010, B KOREAN CHEM SOC, V31, P2581, DOI 10.5012/bkcs.2010.31.9.2581; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; RIORDAN JF, 1967, BIOCHEMISTRY-US, V6, P358, DOI 10.1021/bi00853a053; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Shiraiwa M, 2012, ENVIRON SCI TECHNOL, V46, P6630, DOI 10.1021/es300677a; Vrtala S, 2001, FASEB J; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	46	48	48	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104520	10.1371/journal.pone.0104520	http://dx.doi.org/10.1371/journal.pone.0104520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126882	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300032
J	Camero, S; Benitez, MJ; Cuadros, R; Hernandez, F; Avila, J; Jimenez, JS				Camero, Sergio; Benitez, Maria J.; Cuadros, Raquel; Hernandez, Felix; Avila, Jesus; Jimenez, Juan S.			Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; CYCLE-DEPENDENT PHOSPHORYLATION; NUCLEAR TAU; MICROTUBULE-BINDING; IN-VITRO; AGGREGATION; CELLS; HYPERPHOSPHORYLATION; MECHANISM; ISOFORMS	Tau hyperphosphorylation can be considered as one of the hallmarks of Alzheimer's disease and other tauophaties. Besides its well-known role as a microtubule associated protein, Tau displays a key function as a protector of genomic integrity in stress situations. Phosphorylation has been proven to regulate multiple processes including nuclear translocation of Tau. In this contribution, we are addressing the physicochemical nature of DNA-Tau interaction including the plausible influence of phosphorylation. By means of surface plasmon resonance (SPR) we measured the equilibrium constant and the free energy, enthalpy and entropy changes associated to the Tau-DNA complex formation. Our results show that unphosphorylated Tau binding to DNA is reversible. This fact is in agreement with the protective role attributed to nuclear Tau, which stops binding to DNA once the insult is over. According to our thermodynamic data, oscillations in the concentration of dephosphorylated Tau available to DNA must be the variable determining the extent of Tau binding and DNA protection. In addition, thermodynamics of the interaction suggest that hydrophobicity must represent an important contribution to the stability of the Tau-DNA complex. SPR results together with those from Tau expression in HEK cells show that phosphorylation induces changes in Tau protein which prevent it from binding to DNA. The phosphorylation-dependent regulation of DNA binding is analogous to the Tau-microtubules binding inhibition induced by phosphorylation. Our results suggest that hydrophobicity may control Tau location and DNA interaction and that impairment of this Tau-DNA interaction, due to Tau hyperphosphorylation, could contribute to Alzheimer's pathogenesis.	[Camero, Sergio; Benitez, Maria J.; Jimenez, Juan S.] Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain; [Camero, Sergio; Benitez, Maria J.; Cuadros, Raquel; Hernandez, Felix; Avila, Jesus] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Jimenez, JS (corresponding author), Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain.	juans.jimenez@uam.es	Benitez, María José/G-4404-2015; Avila, Jesus/I-2610-2015; Hernandez, Felix/L-2114-2015; Benitez Moreno, Maria Jose/ABE-8245-2021	Benitez, María José/0000-0002-6034-8557; Avila, Jesus/0000-0002-6288-0571; Hernandez, Felix/0000-0001-8753-8249; Benitez Moreno, Maria Jose/0000-0002-6034-8557; Cuadros Catalan, Raquel/0000-0001-6962-1110; Jimenez Martinez, Juan Salvador/0000-0001-5454-7827; Camero Gigante, Sergio/0000-0001-5283-6510	Spanish Government [SAF2006-02424, P2009/TIC-1476]; Comunidad de Madrid	Spanish Government(Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	Financial support has been provided by grants SAF2006-02424 and P2009/TIC-1476 from the Spanish Government and Comunidad de Madrid. Sergio Camero belonged to CIBERNED (Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas) while writing this contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Avila Jesus, 2012, Int J Alzheimers Dis, V2012, P578373, DOI 10.1155/2012/578373; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Barrantes A, 2012, CURR ALZHEIMER RES, V9, P924, DOI 10.2174/156720512803251101; Benitez MJ, 2002, ANAL BIOCHEM, V302, P161, DOI 10.1006/abio.2001.5547; Bergen M, 2000, PROC NATL ACAD; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Camero S, 2014, J ALZHEIMERS DIS, V39, P649, DOI 10.3233/JAD-131415; CORCES VG, 1980, EUR J BIOCHEM, V105, P7; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Gomez-Ramos A, 2004, BRAIN RES, V1007, P57, DOI 10.1016/j.brainres.2004.01.071; Grundke-Iqbal I, 2006, Bratisl Lek Listy, V107, P359; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hernandez F, EXPT NEUROLOGY, V223, P322; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Hua Q, 2002, PROTEIN PEPTIDE LETT, V9, P349, DOI 10.2174/0929866023408652; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; Krylova SM, 2005, FEBS LETT, V579, P1371, DOI 10.1016/j.febslet.2005.01.032; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; LAMBERT MP, 1995, NEUROBIOL AGING, V16, P583, DOI 10.1016/0197-4580(95)00042-D; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Lu Y, 2013, J ALZHEIMERS DIS, V37, P551, DOI 10.3233/JAD-130602; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; PAPASOZOMENOS SC, 1995, CLIN NEUROPATHOL, V14, P100; PAPASOZOMENOS SC, 1991, P NATL ACAD SCI USA, V88, P4543, DOI 10.1073/pnas.88.10.4543; Perez M, 1996, J NEUROCHEM, V67, P1183; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; Pooler AM, 2014, NEUROPHARMACOLOGY, V76, P1, DOI 10.1016/j.neuropharm.2013.09.018; POPE WB, 1994, EXP NEUROL, V126, P185, DOI 10.1006/exnr.1994.1057; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Qu MH, 2004, NEUROREPORT, V15, P2723; Ramachandran G, 2013, BIOCHEMISTRY-US, V52, P4107, DOI 10.1021/bi400209z; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tatebayashi Y, 2004, J CELL SCI, V117, P1653, DOI 10.1242/jcs.01018; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Thurston VC, 1997, CELL MOTIL CYTOSKEL, V38, P100, DOI 10.1002/(SICI)1097-0169(1997)38:1<100::AID-CM9>3.0.CO;2-C; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600	67	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104690	10.1371/journal.pone.0104690	http://dx.doi.org/10.1371/journal.pone.0104690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126942	Green Published, gold			2022-12-27	WOS:000340879300041
J	De Sarkar, N; Roy, R; Mitra, JK; Ghose, S; Chakraborty, A; Paul, RR; Mukhopadhyay, I; Roy, B				De Sarkar, Navonil; Roy, Roshni; Mitra, Jit Kumar; Ghose, Sandip; Chakraborty, Arnab; Paul, Ranjan Rashmi; Mukhopadhyay, Indranil; Roy, Bidyut			A Quest for miRNA Bio-Marker: A Track Back Approach from Gingivo Buccal Cancer to Two Different Types of Precancers	PLOS ONE			English	Article							CELL-PROLIFERATION; MICRORNA; GENE; HEAD; EXPRESSION; DATABASE; TARGETS; PROTEIN; FAMILY; MIR-1	Deregulation of miRNA expression may contribute to tumorigenesis and other patho-physiology associated with cancer. Using TLDA, expression of 762 miRNAs was checked in 18 pairs of gingivo buccal cancer-adjacent control tissues. Expression of significantly deregulated miRNAs was further validated in cancer and examined in two types of precancer (leukoplakia and lichen planus) tissues by primer-specific TaqMan assays. Biological implications of these miRNAs were assessed bioinformatically. Expression of hsa-miR-1293, hsa-miR-31, hsa-miR-31* and hsa-miR-7 were significantly up-regulated and those of hsa-miR-206, hsa-miR-204 and hsa-miR-133a were significantly down-regulated in all cancer samples. Expression of only hsa-miR-31 was significantly up-regulated in leukoplakia but none in lichen planus samples. Analysis of expression heterogeneity divided 18 cancer samples into clusters of 13 and 5 samples and revealed that expression of 30 miRNAs (including the above-mentioned 7 miRNAs), was significantly deregulated in the cluster of 13 samples. From database mining and pathway analysis it was observed that these miRNAs can significantly target many of the genes present in different cancer related pathways such as "proteoglycans in cancer", PI3K-AKT etc. which play important roles in expression of different molecular features of cancer. Expression of hsa-miR-31 was significantly up-regulated in both cancer and leukoplakia tissues and, thus, may be one of the molecular markers of leukoplakia which may progress to gingivo-buccal cancer.	[De Sarkar, Navonil; Roy, Roshni; Mitra, Jit Kumar; Chakraborty, Arnab; Mukhopadhyay, Indranil; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Ghose, Sandip; Paul, Ranjan Rashmi] Guru Nanak Inst Dent Sci & Res, Dept Oral Pathol, Panihati, Kokata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Roy, B (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	broy@isical.ac.in	Paul, R R/AAS-3560-2021	Paul, R R/0000-0001-6221-6446; Chakraborty, Arnab/0000-0002-1763-7249; De Sarkar, Navonil/0000-0003-2139-7951	Department of Biotechnolgy, Government of India; Indian Statistical Institute	Department of Biotechnolgy, Government of India(Department of Biotechnology (DBT) India); Indian Statistical Institute	All funding came from Department of Biotechnolgy, Government of India, and Indian Statistical Institute to Prof. Bidyut Roy. The funder has no role in study design, data collection, analysis, decision to publish and manuscript preparation.	*AM CANC SOC, 2007, CANC FACTS FIG 2007; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Benjamini Y, 1996, J ROYAL STAT SOC B, V58, P289; Boya Xie, 2010, International Society for Computers and Their Applications. 2nd International Conference on Bioinformatics and Computational Biology (BICoB-2010), P159; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Chang KW, 2013, ORAL ONCOL, V49, P27, DOI 10.1016/j.oraloncology.2012.07.003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kinoshita T, 2012, BIOCHEM BIOPH RES CO, V418, P378, DOI 10.1016/j.bbrc.2012.01.030; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nohata N, 2011, ONCOTARGET, V2, P29; Planchard D, 2012, CANCER-AM CANCER SOC, V118, P5015, DOI 10.1002/cncr.27510; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schooneveld EV, 2010, MOL CELL, V40, P841; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wilson N, 2004, NAT REV GENET, V5, P244, DOI 10.1038/nrg1334; Wu CD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-80; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104839	10.1371/journal.pone.0104839	http://dx.doi.org/10.1371/journal.pone.0104839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126847	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300056
J	Granville, K; Fan, ZZ				Granville, Kevin; Fan, Zhaozhi			Buckley-James Estimator of AFT Models with Auxiliary Covariates	PLOS ONE			English	Article							FAILURE TIME REGRESSION; CENSORED-DATA; MEASUREMENT ERROR; LINEAR-REGRESSION	In this paper we study the Buckley-James estimator of accelerated failure time models with auxiliary covariates. Instead of postulating distributional assumptions on the auxiliary covariates, we use a local polynomial approximation method to accommodate them into the Buckley-James estimating equations. The regression parameters are obtained iteratively by minimizing a consecutive distance of the estimates. Asymptotic properties of the proposed estimator are investigated. Simulation studies show that the efficiency gain of using auxiliary information is remarkable when compared to just using the validation sample. The method is applied to the PBC data from the Mayo Clinic trial in primary biliary cirrhosis as an illustration.	[Granville, Kevin] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Fan, Zhaozhi] Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada	University of Waterloo; Memorial University Newfoundland	Fan, ZZ (corresponding author), Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.	zhaozhi@mun.ca		Granville, Kevin/0000-0003-3912-015X	USRA from the National Sciences and Engineering Research Council of Canada; National Sciences and Engineering Research Council of Canada	USRA from the National Sciences and Engineering Research Council of Canada; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research of Kevin Granville was partially supported by USRA from the National Sciences and Engineering Research Council of Canada. The research of Zhaozhi Fan was partially supported by a Discovery Grant from the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PRIM BIL CIRRH PBC; BUCKLEY J, 1979, BIOMETRIKA, V66, P429; CARROL RJ, 1995, MEASUREMENT ERROR NO; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; Fan ZZ, 2009, J NONPARAMETR STAT, V21, P771, DOI 10.1080/10485250902915903; FLEMING TR, 1991, COUNTING PROCESSES S; Fuller W.A., 2009, MEASUREMENT ERROR MO; Granville K, 2012, J BIOM BIOSTAT, V3, P152, DOI [10.4172/2155-6180.1000152., DOI 10.4172/2155-6180.1000152]; He WQ, 2007, STAT MED, V26, P4817, DOI 10.1002/sim.2892; Hu CC, 2002, SCAND J STAT, V29, P637, DOI 10.1111/1467-9469.00310; Hu P, 1998, BIOMETRICS, V54, P1407, DOI 10.2307/2533667; JAMES IR, 1984, ANN STAT, V12, P590, DOI 10.1214/aos/1176346507; Jin ZZ, 2006, BIOMETRIKA, V93, P147, DOI 10.1093/biomet/93.1.147; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; LAI TL, 1991, ANN STAT, V19, P1370, DOI 10.1214/aos/1176348253; Liu YY, 2010, J MULTIVARIATE ANAL, V101, P679, DOI 10.1016/j.jmva.2009.09.008; Liu YY, 2009, BIOMETRICS, V65, P1184, DOI 10.1111/j.1541-0420.2009.01198.x; Nadaraya TA, 1964, THEOR PROBAB APPL, V10, P186; National Institutes of Health, 2011, PRIM BILL CIRRH; PRENTICE RL, 1982, BIOMETRIKA, V69, P331, DOI 10.1093/biomet/69.2.331; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Wand MP., 1994, KERNEL SMOOTHING; Wang NY, 1998, J AM STAT ASSOC, V93, P249, DOI 10.2307/2669621; Watson GS, 1964, INDIAN J STAT A, V26, P359; Yu MG, 2010, BIOMETRICS, V66, P405, DOI 10.1111/j.1541-0420.2009.01295.x; Zhou H, 2000, J ROY STAT SOC B, V62, P657, DOI 10.1111/1467-9868.00255; ZHOU HB, 1995, BIOMETRIKA, V82, P139	28	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104817	10.1371/journal.pone.0104817	http://dx.doi.org/10.1371/journal.pone.0104817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127479	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000340879300054
J	Shanley, CS; Albert, DM				Shanley, Colin S.; Albert, David M.			Climate Change Sensitivity Index for Pacific Salmon Habitat in Southeast Alaska	PLOS ONE			English	Article							FRESH-WATER ECOSYSTEMS; POPULATION DIVERSITY; SOCKEYE-SALMON; PINK SALMON; CONSERVATION; PATTERNS; TEMPERATURE; PERFORMANCE; RESILIENCE; STRATEGY	Global climate change may become one of the most pressing challenges to Pacific Salmon conservation and management for southeast Alaska in the 21 st Century. Predicted hydrologic change associated with climate change will likely challenge the ability of specific stocks to adapt to new flow regimes and resulting shifts in spawning and rearing habitats. Current research suggests egg-to-fry survival may be one of the most important freshwater limiting factors in Pacific Salmon's northern range due to more frequent flooding events predicted to scour eggs from mobile spawning substrates. A watershed-scale hydroclimatic sensitivity index was developed to map this hypothesis with an historical stream gauge station dataset and monthly multiple regression-based discharge models. The relative change from present to future watershed conditions predicted for the spawning and incubation period (September to March) was quantified using an ensemble global climate model average (ECHAM5, HadCM3, and CGCM3.1) and three global greenhouse gas emission scenarios (B1, A1B, and A2) projected to the year 2080. The models showed the region's diverse physiography and climatology resulted in a relatively predictable pattern of change: northern mainland and steeper, snow-fed mountainous watersheds exhibited the greatest increases in discharge, an earlier spring melt, and a transition into rain-fed hydrologic patterns. Predicted streamflow increases for all watersheds ranged from approximately 1-fold to 3-fold for the spawning and incubation period, with increased peak flows in the spring and fall. The hydroclimatic sensitivity index was then combined with an index of currently mapped salmon habitat and species diversity to develop a research and conservation priority matrix, highlighting potentially vulnerable to resilient high-value watersheds. The resulting matrix and observed trends are put forth as a framework to prioritize long-term monitoring plans, mitigation experiments, and finer-scale climate impact and adaptation studies.	[Shanley, Colin S.; Albert, David M.] Nature Conservancy, Juneau, AK 99801 USA	Nature Conservancy	Shanley, CS (corresponding author), Nature Conservancy, Juneau, AK 99801 USA.	cshanley@tnc.org			Alaska Sustainable Salmon Fund [44550]; Gordon and Betty Moore Foundation	Alaska Sustainable Salmon Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This project was funded by the Alaska Sustainable Salmon Fund (www.akssf.org; project #44550) and the Gordon and Betty Moore Foundation (www.moore.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 2003, ALASKA FISHERY RES B, V10, P83; Albert DM, 2013, CONSERV BIOL, V27, P774, DOI 10.1111/cobi.12109; Anderson D. R., 2008, MODEL BASED INFERENC; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bisson PA, 2009, ECOL SOC, V14; Bottom DL, 2009, ECOL SOC, V14; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Clark John H., 2006, ALASKA FISHERY RESEARCH BULLETIN, V12, P1; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dorava JM, 2000, HYDROL PROCESS, V14, P3149, DOI 10.1002/1099-1085(200011/12)14:16/17<3149::AID-HYP139>3.3.CO;2-P; Edwards RT, 2013, NORTH PACIFIC TEMPERATE RAINFORESTS: ECOLOGY & CONSERVATION, P43; Elsner MM, 2010, CLIMATIC CHANGE, DOI [10.1007/s10584-10010-19855-10580, DOI 10.1007/S10584-10010-19855-10580]; Fellman JB, 2014, HYDROL PROCESS, V28, P2062, DOI 10.1002/hyp.9742; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Halupka KC, 2003, N AM J FISH MANAGE, V23, P1057, DOI 10.1577/M02-152; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hennon PE, 2012, BIOSCIENCE, V62, P147, DOI 10.1525/bio.2012.62.2.8; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Jonsson B, 2012, CAN J FISH AQUAT SCI, V69, P1817, DOI 10.1139/f2012-108; Koski KV, 2009, ECOL SOC, V14; Kovach RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053807; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Larsen CF, 2005, EARTH PLANET SC LETT, V237, P548, DOI 10.1016/j.epsl.2005.06.032; Mantua N, 2010, CLIMATIC CHANGE, DOI [10.1007/s10584-10010-19845-10582, DOI 10.1007/S10584-10010-19845-10582]; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McGarigal K., 2000, MULTIVARIATE STAT WI; Meehl GA, 2004, CLIM DYNAM, V23, P495, DOI 10.1007/s00382-004-0442-9; Milner AM, 2013, NAT CLIM CHANGE, V3, P137, DOI [10.1038/nclimate1665, 10.1038/NCLIMATE1665]; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Montgomery DR, 1999, CAN J FISH AQUAT SCI, V56, P377, DOI 10.1139/cjfas-56-3-377; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Nolin AW, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008968; Pinsky ML, 2009, CONSERV BIOL, V23, P680, DOI 10.1111/j.1523-1739.2008.01156.x; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Radic V, 2011, J CLIMATE, V24, P5257, DOI 10.1175/JCLI-D-11-00011.1; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schoch GM, 2013, ESTUAR COAST, DOI [10.1007/s12237-12013-19622-12233, DOI 10.1007/S12237-12013-19622-12233]; Schwarz TC, 2010, THESIS CORNELL U ITH; Simpson JJ, 2005, ARCTIC, V58, P137; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Taylor SG, 2008, GLOBAL CHANGE BIOL, V14, P229, DOI 10.1111/j.1365-2486.2007.01494.x; USFS, 2012, R10 PR 028; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wipfli MS, 2010, FISHERIES, V35, P373, DOI 10.1577/1548-8446-35.8.373; [No title captured]	57	25	29	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104799	10.1371/journal.pone.0104799	http://dx.doi.org/10.1371/journal.pone.0104799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127398	gold, Green Published			2022-12-27	WOS:000340879300053
J	Uceyler, N; Valet, M; Kafke, W; Tolle, TR; Sommer, C				Ueceyler, Nurcan; Valet, Michael; Kafke, Waldemar; Toelle, Thomas R.; Sommer, Claudia			Local and Systemic Cytokine Expression in Patients with Postherpetic Neuralgia	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; GERMAN RESEARCH NETWORK; HERPES-ZOSTER; DIFFERENTIAL EXPRESSION; NATURAL-HISTORY; SKIN; NEUROPATHY; DIAGNOSIS; RESPONSES; IMMUNE	Background: Postherpetic neuralgia (PHN) is the painful complication of a varicella zoster virus reactivation. We investigated the systemic and local gene expression of pro-and anti-inflammatory cytokine expression in patients with PHN. Methods: Thirteen patients with PHN at the torso (Th4-S1) were recruited. Skin punch biopsies were obtained from the painful and the contralateral painless body area for intraepidermal nerve fiber density (IENFD) and cytokine profiling. Additionally, blood was withdrawn for systemic cytokine expression and compared to blood values of healthy controls. We analyzed the gene expression of selected pro-and anti-inflammatory cytokines (tumor necrosis factor-alpha [TNF] and interleukins [IL]-1 beta, IL-2, and IL-8). Results: IENFD was lower in affected skin compared to unaffected skin (p<0.05), while local gene expression of pro-and anti-inflammatory cytokines did not differ except for two patients who had 7fold higher IL-6 and 10fold higher IL-10 gene expression in the affected skin compared to the contralateral unaffected skin sample. Also, the systemic expression of cytokines in patients with PHN and in healthy controls was similar. Conclusion: While the systemic and local expression of the investigated pro- and anti-inflammatory cytokines was not different from controls, this may have been influenced by study limitations like the low number of patients and different disease durations. Furthermore, other cytokines or pain mediators need to be considered.	[Ueceyler, Nurcan; Kafke, Waldemar; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Valet, Michael; Toelle, Thomas R.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Wurzburg; Technical University of Munich	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, Wurzburg, Germany.	ueceyler_n@ukw.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428; Valet, Michael/0000-0003-3828-9164	Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG); University of Wurzburg	Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	The study was supported by Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS). The publication of the authors' study was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2012, J PAIN, V13, P10, DOI 10.1016/j.jpain.2011.10.003; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Buonocore M, 2012, J CELL PHYSIOL, V227, P934, DOI 10.1002/jcp.22804; Dworkin RH, 2008, J PAIN, V9, pS37, DOI 10.1016/j.jpain.2007.10.008; Failla V, 2011, EUR J DERMATOL, V21, P782, DOI 10.1684/ejd.2011.1424; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Javed S, 2011, J MED VIROL, V83, P2051, DOI 10.1002/jmv.22182; Kennedy WR. W-CG, 2005, PERIPHERAL NEUROPATH, V4th, P869, DOI [10.1016/B978-0-7216-9491-7.50037-5, DOI 10.1016/B978-0-7216-9491-7.50037-5]; Knapp DJ, 2013, CLIN J PAIN, V29, pE6, DOI 10.1097/AJP.0b013e31828b8ef8; Kotani N, 2004, AM J MED, V116, P318, DOI 10.1016/j.amjmed.2003.10.027; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Oaklander AL, 2008, J PAIN, V9, pS10, DOI 10.1016/j.jpain.2007.10.003; Petersen KL, 2007, PAIN, V131, P214, DOI 10.1016/j.pain.2007.03.004; Petersen KL, 2010, PAIN, V150, P75, DOI 10.1016/j.pain.2010.04.002; Pfau DB, 2014, PAIN, V155, P1002, DOI 10.1016/j.pain.2014.02.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rijsdijk M, 2013, EUR J PAIN, V17, P714, DOI 10.1002/j.1532-2149.2012.00233.x; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rotty J, 2006, CLIN INFECT DIS, V43, pE109, DOI 10.1086/509639; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; Thyregod HG, 2007, PAIN, V128, P148, DOI 10.1016/j.pain.2006.09.021; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Uceyler N, 2009, EXP BRAIN RES, V196, P67, DOI 10.1007/s00221-009-1755-z; Zak-Prelich M, 2003, CLIN EXP IMMUNOL, V131, P318, DOI 10.1046/j.1365-2249.2003.02061.x; Zhu SM, 2009, J ZHEJIANG UNIV-SC B, V10, P625, DOI 10.1631/jzus.B0920049	28	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105269	10.1371/journal.pone.0105269	http://dx.doi.org/10.1371/journal.pone.0105269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127283	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300100
J	Vitali, S; Battiston, S				Vitali, Stefania; Battiston, Stefano			The Community Structure of the Global Corporate Network	PLOS ONE			English	Article							SMALL WORLD; TOPOLOGY; MARKET	We investigate the community structure of the global ownership network of transnational corporations. We find a pronounced organization in communities that cannot be explained by randomness. Despite the global character of this network, communities reflect first of all the geographical location of firms, while the industrial sector plays only a marginal role. We also analyze the meta-network in which the nodes are the communities and the links are obtained by aggregating the links among firms belonging to pairs of communities. We analyze the network centrality of the top 50 communities and we provide a quantitative assessment of the financial sector role in connecting the global economy.	[Vitali, Stefania; Battiston, Stefano] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Vitali, Stefania] Univ Politecn Marche, Dipartimento Sci Econ & Sociali, Ancona, Italy	University of Zurich; Marche Polytechnic University	Battiston, S (corresponding author), Univ Zurich, Dept Banking & Finance, Zurich, Switzerland.	stefano.battiston@.uzh	/M-1612-2017	/0000-0002-0051-973X	FET Open Project FOC "Forecasting Financial Crises" [255987]	FET Open Project FOC "Forecasting Financial Crises"	Stefano Battiston acknowledges support from FET Open Project FOC "Forecasting Financial Crises" nr. 255987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Battiston S, 2003, ADV COMPLEX SYST, V6, P631, DOI 10.1142/S0219525903001109; Battiston S, 2003, PHYSICA A, V322, P567, DOI 10.1016/S0378-4371(02)01930-1; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Cajueiro DO, 2008, PHYSICA A, V387, P6825, DOI 10.1016/j.physa.2008.08.031; Chinazzi M, 2012, POSTMORTEM EX INT FI; Cont R, 2011, NETWORK STRUCTURE SY; Conyon MJ, 2006, J BUS FINAN ACCOUNT, V33, P1321, DOI 10.1111/j.1468-5957.2006.00634.x; Corrado R, 2006, IND CORP CHANGE, V15, P319, DOI 10.1093/icc/dtj018; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davis GF, 1997, AM J SOCIOL, V103, P1, DOI 10.1086/231170; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Fenn D, 2008, ARXIV08113988; Ferrara E, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds9; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Granovetter M., 1995, IND CORP CHANGE, V4, P93, DOI DOI 10.1093/ICC/4.1.93; Kaushik R, 2012, ARXIV12050976; Kogut B, 2001, AM SOCIOL REV, V66, P317, DOI 10.2307/3088882; La Porta R, 1999, J FINANC, V54, P471, DOI 10.1111/0022-1082.00115; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Minoiu C, 2012, NETWORK ANAL GLOBA B; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OECD (Organisation for Economic Co-operation and Development), 2000, OECD GUID MULT ENT; Orman GK, 2011, J CONVERGENCE INFORM, V6; Piccardi C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066119; Piccardi C, 2010, PHYSICA A, V389, P5247, DOI 10.1016/j.physa.2010.06.038; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Vitali S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063021; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	45	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104655	10.1371/journal.pone.0104655	http://dx.doi.org/10.1371/journal.pone.0104655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25126722	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000340879300039
J	Wei, J; Chamberlain, JR				Wei, Jessica; Chamberlain, Joel R.			Systemic RNAi Delivery to the Muscles of ROSA26 Mice Reduces lacZ Expression	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; DOUBLE-STRANDED-RNA; MESSENGER-RNA; GENE-TRANSFER; INTERFERENCE; TRANSDUCTION; SHRNA; PERSISTENCE; THERAPY; VECTORS	RNAi has potential for therapeutically downregulating the expression of dominantly inherited genes in a variety of human genetic disorders. Here we used the ROSA26 mouse, which constitutively expresses the bacterial lacZ gene in tissues body wide, as a model to test the ability to downregulate gene expression in striated muscles. Recombinant adeno-associated viral vectors (rAAVs) were generated that express short hairpin RNAs (shRNAs) able to target the lacZ mRNA. Systemic delivery of these rAAV6 vectors led to a decrease of beta-galactosidase expression of 30-50-fold in the striated muscles of ROSA26 mice. However, high doses of vectors expressing 21 nucleotide shRNA sequences were associated with significant toxicity in both liver and cardiac muscle. This toxicity was reduced in cardiac muscle using lower vector doses. Furthermore, improved knockdown in the absence of toxicity was obtained by using a shorter (19 nucleotide) shRNA guide sequence. These results support the possibility of using rAAV vectors to deliver RNAi sequences systemically to treat dominantly inherited disorders of striated muscle.	[Wei, Jessica; Chamberlain, Joel R.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chamberlain, JR (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	Jrcham@uw.edu			NIH [AR56107, AR44533]; Muscular Dystrophy Association Research Grant; Pacific Northwest Friends of FSH Dystrophy Research Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044533, R03AR056107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Research Grant; Pacific Northwest Friends of FSH Dystrophy Research Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH AR56107 and AR44533, Muscular Dystrophy Association Research Grant, Pacific Northwest Friends of FSH Dystrophy Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett A, 2012, MUSCLE FUNDAMENTAL B, P1045; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Borel F, 2014, MOL THER, V22, P692, DOI 10.1038/mt.2013.285; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harper SQ, 2005, METH MOL B, V309, P219; Koornneef A, 2011, MOL THER, V19, P731, DOI 10.1038/mt.2011.6; Lambeth Luke S, 2013, Methods Mol Biol, V942, P205, DOI 10.1007/978-1-62703-119-6_12; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Schultz BR, 2008, MOL THER, V16, P1189, DOI 10.1038/mt.2008.103; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wang HY, 2014, HUM MOL GENET, V23, P668, DOI 10.1093/hmg/ddt454; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yang WQ, 2012, EXPERT OPIN BIOL TH, V12, P1495, DOI 10.1517/14712598.2012.712107; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	47	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102053	10.1371/journal.pone.0102053	http://dx.doi.org/10.1371/journal.pone.0102053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127128	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300003
J	Adams, KM; Abraham, V; Spielman, D; Kolls, JK; Rubenstein, RC; Conner, GE; Cohen, NA; Kreindler, JL				Adams, Kelly M.; Abraham, Valsamma; Spielman, Daniel; Kolls, Jay K.; Rubenstein, Ronald C.; Conner, Gregory E.; Cohen, Noam A.; Kreindler, James L.			IL-17A Induces Pendrin Expression and Chloride-Bicarbonate Exchange in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; HYPER-IGE SYNDROME; CYSTIC-FIBROSIS; TRANSPORT PROTEIN; ANION-EXCHANGERS; MUCIN SECRETION; SURFACE LIQUID; MUCUS RELEASE; SYNDROME GENE; HOST-DEFENSE	The epithelium plays an active role in the response to inhaled pathogens in part by responding to signals from the immune system. Epithelial responses may include changes in chemokine expression, increased mucin production and antimicrobial peptide secretion, and changes in ion transport. We previously demonstrated that interleukin-17A (IL-17A), which is critical for lung host defense against extracellular bacteria, significantly raised airway surface pH in vitro, a finding that is common to a number of inflammatory diseases. Using microarray analysis of normal human bronchial epithelial (HBE) cells treated with IL-17A, we identified the electroneutral chloride-bicarbonate exchanger Pendrin (SLC26A4) as a potential mediator of this effect. These data were verified by real-time, quantitative PCR that demonstrated a time-dependent increase in Pendrin mRNA expression in HBE cells treated with IL-17A up to 48 h. Using immunoblotting and immunofluorescence, we confirmed that Pendrin protein expression is increased in IL-17 treated HBE cells and that it is primarily localized to the mucosal surface of the cells. Functional studies using live-cell fluorescence to measure intracellular pH demonstrated that IL-17A induced chloride-bicarbonate exchange in HBE cells that was not present in the absence of IL-17A. Furthermore, HBE cells treated with short interfering RNA against Pendrin showed substantially reduced chloride-bicarbonate exchange. These data suggest that Pendrin is part of IL-17A-dependent epithelial changes and that Pendrin may therefore be a therapeutic target in IL-17A-dependent lung disease.	[Adams, Kelly M.; Abraham, Valsamma; Rubenstein, Ronald C.; Kreindler, James L.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Adams, Kelly M.; Rubenstein, Ronald C.; Kreindler, James L.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Spielman, Daniel] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Conner, Gregory E.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Pennsylvania; Pennsylvania Medicine	Kreindler, JL (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.	kreindler@email.chop.edu	Kolls, Jay/AAH-1829-2019; Conner, Gregory/AAI-1285-2021	Kolls, Jay/0000-0001-5151-6304; Conner, Gregory/0000-0003-2217-2252; Cohen, Noam/0000-0002-9462-3932; Spielman, Daniel/0000-0003-2602-0416; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health [K08 HL081080]; Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health K08 HL081080 and by funds from the Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Aujla SJ, 2011, BBA-GEN SUBJECTS, V1810, P1066, DOI 10.1016/j.bbagen.2011.02.002; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V18, P67, DOI 10.1159/000095164; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Garnett JP, 2011, J BIOL CHEM; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kreindler JL, 2009, AM J PHYSIOL-LUNG C, V296, pL257, DOI 10.1152/ajplung.00344.2007; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Xie C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015255	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103263\	10.1371/journal.pone.0103263	http://dx.doi.org/10.1371/journal.pone.0103263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141009	Green Accepted, Green Published, gold			2022-12-27	WOS:000342687200005
J	Cameron, DR; Marty, J; Holland, RF				Cameron, D. Richard; Marty, Jaymee; Holland, Robert F.			Whither the Rangeland?: Protection and Conversion in California's Rangeland Ecosystems	PLOS ONE			English	Article							LAND-USE CHANGE; UNITED-STATES; CONSERVATION EASEMENTS; CARBON SEQUESTRATION; EXURBAN DEVELOPMENT; BIODIVERSITY; DIVERSITY; SERVICES; TRENDS	Land use change in rangeland ecosystems is pervasive throughout the western United States with widespread ecological, social and economic implications. In California, rangeland habitats have high biodiversity value, provide significant habitat connectivity and form the foundation for a number of ecosystem services. To comprehensively assess the conservation status of these habitats, we analyzed the extent and drivers of habitat loss and the degree of protection against future loss across a 13.5 M ha study area in California. We analyzed rangeland conversion between 1984 and 2008 using time series GIS data and classified resulting land uses with aerial imagery. In total, over 195,000 hectares of rangeland habitats were converted during this period. The majority of conversions were to residential and associated commercial development (49% of the area converted), but agricultural intensification was surprisingly extensive and diverse (40% across six categories). Voluntary enrollment in an agricultural tax incentive program provided widespread protection from residential and commercial conversions across 37% of the remaining rangeland habitat extent (7.5 M ha), though this program did not protect rangeland from conversion to more intensive agricultural uses. Additionally, 24% of the remaining rangeland was protected by private conservation organizations or public agencies through land or easement ownership while 38% had no protection status at all. By developing a spatial method to analyze the drivers of loss and patterns of protection, this study demonstrates a novel approach to prioritize conservation strategies and implementation locations to avert habitat conversion. We propose that this approach can be used in other ecosystem types, and can serve as a regional conservation baseline assessment to focus strategies to effect widespread, cost-effective conservation solutions.	[Cameron, D. Richard; Marty, Jaymee] Nature Conservancy, San Francisco, CA 94125 USA; [Holland, Robert F.] Geobot Phenomenol, Auburn, CA USA	Nature Conservancy	Cameron, DR (corresponding author), Nature Conservancy, San Francisco, CA 94125 USA.	dcameron@tnc.org						AECOM, 2009, LOSS CENTR VALL VERN; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Blench R, 1999, UNDERSTANDING RANGEL; Booker K, 2013, GLOBAL ENVIRON CHANG, V23, P240, DOI 10.1016/j.gloenvcha.2012.10.001; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Brunson MW, 2008, RANGELAND ECOL MANAG, V61, P137, DOI 10.2111/07-063.1; Calfire, 2006, MULT LAND COV DAT FV; Calfire, 2010, CAL FOR RANG 2010 AS; CDOC, 2008, FARML MAPP MON PROGR; CDOC, 2010, CAL LAND CONS WILL A; CDOC, 2010, WILL ACT LAND STAT; CDOC, 2013, CAL LAND CONS ACT 20; Chaplin-Kramer Rebecca, 2011, Rangelands, V33, P33; CHARBONNEAU R, 1993, ENVIRON MANAGE, V17, P453, DOI 10.1007/BF02394661; Christensen G. A., 2008, CALIFORNIA FOREST RE; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Davis F., 1998, CALIFORNIA GAP ANAL; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Diaz D., 2012, EVALUATION AVOIDED G; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; FSA, 2009, NAT AGR IM PROGR; George M, 2001, ANN RANGE FORAGE PRO; GIN, 2011, CAL PROT AR DAT; Gosnell H, 2011, RANGELANDS, V33, P20, DOI 10.2111/1551-501X-33.5.20; Gosnell H, 2006, SOC NATUR RESOUR, V19, P743, DOI 10.1080/08941920600801181; Greene RP, 2001, SOC SCI J, V38, P543, DOI 10.1016/S0362-3319(01)00150-1; Grismer M, 2012, CALIF AGR, V66, P144, DOI 10.3733/ca.v066n04p144; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Havstad KM, 2007, ECOL ECON, V64, P261, DOI 10.1016/j.ecolecon.2007.08.005; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huntsinger L, 2010, RANGELAND ECOL MANAG, V63, P324, DOI 10.2111/08-166.1; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Knight RL, 2007, RANGELANDS, V29, P4, DOI DOI 10.2111/1551-501X(2007)29[4:RAAKSI]2.0.CO;2; Kucera T. E., 1995, California Agriculture, V49, P23, DOI 10.3733/ca.v049n06p23; Liffmann RH, 2000, J RANGE MANAGE, V53, P362, DOI 10.2307/4003745; Maestas JD, 2003, CONSERV BIOL, V17, P1425, DOI 10.1046/j.1523-1739.2003.02371.x; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Mitchell J. E., 2002, Rangelands, V24, P3, DOI 10.1071/RJv24n1_ED; MURPHY DD, 1988, BIOL CONSERV, V46, P183, DOI 10.1016/0006-3207(88)90067-5; NASS, 2011, CAL HIST COMM DAT AL; NRCS, 2012, SOIL SURV; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Rass N., 2006, POLICIES STRATEGIES; Rissman A.R., 2007, RANGELANDS, V29, P21; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Silver WL, 2010, RANGELAND ECOL MANAG, V63, P128, DOI 10.2111/REM-D-09-00106.1; Sleeter B.M., 2008, CALIFORNIA GEOGRAPHE, V48; Sleeter BM, 2011, ENVIRON MONIT ASSESS, V173, P251, DOI 10.1007/s10661-010-1385-8; Sokolow A. D., 2002, California Agriculture, V56, P9, DOI 10.3733/ca.v056n01p9; Soulard CE, 2013, J LAND USE SCI, P1; Theobald D.M., 2005, ECOL SOC, V10, P34, DOI [10.5751/ES-01390-100132, DOI 10.5751/ES-01390-100132]; TNC, 2006, CAL EC; USDA, 2011, CAL WIN GRAP 1920 20; USFS, 1989, AN LAND BAS SIT US 1; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Volpe RJ, 2010, CALIF AGR, V64, P42, DOI 10.3733/ca.v064n01p42; Wetzel WC, 2012, CALIFORNIA AGR, P66	63	30	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103468	10.1371/journal.pone.0103468	http://dx.doi.org/10.1371/journal.pone.0103468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141171	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200007
J	Ding, R; Chen, XH; Zhang, LJ; Yu, XD; Qu, B; Duan, R; Xu, YF				Ding, Rui; Chen, Xu-Hui; Zhang, Li-Jun; Yu, Xiao-Dan; Qu, Bo; Duan, Ru; Xu, Yu-Feng			Identity and Specificity of Rhizoctonia-Like Fungi from Different Populations of Liparis japonica (Orchidaceae) in Northeast China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DIVERSITY; ENDOPHYTES; PREFERENCE; TOLERANCE; SYMBIOSIS; MARRIAGE; GENETICS; PLANTS; WATER	Mycorrhizal association is known to be important to orchid species, and a complete understanding of the fungi that form mycorrhizas is required for orchid ecology and conservation. Liparis japonica (Orchidaceae) is a widespread terrestrial photosynthetic orchid in Northeast China. Previously, we found the genetic diversity of this species has been reduced recent years due to habitat destruction and fragmentation, but little was known about the relationship between this orchid species and the mycorrhizal fungi. The Rhizoctonia-like fungi are the commonly accepted mycorrhizal fungi associated with orchids. In this study, the distribution, diversity and specificity of culturable Rhizoctonia-like fungi associated with L. japonica species were investigated from seven populations in Northeast China. Among the 201 endophytic fungal isolates obtained, 86 Rhizoctonia-like fungi were identified based on morphological characters and molecular methods, and the ITS sequences and phylogenetic analysis revealed that all these Rhizoctonia-like fungi fell in the same main clade and were closely related to those of Tulasnella calospora species group. These findings indicated the high mycorrhizal specificity existed in L. japonica species regardless of habitats at least in Northeast China. Our results also supported the wide distribution of this fungal partner, and implied that the decline of L. japonica in Northeast China did not result from high mycorrhizal specificity. Using culture-dependent technology, these mycorrhizal fungal isolates might be important sources for the further utilizing in orchids conservation.	[Ding, Rui; Chen, Xu-Hui; Zhang, Li-Jun; Yu, Xiao-Dan; Qu, Bo; Duan, Ru; Xu, Yu-Feng] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning, Peoples R China	Shenyang Agricultural University	Chen, XH (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning, Peoples R China.	chenxh017@163.com			National Natural Science Foundation of China [31100299, 31200011]; China Postdoctoral Science Foundation [2012M510835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was funded by the National Natural Science Foundation of China (No. 31100299 and No. 31200011), (URL: http://www.nsfc.gov.cn/), and China Postdoctoral Science Foundation (No. 2012M510835) (URL: http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058268; Chen XH, 2013, PLANT SYST EVOL, V299, P691, DOI 10.1007/s00606-012-0744-z; CURRAH RS, 1992, MYCOL RES, V96, P583, DOI 10.1016/S0953-7562(09)80984-2; Curtis JT, 1939, AM J BOT, V26, P390, DOI 10.2307/2436839; De Long JR, 2013, ANN BOT-LONDON, V111, P409, DOI 10.1093/aob/mcs294; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Editorial Committee of the Flora of China, 1992, FLORA CHINA, V18, P62; Fomina MA, 2005, SOIL BIOL BIOCHEM, V37, P851, DOI 10.1016/j.soilbio.2004.10.013; Gardes M, 2002, NEW PHYTOL, V154, P4, DOI 10.1046/j.1469-8137.2002.00386.x; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Illyes Z, 2009, J APPL BOT FOOD QUAL, V83, P28; Irwin Mathew John, 2007, Mycoscience, V48, P231, DOI 10.1007/s10267-007-0360-x; Jacquemyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042212; Kohout P, 2013, FUNGAL ECOL, V6, P50, DOI 10.1016/j.funeco.2012.08.005; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Ma M, 2003, MYCOL RES, V107, P1041, DOI 10.1017/S0953756203008281; MASUHARA G, 1994, NEW PHYTOL, V127, P711, DOI 10.1111/j.1469-8137.1994.tb02974.x; McCormick MK, 2014, NEW PHYTOL, V202, P392, DOI 10.1111/nph.12639; McCormick MK, 2004, NEW PHYTOL, V163, P425, DOI 10.1111/j.1469-8137.2004.01114.x; McCormick MK, 2006, ECOLOGY, V87, P903, DOI 10.1890/0012-9658(2006)87[903:OFAMMT]2.0.CO;2; Nontachaiyapoom S, 2010, MYCORRHIZA, V20, P459, DOI 10.1007/s00572-010-0297-3; Oliveira SF, 2014, MYCORRHIZA, V24, P55, DOI 10.1007/s00572-013-0512-0; Otero JT, 2007, AM J BOT, V94, P1944, DOI 10.3732/ajb.94.12.1944; Pandey M, 2013, MOL ECOL, V22, P2341, DOI 10.1111/mec.12249; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasmussen HN, 2002, PLANT SOIL, V244, P149, DOI 10.1023/A:1020246715436; Roche SA, 2010, AM J BOT, V97, P1313, DOI 10.3732/ajb.1000049; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Marquez SS, 2008, FUNGAL DIVERS, V33, P87; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Suarez JP, 2006, MYCOL RES, V110, P1257, DOI 10.1016/j.mycres.2006.08.004; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Swarts ND, 2009, TRENDS PLANT SCI, V14, P590, DOI 10.1016/j.tplants.2009.07.008; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tondello A, 2012, FUNGAL BIOL-UK, V116, P543, DOI 10.1016/j.funbio.2012.02.004; Wei YK, 2007, FUNGAL DIVERS, V24, P329; Xing XK, 2013, MYCORRHIZA, V23, P317, DOI 10.1007/s00572-012-0473-8; Yao MK, 2002, MYCORRHIZA, V12, P235, DOI 10.1007/s00572-002-0176-7; Yukawa T, 2009, AM J BOT, V96, P1997, DOI 10.3732/ajb.0900101; Zeng Y, 2013, MYCORRHIZA, V23, P253, DOI 10.1007/s00572-013-0484-0; Zettler LW, 2011, AM MIDL NAT, V166, P29, DOI 10.1674/0003-0031-166.1.29	54	12	18	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105573	10.1371/journal.pone.0105573	http://dx.doi.org/10.1371/journal.pone.0105573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140872	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200102
J	Kim, H; Terazono, H; Nakamura, Y; Sakai, K; Hattori, A; Odaka, M; Girault, M; Arao, T; Nishio, K; Miyagi, Y; Yasuda, K				Kim, Hyonchol; Terazono, Hideyuki; Nakamura, Yoshiyasu; Sakai, Kazuko; Hattori, Akihiro; Odaka, Masao; Girault, Mathias; Arao, Tokuzo; Nishio, Kazuto; Miyagi, Yohei; Yasuda, Kenji			Development of On-Chip Multi-Imaging Flow Cytometry for Identification of Imaging Biomarkers of Clustered Circulating Tumor Cells	PLOS ONE			English	Article							NUCLEAR MORPHOMETRY; SIZE; CANCER; SYSTEM; SURVIVAL; BLOOD	An on-chip multi-imaging flow cytometry system has been developed to obtain morphometric parameters of cell clusters such as cell number, perimeter, total cross-sectional area, number of nuclei and size of clusters as "imaging biomarkers'', with simultaneous acquisition and analysis of both bright-field (BF) and fluorescent (FL) images at 200 frames per second (fps); by using this system, we examined the effectiveness of using imaging biomarkers for the identification of clustered circulating tumor cells (CTCs). Sample blood of rats in which a prostate cancer cell line (MAT-LyLu) had been pre-implanted was applied to a microchannel on a disposable microchip after staining the nuclei using fluorescent dye for their visualization, and the acquired images were measured and compared with those of healthy rats. In terms of the results, clustered cells having (1) cell area larger than 200 mu m(2) and (2) nucleus area larger than 90 mu m(2) were specifically observed in cancer cell-implanted blood, but were not observed in healthy rats. In addition, (3) clusters having more than 3 nuclei were specific for cancer-implanted blood and (4) a ratio between the actual perimeter and the perimeter calculated from the obtained area, which reflects a shape distorted from ideal roundness, of less than 0.90 was specific for all clusters having more than 3 nuclei and was also specific for cancer-implanted blood. The collected clusters larger than 300 mu m(2) were examined by quantitative gene copy number assay, and were identified as being CTCs. These results indicate the usefulness of the imaging biomarkers for characterizing clusters, and all of the four examined imaging biomarkers-cluster area, nuclei area, nuclei number, and ratio of perimeter-can identify clustered CTCs in blood with the same level of preciseness using multi-imaging cytometry.	[Kim, Hyonchol; Terazono, Hideyuki; Hattori, Akihiro; Odaka, Masao; Girault, Mathias; Yasuda, Kenji] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Terazono, Hideyuki; Yasuda, Kenji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biosyst, Dept Biomed Informat,Chiyoda Ku, Tokyo, Japan; [Nakamura, Yoshiyasu; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Asahi Ku, Yokohama, Kanagawa 2410815, Japan; [Sakai, Kazuko; Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan	Kanagawa Academy Science & Technology; Tokyo Medical & Dental University (TMDU); Kanagawa Prefectural Cancer Center; Kindai University (Kinki University)	Yasuda, K (corresponding author), Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa, Japan.	yasuda.bmi@tmd.ac.jp	Kim, Hyonchol/R-9922-2017; Yasuda, Kenji/L-6520-2016	Kim, Hyonchol/0000-0002-1786-648X; Terazono, Hideyuki/0000-0002-2657-4454; Yasuda, Kenji/0000-0002-1433-4509	Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology	Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology	This work was supported by Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla F, 2009, ANTICANCER RES, V29, P1771; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Buhmeida A, 2006, ANTICANCER RES, V26, P455; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; de Andrea CE, 2011, INT J CLIN EXP PATHO, V4, P169; DEANS GT, 1993, DIS COLON RECTUM, V36, P450, DOI 10.1007/BF02050010; Desitter I, 2011, ANTICANCER RES, V31, P427; DUNDAS SAC, 1988, J CLIN PATHOL, V41, P1273, DOI 10.1136/jcp.41.12.1273; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Hattori A, 2014, JAPANESE J IN PRESS; Hattori A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GM04; Hayashi M, 2011, INT J MOL SCI, V12, P3618, DOI 10.3390/ijms12063618; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; KINOSITA K, 1991, J CELL BIOL, V115, P67, DOI 10.1083/jcb.115.1.67; Meachem MD, 2012, J VET DIAGN INVEST, V24, P525, DOI 10.1177/1040638712440988; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nomura F., 2011, J BIOPROCESS BIOTECH, VS3, P003; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sokmen S, 2001, ANTICANCER RES, V21, P4341; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Takahashi Kazunori, 2004, J Nanobiotechnology, V2, P5, DOI 10.1186/1477-3155-2-5; Tennant TR, 2000, PROSTATE, V43, P295, DOI 10.1002/1097-0045(20000601)43:4<295::AID-PROS9>3.0.CO;2-W; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Yasuda K, 2013, MICROFLUID NANOFLUID, V14, P907, DOI 10.1007/s10404-012-1112-6; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	29	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104372	10.1371/journal.pone.0104372	http://dx.doi.org/10.1371/journal.pone.0104372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140522	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200018
J	Lin, P; Bach, M; Asquith, M; Lee, AY; Akileswaran, L; Stauffer, P; Davin, S; Pan, YZ; Cambronne, ED; Dorris, M; Debelius, JW; Lauber, CL; Ackermann, G; Baeza, YV; Gill, T; Knight, R; Colbert, RA; Taurog, JD; Van Gelder, RN; Rosenbaum, JT				Lin, Phoebe; Bach, Mary; Asquith, Mark; Lee, Aaron Y.; Akileswaran, Lakshmi; Stauffer, Patrick; Davin, Sean; Pan, Yuzhen; Cambronne, Eric D.; Dorris, Martha; Debelius, Justine W.; Lauber, Christian L.; Ackermann, Gail; Baeza, Yoshiki V.; Gill, Tejpal; Knight, Rob; Colbert, Robert A.; Taurog, Joel D.; Van Gelder, Russell N.; Rosenbaum, James T.			HLA-B27 and Human beta 2-Microglobulin Affect the Gut Microbiota of Transgenic Rats	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; KLEBSIELLA-PNEUMONIAE NITROGENASE; ANKYLOSING-SPONDYLITIS; HLA-B27-TRANSGENIC RATS; SALMONELLA-ENTERITIDIS; BACTEROIDES-VULGATUS; INFLAMMATORY DISEASE; AUTOIMMUNE-DISEASE; REACTIVE ARTHRITIS; MOLECULAR MIMICRY	The HLA-B27 gene is a major risk factor for clinical diseases including ankylosing spondylitis, acute anterior uveitis, reactive arthritis, and psoriatic arthritis, but its mechanism of risk enhancement is not completely understood. The gut microbiome has recently been shown to influence several HLA-linked diseases. However, the role of HLA-B27 in shaping the gut microbiome has not been previously investigated. In this study, we characterize the differences in the gut microbiota mediated by the presence of the HLA-B27 gene. We identified differences in the cecal microbiota of Lewis rats transgenic for HLA-B27 and human beta 2-microglobulin (h beta 2m), compared with wild-type Lewis rats, using biome representational in situ karyotyping (BRISK) and 16S rRNA gene sequencing. 16S sequencing revealed significant differences between transgenic animals and wild type animals by principal coordinates analysis. Further analysis of the data set revealed an increase in Prevotella spp. and a decrease in Rikenellaceae relative abundance in the transgenic animals compared to the wild type animals. By BRISK analysis, species-specific differences included an increase in Bacteroides vulgatus abundance in HLA-B27/h beta 2m and h beta 2m compared to wild type rats. The finding that HLA-B27 is associated with altered cecal microbiota has not been shown before and can potentially provide a better understanding of the clinical diseases associated with this gene.	[Lin, Phoebe; Stauffer, Patrick; Davin, Sean; Pan, Yuzhen; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Asquith, Mark; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Div Rheumatol, Portland, OR 97201 USA; [Bach, Mary] Univ Washington, Div Rheumatol, VA Med Ctr, Seattle, WA 98195 USA; [Lee, Aaron Y.] Moorfields Eye Inst London, London, England; [Akileswaran, Lakshmi; Van Gelder, Russell N.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Dorris, Martha; Taurog, Joel D.] Univ Texas Southwestern, Dept Rheumatol, Dallas, TX USA; [Debelius, Justine W.; Lauber, Christian L.; Ackermann, Gail; Baeza, Yoshiki V.; Knight, Rob] Univ Colorado, Boulder, CO 80309 USA; [Rosenbaum, James T.] Devers Eye Inst, Portland, OR USA; [Cambronne, Eric D.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Gill, Tejpal; Colbert, Robert A.] NIAMSD, Pediat Translat Res Branch, NIH, Baltimore, MD USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Boulder; Devers Eye Institute; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); NIH National Institute on Aging (NIA); Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lin, P (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	linp@ohsu.edu	Van Gelder, Russell/ABB-4225-2021; Asquith, Mark/M-1741-2019; Knight, Rob/D-1299-2010; Lee, Aaron/AAT-2839-2020; Gill, Tejpal/A-1139-2014; Pan, YZ/GVS-2269-2022; Gill, Tejpal/AAV-1659-2020; Debelius, Justine/ABE-7272-2021	Van Gelder, Russell/0000-0001-5368-3659; Gill, Tejpal/0000-0001-6248-132X; Knight, Rob/0000-0002-0975-9019; Debelius, Justine/0000-0002-8605-3546	Research to Prevent Blindness Career Development Award; NIH [K08EY022948, P30 EY001730, T32 AR 007108]; Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Burroughs-Wellcome Translational Scientist Award; Research to Prevent Blindness; NIAMS [Z01 AR041184]; NATIONAL EYE INSTITUTE [K08EY022948, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007108, ZIAAR041184] Funding Source: NIH RePORTER	Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Burroughs-Wellcome Translational Scientist Award(Burroughs Wellcome Fund); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	PL is supported by a Research to Prevent Blindness Career Development Award and an NIH award K08EY022948. JTR is supported by the Stan and Madelle Rosenfeld Family Trust and the William and Mary Bauman Foundation. RK is an HHMI Early Career Scientist. RVG and LA were supported by the Burroughs-Wellcome Translational Scientist Award, an unrestricted award from Research to Prevent Blindness, and by NIH P30 EY001730. MB was supported by NIH T32 AR 007108. TG and RAC were supported by the NIAMS Intramural Research Program Z01 AR041184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; DEVRIES DD, 1992, ANN RHEUM DIS, V51, P783, DOI 10.1136/ard.51.6.783; Dhaenens M, 2009, ARTHRITIS RHEUM-US, V60, P2622, DOI 10.1002/art.24780; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; EWING C, 1990, J EXP MED, V171, P1635, DOI 10.1084/jem.171.5.1635; Fert I, 2008, ARTHRITIS RHEUM-US, V58, P3425, DOI 10.1002/art.24023; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Hoentjen F, 2005, INFLAMM BOWEL DIS, V11, P977, DOI 10.1097/01.MIB.0000183421.02316.d5; Hoentjen F, 2007, INFLAMM BOWEL DIS, V13, P317, DOI 10.1002/ibd.20040; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; LAHESMAA R, 1993, IMMUNOL RES, V12, P193, DOI 10.1007/BF02918304; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luckey D, 2013, INDIAN J MED RES, V138, P732; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McHugh K, 2012, RHEUMATOLOGY, V51, P1529, DOI 10.1093/rheumatology/kes061; Mertz AKH, 2000, J IMMUNOL, V164, P1529, DOI 10.4049/jimmunol.164.3.1529; Muthappan V, 2011, GENOME RES, V21, P626, DOI 10.1101/gr.115758.110; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Penttinen MA, 2002, ARTHRITIS RHEUM-US, V46, P2172, DOI 10.1002/art.10557; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Ruuska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050684; Ruuska M, 2012, ARTHRITIS RHEUM-US, V64, P772, DOI 10.1002/art.33391; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; SCHWIMMBECK PL, 1987, J EXP MED, V166, P173, DOI 10.1084/jem.166.1.173; SCOFIELD RH, 1993, P NATL ACAD SCI USA, V90, P9330, DOI 10.1073/pnas.90.20.9330; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Taurog JD, 2012, ARTHRITIS RHEUM-US, V64, P2518, DOI 10.1002/art.34480; Taurog JD, 2009, ARTHRITIS RHEUM, V60, P1977, DOI 10.1002/art.24599; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Utriainen L, 2012, ARTHRITIS RHEUM-US, V64, P3199, DOI 10.1002/art.34561; VANBOHEMEN CG, 1986, IMMUNOL LETT, V13, P71, DOI 10.1016/0165-2478(86)90128-8; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu D, 2003, RHEUM DIS CLIN N AM, V29, P21, DOI 10.1016/S0889-857X(02)00082-0	55	152	158	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105684	10.1371/journal.pone.0105684	http://dx.doi.org/10.1371/journal.pone.0105684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140823	Green Published, gold			2022-12-27	WOS:000342687200120
J	Entin-Meer, M; Levy, R; Goryainov, P; Landa, N; Barshack, I; Avivi, C; Semo, J; Keren, G				Entin-Meer, Michal; Levy, Ran; Goryainov, Pavel; Landa, Natalie; Barshack, Iris; Avivi, Camila; Semo, Jonathan; Keren, Gad			The Transient Receptor Potential Vanilloid 2 Cation Channel Is Abundant in Macrophages Accumulating at the Peri-Infarct Zone and May Enhance Their Migration Capacity towards Injured Cardiomyocytes following Myocardial Infarction	PLOS ONE			English	Article							TRP CHANNELS; TRANSLOCATION	Purpose: A novel family of transient receptor potential (TRP) channels, that may hold a role in calcium homeostasis, has recently been described. By employing a GeneChip array analysis we have demonstrated a clear and specific upregulation of the TRP vanilloid 2 (TRPV2) mRNA in the left ventricles (LV) 3-5 days post-acute myocardial infarction (MI) compared to sham-operated controls, both in rats and in mice. We sought to characterize the cardiac cellular subpopulations in which TRPV2 is overexpressed upon acute MI. Methods: Lewis rats underwent an acute MI by ligation of the left anterior descending artery or chest opening only (sham). The animals were terminated at various time points and an immunohistochemical (IHC) and immunofloerescent (IFC) staining of the LV sections as well as a flow cytometry analysis of LV-derived cells were carried out, using anti-TRPV2 and anti-monocyte/macrophage antibodies. Rat alveolar macrophage cells, NR8383, transiently transfected with TRPV2 siRNA were allowed to migrate towards hypoxic conditioned media of the rat cardiac myoblast line H9C2 using a trans-well migration assay. The macrophage cells migrating to the bottom side of the inserts were counted. Results: The IHC and IFC staining as well as the flow cytometry data demonstrated a substantial expression of TRPV2 in infiltrating macrophages in the peri-infarct region 3-5 days post-acute MI. The in vitro migration assay data demonstrated that following inhibition of the TRPV2 channel, the number of migrating macrophages towards conditioned medium of hypoxic cardiomyocytes was significantly reduced. Conclusions: TRPV2 is highly expressed on the peri-infarct infiltrating macrophages and may play an important role in post-MI phagocytosis. Better characterization of this channel may pave the way for identifying a new target for modulating the dramatic post-MI immune reactions.	[Entin-Meer, Michal; Levy, Ran; Goryainov, Pavel; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Cardiovasc Res Lab, IL-69978 Tel Aviv, Israel; [Entin-Meer, Michal; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Landa, Natalie] Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, Ramat Gan, Israel; [Barshack, Iris; Avivi, Camila] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Keren, G (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Cardiovasc Res Lab, IL-69978 Tel Aviv, Israel.	kereng@tlvmc.gov.il			Israel Science Foundation; Alsa And Leo Abramson Research fund	Israel Science Foundation(Israel Science Foundation); Alsa And Leo Abramson Research fund	Funding provided by Israel Science Foundation; Alsa And Leo Abramson Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 1995, EUR HEART J, V16, P37, DOI 10.1093/eurheartj/16.suppl_N.37; Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Huang W, 2009, HYPERTENSION, V53, P243, DOI 10.1161/HYPERTENSIONAHA.108.118349; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwata Y, 2013, CARDIOVASC RES, V99, P760, DOI 10.1093/cvr/cvt163; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Kojima Itaru, 2007, P105; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matthews KG, 1999, J ENDOCRINOL, V163, P433, DOI 10.1677/joe.0.1630433; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Montange D, 2012, EXP CLIN CARDIOL, V17, P131; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Santoni Giorgio, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P54; Solem ML, 1998, BIOCHEM BIOPH RES CO, V252, P151, DOI 10.1006/bbrc.1998.9626; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Tang MS, 2012, GROWTH HORM IGF RES, V22, P206, DOI 10.1016/j.ghir.2012.09.002; Vennekens R, 2011, J PHYSIOL-LONDON, V589, P1527, DOI 10.1113/jphysiol.2010.202077; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023	27	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105055	10.1371/journal.pone.0105055	http://dx.doi.org/10.1371/journal.pone.0105055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136832	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100064
J	Grau, C; Ginhoux, R; Riera, A; Nguyen, TL; Chauvat, H; Berg, M; Amengual, JL; Pascual-Leone, A; Ruffini, G				Grau, Carles; Ginhoux, Romuald; Riera, Alejandro; Thanh Lam Nguyen; Chauvat, Hubert; Berg, Michel; Amengual, Julia L.; Pascual-Leone, Alvaro; Ruffini, Giulio			Conscious Brain-to-Brain Communication in Humans Using Non-Invasive Technologies	PLOS ONE			English	Article							COMPUTER INTERFACES	Human sensory and motor systems provide the natural means for the exchange of information between individuals, and, hence, the basis for human civilization. The recent development of brain-computer interfaces (BCI) has provided an important element for the creation of brain-to-brain communication systems, and precise brain stimulation techniques are now available for the realization of non-invasive computer-brain interfaces (CBI). These technologies, BCI and CBI, can be combined to realize the vision of non-invasive, computer-mediated brain-to-brain (B2B) communication between subjects (hyperinteraction). Here we demonstrate the conscious transmission of information between human brains through the intact scalp and without intervention of motor or peripheral sensory systems. Pseudo-random binary streams encoding words were transmitted between the minds of emitter and receiver subjects separated by great distances, representing the realization of the first human brain-to-brain interface. In a series of experiments, we established internet-mediated B2B communication by combining a BCI based on voluntary motor imagery-controlled electroencephalographic (EEG) changes with a CBI inducing the conscious perception of phosphenes (light flashes) through neuronavigated, robotized transcranial magnetic stimulation (TMS), with special care taken to block sensory (tactile, visual or auditory) cues. Our results provide a critical proof-of-principle demonstration for the development of conscious B2B communication technologies. More fully developed, related implementations will open new research venues in cognitive, social and clinical neuroscience and the scientific study of consciousness. We envision that hyperinteraction technologies will eventually have a profound impact on the social structure of our civilization and raise important ethical issues.	[Grau, Carles; Riera, Alejandro; Ruffini, Giulio] Starlab Barcelona, Barcelona, Spain; [Grau, Carles] Univ Barcelona, Neurodynam Lab, Dept Psychiat & Clin Psychobiol, Fac Psychol, Barcelona, Spain; [Grau, Carles] Univ Barcelona, Fac Med, Barcelona 7, Spain; [Ginhoux, Romuald; Thanh Lam Nguyen; Chauvat, Hubert; Berg, Michel] Axilum Robot, Strasbourg, France; [Riera, Alejandro; Ruffini, Giulio] Neuroelect Barcelona, Barcelona, Spain; [Amengual, Julia L.] Univ Barcelona, Cognit & Brain Plast Unit, Dept Basic Psychol, Barcelona, Spain; [Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Sch Med, Boston, MA 02215 USA	University of Barcelona; University of Barcelona; University of Barcelona; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ruffini, G (corresponding author), Starlab Barcelona, Barcelona, Spain.	Giulio.Ruffini@Starlab.es	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Ruffini, Giulio/0000-0003-3084-0177	EU FP7 FET Open HIVE project [222079]; Starlab Kolmogorov project [SIF-003]; Generalitat de Catalunya [2009SGR00093]; Neurology Department of the Hospital de Bellvitge; Starlab; Axilum Robotics; Neuroelectrics Barcelona	EU FP7 FET Open HIVE project; Starlab Kolmogorov project; Generalitat de Catalunya(Generalitat de Catalunya); Neurology Department of the Hospital de Bellvitge; Starlab; Axilum Robotics; Neuroelectrics Barcelona	This work was partly supported by the EU FP7 FET Open HIVE project (GR, AR, CG, http://hive-eu.org, FET-Open grant 222079, http://cordis.europa.eu/fp7/ict/fetopen/home_en.html), the Starlab Kolmogorov project (GR, CG, SIF-003, http://starlabint.com), the research group 2009SGR00093 from the Generalitat de Catalunya (GR, CG, http://www10.gencat.cat/agaur_web/AppJava/english/a_beca.jsp?categoria=aitres&id_beca=4861), and by the Neurology Department of the Hospital de Bellvitge (JLA). Co-authors CG, AR and GR were employed by Starlab Barcelona during these studies. The funder, Starlab, provided support in the form of salaries for authors CG, AR and GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-authors RG, TLN and MB are employed by Axilum Robotics. Co-authors AR and GR are employed by Neuroelectrics Barcelona. Axilum Robotics and Neuroelectrics Barcelona provided support in the form of salaries for authors RG, TLN, MB, AR and GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allison B., 2013, PRACTICAL BRAIN COMP; Bashir S, 2011, BRAIN TOPOGR, V24, P54, DOI 10.1007/s10548-010-0165-7; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Deadwyler SA, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00120; Delgado J. M. R., 1969, PHYS CONTROL MIND PS; DEWAN EM, 1967, NATURE, V214, P975, DOI 10.1038/214975a0; Fouche Gaines H, 1989, CRYPTANALYSIS STUDY; Fried PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027204; Ginhoux R, 2013, IEEE ENG MED BIO, P5352, DOI 10.1109/EMBC.2013.6610758; Green DM, 1966, SIGNAL DETECTION THE; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Julkunen P, 2009, NEUROIMAGE, V44, P790, DOI 10.1016/j.neuroimage.2008.09.040; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kandel E, 2013, NEURON, V80, P546, DOI 10.1016/j.neuron.2013.10.039; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Macmillan NA, 2005, DETECTION THEORY USE; Nicolelis MA, 2010, BOUNDARIES NEW NEURO; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Pais-Vieira M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01319; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Schalk G, 2010, PRACTICAL GUIDE TO BRAIN-COMPUTER INTERFACING WITH BCI2000, P1, DOI 10.1007/978-1-84996-092-2; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Shanechi MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4237; Taylor PCJ, 2010, HUM BRAIN MAPP, V31, P1408, DOI 10.1002/hbm.20941; Trimper John B, 2014, Front Neuroeng, V7, P4, DOI 10.3389/fneng.2014.00004; Wichchukit S, 2010, J FOOD SCI, V75, pR183, DOI 10.1111/j.1750-3841.2010.01863.x; WOLPAW JR, 1994, ELECTROEN CLIN NEURO, V90, P444, DOI 10.1016/0013-4694(94)90135-X; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410	32	88	93	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105225	10.1371/journal.pone.0105225	http://dx.doi.org/10.1371/journal.pone.0105225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137064	gold, Green Published			2022-12-27	WOS:000340742100077
J	Kang, S; Kim, JE; Song, NR; Jung, SK; Lee, MH; Park, JS; Yeom, MH; Bode, AM; Dong, ZG; Lee, KW				Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Mee Hyun; Park, Jun Seong; Yeom, Myeong-Hun; Bode, Ann M.; Dong, Zigang; Lee, Ki Won			The Ginsenoside 20-O-beta-D-Glucopyranosyl-20(S)-Protopanaxadiol Induces Autophagy and Apoptosis in Human Melanoma via AMPK/JNK Phosphorylation	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; COMPOUND-K; CELL-DEATH; B-RAF; ACTIVATION; MUTATIONS; NECROSIS; SURVIVAL; BRAF; RB1	Studies have shown that a major metabolite of the red ginseng ginsenoside Rb1, called 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (GPD), exhibits anticancer properties. However, the chemotherapeutic effects and molecular mechanisms behind GPD action in human melanoma have not been previously investigated. Here we report the anticancer activity of GPD and its mechanism of action in melanoma cells. GPD, but not its parent compound Rb1, inhibited melanoma cell proliferation in a dose-dependent manner. Further investigation revealed that GPD treatment achieved this inhibition through the induction of autophagy and apoptosis, while Rb1 failed to show significant effect at the same concentrations. The inhibitory effect of GPD appears to be mediated through the induction of AMPK and the subsequent attenuation of mTOR phosphorylation. In addition, GPD activated c-Jun by inducing JNK phosphorylation. Our findings suggest that GPD suppresses melanoma growth by inducing autophagic cell death and apoptosis via AMPK/JNK pathway activation. GPD therefore has the potential to be developed as a chemotherapeutic agent for the treatment of human melanoma.	[Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Kang, Soouk; Kim, Jong-Eun; Song, Nu Ry; Jung, Sung Keun; Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Kang, Soouk; Kim, Jong-Eun; Jung, Sung Keun; Lee, Mee Hyun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Song, Nu Ry; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea; [Jung, Sung Keun] Korea Food Res Inst, Funct Food Resources Res Grp, Songnam, South Korea; [Park, Jun Seong; Yeom, Myeong-Hun] Amorepacif Corp R&D Ctr, Skin Res Inst, Yongin, South Korea; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Minnesota System; Seoul National University (SNU); Korea Food Research Institute (KFRI); Seoul National University (SNU)	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu; kiwon@snu.ac.kr	Lee, Ki Won/M-4114-2018; kim, jong-eun/B-3550-2017	kim, jong-eun/0000-0002-5030-6126	World Class Institute Program [WCI2009-002]; Leap Research Program Grant through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea [2010-0029233]	World Class Institute Program; Leap Research Program Grant through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea	This work was supported by the World Class Institute Program (WCI2009-002) and the Leap Research Program Grant (2010-0029233) through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; Cuong TT, 2009, LIFE SCI, V85, P625, DOI 10.1016/j.lfs.2009.08.014; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Ha YW, 2010, ANAL BIOANAL CHEM, V396, P3017, DOI 10.1007/s00216-010-3515-0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jia L, 2009, CURR MED CHEM, V16, P2924, DOI 10.2174/092986709788803204; Jung IH, 2012, BIOL PHARM BULL, V35, P573, DOI 10.1248/bpb.35.573; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim K, 2010, CELL BIOL INT, V34, P75, DOI 10.1042/CBI20090020; Lee DCW, 2011, MOLECULES, V16, P2802, DOI 10.3390/molecules16042802; Leung KW, 2007, BRIT J PHARMACOL, V152, P207, DOI 10.1038/sj.bjp.0707359; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li W, 2012, FITOTERAPIA, V83, P192, DOI 10.1016/j.fitote.2011.10.011; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Martin MJ, 2009, CANCER CELL, V15, P163, DOI 10.1016/j.ccr.2009.02.006; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Park JS, 2009, J NEUROIMMUNOL, V209, P40, DOI 10.1016/j.jneuroim.2009.01.020; Park S, 2011, FOOD CHEM TOXICOL, V49, P1367, DOI 10.1016/j.fct.2011.03.021; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Rozenblat S, 2008, BIOCHEM PHARMACOL, V75, P369, DOI 10.1016/j.bcp.2007.08.024; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Vakana E, 2012, J CELL BIOCHEM, V113, P404, DOI 10.1002/jcb.23369; Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690; Wang CZ, 2007, INT J ONCOL, V31, P1149; Wang CZ, 2012, INT J ONCOL, V40, P1970, DOI 10.3892/ijo.2012.1399; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yamada E, 2012, DIABETES, V61, P272, DOI 10.2337/db11-1199; Yoon SH, 2007, BIOL PHARM BULL, V30, P2196, DOI 10.1248/bpb.30.2196; Yun TK, 2001, J KOREAN MED SCI S, V16, P3; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	47	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104305	10.1371/journal.pone.0104305	http://dx.doi.org/10.1371/journal.pone.0104305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137374	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100026
J	Miyazaki, Y; Li, R; Rezk, A; Misirliyan, H; Moore, C; Farooqi, N; Solis, M; Goiry, LG; de Faria, O; Dang, VD; Colman, D; Dhaunchak, AS; Antel, J; Gommerman, J; Prat, A; Fillatreau, S; Bar-Or, A				Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Solis, Mayra; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Van Duc Dang; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Gommerman, Jennifer; Prat, Alexandre; Fillatreau, Simon; Bar-Or, Amit		CIHR MSSC New Emerging Team Grant; MSSRF Canadian B Cells MS Team	A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MICRORNA EXPRESSION; T-CELLS; DISEASE; ACTIVATION; ENCEPHALOMYELITIS; AUTOIMMUNITY; LYMPHOCYTES; GENERATION; INDUCTION	Clinical trial results demonstrating that B-cell depletion substantially reduces new relapses in patients with multiple sclerosis (MS) have established that B cells play a role in the pathophysiology of MS relapses. The same treatment appears not to impact antibodies directed against the central nervous system, which underscores the contribution of antibody-independent functions of B cells to disease activity. One mechanism by which B cells are now thought to contribute to MS activity is by over-activating T cells, including through aberrant expression of B cell pro-inflammatory cytokines. However, the mechanisms underlying the observed B cell cytokine dysregulation in MS remain unknown. We hypothesized that aberrant expression of particular microRNAs might be involved in the dysregulated pro-inflammatory cytokine responses of B cells of patients with MS. Through screening candidate microRNAs in activated B cells of MS patients and matched healthy subjects, we discovered that abnormally increased secretion of lymphotoxin and tumor necrosis factor alpha by MS B cells is associated with abnormally increased expression of miR-132. Over-expression of miR-132 in normal B cells significantly enhanced their production of lymphotoxin and tumor necrosis factor alpha. The over-expression of miR-132 also suppressed the miR-132 target, sirtuin-1. We confirmed that pharmacological inhibition of sirtuin-1 in normal B cells induces exaggerated lymphotoxin and tumor necrosis factor alpha production, while the abnormal production of these cytokines by MS B cells can be normalized by resveratrol, a sirtuin-1 activator. These results define a novel miR-132-sirtuin-1 axis that controls pro-inflammatory cytokine secretion by human B cells, and demonstrate that a dysregulation of this axis underlies abnormal pro-inflammatory B cell cytokine responses in patients with MS.	[Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada; [Miyazaki, Yusei; Li, Rui; Rezk, Ayman; Misirliyan, Hetoum; Moore, Craig; Farooqi, Nasr; Goiry, Lorna Galleguillos; de Faria, Omar, Jr.; Colman, David; Dhaunchak, Ajit Singh; Antel, Jack; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Solis, Mayra; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Clin Res Unit, Montreal, PQ, Canada; [Van Duc Dang; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, Leibniz Inst, Berlin, Germany; [Gommerman, Jennifer] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Prat, Alexandre] Univ Montreal, Neuroimmunol Res Unit, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Expt Therapeut Program, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Toronto; Universite de Montreal; McGill University	Bar-Or, A (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada.	amit.bar-or@mcgill.ca	Li, Rui/O-7397-2016; Bar-Or, Amit/AIC-1416-2022; Moore, Craig/AGF-9555-2022	Li, Rui/0000-0002-7210-8358; Moore, Craig/0000-0003-3333-435X; Prat, Alexandre/0000-0001-6188-0580; Fillatreau, Simon/0000-0002-7730-9917; Dang, Van Duc/0000-0002-0403-6479; antel, jack/0000-0002-5148-0636; Gommerman, Jennifer/0000-0003-4576-6168	Canadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of Canada (MSSC), CIHR/MSSC NET Grant in Clinical Autoimmunity; Research Foundation of the MSSC (MSSRF), Canadian B cells in MS Team; Canadian Bureau for International Education (CBIE)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada (MSSC), CIHR/MSSC NET Grant in Clinical Autoimmunity; Research Foundation of the MSSC (MSSRF), Canadian B cells in MS Team; Canadian Bureau for International Education (CBIE)	This work was supported by the Canadian Institutes of Health Research (CIHR) and the Multiple Sclerosis Society of Canada (MSSC) as part of the CIHR/MSSC NET Grant in Clinical Autoimmunity, and the Research Foundation of the MSSC (MSSRF) as part of the 'Canadian B cells in MS Team'. Y.M. was also supported in part by an award from the Canadian Bureau for International Education (CBIE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Guerau-de-Arellano M, 2011, BRAIN, V134, P3575, DOI 10.1093/brain/awr262; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; HE L, 2004, NAT REV GENET, V5, P522; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Junker A, 2011, FEBS LETT, V585, P3738, DOI 10.1016/j.febslet.2011.03.052; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Nimmagadda VK, 2013, J IMMUNOL, V190, P4595, DOI 10.4049/jimmunol.1202584; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; Sievers C, 2012, CLIN IMMUNOL, V144, P70, DOI 10.1016/j.clim.2012.04.002; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Smith KM, 2012, J IMMUNOL, V189, P1567, DOI 10.4049/jimmunol.1103171; Tan LP, 2009, LAB INVEST, V89, P708, DOI 10.1038/labinvest.2009.26; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tegla CA, 2013, EXP MOL PATHOL, V96, P139; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	46	64	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105421	10.1371/journal.pone.0105421	http://dx.doi.org/10.1371/journal.pone.0105421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136908	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100092
J	Paprotny, D; Andrzejewski, P; Terefenko, P; Furmanczyk, K				Paprotny, Dominik; Andrzejewski, Pawel; Terefenko, Pawel; Furmanczyk, Kazimierz			Application of Empirical Wave Run-Up Formulas to the Polish Baltic Sea Coast	PLOS ONE			English	Article							LEVEL; STORM; HINDCAST; PROJECT; EVENTS	Advanced, multidimensional models are typically applied when researching processes occurring in the nearshore. Relatively simple, empirical equations are commonly used in coastal engineering practice in order to estimate extreme wave run-up on beaches and coastal structures. However, they were mostly calibrated to the characteristics of oceanic coasts, which have different wave regime than a semi-enclosed basin like the Baltic Sea. In this paper we apply the formulas to the Polish Baltic Sea coast. The equations were adjusted to match local conditions in two test sites in Miedzyzdroje and Dziwnowek, where beaches are under continuous video surveillance. Data from WAM wave model and coastal gauge stations were used, as well as precise measurements of the beaches' cross-sections. More than 600 run-up events spanning from June to December 2013 were analysed, including surges causing dune erosion. Extreme wave run-up R-2% was calculated and presented as a percentage value indicating what part of the beach was inundated. The method had a root-mean-square error of 6.1 and 6.5 percentage points depending on the test site. We consider it is a fast and computationally undemanding alternative to morphodynamic models. It will constitute a part of the SatBaltyk Operating System-Shores, delivering forecasts of wave run-up on the beaches for the entire Polish coastline.	[Paprotny, Dominik; Andrzejewski, Pawel; Terefenko, Pawel; Furmanczyk, Kazimierz] Univ Szczecin, Fac Geosci, Szczecin, Poland	University of Szczecin	Paprotny, D (corresponding author), Univ Szczecin, Fac Geosci, Szczecin, Poland.	dominikpaprotny@op.pl	Terefenko, Paweł/J-1907-2019	Terefenko, Paweł/0000-0002-5081-8615; Furmanczyk, Kazimierz/0000-0003-2397-4433; Paprotny, Dominik/0000-0001-5090-8402	European Union [POIG.01.01.02-22-011/09-00]	European Union(European Commission)	This work was supported by the European Union through the Innovative Economy Operational Programme - project No. POIG.01.01.02-22-011/09-00 "The Satellite Monitoring of the Baltic Sea Environment (SatBaltyk)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD T, 1989, J COASTAL RES, V5, P547; [Anonymous], [No title captured]; Battjes J.A., 1974, P 14 INT C COAST ENG, P466, DOI DOI 10.9753/ICCE.V14; Bugajny N, 2013, J COASTAL RES, P672, DOI 10.2112/SI65-114.1; Ciavola P, 2011, ENVIRON SCI POLICY, V14, P924, DOI 10.1016/j.envsci.2011.05.009; Cieslikiewicz W, 2008, COAST ENG, V55, P894, DOI 10.1016/j.coastaleng.2008.02.017; Davidson M, 2007, COAST ENG, V54, P463, DOI 10.1016/j.coastaleng.2007.01.007; Diaz-Sanchez R, 2014, J COASTAL RES, P1, DOI 10.2112/SI70-001.1; DOUGLASS SL, 1992, J WATERW PORT C-ASCE, V118, P220, DOI 10.1061/(ASCE)0733-950X(1992)118:2(220); Dyke PPG, 1985, OFFSHORE COASTAL MOD; Ferreira O, 2009, J COASTAL RES, P1632; Furmanczyk K, 2014, J COASTAL RES, P338, DOI 10.2112/SI70-057.1; GUZA RT, 1981, J GEOPHYS RES-OCEANS, V86, P4133, DOI 10.1029/JC086iC05p04133; Haerens P, 2012, COASTAL ENG P, V1, P1; Hanson H, 2008, J HYDRAUL RES, V46, P292, DOI 10.1080/00221686.2008.9521962; Haslett SK, 2009, ROUTL INTROD ENVIRON, P1; HASSELMANN S, 1988, J PHYS OCEANOGR, V18, P1775; Holland KT, 1997, IEEE J OCEANIC ENG, V22, P81, DOI 10.1109/48.557542; HOLMAN RA, 1986, COAST ENG, V9, P527, DOI 10.1016/0378-3839(86)90002-5; HOLMAN RA, 1984, J GEOPHYS RES-OCEANS, V89, P6446, DOI 10.1029/JC089iC04p06446; Hughes SA, 2004, COAST ENG, V51, P1085, DOI 10.1016/j.coastaleng.2004.07.026; Hunt IA., 1959, J WATERW HARB DIV, V85, P123, DOI DOI 10.1061/JWHEAU.0000129; Institute of Meteorology and Water Management, 2014, MON BLAT; Interdisciplinary Centre for Mathematical and Computational Modelling, 2014, NUM WEATH FOR; Jedrasik J, 2008, COAST ENG, V55, P849, DOI 10.1016/j.coastaleng.2008.02.026; Johansson M, 2001, BOREAL ENVIRON RES, V6, P159; KOBAYASHI N, 1991, J COASTAL RES, V7, P127; Kont A, 2008, J COASTAL RES, V24, P423, DOI 10.2112/07A-0015.1; Kowalewski M, 2011, BOREAL ENVIRON RES, V16, P27; Lakhan VC, 1989, APPL COASTAL MODELLI, P1; LIPPMANN TC, 1989, J GEOPHYS RES-OCEANS, V94, P995, DOI 10.1029/JC094iC01p00995; MASE H, 1989, J WATERW PORT C-ASCE, V115, P649, DOI 10.1061/(ASCE)0733-950X(1989)115:5(649); Massel SR, 2001, OCEANOLOGIA, V43, P61; Mayer R., 1994, P 24 COAST ENG C ASC, P2325; Melby JA, 2012, TR1224 ERDCCHL; NIELSEN P, 1991, J COASTAL RES, V7, P1139; Powell Helen, 2013, P COSTS PORTS 2013 1, P1; Pullen T., 2007, WAVE OVERTOPPING SEA; Remote Sensing and Marine Cartography Unit, 2014, KAM ZTIKM DZIWN ZACH; Roelvink D, 2009, COAST ENG, V56, P1133, DOI 10.1016/j.coastaleng.2009.08.006; Santos F, 2012, PROC SPIE, V8538, DOI 10.1117/12.974679; Schwarzer K, 2003, MAR GEOL, V194, P79, DOI 10.1016/S0025-3227(02)00700-4; Stockdon HF, 2006, COAST ENG, V53, P573, DOI 10.1016/j.coastaleng.2005.12.005; Suursaar U, 2006, BOREAL ENVIRON RES, V11, P143; Suursaar U, 2003, J SEA RES, V49, P295, DOI 10.1016/S1385-1101(03)00022-4; Trenhaile AS, 1997, COASTAL DYNAMICS LAN; U.S. Army Corps of Engineers, 1984, US ARM ENG WAT EXP S; Vousdoukas MI, 2012, OCEAN DYNAM, V62, P123, DOI 10.1007/s10236-011-0480-x; Wozniak B, 2011, OCEANOLOGIA, V53, P897, DOI 10.5697/oc.53-4.897	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105437	10.1371/journal.pone.0105437	http://dx.doi.org/10.1371/journal.pone.0105437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137155	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100096
J	Phinyomark, A; Hettinga, BA; Osis, ST; Ferber, R				Phinyomark, Angkoon; Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed			Gender and Age-Related Differences in Bilateral Lower Extremity Mechanics during Treadmill Running	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; KINEMATICS; SELECTION; INJURIES; PATTERNS	Female runners have a two-fold risk of sustaining certain running-related injuries as compared to their male counterparts. Thus, a comprehensive understanding of the sex-related differences in running kinematics is necessary. However, previous studies have either used discrete time point variables and inferential statistics and/or relatively small subject numbers. Therefore, the first purpose of this study was to use a principal component analysis (PCA) method along with a support vector machine (SVM) classifier to examine the differences in running gait kinematics between female and male runners across a large sample of the running population as well as between two age-specific sub-groups. Bilateral 3-dimensional lower extremity gait kinematic data were collected during treadmill running. Data were analysed on the complete sample (n = 483: female 263, male 220), a younger subject group (n = 56), and an older subject group (n = 51). The PC scores were first sorted by the percentage of variance explained and we also employed a novel approach wherein PCs were sorted based on between-gender statistical effect sizes. An SVM was used to determine if the sex and age conditions were separable and classifiable based on the PCA. Forty PCs explained 84.74% of the variance in the data and an SVM classification accuracy of 86.34% was found between female and male runners. Classification accuracies between genders for younger subjects were higher than a subgroup of older runners. The observed interactions between age and gender suggest these factors must be considered together when trying to create homogenous sub-groups for research purposes.	[Phinyomark, Angkoon; Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Ferber, Reed] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Hettinga, Blayne A.; Osis, Sean T.; Ferber, Reed] Running Injury Clin, Calgary, AB, Canada	University of Calgary; University of Calgary	Ferber, R (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	rferber@ucalgary.ca	Phinyomark, Angkoon/C-7680-2015; Ferber, Reed/AAT-3140-2020	Phinyomark, Angkoon/0000-0003-0170-3245; Ferber, Reed/0000-0002-6154-9115	Alberta Innovates: Health Solutions - Alberta Heritage Foundation; SOLE, Inc.; University of Calgary Eyes High Postdoctoral Research Award program	Alberta Innovates: Health Solutions - Alberta Heritage Foundation; SOLE, Inc.; University of Calgary Eyes High Postdoctoral Research Award program	This work was supported in part by research grants from the Alberta Innovates: Health Solutions (funded by the Alberta Heritage Foundation for Medical Research endowment fund), a charitable donation from SOLE, Inc., and the University of Calgary Eyes High Postdoctoral Research Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astephen JL, 2005, CLIN BIOMECH, V20, P209, DOI 10.1016/j.clinbiomech.2004.09.007; Bus SA, 2003, MED SCI SPORT EXER, V35, P1167, DOI 10.1249/01.MSS.0000074441.55707.D1; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Duda R.O., 2006, PATTERN CLASSIFICATI; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Eskofier BM, 2012, COMPUT METHOD BIOMEC, V15, P467, DOI 10.1080/10255842.2010.542153; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Fellin RE, 2010, J SCI MED SPORT, V13, P646, DOI 10.1016/j.jsams.2010.03.006; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Ferber R, 2009, SPORTS HEALTH, V1, P242, DOI 10.1177/1941738109334272; FERRE L, 1995, COMPUT STAT DATA AN, V19, P669, DOI 10.1016/0167-9473(94)00020-J; Foch E, 2014, J BIOMECH, V47, P81, DOI 10.1016/j.jbiomech.2013.10.008; Fukuchi R, 2008, J SPORT SCI, V26, P1447, DOI 10.1080/02640410802209018; Fukuchi RK, 2014, CLIN BIOMECH, V29, P304, DOI 10.1016/j.clinbiomech.2013.12.007; Fukuchi RK, 2011, J BIOMECH, V44, P540, DOI 10.1016/j.jbiomech.2010.09.031; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Labbe DR, 2010, J BIOMECH, V43, P3080, DOI 10.1016/j.jbiomech.2010.08.011; Lilley K, 2011, GAIT POSTURE, V33, P496, DOI 10.1016/j.gaitpost.2011.01.002; Malinzak RA, 2001, CLIN BIOMECH, V16, P438, DOI 10.1016/S0268-0033(01)00019-5; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; McGibbon CA, 2003, EXERC SPORT SCI REV, V31, P102, DOI 10.1097/00003677-200304000-00009; McKean KA, 2007, J BIOMECH, V40, pS616; Nigg BM, 2012, J BIOMECH, V45, P1692, DOI 10.1016/j.jbiomech.2012.03.027; NIGG BM, 1994, GAIT POSTURE, V2, P213, DOI DOI 10.1016/0966-6362(94)90106-6; Olney SJ, 1998, PHYS THER, V78, P814, DOI 10.1093/ptj/78.8.814; Pohl MB, 2010, GAIT POSTURE, V32, P559, DOI 10.1016/j.gaitpost.2010.07.020; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Vardaxis VG, 2006, J BIOMECH, V39, pS112; von Tscharner V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065063	31	55	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105246	10.1371/journal.pone.0105246	http://dx.doi.org/10.1371/journal.pone.0105246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137240	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100079
J	Sawall, Y; Al-Sofyani, A; Banguera-Hinestroza, E; Voolstra, CR				Sawall, Yvonne; Al-Sofyani, Abdulmohsin; Banguera-Hinestroza, Eulalia; Voolstra, Christian R.			Spatio-Temporal Analyses of Symbiodinium Physiology of the Coral Pocillopora verrucosa along Large-Scale Nutrient and Temperature Gradients in the Red Sea	PLOS ONE			English	Article							GREAT-BARRIER-REEF; STYLOPHORA-PISTILLATA; THERMAL TOLERANCE; CHLOROPHYLL; DIVERSITY; PHOTOACCLIMATION; EUTROPHICATION; ENDOSYMBIONTS; ZOOXANTHELLAE; FLUCTUATIONS	Algal symbionts (zooxanthellae, genus Symbiodinium) of scleractinian corals respond strongly to temperature, nutrient and light changes. These factors vary greatly along the north-south gradient in the Red Sea and include conditions, which are outside of those typically considered optimal for coral growth. Nevertheless, coral communities thrive throughout the Red Sea, suggesting that zooxanthellae have successfully acclimatized or adapted to the harsh conditions they experience particularly in the south (high temperatures and high nutrient supply). As such, the Red Sea is a region, which may help to better understand how zooxanthellae and their coral hosts successfully acclimatize or adapt to environmental change (e. g. increased temperatures and localized eutrophication). To gain further insight into the physiology of coral symbionts in the Red Sea, we examined the abundance of dominant Symbiodinium types associated with the coral Pocillopora verrucosa, and measured Symbiodinium physiological characteristics (i.e. photosynthetic processes, cell density, pigmentation, and protein composition) along the latitudinal gradient of the Red Sea in summer and winter. Despite the strong environmental gradients from north to south, our results demonstrate that Symbiodinium microadriaticum (type A1) was the predominant species in P. verrucosa along the latitudinal gradient. Furthermore, measured physiological characteristics were found to vary more with prevailing seasonal environmental conditions than with region-specific differences, although the measured environmental parameters displayed much higher spatial than temporal variability. We conclude that our findings might present the result of long-term acclimatization or adaptation of S. microadriaticum to regionally specific conditions within the Red Sea. Of additional note, high nutrients in the South correlated with high zooxanthellae density indicating a compensation for a temperature-driven loss of photosynthetic performance, which may prove promising for the resilience of these corals under increase of temperature increase and eutrophication.	[Sawall, Yvonne] Helmholtz Ctr Ocean Res GEOMAR, Benth Ecol Grp, Kiel, Germany; [Al-Sofyani, Abdulmohsin] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Biol, Jeddah 21413, Saudi Arabia; [Banguera-Hinestroza, Eulalia; Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; King Abdulaziz University; King Abdullah University of Science & Technology	Sawall, Y (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Benth Ecol Grp, Kiel, Germany.	ysawall@geomar.de	Voolstra, Christian R/H-7158-2014	Voolstra, Christian R/0000-0003-4555-3795; Banguera-Hinestroza, Eulalia/0000-0002-1798-8911	KAU, Jeddah, Saudi Arabia [T-065/430-DSR]; GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia; Academic Excellence Alliance (AEA) Award [1000000533]	KAU, Jeddah, Saudi Arabia; GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia; Academic Excellence Alliance (AEA) Award	This collaboration of the Jeddah Transect Project between King Abdulaziz University (KAU) and Helmholtz-Center for Ocean Research GEOMAR was funded by KAU, Jeddah, Saudi Arabia, under grant no. T-065/430-DSR. Further support was given by GEOMAR and King Abdullah University for Science and Technology (KAUST), Thuwal, Saudi Arabia for laboratory analyses. This project was partially funded by an Academic Excellence Alliance (AEA) Award (Award Number 1000000533) to CRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Al-Sofyani AA, 2013, OCEANOLOGIA, V55, P917, DOI 10.5697/oc.55-4.917; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; DeVantier L, 2000, CORAL BLEACHING CENT; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Dubinsky Z., 1994, Pacific Science, V48, P313; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako-Lampert S, 2004, J EXP MAR BIOL ECOL, V311, P301, DOI 10.1016/j.jembe.2004.05.015; Kleypas JA, 1999, AM ZOOL, V39, P146; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Loisel H, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003367; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McGinley MP, 2012, MAR ECOL PROG SER, V462, P1, DOI 10.3354/meps09914; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Sawall Y., 2014, J ECOL ECOGR, VS4, P003, DOI DOI 10.4172/2157-7625.S4-003; Sheppard C.R.C., 1991, Fauna of Saudi Arabia, V12, P3; SOUVERMEZOGLOU E, 1989, J MAR RES, V47, P441, DOI 10.1357/002224089785076244; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; TRENCH RK, 1987, J PHYCOL, V23, P469, DOI 10.1111/j.1529-8817.1987.tb02534.x; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Veron JEN, 2000, CORALS WORLD AUSTR I; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661	63	68	70	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103179	10.1371/journal.pone.0103179	http://dx.doi.org/10.1371/journal.pone.0103179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137123	Green Published, gold, Green Accepted			2022-12-27	WOS:000340742100006
J	Wang, XL; Wu, J; Shu, G; Li, Y				Wang, Xiuling; Wu, Jie; Shu, Gang; Li, Ya			Punishment Based on Public Benefit Fund Significantly Promotes Cooperation	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; EVOLUTION; SELECTION; IMPACT; DILEMMAS; NETWORKS; RULES	In prisoner's dilemma game (shortly, PD game), punishment is most frequently used to promote cooperation. However, outcome varies when different punishment approaches are applied. Here the PD game is studied on a square lattice when different punishment patterns are adopted. As is known to all, tax system, a common tool to adjust the temperature of the economy, is widely used in human society. Inspired by this philosophy, players in this study would pay corresponding taxes in accordance with their payoff level. In this way, public benefit fund is established consequently and it would be utilized to punish defectors. There are two main methods for punishing: slight intensity of punishment (shortly, SLP) and severe intensity of punishment (shortly, SEP). When the totaling of public benefit fund keeps relatively fixed, SLP extends further, which means more defectors would be punished; by contrast, SEP has a smaller coverage. It is of interest to verify whether these two measures can promote cooperation and which one is more efficient. Simulate results reveal that both of them can promote cooperation remarkably. Specifically speaking, SLP shows constant advantage from the point of view either of fractions of cooperation or average payoff.	[Wang, Xiuling; Wu, Jie; Li, Ya] Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China; [Shu, Gang] Southwest Univ, Sch Phys Sci & Technol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Li, Y (corresponding author), Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China.	liyaswu@163.com			Fundamental Research Funds for the Central Universities [XDJK2013B029, XDJK2014C082]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities, Grant Nos. XDJK2013B029, XDJK2014C082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor DR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066115; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051104; Cremene M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087471; Deng XY, 2014, EXPERT SYST APPL, V41, P635, DOI 10.1016/j.eswa.2013.07.088; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Gracia-Lazaro C, 2013, CHAOS SOLITON FRACT, V56, P188, DOI 10.1016/j.chaos.2013.08.008; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; Jin Q, 2012, CHAOS SOLITON FRACT, V45, P395, DOI 10.1016/j.chaos.2012.01.004; Kang BY, 2012, KNOWL-BASED SYST, V35, P77, DOI 10.1016/j.knosys.2012.04.007; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Li Y, 2014, PHYSICA A, V403, P284, DOI 10.1016/j.physa.2014.02.051; Liu YK, 2013, PHYSICA A, V392, P3640, DOI 10.1016/j.physa.2013.04.031; Mussweiler T, 2013, P NATL ACAD SCI USA, V110, P19318, DOI 10.1073/pnas.1215443110; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2013, J THEOR BIOL, V325, P34, DOI 10.1016/j.jtbi.2013.02.008; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Vukov J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022123; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012109; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036106; Zhang XZ, 2013, INT J PROD RES, V51, P7405, DOI 10.1080/00207543.2012.757669	51	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105126	10.1371/journal.pone.0105126	http://dx.doi.org/10.1371/journal.pone.0105126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137051	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100067
J	Zhu, Z; Cerina, F; Chessa, A; Caldarelli, G; Riccaboni, M				Zhu, Zhen; Cerina, Federica; Chessa, Alessandro; Caldarelli, Guido; Riccaboni, Massimo			The Rise of China in the International Trade Network: A Community Core Detection Approach	PLOS ONE			English	Article							EVOLUTION; FLOWS	Theory of complex networks proved successful in the description of a variety of complex systems ranging from biology to computer science and to economics and finance. Here we use network models to describe the evolution of a particular economic system, namely the International Trade Network (ITN). Previous studies often assume that globalization and regionalization in international trade are contradictory to each other. We re-examine the relationship between globalization and regionalization by viewing the international trade system as an interdependent complex network. We use the modularity optimization method to detect communities and community cores in the ITN during the years 1995-2011. We find rich dynamics over time both inter- and intra-communities. In particular, the Asia-Oceania community disappeared and reemerged over time along with a switch in leadership from Japan to China. We provide a multilevel description of the evolution of the network where the global dynamics (i.e., communities disappear or reemerge) and the regional dynamics (i.e., community core changes between community members) are related. Moreover, simulation results show that the global dynamics can be generated by a simple dynamic-edge-weight mechanism.	[Zhu, Zhen; Chessa, Alessandro; Caldarelli, Guido; Riccaboni, Massimo] IMT Inst Adv Studies Lucca, Lucca, Italy; [Cerina, Federica] Univ Cagliari, Dept Phys, Cagliari, Italy; [Cerina, Federica; Chessa, Alessandro; Caldarelli, Guido] Linkalab, Complex Syst Computat Lab, Cagliari, Italy; [Caldarelli, Guido] CNR, Ist Sistemi Complessi, Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, London, England; [Riccaboni, Massimo] Katholieke Univ Leuven, Dept Managerial Econ Strategy & Innovat, Leuven, Belgium	IMT School for Advanced Studies Lucca; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); KU Leuven	Zhu, Z (corresponding author), IMT Inst Adv Studies Lucca, Lucca, Italy.	zhen.zhu@imtlucca.it	Zhu, Zhen/AAN-9861-2020; Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010	Zhu, Zhen/0000-0003-0258-1454; RICCABONI, Massimo/0000-0003-4979-8933; Caldarelli, Guido/0000-0001-9377-3616	Ministry of Education, Universities and Research (MIUR) - the Basic Research Investment Fund (FIRB) [RBFR12BA3Y]; 'ViWaN: The Global Virtual Water Network' project; Future Emerging Technologies (FET) project MULTIPLEX [317532]; Future Emerging Technologies (FET) project SIMPOL [610704]; National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government; European Social Fund	Ministry of Education, Universities and Research (MIUR) - the Basic Research Investment Fund (FIRB)(Ministry of Education, Universities and Research (MIUR)); 'ViWaN: The Global Virtual Water Network' project; Future Emerging Technologies (FET) project MULTIPLEX; Future Emerging Technologies (FET) project SIMPOL; National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government(Regione Sardegna); European Social Fund(European Social Fund (ESF))	Massimo Riccaboni and Zhen Zhu acknowledge funding from the Ministry of Education, Universities and Research (MIUR) - the Basic Research Investment Fund (FIRB) project RBFR12BA3Y and from the 'ViWaN: The Global Virtual Water Network' project. All authors acknowledge support from the Future Emerging Technologies (FET) projects MULTIPLEX 317532 and SIMPOL 610704 and the National Research Project (PNR) project CRISIS Lab. FC acknowledges Sardinia Regional Government for the financial support of her PhD scholarship (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013 - Axis IV Human Resources, Objective I.3, Line of Activity I.3.1.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arribas I, 2009, WORLD DEV, V37, P127, DOI 10.1016/j.worlddev.2008.03.009; Athukorala P.C., 2006, N AM J ECON FINANC, V17, P233, DOI [DOI 10.1016/J.NAJEF.2006.07.002, 10.1016/j.najef.2006.07.002]; Athukorala P.C., 2005, ASIAN ECON PAP, V4, P1, DOI DOI 10.1162/ASEP.2005.4.1.1; Baldwin R, 2006, TECHNICAL REPORT; Baldwin R. E., 2008, CHINA ASIA NEW WORLD, P51; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228701; BERGSTRAND JH, 1985, REV ECON STAT, V67, P474, DOI 10.2307/1925976; Buchanan M., 2010, NETWORKS CELL BIOL; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Carrere C, 2006, EUR ECON REV, V50, P223, DOI 10.1016/j.euroecorev.2004.06.001; Cerina F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04546; Chessa A, 2013, SCIENCE, V339, P650, DOI 10.1126/science.1227970; Chortareas GE, 2004, CAMB J ECON, V28, P253, DOI 10.1093/cje/28.2.253; De Benedictis L, 2011, WORLD ECON, V34, P1417, DOI 10.1111/j.1467-9701.2011.01360.x; De Leo V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042810; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Gaulier G., 2020, 201223 CEPII, DOI [10.2139/ssrn.1994500, DOI 10.2139/SSRN.1994500]; Grossman G, 1997, STUDIES INT EC I, P171; Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131; Kim S, 2002, SOC FORCES, V81, P445, DOI 10.1353/sof.2003.0014; Kitsak M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036117; Li CG, 2005, J PHYS A-MATH GEN, V38, P9741, DOI 10.1088/0305-4470/38/45/002; Mansfield ED, 1999, INT ORGAN, V53, P589, DOI 10.1162/002081899551002; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Piccardi C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066119; Reyes J, 2014, WORLD EC IN PRESS; Riccaboni M, 2014, J COMPLEX N IN PRESS; Riccaboni M, 2013, J ECON INTERACT COOR, V8, P33, DOI 10.1007/s11403-012-0101-x; Riccaboni M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/023003; Riccaboni M, 2009, R&D MANAGE, V39, P124, DOI 10.1111/j.1467-9310.2009.00545.x; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Tzekina I, 2008, EUR PHYS J B, V63, P541, DOI 10.1140/epjb/e2008-00181-2	38	21	21	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105496	10.1371/journal.pone.0105496	http://dx.doi.org/10.1371/journal.pone.0105496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136895	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000340742100101
J	Huang, YL; Hu, ZD; Liu, SJ; Sun, Y; Qin, Q; Qin, BD; Zhang, WW; Zhang, JR; Zhong, RQ; Deng, AM				Huang, Yuan-Lan; Hu, Zhi-De; Liu, Shi-Jian; Sun, Yi; Qin, Qin; Qin, Bao-Dong; Zhang, Wei-Wei; Zhang, Jian-Rong; Zhong, Ren-Qian; Deng, An-Mei			Prognostic Value of Red Blood Cell Distribution Width for Patients with Heart Failure: A Systematic Review and Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; MORTALITY; MARKER; ERYTHROPOIESIS; BIOMARKERS; MANAGEMENT; DISEASE; INFLAMMATION; DIAGNOSIS; ANEMIA	Aims: Multiple studies have investigated the prognostic role of red blood cell distribution width (RDW) for patients with heart failure (HF), but the results have been inconsistent. The aim of the present study was to estimate the impact of RDW on the prognosis of HF by performing a systematic review and meta-analysis. Methods and Results: The Embase, PubMed, and Web of Science databases were searched up to November 16, 2013 to identify eligible cohort studies. The quality of each study was assessed using the Newcastle-Ottawa Scale (NOS). The association between RDW, either on admission or at discharge, and HF outcomes (all-cause mortality [ACM], heart transplantation, cardiovascular mortality, and rehospitalization, etc.) were reviewed. The overall hazard ratio (HR) for the effect of RDW on ACM was pooled using a random-effects model, and the publication bias was evaluated using funnel plots and Eggers' tests. Seventeen studies, with a total of 18288 HF patients, were included for systematic review. All eligible studies indicated that RDW on admission and RDW at discharge, as well as its change during treatment, were of prognostic significance for HF patients. The HR for the effect of a 1% increase in baseline RDW on ACM was 1.10 (95% confidence interval: 1.07-1.13), based on pooling of nine studies that provided related data. However, publication bias was observed among these studies. Conclusions: HF patients with higher RDW may have poorer prognosis than those with lower RDW. Further studies are needed to explore the potential mechanisms underlying this association.	[Huang, Yuan-Lan] 455 Hosp Peoples Liberat Army, Dept Lab Med, Shanghai, Peoples R China; [Huang, Yuan-Lan; Sun, Yi; Qin, Qin; Zhang, Wei-Wei; Zhang, Jian-Rong; Deng, An-Mei] Second Mil Med Univ, Changhai Hosp, Dept Lab Diag, Shanghai, Peoples R China; [Huang, Yuan-Lan; Hu, Zhi-De; Qin, Bao-Dong; Zhong, Ren-Qian] Second Mil Med Univ, Changzheng Hosp, Dept Lab Diag, Shanghai, Peoples R China; [Hu, Zhi-De] Gen Hosp, Jinan Mil Reg Peoples Liberat Army, Dept Lab Med, Jinan, Shandong, Peoples R China; [Liu, Shi-Jian] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Pediat Translat Inst,Dept Biobank & Biostat, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Zhong, RQ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Lab Diag, Shanghai, Peoples R China.	rqzhong@hotmail.com; amdeng70@163.com	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022; Hu, Zhi-De/H-5578-2019; Qin, Baodong/ABA-3303-2021	Hu, Zhi-De/0000-0003-3679-4992; 	973 Foundation [2013CB531606]; Shanghai Municipal Commission for Science and Technology [11JC1410902]; Dingyuan Grant of Talent Development in Yangpu District; Wujieping Grant [320.6750.13147]; Changhai Hospital [CH125530300]	973 Foundation(National Basic Research Program of China); Shanghai Municipal Commission for Science and Technology; Dingyuan Grant of Talent Development in Yangpu District; Wujieping Grant; Changhai Hospital	This study was supported by grants from the 973 Foundation (2013CB531606), Shanghai Municipal Commission for Science and Technology (11JC1410902), a Dingyuan Grant of Talent Development in Yangpu District, Wujieping Grant (320.6750.13147), and Changhai Hospital (CH125530300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Aung N, 2013, INT J CARDIOL; Baggish AL, 2010, BIOMARKERS, V15, P307, DOI 10.3109/13547501003632580; Bonaque JC, 2012, REV ESP CARDIOL, V65, P606, DOI [10.1016/j.rec.2011.12.007, 10.1016/j.recesp.2011.12.006]; Bozkurt B, 2010, HEART FAIL REV, V15, P331, DOI 10.1007/s10741-009-9140-3; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cauthen CA, 2012, J CARD FAIL, V18, P146, DOI 10.1016/j.cardfail.2011.10.013; Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Haddad H, 2012, CURR OPIN CARDIOL, V27, P161, DOI 10.1097/HCO.0b013e32834fdc98; Holmstrom A, 2013, EUR GERIATR MED; Hu ZD, 2013, CLIN CHIM ACTA, V425, P202, DOI 10.1016/j.cca.2013.08.007; Hu ZD, 2013, CLIN CHEM LAB MED, V51, P1403, DOI 10.1515/cclm-2012-0704; Jackson CE, 2009, EUR J HEART FAIL, V11, P1152, DOI 10.1093/eurjhf/hfp157; Jung C, 2011, INT J CARDIOL, V152, P417, DOI 10.1016/j.ijcard.2011.08.052; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; LIN CK, 1992, ARCH PATHOL LAB MED, V116, P1030; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Lou YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037644; Maisel AS, 2012, NAT REV CARDIOL, V9, P478, DOI 10.1038/nrcardio.2012.60; Makhoul BF, 2013, INT J CARDIOL, V167, P1412, DOI 10.1016/j.ijcard.2012.04.065; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Nair AP, 2012, CIRC J, V76, P268, DOI 10.1253/circj.CJ-11-1424; Nathan SD, 2012, CHEST; Oh J, 2012, CIRC J, V76, P109, DOI 10.1253/circj.CJ-11-0664; Okonko DO, 2013, INT J CARDIOL, V166, P664, DOI 10.1016/j.ijcard.2011.11.081; Ozsu S, 2012, CLIN APPL THROMB HEM; Pascual-Figal DA, 2009, EUR J HEART FAIL, V11, P840, DOI 10.1093/eurjhf/hfp109; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Rickard John, 2012, Congest Heart Fail, V18, P79, DOI 10.1111/j.1751-7133.2011.00267.x; Ruskoaho H, 2003, ENDOCR REV, V24, P341, DOI 10.1210/er.2003-0006; SHEMIN D, 1946, J BIOL CHEM, V166, P627; Simbaqueba Cesar, 2013, Congest Heart Fail, V19, P180, DOI 10.1111/chf.12010; Spiropoulos A, 2010, CLIN CHEM LAB MED, V48, P199, DOI 10.1515/CCLM.2010.034; Thakur V, 2013, CAN J CARDIOL, V29, P759, DOI 10.1016/j.cjca.2013.02.001; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Vanderheyden M, 2004, EUR J HEART FAIL, V6, P261, DOI 10.1016/j.ejheart.2004.01.004; Wang FL, 2011, ANN MED, V43, P40, DOI 10.3109/07853890.2010.521766; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356; Zalawadiya SK, 2011, J CARD FAIL, V17, P292, DOI 10.1016/j.cardfail.2010.11.006; Zhang ZH, 2013, J THORAC DIS, V5, P730, DOI 10.3978/j.issn.2072-1439.2013.11.14	51	80	82	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104861	10.1371/journal.pone.0104861	http://dx.doi.org/10.1371/journal.pone.0104861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133510	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700046
J	Liang, ZC; Cheng, LL; Zhong, GY; Liu, RH				Liang, Zhenchang; Cheng, Lailiang; Zhong, Gan-Yuan; Liu, Rui Hai			Antioxidant and Antiproliferative Activities of Twenty-Four Vitis vinifera Grapes	PLOS ONE			English	Article							ANTI PROLIFERATIVE ACTIVITIES; WOODCHUCK HEPATITIS-VIRUS; KAPPA-B ACTIVATION; CANCER MCF-7 CELLS; COMMON FRUITS; RED WINES; POLYPHENOLS; ASSAY; PHYTOCHEMICALS; PROFILES	Grapes are rich in phytochemicals with many proven health benefits. Phenolic profiles, antioxidant and antiproliferative activities of twenty-four selected Vitis vinifera grape cultivars were investigated in this study. Large ranges of variation were found in these cultivars for the contents of total phenolics (95.3 to 686.5 mg/100 g) and flavonoids (94.7 to 1055 mg/100 g) and antioxidant activities (oxygen radical absorbance capacity 378.7 to 3386.0 mg of Trolox equivalents/100 g and peroxylradical scavenging capacity14.2 to 557 mg of vitamin C equivalents/100 g), cellular antioxidant activities (3.9 to 139.9 mu mol of quercetin equivalents/100 g without PBS wash and 1.4 to 95.8 mu mol of quercetin equivalents/100 g with PBS wash) and antiproliferative activities (25 to 82% at the concentrations of 100 mg/mL extracts). The total antioxidant activities were significantly correlated with the total phenolics and flavonoids. However, no significant correlations were found between antiproliferative activities and total phenolics or total flavonoids content. Wine grapes and color grapes showed much higher levels of phytochemicals and antioxidant activities than table grapes and green/yellow grapes. Several germplasm accessions with much high contents of phenolics and flavonoids, and total antioxidant activity were identified. These germplasm can be valuable sources of genes for breeding grape cultivars with better nutritional qualities of wine and table grapes in the future.	[Liang, Zhenchang] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Liang, Zhenchang; Liu, Rui Hai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Cheng, Lailiang] Cornell Univ, Dept Hort, Ithaca, NY USA; [Zhong, Gan-Yuan] USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Zhong, GY (corresponding author), USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA.	ganyuan.zhong@ars.usda.gov; rl23@cornell.edu	Liu, Rui Hai/AAE-4865-2019; Liu, Rui Hai/C-2865-2008	Liu, Rui Hai/0000-0002-7018-7929; 	USDA-ARS; Cornell University; United States Department of Agriculture-Agricultural Research Service [1910-21220-004-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cornell University; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors are grateful to Mr. Bernard Prins of the USDA-ARS National Clonal Germplasm Repository for Fruit and Nut Crops in Davis, California and Dr. Christopher Owens of the USDA-ARS Grape Genetics Research Unit in Geneva, New York for providing V. vinifera berry samples. This work was supported by a Special Cooperative Agreement between USDA-ARS and Cornell University. USDA-ARS is an equal opportunity provider and employer. This project was supported by the United States Department of Agriculture-Agricultural Research Service Project 1910-21220-004-00D through a Specific Cooperative Agreement with Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adom KK, 2005, J AGR FOOD CHEM, V53, P6572, DOI 10.1021/jf048318o; Arnous A, 2002, J FOOD COMPOS ANAL, V15, P655, DOI 10.1006/jfca.2002.1070; Bitsch R, 2004, J BIOMED BIOTECHNOL, P293, DOI 10.1155/S1110724304403106; Bub A, 2003, J NUTR BIOCHEM, V14, P90, DOI 10.1016/S0955-2863(02)00255-3; Chu YF, 2002, J AGR FOOD CHEM, V50, P6910, DOI 10.1021/jf020665f; Del Caro A, 2010, ACTA ALIMENT HUNG, V39, P192, DOI 10.1556/AAlim.39.2010.2.11; Eberhardt MV, 2005, J AGR FOOD CHEM, V53, P7421, DOI 10.1021/jf051495k; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Garcia-Alonso M, 2009, J NUTR BIOCHEM, V20, P521, DOI 10.1016/j.jnutbio.2008.05.011; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; He XJ, 2008, J AGR FOOD CHEM, V56, P9337, DOI 10.1021/jf070954+; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kallithraka S, 2009, INT J FOOD SCI TECH, V44, P2385, DOI 10.1111/j.1365-2621.2008.01869.x; Liang ZC, 2008, FOOD CHEM, V111, P837, DOI 10.1016/j.foodchem.2008.04.069; Liang ZC, 2011, FOOD CHEM, V129, P940, DOI 10.1016/j.foodchem.2011.05.050; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; LIU RH, 1992, CANCER RES, V52, P4139; LIU RH, 1994, CARCINOGENESIS, V15, P2875, DOI 10.1093/carcin/15.12.2875; Nikfardjam MSP, 2006, FOOD CHEM, V98, P453, DOI 10.1016/j.foodchem.2005.06.014; Okarter N, 2010, FOOD CHEM, V119, P249, DOI 10.1016/j.foodchem.2009.06.021; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Pirniyazov AZ, 2003, CHEM NAT COMPD+, V39, P349, DOI 10.1023/B:CONC.0000003414.46129.15; Shin Y, 2008, POSTHARVEST BIOL TEC, V49, P201, DOI 10.1016/j.postharvbio.2008.02.008; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Tagliazucchi D, 2010, FOOD CHEM, V120, P599, DOI 10.1016/j.foodchem.2009.10.030; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Valdez LB, 2004, BIOL RES, V37, P279, DOI 10.4067/S0716-97602004000200014; Vita JA, 2005, AM J CLIN NUTR, V81, p292S, DOI 10.1093/ajcn/81.1.292S; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8404, DOI 10.1021/jf8013074; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021; Yoon H, 2008, J AGR FOOD CHEM, V56, P8412, DOI 10.1021/jf8012844; Yoon H, 2007, J AGR FOOD CHEM, V55, P3167, DOI 10.1021/jf0632379; Zhang MW, 2010, J AGR FOOD CHEM, V58, P7580, DOI 10.1021/jf1007665	39	47	49	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105146	10.1371/journal.pone.0105146	http://dx.doi.org/10.1371/journal.pone.0105146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133401	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700077
J	Mele, ML; Federici, S; Dennis, JL				Mele, Maria Laura; Federici, Stefano; Dennis, John Lawrence			Believing Is Seeing: Fixation Duration Predicts Implicit Negative Attitudes	PLOS ONE			English	Article							EYE-MOVEMENTS; BIAS; MICROSACCADE; EMBODIMENT; ACTIVATION; SALIENCE; VELOCITY; BEHAVIOR; LOAD	A prototypical finding of social cognition is that social experiences influence later performance even though those experiences are not introspectively available. Building on social cognition research on implicit attitudes, we evaluate whether ethnic category/attribute pairs influence eye movements during the Implicit Association Test (IAT, Greenwald, McGhee, & Schwartz 1998). Results show that fixation duration predicted implicit attitudes such that when the category/attribute pairs disconfirmed one's implicit negative attitude fixation duration toward that pair increased. The present research provides evidence that eye movements and implicit processes inherent in the IAT are more broadly connected than previously thought.	[Mele, Maria Laura; Federici, Stefano; Dennis, John Lawrence] Dept Philosophy Social & Human Sci & Educ, Perugia, Italy; [Mele, Maria Laura; Federici, Stefano] Univ Roma La Sapienza, ECONA, Interuniv Ctr Res Cognit Proc Nat & Artificial Sy, I-00185 Rome, Italy; [Dennis, John Lawrence] Catholic Univ, Dept Psychol, Milan, Italy; [Dennis, John Lawrence] Umbra Inst, Perugia, Italy	Sapienza University Rome; Catholic University of the Sacred Heart	Mele, ML (corresponding author), Dept Philosophy Social & Human Sci & Educ, Perugia, Italy.	marialaura.mele@unipg.it	Dennis, John Lawrence/F-6002-2016; Federici, Stefano/D-2125-2011	Dennis, John Lawrence/0000-0002-0848-8077; Federici, Stefano/0000-0001-5681-0633				Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Amodio DM, 2006, J PERS SOC PSYCHOL, V91, P652, DOI 10.1037/0022-3514.91.4.652; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Barsalou L. W, 2005, HDB CATEGORIZATION C, P619, DOI [10.1016/b978-008044612-7/50083-4, DOI 10.1016/B978-008044612-7/50083-4, 10.1016/B978-008044612-7/50083-4]; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bohlin G., 1979, ORIENTING REFLEX HUM, P1; Campbell BA, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P41; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; De Houwer J., 2010, HDB IMPLICIT SOCIAL, P176; de Kerckhove D., 1988, ALPHABET BRAIN LATER; Di Stasi LL, 2014, EUR J NEUROSCI, V39, P1384, DOI 10.1111/ejn.12482; Di Stasi LL, 2014, ANN SURG, V259, P824, DOI 10.1097/SLA.0000000000000260; Di Stasi LL, 2013, EUR J NEUROSCI, V38, P2389, DOI 10.1111/ejn.12248; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Durgin FH, 2008, ACTA PSYCHOL, V127, P428, DOI 10.1016/j.actpsy.2007.08.007; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Friese M, 2010, SOC PSYCHOL PERS SCI, V1, P143, DOI 10.1177/1948550609359945; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Henderson JM, 2008, PSYCHON B REV, V15, P566, DOI 10.3758/PBR.15.3.566; Henderson JM, 2014, VIS COGN, V22, P486, DOI 10.1080/13506285.2014.897662; Henderson JM, 2009, VIS COGN, V17, P1055, DOI 10.1080/13506280802685552; Johansen S.A., 2011, P EXTENDED ABSTR HUM, P1177, DOI DOI 10.1145/1979742.1979744; McCamy MB, 2014, J NEUROSCI, V34, P2956, DOI 10.1523/JNEUROSCI.4448-13.2014; Mele ML, 2012, COGN PROCESS, V13, pS261, DOI 10.1007/s10339-012-0499-z; Mele ML, 2012, DISABIL REHABIL-ASSI, V7, P261, DOI 10.3109/17483107.2011.635326; Mele ML, 2012, APPAC ARCH, V19, P1; Neumann R, 2000, J PERS SOC PSYCHOL, V79, P211, DOI 10.1037//0022-3514.79.2.211; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; Rohmer O, 2009, REHABIL PSYCHOL, V54, P76, DOI 10.1037/a0014445; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; van Gog T, 2009, COMPUT HUM BEHAV, V25, P325, DOI 10.1016/j.chb.2008.12.021; Wittenbrink Bernd., 2007, IMPLICIT MEASURES AT	42	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105106	10.1371/journal.pone.0105106	http://dx.doi.org/10.1371/journal.pone.0105106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133639	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700073
J	Nagib, S; Rau, J; Sammra, O; Lammler, C; Schlez, K; Zschock, M; Prenger-Berninghoff, E; Klein, G; Abdulmawjood, A				Nagib, Samy; Rau, Joerg; Sammra, Osama; Laemmler, Christoph; Schlez, Karen; Zschoeck, Michael; Prenger-Berninghoff, Ellen; Klein, Guenter; Abdulmawjood, Amir			Identification of Trueperella pyogenes Isolated from Bovine Mastitis by Fourier Transform Infrared Spectroscopy	PLOS ONE			English	Article							ARCANOBACTERIUM-PYOGENES; CLASSIFICATION; BACTERIA; FOOD	The present study was designed to investigate the potential of Fourier transform infrared (FT-IR) spectroscopy to identify Trueperella (T.) pyogenes isolated from bovine clinical mastitis. FT-IR spectroscopy was applied to 57 isolates obtained from 55 cows in a period from 2009 to 2012. Prior to FT-IR spectroscopy these isolates were identified by phenotypic and genotypic properties, also including the determination of seven potential virulence factor encoding genes. The FT-IR analysis revealed a reliable identification of all 57 isolates as T. pyogenes and a clear separation of this species from the other species of genus Trueperella and from species of genus Arcanobacterium and Actinomyces. The results showed that all 57 isolates were assigned to the correct species indicating that FT-IR spectroscopy could also be efficiently used for identification of this bacterial pathogen.	[Nagib, Samy; Sammra, Osama; Laemmler, Christoph] Univ Giessen, Inst Pharmakol & Toxikol, D-35390 Giessen, Germany; [Rau, Joerg] CVUAS, Fellbach, Germany; [Schlez, Karen; Zschoeck, Michael] Landesbetrieb Hess Landeslabor, Giessen, Germany; [Prenger-Berninghoff, Ellen] Univ Giessen, Inst Hyg & Infekt Krankheiten Tiere, Giessen, Germany; [Klein, Guenter; Abdulmawjood, Amir] Univ Vet Med Hannover, Inst Lebensmittelqual & Sicherheit, Hannover, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation	Abdulmawjood, A (corresponding author), Univ Vet Med Hannover, Inst Lebensmittelqual & Sicherheit, Hannover, Germany.	amir.abdulmawjood@tiho-hannover.de	Abdulmawjood, Amir/C-6083-2015; Abdulmawjood, Amir/AAL-5523-2020; Klein, Günter/G-5321-2013	Abdulmawjood, Amir/0000-0001-5189-8381; Klein, Günter/0000-0003-1931-2701				Al-Tarazi Y., 2012, Journal of Camelid Science, V5, P99; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; GAHRNHANSEN B, 1992, DIAGN MICR INFEC DIS, V15, P349, DOI 10.1016/0732-8893(92)90022-L; Grunert T, 2013, J CLIN MICROBIOL, V51, P2261, DOI 10.1128/JCM.00581-13; HARTWIGK H, 1962, ZBL BAKT PARASIT, V186, P544; HARTWIGK H., 1960, ZENTRALBL BAKT PARASITENK INFEKTIONSKRANKH U HYG, V179, P499; Hijazin M, 2012, VET MICROBIOL, V157, P243, DOI 10.1016/j.vetmic.2011.12.022; Hijazin M, 2011, J DAIRY SCI, V94, P1813, DOI 10.3168/jds.2010-3678; Horlacher S, 2009, AMTSTIERARZTLICHER D; Janbu AO, 2008, FEMS MICROBIOL LETT, V278, P164, DOI 10.1111/j.1574-6968.2007.00995.x; Johler S, 2013, FOODBORNE PATHOG DIS, V10, P777, DOI 10.1089/fpd.2013.1503; Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5; Kavitha K, 2010, J MED MICROBIOL, V59, P736, DOI 10.1099/jmm.0.016485-0; Kuhm AE, 2009, APPL ENVIRON MICROB, V75, P5809, DOI 10.1128/AEM.00206-09; Lammler C, 1995, HDB BAKTERIELLEN INF, VII/3, P196; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Moore R., 2010, CORYNEBACTERIUM ARCA, V4th, P133, DOI [10.1002/9780470958209.CH8, DOI 10.1002/9780470958209.CH8]; Oberreuter H, 2002, INT J SYST EVOL MICR, V52, P91, DOI 10.1099/00207713-52-1-91; Prunner I., 2013, XIII Middle European Buiatrics Congress, Belgrade, Serbia, 5-8 June, 2013., P168; Rau J, 2009, BERL MUNCH TIERARZTL, V122, P25, DOI 10.2376/0005-9366-122-25; Samuels AC, 2009, APPL SPECTROSC, V63, P14, DOI 10.1366/000370209787169867; Schabauer L, 2011, FT IR SPECTR MICR ME; Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x; Udelhoven T, 2003, CHEMOMETR INTELL LAB, V66, P219, DOI 10.1016/S0169-7439(02)00161-2; Udelhoven T, 2000, APPL SPECTROSC, V54, P1471, DOI 10.1366/0003702001948619; Ulbegi-Mohyla H, 2010, J VET SCI, V11, P265, DOI 10.4142/jvs.2010.11.3.265; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; Wortberg F, 2012, J FISH DIS, V35, P1, DOI 10.1111/j.1365-2761.2011.01317.x; Yassin AF, 2011, INT J SYST EVOL MICR, V61, P1265, DOI 10.1099/ijs.0.020032-0	31	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104654	10.1371/journal.pone.0104654	http://dx.doi.org/10.1371/journal.pone.0104654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133407	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700037
J	Zorin, B; Grundman, O; Khozin-Goldberg, I; Leu, S; Shapira, M; Kaye, Y; Tourasse, N; Vallon, O; Boussiba, S				Zorin, Boris; Grundman, Omer; Khozin-Goldberg, Inna; Leu, Stefan; Shapira, Michal; Kaye, Yuval; Tourasse, Nicolas; Vallon, Olivier; Boussiba, Sammy			Development of a Nuclear Transformation System for Oleaginous Green Alga Lobosphaera (Parietochloris) incisa and Genetic Complementation of a Mutant Strain, Deficient in Arachidonic Acid Biosynthesis	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; PHAEODACTYLUM-TRICORNUTUM; NITROGEN STARVATION; NANNOCHLOROPSIS SP; ACCUMULATION; EXPRESSION; PROMOTER; TRIACYLGLYCEROLS; TREBUXIOPHYCEAE; CHLOROPHYTA	Microalgae are considered a promising source for various high value products, such as carotenoids, omega-3 and omega-6 polyunsaturated fatty acids (PUFA). The unicellular green alga Lobosphaera (Parietochloris) incisa is an outstanding candidate for the efficient phototrophic production of arachidonic acid (AA), an essential omega-6 PUFA for infant brain development and a widely used ingredient in the baby formula industry. Although phototrophic production of such algal products has not yet been established, estimated costs are considered to be 2-5 times higher than competing heterotrophic production costs. This alga accumulates unprecedented amounts of AA within triacylglycerols and the molecular pathway of AA biosynthesis in L. incisa has been previously elucidated. Thus, progress in transformation and metabolic engineering of this high value alga could be exploited for increasing the efficient production of AA at competitive prices. We describe here the first successful transformation of L. incisa using the ble gene as a selection marker, under the control of the endogenous RBCS promoter. Furthermore, we have succeeded in the functional complementation of the L. incisa mutant strain P127, containing a mutated, inactive version of the delta-5 (Delta 5) fatty acid desaturase gene. A copy of the functional Delta 5 desaturase gene, linked to the ble selection marker, was transformed into the P127 mutant. The resulting transformants selected for zeocine resistant, had AA biosynthesis partially restored, indicating the functional complementation of the mutant strain with the wild-type gene. The results of this study present a platform for the successful genetic engineering of L. incisa and its long-chain PUFA metabolism.	[Zorin, Boris; Grundman, Omer; Khozin-Goldberg, Inna; Leu, Stefan; Kaye, Yuval; Boussiba, Sammy] Ben Gurion Univ Negev, J Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Microalgal Biotechnol Lab, Midreshet Ben Gurion, Israel; [Shapira, Michal] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Tourasse, Nicolas; Vallon, Olivier] Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, Paris, France	Ben Gurion University; Ben Gurion University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Khozin-Goldberg, I (corresponding author), Ben Gurion Univ Negev, J Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Microalgal Biotechnol Lab, Midreshet Ben Gurion, Israel.	khozin@bgu.ac.il	Khozin-Goldberg, Inna/F-2300-2012; VALLON, Olivier/AAM-7737-2021; Zorin, Boris/AAW-9130-2021	Khozin-Goldberg, Inna/0000-0001-8618-0687; Zorin, Boris/0000-0002-5558-6438; Boussiba, Sammy/0000-0001-9707-0811; Shapira, Michal/0000-0002-6164-7874	European Commission [266401]; Kreitman School of Advanced Graduate Studies at Ben-Gurion University; French state "Initiative d'Excellence" program (Grant "DYNAMO") [ANR-11-LABX-0011-01]	European Commission(European CommissionEuropean Commission Joint Research Centre); Kreitman School of Advanced Graduate Studies at Ben-Gurion University; French state "Initiative d'Excellence" program (Grant "DYNAMO")	This research was financially supported by the European Commission's Seventh Framework Program for Research and Technology Development (FP7), project GIAVAP, Grant No. 266401. BZ, OG and YK acknowledge support from the Kreitman School of Advanced Graduate Studies at Ben-Gurion University. OV acknowledges support from the French state "Initiative d'Excellence" program (Grant "DYNAMO", ANR-11-LABX-0011-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P135, DOI 10.1016/S0031-9422(02)00037-7; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P497, DOI 10.1016/S0031-9422(02)00100-0; Cohen Z., 2010, Single cell oils: microbial and algal oils, P201; Cohen Z, 2009, Parietochloris incisa, Patent No. [WO/2009/022323, 2009022323]; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Guo SL, 2013, J BIOTECHNOL, V163, P61, DOI 10.1016/j.jbiotec.2012.10.020; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Imamura S, 2012, J GEN APPL MICROBIOL, V58, P1; Ishida K, 2007, EUKARYOT CELL, V6, P2157, DOI 10.1128/EC.00304-07; Iskandarov U, 2011, APPL MICROBIOL BIOT, V90, P249, DOI 10.1007/s00253-010-3005-5; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Khozin-Goldberg I, 2005, BBA-MOL CELL BIOL L, V1738, P63, DOI 10.1016/j.bbalip.2005.09.005; Khozin-Goldberg I, 2002, J PHYCOL, V38, P991, DOI 10.1046/j.1529-8817.2002.01160.x; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Lerche K, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-11; Leu S., 2014, Industrial Biotechnology, V10, P169; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Meslet-Cladiere L, 2011, EUKARYOT CELL, V10, P1670, DOI 10.1128/EC.05043-11; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Qin S, 2012, BIOTECHNOL ADV, V30, P1602, DOI 10.1016/j.biotechadv.2012.05.004; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Stevens DR, 1996, MOL GEN GENET, V251, P23; Talebi AF, 2013, MOL BIOL REP, V40, P4421, DOI 10.1007/s11033-013-2532-4; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; van Ooijen G, 2012, JOVE-J VIS EXP, DOI 10.3791/4074; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; von Gromoff ED, 2006, NUCLEIC ACIDS RES, V34, P4767, DOI 10.1093/nar/gkl602; Watanabe Shin, 1996, Phycological Research, V44, P107, DOI 10.1111/j.1440-1835.1996.tb00383.x; Zhang C., 2013, MAR GENOMICS	37	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105223	10.1371/journal.pone.0105223	http://dx.doi.org/10.1371/journal.pone.0105223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133787	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700092
J	Ananthasubramaniam, B; Herzel, H				Ananthasubramaniam, Bharath; Herzel, Hanspeter			Positive Feedback Promotes Oscillations in Negative Feedback Loops	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MODEL; ULTRASENSITIVITY; MOTIFS	A simple three-component negative feedback loop is a recurring motif in biochemical oscillators. This motif oscillates as it has the three necessary ingredients for oscillations: a three-step delay, negative feedback, and nonlinearity in the loop. However, to oscillate, this motif under the common Goodwin formulation requires a high degree of cooperativity (a measure of nonlinearity) in the feedback that is biologically "unlikely.'' Moreover, this recurring negative feedback motif is commonly observed augmented by positive feedback interactions. Here we show that these positive feedback interactions promote oscillation at lower degrees of cooperativity, and we can thus unify several common kinetic mechanisms that facilitate oscillations, such as self-activation and Michaelis-Menten degradation. The positive feedback loops are most beneficial when acting on the shortest lived component, where they function by balancing the lifetimes of the different components. The benefits of multiple positive feedback interactions are cumulative for a majority of situations considered, when benefits are measured by the reduction in the cooperativity required to oscillate. These positive feedback motifs also allow oscillations with longer periods than that determined by the lifetimes of the components alone. We can therefore conjecture that these positive feedback loops have evolved to facilitate oscillations at lower, kinetically achievable, degrees of cooperativity. Finally, we discuss the implications of our conclusions on the mammalian molecular clock, a system modeled extensively based on the three-component negative feedback loop.	[Ananthasubramaniam, Bharath; Herzel, Hanspeter] Charite & Humboldt Univ Berlin, Inst Theoret Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ananthasubramaniam, B (corresponding author), Charite & Humboldt Univ Berlin, Inst Theoret Biol, Berlin, Germany.	bharath.ananthasubramaniam@biologie.hu-berlin.de	Ananthasubramaniam, Bharath/L-7777-2013; Ananthasubramaniam, Bharath/AAT-3641-2021	Ananthasubramaniam, Bharath/0000-0003-4467-1546; Ananthasubramaniam, Bharath/0000-0003-4467-1546	Alexander von Humboldt Foundation; BMBF (T-Sys) [0316164G]; DFG (SPP InKomBio); Bernstein Center for Computational Neuroscience Berlin [01GQ1001C]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); BMBF (T-Sys)(Federal Ministry of Education & Research (BMBF)); DFG (SPP InKomBio)(German Research Foundation (DFG)); Bernstein Center for Computational Neuroscience Berlin	BA was supported by a fellowship from the Alexander von Humboldt Foundation. The authors acknowledge support from BMBF (T-Sys, 0316164G), DFG (SPP InKomBio) and Bernstein Center for Computational Neuroscience Berlin (grant 01GQ1001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; EDSALL JT, 1980, FED PROC, V39, P226; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1990, BIOPHYS CHEM, V37, P341, DOI 10.1016/0301-4622(90)88033-O; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim JK, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.62; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Legewie S, 2005, PLOS COMPUT BIOL, V1, P405, DOI 10.1371/journal.pcbi.0010054; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Meinhardt H., 1982, MODELS BIOL PATTERN; Michaelis L, 1913, BIOCHEM Z, V49, P333; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THRON CD, 1991, B MATH BIOL, V53, P403; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson J., 1978, PROG THEOR BIOL, V5, P1; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035	45	46	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104761	10.1371/journal.pone.0104761	http://dx.doi.org/10.1371/journal.pone.0104761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126951	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300049
J	Hammer, N; Huster, D; Fritsch, S; Hadrich, C; Koch, H; Schmidt, P; Sichting, F; Wagner, MFX; Boldt, A				Hammer, Niels; Huster, Daniel; Fritsch, Sebastian; Haedrich, Carsten; Koch, Holger; Schmidt, Peter; Sichting, Freddy; Wagner, Martin Franz-Xaver; Boldt, Andreas			Do Cells Contribute to Tendon and Ligament Biomechanics?	PLOS ONE			English	Article							ACELLULAR DERMAL MATRIX; ROTATOR CUFF REPAIR; ACHILLES-TENDON; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; BOVINE PERICARDIUM; ILIOTIBIAL TRACT; FLEXOR TENDONS; DECELLULARIZATION; GRAFT	Introduction: Acellular scaffolds are increasingly used for the surgical repair of tendon injury and ligament tears. Despite this increased use, very little data exist directly comparing acellular scaffolds and their native counterparts. Such a comparison would help establish the effectiveness of the acellularization procedure of human tissues. Furthermore, such a comparison would help estimate the influence of cells in ligament and tendon stability and give insight into the effects of acellularization on collagen. Material and Methods: Eighteen human iliotibial tract samples were obtained from nine body donors. Nine samples were acellularized with sodium dodecyl sulphate (SDS), while nine counterparts from the same donors remained in the native condition. The ends of all samples were plastinated to minimize material slippage. Their water content was adjusted to 69%, using the osmotic stress technique to exclude water content-related alterations of the mechanical properties. Uniaxial tensile testing was performed to obtain the elastic modulus, ultimate stress and maximum strain. The effectiveness of the acellularization procedure was histologically verified by means of a DNA assay. Results: The histology samples showed a complete removal of the cells, an extensive, yet incomplete removal of the DNA content and alterations to the extracellular collagen. Tensile properties of the tract samples such as elastic modulus and ultimate stress were unaffected by acellularization with the exception of maximum strain. Discussion: The data indicate that cells influence the mechanical properties of ligaments and tendons in vitro to a negligible extent. Moreover, acellularization with SDS alters material properties to a minor extent, indicating that this method provides a biomechanical match in ligament and tendon reconstruction. However, the given protocol insufficiently removes DNA. This may increase the potential for transplant rejection when acellular tract scaffolds are used in soft tissue repair. Further research will help optimize the SDS-protocol for clinical application.	[Hammer, Niels] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Huster, Daniel; Schmidt, Peter] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Fritsch, Sebastian; Wagner, Martin Franz-Xaver] Tech Univ Chemnitz, Inst Mat Sci & Engn, Chemnitz, Germany; [Haedrich, Carsten] Univ Leipzig, Fac Med, Inst Forens Med, D-04109 Leipzig, Germany; [Koch, Holger; Boldt, Andreas] Univ Leipzig, Fac Med, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Sichting, Freddy] Tech Univ Chemnitz, Dept Human Locomot, Inst Sport Sci, Chemnitz, Germany; [Boldt, Andreas] Univ Leipzig, Fac Med, Inst Clin Immunol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University; Leipzig University; Technische Universitat Chemnitz; Leipzig University	Hammer, N (corresponding author), Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany.	niels.hammer@medizin.uni-leipzig.de	Wagner, Martin/M-9684-2019; Wagner, Martin FX/A-6880-2008	Wagner, Martin/0000-0003-4082-2618; Hammer, Niels/0000-0001-8230-9383	German Federal Ministry of Education and Research (BMBF) [1315883]; German Federal Ministry of Education and Research; Institute of Anatomy, University of Leipzig; German Research Foundation (DFG); Leipzig University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute of Anatomy, University of Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	Parts of the work presented in this paper were supported by the German Federal Ministry of Education and Research (BMBF number 1315883, www.bmbf.de). The authors Holger Koch and Andreas Boldt were financed via the German Federal Ministry of Education and Research. In both, they were involved in data collection, analysis and in the preparation of the manuscript. This work was furthermore made possible by the budgetary resources of the Institute of Anatomy, University of Leipzig. The authors declare that there are no competing interests. They acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016; Adeeb S, 2004, COMPUT METHOD BIOMEC, V7, P33, DOI 10.1080/10255840310001637266; ARNOLD G, 1974, Z ANAT ENTWICKLUNGS, V143, P263, DOI 10.1007/BF00519870; Asundi KR, 2008, ANN BIOMED ENG, V36, P237, DOI 10.1007/s10439-007-9427-2; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Birnbaum K, 2004, SURG RADIOL ANAT, V26, P433, DOI 10.1007/s00276-004-0265-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bos I, 2008, PATHOLOGE, V29, P280, DOI 10.1007/s00292-007-0921-y; Branch JP, 2011, J FOOT ANKLE SURG, V50, P257, DOI 10.1053/j.jfas.2010.12.015; Burk J, 2013, TISSUE ENG C; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chung S, 2003, PLAST RECONSTR SURG, V111, P225, DOI 10.1097/01.PRS.0000034934.05304.ED; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; Ehsan A, 2012, J HAND SURG-AM, V37A, P1538, DOI 10.1016/j.jhsa.2012.04.043; ELDEN HR, 1964, BIOCHIM BIOPHYS ACTA, V79, P592, DOI 10.1016/0926-6577(64)90225-6; Ellis CV, 2012, PLAST RECONSTR SURG, V130, p256S, DOI 10.1097/PRS.0b013e318265a5cf; Ernstberger M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.060506; Farnebo S, 2014, PLAST RECONSTR SURG, V133, P79, DOI 10.1097/01.prs.0000436823.64827.a0; Gawrisch K, 1988, ELECTROMAGNETIC FIEL, P9; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gratz CM, 1931, J BONE JOINT SURG, V13, P334; Hammer N, 2012, J MECH BEHAV BIOMED, V16, P81, DOI 10.1016/j.jmbbm.2012.04.025; Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x; Hwang K, 2007, J CRANIOFAC SURG, V18, P551, DOI 10.1097/scs.0b013e3180534421; Igarza E, 2014, MATER DESIGN, V55, P85, DOI 10.1016/j.matdes.2013.09.055; Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054; Kjaer M, 2008, DISABIL REHABIL, V30, P1514, DOI 10.1080/09638280701785403; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Klatte-Schulz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067209; Koch H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/948320; KOSTROMINOVA TY, 2013, AGE DORDR, P15253; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015; Ma S Z, 2006, Hernia, V10, P229, DOI 10.1007/s10029-006-0071-9; McLaughlin P, 2013, J BIOMECH, V46, P2757, DOI 10.1016/j.jbiomech.2013.08.015; Ozasa Y, 2014, TISSUE ENG PT A, V20, P566, DOI 10.1089/ten.TEA.2013.0284; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pridgen BC, 2011, TISSUE ENG PART C-ME, V17, P819, DOI 10.1089/ten.tec.2010.0457; Rao BM, 2012, INT ORTHOP, V36, P2049, DOI 10.1007/s00264-012-1630-6; Robayo LM, 2011, WOUND REPAIR REGEN, V19, P38, DOI 10.1111/j.1524-475X.2010.00640.x; Romeis B., 1989, ROMEIS MIKROSKOPISCH; Rubin L, 2005, CLIN PODIATR MED SUR, V22, pvi; Rubin Laurence, 2005, Clin Podiatr Med Surg, V22, P533, DOI 10.1016/j.cpm.2005.08.002; Sahoo S, 2012, J SHOULDER ELB SURG, V21, P1413, DOI 10.1016/j.jse.2011.10.028; Schulze-Tanzil G, 2012, CELLS, V1, P1011; Seitz AM, 2012, J MECH BEHAV BIOMED, V10, P120, DOI 10.1016/j.jmbbm.2012.02.027; Song L, 2010, J FOOT ANKLE SURG, V49, P438, DOI 10.1053/j.jfas.2010.06.009; Steinke H, 2012, MED ENG PHYS, V34, P1221, DOI 10.1016/j.medengphy.2011.12.009; Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569; Thorpe CT, 2013, INT J EXP; Tischer T, 2010, TISSUE ENG PT A, V16, P1031, DOI [10.1089/ten.tea.2009.0043, 10.1089/ten.TEA.2009.0043]; Waggett AD, 2006, EUR J CELL BIOL, V85, P1145, DOI 10.1016/j.ejcb.2006.06.002; Yoeruek E, 2012, ACTA OPHTHALMOL, V90, pe125, DOI 10.1111/j.1755-3768.2011.02261.x; Zernia G, 2006, NMR BIOMED, V19, P1010, DOI 10.1002/nbm.1061; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170	59	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105037	10.1371/journal.pone.0105037	http://dx.doi.org/10.1371/journal.pone.0105037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126746	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300071
J	Kim, GJ; Rhee, H; Yoo, JE; Ko, JE; Lee, JS; Kim, H; Choi, JS; Park, YN				Kim, Gi Jeong; Rhee, Hyungjin; Yoo, Jeong Eun; Ko, Jung Eun; Lee, Jee San; Kim, Hyunki; Choi, Jin Sub; Park, Young Nyun			Increased Expression of CCN2, Epithelial Membrane Antigen, and Fibroblast Activation Protein in Hepatocellular Carcinoma with Fibrous Stroma Showing Aggressive Behavior	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; CANCER-ASSOCIATED FIBROBLASTS; MESENCHYMAL TRANSITION; COLON-CANCER; STEM-CELLS; CROSS-TALK; MUC1; MICROENVIRONMENT; PROGRESSION; FAP	Tumor behavior is affected by the tumor microenvironment, composed of cancer-associated fibroblasts (CAFs). Meanwhile, hepatocellular carcinomas (HCC) with fibrous stroma reportedly exhibit aggressive behavior suggestive of tumor-stroma interaction. However, evidence of the crosstalk remains unclear. In this study, CCN2, epithelial membrane antigen (EMA), fibroblast activation protein (FAP), and keratin 19 (K19) expression was studied in 314 HCCs (cohort 1), 42 scirrhous HCCs (cohort 2), and 36 chronic hepatitis/cirrhosis specimens by immunohistochemistry. Clinicopathological parameters were analyzed according to the expressions of these markers. In tumor epithelial cells from cohort 1, CCN2 and EMA were expressed in 15.3% and 17.2%, respectively, and their expressions were more frequent in HCCs with fibrous stroma (>= 5% of tumor area) than those without (P<0.05 for all); CCN2 expression was well correlated with K19 and EMA expression. In tumor stromal cells, FAP expression was found in 6.7%. In cohort 2, CCN2, EMA, and FAP expression was noted in 40.5%, 40.5%, and 66.7%, respectively, which was more frequent than that in cohort 1 (P<0.05 for all). Additionally, EMA expression was associated with the expression of K19, CCN2, and FAP (P<0.05 for all); EMA expressing tumor epithelial cells showed a topographic closeness to FAP-expressing CAFs. Analysis of disease-free survival revealed CCN2 expression to be a worse prognostic factor in both cohort 1 (P = 0.005) and cohort 2 (P = 0.023), as well as EMA as a worse prognostic factor in cohort 2 (P = 0.048). In conclusion, expression of CCN2, EMA, and FAP may be involved in the activation of CAFs in HCC, giving rise to aggressive behavior. Significant correlation between EMA-expressing tumor cells and FAP-expressing CAFs and their topographic closeness suggests possible cross-talk between tumor epithelial cells and stromal cells in the tumor microenvironment of HCC.	[Kim, Gi Jeong; Rhee, Hyungjin; Yoo, Jeong Eun; Ko, Jung Eun; Lee, Jee San; Kim, Hyunki; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Rhee, Hyungjin; Ko, Jung Eun; Lee, Jee San] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	young0608@yuhs.ac	Rhee, Hyungjin/T-7619-2019	Rhee, Hyungjin/0000-0001-7759-4458; Park, Young Nyun/0000-0003-0357-7967; Kim, Hyunki/0000-0003-2292-5584	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0555]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Chen CM, 2007, PEDIATR RES, V62, P128, DOI 10.1203/PDR.0b013e3180987202; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; di Mola FF, 1999, ANN SURG, V230, P63, DOI 10.1097/00000658-199907000-00010; Gao YB, 2013, J CANCER RES CLIN, V139, P669, DOI 10.1007/s00432-012-1370-4; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hafner C, 2005, CURR CANCER DRUG TAR, V5, P393, DOI 10.2174/1568009054863591; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Ichikawa T, 2006, J HEPATO-BILIARY-PAN, V13, P245, DOI 10.1007/s00534-005-1070-4; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Kim SM, 2012, KOREAN J PATHOL, V46, P429, DOI 10.4132/KoreanJPathol.2012.46.5.429; Kwon S, 2007, INT J ONCOL, V31, P693; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Seok JY, 2012, HEPATOLOGY, V55, P1776, DOI 10.1002/hep.25570; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Tanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027922; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; von Mensdorff-Pouilly S, 2000, INT J BIOL MARKER, V15, P343, DOI 10.1177/172460080001500413; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Woenckhaus M, 2008, HUM PATHOL, V39, P126, DOI 10.1016/j.humpath.2007.05.027; Xiang ZL, 2011, ONCOLOGIST, V16, P1028, DOI 10.1634/theoncologist.2010-0358; Xiu M, 2012, WORLD J GASTROENTERO, V18, P7070, DOI 10.3748/wjg.v18.i47.7070; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yuan SF, 2005, WORLD J GASTROENTERO, V11, P4661, DOI 10.3748/wjg.v11.i30.4661	40	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105094	10.1371/journal.pone.0105094	http://dx.doi.org/10.1371/journal.pone.0105094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126747	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300079
J	Ma, ZY; Zhong, ZG; Zheng, ZY; Shi, XM; Zhang, WX				Ma, Zhenyu; Zhong, Zhigang; Zheng, Zhenyang; Shi, Xing-Ming; Zhang, Weixi			Inhibition of Glycogen Synthase Kinase-3 beta Attenuates Glucocorticoid-Induced Suppression of Myogenic Differentiation In Vitro	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; SATELLITE CELLS; MYOBLAST FUSION; GSK-3-BETA; PATHWAYS; RECEPTOR; PHOSPHORYLATION; INACTIVATION; ACTIVATION	Glucocorticoids are the only therapy that has been demonstrated to alter the progress of Duchenne muscular dystrophy (DMD), the most common muscular dystrophy in children. However, glucocorticoids disturb skeletal muscle metabolism and hamper myogenesis and muscle regeneration. The mechanisms involved in the glucocorticoid-mediated suppression of myogenic differentiation are not fully understood. Glycogen synthase kinase-3 beta (GSK-3 beta) is considered to play a central role as a negative regulator in myogenic differentiation. Here, we showed that glucocorticoid treatment during the first 48 h in differentiation medium decreased the level of phosphorylated Ser9-GSK-3 beta, an inactive form of GSK-3 beta, suggesting that glucocorticoids affect GSK-3 beta activity. We then investigated whether GSK-3 beta inhibition could regulate glucocorticoid-mediated suppression of myogenic differentiation in vitro. Two methods were employed to inhibit GSK-3 beta: pharmacological inhibition with LiCl and GSK-3 beta gene knockdown. We found that both methods resulted in enhanced myotube formation and increased levels of muscle regulatory factors and muscle-specific protein expression. Importantly, GSK-3 beta inhibition attenuated glucocorticoid-induced suppression of myogenic differentiation. Collectively, these data suggest the involvement of GSK-3 beta in the glucocorticoid-mediated impairment of myogenic differentiation. Therefore, the inhibition of GSK-3 beta may be a strategy for preventing glucocorticoid-induced muscle degeneration.	[Ma, Zhenyu; Zhong, Zhigang; Zheng, Zhenyang; Zhang, Weixi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Xing-Ming] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA USA	Sun Yat Sen University; University System of Georgia; Augusta University	Zhang, WX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	weixizhang@qq.com			National Natural Science Foundation of China [81371260, 30971026]; Guangdong Natural Science Foundation [S2013010015600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 81371260 and 30971026) and Guangdong Natural Science Foundation (Grant No. S2013010015600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiner JM, 1999, AM J SPORT MED, V27, P2, DOI 10.1177/03635465990270011101; Betters JL, 2008, MUSCLE NERVE, V37, P203, DOI 10.1002/mus.20915; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Dong YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058554; Du WJ, 2009, CELLS TISSUES ORGANS, V190, P11, DOI 10.1159/000167699; Evenson AR, 2005, INT J BIOCHEM CELL B, V37, P2226, DOI 10.1016/j.biocel.2005.06.002; French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Koivisto L, 2004, EXP CELL RES, V293, P68, DOI 10.1016/j.yexcr.2003.09.026; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Martinez A, 2008, MED RES REV, V28, P773, DOI 10.1002/med.20119; OLSON EN, 1993, MOL ENDOCRINOL, V7, P1369, DOI 10.1210/me.7.11.1369; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Velica P, 2010, MOL CELL ENDOCRINOL, V319, P71, DOI 10.1016/j.mce.2010.01.023; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang FS, 2009, LIFE SCI, V85, P685, DOI 10.1016/j.lfs.2009.09.009; Wang Y, 2011, J CELL SCI, V124, P3835, DOI 10.1242/jcs.086686; Wu RW, 2011, BONE, V49, P1255, DOI 10.1016/j.bone.2011.08.022; Zhang CP, 2012, AGING CELL, V11, P14, DOI 10.1111/j.1474-9726.2011.00753.x; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	35	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105528	10.1371/journal.pone.0105528	http://dx.doi.org/10.1371/journal.pone.0105528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127359	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300117
J	Pan, XN; Chen, JJ; Wang, LX; Xiao, RZ; Liu, LL; Fang, ZG; Liu, QT; Long, ZJ; Lin, DJ				Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun			Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation	PLOS ONE			English	Article							ARGININE DEIMINASE RESISTANCE; ANTISENSE OLIGODEOXYNUCLEOTIDES; IN-VIVO; CISPLATIN; MECHANISMS; APOPTOSIS; 10058-F4; COMPLEX; GENES; CYCLE	Nowadays, drug resistance still represents a major obstacle to successful acute myeloid leukemia (AML) treatment and the underlying mechanism is not fully elucidated. Here, we found that high expression of c-Myc was one of the cytogenetic characteristics in the drug-resistant leukemic cells. c-Myc over-expression in leukemic cells induced resistance to chemotherapeutic drugs, enhanced colony formation capacity and inhibited cell differentiation induced by all-trans retinoic acid (ATRA). Meanwhile, inhibition of c-Myc by shRNA or specific c-Myc inhibitor 10058-F4 rescued the sensitivity to cytotoxic drugs, restrained the colony formation ability and promoted differentiation. RT-PCR and western blotting analysis showed that down-regulation of C/EBP beta contributed to the poor differentiation state of leukemic cells induced by c-Myc over-expression. Importantly, over-expression of C/EBP beta could reverse c-Myc induced drug resistance. In primary AML cells, the c-Myc expression was negatively correlated with C/EBP beta. 10058-F4, displayed anti-proliferative activity and increased cellular differentiation with up-regulation of C/EBP beta in primary AML cells. Thus, our study indicated that c-Myc could be a novel target to overcome drug resistance, providing a new approach in AML therapy.	[Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Xiao-Na; Chen, Jia-Jie; Wang, Le-Xun; Xiao, Ruo-Zhi; Liu, Ling-Ling; Fang, Zhi-Gang; Liu, Quentin; Long, Zi-Jie; Lin, Dong-Jun] Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Long, ZJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China.	longzij@mail.sysu.edu.cn; lindj@mail.sysu.edu.cn	liu, xiaoyun/GXV-0330-2022	liu, xiaoyun/0000-0002-5425-7456	Science and Technology Project of Guangzhou [2012J2200077]; Fundamental Research Funds for the Central Universities [11ykpy37]	Science and Technology Project of Guangzhou; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Science and Technology Project of Guangzhou (No. 2012J2200077 to Z.-J. Long), and the Fundamental Research Funds for the Central Universities (No. 11ykpy37 to Z.-J. Long). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Citro G, 1998, CANCER RES, V58, P283; Civenni G, 2013, CANCER RES, V73, P6816, DOI 10.1158/0008-5472.CAN-13-0615; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Estey EH, 2013, AM J HEMATOL, V88, P317, DOI 10.1002/ajh.23404; FIELD JK, 1990, ANTICANCER RES, V10, P1; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Funato T, 2004, EXPERT REV MOL DIAGN, V4, P705, DOI 10.1586/14737159.4.5.705; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Knapp DC, 2003, ANTI-CANCER DRUG, V14, P39, DOI 10.1097/00001813-200301000-00006; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Liu L, 2012, BIOCHEM BIOPH RES CO, V425, P368, DOI 10.1016/j.bbrc.2012.07.098; Liu LL, 2013, MOL CANCER RES, V11, P1326, DOI 10.1158/1541-7786.MCR-13-0172; Long Y, 2013, MOL CANCER THER, V12, P2581, DOI 10.1158/1535-7163.MCT-13-0302; Magri L., 2014, NEUROSCIENCE; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mink S, 1996, P NATL ACAD SCI USA, V93, P6635, DOI 10.1073/pnas.93.13.6635; Nair R, 2013, ONCOGENE; Negoro E, 2011, INT J ONCOL, V38, P911, DOI 10.3892/ijo.2011.933; Nielsen DL, 2004, DAN MED BULL, V51, P393; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Roderick JE, 2014, BLOOD, V123, P1040, DOI 10.1182/blood-2013-08-522698; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Walker TL, 1996, BRIT J CANCER, V73, P610, DOI 10.1038/bjc.1996.105; Wong Rebecca S Y, 2012, Malays J Pathol, V34, P77; Yu L, 2013, ASIAN PAC J TROP MED, V6, P473, DOI 10.1016/S1995-7645(13)60077-2; Zeng DF, 2014, EUR REV MED PHARMACO, V18, P537	38	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105381	10.1371/journal.pone.0105381	http://dx.doi.org/10.1371/journal.pone.0105381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127121	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300107
J	Gilley, DC				Gilley, David C.			Hydrocarbons Emitted by Waggle-Dancing Honey Bees Increase Forager Recruitment by Stimulating Dancing	PLOS ONE			English	Article							STINGLESS BEE; FOOD SOURCES; SCENT MARKS; INFORMATION-FLOW; FLORAL ODORS; COMMUNICATION; BUMBLEBEES; HYMENOPTERA; PHEROMONE; BEHAVIOR	Hydrocarbons emitted by waggle-dancing honey bees are known to reactivate experienced foragers to visit known food sources. This study investigates whether these hydrocarbons also increase waggle-dance recruitment by observing recruitment and dancing behavior when the dance compounds are introduced into the hive. If the hydrocarbons emitted by waggle-dancing bees affect the recruitment of foragers to a food source, then the number of recruits arriving at a food source should be greater after introduction of dance compounds versus a pure-solvent control. This prediction was supported by the results of experiments in which recruits were captured at a feeder following introduction of dance-compounds into a hive. This study also tested two nonexclusive behavioral mechanism(s) by which the compounds might stimulate recruitment; 1) increased recruitment could occur by means of increasing the recruitment effectiveness of each dance and/or 2) increased recruitment could occur by increasing the intensity of waggle-dancing. These hypotheses were tested by examining video records of the dancing and recruitment behavior of individually marked bees following dance-compound introduction. Comparisons of numbers of dance followers and numbers of recruits per dance and waggle run showed no significant differences between dance-compound and solvent-control introduction, thus providing no support for the first hypothesis. Comparison of the number of waggle-dance bouts and the number of waggle runs revealed significantly more dancing during morning dance-compound introduction than morning solvent-control introduction, supporting the second hypothesis. These results suggest that the waggle-dance hydrocarbons play an important role in honey bee foraging recruitment by stimulating foragers to perform waggle dances following periods of inactivity.	William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA		Gilley, DC (corresponding author), William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA.	gilleyd@wpunj.edu			Center for Research, College of Science and Health, William Paterson University of New Jersey; Assigned Release Time Program of William Paterson University	Center for Research, College of Science and Health, William Paterson University of New Jersey; Assigned Release Time Program of William Paterson University	This research was supported by grants from the Center for Research, College of Science and Health, William Paterson University of New Jersey, and by the Assigned Release Time Program of William Paterson University. Erin Crehan Raza Elias, Roy Feliciano, Brian Johnson, Jessika Santamaria, employed by the William Paterson University College of Science and Health, helped collect and analyze the data for this research. Field experiments were conducted on land owned by LANXESS Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2007, NATURWISSENSCHAFTEN, V94, P218, DOI 10.1007/s00114-006-0176-0; Beekman M, 2005, J COMP PHYSIOL A, V191, P1115, DOI 10.1007/s00359-005-0033-1; Biesmeijer JC, 2004, APIDOLOGIE, V35, P143, DOI 10.1051/apido:2004003; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; CAMERON SA, 1981, BEHAV ECOL SOCIOBIOL, V9, P257, DOI 10.1007/BF00299880; Diaz PC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1589, DOI 10.1007/s00265-007-0391-5; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 2003, APIDOLOGIE, V34, P87, DOI 10.1051/apido:2002045; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; FERGUSON AW, 1979, J APICULT RES, V18, P128, DOI 10.1080/00218839.1979.11099956; Fernandez PC, 2001, INSECT SOC, V48, P366, DOI 10.1007/PL00001793; Free J. B., 1987, PHEROMONES SOCIAL BE; FREE JB, 1972, BEHAVIOUR, V41, P314, DOI 10.1163/156853972X00086; FREE JB, 1983, J APICULT RES, V22, P86, DOI 10.1080/00218839.1983.11100564; FREE JB, 1982, J APICULT RES, V21, P151, DOI 10.1080/00218839.1982.11100532; Gilley DC, 2012, APIDOLOGIE, V43, P85, DOI 10.1007/s13592-011-0080-2; GIURFA M, 1993, INSECT SOC, V40, P59, DOI 10.1007/BF01338832; GOULD JL, 1970, SCIENCE, V169, P544, DOI 10.1126/science.169.3945.544; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Goulson D, 2001, J INSECT BEHAV, V14, P669, DOI 10.1023/A:1012231419067; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Hrncir M, 2004, APIDOLOGIE, V35, P3, DOI 10.1051/apido:2003069; Jarau S, 2004, J CHEM ECOL, V30, P793, DOI 10.1023/B:JOEC.0000028432.29759.ed; KERR WE, 1994, J INSECT BEHAV, V7, P123, DOI 10.1007/BF01989832; Kirchner WH, 1998, J INSECT BEHAV, V11, P169, DOI 10.1023/A:1021098405564; LINDAUER M, 1971, AM NAT, V105, P89, DOI 10.1086/282708; LINDAUER M., 1960, BEE WORLD, V41, P29; Nieh JC, 2004, BEHAV ECOL SOCIOBIOL, V56, P435, DOI 10.1007/s00265-004-0804-7; OLDHAM NJ, 1994, PHYSIOL ENTOMOL, V19, P115, DOI 10.1111/j.1365-3032.1994.tb01084.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Renner MA, 2008, INSECT SOC, V55, P417, DOI 10.1007/s00040-008-1021-6; Ribbands C. R., 1954, Proceedings of the Royal Entomological Society of London (A), V29, P141; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Schmitt T, 2007, APIDOLOGIE, V38, P164, DOI 10.1051/apido:2006067; Schmitt U., 1991, Chemoecology, V2, P35, DOI 10.1007/BF01240664; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; Seeley TD, 1998, APIDOLOGIE, V29, P67, DOI 10.1051/apido:19980104; Stout JC, 1998, BEHAV ECOL SOCIOBIOL, V43, P317, DOI 10.1007/s002650050497; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; VALLET A, 1991, J INSECT PHYSIOL, V37, P789, DOI 10.1016/0022-1910(91)90076-C; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1967, SCIENCE, V158, P1072; WENNER AM, 1969, SCIENCE, V164, P84, DOI 10.1126/science.164.3875.84; West B. T., 2006, LINEAR MIXED MODELS, P180	49	10	11	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105671	10.1371/journal.pone.0105671	http://dx.doi.org/10.1371/journal.pone.0105671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140740	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200119
J	Iosub, D; Laniado, D; Castillo, C; Morell, MF; Kaltenbrunner, A				Iosub, Daniela; Laniado, David; Castillo, Carlos; Morell, Mayo Fuster; Kaltenbrunner, Andreas			Emotions under Discussion: Gender, Status and Communication in Online Collaboration	PLOS ONE			English	Article							LANGUAGE USE; SPEECH	Background: Despite the undisputed role of emotions in teamwork, not much is known about the make-up of emotions in online collaboration. Publicly available repositories of collaboration data, such as Wikipedia editor discussions, now enable the large-scale study of affect and dialogue in peer production. Methods: We investigate the established Wikipedia community and focus on how emotion and dialogue differ depending on the status, gender, and the communication network of the approximate to 12,000 editors who have written at least 100 comments on the English Wikipedia's article talk pages. Emotions are quantified using a word-based approach comparing the results of two predefined lexicon-based methods: LIWC and SentiStrength. Principal Findings: We find that administrators maintain a rather neutral, impersonal tone, while regular editors are more emotional and relationship-oriented, that is, they use language to form and maintain connections to other editors. A persistent gender difference is that female contributors communicate in a manner that promotes social affiliation and emotional connection more than male editors, irrespective of their status in the community. Female regular editors are the most relationship-oriented, whereas male administrators are the least relationship-focused. Finally, emotional and linguistic homophily is prevalent: editors tend to interact with other editors having similar emotional styles (e. g., editors expressing more anger connect more with one another). Conclusions/Significance: Emotional expression and linguistic style in online collaboration differ substantially depending on the contributors' gender and status, and on the communication network. This should be taken into account when analyzing collaborative success, and may prove insightful to communities facing gender gap and stagnation in contributor acquisition and participation levels.	[Iosub, Daniela] Univ Cologne, Cologne Grad Sch, D-50931 Cologne, Germany; [Laniado, David; Kaltenbrunner, Andreas] Barcelona Media Fdn, Social Media Res Grp, Barcelona, Spain; [Castillo, Carlos] Qatar Comp Res Inst, Doha, Qatar; [Morell, Mayo Fuster] Berkman Ctr, Cambridge, MA USA	University of Cologne; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute	Kaltenbrunner, A (corresponding author), Barcelona Media Fdn, Social Media Res Grp, Barcelona, Spain.	andreas.kaltenbrunner@barcelonamedia.org	Castillo, Carlos/E-4752-2016; Laniado, David/G-7552-2016; Kaltenbrunner, Andreas/A-7301-2016	Castillo, Carlos/0000-0003-4544-0416; Laniado, David/0000-0003-4574-0881; Kaltenbrunner, Andreas/0000-0002-2271-3066; Castillo, Carlos/0000-0002-1218-0454; Fuster Morell, Mayo/0000-0002-2708-3016				Anagnostopoulos A., 2008, P 14 ACM SIGKDD INT, P7, DOI DOI 10.1145/1401890.1401897; [Anonymous], 2014, WIKIPEDIA TALK PAGE; Bales R. F., 1958, READINGS SOCIAL PSYC, P437; Barrett K. C., 1987, HDB INFANT DEV, P555, DOI DOI 10.1177/0272431613483005; Bass B, 1990, BASS STOGDILLS HANDB; Bass BM, 1997, AM PSYCHOL, V52, P130, DOI 10.1037/0003-066X.52.2.130; Benkler Y., 2006, WEALTH NETWORKS SOCI; Bowers D. G., 1966, ADM SCI Q, V11, P238, DOI DOI 10.2307/2391247; Brebner J, 2003, PERS INDIV DIFFER, V34, P387, DOI 10.1016/S0191-8869(02)00059-4; Chee B, 2010, SICKNESS AND HEALTH; Cheshire C, 2008, J COMPUT-MEDIAT COMM, V13, P705, DOI 10.1111/j.1083-6101.2008.00416.x; Chung C, 2007, FRONT SOC PSYCHOL, P343; Collier Benjamin, 2012, P ACM 2012 C COMP SU, P383, DOI [10.1145/2145204.2145265, DOI 10.1145/2145204.2145265]; Collins R., 1990, RES AGENDAS SOCIOLOG, P27; Counts S., 2013, P 2013 C COMP SUPP C, P303, DOI [10.1145/2441776.2441812, DOI 10.1145/2441776.2441812]; Cristian Danescu-Niculescu-Mizil, 2012, P 21 INT C WORLD WID, P699, DOI DOI 10.1145/2187836.2187931; Danescu-Niculescu-Mizil C., 2013, P 22 INT C WORLD WID, P307, DOI DOI 10.1145/2488388.2488416; Davidov D., 2010, P 14 C COMP NAT LANG, P107; Dino A, 2009, J LANG SOC PSYCHOL, V28, P85, DOI 10.1177/0261927X08325916; Durkheim E, 1893, THE DIVISION OF LABO; ERICKSON B, 1978, J EXP SOC PSYCHOL, V14, P266, DOI 10.1016/0022-1031(78)90015-X; Farrell H, 2008, ETHICS INT AFF, V22, P357; Forte A, 2013, AMERICAN BEHAVIORAL, V57; Goldspink C, 2008, SOCIAL SELF REGULATI; Hancock JT, 2010, BEHAV SCI TERROR POL, V2, P108, DOI 10.1080/19434471003597415; Hara N, 2010, J AM SOC INF SCI TEC, V61, P2097, DOI 10.1002/asi.21373; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hersey P, 1981, TRAINING DEVELOPMENT, V36; Hill B, 2013, WORKING PAPER; Hill BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065782; Izard C.E., 2000, HDB EMOTIONS, V2, P253; Joyce E, 2006, JOURNAL OF COMPUTER, V11; Keltner D, 2008, ADV EXP SOC PSYCHOL, V40, P151, DOI 10.1016/S0065-2601(07)00003-2; Kittur A, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P215; Kivran-Swaine F., 2012, P ACM 2012 C COMPUTE, P139; Kucuktunc O., 2012, P 5 ACM INT C WEB SE, P633, DOI DOI 10.1145/2124295.2124371; Lang PJ, 1999, TECHNICAL REPORT C 1; Laniado D, 2012, WIKISYM, P9; Laniado D., 2011, P ICWSM, P177; Laniado D., 2011, P 22 ACM C HYP HYP E, P201, DOI DOI 10.1145/1995966.1995994; Leaper C, 2007, PERS SOC PSYCHOL REV, V11, P328, DOI 10.1177/1088868307302221; Mehl MR, 2003, J PERS SOC PSYCHOL, V84, P857, DOI 10.1037/0022-3514.84.4.857; MULAC A, 1990, SEX ROLES, V23, P439, DOI 10.1007/BF00289762; MULAC A, 1994, LANG COMMUN, V14, P299, DOI 10.1016/0271-5309(94)90007-8; Mulac A, 2001, HUM COMMUN RES, V27, P121, DOI 10.1093/hcr/27.1.121; Mullen B, 2008, JOURNAL OF EXPERIMEN, V45, P211; Neff JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060584; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Ng S, 1993, POWER IN LANGUAGE VE; Okoli C, 2012, SSRN ELIBRARY; PANCIERA K, 2009, P ACM 2009 INT C SUP, P51, DOI DOI 10.1145/1531674.1531682; Pennebaker J, 2010, TECHNICAL REPORT; Pfitzner R., 2012, 6 INT AAAI C WEBL SO, P543; Reagle J., 2010, GOOD FAITH COLLABORA; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Scholand AJ, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P23; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Thelwall M., 2010, FIRST MONDAY, V15; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Thomson R, 2001, BRIT J SOC PSYCHOL, V40, P193, DOI 10.1348/014466601164812; Tsur Oren, 2010, 4 INT AAAI C WEBL SO; Viegas F. B., 2007, P 40 ANN HAW INT C S, P78, DOI DOI 10.1109/HICSS.2007.511; Wang Yi-Chia, 2012, P ACM 2012 C COMP SU, P833, DOI [10.1145/2145204.2145329, DOI 10.1145/2145204.2145329]; WEGNER DM, 1978, J PERS SOC PSYCHOL, V36, P147, DOI 10.1037/0022-3514.36.2.147; Weintraub W, 2003, PSYCHOL ASSESSMENT P, P137; Wikimedia Foundation, 2011, EDITOR SURVEY; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]; Zhu H., 2012, P ASS COMPUTING MACH, DOI DOI 10.1145/2145204.2145269; Zhu HY, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3431	70	29	29	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104880	10.1371/journal.pone.0104880	http://dx.doi.org/10.1371/journal.pone.0104880			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140870	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200039
J	Rejno, G; Lundholm, C; Gong, T; Larsson, K; Saltvedt, S; Almqvist, C				Rejno, Gustaf; Lundholm, Cecilia; Gong, Tong; Larsson, Kjell; Saltvedt, Sissel; Almqvist, Catarina			Asthma during Pregnancy in a Population-Based Study Pregnancy Complications and Adverse Perinatal Outcomes	PLOS ONE			English	Article							MATERNAL ASTHMA; ANTIASTHMATIC DRUGS; INTRAUTERINE GROWTH; WOMEN; SEVERITY; RISK; EXACERBATIONS; VALIDATION; DISEASE; RACE	Background: Asthma is one of the most common chronic diseases, and prevalence, severity and medication may have an effect on pregnancy. We examined maternal asthma, asthma severity and control in relation to pregnancy complications, labour characteristics and perinatal outcomes. Methods: We retrieved data on all singleton births from July 1, 2006 to December 31, 2009, and prescribed drugs and physician-diagnosed asthma on the same women from multiple Swedish registers. The associations were estimated with logistic regression. Results: In total, 266 045 women gave birth to 284 214 singletons during the study period. Maternal asthma was noted in 26 586 (9.4%) pregnancies. There was an association between maternal asthma and increased risks of pregnancy complications including preeclampsia or eclampsia (adjusted OR 1.15; 95% CI 1.06-1.24) and premature contractions (adj OR 1.52; 95% CI 1.29-1.80). There was also a significant association between maternal asthma and emergency caesarean section (adj OR 1.29; 95% CI 1.23-1.34), low birth weight, and small for gestational age (adj OR 1.23; 95% CI 1.13-1.33). The risk of adverse outcomes such as low birth weight increased with increasing asthma severity. For women with uncontrolled compared to those with controlled asthma the results for adverse outcomes were inconsistent displaying both increased and decreased OR for some outcomes. Conclusion: Maternal asthma is associated with a number of serious pregnancy complications and adverse perinatal outcomes. Some complications are even more likely with increased asthma severity. With greater awareness and proper management, outcomes would most likely improve.	[Rejno, Gustaf; Lundholm, Cecilia; Gong, Tong; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Rejno, Gustaf] Soder Sjukhuset, Obstet & Gynaecol Unit, Stockholm, Sweden; [Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Saltvedt, Sissel] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Saltvedt, Sissel] Karolinska Univ Hosp, Obstet & Gynaecol Unit, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rejno, G (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	gustaf.rejno@ki.se	Rejnö, Gustaf/N-7198-2014; Gong, Tong/HDM-8653-2022	Rejnö, Gustaf/0000-0002-8095-5629; Lundholm, Cecilia/0000-0002-6546-3650	Stockholm County Council; Karolinska Institutet; Swedish Research Council [2011-3060]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]; Swedish Heart-Lung Foundation; Strategic Research Program in Epidemiology at Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Strategic Research Program in Epidemiology at Karolinska Institutet	This work was supported by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (http://www.forskningsstod.sll.se), the Swedish Research Council (http://www.vr.se/) [grant number 2011-3060] and through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework (http://simsam.nu/) [grant number 340-2013-5867], the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/), and the Strategic Research Program in Epidemiology at Karolinska Institutet (http://ki.se/en/research/the-strategic-research-programme-in-epidemiology-sfoepi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; Aly H, 2011, EARLY HUM DEV, V87, P457, DOI 10.1016/j.earlhumdev.2011.03.007; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; BAHNA SL, 1972, ACTA ALLERGOL, V27, P397, DOI 10.1111/j.1398-9995.1972.tb01439.x; Borthen I, 2011, BJOG-INT J OBSTET GY, V118, P956, DOI 10.1111/j.1471-0528.2011.03004.x; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Clifton VL, 2009, AUST NZ J OBSTET GYN, V49, P619, DOI 10.1111/j.1479-828X.2009.01077.x; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; DOUCETTE JT, 1993, EPIDEMIOLOGY, V4, P143, DOI 10.1097/00001648-199303000-00010; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; Getahun D, 2006, AM J OBSTET GYNECOL, V195, P1180, DOI 10.1016/j.ajog.2006.07.027; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P363, DOI 10.1007/s00228-006-0257-1; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P375, DOI 10.1007/s00228-006-0258-0; KRAMER MS, 1995, AM J EPIDEMIOL, V142, P1078, DOI 10.1093/oxfordjournals.aje.a117561; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; Linton A, 2004, BIRTH-ISS PERINAT C, V31, P165, DOI 10.1111/j.0730-7659.2004.00301.x; Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Manderbacka K, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-16; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Namazy JA, 2013, EUR RESPIR J, V41, P1082, DOI 10.1183/09031936.00195111; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; SCHATZ M, 1990, CHEST, V98, P389, DOI 10.1378/chest.98.2.389; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Sorensen TK, 2003, ANN EPIDEMIOL, V13, P267, DOI 10.1016/S1047-2797(02)00413-1; Stephansson O, 2010, INFLAMM BOWEL DIS; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stephansson O, 2010, CLIN GASTROENTEROL H, V8, P509, DOI 10.1016/j.cgh.2010.02.014; Swedish National Board of Health and Welfare, 2003, SWED MED BIRTH REG S; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; Ungar WJ, 2002, AM J RESP CRIT CARE, V165, P190, DOI 10.1164/ajrccm.165.2.2102012; Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	43	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104755	10.1371/journal.pone.0104755	http://dx.doi.org/10.1371/journal.pone.0104755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141021	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200032
J	Rojas-Villarraga, A; Torres-Gonzalez, JV; Ruiz-Sternberg, AM				Rojas-Villarraga, Adriana; Torres-Gonzalez, July-Vianneth; Ruiz-Sternberg, Angela-Maria			Safety of Hormonal Replacement Therapy and Oral Contraceptives in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PREMATURE OVARIAN FAILURE; ESTROGEN PLUS PROGESTIN; RISK-FACTORS; SEX-HORMONES; T-CELL; CARDIOVASCULAR EVENTS; POSTMENOPAUSAL WOMEN; SJOGRENS-SYNDROME; DISEASE-ACTIVITY; GLOMERULONEPHRITIS	Background: There is conflicting data regarding exogenous sex hormones [oral contraceptives (OC) and hormonal replacement therapy (HRT)] exposure and different outcomes on Systemic Lupus Erythematosus (SLE). The aim of this work is to determine, through a systematic review and meta-analysis the risks associated with estrogen use for women with SLE as well as the association of estrogen with developing SLE. Methods and Findings: MEDLINE, EMBASE, SciElo, BIREME and the Cochrane library (1982 to July 2012), were databases from which were selected and reviewed (PRISMA guidelines) randomized controlled trials, cross-sectional, case-control and prospective or retrospective nonrandomized, comparative studies without language restrictions. Those were evaluated by two investigators who extracted information on study characteristics, outcomes of interest, risk of bias and summarized strength of evidence. A total of 6,879 articles were identified; 20 full-text articles were included. Thirty-two meta-analyses were developed. A significant association between HRT exposure (Random model) and an increased risk of developing SLE was found (Rate Ratio: 1.96; 95%-CI: 1.51-2.56; P-value < 0.001). One of eleven meta-analyses evaluating the risk for SLE associated with OC exposure had a marginally significant result. There were no associations between HRT or OC exposure and specific outcomes of SLE. It was not always possible to Meta-analyze all the available data. There was a wide heterogeneity of SLE outcome measurements and estrogen therapy administration. Conclusion: An association between HRT exposure and SLE causality was observed. No association was found when analyzing the risk for SLE among OC users, however since women with high disease activity/Thromboses or antiphospholipid-antibodies were excluded from most of the studies, caution should be exercised in interpreting the present results. To identify risk factors that predispose healthy individuals to the development of SLE who are planning to start HRT or OC is suggested.	[Rojas-Villarraga, Adriana] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia; [Torres-Gonzalez, July-Vianneth] Univ Rosario, Sch Med & Hlth Sci, Med Social Serv Provis Mandatory, Bogota, Colombia; [Ruiz-Sternberg, Angela-Maria] Univ Rosario, Sch Med & Hlth Sci, Dept Invest Grp Invest Clin, Bogota, Colombia	Universidad del Rosario; Universidad del Rosario; Universidad del Rosario	Rojas-Villarraga, A (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.	adrirojas@gmail.com	Ruiz-Sternberg, Angela María/J-1073-2016; Rojas-Villarraga, Adriana/T-7070-2018; Rojas-Villarraga, Adriana/J-2404-2016	Ruiz-Sternberg, Angela María/0000-0002-4651-4635; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Torres-Gonzalez, July/0000-0001-7311-2132				Ackerman LS, 2006, ARCH DERMATOL, V142, P371, DOI 10.1001/archderm.142.3.371; ALEKBEROVA ZS, 1990, TERAPEVT ARKH, V62, P17; Anaya JM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3175; ARDEN NK, 1994, LUPUS, V3, P11, DOI 10.1177/096120339400300104; Beretta L, 2006, SCAND J RHEUMATOL, V35, P468, DOI 10.1080/03009740600844498; Bernier MO, 2009, ARTHRIT RHEUM-ARTHR, V61, P476, DOI 10.1002/art.24398; Bhatia SS, 2007, ANN RHEUM DIS, V66, P267, DOI 10.1136/ard.2006.060004; Blockeel C, 2012, REPROD BIOMED ONLINE, V24, P272, DOI 10.1016/j.rbmo.2011.11.012; Borenstein M, 2009, INTRO METAANALYSIS, DOI [10.1002/9780470743386, DOI 10.1002/9780470743386]; Buyon J P, 1995, J Clin Rheumatol, V1, P205, DOI 10.1097/00124743-199508000-00002; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Capellino S, 2008, CLIN EXP RHEUMATOL, V26, P903; CARLSTEN H, 1991, J AUTOIMMUN, V4, P845, DOI 10.1016/0896-8411(91)90048-H; Choojitarom K, 2008, CLIN RHEUMATOL, V27, P345, DOI 10.1007/s10067-007-0721-z; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; Costenbader KH, 2007, ARTHRITIS RHEUM-US, V56, P1251, DOI 10.1002/art.22510; Cravioto MD, 2011, ARTHRIT CARE RES, V63, P1654, DOI 10.1002/acr.20608; Culwell KR, 2009, OBSTET GYNECOL, V114, P341, DOI 10.1097/AOG.0b013e3181ae9c64; Cutolo M, 2008, RHEUMATOLOGY, V47, P2, DOI 10.1093/rheumatology/ken150; D'Onofrio F, 2006, INT J IMMUNOPATH PH, V19, P445, DOI 10.1177/039463200601900222; Darroch JE, 2013, CONTRACEPTION, V87, P259, DOI 10.1016/j.contraception.2012.08.029; Fernandez M, 2007, JCR-J CLIN RHEUMATOL, V13, P261, DOI 10.1097/RHU.0b013e318156bbf5; Gompel A, 2007, Menopause Int, V13, P65, DOI 10.1258/175404507780796433; GRIMES DA, 1985, AM J OBSTET GYNECOL, V153, P179, DOI 10.1016/0002-9378(85)90108-5; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Herrington DM, 2002, CIRCULATION, V105, P2962, DOI 10.1161/01.CIR.0000019406.74017.B2; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hochman J, 2009, LUPUS, V18, P313, DOI 10.1177/0961203308097475; Hodis HN, 2012, CLIMACTERIC, V15, P217, DOI 10.3109/13697137.2012.656401; Howick J., 2011, 2011 OXFORD CEBM LEV; Jiang B, 2008, IMMUNOL INVEST, V37, P227, DOI 10.1080/08820130801973328; Julkunen H, 2000, SCAND J RHEUMATOL, V29, P146, DOI 10.1080/030097400750002003; JULKUNEN HA, 1993, BRIT J RHEUMATOL, V32, P227; Kiani AN, 2010, J RHEUMATOL, V37, P579, DOI 10.3899/jrheum.090824; Kipp M, 2012, FRONT NEUROENDOCRIN, V33, P1, DOI 10.1016/j.yfrne.2012.01.001; Kreidstein S, 1997, J RHEUMATOL, V24, P2149; Lakasing L, 2001, J FAM PLAN REPROD H, V27, P7, DOI 10.1783/147118901101195029; Li Raymond H. W., 2011, Hong Kong Medical Journal, V17, P487; Li Y, 2010, INTERNAL MED, V49, P611, DOI 10.2169/internalmedicine.49.2737; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; MASI AT, 1978, ARTHRITIS RHEUM-US, V21, P480, DOI 10.1002/art.1780210413; McMurray RW, 2003, ARTHRITIS RHEUM-US, V48, P2100, DOI 10.1002/art.11105; Medeiros PB, 2009, LUPUS, V18, P38, DOI 10.1177/0961203308094652; Meier CR, 1998, J RHEUMATOL, V25, P1515; Mok CC, 1999, ARTHRITIS RHEUM, V42, P1274, DOI 10.1002/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B; Mok CC, 1998, SCAND J RHEUMATOL, V27, P342, DOI 10.1080/03009749850154357; Mostafa S, 2012, EXP EYE RES, V96, P88, DOI 10.1016/j.exer.2011.12.016; Nagy G, 2005, CRIT REV IMMUNOL, V25, P123, DOI 10.1615/CritRevImmunol.v25.i2.30; Onel K, 2004, J THROMB HAEMOST, V2, P670, DOI 10.1111/j.1538-7836.2004.00644.x; Panay Nick, 2012, Menopause Int, V18, P90, DOI 10.1258/mi.2012.012019; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Sanchez-Guerrero J, 2005, NEW ENGL J MED, V353, P2539, DOI 10.1056/NEJMoa050817; Sanchez-Guerrero J, 1999, ARTHRITIS RHEUM, V42, pS71, DOI [10.1002/art.1780422107, DOI 10.1002/ART.1780422107]; Sanchez-Guerrero J, 2007, ARTHRITIS RHEUM-US, V56, P3070, DOI 10.1002/art.22855; SanchezGuerrero J, 1997, ARTHRITIS RHEUM, V40, P804, DOI 10.1002/art.1780400505; SANCHEZGUERRERO J, 1995, ANN INTERN MED, V122, P430, DOI 10.7326/0003-4819-122-6-199503150-00005; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Schwartzman-Morris J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/604892; Schwarz EB, 2006, NEW ENGL J MED, V354, P1203; Shabanova SS, 2008, CLIN EXP RHEUMATOL, V26, P436; Silva CAA, 2007, LUPUS, V16, P531, DOI 10.1177/0961203307079300; Somers EC, 2005, ARTHRITIS RHEUM-US, V52, P2761, DOI 10.1002/art.21263; Somogyi A, 1998, ADVERSE DRUG REACT T, V17, P63; Steinberg A D, 1978, Arthritis Rheum, V21, pS190, DOI 10.1002/art.1780210932; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; STROM BL, 1994, AM J EPIDEMIOL, V140, P632, DOI 10.1093/oxfordjournals.aje.a117302; TALAL N, 1987, J RHEUMATOL, V14, P21; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tartagni M, 2011, MENOPAUSE, V18, P932, DOI 10.1097/gme.0b013e31820dc48d; Vinet E, 2010, INT J CLIN RHEUMTOL, V5, P169; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Zonana-Nacach A, 2002, SALUD PUBLICA MEXICO, V44, P213, DOI 10.1590/S0036-36342002000300004	80	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104303	10.1371/journal.pone.0104303	http://dx.doi.org/10.1371/journal.pone.0104303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137236	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100025
J	Suria, S; Wyniecki, A; Eghiaian, A; Monnet, X; Weil, G				Suria, Stephanie; Wyniecki, Anne; Eghiaian, Alexandre; Monnet, Xavier; Weil, Gregoire			Measurement of Cardiac Index by Transpulmonary Thermodilution Using an Implanted Central Venous Access Port: A Prospective Study in Patients Scheduled for Oncologic High-Risk Surgery	PLOS ONE			English	Article							COMPLICATIONS; CATHETER; METAANALYSIS; ABILITY	Background: Transpulmonary thermodilution allows the measurement of cardiac index for high risk surgical patients. Oncologic patients often have a central venous access (port-a-catheter) for chronic treatment. The validity of the measurement by a port-a-catheter of the absolute cardiac index and the detection of changes in cardiac index induced by fluid challenge are unknown. Methods: We conducted a monocentric prospective study. 27 patients were enrolled. 250 ml colloid volume expansions for fluid challenge were performed during ovarian cytoreductive surgery. The volume expansion-induced changes in cardiac index measured by transpulmonary thermodilution by a central venous access (CIcvc) and by a port-a-catheter (CIport) were recorded. Results: 23 patients were analyzed with 123 pairs of measurements. Using a Bland and Altman for repeated measurements, the bias (lower and upper limits of agreement) between CIport and CIcvc was 0.14 (-0.59 to 0.88) L/min/m(2). The percentage error was 22%. The concordance between the changes in CIport and CIcvc observed during volume expansion was 92% with an r = 0.7 (with exclusion zone). No complications (included sepsis) were observed during the follow up period. Conclusions: The transpulmonary thermodilution by a port-a-catheter is reliable for absolute values estimation of cardiac index and for measurement of the variation after fluid challenge.	[Suria, Stephanie; Wyniecki, Anne; Eghiaian, Alexandre; Weil, Gregoire] Gustave Roussy, Serv Anesthesie, Villejuif, France; [Monnet, Xavier] Hop Bicetre, Serv Reanimat Med, Le Kremlin Bicetre, France; [Monnet, Xavier] Univ Paris 11, Unite Rech EA4533, Le Kremlin Bicetre, France	UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Suria, S (corresponding author), Gustave Roussy, Serv Anesthesie, Villejuif, France.	stephanie.suria@gustaveroussy.fr		Weil, Gregoire/0000-0001-6967-1054; MONNET, Xavier/0000-0001-6820-2678	Edwards Lifesciences	Edwards Lifesciences	S. Suria has received congress funding for ISICEM 2012 from Edwards Lifesciences. X. Monnet is a member of the Medical Advisory Board of Pulsion Medical Systems. G. Weil has received congress funding for ISICEM 2012 from Edwards Lifescience. A. Wyniecki and A. Eghiaian declare that no competing interests exist. The authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Belda FJ, 2011, BRIT J ANAESTH, V106, P482, DOI 10.1093/bja/aeq377; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Cannesson M, 2009, ANESTH ANALG, V108, P513, DOI 10.1213/ane.0b013e318192a36b; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Furuya EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015452; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Macht S, 2012, EUR J RADIOL, V81, P1883, DOI 10.1016/j.ejrad.2011.04.043; Marik PE, 2012, CRIT CARE MED, V40, P2479, DOI 10.1097/CCM.0b013e318255d9bc; Monnet X, 2011, CRIT CARE, V15, DOI 10.1186/cc10421; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Pagano L, 1997, HAEMATOLOGICA, V82, P415; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9; Rafii A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039415; Ruesch S, 2002, CRIT CARE MED, V30, P454, DOI 10.1097/00003246-200202000-00031; Sakka SG, 2012, J CLIN MONIT COMPUT, V26, P347, DOI 10.1007/s10877-012-9378-5; Tsai YF, 2012, EUR SURG RES, V49, P66, DOI 10.1159/000339308; Vincent JL, 2012, J CLIN MONIT COMPUT, V26, P341, DOI 10.1007/s10877-012-9389-2	19	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104369	10.1371/journal.pone.0104369	http://dx.doi.org/10.1371/journal.pone.0104369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136951	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100030
J	Zhu, L; Yang, K; Wang, XE; Wang, X; Wang, CC				Zhu, Li; Yang, Kai; Wang, Xi'e; Wang, Xi; Wang, Chih-chen			A Novel Reaction of Peroxiredoxin 4 towards Substrates in Oxidative Protein Folding	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; REDOX HOMEOSTASIS; ISOMERASE; PEROXIDE; IV; REDUCTASE; DOMAINS; PATHWAY; CELLS	Peroxiredoxin 4 (Prx4) is the only endoplasmic reticulum localized peroxiredoxin. It functions not only to eliminate peroxide but also to promote oxidative protein folding via oxidizing protein disulfide isomerase (PDI). In Prx4-mediated oxidative protein folding we discovered a new reaction that the sulfenic acid form of Prx4 can directly react with thiols in folding substrates, resulting in non-native disulfide cross-linking and aggregation. We also found that PDI can inhibit this reaction by exerting its reductase and chaperone activities. This discovery discloses an off-pathway reaction in the Prx4-mediated oxidative protein folding and the quality control role of PDI.	[Zhu, Li; Yang, Kai; Wang, Xi'e; Wang, Xi; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhu, Li; Yang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, X (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	wangxi@moon.ibp.ac.cn; chihwang@sun5.ibp.ac.cn	Yang, Kai S./AAC-9906-2021	Yang, Kai S./0000-0002-1890-4169	Chinese Ministry of Science and Technology [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31370758]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB910303 and 2012CB911002, http://www.most.gov.cn) and the National Natural Science Foundation of China (31370758, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Chng SS, 2012, MOL MICROBIOL, V85, P996, DOI 10.1111/j.1365-2958.2012.08157.x; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	30	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105529	10.1371/journal.pone.0105529	http://dx.doi.org/10.1371/journal.pone.0105529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137134	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100105
J	Klevebring, D; Neiman, M; Sundling, S; Eriksson, L; Ramqvist, ED; Celebioglu, F; Czene, K; Hall, P; Egevad, L; Gronberg, H; Lindberg, J				Klevebring, Daniel; Neiman, Marten; Sundling, Simon; Eriksson, Louise; Ramqvist, Eva Darai; Celebioglu, Fuat; Czene, Kamila; Hall, Per; Egevad, Lars; Groenberg, Henrik; Lindberg, Johan			Evaluation of Exome Sequencing to Estimate Tumor Burden in Plasma	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; CANCER; DNA; MUTATIONS; DISCOVERY; ALIGNMENT	Accurate estimation of systemic tumor load from the blood of cancer patients has enormous potential. One avenue is to measure the presence of cell-free circulating tumor DNA in plasma. Various approaches have been investigated, predominantly covering hotspot mutations or customized, patient-specific assays. Therefore, we investigated the utility of using exome sequencing to monitor circulating tumor DNA levels through the detection of single nucleotide variants in plasma. Two technologies, claiming to offer efficient library preparation from nanogram levels of DNA, were evaluated. This allowed us to estimate the proportion of starting molecules measurable by sequence capture (<5%). As cell-free DNA is highly fragmented, we designed and provide software for efficient identification of PCR duplicates in single-end libraries with a varying size distribution. On average, this improved sequence coverage by 38% in comparison to standard tools. By exploiting the redundant information in PCR-duplicates the background noise was reduced to similar to 1/35000. By applying our optimized analysis pipeline to a simulation analysis, we determined the current sensitivity limit to similar to 1/2400, starting with 30 ng of cell-free DNA. Subsequently, circulating tumor DNA levels were assessed in seven breast-and one prostate cancer patient. One patient carried detectable levels of circulating tumor DNA, as verified by break-point specific PCR. These results demonstrate exome sequencing on cell-free DNA to be a powerful tool for disease monitoring of metastatic cancers. To enable a broad implementation in the diagnostic settings, the efficiency limitations of sequence capture and the inherent noise levels of the Illumina sequencing technology must be further improved.	[Klevebring, Daniel; Neiman, Marten; Sundling, Simon; Eriksson, Louise; Lindberg, Johan] Karolinska Inst, Sci Life Lab, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ramqvist, Eva Darai; Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Celebioglu, Fuat] Dept Clin Sci & Educ, Stockholm, Sweden; [Czene, Kamila; Hall, Per; Groenberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Lindberg, J (corresponding author), Karolinska Inst, Sci Life Lab, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	johan.lindberg@ki.se		Lindberg, Johan/0000-0003-3610-6774; Czene, Kamila/0000-0002-3233-5695	Linnaeus Cancer Risk Prediction Center [70867902]; AstraZeneca Translational Research Center	Linnaeus Cancer Risk Prediction Center; AstraZeneca Translational Research Center	This study was supported by the Linnaeus Cancer Risk Prediction Center (grant number 70867902) and the AstraZeneca Translational Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2009, CLIN CHEM, V55, P730, DOI 10.1373/clinchem.2008.113597; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Neiman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048616; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; St John J, SEQPREP; Team R.C, R LANG ENV STAT COMP; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	29	21	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104417	10.1371/journal.pone.0104417	http://dx.doi.org/10.1371/journal.pone.0104417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133800	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700028
J	Pena, EJ; Ferriol, I; Sambade, A; Buschmann, H; Niehl, A; Elena, SF; Rubio, L; Heinlein, M				Pena, Eduardo Jose; Ferriol, Inmaculada; Sambade, Adrian; Buschmann, Henrik; Niehl, Annette; Elena, Santiago F.; Rubio, Luis; Heinlein, Manfred			Experimental Virus Evolution Reveals a Role of Plant Microtubule Dynamics and TORTIFOLIA1/SPIRAL2 in RNA Trafficking	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ARABIDOPSIS CORTICAL MICROTUBULES; MOVEMENT PROTEIN; CELL-WALLS; TRANSGENIC PLANTS; HELICAL GROWTH; COAT PROTEIN; ORGANIZATION; COMPLEXES; INFECTION	The cytoskeleton is a dynamic network composed of filamentous polymers and regulatory proteins that provide a flexible structural scaffold to the cell and plays a fundamental role in developmental processes. Mutations that alter the spatial orientation of the cortical microtubule (MT) array of plants are known to cause important changes in the pattern of cell wall synthesis and developmental phenotypes; however, the consequences of such alterations on other MT-network-associated functions in the cytoplasm are not known. In vivo observations suggested a role of cortical MTs in the formation and movement of Tobacco mosaic virus (TMV) RNA complexes along the endoplasmic reticulum (ER). Thus, to probe the significance of dynamic MT behavior in the coordination of MT-network-associated functions related to TMV infection and, thus, in the formation and transport of RNA complexes in the cytoplasm, we performed an evolution experiment with TMV in Arabidopsis thaliana tor1/spr2 and tor2 mutants with specific defects in MT dynamics and asked whether TMV is sensitive to these changes. We show that the altered cytoskeleton induced genetic changes in TMV that were correlated with efficient spread of infection in the mutant hosts. These observations demonstrate a role of dynamic MT rearrangements and of the MT-associated protein TORTIFOLIA1/SPIRAL2 in cellular functions related to virus spread and indicate that MT dynamics and MT-associated proteins represent constraints for virus evolution and adaptation. The results highlight the importance of the dynamic plasticity of the MT network in directing cytoplasmic functions in macromolecular assembly and trafficking and illustrate the value of experimental virus evolution for addressing the cellular functions of dynamic, long-range order systems in multicellular organisms.	[Pena, Eduardo Jose; Heinlein, Manfred] CNRS, Inst Biol Mol Plantes, UPR2357, F-67084 Strasbourg, France; [Ferriol, Inmaculada; Rubio, Luis] Inst Valenciano Invest Agr, Moncada, Spain; [Sambade, Adrian] Univ Valencia, CIBERNED, Inst Cavanilles Biodiversitat & Biol Evolut, Dept Comparat Neurobiol, Valencia, Spain; [Buschmann, Henrik] Univ Osnabruck, Inst Bot, Osnabruck, Germany; [Niehl, Annette; Heinlein, Manfred] Univ Basel, Dept Environm Sci Plant Physiol, Basel, Switzerland; [Elena, Santiago F.] CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Instituto Valenciano de Investigaciones Agrarias (IVIA); CIBERNED; University of Valencia; University Osnabruck; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Rubio, L (corresponding author), Inst Valenciano Invest Agr, Moncada, Spain.	lrubio@ivia.es; manfred.heinlein@ibmp-cnrs.unistra.fr	Ferriol, Inmaculada/T-3950-2017; Rubio, Luis/H-7810-2012; Elena, Santiago F./A-4191-2011	Ferriol, Inmaculada/0000-0003-0111-7537; Rubio, Luis/0000-0002-7964-3062; Elena, Santiago F./0000-0001-8249-5593	Agence National de la Recherche (ANR) [ANR-08-BLAN-244]; Swiss National Science Foundation (SNF) [310031A_140694]; EMBO; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain; Spanish Ministry of Science and Education [AGL2005-07754]; Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2012-30805]	Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO)); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain; Spanish Ministry of Science and Education(Spanish Government); Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion	Work of E.P. and of A.N. was supported by grants from the Agence National de la Recherche (ANR, grant ANR-08-BLAN-244) and the Swiss National Science Foundation (SNF, grant 310031A_140694) to M. H. We also acknowledge the funding of an EMBO short-term fellowship to H. B. I. F. was supported by a pre-doctoral fellowship from the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) from Spain. L. R. was supported by grant AGL2005-07754 from the Spanish Ministry of Science and Education and S. F. E. by grant BFU2012-30805 from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose C, 2013, DEV CELL, V24, P649, DOI 10.1016/j.devcel.2013.02.007; Ashby J, 2006, J VIROL, V80, P8329, DOI 10.1128/JVI.00540-06; Asurmendi S, 2004, P NATL ACAD SCI USA, V101, P1415, DOI 10.1073/pnas.0307778101; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; Boyko V, 2007, PLANT J, V51, P589, DOI 10.1111/j.1365-313X.2007.03163.x; Brandner K, 2008, PLANT PHYSIOL, V147, P611, DOI 10.1104/pp.108.117481; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Buschmann H, 2009, PLANT CELL, V21, P2090, DOI 10.1105/tpc.108.061242; Buschmann H, 2008, MOL PLANT, V1, P888, DOI 10.1093/mp/ssn060; Chan J, 2010, J CELL SCI, V123, P3490, DOI 10.1242/jcs.074641; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Debreczeni DE, 2011, J VIROL METHODS, V176, P32, DOI 10.1016/j.jviromet.2011.05.027; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; DEOM CM, 1990, P NATL ACAD SCI USA, V87, P3284, DOI 10.1073/pnas.87.9.3284; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Ferralli J, 2006, J VIROL, V80, P5807, DOI 10.1128/JVI.00254-06; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; Herzog E, 1998, VIROLOGY, V248, P312, DOI 10.1006/viro.1998.9287; Hirashima K, 2001, J VIROL, V75, P8831, DOI 10.1128/JVI.75.18.8831-8836.2001; HOLT CA, 1991, VIROLOGY, V181, P109, DOI 10.1016/0042-6822(91)90475-Q; Ketelaar T, 2004, FEBS LETT, V567, P302, DOI 10.1016/j.febslet.2004.04.088; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Lloyd C, 2011, INT REV CEL MOL BIO, V287, P287, DOI 10.1016/B978-0-12-386043-9.00007-4; Mansilla C, 2009, MOL PLANT PATHOL, V10, P59, DOI 10.1111/j.1364-3703.2008.00506.x; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niehl A, 2013, PLANT J, V75, P290, DOI 10.1111/tpj.12134; Niehl A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22865; Niehl A, 2012, PLANT PHYSIOL, V160, P2093, DOI 10.1104/pp.112.207399; Oda Y, 2013, CURR OPIN PLANT BIOL, V16, P743, DOI 10.1016/j.pbi.2013.10.010; OSBOURN JK, 1990, VIROLOGY, V179, P921, DOI 10.1016/0042-6822(90)90169-R; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pena EJ, 2013, CURR OPIN PLANT BIOL, V16, P764, DOI 10.1016/j.pbi.2013.10.002; Sambade A, 2008, TRAFFIC, V9, P2073, DOI 10.1111/j.1600-0854.2008.00824.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Wu S, 2013, PLANT J, V74, P148, DOI 10.1111/tpj.12112; Yao M, 2008, J CELL SCI, V121, P2372, DOI 10.1242/jcs.030221	49	8	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105364	10.1371/journal.pone.0105364	http://dx.doi.org/10.1371/journal.pone.0105364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133612	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700105
J	Arnold, T; Freundlich, G; Weilnau, T; Verdi, A; Tibbetts, IR				Arnold, Thomas; Freundlich, Grace; Weilnau, Taylor; Verdi, Arielle; Tibbetts, Ian R.			Impacts of Groundwater Discharge at Myora Springs (North Stradbroke Island, Australia) on the Phenolic Metabolism of Eelgrass, Zostera muelleri, and Grazing by the Juvenile Rabbitfish, Siganus fuscescens	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; WASTING DISEASE; ELEVATED CO2; MORETON BAY; LIGHT-INTENSITY; CARBON-DIOXIDE; CAFFEIC ACID; GROWTH; CHEMISTRY; LEAVES	Myora Springs is one of many groundwater discharge sites on North Stradbroke Island (Queensland, Australia). Here spring waters emerge from wetland forests to join Moreton Bay, mixing with seawater over seagrass meadows dominated by eelgrass, Zostera muelleri. We sought to determine how low pH /high CO2 conditions near the spring affect these plants and their interactions with the black rabbitfish (Siganus fuscescens), a co-occurring grazer. In paired-choice feeding trials S. fuscescens preferentially consumed Z. muelleri shoots collected nearest to Myora Springs. Proximity to the spring did not significantly alter the carbon and nitrogen contents of seagrass tissues but did result in the extraordinary loss of soluble phenolics, including Folin-reactive phenolics, condensed tannins, and phenolic acids by >= 87%. Conversely, seagrass lignin contents were, in this and related experiments, unaffected or increased, suggesting a shift in secondary metabolism away from the production of soluble, but not insoluble, (poly)phenolics. We suggest that groundwater discharge sites such as Myora Springs, and other sites characterized by low pH, are likely to be popular feeding grounds for seagrass grazers seeking to reduce their exposure to soluble phenolics.	[Arnold, Thomas; Freundlich, Grace; Weilnau, Taylor; Verdi, Arielle] Dickinson Coll, Biochem & Mol Biol Program, Carlisle, PA 17013 USA; [Tibbetts, Ian R.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Dickinson College; University of Queensland	Arnold, T (corresponding author), Dickinson Coll, Biochem & Mol Biol Program, Carlisle, PA 17013 USA.	arnoldt@dickinson.edu	Tibbetts, Ian/K-6191-2013	Tibbetts, Ian/0000-0002-1481-238X; Freundlich, Grace/0000-0002-1784-4416	Dickinson College's Research and Development Committee and Center for Sustainability Education [NASA 09-GCCE-0139]; Smithsonian Institution	Dickinson College's Research and Development Committee and Center for Sustainability Education; Smithsonian Institution(Smithsonian Institution)	Support was provided by grants from Dickinson College's Research and Development Committee and Center for Sustainability Education (NASA 09-GCCE-0139) and by a Smithsonian Institution senior postdoctoral fellowship to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIN DE, 1995, ANIM FEED SCI TECH, V53, P29, DOI 10.1016/0377-8401(94)00736-S; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; ARNOLD TM, 1995, MAR ECOL PROG SER, V123, P177, DOI 10.3354/meps123177; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Brand-Gardner SJ, 1999, AUST J ZOOL, V47, P181, DOI 10.1071/ZO98065; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Coley PD, 2002, OECOLOGIA, V133, P62, DOI 10.1007/s00442-002-1005-6; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cseke LJ, 2009, NEW PHYTOL, V182, P891, DOI 10.1111/j.1469-8137.2009.02812.x; Cuttriss AK, 2013, AQUAT BOT, V108, P41, DOI 10.1016/j.aquabot.2013.03.003; de los Santos CB, 2012, MAR ECOL PROG SER, V458, P89, DOI 10.3354/meps09757; Den Hartog C., 1996, SEAGRASS BIOL, P307; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Flamarique IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2490; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Grabber JH, 2003, J AGR FOOD CHEM, V51, P4984, DOI 10.1021/jf030027c; Grice AM, 1996, J EXP MAR BIOL ECOL, V195, P91, DOI 10.1016/0022-0981(95)00096-8; Hagerman AE, 1986, PLANT FLAVONOIDS BIO, P67; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Lanyon J.M., 1989, BIOL SEAGRASSES TREA, P610; Laylock JT, 1975, N STRADBROKE ISLAND; Leach L. M., 2011, Proceedings of the Royal Society of Queensland, V117, P21; Limpus Colin J., 1994, Memoirs of the Queensland Museum, V35, P139; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Luo ZB, 2008, PLANT SOIL, V304, P45, DOI 10.1007/s11104-007-9518-8; Luo ZB, 2009, GLOBAL CHANGE BIOL, V15, P38, DOI 10.1111/j.1365-2486.2008.01768.x; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Mathger LM, 2007, COPEIA, P169; Mattson WJ, 2005, OIKOS, V111, P337, DOI 10.1111/j.0030-1299.2005.13634.x; MCMILLAN C, 1984, AQUAT BOT, V20, P351, DOI 10.1016/0304-3770(84)90099-8; Meehan TD, 2010, SOIL BIOL BIOCHEM, V42, P1132, DOI 10.1016/j.soilbio.2010.03.019; Migliore L, 2012, MEDITERRANEAN SEAGRA; Moss P., 2011, Proceedings of the Royal Society of Queensland, V117, P133; MUEHLSTEIN LK, 1992, CAN J BOT, V70, P2081, DOI 10.1139/b92-258; Natural Resources and Water, 2006, HYDR N STARDBR ISL; Pauly M., 2010, JOVE-J VIS EXP, V37, P1745, DOI [10.3791/1745, DOI 10.3791/1745]; Penuelas J, 1997, PHOTOSYNTHETICA, V33, P313, DOI 10.1023/A:1022120431279; Penuelas J, 1998, TRENDS ECOL EVOL, V13, P20, DOI 10.1016/S0169-5347(97)01235-4; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; QUACKENBUSH RC, 1986, AQUAT BOT, V24, P83, DOI 10.1016/0304-3770(86)90119-1; RAVN H, 1989, BIOCHEM SYST ECOL, V17, P175, DOI 10.1016/0305-1978(89)90076-8; RAVN H, 1994, OPHELIA, V40, P51, DOI 10.1080/00785326.1994.10429550; Steele L, 2005, MAR ECOL PROG SER, V303, P123, DOI 10.3354/meps303123; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Udy JW, 1997, MAR FRESHWATER RES, V48, P605, DOI 10.1071/MF97001; VALIELA I, 1979, NATURE, V280, P55, DOI 10.1038/280055a0; Valkama E, 2007, GLOBAL CHANGE BIOL, V13, P184, DOI 10.1111/j.1365-2486.2006.01284.x; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Vizzini S, 2010, J ECOL, V98, P1284, DOI 10.1111/j.1365-2745.2010.01730.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WENG HT, 1990, ESTUAR COAST SHELF S, V30, P569, DOI 10.1016/0272-7714(90)90093-7; YOUNG P C, 1975, Aquatic Botany, V1, P191, DOI 10.1016/0304-3770(75)90022-4; ZAPATA O, 1979, AQUAT BOT, V7, P307, DOI 10.1016/0304-3770(79)90032-9; [No title captured]	73	17	17	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104738	10.1371/journal.pone.0104738	http://dx.doi.org/10.1371/journal.pone.0104738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127379	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300045
J	da Hora, BT; de Macedo, DM; Barreto, RW; Evans, HC; Mattos, CRR; Maffia, LA; Mizubuti, ESG				da Hora Junior, Braz Tavares; de Macedo, Davi Mesquita; Barreto, Robert Weingart; Evans, Harry C.; Reis Mattos, Carlos Raimundo; Maffia, Luiz Antonio; Mizubuti, Eduardo S. G.			Erasing the Past: A New Identity for the Damoclean Pathogen Causing South American Leaf Blight of Rubber	PLOS ONE			English	Article							RIBOSOMAL DNA; MYCOSPHAERELLA; PHYLOGENY; MICROCYCLUS; SEQUENCE; TREE; PLANISTROMELLACEAE; MORPHOLOGY; BIOLOGY; SPOT	Background: South American leaf blight (SALB) of rubber has been the main constraint to production in its neotropical centre of origin since commercial plantations were first established. The fungal causal agent was identified and described more than a century ago but its precise placement within the Ascomycota still remains uncertain. Indeed, such is the ambiguity surrounding the pathogen that each of the spore morphs would, according to their present classification, be placed in different ascomycete families: the Microcyclus sexual morph in the Planistromellaceae and the two purported asexual morphs - Fusicladium and Aposphaeria - in the Venturiaceae and Lophiostomataceae, respectively. Given the historical importance of the fungus and the ever-menacing threat that it poses to rubber production in the Palaeotropics and, thus to the rubber industry and to the global economy - its phylogeny, as well as its biology, should be resolved as a matter of urgency. Methods and Results: Here, six genomic regions (LSU rRNA, mtSSU, MCM7, EF-1 alpha, Act and ITS) were used for reconstructing the molecular phylogeny of the SALB fungus based on material collected throughout Brazil. The analyses support the classification of the fungus in the family Mycosphaerellaceae s. str. (Capnodiales, Dothideomycetes) and place it firmly within the clade Pseudocercospora s. str., now accepted as one of the distinct genera within Mycosphaerellaceae. The new combination Pseudocercospora ulei is proposed and the life cycle of the fungus is confirmed, based on both experimental and phylogenetic evidence, with the Aposphaeria morph shown to have a spermatial rather than an infective-dispersal function. Conclusions: Because the phylogeny of the SALB fungus has now been clarified, new insights of its epidemiology and genomics can be gained following comparison with closely-related, better-researched crop pathogens.	[da Hora Junior, Braz Tavares; de Macedo, Davi Mesquita; Barreto, Robert Weingart; Evans, Harry C.; Maffia, Luiz Antonio; Mizubuti, Eduardo S. G.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Evans, Harry C.] CAB Int, E UK Ctr, Egham, Surrey, England; [Reis Mattos, Carlos Raimundo] Plantacoes Michelin Bahia, Itubera, Bahia, Brazil	Universidade Federal de Vicosa; Michelin	Mizubuti, ESG (corresponding author), Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil.	mizubuti@ufv.br	Mizubuti, Eduardo/C-3578-2013	Mizubuti, Eduardo/0000-0001-9612-5155	Plantacoes Michelin da Bahia	Plantacoes Michelin da Bahia	The work was funded by Plantacoes Michelin da Bahia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FUNGAL DATABASES; Barr ME, 1996, MYCOTAXON, V60, P433; Beck Andreas, 2005, Mycological Progress, V4, P111, DOI 10.1007/s11557-006-0114-8; Bonorden HF, 1851, HDB ALLGEMEINEN MYKO; Braun Uwe, 2002, Mycological Progress, V1, P19, DOI 10.1007/s11557-006-0002-2; CANNON PF, 1995, MYCOL RES, V99, P353, DOI 10.1016/S0953-7562(09)80912-X; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; CHEE KH, 1986, MALAYSIAN RUBBER RES, V13; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Crous PW, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.58.01; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Crous PW, 2009, PERSOONIA, V23, P99, DOI 10.3767/003158509X479487; Crous PW, 2006, STUD MYCOL, P163, DOI 10.3114/sim.55.1.163; Crous PW, 2004, STUD MYCOL, P19; Crous PW, 2001, MYCOLOGIA, V93, P1081, DOI 10.2307/3761670; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; Davis W, 1997, ONE RIVER SCI ADVENT; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DRING D. M., 1961, TRANS BRIT MYCOL SOC, V44, P253; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson Ove E., 1993, Systema Ascomycetum, V12, P51; Evans H. C., 2002, Tropical mycology: volume 2, micromycetes, P83, DOI 10.1079/9780851995434.0083; Evans HC, 1984, MYCOL PAP, V153, P1; Ferraris T, 1912, FLORA ITALICA CRYPTO, V6, P195; Gasparotto L, 1997, DOENCAS SERINGUERIA; Grandin Greg, 2009, FORDLANDIA RISE FALL; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guyot J, 2014, PLANT PATHOL, V63, P510, DOI 10.1111/ppa.12126; Guyot J, 2010, J PLANT PATHOL, V92, P765; Halle F., 1968, Adansonia, V8, P475; Hennings P, 1904, NOTIZBL BOT GART MUS, V4, P133; Higgins BB, 1920, AM J BOT, V7, P435, DOI 10.2307/2440939; HOLLIDAY P., 1970, Phytopathological Papers; HUGHES SJ, 1953, CAN J BOT, V31, P560, DOI 10.1139/b53-045; INMAN AJ, 1991, MYCOL RES, V95, P1334, DOI 10.1016/S0953-7562(09)80586-8; JUNQUEIRA NTV, 1988, PESQUI AGROPECU BRAS, V23, P877; Junqueira NTV., 1984, REV CERES, V31, P322; Kirk PM., 2008, DICT FUNGI, V10th ed; Langford Michael, 1945, TECHNICAL B USDA, V882, P1; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; LIBERATO JR, 2009, BLACK SIGATOKA BANAN; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Lindau G, 1907, RABENSHORSTS KRYPTOG; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Minnis AM, 2012, PERSOONIA, V29, P11, DOI 10.3767/003158512X658766; Money N.P., 2007, TRIUMPH FUNG ROTT; Mugambi GK, 2009, STUD MYCOL, P103, DOI 10.3114/sim.2009.64.05; Muller E, 1962, FLORA SCHWEIZ, V11, P1; Nylander JAA., 2004, MRMODELTEST V 2 2 PR; Rambaut A., 2007, TRACER V1 4; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SACCARDO PA, 1897, SYLLOGE FUNGORUM, V12; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schubert K., 2003, SCHLECHTENDALIA, V9, P1; SNYDER WC, 1946, PHYTOPATHOLOGY, V36, P481; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Verkley GJM, 2004, MYCOLOGIA, V96, P558, DOI 10.2307/3762175; Verkley GJM, 2004, MYCOL RES, V108, P1271, DOI 10.1017/S0953756204001054; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; von Arx J.A., 1975, STUD MYCOL, V9, P1, DOI DOI 10.2307/3758851; VONARX JA, 1983, P K NED AKAD C BIOL, V86, P15; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wingfield MJ, 2012, MOL PLANT PATHOL, V13, P604, DOI 10.1111/j.1364-3703.2011.00768.x; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhang Y, 2011, FUNGAL DIVERS, V51, P249, DOI 10.1007/s13225-011-0141-x	70	34	34	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104750	10.1371/journal.pone.0104750	http://dx.doi.org/10.1371/journal.pone.0104750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126853	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300048
J	Kiti, MC; Kinyanjui, TM; Koech, DC; Munywoki, PK; Medley, GF; Nokes, DJ				Kiti, Moses Chapa; Kinyanjui, Timothy Muiruri; Koech, Dorothy Chelagat; Munywoki, Patrick Kiio; Medley, Graham Francis; Nokes, David James			Quantifying Age-Related Rates of Social Contact Using Diaries in a Rural Coastal Population of Kenya	PLOS ONE			English	Article							MIXING PATTERNS; DISEASE TRANSMISSION; INFECTIOUS-DISEASES; PANDEMIC INFLUENZA; SPREAD; NETWORKS; RELEVANT; MODELS; IMPACT	Background: Improved understanding and quantification of social contact patterns that govern the transmission dynamics of respiratory viral infections has utility in the design of preventative and control measures such as vaccination and social distancing. The objective of this study was to quantify an age-specific matrix of contact rates for a predominantly rural low-income population that would support transmission dynamic modeling of respiratory viruses. Methods and Findings: From the population register of the Kilifi Health and Demographic Surveillance System, coastal Kenya, 150 individuals per age group (<1, 1-5, 6-15, 16-19, 20-49, 50 and above, in years) were selected by stratified random sampling and requested to complete a day long paper diary of physical contacts (e. g. touch or embrace). The sample was stratified by residence (rural-to-semiurban), month (August 2011 to January 2012, spanning seasonal changes in socio-cultural activities), and day of week. Usable diary responses were obtained from 568 individuals (similar to 50% of expected). The mean number of contacts per person per day was 17.7 (95% CI 16.7-18.7). Infants reported the lowest contact rates (mean 13.9, 95% CI 12.1-15.7), while primary school students (6-15 years) reported the highest (mean 20.1, 95% CI 18.0-22.2). Rates of contact were higher within groups of similar age (assortative), particularly within the primary school students and adults (20-49 years). Adults and older participants (>50 years) exhibited the highest inter-generational contacts. Rural contact rates were higher than semiurban (18.8 vs 15.6, p = 0.002), with rural primary school students having twice as many assortative contacts as their semiurban peers. Conclusions and Significance: This is the first age-specific contact matrix to be defined for tropical Sub-Saharan Africa and has utility in age-structured models to assess the potential impact of interventions for directly transmitted respiratory infections.	[Kiti, Moses Chapa; Kinyanjui, Timothy Muiruri; Koech, Dorothy Chelagat; Munywoki, Patrick Kiio; Nokes, David James] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Kinyanjui, Timothy Muiruri; Medley, Graham Francis; Nokes, David James] Univ Warwick, WIDER, Coventry CV4 7AL, W Midlands, England; [Medley, Graham Francis; Nokes, David James] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Kiti, MC (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	mkiti@kemri-wellcome.org	Kinyanjui, Timothy/S-8489-2019; Munywoki, Patrick K./GQP-4775-2022; Medley, Graham/B-7289-2008; Kiti, Moses Chapa/ABE-8183-2020; Kiti, Moses Chapa/I-1175-2015	Munywoki, Patrick K./0000-0001-9419-7155; Medley, Graham/0000-0002-0030-7278; Kiti, Moses Chapa/0000-0003-2338-9170; Kiti, Moses Chapa/0000-0003-2338-9170; Kinyanjui, Timothy/0000-0001-5461-4946; Koech, Dorothy/0000-0001-8971-3485	Welcome Trust [084633, 098556]	Welcome Trust(Wellcome Trust)	This work was supported by the Welcome Trust, http://www.wellcome.ac.uk/, grant numbers 084633 (DJN) and 098556 (MCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Collins PL, 2007, RESP SYNCYTIAL VIRUS, P233; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GRIMWOOD K, 1983, BRIT MED J, V287, P575, DOI 10.1136/bmj.287.6392.575; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P10, DOI 10.1111/dewb.12014; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Molyneux CS, 2002, ENVIRON URBAN, V14, P203, DOI 10.1177/095624780201400117; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Munywoki PK, 2014, J INFECT DIS, V26, P26; Nair H, 2010, LANCET; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Smith PG, 1992, METHODS FILED TRIALS, P42; Towers S, 2012, J THEOR BIOL, V312, P87, DOI 10.1016/j.jtbi.2012.07.023; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	28	67	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104786	10.1371/journal.pone.0104786	http://dx.doi.org/10.1371/journal.pone.0104786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127257	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000340879300052
J	Kumar, JD; Holmberg, C; Kandola, S; Steele, I; Hegyi, P; Tiszlavicz, L; Jenkins, R; Beynon, RJ; Peeney, D; Giger, OT; Alqahtani, A; Wang, TC; Charvat, TT; Penfold, M; Dockray, GJ; Varro, A				Kumar, J. Dinesh; Holmberg, Chris; Kandola, Sandhir; Steele, Islay; Hegyi, Peter; Tiszlavicz, Laszlo; Jenkins, Rosalind; Beynon, Robert J.; Peeney, David; Giger, Olivier T.; Alqahtani, Ahlam; Wang, Timothy C.; Charvat, Trevor T.; Penfold, Mark; Dockray, Graham J.; Varro, Andrea			Increased Expression of Chemerin in Squamous Esophageal Cancer Myofibroblasts and Role in Recruitment of Mesenchymal Stromal Cells	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; STEM-CELLS; MATRIX METALLOPROTEINASE-7; HELICOBACTER-PYLORI; TUMOR PROGRESSION; DENDRITIC CELLS; FIBROBLASTS; GROWTH; MIGRATION; MICROENVIRONMENT	Stromal cells such as myofibroblasts influence tumor progression. The mechanisms are unclear but may involve effects on both tumor cells and recruitment of bone marrow-derived mesenchymal stromal cells (MSCs) which then colonize tumors. Using iTRAQ and LC-MS/MS we identified the adipokine, chemerin, as overexpressed in esophageal squamous cancer associated myofibroblasts (CAMs) compared with adjacent tissue myofibroblasts (ATMs). The chemerin receptor, ChemR23, is expressed by MSCs. Conditioned media (CM) from CAMs significantly increased MSC cell migration compared to ATM-CM; the action of CAM-CM was significantly reduced by chemerin-neutralising antibody, pretreatment of CAMs with chemerin siRNA, pretreatment of MSCs with ChemR23 siRNA, and by a ChemR23 receptor antagonist, CCX832. Stimulation of MSCs by chemerin increased phosphorylation of p42/44, p38 and JNK-II kinases and inhibitors of these kinases and PKC reversed chemerin-stimulated MSC migration. Chemerin stimulation of MSCs also induced expression and secretion of macrophage inhibitory factor (MIF) that tended to restrict migratory responses to low concentrations of chemerin but not higher concentrations. In a xenograft model consisting of OE21 esophageal cancer cells and CAMs, homing of MSCs administered i.v. was inhibited by CCX832. Thus, chemerin secreted from esophageal cancer myofibroblasts is a potential chemoattractant for MSCs and its inhibition may delay tumor progression.	[Kumar, J. Dinesh; Holmberg, Chris; Kandola, Sandhir; Steele, Islay; Peeney, David; Giger, Olivier T.; Alqahtani, Ahlam; Dockray, Graham J.; Varro, Andrea] Univ Liverpool, Dept Cell & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Hegyi, Peter] Univ Szeged, Dept Med & Surg, Szeged, Hungary; [Jenkins, Rosalind] Univ Liverpool, Inst Translat Med, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England; [Tiszlavicz, Laszlo] Univ Szeged, Dept Pathol, Szeged, Hungary; [Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Charvat, Trevor T.; Penfold, Mark] ChemoCentryx, Mountain View, CA USA; [Wang, Timothy C.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA	University of Liverpool; Szeged University; University of Liverpool; Szeged University; University of Liverpool; Columbia University	Varro, A (corresponding author), Univ Liverpool, Dept Cell & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	avarro@liverpool.ac.uk	Kumar, Jothi Dinesh/I-6168-2019; Varro, Andras/M-2647-2016; Peeney, David/AAG-7448-2021; Beynon, Robert/K-1408-2014	Kumar, Jothi Dinesh/0000-0003-1086-0509; Wang, Timothy/0000-0001-5730-3019; Beynon, Robert/0000-0003-0857-495X; Peeney, David/0000-0002-9126-9923	Cancer Research UK; NIHR; National Institute of Health/NCI [5U54CA126513]; Hungarian Scientific Research Fund [NF100677]; Wellcome Trust; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); National Institute of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Research UK (AV), NIHR (AV), National Institute of Health/NCI (5U54CA126513, TCW, AV) and Hungarian Scientific Research Fund (NF100677, PH), Wellcome Trust (AV, CH, SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; De Boeck A, 2013, PROTEOMICS, V13, P379, DOI 10.1002/pmic.201200179; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Hemers E, 2005, CANCER RES, V65, P7363, DOI 10.1158/0008-5472.CAN-05-0157; Ho IAW, 2013, HISTOL HISTOPATHOL, V28, P1427, DOI 10.14670/HH-28.1427; Holmberg C, 2012, CARCINOGENESIS, V33, P1553, DOI 10.1093/carcin/bgs180; Holmberg C, 2013, J PROTEOME RES, V12, P3413, DOI 10.1021/pr400270q; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lin W, 2011, CLIN LAB, V57, P879; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; McCaig C, 2006, GASTROENTEROLOGY, V130, P1754, DOI 10.1053/j.gastro.2006.02.031; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Quante M, 2009, NAT REV GASTRO HEPAT, V6, P724, DOI 10.1038/nrgastro.2009.195; Satija NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055769; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Smith H, 2012, STEM CELLS DEV, V21, P476, DOI 10.1089/scd.2011.0025; Somja J, 2013, AM J PATHOL, V182, P2168, DOI 10.1016/j.ajpath.2013.02.036; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Teo GSL, 2012, STEM CELLS, V30, P2472, DOI 10.1002/stem.1198; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; Wang CH, 2014, PEPTIDES, V51, P131, DOI 10.1016/j.peptides.2013.10.009; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Wu KC, 1999, GUT, V44, P323, DOI 10.1136/gut.44.3.323; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zheng Y, 2008, EUR J DERMATOL, V18, P638, DOI 10.1684/ejd.2008.0511	50	37	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104877	10.1371/journal.pone.0104877	http://dx.doi.org/10.1371/journal.pone.0104877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127029	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300058
J	Matsui, H; Fujimoto, N; Sasakawa, N; Ohinata, Y; Shima, M; Yamanaka, S; Sugimoto, M; Hotta, A				Matsui, Hideto; Fujimoto, Naoko; Sasakawa, Noriko; Ohinata, Yasuhide; Shima, Midori; Yamanaka, Shinya; Sugimoto, Mitsuhiko; Hotta, Akitsu			Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; LONG-TERM EXPRESSION; SLEEPING-BEAUTY; THERAPY; FVIII; MICE; CELLS	Viral vectors have been used for hemophilia A gene therapy. However, due to its large size, full-length Factor VIII ( FVIII) cDNA has not been successfully delivered using conventional viral vectors. Moreover, viral vectors may pose safety risks, e. g., adverse immunological reactions or virus-mediated cytotoxicity. Here, we took advantages of the non-viral vector gene delivery system based on piggyBac DNA transposon to transfer the full-length FVIII cDNA, for the purpose of treating hemophilia A. We tested the efficiency of this new vector system in human 293T cells and iPS cells, and confirmed the expression of the full-length FVIII in culture media using activity-sensitive coagulation assays. Hydrodynamic injection of the piggyBac vectors into hemophilia A mice temporally treated with an immunosuppressant resulted in stable production of circulating FVIII for over 300 days without development of anti-FVIII antibodies. Furthermore, tail-clip assay revealed significant improvement of blood coagulation time in the treated mice. piggyBac transposon vectors can facilitate the long-term expression of therapeutic transgenes in vitro and in vivo. This novel gene transfer strategy should provide safe and efficient delivery of FVIII.	[Matsui, Hideto; Sugimoto, Mitsuhiko] Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan; [Fujimoto, Naoko; Sasakawa, Noriko; Yamanaka, Shinya; Hotta, Akitsu] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Reprogramming Sci, Sakyo Ku, Kyoto, Japan; [Fujimoto, Naoko; Yamanaka, Shinya; Hotta, Akitsu] Kyoto Univ, iCeMS, Kyoto, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Life Sci Expt Facil, Kofu, Yamanashi, Japan; [Ohinata, Yasuhide; Hotta, Akitsu] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan; [Shima, Midori] Nara Med Univ, Kashihara, Nara 634, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Nara Medical University; Kyoto University; Kyoto University; University of Yamanashi; Japan Science & Technology Agency (JST); Nara Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Matsui, H (corresponding author), Nara Med Univ, Dept Regulatory Med Thrombosis, Kashihara, Nara 634, Japan.	hide-ped@naramed-u.ac.jp; akitsu.hotta@cira.kyoto-u.ac.jp	Wilson, Matthew H/K-3193-2013	Hotta, Akitsu/0000-0002-2619-7441	JSPS KAKENHI [25293237, 24591559, 22890088]; Bayer Hemophilia Awards Program; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Baxter Coagulation Research Fund; Grants-in-Aid for Scientific Research [25293237] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bayer Hemophilia Awards Program; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Baxter Coagulation Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 25293237 for HM, M. Shima, and AH, No. 24591559 for HM, No. 22890088 for AH), research grants from the Bayer Hemophilia Awards Program (http://www.bayer-hemophilia-awards.com/) (HM), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/) (HM), the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/) (AH), and the Baxter Coagulation Research Fund (http://baxter.co.jp/medical/grant/bhf/index.html) (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Cesana D, 2014, MOL THER; Chavez CL, 2012, HUM GENE THER, V23, P390, DOI 10.1089/hum.2011.110; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hackett PB, 2011, CURR GENE THER, V11, P341; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hu CH, 2011, P NATL ACAD SCI USA, V108, P2082, DOI 10.1073/pnas.1015571108; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; KAMISUE S, 1994, BRIT J HAEMATOL, V86, P106, DOI 10.1111/j.1365-2141.1994.tb03259.x; Kang YB, 2005, BLOOD, V106, P1552, DOI 10.1182/blood-2004-11-4358; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; Liras A, 2009, HAEMOPHILIA, V15, P811, DOI 10.1111/j.1365-2516.2009.02010.x; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lu H, 2008, HUM GENE THER, V19, P648, DOI 10.1089/hum.2007.0182; Matrai J, 2010, CURR OPIN HEMATOL, V17, P387, DOI 10.1097/MOH.0b013e32833cd4bd; Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699; Matsui H, 2011, MOL THER, V19, P723, DOI 10.1038/mt.2010.290; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohlfest JR, 2005, BLOOD, V105, P2691, DOI 10.1182/blood-2004-09-3496; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Petrus I, 2010, J GENE MED, V12, P797, DOI 10.1002/jgm.1500; Pipe SW, 2009, HAEMOPHILIA, V15, P1187, DOI 10.1111/j.1365-2516.2009.02026.x; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Reddy LH, 2011, J HEPATOL, V55, P1461, DOI 10.1016/j.jhep.2011.05.039; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; Suda T, 2008, MOL THER, V16, P1098, DOI 10.1038/mt.2008.66; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tatsumi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083280; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	43	36	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104957	10.1371/journal.pone.0104957	http://dx.doi.org/10.1371/journal.pone.0104957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126862	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300064
J	Corrochano, S; Renna, M; Osborne, G; Carter, S; Stewart, M; May, J; Bates, GP; Brown, SDM; Rubinsztein, DC; Acevedo-Arozena, A				Corrochano, Silvia; Renna, Maurizio; Osborne, Georgina; Carter, Sarah; Stewart, Michelle; May, Joel; Bates, Gillian P.; Brown, Steve D. M.; Rubinsztein, David C.; Acevedo-Arozena, Abraham			Reducing Igf-1r Levels Leads To Paradoxical and Sexually Dimorphic Effects in HD Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; HUNTINGTIN-INDUCED TOXICITY; MOUSE MODELS; MOLECULAR-MECHANISMS; REGULATE AUTOPHAGY; MUTANT HUNTINGTIN; TRANSGENIC MICE; SELF-DIGESTION; DISEASE; AKT	Many of the neurodegenerative diseases that afflict people in later life are associated with the formation of protein aggregates. These so-called "proteinopathies" include Alzheimer's disease (AD) and Huntington's disease (HD). The insulin/insulin-like growth factor signalling (IIS) pathway has been proposed to modulate such diseases in model organisms, as well as the general ageing process. In this pathway, insulin-like growth factor binds to insulin-like growth factor receptors, such as the insulin-like growth factor 1 receptor (IGF-1R). Heterozygous deletion of Igf-1r has been shown to lead to increased lifespan in mice. Reducing the activity of this pathway had benefits in a HD C. elegans model, and some of these may be attributed to the expected inhibition of mTOR activity resulting in an increase in autophagy, which would enhance mutant huntingtin clearance. Thus, we tested if heterozygous deletion of Igf-1r would lead to benefits in HD related phenotypes in the mouse. Surprisingly, reducing Igf-1r levels led to some beneficial effects in HD females, but also led to some detrimental effects in HD males. Interestingly, Igf-1r deficiency had no discernible effects on downstream mTOR signalling in HD mice. These results do not support a broad beneficial effect of diminishing the IIS pathway in HD pathology in a mammalian system.	[Corrochano, Silvia; Carter, Sarah; Stewart, Michelle; May, Joel; Brown, Steve D. M.; Acevedo-Arozena, Abraham] MRC Mammalian Genet Unit, Harwell, Oxon, England; [Renna, Maurizio; Rubinsztein, David C.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2QQ, England; [Osborne, Georgina; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England	MRC Harwell; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London	Acevedo-Arozena, A (corresponding author), MRC Mammalian Genet Unit, Harwell, Oxon, England.	a.acevedo@har.mrc.ac.uk	Arozena, Abraham Acevedo/L-6584-2018; Corrochano, Silvia/L-2687-2015; Rubinsztein, David C/C-3472-2011; Bates, Gillian/E-1146-2012	Arozena, Abraham Acevedo/0000-0001-6127-7116; Corrochano, Silvia/0000-0003-0958-0083; Osborne, Georgina/0000-0001-8308-3179; Renna, Maurizio/0000-0001-6522-1750; Bates, Gillian/0000-0002-4041-6305	Wellcome Trust; M.R.C. Programme Grant; CHDI Foundation; MRC [G0600194, MC_UP_A390_1106, MC_U142684172, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [MC_UP_A390_1106, MC_U142684172, 1330882, G0600194, MC_UP_1502/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); M.R.C. Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful for a Wellcome Trust Principal Fellowship in Clinical Science (DCR), an M.R.C. Programme Grant (DCR and SB), and the CHDI Foundation (GPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Burgunder JM, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-2; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Corrochano S, 2012, HUM MOL GENET, V21, P485, DOI 10.1093/hmg/ddr477; Duarte AI, 2011, EXP NEUROL, V231, P314, DOI 10.1016/j.expneurol.2011.06.016; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Gatchel JR, 2008, P NATL ACAD SCI USA, V105, P1291, DOI 10.1073/pnas.0711257105; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopes C, 2014, MOL NEUROBIOL, V49, P1126, DOI 10.1007/s12035-013-8585-5; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nadjar A, 2009, NEUROBIOL AGING, V30, P2021, DOI 10.1016/j.neurobiolaging.2008.02.009; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Renna M, 2013, HUM MOL GENET; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saleh N, 2010, NEUROLOGY, V75, P57, DOI 10.1212/WNL.0b013e3181e62076; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sobolewska A, 2009, EUR J CELL BIOL, V88, P117, DOI 10.1016/j.ejcb.2008.09.004; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; 1993, CELL, V72, P971	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105595	10.1371/journal.pone.0105595	http://dx.doi.org/10.1371/journal.pone.0105595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140802	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200110
J	Straub, C; Granger, AJ; Saulnier, JL; Sabatini, BL				Straub, Christoph; Granger, Adam J.; Saulnier, Jessica L.; Sabatini, Bernardo L.			CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; NMDA RECEPTORS; HUMAN-CELLS; GENOME; MICE; BRAIN; CAS9; SUPPRESSION; GENERATION	The prokaryotic adaptive immune system CRISPR/Cas9 has recently been adapted for genome editing in eukaryotic cells. This technique allows for sequence-specific induction of double-strand breaks in genomic DNA of individual cells, effectively resulting in knock-out of targeted genes. It thus promises to be an ideal candidate for application in neuroscience where constitutive genetic modifications are frequently either lethal or ineffective due to adaptive changes of the brain. Here we use CRISPR/Cas9 to knock-out Grin1, the gene encoding the obligatory NMDA receptor subunit protein GluN1, in a sparse population of mouse pyramidal neurons. Within this genetically mosaic tissue, manipulated cells lack synaptic current mediated by NMDA-type glutamate receptors consistent with complete knock-out of the targeted gene. Our results show the first proof-of-principle demonstration of CRISPR/Cas9-mediated knock-down in neurons in vivo, where it can be a useful tool to study the function of specific proteins in neuronal circuits.	[Straub, Christoph; Granger, Adam J.; Saulnier, Jessica L.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu		Granger, Adam/0000-0002-3953-6764	National Institute of Neurological Disorders and Stroke [NS077907]; Howard Hughes Medical Institute; DAAD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077907] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Neurological Disorders and Stroke NS077907; Howard Hughes Medical Institute; DAAD Postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen PE, 2009, LEARN MEMORY, V16, P635, DOI 10.1101/lm.1316909; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Granger AJ, 2011, J PHYSIOL-LONDON, V589, P4095, DOI 10.1113/jphysiol.2011.213033; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu X, 2014, NAT BIOTECHNOL; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	29	72	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105584	10.1371/journal.pone.0105584	http://dx.doi.org/10.1371/journal.pone.0105584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140704	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200109
J	Tai, WC; Lee, CH; Chiou, SS; Kuo, CM; Kuo, CH; Liang, CM; Lu, LS; Chiu, CH; Wu, KL; Chiu, YC; Hu, TH; Chuah, SK				Tai, Wei-Chen; Lee, Chen-Hsiang; Chiou, Shue-Shian; Kuo, Chung-Mou; Kuo, Chung-Huang; Liang, Chih-Ming; Lu, Lung-Sheng; Chiu, Chien-Hua; Wu, Keng-Liang; Chiu, Yi-Chun; Hu, Tsung-Hui; Chuah, Seng-Kee			The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication	PLOS ONE			English	Article							PROTON-PUMP INHIBITOR; SEQUENTIAL THERAPY; QUADRUPLE THERAPY; INFECTION; AMOXICILLIN; RESISTANCE; CLARITHROMYCIN; SUSCEPTIBILITY; METRONIDAZOLE; MULTICENTER	Quinolone has the disadvantage of easily acquired drug resistance. It is important to prescribe it wisely for a high eradication rate. The current study aimed to determine the clinical and bacteriological factors for optimal levofloxacin-containing triple therapies in second-line H. pylori eradication. We enrolled a total of 158 H. pylori-infected patients who failed H. pylori eradication using the 7-day standard triple therapy (proton-pump inhibitor [PPI] twice daily, 500 mg clarithromycin twice daily, and 1 g amoxicillin twice daily). They were prescribed with either a 10-day (group A) or 14-day (group B) levofloxacin-containing triple therapy group (levofloxacin 500 mg once daily, amoxicillin 1 g twice daily, and esomeprazole 40 mg twice daily for 10 days) by their clinicians. Follow-up studies to assess treatment responses were carried out 8 weeks later. The eradication rates attained by groups A and B were 73.6% (95% confidence interval [CI] = 63.9-85.3%) and 90.5% (95% CI = 84.5-98.1%), respectively in the per protocol analysis (P = 0.008 in the per protocol analysis) and 67.1% (95% CI = 56.6-78.5%) and 84.8% (95% CI = 76.8-93.4%), respectively, in the intention-to-treat analysis (P = 0.009). The subgroup analysis revealed that H. pylori eradication rates for group A patients with levofloxacin-susceptible strains were 92.9% (13/14) but it dropped to 12.5% (1/8) when levofloxacin-resistant strains existed. H. pylori was eradicated among all the group B patients with levofloxacin-susceptible strains, but only half of patients with levofloxacin-resistant strains were successfully eradicated. In conclusion, this study confirms the effectiveness of 14-day treatment. Importantly, the results imply that 10-day treatment duration should be optimal if a culture can be performed to confirm the existence of susceptible strains. The duration of H. pylori eradication and levofloxacin resistance were the influencing factors for successful treatment. This study suggests that tailored levofloxacin-containing therapy should be administered only for patients with susceptible strains because it can achieve >90% success rates.	[Tai, Wei-Chen; Chiou, Shue-Shian; Kuo, Chung-Mou; Kuo, Chung-Huang; Liang, Chih-Ming; Lu, Lung-Sheng; Wu, Keng-Liang; Chiu, Yi-Chun; Hu, Tsung-Hui; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Tai, Wei-Chen; Lee, Chen-Hsiang; Chiou, Shue-Shian; Kuo, Chung-Mou; Kuo, Chung-Huang; Liang, Chih-Ming; Lu, Lung-Sheng; Chiu, Chien-Hua; Wu, Keng-Liang; Chiu, Yi-Chun; Hu, Tsung-Hui; Chuah, Seng-Kee] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Chiu, Chien-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Gen Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Kaohsiung, Taiwan.	chuahsk@seed.net.tw						Antos D, 2006, HELICOBACTER, V11, P39, DOI 10.1111/j.0083-8703.2006.00375.x; Bilardi C, 2004, CLIN GASTROENTEROL H, V2, P997, DOI 10.1016/S1542-3565(04)00458-6; Bonis M, 2012, MICROB DRUG RESIST, V18, P230, DOI 10.1089/mdr.2011.0231; Cambau E, 2009, J CLIN MICROBIOL, V47, P3600, DOI 10.1128/JCM.00744-09; Chuah SK, 2012, HELICOBACTER, V17, P374, DOI 10.1111/j.1523-5378.2012.00960.x; Chuah SK, 2012, HELICOBACTER, V17, P216, DOI 10.1111/j.1523-5378.2012.00937.x; Chuah SK, 2011, WORLD J GASTROENTERO, V17, P3971, DOI 10.3748/wjg.v17.i35.3971; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P71, DOI 10.1111/j.1572-0241.2007.01500.x; Gisbert JP, 2013, J CLIN GASTROENTEROL, V47, P130, DOI 10.1097/MCG.0b013e318254ebdd; Gisbert JP, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/974594; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Guzelbulut F, 2011, MINERVA MED, V102, P171; Hsu PI, 2002, AM J GASTROENTEROL, V97, P2231, DOI 10.1111/j.1572-0241.2002.05977.x; Hsu PI, 2014, HELICOBACTER, V19, P74, DOI 10.1111/hel.12085; Hsu PI, 2011, HELICOBACTER, V16, P139, DOI 10.1111/j.1523-5378.2011.00828.x; Kobayashi I, 2007, J CLIN MICROBIOL, V45, P4006, DOI 10.1128/JCM.00740-07; Kuo CH, 2013, J ANTIMICROB CHEMOTH, V68, P222, DOI 10.1093/jac/dks361; Liou JM, 2013, J ANTIMICROB CHEMOTH, V68, P450, DOI 10.1093/jac/dks407; Liou JM, 2011, ANTIMICROB AGENTS CH, V55, P1123, DOI 10.1128/AAC.01131-10; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Miehlke S, 2011, HELICOBACTER, V16, P420, DOI 10.1111/j.1523-5378.2011.00867.x; Mueller-Lissner S, 2008, Z GASTROENTEROL, V46, P83, DOI 10.1055/s-2007-963548; Murakami K, 2013, J GASTROENTEROL, V48, P1128, DOI 10.1007/s00535-012-0731-8; O'Connor A, 2013, HELICOBACTER, V18, P58, DOI 10.1111/hel.12075; Qureshi NN, 2011, ANTIMICROB AGENTS CH, V55, P101, DOI 10.1128/AAC.00545-10; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Sanchez JEG, 2000, J ANTIMICROB CHEMOTH, V46, P283, DOI 10.1093/jac/46.2.283; Schabereiter-Gurtner C, 2004, J CLIN MICROBIOL, V42, P4512, DOI 10.1128/JCM.42.10.4512-4518.2004; Su P, 2013, HELICOBACTER, V18, P274, DOI 10.1111/hel.12046; Tai WC, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/932478; Tanaka M, 2002, J ANTIMICROB CHEMOTH, V49, P1039, DOI 10.1093/jac/dkf055; Tanimura H, 1998, J GASTROENTEROL, V33, P23, DOI 10.1007/PL00009962; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Wu DC, 2011, MEDICINE, V90, P180, DOI 10.1097/MD.0b013e31821c9d1c; Wu WM, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/723183	39	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105822	10.1371/journal.pone.0105822	http://dx.doi.org/10.1371/journal.pone.0105822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141137	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200123
J	Kalikaki, A; Politaki, H; Souglakos, J; Apostolaki, S; Papadimitraki, E; Georgoulia, N; Tzardi, M; Mavroudis, D; Georgoulias, V; Voutsina, A				Kalikaki, Aristea; Politaki, Helen; Souglakos, John; Apostolaki, Stella; Papadimitraki, Elisavet; Georgoulia, Nefeli; Tzardi, Maria; Mavroudis, Dimitris; Georgoulias, Vassilis; Voutsina, Alexandra			KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; PROGRESSION-FREE; MUTATIONS; EGFR; DNA; HETEROGENEITY; SURVIVAL; THERAPY; PREDICT; BRAF	Introduction: Circulating tumor cells (CTCs) could represent a non-invasive source of cancer cells used for longitudinal monitoring of the tumoral mutation status throughout the course of the disease. The aims of the present study were to investigate the detection of KRAS mutations in CTCs from patients with metastatic colorectal cancer (mCRC) and to compare their mutation status during treatment or disease progression with that of the corresponding primary tumors. Materials and Methods: Identification of the seven most common KRAS mutations on codons 12 and 13 was performed by Peptide Nucleic Acid (PNA)-based qPCR method. The sensitivity of the assay was determined after isolation of KRAS mutant cancer cells spiked into healthy donors' blood, using the CellSearch Epithelial Cell kit. Consistent detection of KRAS mutations was achieved in samples containing at least 10 tumor cells/7.5 ml of blood. Results: The clinical utility of the assay was assessed in 48 blood samples drawn from 31 patients with mCRC. All patients had PIK3CA and BRAF wild type primary tumors and 14 KRAS mutant tumors. CTCs were detected in 65% of specimens obtained from 74% of patients. KRAS mutation analysis in CTC-enriched specimens showed that 45% and 16.7% of patients with mutant and wild type primary tumors, respectively, had detectable mutations in their CTCs. Assessing KRAS mutations in serial blood samples revealed that individual patient's CTCs exhibited different mutational status of KRAS during treatment. Conclusions: The current findings support the rationale for using the CTCs as a dynamic source of tumor cells which, by re-evaluating their KRAS mutation status, could predict, perhaps more accurately, the response of mCRC patients to targeted therapy.	[Kalikaki, Aristea; Politaki, Helen; Souglakos, John; Apostolaki, Stella; Georgoulia, Nefeli; Mavroudis, Dimitris; Georgoulias, Vassilis; Voutsina, Alexandra] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece; [Souglakos, John; Papadimitraki, Elisavet; Mavroudis, Dimitris; Georgoulias, Vassilis] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Crete, Greece; [Tzardi, Maria] Univ Gen Hosp Heraklion, Dept Pathol, Iraklion, Crete, Greece	University of Crete; University Hospital of Heraklion; University Hospital of Heraklion	Voutsina, A (corresponding author), Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Crete, Greece.	voutsina@med.uoc.gr			Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework; National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece	Cretan Association for Biomedical Research (CABR); Hellenic Society of Medical Oncology (HeSMO); Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework; National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece	This work was supported by research grants from the Cretan Association for Biomedical Research (CABR), the Hellenic Society of Medical Oncology (HeSMO) and the Operational Programme "Competitiveness & Entrepreneurship", National Strategic Reference Framework 2007-2013, National Action: "Cooperation", OncoSeed Diagnostics: Biology of Circulating Tumour Cells, Distant Metastasis & Development of Liquid Biopsy Methods; General Secretariat of Research and Technology of Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Allen JE, 2010, CURR COLORECT CANC R, V6, P212, DOI 10.1007/s11888-010-0069-7; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2010, ANN ONCOL, V21, P1851, DOI 10.1093/annonc/mdq030; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2008, BRIT J CANCER, V99, P551, DOI 10.1038/sj.bjc.6604451; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Flores LM, 2010, BRIT J CANCER, V102, P1495, DOI 10.1038/sj.bjc.6605676; Garrigos N, 2010, CLIN TRANSL ONCOL, V12, P142, DOI 10.1007/S12094-010-0479-7; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hodgkinson CL, 2014, NAT MED; Jiang YQ, 2010, CLIN CHEM, V56, P1492, DOI 10.1373/clinchem.2010.143297; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mostert B, 2013, INT J CANCER, V133, P130, DOI 10.1002/ijc.27987; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Sastre J, 2012, ONCOLOGIST, V17, P947, DOI 10.1634/theoncologist.2012-0048; Schneck H, 2013, MOL ONCOL; Fernandez MJS, 2009, CLIN TRANSL ONCOL, V11, P659, DOI 10.1007/s12094-009-0421-z; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Tol J, 2009, ANN ONCOL, V20, P24; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Voutsina A, 2012, MOD PATHOL; Voutsina A, 2013, MODERN PATHOL, V26, P302, DOI 10.1038/modpathol.2012.150; Watanabe T, 2011, DIS COLON RECTUM, V54, P1170, DOI 10.1097/DCR.0b013e31821d37a3	42	36	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104902	10.1371/journal.pone.0104902	http://dx.doi.org/10.1371/journal.pone.0104902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137394	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100053
J	Leotta, CG; Federico, C; Brundo, MV; Tosi, S; Saccone, S				Leotta, Claudia Giovanna; Federico, Concetta; Brundo, Maria Violetta; Tosi, Sabrina; Saccone, Salvatore			HLXB9 Gene Expression, and Nuclear Location during In Vitro Neuronal Differentiation in the SK-N-BE Neuroblastoma Cell Line	PLOS ONE			English	Article							CHROMOSOME TERRITORIES; INTERPHASE NUCLEI; LOCALIZATION; INDUCTION; COMPARTMENTALIZATION; ARRANGEMENTS; ORGANIZATION; ARCHITECTURE; TOPOGRAPHY; MNR2	Different parts of the genome occupy specific compartments of the cell nucleus based on the gene content and the transcriptional activity. An example of this is the altered nuclear positioning of the HLXB9 gene in leukaemia cells observed in association with its over-expression. This phenomenon was attributed to the presence of a chromosomal translocation with breakpoint proximal to the HLXB9 gene. Before becoming an interesting gene in cancer biology, HLXB9 was studied as a developmental gene. This homeobox gene is also known as MNX1 (motor neuron and pancreas homeobox 1) and it is relevant for both motor neuronal and pancreatic beta cells development. A spectrum of mutations in this gene are causative of sacral agenesis and more broadly, of what is known as the Currarino Syndrome, a constitutional autosomal dominant disorder. Experimental work on animal models has shown that HLXB9 has an essential role in motor neuronal differentiation. Here we present data to show that, upon treatment with retinoic acid, the HLXB9 gene becomes over-expressed during the early stages of neuronal differentiation and that this corresponds to a reposition of the gene in the nucleus. More precisely, we used the SK-N-BE human neuroblastoma cell line as an in vitro model and we demonstrated a transient transcription of HLXB9 at the 4th and 5th days of differentiation that corresponded to the presence, predominantly in the cell nuclei, of the encoded protein HB9. The nuclear positioning of the HLXB9 gene was monitored at different stages: a peripheral location was noted in the proliferating cells whereas a more internal position was noted during differentiation, that is while HLXB9 was transcriptionally active. Our findings suggest that HLXB9 can be considered a marker of early neuronal differentiation, possibly involving chromatin remodeling pathways.	[Leotta, Claudia Giovanna; Federico, Concetta; Brundo, Maria Violetta; Saccone, Salvatore] Univ Catania, Sez Biol Anim, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy; [Tosi, Sabrina] Brunel Univ, Div Biosci, Leukaemia & Chromosome Res Lab, London, England	University of Catania; Brunel University	Saccone, S (corresponding author), Univ Catania, Sez Biol Anim, Dipartimento Sci Biol Geol & Ambientali, Catania, Italy.	saccosal@unict.it	Federico, Concetta/M-5553-2015; Saccone, Salvatore/H-1548-2012; Tosi, Sabrina/AAA-7199-2022; Brundo, Maria Violetta/Q-4354-2016	Federico, Concetta/0000-0002-0160-9040; Saccone, Salvatore/0000-0001-7568-5823; Tosi, Sabrina/0000-0002-0036-0191; Brundo, Maria Violetta/0000-0001-5146-3564	University of Catania	University of Catania	The work was supported by PRA from the University of Catania to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abemayor E, 1999, ENV HLTH PERSPECT, V80, P3; Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Ballabio E, 2009, LEUKEMIA, V23, P1179, DOI 10.1038/leu.2009.15; Bartova E, 2005, LEUKEMIA RES, V29, P901, DOI 10.1016/j.leukres.2005.01.011; Bartova E, 2000, GENE, V244, P1, DOI 10.1016/S0378-1119(99)00572-7; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bunone G, 1997, ONCOGENE, V14, P1463, DOI 10.1038/sj.onc.1200972; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; DALESSIO A, 1995, CELL GROWTH DIFFER, V6, P1387; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Federico C, 2008, CHROMOSOMA, V117, P399, DOI 10.1007/s00412-008-0160-x; Ferrier DEK, 2001, DEV GENES EVOL, V211, P103, DOI 10.1007/s004270000124; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Garcia-Barcelo MM, 2009, J PEDIATR SURG, V44, P1892, DOI 10.1016/j.jpedsurg.2009.03.039; Grossi MR, 2014, TOXICOL LETT, V224, P240, DOI 10.1016/j.toxlet.2013.10.012; Hagan DM, 2000, AM J HUM GENET, V66, P1504, DOI 10.1086/302899; Harnicarova A, 2006, EXP CELL RES, V312, P4019, DOI 10.1016/j.yexcr.2006.09.007; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Holland PWH, 2001, J ANAT, V199, P13; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Li H, 1999, NAT GENET, V23, P67; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lukasova E, 2002, CHROMOSOME RES, V10, P535, DOI 10.1023/A:1020958517788; Mahmoud MS, 1998, BLOOD, V92, P3887, DOI 10.1182/blood.V92.10.3887.422a48_3887_3897; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; Murata S, 2007, THYROID, V17, P489, DOI 10.1089/thy.2006.0328; Nagel S, 2005, GENE CHROMOSOME CANC, V42, P170, DOI 10.1002/gcc.20113; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Patel NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003614; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Shiohira H, 2012, BIOMED RES-TOKYO, V33, P291, DOI 10.2220/biomedres.33.291; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Strouboulis J, 1996, J CELL SCI, V109, P1991; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tibullo D, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.5005.5005; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021	54	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105481	10.1371/journal.pone.0105481	http://dx.doi.org/10.1371/journal.pone.0105481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136833	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100100
J	Manyema, M; Veerman, LJ; Chola, L; Tugendhaft, A; Sartorius, B; Labadarios, D; Hofman, KJ				Manyema, Mercy; Veerman, Lennert J.; Chola, Lumbwe; Tugendhaft, Aviva; Sartorius, Benn; Labadarios, Demetre; Hofman, Karen J.			The Potential Impact of a 20% Tax on Sugar-Sweetened Beverages on Obesity in South African Adults: A Mathematical Model	PLOS ONE			English	Article							BODY-WEIGHT; DENTAL-CARIES; RISK; CONSUMPTION; PREVALENCE; CHILDREN; HEALTH; OVERWEIGHT; COUNTRIES; TRIAL	Background/Objectives: The prevalence of obesity in South Africa has risen sharply, as has the consumption of sugar-sweetened beverages (SSBs). Research shows that consumption of SSBs leads to weight gain in both adults and children, and reducing SSBs will significantly impact the prevalence of obesity and its related diseases. We estimated the effect of a 20% tax on SSBs on the prevalence of and obesity among adults in South Africa. Methods: A mathematical simulation model was constructed to estimate the effect of a 20% SSB tax on the prevalence of obesity. We used consumption data from the 2012 SA National Health and Nutrition Examination Survey and a previous meta-analysis of studies on own-and cross-price elasticities of SSBs to estimate the shift in daily energy consumption expected of increased prices of SSBs, and energy balance equations to estimate shifts in body mass index. The population distribution of BMI by age and sex was modelled by fitting measured data from the SA National Income Dynamics Survey 2012 to the lognormal distribution and shifting the mean values. Uncertainty was assessed with Monte Carlo simulations. Results: A 20% tax is predicted to reduce energy intake by about 36kJ per day (95% CI: 9-68kJ). Obesity is projected to reduce by 3.8% (95% CI: 0.6%-7.1%) in men and 2.4% (95% CI: 0.4%-4.4%) in women. The number of obese adults would decrease by over 220 000 (95% CI: 24 197-411 759). Conclusions: Taxing SSBs could impact the burden of obesity in South Africa particularly in young adults, as one component of a multi-faceted effort to prevent obesity.	[Manyema, Mercy; Chola, Lumbwe; Tugendhaft, Aviva; Sartorius, Benn; Hofman, Karen J.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Manyema, Mercy; Chola, Lumbwe; Tugendhaft, Aviva; Hofman, Karen J.] Univ Witwatersrand, Fac Hlth Sci, PRICELESS SA, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Veerman, Lennert J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Labadarios, Demetre] Human Sci Res Council, Cape Town, South Africa; [Hofman, Karen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Witwatersrand; University of Witwatersrand; University of Queensland; University of Kwazulu Natal; Human Sciences Research Council-South Africa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Manyema, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	Mercy.Manyema@wits.ac.za	Chola, Lumbwe/AFX-3377-2022; Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232; Chola, Lumbwe/0000-0001-6488-2813; HOFMAN, KAREN/0000-0001-9512-7220; , bennsartorius/0000-0001-6761-2325	International Development Research Center, Canada [PROP020911E]	International Development Research Center, Canada	This research was supported by grant PROP020911E from the International Development Research Center, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.idrc.ca/EN/Pages/default.aspx	Adami N, 2012, Q DIVISIONAL SEMINAR; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Berardi N, 2012, 415 BANK FRANC; Bertram Melanie Y, 2013, Int J Stroke, V8 Suppl A100, P76, DOI 10.1111/j.1747-4949.2012.00955.x; Bertram MY, 2013, GLOBAL HEALTH ACTION, V6, P206, DOI 10.3402/gha.v6i0.19244; Briggs AD, 2013, BMC PUBLIC HEALTH, V13; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brown M., 2012, NATL INCOME DYNAMICS; Brownell KD, 2005, J HEALTH POLIT POLIC, V30, P955, DOI 10.1215/03616878-30-5-955; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cabrera-Escobar MA, 2013, BMC PUBLIC HEALTH, V13; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chattan N, 2013, MEX C PASS TAX BILL; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; Cheney C, 2011, BATTL COUCH POT HUNG; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; De Villiers L, 2013, NATK INCOME DYNAMICS; De Wet P, 2011, DAY HEART ATTACK FAT; Department of Health, 2007, S AFR DEM HLTH SURV, P258; Dodds C, 2013, MINSTER HLTH GOES SO; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; EU Food Law, 2013, DENM DROPS DEC OLD S; Euromonitor International, 2013, SOFT DRINKS S AFR IN; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Friedman Roberta R, 2012, SUGAR SWEETENED BEVE, P1; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Goris JM, 2010, PUBLIC HEALTH NUTR, V13, P1003, DOI 10.1017/S1368980009992850; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Holmes T, 2013, SALT SELLIERS SHAKEN; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Leibbtandt M, 2009, METHODOLOGY REPORT N; Lobstein T, 2011, MEDICINE, V39, P11; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng M., 2014, LANCET; NIDS, 2013, WAVE 3 SALDRU; NIDS, 2012, INTRO NIDS DAT; NIDS, 2008, FILDW MAN WAV 1; Organization WH, 2009, GLOB HLTH RISKS MORT; Parmalat, 2011, EV MILK NUTR INF PER; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Powell LM, 2014, AM J PUBLIC HEALTH, V104, P672, DOI 10.2105/AJPH.2013.301630; ROSE G, 1990, BRIT MED J, V301, P1031, DOI 10.1136/bmj.301.6759.1031; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Shisana O, 2013, S AFRICAN NATL HLTH, P135; Southern Africa Labour and Development Research Unit, 2014, S AFR NATL INC DYN S; Spiegel, 2011, FRENCH COL TAX APPR; STATA, 2011, STAT STAT SOFTW REL; StatsSA, 2013, MID POP EST 2013; Sturm R, 2013, SAMJ S AFR MED J, V103, P840, DOI [10.7196/SAMJ.7260, 10.7196/samj.7260]; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; UNESDA, 2010, WHY DISCR TEX DONT W; van Walbeek C., 2003, TOBACCO EXCISE TAXAT; Veerman JL, 2007, OBESITY, V15, P2365, DOI 10.1038/oby.2007.280; Veerman JL, 2009, EUR J PUBLIC HEALTH, V19, P365, DOI 10.1093/eurpub/ckp039; von Lengerke T, 2011, MATURITAS, V69, P220, DOI 10.1016/j.maturitas.2011.04.005; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x	71	64	66	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105287	10.1371/journal.pone.0105287	http://dx.doi.org/10.1371/journal.pone.0105287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136987	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100084
J	Banville, N; Burgess, JK; Jaffar, J; Tjin, G; Richeldi, L; Cerri, S; Persiani, E; Black, JL; Oliver, BG				Banville, Nessa; Burgess, Janette K.; Jaffar, Jade; Tjin, Gavin; Richeldi, Luca; Cerri, Stefania; Persiani, Elisa; Black, Judith L.; Oliver, Brian G.			A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM)	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; VON-WILLEBRAND-FACTOR; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CANCER-CELLS; DISEASE; GROWTH; FIBRONECTIN; EXPRESSION; GUIDELINES; SIROLIMUS	Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung condition affecting approximately 3.4-7.5/million women, with an average lag time between symptom onset and diagnosis of upwards of 4 years. The aim of this work was to identify altered proteins in LAM serum which may be potential biomarkers of disease. Serum from LAM patient volunteers and healthy control volunteers were pooled and analysis carried out using quantitative 4-plex iTRAQ technology. Differentially expressed proteins were validated using ELISAs and pathway analysis was carried out using Ingenuity Pathway Analysis. Fourteen proteins were differentially expressed in LAM serum compared to control serum (p < 0.05). Further screening validated the observed differences in extracellular matrix remodelling proteins including fibronectin (30% decrease in LAM, p = 0.03), von Willebrand Factor (40% reduction in LAM, p = 0.03) and Kallikrein III (25% increase in LAM, p = 0.03). Pathway networks elucidated the relationships between the ECM and cell trafficking in LAM. This study was the first to highlight an imbalance in networks important for remodelling in LAM, providing a set of novel potential biomarkers. These understandings may lead to a new effective treatment for LAM in the future.	[Banville, Nessa; Burgess, Janette K.; Jaffar, Jade; Tjin, Gavin; Black, Judith L.; Oliver, Brian G.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Burgess, Janette K.] Univ Sydney, Woolcock Inst Med Res, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Richeldi, Luca] Univ Southampton, Southampton, Hants, England; [Cerri, Stefania; Persiani, Elisa] Univ Modena & Reggio Emilia, Ctr Rare Lung Dis, Modena, Italy; [Oliver, Brian G.] Univ Technol, Sch Med & Mol Biosci, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Woolcock Institute of Medical Research; University of Southampton; Universita di Modena e Reggio Emilia; University of Technology Sydney	Oliver, BG (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	brian.oliver@sydney.edu.au	Richeldi, Luca/ABF-2486-2020; Cerri, Stefania/N-9701-2016; Burgess, Janette K/A-3597-2010; Burgess, Janette/M-7117-2019; Richeldi, Luca/B-6243-2019; Oliver, Brian/E-7939-2010	Richeldi, Luca/0000-0001-8594-1448; Cerri, Stefania/0000-0003-4612-1580; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Tjin, Gavin/0000-0002-7235-6909	LAM Australia Research Alliance; National Health and Medical Research Council (NHMRC) [1009156]; NHMRC Career Development Fellowship [1032695, 1026880]; NHMRC Senior Principal Research Fellowship [571098]; Rebecca L. Cooper PhD scholarship	LAM Australia Research Alliance; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper PhD scholarship	This work was supported by LAM Australia Research Alliance and the National Health and Medical Research Council (NHMRC, 1009156), JKB was supported by a NHMRC Career Development Fellowship #1032695. JLB was supported by a NHMRC Senior Principal Research Fellowship #571098. BGO was supported by a NHMRC Career Development Fellowship #1026880. JJ was supported by a Rebecca L. Cooper PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen MEAPM, 2011, CLIN RADIOL, V66, P625, DOI 10.1016/j.crad.2011.02.009; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cook-Mills JM, 2006, CELL MOL BIOL, V52, P8, DOI 10.1170/T721; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Davis JM, 2013, J HISTOCHEM CYTOCHEM, V61, P580, DOI 10.1369/0022155413489311; Evans SE, 2004, CHEST, V125, P1063, DOI 10.1378/chest.125.3.1063; Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184; Glasgow CG, 2009, CHEST, V135, P1293, DOI 10.1378/chest.08-1160; Hammes SR, 2013, HORM CANCER-US, V4, P70, DOI 10.1007/s12672-012-0128-4; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Jajic I, 1990, Reumatizam, V37, P39; Jawad H, 2012, CLIN CHEST MED, V33, P11, DOI 10.1016/j.ccm.2012.01.002; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Kollara A, 2003, J STEROID BIOCHEM, V84, P493, DOI 10.1016/S0960-0760(03)00069-4; Koumandou VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068074; Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003; Lawless MW, 2009, J CELL MOL MED, V13, P2800, DOI 10.1111/j.1582-4934.2009.00845.x; Lee EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055827; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P1642; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mount DL, 2009, CLIN TRIALS, V6, P416, DOI 10.1177/1740774509344440; Ortea I, 2012, J PROTEOMICS, V77, P372, DOI 10.1016/j.jprot.2012.09.011; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Schiavina M, 2007, AM J RESP CRIT CARE, V176, P96, DOI 10.1164/rccm.200610-1408CR; Sehestedt T, 2011, ATHEROSCLEROSIS, V216, P237, DOI 10.1016/j.atherosclerosis.2011.01.049; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Taveira-DaSilva AM, 2012, EXPERT REV RESP MED, V6, P267, DOI [10.1586/ers.12.26, 10.1586/ERS.12.26]; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Valencia JC, 2001, J INVEST MED, V49, P421, DOI 10.2310/6650.2001.33787; Wang DX, 2013, CHINESE MED J-PEKING, V126, P3656, DOI 10.3760/cma.j.issn.0366-6999.20130400; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0; Zhe XN, 2005, AM J RESP CELL MOL, V32, P28, DOI 10.1165/rcmb.2004-0289OC; Zuo L, 2013, MOL IMMUNOL, V56, P57, DOI 10.1016/j.molimm.2013.04.002	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105365	10.1371/journal.pone.0105365	http://dx.doi.org/10.1371/journal.pone.0105365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133674	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700106
J	Chen, XJ; Yang, JZ; Peek-Asa, C; Chen, KW; Liu, XX; Li, LP				Chen, Xiaojun; Yang, Jingzhen; Peek-Asa, Corinne; Chen, Kangwen; Liu, Xiangxiang; Li, Liping			Hospital-Based Program to Increase Child Safety Restraint Use among Birthing Mothers in China	PLOS ONE			English	Article							ROAD TRAFFIC INJURIES; PASSENGER SAFETY; PUBLIC-HEALTH; INTERVENTION; PROTECTION; KNOWLEDGE; INFANTS; SEATS; DISCHARGE; SCHEME	Objective: To evaluate a hospital-based educational program to increase child safety restraint knowledge and use among birthing mothers. Methods: A prospective experimental and control study was performed in the Obstetrics department of hospitals. A total of 216 new birthing mothers from two hospitals (114 from intervention hospital and 102 from comparison hospital) were recruited and enrolled in the study. Intervention mothers received a height chart, an 8-minute video and a folded pamphlet regarding child safety restraint use during their hospital stay after giving birth. Evaluation data on the child safety seat (CSS) awareness, attitudes, and use were collected among both groups before and after the intervention. An additional phone interview was conducted among the intervention mothers two months after discharge. Results: No significant differences existed between groups when comparing demographics. Over 90% of the intervention mothers found the educational intervention to be helpful to some extent. A significantly higher percentage of mothers in the intervention than the comparison group reported that CSS are necessary and are the safest seating practice. Nearly 20% of the intervention mothers actually purchased CSS for their babies after the intervention. While in both the intervention and comparison group, over 80% of mothers identified the ages of two through five as needing CSS, fewer than 50% of both groups identified infants as needing CSS, even after the intervention. Conclusion: The results indicated that child safety restraint education implemented in hospitals helps increase birthing mothers' overall knowledge and use of CSS. Further efforts are needed to address specific age-related needs to promote car seats use among infants.	[Chen, Xiaojun; Li, Liping] Shantou Univ, Affiliated Hosp 1, Coll Med, Shantou, Peoples R China; [Chen, Xiaojun; Liu, Xiangxiang; Li, Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Peoples R China; [Yang, Jingzhen; Peek-Asa, Corinne] Univ Iowa, Injury Prevent Res Ctr, Iowa City, IA USA; [Chen, Kangwen] Women & Children Hosp Shantou, Shantou, Peoples R China	Shantou University; Shantou University; University of Iowa	Li, LP (corresponding author), Shantou Univ, Affiliated Hosp 1, Coll Med, Shantou, Peoples R China.	lpli@stu.edu.cn	Yang, Jingzhen/N-4786-2014					BULL MJ, 1990, PEDIATRICS, V85, P540; CHANG A, 1982, WESTERN J MED, V137, P162; Chen XJ, 2014, AM J PREV MED, V46, P85, DOI 10.1016/j.amepre.2013.08.017; CHRISTOPHERSEN ER, 1985, PEDIATRICS, V76, P36; CHRISTOPHERSEN ER, 1982, PEDIATRICS, V70, P21; COLLETTI RB, 1983, PEDIATRICS, V71, P771; COLLETTI RB, 1986, PEDIATRICS, V77, P523; COLLETTI RB, 1984, HEALTH EDUC QUART, V11, P207, DOI 10.1177/109019818401100211; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Erkoboni D, 2010, INJURY PREV, V16, P296, DOI 10.1136/ip.2009.023341; GEDDIS DC, 1986, PEDIATRICS, V77, P167; Hu G, 2008, INJURY PREV, V14, P149, DOI 10.1136/ip.2007.016469; Istre GR, 2002, AM J PUBLIC HEALTH, V92, P1096, DOI 10.2105/AJPH.92.7.1096; Kedikoglou S, 2005, SCAND J PUBLIC HEALT, V33, P42, DOI 10.1080/14034940410028334; Pan SM, 2012, INJURY PREV, V18, P133, DOI 10.1136/injuryprev-2011-040049; Purc-Stephenson RJ, 2010, INT J INJ CONTROL SA, V17, P231, DOI 10.1080/17457300.2010.487155; REISINGER KS, 1978, PEDIATRICS, V62, P280; Rock SM, 1996, ACCIDENT ANAL PREV, V28, P487, DOI 10.1016/0001-4575(96)00018-8; Rogers SC, 2012, J TRAUMA ACUTE CARE, V73, pS262, DOI 10.1097/TA.0b013e31826b0146; Shenoi R, 2010, PEDIATR EMERG CARE, V26, P881, DOI 10.1097/PEC.0b013e3181fe909f; Tessier K, 2010, ACCIDENT ANAL PREV, V42, P1041, DOI 10.1016/j.aap.2009.12.011; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; West R, 1992, J Ark Med Soc, V88, P601; Wilson MKR, 2013, NEW ZEAL MED J, V126, P27; WOLF D, 1995, J COMMUN HEALTH, V20, P345, DOI 10.1007/BF02283059; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925	27	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105100	10.1371/journal.pone.0105100	http://dx.doi.org/10.1371/journal.pone.0105100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133502	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700070
J	Li, ZR; Zhao, CQ; Zha, Y; Wan, C; Si, SL; Liu, F; Zhang, R; Li, FC; Yu, B; Yi, ZL; Xu, N; Peng, LC; Li, Q				Li, Zhengru; Zhao, Chunqiao; Zha, Yi; Wan, Can; Si, Shengli; Liu, Fei; Zhang, Rui; Li, Fengcheng; Yu, Bin; Yi, Zili; Xu, Ning; Peng, Liangcai; Li, Qing			The Minor Wall-Networks between Monolignols and Interlinked-Phenolics Predominantly Affect Biomass Enzymatic Digestibility in Miscanthus	PLOS ONE			English	Article							FERMENTABLE SUGAR YIELDS; H2SO4 PRETREATMENTS; ETHANOL-PRODUCTION; POLYMER FEATURES; LIGNIN CONTENT; 4-COUMARATE/COENZYME; RECALCITRANCE; HYDROLYSIS; BIOFUELS; LIGASE	Plant lignin is one of the major wall components that greatly contribute to biomass recalcitrance for biofuel production. In this study, total 79 representative Miscanthus germplasms were determined with wide biomass digestibility and diverse monolignol composition. Integrative analyses indicated that three major monolignols (S, G, H) and S/G ratio could account for lignin negative influence on biomass digestibility upon NaOH and H2SO4 pretreatments. Notably, the biomass enzymatic digestions were predominately affected by the non-KOH-extractable lignin and interlinked-phenolics, other than the KOH-extractable ones that cover 80% of total lignin. Furthermore, a positive correlation was found between the monolignols and phenolics at p < 0.05 level in the non-KOH-extractable only, suggesting their tight association to form the minor wall-networks against cellulases accessibility. The results indicated that the non-KOH-extractable lignin-complex should be the target either for cost-effective biomass pretreatments or for relatively simply genetic modification of plant cell walls in Miscanthus.	[Li, Zhengru; Zhao, Chunqiao; Liu, Fei; Li, Fengcheng; Xu, Ning; Peng, Liangcai] Huazhong Agr Univ, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zha, Yi; Wan, Can; Si, Shengli; Zhang, Rui; Yu, Bin; Peng, Liangcai] Huazhong Agr Univ, Coll Life Sci & Technol, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Yi, Zili] Hunan Agr Univ, Dept Biotechnol, Changsha, Hunan, Peoples R China; [Xu, Ning] Huaiyin Normal Univ, Jiangsu Key Lab Biomass Based Energy & Enzyme Tec, Huaian, Peoples R China; [Li, Qing] Huazhong Agr Univ, Coll Sci, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Hunan Agricultural University; Huaiyin Normal University; Huazhong Agricultural University	Li, Q (corresponding author), Huazhong Agr Univ, Coll Sci, Biomass & Bioenergy Res Ctr, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	liqing@mail.hzau.edu.cn			111 Project [B08032]; Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology [JSBEET1204]; 973 Specific Pre-project [2010CB134401]; Fundamental Research Funds for the Central Universities [2013PY061]	111 Project(Ministry of Education, China - 111 Project); Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology; 973 Specific Pre-project(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by grants from 111 Project (B08032), the Open Project of Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (JSBEET1204), the 973 Specific Pre-project (2010CB134401) and the Fundamental Research Funds for the Central Universities (No2013PY061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2010, MOLECULES, V15, P8641, DOI 10.3390/molecules15118641; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen P, 2013, BIOL CONVERSION BIOM, P83; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dische Z., 1962, METHODS CARBOHYDRATE, V1, P477; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Jung HJG, 2012, BIOENERG RES, V5, P319, DOI 10.1007/s12155-011-9131-9; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V167, P14, DOI 10.1016/j.biortech.2014.04.086; Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Saha BC, 2007, J CHEM TECHNOL BIOT, V82, P913, DOI 10.1002/jctb.1760; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029	34	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105115	10.1371/journal.pone.0105115	http://dx.doi.org/10.1371/journal.pone.0105115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133694	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700074
J	Rochette, PA; Laliberte, M; Bertrand-Grenier, A; Houle, MA; Blache, MC; Legare, F; Pearson, A				Rochette, Pierre-Alexandre; Laliberte, Mathieu; Bertrand-Grenier, Antony; Houle, Marie-Andree; Blache, Marie-Claire; Legare, Francois; Pearson, Angela			Visualization of Mouse Neuronal Ganglia Infected by Herpes Simplex Virus 1 (HSV-1) Using Multimodal Non-Linear Optical Microscopy	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RAMAN SCATTERING MICROSCOPY; IN-VIVO REACTIVATION; 2ND-HARMONIC GENERATION; ZOSTERIFORM SPREAD; NERVOUS-SYSTEM; TYPE-1; CARS; TISSUE; MICE	Herpes simplex virus 1 (HSV-1) is a neurotropic virus that causes skin lesions and goes on to enter a latent state in neurons of the trigeminal ganglia. Following stress, the virus may reactivate from latency leading to recurrent lesions. The in situ study of neuronal infections by HSV-1 is critical to understanding the mechanisms involved in the biology of this virus and how it causes disease; however, this normally requires fixation and sectioning of the target tissues followed by treatment with contrast agents to visualize key structures, which can lead to artifacts. To further our ability to study HSV-1 neuropathogenesis, we have generated a recombinant virus expressing a second generation red fluorescent protein (mCherry), which behaves like the parental virus in vivo. By optimizing the application of a multimodal non-linear optical microscopy platform, we have successfully visualized in unsectioned trigeminal ganglia of mice both infected cells by two-photon fluorescence microscopy, and myelinated axons of uninfected surrounding cells by coherent anti-Stokes Raman scattering (CARS) microscopy. These results represent the first report of CARS microscopy being combined with 2-photon fluorescence microscopy to visualize virus-infected cells deep within unsectioned explanted tissue, and demonstrate the application of multimodal non-linear optical microscopy for high spatial resolution biological imaging of tissues without the use of stains or fixatives.	[Rochette, Pierre-Alexandre; Pearson, Angela] INRS, Inst Armand Frappier, Laval, PQ, Canada; [Laliberte, Mathieu; Bertrand-Grenier, Antony; Houle, Marie-Andree; Blache, Marie-Claire; Legare, Francois] INRS, Ctr Energie Mat Telecommun, Varennes, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; Institut national de la recherche scientifique (INRS)	Pearson, A (corresponding author), INRS, Inst Armand Frappier, Laval, PQ, Canada.	angela.pearson@iaf.inrs.ca		Pearson, Angela/0000-0002-5997-2846	Fondation Armand-Frappier (FAF); INRS-EMT; Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Nature et technologies; Fonds quebecois de la recherche sur la nature et les technologies [125806]; Canada Foundation for Innovation [9991]; Canadian Institute for Photonic Innovations; Canadian Institutes of Health Research [82924]	Fondation Armand-Frappier (FAF); INRS-EMT; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Nature et technologies; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute for Photonic Innovations; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	PAR was the recipient of a scholarship from the Fondation Armand-Frappier (FAF). ML and ABG received financial support from INRS-EMT. MAH received scholarships from the Natural Sciences and Engineering Research Council of Canada and the Fonds de recherche du Quebec - Nature et technologies. This project was supported by a team grant from the Fonds quebecois de la recherche sur la nature et les technologies (125806), to FL and AP, as well as separate infrastructure grants from the Canada Foundation for Innovation to AP (9991) and to FL, and operating funds from the Natural Sciences and Engineering Research Council of Canada, and the Canadian Institute for Photonic Innovations to FL, and from the Canadian Institutes of Health Research (82924) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; BARINGER JR, 1973, NEW ENGL J MED, V288, P648, DOI 10.1056/NEJM197303292881303; BLYTH WA, 1980, INFECT IMMUN, V29, P902; BLYTH WA, 1984, J GEN VIROL, V65, P1477, DOI 10.1099/0022-1317-65-9-1477; Brown CP, 2012, J MECH BEHAV BIOMED, V5, P62, DOI 10.1016/j.jmbbm.2011.08.004; Cheng JX, 2002, J OPT SOC AM B, V19, P1363, DOI 10.1364/JOSAB.19.001363; Cheng JX, 2001, J PHYS CHEM B, V105, P1277, DOI 10.1021/jp003774a; COEN DM, 1985, J VIROL, V53, P477, DOI 10.1128/JVI.53.2.477-488.1985; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; COOK ML, 1973, INFECT IMMUN, V7, P272, DOI 10.1128/IAI.7.2.272-288.1973; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DYSON H, 1987, J GEN VIROL, V68, P2989, DOI 10.1099/0022-1317-68-12-2989; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Folick A, 2011, CURR OPIN GENET DEV, V21, P585, DOI 10.1016/j.gde.2011.09.003; Foster TP, 1999, J VIROL, V73, P8457, DOI 10.1128/JVI.73.10.8457-8468.1999; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Griffiths A, 2003, J VIROL, V77, P2282, DOI 10.1128/JVI.77.3.2282-2286.2003; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HILL TJ, 1983, PROG BRAIN RES, V59, P173; Kimberlin David, 2004, Herpes, V11 Suppl 2, p65A; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lin CY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981817; Luker GD, 2003, J VIROL, V77, P11082, DOI 10.1128/JVI.77.20.11082-11093.2003; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; MOCHIZUKI Y, 1995, ZOOL SCI, V12, P283, DOI 10.2108/zsj.12.283; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Mostaco-Guidolin LB, 2010, BIOMED OPT EXPRESS, V1, P59, DOI 10.1364/BOE.1.000059; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Nagel CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044177; Neumann DM, 2007, J VIROL, V81, P6106, DOI 10.1128/JVI.00070-07; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; POTTAGE JC, 1995, INFECT AGENT DIS, V4, P115; Ramachandran S, 2008, VIROLOGY, V378, P254, DOI 10.1016/j.virol.2008.05.034; Reichelt M, 2008, J VIROL, V82, P3971, DOI 10.1128/JVI.02592-07; Robinson I, 2010, J BIOPHOTONICS, V3, P138, DOI 10.1002/jbio.200910054; Roizman B, 1974, COMPREHENSIVE VIROLO, V3, P175; Roizman B, 2007, FIELDS VIROLOGY, P3177; Sawtell NM, 2003, J VIROL, V77, P4127, DOI 10.1128/JVI.77.7.4127-4138.2003; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; Schurmann S, 2010, BIOPHYS J, V99, P1842, DOI 10.1016/j.bpj.2010.07.005; Shaner NC, 2004, NAT BIOTECHNOL, V22, P6; SMITT PAES, 1993, ACTA HISTOCHEM, V95, P13, DOI 10.1016/S0065-1281(11)80381-8; Snyder A, 2007, J VIROL, V81, P8337, DOI 10.1128/JVI.00520-07; Stoothoff WH, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3050422; Summers BC, 2001, J VIROL, V75, P5069, DOI 10.1128/JVI.75.11.5069-5075.2001; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Volkmer A, 2005, J PHYS D APPL PHYS, V38, pR59, DOI 10.1088/0022-3727/38/5/R01; Volkmer A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.023901; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304	59	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105103	10.1371/journal.pone.0105103	http://dx.doi.org/10.1371/journal.pone.0105103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133579	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341302700072
J	Zhang, P; Xi, M; Zhao, L; Shen, JX; Li, QQ; He, LR; Liu, SL; Liu, MZ				Zhang, Peng; Xi, Mian; Zhao, Lei; Shen, Jing-Xian; Li, Qiao-Qiao; He, Li-Ru; Liu, Shi-Liang; Liu, Meng-Zhong			Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?	PLOS ONE			English	Article							DEFINITIVE CHEMORADIOTHERAPY; PROGNOSTIC-FACTORS; CANCER; CHEMORADIATION; OLDER; OUTCOMES; ADENOCARCINOMA; COMPLICATIONS; CHEMOTHERAPY; RADIOTHERAPY	Background and purpose: The benefit of concurrent chemoradiotherapy (CCRT) in elderly patients with inoperable esophageal squamous cell carcinoma (SCC) is controversial. This study aimed to assess the efficiency and safety of CCRT in elderly thoracic esophageal cancer patients. Methods and materials: Between January 2002 and December 2011, 128 patients aged 65 years or older treated with CCRT or radiotherapy (RT) alone for inoperable thoracic esophageal SCC were analyzed retrospectively (RT alone, n = 55; CCRT, n = 73). Results: No treatment-related deaths occurred and no patients experienced any acute grade 4 non-hematologic toxicities. Patients treated with CCRT developed more severe acute toxicities than patients who received RT alone. The 3-year overall survival (OS) rate was 36.1% for CCRT compared with 28.5% following RT alone (p = 0.008). Multivariate analysis identified T stage and treatment modality as independent prognostic factors for survival. Further analysis revealed that survival was significantly better in the CCRT group than in the RT alone group for patients <= 72 years. Nevertheless, the CCRT group had a similar OS to the RT group for patients > 72 years. Conclusion: Our results suggest that elderly patients with inoperable thoracic esophageal SCC could benefit from CCRT, without major toxicities. However, for patients older than 72 years, CCRT is not superior to RT alone in terms of survival benefit.	[Zhang, Peng; Xi, Mian; Zhao, Lei; Li, Qiao-Qiao; He, Li-Ru; Liu, Shi-Liang; Liu, Meng-Zhong] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Jing-Xian] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Imaging Diag & Intervent Ctr,State Key Lab Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Liu, MZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	liumengzhong@126.com			Sci-Tech Project Foundation of Guangdong Province [42012B031800287]	Sci-Tech Project Foundation of Guangdong Province	This work was supported by the grant from the Sci-Tech Project Foundation of Guangdong Province (No.42012B031800287). Website: http://www.gdstc.gov.cn. PZ and MX received the funding. The funders provided help in data collection and analysis.	Anderson SE, 2007, BRIT J CANCER, V96, P1823, DOI 10.1038/sj.bjc.6603821; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Go SI, 2012, TUMORI, V98, P225, DOI 10.1700/1088.11934; Gockel I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-114; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; HISHIKAWA Y, 1991, INT J RADIAT ONCOL, V20, P685, DOI 10.1016/0360-3016(91)90009-S; Hsu FM, 2008, J SURG ONCOL, V98, P34, DOI 10.1002/jso.21063; Kinugasa S, 2001, ANN THORAC SURG, V71, P414, DOI 10.1016/S0003-4975(00)02333-X; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.24556.1c; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; Liu H, 2011, RADIOTHER ONCOL, V99, P181, DOI 10.1016/j.radonc.2011.05.011; Mak RH, 2010, DIS ESOPHAGUS, V23, P316, DOI 10.1111/j.1442-2050.2009.01014.x; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Nallapareddy S, 2005, ANTICANCER RES, V25, P3055; Reid BC, 2001, CANCER, V92, P2109, DOI 10.1002/1097-0142(20011015)92:8<2109::AID-CNCR1552>3.0.CO;2-M; Sabel MS, 2002, ANN SURG ONCOL, V9, P210, DOI 10.1007/BF02557376; Semrau R, 2012, STRAHLENTHER ONKOL, V188, P226, DOI 10.1007/s00066-011-0039-2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steyerberg EW, 2007, J CLIN ONCOL, V25, P2389, DOI 10.1200/JCO.2006.09.7931; Takeuchi S, 2007, AM J CLIN ONCOL-CANC, V30, P607, DOI 10.1097/COC.0b013e3180ca7c84; Tougeron D, 2008, BRIT J CANCER, V99, P1586, DOI 10.1038/sj.bjc.6604749; Tougeron D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-510; Trumper M, 2006, EUR J CANCER, V42, P827, DOI 10.1016/j.ejca.2005.08.044; Wu Sen, 2012, Zhonghua Zhong Liu Za Zhi, V34, P873, DOI 10.3760/cma.j.issn.0253-3766.2012.11.017; Xu HY, 2014, ONCOL LETT, V7, P260, DOI 10.3892/ol.2013.1694; YAMAKAWA M, 1994, INT J RADIAT ONCOL, V30, P1225, DOI 10.1016/0360-3016(94)90333-6	28	25	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105270	10.1371/journal.pone.0105270	http://dx.doi.org/10.1371/journal.pone.0105270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133495	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700094
J	Farrell, JD; Byrne, S; Paina, C; Asp, T				Farrell, Jacqueline D.; Byrne, Stephen; Paina, Cristiana; Asp, Torben			De Novo Assembly of the Perennial Ryegrass Transcriptome Using an RNA-Seq Strategy	PLOS ONE			English	Article							HKT TRANSPORTERS; SIGNALING PEPTIDES; KEY DETERMINANTS; SALT TOLERANCE; WEB SERVER; ALIGNMENT; ROOT; DISCOVERY; REVEALS; GENES	Background: Perennial ryegrass is a highly heterozygous outbreeding grass species used for turf and forage production. Heterozygosity can affect de-Bruijn graph assembly making de novo transcriptome assembly of species such as perennial ryegrass challenging. Creating a reference transcriptome from a homozygous perennial ryegrass genotype can circumvent the challenge of heterozygosity. The goals of this study were to perform RNA-sequencing on multiple tissues from a highly inbred genotype to develop a reference transcriptome. This was complemented with RNA-sequencing of a highly heterozygous genotype for SNP calling. Result: De novo transcriptome assembly of the inbred genotype created 185,833 transcripts with an average length of 830 base pairs. Within the inbred reference transcriptome 78,560 predicted open reading frames were found of which 24,434 were predicted as complete. Functional annotation found 50,890 transcripts with a BLASTp hit from the Swiss-Prot non-redundant database, 58,941 transcripts with a Pfam protein domain and 1,151 transcripts encoding putative secreted peptides. To evaluate the reference transcriptome we targeted the high-affinity K+ transporter gene family and found multiple orthologs. Using the longest unique open reading frames as the reference sequence, 64,242 single nucleotide polymorphisms were found. One thousand sixty one open reading frames from the inbred genotype contained heterozygous sites, confirming the high degree of homozygosity. Conclusion: Our study has developed an annotated, comprehensive transcriptome reference for perennial ryegrass that can aid in determining genetic variation, expression analysis, genome annotation, and gene mapping.	[Farrell, Jacqueline D.; Byrne, Stephen; Paina, Cristiana; Asp, Torben] Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Asp, T (corresponding author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark.	Torben.Asp@agrsci.dk	Byrne, Stephen/L-3572-2019	Byrne, Stephen/0000-0002-1179-2272; Campbell, Jacqueline D/0000-0003-2787-3955; Paina, Cristiana/0000-0001-7124-1280	The Danish Council for Independent Research [09-070323]	The Danish Council for Independent Research	The research was supported by a grant from The Danish Council for Independent Research, grant number 09-070323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amrutha RN, 2007, PLANT SCI, V172, P708, DOI 10.1016/j.plantsci.2006.11.019; Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Ashraf M, 2013, PLANT BREEDING, V132, P10, DOI 10.1111/pbr.12000; Bafeel S. O., 2013, International Journal of Biology, V5, P64; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fernandez A, 2013, PLANT PHYSIOL, V161, P954, DOI 10.1104/pp.112.206029; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo XL, 2013, PLANTA, V237, P1135, DOI 10.1007/s00425-012-1834-4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Haro R, 2010, PLANT CELL PHYSIOL, V51, P68, DOI 10.1093/pcp/pcp168; Henry RJ, 2012, J BIOSCIENCES, V37, P829, DOI 10.1007/s12038-012-9253-z; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2012, BMC GENOMICS, V13, P1; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Meng L, 2012, PLANT SCI, V183, P106, DOI 10.1016/j.plantsci.2011.10.020; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Ruttink T, 2013, PLANT BIOTECHNOL J, V11, P605, DOI 10.1111/pbi.12051; Schejbel B, 2008, PLANT BREEDING, V127, P368, DOI 10.1111/j.1439-0523.2007.01477.x; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sparks E, 2013, NAT REV GENET, V14, P631, DOI 10.1038/nrg3541; Studer B, 2008, THEOR APPL GENET, V117, P781, DOI 10.1007/s00122-008-0819-y; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Studer B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-177; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Uozumi N, 2000, PLANT PHYSL; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Waters S, 2013, INT J MOL SCI, V14, P7660, DOI 10.3390/ijms14047660; WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Yamada M, 2013, CURR OPIN PLANT BIOL, V16, P56, DOI 10.1016/j.pbi.2012.11.004; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu S, 2013, GENE, V519, P238, DOI 10.1016/j.gene.2013.02.023	79	41	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103567	10.1371/journal.pone.0103567	http://dx.doi.org/10.1371/journal.pone.0103567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126744	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300007
J	Cao, F; Zhang, C; Doan, TTV; Li, Y; Sangi, DH; Koh, JS; Huynh, NA; Bin Aziz, MF; Choo, HY; Ikeda, K; Abbeel, P; Maharbiz, MM; Sato, H				Cao, Feng; Zhang, Chao; Tat Thang Vo Doan; Li, Yao; Sangi, Daniyal Haider; Koh, Jie Sheng; Ngoc Anh Huynh; Bin Aziz, Mohamed Fareez; Choo, Hao Yu; Ikeda, Kazuo; Abbeel, Pieter; Maharbiz, Michel M.; Sato, Hirotaka			A Biological Micro Actuator: Graded and Closed-Loop Control of Insect Leg Motion by Electrical Stimulation of Muscles	PLOS ONE			English	Article							CARBON-DIOXIDE; LOCUST FLIGHT; BIOFUEL CELL; STICK INSECT; COCKROACH; WALKING; KINEMATICS; FREQUENCY	In this study, a biological microactuator was demonstrated by closed-loop motion control of the front leg of an insect (Mecynorrhina torquata, beetle) via electrical stimulation of the leg muscles. The three antagonistic pairs of muscle groups in the front leg enabled the actuator to have three degrees of freedom: protraction/retraction, levation/depression, and extension/flexion. We observed that the threshold amplitude (voltage) required to elicit leg motions was approximately 1.0 V; thus, we fixed the stimulation amplitude at 1.5 V to ensure a muscle response. The leg motions were finely graded by alternation of the stimulation frequencies: higher stimulation frequencies elicited larger leg angular displacement. A closed-loop control system was then developed, where the stimulation frequency was the manipulated variable for leg-muscle stimulation (output from the final control element to the leg muscle) and the angular displacement of the leg motion was the system response. This closed-loop control system, with an optimized proportional gain and update time, regulated the leg to set at predetermined angular positions. The average electrical stimulation power consumption per muscle group was 148 mu W. These findings related to and demonstrations of the leg motion control offer promise for the future development of a reliable, low-power, biological legged machine (i.e., an insect-machine hybrid legged robot).	[Cao, Feng; Zhang, Chao; Tat Thang Vo Doan; Li, Yao; Sangi, Daniyal Haider; Koh, Jie Sheng; Bin Aziz, Mohamed Fareez; Choo, Hao Yu; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Ngoc Anh Huynh] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Ikeda, Kazuo] City Hope Natl Med Ctr, Div Neurosci, Duarte, CA 91010 USA; [Abbeel, Pieter; Maharbiz, Michel M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; City of Hope; University of California System; University of California Berkeley	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014; Vo-Doan, T. Thang/Y-9994-2019	Sato, Hirotaka/0000-0003-4634-1639; Vo-Doan, T. Thang/0000-0002-5065-5887	Nanyang Assistant Professorship (NAP) [M4080740]; Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF) [M4070190]; A*STAR-JST (The Japan Science and Technology Agency) [M4070198]	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF)(Agency for Science Technology & Research (A*STAR)); A*STAR-JST (The Japan Science and Technology Agency)(Agency for Science Technology & Research (A*STAR))	The work is finacially supported by Nanyang Assistant Professorship (NAP, M4080740), Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF, M4070190), and A*STAR-JST (The Japan Science and Technology Agency) joint grant, M4070198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktakka EE, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/9/095016; Altendorfer R, 2001, AUTON ROBOT, V11, P207, DOI 10.1023/A:1012426720699; Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Branscome DD, 2005, PHYSIOL ENTOMOL, V30, P144, DOI 10.1111/j.1365-3032.2005.00439.x; BURNS MD, 1978, COMP BIOCHEM PHYS A, V61, P85, DOI 10.1016/0300-9629(78)90282-7; Buschges A, 2004, EUR J NEUROSCI, V19, P1856, DOI 10.1111/j.1460-9568.2004.03312.x; Colinet H, 2012, BIOL LETTERS, V8, P1050, DOI 10.1098/rsbl.2012.0601; Daly DC, 2010, IEEE J SOLID-ST CIRC, V45, P153, DOI 10.1109/JSSC.2009.2034433; de Haan A, 1998, EXP PHYSIOL, V83, P77, DOI 10.1113/expphysiol.1998.sp004093; DEBRODT B, 1990, ZOOL JAHRB ALLG ZOOL, V94, P101; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Fischer H, 1999, J EXP BIOL, V202, P711; FRIEDLANDER A, 1979, INSECT BIOCHEM, V9, P79, DOI 10.1016/0020-1790(79)90029-5; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Kohut NJ, 2012, PROC SPIE, V8373, DOI 10.1117/12.917874; MALAMUD JG, 1991, J EXP BIOL, V159, P65; Milton CC, 2008, J INSECT PHYSIOL, V54, P32, DOI 10.1016/j.jinsphys.2007.08.001; Mu LY, 2005, J COMP PHYSIOL A, V191, P1037, DOI 10.1007/s00359-005-0029-x; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Reissman T, 2011, PROC SPIE, V7977, DOI 10.1117/12.880702; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shoji K., 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), P1249, DOI 10.1109/MEMSYS.2012.6170415; Shoji K, 2012, BIOMED MICRODEVICES, V14, P1063, DOI 10.1007/s10544-012-9706-z; STEVENSON RD, 1990, J EXP BIOL, V149, P61; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; Tubbs TB, 2011, INT J MICRO AIR VEH, V3, P101, DOI 10.1260/1756-8293.3.2.101; Wang HZ, 2008, J EXP BIOL, V211, P423, DOI 10.1242/jeb.011791; Watson JT, 1998, J COMP PHYSIOL A, V182, P11, DOI 10.1007/s003590050153	33	29	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105389	10.1371/journal.pone.0105389	http://dx.doi.org/10.1371/journal.pone.0105389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140875	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200084
J	Shigeto, J; Nagano, M; Fujita, K; Tsutsumi, Y				Shigeto, Jun; Nagano, Mariko; Fujita, Koki; Tsutsumi, Yuji			Catalytic Profile of Arabidopsis Peroxidases, AtPrx-2, 25 and 71, Contributing to Stem Lignification	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; SUBSTRATE OXIDATION SITES; WALL-BOUND PEROXIDASE; DEHYDROGENATIVE POLYMER; VERSATILE PEROXIDASE; SINAPYL ALCOHOL; VASCULAR TISSUE; DOWN-REGULATION; LIGNIN; ENVIRONMENT	Lignins are aromatic heteropolymers that arise from oxidative coupling of lignin precursors, including lignin monomers (p-coumaryl, coniferyl, and sinapyl alcohols), oligomers, and polymers. Whereas plant peroxidases have been shown to catalyze oxidative coupling of monolignols, the oxidation activity of well-studied plant peroxidases, such as horseradish peroxidase C (HRP-C) and AtPrx53, are quite low for sinapyl alcohol. This characteristic difference has led to controversy regarding the oxidation mechanism of sinapyl alcohol and lignin oligomers and polymers by plant peroxidases. The present study explored the oxidation activities of three plant peroxidases, AtPrx2, AtPrx25, and AtPrx71, which have been already shown to be involved in lignification in the Arabidopsis stem. Recombinant proteins of these peroxidases (rAtPrxs) were produced in Escherichia coli as inclusion bodies and successfully refolded to yield their active forms. rAtPrx2, rAtPrx25, and rAtPrx71 were found to oxidize two syringyl compounds (2,6-dimethoxyphenol and syringaldazine), which were employed here as model monolignol compounds, with higher specific activities than HRP-C and rAtPrx53. Interestingly, rAtPrx2 and rAtPrx71 oxidized syringyl compounds more efficiently than guaiacol. Moreover, assays with ferrocytochrome c as a substrate showed that AtPrx2, AtPrx25, and AtPrx71 possessed the ability to oxidize large molecules. This characteristic may originate in a protein radical. These results suggest that the plant peroxidases responsible for lignin polymerization are able to directly oxidize all lignin precursors.	[Shigeto, Jun; Nagano, Mariko; Fujita, Koki; Tsutsumi, Yuji] Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Kyushu University	Tsutsumi, Y (corresponding author), Kyushu Univ, Fac Agr, Fukuoka 812, Japan.	y-tsutsu@agr.kyushu-u.ac.jp	Fujita, Koki/G-2702-2013; Shigeto, Jun/ABF-4131-2020	Fujita, Koki/0000-0002-3821-8393; , Jun/0000-0003-2170-8895	Japan Society for the Promotion of Science (JSPS) KAKENHI [23380102]; JSPS KAKENHI Young Scientists [25850123]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI Young Scientists	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (B) Grant Number 23380102 (Y.T.) and JSPS KAKENHI Young Scientists (B) Grant Number 25850123 (J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Aoyama W, 2002, J WOOD SCI, V48, P497, DOI 10.1007/BF00766646; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barcelo AR, 2007, TRENDS PLANT SCI, V12, P486, DOI 10.1016/j.tplants.2007.09.002; Blee KA, 2003, PHYTOCHEMISTRY, V64, P163, DOI 10.1016/S0031-9422(03)00212-7; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; El Mansouri I, 1999, PHYSIOL PLANTARUM, V106, P355, DOI 10.1034/j.1399-3054.1999.106401.x; Gabaldon C, 2005, PLANT PHYSIOL, V139, P1138, DOI 10.1104/pp.105.069674; HARKIN JM, 1973, SCIENCE, V180, P296, DOI 10.1126/science.180.4083.296; Herrero J, 2013, PLANTA, V237, P1599, DOI 10.1007/s00425-013-1865-5; Kavousi B, 2010, PHYTOCHEMISTRY, V71, P531, DOI 10.1016/j.phytochem.2010.01.008; Kobayashi T, 2005, J WOOD SCI, V51, P607, DOI 10.1007/s10086-005-0702-2; Li YH, 2003, J PLANT RES, V116, P175, DOI 10.1007/s10265-003-0087-5; Marjamaa K, 2006, TREE PHYSIOL, V26, P605, DOI 10.1093/treephys/26.5.605; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; Miki Y, 2009, PROTEIN EXPRES PURIF, V68, P208, DOI 10.1016/j.pep.2009.06.003; Nielsen KL, 2001, BIOCHEMISTRY-US, V40, P11013, DOI 10.1021/bi010661o; Novo-Uzal E, 2013, J EXP BOT, V64, P3499, DOI 10.1093/jxb/ert221; Ostergaard L, 2000, PLANT MOL BIOL, V44, P231, DOI 10.1023/A:1006442618860; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Pham LTM, 2014, APPL BIOCHEM BIOTECH, V172, P792, DOI 10.1007/s12010-013-0534-2; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Sarkanen KV., 1971, LIGNINS OCCURRENCE F; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; Shigeto J, 2013, J AGR FOOD CHEM, V61, P3781, DOI 10.1021/jf400426g; Shigeto J, 2012, FEBS J, V279, P348, DOI 10.1111/j.1742-4658.2011.08429.x; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Takahama U, 1996, PLANT CELL PHYSIOL, V37, P499, DOI 10.1093/oxfordjournals.pcp.a028972; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3	32	40	41	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105332	10.1371/journal.pone.0105332	http://dx.doi.org/10.1371/journal.pone.0105332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137070	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100086
J	Fang, JY; Tan, SJ; Yang, Z; Tayag, C; Han, B				Fang, Josephine Y.; Tan, Shih-Jye; Yang, Zhi; Tayag, Charisse; Han, Bo			Tumor Bioengineering Using a Transglutaminase Crosslinked Hydrogel	PLOS ONE			English	Article							BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; DRUG-SENSITIVITY; CULTURE MODELS; 3D MATRICES; STEM-CELLS; MICROENVIRONMENT; GROWTH; TISSUE; ANGIOGENESIS	Development of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantages over other alternatives including presenting cell-matrix interaction sites from collagen-derived peptides, geometry-initiated multicellular tumor spheroids, and metabolic gradients in the tumor microenvironment. Also it provides a controllable wide spectrum of gel stiffness for mechanical signals, and technical compatibility with imaging based screening due to its transparent properties. In addition, the Col-Tgel provides a cure-in-situ delivery vehicle for tumor xenograft formation in animals enhancing tumor cell uptake rate. Overall, this distinctive 3D system could offer a platform to more accurately mimic in vivo situations to study tumor formation and progression both in vitro and in vivo.	[Han, Bo] Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Biomed Engn, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Han, B (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Nimni Cordoba Tissue, Los Angeles, CA 90033 USA.	bohan@usc.edu	Fang, Josephine/AAS-5996-2020					Agastin S, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3596530; Ahearne M, 2008, TOP TISSUE ENG, V4, P1; ALBINI A, 1987, CANCER RES, V47, P3239; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; BRAMMER I, 1979, EUR J CANCER, V15, P1329, DOI 10.1016/0014-2964(79)90109-9; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Constantinou AI, 1998, AM J CLIN NUTR, V68, p1426S, DOI 10.1093/ajcn/68.6.1426S; Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Evans CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023434; Fang J, 2014, REGEN MED, V9, P41, DOI [10.2217/RME.13.76, 10.2217/rme.13.76]; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Gordon EM, 1997, HUM GENE THER, V8, P1385, DOI 10.1089/hum.1997.8.11-1385; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ivascu A, 2007, INT J ONCOL, V31, P1403; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI 10.1089/ten.TEC.2009.0406; Kuwahara K, 2011, TISSUE ENG PT A, V17, P2955, DOI 10.1089/ten.tea.2011.0290; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Ma LA, 2010, BIOMED MICRODEVICES, V12, P753, DOI 10.1007/s10544-010-9429-y; Iglesias JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077281; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; MILLER BE, 1985, CANCER RES, V45, P4200; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049; PASSANITI A, 1992, INT J CANCER, V51, P318, DOI 10.1002/ijc.2910510224; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pirazzoli V, 2013, BLOOD, V121, P2316, DOI 10.1182/blood-2012-08-451187; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Saverio B, 2000, CANCER RES, V60, P28; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Su S.F., 2012, ONCOGENE; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Timmins Nicholas E., 2007, V140, P141; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang Y, 2007, J R SOC INTERFACE, V4, P1169, DOI 10.1098/rsif.2007.1044; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	67	29	29	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105616	10.1371/journal.pone.0105616	http://dx.doi.org/10.1371/journal.pone.0105616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133673	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700122
J	Greger, L; Su, J; Rung, J; Ferreira, PG; Lappalainen, T; Dermitzakis, ET; Brazma, A				Greger, Liliana; Su, Jing; Rung, Johan; Ferreira, Pedro G.; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.; Brazma, Alvis		Geuvadis Consortium	Tandem RNA Chimeras Contribute to Transcriptome Diversity in Human Population and Are Associated with Intronic Genetic Variants	PLOS ONE			English	Article							MESSENGER-RNA; POSTTRANSCRIPTIONAL CONTROL; FUSION TRANSCRIPTS; IN-VITRO; EXPRESSION; PROTEINS; POLYADENYLATION; TRANSLOCATIONS; ALIGNMENT; ACCURATE	Chimeric RNAs originating from two or more different genes are known to exist not only in cancer, but also in normal tissues, where they can play a role in human evolution. However, the exact mechanism of their formation is unknown. Here, we use RNA sequencing data from 462 healthy individuals representing 5 human populations to systematically identify and in depth characterize 81 RNA tandem chimeric transcripts, 13 of which are novel. We observe that 6 out of these 81 chimeras have been regarded as cancer-specific. Moreover, we show that a prevalence of long introns at the fusion breakpoint is associated with the chimeric transcripts formation. We also find that tandem RNA chimeras have lower abundances as compared to their partner genes. Finally, by combining our results with genomic data from the same individuals we uncover intronic genetic variants associated with the chimeric RNA formation. Taken together our findings provide an important insight into the chimeric transcripts formation and open new avenues of research into the role of intronic genetic variants in post-transcriptional processing events.	[Greger, Liliana; Su, Jing; Rung, Johan; Brazma, Alvis] EBI, EMBL, Hinxton, England; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva IG3, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Geneva, Switzerland; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA	European Molecular Biology Laboratory (EMBL); University of Geneva; University of Geneva; Swiss Institute of Bioinformatics	Greger, L (corresponding author), EBI, EMBL, Hinxton, England.	lgreger@ebi.ac.uk	Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro G/J-6379-2013; Häsler, Robert/A-4908-2009; Esser, Daniela/ABB-9383-2020; Antonarakis, Stylianos E/N-8866-2014; Meitinger, Thomas/O-1318-2015; Estivill, Xavier/A-3125-2013; Lappalainen, Tuuli/AAE-6532-2020; Beltran, Sergi/I-3408-2015	Ferreira, Pedro G/0000-0003-3838-8664; Häsler, Robert/0000-0003-4174-8229; Antonarakis, Stylianos E/0000-0001-8907-5823; Estivill, Xavier/0000-0002-0723-2256; Lappalainen, Tuuli/0000-0002-7746-8109; Beltran, Sergi/0000-0002-2810-3445; Carracedo, Angel/0000-0003-1085-8986; Friedlander, Marc/0000-0001-6577-4363; Ongen, Halit/0000-0002-4197-5790; MacArthur, Daniel/0000-0002-5771-2290; Meitinger, Thomas/0000-0002-8838-8403; Rung, Johan/0000-0001-5875-8429; Brazma, Alvis/0000-0001-5988-7409	European Commission [GEUVADIS 261123]; EurocanPlatform [260791]	European Commission(European CommissionEuropean Commission Joint Research Centre); EurocanPlatform	This work was supported by grants: the European Commission 7th Framework Programs (FP7) (GEUVADIS 261123) and EurocanPlatform (260791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Bag J, 2010, RNA BIOL, V7, P5, DOI 10.4161/rna.7.1.10256; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Brooks YS, 2009, J BIOL CHEM, V284, P18033, DOI 10.1074/jbc.M109.006999; Carrara M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S2; Chase A, 2010, HAEMATOL-HEMATOL J, V95, P20, DOI 10.3324/haematol.2009.011536; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Courseaux A, 2003, GENOME RES, V13, P369, DOI 10.1101/gr.490303; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Duc C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003867; Ferreira PG, 1914, PLOS GENET UNPUB; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hernandez-Sanchez C, 2006, NUCLEIC ACIDS RES, V34, P3455, DOI 10.1093/nar/gkl436; Holt R, 2012, EUR J HUM GENET, V20, P1141, DOI 10.1038/ejhg.2012.73; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kandul NP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-67; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kim DS, 2012, GENOMICS, V100, P14, DOI 10.1016/j.ygeno.2012.05.005; Kim RN, 2012, FUNCT INTEGR GENOMIC, V12, P45, DOI 10.1007/s10142-011-0260-1; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magrangeas F, 1998, J BIOL CHEM, V273, P16005, DOI 10.1074/jbc.273.26.16005; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Plebani R, 2012, NEOPLASIA, V14, P1087, DOI 10.1593/neo.121342; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qu HQ, 2007, DIABETES, V56, P270, DOI 10.2337/db06-0865; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Takahara T, 2005, MOL CELL, V18, P245, DOI 10.1016/j.molcel.2005.03.018; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Wang K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-348; Wang Y, 2014, METHODS, V65, P350, DOI 10.1016/j.ymeth.2013.08.019; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang YM, 2012, CANCER DISCOV, V2, P598, DOI 10.1158/2159-8290.CD-12-0042	58	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104567	10.1371/journal.pone.0104567	http://dx.doi.org/10.1371/journal.pone.0104567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133550	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700032
J	Jahanshahi, J; Hashemian, F; Pazira, S; Bakhshaei, MH; Farahani, F; Abasi, R; Poorolajal, J				Jahanshahi, Javaneh; Hashemian, Farnaz; Pazira, Sara; Bakhshaei, Mohammad Hossein; Farahani, Farhad; Abasi, Ruholah; Poorolajal, Jalal			Effect of Topical Tranexamic Acid on Bleeding and Quality of Surgical Field during Functional Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis: A Triple Blind Randomized Clinical Trial	PLOS ONE			English	Article							BLOOD-LOSS; ANESTHESIA	Background: The effect of tranexamic acid (TXA) on bleeding and improvement of surgical field during functional endoscopic sinus surgery (FESS) is not clear yet. This study was conducted to answer this question. Methods: This trial was conducted on 60 patients with chronic sinusitis at Beasat Hospital, Hamadan, Iran, from April to November 2013. Thirty patients in the intervention group received three pledgets soaked with TXA 5% and phenylephrine 0.5% for 10 minutes in each nasal cavity before surgery. Thirty patients in the control group received phenylephrine 0.5% with the same way. The amount of bleeding and the quality of surgical field were evaluated at 15, 30, and 45 minutes after the start of surgery using Boezaart grading. Results: The quality of the surgical field in the intervention group compared to the control group was significantly better in the first quarter (P = 0.002) and the second quarter (P = 0.003) but not in the third quarter (P = 0.163). Furthermore, the amount of bleeding was much less during all periods in the intervention group than in the control group (P = 0.001). Conclusion: Topical TXA can efficiently reduce bleeding and improve the surgical field in FESS in patients with rhinosinusitis. Based on these findings, topical TXA may be a useful method for providing a suitable surgical field during the first 30 minutes after use.	[Jahanshahi, Javaneh; Hashemian, Farnaz; Pazira, Sara; Farahani, Farhad; Abasi, Ruholah] Hamadan Univ Med Sci, Sch Med, Dept Ear Nose Throat Surg, Hamadan, Iran; [Bakhshaei, Mohammad Hossein] Hamadan Univ Med Sci, Sch Med, Dept Anesthesiol, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Hamadan, Iran		Poorolajal, J (corresponding author), Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Hamadan, Iran.	poorolajal@umsha.ac.ir	jahanshahi, javaneh/H-1440-2017; Poorolajal, Jalal/D-3506-2013; Bakhshaei, Mohammad hossein/V-1887-2017; hashemian, farnaz/F-6783-2017; farahani, farhad/N-5865-2018; Abbasi, Rohollah/Q-1574-2017	jahanshahi, javaneh/0000-0002-0064-7408; Bakhshaei, Mohammad hossein/0000-0002-3820-2447; hashemian, farnaz/0000-0002-7037-0926; farahani, farhad/0000-0001-7977-089X; Abbasi, Rohollah/0000-0001-7253-8086	Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	This study was funded by the Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami A, 2009, CAN J ANAESTH, V56, P202, DOI 10.1007/s12630-008-9038-x; Ahn HJ, 2008, BRIT J ANAESTH, V100, P50, DOI 10.1093/bja/aem304; Alimian M, 2011, J CLIN ANESTH, V23, P611, DOI 10.1016/j.jclinane.2011.03.004; Athanasiadis T, 2007, AM J RHINOL, V21, P737, DOI 10.2500/ajr.2007.21.3097; BOEZAART AP, 1995, CAN J ANAESTH, V42, P373, DOI 10.1007/BF03015479; Brum MR, 2012, INT J PEDIATR OTORHI, V76, P1401, DOI 10.1016/j.ijporl.2012.04.028; Crescenti A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5701; De Bonis M, 2000, J THORAC CARDIOV SUR, V119, P575, DOI 10.1016/S0022-5223(00)70139-5; Dell'Amore A, 2012, HEART LUNG CIRC, V21, P706, DOI 10.1016/j.hlc.2012.06.016; Feldman M. A., 2009, ANESTHESIA EYE EAR N; Flint PW., 2015, CUMMINGS OTOLARYNGOL; Food and Drug Administration, 2011, CYKLOKAPRON, P8; Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161; Jabalameli M, 2006, IRAN J MED SCI, V31, P221; Kaewpradub P, 2011, J ORAL MAXIL SURG, V69, pE186, DOI 10.1016/j.joms.2010.11.041; Katzung B, 2018, BASIC CLIN PHARMACOL, V14th; Lanza DC, 2001, ENDOSCOPIC SINUS SUR; Lau J, 1999, DIAGNOSIS TERATMENT; LONGSTAFF C, 1994, BLOOD COAGUL FIBRIN, V5, P537; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Lundstrom J, J LABELLED COMP RADI, V12, P307; Ralley FE, 2010, CLIN ORTHOP RELAT R, V468, P1905, DOI 10.1007/s11999-009-1217-8; Shaw CKL, 2000, J LARYNGOL OTOL, V114, P506; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; Tang YMJ, 2012, J PLAST RECONSTR AES, V65, P684, DOI 10.1016/j.bjps.2011.09.028; Wormald P J, 2005, ENDOSCOPIC SINUS SUR; Wormald PJ, 2005, AM J RHINOL, V19, P514, DOI 10.1177/194589240501900516; Wormald PJ, 2005, AM J RHINOL, V19, P288, DOI 10.1177/194589240501900313; Yaniv E, 2006, AM J RHINOL, V20, P227, DOI 10.1177/194589240602000222	30	27	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104477	10.1371/journal.pone.0104477	http://dx.doi.org/10.1371/journal.pone.0104477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133491	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700030
J	Lenormand, M; Picornell, M; Cantu-Ros, OG; Tugores, A; Louail, T; Herranz, R; Barthelemy, M; Frias-Martinez, E; Ramasco, JJ				Lenormand, Maxime; Picornell, Miguel; Cantu-Ros, Oliva G.; Tugores, Antonia; Louail, Thomas; Herranz, Ricardo; Barthelemy, Marc; Frias-Martinez, Enrique; Ramasco, Jose J.			Cross-Checking Different Sources of Mobility Information	PLOS ONE			English	Article								The pervasive use of new mobile devices has allowed a better characterization in space and time of human concentrations and mobility in general. Besides its theoretical interest, describing mobility is of great importance for a number of practical applications ranging from the forecast of disease spreading to the design of new spaces in urban environments. While classical data sources, such as surveys or census, have a limited level of geographical resolution (e.g., districts, municipalities, counties are typically used) or are restricted to generic workdays or weekends, the data coming from mobile devices can be precisely located both in time and space. Most previous works have used a single data source to study human mobility patterns. Here we perform instead a cross-check analysis by comparing results obtained with data collected from three different sources: Twitter, census, and cell phones. The analysis is focused on the urban areas of Barcelona and Madrid, for which data of the three types is available. We assess the correlation between the datasets on different aspects: the spatial distribution of people concentration, the temporal evolution of people density, and the mobility patterns of individuals. Our results show that the three data sources are providing comparable information. Even though the representativeness of Twitter geolocated data is lower than that of mobile phone and census data, the correlations between the population density profiles and mobility patterns detected by the three datasets are close to one in a grid with cells of 2x2 and 1x1 square kilometers. This level of correlation supports the feasibility of interchanging the three data sources at the spatiotemporal scales considered.	[Lenormand, Maxime; Tugores, Antonia; Ramasco, Jose J.] Inst Fis Interdisciplinar & Sist Complejos IFISC, CSIC UIB, Palma de Mallorca, Spain; [Picornell, Miguel; Cantu-Ros, Oliva G.; Herranz, Ricardo] Nommon Solut & Technol, Madrid, Spain; [Louail, Thomas; Barthelemy, Marc] CEA, CNRS, Inst Phys Theorique, URA 2306, F-91198 Gif Sur Yvette, France; [Louail, Thomas] CNRS, UMR 8504, Paris, France; [Barthelemy, Marc] Ctr Anal & Math Sociales, EHESS CNRS, UMR 8557, Paris, France; [Frias-Martinez, Enrique] Tel Res, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Lenormand, M (corresponding author), Inst Fis Interdisciplinar & Sist Complejos IFISC, CSIC UIB, Palma de Mallorca, Spain.	maxime@ifisc.uib-csic.es	Ramasco, Jose Javier/F-2860-2010; Frias, Moises/H-3331-2015	Ramasco, Jose Javier/0000-0003-2499-6095; Frias, Moises/0000-0001-6621-7227; Louail, Thomas/0000-0001-8563-6881	Spanish Ministry of Economy (MINECO); FEDER (EU) under project MODASS [FIS2011-24785]; FEDER (EU) under project INTENSE@COSYP [FIS2012-30634]; EU Commission through project EUNOIA; EU Commission through project LASAGNE; EU Commission through project INSIGHT; Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands; Ramon y Cajal program of MINECO; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	Spanish Ministry of Economy (MINECO)(Spanish Government); FEDER (EU) under project MODASS; FEDER (EU) under project INTENSE@COSYP; EU Commission through project EUNOIA; EU Commission through project LASAGNE; EU Commission through project INSIGHT; Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands; Ramon y Cajal program of MINECO(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Partial financial support has been received from the Spanish Ministry of Economy (MINECO) and FEDER (EU) under projects MODASS (FIS2011-24785) and INTENSE@COSYP (FIS2012-30634), and from the EU Commission through projects EUNOIA, LASAGNE and INSIGHT. ML acknowledges funding from the Conselleria d'Educacio, Cultura i Universitats of the Government of the Balearic Islands, and JJR from the Ramon y Cajal program of MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SECTION DEV TWITTER; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ferrara E, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds9; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hastie T., 2009, UNSUPERVISED LEARNIN; Hawelka B, 2013, ARXIV13110680; Huberman B., 2008, 1 MONDAY, V14; Isaacman S., 2012, ACM, P239, DOI DOI 10.1145/2307636.2307659; Java A., 2007, P 9 WEBKDD 1 SNA KDD; Krishnamurthy B, 2008, P WOSP 08; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Louail T, 2014, ARXIV14014540; Mislove A., 2008, P 1 WORKSH ONL SOC N; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pei T., 2013, ARXIV13106129; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Reades J, 2007, IEEE PERVAS COMPUT, V6, P30, DOI 10.1109/MPRV.2007.53; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Soto V., 2011, P 1 WORKSH PERV URB; Tizzoni M, 2013, ARXIV13097272; Toole JL, 2012, ACM URBCOMP2012; Tugores A, 2013, P 7 IB GRID INFR C; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	45	80	80	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105184	10.1371/journal.pone.0105184	http://dx.doi.org/10.1371/journal.pone.0105184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133549	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700080
J	Zgheel, F; Alhosin, M; Rashid, S; Burban, M; Auger, C; Schini-Kerth, VB				Zgheel, Faraj; Alhosin, Mahmoud; Rashid, Sherzad; Burban, Melanie; Auger, Cyril; Schini-Kerth, Valerie B.			Redox-Sensitive Induction of Src/PI3-kinase/Akt and MAPKs Pathways Activate eNOS in Response to EPA:DHA 6:1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PORCINE CORONARY-ARTERIES; ENDOTHELIUM-DEPENDENT RELAXATION; POLYUNSATURATED FATTY-ACIDS; EDHF-MEDIATED RELAXATIONS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; DIETARY SUPPLEMENTATION; OXIDATIVE STRESS; HEART-DISEASE	Aims: Omega-3 fatty acid products containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have vasoprotective effects, in part, by stimulating the endothelial formation of nitric oxide (NO). This study determined the role of the EPA: DHA ratio and amount, and characterized the mechanism leading to endothelial NO synthase (eNOS) activation. Methods and Results: EPA:DHA 6:1 and 9:1 caused significantly greater endothelium-dependent relaxations in porcine coronary artery rings than EPA: DHA 3:1, 1:1, 1:3, 1:6, 1:9, EPA and DHA alone, and EPA:DHA 6:1 with a reduced EPA + DHA amount, which were inhibited by an eNOS inhibitor. Relaxations to EPA:DHA 6:1 were insensitive to cyclooxygenase inhibition, and reduced by inhibitors of either oxidative stress, Src kinase, PI3-kinase, p38 MAPK, MEK, or JNK. EPA:DHA 6:1 induced phosphorylation of Src, Akt, p38 MAPK, ERK, JNK and eNOS; these effects were inhibited by MnTMPyP. EPA:DHA 6:1 induced the endothelial formation of ROS in coronary artery sections as assessed by dihydroethidium, and of superoxide anions and hydrogen peroxide in cultured endothelial cells as assessed by electron spin resonance with the spin probe CMH, and the Amplex Red based assay, respectively. Conclusion: Omega-3 fatty acids cause endothelium-dependent NO-mediated relaxations in coronary artery rings, which are dependent on the EPA:DHA ratio and amount, and involve an intracellular activation of the redox-sensitive PI3-kinase/Akt and MAPKs pathways to activate eNOS.	[Zgheel, Faraj; Alhosin, Mahmoud; Rashid, Sherzad; Burban, Melanie; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schini-Kerth, VB (corresponding author), Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Alhosin, Mahmoud/AAD-5782-2020; Auger, Cyril/N-4702-2016; Alhosin, Mahmoud/H-8101-2017	Alhosin, Mahmoud/0000-0003-2147-1445; 	Pivotal Therapeutics Inc., Toronto, Canada; Higher Education Ministry, Libya; Higher Education Ministry, KRG, Iraq	Pivotal Therapeutics Inc., Toronto, Canada; Higher Education Ministry, Libya; Higher Education Ministry, KRG, Iraq	This work was supported, in part, by an unrestricted research grant from Pivotal Therapeutics Inc., Toronto, Canada. Faraj Zgheel is supported by a fellowship from the Higher Education Ministry, Libya, and Sherzad Rashid by a fellowship from the Higher Education Ministry, KRG, Iraq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112; BOULANGER C, 1990, BRIT J PHARMACOL, V99, P176, DOI 10.1111/j.1476-5381.1990.tb14673.x; Crnkovic S, 2012, FREE RADICAL BIO MED, V52, P1786, DOI 10.1016/j.freeradbiomed.2012.02.036; de Berrazueta JR, 2009, EUR J CLIN INVEST, V39, P165, DOI 10.1111/j.1365-2362.2008.02072.x; ELLIS EF, 1990, AM J PHYSIOL, V258, pH1780, DOI 10.1152/ajpheart.1990.258.6.H1780; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Madeira SVF, 2009, J VASC RES, V46, P406, DOI 10.1159/000194271; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Kromhout D, 2012, EUR HEART J, V33, P436, DOI 10.1093/eurheartj/ehr362; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Li QR, 2007, ARCH BIOCHEM BIOPHYS, V466, P250, DOI 10.1016/j.abb.2007.06.023; Li QR, 2007, BIOCHIMIE, V89, P169, DOI 10.1016/j.biochi.2006.10.009; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Ndiaye M, 2004, FASEB J, V18, DOI 10.1096/fj.04-2146fje; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; SHIMOKAWA H, 1987, CIRCULATION, V76, P898, DOI 10.1161/01.CIR.76.4.898; SHIMOKAWA H, 1988, BRIT J PHARMACOL, V95, P1191, DOI 10.1111/j.1476-5381.1988.tb11755.x; SHIMOKAWA H, 1989, AM J PHYSIOL, V256, pH968, DOI 10.1152/ajpheart.1989.256.4.H968; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Stirban A, 2010, AM J CLIN NUTR, V91, P808, DOI 10.3945/ajcn.2009.28374; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wang QQ, 2012, ATHEROSCLEROSIS, V221, P536, DOI 10.1016/j.atherosclerosis.2012.01.006	33	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105102	10.1371/journal.pone.0105102	http://dx.doi.org/10.1371/journal.pone.0105102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133540	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700071
J	Chen, JX; Shao, LY; Gong, L; Luo, F; Wang, JE; Shi, Y; Tan, Y; Chen, QL; Zhang, Y; Hui, RT; Wang, YB				Chen, Jinxing; Shao, Liying; Gong, Ling; Luo, Fang; Wang, Jin'e; Shi, Yi; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo			A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients	PLOS ONE			English	Article							VITAMIN-K EPOXIDE; REDUCTASE COMPLEX SUBUNIT-1; GENOME-WIDE ASSOCIATION; VKORC1 HAPLOTYPES; DOSE REQUIREMENTS; GENETIC-VARIANTS; INTERINDIVIDUAL VARIABILITY; ORAL ANTICOAGULATION; AFRICAN-AMERICANS; VALVE-REPLACEMENT	Inconsistent associations with warfarin dose were observed in genetic variants except VKORC1 haplotype and CYP2C9*3 in Chinese people, and few studies on warfarin dose algorithm was performed in a large Chinese Han population lived in Northern China. Of 787 consenting patients with heart-valve replacements who were receiving long-term warfarin maintenance therapy, 20 related Single nucleotide polymorphisms were genotyped. Only VKORC1 and CYP2C9 SNPs were observed to be significantly associated with warfarin dose. In the derivation cohort (n = 551), warfarin dose variability was influenced, in decreasing order, by VKORC1 rs7294 (27.3%), CYP2C9*3(7.0%), body surface area(4.2%), age(2.7%), target INR(1.4%), CYP4F2 rs2108622 (0.7%), amiodarone use(0.6%), diabetes mellitus(0.6%), and digoxin use(0.5%), which account for 45.1% of the warfarin dose variability. In the validation cohort (n = 236), the actual maintenance dose was significantly correlated with predicted dose (r = 0.609, P<0.001). Our algorithm could improve the personalized management of warfarin use in Northern Chinese patients.	[Chen, Jinxing; Shao, Liying; Gong, Ling; Wang, Jin'e; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China; [Chen, Jinxing; Shao, Liying; Gong, Ling; Luo, Fang; Wang, Jin'e; Shi, Yi; Tan, Yu; Chen, Qianlong; Zhang, Yu; Hui, Rutai; Wang, Yibo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gong, Ling; Luo, Fang; Hui, Rutai] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol, Beijing 100730, Peoples R China; [Shi, Yi] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiovasc Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Wang, YB (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	yibowang@hotmail.com		Wang, Yibo/0000-0001-9984-581X	National Natural Science Foundation of China [81322002, 31171220, 81270333]; Fundamental Research Funds for the Central Universities [2013-GZ15-YP]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by National Natural Science Foundation of China with grants 81322002, 31171220, and 81270333, and the Fundamental Research Funds for the Central Universities with grant 2013-GZ15-YP to Dr. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Aso Y, 2002, METABOLISM, V51, P471, DOI 10.1053/meta.2002.31334; Borgiani P, 2007, PHARMACOGENOMICS, V8, P1545, DOI 10.2217/14622416.8.11.1545; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Cha PC, 2007, J HUM GENET, V52, P856, DOI 10.1007/s10038-007-0183-9; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chan SL, 2011, THROMB HAEMOSTASIS, V105, P1100, DOI 10.1160/TH11-01-0018; Chern HD, 2006, CLIN CHIM ACTA, V367, P108, DOI 10.1016/j.cca.2005.11.026; Choi JR, 2011, J HUM GENET, V56, P290, DOI 10.1038/jhg.2011.4; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Costea I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015672; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Garcia D, 2005, CHEST, V127, P2049, DOI 10.1378/chest.127.6.2049; Geisen C, 2005, THROMB HAEMOSTASIS, V94, P773, DOI 10.1160/TH05-04-0290; Gong IY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027808; Gu QA, 2010, EUR J CLIN PHARMACOL, V66, P1217, DOI 10.1007/s00228-010-0863-9; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; Huang SW, 2011, THROMB RES, V127, P131, DOI 10.1016/j.thromres.2010.10.027; Huang SW, 2009, PHARMACOGENET GENOM, V19, P226, DOI 10.1097/FPC.0b013e328326e0c7; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kamali F, 2000, THROMB HAEMOSTASIS, V84, P39; KNOBL P, 1993, DIABETOLOGIA, V36, P1045, DOI 10.1007/BF02374497; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Liang RJ, 2012, J THROMB THROMBOLYS, V34, P120, DOI 10.1007/s11239-012-0725-7; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Liu Yuan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P929; Luxembourg B, 2011, THROMB HAEMOSTASIS, V105, P169, DOI 10.1160/TH10-03-0194; Mazzaccara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071505; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Oldenburg J, 2007, THROMB HAEMOSTASIS, V98, P570, DOI 10.1160/TH07-07-0454; Pautas E, 2010, CLIN PHARMACOL THER, V87, P57, DOI 10.1038/clpt.2009.178; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rusdiana T, 2013, EUR J CLIN PHARMACOL, V69, P395, DOI 10.1007/s00228-012-1356-9; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Suriapranata IM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-80; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tan SL, 2012, PHARMAZIE, V67, P930, DOI 10.1691/ph.2012.2633; Teichert M, 2009, CLIN PHARMACOL THER, V85, P379, DOI 10.1038/clpt.2008.294; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Trujillo TC, 2000, DRUG SAFETY, V23, P509, DOI 10.2165/00002018-200023060-00003; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wang MS, 2012, INT J MED SCI, V9, P472, DOI 10.7150/ijms.4637; Wang TL, 2008, CLIN CHIM ACTA, V396, P76, DOI 10.1016/j.cca.2008.07.005; Wang YB, 2006, CIRCULATION, V113, P1615, DOI 10.1161/CIRCULATIONAHA.105.580167; Wei M, 2012, THROMB HAEMOSTASIS, V107, P1083, DOI 10.1160/TH11-12-0848; Xu Q, 2012, THROMB HAEMOSTASIS, V108, P1132, DOI 10.1160/TH12-05-0362; Yazbek N, 2003, CORONARY ARTERY DIS, V14, P365, DOI 10.1097/01.mca.0000085138.16622.9e; You JHS, 2011, J THROMB THROMBOLYS, V31, P113, DOI 10.1007/s11239-010-0497-x; Zhang W, 2012, PHARMACOGENOMICS, V13, P309, DOI [10.2217/PGS.11.147, 10.2217/pgs.11.147]; Zhong SL, 2012, PHARMACOGENET GENOM, V22, P176, DOI 10.1097/FPC.0b013e32834f45f9	54	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105250	10.1371/journal.pone.0105250	http://dx.doi.org/10.1371/journal.pone.0105250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126975	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300097
J	Golo, PS; Gardner, DR; Grilley, MM; Takemoto, JY; Krasnoff, SB; Pires, MS; Fernandes, EKK; Bittencourt, VREP; Roberts, DW				Golo, Patricia S.; Gardner, Dale R.; Grilley, Michelle M.; Takemoto, Jon Y.; Krasnoff, Stuart B.; Pires, Marcus S.; Fernandes, Everton K. K.; Bittencourt, Vania R. E. P.; Roberts, Donald W.			Production of Destruxins from Metarhizium spp. Fungi in Artificial Medium and in Endophytically Colonized Cowpea Plants	PLOS ONE			English	Article							ANISOPLIAE; PATHOGENICITY; INHIBITION; INSECTS	Destruxins (DTXs) are cyclic depsipeptides produced by many Metarhizium isolates that have long been assumed to contribute to virulence of these entomopathogenic fungi. We evaluated the virulence of 20 Metarhizium isolates against insect larvae and measured the concentration of DTXs A, B, and E produced by these same isolates in submerged (shaken) cultures. Eight of the isolates (ARSEF 324, 724, 760, 1448, 1882, 1883, 3479, and 3918) did not produce DTXs A, B, or E during the five days of submerged culture. DTXs were first detected in culture medium at 2-3 days in submerged culture. Galleria mellonella and Tenebrio molitor showed considerable variation in their susceptibility to the Metarhizium isolates. The concentration of DTXs produced in vitro did not correlate with percent or speed of insect kill. We established endophytic associations of M. robertsii and M. acridum isolates in Vigna unguiculata (cowpeas) and Cucumis sativus (cucumber) plants. DTXs were detected in cowpeas colonized by M. robertsii ARSEF 2575 12 days after fungal inoculation, but DTXs were not detected in cucumber. This is the first instance of DTXs detected in plants endophytically colonized by M. robertsii. This finding has implications for new approaches to fungus-based biological control of pest arthropods.	[Golo, Patricia S.; Pires, Marcus S.; Bittencourt, Vania R. E. P.] Univ Fed Rural Rio de Janeiro, Inst Vet, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Golo, Patricia S.; Grilley, Michelle M.; Takemoto, Jon Y.; Roberts, Donald W.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Gardner, Dale R.] ARS, USDA, Poisonous Plants Res Lab, Logan, UT USA; [Krasnoff, Stuart B.] USDA ARS, Biol Integrated Pest Management Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Fernandes, Everton K. K.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universidade Federal de Goias	Golo, PS (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Vet, Dept Parasitol Anim, Seropedica, RJ, Brazil.	patriciagolo@gmail.com	Golo, Patricia/AAQ-2227-2020; Takemoto, Jon/A-5309-2011; Golo, Patricia/E-6469-2015; , Fernandes/I-4890-2012; Bittencourt, Vania Rita Elias Pinheiro/D-3219-2013	Golo, Patricia/0000-0003-1854-7488; Takemoto, Jon/0000-0001-9919-9168; Golo, Patricia/0000-0003-1854-7488; , Fernandes/0000-0001-7062-3295; Bittencourt, Vania Rita Elias Pinheiro/0000-0001-8473-8501	United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS) [13-8130-0114-CA]; ARS [ARS-0424163] Funding Source: Federal RePORTER	United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported in part by grants from the United States Department of Agriculture (USDA)/Animal Plant Health and Inspection Service (APHIS); Cooperative agreement (CA) #13-8130-0114-CA. The financial support was received by DWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Ayres M., 2007, BIOESTAT 5 0 APLICA; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; BILLS GF, 1991, CAN J BOT, V69, P1477, DOI 10.1139/b91-191; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bittencourt V. R. E. P., 1992, Arquivos da Universidade Federal Rural do Rio de Janeiro, V15, P197; CERENIUS L, 1990, J INSECT PHYSIOL, V36, P785, DOI 10.1016/0022-1910(90)90052-H; Donzelli BGG, 2012, CURR GENET, V58, P105, DOI 10.1007/s00294-012-0368-4; Fernandes EKK, 2008, EXP APPL ACAROL, V46, P71, DOI 10.1007/s10493-008-9161-y; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Han P, 2013, PLOS ONE, V8; HUXHAM IM, 1989, J INSECT PHYSIOL, V35, P97, DOI 10.1016/0022-1910(89)90042-5; JAMES PJ, 1993, J INSECT PHYSIOL, V39, P797, DOI 10.1016/0022-1910(93)90056-W; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; Krasnoff SB, 2006, J AGR FOOD CHEM, V54, P7083, DOI 10.1021/jf061405r; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; Moon YS, 2008, APPL ENVIRON MICROB, V74, P4366, DOI 10.1128/AEM.00285-08; MUROI M, 1994, BIOCHEM BIOPH RES CO, V205, P1358, DOI 10.1006/bbrc.1994.2815; O'Brien TR, 2008, THESIS; Parsa Soroush, 2013, J Vis Exp, DOI 10.3791/50360; Pava-Ripoll M, 2011, MICROBIOL-SGM, V157, P47, DOI 10.1099/mic.0.042200-0; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; Pedras MSC, 2001, P NATL ACAD SCI USA, V98, P747, DOI 10.1073/pnas.021394998; PETRINI O, 1981, Sydowia, V34, P135; Quiot J.M., 1985, ADV CELL CULT, V4, P199, DOI [10.1016/B978-0-12-007904-9.50013-7, DOI 10.1016/B978-0-12-007904-9.50013-7]; Rangel DEN, 2011, FEMS MICROBIOL LETT, V315, P81, DOI 10.1111/j.1574-6968.2010.02168.x; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Samish M, 2004, PARASITOLOGY, V129, pS389, DOI 10.1017/S0031182004005219; Sampaio IBM, 2002, ESTATISTICA APLICADA; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; SAMUELS RI, 1988, MYCOPATHOLOGIA, V104, P51, DOI 10.1007/BF00437924; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Skrobek A, 2008, BIOCONTROL, V53, P361, DOI 10.1007/s10526-007-9077-1; SUZUKI A, 1971, AGR BIOL CHEM TOKYO, V35, P1641, DOI 10.1080/00021369.1971.10860127; Thomsen L., 1996, Bulletin OILB/SROP, V19, P190; TULLOCH M, 1976, T BRIT MYCOL SOC, V66, P407, DOI 10.1016/S0007-1536(76)80209-4; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P475, DOI 10.1016/S0022-1910(96)00120-5; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	42	31	31	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104946	10.1371/journal.pone.0104946	http://dx.doi.org/10.1371/journal.pone.0104946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127450	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300062
J	Hu, J; Jiang, L; Low, MJ; Rui, LY				Hu, Jun; Jiang, Lin; Low, Malcolm J.; Rui, Liangyou			Glucose Rapidly Induces Different Forms of Excitatory Synaptic Plasticity in Hypothalamic POMC Neurons	PLOS ONE			English	Article							ARCUATE PROOPIOMELANOCORTIN NEURONS; ACTIVATED PROTEIN-KINASE; NEUROPEPTIDE-Y; TRPC CHANNELS; BODY-WEIGHT; NUCLEUS; LEPTIN; INSULIN; EXPRESSION; OBESITY	Hypothalamic POMC neurons are required for glucose and energy homeostasis. POMC neurons have a wide synaptic connection with neurons both within and outside the hypothalamus, and their activity is controlled by a balance between excitatory and inhibitory synaptic inputs. Brain glucose-sensing plays an essential role in the maintenance of normal body weight and metabolism; however, the effect of glucose on synaptic transmission in POMC neurons is largely unknown. Here we identified three types of POMC neurons (EPSC(+), EPSC(-), and EPSC(+/-)) based on their glucose-regulated spontaneous excitatory postsynaptic currents (sEPSCs), using whole-cell patch-clamp recordings. Lowering extracellular glucose decreased the frequency of sEPSCs in EPSC(+) neurons, but increased it in EPSC(-) neurons. Unlike EPSC(+) and EPSC(-) neurons, EPSC(+/-) neurons displayed a bi-phasic sEPSC response to glucoprivation. In the first phase of glucoprivation, both the frequency and the amplitude of sEPSCs decreased, whereas in the second phase, they increased progressively to the levels above the baseline values. Accordingly, lowering glucose exerted a bi-phasic effect on spontaneous action potentials in EPSC(+/-) neurons. Glucoprivation decreased firing rates in the first phase, but increased them in the second phase. These data indicate that glucose induces distinct excitatory synaptic plasticity in different subpopulations of POMC neurons. This synaptic remodeling is likely to regulate the sensitivity of the melanocortin system to neuronal and hormonal signals.	[Hu, Jun; Jiang, Lin; Low, Malcolm J.; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hu, Jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; Nanjing Medical University	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu		Low, Malcolm/0000-0002-9900-3708	National Institutes of Health [DK065122, DK091591, DK094014, NIH R01 DK066604]; Michigan Diabetes Research and Training Center [NIH DK20572]; University of Michigan's Cancer Center [NIH CA46592]; University of Michigan Nathan Shock Center [NIH P30AG013283]; University of Michigan Gut Peptide Research Center [NIH DK34933]; National Natural Science Foundation of China [81373397]; State Scholarship Funds [201208320286]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK034933, P60DK020572, R01DK091591, R01DK094014, R01DK065122, R01DK066604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants DK065122, DK091591, DK094014 and NIH R01 DK066604 (MJL) from the National Institutes of Health. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (NIH DK20572), the University of Michigan's Cancer Center (NIH CA46592), the University of Michigan Nathan Shock Center (NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (NIH DK34933). HJ was supported by the grants from the National Natural Science Foundation of China (No. 81373397) and the State Scholarship Funds (No. 201208320286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Campfield LA, 2003, PHYSIOL REV, V83, P25, DOI 10.1152/physrev.00019.2002; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Fioramonti X, 2010, DIABETES, V59, P519, DOI 10.2337/db09-0421; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; Kiss J, 2005, EUR J NEUROSCI, V21, P2111, DOI 10.1111/j.1460-9568.2005.04012.x; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Newton AJ, 2013, ENDOCRINOLOGY, V154, P172, DOI 10.1210/en.2012-1643; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rother E, 2012, P NATL ACAD SCI USA, V109, P18132, DOI 10.1073/pnas.1206147109; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rui LY, 2013, REV ENDOCR METAB DIS, V14, P387, DOI 10.1007/s11154-013-9261-9; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wang R, 2004, DIABETES, V53, P1959, DOI 10.2337/diabetes.53.8.1959; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wittmann G, 2013, J COMP NEUROL, V521, P3287, DOI 10.1002/cne.23350; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang XB, 2013, J PHYSIOL-LONDON, V591, P1731, DOI 10.1113/jphysiol.2012.248385	43	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105080	10.1371/journal.pone.0105080	http://dx.doi.org/10.1371/journal.pone.0105080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127258	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300076
J	Karan, A; Selvaraj, S; Mahal, A				Karan, Anup; Selvaraj, Sakthivel; Mahal, Ajay			Moving to Universal Coverage? Trends in the Burden of Out-Of-Pocket Payments for Health Care across Social Groups in India, 1999-2000 to 2011-12	PLOS ONE			English	Article							EXPENDITURES; POVERTY	In the background of ongoing health sector reforms in India, the paper investigates the magnitude and trends in out-of-pocket and catastrophic payments for key population sub-groups. Data from three rounds of nationally representative consumer expenditure surveys (1999-2000, 2004-05 and 2011-12) were pooled to assess changes over time in a range of out-of-pocket -related outcome indicators for the poorest 20% households, scheduled caste and tribe households and Muslims households relative to their better-off/majority religion counterparts. Our results suggest that the poorest 20% of households experienced a decline in the proportion reporting any OOP for inpatient care relative to the top 20% and Muslim households saw an increase in the proportion reporting any inpatient OOP relative to non-Muslim households during 2000-2012. The change in the proportion of Muslim households or SC/ST households reporting any OOP for outpatient care was similar to that for their respective more advantaged counterparts; but the poorest 20% of households experienced a faster increase in the proportion reporting any OOP for outpatient care than their top 20% counterparts. SC/ST, Muslim and the poorest 20% of households experienced as faster increase in the share of outpatient OOP in total household spending relative to their advantaged counterparts. We conclude that the financial burden of out of pocket spending increased faster among the disadvantaged groups relative to their more advantaged counterparts. Although the poorest 20% saw a relative decline in OOP spending on inpatient care as a share of household spending, this is likely the result of foregoing inpatient care, than of accessing benefits from the recent expansion of cashless publicly financed insurance schemes for inpatient care. Our results highlight the need to explore the reasons underlying the lack of effectiveness of existing public health financing programs and public sector health services in reaching less-advantaged castes and religious minorities.	[Karan, Anup] Indian Inst Publ Hlth Gandhinagar, Gandhinagar, Gujarat, India; [Karan, Anup] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Karan, Anup; Selvaraj, Sakthivel] Publ Hlth Fdn India, New Delhi, India; [Mahal, Ajay] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia	University of Oxford; Public Health Foundation of India; Monash University	Karan, A (corresponding author), Indian Inst Publ Hlth Gandhinagar, Gandhinagar, Gujarat, India.	anup.karan@iiphg.org	Karan, Anup/AAK-2060-2020; Selvaraj, Sakthivel/ABE-6897-2020; Selvaraj, Sakthivel/ABD-5873-2021	Selvaraj, Sakthivel/0000-0001-5940-1958	Wellcome Trust; Alan and Elizabeth Finkel Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Alan and Elizabeth Finkel Foundation	AK is supported by the Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of United Kingdom universities. AM is supported by an establishment grant of the Alan and Elizabeth Finkel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy V, 2009, 20 IRDES I RES INF H; [Anonymous], 2011, HIGH LEV EXP G UNPUB; Berman P., 2010, Economic and Political Weekly, V45, P65; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bonu S, 2007, 102 ERD AS DEV BANK; Centre for Budget and Governance Accountability (CBGA), 2011, NAT RUR HLTH MISS NR; Devadasan N, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-29; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gupta I, 2009, OUT OF POCKET EXPEND; Hou X, 2011, RSBY WORKING PAPER S; Jalan J, 2007, EFFECTIVE TARGETING; Jung J, 2012, DOES HLTH INSURANCE; Krishna A, 2004, WORLD DEV, V32, P121, DOI 10.1016/j.worlddev.2003.08.002; Mahal A, 2002, WHO BENEFITS PUBLIC; Manning WG, 1988, RAND PUBLICATION SER; Mazumdar S, 2011, FINANCIAL INCENTIVES; Ministry of Health and Family Welfare, 2011, ANN REP PEOPL HLTH; Mukherjee S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-1; National Commission on Macro-Economics and Health, 2005, REP NAT COMM MACR HL; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Palacious R, 2011, RSBY WORKING PAPER S; Planning Commission, 2012, REP STEER COMM HLTH; Powell-Jackson T, 2011, ECON POLIT WEEKLY, V48, P53; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roy K, 2007, HEALTH POLICY, V80, P297, DOI 10.1016/j.healthpol.2006.03.012; Sachar Committee, 2006, SOCIAL EC ED STATUS; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Selvaraj S, 2009, ECON POLIT WEEKLY, V47, P60; Selvaraj SNV, 2010, INDIA HLTH REPORT 20; Sun C, 2011, RSBY WORKING PAPER S; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Bank, 2003, HUM DEV NETW HLTH NU; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yang W, 2015, HEALTH POLICY PLANN, V30, P187, DOI 10.1093/heapol/czt111	38	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105162	10.1371/journal.pone.0105162	http://dx.doi.org/10.1371/journal.pone.0105162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25127454	gold, Green Published			2022-12-27	WOS:000340879300086
J	Rezouki, C; Dozieres, A; Le Coeur, C; Thibault, S; Pisanu, B; Chapuis, JL; Baudry, E				Rezouki, Celia; Dozieres, Anne; Le Coeur, Christie; Thibault, Sophie; Pisanu, Benoit; Chapuis, Jean-Louis; Baudry, Emmanuelle			A Viable Population of the European Red Squirrel in an Urban Park	PLOS ONE			English	Article							SCIURUS-VULGARIS; GREY SQUIRRELS; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; VIABILITY ANALYSIS; GENETIC-STRUCTURE; SPACE USE; DYNAMICS; CAROLINENSIS; CONSERVATION	Whether urban parks can maintain viable and self-sustaining populations over the long term is questionable. In highly urbanized landscapes, urban parks could play a role in biodiversity conservation by providing habitat and resources to native species. However, populations inhabiting urban parks are usually small and isolated, leading to increased demographic stochasticity and genetic drift, with expected negative consequences on their viability. Here, we investigated a European red squirrel population located in an urban park close to Paris, France (Parc de Sceaux; 184 ha) to assess its viability. Using mitochondrial D-loop sequences and 13 microsatellite loci, we showed that the population presented high levels of genetic variation and no evidence of inbreeding. The size of the population was estimated at 100-120 individuals based on the comparison of two census techniques, Distance Sampling and Capture-Mark-Recapture. The estimated heterozygosity level and population size were integrated in a Population Viability Analysis to project the likelihood of the population's persistence over time. Results indicate that the red squirrel population of this urban park can be viable on the long term (i.e. 20 years) for a range of realistic demographic parameters (juvenile survival at least >40%) and immigration rates (at least one immigration event every two years). This study highlights that urban parks can be potential suitable refuges for the red squirrel, a locally threatened species across western European countries, provided that ecological corridors are maintained.	[Rezouki, Celia; Dozieres, Anne; Le Coeur, Christie; Pisanu, Benoit; Chapuis, Jean-Louis] Museum Natl Hist Nat, Ctr Ecol & Sci Conservat, F-75231 Paris, France; [Thibault, Sophie; Baudry, Emmanuelle] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France	Museum National d'Histoire Naturelle (MNHN); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Chapuis, JL (corresponding author), Museum Natl Hist Nat, Ctr Ecol & Sci Conservat, F-75231 Paris, France.	chapuis@mnhn.fr	Baudry, Emmanuelle/G-4005-2010		Conseil General des Hauts-de-Seine (Parc de Sceaux); Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE); Office National des Forets (ONF)	Conseil General des Hauts-de-Seine (Parc de Sceaux); Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE); Office National des Forets (ONF)	This work was funded by the Conseil General des Hauts-de-Seine (Parc de Sceaux), the Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE) and the Office National des Forets (ONF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2002, POPULATION VIABILITY ANALYSIS, P50; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Babinska-Werka J, 2008, ANN ZOOL FENN, V45, P270, DOI 10.5735/086.045.0405; Beissinger S. R., 2002, POPULATION VIABILITY; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burnham K. P., 1980, WILDLIFE MONOGR, V72, P1; Chapuis J.-L., 2012, ECUREUILS FRANCE; Cornelis J, 2004, LANDSCAPE URBAN PLAN, V69, P385, DOI 10.1016/j.landurbplan.2003.10.038; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Dozieres A, 2012, THESIS MUSEUM NATL H; Dozieres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047607; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; GOUDET J, 2002, FSTAT SOFTWARE ESTIM; Gurnell J, 2004, MAMMAL REV, V34, P51, DOI 10.1046/j.0305-1838.2003.00028.x; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell J, 1987, NATURAL HIST SQUIRRE; Gurnell J., 2001, 11 FOR COMM; Kendall WL, 1997, ECOLOGY, V78, P563; Kenward RE, 1998, J ZOOL, V244, P23; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; Lacy R.C., 2009, VORTEX STOCHASTIC SI; Laguet S, 2012, ECUREUIL ROUX SCIURU; LaRose JP, 2010, VET REC, V167, P297, DOI 10.1136/vr.c4196; Lurz Peter W. W., 2005, Mammalian Species, P1; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Magris L, 2002, J ZOOL, V256, P99, DOI 10.1017/S0952836902000134; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Ogden R, 2005, CONSERV GENET, V6, P511, DOI 10.1007/s10592-005-9006-8; Pritchard JK, 2000, GENETICS, V155, P945; Robert A, 2011, AM NAT, V177, P99, DOI 10.1086/657434; Shar S., 2008, SCIURUS VULGARIS IUC; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shuttleworth CM, 2000, WILDLIFE BIOL, V6, P149, DOI 10.2981/wlb.2000.010; Shuttleworth Craig M., 2003, Urban Ecosystems, V5, P109, DOI 10.1023/A:1022387620713; Simpson S, 2013, ECOL EVOL, V3, P614, DOI 10.1002/ece3.486; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Trizio I, 2005, MOL ECOL, V14, P469, DOI 10.1111/j.1365-294X.2005.02428.x; Verbeylen G, 2003, ECOGRAPHY, V26, P118, DOI 10.1034/j.1600-0587.2003.03236.x; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05; WAUTERS L, 1994, OIKOS, V69, P140, DOI 10.2307/3545294; WAUTERS L, 1989, J ANIM ECOL, V58, P637, DOI 10.2307/4853; Wauters LA, 2000, ECOL RES, V15, P271, DOI 10.1046/j.1440-1703.2000.00354.x; WAUTERS LA, 1994, P ROY SOC B-BIOL SCI, V255, P107, DOI 10.1098/rspb.1994.0015; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; Wauters LA, 1997, BIOL CONSERV, V82, P101, DOI 10.1016/S0006-3207(97)00007-4; WAUTERS LA, 1995, OIKOS, V72, P402, DOI 10.2307/3546126; WAUTERS LA, 1995, ECOLOGY, V76, P2460, DOI 10.2307/2265820; Wauters LA, 2008, ECOGRAPHY, V31, P104, DOI 10.1111/j.2007.0906-7590.05251.x; Wauters LA, 2011, MAMM BIOL, V76, P369, DOI 10.1016/j.mambio.2010.04.003; Wauters LA, 2010, POPUL ECOL, V52, P527, DOI 10.1007/s10144-010-0203-z	57	22	25	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105111	10.1371/journal.pone.0105111	http://dx.doi.org/10.1371/journal.pone.0105111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126848	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300080
J	Marionnet, C; Pierrard, C; Golebiewski, C; Bernerd, F				Marionnet, Claire; Pierrard, Cecile; Golebiewski, Christelle; Bernerd, Francoise			Diversity of Biological Effects Induced by Longwave UVA Rays (UVA1) in Reconstructed Skin	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; DELAYED-TYPE HYPERSENSITIVITY; LANGERHANS CELL DEPLETION; IN-VITRO; HUMAN KERATINOCYTES; HUMAN-EPIDERMIS; CONTACT HYPERSENSITIVITY; GENE-EXPRESSION; MESSENGER-RNA; BASAL LAYER	Despite their preponderance amongst the ultraviolet (UV) range received on Earth, the biological impacts of longwave UVA1 rays (340-400 nm) upon human skin have not been investigated so thoroughly. Nevertheless, recent studies have proven their harmful effects and involvement in carcinogenesis and immunosuppression. In this work, an in vitro reconstructed human skin model was used for exploring the effects of UVA1 at molecular, cellular and tissue levels. A biological impact of UVA1 throughout the whole reconstructed skin structure could be evidenced, from morphology to gene expression analysis. UVA1 induced immediate injuries such as generation of reactive oxygen species and thymine dimers DNA damage, accumulating preferentially in dermal fibroblasts and basal keratinocytes, followed by significant cellular alterations, such as fibroblast apoptosis and lipid peroxidation. The full genome transcriptomic study showed a clear UVA1 molecular signature with the modulation of expression of 461 and 480 genes in epidermal keratinocytes and dermal fibroblasts, respectively (fold change >= 1.5 and adjusted p value<0.001). Functional enrichment analysis using GO, KEGG pathways and bibliographic analysis revealed a real stress with up-regulation of genes encoding heat shock proteins or involved in oxidative stress response. UVA1 also affected a wide panel of pathways and functions including cancer, proliferation, apoptosis and development, extracellular matrix and metabolism of lipids and glucose. Strikingly, one quarter of modulated genes was related to innate immunity: genes involved in inflammation were strongly up-regulated while genes involved in antiviral defense were severely down-regulated. These transcriptomic data were confirmed in dose-response and time course experiments using quantitative PCR and protein quantification. Links between the evidenced UVA1-induced impacts and clinical consequences of UVA1 exposure such as photo-aging, photo-immunosuppression and cancer are discussed. These early molecular events support the contribution of UVA1 to long term harmful consequences of UV exposure and underline the need of an adequate UVA1 photoprotection.	[Marionnet, Claire; Pierrard, Cecile; Golebiewski, Christelle; Bernerd, Francoise] LOreal Res & Innovat, Aulnay Sous Bois, France	L'Oreal Group	Marionnet, C (corresponding author), LOreal Res & Innovat, Aulnay Sous Bois, France.	cmarionnet@rd.loreal.com			L'Oreal	L'Oreal(L'Oreal Group)	L'Oreal provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aragane Y, 1997, P NATL ACAD SCI USA, V94, P11490, DOI 10.1073/pnas.94.21.11490; Aragane Y, 1997, J IMMUNOL, V158, P5393; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Bernerd F, 2000, PHOTOCHEM PHOTOBIOL, V71, P314, DOI 10.1562/0031-8655(2000)071<0314:EOTPEO>2.0.CO;2; Besaratinia A, 2005, P NATL ACAD SCI USA, V102, P10058, DOI 10.1073/pnas.0502311102; Bestak R, 1996, PHOTOCHEM PHOTOBIOL, V64, P969, DOI 10.1111/j.1751-1097.1996.tb01863.x; Breuckmann F, 2003, J EUR ACAD DERMATOL, V17, P418, DOI 10.1046/j.1468-3083.2003.00761.x; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; BRUNET S, 1989, MUTAT RES, V219, P217, DOI 10.1016/0921-8734(89)90003-9; Commission Internationale de l'Eclairage, 1989, SOL SPECTR IRR; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Damian DL, 2011, BRIT J DERMATOL, V164, P657, DOI 10.1111/j.1365-2133.2010.10161.x; Dekker P, 2005, PHOTOCHEM PHOTOBIOL, V81, P837, DOI 10.1562/2005-02-03-RA-432R.1; deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dissemond J, 2003, BRIT J DERMATOL, V149, P341, DOI 10.1046/j.1365-2133.2003.05457.x; Dumay O, 2001, BRIT J DERMATOL, V144, P1161, DOI 10.1046/j.1365-2133.2001.04225.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Ghorr AA, 1999, J INVEST DERMATOL, V112, P757, DOI 10.1046/j.1523-1747.1999.00565.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; France The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer, 2007, International Journal of Cancer, V120, P1116, DOI 10.1002/ijc.22453; Frederick JE, 1992, BIOL RESPONSES ULTRA, P7; GARMYN M, 1991, LAB INVEST, V65, P471; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godar DE, 1999, J INVEST DERMATOL, V112, P3, DOI 10.1046/j.1523-1747.1999.00474.x; Gordon JRS, 2012, NEW ENGL J MED, V366, pE25, DOI 10.1056/NEJMicm1104059; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Halliday GM, 2012, J INVEST DERMATOL, V132, P265, DOI 10.1038/jid.2011.281; Huang XX, 2009, AM J PATHOL, V174, P1534, DOI 10.2353/ajpath.2009.080318; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katsuta Y, 2005, J INVEST DERMATOL, V124, P1008, DOI 10.1111/j.0022-202X.2005.23682.x; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kerr AC, 2012, CLIN EXP DERMATOL, V37, P219, DOI 10.1111/j.1365-2230.2011.04256.x; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim EJ, 2010, J DERMATOL SCI, V57, P19, DOI 10.1016/j.jdermsci.2009.10.008; KLIGMAN LH, 1991, PHOTOCHEM PHOTOBIOL, V54, P233, DOI 10.1111/j.1751-1097.1991.tb02011.x; Kondo S, 1999, J INVEST DERM SYMP P, V4, P177, DOI 10.1038/sj.jidsp.5640205; Leccia MT, 1999, BIOL TRACE ELEM RES, V69, P177, DOI 10.1007/BF02783870; Ley RD, 2000, PHOTOCHEM PHOTOBIOL, V72, P485, DOI 10.1562/0031-8655(2000)072<0485:UIEAPD>2.0.CO;2; Lim HW, 2001, J AM ACAD DERMATOL, V44, P505, DOI 10.1067/mjd.2001.112913; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; Marionnet C, 2012, J DERMATOL SCI, V66, P238, DOI 10.1016/j.jdermsci.2012.02.018; Marionnet C, 2011, EXP DERMATOL, V20, P477, DOI 10.1111/j.1600-0625.2011.01265.x; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Matthews YJ, 2010, J DERMATOL SCI, V59, P192, DOI 10.1016/j.jdermsci.2010.07.005; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Morita A, 1997, J EXP MED, V186, P1763, DOI 10.1084/jem.186.10.1763; Moyal DD, 2001, J INVEST DERMATOL, V117, P1186, DOI 10.1046/j.0022-202x.2001.01545.x; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Persson AE, 2002, PHOTODERMATOL PHOTO, V18, P287, DOI 10.1034/j.1600-0781.2002.02781.x; Racz E, 2011, BRIT J DERMATOL, V164, P838, DOI 10.1111/j.1365-2133.2010.10169.x; Randhawa M, 2013, MOL BIOSYST, V9, P2045, DOI 10.1039/c3mb25537a; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402; Runger TM, 2012, PHOTOCH PHOTOBIO SCI, V11, P207, DOI 10.1039/c1pp05232b; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Sabziparvar AA, 1999, PHOTOCHEM PHOTOBIOL, V69, P193, DOI 10.1111/j.1751-1097.1999.tb03273.x; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Seite S, 2006, J EUR ACAD DERMATOL, V20, P980, DOI 10.1111/j.1468-3083.2006.01706.x; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Smit N, 2010, PHOTOCHEM PHOTOBIOL, V86, P360, DOI 10.1111/j.1751-1097.2009.00650.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tewari A, 2013, PHOTOCH PHOTOBIO SCI, V12, P95, DOI 10.1039/c2pp25323b; Tewari A, 2012, J INVEST DERMATOL, V132, P394, DOI 10.1038/jid.2011.283; TOVEY MG, 1987, P NATL ACAD SCI USA, V84, P5038, DOI 10.1073/pnas.84.14.5038; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vielhaber G, 2006, PHOTOCH PHOTOBIO SCI, V5, P275, DOI 10.1039/b516702g; Vioux-Chagnoleau C, 2006, J DERMATOL SCI, pS1, DOI 10.1016/j.descs.2006.08.001; Wang F, 2014, JAMA DERMATOL, V150, P401, DOI 10.1001/jamadermatol.2013.8417; Williams IR, 1996, LIFE SCI, V58, P1485, DOI 10.1016/0024-3205(96)00042-2; WLASCHEK M, 1994, PHOTOCHEM PHOTOBIOL, V59, P550, DOI 10.1111/j.1751-1097.1994.tb02982.x; York NR, 2010, INT J DERMATOL, V49, P623, DOI 10.1111/j.1365-4632.2009.04427.x; Yuen KS, 2002, NITRIC OXIDE-BIOL CH, V6, P313, DOI 10.1006/niox.2001.0414; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x	86	59	62	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105263	10.1371/journal.pone.0105263	http://dx.doi.org/10.1371/journal.pone.0105263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140898	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200067
J	Rommelaere, S; Millet, V; Manh, TPV; Gensollen, T; Andreoletti, P; Cherkaoui-Malki, M; Bourges, C; Escaliere, B; Du, X; Xia, Y; Imbert, J; Beutler, B; Kanai, Y; Malissen, B; Malissen, M; Tailleux, A; Staels, B; Galland, F; Naquet, P				Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Andreoletti, Pierre; Cherkaoui-Malki, Mustapha; Bourges, Christophe; Escaliere, Bertrand; Du, Xin; Xia, Yu; Imbert, Jean; Beutler, Bruce; Kanai, Yoshiakira; Malissen, Bernard; Malissen, Marie; Tailleux, Anne; Staels, Bart; Galland, Franck; Naquet, Philippe			Sox17 Regulates Liver Lipid Metabolism and Adaptation to Fasting	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; ACYL-COA THIOESTERASE; PPAR-ALPHA; TRANSCRIPTION FACTORS; BETA-OXIDATION; MOUSE; GENE; TRANSREPRESSION; RESISTANCE; LIPOLYSIS	Liver is a major regulator of lipid metabolism and adaptation to fasting, a process involving PPARalpha activation. We recently showed that the Vnn1 gene is a PPARalpha target gene in liver and that release of the Vanin-1 pantetheinase in serum is a biomarker of PPARalpha activation. Here we set up a screen to identify new regulators of adaptation to fasting using the serum Vanin-1 as a marker of PPARalpha activation. Mutagenized mice were screened for low serum Vanin-1 expression. Functional interactions with PPARalpha were investigated by combining transcriptomic, biochemical and metabolic approaches. We characterized a new mutant mouse in which hepatic and serum expression of Vanin-1 is depressed. This mouse carries a mutation in the HMG domain of the Sox17 transcription factor. Mutant mice display a metabolic phenotype featuring lipid abnormalities and inefficient adaptation to fasting. Upon fasting, a fraction of the PPAR alpha-driven transcriptional program is no longer induced and associated with impaired fatty acid oxidation. The transcriptional phenotype is partially observed in heterozygous Sox17+/- mice. In mutant mice, the fasting phenotype but not all transcriptomic signature is rescued by the administration of the PPARalpha agonist fenofibrate. These results identify a novel role for Sox17 in adult liver as a modulator of the metabolic adaptation to fasting.	[Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] Aix Marseille Univ, UM2, CIML, Marseille, France; [Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] INSERM, U1104, F-13258 Marseille, France; [Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] CNRS, UMR7280, Marseille, France; [Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo, Japan; [Imbert, Jean] Aix Marseille Univ, INSERM, TGML TAGC, UMR S 1090, Marseille, France; [Du, Xin; Xia, Yu; Beutler, Bruce] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Tailleux, Anne; Staels, Bart] Univ Lille 2, INSERM, U1011, Inst Pasteur Lille,EGID, Lille, France; [Andreoletti, Pierre; Cherkaoui-Malki, Mustapha] Univ Bourgogne, Lab BioPeroxIL, EA7270, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Bourgogne	Naquet, P (corresponding author), Aix Marseille Univ, UM2, CIML, Marseille, France.	fgpn@ciml.univ-mrs.fr	TAILLEUX, Anne/R-5530-2018; Staels, Bart/N-9497-2016; ANDREOLETTI, PIERRE/B-5245-2012; Imbert, Jean/G-3248-2013; Imbert, Jean/AAG-1165-2020; Malissen, Bernard/AAK-4659-2020	TAILLEUX, Anne/0000-0003-1430-2627; Staels, Bart/0000-0002-3784-1503; ANDREOLETTI, PIERRE/0000-0003-2118-7858; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Malissen, Bernard/0000-0003-1340-9342; Malissen, Marie/0000-0003-2331-1445; Kanai, Yoshiakira/0000-0003-2116-7806; /0000-0002-9834-5490; Vu Manh, Thien-Phong/0000-0002-0294-342X	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; INCA; European Communities MUGEN; Ministry of Research; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche (ANR) (PhyloGenDC) [ANR-09-BLAN-0073-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); INCA(Institut National du Cancer (INCA) France); European Communities MUGEN; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR) (PhyloGenDC)(French National Research Agency (ANR))	This work was supported by funds from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, INCA, European Communities MUGEN projects. S. R. and T. G. were supported by funds from the Ministry of Research and Fondation pour la Recherche Medicale. T.-P. V. M. was supported by the Agence Nationale de la Recherche (ANR) (PhyloGenDC, ANR-09-BLAN-0073-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Gartner J, 1993, Semin Cell Biol, V4, P45, DOI 10.1006/scel.1993.1006; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pfister S, 2011, INT J DEV BIOL, V55, P45, DOI 10.1387/ijdb.103158sp; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rommelaere S, 2013, FEBS LETT; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; SLAUTER RW, 1984, ARCH BIOCHEM BIOPHYS, V233, P197, DOI 10.1016/0003-9861(84)90617-9; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Uemura M, 2013, DEVELOPMENT, V140, P639, DOI 10.1242/dev.086702; Wilson MJ, 2005, J BIOL CHEM, V280, P5917, DOI 10.1074/jbc.M412806200; Yao CX, 2012, J MOL BIOL, V415, P143, DOI 10.1016/j.jmb.2011.11.011; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005	36	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104925	10.1371/journal.pone.0104925	http://dx.doi.org/10.1371/journal.pone.0104925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141153	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200042
J	Stutz, AJ				Stutz, Aaron Jonas			Modeling the Pre-Industrial Roots of Modern Super-Exponential Population Growth	PLOS ONE			English	Article							INTERGENERATIONAL TRANSFERS; EVOLUTIONARY-THEORY; COEVOLUTION; INEQUALITY; EMERGENCE; LONGEVITY; SELECTION	To Malthus, rapid human population growth-so evident in 18th Century Europe-was obviously unsustainable. In his Essay on the Principle of Population, Malthus cogently argued that environmental and socioeconomic constraints on population rise were inevitable. Yet, he penned his essay on the eve of the global census size reaching one billion, as nearly two centuries of super-exponential increase were taking off. Introducing a novel extension of J. E. Cohen's hallmark coupled difference equation model of human population dynamics and carrying capacity, this article examines just how elastic population growth limits may be in response to demographic change. The revised model involves a simple formalization of how consumption costs influence carrying capacity elasticity over time. Recognizing that complex social resource-extraction networks support ongoing consumption-based investment in family formation and intergenerational resource transfers, it is important to consider how consumption has impacted the human environment and demography-especially as global population has become very large. Sensitivity analysis of the consumption-cost model's fit to historical population estimates, modern census data, and 21st Century demographic projections supports a critical conclusion. The recent population explosion was systemically determined by long-term, distinctly pre-industrial cultural evolution. It is suggested that modern globalizing transitions in technology, susceptibility to infectious disease, information flows and accumulation, and economic complexity were endogenous products of much earlier biocultural evolution of family formation's embeddedness in larger, hierarchically self-organizing cultural systems, which could potentially support high population elasticity of carrying capacity. Modern super-exponential population growth cannot be considered separately from long-term change in the multi-scalar political economy that connects family formation and intergenerational resource transfers to wider institutions and social networks.	[Stutz, Aaron Jonas] Emory Univ, Oxford Coll, Div Hist & Social Sci, Oxford, GA 30054 USA; [Stutz, Aaron Jonas] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Emory University; Emory University	Stutz, AJ (corresponding author), Emory Univ, Oxford Coll, Div Hist & Social Sci, Oxford, GA 30054 USA.	astutz@emory.edu			Faculty Development Committee of Oxford College of Emory University	Faculty Development Committee of Oxford College of Emory University	This project has been supported by a grant from the Faculty Development Committee of Oxford College of Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bengtsson T., 2000, POPULATION EC HUNGER; BENTLEY GR, 1993, CURR ANTHROPOL, V34, P778, DOI 10.1086/204223; BIRABEN JN, 1980, J HUM EVOL, V9, P655, DOI 10.1016/0047-2484(80)90099-8; Blaxter SKL, 1986, PEOPLE FOOD RESOURCE; Bourke AFG, 2007, ANNU REV ECOL EVOL S, V38, P103, DOI 10.1146/annurev.ecolsys.38.091206.095528; CALDWELL JC, 1976, POPUL DEV REV, V2, P321, DOI 10.2307/1971615; Caldwell JC, 2006, DEMOGRAPHIC TRANSITION THEORY, P1, DOI 10.1007/978-1-4020-4498-4; Campbell KL, 1988, NATURAL HUMAN FERTIL, P39, DOI DOI 10.1007/978-1-349-09961-0_4; Chu CYC, 2006, THEOR POPUL BIOL, V69, P193, DOI 10.1016/j.tpb.2005.11.004; Clark C, 1977, POPULATION GROWTH LA; Cohen J. E., 1995, MANY PEOPLE CAN EART; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; Crumley C, 2007, WORLD SYSTEM EARTH S, P15; Crumley C., 1995, ARCHAEOLOGICAL PAPER, V6, P1, DOI [10.1525/ap3a.1995.6.1.1, DOI 10.1525/AP3A.1995.6.1.1]; Darwin C., 1859, ORIGINS SPECIES MEAN; Darwin CR, 1838, CUL DAR123; De Beer G, 1967, DARWINS NOTEBOOKS 6; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Earle Timothy, 1997, CHIEFS COME POWER PO; Ellison P.T., 2001, FERTILE GROUND NATUR; Fagan B. M., 2001, LITTLE ICE AGE CLIMA; Ferguson N., 2008, ASCENT MONEY; Fitzhugh B, 2001, J ANTHROPOL ARCHAEOL, V20, P125, DOI 10.1006/jaar.2001.0380; Flannery K., 2012, CREATION INEQUALITY; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foucault M., 1977, DISCIPLINE PUNISH BI; Foucault Michel, 1973, MADNESS CIVILIZATION; Galor O, 2004, REV ECON STUD, V71, P1001, DOI 10.1111/0034-6527.00312; Galor O, 2000, AM ECON REV, V90, P806, DOI 10.1257/aer.90.4.806; Galor O, 2009, REV ECON STUD, V76, P143, DOI 10.1111/j.1467-937X.2008.00506.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Graeber D, 2011, HAU-J ETHNOGR THEORY, V1, P1, DOI 10.14318/hau1.1.002; Grove M, 2012, J HUM EVOL, V62, P191, DOI 10.1016/j.jhevol.2011.10.012; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P4765, DOI 10.1073/pnas.0611197104; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Haub C, 2002, POPUL REF BUR; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Johnson Allen, 2000, EVOLUTION HUMAN SOC; Johnson-Hanks J, 2008, ANNU REV ANTHROPOL, V37, P301, DOI 10.1146/annurev.anthro.37.081407.085138; Jones Charles I., 2001, ADV MACROECONOMICS, V1, P1, DOI DOI 10.2202/1534-6013.1028; Kaplan H, 2003, POPUL DEV REV, V29, P152; Kaplan HS, 2009, PHILOS T R SOC B, V364, P3289, DOI 10.1098/rstb.2009.0115; Kaplan HS, 2009, P ROY SOC B-BIOL SCI, V276, P1837, DOI 10.1098/rspb.2008.1831; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kirch Patrick V., 2010, CHIEFS BECAME KINGS; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Lee CT, 2008, THEOR POPUL BIOL, V73, P473, DOI 10.1016/j.tpb.2008.03.001; Lee CT, 2009, THEOR POPUL BIOL, V76, P179, DOI 10.1016/j.tpb.2009.06.003; Lee R D, 1988, Math Popul Stud, V1, P265; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; LEE RD, 1986, MALTHUS BOSERUP DYNA, P96; LEE RD, 2007, DEMOGRAPHIC CHANGE W, P17; Lee R, 2008, P NATL ACAD SCI USA, V105, P7124, DOI 10.1073/pnas.0710234105; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Livi-Bacci M., 2012, CONCISE HIST WORLD P; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Low BS, 1991, FAMILY PATTERNS 19 C; Malthus TR, 1798, ESSAY PRINCIPLE POPU, V1; Marx K., 1993, GRUNDRISSE FDN CRITI; McEvedy C., 1978, ATLAS WORLD POPULATI; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pianka E. R, 2011, EVOL ECOL, V7; Poppy GM, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2012.0288, 10.1098/rstb.2012.0272]; Price D, 1999, POPUL ENVIRON, V21, P5, DOI 10.1007/BF02436118; Puleston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087541; Puleston CO, 2008, THEOR POPUL BIOL, V74, P147, DOI 10.1016/j.tpb.2008.05.007; Scott J.C., 1977, MORAL EC PEASANT REB; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; United Nations Population Division, 1999, WORLD 6 BILL; US Census Bureau DIS, INT PROGR WORLD POP; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; Wood JW, 1998, CURR ANTHROPOL, V39, P99, DOI 10.1086/204700	78	5	5	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105291	10.1371/journal.pone.0105291	http://dx.doi.org/10.1371/journal.pone.0105291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141019	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200068
J	Lopes, AM; Machado, JAT				Lopes, Antonio M.; Machado, J. A. Tenreiro			Dynamic Analysis and Pattern Visualization of Forest Fires	PLOS ONE			English	Article							MUTUAL INFORMATION; MODEL	This paper analyses forest fires in the perspective of dynamical systems. Forest fires exhibit complex correlations in size, space and time, revealing features often present in complex systems, such as the absence of a characteristic length-scale, or the emergence of long range correlations and persistent memory. This study addresses a public domain forest fires catalogue, containing information of events for Portugal, during the period from 1980 up to 2012. The data is analysed in an annual basis, modelling the occurrences as sequences of Dirac impulses with amplitude proportional to the burnt area. First, we consider mutual information to correlate annual patterns. We use visualization trees, generated by hierarchical clustering algorithms, in order to compare and to extract relationships among the data. Second, we adopt the Multidimensional Scaling (MDS) visualization tool. MDS generates maps where each object corresponds to a point. Objects that are perceived to be similar to each other are placed on the map forming clusters. The results are analysed in order to extract relationships among the data and to identify forest fire patterns.	[Lopes, Antonio M.] Univ Porto, Inst Engn Mech, Fac Engn, P-4100 Oporto, Portugal; [Machado, J. A. Tenreiro] Polytech Porto, Inst Engn, Oporto, Portugal	Universidade do Porto; Polytechnic Institute of Porto	Lopes, AM (corresponding author), Univ Porto, Inst Engn Mech, Fac Engn, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aml@fe.up.pt	Machado, J. A. Tenreiro/M-2173-2013; Lopes, António M./A-2740-2016	Machado, J. A. Tenreiro/0000-0003-4274-4879; Lopes, António M./0000-0001-7359-4370				Alvarado E., 1998, NORTHWEST SCI, V72, P66; [Anonymous], 2005, EXPLORATORY DATA ANA; BAK P, 1990, PHYS LETT A, V147, P297, DOI 10.1016/0375-9601(90)90451-S; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barford P., 1999, World Wide Web, V2, P15, DOI 10.1023/A:1019236319752; Bradstock RA, 2008, INT J WILDLAND FIRE, V17, P809, DOI 10.1071/WF07153; Costa AM, 2011, BIOINFORMATICS, V27, P1207, DOI 10.1093/bioinformatics/btr131; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Di Bella CM, 2006, GLOBAL ECOL BIOGEOGR, V15, P192, DOI [10.1111/j.1466-822x.2006.00225.x, 10.1111/j.1466-822X.2006.00225.x]; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Fletcher I. N., 2013, BIOGEOSCIENCES DISCU, V10, P14141; Hanson CT, 2014, INT J WILDLAND FIRE, V23, P1, DOI 10.1071/WF13016; HERZEL H, 1994, CHAOS SOLITON FRACT, V4, P97, DOI 10.1016/0960-0779(94)90020-5; Jain AK., 1988, TECHNOMETRICS; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kruskal J, 1978, MULTIDIMENSIONAL SCA; KVALSETH TO, 1987, IEEE T SYST MAN CYB, V17, P517, DOI 10.1109/TSMC.1987.4309069; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Marques S, 2011, EUR J FOREST RES, V130, P775, DOI 10.1007/s10342-010-0470-4; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; Mohajeri N, 2012, ENTROPY-SWITZ, V14, P800, DOI 10.3390/e14040800; Mori T, 1998, PHYSICA D, V116, P275, DOI 10.1016/S0167-2789(97)00302-3; Pinto CMA, 2012, COMMUN NONLINEAR SCI, V17, P3558, DOI 10.1016/j.cnsns.2012.01.013; Posadas A, 2000, PHYS EARTH PLANET IN, V122, P269, DOI 10.1016/S0031-9201(00)00181-3; Preisler HK, 2011, INT J WILDLAND FIRE, V20, P508, DOI 10.1071/WF09087; Prentice IC, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003906; Reed WJ, 2002, ECOL MODEL, V150, P239, DOI 10.1016/S0304-3800(01)00483-5; Ricotta C, 1999, ECOL MODEL, V119, P73, DOI 10.1016/S0304-3800(99)00057-5; Silva FRY, 2010, INT J WILDLAND FIRE, V19, P927, DOI 10.1071/WF09015; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; Telesca L, 2005, ECOL MODEL, V185, P531, DOI 10.1016/j.ecolmodel.2005.01.009; Telesca L, 2011, ENTROPY-SWITZ, V13, P1267, DOI 10.3390/e13071267; Telesca L, 2007, COMMUN NONLINEAR SCI, V12, P1326, DOI 10.1016/j.cnsns.2005.12.003; Machado JAT, 2013, ENTROPY-SWITZ, V15, P3892, DOI 10.3390/e15093892; Tzagarakis C, 2009, EXP BRAIN RES, V194, P369, DOI 10.1007/s00221-009-1709-5; Zamora R, 2010, ECOL MODEL, V221, P19, DOI 10.1016/j.ecolmodel.2009.07.010; Zumbrunnen T, 2011, FOREST ECOL MANAG, V261, P2188, DOI 10.1016/j.foreco.2010.10.009	39	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105465	10.1371/journal.pone.0105465	http://dx.doi.org/10.1371/journal.pone.0105465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137393	gold, Green Published			2022-12-27	WOS:000340742100098
J	Ma, YL; Lin, HF				Ma, Yunlong; Lin, Hongfei			A Multiple Relevance Feedback Strategy with Positive and Negative Models	PLOS ONE			English	Article								A commonly used strategy to improve search accuracy is through feedback techniques. Most existing work on feedback relies on positive information, and has been extensively studied in information retrieval. However, when a query topic is difficult and the results from the first-pass retrieval are very poor, it is impossible to extract enough useful terms from a few positive documents. Therefore, the positive feedback strategy is incapable to improve retrieval in this situation. Contrarily, there is a relatively large number of negative documents in the top of the result list, and it has been confirmed that negative feedback strategy is an important and useful way for adapting this scenario by several recent studies. In this paper, we consider a scenario when the search results are so poor that there are at most three relevant documents in the top twenty documents. Then, we conduct a novel study of multiple strategies for relevance feedback using both positive and negative examples from the first-pass retrieval to improve retrieval accuracy for such difficult queries. Experimental results on these TREC collections show that the proposed language model based multiple model feedback method which is generally more effective than both the baseline method and the methods using only positive or negative model.	[Ma, Yunlong; Lin, Hongfei] Dalian Univ Technol, Sch Comp Sci & Technol, Informat Retrieval Lab, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Lin, HF (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Informat Retrieval Lab, Dalian, Liaoning, Peoples R China.	hflin@dlut.edu.cn						ATTAR R, 1977, J ACM, V24, P397, DOI 10.1145/322017.322021; Berger A, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P222, DOI 10.1145/312624.312681; Buckley Chris, 1994, P 3 TEXT RETR C TREC, P69; Chengxiang Zhai, 2001, Proceedings of the 2001 ACM CIKM. Tenth International Conference on Information and Knowledge Management, P403, DOI 10.1145/502585.502654; Croft B., 2009, SEARCH ENGINES INFOR; CROFT W, 1996, SIGIR 1996 P 19 ANN, P4; Dunlop MD, 1997, ACM T INFORM SYST, V15, P137, DOI 10.1145/248625.248650; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Kankanhalli MS, 2008, P IEEE, V96, P712, DOI 10.1109/JPROC.2008.916383; KARIMZADEHGAN M, 2010, P 19 ACM INT C INF K, P1397, DOI DOI 10.1145/1871437.1871631; Karimzadehgan Maryam, 2011, CIKM 11, P27, DOI DOI 10.1145/2063576.2063586; LAFFERTY J, 2001, P 24 ANN INT ACM SIG, P111, DOI DOI 10.1145/383952.383970; Lavrenko V., 2001, SIGIR Forum, P120; Lv Y., 2009, P 18 ACM C INF KNOWL, P1895, DOI [DOI 10.1145/1645953.1646259, 10.1145/1645953.1646259]; Miller DRH, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P214, DOI 10.1145/312624.312680; NG K, 1999, MAXIMUM LIKELIHOOD R; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Raman K, 2010, LECT NOTES COMPUT SC, V5993, P573, DOI 10.1007/978-3-642-12275-0_50; ROBERTSON SE, 1976, J AM SOC INFORM SCI, V27, P129, DOI 10.1002/asi.4630270302; ROCCHIO J, 1971, SMART RETRIEVAL SYST, V21, P313; Rui Y, 1998, IEEE T CIRC SYST VID, V8, P644, DOI 10.1109/76.718510; SALTON G, 1990, J AM SOC INFORM SCI, V41, P288, DOI 10.1002/(SICI)1097-4571(199006)41:4<288::AID-ASI8>3.0.CO;2-H; Shen X., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P43, DOI 10.1145/1076034.1076045; Singhal A, 1997, PROCEEDINGS OF THE 20TH ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P25, DOI 10.1145/278459.258530; Song F, 1999, PROCEEDINGS OF THE EIGHTH INTERNATIONAL CONFERENCE ON INFORMATION KNOWLEDGE MANAGEMENT, CIKM'99, P316, DOI 10.1145/319950.320022; WANG X, 2007, P C INF KNOWL MAN LI, P991, DOI DOI 10.1145/1321440.1321593; WANG X, 2008, P 31 ANN INT ACM SIG, P219, DOI DOI 10.1145/1390334.1390374; ZHAI C, 2001, P 24 ANN INT ACM SIG, P334, DOI DOI 10.1145/383952.384019; Zhang P, 2010, LECT NOTES COMPUT SC, V6458, P527, DOI 10.1007/978-3-642-17187-1_50	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104707	10.1371/journal.pone.0104707	http://dx.doi.org/10.1371/journal.pone.0104707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137234	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100043
J	Marchetti, A; Del Grammastro, M; Felicioni, L; Malatesta, S; Filice, G; Centi, I; De Pas, T; Santoro, A; Chella, A; Brandes, AA; Venturino, P; Cuccurullo, F; Crino, L; Buttitta, F				Marchetti, Antonio; Del Grammastro, Maela; Felicioni, Lara; Malatesta, Sara; Filice, Giampaolo; Centi, Irene; De Pas, Tommaso; Santoro, Armando; Chella, Antonio; Brandes, Alba Ariela; Venturino, Paola; Cuccurullo, Franco; Crino, Lucio; Buttitta, Fiamma			Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment	PLOS ONE			English	Article							FACTOR-RECEPTOR MUTATIONS; BREAST-CANCER; MOLECULAR CHARACTERIZATION; PROGRESSION-FREE; DISCORDANCE; EXPRESSION; SURVIVAL; THERAPY; DNA	Introduction: Assessment of EGFR mutation in non-small cell lung cancer (NSCLC) patients is mandatory for optimization of pharmacologic treatment. In this respect, mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status. Experimental Design: Blood samples were collected from 37 patients enrolled in the TRIGGER study, a prospective phase II multi-center trial of erlotinib treatment in advanced NSCLC patients with activating EGFR mutations in tumor tissue. 10 CTC preparations from breast cancer patients without EGFR mutations in their primary tumors and 12 blood samples from healthy subjects were analyzed as negative controls. CTC preparations, obtained by the Veridex CellSearch System, were subjected to ultra-deep next generation sequencing (NGS) on the Roche 454 GS junior platform. Results: CTCs fulfilling all Veridex criteria were present in 41% of the patients examined, ranging in number between 1 and 29. In addition to validated CTCs, potential neoplastic elements were seen in 33 cases. These included cells not fulfilling all Veridex criteria (also known as "suspicious objects'') found in 5 (13%) of 37 cases, and isolated or clustered large naked nuclei with irregular shape observed in 33 (89%) cases. EGFR mutations were identified by NGS in CTC preparations of 31 (84%) patients, corresponding to those present in matching tumor tissue. Twenty-five (96%) of 26 deletions at exon 19 and 6 (55%) of 11 mutations at exon 21 were detectable (P = 0.005). In 4 (13%) cases, multiple EGFR mutations, suggesting CTC heterogeneity, were documented. No mutations were found in control samples. Conclusions: We report for the first time that the CellSearch System coupled with NGS is a very sensitive and specific diagnostic tool for EGFR mutation analysis in CTC preparations with potential clinical impact.	[Marchetti, Antonio; Del Grammastro, Maela; Felicioni, Lara; Malatesta, Sara; Filice, Giampaolo; Cuccurullo, Franco; Buttitta, Fiamma] Univ Fdn, Ctr Predict Mol Med, Ctr Excellence Aging, Chieti, Italy; [Felicioni, Lara; Buttitta, Fiamma] Univ Fdn, Oncol & Cardiovasc Mol Med Unit, Ctr Excellence Aging, Chieti, Italy; [Centi, Irene] Hosp SS Annunziata, Pathol Unit, Chieti, Italy; [De Pas, Tommaso] European Inst Oncol, Dept Med, Milan, Italy; [Santoro, Armando] Humanitas Canc Ctr IRCCS, Dept Oncol, Rozzano, Italy; [Chella, Antonio] Univ Pisa, Cardiothorac Dept, Pisa, Italy; [Brandes, Alba Ariela] Azienda USL Bologna, Bellaria Maggiore Hosp, Dept Med Oncol, Bologna, Italy; [Venturino, Paola] Roche SpA, Monza, Italy; [Crino, Lucio] Azienda Osped Perugia, Santa Maria della Misericordia Hosp, Dept Med Oncol, Perugia, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Humanitas Research Hospital; University of Pisa; AUSL di Bologna; Roche Holding; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Marchetti, A (corresponding author), Univ Fdn, Ctr Predict Mol Med, Ctr Excellence Aging, Chieti, Italy.	amarchetti@unich.it; fbuttitta@unich.it	Santoro, Armando/J-9594-2018; De Pas, tommaso/K-4879-2018	Santoro, Armando/0000-0003-1709-9492; 	Roche S.p.A.	Roche S.p.A.	Roche S.p.A. provided support in the form of salaries for authors [PV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Boe Sorensen, 2013, 15 WORLD C LUNG CANC; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Chang YL, 2011, ANN SURG ONCOL, V18, P543, DOI 10.1245/s10434-010-1295-6; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Han HS, 2011, CLIN LUNG CANCER, V12, P380, DOI 10.1016/j.cllc.2011.02.006; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Jiang YQ, 2010, CLIN CHEM, V56, P1492, DOI 10.1373/clinchem.2010.143297; Kobayashi S, 2013, J THORAC ONCOL, V8, P118, DOI 10.1097/JTO.0b013e3182781e35; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lianidou ES, 2013, BRIT J CANCER, V108, P2426, DOI 10.1038/bjc.2013.265; Lianidou ES, 2011, CLIN CHEM, V57, P1242, DOI 10.1373/clinchem.2011.165068; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Marchetti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042164; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mayo C, 2012, PHARMACOGENOMICS, V13, P789, DOI [10.2217/PGS.12.54, 10.2217/pgs.12.54]; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Riethdorf S, 2010, ANN NY ACAD SCI, V1210, P66, DOI 10.1111/j.1749-6632.2010.05779.x; Rink M, 2012, EUR UROL, V61, P810, DOI 10.1016/j.eururo.2012.01.017; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sholl LM, 2009, CANCER RES, V69, P8341, DOI 10.1158/0008-5472.CAN-09-2477; Somlo G, 2011, BREAST CANCER RES TR, V128, P155, DOI 10.1007/s10549-011-1508-0; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587	33	124	127	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103883	10.1371/journal.pone.0103883	http://dx.doi.org/10.1371/journal.pone.0103883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137181	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100015
J	Yang, MY; Wu, H; Lian, Y; Li, XF; Lai, FR; Zhao, GL				Yang, Meiyan; Wu, Hui; Lian, Yan; Li, Xiaofeng; Lai, Furao; Zhao, Guanglei			Influence of Organic Solvents on Catalytic Behaviors and Cell Morphology of Whole-Cell Biocatalysts for Synthesis of 5 '-Arabinocytosine Laurate	PLOS ONE			English	Article							REGIOSELECTIVE ENZYMATIC ACYLATION; 1-BETA-D-ARABINOFURANOSYLCYTOSINE; TOXICITY; ENZYMES	A whole-cell based method was developed for the regioselective synthesis of arabinocytosine laurate. Among the seven kinds of bacteria strains tested in the acylation reaction, Pseudomonas fluorescens gave the highest productivity and a higher 5'-regioselectivity than 99%. Compared with pure organic solvents, the use of organic solvent mixtures greatly promoted the yield of the whole-cell catalyzed reaction, but showed little influence on the 5'-regioselectivity. Of all the tested solvent mixtures, the best reaction result was found in isopropyl ether/pyridine followed by isopentanol/pyridine. However, the whole-cells showed much lower thermostability in isopropyl ether/pyridine than in THF-pyridine. To better understand the toxic effects of the organic solvents on P. fluorescens whole-cells and growing cells were further examined. Significant influences of organic solvents on the biomass of the cells were found, which differed depending on the type of solvents used. SEM analysis visually revealed the changes in the surface morphology of whole-cells and growing cells cultured in media containing various organic solvents, in terms of surface smoothness, bulges and changed cell sizes. Results demonstrated that organic toxicity to cell structure played an important role in whole-cell mediated catalysis.	[Yang, Meiyan; Li, Xiaofeng; Zhao, Guanglei] S China Univ Technol, State Key Lab Pulp & Paper Making Engn, Guangzhou, Guangdong, Peoples R China; [Yang, Meiyan; Wu, Hui; Lian, Yan; Lai, Furao] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Li, XF (corresponding author), S China Univ Technol, State Key Lab Pulp & Paper Making Engn, Guangzhou, Guangdong, Peoples R China.	xflibio@scut.edu.cn; zhaoguanglei@gmail.com			National Natural Science Foundation of China [31270636]; Foundation for Natural Science Foundation of Guangdong Province [S2013010012486]; Project of Department of Education of Guangdong Province [2012KJCX0006]; Program for New Century Excellent Talents in University [NCET-12-0192]; self determined research funds of SCUT from the college basic research and operation of MOE [2013ZM0044, 2013ZZ0068, 2013ZM0065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Project of Department of Education of Guangdong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); self determined research funds of SCUT from the college basic research and operation of MOE	The National Natural Science Foundation of China (No. 31270636), a Foundation for Natural Science Foundation of Guangdong Province (No. S2013010012486), the Project of Department of Education of Guangdong Province (No. 2012KJCX0006), Program for New Century Excellent Talents in University (NCET-12-0192) and self determined research funds of SCUT from the college basic research and operation of MOE (Nos. 2013ZM0044, 2013ZZ0068 and 2013ZM0065) supported the study design, data collection and analysis, decision to publish.	Baumgarten T, 2012, APPL MICROBIOL BIOT, V93, P837, DOI 10.1007/s00253-011-3442-9; Bommarius A.S., 2004, BIOCATALYSIS; Bornscheuer UT, 2002, TRENDS BIOTECHNOL, V20, P433, DOI 10.1016/S0167-7799(02)02046-2; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; de Bont JAM, 1998, TRENDS BIOTECHNOL, V16, P493, DOI 10.1016/S0167-7799(98)01234-7; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Ferrero M, 2000, MONATSH CHEM, V131, P585, DOI 10.1007/s007060070088; Gonzalez-Sabin J, 2011, CHEM SOC REV, V40, P5321, DOI 10.1039/c1cs15081b; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Li XF, 2006, J BIOTECHNOL, V124, P552, DOI 10.1016/j.jbiotec.2006.01.013; Li XF, 2012, PROCESS BIOCHEM, V47, P1826, DOI 10.1016/j.procbio.2012.06.009; Li XF, 2012, BIORESOURCE TECHNOL, V114, P6, DOI 10.1016/j.biortech.2012.03.056; Li XF, 2010, APPL MICROBIOL BIOT, V88, P57, DOI 10.1007/s00253-010-2705-1; Li XF, 2010, BIOORG MED CHEM LETT, V20, P4125, DOI 10.1016/j.bmcl.2010.05.077; Matsuda A, 2004, CANCER SCI, V95, P105, DOI 10.1111/j.1349-7006.2004.tb03189.x; Matsumoto M, 2004, J BIOSCI BIOENG, V98, P344, DOI 10.1016/S1389-1723(04)00293-2; Matsumoto M, 2002, J BIOSCI BIOENG, V94, P45; NAKAJIMA H, 1995, APPL ENVIRON MICROB, V61, P2302, DOI 10.1128/AEM.61.6.2302-2307.1995; Riva S, 2001, CURR OPIN CHEM BIOL, V5, P106, DOI 10.1016/S1367-5931(00)00178-2; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Serdakowski AL, 2008, TRENDS BIOTECHNOL, V26, P48, DOI 10.1016/j.tibtech.2007.10.007; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Torres S, 2009, BIORESOURCE TECHNOL, V100, P896, DOI 10.1016/j.biortech.2008.07.009; Wagner CR, 2000, MED RES REV, V20, P417, DOI 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z	27	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104847	10.1371/journal.pone.0104847	http://dx.doi.org/10.1371/journal.pone.0104847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136983	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100048
J	Chen, J; Lv, FJ; Liu, JR; Ma, Y; Wang, YH; Chen, BL; Meng, YL; Zhou, ZG; Oosterhuis, DM				Chen, Ji; Lv, Fengjuan; Liu, Jingran; Ma, Yina; Wang, Youhua; Chen, Binglin; Meng, Yali; Zhou, Zhiguo; Oosterhuis, Derrick M.			Effect of Late Planting and Shading on Cellulose Synthesis during Cotton Fiber Secondary Wall Development	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; COOL TEMPERATURE; CELL-WALL; IN-VITRO; ELONGATION; METABOLISM; YIELD; LOCALIZATION; INVERTASE; RESPONSES	Cotton-rapeseed or cotton-wheat double cropping systems are popular in the Yangtze River Valley and Yellow River Valley of China. Due to the competition of temperature and light resources during the growing season of double cropping system, cotton is generally late-germinating and late-maturing and has to suffer from the coupling of declining temperature and low light especially in the late growth stage. In this study, late planting (LP) and shading were used to fit the coupling stress, and the coupling effect on fiber cellulose synthesis was investigated. Two cotton (Gossypium hirsutum L.) cultivars were grown in the field in 2010 and 2011 at three planting dates (25 April, 25 May and 10 June) each with three shading levels (normal light, declined 20% and 40% PAR). Mean daily minimum temperature was the primary environmental factor affected by LP. The coupling of LP and shading (decreased cellulose content by 7.8%-25.5%) produced more severe impacts on cellulose synthesis than either stress alone, and the effect of LP (decreased cellulose content by 6.7%-20.9%) was greater than shading (decreased cellulose content by 0.7%-5.6%). The coupling of LP and shading hindered the flux from sucrose to cellulose by affecting the activities of related cellulose synthesis enzymes. Fiber cellulose synthase genes expression were delayed under not only LP but shading, and the coupling of LP and shading markedly postponed and even restrained its expression. The decline of sucrose-phosphate synthase activity and its peak delay may cause cellulose synthesis being more sensitive to the coupling stress during the later stage of fiber secondary wall development (38-45 days post-anthesis). The sensitive difference of cellulose synthesis between two cultivars in response to the coupling of LP and shading may be mainly determined by the sensitiveness of invertase, sucrose-phosphate synthase and cellulose synthase.	[Chen, Ji; Lv, Fengjuan; Liu, Jingran; Ma, Yina; Wang, Youhua; Chen, Binglin; Meng, Yali; Zhou, Zhiguo] Nanjing Agr Univ, Key Lab Crop Physiol & Ecol, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Oosterhuis, Derrick M.] Univ Arkansas, Dept Crop & Soil Environm Sci, Fayetteville, AR 72701 USA	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	Zhou, ZG (corresponding author), Nanjing Agr Univ, Key Lab Crop Physiol & Ecol, Minist Agr, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn			National Natural Science Foundation of China [30971735]; China Agriculture Research System [CARS-18-20]; Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China) [200903003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China)	This work was funded by the National Natural Science Foundation of China (30971735), China Agriculture Research System (CARS-18-20), and the Special Fund for Agro-scientific Research in the Public Interest (Impact of climate change on agriculture production of China, 200903003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Babb VM, 2001, PLANT PHYSIOL, V127, P1234, DOI 10.1104/pp.010424; Bian HaiYun, 2008, Scientia Agricultura Sinica, V41, P1235; Bradow JM, 2010, PHYSIOLOGY OF COTTON, P229, DOI 10.1007/978-90-481-3195-2_21; Dai JL, 2014, FIELD CROP RES, V155, P99, DOI 10.1016/j.fcr.2013.09.017; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; EATON FM, 1954, PLANT PHYSIOL, V29, P39, DOI 10.1104/pp.29.1.39; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Haigler Candace H., 2007, P147, DOI 10.1007/978-1-4020-5380-1_9; HAIGLER CH, 1991, PLANT PHYSIOL, V95, P88, DOI 10.1104/pp.95.1.88; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; KHAYAT E, 1987, PLANT PHYSIOL, V84, P447, DOI 10.1104/pp.84.2.447; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; KOHLE H, 1985, PLANT PHYSIOL, V77, P544, DOI 10.1104/pp.77.3.544; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li Tian, 2006, Acta Agronomica Sinica, V32, P943; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Liu JR, 2013, FIELD CROP RES, V144, P200, DOI 10.1016/j.fcr.2013.02.003; MALTBY D, 1979, PLANT PHYSIOL, V63, P1158, DOI 10.1104/pp.63.6.1158; Martin LK, 2004, CELLULOSE, V11, P339, DOI 10.1023/B:CELL.0000046420.10403.15; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; PETTIGREW WT, 1995, AGRON J, V87, P947, DOI 10.2134/agronj1995.00021962008700050029x; Pettigrew WT, 2001, CROP SCI, V41, P1108, DOI 10.2135/cropsci2001.4141108x; Ren WanJun, 2003, Acta Agronomica Sinica, V29, P785; ROBERTS EM, 1992, PLANT PHYSIOL, V100, P979, DOI 10.1104/pp.100.2.979; Roussopoulos D, 1998, J AGR SCI-CAMBRIDGE, V131, P277, DOI 10.1017/S0021859698005735; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2007, FUNCT PLANT BIOL, V34, P1, DOI 10.1071/FP06234; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; WAFLER U, 1994, PLANT PHYSIOL BIOCH, V32, P697; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang Qingcai, 2005, Yingyong Shengtai Xuebao, V16, P1465; Wang QingCai, 2006, Acta Agronomica Sinica, V32, P671; Wang YouHua, 2008, Scientia Agricultura Sinica, V41, P3865; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; XIE WZ, 1993, CROP SCI, V33, P1258, DOI 10.2135/cropsci1993.0011183X003300060029x; Yeates SJ, 2010, FIELD CROP RES, V116, P300, DOI 10.1016/j.fcr.2010.01.006; Zhang JiWang, 2008, Acta Agronomica Sinica, V34, P1470, DOI 10.3724/SP.J.1006.2008.01470; Zhao D, 2000, EXP AGR, V36, P27, DOI 10.1017/S0014479700361014; Zhao D, 1998, J PLANT GROWTH REGUL, V17, P47, DOI 10.1007/PL00007011; Zhao WenQing, 2012, American Journal of Experimental Agriculture, V2, P133	49	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105088	10.1371/journal.pone.0105088	http://dx.doi.org/10.1371/journal.pone.0105088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133819	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700068
J	Hodgin, JB; Berthier, CC; John, R; Grone, E; Porubsky, S; Grone, HJ; Herzenberg, AM; Scholey, JW; Hladunewich, M; Cattran, DC; Kretzler, M; Reich, HN				Hodgin, Jeffrey B.; Berthier, Celine C.; John, Rohan; Grone, Elisabeth; Porubsky, Stefan; Groene, Hermann-Josef; Herzenberg, Andrew M.; Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Kretzler, Matthias; Reich, Heather N.			The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; VALIDATION; IMMUNOSUPPRESSION; RESVERATROL; INHIBITION; ACTIVATION	IgA nephropathy (IgAN) is a clinically and pathologically heterogeneous disease. Endocapillary proliferation is associated with higher risk of progressive disease, and clinical studies suggest that corticosteroids mitigate this risk. However, corticosteroids are associated with protean cellular effects and significant toxicity. Furthermore the precise mechanism by which they modulate kidney injury in IgAN is not well delineated. To better understand molecular pathways involved in the development of endocapillary proliferation and to identify novel specific therapeutic targets, we evaluated the glomerular transcriptome of microdissected kidney biopsies from 22 patients with IgAN. Endocapillary proliferation was defined according to the Oxford scoring system independently by 3 nephropathologists. We analyzed mRNA expression using microarrays and identified transcripts differentially expressed in patients with endocapillary proliferation compared to IgAN without endocapillary lesions. Next, we employed both transcription factor analysis and in silico drug screening and confirmed that the endocapillary proliferation transcriptome is significantly enriched with pathways that can be impacted by corticosteroids. With this approach we also identified novel therapeutic targets and bioactive small molecules that may be considered for therapeutic trials for the treatment of IgAN, including resveratrol and hydroquinine. In summary, we have defined the distinct molecular profile of a pathologic phenotype associated with progressive renal insufficiency in IgAN. Exploration of the pathways associated with endocapillary proliferation confirms a molecular basis for the clinical effectiveness of corticosteroids in this subgroup of IgAN, and elucidates new therapeutic strategies for IgAN.	[Hodgin, Jeffrey B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Berthier, Celine C.] Univ Michigan, Dept Internal Med Nephrol & Computat Med & Bioinf, Ann Arbor, MI 48109 USA; [John, Rohan; Herzenberg, Andrew M.] Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [John, Rohan; Herzenberg, Andrew M.; Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Grone, Elisabeth; Porubsky, Stefan; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Porubsky, Stefan] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Hladunewich, Michelle] Sunnybrook Hlth Sci Ctr, Dept Nephrol, Toronto, ON M4N 3M5, Canada; [Herzenberg, Andrew M.] Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Scholey, James W.; Hladunewich, Michelle; Cattran, Daniel C.; Reich, Heather N.] Toronto Glomerulonephritis Registry, Toronto, ON, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Reich, HN (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	heather.reich@uhn.ca	Porubsky, Stefan/AAX-9682-2021; Porubsky, Stefan/J-5738-2015	Porubsky, Stefan/0000-0002-7647-7265; Porubsky, Stefan/0000-0002-7647-7265; John, Rohan/0000-0001-7946-3013	NIH [RO1- DK085241, 5-K08-DK088944]; Physicians Services Incorporated Foundation; Amgen Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241, K08DK088944, P30DK081943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physicians Services Incorporated Foundation; Amgen Inc.(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work of CCB was supported by a grant from the NIH (RO1- DK085241). The work of AH and HNR was supported by an initial grant from the Physicians Services Incorporated Foundation and unrestricted investigator-initiated funds from Amgen Inc. The work of JBH was supported by a grant from the NIH (5-K08-DK088944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Butte AJ, 2012, CLIN PHARMACOL THER, V91, P949, DOI 10.1038/clpt.2012.55; Cattran DC, 2009, KIDNEY INT; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; Coppo R, 2010, J NEPHROL, V23, P626; El Karoui K, 2011, KIDNEY INT, V79, P643, DOI 10.1038/ki.2010.460; GESUALDO L, 1990, J IMMUNOL, V145, P3684; Giovannini L, 2001, J CARDIOVASC PHARM, V37, P262, DOI 10.1097/00005344-200103000-00004; Halling SE, 2012, NEPHROL DIAL TRANSPL, V27, P715, DOI 10.1093/ndt/gfr339; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Hotta O, 2002, AM J KIDNEY DIS, V39, P493, DOI 10.1053/ajkd.2002.31399; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee H, 2012, KOREAN J INTERN MED, V27, P293, DOI 10.3904/kjim.2012.27.3.293; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Roberts ISD, 2013, CURR OPIN NEPHROL HY, V22, P281, DOI 10.1097/MNH.0b013e32835fe65c; Roberts IS, 2009, KIDNEY INT; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schmid H, 2006, CURR OPIN NEPHROL HY, V15, P123, DOI 10.1097/01.mnh.0000214770.11609.fb; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082336; Zeng CH, 2012, AM J KIDNEY DIS, V60, P812, DOI 10.1053/j.ajkd.2012.06.011; Zhong YF, 2013, J AM SOC NEPHROL, V24, P801, DOI 10.1681/ASN.2012060590	32	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103413	10.1371/journal.pone.0103413	http://dx.doi.org/10.1371/journal.pone.0103413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133636	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700009
J	Mishiro, K; Imai, T; Sugitani, S; Kitashoji, A; Suzuki, Y; Takagi, T; Chen, H; Oumi, Y; Tsuruma, K; Shimazawa, M; Hara, H				Mishiro, Keisuke; Imai, Takahiko; Sugitani, Sou; Kitashoji, Akira; Suzuki, Yukiya; Takagi, Toshinori; Chen, Huayue; Oumi, Yasunori; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki			Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Leading to Endothelial Apoptosis	PLOS ONE			English	Article							HIGH GLUCOSE; CEREBRAL-ISCHEMIA; UP-REGULATION; RISK-FACTOR; HYPERGLYCEMIA; CELLS; INFLAMMATION; PREVALENCE; SYNTHASE; DAMAGE	Diabetes is a crucial risk factor for stroke and is associated with increased frequency and poor prognosis. Although endothelial dysfunction is a known contributor of stroke, the underlying mechanisms have not been elucidated. The aim of this study was to elucidate the mechanism by which chronic hyperglycemia may contribute to the worsened prognosis following stroke, especially focusing on mitochondrial alterations. We examined the effect of hyperglycemia on hemorrhagic transformation at 24 hours after middle cerebral artery occlusion (MCAO) in streptozotocin (STZ)-induced diabetic mice. We also examined the effects of high-glucose exposure for 6 days on cell death, mitochondrial functions and morphology in human brain microvascular endothelial cells (HBMVECs) or human endothelial cells derived from induced pluripotent stem cells (iCell endothelial cells). Hyperglycemia aggravated hemorrhagic transformation, but not infarction following stroke. High-glucose exposure increased apoptosis, capase-3 activity, and release of apoptosis inducing factor (AIF) and cytochrome c in HBMVECs as well as affected mitochondrial functions (decreased cell proliferation, ATP contents, mitochondrial membrane potential, and increased matrix metalloproteinase (MMP)-9 activity, but not reactive oxygen species production). Furthermore, morphological aberration of mitochondria was observed in diabetic cells (a great deal of fragmentation, vacuolation, and cristae disruption). A similar phenomena were seen also in iCell endothelial cells. In conclusion, chronic hyperglycemia aggravated hemorrhagic transformation after stroke through mitochondrial dysfunction and morphological alteration, partially via MMP-9 activation, leading to caspase-dependent apoptosis of endothelial cells of diabetic mice. Mitochondria-targeting therapy may be a clinically innovative therapeutic strategy for diabetic complications in the future.	[Mishiro, Keisuke; Imai, Takahiko; Sugitani, Sou; Kitashoji, Akira; Suzuki, Yukiya; Takagi, Toshinori; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Takagi, Toshinori] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Chen, Huayue] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan; [Oumi, Yasunori] Gifu Univ, Life Sci Res Ctr, Div Instrument Anal, Gifu, Japan	Gifu Pharmaceutical University; Gifu University; Gifu University; Gifu University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Imai, Takahiko/ABF-6143-2020; Oumi, Yasunori/E-5964-2017	Imai, Takahiko/0000-0002-4422-2946; Oumi, Yasunori/0000-0001-9987-0417; Hara, Hideaki/0000-0003-2046-9001				Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chiu CD, 2013, STROKE, V44, P1682, DOI 10.1161/STROKEAHA.113.675983; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Copin JC, 2005, EUR J NEUROSCI, V22, P1597, DOI 10.1111/j.1460-9568.2005.04367.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Gong L, 2011, BBA-MOL CELL RES, V1813, P1211, DOI 10.1016/j.bbamcr.2011.03.011; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Kageyama S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-73; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; Kissela BM, 2005, DIABETES CARE, V28, P355, DOI 10.2337/diacare.28.2.355; Kumari R, 2011, J NEUROCHEM, V119, P1029, DOI 10.1111/j.1471-4159.2011.07487.x; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luan HY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-28; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Murase S, 2012, J BIOL CHEM, V287, P12184, DOI 10.1074/jbc.M111.297671; Ning HX, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.04.071; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Putaala J, 2011, NEUROLOGY, V76, P1742, DOI 10.1212/WNL.0b013e31821a44ad; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Quast MJ, 1997, J CEREBR BLOOD F MET, V17, P553, DOI 10.1097/00004647-199705000-00009; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith CJ, 2013, J NEUROIMMUNE PHARM, V8, P867, DOI 10.1007/s11481-013-9469-1; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STEGMAYR B, 1995, DIABETOLOGIA, V38, P1061, DOI 10.1007/BF00402176; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Widlansky ME, 2010, TRANSL RES, V156, P15, DOI 10.1016/j.trsl.2010.04.001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198	50	36	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103818	10.1371/journal.pone.0103818	http://dx.doi.org/10.1371/journal.pone.0103818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133692	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700018
J	Pinto, MP; Sousa e Silva, JD; de Lima, AA; Grelle, CEV				Pinto, Miriam Plaza; Sousa e Silva-Junior, Jose de; de Lima, Adriana Almeida; Viveiros Grelle, Carlos Eduardo			Multi-Scales Analysis of Primate Diversity and Protected Areas at a Megadiverse Region	PLOS ONE			English	Article							RESERVE SELECTION; SPECIES RICHNESS; CONSERVATION; BIODIVERSITY; EXTINCTION; FIRE; DEFORESTATION; BIOGEOGRAPHY; HOTSPOTS; FORESTS	In this paper, we address the question of what proportion of biodiversity is represented within protected areas. We assessed the effectiveness of different protected area types at multiple scales in representing primate biodiversity in the Brazilian Legal Amazon. We used point locality data and distribution data for primate species within 1 degrees, 0.5 degrees, and 0.25 degrees spatial resolution grids, and computed the area of reserves within each cell. Four different approaches were used - no reserves (A), exclusively strict use reserves (B), strict and sustainable use reserves (C), and strict and sustainable use reserves and indigenous lands (D). We used the complementarity concept to select reserve networks. The proportions of cells that were classified as reserves at a grid resolution of 1 degrees were 37%, 64%, and 88% for approaches B, C and D, respectively. Our comparison of these approaches clearly showed the effect of an increase in area on species representation. Representation was consistently higher at coarser resolutions, indicating the effect of grain size. The high number of irreplaceable cells for selected networks identified based on approach A could be attributed to the use of point locality occurrence data. Although the limited number of point occurrences for some species may have been due to a Wallacean shortfall, in some cases it may also be the result of an actual restricted geographic distribution. The existing reserve system cannot be ignored, as it has an established structure, legal protection status, and societal recognition, and undoubtedly represents important elements of biodiversity. However, we found that strict use reserves (which are exclusively dedicated to biodiversity conservation) did not effectively represent primate species. This finding may be related to historical criteria for selecting reserves based on political, economic, or social motives.	[Pinto, Miriam Plaza] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Rio De Janeiro, RJ, Brazil; [Sousa e Silva-Junior, Jose de] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [de Lima, Adriana Almeida] Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, RJ, Brazil; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Lab Vertebrados, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Museu Paraense Emilio Goeldi; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Pinto, MP (corresponding author), Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil.	miriamplazapinto@yahoo.com.br	Grelle, Carlos EV/A-9687-2017; Pinto, Míriam Plaza/B-8000-2013	Pinto, Míriam Plaza/0000-0002-4030-5015	FAPERJ [proc. E-26/111.829/2010]; CNPq [PDJ 150721/2010-2]; Carlos Eduardo Viveiros Grelle by CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Eduardo Viveiros Grelle by CNPq	Miriam Plaza Pinto was supported by FAPERJ doctoral scholarship (http://www.faperj.br/) and CNPq pos-doctoral scholarship (PDJ 150721/2010-2; http://www.cnpq.br/) and Carlos Eduardo Viveiros Grelle by CNPq productivity fellowship. This study was supported by grants from CNPq and FAPERJ (Auxilio Instalacao - proc. E-26/111.829/2010 and Jovem Cientista do Estado). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 2012, OCCASIONAL PAPERS CO; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Ball I, 2000, MARXAN V1 8 2 USER M; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bicca-Marques JC, 2006, MAMIFEROS BRASIL; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Brito D, 2006, BIODIVERS CONSERV, V15, P4197, DOI 10.1007/s10531-005-3575-1; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Cochrane MA, 2001, ENVIRONMENT, V43, P28, DOI 10.1080/00139150109604505; Da Silva JMC, 2005, CONSERV BIOL SER, V8, P337; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fuller HL, 2009, J TROP ECOL, V25, P387, DOI 10.1017/S0266467409006063; Game ET, 2008, QUANTITATIVE METHODS; Goldani A., 2006, Braz. J. Biol., V66, P61, DOI 10.1590/S1519-69842006000100009; Grelle CED, 1999, ANIM CONSERV, V2, P149, DOI 10.1111/j.1469-1795.1999.tb00060.x; Grelle CEV, 2005, ORYX, V39, P347, DOI 10.1017/S0030605305000700; Harcourt AH, 2006, J BIOGEOGR, V33, P2077, DOI 10.1111/j.1365-2699.2006.01557.x; Harcourt AH, 2000, BIOL CONSERV, V93, P163, DOI 10.1016/S0006-3207(99)00145-7; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN, 2012, IUCN RED LIST THREAT; Jantke K, 2011, BIODIVERS CONSERV, V20, P581, DOI 10.1007/s10531-010-9968-9; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Laurance William F., 2009, Oecologia Brasiliensis, V13, P434; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Nepstad D, 1998, CONSERV BIOL, V12, P951, DOI 10.1046/j.1523-1739.1998.012005951.x; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; O'Dea N, 2006, DIVERS DISTRIB, V12, P205, DOI 10.1111/j.1366-9516.2006.00235.x; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Pinto MP, 2009, BIODIVERS CONSERV, V18, P957, DOI 10.1007/s10531-008-9513-2; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Schulman L, 2007, BIODIVERS CONSERV, V16, P3011, DOI 10.1007/s10531-007-9158-6; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sebastiao H, 2009, ECOL INDIC, V9, P160, DOI 10.1016/j.ecolind.2008.03.002; Soule ME, 1987, VIABLE POPULATIONS C, P101; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	58	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105205	10.1371/journal.pone.0105205	http://dx.doi.org/10.1371/journal.pone.0105205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133497	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700086
J	van der Linden, ML; Hooper, JE; Cowan, P; Weller, BB; Mercer, TH				van der Linden, Marietta L.; Hooper, Julie E.; Cowan, Paula; Weller, Belinda B.; Mercer, Thomas H.			Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop	PLOS ONE			English	Article							FATIGUE SEVERITY SCALE; RELIABILITY; IMPACT; INVESTIGATE; EXERCISE; QUALITY; ABILITY; DEVICE; STROKE; COST	Background: People with Multiple Sclerosis (pwMS) often experience a disturbed gait function such as foot-drop. The objective of this pilot study was to investigate the medium term effects of using Functional Electrical Stimulation (FES) to treat foot-drop over a period 12 weeks on gait and patient reported outcomes of pwMS. Methods and Findings: Nine pwMS aged 35 to 64 (2 males, 7 females) were assessed on four occasions; four weeks before baseline, at baseline and after six weeks and twelve weeks of FES use. Joint kinematics and performance on the 10 meter and 2 minute walk tests (10WT, 2 minWT) were assessed with and without FES. Participants also completed the MS walking Scale (MSWS), MS impact scale (MSIS29), Fatigue Severity Score (FSS) and wore an activity monitor for seven days after each assessment. Compared to unassisted walking, FES resulted in statistically significant improvements in peak dorsiflexion in swing (p = 0.006), 10MWT (p = 0.006) and 2 minWT (p = 0.002). Effect sizes for the training effect, defined as the change from unassisted walking at baseline to that at 12 weeks, indicated improved ankle angle at initial contact (2.6 degrees, 95% CI -1 degrees to 4 degrees, d = 0.78), and a decrease in perceived exertion over the 2 min walking tests (-1.2 points, 95% CI -5.7 to 3.4, d = -0.86). Five participants exceeded the Minimally Detectable Change (MDC) for a training effect on the 10mWT, but only two did so for the 2 minWT. No effects of the use of FES for 12 weeks were found for MSWS, MSIS29, FSS or step count. Conclusion: Although FES to treat foot-drop appears to offer the potential for a medium term training effect on ankle kinematics and walking speed, this was not reflected in the patient reported outcomes. This observed lack of relationship between objective walking performance and patient reported outcomes warrants further investigation.	[van der Linden, Marietta L.; Mercer, Thomas H.] Queen Margaret Univ, Musselburgh, Scotland; [Hooper, Julie E.] NHS Lothian, Slateford Physiotherapy Clin, Edinburgh, Midlothian, Scotland; [Cowan, Paula] NHS Lothian, Kenilworth Med Ctr, Edinburgh, Midlothian, Scotland; [Weller, Belinda B.] Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland	Queen Margaret University	van der Linden, ML (corresponding author), Queen Margaret Univ, Musselburgh, Scotland.	mvanderlinden@qmu.ac.uk		van der Linden, Marietta/0000-0003-2256-6673	Multiple Sclerosis Society [873/07]	Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was carried out as part of a Multiple Sclerosis Society PhD studentship award funded by the Multiple Sclerosis Society [grant number 873/07]. TM was the PI and budget holder. MvdL, JH and PC were co-applicants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CL, 2009, MULT SCLER J, V15, P493, DOI 10.1177/1352458508101320; Barrett C, 2010, NEUROMODULATION, V13, P58, DOI 10.1111/j.1525-1403.2009.00250.x; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bulley C, 2011, PHYSIOTHERAPY, V97, P226, DOI 10.1016/j.physio.2010.11.001; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crayton HJ, 2006, CLIN THER, V28, P445, DOI 10.1016/j.clinthera.2006.04.005; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Esnouf JE, 2010, MULT SCLER J, V16, P1141, DOI 10.1177/1352458510366013; Feys P, 2014, J NEUROL SCI, V338, P183, DOI 10.1016/j.jns.2014.01.001; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gunn H, 2014, ARCH PHYS MED REHAB, V95, P538, DOI 10.1016/j.apmr.2013.08.244; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Horsley W, 2012, ORTHOTIC FUNCTIONAL; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Learmonth YC, 2013, J NEUROL SCI, V331, P102, DOI 10.1016/j.jns.2013.05.023; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Paul L, 2008, MULT SCLER J, V14, P954, DOI 10.1177/1352458508090667; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Scott SM, 2013, J REHABIL MED, V45, P364, DOI 10.2340/16501977-1109; Sheffler LR, 2009, ARCH PHYS MED REHAB, V90, P362, DOI 10.1016/j.apmr.2008.10.010; Stein RB, 2010, NEUROREHAB NEURAL RE, V24, P152, DOI 10.1177/1545968309347681; Taylor P, 2014, NEUROMODULATION, V17, P75, DOI 10.1111/ner.12048; Taylor P, 2013, J REHABIL MED, V45, P154, DOI 10.2340/16501977-1090; Taylor PN, 1999, ARCH PHYS MED REHAB, V80, P1577, DOI 10.1016/S0003-9993(99)90333-7; van der Linden Marietta L, 2008, Pediatr Phys Ther, V20, P23, DOI 10.1097/PEP.0b013e31815f39c9; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45	34	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103368	10.1371/journal.pone.0103368	http://dx.doi.org/10.1371/journal.pone.0103368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133535	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700007
J	Chugh, PE; Damania, BA; Dittmer, DP				Chugh, Pauline E.; Damania, Blossom A.; Dittmer, Dirk P.			Toll-Like Receptor-3 Is Dispensable for the Innate MicroRNA Response to West Nile Virus (WNV)	PLOS ONE			English	Article							METHYLENE-BLUE PHOTOINACTIVATION; INTERFERON REGULATORY FACTOR-3; PRIMARY EFFUSION LYMPHOMA; BLOOD-BRAIN-BARRIER; PROTEIN-KINASE PKR; COMPLEX CLASS-I; SENSORS RIG-I; IMMUNE-RESPONSE; RNA VIRUSES; ENCEPHALITIS-VIRUS	The innate immune response to West Nile virus (WNV) infection involves recognition through toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), leading to establishment of an antiviral state. MiRNAs (miRNAs) have been shown to be reliable biomarkers of TLR activation. Here, we sought to evaluate the contribution of TLR3 and miRNAs to the host response to WNV infection. We first analyzed HEK293-NULL and HEK293-TLR3 cells for changes in the innate immune response to infection. The presence of TLR3 did not seem to affect WNV load, infectivity or phosphorylation of IRF3. Analysis of experimentally validated NFkB-responsive genes revealed a WNV-induced signature largely independent of TLR3. Since miRNAs are involved in viral pathogenesis and the innate response to infection, we sought to identify changes in miRNA expression upon infection in the presence or absence of TLR3. MiRNA profiling revealed 70 miRNAs induced following WNV infection in a TLR3-independent manner. Further analysis of predicted gene targets of WNV signature miRNAs revealed genes highly associated with pathways regulating cell death, viral pathogenesis and immune cell trafficking.	[Chugh, Pauline E.; Damania, Blossom A.; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr AIDS Res, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dittmer, DP (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr AIDS Res, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	ddittmer@med.unc.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; 	NIH [DE018304, DE018281];  [R01 CA109232-08S1]; NATIONAL CANCER INSTITUTE [R01CA109232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281, R01DE018304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants DE018304 and DE018281. PC is supported by a minority supplement to R01 CA109232-08S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P513; Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403; Backes S, 2014, CELL REP; Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Chugh P, 2010, J VIS EXP; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Floyd RA, 2004, ANTIVIR RES, V61, P141, DOI 10.1016/j.antiviral.2003.11.004; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Galli R, 2013, P NATL ACAD SCI USA, V110, P9812, DOI 10.1073/pnas.1304610110; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Lazear HM, 2013, J VIROL, V87, P11401, DOI 10.1128/JVI.01403-13; Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Marfin AA, 2001, EMERG INFECT DIS, V7, P730; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MMWR, 2008, MMWR MORB MORTAL WKL, V57, P720; O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ostermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043744; Papin JF, 2005, ANTIVIR RES, V68, P84, DOI 10.1016/j.antiviral.2005.07.001; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Ramos JC, 2012, INT J CANCER, V130, P2728, DOI 10.1002/ijc.26302; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik S.V., 2013, J VIROL; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Scholle F, 2005, VIROLOGY, V342, P77, DOI 10.1016/j.virol.2005.07.021; Schumann M, 2009, J VIROL, V83, P8993, DOI 10.1128/JVI.00523-09; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14; Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11; Storey John D, 2003, Methods Mol Biol, V224, P149; Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; Suthar MS, 2012, IMMUNITY; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Tu YC, 2012, J VIROL, V86, P10347, DOI 10.1128/JVI.00525-12; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08; Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoon CH, 2010, EMBO REP, V11, P393, DOI 10.1038/embor.2010.45	89	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104770	10.1371/journal.pone.0104770	http://dx.doi.org/10.1371/journal.pone.0104770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127040	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300050
J	Shiraz, M; Gani, A; Ahmad, RW; Shah, SAA; Karim, A; Rahman, ZA				Shiraz, Muhammad; Gani, Abdullah; Ahmad, Raja Wasim; Shah, Syed Adeel Ali; Karim, Ahmad; Rahman, Zulkanain Abdul			A Lightweight Distributed Framework for Computational Offloading in Mobile Cloud Computing	PLOS ONE			English	Article								The latest developments in mobile computing technology have enabled intensive applications on the modern Smartphones. However, such applications are still constrained by limitations in processing potentials, storage capacity and battery lifetime of the Smart Mobile Devices (SMDs). Therefore, Mobile Cloud Computing (MCC) leverages the application processing services of computational clouds for mitigating resources limitations in SMDs. Currently, a number of computational offloading frameworks are proposed for MCC wherein the intensive components of the application are outsourced to computational clouds. Nevertheless, such frameworks focus on runtime partitioning of the application for computational offloading, which is time consuming and resources intensive. The resource constraint nature of SMDs require lightweight procedures for leveraging computational clouds. Therefore, this paper presents a lightweight framework which focuses on minimizing additional resources utilization in computational offloading for MCC. The framework employs features of centralized monitoring, high availability and on demand access services of computational clouds for computational offloading. As a result, the turnaround time and execution cost of the application are reduced. The framework is evaluated by testing prototype application in the real MCC environment. The lightweight nature of the proposed framework is validated by employing computational offloading for the proposed framework and the latest existing frameworks. Analysis shows that by employing the proposed framework for computational offloading, the size of data transmission is reduced by 91%, energy consumption cost is minimized by 81% and turnaround time of the application is decreased by 83.5% as compared to the existing offloading frameworks. Hence, the proposed framework minimizes additional resources utilization and therefore offers lightweight solution for computational offloading in MCC.	[Shiraz, Muhammad; Gani, Abdullah; Ahmad, Raja Wasim; Shah, Syed Adeel Ali; Karim, Ahmad] Univ Malaya, Ctr Mobile Cloud Comp C4MCC, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Rahman, Zulkanain Abdul] Univ Malaya, Fac Arts & Social Sci, Dept Hist, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Shiraz, M (corresponding author), Univ Malaya, Ctr Mobile Cloud Comp C4MCC, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	muh_shiraz@um.edu.my	Shiraz, Muhammad/ABD-9679-2021; Ahmad, Raja Wasim/AAM-2439-2020; rahman, zaizul ab/AAC-2063-2022; Shah, Syed Adeel Ali/D-4066-2018; Gani, Abdullah/C-2888-2009	Shiraz, Muhammad/0000-0002-0149-7413; Shah, Syed Adeel Ali/0000-0002-8610-3144; Gani, Abdullah/0000-0002-4388-020X	Malaysian Ministry of Higher Education under University of Malaya High Impact Research Grant [UM.C/HIR/MOHE/FCSIT/03]	Malaysian Ministry of Higher Education under University of Malaya High Impact Research Grant	This research is carried out as part of the Mobile Cloud Computing research project funded by the Malaysian Ministry of Higher Education under the University of Malaya High Impact Research Grant with reference UM.C/HIR/MOHE/FCSIT/03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2012, J SYST SOFTWARE, V85, P2755, DOI 10.1016/j.jss.2012.05.091; Abolfazli S., 2012, 1 INT C COMP INF SYS; Armbrust M., 2009, CLOUDS BERKELEY VIEW; Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001; Chun B. G., 2009, AUGMENTED SMARTPHONE; Chun B-G, 2011, CLONECLOUD ELASTIC E; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; HOANG T. D., 2011, WIRELESS COMMUNICATI; Hung SH, 2012, COMPUT MATH APPL, V63, P573, DOI 10.1016/j.camwa.2011.10.044; Iyer R, 2011, IEEE MICRO, V31, P20, DOI 10.1109/MM.2011.37; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Khan Samee U, 2012, FUTURE GENERATION CO; Kosta S, 2012, IEEE INFOCOM SER, P945, DOI 10.1109/INFCOM.2012.6195845; Kovachev D, 2012, INT J INTERACT MULTI, V1, P6, DOI 10.9781/ijimai.2012.171; Kumar K, 2010, COMPUTER, V43, P51, DOI 10.1109/MC.2010.98; Messer A., 2002, DISTRIBUTED PLATFORM; Rongrong J, 2014, IEEE T IMAGE PROCESS; Satyanarayanan M, 2009, IEEE PERVAS COMPUT, V8, P14, DOI 10.1109/MPRV.2009.82; Shiraz Muhammad, 2012, Proceedings of the 2012 IEEE International Conference on Computer Science and Automation Engineering (CSAE 2012), P89, DOI 10.1109/CSAE.2012.6272555; Shiraz M., 2013, COMPUT COMMUN COLLAB, V1, P24; Shiraz M, 2014, J SUPERCOMPUT, V68, P978, DOI 10.1007/s11227-013-1076-7; Shiraz M, 2014, J SUPERCOMPUT, V67, P84, DOI 10.1007/s11227-013-0988-6; Shiraz M, 2013, IEEE COMMUN SURV TUT, V15, P1294, DOI 10.1109/SURV.2012.111412.00045; Shiraz M, 2012, 10TH INTERNATIONAL CONFERENCE ON FRONTIERS OF INFORMATION TECHNOLOGY (FIT 2012), P331, DOI 10.1109/FIT.2012.66; Shiraz M, 2013, J SUPERCOMPUT, V63, P946, DOI 10.1007/s11227-012-0846-y; Zhang XY, 2010, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND SYSTEMS, P161; Zhong B, 2014, PATTERN RECOGN, V47, P1395, DOI 10.1016/j.patcog.2013.10.002	29	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102270	10.1371/journal.pone.0102270	http://dx.doi.org/10.1371/journal.pone.0102270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127245	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300004
J	Eisma, MC; Schut, HAW; Stroebe, MS; van den Bout, J; Stroebe, W; Boelen, PA				Eisma, Maarten C.; Schut, Henk A. W.; Stroebe, Margaret S.; van den Bout, Jan; Stroebe, Wolfgang; Boelen, Paul A.			Is Rumination after Bereavement Linked with Loss Avoidance? Evidence from Eye-Tracking	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS; COGNITIVE AVOIDANCE; DEPRESSION; GRIEF; WORRY; ATTENTION; DISTRESS; VALIDITY; STATES	Rumination is a risk factor in adjustment to bereavement. It is associated with and predicts psychopathology after loss. Yet, the function of rumination in bereavement remains unclear. In the past, researchers often assumed rumination to be a maladaptive confrontation process. However, based on cognitive avoidance theories of worry in generalised anxiety disorder (GAD) and rumination after post-traumatic stress disorder (PTSD), others have suggested that rumination may serve to avoid painful aspects of the loss, thereby contributing to complicated grief. To examine if rumination is linked with loss avoidance, an eye-tracking study was conducted with 54 bereaved individuals (27 high and 27 low ruminators). On 24 trials, participants looked for 10 seconds at a picture of the deceased and a picture of a stranger, randomly combined with negative, neutral or loss-related words. High ruminators were expected to show initial vigilance followed by subsequent disengagement for loss stimuli (i.e., picture deceased with a loss word) in the first 1500 ms. Additionally, we expected high ruminators to avoid these loss stimuli and to show attentional preference for non-loss-related negative stimuli (i.e., picture stranger with a negative word) on longer exposure durations (1500-10000 ms). Contrary to expectations, we found no evidence for an effect of rumination on vigilance and disengagement of loss stimuli in the first 1500 ms. However, in the 1500-10000 ms interval, high ruminators showed shorter gaze times for loss stimuli and longer gaze times for negative (and neutral) non-loss-related stimuli, even when controlling for depression and complicated grief symptom levels. Effects of rumination on average fixation times mirrored these findings. This suggests that rumination and loss avoidance are closely associated. A potential clinical implication is that rumination and grief complications after bereavement may be reduced through the use of exposure and acceptance-based therapeutic techniques.	[Eisma, Maarten C.; Schut, Henk A. W.; Stroebe, Margaret S.; van den Bout, Jan; Boelen, Paul A.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands; [Stroebe, Margaret S.] Univ Groningen, Dept Expt Psychopathol & Clin Psychol, Groningen, Netherlands; [Stroebe, Wolfgang] Univ Groningen, Dept Social & Org Psychol, Groningen, Netherlands; [Stroebe, Wolfgang] Univ Groningen, Dept Social Psychol, Groningen, Netherlands	Utrecht University; University of Groningen; University of Groningen; University of Groningen	Eisma, MC (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands.	m.c.eisma@uu.nl	Schut, Henk/E-7487-2013	Eisma, Maarten/0000-0002-6109-2274; Stroebe, Margaret/0000-0002-8468-3317	Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO) [91208009]	Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO)	This research was funded by a Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO) under Grant number 91208009. Website: www.zonmw.nl. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; BODNAR JC, 1994, PSYCHOL AGING, V9, P372; Boelen PA, 2003, J BEHAV THER EXP PSY, V34, P225, DOI 10.1016/j.jbtep.2003.08.001; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; Bonanno GA, 2005, J CONSULT CLIN PSYCH, V73, P86, DOI 10.1037/0022-006X.73.1.86; Borkovec TD, 1998, COGNITIVE THER RES, V22, P561, DOI 10.1023/A:1018790003416; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cribb G, 2006, BEHAV CHANGE, V23, P165, DOI 10.1375/bech.23.3.165; Dickson KS, 2012, BEHAV THER, V43, P629, DOI 10.1016/j.beth.2011.11.002; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eisma MC, 2014, J PSYCHOPATHOL BEHAV, V36, P165, DOI 10.1007/s10862-013-9377-y; Eisma MC, 2013, J ABNORM PSYCHOL, V122, P961, DOI 10.1037/a0034051; Eisma MC, 2012, GEDRAGSTHERAPIE, V43, P369; ERBER R, 1996, ADV SOC COG, V9, P73; Giorgio JM, 2010, BEHAV RES THER, V48, P1021, DOI 10.1016/j.brat.2010.07.004; Gundel H, 2003, AM J PSYCHIAT, V160, P1946, DOI 10.1176/appi.ajp.160.11.1946; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Joormann J, 2006, BEHAV THER, V37, P269, DOI 10.1016/j.beth.2006.01.002; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Lee Jonathan K., 2010, Cognitive Behaviour Therapy, V39, P126, DOI 10.1080/16506070902966918; Liverant GI, 2011, COGNITIVE THER RES, V35, P253, DOI 10.1007/s10608-010-9304-4; LYUBOMIRSKY S, 1993, J PERS SOC PSYCHOL, V65, P339, DOI 10.1037/0022-3514.65.2.339; Lyubomirsky S, 2003, COGNITIVE THER RES, V27, P309, DOI 10.1023/A:1023918517378; Maccallum F, 2010, J AFFECT DISORDERS, V125, P316, DOI 10.1016/j.jad.2010.01.070; Martell C. R., 2001, DEPRESSION CONTEXT S; MARTIN LL, 1996, ADV SOC COG, V9, P1; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Morina N, 2011, J NERV MENT DIS, V199, P921, DOI 10.1097/NMD.0b013e3182392aae; Moulds ML, 2007, BEHAV RES THER, V45, P251, DOI 10.1016/j.brat.2006.03.003; Newman MG, 2011, CLIN PSYCHOL REV, V31, P371, DOI 10.1016/j.cpr.2011.01.008; Nolen-Hoeksema S., 2001, HDB BEREAVEMENT RES, P545, DOI DOI 10.1037/10436-023; Nolen-Hoeksema S., 1999, COPING LOSS; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NolenHoeksema S, 1997, J PERS SOC PSYCHOL, V72, P855, DOI 10.1037/0022-3514.72.4.855; NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; Querstret D, 2013, CLIN PSYCHOL REV, V33, P996, DOI 10.1016/j.cpr.2013.08.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Scheres Anouk, 2010, Biol Psychiatry, V68, pe17, DOI 10.1016/j.biopsych.2010.05.021; Sexton KA, 2009, COGNITIVE THER RES, V33, P150, DOI 10.1007/s10608-007-9177-3; Stroebe M., 2001, REV GEN PSYCHOL, V5, P62, DOI [DOI 10.1037/1089-2680.5.1.62, 10.1037/1089-2680.5.1.62]; Stroebe M, 2007, EUR ARCH PSY CLIN N, V257, P462, DOI 10.1007/s00406-007-0746-y; TAIT R, 1989, P351; Tull Matthew T., 2011, Cognitive Behaviour Therapy, V40, P5, DOI 10.1080/16506073.2010.515187; Waechter S, 2014, COGNITIVE THER RES, V38, P313, DOI 10.1007/s10608-013-9588-2; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wenzlaff RM, 2003, COGNITIVE THER RES, V27, P293, DOI 10.1023/A:1023966400540; Wisco BE, 2013, CLIN PSYCHOL SCI, V1, P435, DOI 10.1177/2167702613486630; Worden JW, 2009, HDB MENTAL HLTH PRAC	58	37	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104980	10.1371/journal.pone.0104980	http://dx.doi.org/10.1371/journal.pone.0104980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140524	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200045
J	Rivolta, MW; Stampalija, T; Casati, D; Richardson, BS; Ross, MG; Frasch, MG; Bauer, A; Ferrazzi, E; Sassi, R				Rivolta, Massimo W.; Stampalija, Tamara; Casati, Daniela; Richardson, Bryan S.; Ross, Michael G.; Frasch, Martin G.; Bauer, Axel; Ferrazzi, Enrico; Sassi, Roberto			Acceleration and Deceleration Capacity of Fetal Heart Rate in an In-Vivo Sheep Model	PLOS ONE			English	Article							RATE-VARIABILITY; SPECTRAL-ANALYSIS; SURVEILLANCE; PREDICTOR; VAGAL	Background: Fetal heart rate (FHR) variability is an indirect index of fetal autonomic nervous system (ANS) integrity. FHR variability analysis in labor fails to detect early hypoxia and acidemia. Phase-rectified signal averaging (PRSA) is a new method of complex biological signals analysis that is more resistant to non-stationarities, signal loss and artifacts. It quantifies the average cardiac acceleration and deceleration (AC/DC) capacity. Objective: The aims of the study were: (1) to investigate AC/DC in ovine fetuses exposed to acute hypoxic-acidemic insult; (2) to explore the relation between AC/DC and acid-base balance; and (3) to evaluate the influence of FHR decelerations and specific PRSA parameters on AC/DC computation. Methods: Repetitive umbilical cord occlusions (UCOs) were applied in 9 pregnant near-term sheep to obtain three phases of MILD, MODERATE, and SEVERE hypoxic-acidemic insult. Acid-base balance was sampled and fetal ECGs continuously recorded. AC/DC were calculated: (1) for a spectrum of T values (T= 1 divided by 50 beats; the parameter limits the range of oscillations detected by PRSA); (2) on entire series of fetal RR intervals or on "stable'' series that excluded FHR decelerations caused by UCOs. Results: AC and DC progressively increased with UCOs phases (MILD vs. MODERATE and MODERATE vs. SEVERE, p < 0.05 for DC T = 2-5, and AC T = 1-3). The time evolution of AC/DC correlated to acid-base balance (0.4 <vertical bar rho vertical bar <0.9, p < 0.05) with the highest D r D for 2 <= T <= 7. PRSA was not independent from FHR decelerations caused by UCOs. Conclusions: This is the first in-vivo evaluation of PRSA on FHR analysis. In the presence of acute hypoxic-acidemia we found increasing values of AC/DC suggesting an activation of ANS. This correlation was strongest on time scale dominated by parasympathetic modulations. We identified the best performing T parameters (3 <= T <= 5), and found that AC/DC computation is not independent from FHR decelerations. These findings establish the basis for future clinical studies.	[Rivolta, Massimo W.; Sassi, Roberto] Univ Milan, Dept Comp Sci, Milan, Italy; [Stampalija, Tamara] IRCCS Burlo Garofolo, Unit Prenatal Diag, Inst Maternal & Child Hlth, Trieste, Italy; [Casati, Daniela; Ferrazzi, Enrico] Univ Milan, Dept Woman Mother & Neonate, Buzzi Childrens Hosp, Biomed & Clin Sci Sch Med, Milan, Italy; [Richardson, Bryan S.] Univ Western Ontario, Dept Obstet & Gynecol, London, ON, Canada; [Ross, Michael G.] Harbor UCLA Med Ctr, LA BioMed, Dept Obstet & Gynecol, Torrance, CA USA; [Frasch, Martin G.] Univ Montreal, CHU Ste Justine Res Ctr, Dept Obstet Gynaecol, St Hyacinthe, PQ, Canada; [Frasch, Martin G.] Univ Montreal, CHU Ste Justine Res Ctr, Dept Neurosci, St Hyacinthe, PQ, Canada; [Frasch, Martin G.] Univ Montreal, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ, Canada; [Bauer, Axel] Univ Munich, Munich Univ Clin, Dept Cardiol, Munich, Germany; [Bauer, Axel] DZHK German Ctr Cardiovasc Res, Lubeck, Germany	University of Milan; IRCCS Burlo Garofolo; University of Milan; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Munich; German Centre for Cardiovascular Research	Stampalija, T (corresponding author), IRCCS Burlo Garofolo, Unit Prenatal Diag, Inst Maternal & Child Hlth, Trieste, Italy.	tamara.stampalija@burlo.trieste.it	Stampalija, Tamara/K-4900-2014; Rivolta, Massimo/J-6542-2019; Casati, Daniela/AAE-6011-2022; Frasch, Martin/AAN-8507-2020; Ferrazzi, Enrico Mario/AAB-9416-2019; Sassi, Roberto/B-8136-2008	Rivolta, Massimo/0000-0002-8553-2414; Casati, Daniela/0000-0002-8856-442X; Frasch, Martin/0000-0003-3159-6321; Ferrazzi, Enrico Mario/0000-0001-5243-0537; Sassi, Roberto/0000-0001-9729-2641; stampalija, tamara/0000-0002-9080-3848; Bauer, Axel/0000-0001-9201-8555	Fondazione Cure Onlus	Fondazione Cure Onlus	This study was supported by Fondazione Cure Onlus. The funders supported the networking and publications fees. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic Z, 1996, COCHRANE DB SYST REV; Bauer A, 2006, PHYSICA A, V364, P423, DOI 10.1016/j.physa.2005.08.080; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Camm AJ, 1996, CIRCULATION, V93, P1043; Casati D, 2014, EXP PHYSIOL, V99, P466, DOI 10.1113/expphysiol.2013.076539; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; Eick C, 2014, ANN NONINVAS ELECTRO, V19, P122, DOI 10.1111/anec.12107; Fletcher AJW, 2006, AM J PHYSIOL-HEART C, V291, pH3023, DOI 10.1152/ajpheart.00504.2006; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Frasch MG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.022; Graatsma EM, 2012, J MATERN-FETAL NEO M, V25, P2517, DOI 10.3109/14767058.2012.704446; Green LR, 1999, J SOC GYNECOL INVEST, V6, P56, DOI 10.1016/S1071-5576(98)00055-0; Groome LJ, 1999, DEV PSYCHOBIOL, V35, P25, DOI 10.1002/(SICI)1098-2302(199907)35:1<25::AID-DEV4>3.0.CO;2-Q; Huhn EA, 2011, PRENATAL DIAG, V31, P509, DOI 10.1002/pd.2728; ITSKOVITZ J, 1982, AM J PHYSIOL, V242, pH916, DOI 10.1152/ajpheart.1982.242.5.H916; Kantelhardt JW, 2007, CHAOS, V17, DOI 10.1063/1.2430636; Lobmaier SM, 2012, J MATERN-FETAL NEO M, V25, P2523, DOI 10.3109/14767058.2012.696163; Murotsuki J, 1997, AM J OBSTET GYNECOL, V176, P282, DOI 10.1016/S0002-9378(97)70486-1; Neilson JP, 1996, COCHRANE DB SYST REV; PARER JT, 1980, EUR J OBSTET GYN R B, V10, P393, DOI 10.1016/0028-2243(80)90025-8; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Rantonen T, 2001, EARLY HUM DEV, V60, P233, DOI 10.1016/S0378-3782(00)00124-9; Ross MG, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.883; Sabir H, 2010, OBSTET GYNECOL, V115, P419, DOI 10.1097/AOG.0b013e3181c51aeb; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; Westerhuis MEMH, 2007, BJOG-INT J OBSTET GY, V114, P1194, DOI 10.1111/j.1471-0528.2007.01236.x	27	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104193	10.1371/journal.pone.0104193	http://dx.doi.org/10.1371/journal.pone.0104193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141131	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200014
J	Zhou, Z; Li, YD; Sun, N; Sun, ZH; Lv, LX; Wang, YF; Shen, LB; Li, YQ				Zhou, Zhan; Li, Yudong; Sun, Ning; Sun, Zhihao; Lv, Longxian; Wang, Yufeng; Shen, Libing; Li, Yong-Quan			Function and Evolution of Two Forms of SecDF Homologs in Streptomyces coelicolor	PLOS ONE			English	Article							PROTEIN EXPORT; ESCHERICHIA-COLI; SIGNAL PEPTIDES; TRANSLOCATION; SECRETION; EXPRESSION; LIVIDANS; SECYEG; PHYLOGENIES; RESISTANCE	The general secretion (Sec) pathway plays a prominent role in bacterial protein export, and the accessory component SecDF has been shown to improve transportation efficiency. Inspection of Streptomyces coelicolor genome reveals the unexpected presence of two different forms of secDF homologous genes: one in fused form (secDF) and the other in separated form (secD and secF). However, the functional role of two SecDF homologs in S. coelicolor has not yet been determined. Transcriptional analysis of secDF homologs reveals that these genes are constitutively expressed. However, the transcript levels of secD and secF are much higher than that of secDF in S. coelicolor. Deletion of secDF or/and secD/secF in S. coelicolor did result in reduced secretion efficiency of Xylanase A and Amylase C, suggesting that they may have redundant functions for Sec-dependent translocation pathway. Moreover, our results also indicate that SecD/SecF plays a more prominent role than SecDF in protein translocation. Evolutionary analysis suggests that the fused and separated SecDF homologs in Streptomyces may have disparate evolutionary ancestries. SecD/SecF may be originated from vertical transmission of existing components from ancestor of Streptomyces species. However, SecDF may be derived from bacterial ancestors through horizontal gene transfer. Alternately, it is also plausible that SecDF may have arisen through additional gene duplication and fusion events. The acquisition of a second copy may confer a selective benefit to Streptomyces by enhancing protein transport capacity. Taken together, our results provide new insights into the potential biological function and evolutionary aspects of the prokaryotic SecDF complex.	[Zhou, Zhan; Sun, Ning; Sun, Zhihao; Lv, Longxian; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Prov Key Lab Microbial Biochem & Metab Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Yudong] Zhejiang Gongshang Univ, Sch Food Sci & Biotechnol, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhan; Wang, Yufeng] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Zhou, Zhan; Wang, Yufeng] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Zhou, Zhan; Shen, Libing] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhou, Zhan; Shen, Libing] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang Gongshang University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Fudan University; Fudan University	Li, YD (corresponding author), Zhejiang Gongshang Univ, Sch Food Sci & Biotechnol, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China.	lyd@zjsu.edu.cn; lyq@zju.edu.cn	li, yu/HGL-9518-2022; Zhou, Zhan/I-2372-2013; Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022	Zhou, Zhan/0000-0002-2730-5483; Sun, Zhihao/0000-0001-5753-6680; Wang, Yufeng/0000-0002-9959-4149	National Basic Research Program of China (973 Program) [2012CB721005]; National Natural Science Foundation of China [30870033]; Education Bureau of Zhejiang Province [Y201016960]; China Scholarship Council; China Postdoctoral Science Foundation [2013M531117]; National Institutes of Health [GM100806, AI080579, G12MD007591]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM100806, SC1GM081068] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Bureau of Zhejiang Province; China Scholarship Council(China Scholarship Council); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from National Basic Research Program of China (973 Program, 2012CB721005) and National Natural Science Foundation of China (30870033) to YQL, and a grant from the Education Bureau of Zhejiang Province (Y201016960) to YDL. ZZ was supported by a government scholarship from China Scholarship Council and a general financial grant from China Postdoctoral Science Foundation (2013M531117). YW was supported by grants from National Institutes of Health (GM100806, AI080579, and G12MD007591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne J, 2014, BBA-MOL CELL RES, V1843, P1750, DOI 10.1016/j.bbamcr.2013.12.023; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Eichler J, 2003, MOL PHYLOGENET EVOL, V27, P504, DOI 10.1016/S1055-7903(03)00015-0; GARDEL C, 1990, EMBO J, V9, P4205, DOI 10.1002/j.1460-2075.1990.tb07645.x; Geukens N, 2006, MICROBIOL-SGM, V152, P1441, DOI 10.1099/mic.0.28734-0; Green M.R., 2012, MOL CLONING LAB MANU; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hennerdal A, 2010, PROTEIN SCI, V19, P2305, DOI 10.1002/pro.510; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lammertyn E, 1998, APPL MICROBIOL BIOT, V49, P424, DOI 10.1007/s002530051193; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; Mao XM, 2009, J BACTERIOL, V191, P6473, DOI 10.1128/JB.00875-09; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Morosoli R, 1997, FEMS MICROBIOL LETT, V146, P167, DOI 10.1016/S0378-1097(96)00411-9; Morosoli R, 1999, FEMS MICROBIOL LETT, V179, P437, DOI 10.1016/S0378-1097(99)00448-6; Mulder KCL, 2013, PROTEIN EXPRES PURIF, V89, P92, DOI 10.1016/j.pep.2013.02.008; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2005, J BACTERIOL, V187, P6852, DOI 10.1128/JB.187.19.6852-6855.2005; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; Page N, 1996, APPL ENVIRON MICROB, V62, P109; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1993, GENETICS, V133, P763; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; Widdick DA, 2008, J MOL BIOL, V375, P595, DOI 10.1016/j.jmb.2007.11.002; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Yang R, 1998, Chin J Biotechnol, V14, P1; Yin XH, 1998, GENE, V215, P171, DOI 10.1016/S0378-1119(98)00265-0; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zhou Z, 2011, CURR GENOMICS, V12, P404, DOI 10.2174/138920211797248556	55	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105237	10.1371/journal.pone.0105237	http://dx.doi.org/10.1371/journal.pone.0105237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140821	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200066
J	Moretti, DM; Ahuja, LG; Nunes, RD; Cudischevitch, CO; Daumas, CRO; Medeiros-Castro, P; Ventura-Martins, G; Jablonka, W; Gazos-Lopes, F; Senna, R; Sorgine, MHF; Hartfelder, K; Capurro, M; Atella, GC; Mesquita, RD; Silva-Neto, MAC				Moretti, Debora Monteiro; Ahuja, Lalima Gagan; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Hartfelder, Klaus; Capurro, Margareth; Atella, Georgia Correa; Mesquita, Rafael Dias; Cardoso Silva-Neto, Mario Alberto			Molecular Analysis of Aedes aegypti Classical Protein Tyrosine Phosphatases Uncovers an Ortholog of Mammalian PTP-1B Implicated in the Control of Egg Production in Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; FUNCTIONAL ANNOTATION; STRUCTURE PREDICTION; GENE-EXPRESSION; LOCALIZATION; KINASE; IDENTIFICATION; MECHANISM; SIGNAL; SITES	Background: Protein Tyrosine Phosphatases (PTPs) are enzymes that catalyze phosphotyrosine dephosphorylation and modulate cell differentiation, growth and metabolism. In mammals, PTPs play a key role in the modulation of canonical pathways involved in metabolism and immunity. PTP1B is the prototype member of classical PTPs and a major target for treating human diseases, such as cancer, obesity and diabetes. These signaling enzymes are, hence, targets of a wide array of inhibitors. Anautogenous mosquitoes rely on blood meals to lay eggs and are vectors of the most prevalent human diseases. Identifying the mosquito ortholog of PTP1B and determining its involvement in egg production is, therefore, important in the search for a novel and crucial target for vector control. Methodology/Principal Findings: We conducted an analysis to identify the ortholog of mammalian PTP1B in the Aedes aegypti genome. We identified eight genes coding for classical PTPs. In silico structural and functional analyses of proteins coded by such genes revealed that four of these code for catalytically active enzymes. Among the four genes coding for active PTPs, AAEL001919 exhibits the greatest degree of homology with the mammalian PTP1B. Next, we evaluated the role of this enzyme in egg formation. Blood feeding largely affects AAEL001919 expression, especially in the fat body and ovaries. These tissues are critically involved in the synthesis and storage of vitellogenin, the major yolk protein. Including the classical PTP inhibitor sodium orthovanadate or the PTP substrate DiFMUP in the blood meal decreased vitellogenin synthesis and egg production. Similarly, silencing AAEL001919 using RNA interference (RNAi) assays resulted in 30% suppression of egg production. Conclusions/Significance: The data reported herein implicate, for the first time, a gene that codes for a classical PTP in mosquito egg formation. These findings raise the possibility that this class of enzymes may be used as novel targets to block egg formation in mosquitoes.	[Moretti, Debora Monteiro; Ahuja, Lalima Gagan; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular LabSiCel, Rio De Janeiro, RJ, Brazil; [Ahuja, Lalima Gagan] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, Brazil; [Capurro, Margareth] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Mesquita, Rafael Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Rio De Janeiro, RJ, Brazil; [Moretti, Debora Monteiro; Nunes, Rodrigo Dutra; Cudischevitch, Cecilia Oliveira; Oliveira Daumas-Filho, Carlos Renato; Medeiros-Castro, Priscilla; Ventura-Martins, Guilherme; Jablonka, Willy; Gazos-Lopes, Felipe; Senna, Raquel; Ferreira Sorgine, Marcos Henrique; Atella, Georgia Correa; Mesquita, Rafael Dias; Cardoso Silva-Neto, Mario Alberto] Inst Nacl Ciecncia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; University of California System; University of California San Diego; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Silva-Neto, MAC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular LabSiCel, Rio De Janeiro, RJ, Brazil.	maneto@bioqmed.ufrj.br	Atella, Georgia/AAK-7897-2020; Capurro, Margareth L/F-8679-2012; Nunes, Rodrigo/J-6859-2012; Hartfelder, Klaus/L-2300-2019; Mesquita, Rafael Dias/AFP-3693-2022; Jablonka, Willy/D-2333-2017; Hartfelder, Klaus/A-4293-2009; Mesquita, Rafael Dias/AAH-4352-2022; Capurro, Margareth/M-5286-2019	Capurro, Margareth L/0000-0002-7480-2116; Nunes, Rodrigo/0000-0003-1346-291X; Hartfelder, Klaus/0000-0001-7981-8427; Mesquita, Rafael Dias/0000-0002-2882-3362; Hartfelder, Klaus/0000-0001-7981-8427; Mesquita, Rafael Dias/0000-0002-2882-3362; Daumas, Carlos/0000-0002-5753-2812; Jablonka, Willy/0000-0001-5380-7797	FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular)	FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular)	This work was supported by FAPERJ (Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and INCT-EM (Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arik Anam J., 2009, BMC Physiology, V9, P15, DOI 10.1186/1472-6793-9-15; Asthagiri D, 2002, J AM CHEM SOC, V124, P10225, DOI 10.1021/ja020046n; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; Buszard BJ, 2013, MOL CELL BIOL, V33, P1345, DOI 10.1128/MCB.01411-12; Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274; Chang YC, 2008, J PROTEOME RES, V7, P1055, DOI 10.1021/pr700801p; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Fialho E, 2002, INSECT BIOCHEM MOLEC, V32, P871, DOI 10.1016/S0965-1748(01)00175-8; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gazos-Lopes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047285; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Hatzihristidis T, 2014, METHODS, V65, P156, DOI 10.1016/j.ymeth.2013.07.031; Hauck ES, 2013, MICROBES INFECT, V15, P775, DOI 10.1016/j.micinf.2013.05.006; Helbling P, 1998, J INSECT PHYSIOL, V44, P1127, DOI 10.1016/S0022-1910(97)00039-5; Hilger M, 2009, MOL CELL PROTEOMICS, V8, P1908, DOI 10.1074/mcp.M800559-MCP200; Huang CH, 2007, J BIOL CHEM, V282, P32442, DOI 10.1074/jbc.M702583200; Innis CA, 2007, NUCLEIC ACIDS RES, V35, pW489, DOI 10.1093/nar/gkm422; Jablonka W, 2011, MEM I OSWALDO CRUZ, V106, P546, DOI 10.1590/S0074-02762011000500005; Karim FD, 1999, MOL CELL, V3, P741, DOI 10.1016/S1097-2765(01)80006-X; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197; Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Madan LL, 2011, BIOCHEMISTRY-US, V50, P10114, DOI 10.1021/bi201092q; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Mesquita R.D., 2011, FAT FUNCTIONAL ANAL, V11083-6; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Shimizu S, 2003, J BIOL CHEM, V278, P43095, DOI 10.1074/jbc.M306880200; Silveira AB, 2006, INSECT BIOCHEM MOLEC, V36, P200, DOI 10.1016/j.ibmb.2006.01.015; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Ugi S, 2009, J BIOCHEM, V146, P541, DOI 10.1093/jb/mvp104; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Whited JL, 2007, DEVELOPMENT, V134, P43, DOI 10.1242/dev.02718; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Wu CL, 2011, BIOCHEM J, V439, P151, DOI 10.1042/BJ20110799; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161	61	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104878	10.1371/journal.pone.0104878	http://dx.doi.org/10.1371/journal.pone.0104878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137153	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100051
J	Corte, L; Valente, F; Serrano, M; Gomes, CM; Moran, CP; Henriques, AO				Corte, Luisa; Valente, Filipa; Serrano, Monica; Gomes, Claudio M.; Moran, Charles P., Jr.; Henriques, Adriano O.			A Conserved Cysteine Residue of Bacillus subtilis SpoIIIJ Is Important for Endospore Development	PLOS ONE			English	Article							ZETA-CHAIN DIMERIZATION; PERIPLASMIC DOMAIN; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; MOTHER-CELL; SPORULATION; YIDC; GENE; TRANSLOCASE; EXPRESSION	During sporulation in Bacillus subtilis, the onset of activity of the late forespore-specific sigma factor sigma(G) coincides with completion of forespore engulfment by the mother cell. At this stage, the forespore becomes a free protoplast, surrounded by the mother cell cytoplasm and separated from it by two membranes that derive from the asymmetric division septum. Continued gene expression in the forespore, isolated from the surrounding medium, relies on the SpoIIIA-SpoIIQ secretion system assembled from proteins synthesised both in the mother cell and in the forespore. The membrane protein insertase SpoIIIJ, of the YidC/Oxa1/Alb3 family, is involved in the assembly of the SpoIIIA-SpoIIQ complex. Here we show that SpoIIIJ exists as a mixture of monomers and dimers stabilised by a disulphide bond. We show that residue Cys134 within transmembrane segment 2 (TM2) of SpoIIIJ is important to stabilise the protein in the dimeric form. Labelling of Cys134 with a Cys-reactive reagent could only be achieved under stringent conditions, suggesting a tight association at least in part through TM2, between monomers in the membrane. Substitution of Cys134 by an Ala results in accumulation of the monomer, and reduces SpoIIIJ function in vivo. Therefore, SpoIIIJ activity in vivo appears to require dimer formation.	[Corte, Luisa; Valente, Filipa; Serrano, Monica; Gomes, Claudio M.; Henriques, Adriano O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Moran, Charles P., Jr.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Universidade Nova de Lisboa; Emory University	Henriques, AO (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal.	aoh@itqb.unl.pt	Serrano, Mónica/H-8726-2013; Gomes, Cláudio M./A-8152-2008	Serrano, Mónica/0000-0003-3335-3219; Gomes, Cláudio M./0000-0003-4662-6933; Henriques, Adriano/0000-0003-4292-4802	"Fundacao para a Ciencia e a Tecnologia" (FCT) [POCTI/BIA-BCM/60855/2004, PEst-OE/EQB/LA0004/2011]; National Institute of General and Medical Sciences Public Health Services [GM54395-29]; FCT [SFRH/BD/6489/2001, SFRH/BPD/36328/2007, SFRH/BPD/26470/2006]	"Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute of General and Medical Sciences Public Health Services; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants POCTI/BIA-BCM/60855/2004 and PEst-OE/EQB/LA0004/2011 from "Fundacao para a Ciencia e a Tecnologia" (FCT) to A.O.H., and by National Institute of General and Medical Sciences Public Health Services R01 Grant GM54395-29 to C. P. M. LC (SFRH/BD/6489/2001) and M. S (SFRH/BPD/36328/2007) and F. V. (SFRH/BPD/26470/2006) were the recipients of a PhD (LC) and post doctoral fellowships (MS and FV) from the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Bolliger L, 1999, J IMMUNOL, V163, P3867; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Chiang WC, 2008, BIOCHEMISTRY-US, V47, P8775, DOI 10.1021/bi800633d; Doan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000566; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; ERRINGTON J, 1992, J GEN MICROBIOL, V138, P2609, DOI 10.1099/00221287-138-12-2609; Geng YP, 2014, J BACTERIOL, V196, P1318, DOI 10.1128/JB.01084-13; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HENNER DJ, 1990, METHOD ENZYMOL, V185, P223; Henriques AO, 1998, J BACTERIOL, V180, P2285, DOI 10.1128/JB.180.9.2285-2291.1998; HENRIQUES AO, 1995, J BACTERIOL, V177, P3394, DOI 10.1128/jb.177.12.3394-3406.1995; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ILLING N, 1991, MOL MICROBIOL, V5, P1927, DOI 10.1111/j.1365-2958.1991.tb00816.x; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kellner EM, 1996, MOL MICROBIOL, V21, P913, DOI 10.1046/j.1365-2958.1996.461408.x; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Kroos L, 1999, MOL MICROBIOL, V31, P1285, DOI 10.1046/j.1365-2958.1999.01214.x; Kruger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murakami T, 2002, J BACTERIOL, V184, P1998, DOI 10.1128/JB.184.7.1998-2004.2002; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Saller MJ, 2009, J BACTERIOL, V191, P6749, DOI 10.1128/JB.00853-09; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Serrano M, 2003, J BACTERIOL, V185, P3905, DOI 10.1128/JB.185.13.3905-3917.2003; Serrano M, 2008, J BACTERIOL, V190, P7786, DOI 10.1128/JB.00715-08; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Sousa VL, 2003, J BIOL CHEM, V278, P7624, DOI 10.1074/jbc.M209325200; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjalsma H, 2003, J BIOL CHEM, V278, P15622, DOI 10.1074/jbc.M301205200; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; von Heijne G, 2011, BIOCHEM SOC T, V39, P747, DOI 10.1042/BST0390747; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	61	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e99811	10.1371/journal.pone.0099811	http://dx.doi.org/10.1371/journal.pone.0099811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133632	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700001
J	Dal Monte, O; Noble, PL; Turchi, J; Cummins, A; Averbeck, BB				Dal Monte, Olga; Noble, Pamela L.; Turchi, Janita; Cummins, Alex; Averbeck, Bruno B.			CSF and Blood Oxytocin Concentration Changes following Intranasal Delivery in Macaque	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PLASMA OXYTOCIN; SPINAL-CORD; BRAIN; VASOPRESSIN; NASAL; RADIOIMMUNOASSAY; PATHWAYS; BEHAVIOR; RHYTHM	Oxytocin (OT) in the central nervous system (CNS) influences social cognition and behavior, making it a candidate for treating clinical disorders such as schizophrenia and autism. Intranasal administration has been proposed as a possible route of delivery to the CNS for molecules like OT. While intranasal administration of OT influences social cognition and behavior, it is not well established whether this is an effective means for delivering OT to CNS targets. We administered OT or its vehicle (saline) to 15 primates (Macaca mulatta), using either intranasal spray or a nebulizer, and measured OT concentration changes in the cerebral spinal fluid (CSF) and in blood. All subjects received both delivery methods and both drug conditions. Baseline samples of blood and CSF were taken immediately before drug administration. Blood was collected every 10 minutes after administration for 40 minutes and CSF was collected once post-delivery, at the 40 minutes time point. We found that intranasal administration of exogenous OT increased concentrations in both CSF and plasma compared to saline. Both delivery methods resulted in similar elevations of OT concentration in CSF, while the changes in plasma OT concentration were greater after nasal spray compared to nebulizer. In conclusion our study provides evidence that both nebulizer and nasal spray OT administration can elevate CSF OT levels.	[Dal Monte, Olga; Noble, Pamela L.; Turchi, Janita; Cummins, Alex; Averbeck, Bruno B.] NIH, NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Turin	Averbeck, BB (corresponding author), NIH, NIMH, Neuropsychol Lab, Bldg 10, Bethesda, MD 20892 USA.	averbeckbb@mail.nih.gov	Dal Monte, Olga/P-3759-2018	Dal Monte, Olga/0000-0002-7823-4769	Intramural Research Program of the NIMH/NIH/DHHS; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002928] Funding Source: NIH RePORTER	Intramural Research Program of the NIMH/NIH/DHHS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Intramural Research Program of the NIMH/NIH/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1990, J CLIN ENDOCR METAB, V71, P1531, DOI 10.1210/jcem-71-6-1531; AMICO JA, 1983, J CLIN ENDOCR METAB, V57, P947, DOI 10.1210/jcem-57-5-947; Appenrodt E, 1998, PHYSIOL BEHAV, V64, P543, DOI 10.1016/S0031-9384(98)00119-X; ARTMAN HG, 1982, J NEUROSCI, V2, P598; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; BOYD NRH, 1972, J ENDOCRINOL, V52, P59, DOI 10.1677/joe.0.0520059; Burri A, 2008, PSYCHONEUROENDOCRINO, V33, P591, DOI 10.1016/j.psyneuen.2008.01.014; Chang SWC, 2012, P NATL ACAD SCI USA, V109, P959, DOI 10.1073/pnas.1114621109; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Clark CL, 2013, PSYCHONEUROENDOCRINO, V38, P1208, DOI 10.1016/j.psyneuen.2012.10.017; Devarajan K, 2004, NEUROSCI LETT, V367, P144, DOI 10.1016/j.neulet.2004.05.112; Dhanda D.S., 2005, DRUG DELIV TECHNOL, V5, P64; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Evans S, 2011, PSYCHOL MED, V41, P1471, DOI 10.1017/S0033291710001960; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Guastella AJ, 2013, PSYCHONEUROENDOCRINO, V38, P612, DOI 10.1016/j.psyneuen.2012.11.019; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Insel T R, 2001, Prog Brain Res, V133, P59; Jokinen J, 2012, PSYCHONEUROENDOCRINO, V37, P482, DOI 10.1016/j.psyneuen.2011.07.016; Kagerbauer SM, 2013, J NEUROENDOCRINOL, V25, P668, DOI 10.1111/jne.12038; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Lee R, 2009, PSYCHONEUROENDOCRINO, V34, P1567, DOI 10.1016/j.psyneuen.2009.06.002; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; MEISENBERG G, 1983, LIFE SCI, V32, P2611, DOI 10.1016/0024-3205(83)90352-1; Modi ME, 2014, PSYCHONEUROENDOCRINO, V45, P49, DOI 10.1016/j.psyneuen.2014.02.011; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Parker KJ, 2010, BEHAV NEUROSCI, V124, P428, DOI 10.1037/a0019576; Parr LA, 2013, PSYCHONEUROENDOCRINO, V38, P1748, DOI 10.1016/j.psyneuen.2013.02.011; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; ROBINSON ICAF, 1993, ANN NY ACAD SCI, V689, P269; Robinson KJ, 2014, J NEUROSCI METH, V226, P73, DOI 10.1016/j.jneumeth.2014.01.019; SECKL JR, 1987, J ENDOCRINOL, V114, P477, DOI 10.1677/joe.0.1140477; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Striepens N, 2013, SCI REPORTS, P3; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Weisman O, 2013, PSYCHONEUROENDOCRINO, V38, P694, DOI 10.1016/j.psyneuen.2012.08.011; William H, 2002, DRUG DELIV TECHNOL, V2, P46; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128	48	128	131	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103677	10.1371/journal.pone.0103677	http://dx.doi.org/10.1371/journal.pone.0103677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133536	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700015
J	Donders, TH; Hagemans, K; Dekker, SC; de Weger, LA; de Klerk, P; Wagner-Cremer, F				Donders, Timme H.; Hagemans, Kimberley; Dekker, Stefan C.; de Weger, Letty A.; de Klerk, Pim; Wagner-Cremer, Friederike			Region-Specific Sensitivity of Anemophilous Pollen Deposition to Temperature and Precipitation	PLOS ONE			English	Article							CLIMATE-CHANGE; BETULA-PAPYRIFERA; SHOOT DEVELOPMENT; ACCUMULATION RATES; RECORD; ALNUS; VARIABILITY; NITROGEN; FOREST; PINUS	Understanding relations between climate and pollen production is important for several societal and ecological challenges, importantly pollen forecasting for pollinosis treatment, forensic studies, global change biology, and high-resolution palaeoecological studies of past vegetation and climate fluctuations. For these purposes, we investigate the role of climate variables on annual-scale variations in pollen influx, test the regional consistency of observed patterns, and evaluate the potential to reconstruct high-frequency signals from sediment archives. A 43-year pollen-trap record from the Netherlands is used to investigate relations between annual pollen influx, climate variables (monthly and seasonal temperature and precipitation values), and the North Atlantic Oscillation climate index. Spearman rank correlation analysis shows that specifically in Alnus, Betula, Corylus, Fraxinus, Quercus and Plantago both temperature in the year prior to (T-1), as well as in the growing season (T), are highly significant factors (T-April r(s) between 0.30 [P<0.05[ and 0.58 [P<0.0001]; TJuli-1 rs between 0.32 [P<0.05[and 0.56 [P<0.0001]) in the annual pollen influx of wind-pollinated plants. Total annual pollen prediction models based on multiple climate variables yield R-2 between 0.38 and 0.62 (P<0.0001). The effect of precipitation is minimal. A second trapping station in the SE Netherlands, shows consistent trends and annual variability, suggesting the climate factors are regionally relevant. Summer temperature is thought to influence the formation of reproductive structures, while temperature during the flowering season influences pollen release. This study provides a first predictive model for seasonal pollen forecasting, and also aides forensic studies. Furthermore, variations in pollen accumulation rates from a sub-fossil peat deposit are comparable with the pollen trap data. This suggests that high frequency variability pollen records from natural archives reflect annual past climate variability, and can be used in palaeoecological and -climatological studies to bridge between population- and species-scale responses to climate forcing.	[Donders, Timme H.; Hagemans, Kimberley; Wagner-Cremer, Friederike] Univ Utrecht, Fac Geosci, Dept Phys Geog, Lab Palaeobotany & Palynol, Utrecht, Netherlands; [Hagemans, Kimberley; Dekker, Stefan C.] Univ Utrecht, Fac Geosci, Copernicus Inst, Dept Environm Sci, Utrecht, Netherlands; [de Weger, Letty A.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [de Klerk, Pim] Staatliches Museum Naturkunde Karlsruhe, Bot Sect, Karlsruhe, Germany	Utrecht University; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Donders, TH (corresponding author), Univ Utrecht, Fac Geosci, Dept Phys Geog, Lab Palaeobotany & Palynol, Utrecht, Netherlands.	t.h.donders@uu.nl	Dekker, Stefan/F-5581-2013; de Weger, Letty/GLN-7644-2022; Wagner-Cremer, Friederike/B-4225-2009	Dekker, Stefan/0000-0001-7764-2464; Wagner-Cremer, Friederike/0000-0002-8119-3558; Donders, Timme/0000-0003-4698-3463; de Weger, Letty/0000-0002-9067-7407; de Klerk, Pim/0000-0003-3099-9399	Utrecht University; Leiden University Medical Centre	Utrecht University; Leiden University Medical Centre	This work is supported by Utrecht University and Leiden University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN S T, 1980, Grana, V19, P47; Autio J, 2004, GRANA, V43, P31, DOI 10.1080/00173130310017409; Barnekow L, 2007, J QUATERNARY SCI, V22, P653, DOI 10.1002/jqs.1096; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Brewer S, 2007, ENCY QUATERNARY SCI, P2, DOI DOI 10.1016/B0-44-452747-8/00177-0; CAESAR JC, 1984, CAN J BOT, V62, P1708, DOI 10.1139/b84-231; Dahl uO., 1996, AEROBIOLOGIA, V12, P97, DOI [10.1007/BF02446601, DOI 10.1007/BF02446601]; Detandt M., 2000, AEROBIOLOGIA, V16, P55, DOI [10.1023/A:1007619724282, DOI 10.1023/A:1007619724282]; Donders TH, 2013, GEOPHYS RES LETT, V40, P5776, DOI 10.1002/2013GL058038; Emberlin J, 2007, INT J BIOMETEOROL, V51, P181, DOI 10.1007/s00484-006-0059-2; Finsinger W, 2013, J QUATERNARY SCI, V28, P152, DOI 10.1002/jqs.2598; Garcia-Mozo H, 2001, ISRAEL J PLANT SCI, V49, P41, DOI 10.1092/JR25-EB31-9JTG-WTD6; GREEN D, 1988, J ECOL, V76, P790, DOI 10.2307/2260574; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hicks S, 2001, REV PALAEOBOT PALYNO, V117, P1, DOI 10.1016/S0034-6667(01)00074-4; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Jato V, 2004, GRANA, V43, P217, DOI 10.1080/00173130410016274; Joosten H, 2002, REV PALAEOBOT PALYNO, V122, P29, DOI 10.1016/S0034-6667(02)00090-8; Kasprzyk I, 2009, INT J BIOMETEOROL, V53, P345, DOI 10.1007/s00484-009-0221-8; KNAAP WO, 2010, VEG HIST ARCHAEOBOT, V19, P285, DOI DOI 10.1007/S00334-010-0250-6; Kuoppamaa M, 2009, J QUATERNARY SCI, V24, P513, DOI 10.1002/jqs.1276; LAU TC, 1993, AM J BOT, V80, P763, DOI 10.2307/2445596; MACDONALD AD, 1983, CAN J BOT, V61, P3049, DOI 10.1139/b83-342; MACDONALD AD, 1984, CAN J BOT, V62, P437, DOI 10.1139/b84-066; MCVEAN DN, 1955, J ECOL, V43, P46, DOI 10.2307/2257118; Nielsen AB, 2010, VEG HIST ARCHAEOBOT, V19, P309, DOI 10.1007/s00334-010-0253-3; Ranta H, 2005, INT J BIOMETEOROL, V49, P146, DOI 10.1007/s00484-004-0228-0; Ranta H, 2008, FOREST ECOL MANAG, V255, P643, DOI 10.1016/j.foreco.2007.09.040; Rasmussen Alix, 2002, Aerobiologia, V18, P253, DOI 10.1023/A:1021321615254; Rodriguez-Rajo FJ, 2004, ANN AGR ENV MED, V11, P35; ROGERS CA, 1993, REV PALAEOBOT PALYNO, V79, P133, DOI 10.1016/0034-6667(93)90043-T; Shea KM, 2008, J ALLERGY CLIN IMMUN, V122, P443, DOI 10.1016/j.jaci.2008.06.032; Sjogren P, 2006, HOLOCENE, V16, P277, DOI 10.1191/0959683606hl924rp; Spieksma F. Th. M., 2003, Aerobiologia, V19, P171, DOI 10.1023/B:AERO.0000006528.37447.15; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; SPIEKSMA FTM, 1989, GRANA, V28, P25, DOI 10.1080/00173138909431009; Spieksma FTM., 1998, AEROBIOLOGIA, V14, P347, DOI [10.1007/BF02694304, DOI 10.1007/BF02694304, 10.1007/bf02694304]; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tyler G, 2001, ANN BOT-LONDON, V87, P623, DOI 10.1006/anbo.2001.1383; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; Van Vliet AJH, 2002, INT J CLIMATOL, V22, P1757, DOI 10.1002/joc.820; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; Walsh KAJ, 2008, J FORENSIC SCI, V53, P1053, DOI 10.1111/j.1556-4029.2008.00802.x; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska LH, 2000, AUST J PLANT PHYSIOL, V27, P893; 2012, N ATLANTIC OSCILLATI; 2014, NETHERLANDS PHENOLOG	49	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104774	10.1371/journal.pone.0104774	http://dx.doi.org/10.1371/journal.pone.0104774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133631	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700041
J	Qi, QR; Xie, QZ; Liu, XL; Zhou, Y				Qi, Qian-Rong; Xie, Qing-Zhen; Liu, Xue-Li; Zhou, Yun			Osteopontin Is Expressed in the Mouse Uterus during Early Pregnancy and Promotes Mouse Blastocyst Attachment and Invasion In Vitro	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ALPHA-V-BETA-3 INTEGRIN; CONCEPTUS ATTACHMENT; EMBRYO IMPLANTATION; PLACENTAL INTERFACE; ADHESION MOLECULES; TISSUE INHIBITOR; GENE-EXPRESSION; UP-REGULATION; ENDOMETRIUM	Embryo implantation into the maternal uterus is a decisive step for successful mammalian pregnancy. Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein family and participates in cell adhesion and invasion. In this study, we showed that Opn mRNA levels are up-regulated in the mouse uterus on day 4 and at the implantation sites on days 5 and 8 of pregnancy. Immunohistochemistry localized the OPN protein to the glandular epithelium on day 4 and to the decidual zone on day 8 of pregnancy. OPN mRNA and proteins are induced by in vivo and in vitro decidualization. OPN expression in the endometrial stromal cells is regulated by progesterone, a key regulator during decidualization. As a secreted protein, the protein level of OPN in the uterine cavity is enriched on day 4, and in vitro embryo culturing has indicated that OPN can facilitate blastocyst hatching and adhesion. Knockdown of OPN attenuates the adhesion and invasion of blastocysts in mouse endometrial stromal cells by suppressing the expression and enzymatic activity of matrix metalloproteinase-9 in the trophoblast. Our data indicated that OPN expression in the mouse uterus during early pregnancy is essential for blastocyst hatching and adhesion and that the knockdown of OPN in mouse endometrial stroma cells could lead to a restrained in vitro trophoblast invasion.	[Qi, Qian-Rong; Xie, Qing-Zhen; Zhou, Yun] Wuhan Univ, Renmin Hosp, Ctr Reprod Med, Wuhan 430072, Peoples R China; [Liu, Xue-Li] Wuhan Univ, Coll Med, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Xie, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Ctr Reprod Med, Wuhan 430072, Peoples R China.	qingzhenxie@hotmail.com	Qi, Qian-Rong/AAV-7553-2020	Qi, Qian-Rong/0000-0003-0276-7187	Chinese National Natural Science Foundation [30670233]; Natural Science of Hubei Province Foundation [2012FKB04447]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science of Hubei Province Foundation	This work was supported by Chinese National Natural Science Foundation grants (No. 30670233), Natural Science of Hubei Province Foundation grants (No. 2012FKB04447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Casals G, 2012, HUM REPROD, V27, P805, DOI 10.1093/humrep/der432; Chaen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048933; Chen L, 2007, REPRODUCTION, V133, P405, DOI 10.1530/rep.1.01020; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Dahiya S, 2011, J IMMUNOL, V187, P2723, DOI 10.4049/jimmunol.1101342; DeMayo FJ, 2002, ANN NY ACAD SCI, V955, P48, DOI 10.1111/j.1749-6632.2002.tb02765.x; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Elbehery MM, 2011, CLIN LAB, V57, P953; Erikson DW, 2007, REPRODUCTION, V133, P909, DOI 10.1530/REP-06-0228; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030508; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Fluhr H, 2008, FERTIL STERIL, V90, P1384, DOI [10.1016/j.fertnstert.2007.07.1357, 10.1016/j.fertnstert.2007.08.023]; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1; Franchi A, 2008, MOL HUM REPROD, V14, P413, DOI 10.1093/molehr/gan029; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; Garmy-Susini B, 2013, P NATL ACAD SCI USA, V110, P9042, DOI 10.1073/pnas.1219603110; Herington JL, 2007, REPRODUCTION, V133, P1213, DOI 10.1530/REP-07-0085; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Ho HT, 2012, FERTIL STERIL, V97, P974, DOI 10.1016/j.fertnstert.2012.01.116; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Johnson GA, 2003, BIOL REPROD, V69, P92, DOI 10.1095/biolreprod.102.013573; Johnson GA, 2001, BIOL REPROD, V65, P820, DOI 10.1095/biolreprod65.3.820; Juengel E, 2013, EXP BIOL MED MAYWOOD; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; Kaloglu C, 2010, TISSUE CELL, V42, P301, DOI 10.1016/j.tice.2010.07.004; Koizumi M, 2010, HUM REPROD, V25, P192, DOI 10.1093/humrep/dep370; Kumar V, 2010, CANCER RES, V70, P10381, DOI 10.1158/0008-5472.CAN-10-1470; Lee KM, 2013, ACTA BIOMATER, V9, P5600, DOI 10.1016/j.actbio.2012.10.036; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Liu Qian, 2012, Zhonghua Nan Ke Xue, V18, P446; Martinez-Conejero JA, 2011, FERTIL STERIL, V96, P943, DOI 10.1016/j.fertnstert.2011.07.1088; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Paria BC, 1999, DEVELOPMENT, V126, P1997; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Tawfeek MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-10; Wan PC, 2011, REPROD DOMEST ANIM, V46, P840, DOI 10.1111/j.1439-0531.2011.01752.x; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2003, FERTIL STERIL, V80, P736, DOI 10.1016/S0015-0282(03)00782-9; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Weintraub AS, 2004, PEDIATR RES, V55, P419, DOI 10.1203/01.PDR.0000112034.98387.B2; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; White FJ, 2006, REPRODUCTION, V132, P919, DOI 10.1530/REP-06-0068; Whiteside EJ, 2001, BIOL REPROD, V64, P1331, DOI 10.1095/biolreprod64.5.1331; Xie QZ, 2013, INT J MOL SCI, V14, P14504, DOI 10.3390/ijms140714504; Yong-feng Cui, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P210, DOI 10.3881/j.issn.1000-503X.2011.02.022; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao YL, 2010, FERTIL STERIL, V94, P2264, DOI 10.1016/j.fertnstert.2010.01.068; Zhu FX, 2012, GLYCOCONJUGATE J, V29, P347, DOI 10.1007/s10719-012-9426-x	53	20	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104955	10.1371/journal.pone.0104955	http://dx.doi.org/10.1371/journal.pone.0104955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133541	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700055
J	Wang, Y; Tian, Y; Ding, Y; Wang, JC; Yan, S; Zhou, L; Xie, HY; Chen, H; Li, H; Zhang, JH; Zhao, JC; Zheng, SS				Wang, Yan; Tian, Yang; Ding, Yuan; Wang, Jingcheng; Yan, Sheng; Zhou, Lin; Xie, Haiyang; Chen, Hui; Li, Hui; Zhang, Jinhua; Zhao, Jiacong; Zheng, Shusen			MiR-152 May Silence Translation of CaMK II and Induce Spontaneous Immune Tolerance in Mouse Liver Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; SPONTANEOUS ACCEPTANCE; OPERATIONAL TOLERANCE; PERIPHERAL-BLOOD; DENDRITIC CELLS; NONCODING RNAS; MICRORNAS; PROLIFERATION; ALLOGRAFTS; GENE	Spontaneous immune tolerance in mouse liver transplantation has always been a hotspot in transplantation-immune research. Recent studies revealed that regulatory T cells (Tregs), hepatic satellite cells and Kupffer cells play a potential role in spontaneous immune tolerance, however the precise mechanism of spontaneous immune tolerance is still undefined. By using Microarray Chips, we investigated different immune regulatory factors to decipher critical mechanisms of spontaneous tolerance after mouse liver transplantation. Allogeneic (C57BL/6-C3H) and syngeneic (C3H-C3H) liver transplantation were performed by 6-8 weeks old male C57BL/6 and C3H mice. Graft samples (N = 4 each group) were collected from 8 weeks post-operation mice. 11 differentially expressed miRNAs in allogeneic grafts (Allografts) vs. syngeneic grafts (Syngrafts) were identified using Agilent Mouse miRNA Chips. It was revealed that 185 genes were modified by the 11 miRNAs, furthermore, within the 185 target genes, 11 of them were tightly correlated with immune regulation after Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Genbank data cross-comparison. Verified by real-time PCR and western blot, our results indicated that mRNA expression levels of IL-6 and TAB2 were respectively down regulated following miR-142-3p and miR-155 augment. In addition, increased miR-152 just silenced mRNA of CaMK II and down-regulated translation of CaMK II in tolerated liver grafts, which may play a critical role in immune regulation and spontaneous tolerance induction of mouse liver transplantation.	[Wang, Yan; Tian, Yang; Wang, Jingcheng; Zhou, Lin; Xie, Haiyang; Chen, Hui; Li, Hui; Zhang, Jinhua; Zhao, Jiacong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Yuan; Yan, Sheng; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National High Technology Research and Development Program of China (863 program) [2012AA020501-2]; National Natural Science Foundation of China [81372626]; Natural Science Foundation of Zhejiang Province, China [LQ13H030001]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by: 1. National High Technology Research and Development Program of China (863 program. No. 2012AA020501-2); 2. National Natural Science Foundation of China ( Grant No. 81372626); 3. Natural Science Foundation of Zhejiang Province, China (LQ13H030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2012, AM J TRANSPLANT, V12, P3449, DOI 10.1111/j.1600-6143.2012.04269.x; Pons JA, 2011, GASTROENT HEPAT-BARC, V34, P155, DOI 10.1016/j.gastrohep.2010.11.007; Calmus Y, 2009, PRESSE MED, V38, P1307, DOI 10.1016/j.lpm.2009.06.004; Chan CK, 2012, TRANSPLANTATION, V94, P132, DOI 10.1097/TP.0b013e31825940a4; Charles R, 2013, TRANSPLANTATION, V96, P17, DOI 10.1097/TP.0b013e318294caae; Danger R, 2012, J AM SOC NEPHROL, V23, P597, DOI 10.1681/ASN.2011060543; Demetris AJ, 2013, CURR OPIN ORGAN TRAN, V18, P345, DOI 10.1097/MOT.0b013e3283615d48; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fei BJ, 2012, ONCOL RES, V20, P557, DOI 10.3727/096504013X13775486749254; Harris A, 2010, AM J TRANSPLANT, V10, P713, DOI 10.1111/j.1600-6143.2010.03032.x; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Li W, 2008, AM J TRANSPLANT, V8, P1639, DOI 10.1111/j.1600-6143.2008.02300.x; Li W, 2005, AM J TRANSPLANT, V5, P978, DOI 10.1111/j.1600-6143.2005.00823.x; Liu Li-Feng, 2012, Shengli Xuebao, V64, P101; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Malmhall C, 2013, J ALLERGY CLIN IMMUN; Mas VR, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/j.1600-6143.2012.04313.x; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; Morita M, 2010, AM J TRANSPLANT, V10, P40, DOI 10.1111/j.1600-6143.2009.02859.x; Muangchan C, 2013, CLIN EXP RHEUMATOL, V31, pS122; Myrvang Helene, 2012, Nat Rev Nephrol, V8, P194, DOI 10.1038/nrneph.2012.32; Neyrinck A, 2013, CURR OPIN ANESTHESIO, V26, P382, DOI 10.1097/ACO.0b013e328360dc87; Norris S, 2001, TRANSPLANTATION, V71, P711, DOI 10.1097/00007890-200103270-00003; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Otto G, 2013, DIGEST DIS, V31, P164, DOI 10.1159/000347213; Pons JA, 2008, TRANSPLANTATION, V86, P1370, DOI 10.1097/TP.0b013e318188d3e6; QIAN S, 1991, TRANSPLANT P, V23, P705; Rajalingham Sakthiswary, 2012, Inflammation & Allergy Drug Targets, V11, P262; Shalev I, 2012, LIVER TRANSPLANT, V18, P761, DOI 10.1002/lt.23458; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Steger U, 2006, TRANSPLANTATION, V82, P1202, DOI 10.1097/01.tp.0000235913.58337.b4; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Terlou A, 2012, J INVEST DERMATOL, V132, P658, DOI 10.1038/jid.2011.369; THAI NL, 1995, TRANSPL P, V27, P509; Veit TD, 2009, TRANSPL IMMUNOL, V20, P229, DOI 10.1016/j.trim.2008.11.001; Wang P, 2012, J IMMUNOL, V189, P211, DOI 10.4049/jimmunol.1200609; Xu CL, 2013, J BIOL CHEM, V288, P11074, DOI 10.1074/jbc.M112.414862; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye Y, 2013, AM J TRANSPLANT, V13, P569, DOI 10.1111/ajt.12088; Zhao GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074782; Zheng XG, 2013, CANCER LETT, V329, P146, DOI 10.1016/j.canlet.2012.10.026; Zhu C, 2013, PROSTATE, V73, P1082, DOI 10.1002/pros.22656	47	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105096	10.1371/journal.pone.0105096	http://dx.doi.org/10.1371/journal.pone.0105096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133393	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700069
J	Yang, W; Yao, Y; Yang, YQ; Lu, FT; Li, L; Wang, YH; Nakajima, T; Tsuneyama, K; Ridgway, WM; Gershwin, ME; Lian, ZX				Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Nakajima, Takahiko; Tsuneyama, Koichi; Ridgway, William M.; Gershwin, M. Eric; Lian, Zhe-Xiong			Differential Modulation by IL-17A of Cholangitis versus Colitis in IL-2R alpha Deleted Mice	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; T-CELLS; IFN-GAMMA; DISEASE; LIVER; INFLAMMATION; IL-23; IMMUNOBIOLOGY; PATHOGENESIS; NEUTROPHILS	IFN-gamma is a signature Th1 cell associated cytokine critical for the inflammatory response in autoimmunity with both proinflammatory and potentially protective functions. IL-17A is the hallmark of T helper 17 (Th17) cell subsets, produced by gamma delta T, CD8+ T, NK and NKT cells. We have taken advantage of our colony of IL-2R alpha(-/-) mice that spontaneously develop both autoimmune cholangitis and inflammatory bowel disease. In this model CD8+ T cells mediate biliary ductular damage, whereas CD4+ T cells mediate induction of colon-specific autoimmunity. Importantly, IL-2R alpha(-/-) mice have high levels of interferon gamma (IFN-gamma), and interleukin-17A (IL-17A). We produced unique double deletions of mice that were either IL-17A(-/-) IL-2R alpha(-/-) or IFN-gamma(-/-) IL-2R alpha(-/-) to specifically address the precise role of these two cytokines in the natural history of autoimmune cholangitis and colitis. Of note, deletion of IL-17A in IL-2R alpha(-/-) mice led to more severe liver inflammation, but ameliorated colitis. In contrast, there were no significant changes in the immunopathology of double knock-out IFN-gamma(-/-) IL-2R alpha(-/-) mice, compared to single knock-out IL-2R alpha(-/-) mice with respect to cholangitis or colitis. Furthermore, there was a significant increase in pathogenetic CD8+ T cells in the liver of IL-17A(-/-) IL-2R alpha(-/-) mice. Our data suggest that while IL-17A plays a protective role in autoimmune cholangitis, it has a pro-inflammatory role in inflammatory bowel disease. These data take on particular significance in the potential use of anti-IL-17A therapy in humans with primary biliary cirrhosis.	[Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci & Med Ctr, Inst Immunol, Liver Immunol Lab, Hefei 230026, Peoples R China; [Yang, Wei; Yao, Yuan; Yang, Yan-Qing; Lu, Fang-Ting; Li, Liang; Wang, Yin-Hu; Lian, Zhe-Xiong] Univ Sci & Technol China, Sch Life Sci & Med Ctr, CAS Key Lab Innate Immun & Chron Dis, Liver Immunol Lab, Hefei 230026, Peoples R China; [Nakajima, Takahiko; Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 930, Japan; [Ridgway, William M.] Univ Cincinnati, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Lian, Zhe-Xiong] Innovat Ctr Cell Biol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toyama; University System of Ohio; University of Cincinnati; University of California System; University of California Davis	Gershwin, ME (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	megershwin@ucdavis.edu; zxlian1@ustc.edu.cn	Yang, w/AAN-3388-2020; Li, Liang/L-7803-2018	Li, Liang/0000-0003-0745-2571; Tsuneyama, Koichi/0000-0002-0670-9868	National Basic Research Program of China (973 Program) [2010CB945300, 2013CB944900]; National Natural Science Foundation of China [30972738, 31021061, 81130058]; Hundred Talents Program of the Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support provided by the National Basic Research Program of China (973 Program-2010CB945300, 2013CB944900), the National Natural Science Foundation of China (30972738, 31021061, 81130058), and the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ge J, 2010, J CLIN IMMUNOL, V30, P60, DOI 10.1007/s10875-009-9328-2; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Hsu W, 2009, HEPATOLOGY, V49, P133, DOI 10.1002/hep.22591; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Lafdil F, 2010, CELL MOL IMMUNOL, V7, P250, DOI 10.1038/cmi.2010.5; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KA, 2008, CELL IMMUNOL, V251, P50, DOI 10.1016/j.cellimm.2008.03.004; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Shin HCK, 1998, CYTOKINE, V10, P841, DOI 10.1006/cyto.1998.0375; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Wakabayashi K, 2006, HEPATOLOGY, V44, P1240, DOI 10.1002/hep.21385; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105351	10.1371/journal.pone.0105351	http://dx.doi.org/10.1371/journal.pone.0105351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133396	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700101
J	Cardoso, C; Charnikhova, T; Jamil, M; Delaux, PM; Verstappen, F; Amini, M; Lauressergues, D; Ruyter-Spira, C; Bouwmeester, H				Cardoso, Catarina; Charnikhova, Tatsiana; Jamil, Muhammad; Delaux, Pierre-Marc; Verstappen, Francel; Amini, Maryam; Lauressergues, Dominique; Ruyter-Spira, Carolien; Bouwmeester, Harro			Differential Activity of Striga hermonthica Seed Germination Stimulants and Gigaspora rosea Hyphal Branching Factors in Rice and Their Contribution to Underground Communication	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; STRIGOLACTONE PRODUCTION; STRUCTURAL REQUIREMENTS; PHOSPHORUS DEFICIENCY; PHOSPHATE DEFICIENCY; GESNERIOIDES SEEDS; PARASITIC PLANTS; ROOT PARASITES; RED-CLOVER; INHIBITION	Strigolactones (SLs) trigger germination of parasitic plant seeds and hyphal branching of symbiotic arbuscular mycorrhizal (AM) fungi. There is extensive structural variation in SLs and plants usually produce blends of different SLs. The structural variation among natural SLs has been shown to impact their biological activity as hyphal branching and parasitic plant seed germination stimulants. In this study, rice root exudates were fractioned by HPLC. The resulting fractions were analyzed by MRM-LC-MS to investigate the presence of SLs and tested using bioassays to assess their Striga hermonthica seed germination and Gigaspora rosea hyphal branching stimulatory activities. A substantial number of active fractions were revealed often with very different effect on seed germination and hyphal branching. Fractions containing (-)-orobanchol and ent-2'-epi-5-deoxystrigol contributed little to the induction of S. hermonthica seed germination but strongly stimulated AM fungal hyphal branching. Three SLs in one fraction, putative methoxy-5-deoxystrigol isomers, had moderate seed germination and hyphal branching inducing activity. Two fractions contained strong germination stimulants but displayed only modest hyphal branching activity. We provide evidence that these stimulants are likely SLs although no SL-representative masses could be detected using MRM-LC-MS. Our results show that seed germination and hyphal branching are induced to very different extents by the various SLs (or other stimulants) present in rice root exudates. We propose that the development of rice varieties with different SL composition is a promising strategy to reduce parasitic plant infestation while maintaining symbiosis with AM fungi.	[Cardoso, Catarina; Charnikhova, Tatsiana; Jamil, Muhammad; Verstappen, Francel; Amini, Maryam; Ruyter-Spira, Carolien; Bouwmeester, Harro] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Delaux, Pierre-Marc; Lauressergues, Dominique] Univ Toulouse, Unite Mixte Rech UMR 5546, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Delaux, Pierre-Marc; Lauressergues, Dominique] CNRS, Unite Mixte Rech UMR 5546, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Verstappen, Francel; Bouwmeester, Harro] Ctr Biosyst Genom, Wageningen, Netherlands; [Ruyter-Spira, Carolien] Plant Res Int, Wageningen, Netherlands	Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre for BioSystems Genomics	Bouwmeester, H (corresponding author), Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands.	harro.bouwmeester@wur.nl	Jamil, Muhammad/M-8923-2015; Cardoso, Catarina/M-7570-2017; Bouwmeester, Harro J/C-1414-2008	Jamil, Muhammad/0000-0003-0221-518X; Cardoso, Catarina/0000-0003-3323-4447; Delaux, Pierre-Marc/0000-0002-6211-157X; Bouwmeester, Harro/0000-0003-0907-2732	The Netherlands Organization for Scientific Research [865.06.002, 834.08.001]; Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	This work was financed by The Netherlands Organization for Scientific Research with VICI grant nr 865.06.002 and Equipment grant nr 834.08.001, attributed to HB, and co-financed by the Centre for Biosystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, attributed to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gurney AL, 1999, NEW PHYTOL, V143, P573, DOI 10.1046/j.1469-8137.1999.00467.x; Jamil M, 2011, WEED RES, V51, P373, DOI 10.1111/j.1365-3180.2011.00847.x; Jamil M, 2012, PLANTA, V235, P473, DOI 10.1007/s00425-011-1520-y; Jamil M, 2011, NEW PHYTOL, V192, P964, DOI 10.1111/j.1469-8137.2011.03850.x; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kohlen W, 2012, NEW PHYTOL, V196, P535, DOI 10.1111/j.1469-8137.2012.04265.x; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Matusova R, 2006, WAG UR FRON, V16, P39; Motonami N, 2013, PHYTOCHEMISTRY, V93, P41, DOI 10.1016/j.phytochem.2013.02.017; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nomura S, 2013, PLANT CELL REP, V32, P829, DOI 10.1007/s00299-013-1429-y; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sato D, 2003, J AGR FOOD CHEM, V51, P1162, DOI 10.1021/jf025997z; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Ueno K, 2011, J AGR FOOD CHEM, V59, P10485, DOI 10.1021/jf2024193; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Yoneyama K, 2009, PEST MANAG SCI, V65, P467, DOI 10.1002/ps.1726; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706	38	11	12	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104201	10.1371/journal.pone.0104201	http://dx.doi.org/10.1371/journal.pone.0104201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126953	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300017
J	Guta, S; Casal, J; Napp, S; Saez, JL; Garcia-Saenz, A; de Val, BP; Romero, B; Alvarez, J; Allepuz, A				Guta, Sintayehu; Casal, Jordi; Napp, Sebastian; Luis Saez, Jose; Garcia-Saenz, Ariadna; Perez de Val, Bernat; Romero, Beatriz; Alvarez, Julio; Allepuz, Alberto			Epidemiological Investigation of Bovine Tuberculosis Herd Breakdowns in Spain 2009/2011	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; RISK-FACTORS; SIMULATION-MODEL; GREAT-BRITAIN; CATTLE HERDS; NEW-ZEALAND; TRANSMISSION; INFECTIONS; DIAGNOSIS; IRELAND	We analyzed the most likely cause of 687 bovine tuberculosis (bTB) breakdowns detected in Spain between 2009 and 2011 (i.e., 22% of the total number of breakdowns detected during this period). Seven possible causes were considered: i) residual infection; ii) introduction of infected cattle from other herds; iii) sharing of pastures with infected herds; iv) contiguous spread from infected neighbor herds; v) presence of infected goats in the farm; vi) interaction with wildlife reservoirs and vii) contact with an infected human. For each possible cause a decision tree was developed and key questions were included in each of them. Answers to these key questions lead to different events within each decision tree. In order to assess the likelihood of occurrence of the different events a qualitative risk assessment approach was used. For this purpose, an expert opinion workshop was organized and ordinal values, ranging from 0 to 9 (i.e., null to very high likelihood of occurrence) were assigned. The analysis identified residual infection as the most frequent cause of bTB breakdowns (22.3%; 95% CI: 19.4-25.6), followed by interaction with wildlife reservoirs (13.1%; 95% CI: 10.8-15.8). The introduction of infected cattle, sharing of pastures and contiguous spread from infected neighbour herds were also identified as relevant causes. In 41.6% (95% CI: 38.0-45.4) of the breakdowns the origin of infection remained unknown. Veterinary officers conducting bTB breakdown investigations have to state their opinion about the possible cause of each breakdown. Comparison between the results of our analysis and the opinion from veterinary officers revealed a slight concordance. This slight agreement might reflect a lack of harmonized criteria to assess the most likely cause of bTB breakdowns as well as different perceptions about the importance of the possible causes. This is especially relevant in the case of the role of wildlife reservoirs.	[Guta, Sintayehu] Natl Anim Hlth Diagnost & Invest Ctr, Sebeta, Ethiopia; [Guta, Sintayehu; Casal, Jordi; Napp, Sebastian; Garcia-Saenz, Ariadna; Perez de Val, Bernat; Allepuz, Alberto] Univ Autonoma Barcelona, UAB IRTA, Ctr Recerca Sanitat Anim CReSA, E-08193 Barcelona, Spain; [Casal, Jordi; Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Luis Saez, Jose] Minist Agr Alimentac & Medio Ambiente, Direcc Gen Prod Agr, Subdirecc Gen Sanidad & Higiene Anim & Trazabilid, Madrid, Spain; [Romero, Beatriz] Univ Complutense Madrid, Ctr Vigilancia Sanit Vet VISAVET, Madrid, Spain; [Alvarez, Julio] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Complutense University of Madrid; University of Minnesota System; University of Minnesota Twin Cities	Allepuz, A (corresponding author), Univ Autonoma Barcelona, UAB IRTA, Ctr Recerca Sanitat Anim CReSA, E-08193 Barcelona, Spain.	alberto.allepuz@cresa.uab.cat	Napp, Sebastian/F-3331-2016; Casal, Jordi/F-3020-2016; Allepuz, Alberto/N-2398-2014; studies, IT VISAVET Account for bibliometric/C-3115-2014; Romero, Beatriz/J-5942-2015; DE VAL, BERNAT PÉREZ/G-6865-2012; Alvarez, Julio/H-8292-2013	Napp, Sebastian/0000-0001-5813-7286; Casal, Jordi/0000-0002-6909-9366; Allepuz, Alberto/0000-0003-3518-1991; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Romero, Beatriz/0000-0001-5263-1806; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Alvarez, Julio/0000-0002-8999-9417	Ministerio de Ciencia e Innovacion of Spain [AGL-2010-21098, BES-2011-043628]; Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID)	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID)	This research was supported by a grant from the Ministerio de Ciencia e Innovacion of Spain (AGL-2010-21098). PhD studies of S. Guta were funded by Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID), and PhD studies of A. Garcia-Saenz were funded by an FPI grant from Ministerio de Ciencia e Innovacion of Spain (BES-2011-043628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Allepuz A, 2009, VET PARASITOL, V159, P43, DOI 10.1016/j.vetpar.2008.09.027; Alvarez J, 2008, VET MICROBIOL, V128, P72, DOI 10.1016/j.vetmic.2007.08.034; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; [Anonymous], 2004, EFSA J, V176, P1; [Anonymous], 2012, EFSA J, V8, P1496; [Anonymous], 2011, VET MED INT, DOI DOI 10.4061/2011/874924; [Anonymous], 2010, EPIDEMIOLOGICAL QUES; [Anonymous], 2013, WORKING DOCUMENT ERA; Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; CHEESEMAN CL, 1989, EPIDEMIOL INFECT, V103, P113, DOI 10.1017/S0950268800030417; Clegg TA, 2011, PREV VET MED, V100, P147, DOI 10.1016/j.prevetmed.2011.02.015; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Courtenay O, 2006, BIOL LETT-UK, V2, P460, DOI 10.1098/rsbl.2006.0468; Crawshaw T, 2008, VET REC, V163, P127, DOI 10.1136/vr.163.4.127; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delahay RJ, 2001, TUBERCULOSIS, V81, P43, DOI 10.1054/tube.2000.0266; Denny GO, 1999, VET REC, V144, P305, DOI 10.1136/vr.144.12.305; Dommergues L, 2012, TRANSBOUND EMERG DIS, V59, P292, DOI 10.1111/j.1865-1682.2011.01269.x; Dufour B, 2011, REV SCI TECH OIE, V30, P673; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Fritsche A, 2004, INT J TUBERC LUNG D, V8, P903; Garcia-Bocanegra I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034908; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Gordejo FJR, 2006, VET MICROBIOL, V112, P101, DOI 10.1016/j.vetmic.2005.11.034; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; GRIFFIN JM, 1992, IRISH VET J, V45, P126; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; Krajewska M, 2012, VET MICROBIOL, V159, P269, DOI 10.1016/j.vetmic.2012.04.001; Marianelli C, 2010, J VET DIAGN INVEST, V22, P445, DOI 10.1177/104063871002200319; Mendoza MM, 2012, VET J, V191, P267, DOI 10.1016/j.tvjl.2011.05.006; Napp S, 2013, VET REC, V172, DOI 10.1136/vr.101347; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Office International des Epizooties (OIE), 2004, HDB IMP RISK AN AN A, VII; Olea-Popelka FJ, 2008, PREV VET MED, V85, P81, DOI 10.1016/j.prevetmed.2008.01.003; Olea-Popelka F, 2006, IRISH VET J, V59, P683, DOI 10.1186/2046-0481-59-12-683; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; Perez AM, 2002, PREV VET MED, V54, P351, DOI 10.1016/S0167-5877(02)00044-2; Porphyre T, 2007, VET RES, V38, P465, DOI 10.1051/vetres:2007003; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Rodriguez-Prieto V, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-148; Romero B, 2011, EMERG INFECT DIS, V17, P2393, DOI 10.3201/eid1712.101476; Skuce RA, 2012, VET MED INT, P1, DOI [10.1155/2012/621210, DOI 10.1155/2012/621210]; Stevenson M, 2013, EPIR R PACKAGE ANAL; van der Burgt GM, 2013, VET REC, V172, P69, DOI 10.1136/vr.101048; WILESMITH JW, 1983, J HYG-CAMBRIDGE, V90, P159, DOI 10.1017/S0022172400028837; Zanardi G, 2013, RES VET SCI, V95, P430, DOI 10.1016/j.rvsc.2013.04.019	55	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104383	10.1371/journal.pone.0104383	http://dx.doi.org/10.1371/journal.pone.0104383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127254	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000340879300020
J	Ju, ZL; Chavan, SS; Antoine, DJ; Dancho, M; Tsaava, T; Li, JH; Lu, B; Levine, YA; Stiegler, A; Tamari, Y; Al-Abed, Y; Roth, J; Tracey, KJ; Yang, H				Ju, Zhongliang; Chavan, Sangeeta S.; Antoine, Daniel J.; Dancho, Meghan; Tsaava, Tea; Li, Jianhua; Lu, Ben; Levine, Yaakov A.; Stiegler, Andrew; Tamari, Yehuda; Al-Abed, Yousef; Roth, Jesse; Tracey, Kevin J.; Yang, Huan			Sequestering HMGB1 via DNA-Conjugated Beads Ameliorates Murine Colitis	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CYTOKINE ACTIVITY; PROTEIN HMGB1; APOPTOSIS; ACTIVATION; AFFINITY; CYSTEINE; ANTIBODY	Inflammatory bowel disease (IBD) is chronic inflammation of the gastrointestinal tract that affects millions of people worldwide. Although the etiology of IBD is not clear, it is known that products from stressed cells and enteric microbes promote intestinal inflammation. High mobility group box 1 (HMGB1), originally identified as a nuclear DNA binding protein, is a cytokine-like protein mediator implicated in infection, sterile injury, autoimmune disease, and IBD. Elevated levels of HMGB1 have been detected in inflamed human intestinal tissues and in feces of IBD patients and mouse models of colitis. Neutralizing HMGB1 activity by administration of anti-HMGB1 antibodies or HMGB1-specific antagonist improves clinical outcomes in animal models of colitis. Since HMGB1 binds to DNA with high affinity, here we developed a novel strategy to sequester HMGB1 using DNA immobilized on sepharose beads. Screening of DNA-bead constructs revealed that B2 beads, one linear form of DNA conjugated beads, bind HMGB1 with high affinity, capture HMGB1 ex vivo from endotoxin-stimulated RAW 264.7 cell supernatant and from feces of mice with colitis. Oral administration of B2 DNA beads significantly improved body weight, reduced colon injury, and suppressed colonic and circulating cytokine levels in mice with spontaneous colitis (IL-10 knockout) and with dextran sulfate sodium-induced colitis. Thus, DNA beads reduce inflammation by sequestering HMGB1 and may have therapeutic potential for the treatment of IBD.	[Ju, Zhongliang; Chavan, Sangeeta S.; Dancho, Meghan; Tsaava, Tea; Li, Jianhua; Lu, Ben; Roth, Jesse; Tracey, Kevin J.; Yang, Huan] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; [Antoine, Daniel J.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [Levine, Yaakov A.] SetPoint Med Corp, Valencia, Spain; [Stiegler, Andrew; Tamari, Yehuda] Circulatory Technol Inc, Oyster Bay, NY USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Manhasset, NY USA	Northwell Health; University of Liverpool; Northwell Health	Yang, H (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA.	hyang@nshs.edu	Lu, Ben/AAN-1068-2021; Levine, Yaakov/AAA-2578-2020	Lu, Ben/0000-0002-8597-0406; Levine, Yaakov/0000-0002-3313-6858; Tracey, Kevin J/0000-0003-1884-6314	National Institutes of Health [GM098446, GM062508]; Wellcome Trust, UK; SetPoint Medical Corporation; Circulatory Technology Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098446, R01GM062508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust, UK(Wellcome Trust); SetPoint Medical Corporation; Circulatory Technology Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported, in part, by grants from the National Institutes of Health (GM098446 to HY and GM062508 to KJT) and from Wellcome Trust, UK (to DJA). Yaakov A. Levine received salary from SetPoint Medical Corporation, and Andrew Stiegler and Yehuda Tamari received salary from Circulatory Technology Inc to fund part of this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Antoine DJ, 2014, MOL MED, V20, P135, DOI 10.2119/molmed.2014.00022; Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019; Antoine DJ, 2010, MOL MED, V16, P479, DOI 10.2119/molmed.2010.00126; BIANCHI ME, 1988, EMBO J, V7, P843, DOI 10.1002/j.1460-2075.1988.tb02883.x; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chockalingam PS, 2001, MOL BIOTECHNOL, V19, P189, DOI 10.1385/MB:19:2:189; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115; Graff LA, 2011, INFLAMM BOWEL DIS, V17, P1882, DOI 10.1002/ibd.21580; Graff LA, 2009, AM J GASTROENTEROL, V104, P2959, DOI 10.1038/ajg.2009.529; Hill DA, 1997, NUCLEIC ACIDS RES, V25, P3523, DOI 10.1093/nar/25.17.3523; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lix LM, 2008, INFLAMM BOWEL DIS, V14, P1575, DOI 10.1002/ibd.20511; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; Madsen SM, 2001, AM J GASTROENTEROL, V96, P1807, DOI 10.1016/S0002-9270(01)02438-8; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Magro F, 2010, BIODRUGS, V24, P1, DOI 10.2165/11586300-000000000-00000; Matta R, 2012, AM J PHYSIOL-GASTR L, V302, pG1322, DOI 10.1152/ajpgi.00018.2012; Musumeci D, 2011, MOL BIOSYST, V7, P1742, DOI 10.1039/c1mb05009e; Nikolaus S, 2003, GUT, V52, P1286, DOI 10.1136/gut.52.9.1286; Ombrellino M, 1999, LANCET, V354, P1446, DOI 10.1016/S0140-6736(99)02658-6; Palone F, 2014, INFLAMM BOWEL DIS, V20, P1448, DOI 10.1097/MIB.0000000000000113; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Siiman O, 2001, J COLLOID INTERF SCI, V234, P44, DOI 10.1006/jcis.2000.7279; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Vitali R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066527; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Wirtz S, 2005, J CLIN INVEST, V115, P586, DOI 10.1172/JCI200524518; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yanai H, 2011, P NATL ACAD SCI USA, V108, P11542, DOI 10.1073/pnas.1108535108; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang	51	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103992	10.1371/journal.pone.0103992	http://dx.doi.org/10.1371/journal.pone.0103992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127031	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300010
J	Wang, T; Yang, JJ; Han, RH; Ji, XM; Wu, BQ; Han, L; Luo, C; Fan, JJ; Zhu, BL; Ni, CH				Wang, Ting; Yang, Jingjin; Han, Ruhui; Ji, Xiaoming; Wu, Baiqun; Han, Lei; Luo, Chen; Fan, Jingjing; Zhu, Baoli; Ni, Chunhui			Polymorphisms in SPARC and Coal Workers' Pneumoconiosis Risk in a Chinese Population	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FIBROBLASTS; UPDATE; INJURY; MICE	Background: The SPARC is a crucial matricellular protein and may influence the course of various diseases like tumor metastasis and fibrosis. In the present study, we investigated the association between the potential functional polymorphisms in SPA Methods: Five potentially functional polymorphisms (rs1059279, rs1059829, rs1053411, rs2304052 and rs4958281) in SPARC were genotyped and analyzed in a case-control study including 697 CWP cases and 694 controls. The genotyping was used by the TaqMan method with the ABI 7900HT Real Time PCR system. Results: Our results revealed that three SNPs (rs1059279, rs1059829, rs1053411) were significantly associated with increased risk of CWP under an additive model (OR = 1.35, 95%CI = 1.06-1.71, P = 0.015 for rs1059279; OR = 1.20, 95%CI = 1.03-1.39, P = 0.021 for rs1059829; OR = 1.31, 95%CI = 1.03-1.65, P = 0.025 for rs1053411). In the stratification analysis, significant associations were observed between each of these three SNPs and patients with 0-20 pack-years of smoking (OR = 1.73, 95%CI = 1.21-2.45 for rs1059279; OR = 1.48, 95%CI = 1.07-2.05 for rs105982; OR = 1.58, 95%CI = 1.13-2.22 for rs1053411). Furthermore, the association between rs1059279 and CWP risk remained significant among subjects with over 27 years of exposure (OR = 1.27, 95%CI = 1.03-1.56, P = 0.023). In the combined analysis of these five polymorphisms, individuals with multiple risk alleles had a higher risk of CWP (Ptrend = 0.015). Conclusion: Our results indicate that three functional SPARC SNPs are associated with an increased risk of CWP in a Chinese population. Further functional research and validation studies with diverse populations are warranted to confirm our findings.	[Wang, Ting; Yang, Jingjin; Han, Ruhui; Ji, Xiaoming; Wu, Baiqun; Han, Lei; Luo, Chen; Fan, Jingjing; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China; [Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ni, CH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China.	chni@njmu.edu.cn	wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [81273044]; Academic Program Development of Jiangsu Higher Education Institutions[PAPD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Program Development of Jiangsu Higher Education Institutions[PAPD]	This study was partly supported by the National Natural Science Foundation of China (81273044) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions[PAPD]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers CE, 2002, KIDNEY INT, V62, P2073, DOI 10.1046/j.1523-1755.2002.00680.x; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1995, AM J PATHOL, V147, P1759; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Nawrot TS, 2008, AM J RESP CRIT CARE, V177, P696, DOI 10.1164/rccm.200801-116UP; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sangaletti S, 2011, AM J PATHOL, V179, P3000, DOI 10.1016/j.ajpath.2011.08.027; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Trombetta-Esilva Jessica, 2012, Open Rheumatol J, V6, P146, DOI 10.2174/1874312901206010146; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Wang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022624; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P257, DOI 10.1002/art.20785	22	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105226	10.1371/journal.pone.0105226	http://dx.doi.org/10.1371/journal.pone.0105226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126876	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300096
J	Gajecki, M; Berman, AH; Sinadinovic, K; Andersson, C; Ljotsson, B; Hedman, E; Ruck, C; Lindefors, N				Gajecki, Mikael; Berman, Anne H.; Sinadinovic, Kristina; Andersson, Claes; Ljotsson, Brjann; Hedman, Erik; Ruck, Christian; Lindefors, Nils			Effects of Baseline Problematic Alcohol and Drug Use on Internet-Based Cognitive Behavioral Therapy Outcomes for Depression, Panic Disorder and Social Anxiety Disorder	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE USE DISORDERS; PSYCHIATRIC COMORBIDITY; CIGARETTE-SMOKING; SELF-MEDICATION; DSM-IV; DEPENDENCE; SCALE; PAPER; MOOD	Purpose: Patients' problematic substance use prevalence and effects were explored in relation to internet-based cognitive behavioral therapy (ICBT) outcomes for depression, panic disorder and social anxiety disorder. Methods: At baseline and treatment conclusion, 1601 ICBT patients were assessed with self-rated measures for alcohol and drug use (AUDIT/DUDIT), depressive symptoms (MADRS-S), panic disorder symptoms (PDSS-SR) and social anxiety symptoms (LSAS-SR). Results: Problematic substance use (AUDIT >= 8 for men, >= 6 for women; DUDIT >= 1) occurred among 32.4% of the patients; 24.1% only alcohol, 4.6% only drugs, and 3.7% combined alcohol and drug use. Hazardous alcohol use and probable alcohol dependence negatively affected panic disorder outcomes, and hazardous drug use led to worse social anxiety outcomes. Depression outcomes were not affected by substance use. Treatment adherence was negatively affected by problematic drug use among men and 25-34 year olds; combined substance use negatively affected adherence for women and 35-64 year olds. Conclusion: Problematic substance use does not preclude ICBT treatment but can worsen outcomes, particularly problematic alcohol use for panic disorder patients and hazardous drug use for social anxiety patients. ICBT clinicians should exercise particular caution when treating men and younger patients with problematic drug use, and women or older patients with combined substance use.	[Gajecki, Mikael; Berman, Anne H.; Sinadinovic, Kristina; Andersson, Claes] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Berman, Anne H.; Sinadinovic, Kristina] Stockholm Ctr Dependency Disorders, Stockholm, Sweden; [Andersson, Claes] Malmo Univ, Dept Criminol, Malmo, Sweden; [Andersson, Claes] Lund Univ, Dept Clin Sci, Div Psychiat, Lund, Sweden; [Ljotsson, Brjann; Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Ruck, Christian; Lindefors, Nils] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden	Karolinska Institutet; Malmo University; Lund University; Karolinska Institutet; Karolinska Institutet	Gajecki, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.	mikael.gajecki@ki.se	Berman, Anne H/C-4636-2011	Berman, Anne H/0000-0002-7709-0230; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Ruck, Christian/0000-0002-8742-0168; Ljotsson, Brjann/0000-0001-8086-1668; Gajecki, Mikael/0000-0002-0987-9010	Stockholm Center for Dependency Disorders; Psychiatry Southwest; Vinnova [2009-00192]	Stockholm Center for Dependency Disorders; Psychiatry Southwest; Vinnova(Vinnova)	This study was funded by the Stockholm Center for Dependency Disorders (http://www.slso.sll.se/SLPOtemplates/SLPOPage1____6639.aspx), Psychiatry Southwest (http://www.slso.sll.se/slpotemplates/slpopage1____4432.aspx) and Vinnova (http://www.vinnova.se/), grant number 2009-00192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Andersson G., 2007, PSYCHIATRY, V2, P9; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bolton J, 2006, J NERV MENT DIS, V194, P818, DOI 10.1097/01.nmd.0000244481.63148.98; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179; Buckner JD, 2008, DEPRESS ANXIETY, V25, P1028, DOI 10.1002/da.20442; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO; Cruce G, 2007, NORD J PSYCHIAT, V61, P92, DOI 10.1080/08039480701226062; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Eberhard S, 2009, SOC PSYCH PSYCH EPID, V44, P1013, DOI 10.1007/s00127-009-0023-7; Eskildsen A, 2010, NORD J PSYCHIAT, V64, P94, DOI 10.3109/08039480903426929; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Furukawa TA, 2009, DEPRESS ANXIETY, V26, P922, DOI 10.1002/da.20532; Gainsbury S, 2011, CLIN PSYCHOL REV, V31, P490, DOI 10.1016/j.cpr.2010.11.007; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Harrison L., 1997, VALIDITY SELF REPORT; Hedman E, 2013, ACTA PSYCHIAT SCAND, V128, P457, DOI 10.1111/acps.12079; Hedman E, 2014, J AFFECT DISORDERS, V155, P49, DOI 10.1016/j.jad.2013.10.023; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Howell D, 2002, STAT METHODS PSYCHOL; John U, 2004, DRUG ALCOHOL DEPEN, V76, P287, DOI 10.1016/j.drugalcdep.2004.06.004; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kallmen H, 2011, NORD STUD ALCOHOL DR, V28, P123; Kenneson A, 2013, DRUG ALCOHOL DEPEN, V133, P338, DOI 10.1016/j.drugalcdep.2013.06.011; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Kim T, 2003, DHA GUIDE EFFECTIVE; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; McEvoy PM, 2008, J ANXIETY DISORD, V22, P1087, DOI 10.1016/j.janxdis.2007.11.007; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy JM, 2003, AM J PSYCHIAT, V160, P1663, DOI 10.1176/appi.ajp.160.9.1663; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Riper H, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1713; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneier FR, 2010, PSYCHOL MED, V40, P977, DOI 10.1017/S0033291709991231; Shear MK, 1997, AM J PSYCHIAT, V154, P1571, DOI 10.1176/ajp.154.11.1571; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sinadinovic K, 2011, DRUG ALCOHOL DEPEN, V114, P55, DOI 10.1016/j.drugalcdep.2010.09.004; Sinadinovic K, 2010, ADDICT BEHAV, V35, P464, DOI 10.1016/j.addbeh.2009.12.021; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Svanborg P, 2003, NORD J PSYCHIAT, V57, P291, DOI 10.1080/08039480307281; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2011, CURR OPIN PSYCHIATR, V24, P18, DOI 10.1097/YCO.0b013e32833ed18f; Wang YC, 2005, J ADOLESCENT HEALTH, V37, P289, DOI 10.1016/j.jadohealth.2005.03.017; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158	53	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104615	10.1371/journal.pone.0104615	http://dx.doi.org/10.1371/journal.pone.0104615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25122509	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000049
J	Feng, L; Li, P; Wang, XH; Hu, Z; Ma, Y; Tang, WM; Ben, YL; Mahapatra, T; Cao, XL; Mahapatra, S; Ling, M; Gou, AS; Wang, YM; Xiao, JQ; Hou, M; Wang, XL; Lin, B; Wang, FX				Feng, Lei; Li, Ping; Wang, Xihua; Hu, Zhi; Ma, Ying; Tang, Weiming; Ben, Yanli; Mahapatra, Tanmay; Cao, Xiaolin; Mahapatra, Sanchita; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Wang, Faxing			Distribution and Determinants of Non Communicable Diseases among Elderly Uyghur Ethnic Group in Xinjiang, China	PLOS ONE			English	Article							PRESSURE-RELATED DISEASE; NONCOMMUNICABLE DISEASES; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; HEALTH; PREVALENCE; METAANALYSIS; PREVENTION; REGRESSION	Background: Non-communicable diseases (NCDs) are showing an increasing trend globally as well as in China. Elderly population are more prone to these NCDs. Situation in China is worse owing to the higher proportion of geriatric population. Burden of NCDs and the role of their socio-demographic and behavioral predictors among these elderly and more so among the ethnic minority groups among them, need to be investigated specifically, owing to their distinct genetic background, lifestyles and behavior. Methods: A cross-sectional study was conducted among 1329 randomly selected persons of Uyghur ethnicity, aged 60 years or more in Xinjiang, the largest administrative division in China to measure the burden of NCDs, understand the distribution of socio-demographic, behavioral and life event-related potential correlates of them and to estimate the association of the NCDs with these correlates. Results: Among these participants 54.2% were female, 86.8% were married and more than half had only attended elementary school or less. 41.46% was suffering from at least one NCD. 20.22% had one NCD, 12.11% had two and 8.58% had three or more. 27.3% had hypertension, 4.06% had diabetes, 6.02% had hyperlipidemia, 7.37% had angina, 14.52% had cardiovascular diseases, 11.59% had any kind of cancers and 9.78% had chronic obstructive pulmonary diseases. Rural residents (OR = 1.45, 95% CI: 1.17-1.80, AOR = 2.00, 95% CI: 1.53-2.61) and current smokers had higher odds of having more NCDs (AOR = 1.53, 95% CI: 1.00-2.34). Additionally not being satisfied with current life, not being able to take care of self in daily life, currently not being involved in farm work, less intake of fresh vegetables, fruits and garlic, too less or too much salt intake, not having hobbies were found to be positively associated with having more NCDs. Conclusion: Implementation of effective intervention strategies to promote healthy life styles among the Uyghur elderly population of China seems urgent.	[Feng, Lei; Hu, Zhi; Ma, Ying] Anhui Med Univ, Sch Hlth Serv Adm, Dept Hlth Serv management, Hefei, Anhui, Peoples R China; [Feng, Lei; Li, Ping; Wang, Xihua; Ben, Yanli; Cao, Xiaolin; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Wang, Faxing] Peoples Hosp Xinjiang Uighur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China; [Tang, Weiming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China; [Tang, Weiming] Guangdong Ctr Skin Dis & STI Control, Dept STI Control, Guangzhou, Guangdong, Peoples R China; [Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	Anhui Medical University; University of California System; University of California Los Angeles	Wang, FX (corresponding author), Peoples Hosp Xinjiang Uighur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China.	wfx116@126.com		Tang, Weiming/0000-0002-9026-707X	Natural Science Fund Regional Fund of China [8126212]; Science and Technology Project of Xinjiang Autonomous Region [201242178]; National Institutes of Health (NIH) program [1D43TW009532-01]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Natural Science Fund Regional Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Xinjiang Autonomous Region; National Institutes of Health (NIH) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Natural Science Fund Regional Fund of China (8126212) and Science and Technology Project of Xinjiang Autonomous Region (201242178) and National Institutes of Health (NIH) program (1D43TW009532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn T, 2012, LANCET, V379, P2227, DOI 10.1016/S0140-6736(12)60963-5; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Barouki Robert, 2012, Environ Health, V11, P42, DOI 10.1186/1476-069X-11-42; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Cai W, 2014, SCI WORLD J, DOI 10.1155/2014/393628; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chapman IM, 2013, EFFECT AGING SENSITI; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090262; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; DOWSE GK, 1995, BRIT MED J, V311, P1255, DOI 10.1136/bmj.311.7015.1255; Gavrilov LA, 2003, ENCY POPULATION, V1, P32; HARENBERG J, 1988, ATHEROSCLEROSIS, V74, P247, DOI 10.1016/0021-9150(88)90244-4; Institute S, 1996, SAS SYST WIND; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin Z-Y, 2013, CANC PREVENTION RES; Lauritsen J, 2003, COMPREHENSIVE TOOL V; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li LL, 2008, CARDIOVASC TOXICOL, V8, P87, DOI 10.1007/s12012-008-9017-z; Li NF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-499; MacMahon S, 2008, AM J HYPERTENS, V21, P843, DOI 10.1038/ajh.2008.223; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Qin J, 2010, CHINESE J PUBLIC HLT, V7, P055; SILAGY CAS, 1994, J HYPERTENS, V12, P463; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Tang SL, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-7; The World Bank, 2011, HLTH HARM LIF CHIN S; USCDC, 2011, PROBL NONC DIS CDCS; Varagic J, 2001, CURR OPIN CARDIOL, V16, P336, DOI 10.1097/00001573-200111000-00004; Wu Y, 2011, SICK SOC RESPONDING, P241; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423	37	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105536	10.1371/journal.pone.0105536	http://dx.doi.org/10.1371/journal.pone.0105536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141133	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200095
J	Furuhagen, S; Fuchs, A; Belleza, EL; Breitholtz, M; Gorokhova, E				Furuhagen, Sara; Fuchs, Anne; Belleza, Elin Lundstrom; Breitholtz, Magnus; Gorokhova, Elena			Are Pharmaceuticals with Evolutionary Conserved Molecular Drug Targets More Potent to Cause Toxic Effects in Non-Target Organisms?	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; TANDEM MASS-SPECTROMETRY; DAPHNIA-MAGNA; MESSENGER-RNA; RNA/DNA RATIOS; IN-VITRO; FISH; ECOTOXICOLOGY; REPRODUCTION; CALMODULIN	The ubiquitous use of pharmaceuticals has resulted in a continuous discharge into wastewater and pharmaceuticals and their metabolites are found in the environment. Due to their design towards specific drug targets, pharmaceuticals may be therapeutically active already at low environmental concentrations. Several human drug targets are evolutionary conserved in aquatic organisms, raising concerns about effects of these pharmaceuticals in non-target organisms. In this study, we hypothesized that the toxicity of a pharmaceutical towards a non-target invertebrate depends on the presence of the human drug target orthologs in this species. This was tested by assessing toxicity of pharmaceuticals with (miconazole and promethazine) and without (levonorgestrel) identified drug target orthologs in the cladoceran Daphnia magna. The toxicity was evaluated using general toxicity endpoints at individual (immobility, reproduction and development), biochemical (RNA and DNA content) and molecular (gene expression) levels. The results provide evidence for higher toxicity of miconazole and promethazine, i.e. the drugs with identified drug target orthologs. At the individual level, miconazole had the lowest effect concentrations for immobility and reproduction (0.3 and 0.022 mg L-1, respectively) followed by promethazine (1.6 and 0.18 mg L-1, respectively). At the biochemical level, individual RNA content was affected by miconazole and promethazine already at 0.0023 and 0.059 mg L-1, respectively. At the molecular level, gene expression for cuticle protein was significantly suppressed by exposure to both miconazole and promethazine; moreover, daphnids exposed to miconazole had significantly lower vitellogenin expression. Levonorgestrel did not have any effects on any endpoints in the concentrations tested. These results highlight the importance of considering drug target conservation in environmental risk assessments of pharmaceuticals.	[Furuhagen, Sara; Fuchs, Anne; Belleza, Elin Lundstrom; Breitholtz, Magnus; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University	Furuhagen, S (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	sara.furuhagen@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management'; Swedish foundation for strategic environmental research (MISTRA; MistraPharma)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management'; Swedish foundation for strategic environmental research (MISTRA; MistraPharma)	This study was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management' and the Swedish foundation for strategic environmental research (MISTRA; MistraPharma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y; Ahlers J, 2006, ENVIRON TOXICOL CHEM, V25, P2937, DOI 10.1897/05-701R.1; Alam MS, 2008, J PHYS CHEM B, V112, P12962, DOI 10.1021/jp804238k; ALLEN Y, 1995, ENVIRON TOXICOL CHEM, V14, P1625, DOI 10.1002/etc.5620140923; Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; [Anonymous], OECD 202 GUID TEST C; Barata C, 2008, SCI TOTAL ENVIRON, V405, P78, DOI 10.1016/j.scitotenv.2008.06.028; Breitholtz M, 2001, MAR POLLUT BULL, V42, P879, DOI 10.1016/S0025-326X(01)00046-7; Breitholtz M., 2013, ENDOCRINE DISRUPTERS, P116, DOI [10.1002/9781118355961.ch5, DOI 10.1002/9781118355961.CH5]; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q; Campos B, 2012, ENVIRON SCI TECHNOL, V46, P2943, DOI 10.1021/es203157f; Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021; Escher BI, 2005, ENVIRON SCI TECHNOL, V39, P3090, DOI 10.1021/es048590e; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hannas BR, 2011, AQUAT TOXICOL, V101, P351, DOI 10.1016/j.aquatox.2010.11.006; HEGEMANN L, 1993, J INVEST DERMATOL, V100, P343, DOI 10.1111/1523-1747.ep12470043; HENSHAW EC, 1971, J BIOL CHEM, V246, P436; Ibiam U, 2005, ENVIRON TOXICOL CHEM, V24, P1155, DOI 10.1897/04-262R.1; Ioele G, 2012, CURR PHARM ANAL, V8, P196, DOI 10.2174/1573412911208020196; Jukosky JA, 2008, B ENVIRON CONTAM TOX, V81, P230, DOI 10.1007/s00128-008-9462-1; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim J, 2011, ECOTOXICOLOGY, V20, P1741, DOI 10.1007/s10646-011-0707-0; Kvarnryd M, 2011, AQUAT TOXICOL, V103, P18, DOI 10.1016/j.aquatox.2011.02.003; Larsson DGJ, 1999, AQUAT TOXICOL, V45, P91, DOI 10.1016/S0166-445X(98)00112-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTSON MP, 1986, MOL CELL ENDOCRINOL, V48, P135, DOI 10.1016/0303-7207(86)90036-5; Neumann NF, 2002, BIOTECHNOL ADV, V20, P391, DOI 10.1016/S0734-9750(02)00025-3; OECD, 2012, OECD 211 GUID TEST C; Pacheco LF, 2003, J COLLOID INTERF SCI, V258, P146, DOI 10.1016/S0021-9797(02)00103-0; Pereira JL, 2008, ANN LIMNOL-INT J LIM, V44, P169, DOI 10.1051/limn:2008001; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Roberts PH, 2006, J CHROMATOGR A, V1134, P143, DOI 10.1016/j.chroma.2006.08.093; Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0; Soetaert A, 2006, COMP BIOCHEM PHYS C, V142, P66, DOI 10.1016/j.cbpc.2005.10.009; Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076; Sumpter JP, 1995, TOXICOL LETT, V82-3, P737, DOI 10.1016/0378-4274(95)03517-6; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; TUCCIARONE LM, 1982, MOL CELL BIOCHEM, V45, P159; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Vandenbrouck T, 2009, AQUAT TOXICOL, V92, P18, DOI 10.1016/j.aquatox.2008.12.012; Varshney R, 1996, RADIAT PHYS CHEM, V47, P595, DOI 10.1016/0969-806X(95)00056-4; Vena GA, 2008, CURR PHARM DESIGN, V14, P2902, DOI 10.2174/138161208786369777; Versonnen BJ, 2003, ENVIRON TOXICOL CHEM, V22, P329, DOI [10.1002/etc.5620220213, 10.1897/1551-5028(2003)022&lt;0329:IVAIVE&gt;2.0.CO;2]; Vulliet E, 2008, J CHROMATOGR A, V1210, P84, DOI 10.1016/j.chroma.2008.09.034; Walker SD, 2013, CHEMOSPHERE, V93, P2568, DOI 10.1016/j.chemosphere.2013.09.074; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	54	30	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105028	10.1371/journal.pone.0105028	http://dx.doi.org/10.1371/journal.pone.0105028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140792	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200047
J	Bahitham, W; Liao, XP; Peng, F; Bamforth, F; Chan, A; Mason, A; Stone, B; Stothard, P; Sergi, C				Bahitham, Wesam; Liao, Xiaoping; Peng, Fred; Bamforth, Fiona; Chan, Alicia; Mason, Andrew; Stone, Bradley; Stothard, Paul; Sergi, Consolato			Mitochondriome and Cholangiocellular Carcinoma	PLOS ONE			English	Article							DNA G10398A POLYMORPHISM; D-LOOP; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATIONS; BREAST-CANCER; COPY NUMBER; RISK; ASSOCIATION; EXPRESSION; FREQUENCY	Cholangiocellular carcinoma (CCA) of the liver was the target of more interest, recently, due mainly to its increased incidence and possible association to new environmental factors. Somatic mitochondrial DNA (mtDNA) mutations have been found in several cancers. Some of these malignancies contain changes of mtDNA, which are not or, very rarely, found in the mtDNA databases. In terms of evolutionary genetics and oncology, these data are extremely interesting and may be considered a sign of poor fitness, which may conduct in some way to different cellular processes, including carcinogenesis. MitoChip analysis is a strong tool for investigations in experimental oncology and was carried out on three CCA cell lines (HuCCT1, Huh-28 and OZ) with different outcome in human and a Papova-immortalized normal hepatocyte cell line (THLE-3). Real time quantitative PCR, western blot analysis, transmission electron microscopy, confocal laser microscopy, and metabolic assays including L-Lactate and NAD(+)/NADH assays were meticulously used to identify mtDNA copy number, oxidative phosphorylation (OXPHOS) content, ultrastructural morphology, mitochondrial membrane potential (Delta Psi(m)), and differential composition of metabolites, respectively. Among 102 mtDNA changes observed in the CCA cell lines, 28 were non-synonymous coding region alterations resulting in an amino acid change. Thirty-eight were synonymous and 30 involved ribosomal RNA (rRNA) and transfer RNA (tRNA) regions. We found three new heteroplasmic mutations in two CCA cell lines (HuCCT1 and Huh-28). Interestingly, mtDNA copy number was decreased in all three CCA cell lines, while complexes I and III were decreased with depolarization of mitochondria. L-Lactate and NAD+/NADH assays were increased in all three CCA cell lines. MtDNA alterations seem to be a common event in CCA. This is the first study using MitoChip analysis with comprehensive metabolic studies in CCA cell lines potentially creating a platform for future studies on the interactions between normal and neoplastic cells.	[Bahitham, Wesam; Bamforth, Fiona; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Liao, Xiaoping; Peng, Fred; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Chan, Alicia] Univ Alberta, Dept Genet, Edmonton, AB T6G 2E9, Canada; [Mason, Andrew] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Sergi, Consolato] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Stone, Bradley] Benaroya Res Inst, Seattle, WA USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Benaroya Research Institute	Sergi, C (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	sergi@ualberta.ca	Sergi, Consolato/A-1126-2009; Mason, Andrew/D-2938-2013	Mason, Andrew/0000-0002-0470-9522; Sergi, Consolato/0000-0002-2779-7879	Ministry of Higher Education in Saudi Arabia through the Saudi Cultural Bureau, Ottawa, Ontario, Canada	Ministry of Higher Education in Saudi Arabia through the Saudi Cultural Bureau, Ottawa, Ontario, Canada	The authors thank the Ministry of Higher Education in Saudi Arabia for providing the MSc student (W. B.) scholarship and support through the Saudi Cultural Bureau, Ottawa, Ontario, Canada. The authors also thank the University of Alberta for intramural funding to the principal investigator (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuetabh Y, 2011, ANN CLIN LAB SCI, V41, P217; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Calhoun ES, 2003, AM J PATHOL, V163, P1255, DOI 10.1016/S0002-9440(10)63485-2; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Heddi A, 1996, BBA-MOL BASIS DIS, V1316, P203, DOI 10.1016/0925-4439(96)00026-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOMMA S, 1987, Gastroenterologia Japonica, V22, P474; Jakupciak JP, 2006, CURR OPIN MOL THER, V8, P500; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Kothiyal P, 2009, CURR PROTOC HUM GENE, V7; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Maximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7; Mims MP, 2006, CANCER RES, V66, P1880, DOI 10.1158/0008-5472.CAN-05-3774; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Nomoto S, 2002, CLIN CANCER RES, V8, P481; Ohashi Y, 2004, GYNECOL ONCOL, V93, P54, DOI 10.1016/j.ygyno.2004.01.019; Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Schapira AHV, 2002, J INHERIT METAB DIS, V25, P207, DOI 10.1023/A:1015629912477; Sui GP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-73; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WICE BM, 1981, J BIOL CHEM, V256, P7812; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-130; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	48	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104694	10.1371/journal.pone.0104694	http://dx.doi.org/10.1371/journal.pone.0104694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137133	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100042
J	Chui, TTT; Lee, WC				Chui, Tina Tsz-Ting; Lee, Wen-Chung			Estimating Risks and Relative Risks in Case-Base Studies under the Assumptions of Gene-Environment Independence and Hardy-Weinberg Equilibrium	PLOS ONE			English	Article							POPULATION; GENOTYPE	Many diseases result from the interactions between genes and the environment. An efficient method has been proposed for a case-control study to estimate the genetic and environmental main effects and their interactions, which exploits the assumptions of gene-environment independence and Hardy-Weinberg equilibrium. To estimate the absolute and relative risks, one needs to resort to an alternative design: the case-base study. In this paper, the authors show how to analyze a case-base study under the above dual assumptions. This approach is based on a conditional logistic regression of case-counterfactual controls matched data. It can be easily fitted with readily available statistical packages. When the dual assumptions are met, the method is approximately unbiased and has adequate coverage probabilities for confidence intervals. It also results in smaller variances and shorter confidence intervals as compared with a previous method for a case-base study which imposes neither assumption.	[Chui, Tina Tsz-Ting; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	National Science Council, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This paper is partly supported by grants from National Science Council, Taiwan (NSC 102-2628-B-002-036-MY3) and National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee N, 2005, BIOMETRIKA, V92, P399, DOI 10.1093/biomet/92.2.399; Chen YH, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-43; Cheng KF, 2005, STAT MED, V24, P3289, DOI 10.1002/sim.2190; Chui TTT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083275; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; KUPPER LL, 1975, J AM STAT ASSOC, V70, P524, DOI 10.2307/2285927; Lee WC, 2010, STAT MED, V29, P2557, DOI 10.1002/sim.4028; MIETTINEN O, 1982, SCAND J WORK ENV HEA, V8, P7; Olden K, 2007, INT J EPIDEMIOL, V36, P18, DOI 10.1093/ije/dyl292; SATO T, 1994, ENVIRON HEALTH PERSP, V102, P53, DOI 10.1289/ehp.94102s853; SATO T, 1992, BIOMETRICS, V48, P1215, DOI 10.2307/2532713; Sham P, 1998, STAT HUMAN GENETICS, P39; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S	13	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105398	10.1371/journal.pone.0105398	http://dx.doi.org/10.1371/journal.pone.0105398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137392	Green Submitted, gold, Green Published			2022-12-27	WOS:000340742100089
J	Lee, J; An, JN; Hwang, JH; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Oh, YK; Lim, CS; Kim, YS; Lee, JP				Lee, Jeonghwan; An, Jung Nam; Hwang, Jin Ho; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Oh, Yun Kyu; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo			Effect of Dialysis Initiation Timing on Clinical Outcomes: A Propensity-Matched Analysis of a Prospective Cohort Study in Korea	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RESIDUAL RENAL-FUNCTION; PERITONEAL-DIALYSIS; EARLY START; PLANNED INITIATION; SERUM-ALBUMIN; UNITED-STATES; MORTALITY; SURVIVAL; GFR	Background: Controversy persists regarding the appropriate initiation timing of renal replacement therapy for patients with end-stage renal disease. We evaluated the effect of dialysis initiation timing on clinical outcomes. Initiation times were classified according to glomerular filtration rate (GFR). Methods: We enrolled a total of 1691 adult patients who started dialysis between August 2008 and March 2013 in a multi-center, prospective cohort study at the Clinical Research Center for End Stage Renal Disease in the Republic of Korea. The patients were classified into the early-start group or the late-start group according to the mean estimated GFR value, which was 7.37 ml/min/1.73m(2). The primary outcome was patient survival, and the secondary outcomes were hospitalization, cardiovascular events, vascular access complications, change of dialysis modality, and peritonitis. The two groups were compared before and after matching with propensity scores. Results: Before propensity score matching, the early-start group had a poor survival rate (P<0.001). Hospitalization, cardiovascular events, vascular access complications, changes in dialysis modality, and peritonitis were not different between the groups. A total of 854 patients (427 in each group) were selected by propensity score matching. After matching, neither patient survival nor any of the other outcomes differed between groups. Conclusions: There was no clinical benefit after adjustment by propensity scores comparing early versus late initiation of dialysis.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jeonghwan; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Oh, Yun Kyu; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo] Clin Res Ctr End Stage Renal Dis, Taegu, South Korea; [An, Jung Nam; Oh, Yun Kyu; Lim, Chun Soo; Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Hwang, Jin Ho] Chung Ang Univ, Med Ctr, Dept Internal Med, Seoul 156756, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Seoul National University (SNU); Seoul National University Hospital	Lee, JP (corresponding author), Clin Res Ctr End Stage Renal Dis, Taegu, South Korea.	nephrolee@gmail.com	Lee, Jeonghwan/C-5214-2011; Oh, Yun Kyu/J-5542-2012	Lee, Jeonghwan/0000-0003-3199-635X; 	Korea Healthcare Technology R& D Project, Ministry for Health and Welfare, Republic of Korea [A102065]	Korea Healthcare Technology R& D Project, Ministry for Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R& D Project, Ministry for Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, AM J KIDNEY DIS S, V48, pS2, DOI DOI 10.1053/S0272-6386(06)00903-6; Arce CM, 2013, AM J KIDNEY DIS, V62, P312, DOI 10.1053/j.ajkd.2013.02.375; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P3663, DOI 10.1093/ndt/gfq189; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; Chang JH, 2012, J KOREAN MED SCI, V27, P1177, DOI 10.3346/jkms.2012.27.10.1177; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Churchill DN, 1997, AM J KIDNEY DIS, V30, P899, DOI 10.1016/S0272-6386(97)90102-5; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Collins J, 2011, CONTRIB NEPHROL, V171, P1, DOI 10.1159/000327146; Conley J, 2012, AM J KIDNEY DIS, V59, P390, DOI 10.1053/j.ajkd.2011.09.022; Cooper BA, 2003, PERITON DIALYSIS INT, V23, P291; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Crews DC, 2014, AM J KIDNEY DIS, V63, P806, DOI 10.1053/j.ajkd.2013.12.010; Crews DC, 2014, J AM SOC NEPHROL, V25, P370, DOI 10.1681/ASN.2013050567; Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019; European Best Practice Guidelines Expert Group on Hemodialysis European Renal Association, 2002, Nephrol Dial Transplant, V17 Suppl 7, P7; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Grootendorst DC, 2011, NEPHROL DIAL TRANSPL, V26, P1932, DOI 10.1093/ndt/gfq667; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2012, PERITON DIALYSIS INT, V32, P595, DOI 10.3747/pdi.2012.00046; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kelly J, 2005, NEPHROLOGY, V10, pS46, DOI 10.1111/j.1440-1797.2005.00486_1.x; Kim do H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055323, DOI 10.1371/J0URNAL.P0NE.0055323]; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Liu H, 2008, RENAL FAILURE, V30, P685, DOI 10.1080/08860220802212619; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Nesrallah GE, 2014, CAN MED ASSOC J, V186, P112, DOI 10.1503/cmaj.130363; Nguyen DB, 2013, CLIN INFECT DIS, V57, P1393, DOI 10.1093/cid/cit546; O'Hare AM, 2011, ARCH INTERN MED, V171, P1663, DOI 10.1001/archinternmed.2011.436; Oh KH, 2012, J KOREAN MED SCI, V27, P170, DOI 10.3346/jkms.2012.27.2.170; Pan Y, 2012, NEPHRON CLIN PRACT, V120, pC121, DOI 10.1159/000337572; Peritoneal Dialysis Adequacy Working Group, 2006, AM J KIDNEY DIS S, V48, P98; Pupim LB, 2002, AM J KIDNEY DIS, V40, P143, DOI 10.1053/ajkd.2002.33923; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Rosansky SJ, 2013, J AM SOC NEPHROL, V24, P1367, DOI 10.1681/ASN.2013050458; Sawhney S, 2009, NEPHROL DIAL TRANSPL, V24, P3186, DOI 10.1093/ndt/gfp189; Shiao CC, 2008, PERITON DIALYSIS INT, V28, P73; Slinin Y, 2014, CLIN J AM SOC NEPHRO, V9, P310, DOI 10.2215/CJN.04190413; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; Streja E, 2013, SEMIN DIALYSIS, V26, P658, DOI 10.1111/sdi.12130; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Tang SCW, 2007, NEPHROL DIAL TRANSPL, V22, P1926, DOI 10.1093/ndt/gfm109; Tattersall J, 2011, NEPHROL DIAL TRANSPL, V26, P2082, DOI 10.1093/ndt/gfr168; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3182, DOI 10.1093/ndt/gfs052; van de Luijtgaarden MWM, 2012, AM J KIDNEY DIS, V60, P940, DOI 10.1053/j.ajkd.2012.07.015; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909; Yamagata K, 2012, THER APHER DIAL, V16, P111, DOI 10.1111/j.1744-9987.2011.01052.x; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	63	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105532	10.1371/journal.pone.0105532	http://dx.doi.org/10.1371/journal.pone.0105532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137235	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100106
J	Onslow, ACE; Jones, MW; Bogacz, R				Onslow, Angela C. E.; Jones, Matthew W.; Bogacz, Rafal			A Canonical Circuit for Generating Phase-Amplitude Coupling	PLOS ONE			English	Article							GAMMA-BAND SYNCHRONIZATION; NEURONAL OSCILLATIONS; HIPPOCAMPAL THETA; PYRAMIDAL CELLS; PREFRONTAL CORTEX; MEDIAL SEPTUM; POTENTIAL OSCILLATIONS; GLUTAMATERGIC INPUTS; WORKING-MEMORY; DIAGONAL BAND	Phase amplitude coupling' (PAC) in oscillatory neural activity describes a phenomenon whereby the amplitude of higher frequency activity is modulated by the phase of lower frequency activity. Such coupled oscillatory activity - also referred to as 'cross-frequency coupling' or 'nested rhythms' - has been shown to occur in a number of brain regions and at behaviorally relevant time points during cognitive tasks; this suggests functional relevance, but the circuit mechanisms of PAC generation remain unclear. In this paper we present a model of a canonical circuit for generating PAC activity, showing how interconnected excitatory and inhibitory neural populations can be periodically shifted in to and out of oscillatory firing patterns by afferent drive, hence generating higher frequency oscillations phase-locked to a lower frequency, oscillating input signal. Since many brain regions contain mutually connected excitatory-inhibitory populations receiving oscillatory input, the simplicity of the mechanism generating PAC in such networks may explain the ubiquity of PAC across diverse neural systems and behaviors. Analytic treatment of this circuit as a nonlinear dynamical system demonstrates how connection strengths and inputs to the populations can be varied in order to change the extent and nature of PAC activity, importantly which phase of the lower frequency rhythm the higher frequency activity is locked to. Consequently, this model can inform attempts to associate distinct types of PAC with different network topologies and physiologies in real data.	[Onslow, Angela C. E.] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England; [Onslow, Angela C. E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Boston, MA 02215 USA; [Jones, Matthew W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Bogacz, Rafal] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Bogacz, Rafal] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Bogacz, Rafal] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England	University of Bristol; Boston University; University of Bristol; University of Bristol; University of Oxford; University of Oxford	Onslow, ACE (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Queens Bldg, Bristol, Avon, England.	aonslow@googlemail.com		Jones, Matthew/0000-0001-5396-3108	EPSRC [EP/E501214/1]; MRC [G1002064]; MRC; Medical Research Council [G1002064] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ACEO was supported by EPSRC grant EP/E501214/1. MWJ was supported by MRC grant number G1002064. RB was supported by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bland BH, 2006, HIPPOCAMPUS, V16, P673, DOI 10.1002/hipo.20210; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; BORISYUK RM, 1992, BIOL CYBERN, V66, P319, DOI 10.1007/BF00203668; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brunel N, 2006, NEURAL COMPUT, V18, P1066, DOI 10.1162/neco.2006.18.5.1066; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Cohen M, 2009, SOUTHERN HUMAN REV, V43, P21; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deschenes M, 2012, CURR OPIN NEUROBIOL, V22, P243, DOI 10.1016/j.conb.2011.11.013; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Doedel E. J., 1997, AUTO 97 CONTINUATION; Doesburg SM, 2012, BRAIN RES, V1431, P77, DOI 10.1016/j.brainres.2011.11.005; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Hamada Y, 1999, NEUROSCIENCE, V88, P667, DOI 10.1016/S0306-4522(98)00468-0; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hoppensteadt F. C., 1997, APPL MATH SCI, V126; Huh CYL, 2010, J NEUROSCI, V30, P15951, DOI 10.1523/JNEUROSCI.3663-10.2010; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Onslow ACE, 2012, THESIS U BRISTOL UK; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Pavlides A, 2012, EUR J NEUROSCI, V36, P2229, DOI 10.1111/j.1460-9568.2012.08105.x; Rinzel J, 2008, ACTIVITY PATTERNS SL; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Roxin A, 2006, PROG THEOR PHYS SUPP, P68, DOI 10.1143/PTPS.161.68; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Scheffzuk C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028489; Shearkhani O, 2013, NEUROBIOL LEARN MEM, V100, P117, DOI 10.1016/j.nlm.2012.12.014; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Singer W, 2006, ANN NY ACAD SCI, V929, P123; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Spaak E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045688; STEWART M, 1989, J NEUROPHYSIOL, V61, P982, DOI 10.1152/jn.1989.61.5.982; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strogatz SH., 2001, NONLINEAR DYNAMICS C; STUMPF C, 1965, ELECTROEN CLIN NEURO, V18, P477, DOI 10.1016/0013-4694(65)90128-8; Takacs VT, 2012, HIPPOCAMPUS, V22, P1379, DOI 10.1002/hipo.20974; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Wallace E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014804; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wilson MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002560; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036472	107	44	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102591	10.1371/journal.pone.0102591	http://dx.doi.org/10.1371/journal.pone.0102591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136855	gold, Green Published			2022-12-27	WOS:000340742100002
J	Zielonka, M; Krishnan, RK; Swiercz, JM; Offermanns, S				Zielonka, Matthias; Krishnan, Ramesh K.; Swiercz, Jakub M.; Offermanns, Stefan			The I kappa B Kinase Complex Is Required for Plexin-B-Mediated Activation of RhoA	PLOS ONE			English	Article							SIGNALING PATHWAYS; SEMAPHORIN 4D; RECEPTOR PLEXIN-B1; TUMOR ANGIOGENESIS; CANCER METASTASIS; MELANOMA-CELLS; IKK-ALPHA; PROTEINS; GROWTH; TRANSMEMBRANE	Plexins are widely expressed transmembrane proteins that mediate the cellular effects of semaphorins. The molecular mechanisms of plexin-mediated signal transduction are still poorly understood. Here we show that signalling via B-family plexins leading to the activation of the small GTPase RhoA requires activation of the I kappa B kinase (IKK)-complex. In contrast, plexin-B-dependent regulation of R-Ras activity is not affected by IKK activity. This regulation of plexin signalling depends on the kinase activity of the IKK-complex, but is independent of NF-kappa B activation. We confirm that the IKK-complex is active in tumour cells and osteoblasts, and we demonstrate that plexin-B-dependent tumour cell invasiveness and regulation of osteoblast differentiation require an active IKK-complex. This study identifies a novel, NF-kappa B-independent function of the IKK-complex and shows that IKK directs plexin-B signalling to the activation of RhoA.	[Zielonka, Matthias; Krishnan, Ramesh K.; Swiercz, Jakub M.; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Zielonka, Matthias] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Offermanns, Stefan] Goethe Univ Frankfurt, Fac Med, D-60054 Frankfurt, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Swiercz, JM (corresponding author), Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany.	Jakub.Swiercz@mpi-bn.mpg.de; Stefan.Offermanns@mpi-bn.mpg.de	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Devalaraja MN, 1999, CANCER RES, V59, P1372; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Gasparian AV, 2002, J CELL SCI, V115, P141; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Ishikawa K, 1997, DNA Res, V4, P307, DOI 10.1093/dnares/4.5.307; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jain G, 2012, NEOPLASIA, V14, P178, DOI 10.1593/neo.111444; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P524, DOI 10.1006/bbrc.1996.1388; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu S, 2012, J INTERF CYTOK RES, V32, P152, DOI 10.1089/jir.2011.0107; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Maier V, 2011, MOL CELL NEUROSCI, V46, P419, DOI 10.1016/j.mcn.2010.11.005; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ochiai Takanori, 2008, J Med Dent Sci, V55, P49; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; Swiercz JM, 2009, MOL CELL BIOL, V29, P6321, DOI 10.1128/MCB.00103-09; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; van Triest Miranda, 2004, Methods Mol Biol, V250, P97; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Yang JM, 2001, CANCER RES, V61, P4901; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025826; Yeh PY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-53; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432	67	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105661	10.1371/journal.pone.0105661	http://dx.doi.org/10.1371/journal.pone.0105661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137062	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100113
J	Nanjappa, D; Audic, S; Romac, S; Kooistra, WHCF; Zingone, A				Nanjappa, Deepak; Audic, Stephane; Romac, Sarah; Kooistra, Wiebe H. C. F.; Zingone, Adriana			Assessment of Species Diversity and Distribution of an Ancient Diatom Lineage Using a DNA Metabarcoding Approach	PLOS ONE			English	Article							GENUS SKELETONEMA BACILLARIOPHYCEAE; RIBOSOMAL-RNA; PHYLOGENETIC ANALYSES; COMPLEX BACILLARIOPHYCEAE; LEPTOCYLINDRUS-DANICUS; CHAETOCEROS-SOCIALIS; REVEALS; BIOGEOGRAPHY; ENVIRONMENT; MORPHOLOGY	Background: Continuous efforts to estimate actual diversity and to trace the species distribution and ranges in the natural environments have gone in equal pace with advancements of the technologies in the study of microbial species diversity from microscopic observations to DNA-based barcoding. DNA metabarcoding based on Next Generation Sequencing (NGS) constitutes the latest advancement in these efforts. Here we use NGS data from different sites to investigate the geographic range of six species of the diatom family Leptocylindraceae and to identify possible new taxa within the family. Methodology/Principal Findings: We analysed the V4 and V9 regions of the nuclear-encoded SSU rDNA gene region in the NGS database of the European ERA-Biodiversa project BioMarKs, collected in plankton and sediments at six coastal sites in European coastal waters, as well as environmental sequences from the NCBI database. All species known in the family Leptocylindraceae were detected in both datasets, but the much larger Illumina V9 dataset showed a higher species coverage at the various sites than the 454 V4 dataset. Sequences identical or similar to the references of Leptocylindrus aporus, L. convexus, L. danicus/hargravesii and Tenuicylindrus belgicus were found in the Mediterranean Sea, North Atlantic Ocean and Black Sea as well as at locations outside Europe. Instead, sequences identical or close to that of L. minimus were found in the North Atlantic Ocean and the Black Sea but not in the Mediterranean Sea, while sequences belonging to a yet undescribed taxon were encountered only in Oslo Fjord and Baffin Bay. Conclusions/Significance: Identification of Leptocylindraceae species in NGS datasets has expanded our knowledge of the species biogeographic distribution and of the overall diversity of this diatom family. Individual species appear to be widespread, but not all of them are found everywhere. Despite the sequencing depth allowed by NGS and the wide geographic area covered by this study, the diversity of this ancient diatom family appears to be low, at least at the level of the marker used in this study.	[Nanjappa, Deepak; Kooistra, Wiebe H. C. F.; Zingone, Adriana] Stn Zool Anton Dohrn, Naples, Italy; [Audic, Stephane; Romac, Sarah] Univ Sorbonne, UPMC, CNRS, EPEP,UMR,Stn Biol Roscoff, Roscoff, France	Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Nanjappa, D (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	depac.n@gmail.com; zingone@szn.it	Zingone, Adriana/E-4518-2010; Nanjappa, Deepak/AAX-2176-2020	Zingone, Adriana/0000-0001-5946-6532; Kooistra, Wiebe/0000-0002-8641-9739; Audic, Stephane/0000-0001-6193-4374	SZN-Open University PhD program; Progetto Premiale MetaTrac [Bando 21/2012]	SZN-Open University PhD program; Progetto Premiale MetaTrac	D. Nanjappa was supported by the SZN-Open University PhD program and by the Progetto Premiale MetaTrac (Bando 21/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Berney C, 2013, ISME J, V7, P2387, DOI 10.1038/ismej.2013.116; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; FRENCH FW, 1985, J PHYCOL, V21, P477; FRENCH FW, 1986, J PHYCOL, V22, P411, DOI 10.1111/j.1529-8817.1986.tb02482.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gran HH, 1915, PLANKTON PRODUCTION; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hargraves P.E., 1990, NOVA HEDWIGIA S, V100, P47; HARGRAVES PE, 1976, J PHYCOL, V12, P118, DOI 10.1111/j.1529-8817.1976.tb02838.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Huson D. H., 2012, SYSTEMATIC BIOL; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; Meunier A, 1915, MICROPLANKTON MER FL; Montresor M, 2013, MAR ECOL PROG SER, V484, P79, DOI 10.3354/meps10236; Nanjappa D, 2014, MAR DRUGS, V12, P368, DOI 10.3390/md12010368; Nanjappa D, 2013, J PHYCOL, V49, P917, DOI 10.1111/jpy.12102; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Potvin M, 2009, J EUKARYOT MICROBIOL, V56, P174, DOI 10.1111/j.1550-7408.2008.00386.x; Proshkina-Lavrenko AI, 1955, DIATOMOVYE VODOROSIL; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Sarno D, 2007, J PHYCOL, V43, P156, DOI 10.1111/j.1529-8817.2006.00305.x; Shirokawa Y, 2012, EUR J PHYCOL, V47, P245, DOI 10.1080/09670262.2012.697580; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	50	32	33	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103810	10.1371/journal.pone.0103810	http://dx.doi.org/10.1371/journal.pone.0103810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133638	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700017
J	Tabata-Imai, A; Inoue, R; Mori, H				Tabata-Imai, Ayako; Inoue, Ran; Mori, Hisashi			Increased Sensitivity to Inflammatory Pain Induced by Subcutaneous Formalin Injection in Serine Racemase Knock-Out Mice	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; C-FOS EXPRESSION; SPINAL-CORD; DORSAL-HORN; CENTRAL SENSITIZATION; NMDA-RECEPTORS; ACTIVATION; GLUTAMATE; GLYCINE	D-Serine, an endogenous coagonist of the N-methyl-D-aspartate receptor (NMDAR), is widely distributed in the central nervous system and is synthesized from L-serine by serine racemase (SR). NMDAR plays an important role in pain processing including central sensitization that eventually causes hyperalgesia. To elucidate the roles of D-serine and SR in pain transmission, we evaluated the behavioral changes and spinal nociceptive processing induced by formalin using SR knock-out (KO) mice. We found that SR is mainly distributed in lamina II of the dorsal horn of the spinal cord in wild-type (WT) mice. Although the formalin injected subcutaneously induced the biphasic pain response of licking in SR-KO and WT mice, the time spent on licking was significantly longer in the SR-KO mice during the second phase of the formalin test. The number of neurons immunopositive for c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK), which are molecular pain markers, in laminae I-II of the ipsilateral dorsal horn was significantly larger in the SR-KO mice. Immunohistochemical staining revealed that the distribution of SR changed from being broad to being concentrated in cell bodies after the formalin injection. On the other hand, the expression level of the cytosolic SR in the ipsilateral dorsal horn significantly decreased. Oral administration of 10 mM D-serine in drinking water for one week cancelled the difference in pain behaviors between WT and SR-KO mice in phase 2 of the formalin test. These findings demonstrate that the SR-KO mice showed increased sensitivity to inflammatory pain and the WT mice showed translocation of SR and decreased SR expression levels after the formalin injection, which suggest a novel antinociceptive mechanism via SR indicating an important role of D-serine in pain transmission.	[Tabata-Imai, Ayako; Inoue, Ran; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 930, Japan	University of Toyama	Mori, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 930, Japan.	hmori@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25293059]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant No. 25293059; URL: http://www.mext.go.j/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Cornelio AM, 2011, BRAIN RES, V1415, P56, DOI 10.1016/j.brainres.2011.07.058; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; Fukuda T, 2006, ANESTH ANALG, V102, P811, DOI 10.1213/01.ane.0000197690.19075.bd; Fukuda T, 2009, ANESTH ANALG, V109, P1318, DOI 10.1213/ane.0b013e3181b0fe05; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Ghilardi JR, 2004, J NEUROSCI, V24, P2727, DOI 10.1523/JNEUROSCI.5054-03.2004; Gong NA, 2011, J PHARMACOL EXP THER, V336, P282, DOI 10.1124/jpet.110.172353; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Kim Y, 2012, PAIN, V153, P1022, DOI 10.1016/j.pain.2012.02.003; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KOLHEKAR R, 1994, NEUROSCIENCE, V63, P925, DOI 10.1016/0306-4522(94)90560-6; Kovacs G, 2004, NEUROPHARMACOLOGY, V46, P23, DOI 10.1016/S0028-3908(03)00339-3; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Laskowski K, 2011, CAN J ANESTH, V58, P911, DOI 10.1007/s12630-011-9560-0; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lorenzo LE, 2008, J COMP NEUROL, V508, P592, DOI 10.1002/cne.21691; Lu JM, 2012, BRIT J PHARMACOL, V165, P1941, DOI 10.1111/j.1476-5381.2011.01680.x; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P136; MATSUI T, 1995, J NEUROCHEM, V65, P454; Merrill AW, 2006, ANESTH ANALG, V103, P478, DOI 10.1213/01.ane.0000223847.50233.1b; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2011, J CHROMATOGR B, V879, P3184, DOI 10.1016/j.jchromb.2010.08.024; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Mori H, 2010, CHEM BIODIVERS, V7, P1573, DOI 10.1002/cbdv.200900293; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Muth-Selbach U, 2009, EUR J PHARMACOL, V613, P68, DOI 10.1016/j.ejphar.2009.04.043; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Perissin L, 2004, PAIN, V110, P250, DOI 10.1016/j.pain.2004.03.039; Polgar E, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-4; ROSLAND JH, 1991, PAIN, V45, P211, DOI 10.1016/0304-3959(91)90190-9; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Seo YJ, 2006, BRAIN RES BULL, V71, P279, DOI 10.1016/j.brainresbull.2006.09.012; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Svensson CI, 2006, FEBS LETT, V580, P6629, DOI 10.1016/j.febslet.2006.11.012; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; WATANABE M, 1994, J COMP NEUROL, V345, P314, DOI 10.1002/cne.903450212; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoon MH, 1999, ANESTH ANALG, V89, P434, DOI 10.1097/00000539-199908000-00034; Zhao WJ, 2008, CELL MOL NEUROBIOL, V28, P581, DOI 10.1007/s10571-007-9200-y; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	67	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105282	10.1371/journal.pone.0105282	http://dx.doi.org/10.1371/journal.pone.0105282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133605	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700097
J	Duraes, C; Moreira, CS; Alvelos, I; Mendes, A; Santos, LR; Machado, JC; Melo, M; Esteves, C; Neves, C; Sobrinho-Simoes, M; Soares, P				Duraes, Cecilia; Moreira, Carla S.; Alvelos, Ines; Mendes, Adelia; Santos, Liliana R.; Machado, Jose Carlos; Melo, Miguel; Esteves, Cesar; Neves, Celestino; Sobrinho-Simoes, Manuel; Soares, Paula			Polymorphisms in the TNFA and IL6 Genes Represent Risk Factors for Autoimmune Thyroid Disease	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; INTERFERON-GAMMA RECEPTOR; FACTOR-ALPHA PROMOTER; GRAVES-DISEASE; T-CELLS; CHINESE PATIENTS; IFN-GAMMA; ASSOCIATION; SUSCEPTIBILITY; OPHTHALMOPATHY	Background: Autoimmune thyroid disease (AITD) comprises diseases including Hashimoto's thyroiditis and Graves' disease, both characterized by reactivity to autoantigens causing, respectively, inflammatory destruction and autoimmune stimulation of the thyroid-stimulating hormone receptor. AITD is the most common thyroid disease and the leading form of autoimmune disease in women. Cytokines are key regulators of the immune and inflammatory responses; therefore, genetic variants at cytokine-encoding genes are potential risk factors for AITD. Methods: Polymorphisms in the IL6-174 G/C (rs1800795), TNFA-308 G/A (rs1800629), IL1B-511 C/T (rs16944), and IFNGR1-56 T/C (rs2234711) genes were assessed in a case-control study comprising 420 Hashimoto's thyroiditis patients, 111 Graves' disease patients and 735 unrelated controls from Portugal. Genetic variants were discriminated by real-time PCR using TaqMan SNP genotyping assays. Results: A significant association was found between the allele A in TNFA-308 G/A and Hashimoto's thyroiditis, both in the dominant (OR = 1.82, CI = 1.37-2.43, p-value = 4.4x10(-5)) and log-additive (OR = 1.64, CI = 1.28-2.10, p-value = 8.2x10(-5)) models. The allele C in IL6-174 G/C is also associated with Hashimoto's thyroiditis, however, only retained significance after multiple testing correction in the log-additive model (OR = 1.28, CI = 1.06-1.54, p-value = 8.9x10(-3)). The group with Graves' disease also registered a higher frequency of the allele A in TNFA-308 G/A compared with controls both in the dominant (OR = 1.85, CI = 1.19-2.87, p-value = 7.0x10(-3)) and log-additive (OR = 1.69, CI = 1.17-2.44, p-value = 6.6x10(-3)) models. The risk for Hashimoto's thyroiditis and Graves' disease increases with the number of risk alleles (OR for two risk alleles is, respectively, 2.27 and 2.59). Conclusions: This study reports significant associations of genetic variants in TNFA and IL6 with the risk for AITD, highlighting the relevance of polymorphisms in inflammation-related genes in the etiopathogenesis of AITD.	[Duraes, Cecilia; Moreira, Carla S.; Alvelos, Ines; Mendes, Adelia; Machado, Jose Carlos; Melo, Miguel; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Moreira, Carla S.; Santos, Liliana R.; Machado, Jose Carlos; Neves, Celestino; Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Santos, Liliana R.] Univ Coimbra, Fac Med, Coimbra, Portugal; [Melo, Miguel] Univ & Hosp Ctr Coimbra, Dept Diabet Endocrinol & Metab, Coimbra, Portugal; [Melo, Miguel] Univ Coimbra, Fac Med, Unit Endocrinol, Coimbra, Portugal; [Esteves, Cesar; Neves, Celestino] Hosp Sao Joao, Dept Endocrinol, Oporto, Portugal; [Sobrinho-Simoes, Manuel; Soares, Paula] Univ Porto, Fac Med, Dept Pathol & Oncol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Sao Joao Hospital; Universidade do Porto	Soares, P (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	psoares@ipatimup.pt	Soares, Paula/B-6054-2008; Durães, Cecília/I-2117-2013; Sobrinho-Simões, Manuel/J-8290-2013; Santos, Liliana R/T-3316-2019; Machado, Jose Carlos/C-5907-2009; Duraes, Cecilia/AAY-8903-2021; Melo, Miguel/L-2106-2014	Soares, Paula/0000-0001-9607-6998; Durães, Cecília/0000-0001-9282-0708; Machado, Jose Carlos/0000-0003-4741-8415; Duraes, Cecilia/0000-0001-9282-0708; Neves, Celestino/0000-0002-9575-5902; Mendes, Adelia/0000-0001-6636-0453; Sobrinho-Simoes, Manuel/0000-0003-1613-1235; Melo, Miguel/0000-0002-8365-1380	IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant; Caixa Geral de Depositos; BII grant from the Portuguese Foundation for Science and Technology (FCT); FCT [SFRH/BPD/62974/2009]; Portuguese Foundation for Science and Technology (FCT)	IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant; Caixa Geral de Depositos; BII grant from the Portuguese Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by an IPG-UP (Investigacao Cientifica na Pre-Graduacao-Universidade do Porto) grant (with financial support from Caixa Geral de Depositos). Carla Moreira was the recipient of a BII grant from the Portuguese Foundation for Science and Technology (FCT). Cecilia Duraes is supported by an FCT grant (SFRH/BPD/62974/2009). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology (FCT URL: http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari M, 2010, ENDOCRINE, V37, P344, DOI 10.1007/s12020-010-9311-y; Aust G, 1996, CLIN EXP IMMUNOL, V105, P148, DOI 10.1046/j.1365-2249.1996.d01-726.x; Barbieri M, 2005, EXP GERONTOL, V40, P599, DOI 10.1016/j.exger.2005.05.004; Bednarczuk T, 2004, AUTOIMMUNITY, V37, P223, DOI 10.1080/0891693042000193320; Belfer I, 2010, INT J STROKE, V5, P145, DOI 10.1111/j.1747-4949.2010.00422.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkovic MC, 2007, EXP MOL PATHOL, V83, P474, DOI 10.1016/j.yexmp.2007.08.018; BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379; Bougacha-Elleuch N, 2004, J AUTOIMMUN, V23, P75, DOI 10.1016/j.jaut.2004.03.011; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Chen RH, 2005, INT J IMMUNOGENET, V32, P343, DOI 10.1111/j.1744-313X.2005.00536.x; Chen RH, 2005, J CLIN LAB ANAL, V19, P133, DOI 10.1002/jcla.20067; Chen RH, 2006, J CLIN LAB ANAL, V20, P260, DOI 10.1002/jcla.20152; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Fukutani T, 2004, THYROID, V14, P93, DOI 10.1089/105072504322880328; Ganesh BB, 2011, J INTERF CYTOK RES, V31, P721, DOI 10.1089/jir.2011.0049; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gu LQ, 2010, CLIN BIOCHEM, V43, P223, DOI 10.1016/j.clinbiochem.2009.08.012; Horie I, 2011, ENDOCRINOLOGY, V152, P4448, DOI 10.1210/en.2011-1356; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Hunt PJ, 2001, CLIN ENDOCRINOL, V55, P491, DOI 10.1046/j.1365-2265.2001.01356.x; Inoue N, 2011, CLIN EXP IMMUNOL, V163, P318, DOI 10.1111/j.1365-2249.2010.04306.x; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kallen KJ, 2002, BBA-MOL CELL RES, V1592, P323, DOI 10.1016/S0167-4889(02)00325-7; Kammoun-krichen M, 2008, ANN HUM BIOL, V35, P656, DOI 10.1080/03014460802477939; Khalilzadeh O, 2010, ANN ENDOCRINOL-PARIS, V71, P281, DOI 10.1016/j.ando.2010.01.005; Khalilzadeh O, 2009, CLIN EXP OPHTHALMOL, V37, P614, DOI 10.1111/j.1442-9071.2009.02093.x; Kissonerghis A M, 1989, Autoimmunity, V4, P255, DOI 10.3109/08916938909014702; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kula D, 2001, FOLIA HISTOCHEM CYTO, V39, P77; Kutluturk F, 2013, ENDOCR METAB IMMUNE, V13, P163, DOI 10.2174/18715303113139990001; Larsen P R KHM, 2003, WILLIAMS TXB ENDOCRI; Li N, 2008, CLIN BIOCHEM, V41, P881, DOI 10.1016/j.clinbiochem.2008.04.014; Liu N, 2010, HUM IMMUNOL, V71, P397, DOI 10.1016/j.humimm.2010.01.023; Liu YH, 2010, INVEST OPHTH VIS SCI, V51, P6238, DOI 10.1167/iovs.09-4965; Marinou I, 2009, ANN RHEUM DIS, V68, P1494, DOI 10.1136/ard.2008.090001; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Menconi F, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P231, DOI 10.1007/978-1-60327-285-8_44; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Papanas N, 2006, CYTOKINE, V35, P166, DOI 10.1016/j.cyto.2006.07.017; Ramos E, 2004, ANN EPIDEMIOL, V14, P437, DOI 10.1016/j.annepidem.2003.09.013; Ruggeri RM, 2009, J ENDOCRINOL INVEST, V32, P465, DOI [10.3275/6104, 10.1007/BF03346487]; Ruggeri RM, 2006, HISTOL HISTOPATHOL, V21, P249, DOI 10.14670/HH-21.249; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; Shiau MY, 2007, CLIN BIOCHEM, V40, P213, DOI 10.1016/j.clinbiochem.2006.11.009; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tsai LJ, 2009, RHEUMATOL INT, V29, P1001, DOI 10.1007/s00296-009-0900-0; Utiger R., 2000, WERNER INGBARS THYRO, P721; Vangsted AJ, 2009, HAEMATOL-HEMATOL J, V94, P1274, DOI 10.3324/haematol.2008.004572; WEETMAN AP, 1990, J ENDOCRINOL, V127, P357, DOI 10.1677/joe.0.1270357; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	59	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105492	10.1371/journal.pone.0105492	http://dx.doi.org/10.1371/journal.pone.0105492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127106	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300115
J	Forde, BM; Ben Zakour, NL; Stanton-Cook, M; Phan, MD; Totsika, M; Peters, KM; Chan, KG; Schembri, MA; Upton, M; Beatson, SA				Forde, Brian M.; Ben Zakour, Nouri L.; Stanton-Cook, Mitchell; Phan, Minh-Duy; Totsika, Makrina; Peters, Kate M.; Chan, Kok Gan; Schembri, Mark A.; Upton, Mathew; Beatson, Scott A.			The Complete Genome Sequence of Escherichia coli EC958: A High Quality Reference Sequence for the Globally Disseminated Multidrug Resistant E. coli O25b:H4-ST131 Clone	PLOS ONE			English	Article							BETA-LACTAMASE; STRAINS; ASSEMBLIES; COMMENSAL; ALGORITHMS; SELECTION; ISLANDS; GENES	Escherichia coli ST131 is now recognised as a leading contributor to urinary tract and bloodstream infections in both community and clinical settings. Here we present the complete, annotated genome of E. coli EC958, which was isolated from the urine of a patient presenting with a urinary tract infection in the Northwest region of England and represents the most well characterised ST131 strain. Sequencing was carried out using the Pacific Biosciences platform, which provided sufficient depth and read-length to produce a complete genome without the need for other technologies. The discovery of spurious contigs within the assembly that correspond to site-specific inversions in the tail fibre regions of prophages demonstrates the potential for this technology to reveal dynamic evolutionary mechanisms. E. coli EC958 belongs to the major subgroup of ST131 strains that produce the CTX-M-15 extended spectrum beta-lactamase, are fluoroquinolone resistant and encode the fimH30 type 1 fimbrial adhesin. This subgroup includes the Indian strain NA114 and the North American strain JJ1886. A comparison of the genomes of EC958, JJ1886 and NA114 revealed that differences in the arrangement of genomic islands, prophages and other repetitive elements in the NA114 genome are not biologically relevant and are due to misassembly. The availability of a high quality uropathogenic E. coli ST131 genome provides a reference for understanding this multidrug resistant pathogen and will facilitate novel functional, comparative and clinical studies of the E. coli ST131 clonal lineage.	[Forde, Brian M.; Ben Zakour, Nouri L.; Stanton-Cook, Mitchell; Phan, Minh-Duy; Totsika, Makrina; Peters, Kate M.; Schembri, Mark A.; Beatson, Scott A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Upton, Mathew] Plymouth Univ Peninsula Sch Med & Dent, Plymouth, Devon, England	University of Queensland; Universiti Malaya	Beatson, SA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	s.beatson@uq.edu.au	Chan, Kok Gan/B-8347-2010; Forde, Brian/GLQ-9491-2022; ZAKOUR, Nouri L BEN/B-9338-2011; Phan, Minh-Duy/I-9147-2012; Schembri, Mark A/C-7262-2009; Upton, Mathew/J-7514-2019; Beatson, Scott/B-6985-2013; Totsika, Makrina/A-8993-2011	Chan, Kok Gan/0000-0002-1883-1115; Forde, Brian/0000-0002-2264-4785; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Phan, Minh-Duy/0000-0002-3426-1044; Schembri, Mark A/0000-0003-4863-9260; Upton, Mathew/0000-0003-4287-6396; Beatson, Scott/0000-0002-1806-3283; Totsika, Makrina/0000-0003-2468-0293	Australian National Health and Medical Research Council [APP1012076, APP1067455]; University of Malaya HIR Grant (UM-MOHE HIR Grant) [UM.C/625/1/HIR/MOHE/CHAN/14/1]; Australian Research Council (ARC) [FT100100662]; ARC Discovery Early Career Researcher Award [DE130101169]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Malaya HIR Grant (UM-MOHE HIR Grant); Australian Research Council (ARC)(Australian Research Council); ARC Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council to MAS and SAB (APP1012076 and APP1067455) and a University of Malaya HIR Grant to KGC (UM-MOHE HIR Grant UM.C/625/1/HIR/MOHE/CHAN/14/1). MAS is supported by an Australian Research Council (ARC) Future Fellowship (FT100100662). MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1; Avasthi TS, 2011, J BACTERIOL, V193, P4272, DOI 10.1128/JB.05413-11; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fisher CR, 2009, INFECT IMMUN, V77, P1992, DOI 10.1128/IAI.00064-09; Floyd RV, 2012, J INFECT DIS, V206, P1589, DOI 10.1093/infdis/jis554; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; IIDA S, 1987, MOL GEN GENET, V208, P464, DOI 10.1007/BF00328140; IIDA S, 1986, CELL, V45, P71, DOI 10.1016/0092-8674(86)90539-8; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Phan MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003834; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Paul S, 2013, J BACTERIOL, V195, P231, DOI 10.1128/JB.01524-12; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Price L. B., 2013, MBIO, V4, DOI DOI 10.1128/MBIO.00377-13; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ricker N, 2012, GENOMICS, V100, P167, DOI 10.1016/j.ygeno.2012.06.009; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANDMEIER H, 1994, MOL MICROBIOL, V12, P343, DOI 10.1111/j.1365-2958.1994.tb01023.x; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2013, J INFECT DIS, V208, P921, DOI 10.1093/infdis/jit245; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	74	75	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104400	10.1371/journal.pone.0104400	http://dx.doi.org/10.1371/journal.pone.0104400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126841	Green Published, gold			2022-12-27	WOS:000340879300024
J	Hurtado, S; Guisbert, KSK; Sontheimer, EJ				Hurtado, Sara; Guisbert, Karen S. Kim; Sontheimer, Erik J.			SPO24 Is a Transcriptionally Dynamic, Small ORF-Encoding Locus Required for Efficient Sporulation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MEIOTIC GENE-EXPRESSION; NONCODING RNA EXPRESSION; TRANSLATIONAL CONTROL; BUDDING YEAST; PHENOTYPIC ANALYSIS; DEFICIENT MUTANTS; SPORE FORMATION; IN-VIVO; MEIOSIS; PROGRAM	In Saccharomyces cerevisiae, meiosis and sporulation are highly regulated responses that are driven in part by changes in RNA expression. Alternative mRNA forms with extended 5' UTRs are atypical in S. cerevisiae, and 5' extensions with upstream open reading frames (uORFs) are even more unusual. Here we characterize the gene YPR036W-A, now renamed SPO24, which encodes a very small (67-amino-acid) protein. This gene gives rise to two mRNA forms: a shorter form throughout meiosis and a longer, 5'-extended form in mid-late meiosis. The latter form includes a uORF for a 14-amino-acid peptide (Spo24(u14)). Deletion of the downstream ORF (dORF) leads to sporulation defects and the appearance of pseudohyphae-like projections. Experiments with luciferase reporters indicate that the uORF does not downregulate dORF translation. The protein encoded by the dORF (Spo24(d67)) localizes to the prospore membrane and is differentially phosphorylated during meiosis. Transcription of the 5'-extended mRNA in mid-meiosis depends upon the presence of two middle sporulation elements (MSEs). Removal of the MSEs severely inhibits the mid-meiotic appearance of the 5'-extended mRNA and limits the ability of plasmid-borne SPO24 to rescue the sporulation defect of a spo24 Delta mutant, suggesting that the 5'-extended mRNA is functionally important. These results reveal Spo24(d67) as a sporulation-related factor that is encoded by a transcriptionally dynamic, uORF-containing locus.	[Hurtado, Sara; Guisbert, Karen S. Kim; Sontheimer, Erik J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Northwestern University	Sontheimer, EJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA.	erik.sontheimer@umassmed.edu		Sontheimer, Erik/0000-0002-0881-0310; Kim Guisbert, Karen/0000-0001-9907-9502	American Cancer Society; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health (NIH) [R01GM093769]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093769] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a fellowship from the American Cancer Society to KSKG; by a grant from the Chicago Biomedical Consortium (with support from The Searle Funds at the Chicago Community Trust) to EJS; and by a grant from the National Institutes of Health (NIH) (R01GM093769) to EJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Clancy MJ, 1998, CURR BIOL, V8, pR461, DOI 10.1016/S0960-9822(98)70293-3; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; EATON NR, 1954, J BACTERIOL, V68, P110, DOI 10.1128/JB.68.1.110-116.1954; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO MS, 1969, GENETICS, V61, P79; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; FAST D, 1973, J BACTERIOL, V116, P925, DOI 10.1128/JB.116.2.925-930.1973; FREESE EB, 1982, J BACTERIOL, V149, P840, DOI 10.1128/JB.149.3.840-851.1982; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jungbluth M, 2012, EUKARYOT CELL, V11, P1021, DOI 10.1128/EC.05240-11; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; LAW DTS, 1988, MOL CELL BIOL, V8, P912, DOI 10.1128/MCB.8.2.912; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynn R R, 1970, J Cell Biol, V44, P688, DOI 10.1083/jcb.44.3.688; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Miura F, 2001, FEBS LETT, V505, P103, DOI 10.1016/S0014-5793(01)02792-2; MOENS PB, 1971, CAN J MICROBIOL, V17, P507, DOI 10.1139/m71-084; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Ozsarac N, 1997, MOL CELL BIOL, V17, P1152, DOI 10.1128/MCB.17.3.1152; PARK HD, 1992, NUCLEIC ACIDS RES, V20, P1909, DOI 10.1093/nar/20.8.1909; Park JS, 2012, J CELL SCI, V125, P3004, DOI 10.1242/jcs.105114; PATEL PV, 1972, J APPL BACTERIOL, V35, P63, DOI 10.1111/j.1365-2672.1972.tb03674.x; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Rajkowitsch L, 2004, J MOL BIOL, V335, P71, DOI 10.1016/j.jmb.2003.10.049; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Yang HJ, 2008, J CELL BIOL, V183, P1089, DOI 10.1083/jcb.200809178; ZUBENKO GS, 1981, GENETICS, V97, P45	54	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105058	10.1371/journal.pone.0105058	http://dx.doi.org/10.1371/journal.pone.0105058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127041	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300074
J	Weise, FJ; Stratford, KJ; van Vuuren, RJ				Weise, Florian J.; Stratford, Ken J.; van Vuuren, Rudolf J.			Financial Costs of Large Carnivore Translocations - Accounting for Conservation	PLOS ONE			English	Article							LIVESTOCK; WOLF; PREDATION; TOOL; DEPREDATION; CONFLICTS; PAYMENTS; LEOPARDS; AREA; DOGS	Human-carnivore conflict continues to present a major conservation challenge around the world. Translocation of large carnivores is widely implemented but remains strongly debated, in part because of a lack of cost transparency. We report detailed translocation costs for three large carnivore species in Namibia and across different translocation scenarios. We consider the effect of various parameters and factors on costs and translocation success. Total translocation cost for 30 individuals in 22 events was $80,681 (US Dollars). Median translocation cost per individual was $2,393, and $2,669 per event. Median cost per cheetah was $2,760 (n = 23), and $2,108 per leopard (n = 6). One hyaena was translocated at a cost of $1,672. Tracking technology was the single biggest cost element (56%), followed by captive holding and feeding. Soft releases, prolonged captivity and orphaned individuals also increased case-specific costs. A substantial proportion (65.4%) of the total translocation cost was successfully recovered from public interest groups. Less than half the translocations were confirmed successes (44.4%, 3 unknown) with a strong species bias. Four leopards (66.7%) were successfully translocated but only eight of the 20 cheetahs (40.0%) with known outcome met these strict criteria. None of the five habituated cheetahs was translocated successfully, nor was the hyaena. We introduce the concept of Individual Conservation Cost (ICC) and define it as the cost of one successfully translocated individual adjusted by costs of unsuccessful events of the same species. The median ICC for cheetah was $6,898 and $3,140 for leopard. Translocations are costly, but we demonstrate that they are not inherently more expensive than other strategies currently employed in non-lethal carnivore conflict management. We conclude that translocation should be one available option for conserving large carnivores, but needs to be critically evaluated on a case-by-case basis.	[Weise, Florian J.; van Vuuren, Rudolf J.] N Aan Ku Se Res Programme, Res Dept, Windhoek, Khomas, Namibia; [Stratford, Ken J.] Ongava Res Ctr, Res Dept, Outjo, Kunene, Namibia		Weise, FJ (corresponding author), N Aan Ku Se Res Programme, Res Dept, Windhoek, Khomas, Namibia.	florian.weise@gmail.com			National Geographic Big Cats Initiative [B10-11]; Land Rover South Africa; Chester Zoo; Colchester Zoo; Sea World and Busch Gardens; Idea Wild; Sirtrack; SPOTS Foundation; Namibian Wildlife Conservation Trust (UK); West Midland Safari Park; Ongava Game Reserve; Zoological Society of Philadelphia	National Geographic Big Cats Initiative; Land Rover South Africa; Chester Zoo; Colchester Zoo; Sea World and Busch Gardens; Idea Wild; Sirtrack; SPOTS Foundation; Namibian Wildlife Conservation Trust (UK); West Midland Safari Park; Ongava Game Reserve; Zoological Society of Philadelphia	This study was supported by grants (either financially or in-kind) from the National Geographic Big Cats Initiative (grant number: B10-11), Land Rover South Africa, Chester Zoo, Colchester Zoo, Sea World and Busch Gardens, Idea Wild, Sirtrack as well as SPOTS Foundation. Carnivore research at Ongava Research Center is funded by charitable donations from The Namibian Wildlife Conservation Trust (UK), West Midland Safari Park, the directors of Ongava Game Reserve, and the Zoological Society of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; Andelt WF, 2000, J RANGE MANAGE, V53, P259, DOI 10.2307/4003429; Andelt WF, 1984, GREAT PLAINS WILDL D; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; BELDEN RC, 1993, J WILDLIFE MANAGE, V57, P388, DOI 10.2307/3809438; Boitani L, 2010, WILDLIFE RES, V37, P722, DOI 10.1071/WR10029; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buk K., 2010, Africa Insight, V39, P212; Cobb S., 1981, P181; Corff S, 2005, CARNIVORE DAMAGE PRE, V9, P24; Craven S, 1998, WILDLIFE SOC B, V26, P171; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Green J, 1989, 4 E WILDL DAM CONTR; Gusset M., 2009, REINTRODUCTION TOP O, P307; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Hamilton P. H., 1981, LEOPARD PANTHERA PAR; Hayward MW, 2007, AFR J ECOL, V45, P103, DOI 10.1111/j.1365-2028.2006.00673.x; Hotte M, 2001, CARNIVORE DAMAGE PRE, V3, P6; Houser A, 2011, S AFR J WILDL RES, V41, P11, DOI 10.3957/056.041.0111; Hunter Luke, 2009, Cat News, V51, P28; Johnson S, 2010, ECOL MODEL, V221, P641, DOI 10.1016/j.ecolmodel.2009.11.012; Jule KR, 2008, BIOL CONSERV, V141, P355, DOI 10.1016/j.biocon.2007.11.007; Lindsey PA, 2005, CONSERV BIOL, V19, P1205, DOI 10.1111/j.1523-1739.2005.00088.x; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052458; Linkie M, 2007, ORYX, V41, P415, DOI 10.1017/S0030605307041415; Linklater WL, 2011, J APPL ECOL, V48, P493, DOI 10.1111/j.1365-2664.2011.01960.x; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Linnell JDC, 2003, CARNIVORE DAMAGE PRE, V6, P11; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Marker L, 2005, CARNIVORE DAMAGE PRE, V8, P28; Marker L, 2000, CARNIVORE DAMAGE PRE, V2, P7; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Marker LL, 2002, THESIS U OXFORD OXFO; MARKERKRAUS L, 1994, ENVIRON CONSERV, V21, P369, DOI 10.1017/S0376892900033750; Marnewick Kelly, 2009, P282, DOI 10.1002/9781444312034.ch13; Marsh H, 2007, CONSERV BIOL, V21, P387, DOI 10.1111/j.1523-1739.2006.00589.x; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nelson Fred, 2009, Human Dimensions of Wildlife, V14, P381, DOI 10.1080/10871200903045228; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Purchase G.K., 1998, THESIS U ZIMBABWE HA; R Core Team, 2021, R LANGUAGE ENV STAT; RABINOWITZ AR, 1986, WILDLIFE SOC B, V14, P170; Ribeiro S, 2005, CARNIVORE DAMAGE PRE, V9, P27; Riley SJ., 1994, URSUS, V9, P567, DOI [10.2307/3872745, DOI 10.2307/3872745]; Rust NA, 2012, PREDATOR FRIENDLY FA; Ruth TK, 1998, J WILDLIFE MANAGE, V62, P1264, DOI 10.2307/3801990; Schumann M, 2006, S AFR J WILDL RES, V36, P173; Shogren JF, 1999, CONSERV BIOL, V13, P1257, DOI 10.1046/j.1523-1739.1999.98414.x; SKINNER JD, 1987, J ZOOL, V212, P350, DOI 10.1111/j.1469-7998.1987.tb05996.x; SPARKS DN, 1973, ROY STAT SOC C-APP, V22, P126, DOI 10.2307/2346321; STANDER PE, 1990, S AFR J WILDL RES, V20, P37; Stander PE, 1997, P S LIONS LEOP GAM R; Stoynov E, 2005, CARNIVORE DAMAGE PRE, V9, P19; Walton MT, 1989, 4 E WILDL DAM CONTR; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8; Woodroffe Rosie, 1997, P58; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	69	34	35	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105042	10.1371/journal.pone.0105042	http://dx.doi.org/10.1371/journal.pone.0105042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126849	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300072
J	Yuen, JWF; Chung, GTY; Lun, SWM; Cheung, CCM; To, KF; Lo, KW				Yuen, Jessie Wai-Fong; Chung, Grace Tin-Yun; Lun, Samantha Wei-Man; Cheung, Chartia Ching-Mei; To, Ka-Fai; Lo, Kwok-Wai			Epigenetic Inactivation of Inositol polyphosphate 4-phosphatase B (INPP4B), a Regulator of PI3K/AKT Signaling Pathway in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CONSTITUTIVE ACTIVATION; PROTEIN; PTEN; IDENTIFICATION; TRANSFORMATION; ESTABLISHMENT; EXPRESSION; RASSF1A; TARGET	Nasopharyngeal carcinoma (NPC) is a common viral-associated neoplasm in which multiple signaling cascades are interfered with by Epstein-Bar virus (EBV) latent proteins and various genetic alterations. Aside from the previously reported PIK3CA amplification, we examined the role of INPP4B, a negative regulator of the PI3K/AKT signaling pathway in the development of NPC. By RT-PCR and Western blotting, we revealed that the expression of INPP4B was down-regulated in all five established EBV-positive tumor lines. While INPP4B was consistently expressed in normal nasopharyngeal epithelial cells, downregulation of INPP4B was found in 32/65 (49.2%) of primary tumors by immunohistochemistry. Furthermore, our study also demonstrated the hypermethylation of the 5'CpG island of INPP4B in the tumors in which INPP4B transcription was downregulated. Notably, the re-expression of INPP4B was detected in the NPC cells treated with the demethylation agent (5-aza-2'deoxycytidine). Our study showed that promoter hypermethylation was the major mechanism for transcriptional silencing of INPP4B in NPC. Furthermore, restoration of INPP4B expression significantly suppressed PI3K/AKT downstream signals in the NPC C666-1 cells. In vivo growth inhibition was clearly demonstrated in the tumor cells stably expressing INPP4B. The findings indicate that epigenetic inactivation of INPP4B is one of the key mechanisms in activating PI3K/AKT signaling cascade and playing a role in the tumorigenesis of NPC.	[Yuen, Jessie Wai-Fong; Chung, Grace Tin-Yun; Lun, Samantha Wei-Man; Cheung, Chartia Ching-Mei; To, Ka-Fai; Lo, Kwok-Wai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai; Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong	Lo, KW (corresponding author), Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk		Lo, Kwok Wai/0000-0002-3488-6124	Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council [471610, T12-401/13-R]	Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by Li Ka Shing Institute of Health Science and Hong Kong Research Grant Council (471610 and T12-401/13-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bertucci MC, 2013, ANN NY ACAD SCI, V1280, P1, DOI 10.1111/nyas.12036; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chou CC, 2009, MED ONCOL, V26, P322, DOI 10.1007/s12032-008-9124-5; Chow LSN, 2004, INT J CANCER, V109, P839, DOI 10.1002/ijc.20079; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Ferron M, 2006, GENE, V376, P152, DOI 10.1016/j.gene.2006.02.022; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Kwong J, 2002, CLIN CANCER RES, V8, P467; Kwong J, 2007, GENE CHROMOSOME CANC, V46, P171, DOI 10.1002/gcc.20398; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2001, CANCER RES, V61, P3877; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Or YYY, 2010, J PATHOL, V220, P97, DOI 10.1002/path.2609; Or YYY, 2006, INT J CANCER, V118, P1065, DOI 10.1002/ijc.21444; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Shu XS, 2013, CARCINOGENESIS, V34, P1984, DOI 10.1093/carcin/bgt165; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang LY, 2013, CARCINOGENESIS, V34, P454, DOI 10.1093/carcin/bgs346	37	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105163	10.1371/journal.pone.0105163	http://dx.doi.org/10.1371/journal.pone.0105163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126743	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300087
J	Castro, SA; Escobedo, VM; Aranda, J; Carvallo, GO				Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge; Carvallo, Gaston O.			Evaluating Darwin's Naturalization Hypothesis in Experimental Plant Assemblages: Phylogenetic Relationships Do Not Determine Colonization Success	PLOS ONE			English	Article							INVASIONS; BIOGEOGRAPHY; COMMUNITIES; CONUNDRUM; INVADERS; ECOLOGY; BIOLOGY	Darwin's naturalization hypothesis (DNH) proposes that colonization is less likely when the colonizing species is related to members of the invaded community, because evolutionary closeness intensifies competition among species that share similar resources. Studies that have evaluated DNH from correlational evidence have yielded controversial results with respect to its occurrence and generality. In the present study we carried out a set of manipulative experiments in which we controlled the phylogenetic relatedness of one colonizing species (Lactuca sativa) with five assemblages of plants (the recipient communities), and evaluated the colonizing success using five indicators (germination, growth, flowering, survival, and recruitment). The evolutionary relatedness was calculated as the mean phylogenetic distance between Lactuca and the members of each assemblage (MPD) and by the mean phylogenetic distance to the nearest neighbor (MNND). The results showed that the colonization success of Lactuca was not affected by MPD or MNND values, findings that do not support DNH. These results disagree with experimental studies made with communities of microorganisms, which show an inverse relation between colonization success and phylogenetic distances. We suggest that these discrepancies may be due to the high phylogenetic distance used, since in our experiments the colonizing species (Lactuca) was a distant relative of the assemblage members, while in the other studies the colonizing taxa have been related at the congeneric and conspecific levels. We suggest that under field conditions the phylogenetic distance is a weak predictor of competition, and it has a limited role in determining colonization success, contrary to prediction of the DNH. More experimental studies are needed to establish the importance of phylogenetic distance between colonizing species and invaded community on colonization success.	[Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge] Univ Santiago Chile, Lab Ecol & Biodiversidad, Dept Biol, Santiago, Chile; [Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge] Univ Santiago Chile, Ctr Dev Nanosci & Nanotechnol CEDENNA, Santiago, Chile; [Carvallo, Gaston O.] Pontificia Univ Catolica Valparaiso, Inst Biol, Fac Ciencias, Valparaiso, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile; Pontificia Universidad Catolica de Valparaiso	Castro, SA (corresponding author), Univ Santiago Chile, Lab Ecol & Biodiversidad, Dept Biol, Santiago, Chile.	sergio.castro@usach.cl	Escobedo, Víctor Manuel/AAV-9690-2021	Escobedo, Victor/0000-0003-2673-3803	Fondecyt [11085013, PD 3130399]; Linea 6 of CEDENNA	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Linea 6 of CEDENNA	This research has been financially supported by Fondecyt 11085013, Fondecyt PD 3130399, and Linea 6 of CEDENNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burns JH, 2011, P NATL ACAD SCI USA, V108, P5302, DOI 10.1073/pnas.1013003108; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Daehler CC, 2001, AM NAT, V158, P324, DOI 10.1086/321316; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Davis M. A., 2009, INVASION BIOL; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Downie SR, 2000, AM J BOT, V87, P273, DOI 10.2307/2656915; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Escobedo VM, 2011, REV CHIL HIST NAT, V84, P543, DOI 10.4067/S0716-078X2011000400007; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Gerhold P, 2011, AM NAT, V177, P668, DOI 10.1086/659059; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hill SB, 2009, OECOLOGIA, V161, P581, DOI 10.1007/s00442-009-1403-0; Jiang L, 2010, AM NAT, V175, P415, DOI 10.1086/650720; Jones EI, 2013, P NATL ACAD SCI USA, V110, P20627, DOI 10.1073/pnas.1310247110; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lambdon PW, 2006, J BIOGEOGR, V33, P1116, DOI 10.1111/j.1365-2699.2006.01486.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lockwood JL, 2007, INVASION ECOLOGY; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Park DS, 2013, P NATL ACAD SCI USA, V110, P17915, DOI 10.1073/pnas.1309948110; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Proches S, 2008, GLOBAL ECOL BIOGEOGR, V17, P5, DOI 10.1111/j.1466-8238.2007.00333.x; Pysek P, 2006, J BIOGEOGR, V33, P2040, DOI 10.1111/j.1365-2699.2006.01578.x; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Ricciardi A, 2006, BIOL INVASIONS, V8, P1403, DOI 10.1007/s10530-006-0005-6; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; SHIGESADA N, 2001, BIOL INVASIONS THEOR; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Strong D., 1984, INSECTS PLANTS COMMU; Thuiller W, 2010, DIVERS DISTRIB, V16, P461, DOI 10.1111/j.1472-4642.2010.00645.x; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Williamson M., 1996, BIOL INVASIONS	48	9	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105535	10.1371/journal.pone.0105535	http://dx.doi.org/10.1371/journal.pone.0105535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141013	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200094
J	Ramer, SJ; Cohen, ED; Chang, CCH; Unruh, ML; Barnato, AE				Ramer, Sarah J.; Cohen, Elan D.; Chang, Chung-Chou H.; Unruh, Mark L.; Barnato, Amber E.			Survival after Acute Hemodialysis in Pennsylvania, 2005-2007: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; QUALITY-OF-LIFE; REPLACEMENT THERAPY; INTENSIVE-CARE; MORTALITY; DIALYSIS; NONRECOVERY; VALIDATION	Background: Little is known about acute hemodialysis in the US. Here we describe predictors of receipt of acute hemodialysis in one state and estimate the marginal impact of acute hemodialysis on survival after accounting for confounding due to illness severity. Materials and Methods: This is a retrospective cohort study of acute-care hospitalizations in Pennsylvania from October 2005 to December 2007 using data from the Pennsylvania Health Care Cost Containment Council. Exposure variable is acute hemodialysis; dependent variable is survival following acute hemodialysis. We used multivariable logistic regression to determine propensity to receive acute hemodialysis and then, for a Cox proportional hazards model, matched acute hemodialysis and non-acute hemodialysis patients 1:5 on this propensity. Results: In 2,131,248 admissions of adults without end-stage renal disease, there were 6,657 instances of acute hemodialysis. In analyses adjusted for predicted probability of death upon admission plus other covariates and stratified on age, being male, black, and insured were independent predictors of receipt of acute hemodialysis. One-year post-admission mortality was 43% for those receiving acute hemodialysis, compared to 13% among those not receiving acute hemodialysis. After matching on propensity to receive acute hemodialysis and adjusting for predicted probability of death upon admission, patients who received acute hemodialysis had a higher risk of death than patients who did not over at least 1 year of follow-up (hazard ratio 1.82, 95% confidence interval 1.68-1.97). Conclusions: In a populous US state, receipt of acute hemodialysis varied by age, sex, race, and insurance status even after adjustment for illness severity. In a comparison of patients with similar propensity to receive acute hemodialysis, those who did receive it were less likely to survive than those who did not. These findings raise questions about reasons for lack of benefit.	[Ramer, Sarah J.] Rutgers State Univ, Newark, NJ 07102 USA; [Cohen, Elan D.; Chang, Chung-Chou H.; Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Unruh, Mark L.] Univ New Mexico, Sch Med, Dept Internal Med, Div Nephrol, Albuquerque, NM 87131 USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab Clin Res Invest & Syst Modeling Acute, Pittsburgh, PA USA	Rutgers State University Newark; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramer, SJ (corresponding author), Rutgers State Univ, Newark, NJ 07102 USA.	sramer@post.harvard.edu		Ramer, Sarah/0000-0001-8584-1148	Doris Duke Clinical Research Fellowship for Medical Students; National Institutes of Health [R01AG035112]; NATIONAL INSTITUTE ON AGING [R01AG035112] Funding Source: NIH RePORTER	Doris Duke Clinical Research Fellowship for Medical Students; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Doris Duke Clinical Research Fellowship for Medical Students to SR (http://www.ddcf.org/) and by National Institutes of Health grant R01AG035112 to AB (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clec'h C, 2012, CRIT CARE, V16, DOI 10.1186/cc11905; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elseviers MM, 2010, CRIT CARE, V14, DOI 10.1186/cc9355; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Gopal I, 1997, INTENS CARE MED, V23, P766, DOI 10.1007/s001340050407; Hamel MB, 1997, ANN INTERN MED, V127, P195, DOI 10.7326/0003-4819-127-3-199708010-00003; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Johansen KL, 2010, CLIN J AM SOC NEPHRO, V5, P1366, DOI 10.2215/CJN.02570310; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Mehta RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014692.19351.52; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pietropaoli AP, 2010, GENDER MED, V7, P422, DOI 10.1016/j.genm.2010.09.005; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Rauf Anis Abdul, 2008, J Intensive Care Med, V23, P195, DOI 10.1177/0885066608315743; Valentin A, 2003, CRIT CARE MED, V31, P1901, DOI 10.1097/01.CCM.0000069347.78151.50; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wilson FP, 2014, CLIN J AM SOC NEPHRO, V9, P673, DOI 10.2215/CJN.07630713; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P1863, DOI 10.2215/CJN.03540413; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668	28	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105083	10.1371/journal.pone.0105083	http://dx.doi.org/10.1371/journal.pone.0105083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141028	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000342687200050
J	Qu, F; Zheng, SJ; Liu, S; Wu, CS; Duan, ZP; Zhang, JL				Qu, Feng; Zheng, Su-Jun; Liu, Shuang; Wu, Cai-Sheng; Duan, Zhong-Ping; Zhang, Jin-Lan			Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DISEASE SCORING SYSTEM; ACIDIC SPHINGOMYELINASE; INHIBITION; PROGNOSIS; FULMINANT; CELLS; MODEL	Patients with HBV-acute-on-chronic liver failure (HBV-ACLF) have high mortality and frequently require liver transplantation; few reliable prognostic markers are available. As a class of functional lipids, sphingolipids are extensively involved in the process of HBV infection. However, their role in chronic HBV infection remains unknown. The aim of this study was to determine the serum sphingolipid profile in a population of patients with chronic HBV infection, paying special attention to exploring novel prognostic markers in HBV-ACLF. High performance liquid chromatography tandem mass spectrometry was used to examine the levels of 41 sphingolipids in 156 serum samples prospectively collected from two independent cohorts. The training and validation cohorts comprised 20 and 28 healthy controls (CTRL), 29 and 23 patients with chronic hepatitis B (CHB), and 30 and 26 patients with HBV-ACLF, respectively. Biometric analysis was used to evaluate the association between sphingolipid levels and disease stages. Multivariate analysis revealed difference of sphingolipid profiles between CHB and HBV-ACLF was more drastic than that between CTRL and CHB, which indicated that serum sphingolipid levels were more likely to associate with the progression HBV-ACLF rather than CHB. Furthermore, a 3-month mortality evaluation of HBV-ACLF patients showed that dhCer(d18:0/24:0) was significantly higher in survivors than in non-survivors (including deceased patients and those undergoing liver transplantation, p<0.05), and showed a prognostic performance similar to that of the MELD score. The serum sphingolipid composition varies between CTRL and chronic HBV infection patients. In addition, dhCer(d18:0/24:0) may be a useful prognostic indicator for the early prediction of HBV-ACLF.	[Qu, Feng; Wu, Cai-Sheng; Zhang, Jin-Lan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Qu, Feng; Wu, Cai-Sheng; Zhang, Jin-Lan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Su-Jun; Liu, Shuang; Duan, Zhong-Ping] Capital Med Univ, Beijing YouAn Hosp, Artificial Liver Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Duan, ZP (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Artificial Liver Ctr, Beijing, Peoples R China.	duan2517@163.com; zhjl@imm.ac.cn	Wu, Caisheng/AAT-2701-2021; Qu, Feng/L-6355-2013	Qu, Feng/0000-0002-3812-0732	Ministry of Science and Technology of People's Republic of China [2012ZX09301002-006]; National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" [2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006-001]; Beijing Municipal Natural Science Foundation [7102085]; Beijing Municipal Science & Technology Commission [Z131107002213019]; High Technical Personnel Training Item in Beijing Health System [2011-3-083]	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment"; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); High Technical Personnel Training Item in Beijing Health System	The work was supported by Ministry of Science and Technology of People's Republic of China (2012ZX09301002-006), National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" (2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006-001), Beijing Municipal Natural Science Foundation (7102085), Beijing Municipal Science & Technology Commission (No. Z131107002213019); and High Technical Personnel Training Item in Beijing Health System (2011-3-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; Brice SE, 2011, ADV EXP MED BIOL, V721, P1, DOI 10.1007/978-1-4614-0650-1_1; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Chinese Society of Hepatology Chinese Medical Association, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P881; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Dudley JT, 2010, GASTROENTEROLOGY, V139, P735, DOI 10.1053/j.gastro.2010.07.024; Eriksson L., 2013, MULTI MEGAVARIATE DA; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Jia W., 2009, MED METABONOMICS; Liver Failure and Artificial Liver Group Chinese Society of Infectious Diseases Chinese Medical Association, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P643; Llacuna L, 2006, HEPATOLOGY, V44, P561, DOI 10.1002/hep.21285; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Malagarie-Cazenave Sophie, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200546X; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Marrero J, 2003, AM J RESP CRIT CARE, V168, P1421, DOI 10.1164/rccm.200303-361UP; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Morales A, 2012, ANTI-CANCER AGENT ME, V12, P364, DOI 10.2174/187152012800228689; Organization WH, 2012, WHO FACT SHEET 204 D; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Qu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052454; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seijo S, 2013, AM J GASTROENTEROL; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Sun WY, 2012, J ALLERGY, V2012, P1; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tatematsu K, 2011, J MED VIROL, V83, P587, DOI 10.1002/jmv.21970; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Wu XX, 2012, BIOCHEM PHARMACOL, V84, P1164, DOI 10.1016/j.bcp.2012.08.006; Yu JW, 2008, J GASTROEN HEPATOL, V23, P1242, DOI 10.1111/j.1440-1746.2008.05484.x; Zheng YB, 2012, CLIN INVEST MED, V35, pE75	41	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104988	10.1371/journal.pone.0104988	http://dx.doi.org/10.1371/journal.pone.0104988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136927	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100057
J	Wilder, JR; Wegener, DT; David, MZ; Macal, C; Daum, R; Lauderdale, DS				Wilder, Jocelyn R.; Wegener, Duane T.; David, Michael Z.; Macal, Charles; Daum, Robert; Lauderdale, Diane S.			A National Survey of Skin Infections, Care Behaviors and MRSA Knowledge in the United States	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; EMERGENCY-DEPARTMENT; SURVEILLANCE	A nationally representative sample of approximately 2000 individuals was surveyed to assess SSTI infections over their lifetime and then prospectively over six-months. Knowledge of MRSA, future likelihood to self-treat a SSTI and self-care behaviors was also queried. Chi square tests, linear and multinomial regression were used for analysis. About 50% of those with a reported history of a SSTI typical of MRSA had sought medical treatment. MRSA knowledge was low: 28% of respondents could describe MRSA. Use of protective self-care behaviors that may reduce transmission, such as covering a lesion, differed with knowledge of MRSA and socio-demographics. Those reporting a history of a MRSA-like SSTI were more likely to respond that they would self-treat than those without such a history (OR 2.05 95% CI 1.40, 3.01; p<0.001). Since half of respondents reported not seeking care for past lesions, incidence determined from clinical encounters would greatly underestimate true incidence. MRSA knowledge was not associated with seeking medical care, but was associated with self-care practices that may decrease transmission.	[Wilder, Jocelyn R.; David, Michael Z.; Macal, Charles; Daum, Robert; Lauderdale, Diane S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Wegener, Duane T.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Macal, Charles] Argonne Natl Lab, Decis & Informat Sci Div, Argonne, IL 60439 USA	University of Chicago; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Argonne National Laboratory	Wilder, JR (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	jwilder@uchicago.edu	David, Michael Z./X-6737-2019	David, Michael Z./0000-0002-1926-7800	Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation) [0818839]; National Institute of General Medical Sciences (NIGMS) [U01 Gm087729 MIDAS]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087729] Funding Source: NIH RePORTER	Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The survey was supported by Time-Sharing Experiments for the Social Sciences program (TESS; National Science Foundation Grant 0818839; J. Freese and P. S. Visser, principal investigators). Analysis was supported by the National Institute of General Medical Sciences (NIGMS) U01 Gm087729 MIDAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cenizal MJ, 2007, ANTIMICROB AGENTS CH, V51, P2628, DOI 10.1128/AAC.00206-07; Chen AE, 2006, PEDIATR EMERG CARE, V22, P717, DOI 10.1097/01.pec.0000236832.23947.a0; Dukic VM, 2011, EMERG INFECT DIS, V17, P1068, DOI [10.3201/eid1706.101451, 10.3201/eid/1706.101451]; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Hahn W, 2009, J PUBLIC HEALTH MAN, V15, P150, DOI 10.1097/01.PHH.0000346013.74522.f8; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kirby JB, 2010, MAIN REASON NOT HAVI; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Purcell K, 2005, ARCH PEDIAT ADOL MED, V159, P980, DOI 10.1001/archpedi.159.10.980; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308	12	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104277	10.1371/journal.pone.0104277	http://dx.doi.org/10.1371/journal.pone.0104277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137061	gold, Green Submitted, Green Published			2022-12-27	WOS:000340742100023
J	Xia, EH; Jiang, JJ; Huang, H; Zhang, LP; Zhang, HB; Gao, LZ				Xia, En-Hua; Jiang, Jian-Jun; Huang, Hui; Zhang, Li-Ping; Zhang, Hai-Bin; Gao, Li-Zhi			Transcriptome Analysis of the Oil-Rich Tea Plant, Camellia oleifera, Reveals Candidate Genes Related to Lipid Metabolism	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SNP DISCOVERY; MICROSATELLITE MARKERS; SSR-MARKERS; ANNOTATION; GENERATION; PROTEIN; DUPLICATION; BLAST2GO; MODEL	Background: Rapidly driven by the need for developing sustainable sources of nutritionally important fatty acids and the rising concerns about environmental impacts after using fossil oil, oil-plants have received increasing awareness nowadays. As an important oil-rich plant in China, Camellia oleifera has played a vital role in providing nutritional applications, biofuel productions and chemical feedstocks. However, the lack of C. oleifera genome sequences and little genetic information have largely hampered the urgent needs for efficient utilization of the abundant germplasms towards modern breeding efforts of this woody oil-plant. Results: Here, using the 454 GS-FLX sequencing platform, we generated approximately 600,000 RNA-Seq reads from four tissues of C. oleifera. These reads were trimmed and assembled into 104,842 non-redundant putative transcripts with a total length of similar to 38.9 Mb, representing more than 218-fold of all the C. oleifera sequences currently deposited in the GenBank (as of March 2014). Based on the BLAST similarity searches, nearly 42.6% transcripts could be annotated with known genes, conserved domains, or Gene Ontology (GO) terms. Comparisons with the cultivated tea tree, C. sinensis, identified 3,022 pairs of orthologs, of which 211 exhibited the evidence under positive selection. Pathway analysis detected the majority of genes potentially related to lipid metabolism. Evolutionary analysis of omega-6 fatty acid desaturase (FAD2) genes among 20 oil-plants unexpectedly suggests that a parallel evolution may occur between C. oleifera and Olea oleifera. Additionally, more than 2,300 simple sequence repeats (SSRs) and 20,200 single-nucleotide polymorphisms (SNPs) were detected in the C. oleifera transcriptome. Conclusions: The generated transcriptome represents a considerable increase in the number of sequences deposited in the public databases, providing an unprecedented opportunity to discover all related-genes associated with lipid metabolic pathway in C. oleifera. It will greatly enhance the generation of new varieties of C. oleifera with increased yields and high quality.	[Xia, En-Hua; Jiang, Jian-Jun; Huang, Hui; Zhang, Li-Ping; Zhang, Hai-Bin; Gao, Li-Zhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China; [Xia, En-Hua; Zhang, Hai-Bin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn	Xia, Enhua/AAV-4999-2021; , 夏恩华/ABD-9329-2020	Xia, Enhua/0000-0003-3411-9117; Jiang, Jianjun/0000-0003-2637-0782	National Science Foundation of China [U0936603]; Key Project of Natural Science Foundation of Yunnan Province [2008CC016]; Top Talent Program of Yunnan Province [20080A009]; Frontier Grant of Kunming Institute of Botany, CAS [672705232515]; Hundred Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science [KSCX2-YW-N-029]; Kunming Institute of Botany, CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Yunnan Province; Top Talent Program of Yunnan Province; Frontier Grant of Kunming Institute of Botany, CAS; Hundred Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science(Chinese Academy of Sciences); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by National Science Foundation of China (U0936603), Key Project of Natural Science Foundation of Yunnan Province (2008CC016), Top Talent Program of Yunnan Province (20080A009), Frontier Grant of Kunming Institute of Botany, CAS (672705232515), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), and a start-up grant from Kunming Institute of Botany, CAS to L.-Z. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Chen Y.H., 2007, PHYSIOCHEMICAL PROPE; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dalquen DA, 2013, GENOME BIOL EVOL, V5, P1800, DOI 10.1093/gbe/evt132; Drobak BK, 2002, TRENDS PLANT SCI, V7, P132, DOI 10.1016/S1360-1385(01)02213-0; Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao J. Y., 1993, International Camellia Journal, V25, P53; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; He Shanan, 1982, American Camellia Yearbook 1982, P104; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kong Q, 2006, MOL ECOL NOTES, V6, P1234, DOI 10.1111/j.1471-8286.2006.01500.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ma JL, 2011, J VERBRAUCH LEBENSM, V6, P9, DOI 10.1007/s00003-010-0581-3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MURPHY DJ, 1990, PROG LIPID RES, V29, P299; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; OHLROGGE JB, 1994, PLANT PHYSIOL, V104, P821, DOI 10.1104/pp.104.3.821; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi J, 2013, PLANT SYST EVOL, V299, P1387, DOI 10.1007/s00606-013-0814-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; van Oeveren J, 2009, METHODS MOL BIOL, V578, P73, DOI 10.1007/978-1-60327-411-1_4; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang XC, 2012, MOL BIOL REP, V39, P6825, DOI 10.1007/s11033-012-1507-1; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wen Q, 2012, AM J BOT, V99, pE203, DOI 10.3732/ajb.1100486; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xia L. F., 1993, American Camellia Yearbook., P12; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Y., 1999, J NAT RESOUR, V2, P123, DOI [10.1017/S0266078400010713, DOI 10.1017/S0266078400010713]; Zhang D., 2006, ACTA HORTIC, V769, P43, DOI DOI 10.17660/ACTAH0RTIC.2008.769.3; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-329	59	54	64	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104150	10.1371/journal.pone.0104150	http://dx.doi.org/10.1371/journal.pone.0104150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136805	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100018
J	Bryan, MS; Argos, M; Pierce, B; Tong, L; Rakibuz-Zaman, M; Ahmed, A; Rahman, M; Islam, T; Yunus, M; Parvez, F; Roy, S; Jasmine, F; Baron, JA; Kibriya, MG; Ahsan, H				Bryan, Molly Scannell; Argos, Maria; Pierce, Brandon; Tong, Lin; Rakibuz-Zaman, Muhammad; Ahmed, Alauddin; Rahman, Mahfuzar; Islam, Tariqul; Yunus, Muhammad; Parvez, Faruque; Roy, Shantanu; Jasmine, Farzana; Baron, John A.; Kibriya, Muhammad G.; Ahsan, Habibul			Genome-Wide Association Studies and Heritability Estimates of Body Mass Index Related Phenotypes in Bangladeshi Adults	PLOS ONE			English	Article							QT INTERVAL DURATION; COMMON VARIANTS; AFRICAN-AMERICANS; ASIAN POPULATIONS; GENETIC-VARIANTS; MORTALITY RISK; WEIGHT CHANGE; MIXED-MODEL; OVERWEIGHT; OBESITY	Many health outcomes are influenced by a person's body mass index, as well as by the trajectory of body mass index through a lifetime. Although previous research has established that body mass index related traits are influenced by genetics, the relationship between these traits and genetics has not been well characterized in people of South Asian ancestry. To begin to characterize this relationship, we analyzed the association between common genetic variation and five phenotypes related to body mass index in a population-based sample of 5,354 Bangladeshi adults. We discovered a significant association between SNV rs347313 (intron of NOS1AP) and change in body mass index in women over two years. In a linear mixed-model, the G allele was associated with an increase of 0.25 kg/m(2) in body mass index over two years (p-value of 2.3.10(-8)). We also estimated the heritability of these phenotypes from our genotype data. We found significant estimates of heritability for all of the body mass index-related phenotypes. Our study evaluated the genetic determinants of body mass index related phenotypes for the first time in South Asians. The results suggest that these phenotypes are heritable and some of this heritability is driven by variation that differs from those previously reported. We also provide evidence that the genetic etiology of body mass index related traits may differ by ancestry, sex, and environment, and consequently that these factors should be considered when assessing the genetic determinants of the risk of body mass index-related disease.	[Bryan, Molly Scannell; Argos, Maria; Pierce, Brandon; Tong, Lin; Roy, Shantanu; Jasmine, Farzana; Kibriya, Muhammad G.; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Rakibuz-Zaman, Muhammad; Ahmed, Alauddin; Rahman, Mahfuzar; Islam, Tariqul] UChicago Res Bangladesh, Dhaka, Bangladesh; [Yunus, Muhammad] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Parvez, Faruque] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of Chicago; International Centre for Diarrhoeal Disease Research (ICDDR); Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Ahsan, H (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	habib@uchicago.edu		Pierce, Brandon/0000-0002-7829-952X; Scannell Bryan, Molly/0000-0003-1030-3155; Yunus, Mohammed/0000-0003-1116-4978	National Institute of Health [RO1CA107431, P42ES10349]; Nancy Mollin Michael endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Mollin Michael endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health (http://www.nih.gov/) grant numbers RO1CA107431, and P42ES10349 to HA, and the Nancy Mollin Michael endowment to MSB (http://www.bsd.uchicago.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Adams KF, 2013, AM J EPIDEMIOLOGY; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Argos M, 2013, EUR J CLIN INVEST, V43, P579, DOI 10.1111/eci.12085; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Balarajan Y, 2009, J NUTR, V139, P2139, DOI 10.3945/jn.109.112029; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; de Mutsert R, 2014, AM J EPIDEMIOLOGY; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuller LH, 1999, AM J EPIDEMIOL, V149, P515; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meigs JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S16; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ng MCY, 2012, OBESITY, V20, P622, DOI 10.1038/oby.2011.154; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Smemo S, 2014, NATURE; Smith JG, 2012, CIRC-CARDIOVASC GENE, V5, P647, DOI 10.1161/CIRCGENETICS.112.962787; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	52	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105062	10.1371/journal.pone.0105062	http://dx.doi.org/10.1371/journal.pone.0105062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133637	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700065
J	Gomes, S; Marques, PI; Matthiesen, R; Seixas, S				Gomes, Silvia; Marques, Patricia I.; Matthiesen, Rune; Seixas, Susana			Adaptive Evolution and Divergence of SERPINB3: A Young Duplicate in Great Apes	PLOS ONE			English	Article							CARCINOMA ANTIGEN 1; COPY NUMBER VARIATION; REACTIVE-SITE LOOP; PROTEINASE-INHIBITOR; POSITIVE SELECTION; CYSTEINE PROTEASES; GENE; SERINE; CELLS; EXPRESSION	A series of duplication events led to an expansion of clade B Serine Protease Inhibitors (SERPIN), currently displaying a large repertoire of functions in vertebrates. Accordingly, the recent duplicates SERPINB3 and B4 located in human 18q21.3 SERPIN cluster control the activity of different cysteine and serine proteases, respectively. Here, we aim to assess SERPINB3 and B4 coevolution with their target proteases in order to understand the evolutionary forces shaping the accelerated divergence of these duplicates. Phylogenetic analysis of primate sequences placed the duplication event in a Hominoidae ancestor (similar to 30 Mya) and the emergence of SERPINB3 in Homininae (similar to 9 Mya). We detected evidence of strong positive selection throughout SERPINB4/B3 primate tree and target proteases, cathepsin L2 (CTSL2) and G (CTSG) and chymase (CMA1). Specifically, in the Homininae clade a perfect match was observed between the adaptive evolution of SERPINB3 and cathepsin S (CTSS) and most of sites under positive selection were located at the inhibitor/protease interface. Altogether our results seem to favour a coevolution hypothesis for SERPINB3, CTSS and CTSL2 and for SERPINB4 and CTSG and CMA1. A scenario of an accelerated evolution driven by host-pathogen interactions is also possible since SERPINB3/B4 are potent inhibitors of exogenous proteases, released by infectious agents. Finally, similar patterns of expression and the sharing of many regulatory motifs suggest neofunctionalization as the best fitted model of the functional divergence of SERPINB3 and B4 duplicates.	[Gomes, Silvia; Marques, Patricia I.; Seixas, Susana] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Marques, Patricia I.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, P-4100 Oporto, Portugal; [Matthiesen, Rune] Natl Hlth Inst Doutor Ricardo Jorge INSA, Lisbon, Portugal	Universidade do Porto; Universidade do Porto; Instituto Nacional de Saude Dr. Ricardo Jorge	Gomes, S (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	silviap@ipatimup.pt; sseixas@ipatimup.pt	Matthiesen, Rune/AAF-2167-2020; Marques, Patricia Isabel/J-9983-2019; Seixas, Susana/I-5084-2013	Matthiesen, Rune/0000-0002-6353-2616; Marques, Patricia Isabel/0000-0001-6050-628X; Seixas, Susana/0000-0002-7035-7422; Gomes, Silvia/0000-0002-4881-7808	Portuguese Foundation for Science and Technology (FCT) - European Social Funds (COMPETE-FEDER); Portuguese Ministry of Education and Science (POPH-QREN) [SFRH/BPD/77646/2011, SFRH/BD/68940/2010, PTDC/BEXGMG/0242/2012]; FCT	Portuguese Foundation for Science and Technology (FCT) - European Social Funds (COMPETE-FEDER); Portuguese Ministry of Education and Science (POPH-QREN); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT), financed by the European Social Funds (COMPETE-FEDER) and national funds of the Portuguese Ministry of Education and Science (POPH-QREN) fellowship to SFRH/BPD/77646/2011 S. G., SFRH/BD/68940/2010 to P. I. M. and grant PTDC/BEXGMG/0242/2012 to S. S. IPATIMUP is an Associated Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khunaizi M, 2002, BIOCHEMISTRY-US, V41, P3189, DOI 10.1021/bi015999x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashton-Rickardt PG, 2013, IMMUNOL LETT, V152, P65, DOI 10.1016/j.imlet.2013.04.004; Askew DJ, 2004, GENOMICS, V84, P166, DOI 10.1016/j.ygeno.2004.01.014; Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Bartuski AJ, 1997, GENOMICS, V43, P321, DOI 10.1006/geno.1997.4827; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bird PI, 1999, IMMUNOL CELL BIOL, V77, P47, DOI 10.1046/j.1440-1711.1999.00787.x; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; da Fonseca RR, 2010, FEBS LETT, V584, P469, DOI 10.1016/j.febslet.2009.12.022; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; EVANS E, 1995, GENOMICS, V28, P235, DOI 10.1006/geno.1995.1136; Eyre HJ, 1996, GENOMICS, V37, P406, DOI 10.1006/geno.1996.0580; Force A, 1999, GENETICS, V151, P1531; Forni D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004189; Gatto M, 2013, CLIN REV ALLERG IMMU, V45, P267, DOI 10.1007/s12016-013-8353-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hao ZJ, 2012, INT J NANOMED, V7, P827, DOI 10.2147/IJN.S27803; Hardwick RJ, 2011, HUM MUTAT, V32, P743, DOI 10.1002/humu.21491; Hashimoto K, 2005, TUMOR BIOL, V26, P165, DOI 10.1159/000086949; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Izuhara K, 2008, CELL MOL LIFE SCI, V65, P2541, DOI 10.1007/s00018-008-8049-7; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Kantyka T, 2011, BIOL CHEM, V392, P483, DOI 10.1515/BC.2011.044; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Luke C, 2000, BIOCHEMISTRY-US, V39, P7081, DOI 10.1021/bi000050g; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marques PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066889; Niu AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-298; Ohno S., 1970, P1; OHTA T, 1994, J MOL EVOL, V39, P614, DOI 10.1007/BF00160406; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; PONTISSO P, 1991, J HEPATOL, V12, P203, DOI 10.1016/0168-8278(91)90939-9; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ruvoletto MG, 2004, J GEN VIROL, V85, P621, DOI 10.1099/vir.0.19130-0; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Schrodinger L., 2020, PYMOL; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Seixas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032518; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song KJ, 2012, KOREAN J PARASITOL, V50, P1, DOI 10.3347/kjp.2012.50.1.1; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; Vidalino L, 2012, EXP BIOL MED, V237, P793, DOI 10.1258/ebm.2012.012024; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016	75	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104935	10.1371/journal.pone.0104935	http://dx.doi.org/10.1371/journal.pone.0104935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133778	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700052
J	Liu, C; Duan, LG; Lu, WS; Yan, LN; Xiao, GQ; Jiang, L; Yang, J; Yang, JY				Liu, Chang; Duan, Li-gen; Lu, Wu-sheng; Yan, Lu-nan; Xiao, Guang-qin; Jiang, Li; Yang, Jian; Yang, Jia-yin			Prognosis Evaluation in Patients with Hepatocellular Carcinoma after Hepatectomy: Comparison of BCLC, TNM and Hangzhou Criteria Staging Systems	PLOS ONE			English	Article							LIVER-CANCER; ALPHA-FETOPROTEIN; HEPATITIS-C; COHORT; CLIP; TRANSPLANTATION; SURVIVAL; OKUDA	Purpose: This study is to evaluate the Hangzhou criteria (HC) for patients with HCC undergoing surgical resection and to identify whether this staging system is superior to other staging systems in predicting the survival of resectable HCC. Method: 774 HCC patients underwent surgical resection between 2007 and 2009 in West China Hospital were enrolled retrospectively. Predictors of survival were identified using the Kaplan-Meier method and the Cox model. The disease state was staged by the HC, as well as by the TNM and BCLC staging systems. Prognostic powers were quantified using a linear trend chi 2 test, c-index, and the likelihood ratio (LHR) chi 2 test and correlated using Cox's regression model adjusted using the Akaike information criterion (AIC). Results: Serum AFP level (P = 0.02), tumor size (P < 0.001), tumor number (P < 0.001), portal vein invasion (P < 0.001), hepatic vein invasion (P < 0.001), tumor differentiation (P < 0.001), and distant organ (P = 0.016) and lymph node metastasis (P < 0.001) were identified as independent risk factors of survival after resection by multivariate analysis. The comparison of the different staging system results showed that BCLC had the best homogeneity (likelihood ratio chi(2) test 151.119, P < 0.001), the TNM system had the best monotonicity of gradients (linear trend chi(2) test 137.523, P < 0.001), and discriminatory ability was the highest for the BCLC (the AUCs for 1-year mortality were 0.759) and TNM staging systems (the AUCs for 3-, and 5-year mortality were 0.738 and 0.731, respectively). However, based on the c-index and AIC, the HC was the most informative staging system in predicting survival (c-index 0.6866, AIC 5924.4729). Conclusions: The HC can provide important prognostic information after surgery. The HC were shown to be a promising survival predictor in a Chinese cohort of patients with resectable HCC.	[Liu, Chang; Lu, Wu-sheng; Yan, Lu-nan; Xiao, Guang-qin; Jiang, Li; Yang, Jian; Yang, Jia-yin] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China; [Liu, Chang; Lu, Wu-sheng] Sichuan Univ, West China Hosp, Inst Intervent Radiol, Chengdu 610064, Peoples R China; [Duan, Li-gen] Sichuan Univ, West China Hosp, Dept Emergency, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Yang, JY (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China.	docjackyang@163.com			National Sciences and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Sciences and Technology Major Project of China	This work was supported by a grant from the National Sciences and Technology Major Project of China (2012ZX10002-016 and 2012ZX10002-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; De Carlis L, 2003, J AM COLL SURGEONS, V196, P887, DOI 10.1016/S1072-7515(03)00140-6; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Faber W, 2012, SURGERY; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Grieco A, 2005, GUT, V54, P411, DOI 10.1136/gut.2004.048124; Guglielmi A, 2008, AM J GASTROENTEROL, V103, P597, DOI 10.1111/j.1572-0241.2007.01604.x; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XH, 2011, J GASTROINTEST ONCOL, V2, P223, DOI 10.3978/j.issn.2078-6891.2011.024; Lee IC, 2010, LIVER INT, V30, P1161, DOI 10.1111/j.1478-3231.2010.02301.x; Lei J, 2013, J GASTROINTEST SURG; Li Q, 2007, J GASTROEN HEPATOL, V22, P1936, DOI 10.1111/j.1440-1746.2006.04619.x; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lu WP, 2008, J GASTROEN HEPATOL, V23, P1874, DOI 10.1111/j.1440-1746.2008.05527.x; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Poon Ronnie Tung-Ping, 2003, Surg Oncol Clin N Am, V12, P35, DOI 10.1016/S1055-3207(02)00086-8; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schoniger-Hekele M, 2001, GUT, V48, P103, DOI 10.1136/gut.48.1.103; Seo YS, 2008, J GASTROEN HEPATOL, V23, P1267, DOI 10.1111/j.1440-1746.2008.05480.x; Sirivatanauksorn Yongyut, 2011, HPB Surg, V2011, P818217, DOI 10.1155/2011/818217; Skolnick AA, 1996, JAMA-J AM MED ASSOC, V276, P1458, DOI 10.1001/jama.276.18.1458; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Torzilli G, 2008, ARCH SURG-CHICAGO, V143, P1082, DOI 10.1001/archsurg.143.11.1082; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2; Yang TA, 2011, J CANCER RES CLIN, V137, P739, DOI 10.1007/s00432-010-0935-3; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Zhou JG, 2013, TUMOR BIOL, V34, P1061, DOI 10.1007/s13277-013-0646-x	36	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103228	10.1371/journal.pone.0103228	http://dx.doi.org/10.1371/journal.pone.0103228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133493	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700006
J	Lo, HY; Hsiang, CY; Li, TC; Li, CC; Huang, HC; Chen, JC; Ho, TY				Lo, Hsin-Yi; Hsiang, Chien-Yun; Li, Tsai-Chung; Li, Chia-Cheng; Huang, Hui-Chi; Chen, Jaw-Chyun; Ho, Tin-Yun			A Novel Glycated Hemoglobin A1c-Lowering Traditional Chinese Medicinal Formula, Identified by Translational Medicine Study	PLOS ONE			English	Article							OPHIOPOGON-JAPONICUS; GLUCOSE-HOMEOSTASIS; MOMORDICA-CHARANTIA; PANAX-GINSENG; DOUBLE-BLIND; INSULIN; EFFICACY; DIET; POLYSACCHARIDE; ASSOCIATION	Diabetes is a chronic metabolic disorder that has a significant impact on the health care system. The reduction of glycated hemoglobin A1c is highly associated with the improvements of glycemic control and diabetic complications. In this study, we identified a traditional Chinese medicinal formula with a HbA1c-lowering potential from clinical evidences. By surveying 9,973 diabetic patients enrolled in Taiwan Diabetic Care Management Program, we found that Chu-Yeh-Shih-Kao-Tang (CYSKT) significantly reduced HbA1c values in diabetic patients. CYSKT reduced the levels of HbA1c and fasting blood glucose, and stimulated the blood glucose clearance in type 2 diabetic mice. CYSKT affected the expressions of genes associated with insulin signaling pathway, increased the amount of phosphorylated insulin receptor in cells and tissues, and stimulated the translocation of glucose transporter 4. Moreover, CYSKT affected the expressions of genes related to diabetic complications, improved the levels of renal function indexes, and increased the survival rate of diabetic mice. In conclusion, this was a translational medicine study that applied a "bedside-to-bench'' approach to identify a novel HbA1c-lowering formula. Our findings suggested that oral administration of CYSKT affected insulin signaling pathway, decreased HbA1c and blood glucose levels, and consequently reduced mortality rate in type 2 diabetic mice.	[Lo, Hsin-Yi; Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan; [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Li, Chia-Cheng] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Hui-Chi] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Chen, Jaw-Chyun] Da Yeh Univ, Dept Med Bot & Healthcare, Changhua, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Da Yeh University	Ho, TY (corresponding author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.	cyhsiang@mail.cmu.edu.tw	Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015; Li, Tsai-Chung/P-2052-2015	Li, Tsai-Chung/0000-0002-3346-7462	National Research Program for Biopharmaceuticals [NSC101-2325-B-039-007, NSC102-2325-B-039-007, MOST103-2325-B-039-002]; Ministry of Science and Technology [NSC101-2320-B-039-034-MY3, NSC101-3114-Y-466-002, NSC102-2632-B-039-001-MY3, MOST103-2815-C-039-044-B]; Council of Agriculture [103AS-14.3.2-ST-a1]; China Medical University [CMU101-S-21, CMU101-AWARD-09, CMU102-NSC-04, CMU103-SR-44]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	National Research Program for Biopharmaceuticals; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council of Agriculture; China Medical University(China Medical University); CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This work was supported by grants from National Research Program for Biopharmaceuticals (NSC101-2325-B-039-007, NSC102-2325-B-039-007, and MOST103-2325-B-039-002), Ministry of Science and Technology (NSC101-2320-B-039-034-MY3, NSC101-3114-Y-466-002, NSC102-2632-B-039-001-MY3, and MOST103-2815-C-039-044-B), Council of Agriculture (103AS-14.3.2-ST-a1), China Medical University (CMU101-S-21, CMU101-AWARD-09, CMU102-NSC-04, and CMU103-SR-44), and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, EXPERT OPIN PHARMACO, V13, P1797, DOI 10.1517/14656566.2012.705829; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Buts JP, 1997, AM J PHYSIOL-GASTR L, V273, pG217, DOI 10.1152/ajpgi.1997.273.1.G217; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Frass M, 2012, OCHSNER J, V12, P45; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; GHANNAM N, 1986, HORM RES, V24, P288, DOI 10.1159/000180569; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kamble SM, 1996, J RES AYURVEDA SIDDH, VXVII, P77; Kilpatrick ES, 2008, J CLIN PATHOL, V61, P977, DOI 10.1136/jcp.2007.054304; LEATHERDALE BA, 1981, BRIT MED J, V282, P1823, DOI 10.1136/bmj.282.6279.1823; Li CC, 2012, BIOMEDICINE-TAIWAN, V2, P10, DOI 10.1016/j.biomed.2012.02.002; Liu Z, 2013, J ETHNOPHARMACOL, V145, P233, DOI 10.1016/j.jep.2012.10.058; Lo HY, 2013, J AGR FOOD CHEM, V61, P2461, DOI 10.1021/jf3042402; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mae T, 2003, J NUTR, V133, P3369, DOI 10.1093/jn/133.11.3369; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Powers A. C., 2012, HARRISONS PRINCIPLES, P2275; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P281, DOI 10.1016/0378-8741(90)90107-5; SOTANIEMI EA, 1995, DIABETES CARE, V18, P1373, DOI 10.2337/diacare.18.10.1373; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Wang LY, 2012, J ETHNOPHARMACOL, V143, P347, DOI 10.1016/j.jep.2012.06.050; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164	37	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104650	10.1371/journal.pone.0104650	http://dx.doi.org/10.1371/journal.pone.0104650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133699	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700035
J	van Hooff, ML; van Loon, J; van Limbeek, J; de Kleuver, M				van Hooff, Miranda L.; van Loon, Jan; van Limbeek, Jacques; de Kleuver, Marinus			The Nijmegen Decision Tool for Chronic Low Back Pain. Development of a Clinical Decision Tool for Secondary or Tertiary Spine Care Specialists	PLOS ONE			English	Article							LUMBAR DISC SURGERY; START BACK; PROGNOSTIC-FACTORS; SCREENING TOOL; RED FLAGS; DISABILITY; MANAGEMENT; PREDICTORS; FEAR; REHABILITATION	Background: In Western Europe, low back pain has the greatest burden of all diseases. When back pain persists, different medical specialists are involved and a lack of consensus exists among these specialists for medical decision-making in Chronic Low Back Pain (CLBP). Objective: To develop a decision tool for secondary or tertiary spine care specialists to decide which patients with CLBP should be seen by a spine surgeon or by other non-surgical medical specialists. Methods: A Delphi study was performed to identify indicators predicting the outcome of interventions. In the preparatory stage evidence from international guidelines and literature were summarized. Eligible studies were reviews and longitudinal studies. Inclusion criteria: surgical or non-surgical interventions and persistence of complaints, CLBP-patients aged 18-65 years, reported baseline measures of predictive indicators, and one or more reported outcomes had to assess functional status, quality of life, pain intensity, employment status or a composite score. Subsequently, a three-round Delphi procedure, to reach consensus on candidate indicators, was performed among a multidisciplinary panel of 29 CLBP-professionals (>five years CLBP-experience). The pre-set threshold for general agreement was >= 70%. The final indicator set was used to develop a clinical decision tool. Results: A draft list with 53 candidate indicators (38 with conclusive evidence and 15 with inconclusive evidence) was included for the Delphi study. Consensus was reached to include 47 indicators. A first version of the decision tool was developed, consisting of a web-based screening questionnaire and a provisional decision algorithm. Conclusions: This is the first clinical decision tool based on current scientific evidence and formal multidisciplinary consensus that helps referring the patient for consultation to a spine surgeon or a non-surgical spine care specialist. We expect that this tool considerably helps in clinical decision-making spine care, thereby improving efficient use of scarce sources and the outcomes of spinal interventions.	[van Hooff, Miranda L.] Sint Maartensklin, Dept Res, Nijmegen, Netherlands; [van Loon, Jan; de Kleuver, Marinus] Sint Maartenskliniek, Dept Orthoped, Nijmegen, Netherlands; [van Limbeek, Jacques] Achmea Hlth Insurance Co, Zeist, Netherlands; [de Kleuver, Marinus] Vrije Univ Amsterdam Med Ctr, Dept Orthoped, Amsterdam, Netherlands	Sint Maartens Clinic; Sint Maartens Clinic; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Hooff, ML (corresponding author), Sint Maartensklin, Dept Res, Nijmegen, Netherlands.	m.vanhooff@maartenskliniek.nl	van Hooff, Miranda L./A-4872-2019; de Kleuver, Marinus/A-1203-2016	de Kleuver, Marinus/0000-0002-3506-1212				Aalto TJ, 2006, SPINE, V31, pE648, DOI 10.1097/01.brs.0000231727.88477.da; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Apeldoorn A, 2013, FYSIOPRAXIS, V04, P32; Athiviraham A, 2011, SPINE J, V11, P613, DOI 10.1016/j.spinee.2011.03.008; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Bederman SS, 2010, SPINE J, V10, P728, DOI 10.1016/j.spinee.2010.05.008; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Brox JI, 2010, ANN RHEUM DIS, V69, P1643, DOI 10.1136/ard.2009.108902; Bruyere O, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-12; Carreon LY, 2009, SPINE, V34, P725, DOI 10.1097/BRS.0b013e318198cae4; CBO Kwaliteitsinstituut voor de Gezondheidszorg, 2009, KET ASP LAG RUGP; CBO Kwaliteitsinstituut voor de Gezondheidszorg, 2009, KET ASP LAG RUGP; Celestin J, 2009, PAIN MED, V10, P639, DOI 10.1111/j.1526-4637.2009.00632.x; Centeno CJ, 2004, SPINE, V29, P1392, DOI 10.1097/01.BRS.0000128771.48789.FB; Chavannes AW, 2005, HUISARTS WET, V48, P113; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Soriano JC, 2010, EUR SPINE J, V19, P1841, DOI [10.1007/s00586.010.1284.2, 10.1007/s00586-010-1284-2]; Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Dalkey NC, 1969, DELPHI METHOD EXPT S; den Boer JJ, 2006, PAIN, V123, P45, DOI 10.1016/j.pain.2006.02.008; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Fairbank J, 2011, SPINE, V36, pS19, DOI 10.1097/BRS.0b013e31822ef72c; Flink IK, 2010, EUR J PAIN, V14, P887, DOI 10.1016/j.ejpain.2010.02.003; Fourney DR, 2011, SPINE, V36, pS1, DOI 10.1097/BRS.0b013e31822f0a0d; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Fritzell P, 2006, EUR SPINE J, V15, pS57, DOI 10.1007/s00586-005-1051-y; FRYMOYER JW, 1992, CLIN ORTHOP RELAT R, P101; Gheldof ELM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2010.01.003; Glassman SD, 2011, SPINE J, V11, P1108, DOI 10.1016/j.spinee.2011.11.016; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Grotle M, 2010, PAIN, V151, P790, DOI 10.1016/j.pain.2010.09.014; Haldeman S, 2008, SPINE J, V8, P1, DOI 10.1016/j.spinee.2007.10.009; Hall H, 2008, CLIN EVID; Harms MC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-236; Hasenbring M, 1998, Curr Opin Anaesthesiol, V11, P553, DOI 10.1097/00001503-199810000-00018; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Hasenbring MI, 2006, EUR J PAIN, V10, P701, DOI 10.1016/j.ejpain.2005.11.004; Heitz CAM, 2009, EUR SPINE J, V18, P1829, DOI 10.1007/s00586-009-1083-9; Henschke N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008686.pub2; Henschke N, 2012, EUR SPINE J, V21, P375, DOI 10.1007/s00586-011-2023-z; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009; Jensen OK, 2010, SPINE J, V10, P659, DOI 10.1016/j.spinee.2010.03.026; Johansson AC, 2010, DISABIL REHABIL, V32, P521, DOI 10.3109/09638280903177243; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kongsted A, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-10; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Linstone A., 2002, DELPHI METHOD TECHNI; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Main CJ, 2002, BMJ-BRIT MED J, V325, P534, DOI 10.1136/bmj.325.7363.534; Martel MO, 2010, PAIN, V151, P330, DOI 10.1016/j.pain.2010.07.004; McCormick JD, 2013, J AM ACAD ORTHOP SUR, V21, P99, DOI 10.5435/JAAOS-21-02-99; Meijer R, 2003, INT J REHABIL RES, V26, P265, DOI 10.1097/00004356-200312000-00003; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Costa LDM, 2011, EUR J PAIN, V15, P213, DOI 10.1016/j.ejpain.2010.06.014; Mirza SK, 2007, SPINE, V32, P816, DOI 10.1097/01.brs.0000259225.37454.38; Morso L, 2011, EUR SPINE J, V20, P2166, DOI 10.1007/s00586-011-1911-6; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NICE (National Institute for Health and Clinical Excellence), 2009, LOW BACK PAIN EARL M, P88; Oxford Centre for Evidence-based Medicine Levels of Evidence, 2009, LEV EV; Pearson A, 2012, SPINE, V37, P1791, DOI 10.1097/BRS.0b013e3182634b04; Peters ML, 2005, PAIN, V113, P45, DOI 10.1016/j.pain.2004.09.033; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rihn JA, 2009, AM J MED QUAL, V24, p4S, DOI 10.1177/1062860609349214; Rudwaleit M, 2004, Z RHEUMATOL, V63, P193, DOI 10.1007/s00393-004-0629-9; Sanden B, 2011, SPINE, V36, P1059, DOI 10.1097/BRS.0b013e3181e92b36; Sinikallio S, 2010, DISABIL REHABIL, V32, P462, DOI 10.3109/09638280903171477; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Stromqvist B, 2013, EUR SPINE J, V22, P953, DOI 10.1007/s00586-013-2758-9; Susan H, 2002, AM J EPIDEMIOL, V156, P1028, DOI 10.1093/aje/kwf136; Swinkels-Meewisse IEJ, 2006, SPINE, V31, P658, DOI 10.1097/01.brs.0000203709.65384.9d; Trief PM, 2006, SPINE, V31, P823, DOI 10.1097/01.brs.0000206362.03950.5b; Truchon M, 2001, DISABIL REHABIL, V23, P758, DOI 10.1080/09638280110061744; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; van der Hulst M, 2005, SPINE, V30, P813, DOI 10.1097/01.brs.0000157414.47713.78; van Hooff ML, 2011, START BACK SCREENING; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder M, 2011, EUR SPINE J, V20, P999, DOI 10.1007/s00586-011-1885-4; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Weiner BK, 2008, SPINE, V33, P219, DOI 10.1097/BRS.0b013e3181604572; Wessels T, 2006, EUR SPINE J, V15, P1633, DOI 10.1007/s00586-006-0073-4; Wideman TH, 2009, PAIN, V145, P45, DOI 10.1016/j.pain.2009.04.022; Willems PC, 2013, SPINE J, V13, P99, DOI 10.1016/j.spinee.2012.10.001; Williams CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008643.pub2; Woby SR, 2004, EUR J PAIN, V8, P201, DOI 10.1016/j.ejpain.2003.08.002	95	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104226	10.1371/journal.pone.0104226	http://dx.doi.org/10.1371/journal.pone.0104226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133645	gold, Green Published			2022-12-27	WOS:000341302700025
J	Cera, N; Di Pierro, ED; Ferretti, A; Tartaro, A; Romani, GL; Perrucci, MG				Cera, Nicoletta; Di Pierro, Ezio Domenico; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni			Brain Networks during Free Viewing of Complex Erotic Movie: New Insights on Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							RESTING-STATE NETWORKS; VISUAL SEXUAL STIMULI; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; DISTINCT COMPONENTS; AROUSAL; FMRI; ACTIVATION; HEALTHY; SELF	Psychogenic erectile dysfunction (ED) is defined as a male sexual dysfunction characterized by a persistent or recurrent inability to attain adequate penile erection due predominantly or exclusively to psychological or interpersonal factors. Previous fMRI studies were based on the common occurrence in the male sexual behaviour represented by the sexual arousal and penile erection related to viewing of erotic movies. However, there is no experimental evidence of altered brain networks in psychogenic ED patients (EDp). Some studies showed that fMRI activity collected during non sexual movie viewing can be analyzed in a reliable manner with independent component analysis (ICA) and that the resulting brain networks are consistent with previous resting state neuroimaging studies. In the present study, we investigated the modification of the brain networks in EDp compared to healthy controls (HC), using whole-brain fMRI during free viewing of an erotic video clip. Sixteen EDp and nineteen HC were recruited after RigiScan evaluation, psychiatric, and general medical evaluations. The performed ICA showed that visual network (VN), default-mode network (DMN), fronto-parietal network (FPN) and salience network (SN) were spatially consistent across EDp and HC. However, between-group differences in functional connectivity were observed in the DMN and in the SN. In the DMN, EDp showed decreased connectivity values in the inferior parietal lobes, posterior cingulate cortex and medial prefrontal cortex, whereas in the SN decreased and increased connectivity was observed in the right insula and in the anterior cingulate cortex respectively. The decreased levels of intrinsic functional connectivity principally involved the subsystem of DMN relevant for the self relevant mental simulation that concerns remembering of past experiences, thinking to the future and conceiving the viewpoint of the other's actions. Moreover, the between group differences in the SN nodes suggested a decreased recognition of autonomical and sexual arousal changes in EDp.	[Cera, Nicoletta; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Cera, Nicoletta; Ferretti, Antonio; Tartaro, Armando; Romani, Gian Luca; Perrucci, Mauro Gianni] ITAB Inst Adv Biomed Technol, Chieti, Italy; [Di Pierro, Ezio Domenico] Limmacolata Hosp Celano, Div Urol, Celano, Italy; [Di Pierro, Ezio Domenico] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy	G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cera, N (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	n.cera@unich.it	tartaro, armando at/K-2184-2016; Perrucci, Mauro Gianni/J-8446-2016	tartaro, armando at/0000-0003-0095-2792; Perrucci, Mauro Gianni/0000-0002-5725-1623; FERRETTI, Antonio/0000-0002-8459-0129; Cera, Nicoletta/0000-0002-2702-8789				Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bocher M, 2001, NEUROIMAGE, V14, P105, DOI 10.1006/nimg.2001.0794; Bordier C, 2013, NEUROIMAGE, V67, P213, DOI 10.1016/j.neuroimage.2012.11.031; Borg C, 2014, SOC COGN AFFECT NEUR, V9, P158, DOI 10.1093/scan/nss117; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039118; Cera N, 2012, J SEX MED, V9, P1602, DOI 10.1111/j.1743-6109.2012.02719.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Derogatis LR, 1977, SCL 90R MANUAL 1 SCO; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Felician O, 2003, NEUROPSYCHOLOGIA, V41, P1307, DOI 10.1016/S0028-3932(03)00046-0; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; HAJNAL JV, 1994, MAGNET RESON MED, V31, P283, DOI 10.1002/mrm.1910310307; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Holstege G, 2003, J NEUROSCI, V23, P9185; HOON EF, 1976, ARCH SEX BEHAV, V5, P291, DOI 10.1007/BF01542081; Hoon EF, 1986, SEXUALITY RELATED ME; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kim TH, 2013, J SEX MED, V10, P1001, DOI 10.1111/jsm.12057; Koukounas E, 1997, AUST J PSYCHOL, V49, P1, DOI 10.1080/00049539708259843; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Leutmezer F, 1999, NEUROLOGY, V52, P1188, DOI 10.1212/WNL.52.6.1188; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Pamilo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042000; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2001, UROL CLIN N AM, V28, P269, DOI 10.1016/S0094-0143(05)70137-3; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shulman GL, 1997, HUM BRAIN MAPP, V5, P317, DOI 10.1002/(SICI)1097-0193(1997)5:4<317::AID-HBM19>3.0.CO;2-A; Spielberger C. D., 1970, SELF EVALUATION QUES; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Talairach J., 1988, COPLANAR STEREOTAXIC; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wespes E, 2005, GUIDELINES ERECTILE; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272	67	32	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105336	10.1371/journal.pone.0105336	http://dx.doi.org/10.1371/journal.pone.0105336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126947	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300105
J	Pan, C; Hu, YW; Li, J; Wang, ZY; Huang, JJ; Zhang, SZ; Ding, L				Pan, Chi; Hu, Yiwang; Li, Jun; Wang, Zhaoyi; Huang, Jianjin; Zhang, Suzhan; Ding, Ling			Estrogen Receptor-alpha 36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer	PLOS ONE			English	Article							ER-ALPHA; RECEPTOR-ALPHA; VARIANT; ER-ALPHA-36; RESVERATROL; RESISTANCE; CELLS; TRANSDUCTION; INHIBITION; EXPRESSION	Pterostilbene (trans-3,5-dimethoxy-49-hudroxystilbene) is an antioxidant primarily found in blueberries. It also inhibits breast cancer regardless of conventional estrogen receptor (ER-alpha 66) status by inducing both caspase-dependent and caspase-independent apoptosis. However, the pterostilbene-induced apoptosis rate in ER-alpha 66-negative breast cancer cells is much higher than that in ER-alpha 66-positive breast cancer cells. ER-alpha 36, a variant of ER-alpha 66, is widely expressed in ER-alpha 66-negative breast cancer, and its high expression mediates the resistance of ER-alpha 66-positive breast cancer patients to tamoxifen therapy. The aim of the present study is to determine the relationship between the antiproliferation activity of pterostilbene and ER-alpha 36 expression in breast cancer cells. Methyl-thiazolyl-tetrazolium (MTT) assay, apoptosis analysis, and an orthotropic xenograft mouse model were used to examine the effects of pterostilbene on breast cancer cells. The expressions of ER-alpha 36 and caspase 3, the activation of ERK and Akt were also studied through RT-PCR, western blot analysis, and immunohistochemical (IHC) staining. ER-alpha 36 knockdown was found to desensitize ER-alpha 66-negative breast cancer cells to pterostilbene treatment both in vitro and in vivo, and high ER-alpha 36 expression promotes pterostilbene-induced apoptosis in breast cancer cells. Western blot analysis data indicate that MAPK/ERK and PI3K/Akt signaling in breast cancer cells with high ER-alpha 36 expression are mediated by ER-alpha 36, and are inhibited by pterostilbene. These results suggest that ER-alpha 36 is a therapeutic target in ER-alpha 36-positive breast cancer, and pterostilbene is an inhibitor that targets ER-alpha 36 in the personalized therapy against ER-alpha 36-positive breast cancer.	[Pan, Chi; Zhang, Suzhan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yiwang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China; [Li, Jun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Zhaoyi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Huang, Jianjin; Ding, Ling] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Creighton University; Zhejiang University	Ding, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	zrsj@zju.edu.cn; lingding@zju.edu.cn	Pan, Chi/GRR-6330-2022		LD's Zhejiang qianjiang talents project [2011R10029]; Zhejiang medicine scientific research fund projects [2010ZB073]; SZZ's National Natural Science Foundation of China [81102012, 91229104]	LD's Zhejiang qianjiang talents project; Zhejiang medicine scientific research fund projects; SZZ's National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from LD's Zhejiang qianjiang talents project (No. 2011R10029), and Zhejiang medicine scientific research fund projects (No. 2010ZB073) URL: www.zjnsf.gov.cn SZZ's National Natural Science Foundation of China (No. 81102012, No. 91229104). URL: www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Brisdelli F, 2009, CURR DRUG METAB, V10, P530, DOI 10.2174/138920009789375423; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen RJ, 2010, MOL NUTR FOOD RES, V54, P1819, DOI 10.1002/mnfr.201000067; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; FISHER B, 1988, J CLIN ONCOL, V6, P1076, DOI 10.1200/JCO.1988.6.7.1076; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; KINNE DW, 1987, ARCH SURG-CHICAGO, V122, P1303; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Li GL, 2013, MOL ONCOL, V7, P611, DOI 10.1016/j.molonc.2013.02.001; Lin HS, 2009, BIOMED CHROMATOGR, V23, P1308, DOI 10.1002/bmc.1254; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Ohshiro K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030725; Pan MH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep093; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Roupe KA, 2006, CURR CLIN PHARMACOL, V1, P81, DOI 10.2174/157488406775268246; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Wang YS, 2012, AM J TRANSL RES, V4, P44; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	40	25	29	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104459	10.1371/journal.pone.0104459	http://dx.doi.org/10.1371/journal.pone.0104459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127034	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300026
J	Wiltink, J; Michal, M; Wild, PS; Schneider, A; Konig, J; Blettner, M; Munzel, T; Schulz, A; Weber, M; Fottner, C; Pfeiffer, N; Lackner, K; Beutel, ME				Wiltink, Joerg; Michal, Matthias; Wild, Philipp S.; Schneider, Astrid; Koenig, Jochem; Blettner, Maria; Muenzel, Thomas; Schulz, Andreas; Weber, Matthias; Fottner, Christian; Pfeiffer, Norbert; Lackner, Karl; Beutel, Manfred E.			Associations between Depression and Diabetes in the Community: Do Symptom Dimensions Matter? Results from the Gutenberg Health Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ANXIETY DISORDERS; RISK-FACTOR; METAANALYSIS; PREVALENCE; QUESTIONNAIRE; COMORBIDITY; VALIDITY; OBESITY; ADULTS	Objectives: While a bidirectional relationship between diabetes and depression has been established, there is little knowledge if the associations are due to somatic-affective or cognitive-affective dimensions of depression. Research Design and Methods: In a population-based, representative survey of 15.010 participants we therefore studied the associations of the two dimensions of depression with diabetes and health care utilization among depressed and diabetic participants. Depression was assessed by the Patient Health Questionnaire PHQ-9. Results: We found a linear and consistent association between the intensity of depression and the presence of diabetes increasing from 6.9% in no or minimal depression to 7.6% in mild, 9% in moderate and 10.5% in severe depression. There was a strong positive association between somatic-affective symptoms but not with cognitive-affective symptoms and diabetes. Depression and diabetes were both independently related to somatic health care utilisation. Conclusions: Diabetes and depression are associated, and the association is primarily driven by the somatic-affective component of depression. The main limitation of our study pertains to the cross-sectional data acquisition. Further longitudinal work on the relationship of obesity and diabetes should differentiate the somatic and the cognitive symptoms of depression.	[Wiltink, Joerg; Michal, Matthias; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, D-55122 Mainz, Germany; [Wild, Philipp S.; Muenzel, Thomas; Schulz, Andreas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, D-55122 Mainz, Germany; [Wild, Philipp S.] German Ctr Cardiovasc Res DZHK, Partner Site RhineMain, Mainz, Germany; [Schneider, Astrid; Koenig, Jochem; Blettner, Maria] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany; [Weber, Matthias; Fottner, Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 1, D-55122 Mainz, Germany; [Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Lackner, Karl] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Wiltink, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany.	joerg.wiltink@unimedizin-mainz.de	Pfeiffer, Norbert/AAO-7586-2020; Wild, Philipp S./M-2106-2019; König, Jochem/T-3500-2019; Munzel, Thomas/A-2912-2014	König, Jochem/0000-0003-4683-0360; Munzel, Thomas/0000-0001-5503-4150; Wild, Philipp/0000-0003-4413-9752	government of Rhineland-Palatinate ("Stiftung Rheinland Pfalz fur Innovation') [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research [BMBF 01EO1003]; Boehringer Ingelheim; PHILIPS Medical Systems	government of Rhineland-Palatinate ("Stiftung Rheinland Pfalz fur Innovation'); Johannes Gutenberg-University of Mainz; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems	This work/the Gutenberg Health Study is funded through the government of Rhineland-Palatinate ("Stiftung Rheinland Pfalz fur Innovation', contract number AZ 961-386261/733), the research programs 'Wissen schafft Zukunft' and 'Schwerpunkt Vaskulare Pravention' of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. Philipp S. Wild is funded by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Hoen PW, 2010, J AM COLL CARDIOL, V56, P838, DOI 10.1016/j.jacc.2010.03.080; Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lampert T., 2009, MEASUREMENT SOCIOECO, P309, DOI [DOI 10.1007/978-3-531-91643-9_18, 10.1007/978-3-531-91643-9_18]; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Marijnissen RM, 2011, J AM GERIATR SOC, V59, P67, DOI 10.1111/j.1532-5415.2010.03228.x; McGregor M, 2011, J AMBUL CARE MANAG, V34, P152, DOI 10.1097/JAC.0b013e31820ef6a4; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072014; Michal M, 2013, J AFFECT DISORDERS, V146, P355, DOI 10.1016/j.jad.2012.09.019; Moulton AD, 2013, AM J PREV MED, V45, P486, DOI 10.1016/j.amepre.2013.05.017; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Seeley-Wait Elizabeth, 2009, Prim Care Companion J Clin Psychiatry, V11, P231, DOI 10.4088/PCC.07m00576; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stewart SM, 2011, J BEHAV MED, V34, P112, DOI 10.1007/s10865-010-9289-1; Sultan S, 2010, J AFFECT DISORDERS, V123, P332, DOI 10.1016/j.jad.2009.09.022; Wagner G, 2012, DEUT MED WOCHENSCHR, V137, P523, DOI 10.1055/s-0031-1299009; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Wiltink J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-223	34	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105499	10.1371/journal.pone.0105499	http://dx.doi.org/10.1371/journal.pone.0105499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25127227	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300116
J	Li, MW; Oishi, K; He, XH; Qin, YY; Gao, F; Mori, S				Li, Muwei; Oishi, Kenichi; He, Xiaohai; Qin, Yuanyuan; Gao, Fei; Mori, Susumu		Alzheimer's Dis Neuroimaging	An Efficient Approach for Differentiating Alzheimer's Disease from Normal Elderly Based on Multicenter MRI Using Gray-Level Invariant Features	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MULTITASK FEATURE-SELECTION; VOXEL-BASED MORPHOMETRY; VENTRICULAR ENLARGEMENT; IMAGE-ANALYSIS; CLASSIFICATION; BRAIN; DIAGNOSIS; DEMENTIA; PATTERNS	Machine learning techniques, along with imaging markers extracted from structural magnetic resonance images, have been shown to increase the accuracy to differentiate patients with Alzheimer's disease ( AD) from normal elderly controls. Several forms of anatomical features, such as cortical volume, shape, and thickness, have demonstrated discriminative capability. These approaches rely on accurate non-linear image transformation, which could invite several nuisance factors, such as dependency on transformation parameters and the degree of anatomical abnormality, and an unpredictable influence of residual registration errors. In this study, we tested a simple method to extract disease-related anatomical features, which is suitable for initial stratification of the heterogeneous patient populations often encountered in clinical data. The method employed gray-level invariant features, which were extracted from linearly transformed images, to characterize AD-specific anatomical features. The intensity information from a disease-specific spatial masking, which was linearly registered to each patient, was used to capture the anatomical features. We implemented a two-step feature selection for anatomic recognition. First, a statistic-based feature selection was implemented to extract AD-related anatomical features while excluding non-significant features. Then, seven knowledge-based ROIs were used to capture the local discriminative powers of selected voxels within areas that were sensitive to AD or mild cognitive impairment (MCI). The discriminative capability of the proposed feature was measured by its performance in differentiating AD or MCI from normal elderly controls (NC) using a support vector machine. The statistic-based feature selection, together with the knowledge-based masks, provided a promising solution for capturing anatomical features of the brain efficiently. For the analysis of clinical populations, which are inherently heterogeneous, this approach could stratify the large amount of data rapidly and could be combined with more detailed subsequent analyses based on non-linear transformation.	[Li, Muwei; He, Xiaohai] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China; [Oishi, Kenichi; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Qin, Yuanyuan] Huazhong Univ Sci & Technol, Dept Radiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Gao, Fei] Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China	Sichuan University; Johns Hopkins University; Huazhong University of Science & Technology; Shandong University	He, XH (corresponding author), Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China.	hxh@scu.edu.cn; susumu@mri.jhu.edu	qin, yuanyuan/G-4351-2010; Oishi, Kenichi/H-1371-2013	qin, yuanyuan/0000-0002-0673-3200; Oishi, Kenichi/0000-0002-1200-8611	Natural Science Foundations of China [81173356]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Natural Science Foundations of China (No. 81173356, http://www.nsfc.gov.cn/publish/portal1/). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to Rev December 5, 2013 support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Cardillo G., 2008, ROC CURVE COMPUTE RE; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CLAUS JJ, 1994, NEUROLOGY, V44, P454, DOI 10.1212/WNL.44.3_Part_1.454; Cocosco C. A., 1997, NEUROIMAGE, V5, pS425, DOI DOI 10.1016/S1053-8119(97)80018-3; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Guoying Z, 2007, EXPT FACIAL EXPRESSI, V2007, P1091; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Higdon R, 2004, STAT MED, V23, P315, DOI 10.1002/sim.1719; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jie B, 2013, LECT NOTES COMPUT SC, V8149, P275, DOI 10.1007/978-3-642-40811-3_35; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Liu F, 2013, LECT NOTES COMPUT SC, V8150, P311, DOI 10.1007/978-3-642-40763-5_39; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu MH, 2014, HUM BRAIN MAPP, V35, P1305, DOI 10.1002/hbm.22254; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Miller MI, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00031; Mori S, 2013, ANNU REV BIOMED ENG, V15, P71, DOI 10.1146/annurev-bioeng-071812-152335; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Oishi Kenichi, 2011, Front Neurol, V2, P54, DOI 10.3389/fneur.2011.00054; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Qin YY, 2013, NEUROIMAGE-CLIN, V3, P202, DOI 10.1016/j.nicl.2013.08.006; Qiu A, 2008, NEUROIMAGE, V40, P68, DOI 10.1016/j.neuroimage.2007.11.041; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Suk H.-I., 2013, BRAIN STRUCT FUNCT, P1; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wang LQ, 1998, MAGNET RESON MED, V39, P322, DOI 10.1002/mrm.1910390222; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhang TH, 2013, NEUROIMAGE, V79, P94, DOI 10.1016/j.neuroimage.2013.04.063; Zhao GY, 2007, IEEE T PATTERN ANAL, V29, P915, DOI 10.1109/TPAMI.2007.1110; Zhao GY, 2012, IEEE T IMAGE PROCESS, V21, P1465, DOI 10.1109/TIP.2011.2175739; ZWEIG MH, 1993, CLIN CHEM, V39, P561	73	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105563	10.1371/journal.pone.0105563	http://dx.doi.org/10.1371/journal.pone.0105563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140532	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200099
J	Qu, H; Wang, H; Deng, M; Wei, HL; Deng, HC				Qu, Hua; Wang, Hang; Deng, Min; Wei, Huili; Deng, Huacong			Associations between Longer Habitual Day Napping and Non-Alcoholic Fatty Liver Disease in an Elderly Chinese Population	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; HEPATIC STEATOSIS; RISK; PERFORMANCE; COHORT; STEATOHEPATITIS; AFTERNOON; EPIDEMIC; SIESTA; ADULTS	Context: Both longer habitual day napping and Non-Alcoholic Fatty Liver Disease (NAFLD) are associated with diabetes and inflammation, but the association between day napping and NAFLD remains unexplored. Objective: To investigate the association between the duration of habitual day napping and NAFLD in an elderly Chinese population and to gain insight into the role of inflammatory cytokines in this association. Design and Setting: We conducted a series of cross-sectional studies of the community population in Chongqing, China, from 2011 to 2012. Participants: Among 6998 participants aged 40 to 75 years, 6438 eligible participants were included in the first study and analyzed to observe the association between day napping duration and NAFLD. In a separate study, 80 non-nappers and 90 nappers were selected to identify the role of inflammatory cytokines in this association. Logistic regression models were used to examine the odds ratios (ORs) of day nap duration with NAFLD. Results: Day nappers had a significantly higher prevalence of NAFLD (P < 0.001). Longer day napping duration was associated in a dose-dependent manner with NAFLD (P trend < 0.001). After adjustment for potential confounders, the ORs were 1.67 (95% CI 1.13-2.46) for those reporting 0.5-1 h and 1.49 (95% CI 1.01-2.19) for those reporting >1 h of day napping compared with individuals who did not take day naps (all P < 0.05). Longer-duration day nappers had higher levels of IL-6 and progranulin (PGRN) but lower levels of Secreted frizzled-related protein-5 (SFRP5, all P trend < 0.001). After adjusting for IL-6, PGRN, and SFRP5, the association between day napping duration and NAFLD disappeared (all P > 0.05). Conclusion: Longer day napping duration is associated with a higher prevalence of NAFLD, and inflammatory cytokines may be an essential link between day napping and NAFLD.	[Qu, Hua; Wang, Hang; Deng, Min; Wei, Huili; Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Deng, HC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	deng_huacong@126.com		Qu, Hua/0000-0002-4895-5979	National Natural Science Foundation of China [81070639, 81270911, 30771038, 30570744]; Chinese Society of Endocrinology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology	This study is supported by the grants from the Chinese Society of Endocrinology and the National Natural Science Foundation of China (81070639, 81270911, 30771038, and 30570744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ED, 2013, SLEEP BREATH, V17, P505, DOI 10.1007/s11325-012-0729-8; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bursztyn M, 1999, ARCH INTERN MED, V159, P1582, DOI 10.1001/archinte.159.14.1582; Campos H, 2000, INT J EPIDEMIOL, V29, P429, DOI 10.1093/ije/29.3.429; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Fang WM, 2013, SLEEP MED, V14, P950, DOI 10.1016/j.sleep.2013.04.015; Fruci B, 2013, INT J MOL SCI, V14, P22933, DOI 10.3390/ijms141122933; Hayashi M, 1999, CLIN NEUROPHYSIOL, V110, P272, DOI 10.1016/S1388-2457(98)00003-0; Hernandez-Alejandro R, 2012, WORLD J GASTROENTERO, V18, P4145, DOI 10.3748/wjg.v18.i31.4145; Hu XN, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-123; Lam KBH, 2010, SLEEP, V33, P402; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Parola M, 2011, ANTIOXID REDOX SIGN, V15, P461, DOI 10.1089/ars.2010.3848; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Salt William B 2nd, 2004, J Insur Med, V36, P27; Santhi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079688; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Takahashi M, 2000, SLEEP, V23, P813; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tsaoussoglou M, 2010, J CLIN ENDOCR METAB, V95, P143, DOI 10.1210/jc.2009-0435; Vgontzas AN, 2007, AM J PHYSIOL-ENDOC M, V292, pE253, DOI 10.1152/ajpendo.00651.2005; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57	34	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105583	10.1371/journal.pone.0105583	http://dx.doi.org/10.1371/journal.pone.0105583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140521	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200108
J	Yu, CY; Su, S; Xu, YC; Zhao, YQ; Yan, A; Huang, LL; Ali, I; Gan, YB				Yu, Chunyan; Su, Sha; Xu, Yichun; Zhao, Yongqin; Yan, An; Huang, Linli; Ali, Imran; Gan, Yinbo			The Effects of Fluctuations in the Nutrient Supply on the Expression of Five Members of the AGL17 Clade of MADS-Box Genes in Rice	PLOS ONE			English	Article							PHOSPHATE-STARVATION RESPONSES; AFFINITY NITRATE TRANSPORT; ARABIDOPSIS-THALIANA; ROOT ARCHITECTURE; ORYZA-SATIVA; NUTRITIONAL REGULATION; TRANSCRIPTION FACTOR; PLANTS; NITROGEN; METABOLISM	The ANR1 MADS-box gene in Arabidopsis is a key gene involved in regulating lateral root development in response to the external nitrate supply. There are five ANR1-like genes in Oryza sativa, OsMADS23, OsMADS25, OsMADS27, OsMADS57 and OsMADS61, all of which belong to the AGL17 clade. Here we have investigated the responsiveness of these genes to fluctuations in nitrogen (N), phosphorus (P) and sulfur (S) mineral nutrient supply. The MADS-box genes have been shown to have a range of responses to the nutrient supply. The expression of OsMADS61 was transiently induced by N deprivation but was not affected by re-supply with various N sources. The expression of OsMADS25 and OsMADS27 was induced by re-supplying with NO3- and NH4NO3, but downregulated by NH4+. The expression of OsMADS57 was significantly downregulated by N starvation and upregulated by 3 h NO3- re-supply. OsMADS23 was the only gene that showed no response to either N starvation nor NO3- re-supply. OsMADS57 was the only gene not regulated by P fluctuation whereas the expression of OsMADS23, OsMADS25 and OsMADS27 was downregulated by P starvation and P re-supply. In contrast, all five ANR1-related genes were significantly upregulated by S starvation. Our results also indicated that there were interactions among nitrate, sulphate and phosphate transporters in rice.	[Yu, Chunyan; Su, Sha; Xu, Yichun; Zhao, Yongqin; Yan, An; Huang, Linli; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Gan, YB (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Gan, Yinbo/N-1480-2015		International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China [2010DFA34430]; International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province [2013C34G2010017]; National Natural Science Foundation of China [31370215, 31228002]; Zhejiang Provincial Natural Science Foundation of China [Z3110004]	International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China; International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The research was supported by the International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China (grant number 2010DFA34430), International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province (grant number 2013C34G2010017), National Natural Science Foundation of China (Grant No. 31370215; 31228002), and Zhejiang Provincial Natural Science Foundation of China (Grant No. Z3110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Araki R, 2006, BREEDING SCI, V56, P295, DOI 10.1270/jsbbs.56.295; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Aziz T., 2014, PLANT SIGNALING UNDE, P133, DOI DOI 10.1007/978-81-322-1542-4_7; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Burgeff C, 2002, PLANTA, V214, P365, DOI 10.1007/s004250100637; Cai C, 2008, J INTEGR PLANT BIOL, V50, P443, DOI 10.1111/j.1744-7909.2008.00642.x; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; CRAWFORD NM, 2002, ARABIDOPSIS BOOK; Dai XY, 2012, PLANT PHYSIOL, V159, P169, DOI 10.1104/pp.112.194217; Fan XR, 2005, SCI CHINA SER C, V48, P897, DOI 10.1360/062005-281; Feng HM, 2011, J EXP BOT, V62, P2319, DOI 10.1093/jxb/erq403; Filleur S, 2005, BIOCHEM SOC T, V33, P283, DOI 10.1042/BST0330283; Forde BG, 1999, ADV BOT RES, V30, P1; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Gan YB, 2005, PLANTA, V222, P730, DOI 10.1007/s00425-005-0020-3; Gan YB, 2011, AGR SCI CHINA, V10, P335, DOI 10.1016/S1671-2927(11)60012-6; Gan YB, 2012, PLANT CELL PHYSIOL, V53, P1003, DOI 10.1093/pcp/pcs050; Gan YB, 2010, BOTANY, V88, P1023, DOI 10.1139/B10-075; Hou XL, 2005, PLANT CELL ENVIRON, V28, P353, DOI 10.1111/j.1365-3040.2005.01272.x; Ide Y, 2011, J EXP BOT, V62, P1483, DOI 10.1093/jxb/erq345; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Marschner H., 1988, PLANT CELL ENVIRON, V11, P147, DOI [10.1111/1365-3040.ep11604921, DOI 10.1111/1365-3040.EP11604921]; Meng YJ, 2013, NEW PHYTOL, V197, P441, DOI 10.1111/nph.12018; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Prosser IM, 2001, J EXP BOT, V52, P113, DOI 10.1093/jexbot/52.354.113; Puig J, 2013, GENE EXPR PATTERNS, V13, P160, DOI 10.1016/j.gep.2013.02.004; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Rouached H, 2011, PLANT J, V65, P557, DOI 10.1111/j.1365-313X.2010.04442.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Tabe LM, 2002, PLANT PHYSIOL, V128, P1137, DOI 10.1104/pp.010935; Takehisa H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24409; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.010396; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang XB, 2002, GENE, V297, P93, DOI 10.1016/S0378-1119(02)00870-3; Wu P., 2013, GENETICS GENOMICS RI, P217; Yan YS, 2014, PLANT J, V78, P44, DOI 10.1111/tpj.12446; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281	55	15	17	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105597	10.1371/journal.pone.0105597	http://dx.doi.org/10.1371/journal.pone.0105597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140876	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200111
J	Brummitt, CD; Sethi, R; Watts, DJ				Brummitt, Charles D.; Sethi, Rajiv; Watts, Duncan J.			Inside Money, Procyclical Leverage, and Banking Catastrophes	PLOS ONE			English	Article							MARKET LIQUIDITY; SYSTEMIC RISK; CONTAGION; CASCADES; MODEL	We explore a model of the interaction between banks and outside investors in which the ability of banks to issue inside money (short-term liabilities believed to be convertible into currency at par) can generate a collapse in asset prices and widespread bank insolvency. The banks and investors share a common belief about the future value of certain long-term assets, but they have different objective functions; changes to this common belief result in portfolio adjustments and trade. Positive belief shocks induce banks to buy risky assets from investors, and the banks finance those purchases by issuing new short-term liabilities. Negative belief shocks induce banks to sell assets in order to reduce their chance of insolvency to a tolerably low level, and they supply more assets at lower prices, which can result in multiple market-clearing prices. A sufficiently severe negative shock causes the set of equilibrium prices to contract (in a manner given by a cusp catastrophe), causing prices to plummet discontinuously and banks to become insolvent. Successive positive and negative shocks of equal magnitude do not cancel; rather, a banking catastrophe can occur even if beliefs simply return to their initial state. Capital requirements can prevent crises by curtailing the expansion of balance sheets when beliefs become more optimistic, but they can also force larger price declines. Emergency asset price supports can be understood as attempts by a central bank to coordinate expectations on an equilibrium with solvency.	[Brummitt, Charles D.] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Brummitt, Charles D.] Univ Calif Davis, Complex Sci Ctr, Davis, CA 95616 USA; [Sethi, Rajiv] Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA; [Sethi, Rajiv] Santa Fe Inst, Santa Fe, NM 87501 USA; [Watts, Duncan J.] Microsoft Res, New York, NY USA	University of California System; University of California Davis; University of California System; University of California Davis; Columbia University; The Santa Fe Institute; Microsoft	Brummitt, CD (corresponding author), Univ Calif Davis, Dept Math, Davis, CA 95616 USA.	brummitt@gmail.com	Sethi, Rajiv/AAH-3961-2020; Brummitt, Charles/K-8148-2014	Sethi, Rajiv/0000-0003-2631-5644; Brummitt, Charles/0000-0003-2553-8862	Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program; Microsoft Research	Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program(United States Department of Defense); Microsoft Research(Microsoft)	This project began while C.D.B. and R.S. were visitors at Microsoft Research (http://research.microsoft.com/en-us/), which provided funding. CDB was partially supported by the Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program (ndseg.asee.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Microsoft Research, provided support in the form of salaries for authors C.D.B., R.S., and D.J.W. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Acharya VV, 2008, J MONEY CREDIT BANK, V40, P215, DOI 10.1111/j.1538-4616.2008.00110.x; Admati Anat, 2013, BANKERSNEW CLOTHES W; Adrian T, 2010, J FINANC INTERMED, V19, P418, DOI 10.1016/j.jfi.2008.12.002; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Anand K, 2012, J ECON DYN CONTROL, V36, P1088, DOI 10.1016/j.jedc.2012.03.005; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Bianchi J, 2011, AM ECON REV, V101, P3400, DOI 10.1257/aer.101.7.3400; Borio C., 2002, BIS WORKING PAPERS, V14, P1; Brunnermeier MK, 2009, REV FINANC STUD, V22, P2201, DOI 10.1093/rfs/hhn098; Caballero RJ, 2009, 15479 NBER; Caccioli F, 2014, J BANK FINANC, V46, P233, DOI 10.1016/j.jbankfin.2014.05.021; Committee on the Global Financial System, 2010, 36 COMM GLOB FIN SY; Crockett A, 2000, 11 INT C BANK SUP; Danielsson J, 2011, FINANCIAL MARKETS GR, V665; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Elliott M, 2012, FINANCIAL NETWORKS C; Fostel A, 2008, AM ECON REV, V98, P1211, DOI 10.1257/aer.98.4.1211; Freixas X, 2000, J MONEY CREDIT BANK, V32, P611, DOI 10.2307/2601198; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Geanakoplos J., 1997, EC EVOLVING COMPLEX, V27, P285; Geanakoplos J., 2003, ADV EC ECONOMETRICS, V2, P170; Geanakoplos J, 2010, NBER MACROECON ANN; GENNOTTE G, 1990, AM ECON REV, V80, P999; Goodhart Charles A. E., 2010, FUTURE FINANCE LSE R, P165, DOI DOI 10.1111/J.1467-8330.2012.01045.X; Gorton G., 2012, MISUNDERSTANDING FIN; Gorton G, 2014, AM ECON REV, V104, P343, DOI 10.1257/aer.104.2.343; Holmstrom Bengt, 2013, IGNORANCE DEBT UNPUB; Huang X, 2013, SCI REPORTS; Krishnamurthy A, 2012, TECHNICAL REPORT; Lorenzoni G, 2008, REV ECON STUD, V75, P809, DOI 10.1111/j.1467-937X.2008.00494.x; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Minsky, 1986, STABILIZING UNSTABLE; Minsky H. P, 1975, JM KEYNES, DOI DOI 10.1007/978-1-349-02679-1; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Rosser J.B., 1991, CATASTROPHE CHAOS GE; Shin HS, 2010, RISK LIQUIDITY; Viegas E, 2013, COMPLEXITY, V19, P22, DOI 10.1002/cplx.21452; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	38	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104219	10.1371/journal.pone.0104219	http://dx.doi.org/10.1371/journal.pone.0104219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136959	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100021
J	Mustafa, AS				Mustafa, Abu S.			Characterization of a Cross-Reactive, Immunodominant and HLA-Promiscuous Epitope of Mycobacterium tuberculosis-Specific Major Antigenic Protein PPE68	PLOS ONE			English	Article							T-CELL EPITOPES; BLOOD MONONUCLEAR-CELLS; DR BINDING PREDICTION; HUMAN TH1 CELLS; GENOMIC REGIONS; BOVIS BCG; IMMUNE-RESPONSES; HEALTHY-SUBJECTS; SECRETED ANTIGEN; CALMETTE-GUERIN	PPE68 (Rv3873), a major antignic protein encoded by Mycobacteriun tuberculosis-specific genomic region of difference (RD)1, is a strong stimulator of peripheral blood mononuclear cells (PBMCs) obtained from tuberculosis patients and Mycobacterium bovis bacillus Calmette Guerin (BCG)-vaccianted healthy subjects in T helper (Th)1 cell assays, i.e. antigen-induced proliferation and interferon-gamma (IFN-gamma) secretion. To confirm the antigen-specific recognition of PPE68 by T cells in IFN-gamma assays, antigen-induced human T-cell lines were established from PBMCs of M. Bovis BCG-vaccinated and HLA-heterogeneous healthy subjects and tested with peptide pools of RD1 proteins. The results showed that PPE68 was recognized by antigen-specific T-cell lines from HLA-heteregeneous subjects. To further identify the immunodominant and HLA-promiscuous Th1-1 cell epitopes present in PPE68, 24 synthetic peptides covering the sequence of PPE68 were indivdually analyzed for HLA-DR binding prediction analysis and tested with PBMCs from M. bovis BCG-vaccinated and HLA-heterogeuous healthy subjects in IFN-gamma assays. The results identified the peptide P9, i.e. aa 121-VLTATNFFGINTIPIALTEM-DYFIR-145, as an immunodominant and HLA-DR promiscuous peptide of PPE68. Furthermore, by using deletion peptides, the immunodominant and HLA-DR promiscuous core sequence was mapped to aa 127-FFGINTIPIA-136. Interestingly, the core sequence is present in several PPE proteins of M. tuberculosis, and conserved in all sequenced strains/species of M. tuberculosis and M. tuberculosis complex, and several other pathogenic mycobacterial species, including M. leprae and M. avium-intracellulalae complex. These results suggest that the peptide aa 121-145 may be exploited as a peptide-based vaccine candidate against tuberculosis and other mycobacterial diseases.	Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Mustafa, AS (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	abusalim@hsc.edu.kw			Kuwait University Research Sector [MI01/10, SRUL02/13]	Kuwait University Research Sector	This study was supported by Kuwait University Research Sector grants MI01/10 and SRUL02/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah R, 2008, INFECT IMMUN, V76, P4190, DOI 10.1128/IAI.00199-08; Al-Attiyah R, 2004, SCAND J IMMUNOL, V59, P16, DOI 10.1111/j.0300-9475.2004.01349.x; Al-Attiyah R, 2003, INFECT IMMUN, V71, P1953, DOI 10.1128/IAI.71.4.1953-1960.2003; Al-Attiyah R, 2003, FEMS IMMUNOL MED MIC, V38, P249, DOI 10.1016/S0928-8244(03)00166-4; Al-Attiyah RJ, 2009, CLIN EXP IMMUNOL, V158, P64, DOI 10.1111/j.1365-2249.2009.04000.x; Al-Attiyah R, 2010, FEMS IMMUNOL MED MIC, V59, P177, DOI 10.1111/j.1574-695X.2010.00677.x; Al-Khodari NY, 2011, CLIN VACCINE IMMUNOL, V18, P477, DOI 10.1128/CVI.00405-10; Amoudy HA, 2006, MED PRIN PRACT, V15, P137, DOI 10.1159/000090919; Aoshi T, 2008, INFECT IMMUN, V76, P1565, DOI 10.1128/IAI.01381-07; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2003, CLIN EXP IMMUNOL, V133, P260, DOI 10.1046/j.1365-2249.2003.02201.x; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dimitrov I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/705821; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Gupta SK, 2011, INFECT GENET EVOL, V11, P308, DOI 10.1016/j.meegid.2010.10.013; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Mustafa A. S., 2001, Current Pharmaceutical Biotechnology, V2, P157, DOI 10.2174/1389201013378707; Mustafa AS, 2009, SCAND J IMMUNOL, V69, P213, DOI 10.1111/j.1365-3083.2008.02221.x; Mustafa AS, 2008, CLIN VACCINE IMMUNOL, V15, P916, DOI 10.1128/CVI.00056-08; Mustafa AS, 2008, MED PRIN PRACT, V17, P325, DOI 10.1159/000129614; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Mustafa AS, 2011, MICROBIOL IMMUNOL, V55, P267, DOI 10.1111/j.1348-0421.2011.00307.x; Mustafa A, 2010, KUWAIT MED J, V42, P98; Mustafa AS, 2010, MED PRIN PRACT, V19, P122, DOI 10.1159/000273073; Mustafa AS, 2009, EXPERT REV VACCINES, V8, P1309, DOI [10.1586/erv.09.93, 10.1586/ERV.09.93]; Mustafa AS, 2009, MED PRIN PRACT, V18, P385, DOI 10.1159/000226293; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Mustafa AS, 2005, MED PRIN PRACT, V14, P140, DOI 10.1159/000084629; MUSTAFA AS, 1993, VACCINE, V11, P1108, DOI 10.1016/0264-410X(93)90070-E; MUSTAFA AS, 1988, INT J LEPROSY, V56, P265; Mustafa AS, 2003, SCAND J IMMUNOL, V57, P125, DOI 10.1046/j.1365-3083.2003.01204.x; Mustafa AS, 2000, HUM IMMUNOL, V61, P166, DOI 10.1016/S0198-8859(99)00137-8; Mustafa AS, 2000, CLIN INFECT DIS, V30, pS201, DOI 10.1086/313862; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; OFTUNG F, 1988, J IMMUNOL, V141, P2749; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; SILVER RF, 1995, J IMMUNOL, V154, P4665; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Storla DG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-60; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; World Health Organization, 2010, WHOHTMTB20107	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103679	10.1371/journal.pone.0103679	http://dx.doi.org/10.1371/journal.pone.0103679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136958	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100012
J	Raeven, RHM; Brummelman, J; Pennings, JLA; Nijst, OEM; Kuipers, B; Blok, LER; Helm, K; van Riet, E; Jiskoot, W; van Els, CACM; Han, WGH; Kersten, GFA; Metz, B				Raeven, Rene H. M.; Brummelman, Jolanda; Pennings, Jeroen L. A.; Nijst, Olaf E. M.; Kuipers, Betsy; Blok, Laura E. R.; Helm, Kina; van Riet, Elly; Jiskoot, Wim; van Els, Cecile A. C. M.; Han, Wanda G. H.; Kersten, Gideon F. A.; Metz, Bernard			Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; CELL-MEDIATED-IMMUNITY; T-CELLS; RESPIRATORY-INFECTION; DENDRITIC CELLS; CUTTING EDGE; NEUTROPHIL RECRUITMENT; INNATE RESISTANCE; MURINE MODEL; WHOLE-CELL	Worldwide resurgence of pertussis necessitates the need for improvement of pertussis vaccines and vaccination strategies. Since natural infections induce a longer-lasting immunity than vaccinations, detailed knowledge of the immune responses following natural infection can provide important clues for such improvement. The purpose was to elucidate the kinetics of the protective immune response evolving after experimental Bordetella pertussis (B. pertussis) infection in mice. Data were collected from (i) individual analyses, i.e. microarray, flow cytometry, multiplex immunoassays, and bacterial clearance; (ii) twelve time points during the infection; and (iii) different tissues involved in the immune responses, i.e. lungs, spleen and blood. Combined data revealed detailed insight in molecular and cellular sequence of events connecting different phases (innate, bridging and adaptive) of the immune response following the infection. We detected a prolonged acute phase response, broad pathogen recognition, and early gene signatures of subsequent T-cell recruitment in the lungs. Activation of particular transcription factors and specific cell markers provided insight into the time course of the transition from innate towards adaptive immune responses, which resulted in a broad spectrum of systemic antibody subclasses and splenic Th1/Th17 memory cells against B. pertussis. In addition, signatures preceding the local generation of Th1 and Th17 cells as well as IgA in the lungs, considered key elements in protection against B. pertussis, were established. In conclusion, molecular and cellular immunological processes in response to live B. pertussis infection were unraveled, which may provide guidance in selecting new vaccine candidates that should evoke local and prolonged protective immune responses.	[Raeven, Rene H. M.; Nijst, Olaf E. M.; Blok, Laura E. R.; van Riet, Elly; Kersten, Gideon F. A.; Metz, Bernard] Intravacc, Bilthoven, Netherlands; [Raeven, Rene H. M.; Jiskoot, Wim; Kersten, Gideon F. A.] Leiden Acad Ctr Drug Res, Div Drug Delivery Technol, Leiden, Netherlands; [Brummelman, Jolanda; Kuipers, Betsy; Helm, Kina; van Els, Cecile A. C. M.; Han, Wanda G. H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Raeven, RHM (corresponding author), Intravacc, Bilthoven, Netherlands.	Rene.raeven@intravacc.nl	Brummelman, Jolanda/F-5701-2019; Blok, Laura/D-7767-2018; van Riet, Elly/V-2921-2018; Raeven, René/AAV-2461-2020; Jiskoot, Wim/A-6877-2016	Brummelman, Jolanda/0000-0003-3581-4816; Blok, Laura/0000-0002-5196-1448; Raeven, René/0000-0002-1063-271X; Jiskoot, Wim/0000-0002-1012-3456; Pennings, Jeroen L.A./0000-0002-9188-6358				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Aoki N, 2004, INFECT IMMUN, V72, P2477, DOI 10.1128/IAI.72.5.2477-2483.2004; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Ausiello CM, 1997, INFECT IMMUN, V65, P2168, DOI 10.1128/IAI.65.6.2168-2174.1997; Banus HA, 2006, INFECT IMMUN, V74, P2596, DOI 10.1128/IAI.74.5.2596-2605.2006; Banus S, 2007, IMMUNOGENETICS, V59, P555, DOI 10.1007/s00251-007-0227-5; Barbic J, 1997, INFECT IMMUN, V65, P4904, DOI 10.1128/IAI.65.12.4904-4908.1997; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Baxter R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Canthaboo C, 2000, VACCINE, V19, P637, DOI 10.1016/S0264-410X(00)00253-X; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; den Dunnen J, 2009, CANCER IMMUNOL IMMUN, V58, P1149, DOI 10.1007/s00262-008-0615-1; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Doi T, 2012, BIOCHEM BIOPH RES CO, V425, P918, DOI 10.1016/j.bbrc.2012.08.010; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Flak TA, 2000, INFECT IMMUN, V68, P1235, DOI 10.1128/IAI.68.3.1235-1242.2000; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Gianchecchi E, 2013, AUTOIMMUN REV; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Hendrikx LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027681; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hozbor D, 1999, CURR MICROBIOL, V38, P273, DOI 10.1007/PL00006801; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kohrgruber N, 2004, J IMMUNOL, V173, P6592, DOI 10.4049/jimmunol.173.11.6592; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kuwabara T, 2009, J IMMUNOL, V183, P2513, DOI 10.4049/jimmunol.0800729; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liao F, 1999, J IMMUNOL, V162, P186; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Mann PB, 2004, J INFECT DIS, V189, P833, DOI 10.1086/381898; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Miyagawa F, 2012, P NATL ACAD SCI USA, V109, P12123, DOI 10.1073/pnas.1201453109; Miyake K, 2000, J ENDOTOXIN RES, V6, P389, DOI 10.1179/096805100101532324; Molinero LL, 2012, P NATL ACAD SCI USA, V109, P18529, DOI 10.1073/pnas.1204557109; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Moreno G, 2013, MICROBES INFECT; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nishida M, 2010, J BIOL CHEM, V285, P15268, DOI 10.1074/jbc.M109.076232; Nishimura J, 2008, J IMMUNOL, V180, P4032, DOI 10.4049/jimmunol.180.6.4032; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Norderhaug IN, 1999, CRIT REV IMMUNOL, V19, P481; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018866; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Ryan M, 1997, J INFECT DIS, V175, P1246, DOI 10.1086/593682; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SCHMITT E, 1990, EUR J IMMUNOL, V20, P1709, DOI 10.1002/eji.1830200813; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stenger RM, 2011, CLIN VACCINE IMMUNOL, V18, P595, DOI 10.1128/CVI.00061-10; Stoeckle C, 2009, EXP HEMATOL, V37, P266, DOI 10.1016/j.exphem.2008.10.011; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vandebriel RJ, 2003, MICROB PATHOGENESIS, V35, P19, DOI 10.1016/S0882-4010(03)00087-1; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; VERWEY WF, 1949, J BACTERIOL, V58, P127, DOI 10.1128/JB.58.2.127-134.1949; Vukman KV, 2013, J LEUKOC BIOL; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zollinger WD, 2010, VACCINE; Zurita E, 2013, INFECT IMMUN, V81, P2371, DOI 10.1128/IAI.00336-13	117	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104548	10.1371/journal.pone.0104548	http://dx.doi.org/10.1371/journal.pone.0104548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137043	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100040
J	Zhang, HX; Yu, Q; Huang, YX; Zheng, W; Tian, Y; Song, YT; Li, GD; Zhou, DW				Zhang, Hongxiang; Yu, Qiang; Huang, Yingxin; Zheng, Wei; Tian, Yu; Song, Yantao; Li, Guangdi; Zhou, Daowei			Germination Shifts of C-3 and C-4 Species under Simulated Global Warming Scenario	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; ALTERNATING TEMPERATURE; MINIMUM TEMPERATURE; ELEVATED CO2; GRASSLANDS; ECOSYSTEM; SALINITY; IMPACTS	Research efforts around the world have been increasingly devoted to investigating changes in C-3 and C-4 species' abundance or distribution with global warming, as they provide important insight into carbon fluxes and linked biogeochemical cycles. However, changes in the early life stage (e. g. germination) of C-3 and C-4 species in response to global warming, particularly with respect to asymmetric warming, have received less attention. We investigated germination percentage and rate of C-3 and C-4 species under asymmetric (+3/+6 degrees C at day/night) and symmetric warming (+5/+5 degrees C at day/night), simulated by alternating temperatures. A thermal time model was used to calculate germination base temperature and thermal time constant. Two additional alternating temperature regimes were used to test temperature metrics effect. The germination percentage and rate increased continuously for C-4 species, but increased and then decreased with temperature for C-3 species under both symmetric and asymmetric warming. Compared to asymmetric warming, symmetric warming significantly overestimated the speed of germination percentage change with temperature for C-4 species. Among the temperature metrics (minimum, maximum, diurnal temperature range and average temperature), maximum temperature was most correlated with germination of C-4 species. Our results indicate that global warming may favour germination of C-4 species, at least for the C-4 species studied in this work. The divergent effects of asymmetric and symmetric warming on plant germination also deserve more attention in future studies.	[Zhang, Hongxiang; Huang, Yingxin; Li, Guangdi; Zhou, Daowei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Yu, Qiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Zheng, Wei; Li, Guangdi] Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Tian, Yu] Jilin Agr Univ, Anim Sci & Technol Coll, Changchun, Peoples R China; [Song, Yantao] Dalian Nationalities Univ, Coll Environm & Resources, Dalian, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Jilin Agricultural University; Dalian Minzu University	Zhou, DW (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	zhoudaowei@iga.ac.cn	Zhang, Hongxiang/GMW-5541-2022; Yu, Qiang/E-2097-2011; Li, Guangdi/B-8515-2011	Yu, Qiang/0000-0002-5480-0623; Li, Guangdi/0000-0002-4841-3803	National Natural Science Foundation of China [41330640]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research has been supported by the National Natural Science Foundation of China (41330640). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Auerswald K, 2009, BIOGEOSCIENCES, V6, P795, DOI 10.5194/bg-6-795-2009; Bai WM, 2012, BIOGEOSCIENCES, V9, P375, DOI 10.5194/bg-9-375-2012; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Bremond L, 2012, GLOBAL CHANGE BIOL, V18, P2324, DOI 10.1111/j.1365-2486.2012.02690.x; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; Collins SL, 2010, J ARID ENVIRON, V74, P611, DOI 10.1016/j.jaridenv.2009.10.005; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Ekstam B, 1999, SEED SCI RES, V9, P165, DOI 10.1017/S0960258599000185; ELLIS RH, 1994, ANN BOT-LONDON, V74, P519, DOI 10.1006/anbo.1994.1149; Falster D. S., 2006, SMATR STANDARDISED M; Garcia-Huidobro J, 1982, J EXPT BOTANY, V33, P287; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P297, DOI 10.1093/jxb/33.2.297; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Gul B, 1999, CAN J BOT, V77, P240, DOI 10.1139/cjb-77-2-240; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; He JS, 2005, INT J PLANT SCI, V166, P615, DOI 10.1086/430196; Hovenden MJ, 2008, GLOBAL CHANGE BIOL, V14, P1633, DOI 10.1111/j.1365-2486.2008.01597.x; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Khan MA, 2000, J ARID ENVIRON, V45, P207, DOI 10.1006/jare.2000.0640; Khan MA, 1996, ANN BOT-LONDON, V78, P547, DOI 10.1006/anbo.1996.0159; Liu BH, 2004, J CLIMATE, V17, P4453, DOI 10.1175/3230.1; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Markus B, 2004, AQUAT BOT, V79, P15; Paruelo JM, 1996, ECOL APPL, V6, P1212, DOI 10.2307/2269602; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P3263, DOI 10.1111/j.1365-2486.2011.02483.x; Qiu J, 2006, SEED SCI RES, V16, P261, DOI 10.1017/SSR2006258; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Sun DL, 2014, IEEE GEOSCI REMOTE S, V11, P1524, DOI 10.1109/LGRS.2014.2298371; Thorpe J, 2008, CAN J SOIL SCI, V88, P595, DOI 10.4141/CJSS07094; Trudgill DL, 2000, NEW PHYTOL, V145, P107, DOI 10.1046/j.1469-8137.2000.00554.x; von Fischer JC, 2008, GLOBAL CHANGE BIOL, V14, P1141, DOI 10.1111/j.1365-2486.2008.01552.x; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang WQ, 2009, J EXP BOT, V60, P3397, DOI 10.1093/jxb/erp178; Winslow JC, 2003, ECOL MODEL, V163, P153, DOI 10.1016/S0304-3800(02)00415-5; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/NGEO2093, 10.1038/ngeo2093]; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; Zhang H, 2007, SEED SCI TECHNOL, V35, P291, DOI 10.15258/sst.2007.35.2.05; Zhang H., 2008, THESIS	45	8	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105139	10.1371/journal.pone.0105139	http://dx.doi.org/10.1371/journal.pone.0105139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137138	Green Submitted, gold, Green Published			2022-12-27	WOS:000340742100069
J	de Gouw, D; de Jonge, MI; Hermans, PWM; Wessels, HJCT; Zomer, A; Berends, A; Pratt, C; Berbers, GA; Mooi, FR; Diavatopoulos, DA				de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Wessels, Hans J. C. T.; Zomer, Aldert; Berends, Alinda; Pratt, Catherine; Berbers, Guy A.; Mooi, Frits R.; Diavatopoulos, Dimitri A.			Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; DISEASE BURDEN; IMMUNITY; PERTACTIN; CELLS; COLONIZATION; PHAGOCYTOSIS; VACCINATION; EXPRESSION; MATURATION	Pertussis is a highly infectious respiratory disease of humans caused by the bacterium Bordetella pertussis. Despite high vaccination coverage, pertussis has re-emerged globally. Causes for the re-emergence of pertussis include limited duration of protection conferred by acellular pertussis vaccines (aP) and pathogen adaptation. Pathogen adaptations involve antigenic divergence with vaccine strains, the emergence of strains which show enhanced in vitro expression of a number of virulence-associated genes and of strains that do not express pertactin, an important aP component. Clearly, the identification of more effective B. pertussis vaccine antigens is of utmost importance. To identify novel antigens, we used proteomics to identify B. pertussis proteins regulated by the master virulence regulatory system BvgAS in vitro. Five candidates proteins were selected and it was confirmed that they were also expressed in the lungs of naive mice seven days after infection. The five proteins were expressed in recombinant form, adjuvanted with alum and used to immunize mice as stand-alone antigens. Subsequent respiratory challenge showed that immunization with the autotransporters Vag8 and SphB1 significantly reduced bacterial load in the lungs. Whilst these antigens induced strong opsonizing antibody responses, we found that none of the tested alum-adjuvanted vaccines - including a three-component aP - reduced bacterial load in the nasopharynx, suggesting that alternative immunological responses may be required for efficient bacterial clearance from the nasopharynx.	[de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Zomer, Aldert; Berends, Alinda; Mooi, Frits R.; Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [de Gouw, Daan; de Jonge, Marien I.; Hermans, Peter W. M.; Zomer, Aldert; Berends, Alinda; Mooi, Frits R.; Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Wessels, Hans J. C. T.] Radboud Univ Nijmegen, Med Ctr, Radboud Prote Ctr, Nijmegen Ctr Mitochondrial Disorders,Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Berbers, Guy A.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, RIVM, Netherlands Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Pratt, Catherine] Publ Hlth England, Ctr Emergency Preparedness & Response, Salisbury, Wilts, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment; Public Health England	Diavatopoulos, DA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	dimitri.diavatopoulos@radboudumc.nl	de Jonge, Marien I./P-5869-2015; Diavatopoulos, Dimitri A/L-4269-2015; Hermans, Peter W.M./H-8042-2014; Pratt, Catherine/AAD-6118-2022; Mooi, prof.F.R./L-4528-2015; Wessels, Hans J/P-6248-2015	de Jonge, Marien I./0000-0003-2812-5895; Diavatopoulos, Dimitri A/0000-0001-7065-7807; Pratt, Catherine/0000-0001-6132-2570; Wessels, Hans J/0000-0001-5957-3127; Zomer, Aldert/0000-0002-0758-5190	Netherlands Organization of Scientific Research (ZonMw) [125020001]	Netherlands Organization of Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	D.d.G. is supported by Grant 125020001 from the Netherlands Organization of Scientific Research (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi H, 1988, J Med Microbiol, V26, P177; Barkoff AM, 2012, CLIN VACCINE IMMUNOL, V19, P1703, DOI 10.1128/CVI.00367-12; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Boulton Jacqueline, 2013, Br J Nurs, V22, P1046; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Cron LE, 2011, INFECT IMMUN, V79, P3697, DOI 10.1128/IAI.01383-10; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; Lam C, 2014, EMERG INFECT DIS, V20, P626, DOI 10.3201/eid2004.131478; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Mobberley-Schuman PS, 2005, INFECT IMMUN, V73, P7317, DOI 10.1128/IAI.73.11.7317-7323.2005; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; NURMINEN M, 1992, MOL MICROBIOL, V6, P2499; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pawloski LC, 2013, CLIN VACCINE IMMUNOL; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; ROBERTS M, 1992, VACCINE, V10, P43, DOI 10.1016/0264-410X(92)90418-J; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Sukumar N, 2009, INFECT IMMUN, V77, P885, DOI 10.1128/IAI.01076-08; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Trzcinski K, 2008, INFECT IMMUN, V76, P2678, DOI 10.1128/IAI.00141-08; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Warfel JM, 2013, P NATL ACAD SCI US; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	55	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105011	10.1371/journal.pone.0105011	http://dx.doi.org/10.1371/journal.pone.0105011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133400	Green Published, gold			2022-12-27	WOS:000341302700061
J	Hidalgo-Galiana, A; Monge, M; Biron, DG; Canals, F; Ribera, I; Cieslak, A				Hidalgo-Galiana, Amparo; Monge, Marta; Biron, David G.; Canals, Francesc; Ribera, Ignacio; Cieslak, Alexandra			Reproducibility and Consistency of Proteomic Experiments on Natural Populations of a Non-Model Aquatic Insect	PLOS ONE			English	Article							THERMAL TOLERANCE; BRUNNEUS GROUP; HUMAN PLASMA; RESPONSES; PROTEINS; ECOLOGY; STRESS; COLEOPTERA; PHYSIOLOGY	Population proteomics has a great potential to address evolutionary and ecological questions, but its use in wild populations of non-model organisms is hampered by uncontrolled sources of variation. Here we compare the response to temperature extremes of two geographically distant populations of a diving beetle species (Agabus ramblae) using 2-D DIGE. After one week of acclimation in the laboratory under standard conditions, a third of the specimens of each population were placed at either 4 or 27 degrees C for 12 h, with another third left as a control. We then compared the protein expression level of three replicated samples of 2-3 specimens for each treatment. Within each population, variation between replicated samples of the same treatment was always lower than variation between treatments, except for some control samples that retained a wider range of expression levels. The two populations had a similar response, without significant differences in the number of protein spots over-or under-expressed in the pairwise comparisons between treatments. We identified exemplary proteins among those differently expressed between treatments, which proved to be proteins known to be related to thermal response or stress. Overall, our results indicate that specimens collected in the wild are suitable for proteomic analyses, as the additional sources of variation were not enough to mask the consistency and reproducibility of the response to the temperature treatments.	[Hidalgo-Galiana, Amparo; Ribera, Ignacio; Cieslak, Alexandra] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Anim Biodivers & Evolut Program, Barcelona, Spain; [Monge, Marta; Canals, Francesc] VHIO, Barcelona, Spain; [Biron, David G.] Univ Blaise Pascal, Equipe Interact Hotes Parasites, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Vall d'Hebron Institut d'Oncologia (VHIO); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Hidalgo-Galiana, A (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Anim Biodivers & Evolut Program, Barcelona, Spain.	hg.amparo@gmail.com; A.Cieslak@gmx.net	Monge, Marta/I-3667-2015; Ribera, Ignacio/K-2909-2017	Monge, Marta/0000-0002-9839-4903; Ribera, Ignacio/0000-0002-2791-7615	Spanish government through I+D+i programme [CGL2007-61665, CGL2010-15755]	Spanish government through I+D+i programme	This work was funded by the Spanish government through the I+D+i programme, grants CGL2007-61665 and CGL2010-15755. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Barrett J, 2005, INT J PARASITOL, V35, P543, DOI 10.1016/j.ijpara.2005.01.013; Biron DG, 2006, PROTEOMICS, V6, P1712, DOI 10.1002/pmic.200500423; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Cheviron ZA, 2008, MOL ECOL, V17, P4556, DOI 10.1111/j.1365-294X.2008.03942.x; Cieslak A, 2009, ECOSISTEMAS, V18, P34; Cieslak A, 2007, ELECTROPHORESIS, V28, P535, DOI 10.1002/elps.200600620; Corzett TH, 2006, J PROTEOME RES, V5, P2611, DOI 10.1021/pr060100p; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Diz AP, 2012, MOL ECOL, V21, P1060, DOI 10.1111/j.1365-294X.2011.05426.x; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Dowd WW, 2012, INTEGR COMP BIOL, V52, P705, DOI 10.1093/icb/ics093; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hidalgo-Galiana A, 2014, BMC EVOL BI IN PRESS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jorge I, 2005, PROTEOMICS, V5, P222, DOI 10.1002/pmic.200400893; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; McMullen DC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P677, DOI 10.1086/653489; Millan A., 1997, Latissimus, V9, P2; Millan A, 2001, COLEOPTS BULL, V55, P107, DOI 10.1649/0010-065X(2001)055[0107:TAGBGW]2.0.CO;2; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Nedelkov D, 2004, ANAL CHEM, V76, P1733, DOI 10.1021/ac035105+; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pedersen KS, 2010, HEREDITY, V104, P125, DOI 10.1038/hdy.2009.132; Rider MH, 2011, J INSECT PHYSIOL, V57, P1453, DOI 10.1016/j.jinsphys.2011.07.006; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sanchez-Fernandez Aragon P, 2012, PLOS ONE, DOI [10.1371/journal.pone.0048163, DOI 10.1371/J0URNAL.P0NE.0048163]; SAS Institute Inc, 2007, JMP US GUID; Serafini L, 2011, COMP BIOCHEM PHYS D, V6, P322, DOI 10.1016/j.cbd.2011.07.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Storey KB, 2012, CAN J ZOOL, V90, P456, DOI 10.1139/Z2012-011; Thiellement H, 1999, ELECTROPHORESIS, V20, P2013, DOI 10.1002/(SICI)1522-2683(19990701)20:10&lt;2013::AID-ELPS2013&gt;3.0.CO;2-#; Valledor L, 2011, J PROTEOMICS, V74, P1, DOI 10.1016/j.jprot.2010.07.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitehead A, 2012, J EXP BIOL, V215, P884, DOI 10.1242/jeb.058735	46	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104734	10.1371/journal.pone.0104734	http://dx.doi.org/10.1371/journal.pone.0104734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133588	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700040
J	Joers, V; Dilley, K; Rahman, S; Jones, C; Shultz, J; Simmons, H; Emborg, ME				Joers, Valerie; Dilley, Kristine; Rahman, Shahrose; Jones, Corinne; Shultz, Jeanette; Simmons, Heather; Emborg, Marina E.			Cardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman Primates	PLOS ONE			English	Article							ALPHA-SYNUCLEIN EXPRESSION; AUTONOMIC NERVOUS-SYSTEM; RAT ADRENAL-MEDULLA; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; ORTHOSTATIC HYPOTENSION; LEWY-BODY; C-11 HYDROXYEPHEDRINE; MIBG SCINTIGRAPHY; 6-HYDROXYDOPAMINE	Cardiac sympathetic neurodegeneration and dysautonomia affect patients with sporadic and familial Parkinson's disease (PD) and are currently proposed as prodromal signs of PD. We have recently developed a nonhuman primate model of cardiac dysautonomia by iv 6-hydroxydopamine (6-OHDA). Our in vivo findings included decreased cardiac uptake of a sympathetic radioligand and circulating catecholamines; here we report the postmortem characterization of the model. Ten adult rhesus monkeys (5-17 yrs old) were used in this study. Five animals received 6-OHDA (50 mg/kg iv) and five were age-matched controls. Three months post-neurotoxin the animals were euthanized; hearts and adrenal glands were processed for immunohistochemistry. Quantification of immunoreactivity (ir) of stainings was performed by an investigator blind to the treatment group using NIH ImageJ software (for cardiac bundles and adrenals, area above threshold and optical density) and MBF StereoInvestigator (for cardiac fibers, area fraction fractionator probe). Sympathetic cardiac nerve bundle analysis and fiber area density showed a significant reduction in global cardiac tyrosine hydroxylase-ir (TH; catecholaminergic marker) in 6-OHDA animals compared to controls. Quantification of protein gene protein 9.5 (pan-neuronal marker) positive cardiac fibers showed a significant deficit in 6-OHDA monkeys compared to controls and correlated with TH-ir fiber area. Semi-quantitative evaluation of human leukocyte antigen-ir (inflammatory marker) and nitrotyrosine-ir (oxidative stress marker) did not show significant changes 3 months post-neurotoxin. Cardiac nerve bundle alpha-synuclein-ir (presynaptic protein) was reduced (trend) in 6-OHDA treated monkeys; insoluble proteinase-K resistant alpha-synuclein (typical of PD pathology) was not observed. In the adrenal medulla, 6-OHDA monkeys had significantly reduced TH-ir and aminoacid decarboxylase-ir. Our results confirm that systemic 6-OHDA dosing to nonhuman primates induces cardiac sympathetic neurodegeneration and loss of catecholaminergic enzymes in the adrenal medulla, and suggests that this model can be used as a platform to evaluate disease-modifying strategies aiming to induce peripheral neuroprotection.	[Joers, Valerie; Dilley, Kristine; Rahman, Shahrose; Jones, Corinne; Shultz, Jeanette; Simmons, Heather; Emborg, Marina E.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA; [Joers, Valerie; Jones, Corinne; Emborg, Marina E.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Jones, Corinne] Univ Wisconsin, Commun Sci & Disorders Training Program, Madison, WI USA; [Shultz, Jeanette; Emborg, Marina E.] Univ Wisconsin, Cellular & Mol Pathol Training Program, Madison, WI USA; [Emborg, Marina E.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Emborg, ME (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Preclin Parkinsons Res Program, Madison, WI 53706 USA.	emborg@primate.wisc.edu	Joers, Valerie/S-2455-2019; Jones, Corinne/K-7775-2019	Joers, Valerie/0000-0001-6743-6587; Rahman, Shahrose/0000-0003-3138-2518	WNPRC NIH [P51RR000167, R21NS084158, R01HD15433]; UW NIH-CTSA; Graduate School of the University of Wisconsin, Madison; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	WNPRC NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW NIH-CTSA; Graduate School of the University of Wisconsin, Madison; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the WNPRC NIH base grant P51RR000167, R21NS084158, R01HD15433, UW NIH-CTSA pilot project award, and awards from the Graduate School of the University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; ALLMAN KC, 1993, J AM COLL CARDIOL, V22, P1425, DOI 10.1016/0735-1097(93)90553-D; Amino T, 2005, BRAIN PATHOL, V15, P29, DOI 10.1111/j.1750-3639.2005.tb00097.x; Amino T, 2008, NEUROSCI RES, V60, P314, DOI 10.1016/j.neures.2007.11.011; Arbab A S, 1996, Ann Nucl Med, V10, P211; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Buob A, 2010, CLIN RES CARDIOL, V99, P701, DOI 10.1007/s00392-010-0170-6; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; CARMICHAEL SW, 1988, NEW ENGL J MED, V318, P254; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Courbon F, 2003, MOVEMENT DISORD, V18, P890, DOI 10.1002/mds.10461; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Ghebremedhin E, 2009, ACTA NEUROPATHOL, V118, P777, DOI 10.1007/s00401-009-0596-y; Goldstein DS, 2007, NEUROLOGY, V69, P1580, DOI 10.1212/01.wnl.0000268696.57912.64; Goldstein DS, 2007, CLIN AUTON RES, V17, P118, DOI 10.1007/s10286-007-0396-1; Goldstein DS, 2005, HYPERTENSION, V46, P1333, DOI 10.1161/01.HYP.0000188052.69549.e4; Goldstein DS, 2002, NEUROLOGY, V58, P1247, DOI 10.1212/WNL.58.8.1247; Goldstein DS, 2000, ANN INTERN MED, V133, P338, DOI 10.7326/0003-4819-133-5-200009050-00009; GOLDSTEIN DS, 1991, J HYPERTENS, V9, P417, DOI 10.1097/00004872-199105000-00005; Goldstein DS, 2003, J PHARMACOL EXP THER, V306, P855, DOI 10.1124/jpet.103.051714; Goldstein DS, 2003, NEUROLOGY, V60, P1327, DOI 10.1212/01.WNL.0000058766.46428.F3; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; Hattori N, 1996, J NUCL MED, V37, P1985; Henze C, 2005, BRAIN RES, V1052, P97, DOI 10.1016/j.brainres.2005.06.020; Iwanaga K, 1999, NEUROLOGY, V52, P1269, DOI 10.1212/WNL.52.6.1269; JACKSON P, 1985, J NEUROCHEM, V45, P185, DOI 10.1111/j.1471-4159.1985.tb05491.x; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Joers V, 2014, AM J NUCL MED MOLEC, V4, P125; Joers V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035371; KAST A, 1994, LAB ANIM, V28, P80, DOI 10.1258/002367794781065834; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Kawasaki T, 2007, J PHARMACOL EXP THER, V322, P274, DOI 10.1124/jpet.106.119206; KENT C, 1989, J ANAT, V166, P213; Kippenberger AG, 1999, J NEUROCHEM, V73, P1024, DOI 10.1046/j.1471-4159.1999.0731024.x; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Kujawa K, 2000, ARCH NEUROL-CHICAGO, V57, P1461, DOI 10.1001/archneur.57.10.1461; KUMAR R, 1995, J NEUROCHEM, V64, P1703; LAVERTY R, 1965, BRIT J PHARM CHEMOTH, V24, P549, DOI 10.1111/j.1476-5381.1965.tb01745.x; Li ST, 2002, ANN NEUROL, V52, P220, DOI 10.1002/ana.10236; MAJEED SK, 1980, LAB ANIM, V14, P363, DOI 10.1258/002367780781071166; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mathias CJ, 1998, CLIN NEUROSCI, V5, P153; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Miller AD, 2009, VET PATHOL, V46, P1221, DOI 10.1354/vp.09-VP-0022-M-FL; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Muhlfeld C, 2010, J APPL PHYSIOL, V108, P1402, DOI 10.1152/japplphysiol.01013.2009; Navarro-Otano J, 2013, PARKINSONISM RELAT D, V19, P27, DOI 10.1016/j.parkreldis.2012.07.005; Orimo S, 2011, NEUROPATH APPL NEURO, V37, P791, DOI 10.1111/j.1365-2990.2011.01194.x; Orimo S, 2002, J NEUROL NEUROSUR PS, V73, P776, DOI 10.1136/jnnp.73.6.776; PERUMAL AS, 1992, BRAIN RES BULL, V29, P699, DOI 10.1016/0361-9230(92)90142-K; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Raffel DM, 2006, J NUCL MED, V47, P1490; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; SACHS C, 1975, BRAIN RES, V99, P277, DOI 10.1016/0006-8993(75)90029-3; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; SENARD JM, 1993, CLIN NEUROPHARMACOL, V16, P70, DOI 10.1097/00002826-199302000-00008; Sharabi Y, 2008, MOVEMENT DISORD, V23, P1725, DOI 10.1002/mds.22226; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; SISSON JC, 1987, J NUCL MED, V28, P1620; SKELTONSTROUD PN, 1985, VET PATHOL, V22, P141, DOI 10.1177/030098588502200208; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STODDARD SL, 1989, EXP NEUROL, V104, P218, DOI 10.1016/0014-4886(89)90032-0; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tompkins MM, 2003, BRAIN RES, V984, P233, DOI 10.1016/S0006-8993(03)03040-3; TRANZER JP, 1973, EXPERIENTIA, V29, P314, DOI 10.1007/BF01926498; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; WAKABAYASHI K, 1993, ADV NEUROL, V60, P609; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wong KK, 2012, RADIOLOGY, V265, P240, DOI 10.1148/radiol.12112723	83	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104850	10.1371/journal.pone.0104850	http://dx.doi.org/10.1371/journal.pone.0104850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133405	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700045
J	Pinzon, JHC; Beach-Letendre, J; Weil, E; Mydlarz, LD				Pinzon, Jorge H.; Beach-Letendre, Joshuah; Weil, Ernesto; Mydlarz, Laura D.			Relationship between Phylogeny and Immunity Suggests Older Caribbean Coral Lineages Are More Resistant to Disease	PLOS ONE			English	Article							WHITE PLAGUE DISEASE; LIFE-HISTORY STRATEGIES; ROQUES-NATIONAL-PARK; CLIMATE-CHANGE; SCLERACTINIAN CORALS; ECOLOGICAL IMMUNOLOGY; REACTIVE OXYGEN; INNATE IMMUNITY; BAND DISEASE; REEF CORALS	Diseases affect coral species fitness and contribute significantly to the deterioration of coral reefs. The increase in frequency and severity of disease outbreaks has made evaluating and determining coral resistance a priority. Phylogenetic patterns in immunity and disease can provide important insight to how corals may respond to current and future environmental and/or biologically induced diseases. The purpose of this study was to determine if immunity, number of diseases and disease prevalence show a phylogenetic signal among Caribbean corals. We characterized the constitutive levels of six distinct innate immune traits in 14 Caribbean coral species and tested for the presence of a phylogenetic signal on each trait. Results indicate that constitutive levels of some individual immune related processes (i.e. melanin concentration, peroxidase and inhibition of bacterial growth), as well as their combination show a phylogenetic signal. Additionally, both the number of diseases affecting each species and disease prevalence (as measures of disease burden) show a significant phylogenetic signal. The phylogenetic signal of immune related processes, combined with estimates of species divergence times, indicates that among the studied species, those belonging to older lineages tend to resist/fight infections better than more recently diverged coral lineages. This result, combined with the increasing stressful conditions on corals in the Caribbean, suggest that future reefs in the region will likely be dominated by older lineages while modern species may face local population declines and/or geographic extinction.	[Pinzon, Jorge H.; Beach-Letendre, Joshuah; Mydlarz, Laura D.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA	University of Texas System; University of Texas Arlington; University of Puerto Rico; University of Puerto Rico Mayaguez	Pinzon, JHC (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	pinzon@uta.edu	Weil, Ernesto/AAI-3591-2020; Weil, Ernesto/ABF-1290-2020; Pinzon, Jorge/C-7277-2011	Weil, Ernesto/0000-0001-5275-1584; Pinzon, Jorge/0000-0002-3330-8226	NSF grant IOS [1017458, 1017510]; NSF [OCE -1105143]; NSF grant OCE-PRF [1225163]; Division Of Integrative Organismal Systems [1017510] Funding Source: National Science Foundation	NSF grant IOS; NSF(National Science Foundation (NSF)); NSF grant OCE-PRF; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant IOS # 1017458 to L. D. M., NSF grant IOS # 1017510 and OCE -1105143 to E. W., and NSF grant OCE-PRF # 1225163 to J.H.P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; [Anonymous], MICROB ECOL; [Anonymous], BEAST IS CROSS PLATF; [Anonymous], 2005, CARIBBEAN MARINE BIO; [Anonymous], B INVESTIG MAR COSTE; [Anonymous], BIOLOGY; [Anonymous], ENTOMOL EXP APPL; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Arregoitia LDV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1092; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Croquer A, 2005, CARIBB J SCI, V41, P815; Croquer A, 2003, REV BIOL TROP, V51, P167; Croquer A, 2003, REV BIOL TROP, V51, P39; Croquer A, 2009, DIS AQUAT ORGAN, V87, P33, DOI 10.3354/dao02164; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz M, 2011, CORAL REEFS, V30, P73, DOI 10.1007/s00338-010-0668-4; DRUMMOND AJ, 2009, GENEIOUS V4 8; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Garcia A, 2003, REV BIOL TROP, V51, P173; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Krasnov BR, 2011, ECOGRAPHY, V34, P114, DOI 10.1111/j.1600-0587.2010.06502.x; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lewis JB, 1997, MAR POLLUT BULL, V34, P622, DOI 10.1016/S0025-326X(96)00184-1; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Ma ZP, 2010, FISH SHELLFISH IMMUN, V28, P187, DOI 10.1016/j.fsi.2009.10.019; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; McClanahan T. R., 2009, V205, P121; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; MUTHIGA NA, 1987, BIOL BULL-US, V173, P539, DOI 10.2307/1541699; Mydlarz LD, 2011, COMP BIOCHEM PHYS A, V159, P372, DOI 10.1016/j.cbpa.2011.03.029; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Navas-Camacho R, 2010, REV BIOL TROP, V58, P95; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palmer CV, 2011, J EXP BIOL, V214, P4240, DOI 10.1242/jeb.061267; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Santavy DL, 2001, HYDROBIOLOGIA, V460, P39, DOI 10.1023/A:1013194422440; Satake H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00034; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Wang DD, 2012, CELL STRESS CHAPERON, V17, P423, DOI 10.1007/s12192-011-0317-z; Ward JR, 2006, DIS AQUAT ORGAN, V69, P23, DOI 10.3354/dao069023; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2009, CARIBB J SCI, V45, P221; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27	98	23	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104787	10.1371/journal.pone.0104787	http://dx.doi.org/10.1371/journal.pone.0104787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133685	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700042
J	Purohit, P; Perez-Branguli, F; Prots, I; Borger, E; Gunn-Moore, F; Welzel, O; Loy, K; Wenzel, EM; Gromer, TW; Brachs, S; Holzer, M; Buslei, R; Fritsch, K; Regensburger, M; Bohm, KJ; Winner, B; Mielenz, D				Purohit, Pavitra; Perez-Branguli, Francesc; Prots, Iryna; Borger, Eva; Gunn-Moore, Frank; Welzel, Oliver; Loy, Kristina; Wenzel, Eva Maria; Groemer, Teja W.; Brachs, Sebastian; Holzer, Max; Buslei, Rolf; Fritsch, Kristin; Regensburger, Martin; Boehm, Konrad J.; Winner, Beate; Mielenz, Dirk			The Ca2+ Sensor Protein Swiprosin-1/EFhd2 Is Present in Neurites and Involved in Kinesin-Mediated Transport in Neurons	PLOS ONE			English	Article							BINDING ADAPTER PROTEINS; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; EF-HAND; TAU; STAGE; SYNAPTOPHYSIN; DYNAMICS; EFHD2; MICE	Swiprosin-1/EFhd2 (EFhd2) is a cytoskeletal Ca2+ sensor protein strongly expressed in the brain. It has been shown to interact with mutant tau, which can promote neurodegeneration, but nothing is known about the physiological function of EFhd2 in the nervous system. To elucidate this question, we analyzed EFhd2(-/-)/lacZ reporter mice and showed that lacZ was strongly expressed in the cortex, the dentate gyrus, the CA1 and CA2 regions of the hippocampus, the thalamus, and the olfactory bulb. Immunohistochemistry and western blotting confirmed this pattern and revealed expression of EFhd2 during neuronal maturation. In cortical neurons, EFhd2 was detected in neurites marked by MAP2 and co-localized with pre- and post-synaptic markers. Approximately one third of EFhd2 associated with a biochemically isolated synaptosome preparation. There, EFhd2 was mostly confined to the cytosolic and plasma membrane fractions. Both synaptic endocytosis and exocytosis in primary hippocampal EFhd2(-/-) neurons were unaltered but transport of synaptophysin-GFP containing vesicles was enhanced in EFhd2(-/-) primary hippocampal neurons, and notably, EFhd2 inhibited kinesin mediated microtubule gliding. Therefore, we found that EFhd2 is a neuronal protein that interferes with kinesin-mediated transport.	[Purohit, Pavitra; Brachs, Sebastian; Fritsch, Kristin; Mielenz, Dirk] Univ Klinikum Erlangen, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany; [Purohit, Pavitra; Perez-Branguli, Francesc; Prots, Iryna; Brachs, Sebastian; Fritsch, Kristin; Regensburger, Martin; Winner, Beate; Mielenz, Dirk] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Perez-Branguli, Francesc; Prots, Iryna; Winner, Beate] Univ Klinikum Erlangen, IZKF Nachwuchsgrp 3, Erlangen, Germany; [Borger, Eva; Gunn-Moore, Frank] Univ St Andrews, Sch Biol Med & Biol Sci Bldg, St Andrews, Fife, Scotland; [Welzel, Oliver; Loy, Kristina; Wenzel, Eva Maria; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat, D-91054 Erlangen, Germany; [Holzer, Max] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Holzer, Max] Leibniz Inst Age Res, Jena, Germany; [Buslei, Rolf] Univ Erlangen Nurnberg, Inst Neuropathol, D-91054 Erlangen, Germany; [Regensburger, Martin] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Boehm, Konrad J.] Fritz Lipmann Inst, Mol Motors Lab, Jena, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of St Andrews; University of Erlangen Nuremberg; Leipzig University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Erlangen Nuremberg; University of Erlangen Nuremberg; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Mielenz, D (corresponding author), Univ Klinikum Erlangen, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany.	dmielenz@molmed.uni-erlangen.de	Winner, Beate/K-3730-2012; Regensburger, Martin/AAI-2311-2020; Winner, Beate/O-8213-2019; Holzer, Max/A-1729-2008; Prots, Iryna/O-7982-2018; Borger, Eva/H-5999-2013	Winner, Beate/0000-0002-6909-0564; Regensburger, Martin/0000-0002-2172-7386; Winner, Beate/0000-0002-6909-0564; Holzer, Max/0000-0003-1754-9932; Prots, Iryna/0000-0001-9561-0909; Borger, Eva/0000-0003-4965-2969; Brachs, Sebastian/0000-0002-6336-3939; Gunn-Moore, Francis James/0000-0003-3422-3387; Wenzel, Eva Maria/0000-0002-5561-3344	German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) [FOR832]; German Federal Ministry of Education and Research [01GQ113]; Bavarian Ministry of Sciences, Research and the Arts; Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen) [E8]; ELAN Fonds (Universitatsklinikum Erlangen) [11.08.19.1]; Alzheimer's Research UK; Alzheimers Research UK [ART-PG2009-3] Funding Source: researchfish	German Science Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bavarian Ministry of Sciences, Research and the Arts; Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen); ELAN Fonds (Universitatsklinikum Erlangen); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by grants from the German Science Foundation (Deutsche Forschungsgemeinschaft, DFG; FOR832, to DM), the German Federal Ministry of Education and Research (01GQ113; to BW), the Bavarian Ministry of Sciences, Research and the Arts in the framework of the Bavarian Molecular Biosystems Reseach Network, the Interdisciplinary Center for Clinical Research (IZKF, Universitatsklinikum Erlangen; E8, to DM; NIII, to BW; Lab rotation to MR), the ELAN Fonds (Universitatsklinikum Erlangen; 11.08.19.1, to IP), and the Alzheimer's Research UK (EB, FGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2012, CELL SIGNAL, V24, P378, DOI 10.1016/j.cellsig.2011.09.028; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bohm KJ, 2008, CELL BIOL INT, V32, P588, DOI 10.1016/j.cellbi.2007.12.001; Bohm KJ, 1997, CELL MOTIL CYTOSKEL, V37, P226, DOI 10.1002/(SICI)1097-0169(1997)37:3<226::AID-CM4>3.0.CO;2-4; Brachs S, 2014, EUR J IMMUNOL, V44, P3206, DOI 10.1002/eji.201444479; Brachs Sebastian, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P237, DOI 10.1089/mab.2013.0014; BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0; Buslei R, 2007, ACTA NEUROPATHOL, V113, P585, DOI 10.1007/s00401-006-0184-3; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dima AA, 2011, CYTOM PART A, V79A, P545, DOI 10.1002/cyto.a.21079; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Ferrer-Acosta Y, 2013, J NEUROCHEM, V125, P921, DOI 10.1111/jnc.12155; Ferrer-Acosta Y, 2013, PROTEIN PEPTIDE LETT, V20, P573; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hagen S, 2012, CELL CALCIUM, V51, P411, DOI 10.1016/j.ceca.2012.01.004; Hornbruch-Freitag C, 2011, J CELL SCI, V124, P3266, DOI 10.1242/jcs.083907; Hubner K, 2002, INT REV CYTOL, V214, P103; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kroczek C, 2010, J IMMUNOL, V184, P3665, DOI 10.4049/jimmunol.0903642; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Perez-Branguli F, 2014, HUM MOL GENET; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Prots I, 2003, CELL BIOL INT, V27, P251, DOI 10.1016/S1065-6995(02)00313-X; Ribchester RR, 2009, CURR OPIN PHARMACOL, V9, P297, DOI 10.1016/j.coph.2009.03.006; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Welzel O, 2011, EUR BIOPHYS J BIOPHY, V40, P1061, DOI 10.1007/s00249-011-0722-3; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	44	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103976	10.1371/journal.pone.0103976	http://dx.doi.org/10.1371/journal.pone.0103976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133820	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700020
J	Tengroth, L; Arebro, J; Georen, SK; Winqvist, O; Cardell, LO				Tengroth, Lotta; Arebro, Julia; Georen, Susanna Kumlien; Winqvist, Ola; Cardell, Lars-Olaf			Deprived TLR9 Expression in Apparently Healthy Nasal Mucosa Might Trigger Polyp-Growth in Chronic Rhinosinusitis Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; CPG DNA; CELLS; INFLAMMATION; OLIGODEOXYNUCLEOTIDE; TOLL-LIKE-RECEPTOR-9; ACTIVATION; CYTOKINES; DISEASES; NOSE	Background: The origin of nasal polyps in chronic rhinosinusitis is unknown, but the role of viral infections in polyp growth is clinically well established. Toll-like receptors (TLRs) have recently emerged as key players in our local airway defense against microbes. Among these, TLR9 has gained special interest in viral diseases. Many studies on chronic rhinosinusitis with nasal polyps (CRSwNP) compare polyp tissue with nasal mucosa from polyp-free individuals. Knowledge about changes in the turbinate tissue bordering the polyp tissue is limited. Objectives: To analyse the role of TLR9 mediated microbial defense in tissue bordering the polyp. Methods: Nasal polyps and turbinate tissue from 11 patients with CRSwNP and turbinate tissue from 11 healthy controls in total were used. Five biopsies from either group were analysed immediately with flow cytometry regarding receptor expression and 6 biopsies were used for in vitro stimulation with a TLR9 agonist, CpG. Cytokine release was analysed using Luminex. Eight patients with CRSwNP in total were intranasally challenged with CpG/placebo 24 hours before surgery and the biopsies were collected and analysed as above. Results: TLR9 expression was detected on turbinate epithelial cells from healthy controls and polyp epithelial cells from patients, whereas TLR9 was absent in turbinate epithelial cells from patients. CpG stimulation increased the percentage cells expressing TLR9 and decreased percentage cells expressing VEGFR2 in turbinate tissue from patients. After CpG stimulation the elevated levels of IL-6, G-CSF and MIP-1 beta in the turbinate tissue from patients were reduced towards the levels demonstrated in healthy controls. Conclusion: Defects in the TLR9 mediated microbial defense in the mucosa adjacent to the anatomic origin of the polyp might explain virus induced polyp growth. CpG stimulation decreased VEGFR2, suggesting a role for CpG in polyp formation. The focus on turbinate tissue in patients with CRSwNP opens new perspectives in CRSwNP-research.	[Tengroth, Lotta; Arebro, Julia; Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden; [Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255; Arebro, Julia/0000-0002-2584-0941; winqvist, Ola/0000-0003-0842-4441	Swedish Medical Research Council [2011-3357]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Swedish Medical Research Council (Grant number: 2011-3357; http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, ALLERGOLOGIE, V30, P155; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bernstein JM, 2004, OTOLARYNG HEAD NECK, V130, P526, DOI 10.1016/j.otohns.2003.12.022; Bhattacharyya N, 2001, AM J RHINOL, V15, P169, DOI 10.2500/105065801779954184; Bobic S, 2014, ALLERGY, V69, P237, DOI 10.1111/all.12277; Cho GS, 2013, J CLIN MICROBIOL, V51, P979, DOI 10.1128/JCM.02806-12; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Coste A, 2000, EUR RESPIR J, V15, P367, DOI 10.1034/j.1399-3003.2000.15b24.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Gong J, 2013, AM J OTOLARYNGOL; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Kirtsreesakul V, 2006, ARCH OTOLARYNGOL, V132, P1102, DOI 10.1001/archotol.132.10.1102; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kodama S, 2006, LARYNGOSCOPE, V116, P331, DOI 10.1097/01.mlg.0000194222.93067.f7; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg Arthur M, 2007, Proc Am Thorac Soc, V4, P289, DOI 10.1513/pats.200701-021AW; Lane AP, 2006, AM J RHINOL, V20, P138, DOI 10.1177/194589240602000203; LARSEN PL, 1992, LARYNGOSCOPE, V102, P670, DOI 10.1288/00005537-199206000-00013; Lee HS, 2009, AM J RESP CRIT CARE, V180, P1056, DOI 10.1164/rccm.200905-0740OC; Leigh R, 2008, J ALLERGY CLIN IMMUN, V121, P1238, DOI 10.1016/j.jaci.2008.01.067; Li J, 2004, AM J PHYSIOL-LUNG C, V287, pL552, DOI 10.1152/ajplung.00436.2003; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mansson A, 2009, ALLERGY, V64, P1292, DOI 10.1111/j.1398-9995.2009.02012.x; Meltzer EO, 2004, OTOLARYNG HEAD NECK, V131, pS1, DOI 10.1016/j.otohns.2004.09.067; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Park SK, 2009, LARYNGOSCOPE, V119, P409, DOI 10.1002/lary.20085; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Ramanathan M, 2007, AM J RHINOL, V21, P110, DOI 10.2500/ajr.2007.21.2997; Ramanathan M, 2008, AM J RHINOL, V22, P115, DOI 10.2500/ajr.2008.22.3136; Scavuzzo MC, 2005, BIOMED PHARMACOTHER, V59, P323, DOI 10.1016/j.biopha.2004.11.010; Simon HU, 1997, J IMMUNOL, V158, P3902; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tan L, 2009, AM J RHINOL ALLERGY, V23, P123, DOI 10.2500/ajra.2009.23.3279; Tengroth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098239; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang Cheng-shuo, 2003, Zhonghua Er Bi Yan Hou Ke Za Zhi, V38, P243; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039875; Wu CC, 2012, AM J OTOLARYNG, V33, P14, DOI 10.1016/j.amjoto.2010.12.001; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	49	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105618	10.1371/journal.pone.0105618	http://dx.doi.org/10.1371/journal.pone.0105618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133733	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700123
J	Wang, F; McShea, WJ; Wang, DJ; Li, S; Zhao, Q; Wang, H; Lu, Z				Wang, Fang; McShea, William J.; Wang, Dajun; Li, Sheng; Zhao, Qing; Wang, Hao; Lu, Zhi			Evaluating Landscape Options for Corridor Restoration between Giant Panda Reserves	PLOS ONE			English	Article							FOPING-NATURE-RESERVE; WOLONG NATURE-RESERVE; HABITAT SUITABILITY; MINSHAN MOUNTAINS; CONSERVATION; SCENARIO; MODELS; FOREST; CHINA; CONNECTIVITY	The establishment of corridors can offset the negative effects of habitat fragmentation by connecting isolated habitat patches. However, the practical value of corridor planning is minimal if corridor identification is not based on reliable quantitative information about species-environment relationships. An example of this need for quantitative information is planning for giant panda conservation. Although the species has been the focus of intense conservation efforts for decades, most corridor projects remain hypothetical due to the lack of reliable quantitative researches at an appropriate spatial scale. In this paper, we evaluated a framework for giant panda forest corridor planning. We linked our field survey data with satellite imagery, and conducted species occupancy modelling to examine the habitat use of giant panda within the potential corridor area. We then conducted least-cost and circuit models to identify potential paths of dispersal across the landscape, and compared the predicted cost under current conditions and alternative conservation management options considered during corridor planning. We found that due to giant panda's association with areas of low elevation and flat terrain, human infrastructures in the same area have resulted in corridor fragmentation. We then identified areas with high potential to function as movement corridors, and our analysis of alternative conservation scenarios showed that both forest/bamboo restoration and automobile tunnel construction would significantly improve the effectiveness of corridor, while residence relocation would not significantly improve corridor effectiveness in comparison with the current condition. The framework has general value in any conservation activities that anticipate improving habitat connectivity in human modified landscapes. Specifically, our study suggested that, in this landscape, automobile tunnels are the best means to remove current barriers to giant panda movements caused by anthropogenic interferences.	[Wang, Fang; McShea, William J.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Wang, Fang; Wang, Dajun; Li, Sheng; Wang, Hao; Lu, Zhi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Zhao, Qing] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Peking University; Colorado State University	Wang, F (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	wangf@si.edu	Wang, Fang/AIC-7698-2022; Zhao, Qing/K-3486-2015	Zhao, Qing/0000-0003-2759-1114; Wang, Fang/0000-0002-3922-5851; McShea, William/0000-0002-8102-0200	Ocean Park Conservation Foundation, Hong Kong (OPCFHK); Conservation International (CI)	Ocean Park Conservation Foundation, Hong Kong (OPCFHK); Conservation International (CI)	This research was funded by Ocean Park Conservation Foundation, Hong Kong (OPCFHK, www.opcf.org.hk) and Conservation International (CI, www.conservation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2004, WORLDCLIM INTERPOLAT; ASTER G, 2011, VALIDATION TEAM 2009; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; China's Ministry of Forestry & WWF, 1989, COMPR REP CHIN GIANT; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Dang HS, 2010, FOREST ECOL MANAG, V259, P547, DOI 10.1016/j.foreco.2009.11.011; Downes SJ, 1997, CONSERV BIOL, V11, P718, DOI 10.1046/j.1523-1739.1997.96094.x; Erb PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042574; ESRI, 2013, 10 2 DESKT HELP; Feng TT, 2009, J WILDLIFE MANAGE, V73, P852, DOI 10.2193/2008-186; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Huck M, 2010, ACTA THERIOL, V55, P177, DOI 10.4098/j.at.0001-7051.114.2009; Huijser MP, 2009, ECOL SOC, V14; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li S, 2010, IBIS, V152, P299, DOI 10.1111/j.1474-919X.2009.00989.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu XH, 2005, J WILDLIFE MANAGE, V69, P1623, DOI 10.2193/0022-541X(2005)69[1623:GPHSIF]2.0.CO;2; Liu XH, 2002, J WILDLIFE MANAGE, V66, P1179, DOI 10.2307/3802951; Loucks CJ, 2001, SCIENCE, V294, P1465, DOI 10.1126/science.1064710; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McRae B., 2009, CIRCUITSCAPE USER GU; McShea WJ, 2014, ENVIRON CONSERV, V41, P93, DOI 10.1017/S0376892913000581; McShea WJ, 2008, HUMAN WILDLIFE INTER, V76; Muchoney D, 2000, INT J REMOTE SENS, V21, P1115, DOI 10.1080/014311600210100; Olsson MPO, 2008, LANDSCAPE URBAN PLAN, V85, P133, DOI 10.1016/j.landurbplan.2007.10.006; Pan W., 2001, OPPORTUNITY GIANT PA; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Postma TJBM, 2005, TECHNOL FORECAST SOC, V72, P161, DOI 10.1016/j.techfore.2003.11.005; Qi DW, 2012, INTEGR ZOOL, V7, P165, DOI 10.1111/j.1749-4877.2012.00281.x; Rogers S, 2006, POPUL ENVIRON, V28, P41, DOI 10.1007/s11111-007-0033-x; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shen GZ, 2008, CONSERV BIOL, V22, P1144, DOI 10.1111/j.1523-1739.2008.01038.x; Songer Melissa, 2012, International Journal of Ecology, P1; State Forestry Administration, 2006, 3 NAT SURV REP GIANT; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; Thompson JR, 2012, BIOSCIENCE, V62, P367, DOI 10.1525/bio.2012.62.4.8; Tuan Mu M-N, 2012, SPATIOTEMPORAL DYNAM; Wang Q, 2006, FOREST CHRON, V82, P31, DOI 10.5558/tfc82031-1; Wang XZ, 2009, ECOL RES, V24, P1101, DOI 10.1007/s11284-009-0589-2; Wang Xuezhi, 2008, Acta Ecologica Sinica, V28, P821; Wang ZM, 2010, AMBIO, V39, P443, DOI 10.1007/s13280-010-0054-z; Wu PF, 2010, PROCEDIA ENVIRON SCI, V2, P111, DOI 10.1016/j.proenv.2010.10.015; Wu X, 2010, SHAANXI FOREST SCI T, V2, P5, DOI DOI 10.1088/1748-6041/5/4/044105; Yeh ET, 2009, GEOFORUM, V40, P884, DOI 10.1016/j.geoforum.2009.06.004; Yin KP, 2006, INTEGR ZOOL, V1, P170, DOI 10.1111/j.1749-4877.2006.00032.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; [曾治高 ZENG Zhi-gao], 2009, [西北林学院学报, Journal of Northwest Forestry College], V24, P88; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; Zhang ZJ, 2011, BIOL LETTERS, V7, P403, DOI 10.1098/rsbl.2010.1081; Zhen Cao, 2012, 2012 International Conference on Civil Engineering and Urban Planning (CEUP 2012). Proceedings, P56; Zhi-ming B, 2006, J CENTRAL U NATL PHI, V1, P004; Zhu LF, 2011, MOL ECOL, V20, P1122, DOI 10.1111/j.1365-294X.2011.04999.x; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	60	39	48	2	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105086	10.1371/journal.pone.0105086	http://dx.doi.org/10.1371/journal.pone.0105086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133757	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700067
J	Aoki, M; Ehara, M; Saito, Y; Yoshioka, H; Miyazaki, M; Saito, Y; Miyashita, A; Kawakami, S; Yamaguchi, T; Ohashi, A; Nunoura, T; Takai, K; Imachi, H				Aoki, Masataka; Ehara, Masayuki; Saito, Yumi; Yoshioka, Hideyoshi; Miyazaki, Masayuki; Saito, Yayoi; Miyashita, Ai; Kawakami, Shuji; Yamaguchi, Takashi; Ohashi, Akiyoshi; Nunoura, Takuro; Takai, Ken; Imachi, Hiroyuki			A Long-Term Cultivation of an Anaerobic Methane-Oxidizing Microbial Community from Deep-Sea Methane-Seep Sediment Using a Continuous-Flow Bioreactor	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; SULFATE-REDUCING BACTERIA; MARINE SUBSURFACE SEDIMENTS; HANGING SPONGE-CUBES; METHANOTROPHIC ARCHAEA; MESSENGER-RNA; UASB REACTOR; MUD VOLCANO; SP NOV.	Anaerobic oxidation of methane (AOM) in marine sediments is an important global methane sink, but the physiological characteristics of AOM-associated microorganisms remain poorly understood. Here we report the cultivation of an AOM microbial community from deep-sea methane-seep sediment using a continuous-flow bioreactor with polyurethane sponges, called the down-flow hanging sponge (DHS) bioreactor. We anaerobically incubated deep-sea methane-seep sediment collected from the Nankai Trough, Japan, for 2,013 days in the bioreactor at 10 degrees C. Following incubation, an active AOM activity was confirmed by a tracer experiment using C-13-labeled methane. Phylogenetic analyses demonstrated that phylogenetically diverse Archaea and Bacteria grew in the bioreactor. After 2,013 days of incubation, the predominant archaeal components were anaerobic methanotroph (ANME)-2a, Deep-Sea Archaeal Group, and Marine Benthic Group-D, and Gammaproteobacteria was the dominant bacterial lineage. Fluorescence in situ hybridization analysis showed that ANME-1 and -2a, and most ANME-2c cells occurred without close physical interaction with potential bacterial partners. Our data demonstrate that the DHS bioreactor system is a useful system for cultivating fastidious methane-seep-associated sedimentary microorganisms.	[Aoki, Masataka; Saito, Yumi; Miyazaki, Masayuki; Saito, Yayoi; Takai, Ken; Imachi, Hiroyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa, Japan; [Aoki, Masataka; Ehara, Masayuki; Saito, Yayoi; Miyashita, Ai; Kawakami, Shuji; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Environm Syst Engn, Nagaoka, Niigata 94021, Japan; [Yoshioka, Hideyoshi] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan; [Kawakami, Shuji] Anan Natl Coll Technol, Dept Construct Syst Engn, Anan, Tokushima, Japan; [Ohashi, Akiyoshi] Hiroshima Univ, Dept Social & Environm Engn, Hiroshima, Japan; [Nunoura, Takuro] JAMSTEC, Res & Dev Ctr Marine Biosci, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Imachi, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa, Japan.	imachi@jamstec.go.jp	Imachi, Hiroyuki/D-3298-2009; Ohashi, Akiyoshi/H-4744-2011; Nunoura, Takuro/AAL-6266-2020	Imachi, Hiroyuki/0000-0001-6588-5055; Ohashi, Akiyoshi/0000-0003-2213-3915; Nunoura, Takuro/0000-0003-2323-0880; AOKI, MASATAKA/0000-0002-9352-2072	Japan Society for the Promotion of Science (JSPS) KAKENHI [24687011, 13J08869]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23241029] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 24687011 and 13J08869, and by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal LK, 1997, WATER SCI TECHNOL, V36, P433, DOI 10.1016/S0273-1223(97)00552-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araki N, 1999, WATER SCI TECHNOL, V39, P23, DOI 10.1016/S0273-1223(99)00146-8; Bertram S, 2013, ENVIRON MICROBIOL, V15, P2384, DOI 10.1111/1462-2920.12112; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bowman J.P., 2005, BERGEYS MANUAL SYSTE, V2, P248, DOI DOI 10.1007/0-387-28022-7_7; Deusner C, 2010, BIOTECHNOL BIOENG, V105, P524, DOI 10.1002/bit.22553; Durbin AM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00168; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Girguis PR, 2003, APPL ENVIRON MICROB, V69, P5472, DOI 10.1128/AEM.69.9.5472-5482.2003; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Green-Saxena A, 2014, ISME J, V8, P150, DOI 10.1038/ismej.2013.147; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Heijs SK, 2007, MICROB ECOL, V53, P384, DOI 10.1007/s00248-006-9172-3; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Imachi H, 2006, APPL ENVIRON MICROB, V72, P2080, DOI 10.1128/AEM.72.3.2080-2091.2006; Imachi H, 2008, INT J SYST EVOL MICR, V58, P2258, DOI 10.1099/ijs.0.65727-0; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Imachi H, 2009, INT J SYST EVOL MICR, V59, P800, DOI 10.1099/ijs.0.003731-0; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jagersma GC, 2009, ENVIRON MICROBIOL, V11, P3223, DOI 10.1111/j.1462-2920.2009.02036.x; Jorgensen SL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00299; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Kalyuzhnaya MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3785; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kleindienst S, 2012, ENVIRON MICROBIOL, V14, P2689, DOI 10.1111/j.1462-2920.2012.02832.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; Kubota K, 2006, J MICROBIOL METH, V66, P521, DOI 10.1016/j.mimet.2006.02.002; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Machdar I, 2000, WATER SCI TECHNOL, V42, P83, DOI 10.2166/wst.2000.0362; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Meulepas RJW, 2010, FEMS MICROBIOL ECOL, V72, P261, DOI 10.1111/j.1574-6941.2010.00849.x; Meulepas RJW, 2009, BIOTECHNOL BIOENG, V104, P458, DOI 10.1002/bit.22412; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Miyashita A, 2009, FEMS MICROBIOL LETT, V297, P31, DOI 10.1111/j.1574-6968.2009.01648.x; MOENCH T T, 1983, Journal of Microbiological Methods, V1, P199, DOI 10.1016/0167-7012(83)90024-6; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Nunoura T, 2006, FEMS MICROBIOL ECOL, V57, P149, DOI 10.1111/j.1574-6941.2006.00101.x; Nunoura T, 2012, MICROBES ENVIRON, V27, P382, DOI 10.1264/jsme2.ME12032; Onodera T, 2013, BIORESOURCE TECHNOL, V136, P169, DOI 10.1016/j.biortech.2013.02.096; Orcutt BN, 2010, DEEP-SEA RES PT II, V57, P2008, DOI 10.1016/j.dsr2.2010.05.014; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pachiadaki MG, 2010, FEMS MICROBIOL ECOL, V72, P429, DOI 10.1111/j.1574-6941.2010.00857.x; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Schramm A, 2002, ENVIRON MICROBIOL, V4, P713, DOI 10.1046/j.1462-2920.2002.00364.x; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Sekiguchi Y, 2005, WATER SCI TECHNOL, V52, P107, DOI 10.2166/wst.2005.0505; Sekiguchi Y, 1999, APPL ENVIRON MICROB, V65, P1280; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; Sowers KR, 2001, BERGEYS MANUAL SYSTE, P276; Steeb P, 2014, LIMNOL OCEANOGR-METH, V12, P25, DOI 10.4319/lom.2014.12.25; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Uemura S., 2010, ENV ANAEROBIC TECHNO, P91; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vigneron A, 2013, ISME J, V7, P1595, DOI 10.1038/ismej.2013.18; Wang FP, 2014, ISME J, V8, P1069, DOI 10.1038/ismej.2013.212; Wegener G, 2009, BIOGEOSCIENCES, V6, P867, DOI 10.5194/bg-6-867-2009; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; YAMAMOTO S, 1976, J CHEM ENG DATA, V21, P78, DOI 10.1021/je60068a029; Yanagawa K, 2011, GEOMICROBIOL J, V28, P118, DOI 10.1080/01490451003709334; Yoshioka H, 2010, GEOBIOLOGY, V8, P223, DOI 10.1111/j.1472-4669.2009.00231.x; Zhang Y, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-137; Zhang Y, 2010, BIORESOURCE TECHNOL, V101, P3132, DOI 10.1016/j.biortech.2009.11.103	82	15	15	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105356	10.1371/journal.pone.0105356	http://dx.doi.org/10.1371/journal.pone.0105356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141130	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200077
J	Jatrana, S; Richardson, K; Blakely, T; Dayal, S				Jatrana, Santosh; Richardson, Ken; Blakely, Tony; Dayal, Saira			Does Mortality Vary between Asian Subgroups in New Zealand: An Application of Hierarchical Bayesian Modelling	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; UNITED-STATES; RACIAL-DISCRIMINATION; ETHNIC-DIFFERENCES; MEXICAN-AMERICANS; SOUTH ASIANS; RISK-FACTORS; HEALTH; MIGRANT	The aim of this paper was to see whether all-cause and cause-specific mortality rates vary between Asian ethnic subgroups, and whether overseas born Asian subgroup mortality rate ratios varied by nativity and duration of residence. We used hierarchical Bayesian methods to allow for sparse data in the analysis of linked census-mortality data for 25-75 year old New Zealanders. We found directly standardised posterior all-cause and cardiovascular mortality rates were highest for the Indian ethnic group, significantly so when compared with those of Chinese ethnicity. In contrast, cancer mortality rates were lowest for ethnic Indians. Asian overseas born subgroups have about 70% of the mortality rate of their New Zealand born Asian counterparts, a result that showed little variation by Asian subgroup or cause of death. Within the overseas born population, all-cause mortality rates for migrants living 0-9 years in New Zealand were about 60% of the mortality rate of those living more than 25 years in New Zealand regardless of ethnicity. The corresponding figure for cardiovascular mortality rates was 50%. However, while Chinese cancer mortality rates increased with duration of residence, Indian and Other Asian cancer mortality rates did not. Future research on the mechanisms of worsening of health with increased time spent in the host country is required to improve the understanding of the process, and would assist the policy-makers and health planners.	[Jatrana, Santosh] Deakin Univ, Alfred Deakin Res Inst, Geelong, Vic 3217, Australia; [Richardson, Ken; Blakely, Tony; Dayal, Saira] Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand	Deakin University; University of Otago	Jatrana, S (corresponding author), Deakin Univ, Alfred Deakin Res Inst, Waterfront Campus, Geelong, Vic 3217, Australia.	santosh.jatrana@deakin.edu.au		Jatrana, Santosh/0000-0001-5922-2001; Blakely, Tony/0000-0002-6995-4369	University of Otago [ORG 0111-0312]; Health Research Council of New Zealand; New Zealand Ministry of Health	University of Otago; Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Ministry of Health	This study was funded by a University of Otago Research Grant (ORG 0111-0312) and used data from the New Zealand Census-Mortality Study (NZCMS). The NZCMS was initially funded by the Health Research Council of New Zealand, and receives on-going funding from the New Zealand Ministry of Health. The New Zealand Population Health Charitable Trust provided Saira Dayal with financial assistance as a public health medicine registrar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahim S, 2012, SOC SCI MED, V75, P2116, DOI 10.1016/j.socscimed.2012.07.030; Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Abraido-Lanza AF, 2006, AM J PUBLIC HEALTH, V96, P1342, DOI 10.2105/AJPH.2005.064980; Anson J, 2004, EUR J POPUL, V20, P191, DOI 10.1007/s10680-004-0883-1; Baluja KF, 2003, AM J PUBLIC HEALTH, V93, P642, DOI 10.2105/AJPH.93.4.642; Beaglehole A., 2007, IMMIGRATION REGULATI; Bedford R, 2001, ASIAN PAC MIGR J, V10, P585; BEISCHER NA, 1991, DIABETES, V40, P35, DOI 10.2337/diab.40.2.S35; Berry J W, 1990, Arctic Med Res, V49, P142; Bhopal R, 2005, J PUBLIC HEALTH-UK, V27, P93, DOI 10.1093/pubmed/fdh202; Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Blakely T, 2002, NEW ZEAL MED J, V115, P39; Blakely T, 2000, AUST NZ J PUBL HEAL, V24, P92, DOI 10.1111/j.1467-842X.2000.tb00732.x; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Blakely T, 2004, NZ MED J, V117, P1; Blakely T, 2009, DOES MORTALITY VARY; BLAKELY T, 2007, TRACKING DISPARITIES; Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Dayal S, 2007, SOCIOECONOMIC INFLUE; Deboosere P., 2005, POPULATION, V60, P655, DOI [DOI 10.3917/POPE.505.0655, 10.3917/pope.505.0655]; Fawcett J., 2002, 5 NZCMS U OT; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Friis R, 1998, SCAND J SOC MED, V26, P173, DOI 10.1177/14034948980260030601; Gee GC, 2006, AM J PUBLIC HEALTH, V96, P1821, DOI 10.2105/AJPH.2005.080085; Gee GC, 2009, EPIDEMIOL REV, V31, P130, DOI 10.1093/epirev/mxp009; Gissler M, 2003, SOC SCI MED, V57, P1443, DOI 10.1016/S0277-9536(02)00402-1; Goggins WB, 2009, CANCER CAUSE CONTROL, V20, P635, DOI 10.1007/s10552-008-9275-x; Greif SW, 1995, IMMIGRATION NATL IDE; Gushulak B, 2007, CAN MED ASSOC J, V176, P1439, DOI 10.1503/cmaj.070395; Hajat A, 2010, ETHNIC HEALTH, V15, P531, DOI 10.1080/13557858.2010.496479; Harding SA, 2006, INTERN MED J, V36, P759, DOI 10.1111/j.1445-5994.2006.01211.x; Harris R, 2012, AM J PUBLIC HEALTH, V102, P1012, DOI 10.2105/AJPH.2011.300626; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Hodgson R, 2010, EC IMPACTS IMMIGRATI; Hummer RA, 1999, SOC SCI QUART, V80, P136; Hyman I, 2001, 0105 HLTH CAN; Ip M, 2007, TE ARA ENCY NZ; Ivey SL, 2006, ETHNIC DIS, V16, P886; Kalra P, 2004, ETHNIC DIS, V14, P497; Kaur J, 2006, Indian J Public Health, V50, P97; Kouris-Blazos A, 2002, ASIA PAC J CLIN NUTR, V11, pS569, DOI 10.1046/j.1440-6047.11.supp3.2.x; Kurian AK, 2007, ETHNIC DIS, V17, P143; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Leckie J., 2007, INDIAN SETTLERS STOR; Li J, 2009, NZ ASIAN SMOKERS CHA; Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special_Issue_2.S68; Math MV, 2007, INDIAN J MED RES, V125, P590; McKay S., 2006, MIGRANT WORKERS ENGL; McKinnon M., 1996, IMMIGRANTS CITIZENS; Ministry of Health, 2006, AS HLTH CHART BOOK 2; Ministry of Health, 2006, AS HLTH CHARTB; Morales LS, 2002, J HEALTH CARE POOR U, V13, P477, DOI 10.1177/104920802237532; Muennig P, 2004, BMC CARDIOVASCULAR D, P4; Rasanathan K, 2006, ETHNIC HEALTH, V11, P211, DOI 10.1080/13557850600565525; Razum O, 1998, TROP MED INT HEALTH, V3, P297, DOI 10.1046/j.1365-3156.1998.00233.x; Reddy KS, 2007, J AM COLL CARDIOL, V50, P1370, DOI 10.1016/j.jacc.2007.04.097; Richardson K, 2013, DEMOGRAPHY, V50, P2053, DOI 10.1007/s13524-013-0234-0; Rush Elaine, 2004, N Z Med J, V117, pU1203; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; SINGH GK, 2001, AM J PUBLIC HEALTH, V91, P392; Statistics New Zealand, 2005, AS PEOPL; Statistics New Zealand, 2005, STAT STAND ETHN; Stern MP, 1999, PREV MED, V29, pS90, DOI 10.1006/pmed.1998.0464; Strong K, 1998, Aust Health Rev, V21, P124; Taylor R, 1999, AUST NZ J PUBL HEAL, V23, P20, DOI 10.1111/j.1467-842X.1999.tb01200.x; Thornley S, 2011, NEW ZEAL MED J, V124, P21; Tobias M, 2009, INT J EPIDEMIOL, V38, P1711, DOI 10.1093/ije/dyp156; University of Western Sydney, 1988, CHALL RAC SURV; Wells Susan, 2007, N Z Med J, V120, pU2712; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Williams R, 1997, Ethn Health, V2, P21; Wingate MS, 2006, SOC SCI MED, V62, P491, DOI 10.1016/j.socscimed.2005.06.015; Winter H, 1999, BRIT J CANCER, V79, P645, DOI 10.1038/sj.bjc.6690102; Young J, 2006, AM J EPIDEMIOL, V164, P282, DOI 10.1093/aje/kwj171	78	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105141	10.1371/journal.pone.0105141	http://dx.doi.org/10.1371/journal.pone.0105141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140523	gold, Green Published, Green Accepted			2022-12-27	WOS:000342687200054
J	Kinaston, R; Bedford, S; Richards, M; Hawkins, S; Gray, A; Jaouen, K; Valentin, F; Buckley, H				Kinaston, Rebecca; Bedford, Stuart; Richards, Michael; Hawkins, Stuart; Gray, Andrew; Jaouen, Klervia; Valentin, Frederique; Buckley, Hallie			Diet and Human Mobility from the Lapita to the Early Historic Period on Uripiv Island, Northeast Malakula, Vanuatu	PLOS ONE			English	Article							NITROGEN-ISOTOPE RATIOS; STABLE-ISOTOPE; BONE-COLLAGEN; TERRESTRIAL COMPONENTS; CARBON-ISOTOPE; WATOM ISLAND; TEOUMA EFATE; NEW-HEBRIDES; CORAL-REEF; STRONTIUM	Vanuatu was first settled ca. 3000 years ago by populations associated with the Lapita culture. Models of diet, subsistence practices, and human interaction for the Lapita and subsequent occupation periods have been developed mainly using the available archaeological and paleoenvironmental data. We test these models using stable (carbon, nitrogen, and sulfur) and radiogenic (strontium) isotopes to assess the diet and childhood residency of past communities that lived on the small (<1 km(2)) island of Uripiv, located off the northeast coast of Malakula, Vanuatu. The burials are from the initial Lapita occupation of the island (ca. 2800-2600 BP), the subsequent later Lapita (LL, ca. 2600-2500 BP) and post-Lapita (PL, ca. 2500-2000 BP) occupations, in addition to a late prehistoric/historic (LPH, ca. 300-150 BP) occupation period. The human stable isotope results indicate a progressively more terrestrial diet over time, which supports the archaeological model of an intensification of horticultural and arboricultural systems as local resources were depleted, populations grew, and cultural situations changed. Pig diets were similar and included marine foods during the Lapita and PL periods but were highly terrestrial during the LPH period. This dietary pattern indicates that there was little variation in animal husbandry methods during the first 800 years of prehistory; however, there was a subsequent change as animal diets became more controlled in the LPH period. After comparison with the local bioavailable Sr-87/Sr-86 baseline, all of the Lapita and LPH individuals appeared to be 'local', but three of the PL individuals were identified as "non-local.'' We suggest that these "non-locals'' moved to the island after infancy or childhood from one of the larger islands, supporting the model of a high level of regional interaction during the post-Lapita period.	[Kinaston, Rebecca; Buckley, Hallie] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Bedford, Stuart] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Richards, Michael; Jaouen, Klervia] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hawkins, Stuart] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Gray, Andrew] Univ Otago, Otago Sch Med Sci, Dept Prevent & Social Med, Dunedin, New Zealand; [Valentin, Frederique] Maison Archeol & Ethnol, CNRS, Nanterre, France	University of Otago; Australian National University; University of British Columbia; Max Planck Society; Australian National University; University of Otago; Centre National de la Recherche Scientifique (CNRS)	Kinaston, R (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	rebecca.kinaston@gmail.com	Buckley, Hallie/Q-5458-2019; Richards, Michael/O-3717-2016; Gray, Andrew Robert/L-9161-2015	Richards, Michael/0000-0001-5274-8887; Gray, Andrew Robert/0000-0003-4299-2194; Bedford, Stuart/0000-0001-6476-5617	Australian Research Council (ARC) Discovery Grant [DP0556874]; New Zealand Marsden Grant [09-UOO-106]; Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant [NRS UMR 7041]; Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany; Natural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council (SSHRC)	Australian Research Council (ARC) Discovery Grant(Australian Research Council); New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant; Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	The excavation of the Uripiv site, dating of the archaeological material, and the stable isotope analysis was primarily funded by an Australian Research Council (ARC) Discovery Grant (DP0556874, www.arc.gov.au) and a New Zealand Marsden Grant (09-UOO-106, www.royalsociety.org.nz/programmes/funds/marsden/). Further human bone dates were paid for by a Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant (NRS UMR 7041, www.cnrs.fr). Strontium isotope analysis was funded by the Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany (http://www.eva.mpg.de/evolution/), the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca), and the Social Sciences and Humanities Research Council (SSHRC, http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2009, PAC SCI, V63, P477, DOI 10.2984/049.063.0403; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Andersen AJ, 2001, ARCHAEOLOGY LAPITA D; Anderson A, 2002, WORLD ARCHAEOL, V33, P375, DOI 10.1080/00438240120107431; [Anonymous], 1989, CARNEGIE I WASH YR B; Athfield NB, 2008, J ROY SOC NEW ZEAL, V38, P1, DOI 10.1080/03014220809510543; Barrau J., 1973, Man and his foods., P87; Barrau J, 1958, SUBSISTENCE AGR MELA; Bashan Y, 2002, TREES-STRUCT FUNCT, V16, P159, DOI 10.1007/s00468-001-0152-4; Bedford S., 2010, LAPITA ANCETRES OCEA, P122; Bedford S., 2008, ASIAN PERSPECT, V47, P95, DOI DOI 10.1353/ASI.2008.0003; Bedford S., 2003, PACIFIC ARCHAEOLOGY, P147; Bedford S., 2009, NZ ARCHAEOLOGICAL AS, V28, P215; Bedford S, 2011, J PAC ARCHAEOL, V2, P26; Bentley RA, 2007, AM ANTIQUITY, V72, P645, DOI 10.2307/25470438; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Briqueu L, 1994, P OCEAN DRILLING PRO, V134, P393; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; Budd P, 2004, ANTIQUITY, V78, P127, DOI 10.1017/S0003598X0009298X; Budd Paul, 2000, EUR J ARCHAEOL, V3, P370, DOI DOI 10.1177/146195710000300304; Budda P, 1999, COLLOQ SEMI, P301; Buikstra J. E., 1994, STANDARDS DATA COLLE; Burley DV., 2001, ARCHAEOL OCEAN, V36, P89, DOI [10.1002/j.1834-4453.2001.tb00481.x, DOI 10.1002/J.1834-4453.2001.TB00481.X]; Clark G., 2010, LAPITA ANCETRES OCEA, P212; Clark G, 2013, ARCHAEOL OCEAN, V48, P141, DOI 10.1002/arco.5012; COMAR CL, 1957, SCIENCE, V126, P485, DOI 10.1126/science.126.3272.485; Comar CL, 1957, P SOC EXPT BIOL MED, V88; Craig OE, 2010, J ARCHAEOL SCI, V37, P2504, DOI 10.1016/j.jas.2010.05.010; Davidson J, 2001, ARCHAEOLOGY LAPITA D, V17, P115; Deacon A. Bernard, 1934, MALEKULA VANISHING P; Deniel C, 2001, ANAL CHIM ACTA, V426, P95, DOI 10.1016/S0003-2670(00)01185-5; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dickinson WR, 2013, J PAC ARCHAEOL, V4, P1; Dickinson WR, 2001, GEOARCHAEOLOGY, V16, P275, DOI 10.1002/1520-6548(200103)16:3<275::AID-GEA1005>3.0.CO;2-E; Donohue M, 2008, OCEAN LINGUIST, V47, P433; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Evans J, 2010, PARLIAMENT AFF, V63, P1, DOI 10.1093/pa/gsp042; Fell TP, 1998, RADIAT PROT DOSIM, V79, P311, DOI 10.1093/oxfordjournals.rpd.a032417; Field JS, 2009, J ARCHAEOL SCI, V36, P1547, DOI 10.1016/j.jas.2009.03.016; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; Galipaud J, 2014, ARCHAEOL OCEAN; Galipaud JC, 2007, TERRA AUSTRALIS, V26, P151; Green R.C, 1982, NZ J ARCHAEOLOGY, V4, P7; Hamilton AM, 2010, PAC SCI, V64, P149, DOI 10.2984/64.2.149; Hartman G, 2014, GEOCHIM COSMOCHIM AC, V126, P250, DOI 10.1016/j.gca.2013.11.015; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Hide R., 2003, ACIAR MONOGRAPH, V108; Horrocks M, 2014, J ROY SOC NEW ZEAL, V44, P17, DOI 10.1080/03036758.2013.842177; Horrocks M, 2009, J ARCHAEOL SCI, V36, P2048, DOI 10.1016/j.jas.2009.05.024; Horrocks Mark, 2005, Archaeology in Oceania, V40, P67; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; JOHNSON CM, 1990, CONTRIB MINERAL PETR, V104, P99, DOI 10.1007/BF00310649; Jones S, 2009, FOOD GENDER FIJI; Jones S, 2009, J ARCHAEOL SCI, V36, P2742, DOI 10.1016/j.jas.2009.08.014; Katzenberg M. A., 2008, BIOL ANTHR HUMAN SKE, V2, P413; Katzenberg MA, 2012, BLACKW COMPANION ANT, P97; KEEGAN WF, 1988, AM ANTIQUITY, V53, P320, DOI 10.2307/281022; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kennett D, 2006, ORIG HUM BEHAV, V1, P265; Kinaston RL, 2009, J ARCHAEOL SCI, V36, P2780, DOI 10.1016/j.jas.2009.09.004; Kinaston R.L., 2013, PACIFIC ARCHAEOLOGY, P91; Kinaston R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090376; Kinaston RL, 2013, AM J PHYS ANTHROPOL, V151, P589, DOI 10.1002/ajpa.22314; Kinaston RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064580; KIRCH PV, 1997, LAPITA PEOPLES ANCES; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Layard J., 1942, STONE MEN MALEKULA; Leach B, 2003, NZ J ARCHAEOL, V23, P31; Littleton, 2008, FORENSIC APPROACHES, P155; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MacCall G.J.H., 1970, B VOLCANOL, V34, P681, DOI DOI 10.1007/BF02596698; MARSHALL AG, 1976, BIOL J LINN SOC, V8, P319, DOI 10.1111/j.1095-8312.1976.tb00253.x; MEDWAY, 1975, PHILOS T R SOC B, V272, P423, DOI 10.1098/rstb.1975.0096; Montgomery J., 2002, LEAD STRONTIUM ISOTO; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Muldner G, 2007, AM J PHYS ANTHROPOL, V133, P682, DOI 10.1002/ajpa.20561; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Nehlich O, 2009, J ARCHAEOL SCI, V36, P1791, DOI 10.1016/j.jas.2009.04.008; Nojima Y, 2008, COOKING STONES VANUA; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Oliver D, 1989, OCEANIA NATIVE CULTU; Oomen H, 1958, 118 S PAC COMM; PARKINSON R, 1999, 30 YEARS S SEAS; Pawley A, 2010, MIGRATION HIST WORLD, P77; Petchey F, 2005, RADIOCARBON, V47, P181, DOI 10.1017/S0033822200019688; Petchey F, 2011, J ARCHAEOL SCI, V38, P29, DOI 10.1016/j.jas.2010.07.029; Pollock N., 1992, THESE ROOTS REMAIN F; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Quantin P, 1972, NOUVELLES HEBRIDES A; Raos AM, 2004, J VOLCANOL GEOTH RES, V134, P35, DOI 10.1016/j.jvolgeores.2003.12.004; Richards MP, 2009, ARCHAEOL OCEAN, V44, P29, DOI 10.1002/j.1834-4453.2009.tb00042.x; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; Sand C, 2010, LAPITA OCEANIC ANCES, P271; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Shaw B, 2011, J ANTHROPOL ARCHAEOL, V30, P344, DOI 10.1016/j.jaa.2011.05.004; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Shaw BJ, 2009, J ARCHAEOL SCI, V36, P1079, DOI 10.1016/j.jas.2008.12.010; Sheppard PJ, 2011, CURR ANTHROPOL, V52, P799, DOI 10.1086/662201; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Spriggs M., 1997, ISLAND MELANESIANS P; Steadman DW, 1999, COLLOQ SEMI, P375; Summerhayes G, 2001, ARCHAEOLOGY LAPITA D, V17, P25; Szabo K, 2000, ARCHAEOLOGY LAPITA D, P159; Szabo K, 2011, QUATERN INT, V239, P8, DOI 10.1016/j.quaint.2011.02.033; TAYLOR FW, 1980, J GEOPHYS RES, V85, P5367, DOI 10.1029/JB085iB10p05367; TERAKADO Y, 1988, CONTRIB MINERAL PETR, V99, P1, DOI 10.1007/BF00399360; THOMAS WL, 1963, MANS PLACE ISLAND EC, P7; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Trickett MA, 2003, APPL GEOCHEM, V18, P653, DOI 10.1016/S0883-2927(02)00181-6; Valentin F, 2006, J ARCHAEOL SCI, V33, P1396, DOI 10.1016/j.jas.2006.01.012; Valentin F, 2010, J ARCHAEOL SCI, V37, P1820, DOI 10.1016/j.jas.2010.01.039; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Walter A, 1993, NOTES TECHNIQUES ORS; WASSERMAN RH, 1957, AM J PHYSIOL, V189, P91, DOI 10.1152/ajplegacy.1957.189.1.91; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Weightman B, 1989, AGR VANUATU HIST PER; Wirrmann D, 2011, QUATERNARY SCI REV, V30, P3908, DOI 10.1016/j.quascirev.2011.10.003; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P617, DOI 10.4319/lo.1995.40.3.0617; YEN DE, 1974, ECON BOT, V28, P247, DOI 10.1007/BF02861424; Yen DE, 1996, ACIAR PROC, P36	134	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104071	10.1371/journal.pone.0104071	http://dx.doi.org/10.1371/journal.pone.0104071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AQ3JB	25140807	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200011
J	Oh, HY; Seo, SS; Kim, MK; Lee, DO; Chung, YK; Lim, MC; Kim, JY; Lee, CW; Park, SY				Oh, Hea Young; Seo, Sang-Soo; Kim, Mi Kyung; Lee, Dong Ock; Chung, Youn Kyung; Lim, Myong Cheol; Kim, Joo-Young; Lee, Chan Wha; Park, Sang-Yoon			Synergistic Effect of Viral Load and Alcohol Consumption on the Risk of Persistent High-Risk Human Papillomavirus Infection	PLOS ONE			English	Article							CERVICAL-CANCER; CIGARETTE-SMOKING; NATURAL-HISTORY; WOMEN; TYPE-16; PREVALENCE; CLEARANCE; POPULATION; EXPRESSION; HPV-16	Purpose: This prospective study aimed to examine the combined effect of viral load and alcohol consumption on the risk of persistent high-risk (HR) human papillomavirus (HPV) infection. Methods: Among women undergoing health screening between 2002 and 2011 at the National Cancer Center, 284 and 122 women with HR-HPV infection and cytological findings of low-grade squamous intraepithelial or lower-grade lesions were followed up for 1 and 2 years, respectively. Multivariate logistic regression analysis was performed, and the relative excess risk due to interaction (RERI) and synergy index (S) were calculated. Results: Among drinkers, the risks of 1-year (odds ratio [OR] 4.09, 95% confidence interval [CI] 2.05-8.18) and 2-year persistence (OR 8.08, CI 2.36-27.6) were significantly higher for high HPV loads than for low HPV loads; this association was not seen for non-drinkers. The risks for 1-year (OR 4.14, CI 1.89-9.05) and 2-year persistence (OR 6.61, CI 2.09-20.9) were significantly higher in subjects with a high HPV load who were also drinkers than in those who were non-drinkers. A high HPV load together with a longer drinking duration or higher alcohol consumption was associated with increased risks of 1-year (OR 3.07, CI 1.40-6.75 or OR 2.05, CI 0.87-4.83) and 2-year persistence (OR 6.40, CI 1.72-23.8 or OR 4.14, CI 1.18-14.6). The synergistic effect of alcohol consumption and HR-HPV load was stronger on the risk of 2-year persistence (RERI = 3.26, S = 2.38) than on the risk of 1-year persistence (RERI = 1.21, S = 1.63). Conclusions: The synergistic effect of HR-HPV load and alcohol consumption was associated with the risk of HR-HPV persistence and was stronger for longer-term HR-HPV infection. Limiting alcohol consumption might be an important measure to prevent the development of cervical cancer in women with a high HR-HPV load.	[Oh, Hea Young; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang Si, Gyeonggi Do, South Korea; [Seo, Sang-Soo; Lee, Dong Ock; Lim, Myong Cheol; Kim, Joo-Young; Park, Sang-Yoon] Natl Canc Ctr, Ctr Uterine Canc, Goyang Si, Gyeonggi Do, South Korea; [Chung, Youn Kyung; Lee, Chan Wha] Natl Canc Ctr, Ctr Canc Prevent & Detect, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang Si, Gyeonggi Do, South Korea.	alrud@ncc.re.kr			National Cancer Center Korea [1110320, 1310361, 0910221]	National Cancer Center Korea	This research was supported by grants from the National Cancer Center Korea (1110320, 1310361, 0910221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bae J, 2009, GYNECOL ONCOL, V115, P75, DOI 10.1016/j.ygyno.2009.06.016; Briolat J, 2007, INT J CANCER, V121, P2198, DOI 10.1002/ijc.22959; Broccolo F, 2009, J MED VIROL, V81, P278, DOI 10.1002/jmv.21395; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Carcopino X, 2011, J MED VIROL, V83, P637, DOI 10.1002/jmv.22022; Castle PE, 2005, CANCER EPIDEM BIOMAR, V14, P1311, DOI 10.1158/1055-9965.EPI-04-0799; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; Del Nonno F, 2011, MODERN PATHOL, V24, P855, DOI 10.1038/modpathol.2011.40; FERNANDEZ C, 1995, BRIT J CANCER, V72, P1194, DOI 10.1038/bjc.1995.485; Fontaine J, 2008, J CLIN VIROL, V43, P307, DOI 10.1016/j.jcv.2008.07.013; Gage JC, 2010, CANCER EPIDEM BIOMAR, V19, P1668, DOI 10.1158/1055-9965.EPI-09-1286; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; GROOTENHUIS PA, 1995, J CLIN EPIDEMIOL, V48, P859, DOI 10.1016/0895-4356(95)00013-T; Gunnell AS, 2006, CANCER EPIDEM BIOMAR, V15, P2141, DOI 10.1158/1055-9965.EPI-06-0399; Hibma Merilyn H, 2012, Open Virol J, V6, P241, DOI 10.2174/1874357901206010241; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; International Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Int J Cancer, V118, P1481, DOI 10.1002/ijc.21493; Kang WD, 2011, GYNECOL ONCOL, V121, P546, DOI 10.1016/j.ygyno.2011.01.015; Kim JW, 2012, J INT MED RES, V40, P486, DOI 10.1177/147323001204000210; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lee SA, 2003, CANCER LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Marks MA, 2012, J CLIN MICROBIOL, V50, P300, DOI 10.1128/JCM.05979-11; Min KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072142; Nielsen A, 2010, J MED VIROL, V82, P616, DOI 10.1002/jmv.21750; Oh JK, 2009, EUR J CANCER PREV, V18, P56, DOI 10.1097/CEJ.0b013e328305a0a6; Park Young-Joo, 2003, Taehan Kanho Hakhoe Chi, V33, P457; Perluigi M, 2009, J CELL MOL MED, V13, P1809, DOI 10.1111/j.1582-4934.2008.00465.x; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Ryu A, 2010, J GYNECOL ONCOL, V21, P87, DOI 10.3802/jgo.2010.21.2.87; Sammarco ML, 2013, EUR J OBSTET GYN R B, V168, P222, DOI 10.1016/j.ejogrb.2013.01.012; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schmeink CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027937; Siegel EM, 2012, INT J CANCER, V131, P219, DOI 10.1002/ijc.26363; Xi LF, 2011, J INFECT DIS, V203, P1425, DOI 10.1093/infdis/jir049; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763; Xu YC, 2009, INT J CLIN EXP PATHO, V2, P169; Yoon H, 2001, KOREAN J UROL, V42, P13	41	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104374	10.1371/journal.pone.0104374	http://dx.doi.org/10.1371/journal.pone.0104374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140695	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200019
J	Park, E; Song, CH; Park, JI; Ahn, RS; Choi, HS; Ko, C; Lee, K				Park, Eunsook; Song, Chin-Hee; Park, Jae-Il; Ahn, Ryun-Sup; Choi, Hueng-Sik; Ko, CheMyong; Lee, Keesook			Transforming Growth Factor-beta 1 Signaling Represses Testicular Steroidogenesis through Cross-Talk with Orphan Nuclear Receptor Nur77	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEYDIG-CELL STEROIDOGENESIS; P450C17 GENE-TRANSCRIPTION; STAR TRANSCRIPTION; PRIMARY CULTURE; FACTOR-I; NGFI-B; EXPRESSION; SMAD3; PROMOTER	Transforming growth factor-beta 1 (TGF-beta 1) has been reported to inhibit luteinizing hormone (LH) mediated-steroidogenesis in testicular Leydig cells. However, the mechanism by which TGF-beta 1 controls the steroidogenesis in Leydig cells is not well understood. Here, we investigated the possibility that TGF-beta 1 represses steroidogenesis through cross-talk with the orphan nuclear receptor Nur77. Nur77, which is induced by LH/cAMP signaling, is one of major transcription factors that regulate the expression of steroidogenic genes in Leydig cells. TGF-beta 1 signaling inhibited cAMP-induced testosterone production and the expression of steroidogenic genes such as P450c17, StAR and 3 beta-HSD in mouse Leydig cells. Further, TGF-beta 1/ALK5 signaling repressed cAMP-induced and Nur77-activated promoter activity of steroidogenic genes. In addition, TGF-beta 1/ALK5-activated Smad3 repressed Nur77 transactivation of steroidogenic gene promoters by interfering with Nur77 binding to DNA. In primary Leydig cells isolated from Tgfbr2(flox/flox) Cyp17iCre mice, TGF-beta 1-mediated repression of cAMP-induced steroidogenic gene expression was significantly less than that in primary Leydig cells from Tgfbr2flox/flox mice. Taken together, these results suggest that TGF-beta 1/ALK5/Smad3 signaling represses the expression of steroidogenic genes via the suppression of Nur77 transactivation in testicular Leydig cells. These findings may provide a molecular mechanism involved in the TGF-beta 1-mediated repression of testicular steroidogenesis.	[Park, Eunsook; Song, Chin-Hee; Choi, Hueng-Sik; Lee, Keesook] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Park, Jae-Il] Chonnam Natl Univ, Gwangju Ctr, Korea Basic Sci Inst, Kwangju, South Korea; [Ahn, Ryun-Sup] CHA Med Univ, Grad Sch Integrat Med, Seoul, South Korea; [Ko, CheMyong] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61801 USA	Chonnam National University; Chonnam National University; Korea Basic Science Institute (KBSI); University of Illinois System; University of Illinois Urbana-Champaign	Lee, K (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea.	klee@chonnam.ac.kr	Ko, CheMyong Jay/A-7475-2019; Ahn, Ryun S./D-1218-2011	Ko, CheMyong Jay/0000-0002-0963-3731; 	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A2A2A01008388]; STFC [ST/F501761/1, ST/J001511/1] Funding Source: UKRI	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A2A2A01008388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVALLET O, 1994, ENDOCRINOLOGY, V134, P2079, DOI 10.1210/en.134.5.2079; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Derebecka-Holysz N, 2008, MOL CELL BIOCHEM, V307, P65, DOI 10.1007/s11010-007-9585-4; Gnessi L, 1997, ENDOCR REV, V18, P541, DOI 10.1210/er.18.4.541; Gonzalez CR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-148; Gonzalez CR, 2010, J REPROD DEVELOP, V56, P389, DOI 10.1262/jrd.09-166N; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hayes SA, 2001, CANCER RES, V61, P2112; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Ingman WV, 2007, ENDOCRINOLOGY, V148, P4032, DOI 10.1210/en.2006-1759; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Le Roy C, 1999, J STEROID BIOCHEM, V69, P379, DOI 10.1016/S0960-0760(99)00075-8; Lee SY, 2012, MOL CELL ENDOCRINOL, V362, P91, DOI 10.1016/j.mce.2012.05.015; Lee SY, 2009, FREE RADICAL BIO MED, V47, P1591, DOI 10.1016/j.freeradbiomed.2009.09.004; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; LIN T, 1987, BIOCHEM BIOPH RES CO, V146, P387, DOI 10.1016/0006-291X(87)90541-9; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Martin LJ, 2009, J MOL ENDOCRINOL, V42, P119, DOI 10.1677/JME-08-0095; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mellon SH, 1998, ENDOCR RES, V24, P505, DOI 10.3109/07435809809032639; MORERA AM, 1988, J STEROID BIOCHEM, V30, P443, DOI 10.1016/0022-4731(88)90139-2; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ozguden-Akkoc CG, 2012, BIOTECH HISTOCHEM, V87, P154, DOI 10.3109/10520295.2011.592150; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Qamar I, 2010, J BIOL CHEM, V285, P22360, DOI 10.1074/jbc.M109.059949; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; TEERDS KJ, 1993, BIOL REPROD, V48, P40, DOI 10.1095/biolreprod48.1.40; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891	51	14	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104812	10.1371/journal.pone.0104812	http://dx.doi.org/10.1371/journal.pone.0104812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140527	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200036
J	Goetstouwers, T; Van Poucke, M; Coppieters, W; Nguyen, VU; Melkebeek, V; Coddens, A; Van Steendam, K; Deforce, D; Cox, E; Peelman, LJ				Goetstouwers, Tiphanie; Van Poucke, Mario; Coppieters, Wouter; Van Ut Nguyen; Melkebeek, Vesna; Coddens, Annelies; Van Steendam, Katleen; Deforce, Dieter; Cox, Eric; Peelman, Luc J.			Refined Candidate Region for F4ab/ac Enterotoxigenic Escherichia coli Susceptibility Situated Proximal to MUC13 in Pigs	PLOS ONE			English	Article							INTESTINAL RECEPTOR; PURIFIED F4; DIARRHEA; IDENTIFICATION; ASSOCIATION; ADHESION; LINKAGE; K88; POLYMORPHISMS; INHERITANCE	F4 enterotoxigenic Escherichia coli (F4 ETEC) are an important cause of diarrhea in neonatal and newly-weaned pigs. Based on the predicted differential O-glycosylation patterns of the 2 MUC13 variants (MUC13A and MUC13B) in F4ac ETEC susceptible and F4ac ETEC resistant pigs, the MUC13 gene was recently proposed as the causal gene for F4ac ETEC susceptibility. Because the absence of MUC13 on Western blot from brush border membrane vesicles of F4ab/acR(+) pigs and the absence of F4ac attachment to immunoprecipitated MUC13 could not support this hypothesis, a new GWAS study was performed using 52 non-adhesive and 68 strong adhesive pigs for F4ab/ac ETEC originating from 5 Belgian farms. A refined candidate region (chr13: 144,810,100-144,993,222) for F4ab/ac ETEC susceptibility was identified with MUC13 adjacent to the distal part of the region. This candidate region lacks annotated genes and contains a sequence gap based on the sequence of the porcine GenomeBuild 10.2. We hypothesize that a porcine orphan gene or trans-acting element present in the identified candidate region has an effect on the glycosylation of F4 binding proteins and therefore determines the F4ab/ac ETEC susceptibility in pigs.	[Goetstouwers, Tiphanie; Van Poucke, Mario; Peelman, Luc J.] Univ Ghent, Fac Vet Med, Lab Anim Genet, B-9000 Ghent, Belgium; [Coppieters, Wouter] Univ Liege B34, Unit Anim Genom, GIGA R, Liege, Sart Tilman, Belgium; [Coppieters, Wouter] Univ Liege B34, Fac Vet Med, Liege, Sart Tilman, Belgium; [Van Ut Nguyen; Melkebeek, Vesna; Coddens, Annelies; Cox, Eric] Univ Ghent, Fac Vet Med, Immunol Lab, Merelbeke, Belgium; [Van Steendam, Katleen; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; University of Liege; University of Liege; Ghent University; Ghent University	Peelman, LJ (corresponding author), Univ Ghent, Fac Vet Med, Lab Anim Genet, B-9000 Ghent, Belgium.	Luc.Peelman@UGent.be	Coppieters, Wouter/AAF-5030-2021; Deforce, Dieter LD/J-4725-2013	Coppieters, Wouter/0000-0001-8109-7825; Deforce, Dieter LD/0000-0002-0635-661X; Van Poucke, Mario/0000-0002-4316-8984; Nguyen, Ut/0000-0002-3354-6419; Cox, Eric/0000-0003-4281-2990	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen) [080524]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was funded by an agricultural research grant (IWT-LO project 080524) of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen). (http://www.iwt.be/). Authors: E. Cox, L. Peelman, D. Deforce, V.U. Nguyen, T. Goetstouwers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Coddens A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023309; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; Dupuis MC, 2011, MAMM GENOME, V22, P613, DOI 10.1007/s00335-011-9337-3; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; GIBBONS RA, 1977, THEOR APPL GENET, V51, P65, DOI 10.1007/BF00299479; Grange PA, 1996, INFECT IMMUN, V64, P606, DOI 10.1128/IAI.64.2.606-610.1996; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; GUERIN G, 1993, ANIM GENET, V24, P393, DOI 10.1111/j.1365-2052.1993.tb00347.x; Jorgensen C.B., 2004, International application published under the patent cooperation treaty (PCT), Patent No. [PCT/DK2003/000807, 2003000807]; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Jorgensen CB, 2004, Patent No. [WO2004/048606A2, 2004048606A2]; Li HJ, 2008, ASIAN AUSTRAL J ANIM, V21, P489, DOI 10.5713/ajas.2008.70464; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Melkebeek V, 2012, MUCOSAL IMMUNOL, V5, P635, DOI 10.1038/mi.2012.37; Nguyen VU, 2013, VET IMMUNOL IMMUNOP, V152, P93, DOI 10.1016/j.vetimm.2012.09.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Rampoldi A, 2013, APPROACH GENE CONTRO; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Rasschaert K, 2007, VET MICROBIOL, V123, P249, DOI 10.1016/j.vetmic.2007.02.017; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044573; Schroyen M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-70; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Van den Broeck W, 1999, VACCINE, V17, P2020, DOI 10.1016/S0264-410X(98)00406-X; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; Van Poucke M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-13; Wang J, 2006, ASIAN AUSTRAL J ANIM, V19, P1342, DOI 10.5713/ajas.2006.1342; Wang Y, 2007, J ANIM BREED GENET, V124, P225, DOI 10.1111/j.1439-0388.2007.00664.x; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yan XM, 2009, J MED MICROBIOL, V58, P1112, DOI 10.1099/jmm.0.009803-0; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002828	40	20	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105013	10.1371/journal.pone.0105013	http://dx.doi.org/10.1371/journal.pone.0105013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137053	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100059
J	Li, Q; Liu, XM; Gibbs, RA; Boerwinkle, E; Polychronakos, C; Qu, HQ				Li, Quan; Liu, Xiaoming; Gibbs, Richard A.; Boerwinkle, Eric; Polychronakos, Constantin; Qu, Hui-Qi			Gene-Specific Function Prediction for Non-Synonymous Mutations in Monogenic Diabetes Genes	PLOS ONE			English	Article							GLUCOKINASE MUTATIONS; INSULIN-SECRETION; BETA-CELLS; DATABASE; DISEASE; GLUCOSE; IDENTIFICATION; SENSITIVITY; EXPRESSION; DIAGNOSIS	The rapid progress of genomic technologies has been providing new opportunities to address the need of maturity-onset diabetes of the young (MODY) molecular diagnosis. However, whether a new mutation causes MODY can be questionable. A number of in silico methods have been developed to predict functional effects of rare human mutations. The purpose of this study is to compare the performance of different bioinformatics methods in the functional prediction of nonsynonymous mutations in each MODY gene, and provides reference matrices to assist the molecular diagnosis of MODY. Our study showed that the prediction scores by different methods of the diabetes mutations were highly correlated, but were more complimentary than replacement to each other. The available in silico methods for the prediction of diabetes mutations had varied performances across different genes. Applying gene-specific thresholds defined by this study may be able to increase the performance of in silico prediction of disease-causing mutations.	[Li, Quan; Polychronakos, Constantin] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada; [Liu, Xiaoming; Boerwinkle, Eric; Qu, Hui-Qi] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	McGill University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine	Liu, XM (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada.	Xiaoming.Liu@uth.tmc.edu; huiqi.qu@uth.tmc.edu	Qu, Hui-Qi/B-4719-2009; Li, Quan/B-3605-2009; Liu, Xiaoming/C-2743-2008	Qu, Hui-Qi/0000-0001-9317-4488; Liu, Xiaoming/0000-0001-8285-5528	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003273] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dong C, COMP FUNCTIONA UNPUB; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Ellard S, 2000, DIABETOLOGIA, V43, P250, DOI 10.1007/s001250050038; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HANEDA M, 1983, P NATL ACAD SCI-BIOL, V80, P6366, DOI 10.1073/pnas.80.20.6366; Johansen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068370; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Martin D, 2008, DIABETES CARE, V31, P1321, DOI 10.2337/dc07-2017; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Menzel R, 1998, DIABETIC MED, V15, P816, DOI 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Morrison AC, 2013, NATURE, V201, P3; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pearson ER, 2000, DIABETIC MED, V17, P543, DOI 10.1046/j.1464-5491.2000.00305.x; Plengvidhya N, 2007, J CLIN ENDOCR METAB, V92, P2821, DOI 10.1210/jc.2006-1927; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Qu HQ, 2012, AM SOC HUM GEN 2012; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shields BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/s00125-011-2418-8; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Velho G, 2004, MATURITY ONSET DIABE; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wang LL, 2011, BASIC CLIN PHARMACOL, V108, P94, DOI 10.1111/j.1742-7843.2010.00627.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	55	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104452	10.1371/journal.pone.0104452	http://dx.doi.org/10.1371/journal.pone.0104452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136813	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100036
J	Wang, L; Xiao, Y; Ping, YY; Li, J; Zhao, HY; Li, F; Hu, J; Zhang, HY; Deng, YL; Tian, JW; Li, X				Wang, Li; Xiao, Yun; Ping, Yanyan; Li, Jing; Zhao, Hongying; Li, Feng; Hu, Jing; Zhang, Hongyi; Deng, Yulan; Tian, Jiawei; Li, Xia			Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; GROWTH-FACTOR; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; CELL-SURVIVAL; IV COLLAGEN; GENES; EXPRESSION; NETWORK; DISEASE	Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivity to cancer treatment. Moreover, alterations in the abnormal pathways are not limited to single molecular level. Therefore, we proposed a strategy that integrates a large number of biological sources at multiple levels for systematic identification of cross-talk among risk pathways in cancer by random walk on protein interaction network. We applied the method to multi-Omics breast cancer data from The Cancer Genome Atlas (TCGA), including somatic mutation, DNA copy number, DNA methylation and gene expression profiles. We identified close cross-talk among many known cancer-related pathways with complex change patterns. Furthermore, we identified key genes (linkers) bridging these cross-talks and showed that these genes carried out consistent biological functions with the linked cross-talking pathways. Through identification of leader genes in each pathway, the architecture of cross-talking pathways was built. Notably, we observed that linkers cooperated with leaders to form the fundamentation of cross-talk of pathways which play core roles in deterioration of breast cancer. As an example, we observed that KRAS showed a direct connection to numerous cancer-related pathways, such as MAPK signaling pathway, suggesting that it may be a central communication hub. In summary, we offer an effective way to characterize complex cross-talk among disease pathways, which can be applied to other diseases and provide useful information for the treatment of cancer.	[Wang, Li; Xiao, Yun; Ping, Yanyan; Zhao, Hongying; Li, Feng; Hu, Jing; Zhang, Hongyi; Deng, Yulan; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Tian, Jiawei] Harbin Med Univ, Affiliated Hosp 2, Dept Ultrason Med, Harbin, Peoples R China; [Li, Jing] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Ultrason Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Heilongjiang University of Chinese Medicine	Tian, JW (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ultrason Med, Harbin, Peoples R China.	jwtian2004@yahoo.com.cn; lixia@hrbmu.edu.cn	Xiao, Yun/A-8359-2013; li, xia/HHZ-7468-2022; Hu, Jing/GPC-4486-2022; Hu, Jing/AAT-8707-2021	Hu, Jing/0000-0002-5996-4889; Hu, Jing/0000-0002-5996-4889; Deng, Yulan/0000-0003-0269-3931; Zhang, Hongyi/0000-0003-3408-2959; Ping, Yanyan/0000-0002-1810-1200	National High Technology Research and Development Program of China [863 Program] [2014AA021102]; National Program on Key Basic Research Project [973 Program] [2014CB910504]; National Natural Science Foundation of China [91129710, 61073136, 31200997, 61170154, 81070946]; National Science Foundation of Heilongjiang Province [C201207, H0906]; Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-210HLJ]	National High Technology Research and Development Program of China [863 Program](National High Technology Research and Development Program of China); National Program on Key Basic Research Project [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province; Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education; Undergraduate Innovation Funds of Harbin Medical University	This work was supported in part by the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Program on Key Basic Research Project [973 Program, Grant Nos. 2014CB910504], the National Natural Science Foundation of China [Grant Nos. 91129710, 61073136, 31200997, 61170154, and 81070946], the National Science Foundation of Heilongjiang Province (Grant Nos. C201207 and H0906), Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education and the Undergraduate Innovation Funds of Harbin Medical University [Grant Nos. YJSCX2012-210HLJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan K, 1996, SURGERY, V119, P333, DOI 10.1016/S0039-6060(96)80120-6; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Bazzoun D, 2013, PHARMACOL THERAPEUT, V138, P418, DOI 10.1016/j.pharmthera.2013.02.004; Bernards R, 2012, CELL, V151, P465, DOI 10.1016/j.cell.2012.10.014; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chang HH, 2011, IEEE ENG MED BIO, P6849, DOI 10.1109/IEMBS.2011.6091689; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanash S, 2004, NAT REV CANCER, V4, P638, DOI 10.1038/nrc1414; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Karinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018636; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim D, 2012, J BIOMED INFORM, V45, P1191, DOI 10.1016/j.jbi.2012.07.008; Kim JH, 2013, INT J ONCOL, V42, P1257, DOI 10.3892/ijo.2013.1803; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li CQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt161; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mosca E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-76; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nakano S, 1999, LAB INVEST, V79, P281; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Shishido SN, 2012, CLIN IMMUNOL, V144, P142, DOI 10.1016/j.clim.2012.06.002; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Tang WL, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-2; Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Weigel MT, 2013, ANN ONCOL, V24, P126, DOI 10.1093/annonc/mds240; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P7653, DOI 10.1093/nar/gks538; Xiao Y, 2011, GENOMICS, V98, P64, DOI 10.1016/j.ygeno.2011.04.001; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235; Zografos G, 2013, PHARMACOGENOMICS, V14, P5, DOI [10.2217/pgs.12.189, 10.2217/PGS.12.189]	53	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104282	10.1371/journal.pone.0104282	http://dx.doi.org/10.1371/journal.pone.0104282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137136	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100024
J	Xu, F; Wang, XT; Feng, Y; Huang, W; Wang, W; Li, L; Fang, XD; Que, HY; Zhang, GF				Xu, Fei; Wang, Xiaotong; Feng, Yue; Huang, Wen; Wang, Wei; Li, Li; Fang, Xiaodong; Que, Huayong; Zhang, Guofan			Identification of Conserved and Novel MicroRNAs in the Pacific Oyster Crassostrea gigas by Deep Sequencing	PLOS ONE			English	Article							EVOLUTION; GENES; MIRNAS; METABOLISM; EXPRESSION; MIRBASE; STRESS	MicroRNAs (miRNAs) play important roles in regulatory processes in various organisms. To date many studies have been performed in the investigation of miRNAs of numerous bilaterians, but limited numbers of miRNAs have been identified in the few species belonging to the clade Lophotrochozoa. In the current study, deep sequencing was conducted to identify the miRNAs of Crassostrea gigas (Lophotrochozoa) at a genomic scale, using 21 libraries that included different developmental stages and adult organs. A total of 100 hairpin precursor loci were predicted to encode miRNAs. Of these, 19 precursors (pre-miRNA) were novel in the oyster. As many as 53 (53%) miRNAs were distributed in clusters and 49 (49%) precursors were intragenic, which suggests two important biogenetic sources of miRNAs. Different developmental stages were characterized with specific miRNA expression patterns that highlighted regulatory variation along a temporal axis. Conserved miRNAs were expressed universally throughout different stages and organs, whereas novel miRNAs tended to be more specific and may be related to the determination of the novel body plan. Furthermore, we developed an index named the miRNA profile age index (miRPAI) to integrate the evolutionary age and expression levels of miRNAs during a particular developmental stage. We found that the swimming stages were characterized by the youngest miRPAIs. Indeed, the large-scale expression of novel miRNAs indicated the importance of these stages during development, particularly from organogenetic and evolutionary perspectives. Some potentially important miRNAs were identified for further study through significant changes between expression patterns in different developmental events, such as metamorphosis. This study broadened the knowledge of miRNAs in animals and indicated the presence of sophisticated miRNA regulatory networks related to the biological processes in lophotrochozoans.	[Xu, Fei; Wang, Xiaotong; Huang, Wen; Wang, Wei; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China; [Feng, Yue; Fang, Xiaodong] BGI Tech, Shenzhen, Peoples R China; [Huang, Wen] Grad Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, GF (corresponding author), Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China.	gzhang@qdio.ac.cn	huang, wen/GXW-0661-2022; Fang, Xiaodong/K-6743-2018; Xu, Fei/A-1736-2012	Fang, Xiaodong/0000-0001-7061-3337; Xu, Fei/0000-0002-0981-8429	National Basic Research Program of China (973 Program) [2010CB126401]; National High Technology Research and Development Program (863 program) [2012AA10A405]; National Natural Science Foundation of China [40730845]; Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholar and Scholar Climbing Programs of Shandong; Natural Science Foundation of Shandong Province [ZR2010DQ024]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System; Taishan Scholar and Scholar Climbing Programs of Shandong; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was funded by the National Basic Research Program of China (973 Program, 2010CB126401), National High Technology Research and Development Program (863 program, 2012AA10A405), National Natural Science Foundation of China (40730845), Modern Agro-industry Technology Research System (CARS-48), the Taishan Scholar and Scholar Climbing Programs of Shandong and Natural Science Foundation of Shandong Province under Grant ZR2010DQ024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Genard B, 2012, GENE, V499, P70, DOI 10.1016/j.gene.2012.02.021; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; Hansen TB, 2011, RNA BIOL, V8, P378, DOI 10.4161/rna.8.3.14333; HE L, 2004, NAT REV GENET, V5, P522; Huan P, 2012, J PROTEOMICS, V75, P3855, DOI 10.1016/j.jprot.2012.04.051; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Slack J.M.W., 2012, ESSENTIAL DEV BIOL; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Voronezhskaya EE, 2003, J COMP NEUROL, V455, P299, DOI 10.1002/cne.10488; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Xiao ZD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks821; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	48	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104371	10.1371/journal.pone.0104371	http://dx.doi.org/10.1371/journal.pone.0104371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137038	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100031
J	DeSouza, SI; Rashmi, MR; Vasanthi, AP; Joseph, SM; Rodrigues, R				DeSouza, Sherwin I.; Rashmi, M. R.; Vasanthi, Agalya P.; Joseph, Suchitha Maria; Rodrigues, Rashmi			Mobile Phones: The Next Step towards Healthcare Delivery in Rural India?	PLOS ONE			English	Article							MEDICATION ADHERENCE; REMINDERS; INTERVENTION; SYSTEM; TRIAL	Background: Given the ubiquity of mobile phones, their use to support healthcare in the Indian context is inevitable. It is however necessary to assess end-user perceptions regarding mobile health interventions especially in the rural Indian context prior to its use in healthcare. This would contextualize the use of mobile phone communication for health to 70% of the country's population that resides in rural India. Objectives: To explore the acceptability of delivering healthcare interventions through mobile phones among users in a village in rural Bangalore. Methods: This was an exploratory study of 488 mobile phone users, residing in a village, near Bangalore city, Karnataka, South India. A pretested, translated, interviewer-administered questionnaire was used to obtain data on mobile phone usage patterns and acceptability of the mobile phone, as a tool for health-related communication. The data is described using basic statistical measures. Results: The primary use of mobile phones was to make or receive phone calls (100%). Text messaging (SMS) was used by only 70 (14%) of the respondents. Most of the respondents, 484 (99%), were willing to receive health-related information on their mobile phones and did not consider receiving such information, an intrusion into their personal life. While receiving reminders for drug adherence was acceptable to most 479 (98%) of our respondents, 424 (89%) preferred voice calls alone to other forms of communication. Nearly all were willing to use their mobile phones to communicate with health personnel in emergencies and 367 (75%) were willing to consult a doctor via the phone in an acute illness. Factors such as sex, English literacy, employment status, and presence of chronic disease affected preferences regarding mode and content of communication. Conclusion: The mobile phone, as a tool for receiving health information and supporting healthcare through mHealth interventions was acceptable in the rural Indian context.	[DeSouza, Sherwin I.; Rashmi, M. R.; Vasanthi, Agalya P.; Joseph, Suchitha Maria; Rodrigues, Rashmi] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India; [Rashmi, M. R.] Saveetha Med Coll, Dept Community Med, Chennai, Tamil Nadu, India	St. John's National Academy of Health Sciences; Saveetha Institute of Medical & Technical Science; Saveetha Medical College & Hospital	DeSouza, SI (corresponding author), St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India.	desouza.sherwin@gmail.com	Rodrigues, Rashmi J/H-1901-2012	Rodrigues, Rashmi J/0000-0002-0656-0178				Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; Alexander Glory, 2011, Indian J Community Med, V36, P17, DOI 10.4103/0970-0218.80787; [Anonymous], 2004, HLTH LITERACY PRESCR; Bali S, 2007, J TELEMED TELECARE, V13, P421, DOI 10.1258/135763307783064421; Car J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub2; Chib A., 2012, J HLTH INFORM DEV CO, V6, P406; Duncan MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-656; Evans WD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1031; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gold J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-792; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Hofstetter AM, 2013, PREV MED, V57, P75, DOI 10.1016/j.ypmed.2013.04.007; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Huang HL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-127; Ibembe JD, 2011, MOBILE PHONE USE REP; International Telecommunication Union, 2013, WORLD 2014 ICT FACTS; Kishor S., 2009, GENDER EQUALITY WOME; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Knox KL, 2012, AM J PUBLIC HEALTH, V102, pS29, DOI 10.2105/AJPH.2011.300301; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lima A, EXPLOITING CELLULAR; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Ministry of Health and Family Welfare Government of India, 2012, IND IS 2 KARG MOB PH; Mueller DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-17; Nglazi MD, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-6; Niranjan P, 2013, ICTD 2013 CAP TOWN S; Park LG, 2013, TEXT MESSAGING INTER; Perron NJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-125; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Ramachandran A, 2013, LANCET DIABETES ENDO, V1, P191, DOI 10.1016/S2213-8587(13)70067-6; Rodrigues R, 2011, PLOS ONE; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040723; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Sikka N, 2012, J HEALTH COMMUN, V17, P37, DOI 10.1080/10810730.2011.649161; Stockwell MS, 2012, JAMA-J AM MED ASSOC, V307, P1702, DOI 10.1001/jama.2012.502; Telecom Regulatory Authority of India, 2013, TEL SECT IND DEC PRO; Telecom Regulatory Authority of India, 2013, HIGHL TEL SUBSCR DAT; Urban Health Initiative, 2010, EXP CONTR US URB UTT; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Vervloet M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-5; WHO Global Observatory for eHealth, 2011, GLOB OBS EHEALTH SER; Yang CH, 2009, B WORLD HEALTH ORGAN, V87, P619, DOI 10.2471/BLT.08.060905; Yoo HJ, 2009, DIABETIC MED, V26, P628, DOI 10.1111/j.1464-5491.2009.02732.x	44	111	111	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104895	10.1371/journal.pone.0104895	http://dx.doi.org/10.1371/journal.pone.0104895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133610	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700049
J	Godenhielm, M; Kultti, K				Godenhielm, Mats; Kultti, Klaus			Capacity Choice in a Large Market	PLOS ONE			English	Article							COMPETITIVE SEARCH	We analyze endogenous capacity formation in a large frictional market with perfectly divisible goods. Each seller posts a price and decides on a capacity. The buyers base their decision on which seller to visit on both characteristics. In this setting we determine the conditions for the existence and uniqueness of a symmetric equilibrium. When capacity is unobservable there exists a continuum of equilibria. We show that the ''best'' of these equilibria leads to the same seller capacities and the same number of trades as the symmetric equilibrium under observable capacity.	[Godenhielm, Mats] Hanken Sch Econ, Dept Econ, Helsinki, Finland; [Godenhielm, Mats; Kultti, Klaus] HECER, Helsinki, Finland; [Kultti, Klaus] Univ Helsinki, Dept Polit & Econ Studies, Helsinki, Finland	Hanken School of Economics; University of Helsinki	Godenhielm, M (corresponding author), Hanken Sch Econ, Dept Econ, Helsinki, Finland.	mats.godenhielm@hanken.fi		Kultti, Klaus/0000-0003-0827-6338	Academy of Finland [121438]; Finnish Cultural Foundation; OP-Pohjola Group Research Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); OP-Pohjola Group Research Foundation	This work is supported by Academy of Finland (grant number 121438, http://www.aka.fi/en-GB/A/); Yrjo Jahnsson Foundation (http://www.yjs.fi/); Finnish Cultural Foundation (https://skr.fi/en); and OP-Pohjola Group Research Foundation (http://www.en.tutkimusapurahat.fi/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdett K, 2001, J POLIT ECON, V109, P1060, DOI 10.1086/322835; Delacroix A, 2013, J ECON THEORY, V148, P1301, DOI 10.1016/j.jet.2013.04.006; Geromichalos A, 2012, J ECON THEORY, V147, P2303, DOI 10.1016/j.jet.2012.09.008; Godenhielm M., 2012, THESIS U HELSINKI; Hawkins WB, 2013, INT ECON REV, V54, P219, DOI 10.1111/j.1468-2354.2012.00731.x; Kultti K, 1999, GAME ECON BEHAV, V27, P106, DOI 10.1006/game.1998.0658; Lester B, 2010, J ECON THEORY, V145, P2108, DOI 10.1016/j.jet.2010.07.002; MCAFEE RP, 1993, ECONOMETRICA, V61, P1281, DOI 10.2307/2951643; Moen ER, 1997, J POLIT ECON, V105, P385, DOI 10.1086/262077; MONTGOMERY JD, 1991, Q J ECON, V106, P163, DOI 10.2307/2937911; PETERS M, 1991, ECONOMETRICA, V59, P1425, DOI 10.2307/2938374; Shimer R, 2005, J POLIT ECON, V113, P996, DOI 10.1086/444551; Shimer R., 1996, THESIS MIT	13	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e101766	10.1371/journal.pone.0101766	http://dx.doi.org/10.1371/journal.pone.0101766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JF	25133676	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700002
J	Loreto, RG; Elliot, SL; Freitas, MLR; Pereira, TM; Hughes, DP				Loreto, Raquel G.; Elliot, Simon L.; Freitas, Mayara L. R.; Pereira, Thairine M.; Hughes, David P.			Long-Term Disease Dynamics for a Specialized Parasite of Ant Societies: A Field Study	PLOS ONE			English	Article							PHORID PARASITOIDS; HYMENOPTERA; LIFE; NECROPHORESIS; EXPRESSION; ECOLOGY; FOOD	Many studies have investigated how social insects behave when a parasite is introduced into their colonies. These studies have been conducted in the laboratory, and we still have a limited understanding of the dynamics of ant-parasite interactions under natural conditions. Here we consider a specialized parasite of ant societies (Ophiocordyceps camponoti-rufipedis infecting Camponotus rufipes) within a rainforest. We first established that the parasite is unable to develop to transmission stage when introduced within the host nest. Secondly, we surveyed all colonies in the studied area and recorded 100% prevalence at the colony level (all colonies were infected). Finally, we conducted a long-term detailed census of parasite pressure, by mapping the position of infected dead ants and foraging trails (future hosts) in the immediate vicinity of the colonies over 20 months. We report new dead infected ants for all the months we conducted the census - at an average of 14.5 cadavers/month/colony. Based on the low infection rate, the absence of colony collapse or complete recovery of the colonies, we suggest that this parasite represents a chronic infection in the ant societies. We also proposed a "terminal host model of transmission'' that links the age-related polyethism to the persistence of a parasitic infection.	[Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA; [Loreto, Raquel G.; Elliot, Simon L.; Freitas, Mayara L. R.; Pereira, Thairine M.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Loreto, RG (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA.	rzg148@psu.edu; dph14@psu.edu	Carvalho, Claudine/J-6347-2014; Mendes-Pereira, Thairine/GZA-5363-2022; Elliot, Simon Luke/A-5557-2013	Elliot, Simon Luke/0000-0002-7469-2949; Mendes Pereira, Thairine/0000-0002-3707-9790	CAPES-Brazil [6203/10-8]; CNPq-Brazil; Federal University of Vicosa; Pennsylvania State University	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Vicosa; Pennsylvania State University	This work was supported by CAPES-Brazil (project # 6203/10-8), CNPq-Brazil, Federal University of Vicosa, and Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036352; Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; [Anonymous], 1971, INSECT SOC; Banik Sarmistha, 2010, Proceedings of the Zoological Society (Calcutta), V63, P87; Beattie AJ, 2003, PLANT ANIMAL INTERAC, P211; Bos N, 2012, J EVOLUTION BIOL, V25, P324; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Diez L, 2012, NATURWISSENSCHAFTEN, V99, P833, DOI 10.1007/s00114-012-0965-6; Diez L, 2011, ANIM BEHAV, V81, P1171, DOI 10.1016/j.anbehav.2011.02.026; Elizalde L, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.13501; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; Folgarait PJ, 1999, ECOL ENTOMOL, V24, P163, DOI 10.1046/j.1365-2311.1999.00180.x; Gordon DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050472; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hunt JH, 1983, SOCIAL INSECTS TROPI, P97; JAFFE K, 1984, INSECT SOC, V31, P302, DOI 10.1007/BF02223614; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Josens RB, 2000, J INSECT PHYSIOL, V46, P1103, DOI 10.1016/S0022-1910(99)00220-6; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Loreto RG, 2013, NATURWISSENSCHAFTEN, V100, P957, DOI 10.1007/s00114-013-1096-4; Marikovsky P. I., 1962, Insectes Sociaux Paris, V9, P173, DOI 10.1007/BF02224263; NONACS P, 1991, ECOL ENTOMOL, V16, P73, DOI 10.1111/j.1365-2311.1991.tb00194.x; Oliveira Júnior José Carlos de, 2005, Rev. Árvore, V29, P9, DOI 10.1590/S0100-67622005000100002; ORR MR, 1992, BEHAV ECOL SOCIOBIOL, V30, P395; Pontoppidan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004835; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; TRANIELLO JFA, 1987, INSECT SOC, V34, P118, DOI 10.1007/BF02223830; TRANIELLO JFA, 1991, BEHAV ECOL SOCIOBIOL, V29, P283, DOI 10.1007/BF00163986; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	47	34	34	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103516	10.1371/journal.pone.0103516	http://dx.doi.org/10.1371/journal.pone.0103516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133749	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700011
J	Tett, AJ; Karunakaran, R; Poole, PS				Tett, Adrian J.; Karunakaran, Ramakrishnan; Poole, Philip S.			Characterisation of SalRAB a Salicylic Acid Inducible Positively Regulated Efflux System of Rhizobium leguminosarum bv viciae 3841	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ROOT-NODULES; RESISTANCE; NODULATION; PATHOGEN; VECTORS; PUMP; IDENTIFICATION; REQUIREMENT; SELECTION	Salicylic acid is an important signalling molecule in plant-microbe defence and symbiosis. We analysed the transcriptional responses of the nitrogen fixing plant symbiont, Rhizobium leguminosarum bv viciae 3841 to salicylic acid. Two MFS-type multicomponent efflux systems were induced in response to salicylic acid, rmrAB and the hitherto undescribed system salRAB. Based on sequence similarity salA and salB encode a membrane fusion and inner membrane protein respectively. salAB are positively regulated by the LysR regulator SalR. Disruption of salA significantly increased the sensitivity of the mutant to salicylic acid, while disruption of rmrA did not. A salA/rmrA double mutation did not have increased sensitivity relative to the salA mutant. Pea plants nodulated by salA or rmrA strains did not have altered nodule number or nitrogen fixation rates, consistent with weak expression of salA in the rhizosphere and in nodule bacteria. However, BLAST analysis revealed seventeen putative efflux systems in Rlv3841 and several of these were highly differentially expressed during rhizosphere colonisation, host infection and bacteroid differentiation. This suggests they have an integral role in symbiosis with host plants.	[Tett, Adrian J.; Karunakaran, Ramakrishnan] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England; [Poole, Philip S.] Univ Oxford, Dept Plant Sci, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford	Poole, PS (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford, England.	philip.poole@plants.ox.ac.uk		Ramakrishnan, Karunakaran/0000-0002-6450-1299; Tett, Adrian/0000-0003-3141-3943	Biotechnology and Biological Sciences Research Council UK [BB/F004753/1]; BBSRC [BB/F004753/1, BBS/E/J/000C0642] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004753/1, BBS/E/J/000C0642] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK grant no BB/F004753/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, PLANT MOL BIOL, V44, P429, DOI 10.1023/A:1026561029533; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BUCHANANWOLLASTON V, 1979, J GEN MICROBIOL, V112, P135, DOI 10.1099/00221287-112-1-135; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eda S, 2011, APPL ENVIRON MICROB, V77, P2855, DOI 10.1128/AEM.02858-10; FIGURSKI DH, 1979, J MOL BIOL, V133, P295, DOI 10.1016/0022-2836(79)90395-4; Gonzalez-Pasayo R, 2000, MOL PLANT MICROBE IN, V13, P572, DOI 10.1094/MPMI.2000.13.5.572; JOHNSTON AWB, 1975, J GEN MICROBIOL, V87, P343, DOI 10.1099/00221287-87-2-343; Karunakaran R, 2005, MICROBIOL-SGM, V151, P3249, DOI 10.1099/mic.0.28311-0; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; Paulsen IT, 2003, CURR OPIN MICROBIOL, V6, P446, DOI 10.1016/j.mib.2003.08.005; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; POOLE PS, 1994, MICROBIOL-SGM, V140, P2797, DOI 10.1099/00221287-140-10-2797; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ramachandran VK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r106; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sambrook J., 2001, MOL CLONING LAB MANU; Sato T, 2002, SOIL SCI PLANT NUTR, V48, P413, DOI 10.1080/00380768.2002.10409219; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Stoitsova SO, 2008, APPL ENVIRON MICROB, V74, P3387, DOI 10.1128/AEM.02866-07; TRINICK MJ, 1976, NEW PHYTOL, V77, P359, DOI 10.1111/j.1469-8137.1976.tb01525.x; van Spronsen PC, 2003, MOL PLANT MICROBE IN, V16, P83, DOI 10.1094/MPMI.2003.16.1.83; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	35	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103647	10.1371/journal.pone.0103647	http://dx.doi.org/10.1371/journal.pone.0103647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133394	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700013
J	Xu, XL; Jaeger, ER; Wang, XX; Lagler-Ferrez, E; Batalov, S; Mathis, NL; Wiltshire, T; Walker, JR; Cooke, MP; Sauer, K; Huang, YH				Xu, Xiaolu; Jaeger, Emily R.; Wang, Xinxin; Lagler-Ferrez, Erica; Batalov, Serge; Mathis, Nancy L.; Wiltshire, Tim; Walker, John R.; Cooke, Michael P.; Sauer, Karsten; Huang, Yina H.			Mst1 Directs Myosin IIa Partitioning of Low and Higher Affinity Integrins during T Cell Migration	PLOS ONE			English	Article							LYMPHOCYTE MIGRATION; ADHESION; LFA-1; ACTIVATION; MOTILITY; POLARIZATION; PROLIFERATION; TRAFFICKING; CROSSTALK; POLARITY	Chemokines promote T cell migration by transmitting signals that induce T cell polarization and integrin activation and adhesion. Mst1 kinase is a key signal mediator required for both of these processes; however, its molecular mechanism remains unclear. Here, we present a mouse model in which Mst1 function is disrupted by a hypomorphic mutation. Microscopic analysis of Mst1-deficient CD4 T cells revealed a necessary role for Mst1 in controlling the localization and activity of Myosin IIa, a molecular motor that moves along actin filaments. Using affinity specific LFA-1 antibodies, we identified a requirement for Myosin IIa-dependent contraction in the precise spatial distribution of low and higher affinity LFA-1 on the membrane of migrating T cells. Mst1 deficiency or Myosin inhibition resulted in multipolar cells, difficulties in uropod detachment and mis-localization of low affinity LFA-1. Thus, Mst1 regulates Myosin IIa dynamics to organize high and low affinity LFA-1 to the anterior and posterior membrane during T cell migration.	[Xu, Xiaolu; Jaeger, Emily R.; Wang, Xinxin; Mathis, Nancy L.; Huang, Yina H.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Lagler-Ferrez, Erica; Batalov, Serge; Walker, John R.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Wiltshire, Tim] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Huang, Yina H.] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA; [Huang, Yina H.] Geisel Sch Med Dartmouth, Dept Microbiol Immunol, Lebanon, NH USA	Washington University (WUSTL); Novartis; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; Dartmouth College; Dartmouth College	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu; yina.h.huang@dartmouth.edu	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Huang, Yina/0000-0002-0125-9351; Batalov, Sergey/0000-0002-0925-0554	Leukemia and Lymphoma Society Scholar Award [1440-11]; NIH [AI070845, GM100785, AI089805]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089805, R01AI070845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Leukemia and Lymphoma Society Scholar Award 1440-11 to K. S. and by NIH grants AI070845 and GM100785 to K.S. and AI089805 to Y.H.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hoyne GF, 2006, IMMUNOL REV, V210, P27, DOI 10.1111/j.0105-2896.2006.00363.x; Huang YH, 2006, ADV EXP MED BIOL, V584, P245; Huse M, 2013, IMMUNOL REV, V256, P95, DOI 10.1111/imr.12116; Jacobelli J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075151; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	48	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105561	10.1371/journal.pone.0105561	http://dx.doi.org/10.1371/journal.pone.0105561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133611	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700121
J	Coty, D; Aria, C; Garrouste, R; Wils, P; Legendre, F; Nel, A				Coty, David; Aria, Cedric; Garrouste, Romain; Wils, Patricia; Legendre, Frederic; Nel, Andre			The First Ant-Termite Syninclusion in Amber with CT-Scan Analysis of Taphonomy	PLOS ONE			English	Article							HYMENOPTERA; FORMICIDAE; PREDATION; CHIAPAS; INCLUSIONS; SIMOJOVEL; ISOPTERA; RECORD; WORLD; NESTS	We describe here a co-occurrence (i.e. a syninclusion) of ants and termites in a piece of Mexican amber (Totolapa deposit, Chiapas), whose importance is two-fold. First, this finding suggests at least a middle Miocene antiquity for the modern, though poorly documented, relationship between Azteca ants and Nasutitermes termites. Second, the presence of a Neivamyrmex army ant documents an in situ raiding behaviour of the same age and within the same community, confirmed by the fact that the army ant is holding one of the termite worker between its mandibles and by the presence of a termite with bitten abdomen. In addition, we present how CT-scan imaging can be an efficient tool to describe the topology of resin flows within amber pieces, and to point out the different states of preservation of the embedded insects. This can help achieving a better understanding of taphonomical processes, and tests ethological and ecological hypotheses in such complex syninclusions.	[Coty, David; Garrouste, Romain; Legendre, Frederic; Nel, Andre] UPMC, Museum Natl Hist Nat, Inst Systemat, ISYEB,CNRS,EPHE,UMR 7205, Paris, France; [Aria, Cedric] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Aria, Cedric] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Wils, Patricia] Museum Natl Hist Nat, CNRS, UMS 2700, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Royal Ontario Museum; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Coty, D (corresponding author), UPMC, Museum Natl Hist Nat, Inst Systemat, ISYEB,CNRS,EPHE,UMR 7205, Paris, France.	coty.david@gmail.com	Legendre, Frederic/B-5101-2013; Aria, Cédric/J-4449-2019; GARROUSTE, Romain/AAK-3692-2021	Legendre, Frederic/0000-0001-5900-8048; Aria, Cédric/0000-0002-0567-1730; GARROUSTE, Romain/0000-0002-0880-5781	French ISYEB; UPMC; EPHE; Spanish Ministry of Economy and Competitiveness [CGL2011-23948/BTE];  [UMR 7205 CNRS]	French ISYEB; UPMC; EPHE; Spanish Ministry of Economy and Competitiveness(Spanish Government); 	This study is supported by the French ISYEB, UMR 7205 CNRS, UPMC and EPHE, and the Spanish Ministry of Economy and Competitiveness project CGL2011-23948/BTE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.A., 1991, Topics in Geobiology, V9, P25; Allison P.A., 1991, P120; Bignell DE, 2010, BIOL TERMITES MODERN, P576; Bolton Barry, 1994, P1; Boucot A.J., 2010, FOSSIL BEHAV COMPEND, P391; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Castaneda-Posadas C, 2007, AM J BOT, V94, P1821, DOI 10.3732/ajb.94.11.1821; CORNELIUS ML, 1995, SOCIOBIOLOGY, V26, P291; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; Deligne J., 1981, P1; Duran-Ruiz C, 2013, CAN J EARTH SCI, V50, P495, DOI 10.1139/cjes-2012-0166; Ferrusquia-Villafranca I, 2006, J VERTEBR PALEONTOL, V26, P989, DOI 10.1671/0272-4634(2006)26[989:TFPMRO]2.0.CO;2; Frost SH, 1974, CENOZOIC REEF BIOFAC, P1; Goncalves TT, 2005, SOCIOBIOLOGY, V46, P1; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA, P302; GRAY B, 1974, INSECT SOC, V21, P289, DOI 10.1007/BF02226920; Grimaldi D, 2000, ULTR, P77; Grimaldi David, 2005, pi; Henderickx H, 2006, ZOOTAXA, P41, DOI 10.11646/zootaxa.1305.1.4; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; Henwood A, 1992, THESIS U CAMBRIDGE, P166; HIGASHI S, 1989, OECOLOGIA, V80, P145, DOI 10.1007/BF00380142; Holldobler B., 1990, pi; Howse P.E., 1984, P151; JAFFE K, 1995, ANN ENTOMOL SOC AM, V88, P328, DOI 10.1093/aesa/88.3.328; Jolivet P, 1986, FOURMIS PLANTES EXEM, P255; Kaspari M, 2001, GLOBAL ECOL BIOGEOGR, V10, P229, DOI 10.1046/j.1466-822X.2001.00214.x; Koteja J, 1989, WROSTEK, V8, P7; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krishna K, 2013, B AM MUS NAT HIST, V377, P2704; Krishna Kumar, 2013, Bulletin of the American Museum of Natural History, V377, P1; Krishna Kumar, 1996, American Museum Novitates, V3176, P1; Krishna K, 2009, AM MUS NOVIT, P1, DOI 10.1206/633.1; Lak M, 2008, MICROSC MICROANAL, V14, P251, DOI 10.1017/S1431927608080264; LAMBERT JB, 1989, ADV CHEM SER, P381; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Le Breton J, 2007, J APPL ENTOMOL, V131, P740, DOI 10.1111/j.1439-0418.2007.01221.x; Leponce M, 1999, INSECT SOC, V46, P126, DOI 10.1007/s000400050122; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; Mierzejewski P, 1978, PRACE MUZEUM ZEIMI, V28, P81; Nel Andre, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P305; Penney D, 2007, ZOOTAXA, P47; Penney D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047651; Perkovsky EE, 2012, PALEONTOL J+, V46, P293, DOI 10.1134/S0031030112030136; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P85, DOI 10.1007/s00114-007-0301-8; Poinar G, 2002, BOT J LINN SOC, V139, P125, DOI 10.1046/j.1095-8339.2002.00053.x; Poinar Jr. G.O., 1999, AMBER FOREST; Quinet Y, 2005, J INSECT BEHAV, V18, P1, DOI 10.1007/s10905-005-9343-y; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Santos PP, 2010, REV BRAS ENTOMOL, V54, P450, DOI 10.1590/S0085-56262010000300016; SCHNEIRLA T C, 1971, P349; Sennepin A, 1998, ACT COLLOQ INSECT S, V12, P181; Soriano C, 2010, CR PALEVOL, V9, P361, DOI 10.1016/j.crpv.2010.07.014; Souza JLP, 2008, SOCIOBIOLOGY, V52, P399; Sutton M. D., 2014, TECHNIQUES VIRTUAL P; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Vega Francisco J., 2009, Bulletin of the Mizunami Fossil Museum, V35, P51; Weitschat W, 1998, ATLAS PFLANZEN TIERE, P256; WHEELER WILLIAM MORTON, 1936, PROC AMER ACAD ARTS AND SCI, V71, P159, DOI 10.2307/20023221; Wheeler WM, 1910, COLUMBIA U BIOL SERI, V9, p[xxvi, 663]; WILSON E O, 1985, Psyche (Cambridge), V92, P11, DOI 10.1155/1985/63693; WILSON E.O., 1971, INSECT SOC, P562	66	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104410	10.1371/journal.pone.0104410	http://dx.doi.org/10.1371/journal.pone.0104410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140873	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200021
J	de Wouters, T; Ledue, F; Nepelska, M; Dore, J; Blottiere, HM; Lapaque, N				de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas			A Robust and Adaptable High Throughput Screening Method to Study Host-Microbiota Interactions in the Human Intestine	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; METAGENOMICS	The intestinal microbiota has many beneficial roles for its host. However, the precise mechanisms developed by the microbiota to influence the host intestinal cell responses are only partially known. The complexity of the ecosystem and our inability to culture most of these micro-organisms have led to the development of molecular approaches such as functional metagenomics, i.e. the heterologous expression of a metagenome in order to identify functions. This elegant strategy coupled to high throughput screening allowed to identify novel enzymes from different ecosystems where culture methods have not yet been adapted to isolate the candidate microorganisms. We have proposed to use this functional metagenomic approach in order to model the microbiota's interaction with the host by combining this heterologous expression with intestinal reporter cell lines. The addition of the cellular component to this functional metagenomic approach introduced a second important source of variability resulting in a novel challenge for high throughput screening. First attempts of high throughput screening with various reporter cell-lines showed a high distribution of the response and consequent difficulties to reproduce the response, impairing an easy and clear identification of confirmed hits. In this study, we developed a robust and reproducible methodology to combine these two biological systems for high throughput application. We optimized experimental setups and completed them by appropriate statistical analysis tools allowing the use this innovative approach in a high throughput manner and on a broad range of reporter assays. We herewith present a methodology allowing a high throughput screening combining two biological systems. Therefore ideal conditions for homogeneity, sensitivity and reproducibility of both metagenomic clones as well as reporter cell lines have been identified and validated. We believe that this innovative method will allow the identification of new bioactive microbial molecules and, subsequently, will promote understanding of host-microbiota interactions.	[de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas] INRA, UMR MICALIS 1319, Jouy En Josas, France; [de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Dore, Joel; Blottiere, Herve M.] INRA, US MetaGenoPoliS 1367, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Blottiere, HM (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr; nicolas.lapaque@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020; Lapaque, Nicolas/AAB-4530-2021	BLOTTIERE, Hervé M/0000-0002-8390-0607; Lapaque, Nicolas/0000-0003-0824-0108	European Marie-Curie Initial Training Network Cross-Talk [215553]; ANR blanc MicroObes; ANR blanc FunMetaGen; EU MetaHit (Metagenomics of the Human Intestinal Tract) project [HEALTH-F4-2007-201052]	European Marie-Curie Initial Training Network Cross-Talk; ANR blanc MicroObes(French National Research Agency (ANR)); ANR blanc FunMetaGen(French National Research Agency (ANR)); EU MetaHit (Metagenomics of the Human Intestinal Tract) project	TDW, MN and HMB are members of the European Marie-Curie Initial Training Network Cross-Talk (grant agreement#215553). TDW was supported by the ANR blanc MicroObes. This work was supported by the ANR blanc FunMetaGen, by the EU MetaHit (Metagenomics of the Human Intestinal Tract) project HEALTH-F4-2007-201052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blottiere HM, 2013, CURR OPIN MICROBIOL, V16, P232, DOI 10.1016/j.mib.2013.06.006; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; Esser P, 2010, THERMOSCIENTIFIC NUN; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Geuking MB, 2014, GUT MICROBES, V5; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gloux K, 2007, APPL ENVIRON MICROB, V73, P3734, DOI 10.1128/AEM.02204-06; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Lepage P, 2012, GUT; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Makarenkov V, 2007, BIOINFORMATICS, V23, P1648, DOI 10.1093/bioinformatics/btm145; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Tukey JW, 1977, EXPLORATORY DATA ANA	26	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105598	10.1371/journal.pone.0105598	http://dx.doi.org/10.1371/journal.pone.0105598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141006	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200112
J	Hutchins, ED; Markov, GJ; Eckalbar, WL; George, RM; King, JM; Tokuyama, MA; Geiger, LA; Emmert, N; Ammar, MJ; Allen, AN; Siniard, AL; Corneveaux, JJ; Fisher, RE; Wade, J; DeNardo, DF; Rawls, JA; Huentelman, MJ; Wilson-Rawls, J; Kusumi, K				Hutchins, Elizabeth D.; Markov, Glenn J.; Eckalbar, Walter L.; George, Rajani M.; King, Jesse M.; Tokuyama, Minami A.; Geiger, Lauren A.; Emmert, Nataliya; Ammar, Michael J.; Allen, April N.; Siniard, Ashley L.; Corneveaux, Jason J.; Fisher, Rebecca E.; Wade, Juli; DeNardo, Dale F.; Rawls, J. Alan; Huentelman, Matthew J.; Wilson-Rawls, Jeanne; Kusumi, Kenro			Transcriptomic Analysis of Tail Regeneration in the Lizard Anolis carolinensis Reveals Activation of Conserved Vertebrate Developmental and Repair Mechanisms	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; LOCALIZED GROWTH ZONES; SATELLITE CELLS; GREEN ANOLE; EXPRESSION ANALYSIS; LIMB REGENERATION; SPINAL-CORD; STEM-CELLS; GENE; BIOINFORMATICS	Lizards, which are amniote vertebrates like humans, are able to lose and regenerate a functional tail. Understanding the molecular basis of this process would advance regenerative approaches in amniotes, including humans. We have carried out the first transcriptomic analysis of tail regeneration in a lizard, the green anole Anolis carolinensis, which revealed 326 differentially expressed genes activating multiple developmental and repair mechanisms. Specifically, genes involved in wound response, hormonal regulation, musculoskeletal development, and the Wnt and MAPK/FGF pathways were differentially expressed along the regenerating tail axis. Furthermore, we identified 2 microRNA precursor families, 22 unclassified non-coding RNAs, and 3 novel protein-coding genes significantly enriched in the regenerating tail. However, high levels of progenitor/stem cell markers were not observed in any region of the regenerating tail. Furthermore, we observed multiple tissue-type specific clusters of proliferating cells along the regenerating tail, not localized to the tail tip. These findings predict a different mechanism of regeneration in the lizard than the blastema model described in the salamander and the zebrafish, which are anamniote vertebrates. Thus, lizard tail regrowth involves the activation of conserved developmental and wound response pathways, which are potential targets for regenerative medical therapies.	[Hutchins, Elizabeth D.; Markov, Glenn J.; Eckalbar, Walter L.; George, Rajani M.; King, Jesse M.; Tokuyama, Minami A.; Geiger, Lauren A.; Emmert, Nataliya; Ammar, Michael J.; Fisher, Rebecca E.; DeNardo, Dale F.; Rawls, J. Alan; Wilson-Rawls, Jeanne; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Allen, April N.; Siniard, Ashley L.; Corneveaux, Jason J.; Huentelman, Matthew J.; Kusumi, Kenro] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Fisher, Rebecca E.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA; [Wade, Juli] Michigan State Univ, Program Neurosci, Dept Psychol, E Lansing, MI 48824 USA; [Wade, Juli] Michigan State Univ, Program Neurosci, Dept Zool, E Lansing, MI 48824 USA	Arizona State University; Arizona State University-Tempe; Translational Genomics Research Institute; University of Arizona; Michigan State University; Michigan State University	Kusumi, K (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Kenro.Kusumi@asu.edu	George, Rajani Mary/AAM-7256-2020; Kusumi, Kenro/J-2626-2012	George, Rajani Mary/0000-0002-9153-5523; Wilson-Rawls, Jeanne/0000-0002-3704-6956; Kusumi, Kenro/0000-0002-1458-4540; Hutchins, Elizabeth/0000-0003-2543-0798	National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) [R21 RR031305]; National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health [R21 AR064935]; Arizona Biomedical Research Commission [1113]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064935] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP); National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arizona Biomedical Research Commission; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) grant R21 RR031305 (KK, JW-R); National Institute of Arthritis, Musculoskeletal, and Skin Diseases grant R21 AR064935 of the National Institutes of Health (KK); and funding from the Arizona Biomedical Research Commission grant 1113 (KK, REF). Computational analysis was supported by allocations from the Arizona State University Advanced Computing Center (A2C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ALIBARDI L, 2010, ADV ANAT EMBRYOL CEL, V207, P1; Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anderson DM, 2012, J BIOL CHEM, V287, P35351, DOI 10.1074/jbc.M112.399386; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BOOTHBY M, 1981, J BIOL CHEM, V256, P5121; Brown DD, 2005, P NATL ACAD SCI USA, V102, P12455, DOI 10.1073/pnas.0505989102; BUCKBINDER L, 1993, P NATL ACAD SCI USA, V90, P3820, DOI 10.1073/pnas.90.9.3820; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; COX PG, 1969, J EXP ZOOL, V171, P127, DOI 10.1002/jez.1401710202; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; DUFFY MT, 1990, J COMP NEUROL, V293, P208, DOI 10.1002/cne.902930205; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Eckalbar WL, 2012, DEV BIOL, V363, P308, DOI 10.1016/j.ydbio.2011.11.021; Eckalbar WL, 2010, DEV BIOL, V344, P528, DOI 10.1016/j.ydbio.2010.05.385; Fan CM, 2012, WIRES DEV BIOL, V1, P315, DOI 10.1002/wdev.30; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Fisher RE, 2012, ANAT REC, V295, P1609, DOI 10.1002/ar.22537; Furlow JD, 2006, TRENDS ENDOCRIN MET, V17, P38, DOI 10.1016/j.tem.2006.01.007; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George RM, 2013, P NATL ACAD SCI USA, V110, P18549, DOI 10.1073/pnas.1311628110; Goldie RG, 1999, CLIN EXP PHARMACOL P, V26, P145, DOI 10.1046/j.1440-1681.1999.03014.x; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES A, 1959, J EMBRYOL EXP MORPH, V7, P281; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kusumi K, 2013, CURR OPIN GENET DEV, V23, P491, DOI 10.1016/j.gde.2013.02.011; Kusumi K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-554; Lee WS, 1998, CIRC RES, V82, P845; Lees SJ, 2006, AM J PHYSIOL-CELL PH, V290, pC609, DOI 10.1152/ajpcell.00408.2005; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Lovern MB, 2003, J EXP ZOOL PART A, V295A, P206, DOI 10.1002/jez.a.10225; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Montuelle SJ, 2008, J EXP ZOOL PART A, V309A, P563, DOI 10.1002/jez.484; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Panaite PA, 2010, J NEUROSCI RES, V88, P1751, DOI 10.1002/jnr.22344; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pownall M. E., 2010, C SER DEV BIOL, V1, P1, DOI DOI 10.4199/C00011ED1V01Y201004DEB002; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Ritzman TB, 2012, ANAT REC, V295, P1596, DOI 10.1002/ar.22524; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Shen YJ, 2008, NUCLEIC ACIDS RES, V36, P3150, DOI 10.1093/nar/gkn158; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SIMPSON SB, 1994, PROG BRAIN RES, V103, P229; Simpson SB, 1965, REGENERATION ANIMALS, P431; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takahashi Y, 2007, DEV DYNAM, V236, P1484, DOI 10.1002/dvdy.21178; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tatsumi R, 2006, INT J BIOCHEM CELL B, V38, P1678, DOI 10.1016/j.biocel.2006.04.003; Tollis M, 2014, GENETICA, V142, P59, DOI 10.1007/s10709-013-9754-1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wade J, 2012, GEN COMP ENDOCR, V176, P456, DOI 10.1016/j.ygcen.2011.12.011; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wordley C, 2011, MOL ECOL RESOUR, V11, P126, DOI 10.1111/j.1755-0998.2010.02863.x; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434; YABLONKAREUVENI Z, 1987, DEV BIOL, V119, P252, DOI 10.1016/0012-1606(87)90226-0; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025	93	95	98	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105004	10.1371/journal.pone.0105004	http://dx.doi.org/10.1371/journal.pone.0105004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140675	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200046
J	Kim, JY; Jung, WH; Koo, JS				Kim, Ji-Ye; Jung, Woo Hee; Koo, Ja Seung			Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer	PLOS ONE			English	Article							LIGHT-CHAIN 3A; PROSTATE-CANCER; THIOREDOXIN SYSTEM; PROGNOSTIC-FACTORS; MOLECULAR SUBTYPE; OXIDATIVE STRESS; TUMOR-STROMA; BECLIN-1; PATTERNS; INDUCTION	Purpose: The purpose of this study was to investigate the expression of autophagy-related proteins in relation to androgen receptor (AR) status in estrogen receptor (ER)-negative breast cancers. Methods: We extracted 334 ER-negative breast cancer samples to construct tissue microarrays (TMAs), which were immunohistochemically stained for autophagy-related proteins (beclin-1, LC3A, LC3B, p62) and for AR and HER-2. Results: There were 127 AR-positive cases and 207 AR-negative cases, and 140 HER-2-positive cases and 194 HER-2 negative cases. The AR-negative group was associated with tumoral LC3A expression (P < 0.001), while the AR-positive group was associated with tumoral BNIP3 expression (P < 0.001). Tumoral LC3A was most highly expressed in the AR-negative and HER-2 negative group, while stromal LC3A showed the highest expression in the AR-negative and HER-2-positive group. Tumoral BNIP3 and stromal BNIP3 were highest in the AR-positive and HER-2-negative group. In the AR-positive and HER-2-negative group, stromal p62 positivity was an independent factor that was statistically significant in its association with shorter disease-free survival (DFS) (Hazard ratio: 10.21, 95% CI: 1.130-92.31, P = 0.039). Shorter DFS was associated with tumoral LC3A positivity (Hazard ratio: 10.28, 95% CI: 2.068-51.19, P = 0.004) in the AR-negative and HER-2-positive group. Conclusion: In ER-negative breast cancers, AR status was associated with expression of different types of autophagy-related proteins. Tumoral LC3A was most highly expressed in AR-negative breast cancers, while tumor BNIP3 was highest in AR-positive breast cancers.	[Kim, Ji-Ye; Jung, Woo Hee; Koo, Ja Seung] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Hosp,Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Hosp,Dept Pathol, Seoul, South Korea.	kjs1976@yuhs.ac		Migliaccio, Antimo/0000-0002-4197-2055; koo, ja seung/0000-0003-4546-4709	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1002886]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1A1002886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P419, DOI 10.1016/j.semcancer.2006.10.001; Banneau G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2626; Barth RJ, 1999, BREAST CANCER RES TR, V57, P291, DOI 10.1023/A:1006260225618; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Choi J, 2013, HISTOPATHOLOGY, V62, P275, DOI 10.1111/his.12002; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Fukuhara T, 2006, HYBRIDOMA, V25, P51, DOI 10.1089/hyb.2006.25.51; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Giatromanolaki AN, 2011, MODERN PATHOL, V24, P1036, DOI 10.1038/modpathol.2011.63; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Jiang Q, 2012, J UROLOGY, V188, P1361, DOI 10.1016/j.juro.2012.06.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karpathiou G, 2011, CHEST, V140, P127, DOI 10.1378/chest.10-1831; Koo JS, 2011, TUMOR BIOL, V32, P787, DOI 10.1007/s13277-011-0181-6; KuenenBoumeester V, 1996, EUR J CANCER, V32A, P1560, DOI 10.1016/0959-8049(96)00112-8; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Miracco C, 2007, INT J ONCOL, V30, P429; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Riva C, 2005, VIRCHOWS ARCH, V447, P695, DOI 10.1007/s00428-005-0003-6; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Shaida N, 2008, PROSTATE, V68, P336, DOI 10.1002/pros.20707; Shi Y, 2013, MOL ENDOCRINOL, V27, P280, DOI 10.1210/me.2012-1260; Sivridis E, 2011, MELANOMA RES, V21, P188, DOI 10.1097/CMR.0b013e328346612c; Sivridis E, 2010, AM J PATHOL, V176, P2477, DOI 10.2353/ajpath.2010.090049; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spowart JE, 2012, J PATHOL; Tavassoli FA, 2003, IARC WHO CLASSIFICAT; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WILLIAMS ARW, 1990, J PATHOL, V160, P287, DOI 10.1002/path.1711600404; Witkiewicz AK, 2012, CELL CYCLE, V11, P1108, DOI 10.4161/cc.11.6.19530; Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105666	10.1371/journal.pone.0105666	http://dx.doi.org/10.1371/journal.pone.0105666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140630	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200118
J	Barton, KM; Archin, NM; Keedy, KS; Espeseth, AS; Zhang, YL; Gale, J; Wagner, FF; Holson, EB; Margolis, DM				Barton, Kirston M.; Archin, Nancie M.; Keedy, Kara S.; Espeseth, Amy S.; Zhang, Yan-ling; Gale, Jennifer; Wagner, Florence F.; Holson, Edward B.; Margolis, David M.			Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; LONG TERMINAL REPEAT; EXPRESSION; RECRUITMENT; ESTABLISHMENT; THERAPY; IDENTIFICATION	Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for persistent human immunodeficiency virus type 1 (HIV-1) infection. We utilized a combination of small molecule inhibitors and short hairpin (sh) RNA-mediated gene knockdown strategies to delineate the key HDAC(s) to be targeted for selective induction of latent HIV-1 expression. Individual depletion of HDAC3 significantly induced expression from the HIV-1 promoter in the 2D10 latency cell line model. However, depletion of HDAC1 or 22 alone or in combination did not significantly induce HIV-1 expression. Co-depletion of HDAC2 and 23 resulted in a significant increase in expression from the HIV-1 promoter. Furthermore, concurrent knockdown of HDAC1, 22, and 23 resulted in a significant increase in expression from the HIV-1 promoter. Using small molecule HDAC inhibitors of differing selectivity to ablate the residual HDAC activity that remained after (sh) RNA depletion, the effect of depletion of HDAC3 was further enhanced. Enzymatic inhibition of HDAC3 with the selective small-molecule inhibitor BRD3308 activated HIV-1 transcription in the 2D10 cell line. Furthermore, ex vivo exposure to BRD3308 induced outgrowth of HIV-1 from resting CD4+ T cells isolated from antiretroviral-treated, aviremic HIV+ patients. Taken together these findings suggest that HDAC3 is an essential target to disrupt HIV-1 latency, and inhibition of HDAC2 may also contribute to the effort to purge and eradicate latent HIV-1 infection.	[Barton, Kirston M.; Keedy, Kara S.; Margolis, David M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA; [Archin, Nancie M.; Margolis, David M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Margolis, David M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Espeseth, Amy S.] Merck Res Labs, Dept Antiviral Res, West Point, PA USA; [Zhang, Yan-ling; Gale, Jennifer; Wagner, Florence F.; Holson, Edward B.] Broad Inst Massachusetts Inst Technol & Harvard U, Stanley Ctr Psychiat Res, Cambridge, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Margolis, DM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.	dmargo@med.unc.edu		Barton, Kirston/0000-0002-0410-4849	National Institutes of Health to the UNC TRaCS Institute [DA030156, RR024383]; National Institutes of Health to the UNC Center for AIDS Research; James B. Pendleton Charitable Trust; UNC Virology training grant [T32AI007419]; Stanley Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, T32AI007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030156] Funding Source: NIH RePORTER	National Institutes of Health to the UNC TRaCS Institute; National Institutes of Health to the UNC Center for AIDS Research; James B. Pendleton Charitable Trust; UNC Virology training grant; Stanley Medical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health's Grants DA030156 to D. M. M., RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, and an equipment grant from the James B. Pendleton Charitable Trust. K. M. B. was supported by the UNC Virology training grant T32AI007419. BRD3308 compound design, synthesis, and characterization were funded by the Stanley Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Materials from both the Broad Institute and Merck Research Laboratories will be made available, subject to the standard terms of materials transfer agreements in force at each entity.	Archin N, 2012, NATURE; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	43	51	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e102684	10.1371/journal.pone.0102684	http://dx.doi.org/10.1371/journal.pone.0102684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136952	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100003
J	Du, Y; Li, JH; He, F; Lv, YM; Liu, W; Wu, P; Huang, J; Wei, S; Gao, HY				Du, Yu; Li, Junhua; He, Fan; Lv, Yongman; Liu, Wei; Wu, Ping; Huang, Jiao; Wei, Sheng; Gao, Hongyu			The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis	PLOS ONE			English	Article							PHOSPHOLIPASE-A2 RECEPTOR; AUTOANTIBODIES; ANTIBODIES; ANTIGEN	Background: The presence of antibodies against the M-type phospholipase A2 receptor (PLA2R-AB) is considered to be a promising serological diagnostic biomarker of idiopathic membranous nephropathy (iMN). However, controversy remains about the diagnostic accuracy of serum PLA2R-AB testing. Here, we performed a comprehensive meta-analysis to assess the overall diagnostic value of serum PLA2R-AB testing in iMN detection. Methods: PubMed, Embase, and CNKI (Chinese National Knowledge Infrastructure) were searched for relevant original articles through January 31, 2014. The summary sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio (DOR) were estimated using the bivariate model. The heterogeneity among studies was explored by subgroup and meta-regression analysis. Results: 9 articles, including 15 studies, were eventually identified with a total of 2212 patients. The summary sensitivity of all studies is 78% (95% CI: 66% to 87%) and the specificity is 99% (95% CI: 96% to 100%). The summary positive and negative likelihood ratios are 96.1 (95% CI, 19.5 to 472.1) and 0.22 (95% CI: 0.14 to 0.35), respectively. The DOR is 437 (95% CI, 74 to 2592). The subgroup analysis and meta-regression suggest the test interval is the main source of heterogeneity. Conclusions: Serum PLA2R-AB testing is a useful tool to detect iMN. In addition, considering the high heterogeneity and potential publication bias, further high quality studies are needed in the future.	[Du, Yu; Li, Junhua; He, Fan; Lv, Yongman; Liu, Wei; Gao, Hongyu] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Hubei, Peoples R China; [Wu, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430074, Hubei, Peoples R China; [Huang, Jiao; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gao, HY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Hubei, Peoples R China.	gaohongyu2010@gmail.com			National Natural Science Foundation of China [81100498, 81100481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81100498 to JL and 81100481 to HG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon R, 2013, PEDIAT NEPHROL; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Debiec H, 2011, NAT REV NEPHROL, V7, P496, DOI 10.1038/nrneph.2011.106; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Glassock RJ, 2013, CONTRIB NEPHROL, V181, P131, DOI 10.1159/000348472; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Horvatic Ivica, 2012, Lijec Vjesn, V134, P328; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Khosroshahi A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/139409; Murtas C, 2012, CLIN J AM SOC NEPHRO, V7, P1394, DOI 10.2215/CJN.02170312; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Ponticelli C, 2013, CLIN J AM SOC NEPHRO; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Stahl R, 2010, NEW ENGL J MED, V363, P496, DOI 10.1056/NEJMc1003066; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	24	70	82	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104936	10.1371/journal.pone.0104936	http://dx.doi.org/10.1371/journal.pone.0104936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136841	Green Submitted, Green Published, gold			2022-12-27	WOS:000340742100056
J	Lonati, PA; Brembilla, NC; Montanari, E; Fontao, L; Gabrielli, A; Vettori, S; Valentini, G; Laffitte, E; Kaya, G; Meroni, PL; Chizzolini, C				Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Gabrielli, Armando; Vettori, Serena; Valentini, Gabriele; Laffitte, Emmanuel; Kaya, Gurkan; Meroni, Pier-Luigi; Chizzolini, Carlo			High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis	PLOS ONE			English	Article							SCLERODERMA; CELLS; TH17; FIBROBLASTS; DISEASE; CYTOKINES; FAMILY; IL-25; TH2; INTERLEUKIN-17A	Background: High interleukin (IL)-17A levels are characteristically found in the skin of systemic sclerosis (SSc) individuals. Our aim was to investigate whether the dermal expression of IL-17A and related IL-17 family members (i.e. IL-17C, IL-17E and IL-17F) could distinguish fibrotic from healthy skin and could show similarities in SSc and morphea, two disorders with presumed distinct pathogenesis, but characterized by skin fibrosis. Methods: Biopsies were obtained from the involved skin of 14 SSc, 5 morphea and 8 healthy donors (HD) undergoing plastic surgery. Immunohistochemistry/immunofluorescence techniques were coupled to a semi-automated imaging quantification approach to determine the presence of the IL-17 family members in the skin. The in vitro effects induced by the IL-17 family members on fibroblasts from normal and SSc individuals were assessed by ELISA and RIA. Results: Positive cells for each of the IL-17 isoforms investigated were present in the dermis of all the individuals tested, though with variable frequencies. SSc individuals had increased frequency of IL-17A+ (p = 0.0237) and decreased frequency of IL-17F+ (p = 0.0127) and IL-17C+ cells (p = 0.0008) when compared to HD. Similarly, morphea individuals had less frequent IL-17C+ cells (p = 0.0186) in their skin but showed similar number of IL-17A+ and IL-17F+ cells when compared to HD. Finally, IL-17E+ cells were more numerous in morphea (p = 0.0109) and tended to be more frequent in SSc than in HD. Fibroblast production of IL-6, MMP-1 and MCP-1 was enhanced in a dose-dependent manner in the presence of IL-17E and IL-17F, but not in the presence of IL-17C. None of the cytokine tested had significant effect on type I collagen production. Of interest, in SSc the frequency of both IL-17A and IL-17F positive cells increased with disease duration. Conclusions: The frequency of IL-17A and IL-17F distinguish SSc to morphea individuals while dermal expression of IL-17C (low) and IL-17E (high) identifies a fibrosis-specific motif. The specific IL-17C/IL-17E cytokine combination may thus play a role in the development of fibrosis.	[Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Laffitte, Emmanuel; Kaya, Gurkan; Chizzolini, Carlo] Univ Hosp, Geneva, Switzerland; [Lonati, Paola Adele; Brembilla, Nicolo Costantino; Montanari, Elisa; Fontao, Lionel; Laffitte, Emmanuel; Kaya, Gurkan; Chizzolini, Carlo] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Lonati, Paola Adele; Meroni, Pier-Luigi] IRCSS Ist Auxol Italiano, Expt Lab Immunol & Rheumatol Researches, Milan, Italy; [Gabrielli, Armando] Inst Clin Med, Ancona, Italy; [Vettori, Serena; Valentini, Gabriele] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Meroni, Pier-Luigi] Univ Milan, Div Rheumatol, Dept Clin Sci & Community Hlth, Milan, Italy	University of Geneva; University of Geneva; IRCCS Istituto Auxologico Italiano; University of Naples Federico II; University of Milan	Chizzolini, C (corresponding author), Univ Hosp, Geneva, Switzerland.	carlo.chizzolini@unige.ch	Gabrielli, Armando/AAC-3173-2019; Lonati, Paola Adele/AAA-6270-2020; Chizzolini, Carlo/V-4847-2019; Lionel, Fontao/AGN-3640-2022; meroni, pier luigi/K-8473-2016; Vettori, Serena/A-8641-2016	Lonati, Paola Adele/0000-0002-7987-9497; meroni, pier luigi/0000-0002-3394-1451; Vettori, Serena/0000-0001-5617-9829; Fontao, Lionel/0000-0002-5950-564X; VALENTINI, Gabriele/0000-0002-7852-9137	Swiss National Science Foundation [310030_140791]; Hans Wilsdorf foundation; Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hans Wilsdorf foundation; Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy	Work supported in part by grant 310030_140791 from the Swiss National Science Foundation and the Hans Wilsdorf foundation to CC. PL and PLM were supported by a grant from Ricerca Corrente IRCCS Istituto Auxologico Italiano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J RHEUMATOL, V35, P515; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Brembilla NC, 2013, EUR CYTOKINE NETW; Brembilla NC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4334; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Chizzolini C, 2003, ARTHRITIS RHEUM-US, V48, P2593, DOI 10.1002/art.11129; Chizzolini C, 2011, AUTOIMMUN REV, V10, P276, DOI 10.1016/j.autrev.2010.09.016; Chung L, 2006, CLIN DERMATOL, V24, P374, DOI 10.1016/j.clindermatol.2006.07.004; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dharamsi JW, 2013, JAMA DERMATOL, V149, P1159, DOI 10.1001/jamadermatol.2013.4207; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hayashi H, 2013, INFLAMMATION, V36, P830, DOI 10.1007/s10753-013-9609-z; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Limpers A, 2014, EXPERT REV CLIN IMMU, V10, P231, DOI 10.1586/1744666X.2014.872561; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Meloni F, 2009, CLIN EXP RHEUMATOL, V27, P765; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Nakashima T, 2012, J IMMUNOL; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Torres JE, 1998, AM J DERMATOPATH, V20, P242, DOI 10.1097/00000372-199806000-00003; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Truchetet ME, 2013, ARTHRITIS RHEUM; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yaqub A, 2013, RHEUM DIS CLIN N AM, V39, P347, DOI 10.1016/j.rdc.2013.02.013; YOO ZB, 1995, J IMMUNOL, V155, P5483	38	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105008	10.1371/journal.pone.0105008	http://dx.doi.org/10.1371/journal.pone.0105008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136988	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100058
J	Mandal, RK; Akhter, N; Haque, S; Panda, AK; Mittal, RD; Alqumber, MAA				Mandal, Raju K.; Akhter, Naseem; Haque, Shafiul; Panda, Aditya K.; Mittal, Rama D.; Alqumber, Mohammed A. A.			No Correlation between TIMP2-418 G > C Polymorphism and Increased Risk of Cancer: Evidence from a Meta-Analysis	PLOS ONE			English	Article							TISSUE INHIBITOR; GENE POLYMORPHISMS; CLINICOPATHOLOGICAL SIGNIFICANCE; ASSOCIATION; TIMP-2; METALLOPROTEINASE-2; PROMOTERS; MMP-2; MATRIX-METALLOPROTEINASE-2; SUSCEPTIBILITY	Aim: Tissue inhibitor of metalloproteinase (TIMP2) is involved in the regulation of matrix metalloproteinase 2 (MMP2) and shown to implicate in cancer development and progression. The results from the published studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsistent. In this meta-analysis, we aimed to evaluate the potential association between TIMP2 -418 G>C polymorphism and cancer risk. Methodology: We searched PubMed (Medline) and EMBASE web databases to cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until October 2013. The meta-analysis was performed for selected casecontrol studies and pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for all genetic models. Results: A total of 2225 cancer cases and 2532 controls were included from ten eligible case-control studies. Results from overall pooled analysis suggested no evidence of significant risk between TIMP2 -418 G>C polymorphism and cancer risk in any of the genetic models, such as, allele (C vs. G: OR = 1.293, 95% CI = 0.882 to 1.894, p = 0.188), homozygous (CC vs. GG: OR = 0.940, 95% CI = 0.434 to 2.039, p = 0.876), heterozygous (GC vs. GG: OR = 1.397, 95% CI = 0.888 to 2.198, p = 0.148), dominant (CC+ GC vs. GG: OR = 1.387, 95% CI = 0.880 to 2.187, p = 0.159) and recessive (CC vs. GG+ GC: OR = 0.901, 95% CI = 0.442 to 1.838, p = 0.774) models. No evidence of publication bias was detected during the analysis. Conclusions: The present meta-analysis suggests that the TIMP2 -418 G>C polymorphism may not be involved in predisposing risk factor for cancer in overall population. However, future larger studies with group of populations are needed to analyze the possible correlation.	[Mandal, Raju K.; Mittal, Rama D.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India; [Akhter, Naseem; Alqumber, Mohammed A. A.] Albaha Univ, Fac Appl Med Sci, Dept Lab Med, Albaha, Saudi Arabia; [Haque, Shafiul] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Orissa, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Al Baha University; Jamia Millia Islamia; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Alqumber, MAA (corresponding author), Albaha Univ, Fac Appl Med Sci, Dept Lab Med, Albaha, Saudi Arabia.	alqumber@live.com	HAQUE, SHAFIUL/AAN-2946-2020; AKHTER, NASEEM/ABF-4588-2021; Panda, Aditya K/E-1267-2012	HAQUE, SHAFIUL/0000-0002-2989-121X; AKHTER, NASEEM/0000-0003-2011-0955; Panda, Aditya K/0000-0002-1192-1978; Mandal, Raju/0000-0001-6206-1413				Alakus H, 2008, HISTOL HISTOPATHOL, V23, P917, DOI 10.14670/HH-23.917; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; DECLERCK YA, 1994, GENE, V139, P185, DOI 10.1016/0378-1119(94)90753-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kubben FJJM, 2006, BRIT J CANCER, V95, P744, DOI 10.1038/sj.bjc.6603307; Li XY, 2013, J CANCER RES CLIN, V139, P1433, DOI 10.1007/s00432-013-1446-9; Li Xiu-Lan, 2008, Yi Chuan, V30, P455, DOI 10.3724/SP.J.1005.2008.00455; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MANTEL N, 1959, J NATL CANCER I, V22, P719; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; O-charoenrat P, 2006, ORAL ONCOL, V42, P257, DOI 10.1016/j.oraloncology.2005.07.008; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Ross JS, 2003, MODERN PATHOL, V16, P198, DOI 10.1097/01.MP.0000056984.62360.6C; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Srivastava P, 2013, INDIAN J CLIN BIOCHE, V28, P13, DOI 10.1007/s12291-012-0237-4; Srivastava P, 2012, ARCH MED RES, V43, P117, DOI 10.1016/j.arcmed.2012.02.006; Stetler-Stevenson WG, 2005, TRENDS MOL MED, V11, P97, DOI 10.1016/j.molmed.2005.01.007; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Vairaktaris E, 2007, ONCOL REP, V17, P963; Woolf B., 1995, ANN HUM GENET, V19, P251; Wu CY, 2007, EUR J CANCER, V43, P799, DOI 10.1016/j.ejca.2006.10.022; Wu RL, 1999, BIOMETRICS, V55, P355; Yang L, 2008, EJSO-EUR J SURG ONC, V34, P636, DOI 10.1016/j.ejso.2007.09.003; Yi YC, 2009, CLIN CHIM ACTA, V409, P127, DOI 10.1016/j.cca.2009.09.015; Zhou YF, 2004, CARCINOGENESIS, V25, P399, DOI 10.1093/carcin/bgh020	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e88184	10.1371/journal.pone.0088184	http://dx.doi.org/10.1371/journal.pone.0088184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136829	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100001
J	Turrientes, MC; Gonzalez-Alba, JM; del Campo, R; Baquero, MR; Canton, R; Baquero, F; Galan, JC				Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; del Campo, Rosa; Baquero, Maria-Rosario; Canton, Rafael; Baquero, Fernando; Carlos Galan, Juan			Recombination Blurs Phylogenetic Groups Routine Assignment in Escherichia coli: Setting the Record Straight	PLOS ONE			English	Article							COMMENSAL; PCR; IDENTIFICATION; POPULATIONS; DIVERSITY; EBURST	The characterization of population structures plays a main role for understanding outbreaks and the dynamics of bacterial spreading. In Escherichia coli, the widely used combination of multiplex-PCR scheme together with goeBURST has some limitations. The purpose of this study is to show that the combination of different phylogenetic approaches based on concatenated sequences of MLST genes results in a more precise assignment of E. coli phylogenetic groups, complete understanding of population structure and reconstruction of ancestral clones. A collection of 80 Escherichia coli strains of different origins was analyzed following the Clermont and Doumith's multiplex-PCR schemes. Doumith's multiplex-PCR showed only 1.7% of misassignment, whereas Clermont's-2000 protocol reached 14.0%, although the discrepancies reached 30% and 38.7% respectively when recombinant C, F and E phylogroups were considered. Therefore, correct phylogroup attribution is highly variable and depends on the clonal composition of the sample. As far as population structure of these E. coli strains, including 48 E. coli genomes from GenBank, goeBURST provides a quite dispersed population structure; whereas NeighborNet approach reveals a complex population structure. MLST-based eBURST can infer different founder genotypes, for instance ST23/ST88 could be detected as the founder genotypes for STC23; however, phylogenetic reconstructions might suggest ST410 as the ancestor clone and several evolutionary trajectories with different founders. To improve our routine understanding of E. coli molecular epidemiology, we propose a strategy based on three successive steps; first, to discriminate three main groups A/B1/C, D/F/E and B2 following Doumith's protocol; second, visualization of population structure based on MLST genes according to goeBURST, using NeighborNet to establish more complex relationships among STs; and third, to perform, a cost-free characterization of evolutionary trajectories in variants emerging along the clonal expansion using parsimony methods of phylogenetic analysis.	[Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; del Campo, Rosa; Canton, Rafael; Baquero, Fernando; Carlos Galan, Juan] Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Microbiol Serv, Madrid, Spain; [Turrientes, Maria-Carmen; Gonzalez-Alba, Jose-Maria; Baquero, Fernando; Carlos Galan, Juan] CIBER Epidemiol & Salud Publ, Madrid, Spain; [del Campo, Rosa; Canton, Rafael] Red Espanola Invest Enfermedades Infecciosas REIP, Madrid, Spain; [Baquero, Maria-Rosario] Univ Alfonso X El Sabio, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad Alfonso X el Sabio (UAX)	Baquero, F (corresponding author), Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Microbiol Serv, Madrid, Spain.	baquero@bitmailer.net; juancarlos.galan@salud.madrid.org	CANTON, RAFAEL/ABF-6353-2020; del Campo, Rosa/M-9628-2013	Canton, Rafael/0000-0003-1675-3173; Baquero Artigao, Maria Rosario/0000-0001-8825-1696; del Campo, Rosa/0000-0003-1147-7923	European Union [EvoTAR-FP7-Health-2011-282004]; Regional Government of Madrid in Spain [PROMT-S2010/BMD2414]	European Union(European Commission); Regional Government of Madrid in Spain	MCT PhD is supported by the European Union (EvoTAR-FP7-Health-2011-282004) and JMGA is supported by a fellowship from the Regional Government of Madrid in Spain (PROMT-S2010/BMD2414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2013, MBIO, V4, DOI 10.1128/mBio.00066-13; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, ENVIRON MICROBIOL, V13, P2468, DOI 10.1111/j.1462-2920.2011.02519.x; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gonzalez-Gonzalez A, 2013, INFECT GENET EVOL, V13, P187, DOI 10.1016/j.meegid.2012.09.003; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Homeier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010877; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Lemaitre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074423; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Mendonca N, 2011, J CLIN MICROBIOL, V49, P3105, DOI 10.1128/JCM.00585-11; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Molina-Lopez J, 2011, J INFECT DEV COUNTR, V5, P840, DOI 10.3855/jidc.1703; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; del Castillo BR, 2011, ENFERM INFEC MICR CL, V29, P785, DOI 10.1016/j.eimc.2011.07.004; Smati M, 2013, APPL ENVIRON MICROB, V79, P5005, DOI 10.1128/AEM.01423-13; Smet A, 2010, MICROB DRUG RESIST, V16, P129, DOI 10.1089/mdr.2009.0132; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	35	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105395	10.1371/journal.pone.0105395	http://dx.doi.org/10.1371/journal.pone.0105395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137251	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100088
J	Dinakaran, V; Rathinavel, A; Pushpanathan, M; Sivakumar, R; Gunasekaran, P; Rajendhran, J				Dinakaran, Vasudevan; Rathinavel, Andiappan; Pushpanathan, Muthuirulan; Sivakumar, Ramamoorthy; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash			Elevated Levels of Circulating DNA in Cardiovascular Disease Patients: Metagenomic Profiling of Microbiome in the Circulation	PLOS ONE			English	Article							CELL-FREE DNA; CORONARY-HEART-DISEASE; RIBOSOMAL-RNA GENE; CAROTID ATHEROSCLEROSIS; PROGNOSTIC MARKER; SEQUENCE-ANALYSIS; BACTERIAL-DNA; HUMAN VIRUSES; HUMAN BLOOD; WEB SERVER	Cardiovascular diseases (CVDs) are the leading cause of death worldwide. An expanding body of evidence supports the role of human microbiome in the establishment of CVDs and, this has gained much attention recently. This work was aimed to study the circulating human microbiome in CVD patients and healthy subjects. The levels of circulating cell free DNA (circDNA) was higher in CVD patients (n = 80) than in healthy controls (n = 40). More specifically, the relative levels of circulating bacterial DNA and the ratio of 16S rRNA/beta-globin gene copy numbers were higher in the circulation of CVD patients than healthy individuals. In addition, we found a higher circulating microbial diversity in CVD patients (n = 3) in comparison to healthy individuals (n = 3) by deep shotgun sequencing. At the phylum level, we observed a dominance of Actinobacteria in CVD patients, followed by Proteobacteria, in contrast to that in healthy controls, where Proteobacteria was predominantly enriched, followed by Actinobacteria. The circulating virome in CVD patients was enriched with bacteriophages with a preponderance of Propionibacterium phages, followed by Pseudomonas phages and Rhizobium phages in contrast to that in healthy individuals, where a relatively greater abundance of eukaryotic viruses dominated by Lymphocystis virus (LCV) and Torque Teno viruses (TTV) was observed. Thus, the release of bacterial and viral DNA elements in the circulation could play a major role leading to elevated circDNA levels in CVD patients. The increased circDNA levels could be either the cause or consequence of CVD incidence, which needs to be explored further.	[Dinakaran, Vasudevan; Pushpanathan, Muthuirulan; Sivakumar, Ramamoorthy; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash] Madurai Kamaraj Univ, Ctr Excellence Genom Sci, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India; [Rathinavel, Andiappan] Madurai Med Coll, Dept Cardiothorac Surg, Madurai, Tamil Nadu, India; [Rathinavel, Andiappan] Govt Rajaji Hosp, Madurai, Tamil Nadu, India	Madurai Kamaraj University; Madurai Medical College	Rajendhran, J (corresponding author), Madurai Kamaraj Univ, Ctr Excellence Genom Sci, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India.	jrajendhran@gmail.com	Rajendhran, Jeyaprakash/ABD-3893-2020; Vasudevan, Dinakaran/AAE-1954-2020; Pushpanathan, Muthuirulan/K-7302-2019	Vasudevan, Dinakaran/0000-0003-0593-370X; Pushpanathan, Muthuirulan/0000-0001-6240-3073; Rajendhran, Jeyaprakash/0000-0002-1898-1607	Department of Biotechnology, New Delhi [/PR13253GBD/27/237/2009]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	The study was financially supported by the Department of Biotechnology, New Delhi (No./PR13253GBD/27/237/2009 & 11-12-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Arahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI [10.1128/CMR.00028-08, DOI 10.1128/CMR.00028-08]; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Bernardin F, 2010, TRANSFUSION, V50, P2474, DOI 10.1111/j.1537-2995.2010.02699.x; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chevreux B., 2005, THESIS; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cui M, 2013, CARDIOLOGY, V124, P76, DOI 10.1159/000345855; Destouni A, 2009, ACTA CARDIOL, V64, P51, DOI 10.2143/AC.64.1.2034362; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Frances R, 2007, CLIN EXP IMMUNOL, V150, P230, DOI 10.1111/j.1365-2249.2007.03494.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Garg N, 2005, INT J CARDIOL, V98, P253, DOI 10.1016/j.ijcard.2003.10.043; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Groesdonk HV, 2013, J THORAC CARDIOV SUR, V145, P1603, DOI 10.1016/j.jtcvs.2012.11.022; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Huang CH, 2012, RESUSCITATION, V83, P213, DOI 10.1016/j.resuscitation.2011.07.039; LEON SA, 1977, CANCER RES, V37, P646; Li SK, 2012, CLIN MICROBIOL INFEC, V18, P1126, DOI 10.1111/j.1469-0691.2011.03690.x; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lorusso R, 2014, ANN THORAC SURG, V97, P2219, DOI 10.1016/j.athoracsur.2014.01.029; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Moriyama K, 2008, MICROBIOL IMMUNOL, V52, P375, DOI 10.1111/j.1348-0421.2008.00048.x; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nerheim PL, 2004, AM J PATHOL, V164, P589, DOI 10.1016/S0002-9440(10)63148-3; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pedersen KK, 2014, J ACQ IMMUN DEF SYND, V64, P425, DOI [10.1097/QAI.0b013e31 829f919d, DOI 10.1097/QAI.0B013E31_829F919D]; Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292; Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59; Quiros P, 2014, ANTIMICROB AGENTS CH, V58, P606, DOI 10.1128/AAC.01684-13; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rainer TH, 2006, CLIN CHIM ACTA, V368, P110, DOI 10.1016/j.cca.2005.12.021; Rajendhran J, 2013, INT J CARDIOL, V168, P5118, DOI 10.1016/j.ijcard.2013.07.232; Renko J, 2013, EUR J DERMATOL, V23, P53, DOI 10.1684/ejd.2012.1908; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Saey TH, 2014, SCI NEWS, V185, P18, DOI [10.1002/scin.5591850115, DOI 10.1002/SCIN.5591850115]; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2006, NAT MED, V12, P736, DOI 10.1038/nm0706-736; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Veloso TR, 2011, INFECT IMMUN, V79, P2006, DOI 10.1128/IAI.01208-10; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	62	114	116	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105221	10.1371/journal.pone.0105221	http://dx.doi.org/10.1371/journal.pone.0105221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133738	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700091
J	Jorgensen, BP; Hansen, JT; Krych, L; Larsen, C; Klein, AB; Nielsen, DS; Josefsen, K; Hansen, AK; Sorensen, DB				Jorgensen, Bettina Pyndt; Hansen, Julie Torpe; Krych, Lukasz; Larsen, Christian; Klein, Anders Bue; Nielsen, Dennis Sandris; Josefsen, Knud; Hansen, Axel Kornerup; Sorensen, Dorte Bratbo			A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; NEUROTROPHIC FACTOR; HIGH-FAT; MAJOR DEPRESSION; ANIMAL-MODELS; BRAIN; MEMORY; ANXIETY	Major depressive disorder is a debilitating disease in the Western World. A western diet high in saturated fat and refined sugar seems to play an important part in disease development. Therefore, this study is aimed at investigating whether saturated fat or sucrose predisposes mice to develop behavioral symptoms which can be interpreted as depression-like, and the possible influence of the gut microbiota (GM) in this. Fourty-two mice were randomly assigned to one of three experimental diets, a high-fat, a high-sucrose or a control diet for thirteen weeks. Mice on high-fat diet gained more weight (p = 0.00009), displayed significantly less burrowing behavior than the control mice (p = 0.034), and showed decreased memory in the Morris water maze test compared to mice on high-sucrose diet (p = 0.031). Mice on high-sucrose diet burrowed less goal-oriented, showed greater latency to first bout of immobility in the forced swim test when compared to control mice (p = 0.039) and high-fat fed mice (p = 0.013), and displayed less anxiety than mice on high-fat diet in the triple test (p = 0.009). Behavioral changes were accompanied by a significant change in GM composition of mice fed a high-fat diet, while no difference between diet groups was observed for sucrose preferences, LPS, cholesterol, HbA1c, BDNF and the cytokines IL-1 alpha, IL-1 beta, IL-6, IL-10, IL-12(p70), IL-17 and TNF-alpha. A series of correlations was found between GM, behavior, BDNF and inflammatory mediators. In conclusion, the study shows that dietary fat and sucrose affect behavior, sometimes in opposite directions, and suggests a possible association between GM and behavior.	[Jorgensen, Bettina Pyndt; Hansen, Julie Torpe; Larsen, Christian; Hansen, Axel Kornerup; Sorensen, Dorte Bratbo] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg C, Denmark; [Klein, Anders Bue] Rigshosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark; [Krych, Lukasz; Nielsen, Dennis Sandris] Univ Copenhagen, Fac Sci, Dept Food Sci, Frederiksberg C, Denmark; [Josefsen, Knud] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Jorgensen, BP (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg C, Denmark.	bmp@sund.ku.dk	Nielsen, Dennis/A-9769-2015; Krych, Luaksz/F-4446-2015	Nielsen, Dennis/0000-0001-8121-1114; Krych, Luaksz/0000-0003-3224-1346; Sorensen, Dorte Bratbo/0000-0002-6144-1710; Klein, Anders Bue/0000-0002-0236-3089				Abildgaard A, 2010, INT J NEUROPSYCHOPH, V13, P142; Alesci S, 2005, BIOL PSYCHIAT, V57, p124S; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anisman H, 2005, CURR PHARM DESIGN, V11, P963, DOI 10.2174/1381612053381701; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Deussing J.M., 2006, DRUG DISCO TODAY DIS, V3, P375, DOI [DOI 10.1016/J.DDM0D.2006.11.003, 10.1016/J.DDMOD.2006.11.003, DOI 10.1016/J.DDMOD.2006.11.003]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Frazer A, 2005, NEUROSCI BIOBEHAV R, V29, P515, DOI 10.1016/j.neubiorev.2005.03.006; Gaykema RPA, 2004, BRAIN BEHAV IMMUN, V18, P238, DOI 10.1016/j.bbi.2003.08.002; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Lauritsen LFS, 2010, SCAND J LAB ANIM SCI, V37, P43; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014; Maniam J, 2010, BEHAV BRAIN RES, V208, P72, DOI 10.1016/j.bbr.2009.11.005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Salaj R, 2013, SCI WORLD J, DOI 10.1155/2013/135142; Schreurs BG, 2010, NEUROSCI BIOBEHAV R, V34, P1366, DOI 10.1016/j.neubiorev.2010.04.010; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van den Bogert B, 2013, THESIS, P1; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; WEST AP, 1990, PROG NEURO-PSYCHOPH, V14, P863, DOI 10.1016/0278-5846(90)90073-P; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	43	98	100	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103398	10.1371/journal.pone.0103398	http://dx.doi.org/10.1371/journal.pone.0103398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133574	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700008
J	Loizidou, MA; Neophytou, I; Papamichael, D; Kountourakis, P; Vassiliou, V; Marcou, Y; Kakouri, E; Ioannidis, G; Philippou, C; Spanou, E; Tanteles, GA; Anastasiadou, V; Hadjisavvas, A; Kyriacou, K				Loizidou, Maria A.; Neophytou, Ioanna; Papamichael, Demetris; Kountourakis, Panteleimon; Vassiliou, Vassilios; Marcou, Yiola; Kakouri, Eleni; Ioannidis, Georgios; Philippou, Chrystalla; Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta; Hadjisavvas, Andreas; Kyriacou, Kyriacos			The Mutational Spectrum of Lynch Syndrome in Cyprus	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; FOUNDER MUTATION; HEREDITARY; FAMILIES; RISK; MSH2; HNPCC; GENE; MLH1; PREDISPOSITION	Lynch syndrome is the most common form of hereditary colorectal cancer and is caused by germline mutations in the mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2. Mutation carriers have an increased lifetime risk of developing colorectal cancer as well as other extracolonic tumours. The aim of the current study was to evaluate the frequency and distribution of mutations in the MLH1, MSH2 and MSH6 genes within a cohort of Cypriot families that fulfilled the revised Bethesda guidelines. The study cohort included 77 patients who fulfilled at least one of the revised Bethesda guidelines. Mutational analysis revealed the presence of 4 pathogenic mutations, 3 in the MLH1 gene and 1 in the MSH2 gene, in 5 unrelated individuals. It is noted that out of the 4 pathogenic mutations detected, one is novel (c.1610delG in exon 14 of the MLH1) and has been detected for the first time in the Cypriot population. Overall, the pathogenic mutation detection rate in our patient cohort was 7%. This percentage is relatively low but could be explained by the fact that the sole criterion for genetic screening was compliance to the revised Bethesda guidelines. Larger numbers of Lynch syndrome families and screening of the two additional predisposition genes, PMS2 and EPCAM, are needed in order to decipher the full spectrum of mutations associated with Lynch syndrome predisposition in Cyprus.	[Loizidou, Maria A.; Neophytou, Ioanna; Hadjisavvas, Andreas; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, Nicosia, Cyprus; [Papamichael, Demetris; Kountourakis, Panteleimon; Vassiliou, Vassilios; Marcou, Yiola; Kakouri, Eleni] Bank Cyprus Oncol Ctr, Dept Med & Radiat Oncol, Nicosia, Cyprus; [Ioannidis, Georgios] Nicosia Gen Hosp, Dept Oncol, Nicosia, Cyprus; [Philippou, Chrystalla] Limassol Gen Hosp, Dept Oncol, Limassol, Cyprus; [Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta] Makarios III Hosp, Dept Clin Genet, Nicosia, Cyprus; [Spanou, Elena; Tanteles, George A.; Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Nicosia, Cyprus		Hadjisavvas, A (corresponding author), Cyprus Inst Neurol & Genet, Dept Electron Microscopy Mol Pathol, Nicosia, Cyprus.	ahsavvas@cing.ac.cy; kyriacos@cing.ac.cy	Loizidou, Maria A/C-6607-2009; Tanteles, George/H-6190-2012	Tanteles, George/0000-0002-8117-9852				Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; Boland CR, 2010, GASTROENTEROLOGY, V138, P2197, DOI [10.1053/j.gastro.2010.04.024, DOI 10.1053/J.GASTRO.2010.04.024]; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hampel H, 2010, J NATL COMPR CANC NE, V8, P597, DOI 10.6004/jnccn.2010.0044; Jarvinen HJ, 2009, J CLIN ONCOL, V27, P4793, DOI 10.1200/JCO.2009.23.7784; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pinheiro M, 2011, GENET MED, V13, P895, DOI 10.1097/GIM.0b013e31821dd525; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Steinke V, 2013, INT J CANC J INT DU; Stigliano V, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-1; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105501	10.1371/journal.pone.0105501	http://dx.doi.org/10.1371/journal.pone.0105501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133505	Green Submitted, gold, Green Published			2022-12-27	WOS:000341302700118
J	Bruner-Tran, KL; Ding, TB; Yeoman, KB; Archibong, A; Arosh, JA; Osteen, KG				Bruner-Tran, Kaylon L.; Ding, Tianbing; Yeoman, Kallie B.; Archibong, Anthony; Arosh, Joe A.; Osteen, Kevin G.			Developmental Exposure of Mice to Dioxin Promotes Transgenerational Testicular Inflammation and an Increased Risk of Preterm Birth in Unexposed Mating Partners	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; REPRODUCTIVE DISEASE; SEMEN QUALITY; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN EXPOSURE; AH RECEPTOR; INHERITANCE; CELL; INFERTILITY; ASSOCIATION; DISRUPTION	TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, commonly known as dioxin) is a ubiquitous environmental contaminant and known endocrine disruptor. Using a mouse model, we previously found that adult female mice exposed in utero to TCDD (F1 generation) as well as multiple subsequent generations (F2-F4) exhibited reduced fertility and an increased incidence of spontaneous preterm birth. Additional studies revealed that male F1 mice with a similar in utero/developmental TCDD exposure also exhibited diminished fertility and conferred an increased risk of preterm birth to their unexposed mating partners. Herein, we extend these previous observations, reporting that reduced fertility in male F1 mice is linked to testicular inflammation which coincides with apoptosis of developing spermatocytes, sub-fertility and an increased risk of preterm birth in their unexposed mating partners. Significantly, in the absence of additional toxicant exposure, testicular inflammation and reduced fertility persisted in F2 and F3 males and their control mating partners also frequently exhibited spontaneous preterm birth. Although a steady, global decline in male fertility has been noted over the last few decades, the reasons for these changes have not been firmly established. Likewise, the PTB rate in the U. S. and other countries has paralleled industrial development, suggesting a possible relationship between environmental toxicant exposure and adverse pregnancy outcomes. Most current clinical strategies to prevent preterm birth are focused solely on the mother and have yielded limited benefits. In contrast, our studies strongly suggest that the preconception testicular health of the father is a critical determinant of pregnancy outcomes in mice. Future clinical studies should examine the potential contribution of the male to gestation length in women and whether efforts to reduce the incidence of preterm birth should be initiated in both parents prior to pregnancy.	[Bruner-Tran, Kaylon L.; Ding, Tianbing; Yeoman, Kallie B.; Osteen, Kevin G.] Vanderbilt Univ, Sch Med, Dept Obstet & Gynecol, Womens Reprod Hlth Res Ctr, Nashville, TN 37212 USA; [Osteen, Kevin G.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Archibong, Anthony] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Arosh, Joe A.] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Vanderbilt University; Vanderbilt University; Meharry Medical College; Texas A&M University System; Texas A&M University College Station	Bruner-Tran, KL (corresponding author), Vanderbilt Univ, Sch Med, Dept Obstet & Gynecol, Womens Reprod Hlth Res Ctr, Nashville, TN 37212 USA.	kaylon.bruner-tran@vanderbilt.edu; kevin.osteen@vanderbilt.edu			National Institute for Environmental Health Sciences [ES14942]; Vanderbilt University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014942] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Vanderbilt University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute for Environmental Health Sciences (www.niehs.nih.gov) #ES14942 to KBT and KGO, and Vanderbilt University School of Medicine (http://www.mc.vanderbilt.edu/) to KBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Aitken RJ, 2014, REPRODUCTION, V147, pS1, DOI 10.1530/REP-13-0399; Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; Archibong AE, 2012, REPROD TOXICOL, V34, P635, DOI 10.1016/j.reprotox.2012.09.003; Baba T, 2008, SEX DEV, V2, P1, DOI 10.1159/000117714; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bidgoli SA, 2011, SCI TOTAL ENVIRON, V409, P3267, DOI 10.1016/j.scitotenv.2011.03.024; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Bruner-Tran KL, 2012, CURR OBSTET GYNECOL, V1, P116, DOI 10.1007/s13669-012-0014-7; Bruner-Tran KL, 2011, BIOL REPROD, V84, P106, DOI 10.1095/biolreprod.110.086744; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024; Candela S, 2013, EPIDEMIOLOGY, V24, P863, DOI 10.1097/EDE.0b013e3182a712f1; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Dickie M.M., 1975, BIOL LAB MOUSE, P25; Ding TB, 2011, REPROD TOXICOL, V31, P351, DOI 10.1016/j.reprotox.2010.11.003; Esakky P, 2012, REPROD TOXICOL, V34, P665, DOI 10.1016/j.reprotox.2012.10.005; Eskenazi B, 2010, EPIDEMIOLOGY, V21, P224, DOI 10.1097/EDE.0b013e3181cb8b95; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Fisch H, 2008, UROL CLIN N AM, V35, P137, DOI 10.1016/j.ucl.2008.01.001; Golas A, 2011, REPROD BIOL, V11, P250, DOI 10.1016/S1642-431X(12)60070-9; Guerrero-Bosagna C, 2012, MOL CELL ENDOCRINOL, V354, P3, DOI 10.1016/j.mce.2011.10.004; Hansen DA, 2014, BIOL REPROD, V90, P1; Harris RM, 2012, MATURITAS, V72, P108, DOI 10.1016/j.maturitas.2012.03.002; Heindel JJ, 2006, SEMIN REPROD MED, V24, P168, DOI 10.1055/s-2006-944423; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Jones KM, 2009, INT J ENV RES PUB HE, V6, P1124, DOI 10.3390/ijerph6031124; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kretzschmar G, 2010, MOL CELL ENDOCRINOL, V321, P253, DOI 10.1016/j.mce.2010.02.018; Lawrence BP, 2013, SEMIN IMMUNOPATHOL, V35, P615, DOI 10.1007/s00281-013-0395-3; Locke PA, 2011, ALTEX-ALTERN ANIM EX, V28, P266, DOI 10.14573/altex.2011.4.266; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; McConaha ME, 2011, REPRODUCTION, V142, P235, DOI 10.1530/REP-11-0070; Mocarelli P, 2008, ENVIRON HEALTH PERSP, V116, P70, DOI 10.1289/ehp.10399; Mocarelli P, 2011, ENVIRON HEALTH PERSP, V119, P713, DOI 10.1289/ehp.1002134; Morimoto H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095307; Nayyar T, 2007, REPROD TOXICOL, V23, P326, DOI 10.1016/j.reprotox.2006.09.007; Perez Cecilia V, 2013, Spermatogenesis, V3, pe23870; Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x; Pham H, 2010, PANCREAS, V39, P332, DOI 10.1097/MPA.0b013e3181baecbe; Rier S, 2002, TOXICOL SCI, V70, P161, DOI 10.1093/toxsci/70.2.161; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Roman BL, 1998, TOXICOL APPL PHARM, V150, P228, DOI 10.1006/taap.1998.8388; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, P1, DOI DOI 10.1186/1477-7827-11-66; Straub RH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4484; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; Tiano HF, 2002, CANCER RES, V62, P3395; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Vested A, 2013, ENVIRON HEALTH PERSP, V121, P453, DOI 10.1289/ehp.1205118; Vogel CFA, 2003, J BIOCHEM MOL TOXIC, V17, P305, DOI 10.1002/jbt.10096; Walter A, 2010, CLIN CANCER RES, V16, P3562, DOI 10.1158/1078-0432.CCR-09-3136; Wang HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003320; Wang X, 2013, P NATL ACAD SCI USA, V110, P10705, DOI 10.1073/pnas.1308998110; Wang Y, 2002, COMPUTER ENG, P15; Wilson MP, 2012, J OCCUP ENVIRON HYG, V9, pD87, DOI 10.1080/15459624.2012.677802	60	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105084	10.1371/journal.pone.0105084	http://dx.doi.org/10.1371/journal.pone.0105084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127480	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300078
J	Can, H; Doskaya, M; Ajzenberg, D; Ozdemir, HG; Caner, A; Iz, SG; Doskaya, AD; Atalay, E; Cetinkaya, C; Urgen, S; Karacali, S; Un, C; Darde, ML; Guruz, Y				Can, Huseyin; Doskaya, Mert; Ajzenberg, Daniel; Ozdemir, H. Gokhan; Caner, Ayse; Iz, Sultan Gulce; Doskaya, Aysu Degirmenci; Atalay, Esra; Cetinkaya, Cagdas; Urgen, Saygun; Karacali, Sabire; Un, Cemal; Darde, Marie-Laure; Guruz, Yuksel			Genetic Characterization of Toxoplasma gondii Isolates and Toxoplasmosis Seroprevalence in Stray Cats of Izmir, Turkey	PLOS ONE			English	Article							FREE-RANGE CHICKENS; CONGENITAL TOXOPLASMOSIS; TISSUE DISTRIBUTION; SOUTH-AMERICA; GENOTYPE; PREVALENCE; DIVERSITY; ANIMALS; ANTIBODIES; INFECTION	Currently, some Toxoplasma gondii genotypes are being associated with serious clinical presentations. A recent report showing the Africa 1 genotype in two local congenital toxoplasmosis cases acquired in Turkey formed the basis of this study because atypical Africa 1 genotype is most frequently detected in animals and patients from sub-Saharan Africa. Since stray cats are considered as the linkage between wild life and urban life in T. gondii transmission, the present study aimed to isolate and characterize T. gondii strains circulating in stray cats of Izmir (Western Turkey). A secondary objective was to determine toxoplasmosis seroprevalence in this cat population. Tissues obtained from 100 deceased stray cats were bioassayed and isolated strains were genotyped using 15 microsatellite markers. In addition, toxoplasmosis seroprevalence was analyzed in 1121 cat sera collected from several large veterinary clinics in Izmir. Among the 22 isolates, 19 were Type II (86.3%), two were Type III (9%) and one was Africa 1 genotype (4.5%). The overall seropositivity rates in cats were 42-48% and 33.4-34.4% according to IFA and ELISA, respectively. Seroprevalence in deceased cats was significantly higher than in healthy cats (P = 0.0033). Finding both the major clonal Type II lineage together with the Type III lineage also found in Middle East, and an atypical genotype, Africa 1 appears consistent with the specific geographic location of Turkey between three continents and raises the possibility of transportation of these strains between continents through trade routes or long distance migratory birds. In addition, the first large study of toxoplasma seroprevalence in a stray cat population was also reported. The relatively high seropositivity rates and the variety of T. gondii genotypes confirm the local stray cat population as a risk factor for human toxoplasmosis in Izmir.	[Can, Huseyin; Atalay, Esra; Karacali, Sabire; Un, Cemal] Ege Univ, Fac Sci, Dept Mol Biol, Bornova, Turkey; [Doskaya, Mert; Caner, Ayse; Doskaya, Aysu Degirmenci; Guruz, Yuksel] Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey; [Ajzenberg, Daniel; Darde, Marie-Laure] Ctr Hosp Univ Dupuytren, Ctr Natl Reference, Toxoplasmose Toxoplasma Biol Resource Ctr, Limoges, France; [Ajzenberg, Daniel; Darde, Marie-Laure] Univ Limoges, Fac Med, Lab Parasitol Mycol, INSERM UMR 1094, Limoges, France; [Ozdemir, H. Gokhan; Cetinkaya, Cagdas; Urgen, Saygun] Municipal Izmir, Dept Vet Affairs, Izmir, Turkey; [Iz, Sultan Gulce] Ege Univ, Fac Engn, Dept Bioengn, Bornova, Turkey	Ege University; Ege University; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Izmir Metropolitan Municipality; Ege University	Doskaya, M (corresponding author), Ege Univ, Sch Med, Dept Parasitol, Bornova, Turkey.	mert.doskaya@ege.edu.tr	Iz, Gulce/C-4174-2013; Can, Hüseyin/J-2987-2019; ün, cemal/AAH-3099-2020; Caner, Ayse/AAG-8982-2019; Can, Hüseyin/AAG-3152-2020; Degirmenci, Aysu/DET-8805-2022; Doskaya, Mert/W-4682-2017	Caner, Ayse/0000-0003-3058-9971; Can, Hüseyin/0000-0001-9633-9786; Doskaya, Mert/0000-0001-6868-008X; Gulce Iz, Sultan/0000-0002-9275-6272; Ajzenberg, Daniel/0000-0002-5357-3318	Scientific Research Projects Branch Directorate of Ege University, Turkey [2010-TIP-091, 2011-TIP-034]	Scientific Research Projects Branch Directorate of Ege University, Turkey(Ege University)	This study was supported by the grants given by the Scientific Research Projects Branch Directorate of Ege University, Turkey (Grant No: 2010-TIP-091 and 2011-TIP-034) to Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Al-Kappany YM, 2010, J PARASITOL, V96, P1115, DOI 10.1645/GE-2554.1; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Altintas Nazmiye, 1997, Journal of the Egyptian Society of Parasitology, V27, P439; Babur C, 1998, TURKIYE KLINIKLERI J, V14, P55; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; Degirmenci A, 2011, EXP PARASITOL, V128, P1, DOI 10.1016/j.exppara.2011.01.019; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Doskaya M, 2013, PARASITOL INT, V62, P471, DOI 10.1016/j.parint.2013.06.008; Dubey JP, 2008, J PARASITOL, V94, P68, DOI 10.1645/GE-1362.1; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2006, VET PARASITOL, V141, P42, DOI 10.1016/j.vetpar.2006.04.037; Dubey JP, 2006, VET PARASITOL, V140, P76, DOI 10.1016/j.vetpar.2006.03.023; Dubey JP, 2013, J PARASITOL, V99, P56, DOI 10.1645/GE-3229.1; Dubey JP, 2010, VET PARASITOL, V172, P195, DOI 10.1016/j.vetpar.2010.05.013; Dubey JP, 2010, J PARASITOL, V96, P709, DOI 10.1645/GE-2425.1; Dubey JP, 2004, J PARASITOL, V90, P721, DOI 10.1645/GE-382R; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Ertug S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-66; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Karatepe B, 2008, ITAL J ANIM SCI, V7, P113; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lappin MR, 2010, TOP COMPANION ANIM M, V25, P136, DOI 10.1053/j.tcam.2010.07.002; Liang L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006916; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Ozkan AT, 2008, J PARASITOL, V94, P817, DOI 10.1645/GE-1401.1; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Salant H, 2009, VET PARASITOL, V159, P24, DOI 10.1016/j.vetpar.2008.10.011; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Zhou YZ, 2013, VET PARASITOL, V193, P270, DOI 10.1016/j.vetpar.2012.11.031; Zia-Ali N, 2007, PARASITOL RES, V101, P111, DOI 10.1007/s00436-007-0461-7	42	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104930	10.1371/journal.pone.0104930	http://dx.doi.org/10.1371/journal.pone.0104930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127360	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300061
J	Cordier, C; Boutimah, F; Bourdeloux, M; Dupuy, F; Met, E; Alberti, P; Loll, F; Chassaing, G; Burlina, F; Saison-Behmoaras, TE				Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Chassaing, Gerard; Burlina, Fabienne; Saison-Behmoaras, Tula Ester			Delivery of Antisense Peptide Nucleic Acids to Cells by Conjugation with Small Arginine-Rich Cell-Penetrating Peptide (R/W)9	PLOS ONE			English	Article							SPLICE-REDIRECTING ACTIVITY; INTRACELLULAR DELIVERY; ENDOCYTIC PATHWAYS; MASS-SPECTROMETRY; PNA; OLIGONUCLEOTIDES; INTERNALIZATION; CHLOROQUINE; EXPRESSION; TRYPTOPHAN	Peptide nucleic acids (PNAs) are very attractive antisense and antigene agents, but these molecules are not passively taken into cells. Here, using a functional cell assay and fluorescent-based methods, we investigated cell uptake and antisense activity of a tridecamer PNA that targets the HIV-1 polypurine tract sequence delivered using the arginine-rich (R/W)9 peptide (RRWWRRWRR). At micromolar concentrations, without use of any transfection agents, almost 80% inhibition of the target gene expression was obtained with the conjugate in the presence of the endosomolytic agent chloroquine. We show that chloroquine not only induced escape from endosomes but also enhanced the cellular uptake of the conjugate. Mechanistic studies revealed that (R/W)9-PNA conjugates were internalized via pinocytosis. Replacement of arginines with lysines reduced the uptake of the conjugate by six-fold, resulting in the abolition of intracellular target inhibition. Our results show that the arginines play a crucial role in the conjugate uptake and antisense activity. To determine whether specificity of the interactions of arginines with cell surface proteoglycans result in the internalization, we used flow cytometry to examine uptake of arginine-and lysine-rich conjugates in wild-type CHO-K1 and proteoglycan-deficient A745 cells. The uptake of both conjugates was decreased by four fold in CHO-745 cells; therefore proteoglycans promote internalization of cationic peptides, irrespective of the chemical nature of their positive charges. Our results show that arginine-rich cell-penetrating peptides, especially (R/W)9, are a promising tool for PNA internalization.	[Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] Museum Natl Hist Nat, F-75231 Paris, France; [Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] INSERM, U1154, Paris, France; [Cordier, Celine; Boutimah, Fatima; Bourdeloux, Mathilde; Dupuy, Florian; Met, Elisabeth; Alberti, Patrizia; Loll, Francois; Saison-Behmoaras, Tula Ester] CNRS, UMR 7196, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] Univ Paris 06, Lab BioMol, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] CNRS, UMR 7203, Paris, France; [Chassaing, Gerard; Burlina, Fabienne] Ecole Normale Super, Dept Chim, ENS, UMR 7203, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Saison-Behmoaras, TE (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	tula@mnhn.fr		Burlina, Fabienne/0000-0002-6042-680X; Alberti, Patrizia/0000-0002-5231-3768	French Ministry for Research	French Ministry for Research(Ministry of Research, France)	C. C. and F. B. were recipients of a PhD fellowship from the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Abes S, 2007, NUCLEIC ACIDS RES, V35, P4495, DOI 10.1093/nar/gkm418; Amand HL, 2008, BIOCHEM BIOPH RES CO, V371, P621, DOI 10.1016/j.bbrc.2008.04.039; Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Aubry S, 2010, BBA-BIOMEMBRANES, V1798, P2182, DOI 10.1016/j.bbamem.2009.11.011; Aubry S, 2009, FASEB J, V23, P2956, DOI 10.1096/fj.08-127563; Bechara C, 2013, FASEB J, V27, P738, DOI 10.1096/fj.12-216176; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; Berthault N, 2011, CANCER GENE THER, V18, P695, DOI 10.1038/cgt.2011.39; Boutimah-Hamoudi F, 2007, NUCLEIC ACIDS RES, V35, P3907, DOI 10.1093/nar/gkm374; Briceno E, 2007, SURG NEUROL, V67, P388, DOI 10.1016/j.surneu.2006.08.080; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dean DA, 2000, ADV DRUG DELIVER REV, V44, P81, DOI 10.1016/S0169-409X(00)00087-9; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; El-Andaloussi S, 2006, J GENE MED, V8, P1262, DOI 10.1002/jgm.950; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Franco CRC, 2001, BRAZ J MED BIOL RES, V34, P971, DOI 10.1590/S0100-879X2001000800001; Hassane FS, 2009, BIOCONJUGATE CHEM, V20, P1523, DOI 10.1021/bc900075p; Ivanova GD, 2008, NUCLEIC ACIDS RES, V36, P6418, DOI 10.1093/nar/gkn671; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Koppelhus U, 2002, ANTISENSE NUCLEIC A, V12, P51, DOI 10.1089/108729002760070795; Koppelhus U, 2008, BIOCONJUGATE CHEM, V19, P1526, DOI 10.1021/bc800068h; Lebleu B, 2008, ADV DRUG DELIVER REV, V60, P517, DOI 10.1016/j.addr.2007.09.002; Lecosnier S, 2011, FASEB J, V25, P2201, DOI 10.1096/fj.10-169540; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Lundin KE, 2006, ADV GENET, V56, P1, DOI 10.1016/S0065-2660(06)56001-8; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Marlin F, 2010, CHEMBIOCHEM, V11, P1493, DOI 10.1002/cbic.201000138; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nielsen PE, 2010, CHEM BIODIVERS, V7, P786, DOI 10.1002/cbdv.201000005; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rogers FA, 2012, MOL THER, V20, P109, DOI 10.1038/mt.2011.163; Rydberg HA, 2012, BIOCHEMISTRY-US, V51, P5531, DOI 10.1021/bi300454k; Saleh AF, 2010, BIOCONJUGATE CHEM, V21, P1902, DOI 10.1021/bc100275r; Shiraishi T, 2005, CHEM BIOL, V12, P923, DOI 10.1016/j.chembiol.2005.06.009; Shiraishi Takehiko, 2011, Artif DNA PNA XNA, V2, P90; Torres AG, 2012, NUCLEIC ACIDS RES, V40, P2152, DOI 10.1093/nar/gkr885; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu RP, 2007, NUCLEIC ACIDS RES, V35, P5182, DOI 10.1093/nar/gkm478	46	22	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104999	10.1371/journal.pone.0104999	http://dx.doi.org/10.1371/journal.pone.0104999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127364	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300069
J	de Pablo, JFL; Badal, E; Garcia, CF; Martinez-Orti, A; Serra, AS				Fernandez-Lopez de Pablo, Javier; Badal, Ernestina; Ferrer Garcia, Carlos; Martinez-Orti, Alberto; Sanchis Serra, Alfred			Land Snails as a Diet Diversification Proxy during the Early Upper Palaeolithic in Europe	PLOS ONE			English	Article							MOLLUSK EXPLOITATION; MUMBA ROCKSHELTER; HAUA FTEAH; CONSUMPTION; MIDDLE; POPULATION; GASTROPODS; VARIABILITY; TRANSITION; CYRENAICA	Despite the ubiquity of terrestrial gastropods in the Late Pleistocene and Holocene archaeological record, it is still unknown when and how this type of invertebrate resource was incorporated into human diets. In this paper, we report the oldest evidence of land snail exploitation as a food resource in Europe dated to 31.3-26.9 ka yr cal BP from the recently discovered site of Cova de la Barriada (eastern Iberian Peninsula). Mono-specific accumulations of large Iberus alonensis land snails (Ferussac 1821) were found in three different archaeological levels in association with combustion structures, along with lithic and faunal assemblages. Using a new analytical protocol based on taphonomic, microX-Ray Diffractometer (DXR) and biometric analyses, we investigated the patterns of selection, consumption and accumulation of land snails at the site. The results display a strong mono-specific gathering of adult individuals, most of them older than 55 weeks, which were roasted in ambers of pine and juniper under 375 degrees C. This case study uncovers new patterns of invertebrate exploitation during the Gravettian in southwestern Europe without known precedents in the Middle Palaeolithic nor the Aurignacian. In the Mediterranean context, such an early occurrence contrasts with the neighbouring areas of Morocco, France, Italy and the Balkans, where the systematic nutritional use of land snails appears approximately 10,000 years later during the Iberomaurisian and the Late Epigravettian. The appearance of this new subsistence activity in the eastern and southern regions of Spain was coeval to other demographically driven transformations in the archaeological record, suggesting different chronological patterns of resource intensification and diet broadening along the Upper Palaeolithic in the Mediterranean basin.	[Fernandez-Lopez de Pablo, Javier] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Fernandez-Lopez de Pablo, Javier] URV, Area Prehist, Tarragona, Spain; [Badal, Ernestina] Univ Valencia, Fac Geog & Hist, Dept Prehist & Arqueol, Valencia, Spain; [Ferrer Garcia, Carlos; Sanchis Serra, Alfred] SIP, Museu Prehist Valencia, Valencia, Spain; [Martinez-Orti, Alberto] Museu Valencia Hist Nat & Biotaxa, Valencia, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; University of Valencia	de Pablo, JFL (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, Zona Educ 4 Campus Sescelades,Edifici W3, Tarragona, Spain.	jfernandez@iphes.cat	Fernández-López de Pablo, Javier/GXG-1170-2022; de Pablo, Javier Fernández-López/G-6590-2016; Ferrer García, Carlos/ABC-7677-2021; Badal Garcia, Ernestina/K-9462-2014	Fernández-López de Pablo, Javier/0000-0002-6953-7004; Ferrer García, Carlos/0000-0003-0588-5488; Martinez-Orti, Alberto/0000-0001-6816-1140; Badal Garcia, Ernestina/0000-0002-8296-1870	Fundacion Adendia; MINECO Spanish Ministry [RYC-2011-09363, HAR2012-32703, 2012CGL-34717]; Consolidated Research Groug "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria" [SGR-2014-900]	Fundacion Adendia; MINECO Spanish Ministry(Spanish Government); Consolidated Research Groug "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria"	The fieldwork research and the radiocarbon analyses were supported by private funds provided by the Fundacion Adendia in the framework of the research project named "El Poblamiento inicial de Benidorm y la Marina Baixa (Alicante)". JFL is supported by a Ramon y Cajal program postdoctoral research grant (Ref. RYC-2011-09363) of the MINECO Spanish Ministry and the Consolidated Research Groug (Ref. SGR-2014-900) "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria". The MINECO Spanish Ministry also funded the research projects "Paleolitico Medio final y Paleolitico Superior inicial en la region central mediterranea iberica (Valencia y Murcia)" (Ref. HAR2012-32703) and "Paleoflora iberica en un contexto de complejidad: interacciones fisiograficas, ecologicas y evolutivas" (Ref. 2012CGL-34717) that supported the post-excavation palaeobotanical analyses and the cost of a radiocarbon determination. The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Allen John A., 2004, P1, DOI 10.1079/9780851993195.0001; Amara A., 2011, ACT C INT PREH MAGHR, VI; [Anonymous], 2001, NEANDERTALES CROMA O; Aura JE., 2013, PENSANDO GRAVETIENSE, P104; Barker G, 2012, LIBYAN STUDIES, V43, P115, DOI [DOI 10.1017/S026371890000008X, DOI 10.1017/S026371890000008X)]; Barton CM, 2013, QUATERN INT, V318, P53, DOI 10.1016/j.quaint.2013.05.007; Bicho N, 2007, J ARCHAEOL METHOD TH, V14, P81, DOI 10.1007/s10816-007-9025-5; Blasco R, 2008, J ARCHAEOL SCI, V35, P2839, DOI 10.1016/j.jas.2008.05.013; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Cacho I, 2001, PALEOCEANOGRAPHY, V16, P40, DOI 10.1029/2000PA000502; Claassen C., 1998, CAMBRIDGE MANUALS AR; Colonese AC, 2011, QUATERN INT, V244, P76, DOI 10.1016/j.quaint.2011.04.035; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Colonese AC, 2010, P 5 CONV NAZ ARCH RO, P93; Colonese AC, 2005, RIV SCI PREISTORI S1, V1, P271; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Cullity B.D., 1978, ANSWERS PROBLEMS ELE; Diez-Martin F, 2009, J AFR ARCHAEOL, V7, P147, DOI 10.3213/1612-1651-10136; Douka K, 2014, J HUM EVOL, V66, P39, DOI 10.1016/j.jhevol.2013.10.001; Durante S., 1972, Quaternaria, V16, P255; Estrada A, 2009, MONOGRAFIES SERP U B, V7, P83; Fa JE, 2013, J HUM EVOL, V64, P233, DOI 10.1016/j.jhevol.2013.01.002; Faus FV, 1988, SERIES ESTUDIOS BIOL, V10, P19; de Pablo JFL, 2011, QUATERN INT, V244, P45, DOI 10.1016/j.quaint.2011.05.031; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Girod A, 2011, QUATERN INT, V244, P105, DOI 10.1016/j.quaint.2011.04.025; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hey RW, 1967, HAUA FTEAH CYRENAICA, P358; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Hunt CO, 2011, QUATERN INT, V244, P15, DOI 10.1016/j.quaint.2011.04.045; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Jorda JF, 2011, QUATERN INT, V244, P27, DOI 10.1016/j.quaint.2011.04.038; JordaPardo J. F., 2011, Boletin de la Real Sociedad Espanola de Historia Natural, Seccion Geologica, V105, P137; KLEIN RG, 1986, J ARCHAEOL SCI, V13, P515, DOI 10.1016/0305-4403(86)90038-5; Kuhn S.L., 2010, EURASIAN PREHISTORY, V7, P37; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Lloveras L, 2011, QUATERN INT, V244, P37, DOI 10.1016/j.quaint.2011.04.036; Lubell D., 2004, PETITS ANIMAUX SOC H, P77; Lubell D, 2011, QUATERN INT, V244, P1, DOI 10.1016/j.quaint.2011.06.042; Martinez M, 1997, MON MEDITERRANI DESP, P345; Martinez-Orti A, 1999, MALACOLOGIC, P1; Martinez-Orti A, 1999, MOLUSCOS TERRESTRES; MARTINEZ-ORTI Alberto, 2003, MOLUSCOS CONTINENTAL; Martini F., 2009, MEDITERR REV GEOGRAP, V112, P89, DOI DOI 10.4000/MEDITERRANEE.3211; MEADS MJ, 1984, NEW ZEAL J ZOOL, V11, P277, DOI 10.1080/03014223.1984.10428241; MEHLMAN MJ, 1979, WORLD ARCHAEOL, V11, P80, DOI 10.1080/00438243.1979.9979751; MELLARS P, 1989, ANTIQUITY, V63, P761, DOI 10.1017/S0003598X00076894; Miracle P., 2001, DOCUMENTA PRAEHISTOR, V26, P177, DOI DOI 10.4312/DP.28.10; Moreno-Rueda G, 2009, EVOL ECOL, V23, P463, DOI 10.1007/s10682-008-9245-5; Mussi M, 1995, PREHISTOIRE EUROPEEN, V7, P169; Parker JE, 2010, CRYSTENGCOMM, V12, P1590, DOI 10.1039/b921487a; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rey J, 1996, CUADERNOS GEOGRAFIA, V60, P243; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rizner M, 2009, MESOLITHIC HORIZONS, P527; Rodriguez-Hidalgo AJ, 2013, INT J OSTEOARCHAEOL, V23, P34, DOI 10.1002/oa.1238; Rodriguez-Perochena I, 2006, THESIS U COMPLUTENSE; Rosin ZM, 2011, J BIOSCIENCES, V36, P691, DOI 10.1007/s12038-011-9077-2; Sanchis Serra A, 2012, TRABAJOS VARIOS SIP, V115; Serra AS, 2011, ARCHAEOFAUNA, V20, P47; Serra AS, 2008, COMPLUTUM, V19, P25; Schmidt I, 2012, QUATERN INT, V274, P179, DOI 10.1016/j.quaint.2012.01.018; Starkovich B, 2010, EURASIAN PREHISTORY, V7, P107; Stiner MC, 2011, J HUM EVOL, V60, P618, DOI 10.1016/j.jhevol.2010.12.005; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 1999, ANTIQUITY, V73, P735, DOI 10.1017/S0003598X00065492; Stiner MC, 2006, CURR ANTHROPOL, V47, P953; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Tayor VK, 2011, QUATERN INT, V244, P5, DOI 10.1016/j.quaint.2011.04.041; Tixier J., 1970, B MUS BEYROUTH, V23, P173; Vilaseca S, 1991, TRABAJOS PREHIST, V28, P63; Villaverde V, 2013, PENSANDO GRAVETIENSE, P34; Villaverde V, 2010, PALEOLITICO SUPERIOR, P85; Villaverde V., 1994, ARTE PALEOLITICO COV; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Wenk H.R., 2016, PREFERRED ORIENTATIO; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	86	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104898	10.1371/journal.pone.0104898	http://dx.doi.org/10.1371/journal.pone.0104898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141047	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200041
J	Huang, SY; Feng, CW; Hung, HC; Chakraborty, C; Chen, CH; Chen, WF; Jean, YH; Wang, HMD; Sung, CS; Sun, YM; Wu, CY; Liu, WT; Hsiao, CD; Wen, ZH				Huang, Shi-Ying; Feng, Chien-Wei; Hung, Han-Chun; Chakraborty, Chiranjib; Chen, Chun-Hong; Chen, Wu-Fu; Jean, Yen-Hsuan; Wang, Hui-Min David; Sung, Chun-Sung; Sun, Yu-Min; Wu, Chang-Yi; Liu, Wangta; Hsiao, Chung-Der; Wen, Zhi-Hong			A Novel Zebrafish Model to Provide Mechanistic Insights into the Inflammatory Events in Carrageenan-Induced Abdominal Edema	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARP CYPRINUS-CARPIO; INDUCED PAW EDEMA; IN-VIVO; NOCICEPTIVE RESPONSES; KAPPA-CARRAGEENAN; IMMUNE-RESPONSE; ANIMAL-MODELS; MOUSE PAW; RAT MODEL	A suitable small animal model may help in the screening and evaluation of new drugs, especially those from natural products, which can be administered at lower dosages, fulfilling an urgent worldwide need. In this study, we explore whether zebrafish could be a model organism for carrageenan-induced abdominal edema. The research results showed that intraperitoneal (i.p.) administration of 1.5% lambda-carrageenan in a volume of 20 mL significantly increased abdominal edema in adult zebrafish. Levels of the proinflammatory proteins tumor necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS) were increased in carrageenan-injected adult zebrafish during the development of abdominal edema. An associated enhancement was also observed in the leukocyte marker, myeloperoxidase (MPO). To support these results, we further observed that i.p. methylprednisolone (MP; 1 mg), a positive control, significantly inhibited carrageenan-induced inflammation 24 h after carrageenan administration. Furthermore, i.p. pretreatment with either an anti-TNF-alpha antibody (1:5 dilution in a volume of 20 mu L) or the iNOS-selective inhibitor aminoguanidine (AG; 1 mg) inhibited carrageenan-induced abdominal edema in adult zebrafish. This new animal model is uncomplicated, easy to develop, and involves a straightforward inducement of inflammatory edema for the evaluation of small volumes of drugs or test compounds.	[Huang, Shi-Ying; Chakraborty, Chiranjib; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Huang, Shi-Ying] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung 80424, Taiwan; [Huang, Shi-Ying] Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan; [Feng, Chien-Wei; Hung, Han-Chun; Chen, Chun-Hong; Sun, Yu-Min; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Feng, Chien-Wei; Hung, Han-Chun; Chen, Chun-Hong; Sun, Yu-Min; Wen, Zhi-Hong] Acad Sinica, Kaohsiung, Taiwan; [Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Jean, Yen-Hsuan] Ping Tung Christian Hosp, Dept Orthopaed Surg, Pingtung, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Sung, Chun-Sung] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Chun-Sung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; National Kaohsiung University of Science & Technology; National Sun Yat Sen University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Chung Yuan Christian University; Chung Yuan Christian University	Wen, ZH (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan.	wzh@mail.nsysu.edu.tw	Chakraborty, Chiranjib/J-4847-2013; Hsiao, Chung-Der/W-4535-2019; Wen, Zhi-Hong/AAG-8034-2019	Chakraborty, Chiranjib/0000-0002-3958-239X; Hsiao, Chung-Der/0000-0002-6398-8672; Huang, Shi-Ying/0000-0002-0370-1553; Wang, Hui-Min/0000-0002-4692-4917; /0000-0002-8170-5162	National Science Council, Taiwan [NSC100-2325-B-110-001, NSC99-2313-B110-003-MY03]; NSYSU-KMU Joint research project [NSYSUKMU P013]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSYSU-KMU Joint research project	This work was supported, in part, by grants from the National Science Council, Taiwan (NSC100-2325-B-110-001 and NSC99-2313-B110-003-MY03) and the NSYSU-KMU Joint research project (NSYSUKMU P013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhouse N, 2002, PHYTOTHER RES, V16, P562, DOI 10.1002/ptr.997; Backhouse N, 1996, INT J PHARMACOGN, V34, P53, DOI 10.1076/phbi.34.1.53.13176; BACKHOUSE N, 1994, AGENTS ACTIONS, V42, P114, DOI 10.1007/BF01983475; Brown SB, 2007, J LEUKOCYTE BIOL, V82, P79, DOI 10.1189/jlb.0107030; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chan Chi-Chung, 2003, Methods Mol Biol, V225, P321; CHEN YL, 1994, EUR J PHARMACOL, V271, P319; Cheng AC, 2007, FISH SHELLFISH IMMUN, V22, P197, DOI 10.1016/j.fsi.2006.04.009; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Coruzzi G, 2007, EUR J PHARMACOL, V563, P240, DOI 10.1016/j.ejphar.2007.02.026; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Delporte C, 2002, Z NATURFORSCH C, V57, P100; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fleming A, 2010, INFLAMM BOWEL DIS, V16, P1162, DOI 10.1002/ibd.21200; Fujiki K, 1997, J FAC AGR KYUSHU U, V42, P113; Fujiki K, 1997, FISHERIES SCI, V63, P934, DOI 10.2331/fishsci.63.934; Gill N, 2013, INDIAN J PHARMACOL, V45, P278, DOI 10.4103/0253-7613.111944; Huang SY, 2012, MAR DRUGS, V10, P1899, DOI 10.3390/md10091899; Jean YH, 2008, EUR J PHARMACOL, V578, P323, DOI 10.1016/j.ejphar.2007.08.048; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lisu CH, 2007, CURR NEUROVASC RES, V4, P111, DOI 10.2174/156720207780637234; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Moor AN, 2009, WOUND REPAIR REGEN, V17, P832, DOI 10.1111/j.1524-475X.2009.00547.x; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Nishikori T, 2002, EUR J PHARMACOL, V451, P327, DOI 10.1016/S0014-2999(02)02238-0; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Oehlers SH, 2013, ZEBRAFISH, V10, P184, DOI 10.1089/zeb.2012.0824; Oehlers SH, 2011, DEV DYNAM, V240, P288, DOI 10.1002/dvdy.22519; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Panusa A, 2011, J PHARM SCI-US, V100, P4580, DOI 10.1002/jps.22722; Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006; Pase L, 2012, METHOD ENZYMOL, V506, P135, DOI 10.1016/B978-0-12-391856-7.00032-9; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Renkin Eugene M., 1994, Microcirculation (New York), V1, P157, DOI 10.3109/10739689409148270; Renshaw SA, 2006, EUR RESPIR REV, V15, P168, DOI 10.1183/09059180.00010108; Renshaw SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-148; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; Rowland M, 1995, CLIN PHARMACOKINET, P469; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sekiguchi F, 2004, NEUROSCI LETT, V365, P111, DOI 10.1016/j.neulet.2004.04.069; Shin DH, 2000, NEUROSCI LETT, V292, P220, DOI 10.1016/S0304-3940(00)01407-5; Small DL, 2000, BRIT MED BULL, V56, P307, DOI 10.1258/0007142001903238; TIMUR M, 1977, J COMP PATHOL, V87, P89, DOI 10.1016/0021-9975(77)90083-4; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tomassoni D, 2013, INT J MOL SCI, V14, P4580, DOI 10.3390/ijms14034580; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Xu QH, 2011, J NEUROSCI, V31, P2113, DOI 10.1523/JNEUROSCI.2139-10.2011	57	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104414	10.1371/journal.pone.0104414	http://dx.doi.org/10.1371/journal.pone.0104414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141004	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200022
J	Panzarini, E; Inguscio, V; Fimia, GM; Dini, L				Panzarini, Elisa; Inguscio, Valentina; Fimia, Gian Maria; Dini, Luciana			Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; APOPTOTIC CELLS; CANCER-THERAPY; TUMOR-CELLS; CALRETICULIN EXPOSURE; SURFACE EXPRESSION; IN-VITRO; DEATH; HSP70; IMMUNOGENICITY	The new concept of Immunogenic Cell Death (ICD), associated with Damage Associated Molecular Patterns (DAMPs) exposure and/or release, is recently becoming very appealing in cancer treatment. In this context, PhotoDynamic Therapy (PDT) can give rise to ICD and to immune response upon dead cells removal. The list of PhotoSensitizers (PSs) able to induce ICD is still short and includes Photofrin, Hypericin, Foscan and 5-ALA. The goal of the present work was to investigate if Rose Bengal Acetate (RBAc), a powerful PS able to trigger apoptosis and autophagy, enables photosensitized HeLa cells to expose and/or release pivotal DAMPs, i.e. ATP, HSP70, HSP90, HMGB1, and calreticulin (CRT), that characterize ICD. We found that apoptotic HeLa cells after RBAc-PDT exposed and released, early after the treatment, high amount of ATP, HSP70, HSP90 and CRT; the latter was distributed on the cell surface as uneven patches and co-exposed with ERp57. Conversely, autophagic HeLa cells after RBAc-PDT exposed and released HSP70, HSP90 but not CRT and ATP. Exposure and release of HSP70 and HSP90 were always higher on apoptotic than on autophagic cells. HMGB1 was released concomitantly to secondary necrosis (24 h after RBAc-PDT). Phagocytosis assay suggests that CRT is involved in removal of RBAc-PDT generated apoptotic HeLa cells. Altogether, our data suggest that RBAc has all the prerequisites (i.e. exposure and/or release of ATP, CRT, HSP70 and HSP90), that must be verified in future vaccination experiments, to be considered a good PS candidate to ignite ICD. We also showed tha CRT is involved in the clearance of RBAc photokilled HeLa cells. Interestingly, RBAc-PDT is the first cancer PDT protocol able to induce the translocation of HSP90 and plasma membrane co-exposure of CRT with ERp57.	[Panzarini, Elisa; Inguscio, Valentina; Fimia, Gian Maria; Dini, Luciana] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Fimia, Gian Maria] Natl Inst Infect Dis IRCCS L Spallanzani, Rome, Italy	University of Salento; IRCCS Lazzaro Spallanzani	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy.	luciana.dini@unisalento.it	Fimia, Gian Maria/K-3232-2016	Fimia, Gian Maria/0000-0003-4438-3325; Panzarini, Elisa/0000-0003-4219-4272				Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; D'Eliseo D, 2013, CELL STRESS CHAPERON, V18, P801, DOI 10.1007/s12192-013-0422-2; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Dini L, 2010, CANCER BIOL THER, V10, P1048, DOI 10.4161/cbt.10.10.13371; Dudek AM, 2013, CYTOKINE GROWTH F R, V24, P319, DOI 10.1016/j.cytogfr.2013.01.005; Etminan N, 2011, BRIT J CANCER, V105, P961, DOI 10.1038/bjc.2011.327; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galluzzi L, 2012, EMBO J, V31, P1055, DOI 10.1038/emboj.2012.2; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Korbelik M, 2005, CANCER RES, V65, P1018; Korbelik M, 2011, CANCER IMMUNOL IMMUN, V60, P1431, DOI 10.1007/s00262-011-1047-x; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Mitra S, 2011, LASER SURG MED, V43, P632, DOI 10.1002/lsm.21108; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Panzarini E, 2006, J PHOTOCH PHOTOBIO B, V83, P39, DOI 10.1016/j.jphotobiol.2005.11.014; Panzarini E, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.51; Panzarini E, 2013, EXP BIOL MED, V238, P765, DOI 10.1177/1535370213494552; Panzarini E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/482160; Panzarini E, 2011, INT J PHOTOENERGY, V2011, DOI 10.1155/2011/713726; Panzarini E, 2009, ANN NY ACAD SCI, V1171, P617, DOI 10.1111/j.1749-6632.2009.04908.x; Plaetzer K, 2009, LASER MED SCI, V24, P259, DOI 10.1007/s10103-008-0539-1; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P179, DOI 10.4161/onci.1.2.19026; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Zhou F, 2008, CANCER LETT, V264, P135, DOI 10.1016/j.canlet.2008.01.040; Zhou FF, 2009, INT J CANCER, V125, P1380, DOI 10.1002/ijc.24520	45	82	83	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105778	10.1371/journal.pone.0105778	http://dx.doi.org/10.1371/journal.pone.0105778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140900	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200121
J	Amacher, JF; Zhao, RZ; Spaller, MR; Madden, DR				Amacher, Jeanine F.; Zhao, Ruizhi; Spaller, Mark R.; Madden, Dean R.			Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain	PLOS ONE			English	Article							PROTEIN INTERACTIONS; BINDING; INHIBITORS; SELECTIVITY; AFFINITY; DESIGN; PSD-95	PDZ domains are protein-protein interaction modules that coordinate multiple signaling and trafficking pathways in the cell and that include active therapeutic targets for diseases such as cancer, cystic fibrosis, and addiction. Our previous work characterized a PDZ interaction that restricts the apical membrane half-life of the cystic fibrosis transmembrane conductance regulator (CFTR). Using iterative cycles of peptide-array and solution-binding analysis, we targeted the PDZ domain of the CFTR-Associated Ligand (CAL), and showed that an engineered peptide inhibitor rescues cell-surface expression of the most common CFTR disease mutation Delta F508. Here, we present a series of scaffolds containing chemically modifiable side chains at all non-motif positions along the CAL PDZ domain binding cleft. Concordant equilibrium dissociation constants were determined in parallel by fluorescence polarization, isothermal titration calorimetry, and surface plasmon resonance techniques, confirming robust affinity for each scaffold and revealing an enthalpically driven mode of inhibitor binding. Structural studies demonstrate a conserved binding mode for each peptide, opening the possibility of combinatorial modification. Finally, we diversified one of our peptide scaffolds with halogenated substituents that yielded modest increases in binding affinity. Overall, this work validates our approach and provides a stereochemical foundation for further CAL inhibitor design and screening.	[Amacher, Jeanine F.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Zhao, Ruizhi; Spaller, Mark R.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Zhao, Ruizhi; Spaller, Mark R.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; [Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Madden, DR (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	drm0001@dartmouth.edu			National Institutes of Health (NIH) [R01-DK101541, P30-GM106394, T32-DK007301, R01-CA150190]; Hitchcock Foundation; Program Project Grant (PPG; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA150190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101541, T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation; Program Project Grant (PPG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH): http://grants.nih.gov/grants/oer.htm, 1. R01-DK101541 to DRM, 2. P30-GM106394 to DRM, 3. T32-DK007301 to JFA, 4. R01-CA150190 to MRS, and The Hitchcock Foundation: http://med.dartmouth-hitchcock.org/hitchcock_foundation.html, Program Project Grant (PPG) to DRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amacher JF, 2014, STRUCTURE, V22, P82, DOI 10.1016/j.str.2013.09.019; Amacher JF, 2013, J BIOL CHEM, V288, P5114, DOI 10.1074/jbc.M112.401588; Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Bach A, 2011, J MED CHEM, V54, P1333, DOI 10.1021/jm1013924; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XS, 2007, ASSAY DRUG DEV TECHN, V5, P769, DOI 10.1089/adt.2007.092; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Feng J, 1998, PDB VALIDATION SERVE; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Kundu R, 2012, ANGEW CHEM INT EDIT, V51, P7217, DOI 10.1002/anie.201202291; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lohan S, 2013, MINI-REV MED CHEM, V13, P1073, DOI 10.2174/1389557511313070010; Memic A, 2008, CHEMBIOCHEM, V9, P2793, DOI 10.1002/cbic.200800572; Patra CR, 2012, ACS CHEM BIOL, V7, P770, DOI 10.1021/cb200536r; Piserchio A, 2004, CHEM BIOL, V11, P469, DOI 10.1016/j.chembiol.2004.03.013; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Udugamasooriya DG, 2008, CHEMBIOCHEM, V9, P1587, DOI 10.1002/cbic.200800126; Vouilleme L, 2010, ANGEW CHEM INT EDIT, V49, P9912, DOI 10.1002/anie.201005575; Whitby LR, 2012, ACCOUNTS CHEM RES, V45, P1698, DOI 10.1021/ar300025n; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhao R, 2012, THESIS DARTMOUTH COL, P128; Zhou SY, 1999, PROG BIOPHYS MOL BIO, V71, P359, DOI 10.1016/S0079-6107(98)00045-5	39	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103650	10.1371/journal.pone.0103650	http://dx.doi.org/10.1371/journal.pone.0103650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136860	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100011
J	Makarevic, J; Rutz, J; Juengel, E; Kaulfuss, S; Reiter, M; Tsaur, I; Bartsch, G; Haferkamp, A; Blaheta, RA				Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Kaulfuss, Silke; Reiter, Michael; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.			Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2	PLOS ONE			English	Article							P27(KIP1) EXPRESSION; ACTIVATION; APOPTOSIS; LAETRILE; COMPLEMENTARY; DOXORUBICIN; CARCINOMA; SURVIVAL; KINASES; PATHWAY	Amygdalin, a natural compound, has been used by many cancer patients as an alternative approach to treat their illness. However, whether or not this substance truly exerts an anti-tumor effect has never been settled. An in vitro study was initiated to investigate the influence of amygdalin (1.25-10 mg/ml) on the growth of a panel of bladder cancer cell lines (UMUC-3, RT112 and TCCSUP). Tumor growth, proliferation, clonal growth and cell cycle progression were investigated. The cell cycle regulating proteins cdk1, cdk2, cdk4, cyclin A, cyclin B, cyclin D1, p19, p27 as well as the mammalian target of rapamycin (mTOR) related signals phosphoAkt, phosphoRaptor and phosphoRictor were examined. Amygdalin dose-dependently reduced growth and proliferation in all three bladder cancer cell lines, reflected in a significant delay in cell cycle progression and G0/G1 arrest. Molecular evaluation revealed diminished phosphoAkt, phosphoRictor and loss of Cdk and cyclin components. Since the most outstanding effects of amygdalin were observed on the cdk2-cyclin A axis, siRNA knock down studies were carried out, revealing a positive correlation between cdk2/cyclin A expression level and tumor growth. Amygdalin, therefore, may block tumor growth by down-modulating cdk2 and cyclin A. In vivo investigation must follow to assess amygdalin's practical value as an anti-tumor drug.	[Makarevic, Jasmina; Rutz, Jochen; Juengel, Eva; Reiter, Michael; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Hosp, Dept Urol, Frankfurt, Germany; [Kaulfuss, Silke] Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Gottingen	Blaheta, RA (corresponding author), Goethe Univ Hosp, Dept Urol, Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523; Kaulfuss, Silke/0000-0003-2577-9711	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt; RAB	Brigitta und Norbert Muth Stiftung; Freunde und Forderer der Goethe-Universitat Frankfurt; RAB	This work was supported by the "Brigitta und Norbert Muth Stiftung'' (http://www.muth-stiftung.de) and the "Freunde und Forderer der Goethe-Universitat Frankfurt'' (http://www2.uni-frankfurt.de). The funding was received by RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Boss DS, 2010, ANN ONCOL, V21, P884, DOI 10.1093/annonc/mdp377; Calderaro J, 2014, INT J CANCER, V134, P1776, DOI 10.1002/ijc.28518; Canavese M, 2012, CANCER BIOL THER, V13, P451, DOI 10.4161/cbt.19589; Chang HK, 2006, BIOL PHARM BULL, V29, P1597, DOI 10.1248/bpb.29.1597; Chen Y, 2013, IMMUNOPHARM IMMUNOT, V35, P43, DOI 10.3109/08923973.2012.738688; Citrin DL, 2012, ONCOLOGIST, V17, P607, DOI 10.1634/theoncologist.2011-0468; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gillett J, 2012, J ALTERN COMPLEM MED, V18, P1014, DOI 10.1089/acm.2011.0334; Gogolin S, 2013, CELL CYCLE, V12, P1091, DOI 10.4161/cc.24091; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081081; Huebner J, 2014, ANTICANCER RES, V34, P943; Juengel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053100; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kwon HY, 2003, ARCH PHARM RES, V26, P157, DOI 10.1007/BF02976663; Liang PI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-611; Lohberger B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066300; Lotan Y, 2013, EUR UROL, V64, P465, DOI 10.1016/j.eururo.2013.03.043; Merrick KA, 2008, MOL CELL, V32, P662, DOI 10.1016/j.molcel.2008.10.022; Milazzo S, 2007, SUPPORT CARE CANCER, V15, P583, DOI 10.1007/s00520-006-0168-9; Mirmiranpour H, 2012, INDIAN J PATHOL MICR, V55, P211, DOI 10.4103/0377-4929.97874; MOERTEL CG, 1982, NEW ENGL J MED, V306, P201, DOI 10.1056/NEJM198201283060403; Moss Ralph W, 2005, Integr Cancer Ther, V4, P65, DOI 10.1177/1534735404273918; Mundhenk J, 2011, ONCOL LETT, V2, P1089, DOI 10.3892/ol.2011.374; NEWELL GR, 1980, CANCER TREAT REP, V64, P363; Pantazis E, 2011, J BUON, V16, P323; Park HJ, 2005, WORLD J GASTROENTERO, V11, P5156; Pitts TM, 2014, PHARMACOL THERAPEUT, V142, P258, DOI 10.1016/j.pharmthera.2013.12.010; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tsaur I, 2011, CANCER LETT, V313, P84, DOI 10.1016/j.canlet.2011.08.026; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wu X, 2014, ONCOGENE, V33, P1506, DOI 10.1038/onc.2013.108	36	48	56	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105590	10.1371/journal.pone.0105590	http://dx.doi.org/10.1371/journal.pone.0105590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136960	Green Published, gold			2022-12-27	WOS:000340742100111
J	Sun, PS; Wahbi, S; Tsonev, T; Haworth, M; Liu, SR; Centritto, M				Sun, Pengsen; Wahbi, Said; Tsonev, Tsonko; Haworth, Matthew; Liu, Shirong; Centritto, Mauro			On the Use of Leaf Spectral Indices to Assess Water Status and Photosynthetic Limitations in Olea europaea L. during Water-Stress and Recovery	PLOS ONE			English	Article							PHOTOCHEMICAL REFLECTANCE INDEX; CARBON-ISOTOPE DISCRIMINATION; GAS-EXCHANGE; DROUGHT STRESS; USE EFFICIENCY; DIFFUSIONAL LIMITATIONS; MESOPHYLL CONDUCTANCE; PHYSIOLOGICAL STATUS; ISOPRENE EMISSION; OLIVE	Diffusional limitations to photosynthesis, relative water content (RWC), pigment concentrations and their association with reflectance indices were studied in olive (Olea europaea) saplings subjected to water-stress and re-watering. RWC decreased sharply as drought progressed. Following rewatering, RWC gradually increased to pre-stress values. Photosynthesis (A), stomatal conductance (g(s)), mesophyll conductance (g(m)), total conductance (g(t)), photochemical reflectance index (PRI), water index (WI) and relative depth index (RDI) closely followed RWC. In contrast, carotenoid concentration, the carotenoid to chlorophyll ratio, water content reflectance index (WCRI) and structural independent pigment index (SIPI) showed an opposite trend to that of RWC. Photosynthesis scaled linearly with leaf conductance to CO2; however, A measured under non-photorespiratory conditions (A(1%O2)) was approximately two times greater than A measured at 21% [O-2], indicating that photorespiration likely increased in response to drought. A(1%O2) also significantly correlated with leaf conductance parameters. These relationships were apparent in saturation type curves, indicating that under non-photorespiratory conditions, CO2 conductance was not the major limitations to A. PRI was significant correlated with RWC. PRI was also very sensitive to pigment concentrations and photosynthesis, and significantly tracked all CO2 conductance parameters. WI, RDI and WCRI were all significantly correlated with RWC, and most notably to leaf transpiration. Overall, PRI correlated more closely with carotenoid concentration than SIPI; whereas WI tracked leaf transpiration more effectively than RDI and WCRI. This study clearly demonstrates that PRI and WI can be used for the fast detection of physiological traits of olive trees subjected to water-stress.	[Sun, Pengsen; Liu, Shirong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wahbi, Said] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol & Physiol Vegetale, Marrakech, Morocco; [Tsonev, Tsonko] Bulgarian Acad Sci, Inst Plant Physiol & Genet, Sofia, Bulgaria; [Haworth, Matthew; Centritto, Mauro] CNR, Trees & Timber Inst, Florence, Italy	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Cadi Ayyad University of Marrakech; Bulgarian Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR)	Centritto, M (corresponding author), CNR, Trees & Timber Inst, Florence, Italy.	mauro.centritto@cnr.it	Tsonev, Tsonko/AAC-3949-2019; Tsonev, Tsonko/A-7469-2008; Haworth, Matthew/B-7817-2013	Tsonev, Tsonko/0000-0003-0165-7269; Sun, Pengsen/0000-0002-0099-4661; Haworth, Matthew/0000-0002-3225-6620; WAHBI, Said/0000-0002-3066-5586	National Natural Science Foundation of China [31290223]; Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China; Ministero dellIstruzione dellUniversit della Ricerca of Italy	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China; Ministero dellIstruzione dellUniversit della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by the National Natural Science Foundation of China (Grant No. 31290223), the Key Laboratory of Forest Ecology and Environment of State Forestry Administration of China, and the Ministero dellIstruzione dellUniversit della Ricerca of Italy: PRIN 2010-2011 PRO-ROOT and Progetto Premiale 2012 Aqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; ARP WJ, 1991, PLANT CELL ENVIRON, V14, P869, DOI 10.1111/j.1365-3040.1991.tb01450.x; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; Centritto M, 2005, AGR ECOSYST ENVIRON, V106, P303, DOI 10.1016/j.agee.2004.10.016; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 1999, TREE PHYSIOL, V19, P799; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Centritto M, 2011, ECOL STUD-ANAL SYNTH, V212, P31, DOI 10.1007/978-90-481-9834-4_3; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Demmig-Adams B, 2000, NATURE, V403, P371, DOI 10.1038/35000315; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; Dobrowski SZ, 2005, REMOTE SENS ENVIRON, V97, P403, DOI 10.1016/j.rse.2005.05.006; Fereres E, 2011, J EXP BOT, V62, P4079, DOI 10.1093/jxb/err165; Filella I, 2009, INT J REMOTE SENS, V30, P4443, DOI 10.1080/01431160802575661; Flexas J, 2007, J EXP BOT, V58, P1533, DOI 10.1093/jxb/erm027; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Guan XQ, 2004, PHOTOSYNTHETICA, V42, P31, DOI 10.1023/B:PHOT.0000040566.55149.52; Guo JM, 2004, FUNCT PLANT BIOL, V31, P255, DOI 10.1071/FP03185; Gutierrez M, 2010, J EXP BOT, V61, P3291, DOI 10.1093/jxb/erq156; ISMAIL AM, 1994, AUST J PLANT PHYSIOL, V21, P23, DOI 10.1071/PP9940023; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Loreto F, 2008, PLANT BIOSYST, V142, P154, DOI 10.1080/11263500701872937; Magnani F, 1996, PLANTA, V199, P296, DOI 10.1007/BF00196572; Marino G, 2014, ENVIRON EXP BOT, V99, P43, DOI 10.1016/j.envexpbot.2013.10.008; Moriana A, 2002, PLANT CELL ENVIRON, V25, P395, DOI 10.1046/j.0016-8025.2001.00822.x; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Osorio J, 2012, FUNCT PLANT BIOL, V39, P588, DOI 10.1071/FP11284; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; PENUELAS J, 1995, NEW PHYTOL, V131, P291, DOI 10.1111/j.1469-8137.1995.tb03064.x; Ripullone F, 2011, FUNCT PLANT BIOL, V38, P177, DOI 10.1071/FP10078; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Sage RF, 2013, PLANT BIOLOGY, V15, P624, DOI 10.1111/plb.12024; Sarlikioti V, 2010, ANN APPL BIOL, V157, P81, DOI 10.1111/j.1744-7348.2010.00411.x; Serrano L, 2010, AGR ECOSYST ENVIRON, V139, P490, DOI 10.1016/j.agee.2010.09.007; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Suarez L, 2008, REMOTE SENS ENVIRON, V112, P560, DOI 10.1016/j.rse.2007.05.009; Sun P, 2008, INT J REMOTE SENS, V29, P1725, DOI 10.1080/01431160701373754; Tsonev T, 2014, INT J AGRIC BIOL, V16, P335; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wingler A, 1999, PLANT CELL ENVIRON, V22, P361, DOI 10.1046/j.1365-3040.1999.00410.x	44	34	37	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105165	10.1371/journal.pone.0105165	http://dx.doi.org/10.1371/journal.pone.0105165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136798	Green Published, gold			2022-12-27	WOS:000340742100072
J	Behrendt, F; de Lussanet, MHE; Wagner, H				Behrendt, Frank; de Lussanet, Marc H. E.; Wagner, Heiko			Observing a Movement Correction during Walking Affects Evoked Responses but Not Unperturbed Walking	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BIOLOGICAL MOTION PERCEPTION; HUMAN CORTICOSPINAL SYSTEM; MIRROR-NEURON SYSTEM; MOTOR FACILITATION; PREMOTOR CORTEX; SPINAL EXCITABILITY; CUTANEOUS REFLEXES; VISUAL HEMIFIELD; HAND ACTIONS	Seeing an action activates neurons in the premotor, motor, and somatosensory cortex. Since a significant fraction of these pyramidal neurons project to the spinal motor circuits, a central question is why we do not automatically perform the actions that we see. Indeed, seeing an action increases both cortical and spinal excitability of consistent motor patterns that correspond to the observed ones. Thus, it is believed that such imitative motor patterns are either suppressed or remain at a sub-threshold level. This would predict, however, that seeing someone make a corrective movement while one is actively involved in the same action should either suppress evoked responses or suppress or modulate the action itself. Here we tested this prediction, and found that seeing someone occasionally stepping over an obstacle while walking on a treadmill did not affect the normal walking pattern at all. However, cutaneously evoked reflexes in the anterior tibial and soleus muscles were modulated as if the subject was stepping over an obstacle. This result thus indicates that spinal activation was not suppressed and was neither at sub-threshold motor resonance. Rather, the spinal modulation from observed stepping reflects an adaptive mechanism for regulating predictive control mechanisms. We conclude that spinal excitability during action observation is not an adverse side-effect of action understanding but reflects adaptive and predictive motor control.	[Behrendt, Frank; de Lussanet, Marc H. E.; Wagner, Heiko] Univ Munster, D-48149 Munster, Germany	University of Munster	Behrendt, F (corresponding author), Univ Munster, D-48149 Munster, Germany.	frank.behrendt@uni-muenster.de	Wagner, Heiko/D-9677-2013	Wagner, Heiko/0000-0002-5470-5044; Behrendt, Frank/0000-0001-6967-0000	Bundesministerium fur Bildung und Forschung (German Federal Ministry of Education and Research) [BMBF] [01EC1003A]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Muenster	Bundesministerium fur Bildung und Forschung (German Federal Ministry of Education and Research) [BMBF]; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	This work was supported by the Bundesministerium fur Bildung und Forschung (German Federal Ministry of Education and Research) [BMBF grant 01EC1003A]. We also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2012, PSYCHOL RES-PSYCH FO, V76, P503, DOI 10.1007/s00426-011-0380-1; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bawa P, 2002, J NEUROPHYSIOL, V88, P124, DOI 10.1152/jn.2002.88.1.124; Behrendt F, 2013, ACTA PSYCHOL, V142, P343, DOI 10.1016/j.actpsy.2013.01.001; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Borroni P, 2011, EUR J NEUROSCI, V34, P662, DOI 10.1111/j.1460-9568.2011.07779.x; BROUWER B, 1992, EXP BRAIN RES, V89, P649; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Cheng JG, 1998, J NEUROSCI, V18, P4295; Cheng YW, 2005, NEUROREPORT, V16, P1711, DOI 10.1097/01.wnr.0000183325.13618.5f; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; De Lussanet MHE, 2008, EUR J NEUROSCI, V27, P514, DOI 10.1111/j.1460-9568.2007.06009.x; Dietz V, 2001, EUR J NEUROSCI, V14, P1906, DOI 10.1046/j.0953-816x.2001.01813.x; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Duysens J, 2004, CAN J PHYSIOL PHARM, V82, P715, DOI 10.1139/Y04-071; DUYSENS J, 1990, EXP BRAIN RES, V82, P351; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033343; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Leinonen V, 2007, SPINE, V32, pE150, DOI 10.1097/01.brs.0000256886.94791.94; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; Michel J, 2008, EUR J NEUROSCI, V27, P1867, DOI 10.1111/j.1460-9568.2008.06145.x; Michels L, 2009, NEUROIMAGE, V45, P151, DOI 10.1016/j.neuroimage.2008.10.063; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Pineda JA, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-47; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; ROBYBRAMI A, 1987, BRAIN, V110, P707, DOI 10.1093/brain/110.3.707; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schutz-Bosbach Simone, 2007, Cogn Process, V8, P93, DOI 10.1007/s10339-007-0167-x; STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; Vigneswaran G, 2013, CURR BIOL, V23, P236, DOI 10.1016/j.cub.2012.12.006; YANG JF, 1990, J NEUROPHYSIOL, V63, P1109, DOI 10.1152/jn.1990.63.5.1109; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311	53	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104981	10.1371/journal.pone.0104981	http://dx.doi.org/10.1371/journal.pone.0104981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133714	Green Published, gold			2022-12-27	WOS:000341302700059
J	Dinu, LP; Ionescu, RT; Tomescu, AI				Dinu, Liviu P.; Ionescu, Radu Tudor; Tomescu, Alexandru I.			A Rank-Based Sequence Aligner with Applications in Phylogenetic Analysis	PLOS ONE			English	Article							RNA-SEQ; GENOME REARRANGEMENT; VIBRIO-CHOLERAE; READ ALIGNMENT; TIME ALGORITHM; DNA-SEQUENCES; DISTANCE; EVOLUTION; PATHOGEN; TOOL	Recent tools for aligning short DNA reads have been designed to optimize the trade-off between correctness and speed. This paper introduces a method for assigning a set of short DNA reads to a reference genome, under Local Rank Distance (LRD). The rank-based aligner proposed in this work aims to improve correctness over speed. However, some indexing strategies to speed up the aligner are also investigated. The LRD aligner is improved in terms of speed by storing k-mer positions in a hash table for each read. Another improvement, that produces an approximate LRD aligner, is to consider only the positions in the reference that are likely to represent a good positional match of the read. The proposed aligner is evaluated and compared to other state of the art alignment tools in several experiments. A set of experiments are conducted to determine the precision and the recall of the proposed aligner, in the presence of contaminated reads. In another set of experiments, the proposed aligner is used to find the order, the family, or the species of a new (or unknown) organism, given only a set of short Next-Generation Sequencing DNA reads. The empirical results show that the aligner proposed in this work is highly accurate from a biological point of view. Compared to the other evaluated tools, the LRD aligner has the important advantage of being very accurate even for a very low base coverage. Thus, the LRD aligner can be considered as a good alternative to standard alignment tools, especially when the accuracy of the aligner is of high importance. Source code and UNIX binaries of the aligner are freely available for future development and use at http://lrd.herokuapp.com/aligners. The software is implemented in C++ and Java, being supported on UNIX and MS Windows.	[Dinu, Liviu P.; Ionescu, Radu Tudor] Univ Bucharest, Fac Math & Comp Sci, Bucharest, Romania; [Dinu, Liviu P.] Personal Genet, Bucharest, Romania; [Tomescu, Alexandru I.] Univ Helsinki, Helsinki Inst Informat Technol HIIT, Dept Comp Sci, Helsinki, Finland	University of Bucharest; Aalto University; University of Helsinki	Ionescu, RT (corresponding author), Univ Bucharest, Fac Math & Comp Sci, Bucharest, Romania.	raducu.ionescu@gmail.com	Dinu, Liviu P/AAQ-5547-2020; Ionescu, Radu/AAF-6493-2020; Ionescu, Radu Tudor/H-1914-2016	Ionescu, Radu/0000-0002-9301-1950; Tomescu, Alexandru I./0000-0002-5747-8350	Academy of Finland [250345]; European Social Fund [POSDRU/159/1.5/S/137750]	Academy of Finland(Academy of Finland); European Social Fund(European Social Fund (ESF))	The work of Alexandru I. Tomescu was supported by the Academy of Finland under grant 250345 (CoECGR). The work of Radu Tudor Ionescu was supported from the European Social Fund under Grant POSDRU/159/1.5/S/137750. The research of Liviu P. Dinu was supported by Personal Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other funding sources for this study.	Alekseyev MA, 2008, THEOR COMPUT SCI, V395, P193, DOI 10.1016/j.tcs.2008.01.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amir A, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1221, DOI 10.1145/1109557.1109692; Ander C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S2; Bader DA, 2001, LECT NOTES COMPUT SC, V2125, P365; Bafna V, 1998, SIAM J DISCRETE MATH, V11, P224, DOI 10.1137/S089548019528280X; Belda E, 2005, MOL BIOL EVOL, V22, P1456, DOI 10.1093/molbev/msi134; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chimani M., 2011, P M ALG ENG EXP, P13; Dinu LP, 2006, FUND INFORM, V73, P361; Dinu LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037576; Dinu LP, 2012, LECT NOTES COMPUT SC, V7667, P722, DOI 10.1007/978-3-642-34500-5_85; Dinu LP, 2003, FUND INFORM, V55, P39; Felsenstein J., 2004, INFERRING PHYLOGENIE; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hannenhalli S, 1996, DISCRETE APPL MATH, V71, P137, DOI 10.1016/S0166-218X(96)00061-3; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ionescu R. T., 2013, P SYNASC, P221; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Li H, WGSIM READ SIMULATOR; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YC, 2005, J COMPUT BIOL, V12, P102, DOI 10.1089/cmb.2005.12.102; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Popescu M., 2013, P 8 WORKSH INN US NL, P270; Popov VY, 2007, THEOR COMPUT SCI, V385, P115, DOI 10.1016/j.tcs.2007.05.029; Prezza N., 2012, P ACM C BIOINF COMP, P12; Shapira D, 2003, LECT NOTES COMPUT SC, V2857, P369; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Tomescu AI, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S15; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vezzi F, 2012, BIOINFORMATICS, V28, P123, DOI 10.1093/bioinformatics/btr617; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104006	10.1371/journal.pone.0104006	http://dx.doi.org/10.1371/journal.pone.0104006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133391	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700021
J	Li, QL; Li, M; Ma, L; Li, WZ; Wu, XH; Richards, J; Fu, GX; Xu, W; Bythwood, T; Li, X; Wang, JX; Song, Q				Li, Qiling; Li, Min; Ma, Li; Li, Wenzhi; Wu, Xuehong; Richards, Jendai; Fu, Guoxing; Xu, Wei; Bythwood, Tameka; Li, Xu; Wang, Jianxin; Song, Qing			A Method to Evaluate Genome-Wide Methylation in Archival Formalin-Fixed, Paraffin-Embedded Ovarian Epithelial Cells	PLOS ONE			English	Article							NUCLEIC-ACIDS; GENE-EXPRESSION; DNA METHYLATION; MESSENGER-RNA; EXTRACTION; TISSUE; PCR; AMPLIFICATION; CANCER; ASSAY	Background: The use of DNA from archival formalin and paraffin embedded (FFPE) tissue for genetic and epigenetic analyses may be problematic, since the DNA is often degraded and only limited amounts may be available. Thus, it is currently not known whether genome-wide methylation can be reliably assessed in DNA from archival FFPE tissue. Methodology/Principal Findings: Ovarian tissues, which were obtained and formalin-fixed and paraffin-embedded in either 1999 or 2011, were sectioned and stained with hematoxylin-eosin (H&E). Epithelial cells were captured by laser micro dissection, and their DNA subjected to whole genomic bisulfite conversion, whole genomic polymerase chain reaction (PCR) amplification, and purification. Sequencing and software analyses were performed to identify the extent of genomic methylation. We observed that 31.7% of sequence reads from the DNA in the 1999 archival FFPE tissue, and 70.6% of the reads from the 2011 sample, could be matched with the genome. Methylation rates of CpG on the Watson and Crick strands were 32.2% and 45.5%, respectively, in the 1999 sample, and 65.1% and 42.7% in the 2011 sample. Conclusions/Significance: We have developed an efficient method that allows DNA methylation to be assessed in archival FFPE tissue samples.	[Li, Qiling; Li, Xu; Song, Qing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China; [Li, Qiling; Ma, Li; Li, Wenzhi; Richards, Jendai; Fu, Guoxing; Xu, Wei; Bythwood, Tameka; Song, Qing] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Li, Min; Wu, Xuehong; Wang, Jianxin] Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Xi'an Jiaotong University; Morehouse School of Medicine; Central South University	Li, QL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China.	liqilinglady@163.com; qsong@msm.edu	Wang, Jianxin/V-2800-2018; LI, MIN/U-3131-2018; wang, jian/GVS-0711-2022; Ma, Li/AIF-3892-2022	Wang, Jianxin/0000-0003-1516-0480; LI, MIN/0000-0002-0188-1394; wu, xuehong/0000-0003-4861-5648; Li, Qiling/0000-0003-3763-4456	National Institutes of Health [HL003676, RR014758, RR003034]; American Heart Association [09GRNT2300003]; Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR014758] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health grants [HL003676, RR014758, RR003034]; American Heart Association grant [09GRNT2300003]; and in part by the Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Balic M, 2009, J MOL DIAGN, V11, P102, DOI 10.2353/jmoldx.2009.080109; Bonin S, 2005, J CLIN PATHOL, V58, P313, DOI 10.1136/jcp.2004.016477; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Bosso M, 2011, METHODS MOL BIOL, V724, P161, DOI 10.1007/978-1-61779-055-3_11; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chu TY, 2002, INT J GYNECOL CANCER, V12, P171, DOI 10.1046/j.1525-1438.2002.01085.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Chung JY, 2012, ANAL BIOCHEM, V425, P128, DOI 10.1016/j.ab.2012.03.012; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Fu GX, 2011, BIOCHEMISTRY-US, V50, P6292, DOI 10.1021/bi200831a; Fu GX, 2010, BIOCHEMISTRY-US, V49, P8535, DOI 10.1021/bi1005865; Gagnon JF, 2010, EXP MOL PATHOL, V88, P184, DOI 10.1016/j.yexmp.2009.09.020; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kitazawa S, 2000, LAB INVEST, V80, P275, DOI 10.1038/labinvest.3780031; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; LARGEY JS, 1993, CANCER, V71, P1933, DOI 10.1002/1097-0142(19930315)71:6<1933::AID-CNCR2820710602>3.0.CO;2-D; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; LEONARD S, 1993, BIOL PSYCHIAT, V33, P456, DOI 10.1016/0006-3223(93)90174-C; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li QL, 2014, TRANSGENIC RES, V23, P341, DOI 10.1007/s11248-013-9773-9; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Pavelic J, 1996, NEOPLASMA, V43, P75; Poljak M, 2000, PFLUG ARCH EUR J PHY, V439, pR42, DOI 10.1007/s004240000085; Rao WN, 2013, NAT METHODS, V10, P6, DOI 10.1038/nmeth.2308; Santos MCLG, 2008, PATHOL RES PRACT, V204, P633, DOI 10.1016/j.prp.2008.04.005; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P24, DOI 10.1093/jncimonographs/lgr009; Wang LT, 1996, J CLIN PATHOL-CL MOL, V49, pM176; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015; Yuan H, 2010, BIOCHEMISTRY-US, V49, P9542, DOI 10.1021/bi101420w	46	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104481	10.1371/journal.pone.0104481	http://dx.doi.org/10.1371/journal.pone.0104481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133528	gold, Green Submitted, Green Published			2022-12-27	WOS:000341302700031
J	Park, JH; Seo, JH; Wee, HJ; Vo, TTL; Lee, EJ; Choi, H; Cha, JH; Ahn, BJ; Shin, MW; Bae, SJ; Kim, KW				Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won			Nuclear Translocation of hARD1 Contributes to Proper Cell Cycle Progression	PLOS ONE			English	Article							ARREST-DEFECTIVE-1 PROTEIN; ACETYLTRANSFERASE COMPLEX; BREAST-CANCER; ARD1 GENE; ACETYLATION; EXPRESSION; PROLIFERATION; TUMORIGENESIS; STABILITY; HYPOXIA	Arrest defective 1 (ARD1) is an acetyltransferase that is highly conserved across organisms, from yeasts to humans. The high homology and widespread expression of ARD1 across multiple species and tissues signify that it serves a fundamental role in cells. Human ARD1 (hARD1) has been suggested to be involved in diverse biological processes, and its role in cell proliferation and cancer development has been recently drawing attention. However, the subcellular localization of ARD1 and its relevance to cellular function remain largely unknown. Here, we have demonstrated that hARD1 is imported to the nuclei of proliferating cells, especially during S phase. Nuclear localization signal (NLS)-deleted hARD1 (hARD1 Delta N), which can no longer access the nucleus, resulted in cell morphology changes and cellular growth impairment. Notably, hARD1 Delta N-expressing cells showed alterations in the cell cycle and the expression levels of cell cycle regulators compared to hARD1 wild-type cells. Furthermore, these effects were rescued when the nuclear import of hARD1 was restored by exogenous NLS. Our results show that hARD1 nuclear translocation mediated by NLS is required for cell cycle progression, thereby contributing to proper cell proliferation.	[Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVascular Protect Res Ctr, Seoul, South Korea; [Park, Ji-Hyeon; Seo, Ji Hae; Wee, Hee-Jun; Vo, Tam Thuy Lu; Lee, Eun Ji; Choi, Hoon; Cha, Jong-Ho; Ahn, Bum Ju; Shin, Min Wook; Bae, Sung-Jin; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVascular Protect Res Ctr, Seoul, South Korea.	qwonkim@snu.ac.kr	Bae, Sung-Jin/AAX-9144-2021; Kim, Kyu Won/AAJ-7213-2020; shin, minwook/HGA-4297-2022	Bae, Sung-Jin/0000-0001-8975-0876	Global Research Laboratory Program [2011-0021874]; Global Core Research Center (GCRC) Program [2011-0030001]; National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [2013-036038]; Basic Science Research Program through the NRF of Korea - Ministry of Education [2013R1A1A2058956]	Global Research Laboratory Program; Global Core Research Center (GCRC) Program; National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP); Basic Science Research Program through the NRF of Korea - Ministry of Education	This research was supported by the Global Research Laboratory Program (2011-0021874), Global Core Research Center (GCRC) Program (2011-0030001), National Research Foundation (NRF) grant (2013-036038) funded by the Ministry of Science, ICT and Future Planning (MSIP), and Basic Science Research Program through the NRF of Korea funded by the Ministry of Education (2013R1A1A2058956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2005, THYROID, V15, P1131, DOI 10.1089/thy.2005.15.1131; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Bilton R, 2005, J BIOL CHEM, V280, P31132, DOI 10.1074/jbc.M504482200; Chun KH, 2007, BIOCHEM BIOPH RES CO, V353, P18, DOI 10.1016/j.bbrc.2006.11.131; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kim SH, 2006, BIOCHEM BIOPH RES CO, V340, P422, DOI 10.1016/j.bbrc.2005.12.018; Kuo HP, 2010, AM J TRANSL RES, V2, P56; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lee MN, 2010, J NATL CANCER I, V102, P426, DOI 10.1093/jnci/djq026; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Park J, 2012, BIOCHEM BIOPH RES CO, V422, P291, DOI 10.1016/j.bbrc.2012.04.150; Seo JH, 2010, CANCER RES, V70, P4422, DOI 10.1158/0008-5472.CAN-09-3258; Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200; Wang ZH, 2011, ASIAN PAC J CANCER P, V12, P1973; Wang ZH, 2012, P NATL ACAD SCI USA, V109, P3053, DOI 10.1073/pnas.1113356109; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; Xu HY, 2012, CARCINOGENESIS, V33, P1193, DOI 10.1093/carcin/bgs144; Yu M, 2009, CANCER INVEST, V27, P978, DOI 10.3109/07357900902769723	22	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105185	10.1371/journal.pone.0105185	http://dx.doi.org/10.1371/journal.pone.0105185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133627	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700081
J	Zhao, CZ; Xu, J; Li, Q; Li, S; Wang, P; Xiang, FN				Zhao, Cuizhu; Xu, Jin; Li, Qiang; Li, Shuo; Wang, Peng; Xiang, Fengning			Cloning and Characterization of a Phragmites australis Phytochelatin Synthase (PaPCS) and Achieving Cd Tolerance in Tall Fescue	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; HEAVY-METALS POLLUTION; HETEROLOGOUS EXPRESSION; CADMIUM ACCUMULATION; HYPER-ACCUMULATOR; ESCHERICHIA-COLI; GENE FAMILY; ARABIDOPSIS; PLANTS; OVEREXPRESSION	The production of phytochelatins (PCs) provides an important means for plants to achieve tolerance to cadmium (Cd) toxicity. A reed gene encoding PC synthase (PaPCS) was isolated and its function tested through its heterologous expression in a strain of yeast sensitive to Cd. Subsequently, the Cd sensitive and high biomass accumulating species tall fescue was transformed either with PaPCS or PaGCS (a glutamyl cysteine synthetase gene of reed) on their own (single transformants), or with both genes together in the same transgene cassette (double transformant). The single and double transformants showed greater Cd tolerance and accumulated more Cd and PC than wild type plants, and their Cd leaf/root ratio content was higher. The ranking in terms of Cd and PC content for the various transgenic lines was double transformants>PaGCS single transformants>PaPCS single transformants>wild type. Thus PaGCS appears to exert a greater influence than PaPCS over PC synthesis and Cd tolerance/accumulation. The double transformant has interesting potential for phytoremediation.	[Zhao, Cuizhu; Li, Qiang; Li, Shuo; Wang, Peng; Xiang, Fengning] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China; [Zhao, Cuizhu] Northwest A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China; [Xu, Jin] Chinese Acad Sci, Ctr Agr Resources Res, Inst Genet & Dev Biol, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China	Shandong University; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Xiang, FN (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan, Shandong, Peoples R China.	xfn0990@sdu.edu.cn	WANG, Peng/GSN-5263-2022		Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China [2011BAI06B01]; National Natural Science Foundation of China [30970243]; International technology cooperation project of Shandong Province of China [2011176]; Science & Technology Plan of Shandong Province [2009GG10002001]; Chinese Natural Education Ministry Doctor Station Foundation Fellowship [913111006]	Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International technology cooperation project of Shandong Province of China; Science & Technology Plan of Shandong Province; Chinese Natural Education Ministry Doctor Station Foundation Fellowship	This research was supported by Key Projects in the National Science & Technology Pillar Program in the 12th Five year Plan of China (grant no. 2011BAI06B01), the National Natural Science Foundation of China (grant no. 30970243), International technology cooperation project of Shandong Province of China (grant no. 2011176), Science & Technology Plan of Shandong Province (grant 2009GG10002001) and the Chinese Natural Education Ministry Doctor Station Foundation Fellowship (grant no. 913111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett LE, 2003, J ENVIRON QUAL, V32, P432, DOI 10.2134/jeq2003.0432; Bhargava A, 2012, J ENVIRON MANAGE, V105, P103, DOI 10.1016/j.jenvman.2012.04.002; Bonanno G, 2010, ECOL INDIC, V10, P639, DOI 10.1016/j.ecolind.2009.11.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunetti P, 2011, J EXP BOT, V62, P5509, DOI 10.1093/jxb/err228; Buege J A, 1978, Methods Enzymol, V52, P302; Cassina L, 2011, INT J PHYTOREMEDIAT, V13, P90, DOI 10.1080/15226514.2011.568538; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Ding Teng-da, 2012, Yingyong Shengtai Xuebao, V23, P857; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Gisbert C, 2003, BIOCHEM BIOPH RES CO, V303, P440, DOI 10.1016/S0006-291X(03)00349-8; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; Guo JB, 2012, J HAZARD MATER, V199, P309, DOI 10.1016/j.jhazmat.2011.11.008; Guo Xing-liang, 2012, Yingyong Shengtai Xuebao, V23, P798; Gupta M, 1998, CHEMOSPHERE, V37, P785, DOI 10.1016/S0045-6535(98)00073-3; Hirata K, 2005, J BIOSCI BIOENG, V100, P593, DOI 10.1263/jbb.100.593; Huang J, 2009, WASTE MANAGE RES, V27, P668, DOI 10.1177/0734242X09103835; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Lee S, 2003, PLANT PHYSIOL, V131, P656, DOI 10.1104/pp.014118; Li YJ, 2004, PLANT CELL PHYSIOL, V45, P1787, DOI 10.1093/pcp/pch202; Li YJ, 2006, PLANT PHYSIOL, V141, P288, DOI 10.1104/pp.105.074815; Liu ZL, 2012, APPL BIOCHEM BIOTECH, V166, P722, DOI 10.1007/s12010-011-9461-2; Meyer CL, 2011, PLANTA, V234, P83, DOI 10.1007/s00425-011-1378-z; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noctor G, 1996, PLANT PHYSIOL, V112, P1071, DOI 10.1104/pp.112.3.1071; Olguin EJ, 2012, NEW BIOTECHNOL, V30, P3, DOI 10.1016/j.nbt.2012.05.020; Osaki Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3306, DOI 10.1271/bbb.80505; Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4; Peterson AG, 2006, PLANT PHYSIOL BIOCH, V44, P885, DOI 10.1016/j.plaphy.2006.10.021; Pomponi M, 2006, PLANTA, V223, P180, DOI 10.1007/s00425-005-0073-3; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Scebba F, 2006, BIOL PLANTARUM, V50, P688, DOI 10.1007/s10535-006-0107-0; Seth CS, 2012, INT J PHYTOREMEDIAT, V14, P1, DOI 10.1080/15226514.2011.555799; Shukla D, 2013, PROTOPLASMA, V250, P1263, DOI 10.1007/s00709-013-0508-9; Shukla D, 2013, BIOCHEM BIOPH RES CO, V434, P664, DOI 10.1016/j.bbrc.2013.03.138; Shukla D, 2012, PLANT CELL REP, V31, P1687, DOI 10.1007/s00299-012-1283-3; Singh S, 2008, BIOTECHNOL BIOENG, V99, P333, DOI 10.1002/bit.21577; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Tu S, 2004, ENVIRON EXP BOT, V51, P121, DOI 10.1016/j.envexpbot.2003.08.003; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vitoria AP, 2001, PHYTOCHEMISTRY, V57, P701, DOI 10.1016/S0031-9422(01)00130-3; Wang FJ, 2012, ACTA BIOCH BIOPH SIN, V44, P886, DOI 10.1093/abbs/gms073; Wawrzynska A, 2005, ACTA BIOCHIM POL, V52, P109; Wawrzynski A, 2006, J EXP BOT, V57, P2173, DOI 10.1093/jxb/erj176; Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113; Yong X, 2014, LETT APPL MICROBIOL, V58, P255, DOI 10.1111/lam.12185; Zhang ZC, 2010, PLANT CELL ENVIRON, V33, P1248, DOI 10.1111/j.1365-3040.2010.02144.x; Zhao CZ, 2010, PLANT CELL ENVIRON, V33, P877, DOI 10.1111/j.1365-3040.2009.02113.x; Zitka O, 2011, J HAZARD MATER, V192, P794, DOI 10.1016/j.jhazmat.2011.05.088	55	23	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103771	10.1371/journal.pone.0103771	http://dx.doi.org/10.1371/journal.pone.0103771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133575	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700016
J	Heul, AMV; Gakhar, L; Piper, RC; Subramanian, R				Heul, Aaron M. Ver; Gakhar, Lokesh; Piper, Robert C.; Subramanian, Ramaswamy			Crystal Structure of a Complex of NOD1 CARD and Ubiquitin	PLOS ONE			English	Article							POLYUBIQUITIN CHAINS; RIG-I; RECOGNITION; ACTIVATION; PROTEIN; INNATE; DOMAIN; PEPTIDOGLYCAN; PATHWAY; BINDING	The Caspase Recruitment Domain (CARD) from the innate immune receptor NOD1 was crystallized with Ubiquitin (Ub). NOD1 CARD was present as a helix-swapped homodimer similar to other structures of NOD1 CARD, and Ub monomers formed a homodimer similar in conformation to Lys48-linked di-Ub. The interaction between NOD1 CARD and Ub in the crystal was mediated by novel binding sites on each molecule. Comparisons of these sites to previously identified interaction surfaces on both molecules were made along with discussion of their potential functional significance.	[Heul, Aaron M. Ver; Piper, Robert C.] Univ Iowa, Iowa City, IA USA; [Heul, Aaron M. Ver; Gakhar, Lokesh; Subramanian, Ramaswamy] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Carver Coll Med, Prot Crystallog Facil, Iowa City, IA USA; [Subramanian, Ramaswamy] Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India	University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Subramanian, R (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	ramas@instem.res.in	Gakhar, Lokesh/P-8356-2019; Subramanian, Ramaswamy/Q-8671-2019; Gakhar, Lokesh/F-2113-2010	Gakhar, Lokesh/0000-0002-3319-1902; Subramanian, Ramaswamy/0000-0002-6709-190X; Gakhar, Lokesh/0000-0002-3319-1902; Piper, Robert/0000-0001-9995-5699; Ver Heul, Aaron/0000-0003-3386-8351	Department of Science and Technology, Government of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Department of Science and Technology, Government of India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RS was funded by a grant from the Department of Science and Technology, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chin KH, 2007, PROTEINS, V69, P665, DOI 10.1002/prot.21501; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Li X, 2001, FEBS LETT, V507, P169, DOI 10.1016/S0014-5793(01)02954-4; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024227; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Qureshi Insaf A, 2009, BMC Res Notes, V2, P251, DOI 10.1186/1756-0500-2-251; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; TSAO DHH, 1991, BIOCHEMISTRY-US, V30, P4565, DOI 10.1021/bi00232a029; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	50	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104017	10.1371/journal.pone.0104017	http://dx.doi.org/10.1371/journal.pone.0104017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127239	gold, Green Submitted, Green Published			2022-12-27	WOS:000340879300012
J	Ito, S; Yeh, FC; Hiolski, E; Rydygier, P; Gunning, DE; Hottowy, P; Timme, N; Litke, AM; Beggs, JM				Ito, Shinya; Yeh, Fang-Chin; Hiolski, Emma; Rydygier, Przemyslaw; Gunning, Deborah E.; Hottowy, Pawel; Timme, Nicholas; Litke, Alan M.; Beggs, John M.			Large-Scale, High-Resolution Multielectrode-Array Recording Depicts Functional Network Differences of Cortical and Hippocampal Cultures	PLOS ONE			English	Article							NEURONAL AVALANCHES; THETA-OSCILLATIONS; SLICE CULTURES; BETA-RHYTHMS; IN-VIVO; SYNAPTIC DEVELOPMENT; GAMMA-OSCILLATIONS; GRANGER-CAUSALITY; CROSS-CORRELATION; ACTION-POTENTIALS	Understanding the detailed circuitry of functioning neuronal networks is one of the major goals of neuroscience. Recent improvements in neuronal recording techniques have made it possible to record the spiking activity from hundreds of neurons simultaneously with sub-millisecond temporal resolution. Here we used a 512-channel multielectrode array system to record the activity from hundreds of neurons in organotypic cultures of cortico-hippocampal brain slices from mice. To probe the network structure, we employed a wavelet transform of the cross-correlogram to categorize the functional connectivity in different frequency ranges. With this method we directly compare, for the first time, in any preparation, the neuronal network structures of cortex and hippocampus, on the scale of hundreds of neurons, with sub-millisecond time resolution. Among the three frequency ranges that we investigated, the lower two frequency ranges (gamma (30-80 Hz) and beta (12-30 Hz) range) showed similar network structure between cortex and hippocampus, but there were many significant differences between these structures in the high frequency range (100-1000 Hz). The high frequency networks in cortex showed short tailed degree-distributions, shorter decay length of connectivity density, smaller clustering coefficients, and positive assortativity. Our results suggest that our method can characterize frequency dependent differences of network architecture from different brain regions. Crucially, because these differences between brain regions require millisecond temporal scales to be observed and characterized, these results underscore the importance of high temporal resolution recordings for the understanding of functional networks in neuronal systems.	[Ito, Shinya; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Ito, Shinya; Yeh, Fang-Chin; Timme, Nicholas; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Hiolski, Emma] Univ Calif Santa Cruz, Microbiol & Environm Toxicol Dept, Santa Cruz, CA 95064 USA; [Rydygier, Przemyslaw; Hottowy, Pawel] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Gunning, Deborah E.] Univ Strathclyde, Inst Photon, Glasgow, Lanark, Scotland	University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Cruz; AGH University of Science & Technology; University of Strathclyde	Ito, S (corresponding author), Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA.	sito@ucsc.edu	Hottowy, Pawel/R-4981-2019; Gunning, Deborah/P-5825-2015	Timme, Nicholas/0000-0002-7127-4418	NSF [DGE-0809125-006]; Polish-American Fulbright Commission; Royal Academy of Engineering Fellowship [EP/H044639/1]; Polish National Science Centre [DEC-2013/08/W/NZ4/00691]; NSF CRCNS [IIS-0904413, IIS-0904912]; NSF PoLS [10581291]; Div Of Information & Intelligent Systems [0904413] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Polish-American Fulbright Commission; Royal Academy of Engineering Fellowship(Royal Academy of Engineering - UK); Polish National Science Centre; NSF CRCNS(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF PoLS; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by an NSF Fellowship DGE-0809125-006 (EH), a scholarship from the Polish-American Fulbright Commission (PR), Royal Academy of Engineering Fellowship EP/H044639/1 (DEG), Polish National Science Centre (decision DEC-2013/08/W/NZ4/00691) (PH), NSF CRCNS grants IIS-0904413 (AML) and IIS-0904912 (JMB), and an NSF PoLS grant 10581291 (JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Baker RE, 2006, BRAIN RES, V1101, P29, DOI 10.1016/j.brainres.2006.05.028; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Berdondini L, 2009, LAB CHIP, V9, P2644, DOI 10.1039/b907394a; Bibbig A, 2001, J NEUROSCI, V21, P9053, DOI 10.1523/JNEUROSCI.21-22-09053.2001; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brede M., 2005, 0507710CONDMAT ARXIV; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; CAESER M, 1989, EXP BRAIN RES, V77, P234, DOI 10.1007/BF00274981; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; de Franciscis S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036114; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; GOTZ M, 1992, J NEUROBIOL, V23, P783, DOI 10.1002/neu.480230702; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harris-White ME, 1998, J NEUROPHYSIOL, V79, P1045, DOI 10.1152/jn.1998.79.2.1045; Hierlemann A, 2011, P IEEE, V99, P252, DOI 10.1109/JPROC.2010.2066532; Hulata E, 2000, PHYS REV LETT, V85, P4637, DOI 10.1103/PhysRevLett.85.4637; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Kobayashi R, 2013, J COMPUT NEUROSCI, V35, P109, DOI 10.1007/s10827-013-0443-y; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lahtinen H, 2002, J NEUROPHYSIOL, V88, P1469, DOI 10.1152/jn.2002.88.3.1469; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lee D, 2002, J NEUROSCI METH, V115, P67, DOI 10.1016/S0165-0270(02)00002-X; Letelier JC, 2000, J NEUROSCI METH, V101, P93, DOI 10.1016/S0165-0270(00)00250-8; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070894; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pasquale V, 2010, J COMPUT NEUROSCI, V29, P213, DOI 10.1007/s10827-009-0175-1; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plenz D, 1996, NEUROSCIENCE, V70, P861, DOI 10.1016/0306-4522(95)00406-8; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roux SG, 2007, J NEUROSCI METH, V160, P135, DOI 10.1016/j.jneumeth.2006.09.001; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; Shimono M, 2011, NEUROSCI RES, V71, pE304, DOI 10.1016/j.neures.2011.07.1326; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; STUMPF C, 1965, ELECTROEN CLIN NEURO, V18, P477, DOI 10.1016/0013-4694(65)90128-8; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; TJOSTHEIM D, 1981, J ECONOMETRICS, V17, P157, DOI 10.1016/0304-4076(81)90024-5; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00086; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	104	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105324	10.1371/journal.pone.0105324	http://dx.doi.org/10.1371/journal.pone.0105324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126851	Green Published, gold			2022-12-27	WOS:000340879300104
J	Nakajima, EC; Laymon, C; Oborski, M; Hou, WZ; Wang, L; Grandis, JR; Ferris, RL; Mountz, JM; Van Houten, B				Nakajima, Erica C.; Laymon, Charles; Oborski, Matthew; Hou, Weizhou; Wang, Lin; Grandis, Jennifer R.; Ferris, Robert L.; Mountz, James M.; Van Houten, Bennett			Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMAS; GLUCOSE-METABOLISM; CAIX; MICROENVIRONMENT; HIF-1-ALPHA; OXYGENATION; PERFORMANCE; METASTASIS; CANCERS	Purpose: Intratumoral metabolic heterogeneity may increase the likelihood of treatment failure due to the presence of a subset of resistant tumor cells. Using a head and neck squamous cell carcinoma (HNSCC) xenograft model and a real-time fluorescence imaging approach, we tested the hypothesis that tumors are metabolically heterogeneous, and that tumor hypoxia alters patterns of glucose uptake within the tumor. Experimental Design: Cal33 cells were grown as xenograft tumors (n = 16) in nude mice after identification of this cell line's metabolic response to hypoxia. Tumor uptake of fluorescent markers identifying hypoxia, glucose import, or vascularity was imaged simultaneously using fluorescent molecular tomography. The variability of intratumoral 2-deoxyglucose (IR800-2-DG) concentration was used to assess tumor metabolic heterogeneity, which was further investigated using immunohistochemistry for expression of key metabolic enzymes. HNSCC tumors in patients were assessed for intratumoral variability of F-18-fluorodeoxyglucose (F-18-FDG) uptake in clinical PET scans. Results: IR800-2-DG uptake in hypoxic regions of Cal33 tumors was 2.04 times higher compared to the whole tumor (p = 0.0001). IR800-2-DG uptake in tumors containing hypoxic regions was more heterogeneous as compared to tumors lacking a hypoxic signal. Immunohistochemistry staining for HIF-1 alpha, carbonic anhydrase 9, and ATP synthase subunit 5 beta confirmed xenograft metabolic heterogeneity. We detected heterogeneous F-18-FDG uptake within patient HNSCC tumors, and the degree of heterogeneity varied amongst tumors. Conclusion: Hypoxia is associated with increased intratumoral metabolic heterogeneity. F-18-FDG PET scans may be used to stratify patients according to the metabolic heterogeneity within their tumors, which could be an indicator of prognosis.	[Nakajima, Erica C.] Univ Pittsburgh, Phys Scientist Training Program, Pittsburgh, PA USA; [Nakajima, Erica C.] Howard Hughes Med Inst, Bethesda, MD 20817 USA; [Nakajima, Erica C.; Van Houten, Bennett] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Laymon, Charles] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA; [Hou, Weizhou] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Wang, Lin] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Grandis, Jennifer R.; Ferris, Robert L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Van Houten, B (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	vanhoutenb@upmc.edu	Van Houten, Bennett/K-2284-2019		Howard Hughes Medical Institute; National Institutes of Health [U01CA140230, R01CA077308, P30CA047904]; Pennsylvania Commonwealth Universal Research Enhancement; NATIONAL CANCER INSTITUTE [U01CA140230, P30CA047904, P50CA097190, R01CA077308] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Universal Research Enhancement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Howard Hughes Medical Institute Medical Fellow (ECN), National Institutes of Health U01CA140230 (JMM), P50CA097190 (JRG & RLF), R01CA077308 (JRG) P30CA047904 (BVH), Pennsylvania Commonwealth Universal Research Enhancement (BVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer C, 2012, INT J RADIAT ONCOL, V84, pE409, DOI 10.1016/j.ijrobp.2012.04.033; Bettinardi V, 2004, EUR J NUCL MED MOL I, V31, P867, DOI 10.1007/s00259-003-1444-2; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DEVREESE K, 1993, EUR J CLIN CHEM CLIN, V31, P829; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Hatt M, 2011, J NUCL MED, V52, P1690, DOI 10.2967/jnumed.111.092767; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Kappler M, 2008, STRAHLENTHER ONKOL, V184, P393, DOI 10.1007/s00066-008-1813-7; Kidd EA, 2008, CLIN CANCER RES, V14, P5236, DOI 10.1158/1078-0432.CCR-07-5252; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Marusyk A, 2013, SCIENCE, V339, P528, DOI 10.1126/science.1234415; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Mayer A, 2005, CLIN CANCER RES, V11, P7220, DOI 10.1158/1078-0432.CCR-05-0869; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Nakajima EC, 2013, MOL CARCINOGEN, V52, P329, DOI 10.1002/mc.21863; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Rajendran JG, 2004, CLIN CANCER RES, V10, P2245, DOI 10.1158/1078-0432.CCR-0688-3; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Robey IF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/485196; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Swiderek H, 2008, J BIOTECHNOL, V134, P103, DOI 10.1016/j.jbiotec.2008.01.001; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Thorwarth D, 2006, RADIOTHERAPY ONCOLOG, V80; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; Tseng JC, 2012, MOL IMAGING BIOL, V14, P553, DOI 10.1007/s11307-012-0545-3; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; YOKOI T, 1988, Tumor Research, V23, P43; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang QB, 2010, INT J CANCER, V126, P2534, DOI 10.1002/ijc.24979; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051; Ziebart T, 2011, J CANCER RES CLIN, V137, P193, DOI 10.1007/s00432-010-0875-y	44	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e102452	10.1371/journal.pone.0102452	http://dx.doi.org/10.1371/journal.pone.0102452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127378	Green Published, gold, Green Accepted			2022-12-27	WOS:000340879300005
J	Simon, TE; Le Cointe, R; Delarue, P; Morliere, S; Montfort, F; Herve, MR; Poggi, S				Simon, Thomas E.; Le Cointe, Ronan; Delarue, Patrick; Morliere, Stephanie; Montfort, Francoise; Herve, Maxime R.; Poggi, Sylvain			Interplay between Parasitism and Host Ontogenic Resistance in the Epidemiology of the Soil-Borne Plant Pathogen Rhizoctonia solani	PLOS ONE			English	Article							INOCULUM DENSITY; DISEASE; TRANSMISSION; CARBON; INVASION; BEHAVIOR; GROWTH; FUNGI	Spread of soil-borne fungal plant pathogens is mainly driven by the amount of resources the pathogen is able to capture and exploit should it behave either as a saprotroph or a parasite. Despite their importance in understanding the fungal spread in agricultural ecosystems, experimental data related to exploitation of infected host plants by the pathogen remain scarce. Using Rhizoctonia solani / Raphanus sativus as a model pathosystem, we have obtained evidence on the link between ontogenic resistance of a tuberizing host and (i) its susceptibility to the pathogen and (ii) after infection, the ability of the fungus to spread in soil. Based on a highly replicable experimental system, we first show that infection success strongly depends on the host phenological stage. The nature of the disease symptoms abruptly changes depending on whether infection occurred before or after host tuberization, switching from damping-off to necrosis respectively. Our investigations also demonstrate that fungal spread in soil still depends on the host phenological stage at the moment of infection. High, medium, or low spread occurred when infection was respectively before, during, or after the tuberization process. Implications for crop protection are discussed.	[Simon, Thomas E.; Le Cointe, Ronan; Delarue, Patrick; Morliere, Stephanie; Montfort, Francoise; Herve, Maxime R.; Poggi, Sylvain] INRA UMR 1349 IGEPP, Le Rheu, France	INRAE	Poggi, S (corresponding author), INRA UMR 1349 IGEPP, Le Rheu, France.	sylvain.poggi@rennes.inra.fr		POGGI, Sylvain/0000-0003-3051-5091	French National Research Agency through SYSBIOTEL [ANR-08_STRA-14]; INRA "Plant Health & the Environment" Division	French National Research Agency through SYSBIOTEL(French National Research Agency (ANR)); INRA "Plant Health & the Environment" Division	This research was supported by the French National Research Agency (http://www.agence-nationale-recherche.fr) through funding of the SYSBIOTEL project referenced ANR-08_STRA-14. (SP TES FM RLC). Part of this research was also supported by the INRA "Plant Health & the Environment" Division (http://www.spe.inra.fr/). (SP FM RLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anees M, 2010, SOIL BIOL BIOCHEM, V42, P1661, DOI 10.1016/j.soilbio.2010.05.013; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; CASTRO C, 1988, PHYTOPATHOLOGY, V78, P1287, DOI 10.1094/Phyto-78-1287; CHRISTIAS C, 1973, PHYTOPATHOLOGY, V63, P602, DOI 10.1094/Phyto-63-602; Cunniffe NJ, 2008, FUNGAL ECOL, V1, P133, DOI 10.1016/j.funeco.2008.10.007; Ferreira IED, 2013, ECOL INFORM, V14, P53, DOI 10.1016/j.ecoinf.2012.11.005; Deacon JW., 1980, INTRO MODERN MYCOLOG; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; Garrett SD, 1970, BIOL ROOT INFECT FUN; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Gilligan CA, 1997, NEW PHYTOL, V135, P475, DOI 10.1046/j.1469-8137.1997.00673.x; Hack H, 1992, NACHRICHTENBLATT DTS, V44, P265; Jacobs H, 2004, MYCOL RES, V108, P453, DOI 10.1017/S0953756204009840; Kleczkowski A, 1997, P ROY SOC B-BIOL SCI, V264, P979, DOI 10.1098/rspb.1997.0135; Lamour A, 2000, IMA J MATH APPL MED, V17, P329, DOI 10.1093/imamci/17.4.329; Leclerc M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086568; Ludlam JJ, 2012, J R SOC INTERFACE, V9, P949, DOI 10.1098/rsif.2011.0506; Otten W, 2004, NEW PHYTOL, V162, P231, DOI 10.1111/j.1469-8137.2004.01011.x; Otten W, 2005, ECOLOGY, V86, P1948, DOI 10.1890/04-1122; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; PAPAVIZAS G, 1961, PHYTOPATHOLOGY, V51, P693; PAUSTIAN K, 1987, SOIL BIOL BIOCHEM, V19, P613, DOI 10.1016/0038-0717(87)90107-6; PITT D, 1964, ANN APPL BIOL, V54, P231, DOI 10.1111/j.1744-7348.1964.tb01187.x; Poggi S, 2013, PHYTOPATHOLOGY, V103, P1012, DOI 10.1094/PHYTO-02-13-0033-R; Poggi S, 2013, PHYTOPATHOLOGY; Schroeder KL, 2008, PHYTOPATHOLOGY, V98, P304, DOI 10.1094/PHYTO-98-3-0304; SNEH B, 1966, PHYTOPATHOLOGY, V56, P74; Sneh B., 1996, RHIZOCTONIA SPECIES; Stacey AJ, 2001, NEW PHYTOL, V150, P169, DOI 10.1046/j.1469-8137.2001.00082.x; Tamm L, 2010, EUR J PLANT PATHOL, V127, P465, DOI 10.1007/s10658-010-9612-2; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; Zakaria AJ, 2002, FEMS MICROBIOL ECOL, V40, P135, DOI 10.1111/j.1574-6941.2002.tb00945.x	33	28	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105159	10.1371/journal.pone.0105159	http://dx.doi.org/10.1371/journal.pone.0105159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127238	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300084
J	Chen, B; Zhang, YD; Song, XJ; Wang, XY; Zhang, J; Fang, J				Chen, Bin; Zhang, Yudong; Song, Xiaojian; Wang, Xiaoying; Zhang, Jue; Fang, Jing			Quantitative Estimation of Renal Function with Dynamic Contrast-Enhanced MRI Using a Modified Two-Compartment Model	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NEPHROGENIC SYSTEMIC FIBROSIS; FRACTIONAL VASCULAR VOLUME; PATLAK PLOT TECHNIQUE; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; COMPARTMENT MODEL; GRADIENT-ECHO; HUMAN KIDNEY; DCE-MRI	Objective: To establish a simple two-compartment model for glomerular filtration rate (GFR) and renal plasma flow (RPF) estimations by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Materials and Methods: A total of eight New Zealand white rabbits were included in DCE-MRI. The two-compartment model was modified with the impulse residue function in this study. First, the reliability of GFR measurement of the proposed model was compared with other published models in Monte Carlo simulation at different noise levels. Then, functional parameters were estimated in six healthy rabbits to test the feasibility of the new model. Moreover, in order to investigate its validity of GFR estimation, two rabbits underwent acute ischemia surgical procedure in unilateral kidney before DCE-MRI, and pixel-wise measurements were implemented to detect the cortical GFR alterations between normal and abnormal kidneys. Results: The lowest variability of GFR and RPF measurements were found in the proposed model in the comparison. Mean GFR was 3.03 +/- 1.1 ml/min and mean RPF was 2.64 +/- 0.5 ml/g/min in normal animals, which were in good agreement with the published values. Moreover, large GFR decline was found in dysfunction kidneys comparing to the contralateral control group. Conclusion: Results in our study demonstrate that measurement of renal kinetic parameters based on the proposed model is feasible and it has the ability to discriminate GFR changes in healthy and diseased kidneys.	[Chen, Bin; Song, Xiaojian; Wang, Xiaoying; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Zhang, Yudong; Wang, Xiaoying] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China; [Song, Xiaojian] Chengdu Univ Informat Technol, Dept Elect Engn, Chengdu, Sichuan, Peoples R China; [Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Chengdu University of Information Technology; Peking University	Wang, XY (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	cjr.wangxiaoying@vip.163.com; zhangjue@pku.edu.cn						Annet L, 2004, J MAGN RESON IMAGING, V20, P843, DOI 10.1002/jmri.20173; Bokacheva L, 2009, J MAGN RESON IMAGING, V29, P371, DOI 10.1002/jmri.21642; Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791; Craig AJ, 2011, EUR RADIOL, V21, P2211, DOI 10.1007/s00330-011-2157-8; de Priester JA, 2003, J MAGN RESON IMAGING, V17, P95, DOI 10.1002/jmri.10217; Fluckiger JU, 2012, MAGN RESON IMAGING, V30, P934, DOI 10.1016/j.mri.2012.02.011; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hackstein N, 2003, J MAGN RESON IMAGING, V18, P714, DOI 10.1002/jmri.10410; Hackstein N, 2003, AM J ROENTGENOL, V181, P147, DOI 10.2214/ajr.181.1.1810147; Hayashi T, 1999, NEPHRON, V82, P90, DOI 10.1159/000045380; Hermoye L, 2004, MAGN RESON MED, V51, P1017, DOI 10.1002/mrm.20026; Joyce M, 2001, J SURG RES, V101, P79, DOI 10.1006/jsre.2001.6256; Khalifa F, 2013, NMR BIOMED, V26, P1460, DOI 10.1002/nbm.2977; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Kuo PH, 2008, AM J ROENTGENOL, V191, P1861, DOI 10.2214/AJR.08.1179; Laurent D, 2002, MAGN RESON MED, V47, P127, DOI 10.1002/mrm.10034; Lawson RS, 1999, PHYS MED BIOL, V44, pR57, DOI 10.1088/0031-9155/44/4/028; Lee VS, 2007, AM J PHYSIOL-RENAL, V292, pF1548, DOI 10.1152/ajprenal.00347.2006; Lv DJ, 2008, IEEE ENG MED BIOL, V27, P36, DOI 10.1109/MEMB.2008.923949; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Miles KA, 1999, BRIT J RADIOL, V72, P153, DOI 10.1259/bjr.72.854.10365065; OTT CE, 1979, AM J PHYSIOL, V237, pF479, DOI 10.1152/ajprenal.1979.237.6.F479; Pauliah M, 2007, MAGN RESON IMAGING, V25, P1292, DOI 10.1016/j.mri.2007.03.027; Peeters F, 2004, MAGN RESON MED, V51, P710, DOI 10.1002/mrm.20032; Rusinek H, 2007, MAGN RESON MED, V57, P1159, DOI 10.1002/mrm.21240; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Shuter B, 1998, JMRI-J MAGN RESON IM, V8, P853, DOI 10.1002/jmri.1880080415; Sourbron SP, 2008, INVEST RADIOL, V43, P40, DOI 10.1097/RLI.0b013e31815597c5; Tsushima Y, 1999, AM J KIDNEY DIS, V33, P754, DOI 10.1016/S0272-6386(99)70230-1; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Winter JD, 2011, J MAGN RESON IMAGING, V34, P608, DOI 10.1002/jmri.22660; Wolf GL, 1999, AM J KIDNEY DIS, V33, P804, DOI 10.1016/S0272-6386(99)70240-4; Zhang JL, 2008, MAGN RESON MED, V59, P278, DOI 10.1002/mrm.21489; Zhang YD, 2012, CONTRAST MEDIA MOL I, V7, P418, DOI 10.1002/cmmi.1468; Zimmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053849	35	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105087	10.1371/journal.pone.0105087	http://dx.doi.org/10.1371/journal.pone.0105087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141138	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200051
J	Shum, K; Alperin, P; Shalnova, S; Boytsov, S; Kontsevaya, A; Vigdorchik, A; Guetz, A; Eriksson, J; Hughes, D				Shum, Kenny; Alperin, Peter; Shalnova, Svetlana; Boytsov, Sergey; Kontsevaya, Anna; Vigdorchik, Alexey; Guetz, Adam; Eriksson, Jennifer; Hughes, David			Simulating the Impact of Improved Cardiovascular Risk Interventions on Clinical and Economic Outcomes in Russia	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ARTERIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; YAROSLAVL REGION; HEART-DISEASE; MORTALITY; PROGRAM; TRENDS; MANAGEMENT; STROKE	Objectives: Russia faces a high burden of cardiovascular disease. Prevalence of all cardiovascular risk factors, especially hypertension, is high. Elevated blood pressure is generally poorly controlled and medication usage is suboptimal. With a disease-model simulation, we forecast how various treatment programs aimed at increasing blood pressure control would affect cardiovascular outcomes. In addition, we investigated what additional benefit adding lipid control and smoking cessation to blood pressure control would generate in terms of reduced cardiovascular events. Finally, we estimated the direct health care costs saved by treating fewer cardiovascular events. Methods: The Archimedes Model, a detailed computer model of human physiology, disease progression, and health care delivery was adapted to the Russian setting. Intervention scenarios of achieving systolic blood pressure control rates (defined as systolic blood pressure < 140 mmHg) of 40% and 60% were simulated by modifying adherence rates of an antihypertensive medication combination and compared with current care (23.9% blood pressure control rate). Outcomes of major adverse cardiovascular events; cerebrovascular event (stroke), myocardial infarction, and cardiovascular death over a 10-year time horizon were reported. Direct health care costs of strokes and myocardial infarctions were derived from official Russian statistics and tariff lists. Results: To achieve systolic blood pressure control rates of 40% and 60%, adherence rates to the antihypertensive treatment program were 29.4% and 65.9%. Cardiovascular death relative risk reductions were 13.2%, and 29.6%, respectively. For the current estimated 43,855,000-person Russian hypertensive population, each control-rate scenario resulted in an absolute reduction of 1.0 million and 2.4 million cardiovascular deaths, and a reduction of 1.2 million and 2.7 million stroke/myocardial infarction diagnoses, respectively. Averted direct costs from current care levels ($7.6 billion [in United States dollars]) were $1.1 billion and $ 2.6 billion, respectively.	[Shum, Kenny; Alperin, Peter; Guetz, Adam] Archimedes, San Francisco, CA USA; [Shalnova, Svetlana; Boytsov, Sergey; Kontsevaya, Anna] Natl Res Ctr Prevent Med, Moscow, Russia; [Vigdorchik, Alexey] Novartis Pharma LLC, Moscow, Russia; [Eriksson, Jennifer] OptumInsight Life Sci, Stockholm, Sweden; [Hughes, David] Novartis Int AG, Dept Healthcare Syst, Basel, Switzerland	National Medical Research Center for Therapy & Preventive Medicine; Novartis	Shum, K (corresponding author), Evidera Inc, San Francisco, CA 94105 USA.	kenny.shum@evidera.com	Kontsevaya, Anna/H-6061-2013; Drapkina, Oksana/AAE-5376-2021; Shalnova, Svetlana/D-3824-2016; Boytsov, Sergey/AAK-5354-2021; Boytsov, Sergey A/M-4486-2014	Drapkina, Oksana/0000-0002-4453-8430; Boytsov, Sergey/0000-0001-6998-8406; Boytsov, Sergey A/0000-0001-6998-8406; Kontsevaya, Anna/0000-0003-2062-1536	Novartis Pharma, Basel, Switzerland	Novartis Pharma, Basel, Switzerland	The work was funded by Novartis Pharma, Basel, Switzerland. The company played a role in this study due to the employment of two authors of this study in subsidiary Novartis companies (these authors were involved in the study concept and initial design, literature review, input into modeling parameters, interpretation of data analysis and assistance with manuscript writing). However, final decisions on content and the decision to publish were the responsibility of the non-Novartis authors.	Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Belousov Y, 2009, PROBLEMS OF STANDARD; Calhoun DA, 2009, HYPERTENSION, V54, P32, DOI 10.1161/HYPERTENSIONAHA.109.131300; Campbell NRC, 2006, HYPERTENSION, V47, P22, DOI 10.1161/01.HYP.0000196269.98463.fd; Cene CW, 2009, J GEN INTERN MED, V24, P1057, DOI 10.1007/s11606-009-1051-4; Chazova IE, 2010, RUSSIAN GUIDELINES 4, V3, P5; Chazova IE, 2011, ADV THER, V28, P134, DOI 10.1007/s12325-010-0099-1; Cifkova R, 2004, J HUM HYPERTENS, V18, P571, DOI 10.1038/sj.jhh.1001686; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Davidkovova H, 2013, HEART, V99, P409, DOI 10.1136/heartjnl-2012-303123; Dudl RJ, 2009, AM J MANAG CARE, V15, pE88; Eberstadt N, 2009, RUSSIAS DEMOGRAPHIC; Eddy D, 2013, VALIDATION METHODOLO; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Godet-Mardirossian H, 2012, EUR J PREV CARDIOL, V19, P213, DOI 10.1177/1741826710394303; Greenberg HM, 2005, AM J HYPERTENS, V18, P943, DOI 10.1016/j.amjhyper.2005.01.012; Guallar E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-704; Huxley RR, 2014, LANCET DIABETES ENDO; International Monetary Fund, 2011, WORLD ECONOMIC OUTLO; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Karpov Y, 2012, ADV THER, V29, P134, DOI 10.1007/s12325-011-0095-0; Kobalava ZD, 2009, CURR MED RES OPIN, V25, P2229, DOI 10.1185/03007990903157531; Kobalava ZD, 2008, TERAPEVT ARKH, V80, P76; Kobalava ZD, 2007, KARDIOLOGIYA, V47, P38; Kontsevaya A, 2010, J HYPERTENS, V28, pE239, DOI 10.1097/01.hjh.0000378910.33276.72; Kontsevaya A, 2013, VALUE HEALTH REG ISS, V2, P199; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Marcevich SY, 2012, RATION PHARMACOTHER, V8, P681, DOI 10.20996/1819-6446-2012-8-5-681-684; Marquez Patricio M., 2005, DYING TOO YOUNG ADDR; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mozheyko M, 2013, J CLIN HYPERTENS, V15, P918, DOI 10.1111/jch.12214; Mozheyko M, 2012, ADV THER, V29, P1016, DOI 10.1007/s12325-012-0064-2; National High Blood Pressure Education Program, 2004, 7 REP JOINT NATL COM; Nichols M., 2012, EUROPEAN CARDIOVASCU; Oganov RG, 2011, CARDIOVASC THER PREV, V10, P9; Oganov RG, 2001, ROSS MED VESTI, V3, P34; Oparil S, 2010, CLIN THER, V32, P1252, DOI 10.1016/j.clinthera.2010.07.008; Pension Fund of the Russian Federation, PENSION SYSTEM PRINC; Petrukhin IS, 2011, PUBLIC HEALTH REV, V33, P436, DOI 10.1007/BF03391645; Posnenkova OM, 2011, RATION PHARMACOTHER, V7, P725, DOI 10.20996/1819-6446-2011-7-6-725-732; Roberts B, 2012, J EPIDEMIOL COMMUN H, V66, P482, DOI 10.1136/jech.2010.111377; Russian Federal Service of State Statistics, 2011, RUSSIAN FEDERAL SERV; Russian Federation Statistical Service, 2010, THE DEMOGRAPHIC YEAR; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Schuetz CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066454; Shalnova SA, 2011, CARDIOVASC THER PREV, V10, P5, DOI 10.15829/1728-8800-2011-6-5-10; Taylor Addison A, 2003, Congest Heart Fail, V9, P324, DOI 10.1111/j.1527-5299.2003.03269.x; The Health and Social Care Information Centre, 2012, HEALTH SURVEY FOR EN; Tolpygina SN, 2013, RATION PHARMACOTHER, V9, P138, DOI 10.20996/1819-6446-2013-9-2-138-142; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Wilkins K, 2010, HEALTH REP, V21; Wong MCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046309; World Health Organization, 2013, UNIVERSAL HEALTH COV; World Health Organization, 2008, WORLD HEALTH REPORT; World Health Organization, 2009, RUSSIAN FEDERATION 2; World Health Organization, 2012, WORLD HEALTH STATIST; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	62	7	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103280	10.1371/journal.pone.0103280	http://dx.doi.org/10.1371/journal.pone.0103280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141122	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200006
J	Vasconcelos, TS; Prado, VHM; da Silva, FR; Haddad, CFB				Vasconcelos, Tiago S.; Prado, Vitor H. M.; da Silva, Fernando R.; Haddad, Celio F. B.			Biogeographic Distribution Patterns and Their Correlates in the Diverse Frog Fauna of the Atlantic Forest Hotspot	PLOS ONE			English	Article							REPRODUCTIVE MODES; SPECIES-RICHNESS; REGIONALIZATION; REGIONS; BRACHYCEPHALIDAE; BIODIVERSITY; AMPHIBIANS; STRATEGIES; GRADIENTS; FRAMEWORK	Anurans are a highly diverse group in the Atlantic Forest hotspot (AF), yet distribution patterns and species richness gradients are not randomly distributed throughout the biome. Thus, we explore how anuran species are distributed in this complex and biodiverse hotspot, and hypothesize that this group can be distinguished by different cohesive regions. We used range maps of 497 species to obtain a presence/ absence data grid, resolved to 50x50 km grain size, which was submitted to k-means clustering with v-fold cross-validation to determine the biogeographic regions. We also explored the extent to which current environmental variables, topography, and floristic structure of the AF are expected to identify the cluster patterns recognized by the k-means clustering. The biogeographic patterns found for amphibians are broadly congruent with ecoregions identified in the AF, but their edges, and sometimes the whole extent of some clusters, present much less resolved pattern compared to previous classification. We also identified that climate, topography, and vegetation structure of the AF explained a high percentage of variance of the cluster patterns identified, but the magnitude of the regression coefficients shifted regarding their importance in explaining the variance for each cluster. Specifically, we propose that the anuran fauna of the AF can be split into four biogeographic regions: a) less diverse and widely-ranged species that predominantly occur in the inland semideciduous forests; b) northern small-ranged species that presumably evolved within the Pleistocene forest refugia; c) highly diverse and small-ranged species from the southeastern Brazilian mountain chain and its adjacent semideciduous forest; and d) southern species from the Araucaria forest. Finally, the high congruence among the cluster patterns and previous eco-regions identified for the AF suggests that preserving the underlying habitat structure helps to preserve the historical and ecological signals that underlie the geographic distribution of AF anurans.	[Vasconcelos, Tiago S.] Univ Estatual Paulista, Dept Ciencias Biol, Sao Paulo, Brazil; [Prado, Vitor H. M.; Haddad, Celio F. B.] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [da Silva, Fernando R.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Carlos	Vasconcelos, TS (corresponding author), Univ Estatual Paulista, Dept Ciencias Biol, Sao Paulo, Brazil.	zoologia@ig.com.br	da Silva, Fernando Rodrigues/G-3026-2012; Haddad, Célio F. B./C-4267-2012; Prado, Vitor H. M./D-3294-2012	da Silva, Fernando Rodrigues/0000-0002-0983-3207; Haddad, Célio F. B./0000-0002-7044-5764; Prado, Vitor/0000-0001-8598-3621; Vasconcelos, Tiago/0000-0002-5762-0513	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) [2008/50928-1, 2010/50125-6, 2011/18510-0, 2012/07765-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP, grants: 2008/50928-1; 2010/50125-6; 2011/18510-0; 2012/07765-0). CFBH research is also supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAN TECN VEG BRAS; Bishop C.M., 1995, NEURAL NETWORKS PATT; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brusquetti F, 2013, HERPETOLOGICA, V69, P175, DOI 10.1655/HERPETOLOGICA-D-12-00050; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canavero A, 2009, AUSTRAL ECOL, V34, P741, DOI 10.1111/j.1442-9993.2009.01980.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Condez TH, 2014, HERPETOLOGICA, V70, P89, DOI 10.1655/HERPETOLOGICA-D-13-00044; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; dos Santos TG, 2009, J NAT HIST, V43, P973, DOI 10.1080/00222930802702498; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Frost DR, 2013, AMPHIBIAN SPECIES WO; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2008, FOLIA GEOBOT, V43, P345, DOI 10.1007/s12224-008-9007-8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lobo JM, 2002, GLOBAL ECOL BIOGEOGR, V11, P265, DOI 10.1046/j.1466-822X.2002.00291.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; MMA & IBAMA - MINISTERIO DO MEIO AMBIENTE & INSTITUTO BRASILEIRO DO MEIO AMBIENTE EDOS RECURSOS NATURAIS RENOVAVEIS, 2010, MON DESM NOS BIOM BR; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Proches S, 2005, J BIOGEOGR, V32, P607, DOI 10.1111/j.1365-2699.2004.01186.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rueda M, 2013, J BIOGEOGR, V40, P2215, DOI 10.1111/jbi.12214; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vasconcelos TD, 2011, NAT CONSERVACAO, V9, P67, DOI 10.4322/natcon.2011.008; Vasconcelos TD, 2010, J TROP ECOL, V26, P423, DOI 10.1017/S0266467410000167; Villalobos F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056073; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	47	58	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104130	10.1371/journal.pone.0104130	http://dx.doi.org/10.1371/journal.pone.0104130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140882	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200012
J	Hoeve, M; Stams, GJJM; van der Zouwen, M; Vergeer, M; Jurrius, K; Asscher, JJ				Hoeve, Machteld; Stams, Geert Jan J. M.; van der Zouwen, Marion; Vergeer, Margaretha; Jurrius, Kitty; Asscher, Jessica J.			A Systematic Review of Financial Debt in Adolescents and Young Adults: Prevalence, Correlates and Associations with Crime	PLOS ONE			English	Review							LIFE-COURSE-PERSISTENT; LIMITED ANTISOCIAL PATHWAYS; CREDIT-CARD DEBT; BEHAVIOR; ATTITUDES; STUDENTS; INDEBTEDNESS; STRESS; IMPACT; MALES	Financial debt in young people has increased in recent years. Because debt may have severe consequences, and it may enhance criminal behavior, insight into the prevalence and determinants of debt and its association with crime is important. We conducted a systematic review and meta-analysis of 36 manuscripts to examine the prevalence of financial debt (k = 23), correlates and risk factors of debt (k = 16), and associations between debt and criminal behavior in adolescents and young adults (k = 8). Findings revealed that the prevalence of debt is substantial among young people; on average, 49% reported to have at least some debt, 22% had financial problems. Older participants and ethnic minorities were found to have higher levels of debt than younger and indigenous counterparts. Females had more financial problems and higher student loans. Low self-esteem, a pro-debt attitude (of young people and their parents), lack of perceived control towards financial management, poor social functioning, financial stress and external locus of control were found to have the strongest associations with debt. Studies reported strong associations between debt and crime. Particularly, strong associations were found between serious and persistent crime in young people and later (young adult) debt or financial problems.	[Hoeve, Machteld; Stams, Geert Jan J. M.; van der Zouwen, Marion; Asscher, Jessica J.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands; [Vergeer, Margaretha] Kohnstamm Inst, Amsterdam, Netherlands; [Jurrius, Kitty] Alexander Fdn, Amsterdam, Netherlands	University of Amsterdam	Hoeve, M (corresponding author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.	m.hoeve@uva.nl	Ossa, Ulda Omar Figueroa/N-5821-2016	Hoeve, Machteld/0000-0002-4487-5365	Research and Documentation Centre of the Ministry of Security and Justice, the Netherlands [1940]	Research and Documentation Centre of the Ministry of Security and Justice, the Netherlands	This research was supported by a grant from the Research and Documentation Centre of the Ministry of Security and Justice, the Netherlands (project 1940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW R, 1985, SOC FORCES, V64, P151, DOI 10.2307/2578977; Archuleta K. L., 2013, J FINANC COUNS PLAN, V24, P50, DOI DOI 10.1037/T13109-000]; Betti G, 2007, J ECON STUD, V34, P136, DOI 10.1108/01443580710745371; Billieux J, 2008, APPL COGNITIVE PSYCH, V22, P1195, DOI 10.1002/acp.1429; Caputo R. K., 2012, J SOCIOLOGY SOCIAL W, V34, P7; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; Crocker J, 2003, PERS SOC PSYCHOL B, V29, P701, DOI 10.1177/0146167203029006003; DAVIES E, 1995, J ECON PSYCHOL, V16, P663, DOI 10.1016/0167-4870(96)80014-6; Draut T., 2004, GENERATION BROKE GRO; Dwyer RE, 2011, SOC SCI RES, V40, P727, DOI 10.1016/j.ssresearch.2011.02.001; Farrington DP, 2003, CRIMINOLOGY, V41, P221, DOI 10.1111/j.1745-9125.2003.tb00987.x; Gottfredson M.R., 1990, GEN THEORY CRIME; Grable J. E., 2006, COLL STUD J, V40, P400; Gupta R, 2000, J Gambl Stud, V16, P315, DOI 10.1023/A:1009493200768; Ha H, 2013, YOUTH STUDIES AUSTR, V32, P57; Haultain S, 2010, J ECON PSYCHOL, V31, P322, DOI 10.1016/j.joep.2010.01.003; Hedges LV, 2014, STAT METHODS META AN; Henegar J., 2013, J FINANC COUNS PLAN, V24, P37; Hoeve M, 2016, CRIME DELINQUENCY, V62, P1488, DOI 10.1177/0011128714541190; Hogan E. A., 2013, COLL STUD J, V47, P102; Houle JN, 2014, SOCIOL EDUC, V87, P53, DOI 10.1177/0038040713512213; Hox J., 2002, MULTILEVEL ANALYSIS; Hsieh C.-C., 1993, CRIMINAL JUSTICE REV, V18, P182, DOI [10.1177/073401689301800203, DOI 10.1177/073401689301800203]; Jessop DC, 2005, BRIT J HEALTH PSYCH, V10, P421, DOI 10.1348/135910705X25480; JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K; JOHNES G, 1994, APPL ECON, V26, P999, DOI 10.1080/00036849400000107; Joireman J, 2010, J CONSUM AFF, V44, P155, DOI 10.1111/j.1745-6606.2010.01161.x; Jones Joyce E., 2005, J FINANC COUNS PLAN, V16, P9; Kerner H, 1997, CRIM BEHAV MENT HEAL, V7, P401, DOI DOI 10.1002/CBM.197; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Lyons AC, 2004, J CONSUM AFF, V38, P56, DOI 10.1111/j.1745-6606.2004.tb00465.x; McCartney K, 2000, CHILD DEV, V71, P173, DOI 10.1111/1467-8624.00131; McCormick M. H., 2009, J FINANC COUNS PLAN, V20, P70; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Morra DJ, 2008, MED TEACH, V30, P313, DOI 10.1080/01421590801953000; Mullen B., 1989, ADV BASIC METAANALYS; National Center of Education Statistics, 2010, DIGEST ED STAT 2009; Nelissen RMA, 2011, SOC INFLUENCE, V6, P39, DOI 10.1080/15534510.2010.525855; Noorda J, 2009, RISICOJONGEREN SCHUL; Norvilitis JM, 2006, J APPL SOC PSYCHOL, V36, P1395, DOI 10.1111/j.0021-9029.2006.00065.x; Norvilitis JM, 2010, J ECON PSYCHOL, V31, P55, DOI 10.1016/j.joep.2009.10.003; O'Loughlin D, 2006, J CONSUM MARK, V23, P335, DOI 10.1108/07363760610701878; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Oosterbeek H, 2009, ECON EDUC REV, V28, P170, DOI 10.1016/j.econedurev.2008.01.005; Palmer TS, 2001, J PUBLIC POLICY MARK, V20, P105, DOI 10.1509/jppm.20.1.105.17293; Robb C. A., 2009, J FINANC COUNS PLAN, V20, P25; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rosenthal R, 1991, METAANALYTIC PROCEDU; Ross S, 2006, MED EDUC, V40, P584, DOI 10.1111/j.1365-2929.2006.02448.x; Rothstein HR., 2008, J EXP CRIMINOL, V4, P61, DOI [10.1007/s11292-007-9046-9, DOI 10.1007/S11292-007-9046-9]; Schwartz S, 2002, ECON EDUC REV, V21, P497, DOI 10.1016/S0272-7757(01)00041-3; Shim S, 2009, J APPL DEV PSYCHOL, V30, P708, DOI 10.1016/j.appdev.2009.02.003; Siennick SE, 2009, 3 ESSAYS CRIMINALS I; Van Dam C, 2005, JUVENILE CRIMINAL RE; Van den Noortgate W, 2003, EDUC PSYCHOL MEAS, V63, P765, DOI 10.1177/0013164402251027; van Heijst P, 2009, JONGEREN SCHULDEN LE; Van IJzendoorn M. H, 1998, ISSUES EARLY CHILDHO, V8, P156; Verhagen S, 2010, TIJDSCHRIFT SOCIALE, V2010, P8; Wang J, 2009, INT J CONSUM STUD, V33, P2, DOI 10.1111/j.1470-6431.2008.00719.x; Williams K, 2007, MINISTRY JUSTICE RES, V6; Zahn M., 2009, DELINQUENT GIRL; Zara G, 2010, CRIM BEHAV MENT HEAL, V20, P257, DOI 10.1002/cbm.763; Zhang J, 2009, NEW ZEAL J PSYCHOL, V38, P24	67	27	28	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104909	10.1371/journal.pone.0104909	http://dx.doi.org/10.1371/journal.pone.0104909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136797	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100054
J	Mc Sharry, J; Baxter, A; Wallace, LM; Kenton, A; Turner, A; French, DP				Mc Sharry, Jennifer; Baxter, Alison; Wallace, Louise M.; Kenton, Anthony; Turner, Andrew; French, David P.			Delay in Seeking Medical Help following Transient Ischemic Attack (TIA) or "Mini-Stroke": A Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; URGENT TREATMENT; RISK; EXPRESS	Background: Prompt treatment following Transient Ischemic Attack (TIA) can reduce the risk of subsequent stroke and disability. However, many patients delay in making contact with medical services. This study aimed to explore TIA patients' accounts of delay between symptom onset and contacting medical services including how decisions to contact services were made and the factors discussed in relation to delay. Methods: Twenty interviews were conducted with TIA patients in England. Using a previous systematic review as an initial framework, interview data were organised into categories of symptom recognition, presence of others and type of care sought. A thematic analysis was then conducted to explore descriptions of care-seeking relevant to each category. Results: Delay in contacting medical services varied from less than an hour to eight days. Awareness of typical stroke symptoms could lead to urgent action when more severe TIA symptoms were present but could lead to delay when experienced symptoms were less severe. The role of friends and family varied widely from deciding on and enacting care-seeking decisions to simply providing transport to the GP practice. When family or friends played a greater role, and both made and enacted care-seeking decisions, delays were often shorter, even when patients themselves failed to identify symptoms. Healthcare professionals also impacted on patients' care-seeking with greater delays in seeking further care for the same episode described when patients perceived a lack of urgency during initial healthcare interactions. Conclusions: This study provides new information on patients' decisions to contact medical services following TIA and identifies overlapping factors that can lead to delay in receiving appropriate treatment. While recognition of symptoms may contribute to delay in contacting medical services, additional factors, including full responsibility being taken by others and initial healthcare interactions, can over-ride or undermine the importance of patients' own identification of TIA.	[Mc Sharry, Jennifer] Natl Univ Ireland, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland; [Baxter, Alison; Wallace, Louise M.; Turner, Andrew] Coventry Univ, Appl Res Ctr Hlth & Lifestyle Intervent, Coventry, W Midlands, England; [Kenton, Anthony] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [French, David P.] Univ Manchester, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	Ollscoil na Gaillimhe-University of Galway; Coventry University; University of Warwick; University of Manchester	Mc Sharry, J (corresponding author), Natl Univ Ireland, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland.	jenny.mcsharry@nuigalway.ie	French, David P/K-7283-2012	French, David P/0000-0002-7663-7804; Mc Sharry, Jennifer/0000-0001-5459-1588; Turner, Andrew/0000-0001-6538-4242	Coventry and Warwickshire Cardiovascular Network	Coventry and Warwickshire Cardiovascular Network	The research was funded by the Coventry and Warwickshire Cardiovascular Network (http://www.coventryandwarwickshirecardiovascularnetwork.nhs.uk/Home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CHAMBERLAIN K, 2004, RES METHODS CLIN HLT, V0005, P00069; Dombrowski SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039852; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; French DP, 2005, SOC SCI MED, V60, P1411, DOI 10.1016/j.socscimed.2004.08.008; French DP, 2014, PRINCIPLES CONCEPTS; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Kamara Stania, 2012, Prim Health Care Res Dev, V13, P165, DOI 10.1017/S146342361100051X; Kirkpatrick S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066351; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; Mackintosh JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046124; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Robinson TG, 2013, EMERG MED J, V30, P467, DOI 10.1136/emermed-2012-201471; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Sprigg N, 2009, J NEUROL NEUROSUR PS, V80, P871, DOI 10.1136/jnnp.2008.167924; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	24	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104434	10.1371/journal.pone.0104434	http://dx.doi.org/10.1371/journal.pone.0104434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137185	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000340742100034
J	Adam, M; Imboden, M; Boes, E; Schaffner, E; Kunzli, N; Phuleria, HC; Kronenberg, F; Gaspoz, JM; Carballo, D; Probst-Hensch, N				Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Kronenberg, Florian; Gaspoz, Jean-Michel; Carballo, David; Probst-Hensch, Nicole			Modifying Effect of a Common Polymorphism in the Interleukin-6 Promoter on the Relationship between Long-Term Exposure to Traffic-Related Particulate Matter and Heart Rate Variability	PLOS ONE			English	Article							PLASMA IL-6 LEVELS; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; LUNG-DISEASES; SWISS COHORT; RISK-FACTORS; GENE; ASSOCIATION; MORTALITY	Background: Exposure to particulate matter (PM) has been associated with an increase in many inflammatory markers, including interleukin 6 (IL6). Air pollution exposure has also been suggested to induce an imbalance in the autonomic nervous system (ANS), such as a decrease in heart rate variability (HRV). In this study we aimed to investigate the modifying effect of polymorphisms in a major proinflammatory marker gene, interleukin 6 (IL6), on the relationship between long-term exposure to traffic-related PM10 (TPM10) and HRV. Methods: For this cross-sectional study we analysed 1552 participants of the SAPALDIA cohort aged 50 years and older. Included were persons with valid genotype data, who underwent ambulatory 24-hr electrocardiogram monitoring, and reported on medical history and lifestyle. Main effects of annual average TPM10 and IL6 gene variants (rs1800795; rs2069827; rs2069840; rs10242595) on HRV indices and their interaction with average annual exposure to TPM10 were tested, applying a multivariable mixed linear model. Results: No overall association of TPM10 on HRV was found. Carriers of two proinflammatory G-alleles of the functional IL6 - 174 G/C (rs1800795) polymorphism exhibited lower HRV. An inverse association between a 1 mu g/m(3) increment in yearly averaged TPM10 and HRV was restricted to GG genotypes at this locus with a standard deviation of normal-to-normal intervals (SDNN) (GG-carriers: -1.8%; 95% confidence interval -3.5 to 0.01; p(interaction(additive)) = 0.028); and low frequency power (LF) (GG-carriers: -5.7%; 95% CI: -10.4 to 20.8; p(interaction(dominant)) = 0.049). Conclusions: Our results are consistent with the hypothesis that traffic-related air pollution decreases heart rate variability through inflammatory mechanisms.	[Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [Boes, Eva; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Gaspoz, Jean-Michel] Univ Hosp, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Carballo, David] Univ Hosp, Dept Internal Med Specialties, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Medical University of Innsbruck; University of Geneva; University of Geneva	Adam, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.adam@unibas.ch	Kronenberg, Florian/B-1736-2008; Kuenzli, Nino/F-7195-2014	Kronenberg, Florian/0000-0003-2229-1120; Kuenzli, Nino/0000-0001-8360-080X	Swiss National Science Foundation [33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Zurich	This work was supported by the Swiss National Science Foundation (grant numbers 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais and Zurich, the Swiss Lung League and the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais and Zurich. No form of payment was given to any of the authors to produce the manuscript. The study received funding through peer-reviewed grants and donations from non-profit organizations as listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Adam M, 2012, ENVIRON INT, V48, P9, DOI 10.1016/j.envint.2012.06.016; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BIGGER JT, 1993, J AM COLL CARDIOL, V21, P729, DOI 10.1016/0735-1097(93)90106-B; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Chan KHK, 2011, CLIN CHEM, V57, P317, DOI 10.1373/clinchem.2010.154526; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dietrich DF, 2008, ENVIRON HEALTH PERSP, V116, P1357, DOI 10.1289/ehp.11377; Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063; *EL NASOPA, 1996, CIRCULATION, V93, P1043; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656; Hulkkonen J, 2009, ATHEROSCLEROSIS, V203, P454, DOI 10.1016/j.atherosclerosis.2008.07.014; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Imboden M, 2006, Clin Mol Allergy, V4, P9, DOI 10.1186/1476-7961-4-9; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kelberman D, 2004, BBA-MOL BASIS DIS, V1688, P160, DOI 10.1016/j.bbadis.2003.11.010; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Lalouschek W, 2006, CLIN CHEM LAB MED, V44, P918, DOI 10.1515/CCLM.2006.165; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; Lee JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034218; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Link MS, 2010, CURR OPIN CARDIOL, V25, P16, DOI 10.1097/HCO.0b013e32833358cd; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; Ljungman P, 2009, THROMB RES, V124, P57, DOI 10.1016/j.thromres.2008.10.009; Luttmann-Gibson H, 2010, OCCUP ENVIRON MED, V67, P625, DOI 10.1136/oem.2009.050625; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Mills NL, 2011, HEART, V97, P544, DOI 10.1136/hrt.2010.199042; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Probst-Hensch NM, 2008, ENVIRON HEALTH PERSP, V116, P1494, DOI 10.1289/ehp.11402; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Riikola A, 2009, ATHEROSCLEROSIS, V207, P466, DOI 10.1016/j.atherosclerosis.2009.06.004; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sie MPS, 2008, VASC HEALTH RISK MAN, V4, P863; Sie MPS, 2006, ARTERIOSCL THROM VAS, V26, P212, DOI 10.1161/01.ATV.0000194099.65024.17; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104978	10.1371/journal.pone.0104978	http://dx.doi.org/10.1371/journal.pone.0104978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133672	gold, Green Published, Green Accepted			2022-12-27	WOS:000341302700058
J	Meineke, T; Manisseri, C; Voigt, CA				Meineke, Till; Manisseri, Chithra; Voigt, Christian A.			Phylogeny in Defining Model Plants for Lignocellulosic Ethanol Production: A Comparative Study of Brachypodium distachyon, Wheat, Maize, and Miscanthus x giganteus Leaf and Stem Biomass	PLOS ONE			English	Article							CELL-WALL COMPOSITION; LIGNIN MODIFICATION IMPROVES; ENZYMATIC-HYDROLYSIS; DILUTE-ACID; CORN STOVER; FERMENTATION INHIBITORS; CELLULOSE CRYSTALLINITY; BIOFUEL PRODUCTION; FERULIC ACID; PRETREATMENT	The production of ethanol from pretreated plant biomass during fermentation is a strategy to mitigate climate change by substituting fossil fuels. However, biomass conversion is mainly limited by the recalcitrant nature of the plant cell wall. To overcome recalcitrance, the optimization of the plant cell wall for subsequent processing is a promising approach. Based on their phylogenetic proximity to existing and emerging energy crops, model plants have been proposed to study bioenergy-related cell wall biochemistry. One example is Brachypodium distachyon, which has been considered as a general model plant for cell wall analysis in grasses. To test whether relative phylogenetic proximity would be sufficient to qualify as a model plant not only for cell wall composition but also for the complete process leading to bioethanol production, we compared the processing of leaf and stem biomass from the C-3 grasses B. distachyon and Triticum aestivum (wheat) with the C-4 grasses Zea mays (maize) and Miscanthus x giganteus, a perennial energy crop. Lambda scanning with a confocal laser-scanning microscope allowed a rapid qualitative analysis of biomass saccharification. A maximum of 108-117 mg ethanol.g(-1) dry biomass was yielded from thermo-chemically and enzymatically pretreated stem biomass of the tested plant species. Principal component analysis revealed that a relatively strong correlation between similarities in lignocellulosic ethanol production and phylogenetic relation was only given for stem and leaf biomass of the two tested C-4 grasses. Our results suggest that suitability of B. distachyon as a model plant for biomass conversion of energy crops has to be specifically tested based on applied processing parameters and biomass tissue type.	[Meineke, Till; Manisseri, Chithra; Voigt, Christian A.] Univ Hamburg, Bioctr Klein Flottbek, Hamburg, Germany	University of Hamburg	Voigt, CA (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Martinistr 52, Hamburg, Germany.	christian.voigt@uni-hamburg.de	Voigt, Christian A/O-5327-2016; Manisseri, Chithra/ABD-2712-2021	Voigt, Christian A/0000-0001-7658-7889; Manisseri, Chithra/0000-0002-9402-4577	German Federal Ministry of Education and Research [FKZ 0315521A]; Dr. Elisabeth Appuhn Stiftung	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Dr. Elisabeth Appuhn Stiftung	The study was financially supported by the German Federal Ministry of Education and Research (grant no. FKZ 0315521A to CAV and CM) and the Dr. Elisabeth Appuhn Stiftung (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon BG, 2006, J AGR FOOD CHEM, V54, P3896, DOI 10.1021/jf052872w; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Arora R, 2010, BIOENERG RES, V3, P134, DOI 10.1007/s12155-010-9087-1; Ash C, 2013, SCIENCE, V341, P472, DOI 10.1126/science.341.6145.472; Beale CV, 1997, BIOMASS BIOENERG, V12, P419, DOI 10.1016/S0961-9534(97)00016-0; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; BONN G, 1984, CHROMATOGRAPHIA, V18, P445, DOI 10.1007/BF02262975; Brosse N, 2009, IND ENG CHEM RES, V48, P8328, DOI 10.1021/ie9006672; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; FANTA GF, 1984, BIOTECHNOL BIOENG, V26, P1122, DOI 10.1002/bit.260260916; FAOSTAT Gateway, 2014, FAOSTAT GAT; FINCHER GB, 1976, J I BREWING, V82, P347, DOI 10.1002/j.2050-0416.1975.tb06961.x; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fukushima RS, 2004, J AGR FOOD CHEM, V52, P3713, DOI 10.1021/jf035497l; GAILLARD BLANCHE D. E., 1965, PHYTOCHEMISTRY, V4, P631, DOI 10.1016/S0031-9422(00)86226-3; Gomez LD, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-15; GREEN CE, 1975, CROP SCI, V15, P417, DOI 10.2135/cropsci1975.0011183X001500030040x; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOHENSTEIN WG, 1994, BIOMASS BIOENERG, V6, P161, DOI 10.1016/0961-9534(94)90073-6; Hu ZJ, 2011, BIORESOURCE TECHNOL, V102, P7224, DOI 10.1016/j.biortech.2011.04.029; Hughes JK, 2010, GCB BIOENERGY, V2, P79, DOI 10.1111/j.1757-1707.2010.01042.x; Huyen TLN, 2010, BIORESOURCE TECHNOL, V101, P8224, DOI 10.1016/j.biortech.2010.05.087; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Jung HG, 2006, CROP SCI, V46, P1793, DOI 10.2135/cropsci2005.02-0085; JUNG HJG, 1992, J SCI FOOD AGR, V59, P169, DOI 10.1002/jsfa.2740590206; JUNG HJG, 1994, J SCI FOOD AGR, V66, P313, DOI 10.1002/jsfa.2740660308; Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kim S, 2005, BIORESOURCE TECHNOL, V96, P1994, DOI 10.1016/j.biortech.2005.01.014; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Kulkarni AR, 2012, IND BIOTECHNOL, V8, P222, DOI DOI 10.1089/IND.2012.0014; Kumar L, 2011, BIOTECHNOL BIOENG, V108, P2300, DOI 10.1002/bit.23185; Kumar L, 2010, BIORESOURCE TECHNOL, V101, P7827, DOI 10.1016/j.biortech.2010.05.023; Larsson S, 2001, APPL ENVIRON MICROB, V67, P1163, DOI 10.1128/AEM.67.3.1163-1170.2001; Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; Marzialetti T, 2008, IND ENG CHEM RES, V47, P7131, DOI 10.1021/ie800455f; Mechin V, 2000, J SCI FOOD AGR, V80, P574, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;574::AID-JSFA575&gt;3.0.CO;2-R; Morrison TA, 1998, CROP SCI, V38, P455, DOI 10.2135/cropsci1998.0011183X003800020031x; Murnen HK, 2007, BIOTECHNOL PROGR, V23, P846, DOI [10.1021/bp070098m, 10.1002/bp070098m]; Ohgren K, 2006, BIOMASS BIOENERG, V30, P863, DOI 10.1016/j.biombioe.2006.02.002; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Pohlker C, 2012, ATMOS MEAS TECH, V5, P37, DOI 10.5194/amt-5-37-2012; Pu YQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-15; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266; Roshchina VV, 2012, INT J SPECTROSC, DOI 10.1155/2012/124672; Roth AM, 2005, BIOMASS BIOENERG, V28, P490, DOI 10.1016/j.biombioe.2004.11.001; Saha BC, 2005, PROCESS BIOCHEM, V40, P3693, DOI 10.1016/j.procbio.2005.04.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; Sojinu OSS, 2010, J HAZARD MATER, V174, P641, DOI 10.1016/j.jhazmat.2009.09.099; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sorensen A, 2008, BIORESOURCE TECHNOL, V99, P6602, DOI 10.1016/j.biortech.2007.09.091; Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12; van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107; Van Hulle S, 2012, GRASSLAND SCI EUR, V17, P499; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Varga E, 2004, BIOTECHNOL BIOENG, V88, P567, DOI 10.1002/bit.20222; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Wang HZ, 2012, IND CROP PROD, V37, P170, DOI 10.1016/j.indcrop.2011.12.014; Wang XJ, 2012, CHINESE SCI BULL, V57, P1796, DOI 10.1007/s11434-012-5079-1; Weil JR, 2002, IND ENG CHEM RES, V41, P6132, DOI 10.1021/ie0201056; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	79	19	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e103580	10.1371/journal.pone.0103580	http://dx.doi.org/10.1371/journal.pone.0103580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133818	gold, Green Published, Green Accepted			2022-12-27	WOS:000341302700012
J	Fariello, MI; Servin, B; Tosser-Klopp, G; Rupp, R; Moreno, C; San Cristobal, M; Boitard, S				Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali; Boitard, Simon		Int Sheep Genomics Consortium	Selection Signatures in Worldwide Sheep Populations	PLOS ONE			English	Article							HOLSTEIN CATTLE; ARTIFICIAL SELECTION; MISSENSE MUTATION; GENOTYPE DATA; ADULT HEIGHT; COAT COLOR; GENE; GENOME; BREEDS; RECEPTOR	The diversity of populations in domestic species offers great opportunities to study genome response to selection. The recently published Sheep HapMap dataset is a great example of characterization of the world wide genetic diversity in sheep. In this study, we re-analyzed the Sheep HapMap dataset to identify selection signatures in worldwide sheep populations. Compared to previous analyses, we made use of statistical methods that (i) take account of the hierarchical structure of sheep populations, (ii) make use of linkage disequilibrium information and (iii) focus specifically on either recent or older selection signatures. We show that this allows pinpointing several new selection signatures in the sheep genome and distinguishing those related to modern breeding objectives and to earlier post-domestication constraints. The newly identified regions, together with the ones previously identified, reveal the extensive genome response to selection on morphology, color and adaptation to new environments.	[Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] INRA, Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] Ecole Natl Vet Toulouse, Castanet Tolosan, France; [Fariello, Maria-Ines; Servin, Bertrand; Tosser-Klopp, Gwenola; Rupp, Rachel; Moreno, Carole; San Cristobal, Magali] Ecole Natl Super Agron Toulouse, Castanet Tolosan, France; [Fariello, Maria-Ines] Univ Republica, Inst Matamat & Estadist Prof Ing Rafael Laguardia, Fac Ingn, Montevideo, Uruguay; [Fariello, Maria-Ines] Inst Pasteur, Bioinformat Unit, Montevideo, Uruguay; Www Sheephapmap Org, Geneva, Switzerland; [Boitard, Simon] INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Boitard, Simon] AgroParisTech, Jouy En Josas, France; [Boitard, Simon] Museum Natl Hist Nat, Origine Struct & Evolut Biodivers, F-75231 Paris, France; [Boitard, Simon] Ecole Prat Hautes Etud, Paris, France; [Boitard, Simon] CNRS, Paris, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS)	Boitard, S (corresponding author), INRA, Genet Anim & Biol Integrat, Jouy En Josas, France.	sboitard@mnhn.fr	Hayes, Ben J/L-3308-2016; Kijas, James W/A-4656-2011; Calvo, Jorge H/E-5240-2016; Simianer, Henner/A-6574-2015; Cemal, Ibrahim/AAC-2783-2020; D'ANDREA, Mariasilvia/AAQ-9396-2020; Arranz, Juan-Jose/H-1225-2015; D'Andrea, Mariasilvia/E-5760-2012; Barendse, William J/D-8608-2011; Slate, Jon/D-2925-2012; McEwan, John/A-1143-2008; Servin, Bertrand/B-2206-2008; Coltman, David/A-4453-2012; Miltiadou, Despoina/E-2204-2016	Hayes, Ben J/0000-0002-5606-3970; Kijas, James W/0000-0002-1417-8278; Calvo, Jorge H/0000-0001-9513-0219; Simianer, Henner/0000-0002-7551-3797; Arranz, Juan-Jose/0000-0001-9058-131X; D'Andrea, Mariasilvia/0000-0002-8932-4057; Barendse, William J/0000-0002-5464-0658; Slate, Jon/0000-0003-3356-5123; McEwan, John/0000-0003-4801-6207; Servin, Bertrand/0000-0001-5141-0913; Carta, Antonello/0000-0003-0534-4876; MacHugh, David/0000-0002-8112-4704; PILLA, Fabio/0000-0002-1781-994X; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673; ciani, elena/0000-0001-5673-0975; Rupp, Rachel/0000-0003-3375-5816; Coltman, David/0000-0002-1268-2307; Drogemuller, Cord/0000-0001-9773-522X; Lenstra, Johannes A./0000-0003-1745-7739; Hanotte, Olivier/0000-0002-2877-4767; Banos, Georgios/0000-0002-7674-858X; Pardeshi, Varsha/0000-0001-7753-9897; Fariello, Maria Ines/0000-0002-3337-1209; Heaton, Michael/0000-0003-1386-1208; Cemal, Ibrahim/0000-0002-4069-4815; Miltiadou, Despoina/0000-0002-5940-3520				Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Balasse Marie, 2007, Anthropozoologica, V42, P71; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Bidinost F, 2008, SMALL RUMINANT RES, V74, P113, DOI 10.1016/j.smallrumres.2007.04.005; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bongiorni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050137; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Dominik S, 2012, ANIM GENET, V43, P468, DOI 10.1111/j.1365-2052.2011.02271.x; Druet T, 2013, ANIM GENET, V44, P758, DOI 10.1111/age.12073; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Jacobs LC, 2013, HUM GENET, V132, P147, DOI 10.1007/s00439-012-1232-9; Joerg H, 1996, MAMM GENOME, V7, P317, DOI 10.1007/s003359900090; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; LEWONTIN RC, 1973, GENETICS, V74, P175; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Mancini G, 2014, MOL BIOL REP, V41, P957, DOI 10.1007/s11033-013-2940-5; Moradi MH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-10; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Noguchi K, 2010, J PHARMACOL SCI, V112, P89, DOI 10.1254/jphs.09254FP; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pintus E, 2013, ANIM GENET; Pritchard JK, 2000, GENETICS, V155, P945; Qu SM, 1998, DEVELOPMENT, V125, P2711; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rincon G, 2012, J DAIRY RES, V79, P66, DOI 10.1017/S002202991100080X; Rothammer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-908; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stattin EL, 2010, AM J HUM GENET, V86, P126, DOI 10.1016/j.ajhg.2009.12.018; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yang TL, 2010, ANN HUM GENET, V74, P11, DOI 10.1111/j.1469-1809.2009.00555.x; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zhang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065942	57	100	106	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e103813	10.1371/journal.pone.0103813	http://dx.doi.org/10.1371/journal.pone.0103813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126940	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300009
J	Kim, HY; Park, SY; Lee, SW; Lee, HR; Lee, WS; Rhim, BY; Hong, KW; Kim, CD				Kim, Hye Young; Park, So Youn; Lee, Sung Won; Lee, Hye Rin; Lee, Won Suk; Rhim, Byung Yong; Hong, Ki Whan; Kim, Chi Dae			Inhibition of HMGB1-Induced Angiogenesis by Cilostazol via SIRT1 Activation in Synovial Fibroblasts from Rheumatoid Arthritis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GROUP BOX CHROMOSOMAL-PROTEIN-1; HYPOXIA-INDUCIBLE FACTOR-1; NF-KAPPA-B; ADHESION MOLECULES; IN-VIVO; CELLS; CYTOKINE; EXPRESSION; PROTEIN	High mobility group box chromosomal protein 1 (HMGB-1) released from injured cells plays an important role in the development of arthritis. This study investigated the anti-angiogenic effects of cilostazol in collagen-induced arthritis (CIA) of mice, and the underlying mechanisms involved. The expressions of HIF-1 alpha, VEGF, NF-kappa B p65 and SIRT1 in synovial fibroblasts obtained from rheumatoid arthritis (RA) patients were assessed by Western blotting, and in vitro and in vivo angiogenesis were analyzed. Tube formations by human microvascular endothelial cells (HMVECs) were significantly increased by direct exposure to HMGB1 or to conditioned medium derived from HMGB1-stimulated RA fibroblasts, and these increases were attenuated by cilostazol, the latter of which was blocked by sirtinol. HMGB1 increased the expression of HIF-1 alpha and VEGF and concomitantly increased nuclear NF-kappa B p65 and DNA binding activity, but these effects of HMGB1 were inhibited by cilostazol. SIRT1 protein expression was time-dependently decreased (3-24 hr) by HMGB1, which was recovered by pretreatment with cilostazol (1-30 mu M) or resveratrol, accompanying with increased SIRT1 deacetylase activity. In the tibiotarsal joint tissues of CIA mice treated with vehicle, HIF-1 alpha-and VEGF-positive spots and CD31 staining were markedly exaggerated, whereas SIRT1 immunofluorescence was diminished. These variables were wholly reversed in cilostazol (30 mg/kg/day)-treated mice. Furthermore, number of blood vessels stained by von Willebrand factor antibody was significantly lower in cilostazol-treated CIA mice. Summarizing, cilostazol activated SIRT1 and inhibited NF-kappa B-mediated transcription, thereby suppressing the expression of HIF-1 alpha and VEGF. In addition, cilostazol caused HIF-1 alpha deacetylation by enhancing SIRT1 activity and reduced VEGF production, thereby had an anti-angiogenic effect in vitro studies and in CIA murine model.	[Kim, Hye Young; Park, So Youn; Lee, Hye Rin; Lee, Won Suk; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Yangsan, Gyeongnam, South Korea; [Lee, Won Suk; Rhim, Byung Yong; Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea; [Lee, Sung Won] Dong A Univ, Coll Med, Dept Internal Med, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Dong A University	Kim, CD (corresponding author), Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Yangsan, Gyeongnam, South Korea.	chidkim@pusan.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A2A2A01067921, NRF-2011-0009020]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported partly by the programs of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A2A2A01067921 and NRF-2011-0009020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hamada T, 2008, ARTHRITIS RHEUM-US, V58, P2675, DOI 10.1002/art.23729; KOCH AE, 1994, J IMMUNOL, V152, P4149; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Neidhart M, 2003, ARTHRITIS RHEUM, V48, P1873, DOI 10.1002/art.11166; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Park SY, 2006, J PHARMACOL EXP THER, V317, P1238, DOI 10.1124/jpet.105.098509; Park SY, 2005, J PHARMACOL EXP THER, V312, P1241, DOI 10.1124/jpet.104.077826; Park SY, ARTHRITIS RHEUM, V62, P732; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Torii S, 2009, J BIOCHEM, V146, P839, DOI 10.1093/jb/mvp129; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Westra J, 2007, ANN NY ACAD SCI, V1108, P340, DOI 10.1196/annals.1422.035	31	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104743	10.1371/journal.pone.0104743	http://dx.doi.org/10.1371/journal.pone.0104743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126750	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300047
J	Marchant, HK; Lavik, G; Holtappels, M; Kuypers, MMM				Marchant, Hannah K.; Lavik, Gaute; Holtappels, Moritz; Kuypers, Marcel M. M.			The Fate of Nitrate in Intertidal Permeable Sediments	PLOS ONE			English	Article							CONTINENTAL-SHELF; ATLANTIC BIGHT; MINERALIZATION RATES; NITROGEN REMOVAL; NUTRIENT FLUXES; AMMONIUM DNRA; DENITRIFICATION; REDUCTION; SEA; TRANSPORT	Coastal zones act as a sink for riverine and atmospheric nitrogen inputs and thereby buffer the open ocean from the effects of anthropogenic activity. Recently, microbial activity in sandy permeable sediments has been identified as a dominant source of N-loss in coastal zones, namely through denitrification. Some of the highest coastal denitrification rates measured so far occur within the intertidal permeable sediments of the eutrophied Wadden Sea. Still, denitrification alone can often account for only half of the substantial nitrate (NO3-) consumption. Therefore, to investigate alternative NO3- sinks such as dissimilatory nitrate reduction to ammonium (DNRA), intracellular nitrate storage by eukaryotes and isotope equilibration effects we carried out (NO3-)-N-15 amendment experiments. By considering all of these sinks in combination, we could quantify the fate of the (NO3-)-N-15 added to the sediment. Denitrification was the dominant nitrate sink (50-75%), while DNRA, which recycles N to the environment accounted for 10-20% of NO3- consumption. Intriguingly, we also observed that between 20 and 40% of (NO3-)-N-15 added to the incubations entered an intracellular pool of NO3- and was subsequently respired when nitrate became limiting. Eukaryotes were responsible for a large proportion of intracellular nitrate storage, and it could be shown through inhibition experiments that at least a third of the stored nitrate was subsequently also respired by eukaryotes. The environmental significance of the intracellular nitrate pool was confirmed by in situ measurements which revealed that intracellular storage can accumulate nitrate at concentrations six fold higher than the surrounding porewater. This intracellular pool is so far not considered when modeling N-loss from intertidal permeable sediments; however it can act as a reservoir for nitrate during low tide. Consequently, nitrate respiration supported by intracellular nitrate storage can add an additional 20% to previous nitrate reduction estimates in intertidal sediments, further increasing their contribution to N-loss.	[Marchant, Hannah K.; Lavik, Gaute; Holtappels, Moritz; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Bremen, Germany	Max Planck Society	Marchant, HK (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	hmarchan@mpi-bremen.de	Holtappels, Moritz/ABC-7901-2020	Marchant, Hannah/0000-0002-1482-9165; Holtappels, Moritz/0000-0003-3682-1903	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADMIRAAL W, 1987, MAR ECOL PROG SER, V40, P267, DOI 10.3354/meps040267; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; An SM, 2002, MAR ECOL PROG SER, V237, P41, DOI 10.3354/meps237041; Billerbeck M, 2006, MAR ECOL PROG SER, V326, P61, DOI 10.3354/meps326061; Billerbeck M, 2006, MAR ECOL PROG SER, V316, P35, DOI 10.3354/meps316035; Boer SI, 2009, BIOGEOSCIENCES, V6, P1149; Bonin P, 1998, HYDROBIOLOGIA, V389, P169, DOI 10.1023/A:1003585115481; Boyer EW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002537; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Chipman L, 2012, CONT SHELF RES, V45, P116, DOI 10.1016/j.csr.2012.06.010; Christensen PB, 2000, AQUAT MICROB ECOL, V21, P73, DOI 10.3354/ame021073; Cook PLM, 2006, LIMNOL OCEANOGR-METH, V4, P294, DOI 10.4319/lom.2006.4.294; Cook PLM, 2004, MAR ECOL PROG SER, V280, P39, DOI 10.3354/meps280039; Dahnke K, 2012, BIOGEOSCIENCES, V9, P4059, DOI 10.5194/bg-9-4059-2012; de Beer D, 2005, LIMNOL OCEANOGR, V50, P113, DOI 10.4319/lo.2005.50.1.0113; Deek A, 2013, MAR ECOL PROG SER, V493, P9, DOI 10.3354/meps10514; Deek A, 2012, BIOGEOCHEMISTRY, V108, P467, DOI 10.1007/s10533-011-9611-1; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Ehrenhauss S, 2004, MAR ECOL PROG SER, V271, P99, DOI 10.3354/meps271099; Ehrenhauss S, 2004, CONT SHELF RES, V24, P721, DOI 10.1016/j.csr.2004.01.002; Emery K.O., 1968, AAPG BULL, V52, P445, DOI 10.1306/5D25C2E7-16C1-11D7-8645000102C1865D; FeuilletGirard M, 1997, AQUAT LIVING RESOUR, V10, P49, DOI 10.1051/alr:1997005; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Fussel J, 2012, ISME J, V6, P1200, DOI 10.1038/ismej.2011.178; FUHRMAN JA, 1984, SCIENCE, V224, P1257, DOI 10.1126/science.224.4654.1257; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gao H, 2012, LIMNOL OCEANOGR, V57, P185, DOI 10.4319/lo.2012.57.1.0185; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; Garcia-Robledo E, 2010, MAR ECOL PROG SER, V403, P155, DOI 10.3354/meps08470; Gardner WS, 2006, LIMNOL OCEANOGR, V51, P558, DOI 10.4319/lo.2006.51.1_part_2.0558; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Goineau A, 2011, J SEA RES, V65, P58, DOI 10.1016/j.seares.2010.07.007; Grasshoff K, 1999, DETERMINATION NUTR M, P159; Grippo MA, 2010, CONT SHELF RES, V30, P456, DOI 10.1016/j.csr.2009.12.015; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hall POJ, 1992, RAPID; Heisterkamp IM, 2012, MAR ECOL PROG SER, V445, P181, DOI 10.3354/meps09464; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hogslund S, 2008, NITRATE STORAGE ADAP; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Huettel M, 2000, LIMNOL OCEANOGR, V45, P534, DOI 10.4319/lo.2000.45.3.0534; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; Jahnke RA, 2000, CONT SHELF RES, V20, P109, DOI 10.1016/S0278-4343(99)00063-1; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; KING D, 1987, FEMS MICROBIOL ECOL, V45, P15, DOI 10.1111/j.1574-6968.1987.tb02333.x; Koop-Jakobsen K, 2010, LIMNOL OCEANOGR, V55, P789, DOI 10.4319/lo.2009.55.2.0789; Laursen AE, 2002, CONT SHELF RES, V22, P1397, DOI 10.1016/S0278-4343(02)00008-0; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; LOMSTEIN E, 1990, MAR ECOL PROG SER, V61, P97, DOI 10.3354/meps061097; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954, DOI 10.1128/AEM.62.3.954-958.1996; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Polerecky L, 2005, LIMNOL OCEANOGR-METH, V3, P75, DOI 10.4319/lom.2005.3.75; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Rao AMF, 2008, CONT SHELF RES, V28, P602, DOI 10.1016/j.csr.2007.11.007; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Rusch A, 2003, FEMS MICROBIOL ECOL, V44, P89, DOI 10.1111/j.1574-6941.2003.tb01093.x; Santos IR, 2012, ESTUAR COAST SHELF S, V98, P1, DOI 10.1016/j.ecss.2011.10.024; Sayama M, 2001, APPL ENVIRON MICROB, V67, P3481, DOI 10.1128/AEM.67.8.3481-3487.2001; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sokoll S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00395; Song G., 2013, BIOGEOSCIENCES, V10, P4671, DOI DOI 10.5194/BGD-10-4671-2013; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Stief Peter, 2013, PLoS One, V8, pe73257, DOI 10.1371/journal.pone.0073257; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2012, ANNU REV ECOL EVOL S, V43, P407, DOI 10.1146/annurev-ecolsys-102710-145048; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; van Beusekom JEE, 2005, HELGOLAND MAR RES, V59, P45, DOI 10.1007/s10152-004-0206-2; van Beusekom JEE, 2001, WADDEN SEA SPECIFIC; Warembourg F. R, 1993, NITROGEN ISOTOPE TEC, P157; Werner U, 2006, LIMNOL OCEANOGR, V51, P2549, DOI 10.4319/lo.2006.51.6.2549	78	52	52	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104517	10.1371/journal.pone.0104517	http://dx.doi.org/10.1371/journal.pone.0104517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127459	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300030
J	McCormick, N; Lacaille, D; Bhole, V; Avina-Zubieta, JA				McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio			Validity of Heart Failure Diagnoses in Administrative Databases: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ELECTRONIC MEDICAL-RECORDS; HOSPITAL DISCHARGE; OUTCOMES RESEARCH; CODING ACCURACY; ECONOMIC BURDEN; CLINICAL-DATA; TASK-FORCE; HEALTH; COMMUNITY; VALIDATION	Objective: Heart failure (HF) is an important covariate and outcome in studies of elderly populations and cardiovascular disease cohorts, among others. Administrative data is increasingly being used for long-term clinical research in these populations. We aimed to conduct the first systematic review and meta-analysis of studies reporting on the validity of diagnostic codes for identifying HF in administrative data. Methods: MEDLINE and EMBASE were searched (inception to November 2010) for studies: (a) Using administrative data to identify HF; or (b) Evaluating the validity of HF codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value [PPV], negative predictive value, or Kappa scores) for HF, or data sufficient for their calculation. Additional articles were located by hand search (up to February 2011) of original papers. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Using a random-effects model, pooled sensitivity and specificity values were produced, along with estimates of the positive (LR+) and negative (LR-) likelihood ratios, and diagnostic odds ratios (DOR = LR+/LR-) of HF codes. Results: Nineteen studies published from 1999-2009 were included in the qualitative review. Specificity was >= 95% in all studies and PPV was >= 87% in the majority, but sensitivity was lower (>= 69% in >= 50% of studies). In a meta-analysis of the 11 studies reporting sensitivity and specificity values, the pooled sensitivity was 75.3% (95% CI: 74.7-75.9) and specificity was 96.8% (95% CI: 96.8-96.9). The pooled LR+ was 51.9 (20.5-131.6), the LR- was 0.27 (0.20-0.37), and the DOR was 186.5 (96.8-359.2). Conclusions: While most HF diagnoses in administrative databases do correspond to true HF cases, about one-quarter of HF cases are not captured. The use of broader search parameters, along with laboratory and prescription medication data, may help identify more cases.	[McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Arthrit Res Ctr Canada, Richmond, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] Canadian Rheumatol Adm Data Network, Cardiovasc Comm, Richmond, BC, Canada; [Bhole, Vidula] EpiSolut Consultancy Serv, Thana, India	University of British Columbia; University of British Columbia	Avina-Zubieta, JA (corresponding author), Arthrit Res Ctr Canada, Richmond, BC, Canada.	azubieta@arthritisresearch.ca		McCormick, Natalie/0000-0002-4147-8348	Canadian Arthritis Network; Canadian Institutes of Health Research; Arthritis Society of Canada; Michael Smith Foundation for Health Research	Canadian Arthritis Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded in part by the Canadian Arthritis Network (http://www.canradnetwork.ca). Natalie McCormick is supported by a Doctoral Research Award from the Canadian Institutes of Health Research. J. Antonio Avina-Zubieta held a salary award from the Canadian Arthritis Network and The Arthritis Society of Canada. He is currently the British Columbia Lupus Society Scholar and holds a Scholar Award from the Michael Smith Foundation for Health Research. Diane Lacaille holds the Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqaisi F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-237; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038; Bradley CJ, 2010, HEALTH SERV RES, V45, P1468, DOI 10.1111/j.1475-6773.2010.01142.x; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; CARLSON KJ, 1985, J CHRON DIS, V38, P733, DOI 10.1016/0021-9681(85)90115-8; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Dai SL, 2012, CAN J CARDIOL, V28, P74, DOI 10.1016/j.cjca.2011.05.002; Dean BB, 2009, MED CARE RES REV, V66, P611, DOI 10.1177/1077558709332440; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Friedlin Jeff, 2006, AMIA Annu Symp Proc, P269; Friedman C, 1999, J AM MED INFORM ASSN, V6, P76, DOI 10.1136/jamia.1999.0060076; GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; Hawkins NM, 2010, EUR J HEART FAIL, V12, P17, DOI 10.1093/eurjhf/hfp160; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Khand AU, 2005, EUR J HEART FAIL, V7, P792, DOI 10.1016/j.ejheart.2005.04.001; KRAMER M, 1988, DIAGNOSTIC TESTS CLI, P236; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LIU F, 2012, NATURAL LANGUAGE PRO, P305; MARANTZ PR, 1988, ANN INTERN MED, V109, P55, DOI 10.7326/0003-4819-109-1-55; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; MILLER RG, 1974, BIOMETRIKA, V61, P1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; Onofrei Mihai, 2004, Inform Prim Care, V12, P139; Pakhomov S, 2007, AM J MANAG CARE, V13, P281; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Rector TS, 2004, HEALTH SERV RES, V39, P1839, DOI 10.1111/j.1475-6773.2004.00321.x; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; ROGER VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI [DOI 10.1001/JAMA.292.3.344, 10.1001/jama.292.3.344]; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szeto HC, 2002, AM J MANAG CARE, V8, P37; van Deursen VM, 2014, HEART FAIL REV, V19, P163, DOI 10.1007/s10741-012-9370-7; van Deursen VM, 2014, EUR J HEART FAIL, V16, P103, DOI 10.1002/ejhf.30; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	69	133	136	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104519	10.1371/journal.pone.0104519	http://dx.doi.org/10.1371/journal.pone.0104519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8UD	25126761	Green Submitted, gold, Green Published			2022-12-27	WOS:000340879300031
J	Ohm, IK; Alfsnes, K; Olsen, MB; Ranheim, T; Sandanger, O; Dahl, TB; Aukrust, P; Finsen, AV; Yndestad, A; Vinge, LE				Ohm, Ingrid Kristine; Alfsnes, Katrine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Dahl, Tuva Borresdatter; Aukrust, Pal; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik			Toll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; HEART-FAILURE; BACTERIAL-DNA; MYOCARDIAL-INFARCTION; PATHOGEN RECOGNITION; MITOCHONDRIAL-DNA; INNATE IMMUNITY; IN-VITRO; INFLAMMATION; TOLL-LIKE-RECEPTOR-9	Altered cardiac Toll-like receptor 9 (TLR9) signaling is important in several experimental cardiovascular disorders. These studies have predominantly focused on cardiac myocytes or the heart as a whole. Cardiac fibroblasts have recently been attributed increasing significance in mediating inflammatory signaling. However, putative TLR9-signaling through cardiac fibroblasts remains non-investigated. Thus, our aim was to explore TLR9-signaling in cardiac fibroblasts and investigate the consequence of such receptor activity on classical cardiac fibroblast cellular functions. Cultivated murine cardiac fibroblasts were stimulated with different TLR9 agonists (CpG A, B and C) and assayed for the secretion of inflammatory cytokines (tumor necrosis factor alpha [TNF alpha], CXCL2 and interferon alpha/beta). Expression of functional cardiac fibroblast TLR9 was proven as stimulation with CpG B and -C caused significant CXCL2 and TNF alpha-release. These responses were TLR9-specific as complete inhibition of receptor-stimulated responses was achieved by co-treatment with a TLR9-antagonist (ODN 2088) or chloroquine diphosphate. TLR9-stimulated responses were also found more potent in cardiac fibroblasts when compared with classical innate immune cells. Stimulation of cardiac fibroblasts TLR9 was also found to attenuate migration and proliferation, but did not influence myofibroblast differentiation in vitro. Finally, results from in vivo TLR9-stimulation with subsequent fractionation of specific cardiac cell-types (cardiac myocytes, CD45+ cells, CD31+ cells and cardiac fibroblast-enriched cell-fractions) corroborated our in vitro data and provided evidence of differentiated cell-specific cardiac responses. Thus, we conclude that cardiac fibroblast may constitute a significant TLR9 responder cell within the myocardium and, further, that such receptor activity may impact important cardiac fibroblast cellular functions.	[Ohm, Ingrid Kristine; Alfsnes, Katrine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Dahl, Tuva Borresdatter; Aukrust, Pal; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ohm, Ingrid Kristine; Dahl, Tuva Borresdatter; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Ohm, Ingrid Kristine; Olsen, Maria Belland; Ranheim, Trine; Sandanger, Oystein; Finsen, Alexandra Vanessa; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Finsen, Alexandra Vanessa; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Vinge, Leif Erik] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ohm, IK (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	Ingrid.Kristine.Ohm@rr-research.no	Olsen, Maria/GXA-1825-2022; Olsen, Maria Belland/GQP-4485-2022	Sandanger, Oystein/0000-0001-7475-7362; Dahl, Tuva/0000-0001-7818-9411	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	This work was supported by the University of Oslo; Center for Heart Failure Research; and The South-Eastern Norway Regional Health Authority (Helse Sor-Ost); http://www.helse-sorost.no/Sider/side.aspx, http://www.heartfailure.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lievens D, 2012, EUR HEART J; Marshall JD, 2005, DNA CELL BIOL, V24, P63, DOI 10.1089/dna.2005.24.63; Mathur S, 2011, SHOCK, V36, P478, DOI 10.1097/SHK.0b013e31822d6442; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meneghin A, 2008, HISTOCHEM CELL BIOL, V130, P979, DOI 10.1007/s00418-008-0466-z; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pagni PP, 2010, AUTOIMMUNITY, V43, P275, DOI 10.3109/08916930903509056; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Velten M, 2012, CARDIOVASC RES; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104398	10.1371/journal.pone.0104398	http://dx.doi.org/10.1371/journal.pone.0104398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126740	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300023
J	Takahashi, H; Sai, K; Saito, Y; Kaniwa, N; Matsumura, Y; Hamaguchi, T; Shimada, Y; Ohtsu, A; Yoshino, T; Doi, T; Okuda, H; Ichinohe, R; Takahashi, A; Doi, A; Odaka, Y; Okuyama, M; Saijo, N; Sawada, J; Sakamoto, H; Yoshida, T				Takahashi, Hiro; Sai, Kimie; Saito, Yoshiro; Kaniwa, Nahoko; Matsumura, Yasuhiro; Hamaguchi, Tetsuya; Shimada, Yasuhiro; Ohtsu, Atsushi; Yoshino, Takayuki; Doi, Toshihiko; Okuda, Haruhiro; Ichinohe, Risa; Takahashi, Anna; Doi, Ayano; Odaka, Yoko; Okuyama, Misuzu; Saijo, Nagahiro; Sawada, Jun-ichi; Sakamoto, Hiromi; Yoshida, Teruhiko			Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect	PLOS ONE			English	Article							ADAPTIVE RESONANCE THEORY; CELL LUNG-CANCER; BOOSTED FUZZY CLASSIFIER; GENE-EXPRESSION ANALYSIS; MESSENGER-RNA STABILITY; ACTIVE METABOLITE SN-38; SWEEP OPERATOR METHOD; PART FILTERING METHOD; SOFT-TISSUE SARCOMAS; ARABIDOPSIS-THALIANA	Interindividual variation in a drug response among patients is known to cause serious problems in medicine. Genomic information has been proposed as the basis for "personalized" health care. The genome-wide association study (GWAS) is a powerful technique for examining single nucleotide polymorphisms (SNPs) and their relationship with drug response variation; however, when using only GWAS, it often happens that no useful SNPs are identified due to multiple testing problems. Therefore, in a previous study, we proposed a combined method consisting of a knowledge-based algorithm, 2 stages of screening, and a permutation test for identifying SNPs. In the present study, we applied this method to a pharmacogenomics study where 109,365 SNPs were genotyped using Illumina Human-1 BeadChip in 168 cancer patients treated with irinotecan chemotherapy. We identified the SNP rs9351963 in potassium voltage-gated channel subfamily KQT member 5 (KCNQ5) as a candidate factor related to incidence of irinotecan-induced diarrhea. The p value for rs9351963 was 3.31x10(-5) in Fisher's exact test and 0.0289 in the permutation test (when multiple testing problems were corrected). Additionally, rs9351963 was clearly superior to the clinical parameters and the model involving rs9351963 showed sensitivity of 77.8% and specificity of 57.6% in the evaluation by means of logistic regression. Recent studies showed that KCNQ4 and KCNQ5 genes encode members of the M channel expressed in gastrointestinal smooth muscle and suggested that these genes are associated with irritable bowel syndrome and similar peristalsis diseases. These results suggest that rs9351963 in KCNQ5 is a possible predictive factor of incidence of diarrhea in cancer patients treated with irinotecan chemotherapy and for selecting chemotherapy regimens, such as irinotecan alone or a combination of irinotecan with a KCNQ5 opener. Nonetheless, clinical importance of rs9351963 should be further elucidated.	[Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Takahashi, Hiro; Takahashi, Anna] Chubu Univ, Plant Biol Res Ctr, Kasugai, Aichi 487, Japan; [Takahashi, Hiro; Ichinohe, Risa; Doi, Ayano; Odaka, Yoko; Okuyama, Misuzu; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Sai, Kimie; Saito, Yoshiro; Kaniwa, Nahoko; Okuda, Haruhiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Japan; [Matsumura, Yasuhiro] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Dev Therapeut, Kashiwa, Chiba, Japan; [Hamaguchi, Tetsuya; Shimada, Yasuhiro] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Ohtsu, Atsushi; Yoshino, Takayuki; Doi, Toshihiko] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Ichinohe, Risa; Doi, Ayano] Chiba Univ, Fac Hort, Matsudo, Chiba 271, Japan; [Saijo, Nagahiro] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Sawada, Jun-ichi] Natl Inst Hlth Sci, Div Funct Biochem & Genom, Tokyo, Japan	Chiba University; Chubu University; National Cancer Center - Japan; National Institute of Health Sciences - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Chiba University; National Cancer Center - Japan; National Institute of Health Sciences - Japan	Takahashi, H (corresponding author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan.	hiro.takahashi@chiba-u.jp	Matsumura, Yasuhiro/N-4472-2016; Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524; Matsumura, Yasuhiro/0000-0003-4331-8177	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [21710211, 24710222, 26114703]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation [NIBIO ID10-41]; Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu; Nakajima Foundation; Grants-in-Aid for Scientific Research [26114703] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu(Research Foundation for the Electrotechnology of Chubu); Nakajima Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT): Grants-in-Aid for Scientific Research for Young Scientists (B) (nos. 21710211 and 24710222 to H. T.) and Grant-in-Aid for Scientific Research on Innovative Areas (no. 26114703 to H. T.). This work was also supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO ID10-41), the Futaba Electronics Memorial Foundation, the Research Foundation for the Electrotechnology of Chubu, and the Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ando Y, 2000, CANCER RES, V60, P6921; Benjamini Y., 1995, J ROYAL STAT SOC B, V57, P298; Blandizzi C, 2001, BRIT J PHARMACOL, V132, P73, DOI 10.1038/sj.bjp.0703766; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cavaliere S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062445; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Ciotti M, 1999, BIOCHEM BIOPH RES CO, V260, P199, DOI 10.1006/bbrc.1999.0453; de Jong FA, 2007, CLIN PHARMACOL THER, V81, P42, DOI 10.1038/sj.clpt.6100019; de Jong FA, 2004, CLIN CANCER RES, V10, P5889, DOI 10.1158/1078-0432.CCR-04-0144; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Efferth T, 2005, PHARMACOL THERAPEUT, V107, P155, DOI 10.1016/j.pharmthera.2005.02.005; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Haaz MC, 1998, CANCER RES, V58, P468; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; Han JY, 2009, LUNG CANCER, V63, P115, DOI 10.1016/j.lungcan.2007.12.003; Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239; Hyatt JL, 2005, CHEM-BIOL INTERACT, V157, P247, DOI 10.1016/j.cbi.2005.10.033; Ichihara S, 2007, INT J CANCER, V120, P1239, DOI 10.1002/ijc.22513; Ingelman-Sundberg M, 2008, NEW ENGL J MED, V358, P637, DOI 10.1056/NEJMe0708842; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jada SR, 2007, CANCER SCI, V98, P1461, DOI 10.1111/j.1349-7006.2007.00541.x; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Kawamura T, 2008, J BIOSCI BIOENG, V105, P81, DOI 10.1263/jbb.105.81; KAWATO Y, 1993, J PHARM PHARMACOL, V45, P444, DOI 10.1111/j.2042-7158.1993.tb05573.x; Kojima S, 2011, PLANT CELL PHYSIOL, V52, P1259, DOI 10.1093/pcp/pcr083; Kotooka N, 2013, INT J CARDIOL, V167, P1068, DOI 10.1016/j.ijcard.2012.10.066; Kuhn JG, 1998, ONCOLOGY-NY, V12, P39; Ma F, 2009, LUNG CANCER, V66, P114, DOI 10.1016/j.lungcan.2008.12.025; Mathijssen RHJ, 2003, CLIN CANCER RES, V9, P3246; Matsuo N, 2009, PLANT BIOTECHNOL-NAR, V26, P385, DOI 10.5511/plantbiotechnology.26.385; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Michael M, 2006, J CLIN ONCOL, V24, P4228, DOI 10.1200/JCO.2005.04.8496; Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakagawa A, 2012, PLANT MOL BIOL, V79, P569, DOI 10.1007/s11103-012-9929-7; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Perez C, 2010, NEUROSCI LETT, V468, P238, DOI 10.1016/j.neulet.2009.11.004; Pitman EJG, 1938, BIOMETRIKA, V29, P322, DOI 10.1093/biomet/29.3-4.322; Raida M, 2001, CLIN CANCER RES, V7, P2832; Sai K, 2006, ANN HUM GENET, V70, P605, DOI 10.1111/j.1469-1809.2006.00260.x; Sai K, 2003, PHARMACOGENETICS, V13, P741, DOI 10.1097/00008571-200312000-00005; Sai K, 2008, CANCER CHEMOTH PHARM, V62, P529, DOI 10.1007/s00280-007-0634-1; Sai K, 2008, CANCER LETT, V261, P165, DOI 10.1016/j.canlet.2007.11.009; Sai K, 2010, CANCER CHEMOTH PHARM, V66, P95, DOI 10.1007/s00280-009-1138-y; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Sato Y, 2009, PHARMACOGENOMICS J, V9, P137, DOI 10.1038/tpj.2008.17; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Seo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076960; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slatter JG, 1997, DRUG METAB DISPOS, V25, P1157; Sparreboom A, 2003, DRUG RESIST UPDATE, V6, P71, DOI 10.1016/S1368-7646(03)00005-0; Spasovski V, 2013, J APPL GENET, V54, P21, DOI 10.1007/s13353-012-0125-x; Takahashi H, 2004, J BIOSCI BIOENG, V98, P193, DOI 10.1263/jbb.98.193; Takahashi H, 2003, J BIOSCI BIOENG, V96, P154, DOI 10.1263/jbb.96.154; Takahashi H, 2005, BIOINFORMATICS, V21, P179, DOI 10.1093/bioinformatics/bth473; Takahashi H, 2006, J BIOSCI BIOENG, V101, P137, DOI 10.1263/jbb.101.137; Takahashi H, 2005, J CHEM ENG JPN, V38, P763, DOI 10.1252/jcej.38.763; Takahashi H, 2008, J BIOSCI BIOENG, V106, P587, DOI 10.1263/jbb.106.587; Takahashi H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-399; Takahashi H, 2007, BIOCHEM ENG J, V33, P100, DOI 10.1016/j.bej.2006.08.004; Takahashi H, 2006, J BIOSCI BIOENG, V102, P46, DOI 10.1263/jbb.102.46; Takahashi H, 2006, BIOINFORMATICS, V22, P1662, DOI 10.1093/bioinformatics/btl156; Takahashi H, 2013, J BIOSCI BIOENG, V116, P768, DOI 10.1016/j.jbiosc.2013.05.021; Takahashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078250; Takahashi H, 2013, PLANT CELL PHYSIOL, V54, P418, DOI 10.1093/pcp/pct027; Takahashi H, 2012, BIOINFORMATICS, V28, P2231, DOI 10.1093/bioinformatics/bts303; Takahashi H, 2006, J CHEM ENG JPN, V39, P767, DOI 10.1252/jcej.39.767; Takakura A, 2012, ONCOL LETT, V3, P520, DOI 10.3892/ol.2011.519; Takane H, 2007, THER DRUG MONIT, V29, P666, DOI 10.1097/FTD.0b013e3181357364; van Kuilenburg ABP, 2001, CLIN CANCER RES, V7, P1149; Xiang XQ, 2006, PHARMACOGENET GENOM, V16, P683, DOI 10.1097/01.fpc.0000230420.05221.71; Xue GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032870; Yajima I, 2012, AM J CANCER RES, V2, P322; Yamamoto M, 2008, ONCOL REP, V20, P727, DOI 10.3892/or_00000066; Yang XX, 2005, CURR MED CHEM, V12, P1343, DOI 10.2174/0929867054020972; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Zhou QY, 2005, BRIT J CLIN PHARMACO, V59, P415, DOI 10.1111/j.1365-2125.2004.02330.x	90	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105160	10.1371/journal.pone.0105160	http://dx.doi.org/10.1371/journal.pone.0105160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127363	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300085
J	Yang, F; Zhao, JF; Shou, QY; Huang, XJ; Chen, G; Yang, KB; Zhang, SG; Lv, BD; Fu, HY				Yang, Fan; Zhao, Jian F.; Shou, Qi Y.; Huang, Xiao J.; Chen, Gang; Yang, Ke B.; Zhang, Shi G.; Lv, Bo D.; Fu, Hui Y.			Phenotypic Modulation of Corpus Cavernosum Smooth Muscle Cells in a Rat Model of Cavernous Neurectomy	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; RADICAL PROSTATECTOMY; MOLECULAR-MECHANISMS; NERVE ABLATION; FIBROSIS; DIFFERENTIATION; PROLIFERATION; NEUROTOMY; HYPOXIA	Background: Patients undergoing radical prostatectomy (RP) are at high risk for erectile dysfunction (ED) due to potential cavernous nerve (CN) damage during surgery. Penile hypoxia after RP is thought to significantly contribute to ED pathogenesis. Aim: We previously showed that corpora cavernosum smooth muscle cells (CCSMCs) undergo phenotypic modulation under hypoxic conditions in vitro. Here, we studied such changes in an in vivo post-RP ED model by investigating CCSMCs in bilateral cavernous neurectomy (BCN) rats. Methods: Sprague-Dawley rats underwent sham (n = 12) or BCN (n = 12) surgery. After 12 weeks, they were injected with apomorphine to determine erectile function. The penile tissues were harvested and assessed for fibrosis using Masson trichrome staining and for molecular markers of phenotypic modulation using immunohistochemistry and western blotting. CCSMC morphological structure was evaluated by hematoxylin-eosin (H&E) staining and transmission electron microscopy (TEM). Results: Erectile function was significantly lower in BCN rats than in sham rats. BCN increased hypoxia-inducible factor-1 alpha and collagen protein expression in corpora cavernous tissue. H&E staining and TEM showed that CCSMCs in BCN rats underwent hypertrophy and showed rough endoplasmic reticulum formation. The expression of CCSMC phenotypic markers, such as smooth muscle alpha-actin, smooth muscle myosin heavy chain, and desmin, was markedly lower, whereas vimentin protein expression was significantly higher in BCN rats than in control rats. Conclusions: CCSMCs undergo phenotype modulation in rats with cavernous neurectomy. The results have unveiled physiological transformations that occur at the cellular and molecular levels and have helped characterize CN injury-induced ED.	[Yang, Fan; Zhao, Jian F.; Huang, Xiao J.; Chen, Gang; Yang, Ke B.; Zhang, Shi G.; Lv, Bo D.] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China; [Shou, Qi Y.] Zhejiang Chinese Med Univ, Lab Anim Res Ctr, Hangzhou, Zhejiang, Peoples R China; [Fu, Hui Y.] Zhejiang Chinese Med Univ, Clin Med Coll 2, Cent Lab, Hangzhou, Zhejiang, Peoples R China; [Lv, Bo D.; Fu, Hui Y.] Zhejiang Prov Key Lab Tradit Chinese Med, Androl Lab Integrat Chinese & Western Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Lv, BD (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Urol, Hangzhou, Zhejiang, Peoples R China.	lbd168@126.com; fhy131@126.com	fu, huiying/GZG-2399-2022		 [WKJ2010-2-020];  [2009ZA009];  [Y2111167]	; ; 	This work was supported by the following: WKJ2010-2-020 (http://www.zjwst.gov.cn/), 2009ZA009 (http://zgj.zjtcm.net/), and Y2111167 (http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Ferrini MG, 2009, J SEX MED, V6, P415, DOI 10.1111/j.1743-6109.2008.01105.x; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HEDIN U, 1987, DIFFERENTIATION, V33, P239, DOI 10.1111/j.1432-0436.1987.tb01563.x; Hu WL, 2004, ASIAN J ANDROL, V6, P111; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leungwattanakij S, 2003, J ANDROL, V24, P239; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Liu K, 2012, J ANDROL, V33, P1186, DOI 10.2164/jandrol.112.016642; Magheli A, 2009, NAT REV UROL, V6, P415, DOI 10.1038/nrurol.2009.126; Meng MV, 2003, J UROLOGY, V170, P2279, DOI 10.1097/01.ju.0000094190.46523.b2; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Meuleman EJH, 2003, EUR UROL, V43, P95, DOI 10.1016/S0302-2838(02)00546-8; Montorsi F, 1997, J UROLOGY, V158, P1408, DOI 10.1016/S0022-5347(01)64227-7; Moreland RB, 1998, INT J IMPOT RES, V10, P113, DOI 10.1038/sj.ijir.3900328; Nehra A, 1996, J UROLOGY, V156, P1320, DOI 10.1016/S0022-5347(01)65578-2; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Vignozzi L, 2006, J SEX MED, V3, P419, DOI 10.1111/j.1743-6109.2006.00208.x; Wei AY, 2012, INT J IMPOT RES, V24, P196, DOI 10.1038/ijir.2012.16; Welliver RC, 2014, J SEX MED, V11, P1071, DOI 10.1111/jsm.12445; Zhang XH, 2002, CHINESE MED J-PEKING, V115, P1179	27	17	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105186	10.1371/journal.pone.0105186	http://dx.doi.org/10.1371/journal.pone.0105186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127037	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300090
J	Kret, ME; Tomonaga, M; Matsuzawa, T				Kret, Mariska E.; Tomonaga, Masaki; Matsuzawa, Tetsuro			Chimpanzees and Humans Mimic Pupil-Size of Conspecifics	PLOS ONE			English	Article							HUMAN AMYGDALA; PHYSIOLOGICAL LINKAGE; EYE CONTACT; PERCEPTION; RECOGNITION; SENSITIVITY; EVOLUTION; RESPONSES; INGROUP; MODELS	Group-living typically provides benefits to individual group members but also confers costs. To avoid incredulity and betrayal and allow trust and cooperation, individuals must understand the intentions and emotions of their group members. Humans attend to other's eyes and from gaze and pupil-size cues, infer information about the state of mind of the observed. In humans, pupil-size tends to mimic that of the observed. Here we tested whether pupil-mimicry exists in our closest relative, the chimpanzee (P. troglodytes). We conjectured that if pupil-mimicry has adaptive value, e.g. to promote swift communication of inner states and facilitate shared understanding and coordination, pupil-mimicry should emerge within but not across species. Pupillometry data was collected from human and chimpanzee subjects while they observed images of the eyes of both species with dilating/constricting pupils. Both species showed enhanced pupil-mimicry with members of their own species, with effects being strongest in humans and chimpanzee mothers. Pupil-mimicry may be deeply-rooted, but probably gained importance from the point in human evolution where the morphology of our eyes became more prominent. Humans' white sclera surrounding the iris, and the fine muscles around their eyes facilitate nonverbal communication via eye signals.	[Kret, Mariska E.; Tomonaga, Masaki; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kret, Mariska E.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Kret, Mariska E.] Amsterdam Brain & Cognit ABC Ctr, Amsterdam, Netherlands	Kyoto University; University of Amsterdam	Kret, ME (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	m.e.kret@uva.nl	Matsuzawa, Tetsuro/ABE-9654-2021; Kret, Mariska/B-4798-2010	Matsuzawa, Tetsuro/0000-0002-8147-2725; Kret, Mariska/0000-0002-3197-5084	Japan Society for the Promotion of Science [pE10084, BR120105]; Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen [UPS/BP/5215]; JSPS [23220006, 20002001, 24000001]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (pE10084 and BR120105) and the Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen (UPS/BP/5215) awarded to MEK and JSPS Grants in Aid for Scientific Research to MT (#23220006) and TM (#20002001, #24000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Anders S, 2011, NEUROIMAGE, V54, P439, DOI 10.1016/j.neuroimage.2010.07.004; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Campbell MW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0013; Carruthers P., 1996, THEORIES THEORIES MI, DOI 10.1017/CBO9780511597985; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal FB, 2013, BONOBO ATHEIST SEARC, P141; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Harrison NA, 2009, SOC NEUROSCI-UK, V4, P233, DOI 10.1080/17470910802553508; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hattori Y, 2010, BIOL LETTERS, V6, P610, DOI 10.1098/rsbl.2010.0120; Haun DBM, 2008, CURR BIOL, V18, pR288, DOI 10.1016/j.cub.2008.02.031; Helm JL, 2012, EMOTION, V12, P748, DOI 10.1037/a0025036; HESS EH, 1975, SCI AM, V233, P110, DOI 10.1038/scientificamerican1175-110; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Iriki A, 1996, NEUROSCI RES, V25, P173; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Lee DH, 2013, PSYCHOL SCI, V24, P957, DOI 10.1177/0956797612464500; LEVENSON RW, 1983, J PERS SOC PSYCHOL, V45, P587, DOI 10.1037/0022-3514.45.3.587; Lipps T., 1905, PSYCHOL UNTERSUCHUNG, V4, P694; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; MATSUZAWA T, 1990, FOLIA PRIMATOL, V55, P24, DOI 10.1159/000156494; May PJ, 2008, PROG BRAIN RES, V171, P97, DOI 10.1016/S0079-6123(08)00613-4; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Mussweiler T, 2013, P NATL ACAD SCI USA, V110, P19318, DOI 10.1073/pnas.1215443110; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Parr LA, 2006, SOC COGN AFFECT NEUR, V1, P221, DOI 10.1093/scan/nsl031; Reed RG, 2013, INT J PSYCHOPHYSIOL, V88, P309, DOI 10.1016/j.ijpsycho.2012.08.009; Simms MS, 1967, PERCEP PSYCHOPHYS, V2; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2010, J COGNITIVE NEUROSCI, V22, P888, DOI 10.1162/jocn.2009.21225; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Tomonaga M, 2007, J COMP PSYCHOL, V121, P156, DOI 10.1037/0735-7036.121.2.156; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; West B. T., 2006, LINEAR MIXED MODELS, P180; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	63	62	63	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104886	10.1371/journal.pone.0104886	http://dx.doi.org/10.1371/journal.pone.0104886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140998	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200040
J	Petersson, ME; Obreja, O; Lampert, A; Carr, RW; Schmelz, M; Fransen, E				Petersson, Marcus E.; Obreja, Otilia; Lampert, Angelika; Carr, Richard W.; Schmelz, Martin; Fransen, Erik			Differential Axonal Conduction Patterns of Mechano-Sensitive and Mechano-Insensitive Nociceptors - A Combined Experimental and Modelling Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; INNERVATING HUMAN SKIN; C-NOCICEPTORS; SODIUM-CHANNELS; FIBERS; PAIN; NEURONS; IDENTIFICATION; EXCITABILITY; CURRENTS	Cutaneous pain sensations are mediated largely by C-nociceptors consisting of both mechano-sensitive (CM) and mechano-insensitive (CMi) fibres that can be distinguished from one another according to their characteristic axonal properties. In healthy skin and relative to CMi fibres, CM fibres show a higher initial conduction velocity, less activity-dependent conduction velocity slowing, and less prominent post-spike supernormality. However, after sensitization with nerve growth factor, the electrical signature of CMi fibres changes towards a profile similar to that of CM fibres. Here we take a combined experimental and modelling approach to examine the molecular basis of such alterations to the excitation thresholds. Changes in electrical activation thresholds and activity-dependent slowing were examined in vivo using single-fibre recordings of CM and CMi fibres in domestic pigs following NGF application. Using computational modelling, we investigated which axonal mechanisms contribute most to the electrophysiological differences between the fibre classes. Simulations of axonal conduction suggest that the differences between CMi and CM fibres are strongly influenced by the densities of the delayed rectifier potassium channel (Kdr), the voltage-gated sodium channels Na(V)1.7 and Na(V)1.8, and the Na+/K+-ATPase. Specifically, the CM fibre profile required less K-dr and Na(V)1.8 in combination with more Na(V)1.7 and Na+/ K(+)AT-Pase. The difference between CM and CMi fibres is thus likely to reflect a relative rather than an absolute difference in protein expression. In support of this, it was possible to replicate the experimental reduction of the ADS pattern of CMi nociceptors towards a CM-like pattern following intradermal injection of nerve growth factor by decreasing the contribution of Kdr (by 50%), increasing the Na+/K+-ATPase (by 10%), and reducing the branch length from 2 cm to 1 cm. The findings highlight key molecules that potentially contribute to the NGF-induced switch in nociceptors phenotype, in particular NaV1.7 which has already been identified clinically as a principal contributor to chronic pain states such as inherited erythromelalgia.	[Petersson, Marcus E.; Fransen, Erik] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden; [Petersson, Marcus E.; Fransen, Erik] KTH Royal Inst Technol, Stockholm Brain Inst, Stockholm, Sweden; [Obreja, Otilia; Carr, Richard W.; Schmelz, Martin] Heidelberg Univ, Univ Med Mannheim, Dept Anaesthesiol, Mannheim, Germany; [Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Royal Institute of Technology; Royal Institute of Technology; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Fransen, E (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden.	erikf@csc.kth.se	Lampert, Angelika/F-7198-2010; Schmelz, Martin/A-9327-2013; Carr, Richard/AAE-9188-2020; Carr, Richard/GSD-4859-2022	Lampert, Angelika/0000-0001-6319-6272; Schmelz, Martin/0000-0002-9736-7241; Carr, Richard/0000-0001-8617-9133; Obreja, Otilia/0000-0002-0230-7538	Swedish Research council [VR 621-2007-4223]; Pain Excellence Consortium Baden-Wurttemberg, Germany; IASP grant; Astra-Zeneca R&D Sodertalje, Sweden	Swedish Research council(Swedish Research CouncilEuropean Commission); Pain Excellence Consortium Baden-Wurttemberg, Germany; IASP grant; Astra-Zeneca R&D Sodertalje, Sweden(AstraZeneca)	This study was funded by the Swedish Research council, VR 621-2007-4223, http://www.vr.se/; the Pain Excellence Consortium Baden-Wurttemberg, Germany; and the IASP grant to OO, http://www.iasp-pain.org/. Research funding was received from Astra-Zeneca R&D Sodertalje, Sweden, http://www.astrazeneca.se/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock H, 2003, J PHYSIOL-LONDON, V553, P649, DOI 10.1113/jphysiol.2003.046342; Choi JS, 2011, J NEUROPHYSIOL, V106, P3173, DOI 10.1152/jn.00100.2011; Diss JKJ, 2008, MOL CELL NEUROSCI, V37, P537, DOI 10.1016/j.mcn.2007.12.002; Fjell J, 1999, J NEUROPHYSIOL, V81, P803, DOI 10.1152/jn.1999.81.2.803; Gould HJ, 2000, BRAIN RES, V854, P19, DOI 10.1016/S0006-8993(99)02216-7; Handwerker HO, 2010, PAIN, V148, P355, DOI 10.1016/j.pain.2009.12.012; HODGKIN AL, 1952, COLD SPRING HARB SYM, V17, P43, DOI 10.1101/SQB.1952.017.01.007; INOUE N, 1988, J NEUROCHEM, V50, P230, DOI 10.1111/j.1471-4159.1988.tb13254.x; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Kleggetveit IP, 2012, PAIN, V153, P2040, DOI 10.1016/j.pain.2012.05.017; MEYER RA, 1988, BRAIN RES, V441, P81, DOI 10.1016/0006-8993(88)91385-6; Obreja O, 2011, PAIN, V152, P2138, DOI 10.1016/j.pain.2011.05.021; Obreja O, 2011, PAIN, V152, P1856, DOI 10.1016/j.pain.2011.04.002; Obreja O, 2010, PAIN, V148, P59, DOI 10.1016/j.pain.2009.10.006; Orstavik K, 2003, BRAIN, V126, P567, DOI 10.1093/brain/awg060; Orstavik K, 2006, J NEUROSCI, V26, P11287, DOI 10.1523/JNEUROSCI.2659-06.2006; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHMELZ M, 1995, EXP BRAIN RES, V104, P331; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Schmidt R, 2002, J NEUROPHYSIOL, V88, P1859, DOI 10.1152/jn.2002.88.4.1859; Schmidt R, 2000, NEUROSCIENCE, V98, P793, DOI 10.1016/S0306-4522(00)00189-5; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Serra J, 2011, PAIN; Tigerholm J, 2013, J NEUROPHYSIOL; TOREBJORK HE, 1974, BRAIN RES, V67, P387, DOI 10.1016/0006-8993(74)90489-2; Waxman SG, 2011, NATURE, V472, P173, DOI 10.1038/472173a; Weidner C, 1999, J NEUROSCI, V19, P10184; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weidner C, 2003, J PHYSIOL-LONDON, V547, P931, DOI 10.1113/jphysiol.2002.028712; Weidner C, 2002, J NEUROSCI, V22, P6704; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zhu ZR, 2009, NEUROSIGNALS, V17, P181, DOI 10.1159/000209279	34	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e103556	10.1371/journal.pone.0103556	http://dx.doi.org/10.1371/journal.pone.0103556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136824	gold, Green Published, Green Submitted			2022-12-27	WOS:000340742100010
J	de Oliveira, AR; Colombo, AC; Muthuraju, S; Almada, RC; Brandao, ML				de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira			Dopamine D-2-Like Receptors Modulate Unconditioned Fear: Role of the Inferior Colliculus	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GABAERGIC NIGROCOLLICULAR PATHWAYS; NUCLEUS-ACCUMBENS DOPAMINE; VENTRAL TEGMENTAL AREA; EVOKED-POTENTIALS; CONDITIONED FEAR; MIDBRAIN TECTUM; EXTRACELLULAR DOPAMINE; ELECTRICAL-STIMULATION; DEFENSIVE BEHAVIOR	Background: A reduction of dopamine release or D-2 receptor blockade in the terminal fields of the mesolimbic system clearly reduces conditioned fear. Injections of haloperidol, a preferential D-2 receptor antagonist, into the inferior colliculus (IC) enhance the processing of unconditioned aversive information. However, a clear characterization of the interplay of D-2 receptors in the mediation of unconditioned and conditioned fear is still lacking. Methods: The present study investigated the effects of intra-IC injections of the D-2 receptor-selective antagonist sulpiride on behavior in the elevated plus maze (EPM), auditory-evoked potentials (AEPs) to loud sounds recorded from the IC, fear-potentiated startle (FPS), and conditioned freezing. Results: Intra-IC injections of sulpiride caused clear proaversive effects in the EPM and enhanced AEPs induced by loud auditory stimuli. Intra-IC sulpiride administration did not affect FPS or conditioned freezing. Conclusions: Dopamine D-2-like receptors of the inferior colliculus play a role in the modulation of unconditioned aversive information but not in the fear-potentiated startle response.	[de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Neuropsicofarmacol, Ribeirao Preto, SP, Brazil; [de Oliveira, Amanda Ribeiro; Colombo, Ana Caroline; Muthuraju, Sangu; Almada, Rafael Carvalho; Brandao, Marcus Lira] INeC, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Brandao, ML (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Lab Neuropsicofarmacol, Ribeirao Preto, SP, Brazil.	mbrandao@usp.br	SANGU, MUTHURAJU/C-3200-2011; SANGU, MUTHURAJU/AAY-8060-2020; MUTHURAJU, SANGU/B-2742-2018; Colombo, Ana Caroline/J-5412-2015; Almada, Rafael C/G-9555-2012; Brandao, Marcus L/C-5657-2012	SANGU, MUTHURAJU/0000-0002-7949-2110; MUTHURAJU, SANGU/0000-0002-7949-2110; Colombo, Ana Caroline/0000-0002-6547-0340; Almada, Rafael C/0000-0003-3215-7435; Brandao, Marcus L/0000-0001-7437-2382; Ribeiro de Oliveira, Amanda/0000-0002-8457-7338	FAPESP [11/00041-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Proc. no. 11/00041-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISMAN H, 1991, ANIMAL MODELS PSYCHI, V2, P1; Anseloni VZ, 1997, BEHAV PHARMACOL, V8, P533, DOI 10.1097/00008877-199711000-00011; Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Aparicio MA, 2010, NEUROSCIENCE, V166, P653, DOI 10.1016/j.neuroscience.2009.12.074; Baas JMP, 2006, BIOL PSYCHIAT, V59, P588, DOI 10.1016/j.biopsych.2005.09.009; BIGGIO G, 1990, PHARMACOL THERAPEUT, V48, P121, DOI 10.1016/0163-7258(90)90077-F; Borelli KG, 2008, HORM BEHAV, V53, P40, DOI 10.1016/j.yhbeh.2007.08.013; Brandao ML, 2005, NEUROSCI BIOBEHAV R, V29, P1299, DOI 10.1016/j.neubiorev.2005.04.013; Brandao ML, 1999, NEUROSCI BIOBEHAV R, V23, P863, DOI 10.1016/S0149-7634(99)00038-X; BRANDAO ML, 1982, PHARMACOL BIOCHEM BE, V16, P397, DOI 10.1016/0091-3057(82)90441-5; BRANDAO ML, 1993, BEHAV BRAIN RES, V58, P49, DOI 10.1016/0166-4328(93)90089-9; BRANDAO ML, 1988, PHYSIOL BEHAV, V44, P361, DOI 10.1016/0031-9384(88)90038-8; BRANDAO ML, 1994, NEUROSCI BIOBEHAV R, V18, P339, DOI 10.1016/0149-7634(94)90047-7; Brandao ML, 2001, PHYSIOL BEHAV, V72, P365, DOI 10.1016/S0031-9384(00)00418-2; Cabral A, 2009, NEUROSCIENCE, V161, P707, DOI 10.1016/j.neuroscience.2009.03.073; CARDOSO SH, 1992, BEHAV PHARMACOL, V3, P489; CARDOSO SH, 1994, BEHAV BRAIN RES, V63, P17, DOI 10.1016/0166-4328(94)90046-9; Casseday JH, 1996, BRAIN BEHAV EVOLUT, V47, P311, DOI 10.1159/000113249; Castellan-Baldan L, 2006, J CHEM NEUROANAT, V32, P1, DOI 10.1016/j.jchemneu.2006.05.002; Castilho VM, 2001, PSYCHOPHARMACOLOGY, V155, P154, DOI 10.1007/s002130100697; COIMBRA NC, 1993, BEHAV BRAIN RES, V59, P131, DOI 10.1016/0166-4328(93)90159-N; Colombo AC, 2013, BEHAV BRAIN RES, V257, P201, DOI 10.1016/j.bbr.2013.10.002; COVEY E, 1987, J COMP NEUROL, V263, P179, DOI 10.1002/cne.902630203; Cuadra G, 2000, BRAIN RES BULL, V52, P413, DOI 10.1016/S0361-9230(00)00278-1; Datla KP, 2002, EUR J NEUROSCI, V16, P1987, DOI 10.1046/j.1460-9568.2002.02249.x; David AS, 1996, NEUROREPORT, V7, P932, DOI 10.1097/00001756-199603220-00021; de Oliveira AR, 2013, EUR NEUROPSYCHOPHARM, V23, P379, DOI 10.1016/j.euroneuro.2012.05.007; de Oliveira AR, 2006, PHARMACOL BIOCHEM BE, V84, P102, DOI 10.1016/j.pbb.2006.04.012; de Oliveira AR, 2011, NEUROBIOL LEARN MEM, V95, P37, DOI 10.1016/j.nlm.2010.10.005; de Oliveira AR, 2009, BEHAV BRAIN RES, V199, P271, DOI 10.1016/j.bbr.2008.12.004; Caetano KAD, 2013, BEHAV PHARMACOL, V24, P264, DOI 10.1097/FBP.0b013e32836356c4; Del Cano GG, 2006, J COMP NEUROL, V499, P716, DOI 10.1002/cne.21107; Espejo EF, 1999, NEUROSCIENCE, V88, P609, DOI 10.1016/S0306-4522(98)00258-9; FADDA F, 1978, LIFE SCI, V23, P2219, DOI 10.1016/0024-3205(78)90207-2; FAINGOLD CL, 1989, HEARING RES, V40, P127, DOI 10.1016/0378-5955(89)90106-8; FEENSTRA MGP, 1995, NEUROSCI LETT, V189, P81, DOI 10.1016/0304-3940(95)11456-7; Ferreira-Netto C, 2007, EXP NEUROL, V204, P693, DOI 10.1016/j.expneurol.2006.12.023; Garcia AMB, 2005, PHYSIOL BEHAV, V85, P440, DOI 10.1016/j.physbeh.2005.04.027; Gomez-Nieto R, 2014, BRAIN STRUC IN PRESS; HALL RD, 1967, J NEUROPHYSIOL, V30, P893, DOI 10.1152/jn.1967.30.4.893; Hurd YL, 2001, J CHEM NEUROANAT, V22, P127, DOI 10.1016/S0891-0618(01)00122-3; LEDOUX JE, 1984, J NEUROSCI, V4, P683; Li Y, 1998, HEARING RES, V121, P1, DOI 10.1016/S0378-5955(98)00066-5; LONG KJ, 1984, ARCH NEUROL-CHICAGO, V41, P1109, DOI 10.1001/archneur.1984.04050210111028; Lopez DE, 1999, J COMP NEUROL, V415, P160; Maisonnette SS, 1996, BRAIN RES BULL, V40, P93, DOI 10.1016/0361-9230(95)02136-1; Marinelli S, 2005, NEUROPSYCHOPHARMACOL, V30, P864, DOI 10.1038/sj.npp.1300615; Martinez RCR, 2008, NEUROSCI LETT, V446, P112, DOI 10.1016/j.neulet.2008.09.057; MASINO T, 1993, J NEUROSCI, V13, P351; MCCULLOUGH LD, 1992, PSYCHOPHARMACOLOGY, V109, P379, DOI 10.1007/BF02245888; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Melo LL, 2010, BRAIN RES, V1349, P41, DOI 10.1016/j.brainres.2010.06.020; MORIIZUMI T, 1991, EXP BRAIN RES, V87, P223; Morrow BA, 1999, NEUROSCIENCE, V92, P553, DOI 10.1016/S0306-4522(99)00014-7; Muthuraju S, 2014, NEUROSCIENCE, V261, P195, DOI 10.1016/j.neuroscience.2013.11.063; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Nobre MJ, 2004, BRAIN RES, V999, P124, DOI 10.1016/j.brainres.2003.12.001; Nobre MJ, 2003, HEARING RES, V184, P82, DOI [10.1016/S0378-5955(03)00231-4, 10.1016/S0378-5955(03)00231 -4]; OLAZABAL UE, 1989, J COMP NEUROL, V282, P98, DOI 10.1002/cne.902820108; Pandossio JE, 1999, PSYCHOPHARMACOLOGY, V142, P360, DOI 10.1007/s002130050900; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Reis FLV, 2004, PHARMACOL BIOCHEM BE, V79, P359, DOI 10.1016/j.pbb.2004.08.006; RODGERS RJ, 1994, PHARMACOL BIOCHEM BE, V49, P985, DOI 10.1016/0091-3057(94)90253-4; Salamone JD, 1996, J NEUROSCI METH, V64, P137, DOI 10.1016/0165-0270(95)00125-5; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Sandner G, 2002, BEHAV BRAIN RES, V128, P161, DOI 10.1016/S0166-4328(01)00273-X; SCHMITT P, 1986, BEHAV BRAIN RES, V22, P181, DOI 10.1016/0166-4328(86)90039-2; SZCZEPANIAK WS, 1995, NEUROSCI LETT, V196, P77, DOI 10.1016/0304-3940(95)11851-M; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Young AMJ, 2004, J NEUROSCI METH, V138, P57, DOI 10.1016/j.jneumeth.2004.03.003	71	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104228	10.1371/journal.pone.0104228	http://dx.doi.org/10.1371/journal.pone.0104228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133693	Green Submitted, Green Published, gold			2022-12-27	WOS:000341302700026
J	Mahdavi, S; Kuyucak, S				Mahdavi, Somayeh; Kuyucak, Serdar			Molecular Dynamics Study of Binding of mu-Conotoxin GIIIA to the Voltage-Gated Sodium Channel Na(v)1.4	PLOS ONE			English	Article							FREE-ENERGY SIMULATIONS; KV1 POTASSIUM CHANNELS; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; OUTER VESTIBULE; ION-CHANNEL; CYSTEINE MUTAGENESIS; NA+; PORE; SITE	Homology models of mammalian voltage-gated sodium (Na-v) channels based on the crystal structures of the bacterial counterparts are needed to interpret the functional data on sodium channels and understand how they operate. Such models would also be invaluable in structure-based design of therapeutics for diseases involving sodium channels such as chronic pain and heart diseases. Here we construct a homology model for the pore domain of the Na(v)1.4 channel and use the functional data for the binding of mu-conotoxin GIIIA to Na(v)1.4 to validate the model. The initial poses for the Na(v)1.4-GIIIA complex are obtained using the HADDOCK protein docking program, which are then refined in molecular dynamics simulations. The binding mode for the final complex is shown to be in broad agreement with the available mutagenesis data. The standard binding free energy, determined from the potential of mean force calculations, is also in good agreement with the experimental value. Because the pore domains of Na(v)1 channels are highly homologous, the model constructed for Na(v)1.4 will provide an excellent template for other Na(v)1 channels.	[Mahdavi, Somayeh; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021	Kuyucak, Serdar/0000-0003-4315-9532				Amaral C, 2012, P NATL ACAD SCI USA, V109, P21336, DOI 10.1073/pnas.1218087109; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Bastug T, 2006, BIOPHYS J, V90, P3941, DOI 10.1529/biophysj.105.074633; Bastug T, 2009, BIOPHYS J, V96, P4006, DOI 10.1016/j.bpj.2009.02.041; Becker S, 1992, ACTION DERIVATIVE; Carnevale V, 2011, J PHYS CHEM LETT, V2, P2504, DOI 10.1021/jz2011379; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Chen PC, 2012, TOXINS, V4, P110, DOI 10.3390/toxins4020110; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; Chen PC, 2009, BIOPHYS J, V96, P2577, DOI 10.1016/j.bpj.2008.12.3952; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Corry B, 2012, J AM CHEM SOC, V134, P1840, DOI 10.1021/ja210020h; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; Furini S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002476; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Ke S, 2013, BIOCHEM BIOPH RES CO, V430, P1272, DOI 10.1016/j.bbrc.2012.12.055; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Li RA, 2004, TOXICON, V44, P117, DOI 10.1016/j.toxicon.2004.03.028; Li RA, 2002, FEBS LETT, V511, P159, DOI 10.1016/S0014-5793(01)03316-6; Li RA, 1997, BIOPHYS J, V73, P1874, DOI 10.1016/S0006-3495(97)78218-3; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Mahdavi S, 2013, BIOCHEMISTRY-US, V52, P1631, DOI 10.1021/bi301257p; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; OHIZUMI Y, 1986, J PHARMACOL EXP THER, V239, P243; OTT KH, 1991, FEBS LETT, V278, P160, DOI 10.1016/0014-5793(91)80107-E; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pennington MW, 2012, FEBS LETT, V586, P3996, DOI 10.1016/j.febslet.2012.09.038; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu H, 2012, BBA-BIOMEMBRANES, V1818, P2529, DOI 10.1016/j.bbamem.2012.06.003; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Rashid MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04509; Rashid MH, 2014, J PHYS CHEM B, V118, P707, DOI 10.1021/jp410950h; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SATO K, 1991, J BIOL CHEM, V266, P16989; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Twede VD, 2009, IDRUGS, V12, P231; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Xue T, 2003, BIOPHYS J, V85, P2299, DOI 10.1016/S0006-3495(03)74654-2; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	74	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105300	10.1371/journal.pone.0105300	http://dx.doi.org/10.1371/journal.pone.0105300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133704	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700099
J	Moussa, M; Goldberg, SN; Kumar, G; Sawant, RR; Levchenko, T; Torchilin, VP; Ahmed, M				Moussa, Marwan; Goldberg, S. Nahum; Kumar, Gaurav; Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.; Ahmed, Muneeb			Nanodrug-Enhanced Radiofrequency Tumor Ablation: Effect of Micellar or Liposomal Carrier on Drug Delivery and Treatment Efficacy	PLOS ONE			English	Article							COLORECTAL LIVER METASTASES; THERMAL ABLATION; DOXORUBICIN ACCUMULATION; MODEL; ADJUVANT; CANCER; COAGULATION; DESTRUCTION; COMBINATION; CARCINOMA	Purpose: To determine the effect of different drug-loaded nanocarriers (micelles and liposomes) on delivery and treatment efficacy for radiofrequency ablation (RFA) combined with nanodrugs. Materials/Methods: Fischer 344 rats were used (n = 196). First, single subcutaneous R3230 tumors or normal liver underwent RFA followed by immediate administration of IV fluorescent beads (20, 100, and 500 nm), with fluorescent intensity measured at 4-24 hr. Next, to study carrier type on drug efficiency, RFA was combined with micellar (20 nm) or liposomal (100 nm) preparations of doxorubicin (Dox; targeting HIF-1 alpha) or quercetin (Qu; targeting HSP70). Animals received RFA alone, RFA with Lipo-Dox or Mic-Dox (1 mg IV, 15 min post-RFA), and RFA with Lipo-Qu or Mic-Qu given 24 hr pre- or 15 min post-RFA (0.3 mg IV). Tumor coagulation and HIF-1 alpha orHSP70 expression were assessed 24 hr post-RFA. Third, the effect of RFA combined with IV Lipo-Dox, Mic-Dox, Lipo-Qu, or Mic-Qu (15 min post-RFA) compared to RFA alone on tumor growth and animal endpoint survival was evaluated. Finally, drug uptake was compared between RFA/Lipo-Dox and RFA/Mic-Dox at 4-72 hr. Results: Smaller 20 nm beads had greater deposition and deeper tissue penetration in both tumor (100 nm/500 nm) and liver (100 nm) (p < 0.05). Mic-Dox and Mic-Qu suppressed periablational HIF-1 alpha or HSP70 rim thickness more than liposomal preparations (p < 0.05). RFA/Mic-Dox had greater early (4 hr) intratumoral doxorubicin, but RFA/Lipo-Dox had progressively higher intratumoral doxorubicin at 24-72 hr post-RFA (p < 0.04). No difference in tumor growth and survival was seen between RFA/Lipo-Qu and RFA/Mic-Qu. Yet, RFA/Lipo-Dox led to greater animal endpoint survival compared to RFA/Mic-Dox (p < 0.03). Conclusion: With RF ablation, smaller particle micelles have superior penetration and more effective local molecular modulation. However, larger long-circulating liposomal carriers can result in greater intratumoral drug accumulation over time and reduced tumor growth. Accordingly, different carriers provide specific advantages, which should be considered when formulating optimal combination therapies.	[Moussa, Marwan; Goldberg, S. Nahum; Kumar, Gaurav; Ahmed, Muneeb] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol,Lab Minimally Invas Tumor Therapies, Boston, MA 02115 USA; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Div Image Guided Therapy & Intervent Oncol, Jerusalem, Israel; [Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Sawant, Rupa R.; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew University of Jerusalem; Hadassah University Medical Center; Northeastern University; Northeastern University	Ahmed, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol,Lab Minimally Invas Tumor Therapies, Boston, MA 02115 USA.	mahmed@bidmc.harvard.edu	Ahmed, Muneeb/X-8479-2018; Goldberg, S. Nahum/AAV-4526-2020		National Cancer Institute, National Institutes of Health, Bethesda, MD [R01CA133114, R01 CA100045, CCNE 1U54CA151881-01]; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Israel Science Foundation; NATIONAL CANCER INSTITUTE [U54CA151881, R01CA133114, R01CA100045] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Medical Faculty Physicians Faculty Radiology Foundation; Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute, National Institutes of Health, Bethesda, MD (R01CA133114, R01 CA100045, and CCNE 1U54CA151881-01), Harvard Medical Faculty Physicians Faculty Radiology Foundation, and the Israel Science Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2005, J VASC INTERV RADIOL, V16, P1365, DOI 10.1097/01.RVI.0000175324.63304.25; Ahmed M, 2004, INT J HYPERTHER, V20, P781, DOI 10.1080/02656730410001711655; Ahmed M, 2003, CANCER RES, V63, P6327; Ahmed M, 2012, CHEM PHYS LIPIDS; Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Andriyanov AV, 2014, PLOS ONE IN PRESS; D'Ippolito G, 2003, RADIOLOGY, V228, P112, DOI 10.1148/radiol.2281020358; de Smet M, 2013, INVEST RADIOL, V48, P395, DOI 10.1097/RLI.0b013e3182806940; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; Goldberg SN, 2002, AM J ROENTGENOL, V179, P93, DOI 10.2214/ajr.179.1.1790093; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Hamano N, 2014, BIOL PHARM BULL, V37, P174, DOI 10.1248/bpb.b13-00605; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lukyanov AN, 2002, PHARMACEUT RES, V19, P1424, DOI 10.1023/A:1020488012264; Monsky WL, 2002, RADIOLOGY, V224, P823, DOI 10.1148/radiol.2243011421; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; Poon RTP, 2011, FUTURE ONCOL, V7, P937, DOI [10.2217/fon.11.73, 10.2217/FON.11.73]; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Rapoport N, 2012, INT J HYPERTHER, V28, P374, DOI 10.3109/02656736.2012.665567; Sawant RR, 2011, METHODS MOL BIOL, V751, P357, DOI 10.1007/978-1-61779-151-2_23; Sofocleous CT, 2008, RADIOLOGY, V249, P364, DOI 10.1148/radiol.2491071752; Sofocleous CT, 2013, ANN SURG ONCOL; Solazzo SA, 2010, RADIOLOGY, V255, P62, DOI 10.1148/radiol.09091196; Soundararajan A, 2011, RADIOLOGY, V261, P813, DOI 10.1148/radiol.11110361; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Tsukioka Y, 2002, JPN J CANCER RES, V93, P1145, DOI 10.1111/j.1349-7006.2002.tb01217.x; Weissig V, 1998, PHARMACEUT RES, V15, P1552, DOI 10.1023/A:1011951016118; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018; Yamazaki Y, 2006, BIOL PHARM BULL, V29, P1999, DOI 10.1248/bpb.29.1999; Yang W, 2012, J CONTROL RELEASE; Yang W, 2011, INT J HYPERTHER, V27, P527, DOI 10.3109/02656736.2011.582474; Yang W, 2010, RADIOLOGY, V257, P685, DOI 10.1148/radiol.10100500	37	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e102727	10.1371/journal.pone.0102727	http://dx.doi.org/10.1371/journal.pone.0102727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133740	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700003
J	Xu, L; Zhang, K; Wang, J				Xu, Li; Zhang, Kun; Wang, Jin			Exploring the Mechanisms of Differentiation, Dedifferentiation, Reprogramming and Transdifferentiation	PLOS ONE			English	Article							STEM-CELL; POTENTIAL LANDSCAPE; B-CELLS; FIBROBLASTS; CONVERSION; INDUCTION; THERMODYNAMICS; CARDIOMYOCYTES; TROPHECTODERM; COMMITMENT	We explored the underlying mechanisms of differentiation, dedifferentiation, reprogramming and transdifferentiation (cell type switchings) from landscape and flux perspectives. Lineage reprogramming is a new regenerative method to convert a matured cell into another cell including direct transdifferentiation without undergoing a pluripotent cell state and indirect transdifferentiation with an initial dedifferentiation-reversion (reprogramming) to a pluripotent cell state. Each cell type is quantified by a distinct valley on the potential landscape with higher probability. We investigated three driving forces for cell fate decision making: stochastic fluctuations, gene regulation and induction, which can lead to cell type switchings. We showed that under the driving forces the direct transdifferentiation process proceeds from a differentiated cell valley to another differentiated cell valley through either a distinct stable intermediate state or a certain series of unstable indeterminate states. The dedifferentiation process proceeds through a pluripotent cell state. Barrier height and the corresponding escape time from the valley on the landscape can be used to quantify the stability and efficiency of cell type switchings. We also uncovered the mechanisms of the underlying processes by quantifying the dominant biological paths of cell type switchings on the potential landscape. The dynamics of cell type switchings are determined by both landscape gradient and flux. The flux can lead to the deviations of the dominant biological paths for cell type switchings from the naively expected landscape gradient path. As a result, the corresponding dominant paths of cell type switchings are irreversible. We also classified the mechanisms of cell fate development from our landscape theory: super-critical pitchfork bifurcation, sub-critical pitchfork bifurcation, sub-critical pitchfork with two saddle-node bifurcation, and saddle-node bifurcation. Our model showed good agreements with the experiments. It provides a general framework to explore the mechanisms of differentiation, dedifferentiation, reprogramming and transdifferentiation.	[Xu, Li; Zhang, Kun; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu			Natural Science Foundation of China (NSFC) [21190040, 91227114, 11174105, 11305176]; Natural Science Foundation of China (973 project) [2010CB933600]; National Science Foundation [NSFMCB-0947767]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China (973 project); National Science Foundation(National Science Foundation (NSF))	This work is supported in part by Natural Science Foundation of China (NSFC Grant Nos. 21190040, 91227114, 11174105, and 11305176, 973 project 2010CB933600) and National Science Foundation (NSFMCB-0947767). NSFC website is: www.nsfc.gov.cn. NSF website: www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Ao P, 2013, THEORY MESOSCOPIC PH; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Chen L., 2013, QUANT BIOL, V1, P105, DOI DOI 10.1007/S40484-013-0008-0; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Feng HD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00550; Feng HD, 2012, BIOPHYS J, V102, P1001, DOI 10.1016/j.bpj.2012.02.002; Feng HD, 2011, J PHYS CHEM B, V115, P1254, DOI 10.1021/jp109036y; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Ge H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051133; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Graham R., 1989, NOISE NON D, V1, P225; Guckenheimer J., 1990, APPL MATH SCI; Haken H., 1987, ADV SYNERGETICS INST; HU G, 1986, Z PHYS B CON MAT, V65, P103, DOI 10.1007/BF01308404; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Li CH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0787; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; Li CH, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4716466; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Miller CA, 2008, BIOPHYS J, V95, P2183, DOI 10.1529/biophysj.107.126185; Mitchell IM, 2008, J SCI COMPUT, V35, P300, DOI 10.1007/s10915-007-9174-4; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nicolis G, 1977, SELF ORG NONEQUILIBR; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pournasr B, 2011, STEM CELLS, V29, P1933, DOI 10.1002/stem.760; Pujato M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002865; Qian H, 2006, J PHYS CHEM B, V110, P15063, DOI 10.1021/jp061858z; Qian H, 2012, ANNU REV BIOPHYS, V41, P179, DOI 10.1146/annurev-biophys-050511-102240; Qian H, 2010, J STAT PHYS, V141, P990, DOI 10.1007/s10955-010-0093-7; Qian H, 2009, METHOD ENZYMOL, V467, P111, DOI 10.1016/S0076-6879(09)67005-1; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waddington C., 1957, STRATEGY GENES; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478547; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Xu L, 2013, NONLINEARITY, V26, pR69, DOI 10.1088/0951-7715/26/2/R69; Zhang F, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734305; Zhang K, 2013, P NATL ACAD SCI USA, V110, P14930, DOI 10.1073/pnas.1305604110; Zheng LK, 2012, J MATH PHYS, V53, DOI 10.1063/1.4762825; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	61	33	35	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105216	10.1371/journal.pone.0105216	http://dx.doi.org/10.1371/journal.pone.0105216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133589	Green Published, Green Submitted			2022-12-27	WOS:000341302700088
J	Kataoka, H; Kono, H; Patel, Z; Rock, KL				Kataoka, Hiroshi; Kono, Hajime; Patel, Zubin; Rock, Kenneth L.			Evaluation of the Contribution of Multiple DAMPs and DAMP Receptors in Cell Death-Induced Sterile Inflammatory Responses	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; ISCHEMIA-REPERFUSION INJURY; INDUCED LIVER-INJURY; DYING CELLS; PARACELLULAR PERMEABILITY; COMPLEMENT ACTIVATION; RAT-LIVER; MICE; DANGER; INNATE	When cells die by necrosis in vivo they stimulate an inflammatory response. It is thought that this response is triggered when the injured cells expose proinflammatory molecules, collectively referred to as damage associated molecular patterns (DAMPs), which are recognized by cells or soluble molecules of the innate or adaptive immune system. Several putative DAMPs and/or their receptors have been identified, but whether and how much they participate in responses in vivo is incompletely understood, and they have not previously been compared side-by-side in the same models. This study focuses on evaluating the contribution of multiple mechanisms that have been proposed to or potentially could participate in cell death-induced inflammation: The third component of complement (C3), ATP (and its receptor P2X7), antibodies, the C-type lectin receptor Mincle (Clec4e), and protease-activated receptor 2 (PAR2). We investigate the role of these factors in cell death-induced inflammation to dead cells in the peritoneum and acetaminophen-induced liver damage. We find that mice deficient in antibody, C3 or PAR2 have impaired inflammatory responses to dying cells. In contrast there was no reduction in inflammation to cell death in the peritoneum or liver of mice that genetically lack Mincle, the P2X7 receptor or that were treated with apyrase to deplete ATP. These results indicate that antibody, complement and PAR2 contribute to cell death-induced inflammation but that Mincle and ATP-P2X7 receptor are not required for this response in at least 2 different in vivo models.	[Kataoka, Hiroshi; Patel, Zubin; Rock, Kenneth L.] UMass Med Sch, Dept Pathol, Worcester, MA 01655 USA; [Kono, Hajime] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan	University of Massachusetts System; University of Massachusetts Worcester; Teikyo University	Rock, KL (corresponding author), UMass Med Sch, Dept Pathol, Worcester, MA 01655 USA.	Kenneth.rock@umassmed.edu	Kataoka, Hiroshi/AAR-1444-2020	Kataoka, Hiroshi/0000-0002-2502-8304; Kono, Hajime/0000-0002-4578-8677	NIH; Diabetes Endocrinology Research Center [DK32520]; Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation; Bristol-Myers Squibb; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26670411] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the NIH to KLR and core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. H. Kono is supported by a Grant for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare and Grant-in-Aid (C) and Grant-in-Aid for Scientific Research on Innovative Areas for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. H. Kono is also supported by grants from The Naito Foundation and Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; HILL JH, 1971, J EXP MED, V133, P885, DOI 10.1084/jem.133.4.885; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; KAMIIKE W, 1982, J BIOCHEM-TOKYO, V91, P1349, DOI 10.1093/oxfordjournals.jbchem.a133822; Kanevets U, 2009, J IMMUNOL, V182, P1912, DOI 10.4049/jimmunol.0803777; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; MAJNO G, 1995, AM J PATHOL, V146, P3; MAJNO G, 1960, VIRCHOWS ARCH A, V333, P421, DOI 10.1007/BF00955327; Majno G., 2004, CELLS TISSUES DIS PR; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; PAGE AR, 1958, AM J PATHOL, V34, P645; PINCKARD RN, 1980, J CLIN INVEST, V66, P1050, DOI 10.1172/JCI109933; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vendemiale G, 1996, BIOCHEM PHARMACOL, V52, P1147, DOI 10.1016/0006-2952(96)00414-5; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390	50	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104741	10.1371/journal.pone.0104741	http://dx.doi.org/10.1371/journal.pone.0104741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127469	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300046
J	Lau, SC; Lim, HN; Basri, M; Masoumi, HRF; Tajudin, AA; Huang, NM; Pandikumar, A; Chia, CH; Andou, Y				Lau, Siaw Cheng; Lim, Hong Ngee; Basri, Mahiran; Masoumi, Hamid Reza Fard; Tajudin, Asilah Ahmad; Huang, Nay Ming; Pandikumar, Alagarsamy; Chia, Chi Hua; Andou, Yoshito			Enhanced Biocatalytic Esterification with Lipase-Immobilized Chitosan/Graphene Oxide Beads	PLOS ONE			English	Article							CANDIDA-RUGOSA LIPASE; CHITOSAN; OPTIMIZATION; SUPPORT	In this work, lipase from Candida rugosa was immobilized onto chitosan/graphene oxide beads. This was to provide an enzyme-immobilizing carrier with excellent enzyme immobilization activity for an enzyme group requiring hydrophilicity on the immobilizing carrier. In addition, this work involved a process for the preparation of an enzymatically active product insoluble in a reaction medium consisting of lauric acid and oleyl alcohol as reactants and hexane as a solvent. This product enabled the stability of the enzyme under the working conditions and allowed the enzyme to be readily isolated from the support. In particular, this meant that an enzymatic reaction could be stopped by the simple mechanical separation of the "insoluble'' enzyme from the reaction medium. Chitosan was incorporated with graphene oxide because the latter was able to enhance the physical strength of the chitosan beads by its superior mechanical integrity and low thermal conductivity. The X-ray diffraction pattern showed that the graphene oxide was successfully embedded within the structure of the chitosan. Further, the lipase incorporation on the beads was confirmed by a thermo-gravimetric analysis. The lipase immobilization on the beads involved the functionalization with coupling agents, N-hydroxysulfosuccinimide sodium (NHS) and 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC), and it possessed a high enzyme activity of 64 U. The overall esterification conversion of the prepared product was 78% at 60 degrees C, and it attained conversions of 98% and 88% with commercially available lipozyme and novozyme, respectively, under similar experimental conditions.	[Lau, Siaw Cheng; Lim, Hong Ngee; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Lim, Hong Ngee] Univ Putra Malaysia, Inst Adv Technol, Serdang 43400, Selangor, Malaysia; [Basri, Mahiran] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang 43400, Selangor, Malaysia; [Tajudin, Asilah Ahmad] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang 43400, Selangor, Malaysia; [Huang, Nay Ming; Pandikumar, Alagarsamy] Univ Malaya, Dept Phys, Fac Sci, Low Dimens Mat Res Ctr, Kuala Lumpur 59100, Malaysia; [Chia, Chi Hua] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia; [Andou, Yoshito] Kyushu Inst Technol, Ecotown Collaborat Res & Dev Ctr Environm & Recyc, Fukuoka, Japan	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Kebangsaan Malaysia; Kyushu Institute of Technology	Lim, HN (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.	janet_limhn@yahoo.com	Chia, Chin-hua/I-7261-2013; Huang, NM/C-2423-2009; Alagarsamy, Pandikumar/AAG-4582-2019; Lim, HN/C-4927-2011; Alagarsamy, Pandikumar/D-6811-2011	Chia, Chin-hua/0000-0002-5269-4070; Alagarsamy, Pandikumar/0000-0002-8804-5195; Lim, HN/0000-0003-2436-8953; Alagarsamy, Pandikumar/0000-0002-8804-5195	Ministry of Higher Education [FRGS/1/2012/ST05/UPM/02/3, UM.C/625/1/HIR/MOHE/SC/21]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This research work was supported by the Fundamental Research Grant Scheme (FRGS/1/2012/ST05/UPM/02/3) and a High Impact Research Grant (UM.C/625/1/HIR/MOHE/SC/21) from the Ministry of Higher Education. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Aghabarari B, 2014, J TAIWAN INST CHEM E, V45, P1468, DOI 10.1016/j.jtice.2014.03.006; Arena B.J., 1981, US Pat, Patent No. [4274980, 4,274,980]; Basri M, 2013, J MOL CATAL B-ENZYM, V85-86, P214, DOI 10.1016/j.molcatb.2012.09.013; Belhaj-Ben Romdhane I, 2011, J MOL CATAL B-ENZYM, V68, P230, DOI 10.1016/j.molcatb.2010.11.010; Betigeri SS, 2002, BIOMATERIALS, V23, P3627, DOI 10.1016/S0142-9612(02)00095-9; Cabrera Z, 2009, J MOL CATAL B-ENZYM, V57, P171, DOI 10.1016/j.molcatb.2008.08.012; Chiou SH, 2004, BIOMATERIALS, V25, P197, DOI 10.1016/S0142-9612(03)00482-4; Foresti ML, 2007, ENZYME MICROB TECH, V40, P769, DOI 10.1016/j.enzmictec.2006.06.009; Glasser W.G., 1998, Patent No. [WO/1998/041546, 1998041546]; Gunawan E.R., 2004, J OLEO SCI, V53, P471, DOI [10.5650/jos.53.471, DOI 10.5650/JOS.53.471, DOI 10.5650/jos.53.471]; Haigh KF, 2014, CHEM ENG RES DES, V92, P713, DOI 10.1016/j.cherd.2014.01.006; Hernandez-Martin E, 2009, J AGR FOOD CHEM, V57, P701, DOI 10.1021/jf802017x; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Huang XJ, 2007, EUR POLYM J, V43, P3710, DOI 10.1016/j.eurpolymj.2007.06.010; Hung TC, 2003, J MOL CATAL B-ENZYM, V26, P69, DOI 10.1016/S1381-1177(03)00167-X; Juan C, 2014, NEW BIOTECHNOLOGY; Kawamura Y, 1996, United States Patent, Patent No. 5508185; Kuo CH, 2012, CARBOHYD POLYM, V87, P2538, DOI 10.1016/j.carbpol.2011.11.026; KWON DY, 1986, J AM OIL CHEM SOC, V63, P89, DOI 10.1007/BF02676129; Kyzas GZ, 2014, MATER LETT, V128, P46, DOI 10.1016/j.matlet.2014.04.129; Lee DG, 2009, J MOL CATAL B-ENZYM, V57, P62, DOI 10.1016/j.molcatb.2008.06.017; Leuba, 1978, [No title captured], Patent No. [4 094 743, 4094743]; Lim HN, 2012, J NON-CRYST SOLIDS, V358, P525, DOI 10.1016/j.jnoncrysol.2011.11.007; Lu XX, 2012, J AGR FOOD CHEM, V60, P9273, DOI 10.1021/jf303096c; Mizuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066528; Orrego CE, 2010, CARBOHYD POLYM, V79, P9, DOI 10.1016/j.carbpol.2009.06.015; Pires-Cabral P, 2010, BIOCHEM ENG J, V48, P246, DOI 10.1016/j.bej.2009.10.021; Raghavendra T, 2013, BIORESOURCE TECHNOL, V140, P103, DOI 10.1016/j.biortech.2013.04.071; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Wang J., 2010, Pat, Patent No. [WO 2010065121 A1, 2010065121, WO/2010/065121]; Wang JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043478; Weber N, 2001, J AGR FOOD CHEM, V49, P5210, DOI 10.1021/jf0107407; Won K, 2005, PROCESS BIOCHEM, V40, P2149, DOI 10.1016/j.procbio.2004.08.014; Xie WL, 2012, BIOMASS BIOENERG, V36, P373, DOI 10.1016/j.biombioe.2011.11.006; Xu J, 2006, J MEMBRANE SCI, V281, P410, DOI 10.1016/j.memsci.2006.04.009; Ye P, 2006, BIOMATERIALS, V27, P4169, DOI 10.1016/j.biomaterials.2006.03.027; Yi SS, 2009, J MOL CATAL B-ENZYM, V57, P123, DOI 10.1016/j.molcatb.2008.08.002; Zang LM, 2014, IND ENG CHEM RES, V53, P3448, DOI 10.1021/ie404072s	39	23	24	2	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104695	10.1371/journal.pone.0104695	http://dx.doi.org/10.1371/journal.pone.0104695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127038	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000340879300042
J	Tsai, JZ; Peng, SJ; Chen, YW; Wang, KW; Li, CH; Wang, JY; Chen, CJ; Lin, HJ; Smith, EE; Wu, HK; Sung, SF; Yeh, PS; Hsin, YL				Tsai, Jang-Zern; Peng, Syu-Jyun; Chen, Yu-Wei; Wang, Kuo-Wei; Li, Chen-Hua; Wang, Jing-Yi; Chen, Chi-Jen; Lin, Huey-Juan; Smith, Eric Edward; Wu, Hsiao-Kuang; Sung, Sheng-Feng; Yeh, Poh-Shiow; Hsin, Yue-Loong			Automated Segmentation and Quantification of White Matter Hyperintensities in Acute Ischemic Stroke Patients with Cerebral Infarction	PLOS ONE			English	Article							SMALL VESSEL DISEASE; MULTIPLE-SCLEROSIS LESIONS; MR FLAIR IMAGES; PROBABILISTIC SEGMENTATION; INTRACEREBRAL HEMORRHAGE; AMYLOID ANGIOPATHY; REGISTRATION; RELIABILITY; PROGRESSION; PREDICTORS	White matter hyperintensities (WMHs) of presumed vascular origin are common in ageing population, especially in patients with acute cerebral infarction and the volume has been reported to be associated with mental impairment and the risk of hemorrhage from antithrombotic agents. WMHs delineation can be computerized to minimize human bias. However, the presence of cerebral infarcts greatly degrades the accuracy of WMHs detection and thus limits the application of computerized delineation to patients with acute cerebral infarction. We propose a computer-assisted segmentation method to depict WMHs in the presence of cerebral infarcts in combined T1-weighted, fluid attenuation inversion recovery, and diffusion-weighted magnetic resonance imaging (MRI). The proposed method detects WMHs by empirical threshold and atlas information, with subtraction of white matter voxels affected by acute infarction. The method was derived using MRI from 25 hemispheres with WMHs only and 13 hemispheres with both WMHs and cerebral infarcts. Similarity index (SI) and correlation were utilized to assess the agreement between the new automated method and a gold standard visually guided semi-automated method done by an expert rater. The proposed WMHs segmentation approach produced average SI, sensitivity and specificity of 83.142 +/- 11.742, 84.154 +/- 16.086 and 99.988 +/- 0.029% with WMHs only and of 68.826 +/- 14.036, 74.381 +/- 18.473 and 99.956 +/- 0.054% with both WMHs and cerebral infarcts in the derivation cohort. The performance of the proposed method with an external validation cohort was also highly consistent with that of the experienced rater.	[Tsai, Jang-Zern; Peng, Syu-Jyun; Wang, Kuo-Wei] Natl Cent Univ, Dept Elect Engn, Jhongli, Taoyuan County, Taiwan; [Chen, Yu-Wei; Wu, Hsiao-Kuang] Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan; [Chen, Yu-Wei; Li, Chen-Hua; Wang, Jing-Yi] Landseed Hosp, Dept Neurol, Pingzhen City, Taoyuan County, Taiwan; [Chen, Yu-Wei; Li, Chen-Hua] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Kuo-Wei] Landseed Hosp, Dept Med Imaging, Pingzhen City, Taoyuan County, Taiwan; [Chen, Chi-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei City, Taiwan; [Lin, Huey-Juan; Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Smith, Eric Edward] Univ Calgary, Dept Clin Neurosci Radiol & Community Hlth Sci, Calgary, AB, Canada; [Sung, Sheng-Feng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Hsin, Yue-Loong] Chung Shan Med Univ, Dept Neurol, Taichung, Taiwan; [Hsin, Yue-Loong] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Hsin, Yue-Loong] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan	National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Chi Mei Hospital; University of Calgary; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University	Chen, YW (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Jhongli, Taoyuan County, Taiwan.	yuwchen@gmail.com	Smith, Eric E/C-5443-2012; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022	Smith, Eric E/0000-0003-3956-1668; 	Annual National Central University [NCU/LSH-100-A-006]; Landseed Hospital Joint R & D Project, Taiwan; National Science Council, Taiwan [NSC 101-2221-E-008-015-MY3]	Annual National Central University; Landseed Hospital Joint R & D Project, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The study is supported by a grant (NCU/LSH-100-A-006) from 2011 Annual National Central University and Landseed Hospital Joint R & D Project, Taiwan and in part by a grant (NSC 101-2221-E-008-015-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; Anbeek P, 2005, NEUROIMAGE, V27, P795, DOI 10.1016/j.neuroimage.2005.05.046; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2004, MED IMAGE ANAL, V8, P205, DOI 10.1016/j.media.2004.06.019; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Beare R, 2009, NEUROIMAGE, V47, P199, DOI 10.1016/j.neuroimage.2009.03.055; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dyrby TB, 2008, NEUROIMAGE, V41, P335, DOI 10.1016/j.neuroimage.2008.02.024; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huppertz HJ, 2008, EPILEPSIA, V49, P772, DOI 10.1111/j.1528-1167.2007.01436.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Khayati R, 2008, COMPUT BIOL MED, V38, P379, DOI 10.1016/j.compbiomed.2007.12.005; Khayati R, 2008, COMPUT MED IMAG GRAP, V32, P124, DOI 10.1016/j.compmedimag.2007.10.003; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Pantoni L, 2002, STROKE, V33, P2827, DOI 10.1161/01.STR.0000038424.70926.5E; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schoonheim MM, 2014, HUM BRAIN MAPP, V35, P2348, DOI 10.1002/hbm.22332; Schulz UG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000261; Shi L, 2013, J NEUROSCI METH, V213, P138, DOI 10.1016/j.jneumeth.2012.12.014; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Smith EE, 2010, STROKE, V41, P1933, DOI 10.1161/STROKEAHA.110.579078; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tsai JZ, 2014, BIOMED RES INT, V2014; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weinstein G, 2013, STROKE, V44, P2787, DOI 10.1161/STROKEAHA.113.000947; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	45	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104011	10.1371/journal.pone.0104011	http://dx.doi.org/10.1371/journal.pone.0104011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127120	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300011
J	Fisher, A; Bassett, K; Wright, JM; Brookhart, MA; Freeman, H; Dormuth, CR				Fisher, Anat; Bassett, Ken; Wright, James M.; Brookhart, M. Alan; Freeman, Hugh; Dormuth, Colin R.			Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis - A Population-Based Cohort Study	PLOS ONE			English	Article							NECROSIS-FACTOR ANTAGONISTS; ANTI-TNF; CLINICAL-PRACTICE; BLOCKING-AGENTS; FACTOR INHIBITORS; ALPHA AGENTS; INFLIXIMAB; EFFICACY; ETANERCEPT; ADHERENCE	Objective: To compare persistence with tumor necrosis factor alpha (TNF) antagonists among rheumatoid arthritis patients in British Columbia. Treatment persistence has been suggested as a proxy for real-world therapeutic benefit and harm of treatments for chronic non-curable diseases, including rheumatoid arthritis. We hypothesized that the different pharmacological characteristics of infliximab, adalimumab and etanercept cause statistically and clinically significant differences in persistence. Methods: We conducted a population-based cohort study using administrative health data from the Canadian province of British Columbia. The study cohort included rheumatoid arthritis patients who initiated the first course of a TNF antagonist between 2001 and 2008. Persistence was measured as the time between first dispensing to discontinuation. Drug discontinuation was defined as a drug-free interval of 180 days or switching to another TNF antagonist, anakinra, rituximab or abatacept. Persistence was estimated and compared using survival analysis. Results: The study cohort included 2,923 patients, 63% treated with etanercept. Median persistence in years (95% confidence interval) with infliximab was 3.7 (2.9-4.9), with adalimumab 3.3 (2.6-4.1) and with etanercept 3.8 (3.3-4.3). Similar risk of discontinuation was observed for the three drugs: the hazard ratio (95% confidence interval) was 0.98 (0.85-1.13) comparing infliximab with etanercept, 0.95 (0.78-1.15) comparing infliximab with adalimumab and 1.04 (0.88-1.22) comparing adalimumab with etanercept. Conclusions: Similar persistence was observed with infliximab, adalimumab and etanercept in rheumatoid arthritis patients during the first 9 years of use. If treatment persistence is a good proxy for the therapeutic benefit and harm of these drugs, then this finding suggests that the three drugs share an overall similar benefit-harm profile in rheumatoid arthritis patients.	[Fisher, Anat; Bassett, Ken; Wright, James M.; Dormuth, Colin R.] Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada; [Fisher, Anat; Bassett, Ken; Wright, James M.; Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Bassett, Ken] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.; Freeman, Hugh] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Fisher, A (corresponding author), Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada.	anat.fisher@ti.ubc.ca		Fisher, Anat/0000-0001-9730-5107; Dormuth, Colin/0000-0001-8577-8783	University of British Columbia; British Columbia Ministry of Health	University of British Columbia; British Columbia Ministry of Health	The study was supported by the University of British Columbia Graduate Fellowship and a grant to the University of British Columbia from the British Columbia Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa NE, 2010, CLIN REV ALLERG IMMU, V38, P82, DOI 10.1007/s12016-009-8140-3; Amuah JE, 2010, PHARMACOEPIDEM DR S, V19, P670, DOI 10.1002/pds.1946; Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bensen B, 2011, J RHEUMATOL, V38, P1155; Berthelot JM, 2010, JOINT BONE SPINE, V77, P564, DOI 10.1016/j.jbspin.2010.05.011; Blum MA, 2011, CLIN THER, V33, P901, DOI 10.1016/j.clinthera.2011.06.001; BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293; British Columbia Ministry of Health, 2011, YOUR LEV FAIR PHARMA; British Columbia Ministry of Health, 2011, SPEC AUTH REQ AB AD; Brocq O, 2007, JOINT BONE SPINE, V74, P148, DOI 10.1016/j.jbspin.2006.06.011; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Carmona L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1941; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cruyssen BV, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2001; Devine EB, 2011, PHARMACOTHERAPY, V31, P39, DOI 10.1592/phco.31.1.39; Du Pan SM, 2009, ARTHRIT RHEUM-ARTHR, V61, P560, DOI 10.1002/art.24463; eCPS (online Compendium of Pharmaceuticals and Specialties), 2008, REM INFL; eCPS (online Compendium of Pharmaceuticals and Specialties), 2009, ENB ET; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fernandez-Nebro A, 2007, J RHEUMATOL, V34, P2334; Filippini M, 2010, CLIN REV ALLERG IMMU, V38, P90, DOI 10.1007/s12016-009-8142-1; Finckh A, 2006, ANN RHEUM DIS, V65, P746, DOI 10.1136/ard.2005.045062; Flendrie M, 2003, ANN RHEUM DIS, V62, P30; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hochberg MC, 2003, ANN RHEUM DIS, V62, P13, DOI 10.1136/ard.62.suppl_2.ii13; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Hyrich KL, 2011, RHEUMATOLOGY, V50, P117, DOI 10.1093/rheumatology/keq209; Ingham M, 2010, ARTHRITIS RHEUM, V62, P76; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Koncz T, 2010, EXPERT OPIN BIOL TH, V10, P1367, DOI 10.1517/14712598.2010.510508; Kristensen LE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2084; Kristensen LE, 2006, ARTHRITIS RHEUM, V54, P600, DOI 10.1002/art.21570; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; Marchesoni A, 2009, ANN NY ACAD SCI, V1173, P837, DOI 10.1111/j.1749-6632.2009.04621.x; Nestorov I, 2005, SEMIN ARTHRITIS RHEU, V34, P12, DOI 10.1016/j.semarthrit.2005.01.004; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Ogale S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-204; Ostergaard M, 2007, SCAND J RHEUMATOL, V36, DOI 10.1080/03009740601089267; Pincus T, 2004, RHEUM DIS CLIN N AM, V30, P701, DOI 10.1016/j.rdc.2004.08.002; Pocock JM, 2009, RHEUMATOLOGY, V48, pI69; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Sokka T, 2003, ARTHRITIS RHEUM-US, V48, P313, DOI 10.1002/art.10817; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; WOLFE F, 1995, BAILLIERE CLIN RHEUM, V9, P619, DOI 10.1016/S0950-3579(05)80305-X; Wu E, 2008, CURR MED RES OPIN, V24, P2229, DOI 10.1185/03007990802229548; Yazici Y, 2009, J RHEUMATOL, V36, P907, DOI 10.3899/jrheum.080592; Zhang J, 2011, ARTHRIT CARE RES, V63, P1672, DOI 10.1002/acr.20643; Zink A, 2006, ARTHRITIS RHEUM-US, V54, P3399, DOI 10.1002/art.22193	57	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105193	10.1371/journal.pone.0105193	http://dx.doi.org/10.1371/journal.pone.0105193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141123	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200059
J	Khibnik, LA; Tritsch, NX; Sabatini, BL				Khibnik, Lena A.; Tritsch, Nicolas X.; Sabatini, Bernardo L.			A Direct Projection from Mouse Primary Visual Cortex to Dorsomedial Striatum	PLOS ONE			English	Article							BASAL GANGLIA; CORTICOSTRIATAL NEURONS; FUNCTIONAL-ORGANIZATION; SUPERIOR COLLICULUS; CAUDATE-NUCLEUS; CRE-RECOMBINASE; CORTICAL INPUT; RAT; CAT; PATHWAY	The mammalian striatum receives inputs from many cortical areas, but the existence of a direct axonal projection from the primary visual cortex (V1) is controversial. In this study we use anterograde and retrograde tracing techniques to demonstrate that V1 directly innervates a topographically defined longitudinal strip of dorsomedial striatum in mice. We find that this projection forms functional excitatory synapses with direct and indirect pathway striatal projection neurons (SPNs) and engages feed-forward inhibition onto these cells. Importantly, stimulation of V1 afferents is sufficient to evoke phasic firing in SPNs. These findings therefore identify a striatal region that is functionally innervated by V1 and suggest that early visual processing may play an important role in striatal-based behaviors.	[Khibnik, Lena A.; Tritsch, Nicolas X.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Tritsch, Nicolas/U-5266-2019	Tritsch, Nicolas/0000-0003-3181-7681	NINDS [NS046579, NS007484]; Nancie Lurie Marks Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancie Lurie Marks Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS NS046579 and NS007484, and by the Nancie Lurie Marks Foundation (http://www.nlmfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; BATTAGLINI PP, 1982, EXP BRAIN RES, V47, P28; CARMAN JB, 1963, BRAIN, V86, P525, DOI 10.1093/brain/86.3.525; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; FAULL RLM, 1986, NEUROSCIENCE, V19, P1119, DOI 10.1016/0306-4522(86)90128-4; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; LOPEZFIGUEROA MO, 1995, ACTA NEUROBIOL EXP, V55, P165; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Nagy A, 2003, EUR J NEUROSCI, V18, P449, DOI 10.1046/j.1460-9568.2003.02764.x; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; RHOADES RW, 1982, J COMP NEUROL, V208, P239, DOI 10.1002/cne.902080304; RHOADES RW, 1985, DEV BRAIN RES, V17, P171, DOI 10.1016/0165-3806(85)90141-5; Rosell A, 1999, NEUROSCI RES, V34, P257, DOI 10.1016/S0168-0102(99)00060-7; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schulz Jan M, 2010, Front Synaptic Neurosci, V2, P23, DOI 10.3389/fnsyn.2010.00023; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; STRECKER RE, 1985, BRAIN RES, V329, P350, DOI 10.1016/0006-8993(85)90548-7; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; UPDYKE BV, 1993, J COMP NEUROL, V327, P159, DOI 10.1002/cne.903270202; VEENING JG, 1980, NEUROSCIENCE, V5, P1253, DOI 10.1016/0306-4522(80)90198-0; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; WEBSTER KE, 1965, J ANAT, V99, P329; WEBSTER KE, 1961, J ANAT, V95, P532; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	42	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104501	10.1371/journal.pone.0104501	http://dx.doi.org/10.1371/journal.pone.0104501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141172	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200024
J	Singh, S; Dabur, R; Gatne, MM; Singh, B; Gupta, S; Pawar, S; Sharma, SK; Sharma, GL				Singh, Seema; Dabur, Rajesh; Gatne, Madhumanjiri M.; Singh, Bharat; Gupta, Shilpi; Pawar, Sharad; Sharma, Sunil K.; Sharma, Gainda L.			In Vivo Efficacy of a Synthetic Coumarin Derivative in a Murine Model of Aspergillosis	PLOS ONE			English	Article							LIPOSOMAL AMPHOTERICIN-B; INVASIVE ASPERGILLOSIS; FUMIGATUS INFECTION; ANTIFUNGAL ACTIVITY; PHARMACOKINETICS; CASPOFUNGIN; COMBINATION; TOXICITY; THERAPY; PATIENT	Despite advances in therapeutic modalities, aspergillosis remains a leading cause of mortality. This has necessitated the identification of effective and safe antifungal molecules. In the present study, in vivo safety and antifungal efficacy of a coumarin derivative, N, N, N-Triethyl-11-(4-methyl-2-oxo-2H-benzopyran-7-yloxy)-11-oxoundecan-1-aminium bromide (SCD-1), was investigated. The maximum tolerable dose of compound was determined according to OECD 423 guidelines. The compound could be assigned to category IV of the Globally Harmonized System and its LD50 cut-off was found to be 2000 mg/kg body weight. The survival increased in Aspergillus fumigatus-infected mice treated with a dose of 200 mg/kg, orally or 100 mg/kg body weight, intraperitoneally, of SCD-1 in comparison to infected-untreated animals. The SCD-1 treatment resulted in significant reduction in colony counts in vital organs of the animals. Its protective effect was also observed on day 14 as there was marked reduction in fungal colonies. The treatment with SCD-1 also reduced the levels of serum biochemical parameters with respect to infected-untreated animals. It could be concluded that SCD-1 is a quite safe antifungal compound, which conferred dose dependent protection against experimental aspergillosis. Therefore, SCD-1 holds potential for developing new formulations for aspergillosis.	[Singh, Seema; Singh, Bharat; Sharma, Gainda L.] CSIR Inst Genom & Integrat Biol, Delhi, India; [Singh, Seema] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Dabur, Rajesh] Maharshi Dayanand Univ, Dept Biochem, Rohtak, Haryana, India; [Gatne, Madhumanjiri M.] Bombay Vet Coll, Dept Pharmacol & Toxicol, Mumbai, Maharashtra, India; [Gupta, Shilpi; Sharma, Sunil K.] Univ Delhi, Dept Chem, New Delhi, India; [Pawar, Sharad] Natl Res Inst Basic Ayurved Sci, Dept Pharmacol, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University; Maharshi Dayanand University; Maharashtra Animal & Fishery Sciences University; University of Delhi	Sharma, GL (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	drglsharma@hotmail.com	Pawar, Sharad/GRR-2010-2022; Singh, Bharat/GOK-1138-2022; Dabur, Rajesh/AAG-2681-2019	Pawar, Sharad/0000-0003-3765-9426; Dabur, Rajesh/0000-0001-7189-5188; Singh, Bharat/0000-0001-9290-1225; Gupta, Dr. Shilpi/0000-0001-5084-4592	Council of Scientific and Industrial Research, Government of India; University Grants Commission, Government of India; Defence Research and Development Organisation (DRDO), Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Defence Research and Development Organisation (DRDO), Government of India(Defence Research & Development Organisation (DRDO))	The authors are thankful to Council of Scientific and Industrial Research, Government of India for providing research facilities and financial support. SS is the recipient of fellowship from University Grants Commission, Government of India. The authors also acknowledge the Defence Research and Development Organisation (DRDO), Government of India, for supporting the project at Department of Chemistry, University of Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Benincasa M, 2011, ACS NANO, V5, P199, DOI 10.1021/nn1023522; Cardoso SH, 2011, CHEM BIOL DRUG DES, V77, P489, DOI 10.1111/j.1747-0285.2011.01120.x; Carvalho A, 2012, CLIN MICROBIOL INFEC, V18, P120, DOI 10.1111/j.1469-0691.2011.03681.x; Cekmen N, 2011, J RES MED SCI, V16, P219; Clark CR, 2013, REGUL TOXICOL PHARM, V67, P409, DOI 10.1016/j.yrtph.2013.08.020; Gershkovich P, 2009, J ANTIMICROB CHEMOTH, V64, P101, DOI 10.1093/jac/dkp140; Graybill JR, 2003, J ANTIMICROB CHEMOTH, V52, P656, DOI 10.1093/jac/dkg425; Groll AH, 2006, ANTIMICROB AGENTS CH, V50, P3418, DOI 10.1128/AAC.00241-06; Gupta S, 2012, J CHEM SCI, V124, P437, DOI 10.1007/s12039-011-0147-7; Hadjipavlou-Litina D, 2007, J ENZYM INHIB MED CH, V22, P287, DOI 10.1080/14756360601073914; Hadrich I, 2012, MYCOPATHOLOGIA, V174, P131, DOI 10.1007/s11046-012-9526-y; Hope WW, 2010, ANTIMICROB AGENTS CH, V54, P4879, DOI 10.1128/AAC.00673-10; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Karthaus M, 2013, CURR PHARM DESIGN, V19, P3569, DOI 10.2174/13816128113199990330; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kleinberg M, 2006, INT J ANTIMICROB AG, V27, pS12, DOI 10.1016/j.ijantimicag.2006.03.013; Kostova Irena, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P29, DOI 10.2174/1568011053352550; Lamoth F, 2013, ANTIMICROB AGENTS CH, V57, P1035, DOI 10.1128/AAC.01857-12; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee S, 2006, BIOORG MED CHEM LETT, V16, P4596, DOI 10.1016/j.bmcl.2006.06.007; Lehievre L, 2013, MED MALADIES INFECT, V43, P139, DOI 10.1016/j.medmal.2013.02.010; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lewis RE, 2002, ANTIMICROB AGENTS CH, V46, P3208, DOI 10.1128/AAC.46.10.3208-3214.2002; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; Montagner C, 2008, Z NATURFORSCH C, V63, P21; OECD Guideline for testing of Chemicals, 2001, GUID 423 AC OR TOX A; Phuttharak W, 2005, AM J NEURORADIOL, V26, P835; Richie DL, 2011, VIRULENCE, V2, P12, DOI 10.4161/viru.2.1.13345; Schlede E, 2005, REGUL TOXICOL PHARM, V42, P15, DOI 10.1016/j.yrtph.2004.12.006; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; Seidle T, 2010, TOXICOL SCI, V116, P382, DOI 10.1093/toxsci/kfq143; Sheng CQ, 2011, CURR MED CHEM, V18, P733, DOI 10.2174/092986711794480113; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Singh G, 2005, ANTIMICROB AGENTS CH, V49, P1369, DOI 10.1128/AAC.49.4.1369-1376.2005; Singh S, 2012, J PROTEOME RES, V11, P3259, DOI 10.1021/pr300006j; Sionov E, 2006, J INFECTION, V53, P131, DOI 10.1016/j.jinf.2005.10.015; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Stein AC, 2006, J ETHNOPHARMACOL, V107, P95, DOI 10.1016/j.jep.2006.02.009; SZOKA FC, 1987, ANTIMICROB AGENTS CH, V31, P421, DOI 10.1128/AAC.31.3.421; Wallace TL, 1997, ANTIMICROB AGENTS CH, V41, P2238, DOI 10.1128/AAC.41.10.2238; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103039	10.1371/journal.pone.0103039	http://dx.doi.org/10.1371/journal.pone.0103039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140804	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200003
J	Fueller, E; Schaefer, D; Fischer, U; Krell, PFI; Stanulla, M; Borkhardt, A; Slany, RK				Fueller, Elisa; Schaefer, Daniel; Fischer, Ute; Krell, Pina F. I.; Stanulla, Martin; Borkhardt, Arndt; Slany, Robert K.			Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL), a New Method to Detect Translocations in Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MLL BREAKPOINTS; AIEOP-BFM; CLUSTER; GENE; REARRANGEMENTS; ELEMENTS; FUSION; REGION; CELL	Here we present a novel method "Genomic inverse PCR for exploration of ligated breakpoints" (GIPFEL) that allows the sensitive detection of recurrent chromosomal translocations. This technique utilizes limited amounts of DNA as starting material and relies on PCR based quantification of unique DNA sequences that are created by circular ligation of restricted genomic DNA from translocation bearing cells. Because the complete potential breakpoint region is interrogated, a prior knowledge of the individual, specific interchromosomal fusion site is not required. We validated GIPFEL for the five most common gene fusions associated with childhood leukemia (MLL-AF4, MLL-AF9, MLL-ENL, ETV6-RUNX1, and TCF3-PBX1). A workflow of restriction digest, purification, ligation, removal of linear fragments and precipitation enriching for circular DNA was developed. GIPFEL allowed detection of translocation specific signature sequences down to a 10(-4) dilution which is close to the theoretical limit. In a blinded proof-of-principle study utilizing DNA from cell lines and 144 children with B-precursor-ALL associated translocations this method was 100% specific with no false positive results. Sensitivity was 83%, 65%, and 24% for t(4;11), t(9;11) and t(11;19) respectively. Translocation t(12;21) was correctly detected in 64% and t(1;19) in 39% of the cases. In contrast to other methods, the characteristics of GIPFEL make it particularly attractive for prospective studies.	[Fueller, Elisa; Slany, Robert K.] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany; [Schaefer, Daniel; Fischer, Ute; Krell, Pina F. I.; Borkhardt, Arndt] Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Univ Childrens Hosp, Dusseldorf, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany	University of Erlangen Nuremberg; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Borkhardt, A (corresponding author), Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Univ Childrens Hosp, Dusseldorf, Germany.	arndt.borkhardt@med.uni-duesseldorf.de; robert.slany@fau.de	Stanulla, Martin/N-4674-2017	Stanulla, Martin/0000-0002-3834-0727	German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS) [3612S70019]	German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS)	This research was funded by a grant of the German Ministry for Radiation Protection (Bundesministerium fur Strahlenschutz, BfS) grant number 3612S70019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2000, GENE CHROMOSOME CANC, V27, P412, DOI 10.1002/(SICI)1098-2264(200004)27:4<412::AID-GCC11>3.0.CO;2-X; Cimino G, 1997, CANCER RES, V57, P2879; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Emerenciano M, 2013, BRIT J HAEMATOL, V161, P224, DOI 10.1111/bjh.12250; Felix CA, 1997, BLOOD, V90, P4679, DOI 10.1182/blood.V90.12.4679.4679_4679_4686; Ghosh S, 2013, LEUKEMIA, V27, P1745, DOI 10.1038/leu.2013.1; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KOBAYASHI H, 1993, BLOOD, V82, P547; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; Lausten-Thomsen U, 2008, EUR J HAEMATOL, V81, P161, DOI 10.1111/j.1600-0609.2008.01091.x; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; Megonigal MD, 1997, P NATL ACAD SCI USA, V94, P11583, DOI 10.1073/pnas.94.21.11583; Meyer C, 2005, P NATL ACAD SCI USA, V102, P449, DOI 10.1073/pnas.0406994102; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Rodic N, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-22; Rowley JD, 2013, SCIENCE, V340, P1412, DOI 10.1126/science.1241318; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Thandla SP, 1999, BLOOD, V93, P293, DOI 10.1182/blood.V93.1.293.401k37_293_299; van der Burg M, 1999, LEUKEMIA, V13, P2107, DOI 10.1038/sj.leu.2401595; von Goessel H, 2009, LEUKEMIA RES, V33, P1082, DOI 10.1016/j.leukres.2008.11.001; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Wiemels JL, 2008, CANCER RES, V68, P9935, DOI 10.1158/0008-5472.CAN-08-2139	24	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104419	10.1371/journal.pone.0104419	http://dx.doi.org/10.1371/journal.pone.0104419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137060	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100032
J	Hofman, R; de Bekker-Grob, EW; Richardus, JH; de Koning, HJ; van Ballegooijen, M; Korfage, IJ				Hofman, Robine; de Bekker-Grob, Esther W.; Richardus, Jan Hendrik; de Koning, Harry J.; van Ballegooijen, Marjolein; Korfage, Ida J.			Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; WILLINGNESS-TO-PAY; HEALTH-CARE; EFFICACY; COHORT; WOMEN; RISK	Objectives: To assess how girls' preferences have changed almost 3 years after the much debated start of the human papillomavirus (HPV) vaccination program. Methods: A discrete choice experiment (DCE) was conducted among girls aged 11-15 years who were invited, or were not yet invited, to get vaccinated. A panel latent class model was used to determine girls' preferences for vaccination based on five characteristics: degree of protection against cervical cancer; duration of protection; risk of mild side-effects; age of vaccination; and the number of required doses of the vaccine. Results: The response rate was 85% (500/592). Most girls preferred vaccination at age 14 years (instead of at age 9 years) and a 2-dose scheme (instead of the current 3-dose scheme). Girls were willing to trade-off 7% (CI: 3.2% to 10.8%) of the degree of protection to have 10% less risk of mild side-effects, and 4% (CI: 1.2% to 5.9%) to receive 2 doses instead of 3 doses. Latent class analyses showed that there was preference heterogeneity among girls, i.e., higher educated girls and HPV vaccinated girls had a higher probability to opt for HPV vaccination at a higher age than lower educated girls or non-vaccinated girls. Conclusions: Three years after the start of HPV vaccination program the risk of mild side-effects and age at vaccination seem to have become less important. For the Dutch national immunization program, we recommend not to lower the current target age of 12 years. A 2-dose scheme may result in a higher uptake and we recommend that if this scheme is introduced, it needs to receive adequate publicity.	[Hofman, Robine; de Bekker-Grob, Esther W.; Richardus, Jan Hendrik; de Koning, Harry J.; van Ballegooijen, Marjolein; Korfage, Ida J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Richardus, Jan Hendrik] Municipal Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hofman, R (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	r.hofman@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021; de+Koning, Harry/AAF-9062-2019	Richardus, Jan Hendrik/0000-0003-0564-6313; de+Koning, Harry/0000-0003-4682-3646	Dutch Cancer Society [EMCR 2009-4561]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was funded by the Dutch Cancer Society (no. EMCR 2009-4561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AJ, 2004, BJOG-INT J OBSTET GY, V111, P775, DOI 10.1111/j.1471-0528.2004.00197.x; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brown DS, 2010, VACCINE, V28, P1702, DOI 10.1016/j.vaccine.2009.12.024; Centers for Disease Control and Prevention, 2013, WHAT AR RISKS THIS V; Centers for Disease Control and Prevention, 2014, POSS SID EFF VACC; de Bekker-Grob EW, 2013, BRIT J CANCER, V108, P533, DOI 10.1038/bjc.2013.5; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Bekker-Grob EW, 2010, VACCINE, V28, P6692, DOI 10.1016/j.vaccine.2010.08.001; de Hoogh PAAM, 2011, IMMUNIZATION COVERAG; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Herbild L, 2009, VALUE HEALTH, V12, P560, DOI 10.1111/j.1524-4733.2008.00465.x; Hole AR, 2007, HEALTH ECON, V16, P827, DOI 10.1002/hec.1197; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2006, HEALTH ECON, V15, P797, DOI 10.1002/hec.1104; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Oteng B, 2011, SEX TRANSM INFECT, V87, P52, DOI 10.1136/sti.2009.041392; Phillips Kathryn A, 2006, Prev Chronic Dis, V3, pA75; Puthanakit T, 2013, IMMUNE RESPONSES 2 D; RIVM, 2014, VOORT 1 PRIK MIND TE; Roteli-Martins CM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18865; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Ryan M, 2009, HEALTH ECON, V18, P321, DOI 10.1002/hec.1369; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Zwakhals S, 2012, HPV COHORT 1998 INTE	31	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104772	10.1371/journal.pone.0104772	http://dx.doi.org/10.1371/journal.pone.0104772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6XM	25136919	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100047
J	Liu, XW; Long, ZW; Cai, H; Huang, H; Shi, YQ; Wang, YN				Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong			Analysis of Lymph Node Metastasis Correlation with Prognosis in Patients with T2 Gastric Cancer	PLOS ONE			English	Article							ADENOCARCINOMA	Purpose: To investigate the correlated factors for lymph node metastasis and prognosis for patients with T2 gastric cancer. Methods: A total of 442 patients with T2 gastric cancer who underwent gastrectomy from January 1996 to December 2009 were evaluated. The clinicopathological parameters were analyzed for lymph node metastasis and prognosis, including gender, age, tumor size, tumor location, histological type, depth of invasion, vascular tumor emboli, nervous invasion, resection type, and pathological stage. Results: The rate of lymph node metastasis was 45.9%. Univariate analysis showed that depth of invasion, tumor size, and vascular tumor emboli were associated with lymph node metastasis. Logistic regression demonstrated that depth of invasion, tumor size, and vascular tumor emboli were independently predictive factors for lymph node metastasis. The 5-year survival rate was 64.0%. Multivariate analysis showed that tumor size, tumor location, resection type, and pathological stage were independent prognostic factors. Based on tumor size, there were significant differences of 5-year survival between small size tumor (<6 cm) and large size tumor (>= 6 cm) according to stage IIA (P = 0.006). Based on tumor location, there were significant differences of 5-year survival among different tumor location according to stage IB. Based on resection type, there were significant differences of overall 5-year survival between curative surgery and palliative surgery according to stage IIB (P = 0.015) and IIIA (P = 0.001). Conclusion: Depth of invasion, tumor size, and vascular tumor emboli were independently predictive factors for lymph node metastasis. Tumor size, tumor location, resection type, and pathological stage were independent prognostic factors.	[Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Long, Ziwen; Cai, Hong; Huang, Hua; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, YN (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						ADACHI Y, 1994, GUT, V35, P1368, DOI 10.1136/gut.35.10.1368; Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Gammerer G, 2012, ANTICANCER RES, V32, P1839; Hsu JT, 2013, EJSO-EUR J SURG ONC, V39, P1287, DOI 10.1016/j.ejso.2013.07.183; Kim DY, 2006, WORLD J GASTROENTERO, V12, P1182, DOI 10.3748/wjg.v12.i8.1182; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; KIM JP, 1994, WORLD J SURG, V18, P872, DOI 10.1007/BF00299091; Lim MS, 2011, J GASTROINTEST SURG, V15, P1783, DOI 10.1007/s11605-011-1624-5; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Lu J, 2013, SURG ONCOL, V22, P167, DOI 10.1016/j.suronc.2013.05.002; MARUYAMA K, 1987, SCAND J GASTROENTERO, V22, P63, DOI 10.3109/00365528709091021; Nitti D, 2009, BRIT J SURG, V96, P398, DOI 10.1002/bjs.6487; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiu MZ, 2011, TUMOR BIOL, V32, P489, DOI 10.1007/s13277-010-0142-5; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; Shou ZX, 2012, ANN SURG, V256, P1014, DOI 10.1097/SLA.0b013e3182592f56; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Wu CY, 2002, HEPATO-GASTROENTEROL, V49, P1465; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105112	10.1371/journal.pone.0105112	http://dx.doi.org/10.1371/journal.pone.0105112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136920	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100065
J	Sachdev, PS; Mohan, A; Cannon, E; Crawford, JD; Silberstein, P; Cook, R; Coyne, T; Silburn, PA				Sachdev, Perminder S.; Mohan, Adith; Cannon, Elisabeth; Crawford, John D.; Silberstein, Paul; Cook, Raymond; Coyne, Terrence; Silburn, Peter A.			Deep Brain Stimulation of the Antero-Medial Globus Pallidus Interna for Tourette Syndrome	PLOS ONE			English	Review							THALAMIC-STIMULATION; SCALE; PALLIDOTOMY; NUCLEUS	Background: We have previously reported the results of Deep Brain Stimulation (DBS) of the antero-medial globus pallidus interna (GPi) for severe Tourette Syndrome (TS) in 11 patients. We extend this case series to 17 patients and a longer follow-up to a maximum of 46 months. Methods: 17 patients (14 male; mean age 29.1 years, range 17-51 years) with severe and medically intractable TS were implanted with Medtronic quadripolar electrodes bilaterally in the antero-medial GPi. The primary outcome measure was the Yale Global Tic Severity Scale (YGTSS). Secondary outcome measures included the Yale-Brown Obsessive Compulsive Scale, Hamilton Depression Rating Scale, Gilles de la Tourette Quality of Life Scale and Global Assessment of Functioning. Follow up was at one month, three months and finally at a mean 24.1 months (range 8-46 months) following surgery. Results: Overall, there was a 48.3% reduction in motor tics and a 41.3% reduction in phonic tics at one month, and this improvement was maintained at final follow-up. 12 out of 17 (70.6%) patients had a>50% reduction in YGTSS score at final follow up. Only 8 patients required ongoing pharmacotherapy for tics post-surgery. Patients improved significantly on all secondary measures. Adverse consequences included lead breakage in 4 patients, infection (1), transient anxiety (2), dizziness (1), poor balance (1) and worsening of stuttering (1). Conclusions: This case series provides further support that antero-medial GPi DBS is an effective and well tolerated treatment for a subgroup of severe TS, with benefits sustained up to 4 years.	[Sachdev, Perminder S.; Mohan, Adith; Cannon, Elisabeth] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Sachdev, Perminder S.; Mohan, Adith; Crawford, John D.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Silberstein, Paul; Cook, Raymond] North Shore Private Hosp, Sydney, NSW, Australia; [Coyne, Terrence; Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Coyne, Terrence; Silburn, Peter A.] St Andrews War Mem Hosp, Spring Hill, Qld, Australia	University of New South Wales Sydney; University of Queensland	Sachdev, PS (corresponding author), Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220	University of New South Wales (UNSW) Australia & Prince of Wales Hospital; Prince of Wales Hospital; UNSW Australia; North Shore Private Hospital; University of Queensland; St. Andrew's War Memorial Hospital; National Health and Medical Research Council of Australia Program [401162]; NSW Institute of Psychiatry Training Fellowship	University of New South Wales (UNSW) Australia & Prince of Wales Hospital; Prince of Wales Hospital(Chinese University of Hong Kong); UNSW Australia; North Shore Private Hospital; University of Queensland(University of Queensland); St. Andrew's War Memorial Hospital; National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); NSW Institute of Psychiatry Training Fellowship	Employment: PSS and AM - University of New South Wales (UNSW) Australia & Prince of Wales Hospital; EC - Prince of Wales Hospital; JDC - UNSW Australia; PS and RC - North Shore Private Hospital; TC and PAS - University of Queensland and St. Andrew's War Memorial Hospital. Grants: PSS and AM - National Health and Medical Research Council of Australia Program Grant (no. 401162); EC - NSW Institute of Psychiatry Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermans L, 2011, BRAIN, V134, P832, DOI 10.1093/brain/awq380; Cannon E, 2012, AM J PSYCHIAT, V169, P860, DOI 10.1176/appi.ajp.2012.11101583; Cavanna AE, 2008, NEUROLOGY, V71, P1410, DOI 10.1212/01.wnl.0000327890.02893.61; Cook RJ, 1998, J CLIN NEUROSCI, V5, P20, DOI 10.1016/S0967-5868(98)90196-5; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hariz MI, 2010, EUR J NEUROSCI, V32, P1128, DOI 10.1111/j.1460-9568.2010.07415.x; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kennedy SH, 2011, AM J PSYCHIAT, V168, P502, DOI 10.1176/appi.ajp.2010.10081187; LAITINEN LV, 1992, STEREOT FUNCT NEUROS, V58, P14, DOI 10.1159/000098965; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Martinez-Fernandez R, 2011, MOVEMENT DISORD, V26, P1922, DOI 10.1002/mds.23734; Massano J, 2013, J NEUROL, V260, P2417, DOI 10.1007/s00415-013-7049-1; Motlagh MG, 2013, TREMOR OTHER HYPERKI, P3; Muller-Vahl KR, 2013, NEUROSCI BIOBEHAV R, V37, P1178, DOI 10.1016/j.neubiorev.2012.09.012; Nebel A, 2009, J NEURAL TRANSM, V116, P167, DOI 10.1007/s00702-008-0173-x; Porta M, 2012, ACTA NEUROCHIR, V154, P2029, DOI 10.1007/s00701-012-1497-8; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Servello D, 2010, NEUROMODULATION, V13, P187, DOI 10.1111/j.1525-1403.2009.00253.x; Starr PA, 2002, J NEUROSURG, V97, P370, DOI 10.3171/jns.2002.97.2.0370; Toft M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-44; Welter ML, 2008, ARCH NEUROL-CHICAGO, V65, P952, DOI 10.1001/archneur.65.7.952	25	50	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104926	10.1371/journal.pone.0104926	http://dx.doi.org/10.1371/journal.pone.0104926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136825	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100055
J	Suzuki, C; Kawazuma, K; Horita, S; Terada, T; Tanokura, M; Okada, K; Yamane, H; Nojiri, H				Suzuki, Chiho; Kawazuma, Kohei; Horita, Shoichiro; Terada, Tohru; Tanokura, Masaru; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki			Oligomerization Mechanisms of an H-NS Family Protein, Pmr, Encoded on the Plasmid pCAR1 Provide a Molecular Basis for Functions of H-NS Family Members	PLOS ONE			English	Article							HORIZONTALLY ACQUIRED DNA; ESCHERICHIA-COLI; DIMERIZATION DOMAIN; PSEUDOMONAS-PUTIDA; SELF-ASSOCIATION; GENE-EXPRESSION; FOREIGN DNA; BINDING; MVAT; FOLD	Enterobacterial H-NS-like proteins and Pseudomonas MvaT-like proteins share low homology at the amino acid sequence level, but both can function as xenogeneic silencers and are included in the H-NS family of proteins. H-NS family members have dimerization/oligomerization and DNA-binding domains connected by a flexible linker and form large nucleoprotein complexes using both domains. Pmr, an MvaT-like protein encoded on the IncP-7 carbazole-degradative plasmid pCAR1, is a key regulator of an interaction between pCAR1 and its host Pseudomonas putida KT2440. KT2440 has two transcribed genes that encode the MvaT-like proteins TurA and TurB. Our previous transcriptome analyses suggested that the functions of Pmr, TurA and TurB are non-equivalent, although the detailed underlying mechanisms remain unclear. In this study, we focused on the protein-protein interactions of Pmr, and assessed the homo-oligomerization capacity of various substituted and truncated Pmr derivatives by protein-protein cross-linking analysis. Six of the seven residues identified as important for homo-oligomerization in Pmr were located near the N-terminus, and the putative flexible linker or the region near that was not involved in homo-oligomerization, suggesting that Pmr homo-oligomerization is different from that of enterobacterial H-NS and that the functional mechanism differs between H-NS-like and MvaT-like proteins. In addition, we assessed homo- and hetero-oligomerization of Pmr by surface plasmon resonance analysis and found that the coupling ratio of TurB-Pmr oligomers is smaller than that of Pmr-Pmr or TurA-Pmr oligomers. These results raised the possibility that composition of the hetero-oligomers of Pmr, TurA, and TurB could explain why the different gene sets were affected by either pmr, turA, or turB disruption in our previous studies.	[Suzuki, Chiho; Kawazuma, Kohei; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Horita, Shoichiro; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Terada, Tohru; Nojiri, Hideaki] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nojiri, H (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan.	anojiri@mail.ecc.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019	Terada, Tohru/0000-0002-7091-0646; Nojiri, Hideaki/0000-0003-3091-8691; Suzuki-Minakuchi, Chiho/0000-0001-6622-1955; Tanokura, Masaru/0000-0001-5072-2480	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [24380043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	CS was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. This work was supported in part by a Grant-in-Aid for Scientific Research (24380043) (to HN) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fernandez-de-Alba C, 2013, J MOL BIOL, V425, P2347, DOI 10.1016/j.jmb.2013.03.006; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Leonard PG, 2009, MOL MICROBIOL, V73, P165, DOI 10.1111/j.1365-2958.2009.06754.x; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Lucchini S, 2009, MOL MICROBIOL, V74, P1169, DOI 10.1111/j.1365-2958.2009.06929.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nojiri H, 2013, CURR OPIN BIOTECH, V24, P423, DOI 10.1016/j.copbio.2012.09.014; Nojiri H, 2012, BIOSCI BIOTECH BIOCH, V76, P1, DOI 10.1271/bbb.110620; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Renzi F, 2010, ENVIRON MICROBIOL, V12, P254, DOI 10.1111/j.1462-2920.2009.02064.x; Rescalli E, 2004, J BIOL CHEM, V279, P7777, DOI 10.1074/jbc.M310580200; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sette M, 2009, J BIOL CHEM, V284, P30453, DOI 10.1074/jbc.M109.044313; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SHI XL, 1994, J BACTERIOL, V176, P6769, DOI 10.1128/JB.176.21.6769-6775.1994; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; Suzuki C, 2011, BIOSCI BIOTECH BIOCH, V75, P711, DOI 10.1271/bbb.100841; Takeda T., 2011, INT J EVOL BIOL; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tendeng C, 2003, MICROBIOL-SGM, V149, P3047, DOI 10.1099/mic.0.C0125-0; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Yun CS, 2010, J BACTERIOL, V192, P4720, DOI 10.1128/JB.00591-10; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	50	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105656	10.1371/journal.pone.0105656	http://dx.doi.org/10.1371/journal.pone.0105656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137042	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100112
J	Wei, M; Yu, R; Deutsch, SC				Wei, Meng; Yu, Run; Deutsch, Stephen C.			Insignificant Medium-Term Vitamin D Status Change after 25-Hydroxyvitamin D Testing in a Large Managed Care Population	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; D DEFICIENCY; GENERAL-PRACTITIONERS; PRESCRIBING SUNSHINE; SUPPLEMENTATION; INSUFFICIENCY; PREVENTION; FRACTURES; ADULTS	Objectives: To examine the clinical utility of 25-hydroxyvitamin D (25(OH)D) testing in achieving medium-term vitamin D (VD) sufficiency in a managed care population. Methods: Retrospective study of a continuously-enrolled patient population in a 3-year period between 2011 and 2013. Primary outcome was VD status at similar to 1 year after 25(OH)D testing. Patient demographics, comorbidities, medications, and 25(OH)D test results were gathered from relevant databases and multivariate logistic regression analysis used to study the risk factors of persistent VD deficiency or insufficiency. Results: Of 22,784 patients, 7533 (females 69.3%) did 14,563 25(OH)D tests, with an estimated cost of $582,520. Of the 7533 patients, 1126 had another 25(OH)D test at 300-400 days after the first one. Based on the two test results, 234 patients (20.8%) maintained sufficient 25(OH)D levels; 132 (11.7%) turned from VD-sufficient into VD-insufficient or -deficient; 538 (47.8%) remained VD-insufficient or -deficient, and only 222 (19.7%) improved to be VD-sufficient. Overall, only 8.0% more patients were VD-sufficient at similar to 1 year after 25(OH)D testing. Only younger age and higher BMI were independent risk factors for persistent low 25(OH)D levels and high-dose VD use was not associated with achieving VD sufficiency. Conclusions: 25(OH)D testing only benefits a small portion of patients thus lacks clinical utility in achieving VD sufficiency in the medium term but incurs a significant cost. A practical strategy to treat VD deficiency or insufficiency is needed; without it, 25(OH)D testing adds little value to most patients' health and should be used with discretion.	[Wei, Meng; Deutsch, Stephen C.] Cedars Sinai Med Care Fdn, Beverly Hills, CA USA; [Yu, Run] Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Yu, R (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol, Los Angeles, CA 90048 USA.	run.yu@cshs.org						Basit S, 2013, BRIT J BIOMED SCI, V70, P161, DOI 10.1080/09674845.2013.11669951; Bilinski KL, 2012, MED J AUSTRALIA, V197, P90, DOI 10.5694/mja12.10561; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bonevski B, 2012, INT J CANCER, V130, P2138, DOI 10.1002/ijc.26225; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; IOM, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Lee P, 2009, AM J MED, V122, P1056, DOI 10.1016/j.amjmed.2009.06.008; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Pietras SM, 2009, ARCH INTERN MED, V169, P1806, DOI 10.1001/archinternmed.2009.361; Reeder AI, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-85; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Stratton-Loeffler MJ, 2012, J MANAGE CARE PHARM, V18, P497, DOI 10.18553/jmcp.2012.18.7.497; Vogt TM, 2004, AM J MANAG CARE, V10, P643; Yu R, 2014, SOUTH MED J, V107, P218, DOI 10.1097/SMJ.0000000000000094	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105571	10.1371/journal.pone.0105571	http://dx.doi.org/10.1371/journal.pone.0105571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136806	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100108
J	Wylie, SJ; Li, H; Saqib, M; Jones, MGK				Wylie, Stephen J.; Li, Hua; Saqib, Muhammad; Jones, Michael G. K.			The Global Trade in Fresh Produce and the Vagility of Plant Viruses: A Case Study in Garlic	PLOS ONE			English	Article							SEQUENCE; RNA; POTYVIRUS; HOMOLOGY	As cuisine becomes globalized, large volumes of fresh produce are traded internationally. The potential exists for pathogens infecting fresh produce to hitchhike to new locations and perhaps to establish there. It is difficult to identify them using traditional methods if pathogens are novel, scarce, and/or unexpected. In an attempt to overcome this limitation, we used high-throughput sequencing technology as a means of detecting all RNA viruses infecting garlic (Allium sativum L.) bulbs imported into Australia from China, the USA, Mexico, Argentina and Spain, and those growing in Australia. Bulbs tested were grown over multiple vegetative generations and all were stably infected with one or more viruses, including two species not previously recorded in Australia. Present in various combinations from 10 garlic bulbs were 41 virus isolates representing potyviruses (Onion yellow dwarf virus, Leek yellow stripe virus), carlaviruses (Shallot latent virus, Garlic common latent virus) and allexiviruses (Garlic virus A, B, C, D, and X), for which 19 complete and 22 partial genome sequences were obtained, including the first complete genome sequences of two isolates of GarVD. The most genetically distinct isolates of GarVA and GarVX described so far were identified from Mexico and Argentina, and possible scenarios explaining this are presented. The complete genome sequence of an isolate of the potexvirus Asparagus virus 3 (AV3) was obtained in Australia from wild garlic (A. vineale L.), a naturalized weed. This is first time AV3 has been identified from wild garlic and the first time it has been identified beyond China and Japan. The need for routine generic diagnosis and appropriate legislation to address the risks to primary production and wild plant communities from pathogens spread through the international trade in fresh produce is discussed.	[Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.] Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Virol Grp, Perth, WA, Australia; [Saqib, Muhammad] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Plant Gene Regulat Res Grp, Tsukuba, Ibaraki, Japan	Murdoch University; National Institute of Advanced Industrial Science & Technology (AIST)	Wylie, SJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Virol Grp, Perth, WA, Australia.	s.wylie@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Wylie, Stephen/M-5910-2013	Jones, Michael G.K./0000-0001-5002-0227; Li, Hua/0000-0002-0973-5762; Wylie, Stephen/0000-0002-5639-7460				Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; [Anonymous], 2013, COMMODITY 070320 GAR; BARTON JOHN H., 2010, EVOLUTION TRADE REGI; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Chen J, 2004, ARCH VIROL, V149, P435, DOI 10.1007/s00705-003-0234-2; Chen J, 2002, ARCH VIROL, V147, P683, DOI 10.1007/s007050200018; Conci VC, 2010, J PHYTOPATHOL, V158, P186, DOI 10.1111/j.1439-0434.2009.01601.x; FUJISAWA I, 1986, Annals of the Phytopathological Society of Japan, V52, P193, DOI 10.3186/jjphytopath.52.193; Hagen C, 2012, ARCH VIROL, V157, P907, DOI 10.1007/s00705-012-1253-7; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hashimoto M, 2008, ARCH VIROL, V153, P219, DOI 10.1007/s00705-007-1052-8; Hirschegger P, 2010, MOL PHYLOGENET EVOL, V54, P488, DOI 10.1016/j.ympev.2009.08.030; Ipek M, 2006, GENOME, V49, P1246, DOI 10.1139/G06-092; King A. M. Q, 2012, VIRUS TAXONOMY; Loebenstein G, 2012, VIRUSES POTATO VIRUS, P210; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Pu YY, 2011, J VIROL, V85, P2975, DOI 10.1128/JVI.02147-10; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Espino HS, 2012, GENETIC DIVERSITY IN PLANTS, P479; Stannard D., 1993, AM HOLOCAUST CONQUES; Symons M, 2007, ONE CONTINUOUS PICNI; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Uyttendaele M, 2014, GLOBAL SAFETY FRESH, V33; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Wylie SJ, 2012, AUSTRALAS PLANT DIS, V7, P23, DOI 10.1007/s13314-011-0038-2; Wylie SJ, 2012, ARCH VIROL, V157, P1471, DOI 10.1007/s00705-012-1319-6; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zohary D, 1988, DOMESTICATION PLANTS, P249	30	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105044	10.1371/journal.pone.0105044	http://dx.doi.org/10.1371/journal.pone.0105044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133543	Green Published, gold			2022-12-27	WOS:000341302700063
J	Columbaro, M; Ravera, S; Capanni, C; Panfoli, I; Cuccarolo, P; Stroppiana, G; Degan, P; Cappelli, E				Columbaro, Marta; Ravera, Silvia; Capanni, Cristina; Panfoli, Isabella; Cuccarolo, Paola; Stroppiana, Giorgia; Degan, Paolo; Cappelli, Enrico			Treatment of FANCA Cells with Resveratrol and N-Acetylcysteine: A Comparative Study	PLOS ONE			English	Article							COMPLEMENTATION GROUP-A; COMPLEX I DEFECTS; ANEMIA CELLS; MITOCHONDRIAL; INHIBITION; MECHANISM; DISEASE; SYNTHASE; STRESS	Fanconi anemia (FA) is a genetic disorder characterised by chromosome instability, cytokine ipersensibility, bone marrow failure and abnormal haematopoiesis associated with acute myelogenous leukemia. Recent reports are contributing to characterize the peculiar FA metabolism. Central to these considerations appears that cells from complementation group A (FANCA) display an altered red-ox metabolism. Consequently the possibility to improve FA phenotypical conditions with antioxidants is considered. We have characterized from the structural and biochemical point of view the response of FANCA lymphocytes to N-acetyl-cysteine (NAC) and resveratrol (RV). Surprisingly both NAC and RV failed to revert all the characteristic of FA phenotype and moreover their effects are not super imposable. Our data suggest that we must be aware of the biological effects coming from antioxidant treatment.	[Columbaro, Marta] IOR, SC Lab Musculoskeletal Cell Biol, Bologna, Italy; [Ravera, Silvia; Panfoli, Isabella] Univ Genoa, DIFAR Biochem Lab, Genoa, Italy; [Capanni, Cristina] CNR, Inst Mol Genet, Unit Bologna IOR, I-40126 Bologna, Italy; [Cuccarolo, Paola; Degan, Paolo] Ist Nazl Ric Canc, IRCCS AOU San Martino IST, SC Mutagenesis, I-16132 Genoa, Italy; [Stroppiana, Giorgia] Ist Giannina Gaslini, Ctr Diagnost Genet & Biochim Malattie Metab, I-16148 Genoa, Italy; [Cappelli, Enrico] Ist Giannina Gaslini, Hematol Unit, I-16148 Genoa, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Cappelli, E (corresponding author), Ist Giannina Gaslini, Hematol Unit, I-16148 Genoa, Italy.	enricocappelli@ospedale-gaslini.ge.it	Columbaro, Marta/C-6960-2019; degan, paolo/AAB-6713-2019; capanni, cristina/C-6995-2019; Cappelli, Enrico/K-7954-2016; Ravera, Silvia/AAA-7982-2019; Panfoli, Isabella/X-1247-2019; degan, paolo/AAB-4093-2019	degan, paolo/0000-0003-0855-8896; capanni, cristina/0000-0001-8030-2508; Cappelli, Enrico/0000-0001-5910-9260; Ravera, Silvia/0000-0002-0803-1042; Panfoli, Isabella/0000-0002-6261-1128; Columbaro, Marta/0000-0002-4439-8976	Telethon Genetic Biobank Network [GTB07001]	Telethon Genetic Biobank Network(Fondazione Telethon)	The samples were obtained from the "Cell Line and DNA Biobank from Patients affected by Genetic Diseases" (G. Gaslini Institute) - Telethon Genetic Biobank Network (Project No. GTB07001). AIRFA, ERG spa, Cambiaso & Risso, Rimorchiatori Riuniti, Saar Depositi Oleari Portuali, UC Sampdoria are aknowledged for supporting the activity of the Clinical & Experimental Hematology Unit of G. Gaslini Institute.	Bergmeyer H.U., 1983, METHOD ENZYMAT AN, P249; Capanni C, 2013, BIOCHIMIE, V95, P1838, DOI 10.1016/j.biochi.2013.06.024; Cappelli E, 2013, TRENDS MOL MED, V19, P513, DOI 10.1016/j.molmed.2013.07.008; Castella M, 2011, BLOOD, V117, P3759, DOI 10.1182/blood-2010-08-299917; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Cuccarolo P, 2012, FEBS J, V279, P2479, DOI 10.1111/j.1742-4658.2012.08629.x; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Jangamreddy JR, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6159; Kumari U, 2014, ONCOGENE, V33, P165, DOI 10.1038/onc.2012.583; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li XX, 2004, BLOOD, V104, P1204, DOI 10.1182/blood-2004-03-1094; Low ICC, 2010, ANTIOXID REDOX SIGN, V13, P807, DOI 10.1089/ars.2009.3050; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Ponte F, 2012, ORPHANET J RARE DIS, V16, P7; Ravera S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2790919; Ravera S, 2013, BIOCHIMIE, V95, P1828, DOI 10.1016/j.biochi.2013.06.006; Ravera S, 2009, INT J BIOCHEM CELL B, V41, P1581, DOI 10.1016/j.biocel.2009.01.009; Roomi MW, 2012, INT J ONCOL, V41, P1996, DOI 10.3892/ijo.2012.1639; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869; Zhang QS, 2014, PEDIATR BLOOD CANCER, V61, P740, DOI 10.1002/pbc.24780; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104857	10.1371/journal.pone.0104857	http://dx.doi.org/10.1371/journal.pone.0104857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126945	gold, Green Published, Green Submitted			2022-12-27	WOS:000340879300057
J	Garcia, G; Rios, N; Gutierrrez, V; Varela, JG; Fernandez, CB; Pardo, BG; Portela, PM				Garcia, Graciela; Rios, Nestor; Gutierrrez, Veronica; Guerra Varela, Jorge; Bouza Fernandez, Carmen; Gomez Pardo, Belen; Martinez Portela, Paulino			Promiscuous Speciation with Gene Flow in Silverside Fish Genus Odontesthes (Atheriniformes, Atherinopsidae) from South Western Atlantic Ocean Basins	PLOS ONE			English	Article							POPULATION-GROWTH; BONARIENSIS VALENCIENNES; PRESBYTER CUVIER; TELEOSTEI; SOFTWARE; INFERENCE; WINDOWS; MARINE; BRAZIL; MODEL	The present paper integrates phylogenetic and population genetics analyses based on mitochondrial and nuclear molecular markers in silversides, genus Odontesthes, from a non-sampled area in the SW Atlantic Ocean to address species discrimination and to define Managements Units for sustainable conservation. All phylogenetic analyses based on the COI mitochondrial gene were consistent to support the monophyly of the genus Odontesthes and to include O. argentinensis, O. perugiae-humensis and some O. bonariensis haplotypes in a basal polytomy conforming a major derivative clade. Microsatellites data revealed somewhat higher genetic variability values in the O. argentinensis-perugia populations than in O. bonariensis and O. perugia-humensis taxa. Contrasting population genetics structuring emerged from mitochondrial and microsatellites analyses in these taxa. Whereas mitochondrial data supported two major groups (O. argentinensis-perugiahumensis vs. O. bonariensis-perugiae-humensis populations), microsatellite data detected three major genetic entities represented by O. bonariensis, O. perugiae-humensis and an admixture of populations belonging to O. argentinensis-perugiae respectively. Therefore, the star COI polytomy in the tree topology involving these taxa could be interpreted by several hypothetic scenarios such as the existence of shared ancestral polymorphisms, incomplete lineage sorting in a radiating speciation process and/or reticulation events. Present findings support that promiscuous and recent contact between incipient species sharing asymmetric gene flow exchanges, blurs taxa boundaries yielding complicated taxonomy and Management Units delimitation in silverside genus Odontesthes from SW Atlantic Ocean basins.	[Garcia, Graciela; Rios, Nestor; Gutierrrez, Veronica] UdelaR, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay; [Guerra Varela, Jorge; Bouza Fernandez, Carmen; Gomez Pardo, Belen; Martinez Portela, Paulino] Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain	Universidad de la Republica, Uruguay; Universidade de Santiago de Compostela	Garcia, G (corresponding author), UdelaR, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	ggarcia@fcien.edu.uy	PARDO, BELEN G./K-9652-2014; Martínez, Paulino/K-8636-2014; Gómez, ACUIGEN/ABD-5337-2020	PARDO, BELEN G./0000-0003-3548-6306; Martínez, Paulino/0000-0001-8438-9305; Rios, Nestor/0000-0002-0669-7668; Gutierrez Coppetti, Veronica/0000-0002-6627-0519; Guerra-Varela, Jorge/0000-0002-8365-7125	Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay [Fondo Maria Vinas_2009_1_2793, FMV_2009_1_2793_Project]	Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay	This research received financial support from the project Fondo Maria Vinas_2009_1_2793 (FMV_2009_1_2793_Project) granted by the Agencia Nacional de Investigacion e Inovacion (ANII) of Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], UDELAR REV FACULTAD; BAMBER RN, 1988, J FISH BIOL, V33, P17, DOI 10.1111/j.1095-8649.1988.tb05554.x; BAMBER RN, 1985, BIOL J LINN SOC, V25, P61, DOI 10.1111/j.1095-8312.1985.tb00386.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Beheregaray LB, 2001, MOL ECOL, V10, P2849, DOI 10.1046/j.1365-294X.2001.t01-1-01406.x; Beheregaray LB, 2000, COPEIA, P441; Bemvenuti MA, 2006, BIOCELL, V30, P111; Bemvenuti MA, 2002, REVTA BRAS ZOOL CURI, V19, P239; Bemvenuti Marlise de Azevedo, 1997, Atlantica, V19, P113; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Campos H, 1984, SERIE ZOOLOGIA, V13, P71; Carnevia D, 2008, PLAN NACL DESARROLLO; CREECH S, 1991, J FISH BIOL, V39, P807, DOI 10.1111/j.1095-8649.1991.tb04410.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer BS, 2006, BIOCELL, V30, P69; Dyer BS, 1998, PHYLOGENY CLASSIFICA; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Froese R, 2012, SPECIES ODONTESTHES; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heras S, 2011, CR BIOL, V334, P273, DOI 10.1016/j.crvi.2011.03.004; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koshimizu E., 2009, MOL ECOL RESOUR, V9, P1460; Langella O., 1999, POPULATIONS 1 2 28; Liedloff A. C., 1999, MANTEL NONPARAMETRIC; Malabarba Luiz R., 2002, Ichthyological Exploration of Freshwaters, V13, P257; MANTEL N, 1967, CANCER RES, V27, P209; MCDADE LA, 1992, EVOLUTION, V46, P1329, DOI 10.1111/j.1558-5646.1992.tb01127.x; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Miranda LA, 2005, AQUAC RES, V36, P1473, DOI 10.1111/j.1365-2109.2005.01357.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POTTER IC, 1986, HYDROBIOLOGIA, V139, P23, DOI 10.1007/BF00770239; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TRACER V 1 5; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SPRECHMANN P, 1978, Zitteliana, V4, P3; Strussmann CA, 1997, J EXP ZOOL, V278, P167, DOI 10.1002/(SICI)1097-010X(19970615)278:3&lt;167::AID-JEZ6&gt;3.0.CO;2-M; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejedor D., 2001, FUNDAMENTOS BIOL EC; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tombari AD, 2005, REV CHIL HIST NAT, V78, P623; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zardi GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019402	63	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104659	10.1371/journal.pone.0104659	http://dx.doi.org/10.1371/journal.pone.0104659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126842	Green Submitted, Green Published, gold			2022-12-27	WOS:000340879300040
J	Lou, PH; Lucchinetti, E; Zhang, LY; Affolter, A; Gandhi, M; Hersberger, M; Warren, BE; Lemieux, H; Sobhi, HF; Clanachan, AS; Zaugg, M				Lou, Phing-How; Lucchinetti, Eliana; Zhang, Liyan; Affolter, Andreas; Gandhi, Manoj; Hersberger, Martin; Warren, Blair E.; Lemieux, Helene; Sobhi, Hany F.; Clanachan, Alexander S.; Zaugg, Michael			Loss of Intralipid (R)- but Not Sevoflurane-Mediated Cardioprotection in Early Type-2 Diabetic Hearts of Fructose-Fed Rats: Importance of ROS Signaling	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; IN-VIVO; MITOCHONDRIAL; ISOFLURANE; REPERFUSION; SUPEROXIDE; ISCHEMIA; ISCHAEMIA/REPERFUSION; MYOCARDIUM	Background: Insulin resistance and early type-2 diabetes are highly prevalent. However, it is unknown whether Intralipid (R) and sevoflurane protect the early diabetic heart against ischemia-reperfusion injury. Methods: Early type-2 diabetic hearts from Sprague-Dawley rats fed for 6 weeks with fructose were exposed to 15 min of ischemia and 30 min of reperfusion. Intralipid (R) (1%) was administered at the onset of reperfusion. Peri-ischemic sevoflurane (2 vol.-%) served as alternative protection strategy. Recovery of left ventricular function was recorded and the activation of Akt and ERK 1/2 was monitored. Mitochondrial function was assessed by high-resolution respirometry and mitochondrial ROS production was measured by Amplex Red and aconitase activity assays. Acylcarnitine tissue content was measured and concentration-response curves of complex IV inhibition by palmitoylcarnitine were obtained. Results: Intralipid (R) did not exert protection in early diabetic hearts, while sevoflurane improved functional recovery. Sevoflurane protection was abolished by concomitant administration of the ROS scavenger N-2-mercaptopropionyl glycine. Sevoflurane, but not Intralipid (R) produced protective ROS during reperfusion, which activated Akt. Intralipid (R) failed to inhibit respiratory complex IV, while sevoflurane inhibited complex I. Early diabetic hearts exhibited reduced carnitine-palmitoyl-transferase-1 activity, but palmitoylcarnitine could not rescue protection and enhance postischemic functional recovery. Cardiac mitochondria from early diabetic rats exhibited an increased content of subunit IV-2 of respiratory complex IV and of uncoupling protein-3. Conclusions: Early type-2 diabetic hearts lose complex IV-mediated protection by Intralipid (R) potentially due to a switch in complex IV subunit expression and increased mitochondrial uncoupling, but are amenable to complex I-mediated sevoflurane protection.	[Lou, Phing-How] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Lucchinetti, Eliana; Zhang, Liyan; Zaugg, Michael] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Affolter, Andreas; Hersberger, Martin] Univ Childrens Hosp Zurich, Dept Clin Chem, Zurich, Switzerland; [Gandhi, Manoj; Clanachan, Alexander S.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Warren, Blair E.; Lemieux, Helene] Univ Alberta, Edmonton, AB, Canada; [Sobhi, Hany F.] Coppin State Univ, Coppin Ctr Organ Synth, Baltimore, MD USA	University of Alberta; University of Alberta; University Children's Hospital Zurich; University of Alberta; University of Alberta; University System of Maryland; Coppin State University	Zaugg, M (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada.	michael.zaugg@ualberta.ca	Zaugg, Michael/G-4287-2016; Zhang, Li/GWM-7501-2022	Lucchinetti, Eliana/0000-0003-3338-1279; Hersberger, Martin/0000-0002-4472-329X; Zaugg, Michael/0000-0002-2016-8973; lemieux, Helene/0000-0002-8864-6062	Heart and Stroke Foundation of Alberta; Northwest Territories; Canadian Institutes of Health Research [MOP115055]; Natural Sciences and Engineering Research Council of Canada; Mazankowski Alberta Heart Institute, Edmonton, Canada; "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada; Nunavut (Canada)	Heart and Stroke Foundation of Alberta; Northwest Territories; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mazankowski Alberta Heart Institute, Edmonton, Canada; "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada; Nunavut (Canada)	The study was supported by grants from the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut (Canada), and the Canadian Institutes of Health Research (MOP115055), a discovery grant from the Natural Sciences and Engineering Research Council of Canada, and a grant from the Mazankowski Alberta Heart Institute, Edmonton, Canada. BEW was supported by a "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; DAI S, 1995, J PHARMACOL TOX MET, V33, P101, DOI 10.1016/1056-8719(94)00063-A; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; Deyhimy DI, 2007, ANESTH ANALG, V105, P316, DOI 10.1213/01.ane.0000267524.71445.e7; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gonsolin D, 2007, MOL CELL BIOCHEM, V295, P217, DOI 10.1007/s11010-006-9291-7; Hanley PJ, 2002, J PHYSIOL-LONDON, V544, P687, DOI 10.1113/jphysiol.2002.025015; Harmancey R, 2013, FASEB J, V27, P3966, DOI 10.1096/fj.13-234914; Herlitz J, 1996, DIABETES CARE, V19, P698, DOI 10.2337/diacare.19.7.698; Hirata N, 2011, ANESTHESIOLOGY, V115, P531, DOI 10.1097/ALN.0b013e31822a2316; Hiser C, 2013, BIOCHEMISTRY-US, V52, P1385, DOI 10.1021/bi3014505; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Huhn R, 2010, NUTR METAB CARDIOVAS, V20, P706, DOI 10.1016/j.numecd.2009.06.010; Huisamen B, 2003, MOL CELL BIOCHEM, V249, P31, DOI 10.1023/A:1024749614222; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kevin LG, 2003, ANESTH ANALG, V96, P949, DOI 10.1213/01.ANE.0000052515.25465.35; Lemoine S, 2010, DIABETES METAB, V36, P21, DOI 10.1016/j.diabet.2009.06.006; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Liu JJ, 2013, ANTIOXID REDOX SIGN, V19, P1916, DOI 10.1089/ars.2012.4589; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lou PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087205; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Malingriaux EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077786; Morel S, 2003, CLIN EXP PHARMACOL P, V30, P446, DOI 10.1046/j.1440-1681.2003.03858.x; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mullenheim J, 2002, ANESTHESIOLOGY, V96, P934; Muravyeva M, 2014, ANESTHESIOLOGY, V120, P870, DOI 10.1097/ALN.0000000000000107; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Sedlic F, 2009, ANESTH ANALG, V109, P405, DOI 10.1213/ane.0b013e3181a93ad9; Sharpe M, 1997, BIOCHEM CELL BIOL, V75, P71, DOI 10.1139/bcb-75-1-71; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Stewart JM, 2000, BIOCHEM CELL BIOL, V78, P675, DOI 10.1139/bcb-78-6-675; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Wang LG, 2010, ANESTHESIOLOGY, V113, P541, DOI 10.1097/ALN.0b013e3181e2c1a1; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Zaugg M, 2012, ANESTHESIOLOGY, V116, P648, DOI 10.1097/ALN.0b013e318247225a; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	55	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104971	10.1371/journal.pone.0104971	http://dx.doi.org/10.1371/journal.pone.0104971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127027	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000340879300066
J	Nakagawa, K; Sawada, N; Hirota, Y; Uchino, Y; Suhara, Y; Hasegawa, T; Amizuka, N; Okamoto, T; Tsugawa, N; Kamao, M; Funahashi, N; Okano, T				Nakagawa, Kimie; Sawada, Natsumi; Hirota, Yoshihisa; Uchino, Yuri; Suhara, Yoshitomo; Hasegawa, Tomoka; Amizuka, Norio; Okamoto, Tadashi; Tsugawa, Naoko; Kamao, Maya; Funahashi, Nobuaki; Okano, Toshio			Vitamin K-2 Biosynthetic Enzyme, UBIAD1 Is Essential for Embryonic Development of Mice	PLOS ONE			English	Article							MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; CARCINOMA-CELLS; COENZYME Q(10); TARGET GENES; CHOLESTEROL; TERE1; PRENYLTRANSFERASE; PURESORB-Q(TM)40; ACCUMULATION	UbiA prenyltransferase domain containing 1 (UBIAD1) is a novel vitamin K-2 biosynthetic enzyme screened and identified from the human genome database. UBIAD1 has recently been shown to catalyse the biosynthesis of Coenzyme Q10 (CoQ10) in zebrafish and human cells. To investigate the function of UBIAD1 in vivo, we attempted to generate mice lacking Ubiad1, a homolog of human UBIAD1, by gene targeting. Ubiad1-deficient (Ubiad1(-/-)) mouse embryos failed to survive beyond embryonic day 7.5, exhibiting small-sized body and gastrulation arrest. Ubiad1(-/-) embryonic stem (ES) cells failed to synthesize vitamin K-2 but were able to synthesize CoQ9, similar to wild-type ES cells. Ubiad1(+/-) mice developed normally, exhibiting normal growth and fertility. Vitamin K-2 tissue levels and synthesis activity were approximately half of those in the wild-type, whereas CoQ9 tissue levels and synthesis activity were similar to those in the wild-type. Similarly, UBIAD1 expression and vitamin K-2 synthesis activity of mouse embryonic fibroblasts prepared from Ubiad1(+/-) E15.5 embryos were approximately half of those in the wild-type, whereas CoQ9 levels and synthesis activity were similar to those in the wildtype. Ubiad1(-/-) mouse embryos failed to be rescued, but their embryonic lifespans were extended to term by oral administration of MK-4 or CoQ10 to pregnant Ubiad1(+/-) mice. These results suggest that UBIAD1 is responsible for vitamin K-2 synthesis but may not be responsible for CoQ9 synthesis in mice. We propose that UBIAD1 plays a pivotal role in embryonic development by synthesizing vitamin K-2, but may have additional functions beyond the biosynthesis of vitamin K-2.	[Nakagawa, Kimie; Sawada, Natsumi; Hirota, Yoshihisa; Uchino, Yuri; Tsugawa, Naoko; Kamao, Maya; Funahashi, Nobuaki; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 658, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan; [Hasegawa, Tomoka; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Div Oral Hlth Sci, Sapporo, Hokkaido 060, Japan; [Okamoto, Tadashi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Hlth Sci & Social Pharm, Kobe, Hyogo, Japan	Kobe Pharmaceutical University; Shibaura Institute of Technology; Hokkaido University; Kobe Gakuin University	Nakagawa, K (corresponding author), Kobe Pharmaceut Univ, Dept Hygien Sci, Kobe, Hyogo 658, Japan.	nakagawa@kobepharma-u.ac.jp; t-okano@kobepharma-u.ac.jp	Funahashi, Nobuaki/ABF-1529-2021; Hirota, Yoshihisa/R-6741-2019	Funahashi, Nobuaki/0000-0003-0888-1060; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	JSPS [23390022, 23790110]; Naito Foundation;  [24-7941]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); 	This work was supported in part by a Grant-in-aid for Scientific Research (B) [grant number 23390022] to TO, a Grant-in-aid for Scientific Research (Young Scientists-B) [grant number 23790110] to KN from JSPS, the Naito Foundation Subsidy for Female Researchers after Maternity Leave to KN from the Naito Foundation and a Grant-in-aid for JSPS Fellows [grant number 24-7941] to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2009, ENDOCR J, V56, P843, DOI 10.1507/endocrj.K09E-108; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gaynor PM, 1996, ARTERIOSCL THROM VAS, V16, P992, DOI 10.1161/01.ATV.16.8.992; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Iwaki T, 2010, J THROMB HAEMOST, V8, P2341, DOI 10.1111/j.1538-7836.2010.03995.x; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P387, DOI 10.1538/expanim1978.41.3_387; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Nukui K, 2007, J NUTR SCI VITAMINOL, V53, P187, DOI 10.3177/jnsv.53.187; Nukui K, 2008, BIOFACTORS, V32, P209, DOI 10.1002/biof.5520320125; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; QUINN P, 1985, FERTIL STERIL, V44, P493; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Sato Y, 2005, BONE, V36, P61, DOI 10.1016/j.bone.2004.09.018; Stanley TB, 1998, BIOCHEMISTRY-US, V37, P13262, DOI 10.1021/bi981031y; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072015; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]; Zu YG, 2006, J SEP SCI, V29, P1607, DOI 10.1002/jssc.200600047	37	28	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104078	10.1371/journal.pone.0104078	http://dx.doi.org/10.1371/journal.pone.0104078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127365	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300013
J	Proenca, DN; Fonseca, L; Powers, TO; Abrantes, IMO; Morais, PV				Proenca, Diogo Neves; Fonseca, Luis; Powers, Thomas O.; Abrantes, Isabel M. O.; Morais, Paula V.			Diversity of Bacteria Carried by Pinewood Nematode in USA and Phylogenetic Comparison with Isolates from Other Countries	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; WILT DISEASE; PATHOGENICITY; ENDOPHYTES; DATABASE	Pine wilt disease (PWD) is native to North America and has spread to Asia and Europe. Lately, mutualistic relationship has been suggested between the pinewood nematode (PWN), Bursaphelenchus xylophilus the causal nematode agent of PWD, and bacteria. In countries where PWN occurs, nematodes from diseased trees were reported to carry bacteria from several genera. However no data exists for the United States. The objective of this study was to evaluate the diversity of the bacterial community carried by B. xylophilus, isolated from different Pinus spp. with PWD in Nebraska, United States. The bacteria carried by PWN belonged to Gammaproteobacteria (79.9%), Betaproteobacteria (11.7%), Bacilli (5.0%), Alphaproteobacteria (1.7%) and Flavobacteriia (1.7%). Strains from the genera Chryseobacterium and Pigmentiphaga were found associated with the nematode for the first time. These results were compared to results from similar studies conducted from other countries of three continents in order to assess the diversity of bacteria with associated with PWN. The isolates from the United States, Portugal and China belonged to 25 different genera and only strains from the genus Pseudomonas were found in nematodes from all countries. The strains from China were closely related to P. fluorescens and the strains isolated from Portugal and USA were phylogenetically related to P. mohnii and P. lutea. Nematodes from the different countries are associated with bacteria of different species, not supporting a relationship between PWN with a particular bacterial species. Moreover, the diversity of the bacteria carried by the pinewood nematode seems to be related to the geographic area and the Pinus species. The roles these bacteria play within the pine trees or when associated with the nematodes, might be independent of the presence of the nematode in the tree and only related on the bacteria's relationship with the tree.	[Proenca, Diogo Neves; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, IMAR CMA, Coimbra, Portugal; [Powers, Thomas O.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; University of Nebraska System; University of Nebraska Lincoln; Universidade de Coimbra	Morais, PV (corresponding author), Univ Coimbra, IMAR CMA, Coimbra, Portugal.	pvmorais@ci.uc.pt	Abrantes, Isabel/CAG-1426-2022; Morais, Paula Vasconcelos/C-9756-2014; Proença, Diogo Neves/K-1801-2015	Abrantes, Isabel/0000-0002-8761-2151; Morais, Paula Vasconcelos/0000-0002-1939-6389; Proença, Diogo Neves/0000-0002-1284-9082; Fonseca, Luis/0000-0001-7405-8916	FEDER through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/AGR-CFL/115373/2009]; FCT [SFRH/BD/61311/2009]	FEDER through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financial supported by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and by national funds through the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, under the project PTDC/AGR-CFL/115373/2009. DNP was supported by FCT, graduate fellowship SFRH/BD/61311/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; El-Hadad ME, 2011, BRAZ J MICROBIOL, V42, P105, DOI 10.1590/S1517-83822011000100014; *EPPO OEPP, 2009, B OEPP EPPO, V39, P344; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Guo QQ, 2007, J NEMATOL, V39, P243; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Higgins D. F., 1999, Sustainability of pine forests in relation to pine wilt and decline. Proceedings of International Symposium, Tokyo, Japan, 27-28 October, 1998, P23; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JUKES T H, 1969, P21; Kawazu K, 1996, BIOSCI BIOTECH BIOCH, V60, P1413, DOI 10.1271/bbb.60.1413; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; NICKLE WR, 1981, J NEMATOL, V13, P385; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Paiva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079705; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Proenca DN, 2012, J BACTERIOL, V194, P4789, DOI 10.1128/JB.01116-12; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Proenca DN, 2011, BACTERIA ARCHAEA COM; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RAINEY FA, 1992, SYST APPL MICROBIOL, V15, P197, DOI 10.1016/S0723-2020(11)80092-5; Ribeiro B, 2012, FOREST PATHOL, V42, P521, DOI 10.1111/efp.12010; Rodrigues JM, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P5, DOI 10.1007/978-1-4020-8455-3_1; Roriz M, 2011, EXP PARASITOL, V128, P357, DOI 10.1016/j.exppara.2011.04.008; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Scholl EH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r39; Scholl EH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-9; Sniezko RA, 2006, CAN J PLANT PATHOL, V28, pS270, DOI 10.1080/07060660609507384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian Xueliang, 2010, Weishengwu Xuebao, V50, P909; Toth Agnes, 2011, Acta Biologica Szegediensis, V55, P213; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Vicente CSL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046661; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhao BG, 2009, J NEMATOL, V41, P11; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	46	14	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105190	10.1371/journal.pone.0105190	http://dx.doi.org/10.1371/journal.pone.0105190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127255	Green Published, gold			2022-12-27	WOS:000340879300092
J	Reverter, JL; Fajardo, C; Resmini, E; Salinas, I; Mora, M; Llatjos, M; Sesmilo, G; Rius, F; Halperin, I; Webb, SM; Ricart, V; Riesgo, P; Mauricio, D; Puig-Domingo, M				Reverter, Jordi L.; Fajardo, Carmen; Resmini, Eugenia; Salinas, Isabel; Mora, Mireia; Llatjos, Mariona; Sesmilo, Gemma; Rius, Ferran; Halperin, Irene; Webb, Susan M.; Ricart, Veronica; Riesgo, Pedro; Mauricio, Didac; Puig-Domingo, Manel			Benign and Malignant Nodular Thyroid Disease in Acromegaly. Is a Routine Thyroid Ultrasound Evaluation Advisable?	PLOS ONE			English	Article							SONOGRAPHIC CRITERIA; HIGH PREVALENCE; CARCINOMA; CANCER; POPULATION; MANAGEMENT; VOLUME; GLAND; SPAIN	Data on the prevalence of benign and malignant nodular thyroid disease in patients with acromegaly is a matter of debate. In the last decade an increasing incidence of thyroid cancer has been reported. The aim of this study was to evaluate the prevalence of goiter, thyroid nodules and thyroid cancer in a large series of patients with acromegaly with a cross-sectional study with a control group. Six Spanish university hospitals participated. One hundred and twenty three patients (50% men; mean age 59 +/- 13 years; disease duration 6.7 +/- 7.2 years) and 50 controls (51% males, mean age 58 +/- 15 years) were studied. All participants underwent thyroid ultrasound and fine needle aspiration. Cytological analysis was performed in suspicious nodules between 0.5 and 1.0 cm and in all nodules greater than 1.0 cm. Goiter was more frequently found in patients than in controls (24.9 vs. 8.3%, respectively; p < 0.001). Nodular thyroid disease as well as nodules greater than 1 cm were also more prevalent in acromegalic patients (64.6%, vs. 28.6%, p < 0.05 and 53.3 vs. 28.6%, respectively; p < 0.05), and all underwent fine needle aspiration. Suspicious cytology was detected in 4 patients and in none of the controls. After thyroidectomy, papillary thyroid carcinoma was confirmed in two cases (3.3% of patients with thyroid nodules), representing 1.6% of the entire group of patients with acromegaly (2.4% including a case with previously diagnosed papillary thyroid carcinoma). These data indicated that thyroid nodular disease and cancer are increased in acromegaly, thus justifying its routine ultrasound screening.	[Reverter, Jordi L.; Salinas, Isabel; Mauricio, Didac; Puig-Domingo, Manel] Univ Autonoma Barcelona, Serv Endocrinol & Nutr, Dept Med, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Fajardo, Carmen] Hosp Univ la Ribera, Serv Endocrinol, Alzira, Spain; [Resmini, Eugenia; Webb, Susan M.] Univ Autonoma Barcelona, IIB St Pau, Hosp St Pau, E-08193 Barcelona, Spain; [Resmini, Eugenia; Webb, Susan M.] Univ Autonoma Barcelona, Serv Endocrinol, Ctr Invest Biomed Enfermedades Raras CIBER ER Uni, Dept Med,Hosp St Pau, E-08193 Barcelona, Spain; [Mora, Mireia; Halperin, Irene] Hosp Clin Barcelona, Serv Endocrinol, Barcelona, Spain; [Llatjos, Mariona] Univ Autonoma Barcelona, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Dept Med, Serv Pathol, Badalona, Spain; [Sesmilo, Gemma] Hosp Univ Quiron Dexeus, Serv Endocrinol, Barcelona, Spain; [Rius, Ferran] Hosp Arnau Vilanova, Serv Endocrinol, Lleida, Spain; [Ricart, Veronica] Hosp Univ la Ribera, Serv Radiol, Alzira, Spain; [Riesgo, Pedro] Hosp Univ la Ribera, Neurosurg Serv, Alzira, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; quironsalud Group; University Hospital Arnau de Vilanova	Reverter, JL (corresponding author), Univ Autonoma Barcelona, Serv Endocrinol & Nutr, Dept Med, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain.	reverter.germanstrias@gencat.cat	Puig-Domingo, Manel/S-2169-2019; Mauricio, Didac/B-7951-2009; Dagdelen, Selcuk/A-9432-2017; Mora, Mireia/R-6696-2018	Puig-Domingo, Manel/0000-0002-6744-7195; Mauricio, Didac/0000-0002-2868-0250; Dagdelen, Selcuk/0000-0002-0513-1750; Fajardo-Montanana, Carmen/0000-0002-0784-0761; Halperin Rabinovich, Irene/0000-0003-3151-5990; Webb, Susan/0000-0001-7052-6436; Mora, Mireia/0000-0002-5887-5016	Pfizer, Spain	Pfizer, Spain(Pfizer)	This study received a unrestricted grant from Pfizer, Spain, for editorial managing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ENDOCRINOL NUTR, DOI DOI 10.1016/S1575-0922(04)74574-X; Ben-Shlomo A, 2011, PITUITARY, V14, P284, DOI 10.1007/s11102-011-0310-7; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; dos Santos MCC, 2013, PITUITARY, V16, P109, DOI 10.1007/s11102-012-0383-y; Cheung NW, 1997, CLIN ENDOCRINOL, V46, P545, DOI 10.1046/j.1365-2265.1997.1680985.x; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dagdelen S, 2013, PITUITARY, V9; Dogan S, 2014, ENDOCRINE, V45, P114, DOI 10.1007/s12020-013-9981-3; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P240, DOI 10.1007/BF03343997; Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526; Guth S, 2009, EUR J CLIN INVEST, V39, P699, DOI 10.1111/j.1365-2362.2009.02162.x; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Iannuccilli JD, 2004, J ULTRAS MED, V23, P1455, DOI 10.7863/jum.2004.23.11.1455; Jallad RS, 2013, EXPERT OPIN PHARMACO, V14, P1001, DOI 10.1517/14656566.2013.784744; Jenkins PJ, 2001, J CLIN ENDOCR METAB, V86, P1509; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Leenhardt L, 2004, THYROID, V14, P1056, DOI 10.1089/thy.2004.14.1056; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Maravall FJ, 2004, HORM METAB RES, V36, P645, DOI 10.1055/s-2004-825901; MARTINEZTELLO FJ, 1993, CANCER-AM CANCER SOC, V71, P4022, DOI 10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Minniti G, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-167; Popovic V, 1998, CLIN ENDOCRINOL, V49, P441, DOI 10.1046/j.1365-2265.1998.00536.x; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Reverter Jordi L, 2010, Endocrinol Nutr, V57, P364, DOI 10.1016/j.endonu.2010.06.004; Roelfsema F, 2012, PITUITARY, V15, P71, DOI 10.1007/s11102-011-0347-7; Rogozinski A, 2012, ARQ BRAS ENDOCRINOL, V56, P300, DOI 10.1590/S0004-27302012000500004; Shabana W, 2006, AM J ROENTGENOL, V186, P234, DOI 10.2214/AJR.04.0816; Shaha AR, 2012, ENDOCR PRACT, V18, P600, DOI 10.4158/EP12047.CO; Siegel G, 2005, ENDOCR RES, V31, P51, DOI 10.1080/07435800500229177; Tita P, 2005, CLIN ENDOCRINOL, V63, P161, DOI 10.1111/j.1365-2265.2005.02316.x; van den Beld AW, 2005, J CLIN ENDOCR METAB, V90, P6403, DOI 10.1210/jc.2005-0872; Vila L, 2006, MED CLIN-BARCELONA, V127, P730, DOI 10.1157/13095522; Wolinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088787	38	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104174	10.1371/journal.pone.0104174	http://dx.doi.org/10.1371/journal.pone.0104174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127456	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300014
J	Liu, Q; Liu, H; Wen, J; Peterson, PM				Liu, Qing; Liu, Huan; Wen, Jun; Peterson, Paul M.			Infrageneric Phylogeny and Temporal Divergence of Sorghum (Andropogoneae, Poaceae) Based on Low-Copy Nuclear and Plastid Sequences	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; ALLOTETRAPLOID ORIGIN; CHLOROPLAST GENOME; CLIMATIC-CHANGE; EVOLUTIONARY; PLANT; GENE; DIVERSIFICATION; MIOCENE; GRASSES	The infrageneric phylogeny and temporal divergence of Sorghum were explored in the present study. Sequence data of two low-copy nuclear (LCN) genes, phosphoenolpyruvate carboxylase 4 (Pepc4) and granule-bound starch synthase I (GBSSI), from 79 accessions of Sorghum plus Cleistachne sorghoides together with those from outgroups were used for maximum likelihood (ML) and Bayesian inference (BI) analyses. Bayesian dating based on three plastid DNA markers (ndhA intron, rpl32-trnL, and rps16 intron) was used to estimate the ages of major diversification events in Sorghum. The monophyly of Sorghum plus Cleistachne sorghoides (with the latter nested within Sorghum) was strongly supported by the Pepc4 data using BI analysis, and the monophyly of Sorghum was strongly supported by GBSSI data using both ML and BI analyses. Sorghum was divided into three clades in the Pepc4, GBSSI, and plastid phylograms: the subg. Sorghum lineage; the subg. Parasorghum and Stiposorghum lineage; and the subg. Chaetosorghum and Heterosorghum lineage. Two LCN homoeologous loci of Cleistachne sorghoides were first discovered in the same accession. Sorghum arundinaceum, S. bicolor, S. x drummondii, S. propinquum, and S. virgatum were closely related to S. x almum in the Pepc4, GBSSI, and plastid phylograms, suggesting that they may be potential genome donors to S. almum. Multiple LCN and plastid allelic variants have been identified in S. halepense of subg. Sorghum. The crown ages of Sorghum plus Cleistachne sorghoides and subg. Sorghum are estimated to be 12.7 million years ago (Mya) and 8.6 Mya, respectively. Molecular results support the recognition of three distinct subgenera in Sorghum: subg. Chaetosorghum with two sections, each with a single species, subg. Parasorghum with 17 species, and subg. Sorghum with nine species and we also provide a new nomenclatural combination, Sorghum sorghoides.	[Liu, Qing; Liu, Huan] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Liu, Huan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wen, Jun; Peterson, Paul M.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Liu, Q (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	liuqing@scib.ac.cn; peterson@si.edu	Peterson, Paul M./S-9572-2019	Peterson, Paul M./0000-0001-9405-5528; Liu, Qing/0000-0003-2712-6028	National Natural Science Foundation of China [31270275, 31310103023]; Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China [2013FY112100]; Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS [201212ZS]; 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2011-1139]; Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China; Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS(Chinese Academy of Sciences); 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution	This work was supported by the National Natural Science Foundation of China (31270275, 31310103023), the Special Basic Research Foundation of Ministry of Science and Technology of the People's Republic of China (2013FY112100), the Key Project of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, CAS (201212ZS), the 42nd Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2011-1139), and the Laboratories of Analytical Biology of the National Museum of Natural History, Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHSAN SMN, 1994, ANN MO BOT GARD, V81, P775, DOI 10.2307/2399922; Baltisberger M., 2010, TAXON, V59, P1298; BHATTI A. G., 1960, Journal of Heredity, V51, P107; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; CELARIER ROBERT P., 1958, CYTOLOGIA [TOKYO], V23, P395, DOI 10.1508/cytologia.23.395; CELARIER ROBERT P., 1956, CYTOLOGIA, V21, P272, DOI 10.1508/cytologia.21.272; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen S.L., 2006, FLORA CHINA, V22, P602; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Clayton W. D., 2006, GRASSBASE ONLINE WOR; CLAYTON WD, 1982, FLORA TROPICAL E AFR, P320; Clayton WD, 1986, KEW B ADDIT SER, V13, P320; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI 10.1111/j.1558-5646.1967.tb03434.x; Dillon SL, 2007, PLANT SYST EVOL, V268, P29, DOI 10.1007/s00606-007-0571-9; Dillon SL, 2004, PLANT SYST EVOL, V249, P233, DOI 10.1007/s00606-004-0210-7; Dillon SL, 2001, PLANT SYST EVOL, V230, P97, DOI 10.1007/s006060170007; Doggett H., 1976, Evolution of crop plants., P112; DOGGETT J, 1970, SORGHUM; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUVALL MR, 1990, SYST BOT, V15, P472, DOI 10.2307/2419363; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Finarelli JA, 2010, P ROY SOC B-BIOL SCI, V277, P2721, DOI 10.1098/rspb.2010.0348; Fortune PM, 2007, MOL PHYLOGENET EVOL, V43, P1040, DOI 10.1016/j.ympev.2006.11.018; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; GU MH, 1984, J HERED, V75, P196, DOI 10.1093/oxfordjournals.jhered.a109911; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; HARTLEY W., 1958, AUSTRALIAN JOUR BOT, V6, P116, DOI 10.1071/BT9580116; Hata S, 1998, PLANT J, V13, P267, DOI 10.1046/j.1365-313X.1998.00022.x; HIRAISHI A, 1995, J FERMENT BIOENG, V79, P523, DOI 10.1016/0922-338X(95)94742-A; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; House L.R., 1985, GUIDE SORGHUM BREEDI; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Jiang Bin, 2011, Journal of Tropical and Subtropical Botany, V19, P195; Kellogg E. A., 2000, Grasses: systematics and evolution., P149; Keng Y. L., 1939, SINENSIA, V10, P274; KNOBLOCH I W, 1972, Taxon, V21, P97, DOI 10.2307/1219229; Knobloch I.W., 1968, CHECK LIST CROSSES G; Laerdal T, 2002, PALAEOGEOGR PALAEOCL, V187, P213, DOI 10.1016/S0031-0182(02)00478-9; LAZARIDES M, 1991, Australian Systematic Botany, V4, P591, DOI 10.1071/SB9910591; LEPINIEC L, 1994, PLANT SCI, V99, P111, DOI 10.1016/0168-9452(94)90168-6; Li FW, 2012, SYST BOT, V37, P845, DOI 10.1600/036364412X656626; LI N, 2009, THESIS ZHEJIANG NORM; Liao Fang, 2009, Yichuan, V31, P523, DOI 10.3724/SP.J.1005.2009.00523; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Liu Huan, 2014, Journal of Tropical and Subtropical Botany, V22, P1; Liu Q, 2011, PLANT ECOL, V212, P1733, DOI 10.1007/s11258-011-9946-7; Liu Q, 2011, ANN BOT-LONDON, V108, P1287, DOI 10.1093/aob/mcr231; LU QS, 2006, CROPS THEIR WILD REL, P360; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; MARTIN JH, 1959, HDB PFLANZENZUCHTUNG, V2, P565; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Mathews S, 2002, INT J PLANT SCI, V163, P441, DOI 10.1086/339155; MORDEN CW, 1990, THEOR APPL GENET, V80, P296, DOI 10.1007/BF00210063; NAMBUDIRI EMV, 1978, NATURE, V276, P816, DOI 10.1038/276816a0; Ness RW, 2011, MOL BIOL EVOL, V28, P3009, DOI 10.1093/molbev/msr119; Ng'uni D, 2010, ANN BOT-LONDON, V105, P471, DOI 10.1093/aob/mcp305; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Phillips S, 1995, FLORA ETHIOPIA ERITR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; REDDI VR, 1970, GENETICA, V41, P321, DOI 10.1007/BF00958915; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rothfels CJ, 2014, SYST BIOL, V63, P31, DOI 10.1093/sysbio/syt058; RUSSELLSMITH J, 1995, KAKADU NATURAL CULTU, P94; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SNOWDEN J. D., 1955, JOUR LINN SOC [BOT], V55, P191; Soreng RJ, 2014, WORLD WIDE PHYLOGENE; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Spangler RE, 2003, AUST SYST BOT, V16, P279, DOI 10.1071/SB01006; STENHOUSE JW, 1997, BIODIVERSITY TRUST C, P292; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swezey CS, 2009, J AFR EARTH SCI, V53, P89, DOI 10.1016/j.jafrearsci.2008.08.001; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TANG H, 1988, THEOR APPL GENET, V76, P277; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VAHIDY AA, 1987, ANN MO BOT GARD, V74, P432, DOI 10.2307/2399415; VANOOSTERHOUT SAM, 1992, THESIS U ZIMBABWE; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Voje KL, 2009, MOL ECOL, V18, P93, DOI 10.1111/j.1365-294X.2008.04002.x; Wheeler MC, 2005, S-P B ENVIRON SCI, P125, DOI 10.1007/3-540-27250-X_5; WHISTLER DP, 1992, GEOL SOC AM BULL, V104, P644, DOI 10.1130/0016-7606(1992)104<0644:MBABOT>2.3.CO;2; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106; WU T-P, 1990, Cytologia (Tokyo), V55, P141, DOI 10.1508/cytologia.55.141; WU TP, 1993, J HERED, V84, P484, DOI 10.1093/oxfordjournals.jhered.a111377; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zhang Y, 2014, TURK J BOT, V38, P665, DOI 10.3906/bot-1308-27; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015; Zwickl DJ., 2006, THESIS	108	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104933	10.1371/journal.pone.0104933	http://dx.doi.org/10.1371/journal.pone.0104933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122516	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000077
J	Biswas, H; Chattopadhyaya, R				Biswas, Himadri; Chattopadhyaya, Rajagopal			Thermal, Chemical and pH Induced Unfolding of Turmeric Root Lectin: Modes of Denaturation	PLOS ONE			English	Article							LINEAR EXTRAPOLATION METHOD; WHEAT-GERM-AGGLUTININ; ESCHERICHIA-COLI; THERMODYNAMIC CHARACTERIZATION; CARBOHYDRATE-RECOGNITION; CONFORMATIONAL STABILITY; BINDING-PROTEINS; LEGUME LECTINS; PLANT LECTIN; FAMILY	Curcuma longa rhizome lectin, of non-seed origin having antifungal, antibacterial and a-glucosidase inhibitory activities, forms a homodimer with high thermal stability as well as acid tolerance. Size exclusion chromatography and dynamic light scattering show it to be a dimer at pH 7, but it converts to a monomer near pH 2. Circular dichroism spectra and fluorescence emission maxima are virtually indistinguishable from pH 7 to 2, indicating secondary and tertiary structures remain the same in dimer and monomer within experimental error. The tryptophan environment as probed by acrylamide quenching data yielded very similar data at pH 2 and pH 7, implying very similar folding for monomer and dimer. Differential scanning calorimetry shows a transition at 350.3 K for dimer and at 327.0 K for monomer. Thermal unfolding and chemical unfolding induced by guanidinium chloride for dimer are both reversible and can be described by two-state models. The temperatures and the denaturant concentrations at which one-half of the protein molecules are unfolded, are protein concentration-dependent for dimer but protein concentration-independent for monomer. The free energy of unfolding at 298 K was found to be 5.23 Kcal mol(-1) and 14.90 Kcal mol(-1) for the monomer and dimer respectively. The value of change in excess heat capacity upon protein denaturation (Delta C-p) is 3.42 Kcal mol(-1) K-1 for dimer. The small Delta C-p for unfolding of CLA reflects a buried hydrophobic core in the folded dimeric protein. These unfolding experiments, temperature dependent circular dichroism and dynamic light scattering for the dimer at pH 7 indicate its higher stability than for the monomer at pH 2. This difference in stability of dimeric and monomeric forms highlights the contribution of inter-subunit interactions in the former.	[Biswas, Himadri; Chattopadhyaya, Rajagopal] Bose Inst, Dept Biochem, Kolkata 700009, W Bengal, India	Department of Science & Technology (India); Bose Institute	Chattopadhyaya, R (corresponding author), Bose Inst, Dept Biochem, Kolkata 700009, W Bengal, India.	raja@jcbose.ac.in			Bose Institute from the Department of Science and Technology, Government of India	Bose Institute from the Department of Science and Technology, Government of India	All funding for this study received from Bose Institute, which in turn receives funding from the Department of Science and Technology, Government of India. The funder provided support in the form of salaries for authors [HB,RC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324; Bohm G, 1998, CDNN PROGRAM; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Chakrabarty SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1743, DOI 10.1016/j.bbapap.2010.06.010; Chatterjee A, 2005, INT J BIOL MACROMOL, V35, P103, DOI 10.1016/j.ijbiomac.2005.01.005; Chen JW, 2001, PROTEIN SCI, V10, P1079, DOI 10.1110/ps.53201; Portillo-Tellez MD, 2011, BIOPHYS J, V101, P1423, DOI 10.1016/j.bpj.2011.07.037; FUKADA H, 1983, J BIOL CHEM, V258, P3193; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; Ghosh G, 2014, BIOCHIMIE, V99, P138, DOI 10.1016/j.biochi.2013.11.022; Gold ER, 1975, RECEPTOR SPECIFIC PR, P251; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Gurjar MM, 1998, BBA-GEN SUBJECTS, V1381, P256, DOI 10.1016/S0304-4165(98)00034-8; Harata K, 2001, ACTA CRYSTALLOGR D, V57, P1513, DOI 10.1107/S090744490101232X; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; KAN VL, 1988, J INFECT DIS, V158, P407, DOI 10.1093/infdis/158.2.407; Khan MJ, 2013, PLOS ONE, V8; LADBURY JE, 1994, BIOCHEMISTRY-US, V33, P3688, DOI 10.1021/bi00178a027; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Marcos MJ, 2000, EUR J BIOCHEM, V267, P2127, DOI 10.1046/j.1432-1327.2000.01233.x; Mullen CA, 1996, J MOL BIOL, V262, P746, DOI 10.1006/jmbi.1996.0549; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; NG TB, 1989, INT J BIOCHEM, V21, P149, DOI 10.1016/0020-711X(89)90103-1; Nicholson EM, 1996, BIOCHEMISTRY-US, V35, P11369, DOI 10.1021/bi960863y; Pace CN, 2000, PROTEINS, P1; Petnual P, 2010, FOOD SCI BIOTECHNOL, V19, P907, DOI 10.1007/s10068-010-0128-5; PINEDA T, 1995, EUR J BIOCHEM, V228, P683, DOI 10.1111/j.1432-1033.1995.0683m.x; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Sinha S, 2005, BIOPHYS J, V88, P4243, DOI 10.1529/biophysj.105.061309; SPEERT DP, 1988, J CLIN INVEST, V82, P872, DOI 10.1172/JCI113692; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; VANDAMME EJM, 1995, PLANT PHYSIOL, V107, P1147, DOI 10.1104/pp.107.4.1147; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; WRIGHT HT, 1991, J MOL EVOL, V33, P283, DOI 10.1007/BF02100680	42	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103579	10.1371/journal.pone.0103579	http://dx.doi.org/10.1371/journal.pone.0103579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140525	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200009
J	Cizza, G; Piaggi, P; Rother, KI; Csako, G				Cizza, Giovanni; Piaggi, Paolo; Rother, Kristina I.; Csako, Gyorgy		Sleep Extension Study Grp	Hawthorne Effect with Transient Behavioral and Biochemical Changes in a Randomized Controlled Sleep Extension Trial of Chronically Short-Sleeping Obese Adults: Implications for the Design and Interpretation of Clinical Studies	PLOS ONE			English	Article							DURATION; QUALITY; PLACEBO; IMPACT; INTERVENTION; METAANALYSIS; INDEX	Objective: To evaluate the effects of study participation per se at the beginning of a sleep extension trial between screening, randomization, and the run-in visit. Design: Subjects were screened, returned for randomization (Comparison vs. Intervention) after 81 days (median), and attended run-in visit 121 days later. Setting: Outpatient. Patients: Obese (N = 125; M/F, 30/95; Blacks/Whites/Other, N = 73/44/8), mean weight 107.6 +/- 19.7 kg, <6.5 h sleep/night. Intervention: Non-pharmacological sleep extension. Measurements: Sleep duration (diaries and actigraphy watch), sleep quality (Pittsburgh Sleep Quality Index), daily sleepiness (Epworth Sleepiness Scale), fasting glucose, insulin and lipids. Results: Prior to any intervention, marked improvements occurred between screening and randomization. Sleep duration increased (diaries: 357.4 +/- 51.2 vs. 388.1 +/- 48.6 min/night; mean +/- SD; P < 0.001 screening vs. randomization; actigraphy: 344.3 +/- 41.9 vs. 358.6 +/- 48.2 min/night; P < 0.001) sleep quality improved (9.1 +/- 3.2 vs. 8.2 +/- 3.0 PSQI score; P < 0.001), sleepiness tended to improve (8.9 +/- 4.6 vs. 8.3 +/- 4.5 ESS score; P = 0.06), insulin resistance decreased (0.327 +/- 0.038 vs. 0.351 +/- 0.045; Quicki index; P < 0.001), and lipids improved, except for HDL-C. Abnormal fasting glucose (25% vs. 11%; P = 0.007), and metabolic syndrome (42% vs. 29%; P = 0.007) both decreased. In absence of intervention, the earlier metabolic improvements disappeared at the run-in visit. Limitations: Relatively small sample size. Conclusions: Improvements in biochemical and behavioral parameters between screening and randomization changed the "true'' study baseline, thereby potentially affecting outcome. While regression to the mean and placebo effect were considered, these findings are most consistent with the "Hawthorne effect'', according to which behavior measured in the setting of an experimental study changes in response to the attention received from study investigators. This is the first time that biochemical changes were documented with respect to the Hawthorne effect. The findings have implications for the design and conduct of clinical research.	[Cizza, Giovanni] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, Bethesda, MD 20892 USA; [Piaggi, Paolo] Univ Hosp Pisa, Obes Res Ctr, Endocrinol Unit, Pisa, Italy; [Rother, Kristina I.] NIDDK, Sect Pediat Diabet & Metab, Diabet Endocrinol & Obes Branch, Bethesda, MD 20892 USA; [Csako, Gyorgy] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pisa; Azienda Ospedaliero Universitaria Pisana; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Cizza, G (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, Bethesda, MD 20892 USA.	gcizza@gmail.com	Piaggi, Paolo/E-2539-2011	Piaggi, Paolo/0000-0003-2774-9161	intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases; Clinical Center, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047049] Funding Source: NIH RePORTER	intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases and Clinical Center, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carlino E, 2012, CURR OPIN SUPPORT PA, V6, P220, DOI 10.1097/SPC.0b013e32835269c1; Chaput JP, 2014, OBESITY, V22, pE9, DOI 10.1002/oby.20701; Chaput JP, 2012, OBESITY FACTS, V5, P561, DOI 10.1159/000342054; Cizza G, 2005, SLEEP, V28, P1217, DOI 10.1093/sleep/28.10.1217; Cizza G, 2010, CLIN TRIALS, V7, P274, DOI 10.1177/1740774510368298; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; de Jonge L, 2012, J CLIN ENDOCR METAB, V97, P2881, DOI 10.1210/jc.2011-2858; Ford ES, 2014, OBESITY, V22, P598, DOI 10.1002/oby.20558; Guerrero DM, 2013, INFECT CONT HOSP EP, V34, P524, DOI 10.1086/670213; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaneita Y, 2008, SLEEP, V31, P645, DOI 10.1093/sleep/31.5.645; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McCambridge J., 2014, J CLIN EPIDEMIOL; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Owens B, 2013, NATURE, V497, pS8, DOI 10.1038/497S8a; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Quitkin FM, 1998, BRIT J PSYCHIAT, V173, P242, DOI 10.1192/bjp.173.3.242; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Roth T, 2008, SLEEP, V31, P1277; Schwartz D, 2013, P NATL ACAD SCI USA, V110, P15242, DOI 10.1073/pnas.1301687110; Thomson CA, 2012, OBESITY, V20, P1419, DOI 10.1038/oby.2012.62; Toor P, 2012, OBES SURG, V22, P890, DOI 10.1007/s11695-011-0541-8; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138	32	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104176	10.1371/journal.pone.0104176	http://dx.doi.org/10.1371/journal.pone.0104176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141012	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200013
J	Friesenhengst, A; Pribitzer-Winner, T; Schreiber, M				Friesenhengst, Andrea; Pribitzer-Winner, Tamara; Schreiber, Martin			Association of the G473A Polymorphism and Expression of Lysyl Oxidase with Breast Cancer Risk and Survival in European Women: A Hospital-Based Case-Control Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; PROPEPTIDE DOMAIN; OVARIAN-CANCER; METASTASIS; LOX; POPULATION; HYPOXIA; SUSCEPTIBILITY; SPECIFICITY	Background: Lysyl oxidase (LOX) is an extracellular enzyme essential for the covalent crosslinking of extracellular matrix proteins and may also have additional functions. LOX expression can be both up- and downregulated in cancer and is associated both with tumour suppression and metastasis progression. The G473A polymorphism (rs1800449) results in the Arg158Gln amino acid substitution in the LOX propeptide, compromises its tumour suppressive activity, and was associated with an increased breast cancer risk in a Chinese Han population. In the first hospital-based case-control study in European women, we aimed at investigating the association of LOX expression and the G473A polymorphism with breast cancer risk and survival in unselected and estrogen receptor (ER) negative patients. Methodology/Principal Findings: The G473A polymorphism was genotyped in 386 breast cancer patients and 243 female controls. Moreover, LOX mRNA expression was quantified in the tumors of 105 patients by qRT-PCR. We found that the minor A-allele of this polymorphism is associated with a later age at breast cancer onset, a trend towards a decreased disease-free and metastasis-free survival, but not with an increased breast cancer risk. LOX mRNA expression was significantly elevated in tumours of patients older than 55 years, postmenopausal patients, estrogen receptor positive tumours, and p53 negative tumours, but was unaffected by G473A genotype in tumours and breast cancer cell lines. High LOX expression was associated with a poor disease-free and metastasis-free survival in ER negative but not ER positive patients. LOX expression was an independent prognostic parameter in multivariate analysis, whereas G473A genotype was not. A small, distinct subgroup of the ER negative patients was identified which exhibited a considerably elevated LOX expression and a very poor disease-free (p = 0.001) and metastasis-free survival (p = 0.0003). Conclusions/Significance: This newly identified ER negative/LOX high subgroup may be a suitable collective for future individualized breast cancer diagnosis and therapy.	[Friesenhengst, Andrea; Pribitzer-Winner, Tamara; Schreiber, Martin] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Pribitzer-Winner, Tamara] Univ Appl Sci, Vienna, Austria; [Schreiber, Martin] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Schreiber, M (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	martin.schreiber@meduniwien.ac.at	Martin, Schreiber/F-2175-2013	Martin, Schreiber/0000-0003-1102-7789	Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU); Anniversary Fund of the "Oesterreichische Nationalbank" [12994]	Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU); Anniversary Fund of the "Oesterreichische Nationalbank"	This study was supported by the Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU) (http://www.genau.at/); Anniversary Fund of the "Oesterreichische Nationalbank" (12994) (http://www.oenb.at/en/About-Us/Research-Promotion/The-OeNB-Anniversary-Fund.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041610; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Proestling K, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0047325; Ren JH, 2011, DNA CELL BIOL, V30, P111, DOI 10.1089/dna.2010.1098; Rost T, 2003, ANTICANCER RES, V23, P1565; Shi WW, 2012, TUMOR BIOL, V33, P2379, DOI 10.1007/s13277-012-0501-5; Sleeman JP, 2012, SEMIN CANCER BIOL, V22, P174, DOI 10.1016/j.semcancer.2012.02.007; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Stampfer M R, 1988, Cancer Treat Res, V40, P1; Taubenschuss E, 2013, INT J MOL SCI, V14, P15376, DOI 10.3390/ijms140815376; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; Wang X, 2012, J INT MED RES, V40, P917, DOI 10.1177/147323001204000310; Wu J, 2012, GENET TEST MOL BIOMA, V16, P915, DOI 10.1089/gtmb.2011.0374; Yoon JH, 2011, APMIS, V119, P762, DOI 10.1111/j.1600-0463.2011.02802.x	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105579	10.1371/journal.pone.0105579	http://dx.doi.org/10.1371/journal.pone.0105579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141126	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200104
J	Raghavendran, HRB; Puvaneswary, S; Talebian, S; Murali, MR; Naveen, SV; Krishnamurithy, G; McKean, R; Kamarul, T				Raghavendran, Hanumantha Rao Balaji; Puvaneswary, Subramaniam; Talebian, Sepehr; Murali, Malliga Raman; Naveen, Sangeetha Vasudevaraj; Krishnamurithy, G.; McKean, Robert; Kamarul, Tunku			A Comparative Study on In Vitro Osteogenic Priming Potential of Electron Spun Scaffold PLLA/HA/Col, PLLA/HA, and PLLA/Col for Tissue Engineering Application	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; ELECTROSPINNING TECHNIQUE; GENE-EXPRESSION; KINASE; PROLIFERATION; BIOMATERIALS; VIVO; FIBRONECTIN	A comparative study on the in vitro osteogenic potential of electrospun poly-L-lactide/hydroxyapatite/collagen (PLLA/HA/Col, PLLA/HA, and PLLA/Col) scaffolds was conducted. The morphology, chemical composition, and surface roughness of the fibrous scaffolds were examined. Furthermore, cell attachment, distribution, morphology, mineralization, extracellular matrix protein localization, and gene expression of human mesenchymal stromal cells (hMSCs) differentiated on the fibrous scaffolds PLLA/Col/HA, PLLA/Col, and PLLA/HA were also analyzed. The electrospun scaffolds with a diameter of 200-950 nm demonstrated well-formed interconnected fibrous network structure, which supported the growth of hMSCs. When compared with PLLA/H% A and PLLA/Col scaffolds, PLLA/Col/HA scaffolds presented a higher density of viable cells and significant upregulation of genes associated with osteogenic lineage, which were achieved without the use of specific medium or growth factors. These results were supported by the elevated levels of calcium, osteocalcin, and mineralization (P < 0.05) observed at different time points (0, 7, 14, and 21 days). Furthermore, electron microscopic observations and fibronectin localization revealed that PLLA/Col/HA scaffolds exhibited superior osteoinductivity, when compared with PLLA/Col or PLLA/HA scaffolds. These findings indicated that the fibrous structure and synergistic action of Col and nano-HA with high-molecular-weight PLLA played a vital role in inducing osteogenic differentiation of hMSCs. The data obtained in this study demonstrated that the developed fibrous PLLA/Col/HA biocomposite scaffold may be supportive for stem cell based therapies for bone repair, when compared with the other two scaffolds.	[Raghavendran, Hanumantha Rao Balaji; Puvaneswary, Subramaniam; Murali, Malliga Raman; Naveen, Sangeetha Vasudevaraj; Krishnamurithy, G.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg,TEG, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Kuala Lumpur, Malaysia; [McKean, Robert] Electrospinning Co Ltd, Rutherford Appleton Lab, Harwell Oxford, Didcot, Oxon, England; [Kamarul, Tunku] Univ Malaya, Fac Med, Clin Invest Ctr, Med Ctr, Kuala Lumpur, Malaysia; [Talebian, Sepehr] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia	Universiti Malaya; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Universiti Malaya; Universiti Malaya	Raghavendran, HRB (corresponding author), Univ Malaya, Fac Med, Dept Orthopaed Surg,TEG, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Kuala Lumpur, Malaysia.	hbr_bala@yahoo.com; tkzrea@um.edu.my	Genasan, Krishnamurithy/AAK-1277-2020; Raman, Murali Malliga/A-6987-2012; Talebian, Sepehr/E-6537-2016; genasan, krishnamurithy/M-4049-2018; Naveen, Sangeetha/F-4035-2011; Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; raghavendran, hanumantha rao balaji/B-8507-2012; S., Naveen/E-8678-2013	Raman, Murali Malliga/0000-0002-5696-4541; Talebian, Sepehr/0000-0002-4735-0986; Naveen, Sangeetha/0000-0003-3180-6237; Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; S., Naveen/0000-0001-6316-7973	UMRG from the University of Malaya; University of Malaya [UM.C/625/1/HIR/MOHE/CHAN/03, A000003-50001]; Electrospinning Company Ltd	UMRG from the University of Malaya; University of Malaya(Universiti Malaya); Electrospinning Company Ltd	This work was supported in part by UMRG from the University of Malaya and major grant support (Reference number -UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001), University of Malaya. The Electrospinning Company Ltd provided support in the form of salaries for author RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014; Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084; Bidder M, 2002, J BIOL CHEM, V277, P44485, DOI 10.1074/jbc.M206235200; Black J, 1988, HDB BIOMATERIALS PRO; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Cao D, 2011, COLLOID SURFACE B, V84, P26, DOI 10.1016/j.colsurfb.2010.12.005; Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528; Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084; CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3; Eslaminejad Mohamadreza Baghaban, 2010, Iranian Journal of Biotechnology, V8, P234; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Ha YM, 2013, COLLOID SURFACE B, V102, P795, DOI 10.1016/j.colsurfb.2012.09.018; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.tea.2013.0064, 10.1089/ten.TEA.2013.0064]; Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim SS, 2008, J BIOMED MATER RES A, V87A, P245, DOI 10.1002/jbm.a.31782; Krishnamurithy G, 2014, CERAM INT, V40, P771, DOI 10.1016/j.ceramint.2013.06.067; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439; Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718; Lode A, 2008, J TISSUE ENG REGEN M, V2, P400, DOI 10.1002/term.110; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Morsczeck C, 2006, CALCIFIED TISSUE INT, V78, P98, DOI 10.1007/s00223-005-0146-0; Moursi AM, 1997, J CELL SCI, V110, P2187; Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151; Ngiam M, 2011, ANN ACAD MED SINGAP, V40, P213; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Nguyen LTH, 2012, BIOMATERIALS AND STEM CELLS IN REGENERATIVE MEDICINE, P299; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; Park J. B., 1984, BIOMATERIALS SCI ENG, P193; Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211; Pompe T, 2005, BIOPHYS J, V88, P527, DOI 10.1529/biophysj.104.049074; Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3; Thomas DP, 2000, J CELL SCI, V113, P439; Woodruff MA, 2007, J MOL HISTOL, V38, P491, DOI 10.1007/s10735-007-9142-1; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Zang JT, 2010, CHEM RES CHINESE U, V26, P662; ZHAO GQ, 1994, DEV BIOL, V164, P37, DOI 10.1006/dbio.1994.1178; Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009	46	37	38	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104389	10.1371/journal.pone.0104389	http://dx.doi.org/10.1371/journal.pone.0104389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140798	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200020
J	Jeon, JW; Ha, UH; Paek, SH				Jeon, Jin-Woo; Ha, Un-Hwan; Paek, Se-Hwan			In Vitro Inflammation Inhibition Model Based on Semi-Continuous Toll-Like Receptor Biosensing	PLOS ONE			English	Article							NF-KAPPA-B; ENERGY-TRANSFER; CELL-LINES; SALICYLATE; ACTIVATION; ASPIRIN; EXPRESSION; DISEASE; MACROPHAGES; RESONANCE	In A chemical inhibition model of inflammation is proposed by semi-continuous monitoring the density of toll-like receptor 1 (TLR1) expressed on mammalian cells following bacterial infection to investigate an in vivo-mimicked drug screening system. The inflammation was induced by adding bacterial lysate (e.g., Pseudomonas aeruginosa) to a mammalian cell culture (e.g., A549 cell line). The TLR1 density on the same cells was immunochemically monitored up to three cycles under optimized cyclic bacterial stimulation-and-restoration conditions. The assay was carried out by adopting a cell-compatible immunoanalytical procedure and signal generation method. Signal intensity relative to the background control obtained without stimulation was employed to plot the standard curve for inflammation. To suppress the inflammatory response, sodium salicylate, which inhibits nuclear factor-kappa B activity, was used to prepare the standard curve for anti-inflammation. Such measurement of differential TLR densities was used as a biosensing approach discriminating the anti-inflammatory substance from the non-effector, which was simulated by using caffeic acid phenethyl ester and acetaminophen as the two components, respectively. As the same cells exposed to repetitive bacterial stimulation were semi-continuously monitored, the efficacy and toxicity of the inhibitors may further be determined regarding persistency against time. Therefore, this semi-continuous biosensing model could be appropriate as a substitute for animal-based experimentation during drug screening prior to pre-clinical tests.	[Jeon, Jin-Woo; Paek, Se-Hwan] Korea Univ, Dept Bio Microsyst Technol, Seoul, South Korea; [Ha, Un-Hwan; Paek, Se-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea	Korea University; Korea University	Paek, SH (corresponding author), Korea Univ, Dept Bio Microsyst Technol, Seoul, South Korea.	shpaek@korea.ac.kr	Ha, Un-Hwan/ABH-8017-2020	Ha, Un-Hwan/0000-0001-9182-7000	Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Korea [2013K000249]; BK21 plus program of the Ministry of Education, Korea	Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Korea; BK21 plus program of the Ministry of Education, Korea	This research was supported by the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning, Korea (No. 2013K000249). This work was also supported by the BK21 plus program of the Ministry of Education, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cho IH, 2012, ANAL CHEM, V84, P9713, DOI 10.1021/ac300668y; Chyka PA, 2007, CLIN TOXICOL, V45, P95, DOI 10.1080/15563650600907140; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cugno M, 2000, CLIN SCI, V99, P461, DOI 10.1042/CS20000095; de Lara LGV, 2003, AM J PHYSIOL-LUNG C, V285, pL899, DOI 10.1152/ajplung.00082.2003; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; FITZPATRICK FA, 1980, PROSTAGLANDINS, V19, P917, DOI 10.1016/0090-6980(80)90126-4; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; GRANSTROM E, 1980, PROSTAG OTH LIPID M, V19, P933, DOI 10.1016/0090-6980(80)90127-6; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; HogenEsch H, 2012, J CONTROL RELEASE, V164, P183, DOI 10.1016/j.jconrel.2012.02.031; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Huttunen K, 2003, ENVIRON HEALTH PERSP, V111, P85, DOI 10.1289/ehp.5478; Intahphuak S, 2004, J ETHNOPHARMACOL, V90, P69, DOI 10.1016/j.jep.2003.09.026; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jeon JW, 2014, SCI REP UK IN PRESS; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lan T, 2007, P NATL ACAD SCI USA, V104, P13750, DOI 10.1073/pnas.0706059104; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Liu QJ, 2014, CHEM REV, V114, P6423, DOI 10.1021/cr2003129; MARGOLIUS HS, 1995, HYPERTENSION, V26, P221, DOI 10.1161/01.HYP.26.2.221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; Panter G, 2009, CURR OPIN MOL THER, V11, P133; Prado GN, 2002, J CELL PHYSIOL, V193, P275, DOI 10.1002/jcp.10175; PRESCOTT LF, 1982, BRIT MED J, V285, P1383, DOI 10.1136/bmj.285.6352.1383; RAYMOND P, 1995, J IMMUNOL METHODS, V180, P247, DOI 10.1016/0022-1759(94)00320-V; Sabourin T, 2002, AM J PHYSIOL-HEART C, V283, pH227, DOI 10.1152/ajpheart.00978.2001; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seabrook GR, 1997, NEUROPHARMACOLOGY, V36, P1009, DOI 10.1016/S0028-3908(97)00065-8; Shin HS, 2013, PATHOG DIS, V69, P149, DOI 10.1111/2049-632X.12074; Shin HS, 2011, CURR MICROBIOL, V63, P138, DOI 10.1007/s00284-011-9959-4; Singh AK, 2013, J IMMUNOTOXICOL, V10, P141, DOI 10.3109/1547691X.2012.700653; SNYDER DS, 1976, PROSTAGLANDINS, V11, P631, DOI 10.1016/0090-6980(76)90066-6; Stamme C, 2000, AM J RESP CELL MOL, V23, P772, DOI 10.1165/ajrcmb.23.6.4083; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tian H, 2007, BRIT J PHARMACOL, V150, P321, DOI 10.1038/sj.bjp.0706988; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weiss U, 2008, NATURE, V454, P427, DOI 10.1038/454427a; Wu SH, 2013, SMALL, V9, P3532, DOI 10.1002/smll.201203125; Xu Z, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-2; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	56	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105212	10.1371/journal.pone.0105212	http://dx.doi.org/10.1371/journal.pone.0105212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136864	Green Published, Green Submitted, gold			2022-12-27	WOS:000340742100074
J	Molina-Navarro, MM; Trivino, JC; Martinez-Dolz, L; Lago, F; Gonzalez-Juanatey, JR; Portoles, M; Rivera, M				Micaela Molina-Navarro, Maria; Carlos Trivino, Juan; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Portoles, Manuel; Rivera, Miguel			Functional Networks of Nucleocytoplasmic Transport-Related Genes Differentiate Ischemic and Dilated Cardiomyopathies. A New Therapeutic Opportunity	PLOS ONE			English	Article							RAN-BINDING PROTEIN-3; NF-KAPPA-B; HEART-FAILURE; RNA-SEQ; NUCLEAR IMPORT; CLINICAL-IMPLICATIONS; EXPRESSION; PYK2; PHOSPHORYLATION; QUANTIFICATION	Heart failure provokes alterations in the expression of nucleocytoplasmic transport-related genes. To elucidate the nucleocytoplasmic transport-linked functional network underlying the two major causes of heart failure, ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM), we examined global transcriptome profiles of left ventricular myocardium tissue samples from 31 patients (ICM, n = 10; DCM, n = 13) undergoing heart transplantation and control donors (CNT, n = 8) using RNA-Sequencing and GeneMANIA. Comparative profiling of ICM versus control and DCM versus control showed 1081 and 2440 differentially expressed genes, respectively (>1.29-fold; P<0.05). GeneMANIA revealed differentially regulated functional networks specific to ICM and DCM. In comparison with CNT, differential expression was seen in 9 and 12 nucleocytoplasmic transport-related genes in ICM and DCM groups, respectively. DDX3X, KPNA2, and PTK2B were related to ICM, while SMURF2, NUP153, IPO5, RANBP3, NOXA1, and RHOJ were involved in DCM pathogenesis. Furthermore, the two pathologies shared 6 altered genes: XPO1, ARL4, NFKB2, FHL3, RANBP2, and RHOU showing an identical trend in expression in both ICM and DCM. Notably, the core of the derived functional networks composed of nucleocytoplasmic transport-related genes (XPO1, RANBP2, NUP153, IPO5, KPNA2, and RANBP3) branched into several pathways with downregulated genes. Moreover, we identified genes whose expression levels correlated with left ventricular mass index and left ventricular function parameters in HF patients. Collectively, our study provides a clear distinction between the two pathologies at the transcriptome level and opens up new possibilities to search for appropriate therapeutic targets for ICM and DCM.	[Micaela Molina-Navarro, Maria; Portoles, Manuel; Rivera, Miguel] Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain; [Carlos Trivino, Juan] Sistemas Genom, Valencia, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain.	miguelrivera492@gmail.com	PORTOLES, MANUEL/B-4789-2009; Dolz, Luis Martinez/X-4627-2018	PORTOLES, MANUEL/0000-0002-4415-7160; Dolz, Luis Martinez/0000-0001-5145-8191; , Micaela/0000-0002-2103-0351; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RD12/0042/0003]; FIS Project [PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III''; FIS Project	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RD12/0042/0003; FIS Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; Auerbach SS, 2010, TOXICOL PATHOL, V38, P923, DOI 10.1177/0192623310382864; Balan M, 2011, CELL STRESS CHAPERON, V16, P105, DOI 10.1007/s12192-010-0217-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Giubbini R, 2009, EUR J NUCL MED MOL I, V36, P2068, DOI 10.1007/s00259-009-1246-2; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hart DL, 2008, J MOL CELL CARDIOL, V45, P93, DOI 10.1016/j.yjmcc.2008.04.002; Heidkamp MC, 2005, AM J PHYSIOL-CELL PH, V289, pC471, DOI 10.1152/ajpcell.00130.2005; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim T, 2014, MOL CELLS, V37, P81, DOI 10.14348/molcells.2014.2337; Lang D, 2011, AM J PHYSIOL-HEART C, V301, pH975, DOI 10.1152/ajpheart.00241.2011; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Nemergut ME, 2002, J BIOL CHEM, V277, P17385, DOI 10.1074/jbc.c100620200; Niu XL, 2010, CIRCULATION, V121, P549, DOI 10.1161/CIRCULATIONAHA.109.908319; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouleau JL, 1993, J AM COLL CARDIOL, V22, P390, DOI 10.1016/0735-1097(93)90042-Y; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Sturchler E, 2013, BBA-MOL CELL RES, V1833, P583, DOI 10.1016/j.bbamcr.2012.10.023; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	50	20	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e104709	10.1371/journal.pone.0104709	http://dx.doi.org/10.1371/journal.pone.0104709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137373	Green Published, gold, Green Submitted			2022-12-27	WOS:000340742100044
J	Sauter, KA; Pridans, C; Sehgal, A; Bain, CC; Scott, C; Moffat, L; Rojo, R; Stutchfield, BM; Davies, CL; Donaldson, DS; Renault, K; McColl, BW; Mowat, AM; Serrels, A; Frame, MC; Mabbott, NA; Hume, DA				Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Bain, Calum C.; Scott, Charlotte; Moffat, Lindsey; Rojo, Rocio; Stutchfield, Ben M.; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mowat, Alan M.; Serrels, Alan; Frame, Margaret C.; Mabbott, Neil A.; Hume, David A.			The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MONONUCLEAR PHAGOCYTE SYSTEM; ISOLATED LYMPHOID FOLLICLES; INTESTINAL LAMINA PROPRIA; HEMATOPOIETIC STEM-CELLS; FACTOR-I CSF-1; FACTOR-1 RECEPTOR; T-CELLS; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL TRANSCRIPTION	The MacBlue transgenic mouse uses the Csf1r promoter and first intron to drive expression of gal4-VP16, which in turn drives a cointegrated gal4-responsive UAS-ECFP cassette. The Csf1r promoter region used contains a deletion of a 150 bp conserved region covering trophoblast and osteoclast-specific transcription start sites. In this study, we examined expression of the transgene in embryos and adult mice. In embryos, ECFP was expressed in the large majority of macrophages derived from the yolk sac, and as the liver became a major site of monocytopoiesis. In adults, ECFP was detected at high levels in both Ly6C(+) and Ly6C(-) monocytes and distinguished them from Ly6C(+), F4/80(+), CSF1R(+) immature myeloid cells in peripheral blood. ECFP was also detected in the large majority of microglia and Langerhans cells. However, expression was lost from the majority of tissue macrophages, including Kupffer cells in the liver and F4/80(+) macrophages of the lung, kidney, spleen and intestine. The small numbers of positive cells isolated from the liver resembled blood monocytes. In the gut, ECFP+ cells were identified primarily as classical dendritic cells or blood monocytes in disaggregated cell preparations. Immunohistochemistry showed large numbers of ECFP+ cells in the Peyer's patch and isolated lymphoid follicles. The MacBlue transgene was used to investigate the effect of treatment with CSF1-Fc, a form of the growth factor with longer half-life and efficacy. CSF1-Fc massively expanded both the immature myeloid cell (ECFP-) and Ly6C(+) monocyte populations, but had a smaller effect on Ly6C(-) monocytes. There were proportional increases in ECFP+ cells detected in lung and liver, consistent with monocyte infiltration, but no generation of ECFP+ Kupffer cells. In the gut, there was selective infiltration of large numbers of cells into the lamina propria and Peyer's patches. We discuss the use of the MacBlue transgene as a marker of monocyte/macrophage/dendritic cell differentiation.	[Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Moffat, Lindsey; Rojo, Rocio; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mabbott, Neil A.; Hume, David A.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Sauter, Kristin A.; Pridans, Clare; Sehgal, Anuj; Moffat, Lindsey; Rojo, Rocio; Davies, Claire L.; Donaldson, David S.; Renault, Kathleen; McColl, Barry W.; Mabbott, Neil A.; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Bain, Calum C.; Scott, Charlotte; Mowat, Alan M.] Univ Glasgow, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Stutchfield, Ben M.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Serrels, Alan; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	David.hume@roslin.ed.ac.uk	Mowat, Allan M/H-7932-2016; Rojo, Rocio/S-7515-2018; Pridans, Clare/AAF-9953-2020; Mabbott, Neil/AAF-8777-2020; Scott, Charlotte/K-3563-2014	Mowat, Allan M/0000-0001-9389-3079; Rojo, Rocio/0000-0001-9686-3377; Pridans, Clare/0000-0001-9423-557X; Mabbott, Neil/0000-0001-7395-1796; Frame, Margaret/0000-0001-5882-1942; Sehgal, Anuj/0000-0002-5210-1730; Donaldson, David/0000-0002-8523-7853; Bain, Calum/0000-0001-8884-327X; McColl, Barry W/0000-0002-0521-9656; Hume, David/0000-0002-2615-1478; Sauter, Kristin/0000-0002-8721-3222; Scott, Charlotte/0000-0003-4914-6580	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC doctoral training studentship [BB/J01666X/1]; Cancer Research UK [C157/A15703]; BBSRC [BB/J014672/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/J014672/1, BBS/E/D/20251969] Funding Source: researchfish; Cancer Research UK [15703] Funding Source: researchfish; Medical Research Council [G0901193, MR/L003384/1] Funding Source: researchfish; BBSRC [BBS/E/D/20251969, BBS/E/D/20221657] Funding Source: UKRI; MRC [G0901193, MR/L003384/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC doctoral training studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Biotechnology and Biological Sciences Research Council (BBSRC). http://www.bbsrc.ac.uk/home/home.aspx. AS was supported by a BBSRC doctoral training studentship (BB/J01666X/1); DSD and NAM were supported by project funding from the BBSRC (BB/J014672/1). 338CPC R41310 CD, 338CPC RA2025 BM, Darwin Trust of Edinburgh PhD scholarship - KR, Medical Research Council, http://www.mrc.ac.uk/, MRC 338CPC RA2613 BM, Cancer Research UK (program grant C157/A15703). http://www.cancerresearchuk.org/AS,MSF. The author(s) received no specific funding for this work: KAS, CP, LM, RR, BMS, AMM, DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcora D, 2013, STEM CELL RES, V10, P203, DOI 10.1016/j.scr.2012.12.001; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Alikhan MA, 2011, AM J PATHOL, V179, P1243, DOI 10.1016/j.ajpath.2011.05.037; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Behringer R, 2014, MANIPULATING MOUSE E, V4; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; FAVOT P, 1995, ONCOGENE, V11, P1371; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Fries PN, 2011, CELL TISSUE RES, V343, P33, DOI 10.1007/s00441-010-1030-4; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gow DJ, 2012, CYTOKINE, V60, P793, DOI 10.1016/j.cyto.2012.08.008; Gow DJ, 2014, MOLTHERAPY UNPUB; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Hoeffel G, 2012, J EXP MED; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 1988, J IMMUNOL, V141, P3405; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jacquelin S, 2013, BLOOD; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jenkins SJ, 2013, JEXPMED IN PRESS; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Menke J, 2009, J CLIN INVEST, V119, P2330, DOI 10.1172/JCI39087; Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; PAVLI P, 1990, IMMUNOLOGY, V70, P40; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sauter KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054935; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serrels A, 2012, INT J CANCER, V131, P287, DOI 10.1002/ijc.26351; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; ULICH TR, 1990, BLOOD, V75, P846; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	74	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105429	10.1371/journal.pone.0105429	http://dx.doi.org/10.1371/journal.pone.0105429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25137049	Green Published, Green Accepted, gold			2022-12-27	WOS:000340742100094
J	Zhussupova, A; Hayashida, T; Takahashi, M; Miyao, K; Okazaki, H; Jinno, H; Kitagawa, Y				Zhussupova, Aisulu; Hayashida, Tetsu; Takahashi, Maiko; Miyao, Kazuhiro; Okazaki, Hiroshi; Jinno, Hiromitsu; Kitagawa, Yuko			An E2F1-HOXB9 Transcriptional Circuit Is Associated with Breast Cancer Progression	PLOS ONE			English	Article							TUMOR-GROWTH; FACTOR E2F-1; HOMEODOMAIN PROTEIN; KINASE 4/6; EXPRESSION; HOXB9; PROGNOSIS; CARCINOMA; ACTIVATION; GENES	Homeobox B9 (HOXB9), a member of the homeobox gene family, is overexpressed in breast cancer and promotes tumor progression and metastasis by stimulating epithelial-to-mesenchymal transition and angiogenesis within the tumor microenvironment. HOXB9 activates the TGF beta-ATM axis, leading to checkpoint activation and DNA repair, which engenders radioresistance in breast cancer cells. Despite detailed reports of the role of HOXB9 in breast cancer, the factors that regulate HOXB9 transcription have not been extensively examined. Here we uncover an underlying mechanism that may suggest novel targeting strategies for breast cancer treatment. To identify a transcription factor binding site (TFBS) in the HOXB9 promoter region, a dual luciferase reporter assay was conducted. Protein candidates that may directly attach to a TFBS of HOXB9 were examined by Q-PCR, electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP), and mutation analysis. A HOXB9 promoter region from -404 to -392 was identified as TFBS, and E2F1 was a potential binding candidate in this region. The induction of HOXB9 expression by E2F1 was observed by Q-PCR in several breast cancer cell lines overexpressing E2F1. The stimulatory effect of E2F1 on HOXB9 transcription and its ability to bind the TFBS were confirmed by luciferase, EMSA and ChIP assay. Immunohistochemical analysis of 139 breast cancer tissue samples revealed a significant correlation between E2F1 and HOXB9 expression (p<0.001). Furthermore, a CDK4/6 inhibitor suppressed E2F1 expression and also reduced expression of HOXB9 and its downstream target genes. Our in vitro analysis identified the TFBS of the HOXB9 promoter region and suggested that E2F1 is a direct regulator of HOXB9 expression; these data support the strong correlation we found between E2F1 and HOXB9 in clinical breast cancer samples. These results suggest that targeting the E2F1/HOXB9 axis may be a novel strategy for the control or prevention of cancer progression and metastasis.	[Zhussupova, Aisulu; Hayashida, Tetsu; Takahashi, Maiko; Miyao, Kazuhiro; Okazaki, Hiroshi; Jinno, Hiromitsu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Keio University	Hayashida, T (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	tetsu@z7.keio.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293292, 25461997, 25861163]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan Grants-in-Aid for Scientific Research (Grant NOS. #25293292, #25461997, and #25861163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, ONCOL REP, V15, P797; Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; Bramis J, 2004, ANTICANCER RES, V24, P3041; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Ebihara Y, 2004, DIS ESOPHAGUS, V17, P150, DOI 10.1111/j.1442-2050.2004.00393.x; Evangelou K, 2008, J CLIN PATHOL, V61, P601, DOI 10.1136/jcp.2007.050963; FAIELLA A, 1994, P NATL ACAD SCI USA, V91, P5335, DOI 10.1073/pnas.91.12.5335; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Finn RS Crown JP, 2012, CAN RES S3, V72; Flagiello D, 1997, FEBS LETT, V415, P263, DOI 10.1016/S0014-5793(97)01118-6; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Han SH, 2003, BREAST CANC RES TREA, V82, P6; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hoshino Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-102; Huang K, 2014, CHINESE J CANCER RES, V26, P72, DOI 10.3978/j.issn.1000-9604.2014.01.11; Jin K, 2012, P NATL ACAD SCI USA, V109, P2736, DOI 10.1073/pnas.1018859108; Kwon MJ, 2010, ANN SURG ONCOL, V17, P564, DOI 10.1245/s10434-009-0767-z; Lechner JF, 2001, RADIAT RES, V155, P235, DOI 10.1667/0033-7587(2001)155[0235:PCDTMA]2.0.CO;2; Lee J, 2008, CLIN CANCER RES, V14, P82, DOI 10.1158/1078-0432.CCR-07-0612; Mega S, 2005, DIS ESOPHAGUS, V18, P109, DOI 10.1111/j.1442-2050.2005.00463.x; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Oyama T, 2005, ANTICANCER RES, V25, P1193; Palaiologou M, 2012, VIRCHOWS ARCH, V460, P439, DOI 10.1007/s00428-012-1220-4; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Seki H, 2012, ANN SURG ONCOL, V19, P1831, DOI 10.1245/s10434-012-2295-5; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; Stavnes HT, 2013, GYNECOL ONCOL, V129, P358, DOI 10.1016/j.ygyno.2013.02.021; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Wyllie AH, 2002, J PATHOL, V198, P139, DOI 10.1002/path.1238; Yamazaki K, 2003, PATHOL RES PRACT, V199, P23, DOI 10.1078/0344-0338-00348; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2014	9	8							e105285	10.1371/journal.pone.0105285	http://dx.doi.org/10.1371/journal.pone.0105285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6XM	25136922	Green Published, gold			2022-12-27	WOS:000340742100083
J	Firacative, C; Duan, S; Meyer, W				Firacative, Carolina; Duan, Shuyao; Meyer, Wieland			Galleria mellonella Model Identifies Highly Virulent Strains among All Major Molecular Types of Cryptococcus gattii	PLOS ONE			English	Article							EMERGING FUNGAL PATHOGEN; CANDIDA-ALBICANS MUTANTS; GENETIC DIVERSITY; SEROTYPE-C; NEOFORMANS; INFECTION; SUSCEPTIBILITY; EPIDEMIOLOGY; OUTBREAK; ORIGIN	Cryptococcosis is mainly caused by Cryptococcus neoformans. However, the number of cases due to C. gattii is increasing, affecting mainly immunocompetent hosts. C. gattii is divided into four major molecular types, VGI to VGIV, which differ in their host range, epidemiology, antifungal susceptibility and geographic distribution. Besides studies on the Vancouver Island outbreak strains, which showed that the subtype VGIIa is highly virulent compared to the subtype VGIIb, little is known about the virulence of the other major molecular types. To elucidate the virulence potential of the major molecular types of C. gattii, Galleria mellonella larvae were inoculated with ten globally selected strains per molecular type. Survival rates were recorded and known virulence factors were studied. One VGII, one VGIII and one VGIV strain were more virulent (p<0.05) than the highly virulent Vancouver Island outbreak strain VGIIa (CDCR265), 11 (four VGI, two VGII, four VGIII and one VGIV) had similar virulence (p>0.05), 21 (five VGI, five VGII, four VGIII and seven VGIV) were less virulent (p<0.05) while one strain of each molecular type were avirulent. Cell and capsule size of all strains increased markedly during larvae infection (p<0.001). No differences in growth rate at 37 degrees C were observed. Melanin synthesis was directly related with the level of virulence: more virulent strains produced more melanin than less virulent strains (p<0.05). The results indicate that all C. gattii major molecular types exhibit a range of virulence, with some strains having the potential to be more virulent. The study highlights the necessity to further investigate the genetic background of more and less virulent strains in order to recognize critical features, other than the known virulence factors (capsule, melanin and growth at mammalian body temperature), that maybe crucial for the development and progression of cryptococcosis.	[Firacative, Carolina; Duan, Shuyao; Meyer, Wieland] Univ Sydney, Westmead Hosp, Sydney Med Sch,Westmead Millennium Inst,Mol Mycol, Ctr Infect Dis & Microbiol,Marie Bashir Inst Infe, Sydney, NSW 2006, Australia; [Firacative, Carolina] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia	University of Sydney; Westmead Institute for Medical Research; Instituto Nacional de Salud (Colombia)	Meyer, W (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med Sch,Westmead Millennium Inst,Mol Mycol, Ctr Infect Dis & Microbiol,Marie Bashir Inst Infe, Sydney, NSW 2006, Australia.	wieland.meyer@sydney.edu.au	Meyer, Wieland/G-1204-2015; Firacative, Carolina/ABB-9942-2021	Meyer, Wieland/0000-0001-9933-8340; Firacative, Carolina/0000-0001-7547-5172	NHMRC [APP1031943]; COLCIENCIAS Colombia	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); COLCIENCIAS Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported by an NH&MRC project grant # APP1031943 to WM. Carolina Firacative was supported by a PhD scholarship "Becas Francisco Jose de Caldas" from COLCIENCIAS Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Capilla J, 2006, MED MYCOL, V44, P601, DOI 10.1080/13693780600810040; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Olivares LRC, 2009, MED MYCOL, V47, P713, DOI 10.3109/13693780802559031; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen YL, 2013, G3-GENES GENOM GENET, V3, P527, DOI 10.1534/g3.112.004242; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cogliati M, 2012, MYCOSES, V55, P262, DOI 10.1111/j.1439-0507.2011.02082.x; Dunphy GB, 2003, CAN J MICROBIOL, V49, P514, DOI 10.1139/W03-064; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; Feldmesser M, 2001, MICROBIOL-SGM, V147, P2355, DOI 10.1099/00221287-147-8-2355; Firacative C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037566; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Garcia-Solache MA, 2013, MBIO, V4, DOI 10.1128/mBio.00100-13; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Krockenberger MB, 2010, MYCOPATHOLOGIA, V170, P315, DOI 10.1007/s11046-010-9328-z; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; Lockhart SR, 2012, DIAGN MICR INFEC DIS, V73, P144, DOI 10.1016/j.diagmicrobio.2012.02.018; Loperena-Alvarez Y, 2010, MYCOPATHOLOGIA, V170, P279, DOI 10.1007/s11046-010-9296-3; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Posteraro B, 2012, J CLIN MICROBIOL, V50, P2472, DOI 10.1128/JCM.00737-12; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Sabiiti Wilber, 2012, Int J Microbiol, V2012, P626745, DOI 10.1155/2012/626745; Scorzoni L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060047; Sellers B, 2012, AM J MED SCI, V343, P510, DOI 10.1097/MAJ.0b013e3182464bc7; Steenbergen JN, 2003, MICROBES INFECT, V5, P667, DOI 10.1016/S1286-4579(03)00092-3; Sukroongreung S, 1996, MYCOPATHOLOGIA, V135, P75, DOI 10.1007/BF00436454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson GR, 2014, INFECT IMMUN, V82, P3058, DOI 10.1128/IAI.01805-14; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; Voelz K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003771; Walraven CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028625; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	51	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105076	10.1371/journal.pone.0105076	http://dx.doi.org/10.1371/journal.pone.0105076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133687	Green Published, Green Submitted, gold			2022-12-27	WOS:000341302700066
J	Gevaert, E; Dolle, L; Billiet, T; Dubruel, P; van Grunsven, L; van Apeldoorn, A; Cornelissen, R				Gevaert, Elien; Dolle, Laurent; Billiet, Thomas; Dubruel, Peter; van Grunsven, Leo; van Apeldoorn, Aart; Cornelissen, Ria			High Throughput Micro-Well Generation of Hepatocyte Micro-Aggregates for Tissue Engineering	PLOS ONE			English	Article							CELL-LADEN MICROGELS; E-CADHERIN; SPHEROIDS; LIVER; SIZE; CONSTRUCTS; VIABILITY; CULTURES	The main challenge in hepatic tissue engineering is the fast dedifferentiation of primary hepatocytes in vitro. One successful approach to maintain hepatocyte phenotype on the longer term is the cultivation of cells as aggregates. This paper demonstrates the use of an agarose micro-well chip for the high throughput generation of hepatocyte aggregates, uniform in size. In our study we observed that aggregation of hepatocytes had a beneficial effect on the expression of certain hepatocyte specific markers. Moreover we observed that the beneficial effect was dependent on the aggregate dimensions, indicating that aggregate parameters should be carefully considered. In a second part of the study, the selected aggregates were immobilized by encapsulation in methacrylamide-modified gelatin. Phenotype evaluations revealed that a stable hepatocyte phenotype could be maintained during 21 days when encapsulated in the hydrogel. In conclusion we have demonstrated the beneficial use of micro-well chips for hepatocyte aggregation and the size-dependent effects on hepatocyte phenotype. We also pointed out that methacrylamide-modified gelatin is suitable for the encapsulation of these aggregates.	[Gevaert, Elien; Cornelissen, Ria] Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium; [Dolle, Laurent; van Grunsven, Leo] Vrije Univ Brussels, Liver cell Biol Lab, Brussels, Belgium; [Billiet, Thomas; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium; [van Apeldoorn, Aart] Univ Twente, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands	Ghent University; Vrije Universiteit Brussel; Ghent University; University of Twente	Cornelissen, R (corresponding author), Univ Ghent, Tissue Engn Grp, B-9000 Ghent, Belgium.	Ria.Cornelissen@UGent.be	van Apeldoorn, Aart/AAP-5433-2021; van Grunsven, Leo/E-5839-2010	van Apeldoorn, Aart/0000-0002-2940-5699; van Grunsven, Leo/0000-0002-0990-7034; Dubruel, Peter/0000-0002-5928-7726	IWT_SBO Grant from the 'Agentschap voor Innovatie door Wetenschap en Technologie' [090066 HepStem]; Interuniversity Attraction Poles (IAP) - phase VII (Federal Science Policy -BELSPO) [P7/47, 10/2012-09/2017]; Brustem: Impulse program - Brustem (Brussels Government) [2011-IP-LS-104, 06/2011-05/2014]	IWT_SBO Grant from the 'Agentschap voor Innovatie door Wetenschap en Technologie'; Interuniversity Attraction Poles (IAP) - phase VII (Federal Science Policy -BELSPO); Brustem: Impulse program - Brustem (Brussels Government)	This work was supported by the IWT_SBO Grant 090066 HepStem from the 'Agentschap voor Innovatie door Wetenschap en Technologie'. LD and LvG: Interuniversity Attraction Poles (IAP) - phase VII - contract P7/47 (Federal Science Policy -BELSPO) (10/2012-09/2017); Brustem: Impulse program 2011-IP-LS-104 - Brustem (Brussels Government) (06/2011-05/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. port not to have conflicts of interest and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asthana A, 2012, DRUG DISCOV TODAY, V17, P810, DOI 10.1016/j.drudis.2012.03.004; Billiet T, 2013, MACROMOL BIOSCI; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Brophy CM, 2009, HEPATOLOGY, V49, P578, DOI 10.1002/hep.22674; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Du Y, 2008, CELL MOL BIOENG, V1, P157, DOI 10.1007/s12195-008-0020-z; Fukuda J, 2005, TISSUE ENG, V11, P1254, DOI 10.1089/ten.2005.11.1254; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Jindal R, 2010, TISSUE ENG C; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Luebke-Wheeler JL, 2009, CELL TRANSPLANT, V18, P1281, DOI 10.3727/096368909X474258; Mei Y, 2010, J BIOTECHNOL, V150, P438, DOI 10.1016/j.jbiotec.2010.09.953; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Pang Y, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045004; Ramaiahgari S.C., 2014, ARCH TOXICOL; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Rivron NC, 2009, BIOMATERIALS, V30, P4851, DOI 10.1016/j.biomaterials.2009.06.037; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Taguchi T, 2011, J MATER SCI-MATER M, V22, P2357, DOI 10.1007/s10856-011-4414-4; Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008; van Zijl F, 2010, WORLD J HEPATOL, V2, P1, DOI 10.4254/wjh.v2.i1.1; Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028	27	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e105171	10.1371/journal.pone.0105171	http://dx.doi.org/10.1371/journal.pone.0105171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133500	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700078
J	Hartung, V; Prell, T; Gaser, C; Turner, MR; Tietz, F; Ilse, B; Bokemeyer, M; Witte, OW; Grosskreutz, J				Hartung, Viktor; Prell, Tino; Gaser, Christian; Turner, Martin R.; Tietz, Florian; Ilse, Benjamin; Bokemeyer, Martin; Witte, Otto W.; Grosskreutz, Julian			Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							BRAIN ATROPHY; HEXANUCLEOTIDE REPEAT; WHOLE-BRAIN; MORPHOMETRY; ALS; DEGENERATION; INVOLVEMENT; PROGRESSION; ACTIVATION; C9ORF72	Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of upper and lower motor neurons. Advanced MRI techniques such as diffusion tensor imaging have shown great potential in capturing a common white matter pathology. However the sensitivity is variable and diffusion tensor imaging is not yet applicable to the routine clinical environment. Voxel-based morphometry (VBM) has revealed grey matter changes in ALS, but the bias-reducing algorithms inherent to traditional VBM are not optimized for the assessment of the white matter changes. We have developed a novel approach to white matter analysis, namely voxel-based intensitometry (VBI). High resolution T1-weighted MRI was acquired at 1.5 Tesla in 30 ALS patients and 37 age-matched healthy controls. VBI analysis at the group level revealed widespread white matter intensity increases in the corticospinal tracts, corpus callosum, sub-central, frontal and occipital white matter tracts and cerebellum. VBI results correlated with disease severity (ALSFRS-R) and patterns of cerebral involvement differed between bulbar- and limb-onset. VBI would be easily translatable to the routine clinical environment, and once optimized for individual analysis offers significant biomarker potential in ALS.	[Hartung, Viktor; Prell, Tino; Tietz, Florian; Witte, Otto W.; Grosskreutz, Julian] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany; [Gaser, Christian] Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany; [Bokemeyer, Martin] Univ Hosp Jena, Dept Radiol, Neuroradiol Sect, Jena, Germany; [Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Witte, Otto W.] Univ Hosp Jena, CSCC, Jena, Germany; [Ilse, Benjamin] Univ Med Ctr, Dept Palliat Med, Gottingen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Oxford; Friedrich Schiller University of Jena; University of Gottingen	Prell, T (corresponding author), Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany.	tino.prell@med.uni-jena.de	Grosskreutz, Julian/G-2293-2010; Gaser, Christian/F-5103-2010; Witte, Otto/P-4127-2018; Prell, Tino/AAE-5492-2020	Grosskreutz, Julian/0000-0001-9525-1424; Gaser, Christian/0000-0002-9940-099X; Witte, Otto/0000-0003-2101-4105; Prell, Tino/0000-0002-6423-3108; Hartung, Viktor/0000-0002-6273-9172; Turner, Martin/0000-0003-0267-3180	German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA; BMBF grant PYRAMID; BMBF; Medical Research Council [MR/K01014X/1] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish; MRC [MR/K01014X/1] Funding Source: UKRI	German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA(Federal Ministry of Education & Research (BMBF)); BMBF grant PYRAMID; BMBF(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project is supported by the German Bundesministerium fur Bildung und Forschung (BMBF) grant SOPHIA to JG under the aegis of the EU Joint Programme - Neurodegenerative Disease Research (JPND - www.jpnd.eu) and a BMBF grant PYRAMID to JG in the framework of the ERANET E-RARE program (www.e-rare.eu). This study was undertaken in cooperation with the BMBF funded MND-NET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2009, AMYOTROPH LATERAL SC, V10, P168, DOI 10.1080/17482960802603841; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Canu E, 2011, AM J NEURORADIOL, V32, P1307, DOI 10.3174/ajnr.A2469; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Ding XQ, 2011, AMYOTROPH LATERAL SC, V12, P406, DOI 10.3109/17482968.2011.597402; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kassubek J, 2005, J CLIN NEUROSCI, V12, P588, DOI 10.1016/j.jocn.2004.07.020; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Menke RAL, 2012, ARCH NEUROL-CHICAGO, V69, P1493, DOI 10.1001/archneurol.2012.1122; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rose S, 2012, NEUROIMAGE, V59, P2661, DOI 10.1016/j.neuroimage.2011.08.054; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Swash M, 2012, J NEUROL NEUROSUR PS, V83, P659, DOI 10.1136/jnnp-2012-302315; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104894	10.1371/journal.pone.0104894	http://dx.doi.org/10.1371/journal.pone.0104894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133577	Green Published, gold, Green Submitted			2022-12-27	WOS:000341302700048
J	Pedrazzi, M; Nash, B; Meucci, O; Brandimarti, R				Pedrazzi, Manuela; Nash, Bradley; Meucci, Olimpia; Brandimarti, Renato			Molecular Features Contributing to Virus-Independent Intracellular Localization and Dynamic Behavior of the Herpesvirus Transport Protein U(S)9	PLOS ONE			English	Article							FAST AXONAL-TRANSPORT; II MEMBRANE-PROTEIN; PSEUDORABIES VIRUS; ANTEROGRADE TRANSPORT; ORGANELLE TRANSPORT; ENVELOPE PROTEIN; NERVOUS-SYSTEM; IN-VITRO; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DYNEIN	Reaching the right destination is of vital importance for molecules, proteins, organelles, and cargoes. Thus, intracellular traffic is continuously controlled and regulated by several proteins taking part in the process. Viruses exploit this machinery, and viral proteins regulating intracellular transport have been identified as they represent valuable tools to understand and possibly direct molecules targeting and delivery. Deciphering the molecular features of viral proteins contributing to (or determining) this dynamic phenotype can eventually lead to a virus-independent approach to control cellular transport and delivery. From this virus-independent perspective we looked at U(S)9, a virion component of Herpes Simplex Virus involved in anterograde transport of the virus inside neurons of the infected host. As the natural cargo of U(S)9-related vesicles is the virus (or its parts), defining its autonomous, virus-independent role in vesicles transport represents a prerequisite to make U(S)9 a valuable molecular tool to study and possibly direct cellular transport. To assess the extent of this autonomous role in vesicles transport, we analyzed U(S)9 behavior in the absence of viral infection. Based on our studies, Us9 behavior appears similar in different cell types; however, as expected, the data we obtained in neurons best represent the virus-independent properties of U(S)9. In these primary cells, transfected U(S)9 mostly recapitulates the behavior of U(S)9 expressed from the viral genome. Additionally, ablation of two major phosphorylation sites (i.e. Y32Y33 and S34ES36) have no effect on protein incorporation on vesicles and on its localization on both proximal and distal regions of the cells. These results support the idea that, while U(S)9 post-translational modification may be important to regulate cargo loading and, consequently, virion export and delivery, no additional viral functions are required for U(S)9 role in intracellular transport.	[Pedrazzi, Manuela; Brandimarti, Renato] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Nash, Bradley; Meucci, Olimpia; Brandimarti, Renato] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	University of Bologna; Drexel University; Drexel University	Meucci, O (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	omeucci@drexelmed.edu; renato.brandimarti@unibo.it		BRANDIMARTI, RENATO/0000-0003-3078-9009	National Institutes of Health (NIH) [DA15014, DA 32444]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH097623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA032444] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was partially supported by the National Institutes of Health (NIH), grants DA15014 and DA 32444 to OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandimarti R, 1997, P NATL ACAD SCI USA, V94, P13973, DOI 10.1073/pnas.94.25.13973; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brideau AD, 2000, J VIROL, V74, P4549, DOI 10.1128/JVI.74.10.4549-4561.2000; Brideau AD, 1999, J VIROL, V73, P4372, DOI 10.1128/JVI.73.5.4372-4384.1999; Brideau AD, 1998, J VIROL, V72, P4560, DOI 10.1128/JVI.72.6.4560-4570.1998; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; Butchi NB, 2007, J NEUROVIROL, V13, P384, DOI 10.1080/13550280701375433; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Chowdhury SI, 2002, J VIROL, V76, P3839, DOI 10.1128/JVI.76.8.3839-3851.2002; Coller KE, 2008, TRAFFIC, V9, P1458, DOI 10.1111/j.1600-0854.2008.00782.x; DAIKOKU T, 1994, J GEN VIROL, V75, P2065, DOI 10.1099/0022-1317-75-8-2065; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Enquist LW, 2002, VET MICROBIOL, V86, P5, DOI 10.1016/S0378-1135(01)00486-2; Feierbach B, 2007, J VIROL, V81, P6846, DOI 10.1128/JVI.00069-07; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; FRAME MC, 1986, VIROLOGY, V150, P321, DOI 10.1016/0042-6822(86)90297-7; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Ibiricu I, 2013, CELL MICROBIOL, V15, P285, DOI 10.1111/cmi.12093; Kato A, 2005, J VIROL, V79, P9325, DOI 10.1128/JVI.79.14.9325-9331.2005; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kramer T, 2012, CELL HOST MICROBE, V12, P806, DOI 10.1016/j.chom.2012.10.013; Kratchmarov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058776; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; LaVail JH, 2007, NEUROSCIENCE, V146, P974, DOI 10.1016/j.neuroscience.2007.02.010; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lyman MG, 2008, J VIROL, V82, P10308, DOI 10.1128/JVI.01204-08; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Lyman MG, 2009, J VIROL, V83, P6978, DOI 10.1128/JVI.00598-09; Lyman MG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000065; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MCGEOCH DJ, 1985, J MOL BIOL, V181, P1, DOI 10.1016/0022-2836(85)90320-1; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nascimento R, 2012, PROTOPLASMA, V249, P519, DOI 10.1007/s00709-011-0327-9; Nguyen ML, 2005, VIROLOGY, V336, P274, DOI 10.1016/j.virol.2005.03.026; Pautke C, 2004, ANTICANCER RES, V24, P3743; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; ROIZMAN B, 2001, FIELDS VIROLOGY, V2, P2399; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Snyder A, 2008, J VIROL, V82, P10613, DOI 10.1128/JVI.01241-08; Taylor MP, 2012, MBIO, V3, DOI 10.1128/mBio.00063-12; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2014	9	8							e104634	10.1371/journal.pone.0104634	http://dx.doi.org/10.1371/journal.pone.0104634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JF	25133647	gold, Green Published, Green Submitted			2022-12-27	WOS:000341302700034
J	Ata-Ul-Karim, ST; Yao, X; Liu, XJ; Cao, WX; Zhu, Y				Ata-Ul-Karim, Syed Tahir; Yao, Xia; Liu, Xiaojun; Cao, Weixing; Zhu, Yan			Determination of Critical Nitrogen Dilution Curve Based on Stem Dry Matter in Rice	PLOS ONE			English	Article							NUTRITION INDEX; MANAGEMENT; YIELD; ACCUMULATION; BIOMASS; CORN	Plant analysis is a very promising diagnostic tool for assessment of crop nitrogen (N) requirements in perspectives of cost effective and environment friendly agriculture. Diagnosing N nutritional status of rice crop through plant analysis will give insights into optimizing N requirements of future crops. The present study was aimed to develop a new methodology for determining the critical nitrogen (N-c) dilution curve based on stem dry matter (S-DM) and to assess its suitability to estimate the level of N nutrition for rice (Oryza sativa L.) in east China. Three field experiments with varied N rates (0-360 kg N ha(-1)) using three Japonica rice hybrids, Lingxiangyou-18, Wuxiangjing-14 and Wuyunjing were conducted in Jiangsu province of east China. S-DM and stem N concentration (SNC) were determined during vegetative stage for growth analysis. A N-c dilution curve based on S-DM was described by the equation (N-c = 2.17W(-0.27) with W being S-DM in t ha(-1)), when S-DM ranged from 0.88 to 7.94 t ha(-1). However, for S-DM, < 0.88 t h(-1), the constant critical value N-c = 1.76% S-DM was applied. The curve was dually validated for N-limiting and non-N-limiting growth conditions. The N nutrition index (NNI) and accumulated N deficit (N-and) of stem ranged from 0.57 to 1.06 and 51.1 to -7.07 kg N ha(-1), respectively, during key growth stages under varied N rates in 2010 and 2011. The values of Delta N derived from either NNI or N-and could be used as references for N dressing management during rice growth. Our results demonstrated that the present curve well differentiated the conditions of limiting and non-limiting N nutrition in rice crop. The S-DM based N-c dilution curve can be adopted as an alternate and novel approach for evaluating plant N status to support N fertilization decision during the vegetative growth of Japonica rice in east China.	[Ata-Ul-Karim, Syed Tahir; Yao, Xia; Liu, Xiaojun; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	yanzhu@njau.edu.cn	Ata-Ul-Karim, Syed Tahir/AAB-6257-2020; Zhu, Yan/AAK-6927-2020; Ata-Ul-Karim, Syed Tahir/F-7468-2017	Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Zhu, Yan/0000-0002-8912-3888; Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Yao, Xia/0000-0002-1093-1736	National High-Tech Research and Development Program of China (863 Program) [2011AA100703]; Special Program for Agriculture Science and Technology from Ministry of Agriculture in China [201303109]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Science and Technology Support Plan of Jiangsu Province [BE2011351, BE2012302]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Special Program for Agriculture Science and Technology from Ministry of Agriculture in China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Science and Technology Support Plan of Jiangsu Province	This work was supported by grants from the National High-Tech Research and Development Program of China (863 Program) (2011AA100703), Special Program for Agriculture Science and Technology from Ministry of Agriculture in China (201303109), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Science and Technology Support Plan of Jiangsu Province (BE2011351, BE2012302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira ECA, 2013, J PLANT NUTR SOIL SC, V176, P712, DOI 10.1002/jpln.201200133; de Oliveira ECA, 2010, REV BRAS CIENC SOLO, V34, P1343, DOI 10.1590/S0100-06832010000400031; Ata-Ul-Karim ST, 2014, FIELD CROP RES, V167, P76, DOI 10.1016/j.fcr.2014.07.010; Ata-Ul-Karim ST, 2013, FIELD CROP RES, V149, P149, DOI 10.1016/j.fcr.2013.03.012; Belanger G, 2000, PLANT SOIL, V219, P177, DOI 10.1023/A:1004749828745; Cabangon RJ, 2011, FIELD CROP RES, V121, P136, DOI 10.1016/j.fcr.2010.12.002; Chen J, 2011, AGR ECOSYST ENVIRON, V142, P195, DOI 10.1016/j.agee.2011.05.005; Confalonieri R, 2011, J AGR SCI-CAMBRIDGE, V149, P633, DOI 10.1017/S0021859611000177; Debaeke P, 2006, J PLANT NUTR, V29, P75, DOI 10.1080/01904160500416471; Gayler S, 2002, GEODERMA, V105, P367, DOI 10.1016/S0016-7061(01)00113-6; Ghosh M, 2004, J AGR SCI, V142, P183, DOI 10.1017/S002185960400423X; Hahn WS, 1997, STAT METHODS AGR LIF; Islam M. A., 2008, Journal of Agriculture & Rural Development (Gazipur), V6, P7; Jaggard KW, 2009, J AGR SCI-CAMBRIDGE, V147, P287, DOI 10.1017/S0021859609008478; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kage H, 2002, PLANT SOIL, V246, P201, DOI 10.1023/A:1020627723616; Lemaire G, 2008, EUR J AGRON, V28, P614, DOI 10.1016/j.eja.2008.01.005; Lin FF, 2010, COMPUT ELECTRON AGR, V71, pS60, DOI 10.1016/j.compag.2009.09.006; Shan YuHua, 2001, Journal of Yangzhou University, Natural Science Edition, V4, P42; Sheehy JE, 1998, FIELD CROP RES, V59, P31, DOI 10.1016/S0378-4290(98)00105-1; SMEAL D, 1994, COMMUN SOIL SCI PLAN, V25, P1495, DOI 10.1080/00103629409369130; Vouillot MO, 1998, AGRONOMIE, V18, P117, DOI 10.1051/agro:19980202; Wang W, 2012, J INTEGR AGR, V11, P2001, DOI 10.1016/S2095-3119(12)60457-2; Yao X, 2014, EUR J AGRON, V55, P20, DOI 10.1016/j.eja.2013.12.004; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yoshida H, 2006, FIELD CROP RES, V97, P337, DOI 10.1016/j.fcr.2005.11.004; Yue SC, 2012, AGRON J, V104, P523, DOI 10.2134/agronj2011.0258; Zhao B, 2014, AGRON J, V106, P379, DOI 10.2134/agronj2013.0213; Ziadi N, 2008, AGRON J, V100, P271, DOI 10.2134/agronj2007.0059; Ziadi N, 2010, AGRON J, V102, P241, DOI 10.2134/agronj2009.0266; Ziadi N, 2009, AGRON J, V101, P947, DOI 10.2134/agronj2008.0172x	31	26	34	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104540	10.1371/journal.pone.0104540	http://dx.doi.org/10.1371/journal.pone.0104540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127042	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300034
J	Mi, SF; Jia, XJ; Wang, JZ; Qiao, WB; Peng, XW; Han, YJ				Mi, Shuofu; Jia, Xiaojing; Wang, Jinzhi; Qiao, Weibo; Peng, Xiaowei; Han, Yejun			Biochemical Characterization of Two Thermostable Xylanolytic Enzymes Encoded by a Gene Cluster of Caldicellulosiruptor owensensis	PLOS ONE			English	Article							GH39 BETA-XYLOSIDASE; THERMOANAEROBACTERIUM-SACCHAROLYTICUM; STRUCTURAL INSIGHTS; ESCHERICHIA-COLI; PLANT BIOMASS; FAMILY 10; XYLANASE; CLONING; EXPRESSION; OVEREXPRESSION	The xylanolytic extremely thermophilic bacterium Caldicellulosiruptor owensensis provides a promising platform for xylan utilization. In the present study, two novel xylanolytic enzymes, GH10 endo-beta-1,4-xylanase (Coxyn A) and GH39 beta-1,4-xylosidase (Coxyl A) encoded in one gene cluster of C. owensensis were heterogeneously expressed and biochemically characterized. The optimum temperature of the two xylanlytic enzymes was 75 degrees C, and the respective optimum pH for Coxyn A and Coxyl A was 7.0 and 5.0. The difference of Coxyn A and Coxyl A in solution was existing as monomer and homodimer respectively, it was also observed in predicted secondary structure. Under optimum condition, the catalytic efficiency (k(cat)/K-m) of Coxyn A was 366 mg ml(-1) s(-1) on beechwood xylan, and the catalytic efficiency (k(cat)/K-m) of Coxyl A was 2253 mM(-1) s(-1) on pNP-beta-D-xylopyranoside. Coxyn A degraded xylan to oligosaccharides, which were converted to monomer by Coxyl A. The two intracellular enzymes might be responsible for xylooligosaccharides utilization in C. owensensis, also provide a potential way for xylan degradation in vitro.	[Mi, Shuofu; Jia, Xiaojing; Qiao, Weibo; Peng, Xiaowei; Han, Yejun] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Wang, Jinzhi] Chinese Acad Agr Sci, Inst Agrofood Sci & Technol, Beijing 100193, Peoples R China; [Qiao, Weibo] Shenyang Agr Univ, Shenyang 110161, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Chinese Academy of Agricultural Sciences; Shenyang Agricultural University	Han, YJ (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.	yejunhan09@gmail.com	Han, Yejun/AAC-7411-2019		National High Technology Research and Development Program of China (863 Project) [2014AA021905]	National High Technology Research and Development Program of China (863 Project)(National High Technology Research and Development Program of China)	YH received funding from National High Technology Research and Development Program of China (863 Project), grant number is 2014AA021905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, APPL MICROBIOL BIOT, V84, P19, DOI 10.1007/s00253-009-2079-4; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; BLAKENEY AB, 1980, J SCI FOOD AGR, V31, P889, DOI 10.1002/jsfa.2740310905; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2012, J BACTERIOL, V194, P4015, DOI 10.1128/JB.00266-12; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravman T, 2001, FEBS LETT, V495, P39, DOI 10.1016/S0014-5793(01)02360-2; Correa JM, 2012, APPL BIOCHEM BIOTECH, V168, P2218, DOI 10.1007/s12010-012-9931-1; Deutschmann R, 2012, BIOTECHNOL ADV, V30, P1627, DOI 10.1016/j.biotechadv.2012.07.001; Dwivedi PP, 1996, APPL MICROBIOL BIOT, V45, P86, DOI 10.1007/s002530050653; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; FUKUMURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P40, DOI 10.1271/bbb.59.40; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Huang CY, 1998, INT J SYST BACTERIOL, V48, P91, DOI 10.1099/00207713-48-1-91; LEE YE, 1993, APPL ENVIRON MICROB, V59, P3134, DOI 10.1128/AEM.59.9.3134-3137.1993; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P2677; MORIYAMA H, 1987, EUR J BIOCHEM, V166, P539, DOI 10.1111/j.1432-1033.1987.tb13547.x; Morris DD, 1999, EXTREMOPHILES, V3, P103, DOI 10.1007/s007920050105; Ochs M, 2013, J MOL CATAL B-ENZYM, V96, P21, DOI 10.1016/j.molcatb.2013.06.001; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rizzatti ACS, 2001, J IND MICROBIOL BIOT, V26, P156, DOI 10.1038/sj.jim.7000107; Sa-Pereira P, 2003, MOL BIOTECHNOL, V24, P257, DOI 10.1385/MB:24:3:257; Shao WL, 2011, APPL ENVIRON MICROB, V77, P719, DOI 10.1128/AEM.01511-10; Shi H, 2014, BIOTECHNOL LETT, V36, P587, DOI 10.1007/s10529-013-1392-2; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-27; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Takahashi Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-447; VanFossen AL, 2011, BIOTECHNOL BIOENG, V108, P1559, DOI 10.1002/bit.23093; Verma D, 2012, BIORESOURCE TECHNOL, V117, P360, DOI 10.1016/j.biortech.2012.04.034; Viborg AH, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-56; Wongwisansri S, 2013, BIORESOURCE TECHNOL, V132, P410, DOI 10.1016/j.biortech.2012.11.117; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Ying Y, 2013, ENZYME MICROB TECH, V53, P194, DOI 10.1016/j.enzmictec.2013.04.004; Zverlov V, 1996, APPL MICROBIOL BIOT, V45, P245, DOI 10.1007/s002530050678	40	20	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105264	10.1371/journal.pone.0105264	http://dx.doi.org/10.1371/journal.pone.0105264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127169	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300099
J	Ohm, IK; Gao, E; Olsen, MB; Alfsnes, K; Bliksoen, M; Ogaard, J; Ranheim, T; Nymo, SH; Holmen, YD; Aukrust, P; Yndestad, A; Vinge, LE				Ohm, Ingrid Kristine; Gao, Erhe; Olsen, Maria Belland; Alfsnes, Katrine; Bliksoen, Marte; Ogaard, Jonas; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Aukrust, Pal; Yndestad, Arne; Vinge, Leif Erik			Toll-Like Receptor 9-Activation during Onset of Myocardial Ischemia Does Not Influence Infarct Extension	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; INJURY; EXPRESSION	Aim: Myocardial infarction (MI) remains a major cause of death and disability worldwide, despite available reperfusion therapies. Inflammatory signaling is considered nodal in defining final infarct size. Activation of the innate immune receptor toll-like receptors (TLR) 9 prior to ischemia and reperfusion (I/R) reduces infarct size, but the consequence of TLR9 activation timed to the onset of ischemia is not known. Methods and Results: The TLR9-agonist; CpG B was injected i.p. in C57BL/6 mice immediately after induction of ischemia (30 minutes). Final infarct size, as well as area-at-risk, was measured after 24 hours of reperfusion. CpG B injection resulted in a significant increase in circulating granulocytes and monocytes both in sham and I/R mice. Paradoxically, clear evidence of reduced cardiac infiltration of both monocytes and granulocytes could be demonstrated in I/R mice treated with CpG B (immunocytochemistry, myeloperoxidase activity and mRNA expression patterns). In addition, systemic TLR9 activation elicited significant alterations of cardiac inflammatory genes. Despite these biochemical and cellular changes, there was no difference in infarct size between vehicle and CpG B treated I/R mice. Conclusion: Systemic TLR9-stimulation upon onset of ischemia and subsequent reperfusion does not alter final infarct size despite causing clear alterations of both systemic and cardiac inflammatory parameters. Our results question the clinical usefulness of TLR9 activation during cardiac I/R.	[Ohm, Ingrid Kristine; Olsen, Maria Belland; Alfsnes, Katrine; Bliksoen, Marte; Ogaard, Jonas; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Aukrust, Pal; Yndestad, Arne; Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Ohm, Ingrid Kristine; Nymo, Stale Haugset; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Fac Med, Oslo, Norway; [Ohm, Ingrid Kristine; Olsen, Maria Belland; Bliksoen, Marte; Ranheim, Trine; Nymo, Stale Haugset; Holmen, Yangchen Dhondup; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA USA; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Vinge, Leif Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Vinge, Leif Erik] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Ohm, IK (corresponding author), Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway.	Ingrid.Kristine.Ohm@rr-research.no	Olsen, Maria/GXA-1825-2022; Olsen, Maria Belland/GQP-4485-2022	Ogaard, Jonas/0000-0001-9194-5939	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	University of Oslo; Center for Heart Failure Research; The South-Eastern Norway Regional Health Authority (Helse Sor-Ost)	This work was supported by the University of Oslo; and Center for Heart Failure Research; and The South-Eastern Norway Regional Health Authority (Helse Sor-Ost), http://www.helse-sorost.no/Sider/side.aspx, http://www.heartfailure.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047; Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Filep JG, 1997, CIRCULATION, V96, P295; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Markowski P, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0376-7; Mersmann J, 2010, CRIT CARE MED, V38, P903, DOI 10.1097/CCM.0b013e3181ce50e6; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; WILLIAMS FM, 1994, BRIT J PHARMACOL, V111, P1123, DOI 10.1111/j.1476-5381.1994.tb14861.x; Xia Ying, 2007, Inflammation & Allergy Drug Targets, V6, P101; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	24	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104407	10.1371/journal.pone.0104407	http://dx.doi.org/10.1371/journal.pone.0104407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126943	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300025
J	Thompson, CE; Biesmeijer, JC; Allnutt, TR; Pietravalle, S; Budge, GE				Thompson, Catherine E.; Biesmeijer, Jacobus C.; Allnutt, Theodore R.; Pietravalle, Stephane; Budge, Giles E.			Parasite Pressures on Feral Honey Bees (Apis mellifera sp.)	PLOS ONE			English	Article							VARROA-DESTRUCTOR; GENE-EXPRESSION; PCR; COLONIES; VIRUS; ADAPTATIONS; RESISTANCE; BRAIN; MITES	Feral honey bee populations have been reported to be in decline due to the spread of Varroa destructor, an ectoparasitic mite that when left uncontrolled leads to virus build-up and colony death. While pests and diseases are known causes of large-scale managed honey bee colony losses, no studies to date have considered the wider pathogen burden in feral colonies, primarily due to the difficulty in locating and sampling colonies, which often nest in inaccessible locations such as church spires and tree tops. In addition, little is known about the provenance of feral colonies and whether they represent a reservoir of Varroa tolerant material that could be used in apiculture. Samples of forager bees were collected from paired feral and managed honey bee colonies and screened for the presence of ten honey bee pathogens and pests using qPCR. Prevalence and quantity was similar between the two groups for the majority of pathogens, however feral honey bees contained a significantly higher level of deformed wing virus than managed honey bee colonies. An assessment of the honey bee race was completed for each colony using three measures of wing venation. There were no apparent differences in wing morphometry between feral and managed colonies, suggesting feral colonies could simply be escapees from the managed population. Interestingly, managed honey bee colonies not treated for Varroa showed similar, potentially lethal levels of deformed wing virus to that of feral colonies. The potential for such findings to explain the large fall in the feral population and the wider context of the importance of feral colonies as potential pathogen reservoirs is discussed.	[Thompson, Catherine E.; Biesmeijer, Jacobus C.] Univ Leeds, Leeds, W Yorkshire, England; [Allnutt, Theodore R.; Pietravalle, Stephane; Budge, Giles E.] Food & Environm Res Agcy, York, N Yorkshire, England	University of Leeds; Food & Environment Research Agency	Thompson, CE (corresponding author), Univ Leeds, Woodhouse Lane, Leeds, W Yorkshire, England.	fbsct@leeds.ac.uk		Biesmeijer, Koos/0000-0003-0328-0573	BBSRC [BB/D526488/1]; Defra; NERC; Scottish Government; Wellcome Trust, under the Insect Pollinator Initiative [BB/I000801/1]; BBSRC [BB/I000801/1, BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1, BB/I000801/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust, under the Insect Pollinator Initiative(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CET was funded as part of a 4 year BBSRC PhD (Grant BB/D526488/1)(http://www.bbsrc.ac.uk/funding/studentships). GEB was funded by a grant from BBSRC, Defra, NERC, the Scottish Government, and the Wellcome Trust, under the Insect Pollinator Initiative (Grants BB/I000801/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Bailey L., 1961, AM BEE J, V101, P89; Belloy L, 2007, APIDOLOGIE, V38, P136, DOI [10.1051/apido:2006069, 10.1051/apido:2007039]; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bouga M, 2011, J APICULT RES, V50, P51, DOI 10.3896/IBRA.1.50.1.06; Budge G, 2010, INVESTIGATING HONEY, P1; Budge GE, 2014, PLOS ONE IN PRESS; Budge GE, 2010, J INVERTEBR PATHOL, V105, P164, DOI 10.1016/j.jip.2010.06.004; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Carreck NL, 2002, APIACTA, V37, P33; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; DEFRA, 2013, BEES OTH POLL THEIR; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Doebler SA, 2000, BIOSCIENCE, V50, P738, DOI 10.1641/0006-3568(2000)050[0738:TRAFOT]2.0.CO;2; Edwards P, 2007, MORPHPLOTV2 2; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Green DM, 2000, HEREDITY, V85, P450, DOI 10.1046/j.1365-2540.2000.00788.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hollander M., 1973, NONPARAMETRIC STAT M; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Kerstes NAG, 2014, INSECT SCI, V21, P401, DOI 10.1111/1744-7917.12064; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; MORITZ RFA, 1991, J APICULT RES, V30, P54, DOI 10.1080/00218839.1991.11101234; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; RATNIEKS FLW, 1989, ECOL ENTOMOL, V14, P475, DOI 10.1111/j.1365-2311.1989.tb00951.x; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Taylor MA, 2007, NEW ZEAL J CROP HORT, V35, P313, DOI 10.1080/01140670709510197; Thompson C.E., 2010, BEE CRAFT, V92, P22; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; Tofilski A, 2008, APIDOLOGIE, V39, P558, DOI 10.1051/apido:2008037; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Villa JD, 2008, J ECON ENTOMOL, V101, P1756, DOI 10.1603/0022-0493-101.6.1756; VSNInternational, 2011, GENSTAT WINDOWS; Wallner K., 2003, Pesticide Outlook, V14, P80, DOI 10.1039/b301510f; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	51	34	34	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e105164	10.1371/journal.pone.0105164	http://dx.doi.org/10.1371/journal.pone.0105164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25126840	Green Published, gold, Green Submitted			2022-12-27	WOS:000340879300088
J	Yan, J; Zhang, L; Xu, JS; Sultana, N; Hu, J; Cai, XQ; Li, J; Xu, PX; Cai, CL				Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng			Smad4 Regulates Ureteral Smooth Muscle Cell Differentiation during Mouse Embryogenesis	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; NEURAL CREST CELLS; URINARY-TRACT; URETEROPELVIC JUNCTION; VASCULAR DEVELOPMENT; SIGNAL-TRANSDUCTION; EXPRESSION; TBX18; MESENCHYME; MYOCARDIN	Proper formation of ureteral smooth muscle cells (SMCs) during embryogenesis is essential for ureter peristalsis that propels urine from the kidney to the bladder in mammals. Currently the molecular factors that regulate differentiation of ureteral mesenchymal cells into SMCs are incompletely understood. A recent study has reported that Smad4 deficiency reduces the number of ureteral SMCs. However, its precise role in the ureteral smooth muscle development remains largely unknown. Here, we used Tbx18:Cre knock-in mouse line to delete Smad4 to examine its requirement in the development of ureteral mesenchyme and SMC differentiation. We found that mice with specific deletion of Smad4 in Tbx18-expressing ureteral mesenchyme exhibited hydroureter and hydronephrosis at embryonic day (E) 16.5, and the mutant mesenchymal cells failed to differentiate into SMCs with increased apoptosis and decreased proliferation. Molecular markers for SMCs including alpha smooth muscle actin (alpha-SMA) and smooth muscle myosin heavy chain (SM-MHC) were absent in the mutant ureters. Moreover, disruption of Smad4 significantly reduced the expression of genes, including Sox9, Tbx18 and Myocardin associated with SMC differentiation. These findings suggest that Smad4 is essential for initiating the SMC differentiation program during ureter development.	[Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Yan, Jianyun; Zhang, Lu; Xu, Jinshu; Sultana, Nishat; Hu, Jun; Cai, Xiaoqiang; Li, Jun; Xu, Pin-Xian; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Xu, Jinshu; Li, Jun; Xu, Pin-Xian] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Yan, Jianyun] Southern Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Southern Medical University - China	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020; Xu, Jinshu/Q-3879-2017	Yan, Jianyun/0000-0002-6962-1169; Xu, Jinshu/0000-0002-6287-5633	NHLBI [1R01HL095810, 1K02HL094688]; American Heart Association [0855808D]; March of Dimes Foundation [5-FY07-642]; NIDDK [R01 DK064640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL094688, R01HL095810] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by grants to C.L.C. from the NHLBI (1R01HL095810 and 1K02HL094688), the American Heart Association (0855808D) and the March of Dimes Foundation (5-FY07-642), and grant to P-X. X. from the NIDDK (R01 DK064640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bohnenpoll T, 2013, DEV BIOL, V380, P25, DOI 10.1016/j.ydbio.2013.04.036; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Grisanti L, 2013, J INVEST DERMATOL, V133, P344, DOI 10.1038/jid.2012.329; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; Ko SO, 2007, DEV BIOL, V312, P435, DOI 10.1016/j.ydbio.2007.09.050; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063721; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Nie XG, 2008, DEV BIOL, V316, P417, DOI 10.1016/j.ydbio.2008.02.006; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tripathi P, 2012, J AM SOC NEPHROL, V23, P618, DOI 10.1681/ASN.2011060566; Trowe MO, 2012, DEVELOPMENT, V139, P3099, DOI 10.1242/dev.077388; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wilkinson D. G., 1998, SITU HYBRIDIZATION P; Woolf AS, 2013, J AM SOC NEPHROL, V24, P19, DOI 10.1681/ASN.2012020127; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	53	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2014	9	8							e104503	10.1371/journal.pone.0104503	http://dx.doi.org/10.1371/journal.pone.0104503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8UD	25127126	Green Published, Green Submitted, gold			2022-12-27	WOS:000340879300027
J	Wu, JN; Yan, SZ; Zhao, JL; Ye, YY				Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying			Barbs Facilitate the Helical Penetration of Honeybee (Apis mellifera ligustica) Stingers	PLOS ONE			English	Article							OVIPOSITOR; HYMENOPTERA; INSECTA; WASPS	The stinger is a very small and efficient device that allows honeybees to perform two main physiological activities: repelling enemies and laying eggs for reproduction. In this study, we explored the specific characteristics of stinger penetration, where we focused on its movements and the effects of it microstructure. The stingers of Italian honeybees (Apis mellifera ligustica) were grouped and fixed onto four types of cubic substrates, before pressing into different substrates. The morphological characteristics of the stinger cross-sections were analyzed before and after penetration by microscopy. Our findings suggest that the honeybee stinger undergoes helical and clockwise rotation during penetration. We also found that the helical penetration of the stinger is associated directly with the spiral distribution of the barbs, thereby confirming that stinger penetration involves an advanced microstructure rather than a simple needle-like apparatus. These results provide new insights into the mechanism of honeybee stinger penetration.	[Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying] Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China	Tsinghua University	Yan, SZ (corresponding author), Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China.	yansz@mail.tsinghua.edu.cn	Zhao, Jieliang/B-1872-2016; Yan, Shaoze/M-1707-2015; yan, shaoze/X-5768-2019; Yu, GH/H-4968-2013	Zhao, Jieliang/0000-0001-6879-0537; Yan, Shaoze/0000-0003-2578-6831; Yu, GH/0000-0002-5699-779X	Research Project of the State Key Laboratory of Tribology [SKLT11B03]	Research Project of the State Key Laboratory of Tribology	This work was funded by the Research Project of the State Key Laboratory of Tribology under Contract no. SKLT11B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007; Brown PE, 1998, J INSECT PHYSIOL, V44, P1017, DOI 10.1016/S0022-1910(98)00072-9; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; Dade H.A., 1994, ANATOMY DISSECTION H; Duan JJ, 2000, J INSECT BEHAV, V13, P175, DOI 10.1023/A:1007780029320; Frasson L, 2010, P I MECH ENG H, V224, P775, DOI 10.1243/09544119JEIM663; Gao Y, 2007, J SPACECRAFT ROCKETS, V44, P703, DOI 10.2514/1.23025; Izumi H, 2011, SENSOR ACTUAT A-PHYS, V165, P115, DOI 10.1016/j.sna.2010.02.010; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong XQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011910; Rahman MH, 1998, ZOOL SCR, V27, P333, DOI 10.1111/j.1463-6409.1998.tb00465.x; Robbins CR., 2002, CHEM PHYS BEHAV HUMA, V4th ed.; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J., 2008, BUZZ BEES BIOL SUPER; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Visscher PK, 1996, LANCET, V348, P301, DOI 10.1016/S0140-6736(96)01367-0; Winston M. L. L., 1991, BIOL HONEY BEE; WU E, 1994, EXP MECH, V34, P93, DOI 10.1007/BF02325705	22	35	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103823	10.1371/journal.pone.0103823	http://dx.doi.org/10.1371/journal.pone.0103823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25137372	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700058
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital	Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017; Hsu, Yuan-Man/K-7074-2015	Wu, Chia-Chou/0000-0002-4009-6858; Chang, Jia-Hao/0000-0001-7843-2688; Chang, Chiung-Hung/0000-0001-6917-4875; Hsu, Yuan-Man/0000-0002-4575-7475	National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902	http://dx.doi.org/10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926785	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100009
J	Lee, MD; Steyvers, M; Miller, B				Lee, Michael D.; Steyvers, Mark; Miller, Brent			A Cognitive Model for Aggregating People's Rankings	PLOS ONE			English	Article								We develop a cognitive modeling approach, motivated by classic theories of knowledge representation and judgment from psychology, for combining people's rankings of items. The model makes simple assumptions about how individual differences in knowledge lead to observed ranking data in behavioral tasks. We implement the cognitive model as a Bayesian graphical model, and use computational sampling to infer an aggregate ranking and measures of the individual expertise. Applications of the model to 23 data sets, dealing with general knowledge and prediction tasks, show that the model performs well in producing an aggregate ranking that is often close to the ground truth and, as in the "wisdom of the crowd'' effect, usually performs better than most of individuals. We also present some evidence that the model outperforms the traditional statistical Borda count method, and that the model is able to infer people's relative expertise surprisingly well without knowing the ground truth. We discuss the advantages of the cognitive modeling approach to combining ranking data, and in wisdom of the crowd research generally, as well as highlighting a number of potential directions for future model development.	[Lee, Michael D.; Steyvers, Mark; Miller, Brent] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Lee, MD (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	mdlee@uci.edu	; , Chris/A-5366-2009	Komar, John/0000-0002-2063-4065; Steyvers, mark/0000-0003-1466-5647; , Chris/0000-0003-1158-8244	University California Irvine [85299]; Department of Interior National Business Center (DoI/NBC) [D11PC20059]	University California Irvine; Department of Interior National Business Center (DoI/NBC)	This research was supported by SURP Award 85299 (http://www.urop.uci.edu/SURP.html) from the University California Irvine, and by the Intelligence Advanced Research Projects Activity (IARPA: http://www.iarpa.gov/) via Department of Interior National Business Center (DoI/NBC) contract number D11PC20059. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. Disclaimer: The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DoI/NBC, or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockenholt U., 1993, PROBABILITY MODELS S, P157; Borg I., 1997, MODERN MULTIDIMENSIO; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; DeBoeck P., 2004, FRAMEWORK ITEM RESPO; Gordon K, 1924, J EXP PSYCHOL, V7, P398, DOI 10.1037/h0074666; Henson R, 2001, PSYCHOLOGIST, V14, P70; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huang J, 2009, J MACH LEARN RES, V10, P997; Johnson TR, 2013, BEHAV RES METHODS; Karabatsos G, 2003, PSYCHOMETRIKA, V68, P373, DOI 10.1007/BF02294733; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Klementiev A, 2009, INT JOINT C ART INT; KONDOR R., 2007, P 11 INT C ART INT S; Lebanon G, 2002, P 19 INT C MACH LEAR; Lebanon G, 2008, J MACH LEARN RES, V9, P2401; Lee M., 2011, P 33 ANN C COGN SCI, P1304; Lee MD, 2012, TOP COGN SCI, V4, P151, DOI 10.1111/j.1756-8765.2011.01175.x; Lee MD, 2011, MEM COGNITION, V39, P914, DOI 10.3758/s13421-010-0059-7; LUCE RD, 1994, PSYCHOL REV, V101, P271, DOI 10.1037/0033-295X.101.2.271; Marden JI, 1995, ANAL MODELING RANK D; Oravecz Z, 2013, PSYCHOMETRIKA; Plummer M., 2003, P 3 INT WORKSH DISTR; ROMNEY AK, 1987, AM BEHAV SCI, V31, P163, DOI 10.1177/000276487031002003; Steyvers M., 2009, ADV NEURAL INFORM PR, V22, P1785; Surowiecki James, 2004, WISDOM CROWDS; Thompson B, 2004, EXPLORATORY CONFIRMA; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Weiss DJ, 2014, APPL COGNITIVE PSYCH; Zhang SN, 2010, COGNITION IN FLUX, P1118	29	83	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e96431	10.1371/journal.pone.0096431	http://dx.doi.org/10.1371/journal.pone.0096431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	25140822	gold, Green Published			2022-12-27	WOS:000336838000037
J	Tan, YW; Ge, GH; Pan, TL; Wen, DF; Gan, JH				Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng; Gan, Jianhe			A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HEPATIC STEATOSIS; EXPRESSION LEVELS; RT-PCR; STEATOHEPATITIS; FIBROSIS; MIR-122; INJURY; INFLAMMATION; CARCINOMA	Background: The invasive nature of liver biopsy makes the histopathological diagnosis of non-alcoholic fatty liver disease (NAFLD) difficult and its diagnostic performance unsatisfactory. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for NAFLD. Methods: Serum miRNA expression was investigated using three cohorts comprising 465 participants (healthy controls and NAFLD patients) recruited between August 2010 and June 2013. miRNA expression was initially screened by Illumina sequencing using serum samples pooled from 20 patients and 20 controls. Quantitative reverse transcriptase polymerase chain reaction assay was then used to evaluate the expression of selected miRNAs. A logistic regression model was constructed using a training cohort (n = 242) and validated using another cohort (n = 183). The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We identified an miRNA panel (hsa-miR-122-5p, hsa-miR-1290, hsa-miR-27b-3p, and hsa-miR-192-5p) with a high diagnostic accuracy for NAFLD. The satisfactory diagnostic performance of the miRNA panel remained regardless of the NAFLD activity score (NAS) status. There was significant difference between the AUC values of the miRNA panel and those of ALT (AUC = 0.786, 95% CI = 0.717-0.855; P = 0.142) and FIB-4 (AUC = 0.795, 95% CI = 0.730-0.860; sensitivity = 69.9%, specificity = 83.7%. Conclusion: We identified a serum microRNA panel with considerable clinical value in NAFLD diagnosis. The results indicate that the miRNA panel is a more sensitive and specific biomarker for NAFLD than ALT and FIB-4.	[Tan, Youwen; Gan, Jianhe] Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China; [Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng] Zhenjiang Affiliated Jiangsu Univ, Hosp 3, Dept Hepatosis, Zhenjiang, Peoples R China	Soochow University - China	Gan, JH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China.	ganjianhe@aliyun.com			Natural Science Foundation of Jiangsu Province, China [BK2011151]; Medical Project of Health Department Jiangsu Province [H201248]; Social Development Project of Zhenjiang City [SH201346]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011151) (http://www.jstd.gov.cn/), Medical Project of Health Department Jiangsu Province (H201248) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH201346) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Blanco-Calvo M, 2012, SENSORS-BASEL, V12, P9349, DOI 10.3390/s120709349; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Castera L, 2010, LANCET, V375, P1419, DOI 10.1016/S0140-6736(09)62195-4; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Ge Yan, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P908, DOI 10.3969/j.issn.1672-7347.2011.09.017; Geng L, 2013, ONCOGENE; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gougelet A, 2013, M S-MED SCI, V29, P861, DOI 10.1051/medsci/20132910013; Gougelet A, 2013, WORLD J GASTROENTERO, V19, P440, DOI 10.3748/wjg.v19.i4.440; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; Hsu Shu-Hao, 2013, Curr Pathobiol Rep, V1, P53; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Iino I, 2013, CANCER SCI, V104, P624, DOI 10.1111/cas.12122; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li A, 2013, CLIN CANCER RES, V19, P5252, DOI 10.1158/1078-0432.CCR-13-1899; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Mottin CC, 2004, OBES SURG, V14, P635, DOI 10.1381/096089204323093408; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x	42	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105192	10.1371/journal.pone.0105192	http://dx.doi.org/10.1371/journal.pone.0105192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	24736723	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200058
J	Tan, Y; Liu, TR; Hu, SW; Tian, D; Li, C; Zhong, JK; Sun, HG; Luo, TT; Lai, WY; Guo, ZG				Tan, Ying; Liu, Ting Rong; Hu, Shui Wang; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang			Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; DYSFUNCTIONAL HDL; APOLIPOPROTEIN-E; MACROPHAGES; DISEASE; ATHEROSCLEROSIS; INFLAMMATION; HEMOGLOBIN; ACTIVATION	Objectives: This study examined alterations in the functions and proteome of high-density lipoprotein (HDL) subfractions (HDL2 and HDL3) isolated from patients with acute coronary syndrome (ACS) compared with control subjects. Methods: We measured HDL subfraction cholesterol efflux capacity, inflammatory index (HII), paraoxonase-1 (PON1) activity, and lipid hydroperoxide (LOOH) levels in both male age-matched controls and the ACS group (n = 40/group). Additionally, proteomic analysis was used to monitor changes in the HDL subfraction proteome between controls and ACS subjects. Results: Both HDL2 and HDL3 from ACS patients had greater HII and LOOH levels compared with controls (P<0.001); PON1 activity and cholesterol efflux capacity in both HDL2 and HDL3 from the ACS group were significantly less than those of controls (P<0.001). Using proteomic analysis, we demonstrated that, compared with the control group, nine proteins were selectively enriched in HDL3 from subjects with ACS, and ras-related protein Rab-7b was decreased in HDL3. Additionally, in the ACS subjects, 12 proteins were decreased in HDL2 and 4 proteins were increased in HDL2. Conclusions: Functional HDL subfractions shifted to dysfunctional HDL subfractions during ACS, and the functional impairment was linked to remodeled protein cargo in HDL subfractions from ACS patients.	[Tan, Ying; Liu, Ting Rong; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang] Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China; [Hu, Shui Wang] Southern Med Univ, Lab Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Guo, ZG (corresponding author), Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China.	guozhigang126@126.com			Natural Science Foundation of Guangdong Province of China [10151051501000073]; Special Doctor Station Foundation of the University of the Education Department of China [20104433110006]	Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Special Doctor Station Foundation of the University of the Education Department of China	This work was supported by the Natural Science Foundation of Guangdong Province of China (10151051501000073) and the Special Doctor Station Foundation of the University of the Education Department of China (20104433110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Arab K, 2004, ANAL BIOCHEM, V325, P158, DOI 10.1016/j.ab.2003.10.022; Beltowski J, 2005, PHARMACOL RES, V51, P523, DOI 10.1016/j.phrs.2005.01.007; Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Di Filippo C, 2006, CARDIOVASC DRUG REV, V24, P77; Dodani S, 2008, INT J CARDIOL, V129, P125, DOI 10.1016/j.ijcard.2007.12.019; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Guo ZG, 2012, CHEM PHYS LIPIDS, V165, P32, DOI 10.1016/j.chemphyslip.2011.10.005; Julia Z, 2010, J LIPID RES, V51, P3350, DOI 10.1194/jlr.P009746; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li XA, 1998, BIOCHEM BIOPH RES CO, V244, P249, DOI 10.1006/bbrc.1998.8248; Lin CY, 1999, J LIPID RES, V40, P1618; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Nabais S, 2009, PROGNOSTIC IMPACT HE; Nagy E, 2009, ARTERIOSCLER THROMB, V30, P1347; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Ortiz-Munoz G, 2009, FASEB J, V23, P3129, DOI 10.1096/fj.08-127928; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Previsdomini M, 2007, AM J CARDIOL, V100, P579, DOI 10.1016/j.amjcard.2007.03.065; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Schultz JR, 1993, PROTEIN COMPOSITION; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Song ZQ, 2010, ATHEROSCLEROSIS, V211, P90, DOI 10.1016/j.atherosclerosis.2010.01.046; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; YAMAMOTO N, 1991, J IMMUNOL, V147, P273; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249	38	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94264	10.1371/journal.pone.0094264	http://dx.doi.org/10.1371/journal.pone.0094264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736723	Green Submitted, gold, Green Published			2022-12-27	WOS:000336922600055
J	Wang, J; Qin, TQ; Chen, JR; Li, YL; Wang, L; Huang, H; Li, J				Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Yulin; Wang, Ling; Huang, He; Li, Jing			Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Article							SERUM URIC-ACID; MUSCLE-CELL-PROLIFERATION; BLOOD-PRESSURE; PREDICTORS; CHINESE; PATHOGENESIS; ASSOCIATION; COHORT; LEVEL; BIAS	Background: Observational studies of the relationship between hyperuricemia and the incidence of hypertension are controversial. We conducted a systematic review and meta-analysis to assess the association and consistency between uric acid levels and the risk of hypertension development. Methods: We searched MEDLINE, EMBASE, CBM (Chinese Biomedicine Database) through September 2013 and reference lists of retrieved studies to identify cohort studies and nested case-control studies with uric acid levels as exposure and incident hypertension as outcome variables. Two reviewers independently extracted data and assessed study quality using Newcastle-Ottawa Scale. Extracted information included study design, population, definition of hyperuricemia and hypertension, number of incident hypertension, effect sizes, and adjusted confounders. Pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) for the association between hyperuricemia and risk of hypertension were calculated using a random-effects model. Results: We included 25 studies with 97,824 participants assessing the association between uric acid and incident hypertension in our meta-analysis. The quality of included studies is moderate to high. Random-effects meta-analysis showed that hyperuricemia was associated with a higher risk of incident hypertension, regardless of whether the effect size was adjusted or not, whether the data were categorical or continuous as 1 SD/1 mg/dl increase in uric acid level (unadjusted: RR=1.73, 95% CI 1.46 similar to 2.06 for categorical data, RR=1.22, 95% CI 1.03 similar to 1.45 for a 1 SD increase; adjusted: RR=1.48, 95% CI 1.33 similar to 1.65 for categorical data, RR=1.15, 95% CI 1.06 similar to 1.26 for a 1 mg/dl increase), and the risk is consistent in subgroup analyses and have a dose-response relationship. Conclusions: Hyperuricemia may modestly increase the risk of hypertension incidence, consistent with a dose-response relationship.	[Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Jing] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China; [Li, Yulin] Chengdu Univ, TCM, Affiliated Hosp 2, Chengdu, Peoples R China; [Wang, Ling] Mianyang Peoples Hosp, Dept Cardiol, Mianyang City, Peoples R China; [Huang, He] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University; Chengdu University; Sichuan University	Li, J (corresponding author), Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China.	lijing68@hotmail.com		Li, Jing/0000-0003-1191-9971; Norback, Dan/0000-0002-5174-6668				Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; FESSEL WJ, 1980, AM J MED, V68, P401, DOI 10.1016/0002-9343(80)90111-4; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Gaffo AL, 2013, ANN RHEUM DIS, V72, P1321, DOI 10.1136/annrheumdis-2012-201916; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HUNT SC, 1991, HYPERTENSION, V17, P969, DOI 10.1161/01.HYP.17.6.969; Imazu M, 2001, HYPERTENS RES, V24, P531, DOI 10.1291/hypres.24.531; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; KAHN HA, 1972, AM HEART J, V84, P171, DOI 10.1016/0002-8703(72)90331-6; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Mahomed F.-A., 1879, LANCET, V113, P399; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nakanishi N, 1998, J HYPERTENS, V16, P753, DOI 10.1097/00004872-199816060-00006; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; RAO GN, 1991, J BIOL CHEM, V266, P8604; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; SELBY JV, 1990, AM J EPIDEMIOL, V131, P1017, DOI 10.1093/oxfordjournals.aje.a115593; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Wells G.A., NEWCASTLE OTTAWA SCA; [吴云涛 Wu Yuntao], 2010, [中华高血压杂志, Chinese Journal of Hypertension], V18, P545; Yang T, 2012, METABOLISM, V61, P1747, DOI 10.1016/j.metabol.2012.05.006; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang H, 2001, CHIN J HYPERTENS, V9, P160; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891	46	168	190	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114259	10.1371/journal.pone.0114259	http://dx.doi.org/10.1371/journal.pone.0114259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25136984	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900134
J	You, ZQ; Chen, MX; Yang, S; Zhou, ZK; Qin, P				You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui; Qin, Ping			Childhood Adversity, Recent Life Stressors and Suicidal Behavior in Chinese College Students	PLOS ONE			English	Article							EVENTS; ABUSE; RISK; ADOLESCENCE; IDEATION; GENDER; WOMEN	Background: Although the independent effects of childhood adversities and of recent negative events on suicidality have been well-documented, the combinative role of childhood and recent adversities on risk for suicidality is still underexplored, especially in the context of Chinese culture and in consideration of specific types of negative events. Method: 5989 students, randomly sampled from six universities in central China, completed the online survey for this study. Suicidal behavior, life adversity during childhood and stressful events in recent school life were assessed with designed questionnaires. Results: Students experiencing recent stressful life events more often reported an experience of life adversity during childhood. While recent stressful life events and childhood life adversity both were associated with an increased risk for suicidal behavior, the two exposures presented conjunctively and acted interactively to increase the risk. There was noticeable variation of effects associated with specific childhood life adversities, and sexual abuse, poor parental relationship, divorce of parents and loss of a parent were among the adversities associated with the highest increased risk. Recent conflicts with classmates, poor school performance and rupture of romantic relationships were the recent school life stressors associated with the highest increased risk. Conclusions: Childhood adversity and recent school life stressors had a combinative role in predicting suicidality of young people studying in Chinese colleges. Unhappy family life during childhood and recent interpersonal conflicts in school were the most important predictors of suicidality in this population.	[You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [You, Zhiqi; Chen, Mingxi; Yang, Sen; Zhou, Zongkui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Qin, Ping] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Qin, Ping] Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway	Central China Normal University; Aarhus University; University of Oslo	Zhou, ZK (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzk@mail.ccnu.edu.cn	; Park, Cheol-Young/C-6690-2018	You, Zhiqi/0000-0002-2140-5870; Park, Cheol-Young/0000-0002-9415-9965; Yang, Soo Jin/0000-0001-7892-7648	Key Project of International Cooperation from the Chinese Ministry of Science and Technology [2010DFA31790]; Major Program of National Social Science Foundation of P.R. China [11ZD151]; Excellent doctoral dissertation cultivation grant from Central China Normal University [2013YBZD05]	Key Project of International Cooperation from the Chinese Ministry of Science and Technology; Major Program of National Social Science Foundation of P.R. China; Excellent doctoral dissertation cultivation grant from Central China Normal University	This work was funded by Key Project of International Cooperation from the Chinese Ministry of Science and Technology [project number: 2010DFA31790], Major Program of National Social Science Foundation of P.R. China [project number: 11&ZD151] and Excellent doctoral dissertation cultivation grant from Central China Normal University [project number: 2013YBZD05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman BP, 2004, DEV PSYCHOL, V40, P367, DOI 10.1037/0012-1649.40.3.367; Bedi S, 2011, SUICIDE LIFE-THREAT, V41, P406, DOI 10.1111/j.1943-278X.2011.00040.x; Buchmann AF, 2012, PRAX KINDERPSYCHOL K, V61, P32, DOI 10.13109/prkk.2012.61.1.32; Cupina D, 2009, AUSTRALAS PSYCHIATRY, V17, P233, DOI 10.1080/10398560802680746; Frederick J, 2008, CHILD FAM SOC WORK, V13, P300, DOI 10.1111/j.1365-2206.2008.00554.x; Galera C, 2008, ACTA PSYCHIAT SCAND, V118, P480, DOI 10.1111/j.1600-0447.2008.01262.x; Grover KE, 2009, J CLIN PSYCHOL, V65, P1281, DOI 10.1002/jclp.20632; Hawton K, 2001, PSYCHOL MED, V31, P827, DOI 10.1017/S0033291701003993; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; HILL EM, 1994, ETHOL SOCIOBIOL, V15, P323, DOI 10.1016/0162-3095(94)90006-X; Vazquez JJ, 2010, J COMMUNITY APPL SOC, V20, P288, DOI 10.1002/casp.1036; Kleiman EM, 2012, J AFFECT DISORDERS, V143, P236, DOI 10.1016/j.jad.2012.05.014; Kwok SYCL, 2011, NURS RES, V60, P422, DOI 10.1097/NNR.0b013e31823585d6; Moscicki Eve K., 1994, Annals of Epidemiology, V4, P152; Pedersen NL, 2010, EUR PSYCHIAT, V25, P264, DOI 10.1016/j.eurpsy.2009.12.008; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pompili M, 2009, J HEADACHE PAIN, V10, P283, DOI 10.1007/s10194-009-0134-2; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Sfoggia A, 2008, CRISIS, V29, P154, DOI 10.1027/0227-5910.29.3.154; Singh S, 2012, ASIAN J PSYCHIATR, V5, P154, DOI 10.1016/j.ajp.2012.02.024; Skopp NA, 2011, J SOC CLIN PSYCHOL, V30, P361, DOI 10.1521/jscp.2011.30.4.361; Spokas M, 2009, J TRAUMA STRESS, V22, P467, DOI 10.1002/jts.20438; Sundin M, 2011, SUBST USE MISUSE, V46, P1690, DOI 10.3109/10826084.2011.605414; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Van Heeringen K, 2000, CRISIS, V21, p192a, DOI [10.1201/b12215-7, DOI 10.1201/B12215-7]; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Violato C., 2004, INDIVID DIFFER RES, V2, P162; Wang YQ, 2012, PSYCHIAT ANN, V42, P101, DOI 10.3928/00485713-20120217-07; Yen S, 2009, ACTA PSYCHIAT SCAND, V120, P222, DOI 10.1111/j.1600-0447.2009.01366.x; Zhang J, 2006, DEATH STUD, V30, P259, DOI 10.1080/07481180500493443; Zhang J, 2012, J AFFECT DISORDERS, V140, P161, DOI 10.1016/j.jad.2012.01.010	31	37	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e86672	10.1371/journal.pone.0086672	http://dx.doi.org/10.1371/journal.pone.0086672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	25133775	Green Published, gold, Green Submitted			2022-12-27	WOS:000333678100001
J	Raizada, N; Sachdeva, KS; Chauhan, DS; Malhotra, B; Reddy, K; Dave, PV; Mundade, Y; Patel, P; Ramachandran, R; Das, R; Solanki, R; Wares, DF; Sahu, S; O'Brien, R; Paramasivan, CN; Dewan, PK				Raizada, Neeraj; Sachdeva, K. S.; Chauhan, D. S.; Malhotra, Bharti; Reddy, Kishore; Dave, P. V.; Mundade, Yamuna; Patel, Pranav; Ramachandran, Ranjani; Das, Ram; Solanki, Rajesh; Wares, Douglas Fraser; Sahu, Suvanand; O'Brien, Rick; Paramasivan, C. N.; Dewan, Puneet K.			A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens	PLOS ONE			English	Article							GENOTYPE MTBDR ASSAY; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; TREATMENT OUTCOMES; SOUTH-AFRICA; METAANALYSIS; RIFAMPIN; STRAINS; PERFORMANCE; MUTATIONS	Rifampicin (R) and isoniazid (H) are key first-line anti-tuberculosis drugs. Failure to detect resistance to these two drugs early results in treatment failure and poor clinical outcomes. The study purpose was to validate the use of the GenoType MTBDRplus line probe assay (LPA) to detect resistance to R and H in Mycobacterium tuberculosis strains directly from smearpositive sputum samples in India. Method: Smear positive sputum specimens from 320 patients were subjected to LPA and results compared against those from conventional Lowenstein Jensen (LJ) culture and drug susceptibility testing (C& DST). All specimens with discordant R DST results were subjected to either sequencing of the rpoB gene and/or repeat DST on liquid culture (MGIT 960) at a National Reference Laboratory. Results: Significantly higher proportion of interpretable results were observed with LPA compared to LJ C& DST (94% vs. 80%, p-value,0.01). A total of 248 patients had both LJ and LPA DST results available; 232 (93.5%) had concordant R DST results. Among the 16 discordant R DST results, 13 (81%) were resolved in agreement with LPA results. Final LPA performance characteristics were sensitivity 96% (CI: 90%-98%), specificity 99% (CI: 95%-99%), positive predictive value 99% (CI: 95%-99%), and negative predictive value 95% (CI: 89%-98%). The median turnaround testing time, including specimen transportation time, on LPA was 11 days as compared with 89 days for LJ C&DST. Conclusions: LPA proved highly accurate in the rapid detection of R resistance. The reduction in time to diagnosis may potentially enable earlier commencement of the appropriate drug therapy, leading to some reduction of transmission of drug-resistant strains.	[Raizada, Neeraj; Reddy, Kishore; Paramasivan, C. N.] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, K. S.] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Chauhan, D. S.; Das, Ram] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Malhotra, Bharti] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India; [Dave, P. V.; Patel, Pranav; Solanki, Rajesh] Directorate Hlth Serv, Gandhinagar, Gujarat, India; [Mundade, Yamuna] UNITAID, Geneva, Switzerland; [Ramachandran, Ranjani; Dewan, Puneet K.] WHO, New Delhi, India; [Wares, Douglas Fraser] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [O'Brien, Rick] Fdn Innovat New Diagnost FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; SMS Medical College & Hospital; World Health Organization; World Health Organization; Foundation For Innovative New Diagnostics	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com	Solanki, Dr. Rajesh/ABE-8666-2021	Solanki, Dr. Rajesh/0000-0003-3915-6064; Gray, Christen/0000-0002-9723-3032; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Chauhan, Devendra Singh/0000-0001-6519-3200	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; [Anonymous], GEN MTBDRPLUS VERS 1; [Anonymous], 2012, GUID PROGR MAN DRUG, P19; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2006, J CLIN MICROBIOL, V44, P2338, DOI 10.1128/JCM.00425-06; Evans J, 2009, J ANTIMICROB CHEMOTH, V63, P11, DOI 10.1093/jac/dkn433; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kent PT, 1985, GUIDE LEVEL 3 LAB; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Revised National tuberculosis programme, RNTCP STAT REP 2009; Srisuwanvilai LO, 2008, DIAGN MICR INFEC DIS, V61, P402, DOI 10.1016/j.diagmicrobio.2008.02.015; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; VESTAL AL, 1977, US DHEW PUBLICATION, P15; World Health Organisation, WHOHTMTB2012411	24	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88626	10.1371/journal.pone.0088626	http://dx.doi.org/10.1371/journal.pone.0088626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586360	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900035
J	Tang, YN; Li, X; Yao, YF; Ferguson, DK; Li, CS				Tang, Ye-Na; Li, Xiao; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen			Environmental Reconstruction of Tuyoq in the Fifth Century and Its Bearing on Buddhism in Turpan, Xinjiang, China	PLOS ONE			English	Article							YANGHAI TOMBS; POLLEN; L.; QUATERNARY; PLATEAU; UPLIFT; BP	The Thousand Buddha Grottoes of Tuyoq, Turpan, Xinjiang, China were once a famous Buddhist temple along the ancient Silk Road which was first constructed in the Fifth Century (A.D.). Although archaeological researches about the Grottoes have been undertaken for over a century, the ancient environment has remained enigmatic. Based on seven clay samples from the Grottoes' adobes, pollen and leaf epidermis were analyzed to decipher the vegetation and climate of Fifth Century Turpan, and the environmental landscape was reconstructed in three dimensions. The results suggest that temperate steppe vegetation dominated the Tuyoq region under a warmer and wetter environment with more moderate seasonality than today, as the ancient mean annual temperature was 15.3 degrees C, the mean annual precipitation was approximately 1000 mm and the temperature difference between coldest and warmest months was 24 degrees C using Co-existence Approach. Taken in the context of wheat and grape cultivation as shown by pollen of Vitis and leaf epidermis of Triticum, we infer that the Tuyoq region was an oasis with booming Buddhism in the Fifth Century, which was probably encouraged by a 1 degrees C warmer temperature with an abundant water supply compared to the coeval world that experienced the 1.4 k BP cooling event.	[Tang, Ye-Na; Yao, Yi-Feng; Ferguson, David Kay; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Li, Xiao] Renmin Univ China, Sch Chinese Class, Beijing, Peoples R China; [Ferguson, David Kay] Univ Vienna, Dept Paleontol, Vienna, Austria	Chinese Academy of Sciences; Institute of Botany, CAS; Renmin University of China; University of Vienna	Yao, YF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yaoyf@ibcas.ac.cn; lics@ibcas.ac.cn		Rajwa, Bartek/0000-0001-7540-8236; Bhunia, Arun/0000-0003-3640-1554; Bae, Euiwon/0000-0001-6095-3223	China National Key Basic Research Program [2014CB954201]	China National Key Basic Research Program(National Basic Research Program of China)	This research was supported by China National Key Basic Research Program (2014CB954201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdirahman H, 2009, J CHINA HYDROL, V29, P50; Andersen TS, 1972, GRANA, V12, P79, DOI 10.1080/00173137209428830; Anjum Perveen, 2006, World Applied Sciences Journal, V1, P60; [Anonymous], LAND CLIM DAT CHIN 1; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Cai LB, 1995, ACTA BOT BOREAL OCCI, V15, P323; [罗传秀 LUO Chuanxiu], 2007, [干旱区地理, Arid Land Geography], V30, P536; Chen S.L., 1993, MICROMORPHOLOGICAL A; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; Cheng J., 2006, HOLOCENE VEGETATION, P283; DRIESSEN MNBM, 1989, GRANA, V28, P115, DOI 10.1080/00173138909429962; Editorial office, 2007, CHIN CULT HERIT, P80; Editorial office, 2012, HIST REF, V22, P24; ELLIS R P, 1979, Bothalia, V12, P641; Fan ZL, 1995, ARID ZONE RES S, V12, P308; Ferguson DK, 2007, CR PALEVOL, V6, P423, DOI 10.1016/j.crpv.2007.09.018; [葛全胜 Ge Quansheng], 2002, [第四纪研究, Quaternary Sciences], V22, P166; IBCAS (Institute of Botany the Chinese Academy of Sciences), 1976, SPOR PTER PHYT SIN; IDBMC, 1983, LAND CLIM DAT CHIN 2, p[4, 126]; IDBMC (Information Department of Beijing Meteorological Center), 1983, LAND CLIM DAT CHIN 6; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 3; IDBMC (Information Department of Beijing Meteorological Center), 1984, LAND CLIM DAT CHIN 4, V4-6, P99; IDBMC (INFORMATION DEPARTMENT OF BEIJING METEOROLOGICAL CENTER), 1984, LAND CLIM DAT CHIN 5; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2011, ARCHAEOLOGY, V7, P27; JAT (Joint Archaeological Team of Research Center for Frontier Archaeology of the Institute of Archaeology Chinese Academy of Social Sciences and Academia Turfanica and Kizil Research Institute), 2012, ARCHAEOLOGY, P7; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Klementz Dmitriy A., 1899, NACHRICHTEN KAISERLI; Le Coq VA, 1913, CHOSTSCHO; Li JF, 1985, P QUAT XINJ AR AR, P1; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; LI WY, 1998, QUATERNARY VEGETATIO; Li X., 1993, ARID LAND GEOGRAPHY, V16, P63; Li XQ, 1999, ACTA BOT SIN, V41, P782; Lin M, 1996, CULT RELIC, V12, P54; Lin XL, 2008, THESIS SHANDONG NORM; Luo CX, 2008, ARID LAND GEOGR, V28, P272; Ma QingWen, 2005, Bulletin of Botanical Research, V25, P307; Ma YX, 2004, B BOT RES, V24; [毛礼米 MAO Limi], 2011, [微体古生物学报, Acta Micropalaeontologica Sinica], V28, P169; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Mokushiki K, 1999, XIYU KAO GU TU PU; Moore P.D., 1991, BLACKWELL SCI PUBLI; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; PAGE J S, 1978, Kew Bulletin, V32, P313, DOI 10.2307/4117102; Pan W, 2003, URANIUM GEOL, V19, P332; Qiu ZW, 2012, ECON BOT, V66, P255, DOI 10.1007/s12231-012-9204-5; [舒强 SHU Qiang], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P95; The editorial board of Chinese Frescoes Corpus, 1995, CORP CHIN ART CLASS; Wang FX, 1995, POLLEN FLORA CHINA; Wang S, 2000, GAOCHANG HIST TRANSP, P85; Weng Cheng-Yu, 1993, Acta Botanica Sinica, V35, P69; Wu Z. Y., 1999, SEED PLANTS CHINA; Xi YZ, 1994, YUSHANIA, V11, P119; Xie XM, 1994, J INN MONG NORM U NA, V1, P53; Yan S., 1991, ARID LAND GEOGR, V14, P1; Yan S, 1989, ARID ZONE RES, V6, P26; Yao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039780; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762; Zhong Wei, 2001, Arid Land Geography, V24, P212; Zhou XJ, 1989, J ARID REGIONS RES, V1, P9; 蔡联炳, 1996, 西北植物学报, V16, P65	67	40	43	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e86363	10.1371/journal.pone.0086363	http://dx.doi.org/10.1371/journal.pone.0086363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301BI	25136836	Green Published, gold, Green Submitted			2022-12-27	WOS:000330507300057
J	Wu, CH; Chen, LS; Yen, MF; Chiu, YH; Fann, CY; Chen, HH; Pan, SL				Wu, Chueh-Hung; Chen, Li-Sheng; Yen, Ming-Fang; Chiu, Yueh-Hsia; Fann, Ching-Yuan; Chen, Hsiu-Hsi; Pan, Shin-Liang			Does Non-Central Nervous System Tuberculosis Increase the Risk of Ischemic Stroke? A Population-Based Propensity Score-Matched Follow-Up Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; CHRONIC INFECTIONS; CIGARETTE-SMOKING; HEALTH-INSURANCE; PREVALENCE; TAIWAN; SEX; AGE	Background: Previous studies on the association between tuberculosis and the risk of developing ischemic stroke have generated inconsistent results. We therefore performed a population-based, propensity score-matched longitudinal follow-up study to investigate whether contracting non-central nervous system (CNS) tuberculosis leads to an increased risk of ischemic stroke. Methods: We used a logistic regression model that includes age, sex, pre-existing comorbidities and socioeconomic status as covariates to compute the propensity score. A total of 5804 persons with at least three ambulatory visits in 2001 with the principal diagnosis of non-CNS tuberculosis were enrolled in the tuberculosis group. The non-tuberculosis group consisted of 5804, propensity score-matched subjects without tuberculosis. The three-year ischemic stroke-free survival rates for these 2 groups were estimated using the Kaplan-Meier method. The stratified Cox proportional hazards regression was used to estimate the effect of tuberculosis on the occurrence of ischemic stroke. Results: During three-year follow-up, 176 subjects in the tuberculosis group (3.0%) and 207 in the non-tuberculosis group (3.6%) had ischemic stroke. The hazard ratio for developing ischemic stroke in the tuberculosis group was 0.92 compared to the non-tuberculosis group (95% confidence interval: 0.73-1.14, P = 0.4299). Conclusions: Non-CNS tuberculosis does not increase the risk of subsequent ischemic stroke.	[Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Li-Sheng; Yen, Ming-Fang] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Taoyuan, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Chang Gung University; Nan Kai University Technology; National Taiwan University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		Chen, Hsiu-Hsi/0000-0002-5799-6705; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; PAN, SHIN-LIANG/0000-0001-6451-4666; WU, CHUEH-HUNG/0000-0002-3979-3541	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health, Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China. This study used the complete National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The interpretation and conclusions contained in this study do not necessarily represent those of the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Asplund K, 2009, STROKE, V40, P2319, DOI 10.1161/STROKEAHA.109.547869; Byberg S, 2012, EUR RESPIR J, V40, P1289, DOI 10.1183/09031936.00039612; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAVIS PH, 1987, ANN NEUROL, V22, P319, DOI 10.1002/ana.410220307; De Silva DA, 2009, J NEUROL SCI, V285, P118, DOI 10.1016/j.jns.2009.06.013; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Espinola-Klein C, 2002, STROKE, V33, P2581, DOI 10.1161/01.STR.0000034789.82859.A4; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Giral P, 2007, ATHEROSCLEROSIS, V190, P150, DOI 10.1016/j.atherosclerosis.2006.01.008; Hagiwara Noriko, 2007, J Stroke Cerebrovasc Dis, V16, P145, DOI 10.1016/j.jstrokecerebrovasdis.2007.02.001; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 2002, STROKE, V33, P2170, DOI 10.1161/01.STR.0000027209.59821.98; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011; Parsons L.S., 2004, PERFORMING 1 N CASE; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WHO, 2009, GLOB TUB CONTR EP ST, P6; WOLF PA, 1985, STROKE, V16, P359, DOI 10.1161/01.STR.16.3.359; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e98158	10.1371/journal.pone.0098158	http://dx.doi.org/10.1371/journal.pone.0098158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25133789	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100001
J	Sun, XR; Sun, Z; Zhu, Z; Guan, HX; Zhang, JY; Zhang, YN; Xu, HM; Sun, MJ				Sun, Xuren; Sun, Zhe; Zhu, Zhi; Guan, Haixia; Zhang, Junyan; Zhang, Yining; Xu, Huimian; Sun, Mingjun			Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; LDH-A; CELLS; GROWTH	Introduction: LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and antiapoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC. Methods: We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined. Results: There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95% CI 1.375-2.433, P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells. Conclusions: Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.	[Sun, Xuren; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Sun, Zhe; Zhu, Zhi; Zhang, Junyan; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning Provin, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Yining; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	smjmw@sina.com		Pan, Chen-Wei/0000-0003-3362-4613	Liaoning Province Science and Technology Department [2007225017, 2009225011-2, 2011415052]; Science and Technology projects in Shenyang City [F11-264-1-19]	Liaoning Province Science and Technology Department; Science and Technology projects in Shenyang City	This study was supported by grants from the research projects in Liaoning Province Science and Technology Department (No. 2007225017, No. 2009225011-2 and No. 2011415052) and Science and Technology projects in Shenyang City (No. F11-264-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yao F, 2013, TUMOR BIOL, V34, P25, DOI 10.1007/s13277-012-0506-0; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	18	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91068	10.1371/journal.pone.0091068	http://dx.doi.org/10.1371/journal.pone.0091068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24788769	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800094
